1	ANNUAL	JJ	SET	annual	amod	2	SENT_1	[p1l806t253r1075b304],
2	REVIEWS	NNS	O	review	_	0	SENT_1	[p1l807t324r1075b375],
3	FU	NN	O	fu	nn	4	SENT_1	[p1l1113t255r1272b372],
4	rth	NN	O	rth	dep	2	SENT_1	[p1l1299t249r1508b372],
5	e	SYM	O	e	dep	6	SENT_1	[p1l1531t285r1606b372],
6	r	NN	O	r	rcmod	4	SENT_1	[p1l1628t285r1675b371],

1	Click	VB	O	click	_	0	SENT_2	[p1l806t447r961b505],
2	here	RB	O	here	advmod	1	SENT_2	[p1l982t447r1124b505],
3	for	IN	O	for	_	0	SENT_2	[p1l1144t446r1228b505],
4	quick	JJ	O	quick	amod	5	SENT_2	[p1l1249t447r1417b519],
5	links	NNS	O	link	prep_for	1	SENT_2	[p1l1440t447r1571b504],
6	to	TO	O	to	_	0	SENT_2	[p1l1591t456r1654b505],
7	Annual	JJ	SET	annual	amod	8	SENT_2	[p1l806t542r1025b600],
8	Reviews	NNS	MISC	review	prep_to	5	SENT_2	[p1l1054t545r1303b600],
9	content	JJ	O	content	dep	10	SENT_2	[p1l1326t552r1572b600],
10	online	NN	O	online	amod	8	SENT_2	[p1l1594t542r1802b609],
11	,	,	O	,	_	0	SENT_2	[p1l1594t542r1802b609],
12	including	VBG	O	include	partmod	8	SENT_2	[p1l809t638r1115b712],
13	:	:	O	:	_	0	SENT_2	[p1l809t638r1115b712],

1	-	:	O	-	_	0	SENT_3	[p1l792t797r806b811],
2	Other	JJ	O	other	amod	3	SENT_3	[p1l829t768r1010b826],
3	articles	NNS	O	article	_	0	SENT_3	[p1l1031t768r1248b826],
4	in	IN	O	in	_	0	SENT_3	[p1l1274t772r1322b825],
5	this	DT	O	this	det	6	SENT_3	[p1l1346t768r1455b826],
6	volume	NN	O	volume	prep_in	3	SENT_3	[p1l1477t768r1714b826],
7	-	:	O	-	_	0	SENT_3	[p1l792t866r938b937],
8	Top	JJ	O	top	nsubj	9	SENT_3	[p1l792t866r938b937],
9	cited	VBD	O	cite	dep	6	SENT_3	[p1l961t864r1111b921],
10	articles	NNS	O	article	dobj	9	SENT_3	[p1l1136t864r1354b921],
11	-	:	O	-	_	0	SENT_3	[p1l792t962r938b1032],
12	Top	JJ	O	top	dep	6	SENT_3	[p1l792t962r938b1032],
13	downloaded	VBN	O	download	partmod	12	SENT_3	[p1l961t959r1358b1017],
14	articles	NNS	O	article	dobj	13	SENT_3	[p1l1384t959r1601b1017],
15	-	:	O	-	_	0	SENT_3	[p1l792t1083r806b1097],
16	Our	PRP$	O	we	poss	18	SENT_3	[p1l829t1056r944b1112],
17	comprehensive	JJ	O	comprehensive	amod	18	SENT_3	[p1l965t1054r1451b1127],
18	search	NN	O	search	dep	14	SENT_3	[p1l1475t1054r1672b1112],

1	Annu	NNP	PERSON	Annu	_	0	SENT_4	[p1l509t2884r710b2943],
2	.	.	O	.	_	0	SENT_4	[p1l509t2884r710b2943],

1	Rev.	NNP	O	Rev.	nn	2	SENT_5	[p1l737t2885r880b2943],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_5	[p1l906t2882r1281b2943],
3	.	.	O	.	_	0	SENT_5	[p1l906t2882r1281b2943],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_6	[p1l1306t2882r1583b2943],
2	.	.	O	.	_	0	SENT_6	[p1l1306t2882r1583b2943],

1	2	CD	NUMBER	2	num	2	SENT_7	[p1l1611t2886r1642b2942],
2	012	CD	NUMBER	012	_	0	SENT_7	[p1l1653t2886r1789b2943],
3	.	.	O	.	_	0	SENT_7	[p1l1653t2886r1789b2943],

1	5	CD	NUMBER	5	_	0	SENT_8	[p1l1819t2885r1849b2944],
2	2	CD	NUMBER	2	number	3	SENT_8	[p1l1858t2886r1889b2942],
3	:249	CD	NUMBER	:249	num	4	SENT_8	[p1l1902t2884r2116b2944],
4	—	NN	O	—	dep	1	SENT_8	[p1l1902t2884r2116b2944],
5	7	CD	NUMBER	7	number	6	SENT_8	[p1l1902t2884r2116b2944],
6	3	CD	NUMBER	3	amod	4	SENT_8	[p1l2127t2886r2153b2944],

1	2012.5	CD	NUMBER	2012.5	_	0	SENT_9	[p1l6t2862r70b3105],
2	2:249	CD	NUMBER	2:249	number	3	SENT_9	[p1l6t2423r70b2810],
3	-273	CD	NUMBER	-273	num	1	SENT_9	[p1l6t2423r70b2810],
4	.	.	O	.	_	0	SENT_9	[p1l6t2423r70b2810],

1	Downloaded	VBN	O	download	_	0	SENT_10	[p1l6t1932r70b2393],
2	from	IN	O	from	_	0	SENT_10	[p1l6t1731r69b1906],
3	www.annualreViews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_10	[p1l6t822r88b1707],
4	onsin	NN	O	onsin	nn	6	SENT_10	[p1l96t2939r160b3132],
5	—	CD	NUMBER	—	num	6	SENT_10	[p1l135t2889r141b2912],
6	Madison	NNP	O	Madison	dobj	1	SENT_10	[p1l96t2501r160b2818],
7	on	IN	O	on	_	0	SENT_10	[p1l116t2389r160b2475],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_10	[p1l96t2026r160b2363],
9	.	.	O	.	_	0	SENT_10	[p1l96t2026r160b2363],

1	For	IN	O	for	_	0	SENT_11	[p1l98t1870r160b1996],
2	personal	JJ	O	personal	amod	3	SENT_11	[p1l97t1541r179b1848],
3	use	NN	O	use	pobj	1	SENT_11	[p1l116t1397r160b1516],
4	only	RB	O	only	advmod	3	SENT_11	[p1l97t1194r179b1370],
5	.	.	O	.	_	0	SENT_11	[p1l97t1194r179b1370],

1	First	JJ	ORDINAL	first	advmod	2	SENT_12	[p1l512t3054r668b3113],
2	published	VBN	O	publish	_	0	SENT_12	[p1l689t3051r1011b3132],
3	online	NN	O	online	dep	2	SENT_12	[p1l1035t3051r1242b3113],
4	as	IN	O	as	_	0	SENT_12	[p1l1267t3075r1327b3113],
5	a	DT	O	a	det	6	SENT_12	[p1l1352t3075r1383b3113],
6	Review	NN	O	review	prep_as	2	SENT_12	[p1l1407t3054r1650b3113],
7	in	IN	O	in	_	0	SENT_12	[p1l1670t3055r1735b3112],
8	Advance	NNP	O	Advance	prep_in	6	SENT_12	[p1l1755t3051r2037b3113],
9	on	IN	O	on	prep	2	SENT_12	[p1l2062t3074r2145b3113],

1	September	NNP	DATE	September	_	0	SENT_13	[p2l514t26r873b107],
2	19	CD	DATE	19	num	1	SENT_13	[p2l903t31r992b102],
3	,	,	DATE	,	_	0	SENT_13	[p2l903t31r992b102],
4	2011	CD	DATE	2011	appos	1	SENT_13	[p2l1019t31r1172b88],

1	The	DT	O	the	det	3	SENT_14	[p2l509t197r651b257],
2	Annual	JJ	SET	annual	amod	3	SENT_14	[p2l667t198r912b257],
3	Review	NN	O	review	nsubj	8	SENT_14	[p2l927t200r1147b257],
4	of	IN	O	of	_	0	SENT_14	[p2l1173t197r1241b278],
5	P/mrimzcology	NN	O	p/mrimzcology	prep_of	3	SENT_14	[p2l1245t198r1675b279],
6	and	CC	O	and	_	0	SENT_14	[p2l1695t198r1814b257],
7	Toxicology	NN	O	toxicology	prep_of	3	SENT_14	[p2l1836t198r2150b279],
8	is	VBZ	O	be	_	0	SENT_14	[p2l511t302r559b360],
9	online	NN	O	online	dep	8	SENT_14	[p2l584t298r791b360],
10	at	IN	O	at	_	0	SENT_14	[p2l817t316r876b360],
11	pharmtox.annualreviews.org	NN	O	pharmtox.annualreviews.org	prep_at	8	SENT_14	[p2l897t298r1846b380],

1	This	DT	O	this	det	2	SENT_15	[p2l509t468r665b530],
2	article	NN	O	article	_	0	SENT_15	[p2l690t468r944b530],
3	’s	POS	O	’s	possessive	2	SENT_15	[p2l690t468r944b530],
4	doi	FW	O	doi	dep	2	SENT_15	[p2l970t468r1089b530],
5	:	:	O	:	_	0	SENT_15	[p2l970t468r1089b530],
6	10.1	CD	NUMBER	10.1	number	7	SENT_15	[p2l520t573r646b631],
7	146	CD	NUMBER	146	dep	4	SENT_15	[p2l663t573r808b632],
8	/	:	O	/	punct	12	SENT_15	[p2l663t573r808b632],
9	annurev	NN	O	annurev	nn	12	SENT_15	[p2l809t570r1499b651],
10	—	NN	O	—	nn	12	SENT_15	[p2l809t570r1499b651],
11	pharmtox	NN	O	pharmtox	nn	12	SENT_15	[p2l809t570r1499b651],
12	—	NN	O	—	dep	7	SENT_15	[p2l809t570r1499b651],
13	o	NN	O	o	dep	12	SENT_15	[p2l809t570r1499b651],
14	1	CD	NUMBER	1	num	13	SENT_15	[p2l1511t574r1534b631],
15	061	CD	NUMBER	061	number	16	SENT_15	[p2l1546t573r1657b631],
16	1	CD	NUMBER	1	num	17	SENT_15	[p2l1676t573r1936b632],
17	—	NN	O	—	dep	13	SENT_15	[p2l1676t573r1936b632],
18	13452	CD	NUMBER	13452	num	19	SENT_15	[p2l1676t573r1936b632],
19	9	CD	NUMBER	9	dep	2	SENT_15	[p2l1947t574r1983b632],

1	by	IN	O	by	_	0	SENT_16	[p2l96t724r179b813],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_16	[p2l96t317r179b699],
3	of	IN	ORGANIZATION	of	_	0	SENT_16	[p2l96t212r160b291],
4	Wise	NNP	ORGANIZATION	Wise	prep_of	2	SENT_16	[p2l96t10r160b195],

1	Copyright	NN	O	copyright	_	0	SENT_17	[p2l513t739r858b822],
2	©	CD	NUMBER	©	num	3	SENT_17	[p2l882t742r954b817],
3	2012	CD	DATE	2012	dep	1	SENT_17	[p2l980t744r1135b801],
4	by	IN	O	by	_	0	SENT_17	[p2l1165t739r1246b822],
5	Annual	JJ	SET	annual	amod	6	SENT_17	[p2l1263t739r1503b801],
6	Reviews	NNS	O	review	prep_by	3	SENT_17	[p2l1528t742r1814b801],
7	.	.	O	.	_	0	SENT_17	[p2l1528t742r1814b801],

1	All	DT	O	all	det	2	SENT_18	[p2l509t841r606b902],
2	rights	NNS	O	rights	nsubj	3	SENT_18	[p2l629t841r819b923],
3	reserved	VBD	O	reserve	_	0	SENT_18	[p2l843t841r1120b903],

1	0362-1642/12	CD	DURATION	0362-1642/12	_	0	SENT_19	[p2l513t1009r1593b1077],
2	/	:	O	/	punct	1	SENT_19	[p2l513t1009r1593b1077],
3	0210	CD	DATE	0210	dep	1	SENT_19	[p2l513t1009r1593b1077],
4	.	.	O	.	_	0	SENT_19	[p2l513t1009r1593b1077],

1	—	NN	O	—	_	0	SENT_20	[p2l513t1009r1593b1077],
2	.	.	O	.	_	0	SENT_20	[p2l513t1009r1593b1077],

1	O249	CD	NUMBER	o249	_	0	SENT_21	[p2l513t1009r1593b1077],
2	$	$	MONEY	$	dep	1	SENT_21	[p2l513t1009r1593b1077],
3	20.00	CD	MONEY	20.00	num	2	SENT_21	[p2l513t1009r1593b1077],

1	Annu	NNP	PERSON	Annu	_	0	SENT_22	[p2l6t963r70b1178],
2	.	.	O	.	_	0	SENT_22	[p2l6t963r70b1178],

1	Rev.	NNP	O	Rev.	nn	2	SENT_23	[p2l7t771r70b933],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_23	[p2l6t337r70b741],
3	.	.	O	.	_	0	SENT_23	[p2l6t337r70b741],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_24	[p2l6t9r70b307],
2	.	.	O	.	_	0	SENT_24	[p2l6t9r70b307],

1	Drug	NN	O	drug	nn	2	SENT_25	[p2l15t1317r369b1471],
2	Transporters	NNS	O	transporter	_	0	SENT_25	[p2l409t1313r1280b1470],
3	in	IN	O	in	_	0	SENT_25	[p2l1329t1317r1456b1429],
4	Drug	NN	O	drug	nn	5	SENT_25	[p2l1505t1317r1859b1471],
5	Efficacy	NN	O	efficacy	prep_in	2	SENT_25	[p2l13t1504r539b1664],
6	and	CC	O	and	_	0	SENT_25	[p2l583t1502r815b1623],
7	Toxicity	NN	O	toxicity	prep_in	2	SENT_25	[p2l859t1506r1427b1664],

1	M.K.	NNP	PERSON	M.K.	nn	2	SENT_26	[p2l8t1795r205b1861],
2	DeGorter	NNP	PERSON	DeGorter	_	0	SENT_26	[p2l238t1784r665b1876],
3	,1	CD	NUMBER	,1	num	5	SENT_26	[p2l238t1784r665b1876],
4	C.Q.	NNP	O	C.Q.	nn	5	SENT_26	[p2l703t1794r885b1874],
5	Xia	NNP	O	Xia	dep	2	SENT_26	[p2l913t1784r1093b1876],
6	,2	CD	NUMBER	,2	num	7	SENT_26	[p2l913t1784r1093b1876],
7	JJ	NN	O	jj	dep	5	SENT_26	[p2l1117t1795r1234b1879],
8	.	.	O	.	_	0	SENT_26	[p2l1117t1795r1234b1879],

1	Yang	NNP	PERSON	Yang	nn	2	SENT_27	[p2l1261t1784r1509b1884],
2	}	NNP	O	}	_	0	SENT_27	[p2l1261t1784r1509b1884],
3	and	CC	O	and	_	0	SENT_27	[p2l1544t1791r1678b1861],
4	R.B.	NNP	PERSON	R.B.	nn	5	SENT_27	[p2l1706t1795r1866b1861],
5	Kiml	NNP	PERSON	Kiml	conj_and	2	SENT_27	[p2l1897t1784r2088b1860],
6	1Division	NN	O	1division	dep	2	SENT_27	[p2l14t1941r221b1988],
7	of	IN	O	of	_	0	SENT_27	[p2l236t1947r284b1988],
8	Clinical	JJ	O	clinical	amod	9	SENT_27	[p2l295t1946r465b1988],
9	Pharmacology	NN	O	pharmacology	prep_of	6	SENT_27	[p2l480t1946r811b2001],
10	,	,	O	,	_	0	SENT_27	[p2l480t1946r811b2001],
11	University	NNP	ORGANIZATION	University	appos	9	SENT_27	[p2l827t1949r1062b2001],
12	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l1075t1947r1123b1988],
13	Western	NNP	ORGANIZATION	Western	nn	14	SENT_27	[p2l1131t1949r1323b1988],
14	Ontario	NNP	ORGANIZATION	Ontario	prep_of	11	SENT_27	[p2l1339t1948r1524b1997],
15	,	,	O	,	_	0	SENT_27	[p2l1339t1948r1524b1997],
16	London	NNP	LOCATION	London	prep_of	11	SENT_27	[p2l1541t1946r1730b1997],
17	,	,	O	,	_	0	SENT_27	[p2l1541t1946r1730b1997],
18	Canada	NNP	LOCATION	Canada	nn	19	SENT_27	[p2l1748t1946r1913b1988],
19	N6A	NNP	O	N6A	prep_of	11	SENT_27	[p2l1926t1948r2036b1988],
20	5A5	NN	O	5a5	dep	19	SENT_27	[p2l2051t1948r2148b1997],
21	;	:	O	;	_	0	SENT_27	[p2l2051t1948r2148b1997],
22	email	NN	O	email	conj_and	14	SENT_27	[p2l11t2013r140b2054],
23	:	:	O	:	_	0	SENT_27	[p2l11t2013r140b2054],
24	Richard.Kim@lhsc.on.ca	NN	O	richard.kim@lhsc.on.ca	nn	25	SENT_27	[p2l159t2013r705b2054],
25	2Department	NN	O	2department	conj_and	14	SENT_27	[p2l10t2072r306b2132],
26	of	IN	O	of	_	0	SENT_27	[p2l321t2078r369b2119],
27	Drug	NN	MISC	drug	nn	28	SENT_27	[p2l379t2080r498b2133],
28	Metabolism	NN	MISC	metabolism	prep_of	25	SENT_27	[p2l510t2078r775b2119],
29	and	CC	O	and	_	0	SENT_27	[p2l791t2078r869b2119],
30	Pharmacokinetics	NNS	O	pharmacokinetic	conj_and	14	SENT_27	[p2l885t2078r1289b2128],
31	,	,	O	,	_	0	SENT_27	[p2l885t2078r1289b2128],
32	Millennium	NNP	ORGANIZATION	Millennium	nn	39	SENT_27	[p2l1305t2078r1569b2119],
33	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	39	SENT_27	[p2l1584t2078r1944b2119],
34	Inc.	NNP	ORGANIZATION	Inc.	nn	39	SENT_27	[p2l1960t2080r2055b2128],
35	,	,	O	,	_	0	SENT_27	[p2l1960t2080r2055b2128],
36	Cambridge	NNP	LOCATION	Cambridge	appos	39	SENT_27	[p2l11t2145r270b2199],
37	,	,	O	,	_	0	SENT_27	[p2l11t2145r270b2199],
38	Massachusetts	NNP	LOCATION	Massachusetts	appos	39	SENT_27	[p2l286t2145r601b2186],
39	02	NN	NUMBER	02	appos	30	SENT_27	[p2l618t2148r665b2186],
40	139	CD	NUMBER	139	num	39	SENT_27	[p2l677t2148r751b2186],

1	Keywords	NNPS	O	Keywords	_	0	SENT_28	[p2l10t2335r351b2413],
2	ATP	NN	O	atp	nn	7	SENT_28	[p2l8t2431r361b2484],
3	—	NN	O	—	nn	7	SENT_28	[p2l8t2431r361b2484],
4	bindin	NN	O	bindin	nn	7	SENT_28	[p2l8t2431r361b2484],
5	cassette	NN	O	cassette	nn	7	SENT_28	[p2l416t2446r630b2484],
6	trans	JJ	O	trans	amod	7	SENT_28	[p2l651t2446r789b2484],
7	orters	NNS	O	orter	nsubj	8	SENT_28	[p2l829t2446r993b2484],
8	solute	VBP	O	solute	rcmod	1	SENT_28	[p2l1031t2431r1198b2484],
9	carrier	NN	O	carrier	nn	11	SENT_28	[p2l1220t2434r1406b2484],
10	trans	JJ	O	trans	amod	11	SENT_28	[p2l1426t2446r1564b2484],
11	orters	NNS	O	orter	dobj	8	SENT_28	[p2l1604t2446r1784b2496],
12	,	,	O	,	_	0	SENT_28	[p2l1604t2446r1784b2496],

1	g	NN	O	g	nn	2	SENT_29	[p2l364t2452r397b2502],
2	P	NN	O	p	_	0	SENT_29	[p2l792t2451r825b2501],
3	2	CD	NUMBER	2	num	4	SENT_29	[p2l999t2475r1009b2496],
4	P	NN	O	p	dep	2	SENT_29	[p2l1566t2451r1600b2501],

1	pharmacokinetics	NNS	O	pharmacokinetic	nn	5	SENT_30	[p2l10t2522r524b2591],
2	,	,	O	,	_	0	SENT_30	[p2l10t2522r524b2591],
3	pharmacogenetics	NNS	O	pharmacogenetic	dep	5	SENT_30	[p2l546t2522r1074b2592],
4	,	,	O	,	_	0	SENT_30	[p2l546t2522r1074b2592],
5	drug	NN	O	drug	_	0	SENT_30	[p2l1098t2522r1390b2592],
6	—	CD	NUMBER	—	num	8	SENT_30	[p2l1098t2522r1390b2592],
7	drug	NN	O	drug	nn	8	SENT_30	[p2l1098t2522r1390b2592],
8	interactions	NNS	O	interaction	dep	5	SENT_30	[p2l1408t2525r1758b2586],
9	,	,	O	,	_	0	SENT_30	[p2l1408t2525r1758b2586],
10	transporter	NN	O	transporter	nn	12	SENT_30	[p2l1781t2537r2099b2591],
11	knockout	NN	O	knockout	nn	12	SENT_30	[p2l10t2612r277b2664],
12	mice	NNS	O	mouse	appos	8	SENT_30	[p2l294t2615r428b2664],

1	Abstract	JJ	O	abstract	amod	3	SENT_31	[p2l7t2755r298b2814],
2	Drug	NN	O	drug	nn	3	SENT_31	[p2l11t2868r164b2935],
3	transporters	NNS	O	transporter	nsubj	6	SENT_31	[p2l180t2880r522b2935],
4	are	VBP	O	be	cop	6	SENT_31	[p2l542t2885r626b2918],
5	now	RB	DATE	now	advmod	6	SENT_31	[p2l644t2885r766b2918],
6	widely	RB	O	widely	_	0	SENT_31	[p2l780t2865r967b2935],
7	acknowledged	VBD	O	acknowledge	ccomp	6	SENT_31	[p2l984t2865r1385b2935],
8	as	RB	O	as	advmod	9	SENT_31	[p2l1404t2886r1455b2918],
9	important	JJ	O	important	amod	10	SENT_31	[p2l1473t2868r1760b2935],
10	determinants	NNS	O	determinant	dobj	7	SENT_31	[p2l1778t2865r2149b2918],
11	governing	VBG	O	govern	xcomp	7	SENT_31	[p2l11t2958r299b3025],
12	drug	NN	O	drug	nn	13	SENT_31	[p2l327t2955r459b3025],
13	absorption	NN	O	absorption	dobj	11	SENT_31	[p2l486t2955r803b3024],
14	,	,	O	,	_	0	SENT_31	[p2l486t2955r803b3024],
15	excretion	NN	O	excretion	appos	13	SENT_31	[p2l834t2958r1110b3019],
16	,	,	O	,	_	0	SENT_31	[p2l834t2958r1110b3019],
17	and	CC	O	and	_	0	SENT_31	[p2l1141t2955r1256b3019],
18	,	,	O	,	_	0	SENT_31	[p2l1141t2955r1256b3019],
19	in	IN	O	in	conj_and	13	SENT_31	[p2l1286t2958r1341b3007],
20	many	JJ	O	many	amod	21	SENT_31	[p2l1368t2975r1526b3025],
21	cases	NNS	O	case	pobj	19	SENT_31	[p2l1551t2975r1704b3019],
22	,	,	O	,	_	0	SENT_31	[p2l1551t2975r1704b3019],
23	extent	NN	O	extent	appos	21	SENT_31	[p2l1736t2970r1909b3008],
24	of	IN	O	of	_	0	SENT_31	[p2l1936t2955r1998b3008],
25	drug	NN	O	drug	nn	26	SENT_31	[p2l2019t2955r2151b3025],
26	entry	NN	O	entry	prep_of	23	SENT_31	[p2l12t3060r161b3116],
27	into	IN	O	into	_	0	SENT_31	[p2l185t3048r297b3098],
28	target	NN	O	target	nn	29	SENT_31	[p2l325t3060r492b3116],
29	organs	NNS	O	organ	prep_into	11	SENT_31	[p2l518t3065r720b3116],
30	.	.	O	.	_	0	SENT_31	[p2l518t3065r720b3116],

1	There	EX	O	there	expl	2	SENT_32	[p2l748t3046r926b3098],
2	is	VBZ	O	be	_	0	SENT_32	[p2l953t3048r994b3098],
3	also	RB	O	also	advmod	2	SENT_32	[p2l1023t3045r1129b3098],
4	a	DT	O	a	det	6	SENT_32	[p2l1158t3066r1185b3098],
5	greater	JJR	O	greater	amod	6	SENT_32	[p2l1213t3060r1413b3116],
6	appreciation	NN	O	appreciation	nsubj	2	SENT_32	[p2l1440t3048r1791b3115],
7	that	WDT	O	that	nsubj	8	SENT_32	[p2l1819t3046r1930b3098],
8	altered	VBD	O	alter	rcmod	6	SENT_32	[p2l1956t3045r2149b3098],
9	drug	NN	O	drug	nn	11	SENT_32	[p2l12t3135r144b3205],
10	transporter	NN	O	transporter	nn	11	SENT_32	[p2l171t3150r489b3204],
11	function	NN	O	function	nsubj	31	SENT_32	[p2l517t3135r769b3199],
12	,	,	O	,	_	0	SENT_32	[p2l517t3135r769b3199],
13	whether	IN	O	whether	dep	11	SENT_32	[p2l798t3135r1033b3188],
14	due	JJ	O	due	_	0	SENT_32	[p2l1061t3135r1161b3188],
15	to	TO	O	to	_	0	SENT_32	[p2l1190t3150r1245b3188],
16	genetic	JJ	O	genetic	amod	17	SENT_32	[p2l1275t3138r1479b3205],
17	polymorphisms	NNS	O	polymorphism	prep_due_to	11	SENT_32	[p2l1506t3135r1961b3205],
18	,	,	O	,	_	0	SENT_32	[p2l1506t3135r1961b3205],
19	drugdrug	NN	O	drugdrug	nn	20	SENT_32	[p2l1993t3135r2148b3205, p2l12t3209r144b3279],
20	interactions	NNS	O	interaction	prep_due_to	11	SENT_32	[p2l159t3212r509b3273],
21	,	,	O	,	_	0	SENT_32	[p2l159t3212r509b3273],
22	or	CC	O	or	_	0	SENT_32	[p2l531t3229r591b3261],
23	environmental	JJ	O	environmental	amod	24	SENT_32	[p2l610t3209r1022b3261],
24	factors	NNS	O	factor	prep_due_to	11	SENT_32	[p2l1040t3209r1228b3261],
25	such	JJ	O	such	_	0	SENT_32	[p2l1247t3209r1374b3261],
26	as	IN	O	as	_	0	SENT_32	[p2l1392t3229r1443b3261],
27	dietary	JJ	O	dietary	amod	28	SENT_32	[p2l1464t3209r1661b3279],
28	constituents	NNS	O	constituent	prep_such_as	24	SENT_32	[p2l1677t3212r2034b3273],
29	,	,	O	,	_	0	SENT_32	[p2l1677t3212r2034b3273],
30	can	MD	O	can	aux	31	SENT_32	[p2l2055t3228r2150b3261],
31	result	VB	O	result	ccomp	8	SENT_32	[p2l10t3299r170b3352],
32	in	IN	O	in	_	0	SENT_32	[p2l194t3302r249b3351],
33	unexpected	JJ	O	unexpected	amod	34	SENT_32	[p2l273t3299r595b3369],
34	toxicity	NN	O	toxicity	prep_in	31	SENT_32	[p2l621t3302r845b3369],
35	.	.	O	.	_	0	SENT_32	[p2l621t3302r845b3369],

1	Such	JJ	O	such	amod	2	SENT_33	[p2l876t3299r1014b3352],
2	effects	NNS	O	effect	nsubj	6	SENT_33	[p2l1040t3300r1215b3352],
3	are	VBP	O	be	cop	6	SENT_33	[p2l1243t3319r1327b3352],
4	in	IN	O	in	_	0	SENT_33	[p2l1353t3302r1408b3351],
5	part	NN	O	part	prep_in	6	SENT_33	[p2l1433t3314r1549b3369],
6	due	JJ	O	due	_	0	SENT_33	[p2l1574t3299r1673b3352],
7	to	TO	O	to	_	0	SENT_33	[p2l1700t3314r1756b3352],
8	the	DT	O	the	det	9	SENT_33	[p2l1783t3299r1871b3352],
9	interplay	NN	O	interplay	prep_to	6	SENT_33	[p2l1897t3299r2152b3369],
10	between	IN	O	between	_	0	SENT_33	[p2l10t3373r246b3426],
11	various	JJ	O	various	amod	12	SENT_33	[p2l265t3376r468b3426],
12	uptake	NN	O	uptake	prep_between	9	SENT_33	[p2l489t3373r678b3442],
13	and	CC	O	and	_	0	SENT_33	[p2l701t3373r801b3426],
14	efﬂux	NN	O	efﬂux	nn	15	SENT_33	[p2l824t3373r976b3426],
15	transporters	NNS	O	transporter	prep_between	9	SENT_33	[p2l996t3388r1338b3442],
16	with	IN	O	with	_	0	SENT_33	[p2l1358t3373r1485b3426],
17	overlapping	VBG	O	overlap	amod	19	SENT_33	[p2l1507t3373r1843b3443],
18	functional	JJ	O	functional	amod	19	SENT_33	[p2l1863t3373r2150b3426],
19	capabilities	NNS	O	capability	prep_with	12	SENT_33	[p2l11t3447r324b3516],
20	that	WDT	O	that	nsubj	22	SENT_33	[p2l351t3447r463b3499],
21	can	MD	O	can	aux	22	SENT_33	[p2l487t3467r582b3499],
22	manifest	VB	O	manifest	rcmod	19	SENT_33	[p2l607t3447r849b3499],
23	as	IN	O	as	_	0	SENT_33	[p2l874t3467r925b3499],
24	marked	JJ	O	marked	amod	26	SENT_33	[p2l951t3447r1163b3499],
25	interindividual	JJ	O	interindividual	amod	26	SENT_33	[p2l1188t3447r1606b3499],
26	variability	NN	O	variability	prep_as	22	SENT_33	[p2l1629t3447r1916b3517],
27	in	IN	O	in	_	0	SENT_33	[p2l1938t3450r1993b3499],
28	drug	NN	O	drug	nn	29	SENT_33	[p2l2020t3447r2151b3517],
29	disposition	NN	O	disposition	prep_in	26	SENT_33	[p2l12t3521r320b3591],
30	in	FW	O	in	prep	29	SENT_33	[p2l339t3524r394b3573],
31	vivo	FW	O	vivo	pobj	30	SENT_33	[p2l411t3524r544b3574],
32	.	.	O	.	_	0	SENT_33	[p2l411t3524r544b3574],

1	Here	RB	O	here	advmod	3	SENT_34	[p2l566t3524r711b3574],
2	we	PRP	O	we	nsubj	3	SENT_34	[p2l730t3542r808b3574],
3	review	VBP	O	review	_	0	SENT_34	[p2l828t3524r1014b3574],
4	transporters	NNS	O	transporter	nsubj	18	SENT_34	[p2l1033t3536r1375b3591],
5	of	IN	O	of	_	0	SENT_34	[p2l1396t3522r1458b3574],
6	the	DT	O	the	det	11	SENT_34	[p2l1471t3521r1559b3574],
7	solute	JJ	O	solute	amod	11	SENT_34	[p2l1580t3521r1747b3574],
8	carrier	NN	O	carrier	nn	11	SENT_34	[p2l1768t3524r1955b3574],
9	(	CD	NUMBER	(	num	11	SENT_34	[p2l1975t3523r2148b3587],
10	SLC	NN	O	slc	nn	11	SENT_34	[p2l1975t3523r2148b3587],
11	)	NN	O	)	prep_of	4	SENT_34	[p2l1975t3523r2148b3587],
12	and	CC	O	and	_	0	SENT_34	[p2l11t3611r112b3664],
13	ATP-binding	JJ	O	atp-binding	amod	14	SENT_34	[p2l136t3611r525b3681],
14	cassette	NN	O	cassette	prep_of	4	SENT_34	[p2l550t3626r764b3664],
15	(	CD	NUMBER	(	num	18	SENT_34	[p2l792t3613r970b3677],
16	ABC	NNP	ORGANIZATION	ABC	nn	18	SENT_34	[p2l792t3613r970b3677],
17	)	CD	NUMBER	)	num	18	SENT_34	[p2l792t3613r970b3677],
18	superfamilies	NNS	O	superfamily	xcomp	3	SENT_34	[p2l998t3611r1370b3680],
19	considered	VBN	O	consider	partmod	18	SENT_34	[p2l1398t3611r1703b3664],
20	to	TO	O	to	aux	21	SENT_34	[p2l1730t3626r1786b3664],
21	be	VB	O	be	xcomp	19	SENT_34	[p2l1812t3611r1877b3664],
22	of	IN	O	of	_	0	SENT_34	[p2l1905t3611r1967b3664],
23	major	JJ	O	major	amod	24	SENT_34	[p2l1985t3614r2150b3681],
24	importance	NN	O	importance	prep_of	21	SENT_34	[p2l10t3704r333b3771],
25	in	IN	O	in	_	0	SENT_34	[p2l353t3704r409b3753],
26	drug	NN	O	drug	nn	27	SENT_34	[p2l430t3701r562b3772],
27	therapy	NN	O	therapy	prep_in	24	SENT_34	[p2l582t3702r798b3772],
28	and	CC	O	and	_	0	SENT_34	[p2l817t3701r917b3754],
29	outline	VB	O	outline	conj_and	21	SENT_34	[p2l939t3702r1137b3754],
30	how	WRB	O	how	advmod	31	SENT_34	[p2l1157t3701r1279b3754],
31	understanding	VBG	O	understand	ccomp	29	SENT_34	[p2l1297t3701r1708b3772],
32	the	DT	O	the	det	33	SENT_34	[p2l1727t3701r1815b3754],
33	expression	NN	O	expression	dobj	31	SENT_34	[p2l1838t3704r2147b3771],
34	,	,	O	,	_	0	SENT_34	[p2l1838t3704r2147b3771],

1	function	NN	O	function	nsubj	25	SENT_35	[p3l11t9r263b72],
2	,	,	O	,	_	0	SENT_35	[p3l11t9r263b72],
3	and	CC	O	and	_	0	SENT_35	[p3l285t8r385b61],
4	genetic	JJ	O	genetic	amod	5	SENT_35	[p3l404t11r607b78],
5	variation	NN	O	variation	conj_and	1	SENT_35	[p3l622t11r874b61],
6	in	IN	O	in	_	0	SENT_35	[p3l890t11r946b60],
7	such	JJ	O	such	amod	9	SENT_35	[p3l963t8r1090b61],
8	drug	NN	O	drug	nn	9	SENT_35	[p3l1108t8r1240b78],
9	transporters	NNS	O	transporter	prep_in	5	SENT_35	[p3l1256t23r1598b77],
10	will	MD	O	will	aux	11	SENT_35	[p3l1614t8r1718b61],
11	result	VB	O	result	_	0	SENT_35	[p3l1735t8r1895b61],
12	in	IN	O	in	_	0	SENT_35	[p3l1910t11r1965b60],
13	better	JJR	O	better	amod	14	SENT_35	[p3l1982t8r2151b61],
14	strategies	NNS	O	strategy	prep_in	11	SENT_35	[p3l11t101r275b168],
15	for	IN	O	for	_	0	SENT_35	[p3l297t98r379b151],
16	optimal	JJ	O	optimal	amod	18	SENT_35	[p3l400t98r616b167],
17	drug	NN	O	drug	nn	18	SENT_35	[p3l638t98r770b168],
18	design	NN	O	design	prep_for	14	SENT_35	[p3l791t98r971b168],
19	and	CC	O	and	_	0	SENT_35	[p3l992t98r1093b151],
20	tissue	NN	O	tissue	nn	21	SENT_35	[p3l1114t101r1270b151],
21	targeting	NN	O	targeting	conj_and	18	SENT_35	[p3l1291t101r1550b168],
22	as	RB	O	as	_	0	SENT_35	[p3l1570t118r1620b151],
23	well	RB	O	well	_	0	SENT_35	[p3l1640t98r1756b151],
24	as	IN	O	as	_	0	SENT_35	[p3l1778t118r1829b151],
25	reduce	VB	O	reduce	conj_and	11	SENT_35	[p3l1850t98r2039b151],
26	the	DT	O	the	det	27	SENT_35	[p3l2061t98r2149b151],
27	risk	NN	O	risk	dobj	25	SENT_35	[p3l10t189r115b241],
28	for	IN	O	for	_	0	SENT_35	[p3l132t189r214b241],
29	drug	NN	O	drug	prep_for	27	SENT_35	[p3l235t189r527b259],
30	—	CD	NUMBER	—	num	29	SENT_35	[p3l235t189r527b259],
31	drug	NN	O	drug	nn	32	SENT_35	[p3l235t189r527b259],
32	interactions	NNS	O	interaction	dobj	11	SENT_35	[p3l544t191r879b241],
33	and	CC	O	and	_	0	SENT_35	[p3l901t189r1001b241],
34	adverse	JJ	O	adverse	amod	36	SENT_35	[p3l1022t189r1230b241],
35	drug	NN	O	drug	nn	36	SENT_35	[p3l1252t189r1384b259],
36	responses	NNS	O	response	dobj	11	SENT_35	[p3l1401t208r1688b258],
37	.	.	O	.	_	0	SENT_35	[p3l1401t208r1688b258],

1	Annu	NNP	PERSON	Annu	_	0	SENT_36	[p3l73t2317r96b2397],
2	.	.	O	.	_	0	SENT_36	[p3l73t2317r96b2397],

1	Rev.	NNP	O	Rev.	nn	2	SENT_37	[p3l73t2246r96b2306],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_37	[p3l73t2087r96b2236],
3	.	.	O	.	_	0	SENT_37	[p3l73t2087r96b2236],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_38	[p3l73t1967r96b2076],
2	.	.	O	.	_	0	SENT_38	[p3l73t1967r96b2076],

1	20l2	NN	O	20l2	_	0	SENT_39	[p3l73t1721r97b1955],
2	.52:249	CD	NUMBER	.52:249	number	3	SENT_39	[p3l73t1721r97b1955],
3	-273	CD	NUMBER	-273	num	1	SENT_39	[p3l73t1721r97b1955],
4	.	.	O	.	_	0	SENT_39	[p3l73t1721r97b1955],

1	Downloaded	VBN	O	download	_	0	SENT_40	[p3l73t1540r96b1710],
2	from	IN	O	from	_	0	SENT_40	[p3l73t1467r96b1531],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_40	[p3l73t1134r103b1458],
4	by	IN	O	by	_	0	SENT_40	[p3l106t2229r137b2262],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_40	[p3l106t2080r137b2220],
6	of	IN	ORGANIZATION	of	_	0	SENT_40	[p3l106t2042r130b2070],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_40	[p3l106t1895r130b2035],
8	-	:	O	-	_	0	SENT_40	[p3l120t1876r123b1885],
9	Madison	NNP	O	Madison	prep_by	1	SENT_40	[p3l106t1750r130b1866],
10	on	IN	O	on	_	0	SENT_40	[p3l114t1709r130b1741],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_40	[p3l106t1575r130b1699],
12	.	.	O	.	_	0	SENT_40	[p3l106t1575r130b1699],

1	For	IN	O	for	_	0	SENT_41	[p3l107t1518r130b1564],
2	personal	JJ	O	personal	amod	3	SENT_41	[p3l106t1397r137b1509],
3	use	NN	O	use	pobj	1	SENT_41	[p3l114t1345r130b1388],
4	only	RB	O	only	advmod	3	SENT_41	[p3l106t1270r137b1335],
5	.	.	O	.	_	0	SENT_41	[p3l106t1270r137b1335],

1	SLC	NNP	O	SLC	_	0	SENT_42	[p3l193t604r267b629],
2	:	:	O	:	_	0	SENT_42	[p3l193t604r267b629],
3	solute	JJ	O	solute	amod	4	SENT_42	[p3l287t603r369b629],
4	carrier	NN	O	carrier	dep	1	SENT_42	[p3l379t604r471b629],

1	OCT	NN	DATE	oct	_	0	SENT_43	[p3l193t661r281b686],
2	:	:	O	:	_	0	SENT_43	[p3l193t661r281b686],
3	organic	JJ	O	organic	amod	6	SENT_43	[p3l301t662r405b689],
4	cation	NN	O	cation	nn	6	SENT_43	[p3l415t662r500b686],
5	tl	NN	O	tl	nn	6	SENT_43	[p3l192t719r310b745],
6	‘	NN	O	‘	dep	1	SENT_43	[p3l192t719r310b745],
7	3	CD	NUMBER	3	dep	6	SENT_43	[p3l192t719r310b745],
8	.	.	O	.	_	0	SENT_43	[p3l192t719r310b745],

1	I1SpOI	NN	O	i1spous	nn	3	SENT_44	[p3l192t719r310b745],
2	‘	CD	NUMBER	‘	num	3	SENT_44	[p3l192t719r310b745],
3	C61	NN	O	c61	_	0	SENT_44	[p3l311t719r349b737],
4	‘	CD	NUMBER	‘	num	5	SENT_44	[p3l311t719r349b737],
5	MATE	NN	O	mate	dep	3	SENT_44	[p3l191t770r306b795],
6	:	:	O	:	_	0	SENT_44	[p3l191t770r306b795],
7	multidrug	JJ	O	multidrug	dep	3	SENT_44	[p3l326t769r466b804],
8	and	CC	O	and	_	0	SENT_44	[p3l193t811r242b836],
9	toxin	NN	O	toxin	nn	10	SENT_44	[p3l252t812r322b836],
10	extrusion	NN	O	extrusion	dep	3	SENT_44	[p3l332t812r461b836],

1	OAT	NN	O	oat	_	0	SENT_45	[p3l193t926r278b951],
2	:	:	O	:	_	0	SENT_45	[p3l193t926r278b951],
3	organic	JJ	O	organic	amod	6	SENT_45	[p3l298t927r402b960],
4	anion	NN	O	anion	nn	6	SENT_45	[p3l412t927r489b951],
5	transporter	NN	O	transporter	nn	6	SENT_45	[p3l192t975r349b1001],
6	OATP	NN	O	oatp	dep	1	SENT_45	[p3l193t1026r300b1051],
7	:	:	O	:	_	0	SENT_45	[p3l193t1026r300b1051],
8	organic	JJ	O	organic	amod	9	SENT_45	[p3l320t1027r424b1060],
9	anion	NN	O	anion	dep	6	SENT_45	[p3l434t1027r512b1051],
10	transporting	VBG	O	transport	partmod	9	SENT_45	[p3l192t1068r366b1101],
11	polypeptide	NN	O	polypeptide	nn	12	SENT_45	[p3l192t1114r356b1148],
12	ABC	NNP	O	ABC	dobj	10	SENT_45	[p3l191t1172r272b1197],
13	:	:	O	:	_	0	SENT_45	[p3l191t1172r272b1197],
14	ATP-binding	JJ	O	atp-binding	amod	15	SENT_45	[p3l291t1171r482b1205],
15	cassette	NN	O	cassette	dep	12	SENT_45	[p3l193t1220r298b1239],

1	MRP	NN	O	mrp	_	0	SENT_46	[p3l191t1273r279b1297],
2	:	:	O	:	_	0	SENT_46	[p3l191t1273r279b1297],
3	multidrug	JJ	O	multidrug	amod	5	SENT_46	[p3l298t1271r439b1306],
4	resistance-associated	JJ	O	resistance-associated	amod	5	SENT_46	[p3l192t1313r480b1338],
5	protein	NN	O	protein	dep	1	SENT_46	[p3l192t1356r294b1388],

1	INTRODUCTION	NNP	O	INTRODUCTION	nn	2	SENT_47	[p3l565t508r946b540],
2	Optimizing	NNP	O	Optimizing	nsubj	9	SENT_47	[p3l567t558r748b596],
3	ding	VBG	O	ding	dep	2	SENT_47	[p3l764t557r837b596],
4	efﬁcacy	NN	O	efﬁcacy	dobj	3	SENT_47	[p3l852t557r968b596],
5	and	CC	O	and	_	0	SENT_47	[p3l983t557r1038b586],
6	minimizing	VBG	O	minimize	dep	2	SENT_47	[p3l1054t559r1235b596],
7	drug	NN	O	drug	nn	8	SENT_47	[p3l1250t557r1323b596],
8	toxicity	NN	O	toxicity	dobj	6	SENT_47	[p3l1338t559r1455b596],
9	requires	VBZ	O	require	_	0	SENT_47	[p3l1469t559r1596b596],
10	that	IN	O	that	complm	13	SENT_47	[p3l1612t557r1674b586],
11	the	DT	O	the	det	12	SENT_47	[p3l1689t557r1737b586],
12	drug	NN	O	drug	nsubj	13	SENT_47	[p3l1754t557r1827b596],
13	reach	VB	O	reach	ccomp	9	SENT_47	[p3l1842t557r1926b586],
14	its	PRP$	O	its	poss	15	SENT_47	[p3l1942t559r1977b586],
15	target	NN	O	target	dobj	13	SENT_47	[p3l1993t565r2085b596],
16	at	IN	O	at	_	0	SENT_47	[p3l566t604r595b625],
17	adequate	JJ	O	adequate	amod	18	SENT_47	[p3l608t596r747b635],
18	concentration	NN	O	concentration	prep_at	15	SENT_47	[p3l762t598r988b632],
19	,	,	O	,	_	0	SENT_47	[p3l762t598r988b632],
20	without	IN	O	without	_	0	SENT_47	[p3l1002t596r1126b625],
21	excessive	JJ	O	excessive	amod	22	SENT_47	[p3l1140t598r1278b625],
22	accumulation	NN	O	accumulation	prep_without	13	SENT_47	[p3l1293t596r1503b625],
23	in	IN	O	in	_	0	SENT_47	[p3l1517t598r1547b625],
24	other	JJ	O	other	amod	25	SENT_47	[p3l1562t596r1646b625],
25	tissues	NNS	O	tissue	prep_in	22	SENT_47	[p3l1659t598r1768b625],
26	.	.	O	.	_	0	SENT_47	[p3l1659t598r1768b625],

1	For	IN	O	for	_	0	SENT_48	[p3l1784t597r1840b625],
2	many	JJ	O	many	amod	3	SENT_48	[p3l1854t607r1941b635],
3	drugs	NNS	O	drug	prep_for	12	SENT_48	[p3l1954t596r2040b635],
4	in	IN	O	in	_	0	SENT_48	[p3l2054t598r2084b625],
5	clinical	JJ	O	clinical	amod	6	SENT_48	[p3l566t645r677b674],
6	use	NN	O	use	prep_in	3	SENT_48	[p3l687t656r737b674],
7	today	NN	DATE	today	tmod	12	SENT_48	[p3l749t645r843b684],
8	,	,	O	,	_	0	SENT_48	[p3l749t645r843b684],
9	intracellular	JJ	O	intracellular	amod	10	SENT_48	[p3l855t645r1046b674],
10	concentration	NN	O	concentration	nsubjpass	12	SENT_48	[p3l1057t647r1274b674],
11	is	VBZ	O	be	auxpass	12	SENT_48	[p3l1285t647r1308b674],
12	determined	VBN	O	determine	_	0	SENT_48	[p3l1320t645r1499b674],
13	by	IN	O	by	_	0	SENT_48	[p3l1511t645r1549b684],
14	the	DT	O	the	det	15	SENT_48	[p3l1559t645r1607b674],
15	balance	NN	O	balance	agent	12	SENT_48	[p3l1619t645r1735b674],
16	in	IN	O	in	_	0	SENT_48	[p3l1747t647r1777b674],
17	activity	NN	O	activity	prep_in	15	SENT_48	[p3l1788t647r1902b684],
18	of	IN	O	of	_	0	SENT_48	[p3l1912t645r1947b674],
19	multiple	JJ	O	multiple	amod	20	SENT_48	[p3l1953t645r2084b684],
20	uptake	NN	O	uptake	prep_of	17	SENT_48	[p3l565t704r669b742],
21	and	CC	O	and	_	0	SENT_48	[p3l683t704r738b733],
22	efﬂux	NN	O	efﬂux	nn	23	SENT_48	[p3l752t704r836b733],
23	transporters	NNS	O	transporter	prep_of	17	SENT_48	[p3l848t712r1037b742],
24	that	WDT	O	that	nsubj	25	SENT_48	[p3l1051t704r1112b733],
25	facilitate	VBP	O	facilitate	rcmod	15	SENT_48	[p3l1124t704r1257b733],
26	the	DT	O	the	det	27	SENT_48	[p3l1271t704r1320b733],
27	drugs	NNS	O	drug	nsubj	28	SENT_48	[p3l1333t704r1428b743],
28	’	VBP	O	’	ccomp	25	SENT_48	[p3l1333t704r1428b743],
29	movement	NN	O	movement	dobj	28	SENT_48	[p3l1441t712r1609b733],
30	across	IN	O	across	_	0	SENT_48	[p3l1621t715r1714b733],
31	biological	JJ	O	biological	amod	32	SENT_48	[p3l1727t704r1880b743],
32	membranes	NNS	O	membrane	prep_across	28	SENT_48	[p3l1893t704r2082b733],
33	.	.	O	.	_	0	SENT_48	[p3l1893t704r2082b733],

1	Transporters	NNS	O	transporter	nsubj	6	SENT_49	[p3l565t755r772b792],
2	are	VBP	O	be	cop	6	SENT_49	[p3l781t765r827b783],
3	large	JJ	O	large	amod	6	SENT_49	[p3l835t754r921b792],
4	,	,	O	,	_	0	SENT_49	[p3l835t754r921b792],
5	membrane-bound	JJ	O	membrane-bound	amod	6	SENT_49	[p3l930t754r1213b783],
6	proteins	NNS	O	protein	dep	48	SENT_49	[p3l1221t755r1349b792],
7	expressed	VBN	O	express	partmod	6	SENT_49	[p3l1358t754r1507b792],
8	in	IN	O	in	_	0	SENT_49	[p3l1515t755r1545b782],
9	tissues	NNS	O	tissue	prep_in	7	SENT_49	[p3l1553t755r1653b783],
10	throughout	IN	O	throughout	_	0	SENT_49	[p3l1662t754r1842b792],
11	the	DT	O	the	det	12	SENT_49	[p3l1849t754r1898b783],
12	body	NN	O	body	prep_throughout	9	SENT_49	[p3l1907t754r1992b792],
13	;	:	O	;	_	0	SENT_49	[p3l1907t754r1992b792],
14	those	DT	O	those	nsubj	15	SENT_49	[p3l2001t754r2084b783],
15	found	VBN	O	find	parataxis	6	SENT_49	[p3l566t804r657b833],
16	in	IN	O	in	_	0	SENT_49	[p3l664t805r694b832],
17	the	DT	O	the	det	18	SENT_49	[p3l701t804r750b833],
18	epithelia	NN	O	epithelium	prep_in	15	SENT_49	[p3l758t804r892b842],
19	of	IN	O	of	_	0	SENT_49	[p3l899t804r933b833],
20	maj	NN	O	maj	prep_of	18	SENT_49	[p3l936t805r990b842],
21	or	CC	O	or	_	0	SENT_49	[p3l994t815r1027b833],
22	organs	NNS	O	organ	prep_in	15	SENT_49	[p3l1034t814r1137b842],
23	of	IN	O	of	_	0	SENT_49	[p3l1145t804r1179b833],
24	absorption	NN	O	absorption	prep_of	22	SENT_49	[p3l1182t804r1350b842],
25	and	CC	O	and	_	0	SENT_49	[p3l1357t804r1412b833],
26	secretion	NN	O	secretion	prep_of	22	SENT_49	[p3l1420t805r1562b833],
27	such	JJ	O	such	_	0	SENT_49	[p3l1569t804r1639b833],
28	as	IN	O	as	_	0	SENT_49	[p3l1646t815r1674b833],
29	liver	NN	O	liver	prep_such_as	22	SENT_49	[p3l1681t804r1758b839],
30	,	,	O	,	_	0	SENT_49	[p3l1681t804r1758b839],
31	intestine	NN	O	intestine	prep_such_as	22	SENT_49	[p3l1766t805r1909b839],
32	,	,	O	,	_	0	SENT_49	[p3l1766t805r1909b839],
33	and	CC	O	and	_	0	SENT_49	[p3l1918t804r1973b833],
34	kidney	NN	O	kidney	prep_such_as	22	SENT_49	[p3l1980t804r2086b842],
35	and	CC	O	and	_	0	SENT_49	[p3l566t910r622b939],
36	in	IN	O	in	_	0	SENT_49	[p3l634t912r664b939],
37	sanctuary	NN	O	sanctuary	nn	38	SENT_49	[p3l676t918r825b949],
38	sites	NNS	O	site	prep_in	15	SENT_49	[p3l835t912r901b939],
39	such	JJ	O	such	_	0	SENT_49	[p3l914t910r983b939],
40	as	IN	O	as	_	0	SENT_49	[p3l996t921r1024b939],
41	the	DT	O	the	det	42	SENT_49	[p3l1036t910r1085b939],
42	brain	NN	O	brain	prep_such_as	38	SENT_49	[p3l1097t910r1186b945],
43	,	,	O	,	_	0	SENT_49	[p3l1097t910r1186b945],
44	testes	NNS	O	testis	prep_such_as	38	SENT_49	[p3l1200t918r1293b945],
45	,	,	O	,	_	0	SENT_49	[p3l1200t918r1293b945],
46	and	CC	O	and	_	0	SENT_49	[p3l1307t910r1363b939],
47	placenta	NN	O	placenta	prep_such_as	38	SENT_49	[p3l1374t910r1504b948],
48	are	VBP	O	be	_	0	SENT_49	[p3l1516t921r1563b939],
49	of	IN	O	of	_	0	SENT_49	[p3l1575t910r1609b939],
50	particular	JJ	O	particular	amod	51	SENT_49	[p3l1617t910r1768b948],
51	importance	NN	O	importance	prep_of	48	SENT_49	[p3l1779t912r1958b948],
52	in	IN	O	in	_	0	SENT_49	[p3l1970t912r2000b939],
53	drug	NN	O	drug	nn	54	SENT_49	[p3l2012t910r2085b949],
54	disposition	NN	O	disposition	prep_in	51	SENT_49	[p3l567t960r737b998],
55	(	CD	NUMBER	(	num	58	SENT_49	[p3l750t961r872b999],
56	Figure	NN	O	figure	nn	58	SENT_49	[p3l750t961r872b999],
57	1	CD	NUMBER	1	num	58	SENT_49	[p3l889t961r925b996],
58	)	NN	O	)	nsubj	48	SENT_49	[p3l889t961r925b996],
59	.	.	O	.	_	0	SENT_49	[p3l889t961r925b996],

1	Interindividual	JJ	O	interindividual	amod	2	SENT_50	[p3l939t960r1173b989],
2	variation	NN	O	variation	nsubj	7	SENT_50	[p3l1184t962r1323b989],
3	in	IN	O	in	_	0	SENT_50	[p3l1335t962r1365b989],
4	transporter	NN	O	transporter	nn	5	SENT_50	[p3l1378t968r1554b999],
5	activity	NN	O	activity	prep_in	2	SENT_50	[p3l1566t962r1680b999],
6	can	MD	O	can	aux	7	SENT_50	[p3l1691t971r1743b989],
7	arise	VB	O	arise	_	0	SENT_50	[p3l1756t962r1827b989],
8	from	IN	O	from	_	0	SENT_50	[p3l1839t960r1916b989],
9	numerous	JJ	O	numerous	amod	10	SENT_50	[p3l1927t971r2084b989],
10	factors	NNS	O	factor	prep_from	7	SENT_50	[p3l566t1010r679b1045],
11	,	,	O	,	_	0	SENT_50	[p3l566t1010r679b1045],
12	including	VBG	O	include	_	0	SENT_50	[p3l690t1010r839b1049],
13	genetic	JJ	O	genetic	amod	14	SENT_50	[p3l849t1012r962b1049],
14	heterogeneity	NN	O	heterogeneity	prep_including	7	SENT_50	[p3l972t1010r1197b1049],
15	,	,	O	,	_	0	SENT_50	[p3l972t1010r1197b1049],
16	certain	JJ	O	certain	amod	18	SENT_50	[p3l1210t1012r1317b1039],
17	disease	NN	O	disease	nn	18	SENT_50	[p3l1328t1010r1435b1039],
18	processes	NNS	O	process	conj_and	14	SENT_50	[p3l1446t1021r1600b1048],
19	,	,	O	,	_	0	SENT_50	[p3l1446t1021r1600b1048],
20	concomitant	JJ	O	concomitant	amod	21	SENT_50	[p3l1613t1012r1810b1039],
21	medications	NNS	O	medication	conj_and	14	SENT_50	[p3l1819t1010r2016b1045],
22	,	,	O	,	_	0	SENT_50	[p3l1819t1010r2016b1045],
23	and	CC	O	and	_	0	SENT_50	[p3l2029t1010r2084b1039],
24	herbals	NNS	O	herbal	conj_and	14	SENT_50	[p3l565t1060r677b1089],
25	and	CC	O	and	_	0	SENT_50	[p3l695t1060r751b1089],
26	dietary	JJ	O	dietary	amod	27	SENT_50	[p3l768t1060r877b1098],
27	constituents	NNS	O	constituent	conj_and	14	SENT_50	[p3l893t1061r1081b1089],
28	that	WDT	O	that	nsubj	30	SENT_50	[p3l1099t1060r1161b1089],
29	may	MD	O	may	aux	30	SENT_50	[p3l1176t1071r1242b1098],
30	inhibit	VB	O	inhibit	rcmod	27	SENT_50	[p3l1257t1060r1362b1089],
31	or	CC	O	or	_	0	SENT_50	[p3l1379t1071r1412b1089],
32	induce	VB	O	induce	conj_or	30	SENT_50	[p3l1428t1060r1532b1089],
33	transporter	NN	O	transporter	nn	34	SENT_50	[p3l1549t1068r1725b1098],
34	expression	NN	O	expression	dobj	30	SENT_50	[p3l1742t1061r1905b1098],
35	or	CC	O	or	_	0	SENT_50	[p3l1922t1071r1955b1089],
36	activity	NN	O	activity	dobj	30	SENT_50	[p3l1972t1061r2086b1098],
37	(	CD	NUMBER	(	num	36	SENT_50	[p3l567t1116r654b1151],
38	1-3	CD	NUMBER	1-3	num	39	SENT_50	[p3l567t1116r654b1151],
39	)	NN	O	)	dep	36	SENT_50	[p3l567t1116r654b1151],
40	.	.	O	.	_	0	SENT_50	[p3l567t1116r654b1151],

1	Transporter	NN	O	transporter	nn	2	SENT_51	[p3l615t1165r809b1202],
2	function	NN	O	function	nsubjpass	5	SENT_51	[p3l820t1164r951b1193],
3	has	VBZ	O	have	aux	5	SENT_51	[p3l963t1164r1012b1193],
4	been	VBN	O	be	auxpass	5	SENT_51	[p3l1024t1164r1099b1193],
5	studied	VBN	O	study	_	0	SENT_51	[p3l1110t1164r1223b1193],
6	extensively	RB	O	extensively	advmod	5	SENT_51	[p3l1235t1164r1407b1203],
7	in	FW	O	in	nn	8	SENT_51	[p3l1416t1166r1447b1193],
8	vitro	FW	O	vitro	advmod	15	SENT_51	[p3l1457t1166r1531b1193],
9	through	IN	O	through	dep	15	SENT_51	[p3l1543t1164r1670b1203],
10	the	DT	O	the	det	11	SENT_51	[p3l1682t1164r1730b1193],
11	use	NN	O	use	nsubj	15	SENT_51	[p3l1742t1175r1792b1193],
12	of	IN	O	of	_	0	SENT_51	[p3l1804t1164r1839b1193],
13	cRNA	NN	O	crna	prep_of	11	SENT_51	[p3l1847t1164r2084b1203],
14	—	CD	NUMBER	—	num	13	SENT_51	[p3l1847t1164r2084b1203],
15	injected	VBD	O	inject	ccomp	5	SENT_51	[p3l1847t1164r2084b1203],
16	Xenopus	NN	MISC	xenopus	dobj	15	SENT_51	[p3l563t1215r687b1253],
17	Idem	NNP	MISC	Idem	dep	16	SENT_51	[p3l701t1215r782b1243],
18	’	CD	NUMBER	’	num	17	SENT_51	[p3l701t1215r782b1243],
19	:	:	O	:	_	0	SENT_51	[p3l701t1215r782b1243],
20	oocytes	NNS	O	oocyte	dep	16	SENT_51	[p3l796t1222r912b1253],
21	and	CC	O	and	_	0	SENT_51	[p3l928t1214r984b1243],
22	transfected	VBN	O	transfect	conj_and	5	SENT_51	[p3l999t1214r1171b1243],
23	mammalian	JJ	O	mammalian	amod	25	SENT_51	[p3l1186t1214r1370b1243],
24	cell	NN	O	cell	nn	25	SENT_51	[p3l1385t1214r1438b1243],
25	lines	NNS	O	line	dobj	22	SENT_51	[p3l1453t1214r1533b1243],
26	.	.	O	.	_	0	SENT_51	[p3l1453t1214r1533b1243],

1	Knockout	NNP	O	Knockout	nn	2	SENT_52	[p3l1549t1214r1706b1243],
2	mice	NNS	O	mouse	nsubj	8	SENT_52	[p3l1720t1215r1794b1243],
3	and	CC	O	and	_	0	SENT_52	[p3l1810t1214r1865b1243],
4	other	JJ	O	other	amod	6	SENT_52	[p3l1881t1214r1965b1243],
5	animal	NN	O	animal	nn	6	SENT_52	[p3l1980t1214r2084b1243],
6	models	NNS	O	model	conj_and	2	SENT_52	[p3l566t1264r677b1293],
7	have	VBP	O	have	aux	8	SENT_52	[p3l689t1264r760b1293],
8	provided	VBN	O	provide	_	0	SENT_52	[p3l772t1264r911b1302],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_52	[p3l923t1264r1085b1303],
10	insights	NNS	O	insight	dobj	8	SENT_52	[p3l1096t1264r1216b1303],
11	into	IN	O	into	_	0	SENT_52	[p3l1228t1266r1291b1293],
12	the	DT	O	the	det	13	SENT_52	[p3l1303t1264r1352b1293],
13	role	NN	O	role	prep_into	8	SENT_52	[p3l1364t1264r1425b1293],
14	of	IN	O	of	_	0	SENT_52	[p3l1438t1264r1472b1293],
15	transporters	NNS	O	transporter	prep_of	13	SENT_52	[p3l1480t1272r1669b1302],
16	in	FW	O	in	prep	15	SENT_52	[p3l1681t1266r1711b1293],
17	vivo	FW	O	vivo	pobj	16	SENT_52	[p3l1722t1266r1796b1299],
18	,	,	O	,	_	0	SENT_52	[p3l1722t1266r1796b1299],
19	particularly	RB	O	particularly	advmod	22	SENT_52	[p3l1809t1264r1990b1303],
20	when	WRB	O	when	advmod	22	SENT_52	[p3l1999t1264r2084b1293],
21	multiple	JJ	O	multiple	amod	22	SENT_52	[p3l566t1314r696b1352],
22	transporters	NNS	O	transporter	nsubjpass	28	SENT_52	[p3l704t1322r893b1352],
23	with	IN	O	with	_	0	SENT_52	[p3l899t1314r969b1343],
24	overlapping	VBG	O	overlap	amod	26	SENT_52	[p3l976t1314r1162b1353],
25	substrate	NN	O	substrate	nn	26	SENT_52	[p3l1169t1314r1308b1343],
26	speciﬁcities	NNS	O	speciﬁcities	prep_with	22	SENT_52	[p3l1315t1314r1494b1352],
27	are	VBP	O	be	auxpass	28	SENT_52	[p3l1502t1325r1548b1343],
28	expressed	VBN	O	express	rcmod	13	SENT_52	[p3l1556t1314r1705b1352],
29	in	IN	O	in	_	0	SENT_52	[p3l1712t1316r1742b1343],
30	the	DT	O	the	det	32	SENT_52	[p3l1749t1314r1798b1343],
31	same	JJ	O	same	amod	32	SENT_52	[p3l1805t1325r1882b1343],
32	tissue	NN	O	tissue	prep_in	28	SENT_52	[p3l1890t1316r1984b1343],
33	.	.	O	.	_	0	SENT_52	[p3l1890t1316r1984b1343],

1	However	RB	O	however	advmod	13	SENT_53	[p3l1993t1315r2084b1343, p3l567t1375r639b1399],
2	,	,	O	,	_	0	SENT_53	[p3l1993t1315r2084b1343, p3l567t1375r639b1399],
3	species-related	JJ	O	species-related	amod	4	SENT_53	[p3l654t1364r885b1402],
4	differences	NNS	O	difference	nsubj	15	SENT_53	[p3l899t1364r1066b1393],
5	in	IN	O	in	_	0	SENT_53	[p3l1080t1365r1110b1392],
6	transporter	NN	O	transporter	nn	7	SENT_53	[p3l1123t1372r1300b1402],
7	expression	NN	O	expression	prep_in	4	SENT_53	[p3l1313t1365r1476b1402],
8	and	CC	O	and	_	0	SENT_53	[p3l1490t1364r1545b1393],
9	substrate	NN	O	substrate	nn	10	SENT_53	[p3l1559t1364r1698b1393],
10	speciﬁcity	NN	O	speciﬁcity	prep_in	4	SENT_53	[p3l1712t1364r1869b1402],
11	are	VBP	O	be	cop	13	SENT_53	[p3l1881t1375r1927b1393],
12	relatively	RB	O	relatively	advmod	13	SENT_53	[p3l1941t1364r2086b1402],
13	common	JJ	O	common	_	0	SENT_53	[p3l566t1425r705b1443],
14	and	CC	O	and	_	0	SENT_53	[p3l717t1414r772b1443],
15	need	VB	O	need	conj_and	13	SENT_53	[p3l784t1414r858b1443],
16	to	TO	O	to	aux	18	SENT_53	[p3l871t1422r901b1443],
17	be	VB	O	be	auxpass	18	SENT_53	[p3l913t1414r949b1443],
18	considered	VBN	O	consider	xcomp	15	SENT_53	[p3l962t1414r1131b1443],
19	when	WRB	O	when	advmod	29	SENT_53	[p3l1142t1414r1227b1443],
20	the	DT	O	the	det	21	SENT_53	[p3l1239t1414r1288b1443],
21	results	NNS	O	result	nsubjpass	29	SENT_53	[p3l1300t1414r1400b1443],
22	of	IN	O	of	_	0	SENT_53	[p3l1413t1414r1448b1443],
23	experiments	NNS	O	experiment	prep_of	21	SENT_53	[p3l1456t1415r1645b1452],
24	in	IN	O	in	_	0	SENT_53	[p3l1657t1415r1688b1442],
25	rodent	JJ	O	rodent	amod	26	SENT_53	[p3l1699t1414r1804b1443],
26	models	NNS	O	model	prep_in	23	SENT_53	[p3l1815t1414r1926b1443],
27	are	VBP	O	be	aux	29	SENT_53	[p3l1939t1425r1985b1443],
28	being	VBG	O	be	auxpass	29	SENT_53	[p3l1998t1414r2085b1452],
29	interpreted	VBN	O	interpret	advcl	18	SENT_53	[p3l565t1463r750b1502],
30	.	.	O	.	_	0	SENT_53	[p3l565t1463r750b1502],

1	In	IN	O	in	_	0	SENT_54	[p3l764t1465r797b1492],
2	humans	NNS	O	human	prep_in	16	SENT_54	[p3l809t1463r940b1499],
3	,	,	O	,	_	0	SENT_54	[p3l809t1463r940b1499],
4	the	DT	O	the	det	5	SENT_54	[p3l954t1463r1003b1492],
5	role	NN	O	role	nsubjpass	16	SENT_54	[p3l1015t1463r1076b1492],
6	of	IN	O	of	_	0	SENT_54	[p3l1089t1464r1124b1492],
7	transporters	NNS	O	transporter	prep_of	5	SENT_54	[p3l1132t1472r1321b1502],
8	in	IN	O	in	_	0	SENT_54	[p3l1333t1465r1364b1492],
9	drug	NN	O	drug	nn	10	SENT_54	[p3l1377t1464r1450b1502],
10	efficacy	NN	O	efficacy	prep_in	7	SENT_54	[p3l1462t1464r1578b1502],
11	and	CC	O	and	_	0	SENT_54	[p3l1590t1463r1645b1492],
12	toxicity	NN	O	toxicity	conj_and	10	SENT_54	[p3l1658t1465r1775b1502],
13	has	VBZ	O	have	aux	16	SENT_54	[p3l1785t1463r1835b1492],
14	been	VBN	O	be	auxpass	16	SENT_54	[p3l1848t1463r1922b1492],
15	indirectly	RB	O	indirectly	advmod	16	SENT_54	[p3l1934t1463r2086b1502],
16	shown	VBN	O	show	_	0	SENT_54	[p3l566t1513r666b1542],
17	by	IN	O	by	_	0	SENT_54	[p3l681t1513r719b1552],
18	inhibition	NN	O	inhibition	nn	21	SENT_54	[p3l732t1513r887b1542],
19	or	CC	O	or	_	0	SENT_54	[p3l902t1524r935b1542],
20	induction	NN	O	induction	conj_or	18	SENT_54	[p3l949t1513r1100b1542],
21	studies	NNS	O	study	agent	16	SENT_54	[p3l1114t1513r1220b1542],
22	both	CC	O	both	preconj	16	SENT_54	[p3l1235t1513r1307b1542],
23	in	IN	O	in	_	0	SENT_54	[p3l1321t1515r1352b1542],
24	healthy	JJ	O	healthy	amod	25	SENT_54	[p3l1366t1513r1482b1552],
25	volunteers	NNS	O	volunteer	prep_in	16	SENT_54	[p3l1494t1513r1658b1542],
26	and	CC	O	and	_	0	SENT_54	[p3l1673t1513r1728b1542],
27	in	IN	O	in	_	0	SENT_54	[p3l1743t1515r1773b1542],
28	patients	NNS	O	patient	prep_in	16	SENT_54	[p3l1787t1515r1918b1552],
29	.	.	O	.	_	0	SENT_54	[p3l1787t1515r1918b1552],

1	Naturally	RB	O	naturally	advmod	2	SENT_55	[p3l1933t1513r2086b1552],
2	occurring	VBG	O	occur	_	0	SENT_55	[p3l566t1565r719b1602],
3	genetic	JJ	O	genetic	amod	4	SENT_55	[p3l731t1565r844b1602],
4	polymorphisms	NNS	O	polymorphism	dobj	2	SENT_55	[p3l856t1563r1099b1602],
5	cause	VBP	O	cause	dep	2	SENT_55	[p3l1113t1574r1195b1592],
6	reduced	VBN	O	reduce	amod	7	SENT_55	[p3l1209t1563r1333b1592],
7	expression	NN	O	expression	dobj	5	SENT_55	[p3l1347t1565r1510b1601],
8	or	CC	O	or	_	0	SENT_55	[p3l1523t1574r1557b1592],
9	function	NN	O	function	dobj	5	SENT_55	[p3l1569t1563r1701b1592],
10	of	IN	O	of	_	0	SENT_55	[p3l1714t1563r1748b1592],
11	speciﬁc	NN	O	speciﬁc	prep_of	7	SENT_55	[p3l1757t1563r1872b1601],
12	transporters	NNS	O	transporter	nsubj	2	SENT_55	[p3l1885t1571r2083b1601],
13	,	,	O	,	_	0	SENT_55	[p3l1885t1571r2083b1601],
14	an	DT	O	a	det	15	SENT_55	[p3l566t1624r602b1642],
15	effect	NN	O	effect	appos	12	SENT_55	[p3l613t1613r697b1642],
16	that	WDT	O	that	nsubjpass	20	SENT_55	[p3l707t1613r769b1642],
17	is	VBZ	O	be	auxpass	20	SENT_55	[p3l778t1615r801b1642],
18	not	RB	O	not	neg	20	SENT_55	[p3l811t1621r865b1642],
19	readily	RB	O	readily	advmod	20	SENT_55	[p3l874t1613r982b1652],
20	achieved	VBN	O	achieve	rcmod	15	SENT_55	[p3l991t1613r1126b1642],
21	by	IN	O	by	_	0	SENT_55	[p3l1136t1613r1175b1652],
22	pharmacological	JJ	O	pharmacological	amod	23	SENT_55	[p3l1183t1613r1442b1652],
23	inhibitors	NNS	O	inhibitor	agent	20	SENT_55	[p3l1453t1613r1605b1642],
24	in	IN	O	in	_	0	SENT_55	[p3l1615t1615r1646b1642],
25	most	JJS	O	most	amod	26	SENT_55	[p3l1656t1621r1733b1642],
26	cases	NNS	O	case	prep_in	23	SENT_55	[p3l1743t1624r1827b1642],
27	.	.	O	.	_	0	SENT_55	[p3l1743t1624r1827b1642],

1	For	IN	O	for	_	0	SENT_56	[p3l1840t1614r1896b1642],
2	this	DT	O	this	det	3	SENT_56	[p3l1906t1613r1962b1642],
3	reason	NN	O	reason	prep_for	14	SENT_56	[p3l1973t1624r2083b1648],
4	,	,	O	,	_	0	SENT_56	[p3l1973t1624r2083b1648],
5	studies	NNS	O	study	nsubj	14	SENT_56	[p3l566t1663r672b1692],
6	in	IN	O	in	_	0	SENT_56	[p3l687t1664r717b1691],
7	human	JJ	O	human	amod	8	SENT_56	[p3l731t1663r840b1692],
8	subjects	NNS	O	subject	prep_in	5	SENT_56	[p3l854t1663r976b1701],
9	with	IN	O	with	_	0	SENT_56	[p3l990t1663r1060b1692],
10	genetic	JJ	O	genetic	amod	11	SENT_56	[p3l1075t1664r1187b1701],
11	polymorphisms	NNS	O	polymorphism	prep_with	8	SENT_56	[p3l1202t1663r1444b1701],
12	have	VBP	O	have	aux	14	SENT_56	[p3l1459t1663r1529b1692],
13	been	VBN	O	be	cop	14	SENT_56	[p3l1545t1663r1619b1692],
14	instrumental	JJ	O	instrumental	_	0	SENT_56	[p3l1633t1663r1833b1692],
15	in	IN	O	in	_	0	SENT_56	[p3l1847t1664r1877b1691],
16	deﬁning	VBG	O	deﬁning	prepc_in	14	SENT_56	[p3l1892t1663r2021b1701],
17	the	DT	O	the	det	19	SENT_56	[p3l2035t1663r2084b1692],
18	clinical	JJ	O	clinical	amod	19	SENT_56	[p3l566t1713r677b1742],
19	relevance	NN	O	relevance	dobj	16	SENT_56	[p3l687t1713r834b1742],
20	of	IN	O	of	_	0	SENT_56	[p3l846t1713r880b1742],
21	certain	JJ	O	certain	amod	22	SENT_56	[p3l888t1714r994b1742],
22	transporters	NNS	O	transporter	prep_of	19	SENT_56	[p3l1006t1721r1194b1751],
23	to	TO	O	to	_	0	SENT_56	[p3l1206t1721r1237b1742],
24	drug	NN	O	drug	nn	25	SENT_56	[p3l1249t1713r1322b1751],
25	disposition	NN	O	disposition	prep_to	16	SENT_56	[p3l1333t1713r1503b1751],
26	and	CC	O	and	_	0	SENT_56	[p3l1514t1713r1570b1742],
27	response	NN	O	response	prep_to	16	SENT_56	[p3l1581t1724r1725b1751],
28	.	.	O	.	_	0	SENT_56	[p3l1581t1724r1725b1751],

1	Given	VBN	O	give	prep	20	SENT_57	[p3l617t1764r711b1792],
2	the	DT	O	the	det	4	SENT_57	[p3l721t1763r769b1792],
3	critical	JJ	O	critical	amod	4	SENT_57	[p3l780t1763r886b1792],
4	role	NN	O	role	dep	1	SENT_57	[p3l895t1763r956b1792],
5	of	IN	O	of	_	0	SENT_57	[p3l966t1763r1000b1792],
6	transporters	NNS	O	transporter	prep_of	4	SENT_57	[p3l1005t1771r1194b1801],
7	in	IN	O	in	_	0	SENT_57	[p3l1204t1764r1234b1791],
8	mediating	VBG	O	mediate	prepc_in	6	SENT_57	[p3l1243t1762r1401b1801],
9	the	DT	O	the	det	10	SENT_57	[p3l1410t1763r1458b1792],
10	pharmacokinetics	NNS	O	pharmacokinetic	dobj	8	SENT_57	[p3l1468t1763r1743b1801],
11	of	IN	O	of	_	0	SENT_57	[p3l1753t1763r1788b1792],
12	many	JJ	O	many	amod	13	SENT_57	[p3l1793t1773r1879b1801],
13	drugs	NNS	O	drug	prep_of	10	SENT_57	[p3l1888t1763r1982b1801],
14	,	,	O	,	_	0	SENT_57	[p3l1888t1763r1982b1801],
15	transporter	NN	O	transporter	nn	16	SENT_57	[p3l1993t1771r2083b1792, p3l566t1821r664b1851],
16	studies	NNS	O	study	nsubj	20	SENT_57	[p3l678t1812r784b1842],
17	are	VBP	O	be	cop	20	SENT_57	[p3l800t1824r846b1842],
18	an	DT	O	a	det	20	SENT_57	[p3l862t1823r898b1842],
19	important	JJ	O	important	amod	20	SENT_57	[p3l912t1814r1071b1851],
20	part	NN	O	part	_	0	SENT_57	[p3l1084t1821r1148b1851],
21	of	IN	O	of	_	0	SENT_57	[p3l1162t1813r1196b1842],
22	the	DT	O	the	det	24	SENT_57	[p3l1207t1813r1256b1842],
23	drug	NN	O	drug	nn	24	SENT_57	[p3l1272t1813r1345b1851],
24	discovery	NN	O	discovery	prep_of	20	SENT_57	[p3l1359t1812r1507b1851],
25	and	CC	O	and	_	0	SENT_57	[p3l1521t1812r1576b1842],
26	development	NN	O	development	nn	27	SENT_57	[p3l1592t1813r1795b1851],
27	process	NN	O	process	prep_of	20	SENT_57	[p3l1809t1823r1932b1851],
28	.	.	O	.	_	0	SENT_57	[p3l1809t1823r1932b1851],

1	A	DT	O	a	det	3	SENT_58	[p3l1947t1814r1974b1841],
2	recent	JJ	O	recent	amod	3	SENT_58	[p3l1986t1821r2085b1842],
3	report	NN	O	report	nsubj	9	SENT_58	[p3l566t1871r665b1901],
4	from	IN	O	from	_	0	SENT_58	[p3l676t1863r752b1891],
5	the	DT	O	the	det	8	SENT_58	[p3l765t1862r813b1891],
6	International	NNP	ORGANIZATION	International	nn	8	SENT_58	[p3l826t1862r1032b1891],
7	Transporter	NNP	ORGANIZATION	Transporter	nn	8	SENT_58	[p3l1043t1863r1237b1901],
8	Consortium	NNP	ORGANIZATION	Consortium	prep_from	3	SENT_58	[p3l1250t1863r1440b1891],
9	provides	VBZ	O	provide	_	0	SENT_58	[p3l1452t1862r1584b1901],
10	some	DT	O	some	det	53	SENT_58	[p3l1597t1873r1678b1891],
11	guidance	NN	O	guidance	amod	53	SENT_58	[p3l1691t1862r1830b1901],
12	for	IN	O	for	_	0	SENT_58	[p3l1843t1863r1888b1891],
13	the	DT	O	the	det	14	SENT_58	[p3l1900t1862r1949b1891],
14	circumstances	NNS	O	circumstance	prep_for	11	SENT_58	[p3l1962t1864r2084b1891, p3l566t1921r675b1941],
15	under	IN	O	under	_	0	SENT_58	[p3l688t1912r780b1941],
16	which	WDT	O	which	dobj	21	SENT_58	[p3l791t1912r886b1941],
17	transporter	NN	O	transporter	nn	18	SENT_58	[p3l898t1921r1075b1951],
18	studies	NNS	O	study	nsubjpass	21	SENT_58	[p3l1087t1912r1193b1941],
19	may	MD	O	may	aux	21	SENT_58	[p3l1206t1923r1272b1951],
20	be	VB	O	be	auxpass	21	SENT_58	[p3l1283t1912r1318b1941],
21	indicated	VBN	O	indicate	prepc_under	11	SENT_58	[p3l1331t1912r1474b1941],
22	for	IN	O	for	_	0	SENT_58	[p3l1487t1912r1533b1941],
23	a	DT	O	a	det	26	SENT_58	[p3l1545t1923r1560b1941],
24	new	JJ	O	new	amod	26	SENT_58	[p3l1572t1923r1636b1941],
25	molecular	JJ	O	molecular	amod	26	SENT_58	[p3l1648t1912r1804b1941],
26	entity	NN	O	entity	prep_for	21	SENT_58	[p3l1817t1914r1908b1951],
27	during	IN	O	during	_	0	SENT_58	[p3l1919t1912r2024b1951],
28	the	DT	O	the	det	31	SENT_58	[p3l2035t1912r2084b1941],
29	drug	NN	O	drug	nn	31	SENT_58	[p3l567t1962r640b2001],
30	development	NN	O	development	nn	31	SENT_58	[p3l650t1962r853b2000],
31	process	NN	O	process	prep_during	21	SENT_58	[p3l863t1973r987b2000],
32	,	,	O	,	_	0	SENT_58	[p3l863t1973r987b2000],
33	with	IN	O	with	_	0	SENT_58	[p3l998t1962r1068b1991],
34	the	DT	O	the	det	35	SENT_58	[p3l1079t1962r1128b1991],
35	caveat	NN	O	caveat	prep_with	21	SENT_58	[p3l1139t1970r1235b1991],
36	that	IN	O	that	complm	42	SENT_58	[p3l1246t1962r1307b1991],
37	the	DT	O	the	det	40	SENT_58	[p3l1318t1962r1366b1991],
38	proposed	VBN	O	propose	amod	40	SENT_58	[p3l1377t1962r1522b2000],
39	decision	NN	O	decision	nn	40	SENT_58	[p3l1534t1962r1661b1991],
40	structures	NNS	O	structure	nsubj	42	SENT_58	[p3l1673t1970r1826b1991],
41	will	MD	O	will	aux	42	SENT_58	[p3l1837t1962r1894b1991],
42	continue	VB	O	continue	dep	35	SENT_58	[p3l1905t1964r2042b1991],
43	to	TO	O	to	aux	44	SENT_58	[p3l2053t1970r2084b1991],
44	evolve	VB	O	evolve	xcomp	42	SENT_58	[p3l567t2012r664b2041],
45	as	IN	O	as	mark	50	SENT_58	[p3l676t2023r704b2041],
46	the	DT	O	the	det	49	SENT_58	[p3l715t2012r764b2041],
47	drug	NN	O	drug	nn	49	SENT_58	[p3l776t2012r849b2050],
48	transporter	NN	O	transporter	nn	49	SENT_58	[p3l859t2020r1036b2050],
49	ﬁeld	NN	O	ﬁeld	nsubj	50	SENT_58	[p3l1046t2012r1114b2041],
50	matures	VBZ	O	mature	advcl	44	SENT_58	[p3l1125t2020r1249b2041],
51	(	RB	O	(	advmod	50	SENT_58	[p3l1261t2013r1310b2048],
52	1	CD	NUMBER	1	num	53	SENT_58	[p3l1261t2013r1310b2048],
53	)	NN	O	)	dobj	9	SENT_58	[p3l1261t2013r1310b2048],
54	.	.	O	.	_	0	SENT_58	[p3l1261t2013r1310b2048],

1	In	IN	O	in	_	0	SENT_59	[p3l615t2063r649b2090],
2	this	DT	O	this	det	3	SENT_59	[p3l662t2062r717b2091],
3	review	NN	O	review	prep_in	6	SENT_59	[p3l730t2063r841b2097],
4	,	,	O	,	_	0	SENT_59	[p3l730t2063r841b2097],
5	we	PRP	O	we	nsubj	6	SENT_59	[p3l854t2073r897b2091],
6	focus	VBP	O	focus	_	0	SENT_59	[p3l910t2062r990b2091],
7	on	IN	O	on	_	0	SENT_59	[p3l1004t2073r1043b2091],
8	transporters	NNS	O	transporter	prep_on	6	SENT_59	[p3l1056t2070r1245b2100],
9	with	IN	O	with	_	0	SENT_59	[p3l1257t2062r1327b2091],
10	well-deﬁned	JJ	O	well-deﬁned	amod	11	SENT_59	[p3l1338t2062r1534b2091],
11	roles	NNS	O	role	prep_with	8	SENT_59	[p3l1547t2062r1621b2091],
12	in	IN	O	in	_	0	SENT_59	[p3l1634t2063r1664b2090],
13	drug	NN	O	drug	nn	14	SENT_59	[p3l1678t2062r1751b2100],
14	efficacy	NN	O	efficacy	prep_in	11	SENT_59	[p3l1763t2062r1879b2100],
15	and	CC	O	and	_	0	SENT_59	[p3l1891t2062r1946b2091],
16	toxicity	NN	O	toxicity	conj_and	14	SENT_59	[p3l1959t2063r2083b2100],
17	.	.	O	.	_	0	SENT_59	[p3l1959t2063r2083b2100],

1	From	IN	O	from	_	0	SENT_60	[p3l566t2113r653b2141],
2	the	DT	O	the	det	4	SENT_60	[p3l676t2112r725b2141],
3	solute	JJ	O	solute	amod	4	SENT_60	[p3l748t2112r840b2141],
4	carrier	NN	O	carrier	prep_from	26	SENT_60	[p3l864t2113r967b2141],
5	(	CD	NUMBER	(	num	8	SENT_60	[p3l990t2113r1086b2148],
6	SLC	NNP	O	SLC	nn	8	SENT_60	[p3l990t2113r1086b2148],
7	)	CD	NUMBER	)	num	8	SENT_60	[p3l990t2113r1086b2148],
8	superfamily	NN	O	superfamily	nsubj	11	SENT_60	[p3l1109t2112r1300b2150],
9	,	,	O	,	_	0	SENT_60	[p3l1109t2112r1300b2150],
10	these	DT	O	these	nsubj	11	SENT_60	[p3l1325t2111r1404b2141],
11	include	VBP	O	include	dep	26	SENT_60	[p3l1427t2111r1541b2141],
12	the	DT	O	the	det	15	SENT_60	[p3l1565t2111r1613b2141],
13	organic	JJ	O	organic	amod	15	SENT_60	[p3l1637t2113r1754b2150],
14	cation	NN	O	cation	nn	15	SENT_60	[p3l1777t2113r1872b2141],
15	transporters	NNS	O	transporter	nsubj	16	SENT_60	[p3l1895t2120r2084b2150],
16	(	VBP	O	(	ccomp	11	SENT_60	[p3l567t2162r846b2198],
17	OCTs/SLC22/1	NN	O	octs/slc22/1	nn	18	SENT_60	[p3l567t2162r846b2198],
18	)	NN	O	)	dobj	16	SENT_60	[p3l567t2162r846b2198],
19	,	,	O	,	_	0	SENT_60	[p3l567t2162r846b2198],
20	the	DT	O	the	det	21	SENT_60	[p3l857t2161r906b2190],
21	multidrug	JJ	O	multidrug	nsubj	26	SENT_60	[p3l915t2161r1074b2200],
22	and	CC	O	and	_	0	SENT_60	[p3l1083t2161r1138b2190],
23	toxin	NN	O	toxin	nn	25	SENT_60	[p3l1148t2163r1227b2190],
24	extrusion	NN	O	extrusion	nn	25	SENT_60	[p3l1238t2163r1382b2190],
25	transporters	NNS	O	transporter	conj_and	21	SENT_60	[p3l1391t2170r1581b2200],
26	(	VBP	O	(	_	0	SENT_60	[p3l1592t2162r1717b2198],
27	MATE	NN	O	mate	nn	28	SENT_60	[p3l1592t2162r1717b2198],
28	transporters	NNS	O	transporter	nsubj	37	SENT_60	[p3l1727t2163r1931b2200],
29	/	:	O	/	punct	31	SENT_60	[p3l1727t2163r1931b2200],
30	SLC47/1	NN	O	slc47/1	nn	31	SENT_60	[p3l1932t2162r2083b2198],
31	)	NN	O	)	dep	28	SENT_60	[p3l1932t2162r2083b2198],
32	,	,	O	,	_	0	SENT_60	[p3l1932t2162r2083b2198],
33	the	DT	O	the	det	36	SENT_60	[p3l566t2211r615b2240],
34	organic	JJ	O	organic	amod	36	SENT_60	[p3l625t2213r742b2250],
35	anion	NN	O	anion	nn	36	SENT_60	[p3l751t2213r838b2240],
36	transporters	NNS	O	transporter	appos	31	SENT_60	[p3l848t2219r1037b2249],
37	(	VBP	O	(	ccomp	26	SENT_60	[p3l1048t2212r1323b2247],
38	OATS/SLCZZA	NN	O	oats/slczza	nn	39	SENT_60	[p3l1048t2212r1323b2247],
39	)	NN	O	)	dobj	37	SENT_60	[p3l1048t2212r1323b2247],
40	,	,	O	,	_	0	SENT_60	[p3l1048t2212r1323b2247],
41	and	CC	O	and	_	0	SENT_60	[p3l1335t2211r1390b2240],
42	the	DT	O	the	det	44	SENT_60	[p3l1400t2211r1449b2240],
43	organic	JJ	O	organic	amod	44	SENT_60	[p3l1459t2213r1576b2250],
44	anion	NN	O	anion	nsubj	45	SENT_60	[p3l1585t2213r1672b2240],
45	transporting	VBG	O	transport	conj_and	26	SENT_60	[p3l1682t2213r1877b2250],
46	polypeptides	NNS	O	polypeptide	nsubj	49	SENT_60	[p3l1885t2211r2084b2250],
47	(	CD	NUMBER	(	num	49	SENT_60	[p3l567t2262r829b2297],
48	OATPS/SLCO	NN	O	oatps/slco	nn	49	SENT_60	[p3l567t2262r829b2297],
49	)	NN	O	)	xcomp	45	SENT_60	[p3l567t2262r829b2297],
50	.	.	O	.	_	0	SENT_60	[p3l567t2262r829b2297],

1	Members	NNS	O	member	nsubj	16	SENT_61	[p3l844t2261r994b2290],
2	of	IN	O	of	_	0	SENT_61	[p3l1010t2261r1044b2290],
3	the	DT	O	the	det	5	SENT_61	[p3l1055t2261r1104b2290],
4	ATP-binding	JJ	O	atp-binding	amod	5	SENT_61	[p3l1118t2261r1333b2300],
5	cassette	NN	O	cassette	prep_of	1	SENT_61	[p3l1348t2269r1466b2290],
6	(	CD	NUMBER	(	num	9	SENT_61	[p3l1482t2262r1580b2297],
7	ABC	NNP	ORGANIZATION	ABC	nn	9	SENT_61	[p3l1482t2262r1580b2297],
8	)	CD	NUMBER	)	num	9	SENT_61	[p3l1482t2262r1580b2297],
9	superfamily	NN	O	superfamily	nsubj	16	SENT_61	[p3l1596t2261r1781b2300],
10	important	JJ	O	important	advmod	16	SENT_61	[p3l1794t2263r1952b2299],
11	in	IN	O	in	_	0	SENT_61	[p3l1966t2263r1997b2290],
12	drug	NN	O	drug	nn	13	SENT_61	[p3l2012t2261r2085b2300],
13	efﬁcacy	NN	O	efﬁcacy	prep_in	10	SENT_61	[p3l567t2311r683b2349],
14	and	CC	O	and	_	0	SENT_61	[p3l698t2311r753b2340],
15	toxicity	NN	O	toxicity	conj_and	13	SENT_61	[p3l770t2312r887b2349],
16	include	VBP	O	include	_	0	SENT_61	[p3l901t2311r1015b2340],
17	P-glycoprotein	NN	O	p-glycoprotein	nn	20	SENT_61	[p3l1031t2311r1268b2349],
18	(	CD	NUMBER	(	num	20	SENT_61	[p3l1285t2312r1557b2347],
19	MDRI/ABCB1	NN	O	mdri/abcb1	nn	20	SENT_61	[p3l1285t2312r1557b2347],
20	)	NN	O	)	dobj	16	SENT_61	[p3l1285t2312r1557b2347],
21	,	,	O	,	_	0	SENT_61	[p3l1285t2312r1557b2347],
22	breast	NN	O	breast	nn	28	SENT_61	[p3l1575t2311r1669b2340],
23	cancer	NN	O	cancer	nn	28	SENT_61	[p3l1685t2322r1786b2340],
24	resistance	NN	O	resistance	nn	28	SENT_61	[p3l1801t2312r1953b2340],
25	protein	NN	O	protein	nn	28	SENT_61	[p3l1970t2312r2085b2349],
26	(	CD	NUMBER	(	num	28	SENT_61	[p3l567t2362r834b2397],
27	BCRP/ABCG2	NN	O	bcrp/abcg2	nn	28	SENT_61	[p3l567t2362r834b2397],
28	)	NN	O	)	conj_and	20	SENT_61	[p3l567t2362r834b2397],
29	,	,	O	,	_	0	SENT_61	[p3l567t2362r834b2397],
30	and	CC	O	and	_	0	SENT_61	[p3l849t2361r904b2389],
31	transporters	NNS	O	transporter	conj_and	20	SENT_61	[p3l918t2369r1107b2399],
32	of	IN	O	of	_	0	SENT_61	[p3l1122t2361r1156b2390],
33	the	DT	O	the	det	41	SENT_61	[p3l1165t2361r1214b2390],
34	multidrug	JJ	O	multidrug	amod	41	SENT_61	[p3l1228t2361r1386b2399],
35	resistance-associated	JJ	O	resistance-associated	amod	41	SENT_61	[p3l1398t2361r1723b2390],
36	protein	NN	O	protein	nn	41	SENT_61	[p3l1736t2362r1851b2399],
37	(	NN	O	(	nn	41	SENT_61	[p3l1865t2361r2050b2397],
38	MRP/ABC	NN	O	mrp/abc	nn	41	SENT_61	[p3l1865t2361r2050b2397],
39	C	NN	O	c	nn	41	SENT_61	[p3l2051t2362r2083b2397],
40	)	NN	O	)	nn	41	SENT_61	[p3l2051t2362r2083b2397],
41	family	NN	O	family	prep_of	31	SENT_61	[p3l566t2399r671b2438],
42	.	.	O	.	_	0	SENT_61	[p3l566t2399r671b2438],

1	UPTAKE	NNP	O	UPTAKE	nn	2	SENT_62	[p3l565t2513r752b2545],
2	TRANSPORTERS	NNPS	O	TRANSPORTERS	_	0	SENT_62	[p3l764t2513r1129b2545],
3	OF	IN	O	of	_	0	SENT_62	[p3l1143t2513r1205b2545],
4	THE	DT	O	the	det	7	SENT_62	[p3l1215t2513r1315b2544],
5	SOLUTE	NNP	O	SOLUTE	nn	7	SENT_62	[p3l566t2563r751b2595],
6	CARRIER	NNP	O	CARRIER	nn	7	SENT_62	[p3l764t2564r964b2595],
7	SUPERFAMILY	NNP	O	SUPERFAMILY	prep_of	2	SENT_62	[p3l976t2564r1293b2595],

1	The	DT	O	the	det	3	SENT_63	[p3l565t2632r631b2661],
2	SLC	NNP	O	SLC	nn	3	SENT_63	[p3l646t2633r717b2661],
3	superfamily	NN	O	superfamily	nsubj	7	SENT_63	[p3l731t2632r915b2671],
4	is	VBZ	O	be	cop	7	SENT_63	[p3l925t2634r948b2661],
5	a	DT	O	a	det	7	SENT_63	[p3l962t2643r976b2661],
6	large	JJ	O	large	amod	7	SENT_63	[p3l989t2632r1066b2671],
7	family	NN	O	family	_	0	SENT_63	[p3l1079t2632r1177b2671],
8	of	IN	O	of	_	0	SENT_63	[p3l1189t2632r1223b2661],
9	membrane-bound	JJ	O	membrane-bound	amod	10	SENT_63	[p3l1231t2632r1514b2661],
10	transporters	NNS	O	transporter	prep_of	7	SENT_63	[p3l1527t2640r1716b2671],
11	that	WDT	O	that	nsubj	12	SENT_63	[p3l1729t2632r1791b2661],
12	share	VBP	O	share	rcmod	7	SENT_63	[p3l1803t2632r1884b2661],
13	20-25	CD	PERCENT	20-25	num	14	SENT_63	[p3l1897t2633r2024b2662],
14	%	NN	PERCENT	%	dobj	12	SENT_63	[p3l1897t2633r2024b2662],
15	sequence	NN	O	sequence	nn	16	SENT_63	[p3l2040t2643r2083b2661, p3l567t2691r676b2719],
16	homology	NN	O	homology	dep	14	SENT_63	[p3l693t2680r860b2719],
17	.	.	O	.	_	0	SENT_63	[p3l693t2680r860b2719],

1	SLC	NNP	O	SLC	nn	2	SENT_64	[p3l880t2681r951b2709],
2	transporters	NNS	O	transporter	nsubj	3	SENT_64	[p3l968t2688r1157b2719],
3	translocate	VBP	O	translocate	_	0	SENT_64	[p3l1175t2680r1344b2709],
4	their	PRP$	O	they	poss	5	SENT_64	[p3l1362t2680r1436b2709],
5	substrates	NNS	O	substrate	dobj	3	SENT_64	[p3l1452t2680r1605b2709],
6	across	IN	O	across	_	0	SENT_64	[p3l1623t2691r1716b2709],
7	biological	JJ	O	biological	amod	8	SENT_64	[p3l1733t2680r1886b2719],
8	membranes	NNS	O	membrane	prep_across	3	SENT_64	[p3l1903t2680r2084b2709],
9	through	IN	O	through	_	0	SENT_64	[p3l566t2728r693b2767],
10	numerous	JJ	O	numerous	amod	11	SENT_64	[p3l705t2739r862b2758],
11	mechanisms	NNS	O	mechanism	prep_through	3	SENT_64	[p3l875t2728r1075b2764],
12	,	,	O	,	_	0	SENT_64	[p3l875t2728r1075b2764],
13	including	VBG	O	include	_	0	SENT_64	[p3l1089t2728r1238b2767],
14	facilitated	VBN	O	facilitate	prepc_including	3	SENT_64	[p3l1250t2728r1404b2758],
15	diﬂiusion	NN	O	diﬂiusion	dobj	14	SENT_64	[p3l1418t2728r1561b2764],
16	,	,	O	,	_	0	SENT_64	[p3l1418t2728r1561b2764],
17	ion	NN	O	ion	nn	18	SENT_64	[p3l1575t2730r1626b2758],
18	coupling	NN	O	coupling	dobj	14	SENT_64	[p3l1639t2728r1784b2767],
19	,	,	O	,	_	0	SENT_64	[p3l1639t2728r1784b2767],
20	and	CC	O	and	_	0	SENT_64	[p3l1799t2728r1854b2758],
21	ion	NN	O	ion	nn	22	SENT_64	[p3l1867t2730r1918b2758],
22	exchange	NN	O	exchange	dobj	14	SENT_64	[p3l1931t2728r2083b2767],
23	,	,	O	,	_	0	SENT_64	[p3l1931t2728r2083b2767],
24	which	WDT	O	which	nsubjpass	31	SENT_64	[p3l565t2776r668b2812],
25	,	,	O	,	_	0	SENT_64	[p3l565t2776r668b2812],
26	in	IN	O	in	_	0	SENT_64	[p3l680t2778r710b2805],
27	some	DT	O	some	det	28	SENT_64	[p3l721t2787r802b2805],
28	cases	NNS	O	case	prep_in	31	SENT_64	[p3l814t2787r898b2812],
29	,	,	O	,	_	0	SENT_64	[p3l814t2787r898b2812],
30	is	VBZ	O	be	auxpass	31	SENT_64	[p3l911t2778r933b2805],
31	driven	VBN	O	drive	rcmod	22	SENT_64	[p3l946t2776r1044b2805],
32	by	IN	O	by	_	0	SENT_64	[p3l1055t2776r1093b2815],
33	an	DT	O	a	det	35	SENT_64	[p3l1103t2787r1139b2805],
34	ion	NN	O	ion	nn	35	SENT_64	[p3l1150t2778r1200b2805],
35	gradient	NN	O	gradient	agent	31	SENT_64	[p3l1212t2776r1342b2815],
36	that	WDT	O	that	nsubjpass	38	SENT_64	[p3l1352t2776r1414b2805],
37	is	VBZ	O	be	auxpass	38	SENT_64	[p3l1424t2778r1447b2805],
38	maintained	VBN	O	maintain	rcmod	35	SENT_64	[p3l1458t2776r1633b2805],
39	by	IN	O	by	_	0	SENT_64	[p3l1645t2776r1683b2815],
40	active	JJ	O	active	amod	41	SENT_64	[p3l1693t2778r1781b2805],
41	transporters	NNS	O	transporter	agent	38	SENT_64	[p3l1793t2784r1982b2815],
42	of	IN	O	of	_	0	SENT_64	[p3l1994t2776r2028b2805],
43	the	DT	O	the	det	48	SENT_64	[p3l2035t2776r2084b2805],
44	ABC	NNP	ORGANIZATION	ABC	nn	48	SENT_64	[p3l565t2825r641b2853],
45	superfamily	NN	O	superfamily	nn	48	SENT_64	[p3l653t2824r837b2863],
46	(	NN	O	(	nn	48	SENT_64	[p3l848t2825r896b2860],
47	4	CD	NUMBER	4	num	48	SENT_64	[p3l848t2825r896b2860],
48	)	NN	O	)	prep_of	41	SENT_64	[p3l848t2825r896b2860],
49	.	.	O	.	_	0	SENT_64	[p3l848t2825r896b2860],

1	DEGWTET	NNP	O	DEGWTET	_	0	SENT_65	[p3l566t2938r677b2960],
2	et	FW	O	et	nn	3	SENT_65	[p3l684t2943r704b2960],
3	al.	FW	O	al.	dep	1	SENT_65	[p3l710t2938r736b2960],
4	.	.	O	.	_	0	SENT_65	[p3l710t2938r736b2960],

1	Intestinal	JJ	O	intestinal	amod	3	SENT_66	[p3l1688t3114r1943b3160],
2	Blood	NN	O	blood	nn	3	SENT_66	[p3l739t3178r896b3225],
3	lumen	NN	O	luman	_	0	SENT_66	[p3l1730t3178r1901b3225],

1	Enterocyte	NN	O	enterocyte	_	0	SENT_67	[p3l993t3470r1290b3528],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_68	[p4l6t2191r51b2404],
2	.	.	O	.	_	0	SENT_68	[p4l6t2191r51b2404],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_69	[p4l6t1711r52b2168],
2	-273	CD	NUMBER	-273	_	0	SENT_69	[p4l6t1711r52b2168],
3	.	.	O	.	_	0	SENT_69	[p4l6t1711r52b2168],

1	Downloaded	VBN	O	download	_	0	SENT_70	[p4l6t1357r51b1690],
2	from	IN	O	from	_	0	SENT_70	[p4l6t1214r51b1339],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_70	[p4l6t561r65b1196],
4	of	IN	O	of	_	0	SENT_70	[p4l71t2337r117b2393],
5	Wisconsin	NNP	LOCATION	Wisconsin	nn	7	SENT_70	[p4l71t2050r117b2324],
6	—	NNP	O	—	nn	7	SENT_70	[p4l99t2014r103b2031],
7	Madison	NNP	O	Madison	prep_of	3	SENT_70	[p4l71t1767r117b1994],
8	on	IN	O	on	_	0	SENT_70	[p4l85t1686r117b1748],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_70	[p4l71t1425r117b1667],
10	.	.	O	.	_	0	SENT_70	[p4l71t1425r117b1667],

1	For	IN	O	for	_	0	SENT_71	[p4l72t1313r117b1404],
2	personal	JJ	O	personal	amod	3	SENT_71	[p4l71t1077r130b1297],
3	use	NN	O	use	pobj	1	SENT_71	[p4l85t974r117b1059],
4	only	RB	O	only	advmod	3	SENT_71	[p4l71t828r130b955],
5	.	.	O	.	_	0	SENT_71	[p4l71t828r130b955],

1	Blood	NN	O	blood	_	0	SENT_72	[p4l303t2616r531b2684],

1	MRP3	NN	O	mrp3	_	0	SENT_73	[p4l568t174r723b219],
2	é	NN	O	é	dep	1	SENT_73	[p4l749t155r1131b234],
3	.	.	O	.	_	0	SENT_73	[p4l749t155r1131b234],

1	<	JJR	O	<	_	0	SENT_74	[p4l1332t248r1676b328],
2	-	:	O	-	_	0	SENT_74	[p4l1332t248r1676b328],
3	.	.	O	.	_	0	SENT_74	[p4l1332t248r1676b328],

1	OATP2B1	NN	O	oatp2b1	_	0	SENT_75	[p4l1707t267r1953b312],

1	€	NN	O	€	_	0	SENT_76	[p4l1340t439r1685b518],
2	.	.	O	.	_	0	SENT_76	[p4l1340t439r1685b518],

1	ASBT	NN	O	asbt	_	0	SENT_77	[p4l1707t457r1851b502],

1	é	NN	O	é	_	0	SENT_78	[p4l1340t627r1685b707],
2	.	.	O	.	_	0	SENT_78	[p4l1340t627r1685b707],

1	PEPT1	NN	O	pept1	_	0	SENT_79	[p4l1710t648r1868b692],

1	Blood	NN	O	blood	_	0	SENT_80	[p4l739t1042r896b1089],

1	C	NN	O	c	nn	2	SENT_81	[p4l705t1205r744b1255],
2	Hepatocyte	NN	O	hepatocyte	_	0	SENT_81	[p4l1017t1223r1336b1282],

1	MATE1	NN	O	mate1	nn	2	SENT_82	[p4l1341t1302r1523b1347],
2	BSEP	NN	O	bsep	_	0	SENT_82	[p4l2020t1302r2153b1347],

1	OATP1B1	CD	NUMBER	oatp1b1	num	2	SENT_83	[p4l417t1385r726b1437],
2	,3	CD	NUMBER	,3	_	0	SENT_83	[p4l417t1385r726b1437],

1	OATP2B1	CD	NUMBER	oatp2b1	number	2	SENT_84	[p4l472t1454r718b1499],
2	‘	CD	NUMBER	‘	num	3	SENT_84	[p4l751t1416r1094b1496],
3	.9	NN	NUMBER	.9	_	0	SENT_84	[p4l751t1416r1094b1496],

1	OCT1	NN	O	oct1	_	0	SENT_85	[p4l520t1624r725b1677],
2	,3	CD	NUMBER	,3	num	3	SENT_85	[p4l520t1624r725b1677],
3	—	NN	O	—	dep	1	SENT_85	[p4l751t1605r1095b1685],
4	.9	CD	NUMBER	.9	dep	1	SENT_85	[p4l751t1605r1095b1685],

1	MRP2	NN	O	mrp2	_	0	SENT_86	[p4l1107t1701r1622b1781],
2	—	NN	O	—	dep	1	SENT_86	[p4l1107t1701r1622b1781],
3	.	.	O	.	_	0	SENT_86	[p4l1107t1701r1622b1781],

1	$	$	MONEY	$	_	0	SENT_87	[p4l1107t1701r1622b1781],
2	Blle	JJ	MONEY	blle	dep	1	SENT_87	[p4l1730t1714r1827b1761],

1	MRP3	NN	O	mrp3	_	0	SENT_88	[p4l513t1815r727b1867],
2	,4	CD	NUMBER	,4	number	3	SENT_88	[p4l513t1815r727b1867],
3	6	CD	NUMBER	6	num	1	SENT_88	[p4l751t1796r1095b1876, p4l576t2006r726b2051],
4	.	.	O	.	_	0	SENT_88	[p4l751t1796r1095b1876, p4l576t2006r726b2051],

1	OAT2	NN	O	oat2	_	0	SENT_89	[p4l751t1796r1095b1876, p4l576t2006r726b2051],

1	—	NN	O	—	_	0	SENT_90	[p4l759t1987r1103b2067],
2	.9	CD	NUMBER	.9	dep	1	SENT_90	[p4l759t1987r1103b2067],
3	/	:	O	/	punct	1	SENT_90	[p4l1456t1898r1702b2144],
4	Z	NN	O	z	nn	5	SENT_90	[p4l1456t1898r1702b2144],
5	R	NN	O	r	dep	1	SENT_90	[p4l1831t1898r2077b2144],
6	‘	CD	NUMBER	‘	dep	5	SENT_90	[p4l1831t1898r2077b2144],
7	NTCP	NN	O	ntcp	dep	6	SENT_90	[p4l581t2197r726b2242],
8	—	NN	O	—	dobj	7	SENT_90	[p4l759t2176r1103b2256],
9	.9	CD	NUMBER	.9	rcmod	8	SENT_90	[p4l759t2176r1103b2256],
10	BCRP	NN	O	bcrp	prep	9	SENT_90	[p4l1342t2161r1484b2207],
11	P	NN	O	p	dep	10	SENT_90	[p4l2020t2162r2145b2219],
12	'	''	O	'	_	0	SENT_90	[p4l2020t2162r2145b2219],
13	9	CD	NUMBER	9	dep	9	SENT_90	[p4l2020t2162r2145b2219],
14	'	''	O	'	_	0	SENT_90	[p4l2020t2162r2145b2219],
15	°	SYM	O	°	dep	8	SENT_90	[p4l2020t2162r2145b2219],

1	Urine	NN	O	urine	_	0	SENT_91	[p4l1760t2617r1973b2684],

1	Kidney	NN	O	kidney	_	0	SENT_92	[p4l804t2875r1081b2963],
2	proximal	JJ	O	proximal	amod	3	SENT_92	[p4l763t2969r1116b3055],
3	tubule	NN	O	tubule	dep	1	SENT_92	[p4l807t3062r1071b3132],

1	—	NN	O	—	_	0	SENT_93	[p4l1163t3160r1661b3275],
2	.9	CD	NUMBER	.9	num	1	SENT_93	[p4l1163t3160r1661b3275],
3	MATE1	NN	O	mate1	dep	1	SENT_93	[p4l1709t3183r2153b3258],
4	,2	CD	NUMBER	,2	num	3	SENT_93	[p4l1709t3183r2153b3258],
5	.	.	O	.	_	0	SENT_93	[p4l1709t3183r2153b3258],

1	—	NN	O	—	_	0	SENT_94	[p4l1709t3183r2153b3258],
2	.	.	O	.	_	0	SENT_94	[p4l1709t3183r2153b3258],

1	K	NN	O	k	_	0	SENT_95	[p4l1709t3183r2153b3258],

1	oAT1	NN	O	oat1	_	0	SENT_96	[p4l7t3324r871b3440],
2	,3	CD	NUMBER	,3	dep	1	SENT_96	[p4l7t3324r871b3440],
3	.	.	O	.	_	0	SENT_96	[p4l7t3324r871b3440],

1	—	NN	O	—	_	0	SENT_97	[p4l7t3324r871b3440],
2	.	.	O	.	_	0	SENT_97	[p4l7t3324r871b3440],

1	C	NN	O	c	_	0	SENT_98	[p4l7t3324r871b3440],
2	+	CC	O	+	_	0	SENT_98	[p4l7t3324r871b3440],
3	-19	CD	NUMBER	-19	num	6	SENT_98	[p4l1163t3324r1661b3440],
4	P-gp	JJ	O	p-gp	amod	6	SENT_98	[p4l1710t3349r1892b3433],
5	ocT2	NN	O	oct2	nn	6	SENT_98	[p4l84t3494r871b3610],
6	—	NN	O	—	conj_+	1	SENT_98	[p4l84t3494r871b3610],
7	.	.	O	.	_	0	SENT_98	[p4l84t3494r871b3610],

1	-9	CD	NUMBER	-9	num	2	SENT_99	[p4l84t3494r871b3610],
2	—	NN	O	—	_	0	SENT_99	[p4l1163t3494r1661b3610],
3	.9	CD	NUMBER	.9	num	4	SENT_99	[p4l1163t3494r1661b3610],
4	MRP2	NN	O	mrp2	dep	2	SENT_99	[p4l1709t3522r2020b3597],
5	,4	CD	NUMBER	,4	num	6	SENT_99	[p4l1709t3522r2020b3597],
6	é	NN	O	é	dep	4	SENT_99	[p4l1175t3667r1675b3782],
7	.	.	O	.	_	0	SENT_99	[p4l1175t3667r1675b3782],

1	PEPT1	NN	O	pept1	_	0	SENT_100	[p4l1710t3694r2031b3769],
2	,2	CD	NUMBER	,2	num	1	SENT_100	[p4l1710t3694r2031b3769],

1	An	DT	O	a	det	2	SENT_101	[p5l41t2050r64b2090],
2	nu	NN	O	nu	_	0	SENT_101	[p5l48t2006r64b2045],
3	.	.	O	.	_	0	SENT_101	[p5l48t2006r64b2045],

1	Rev.	NNP	O	Rev.	nn	2	SENT_102	[p5l41t1935r64b1995],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_102	[p5l41t1776r64b1925],
3	.	.	O	.	_	0	SENT_102	[p5l41t1776r64b1925],

1	by	IN	O	by	_	0	SENT_103	[p5l74t1918r105b1951],
2	University	NNP	O	University	nn	3	SENT_103	[p5l74t1769r105b1909],
3	iews.org	NN	O	iews.org	pobj	1	SENT_103	[p5l74t3279r104b3392],

1	Figure	NNP	O	Figure	_	0	SENT_104	[p5l226t1793r325b1826],
2	1	CD	NUMBER	1	dep	1	SENT_104	[p5l339t1793r350b1817],

1	OCTN1	NN	O	octn1	_	0	SENT_105	[p5l1707t73r2062b149],
2	,2	CD	NUMBER	,2	num	1	SENT_105	[p5l1707t73r2062b149],

1	Blood	NN	O	blood	nn	2	SENT_106	[p5l830t397r1057b465],
2	Brain	NN	O	brain	_	0	SENT_106	[p5l1924t400r2125b465],

1	Blood-brain	JJ	O	blood-brain	amod	2	SENT_107	[p5l1242t647r1713b715],
2	barrier	NN	O	barrier	_	0	SENT_107	[p5l1346t741r1614b810],

1	OATP1A2	CD	NUMBER	oatp1a2	num	2	SENT_108	[p5l1394t1528r1774b1595],
2	OATPZB1	NN	O	oatpzb1	_	0	SENT_108	[p5l1394t1629r1756b1694],

1	Expression	NN	O	expression	_	0	SENT_109	[p5l227t1845r379b1878],
2	of	IN	O	of	_	0	SENT_109	[p5l389t1844r420b1870],
3	transporters	NNS	O	transporter	prep_of	1	SENT_109	[p5l426t1851r594b1878],
4	with	IN	O	with	_	0	SENT_109	[p5l603t1844r665b1870],
5	major	JJ	O	major	amod	6	SENT_109	[p5l675t1845r756b1878],
6	roles	NNS	O	role	prep_with	3	SENT_109	[p5l765t1844r831b1870],
7	in	IN	O	in	_	0	SENT_109	[p5l841t1845r868b1869],
8	drug	NN	O	drug	nn	9	SENT_109	[p5l878t1844r943b1878],
9	efﬁcacy	NN	O	efﬁcacy	prep_in	1	SENT_109	[p5l953t1844r1056b1878],
10	or	CC	O	or	_	0	SENT_109	[p5l1065t1853r1094b1870],
11	toxicity	NN	O	toxicity	conj_or	9	SENT_109	[p5l1104t1845r1208b1878],
12	in	IN	O	in	_	0	SENT_109	[p5l1216t1845r1243b1869],
13	(	CD	NUMBER	(	prep_in	1	SENT_109	[p5l1253t1845r1287b1876],
14	a	DT	O	a	det	15	SENT_109	[p5l1253t1845r1287b1876],
15	)	NN	O	)	dep	26	SENT_109	[p5l1253t1845r1287b1876],
16	human	JJ	O	human	amod	18	SENT_109	[p5l1297t1844r1393b1870],
17	intestinal	JJ	O	intestinal	amod	18	SENT_109	[p5l1403t1844r1531b1870],
18	epithelia	NN	O	epithelium	dep	15	SENT_109	[p5l1541t1844r1667b1878],
19	,	,	O	,	_	0	SENT_109	[p5l1541t1844r1667b1878],
20	(	CD	NUMBER	(	num	21	SENT_109	[p5l1679t1845r1712b1877],
21	Ia	NN	MISC	ia	appos	18	SENT_109	[p5l1679t1845r1712b1877],
22	)	CD	NUMBER	)	num	23	SENT_109	[p5l1679t1845r1712b1877],
23	kidney	NN	O	kidney	dep	26	SENT_109	[p5l1722t1844r1817b1878],
24	proximal	JJ	O	proximal	amod	26	SENT_109	[p5l1825t1844r1948b1878],
25	tubule	NN	O	tubule	nn	26	SENT_109	[p5l1958t1844r2045b1870],
26	epithelia	NN	O	epithelium	dep	37	SENT_109	[p5l227t1885r353b1919],
27	,	,	O	,	_	0	SENT_109	[p5l227t1885r353b1919],
28	(	NN	O	(	nn	31	SENT_109	[p5l365t1886r394b1918],
29	c	NN	O	c	nn	31	SENT_109	[p5l365t1886r394b1918],
30	)	CD	NUMBER	)	num	31	SENT_109	[p5l365t1886r394b1918],
31	hepatocytes	NNS	O	hepatocyte	dep	37	SENT_109	[p5l404t1885r575b1920],
32	,	,	O	,	_	0	SENT_109	[p5l404t1885r575b1920],
33	and	CC	O	and	_	0	SENT_109	[p5l587t1885r636b1911],
34	(	NN	O	(	nn	35	SENT_109	[p5l647t1886r686b1918],
35	d	NN	O	d	dep	37	SENT_109	[p5l647t1886r686b1918],
36	)	CD	NUMBER	)	num	37	SENT_109	[p5l647t1886r686b1918],
37	brain	NN	O	brain	dep	1	SENT_109	[p5l696t1885r768b1911],
38	capillary	JJ	O	capillary	amod	40	SENT_109	[p5l779t1885r897b1920],
39	endothelial	JJ	O	endothelial	amod	40	SENT_109	[p5l906t1885r1061b1911],
40	cells	NNS	O	cell	dep	37	SENT_109	[p5l1071t1885r1138b1911],
41	.	.	O	.	_	0	SENT_109	[p5l1071t1885r1138b1911],

1	Transporters	NNS	O	transporter	nsubjpass	7	SENT_110	[p5l1148t1886r1332b1919],
2	discussed	VBN	O	discuss	partmod	1	SENT_110	[p5l1343t1885r1470b1911],
3	in	IN	O	in	_	0	SENT_110	[p5l1480t1887r1507b1911],
4	the	DT	O	the	det	5	SENT_110	[p5l1517t1885r1560b1911],
5	text	NN	O	text	prep_in	2	SENT_110	[p5l1570t1893r1622b1911],
6	are	VBP	O	be	auxpass	7	SENT_110	[p5l1631t1895r1672b1911],
7	colored	VBN	O	color	_	0	SENT_110	[p5l1683t1885r1787b1911],
8	red	JJ	O	red	acomp	7	SENT_110	[p5l1797t1885r1849b1911],
9	.	.	O	.	_	0	SENT_110	[p5l1797t1885r1849b1911],

1	NTCP	NNP	ORGANIZATION	NTCP	nn	3	SENT_111	[p5l1860t1886r1967b1917],
2	,	,	O	,	_	0	SENT_111	[p5l1860t1886r1967b1917],
3	ASBT	NNP	O	ASBT	nsubj	10	SENT_111	[p5l1977t1886r2072b1917],
4	,	,	O	,	_	0	SENT_111	[p5l1977t1886r2072b1917],
5	and	CC	O	and	_	0	SENT_111	[p5l227t1927r276b1953],
6	BSEP	NN	O	bsep	nsubj	10	SENT_111	[p5l287t1928r368b1953],
7	are	VBP	O	be	cop	10	SENT_111	[p5l379t1936r420b1953],
8	bile	NN	O	bile	nn	10	SENT_111	[p5l430t1927r480b1953],
9	acid	NN	O	acid	nn	10	SENT_111	[p5l491t1927r545b1953],
10	transporters	NNS	O	transporter	_	0	SENT_111	[p5l556t1934r731b1961],
11	.	.	O	.	_	0	SENT_111	[p5l556t1934r731b1961],

1	PEPT1	NN	O	pept1	nn	4	SENT_112	[p5l742t1927r846b1952],
2	and	CC	O	and	_	0	SENT_112	[p5l859t1927r908b1953],
3	PEPT2	NN	O	pept2	nn	4	SENT_112	[p5l918t1927r1022b1952],
4	transport	NN	O	transport	_	0	SENT_112	[p5l1035t1934r1164b1961],
5	small	JJ	O	small	amod	7	SENT_112	[p5l1173t1927r1244b1953],
6	peptide	NN	O	peptide	nn	7	SENT_112	[p5l1254t1927r1357b1961],
7	fragments	NNS	O	fragment	dep	4	SENT_112	[p5l1367t1927r1513b1961],
8	.	.	O	.	_	0	SENT_112	[p5l1367t1927r1513b1961],

1	OCTN1	NN	O	octn1	nn	4	SENT_113	[p5l1525t1927r1645b1953],
2	and	CC	O	and	_	0	SENT_113	[p5l1658t1927r1708b1953],
3	OCTN2	NN	O	octn2	nn	4	SENT_113	[p5l1718t1927r1839b1953],
4	transport	NN	O	transport	_	0	SENT_113	[p5l1851t1934r1980b1961],
5	organic	JJ	O	organic	amod	6	SENT_113	[p5l1989t1928r2093b1961],
6	cations	NNS	O	cation	dep	4	SENT_113	[p5l227t1970r323b1994],
7	and	CC	O	and	_	0	SENT_113	[p5l334t1968r383b1994],
8	carnitine	NN	O	carnitine	dep	4	SENT_113	[p5l394t1970r523b1994],
9	.	.	O	.	_	0	SENT_113	[p5l394t1970r523b1994],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_114	[p5l534t1968r735b1994],
2	:	:	O	:	_	0	SENT_114	[p5l534t1968r735b1994],
3	ASBT	NNP	O	ASBT	dep	1	SENT_114	[p5l745t1969r840b2000],
4	,	,	O	,	_	0	SENT_114	[p5l745t1969r840b2000],
5	apical	JJ	O	apical	amod	7	SENT_114	[p5l852t1968r931b2002],
6	sodium-dependent	JJ	O	sodium-dependent	amod	7	SENT_114	[p5l941t1968r1203b2002],
7	bile	NN	O	bile	appos	3	SENT_114	[p5l1212t1968r1262b1994],
8	acid	NN	O	acid	nn	9	SENT_114	[p5l1273t1968r1328b1994],
9	cotransporter	NN	O	cotransporter	dep	7	SENT_114	[p5l1338t1976r1534b2002],
10	;	:	O	;	_	0	SENT_114	[p5l1338t1976r1534b2002],
11	BCRP	NN	O	bcrp	dep	7	SENT_114	[p5l1545t1969r1642b2000],
12	,	,	O	,	_	0	SENT_114	[p5l1545t1969r1642b2000],
13	breast	NN	O	breast	nn	16	SENT_114	[p5l1653t1968r1737b1994],
14	cancer	NN	O	cancer	nn	16	SENT_114	[p5l1746t1978r1836b1994],
15	resistance	NN	O	resistance	nn	16	SENT_114	[p5l1845t1970r1980b1994],
16	protein	NN	O	protein	appos	11	SENT_114	[p5l1990t1970r2099b2002],
17	;	:	O	;	_	0	SENT_114	[p5l1990t1970r2099b2002],
18	BSEP	NNP	O	BSEP	dep	7	SENT_114	[p5l227t2011r316b2041],
19	,	,	O	,	_	0	SENT_114	[p5l227t2011r316b2041],
20	bile-salt	JJ	O	bile-salt	amod	22	SENT_114	[p5l327t2010r439b2036],
21	export	NN	O	export	nn	22	SENT_114	[p5l449t2017r538b2044],
22	pump	NN	O	pump	appos	18	SENT_114	[p5l546t2019r634b2044],
23	;	:	O	;	_	0	SENT_114	[p5l546t2019r634b2044],
24	MATE	NNP	O	MATE	dep	7	SENT_114	[p5l643t2010r753b2041],
25	,	,	O	,	_	0	SENT_114	[p5l643t2010r753b2041],
26	multidrug	JJ	O	multidrug	amod	29	SENT_114	[p5l764t2010r905b2044],
27	and	CC	O	and	_	0	SENT_114	[p5l914t2010r964b2036],
28	toxin	NN	O	toxin	amod	29	SENT_114	[p5l974t2011r1044b2036],
29	extrusion	NN	O	extrusion	appos	24	SENT_114	[p5l1054t2011r1189b2041],
30	;	:	O	;	_	0	SENT_114	[p5l1054t2011r1189b2041],
31	MRP	NN	ORGANIZATION	mrp	dep	7	SENT_114	[p5l1199t2011r1283b2041],
32	,	,	O	,	_	0	SENT_114	[p5l1199t2011r1283b2041],
33	multidrug	JJ	O	multidrug	amod	35	SENT_114	[p5l1294t2010r1434b2044],
34	resistance-associated	JJ	O	resistance-associated	amod	35	SENT_114	[p5l1443t2010r1731b2036],
35	protein	NN	O	protein	appos	31	SENT_114	[p5l1741t2011r1850b2044],
36	;	:	O	;	_	0	SENT_114	[p5l1741t2011r1850b2044],
37	NTCP	NN	O	ntcp	dep	7	SENT_114	[p5l1861t2010r1968b2041],
38	,	,	O	,	_	0	SENT_114	[p5l1861t2010r1968b2041],
39	sodium	NN	O	sodium	nn	40	SENT_114	[p5l227t2055r489b2090],
40	—	NN	O	—	appos	37	SENT_114	[p5l227t2055r489b2090],
41	dependent	JJ	O	dependent	amod	42	SENT_114	[p5l227t2055r489b2090],
42	taurocholate	JJ	O	taurocholate	amod	44	SENT_114	[p5l498t2055r673b2082],
43	cotransporting	NN	O	cotransporting	nn	44	SENT_114	[p5l683t2057r889b2090],
44	polypeptide	NN	O	polypeptide	dep	40	SENT_114	[p5l898t2055r1070b2090],
45	;	:	O	;	_	0	SENT_114	[p5l898t2055r1070b2090],
46	OAT	NN	O	oat	dep	7	SENT_114	[p5l1081t2056r1162b2087],
47	,	,	O	,	_	0	SENT_114	[p5l1081t2056r1162b2087],
48	organic	JJ	O	organic	amod	50	SENT_114	[p5l1174t2057r1277b2090],
49	anion	NN	O	anion	nn	50	SENT_114	[p5l1288t2057r1365b2082],
50	transporter	NN	O	transporter	appos	46	SENT_114	[p5l1375t2063r1538b2090],
51	;	:	O	;	_	0	SENT_114	[p5l1375t2063r1538b2090],
52	OATP	NNP	O	OATP	dep	7	SENT_114	[p5l1550t2056r1652b2087],
53	,	,	O	,	_	0	SENT_114	[p5l1550t2056r1652b2087],
54	organic	JJ	O	organic	amod	55	SENT_114	[p5l1663t2057r1767b2090],
55	anion	NN	O	anion	appos	52	SENT_114	[p5l1777t2057r1854b2082],
56	transporting	VBG	O	transport	partmod	3	SENT_114	[p5l1864t2057r2038b2090],
57	polypeptide	NN	O	polypeptide	dobj	56	SENT_114	[p5l226t2091r398b2125],
58	;	:	O	;	_	0	SENT_114	[p5l226t2091r398b2125],
59	OCT	NN	DATE	oct	dep	1	SENT_114	[p5l410t2091r494b2122],
60	,	,	O	,	_	0	SENT_114	[p5l410t2091r494b2122],
61	organic	JJ	O	organic	amod	63	SENT_114	[p5l505t2092r609b2125],
62	cation	NN	O	cation	nn	63	SENT_114	[p5l619t2092r704b2117],
63	transporter	NN	O	transporter	appos	59	SENT_114	[p5l714t2098r877b2125],
64	;	:	O	;	_	0	SENT_114	[p5l714t2098r877b2125],
65	OCTN	NNP	O	OCTN	dep	59	SENT_114	[p5l889t2091r1002b2122],
66	,	,	O	,	_	0	SENT_114	[p5l889t2091r1002b2122],
67	organic	JJ	O	organic	amod	69	SENT_114	[p5l1013t2092r1117b2125],
68	Cation/carnitine	NN	O	cation/carnitine	nn	69	SENT_114	[p5l1127t2092r1348b2117],
69	transporter	NN	O	transporter	appos	65	SENT_114	[p5l1358t2098r1522b2125],
70	;	:	O	;	_	0	SENT_114	[p5l1358t2098r1522b2125],
71	PEPT	NNP	O	PEPT	dep	59	SENT_114	[p5l1532t2091r1629b2122],
72	,	,	O	,	_	0	SENT_114	[p5l1532t2091r1629b2122],
73	peptide	NN	O	peptide	nn	74	SENT_114	[p5l1640t2091r1743b2125],
74	transporter	NN	O	transporter	appos	71	SENT_114	[p5l1753t2098r1917b2125],
75	;	:	O	;	_	0	SENT_114	[p5l1753t2098r1917b2125],
76	P-gp	NN	O	p-gp	dep	59	SENT_114	[p5l226t2133r302b2166],
77	,	,	O	,	_	0	SENT_114	[p5l226t2133r302b2166],
78	P-glycoprotein	NN	O	p-glycoprotein	appos	76	SENT_114	[p5l313t2132r530b2166],
79	.	.	O	.	_	0	SENT_114	[p5l313t2132r530b2166],

1	Organic	NNP	O	Organic	nn	6	SENT_115	[p5l227t2214r379b2256],
2	Cation	NNP	O	Cation	nn	6	SENT_115	[p5l393t2214r520b2246],
3	Transporters	NNP	O	Transporters	nn	6	SENT_115	[p5l531t2214r782b2256],
4	Organic	NNP	O	Organic	nn	6	SENT_115	[p5l227t2265r355b2303],
5	cation	NN	O	cation	nn	6	SENT_115	[p5l371t2265r466b2293],
6	transporters	NNS	O	transporter	nsubj	7	SENT_115	[p5l481t2272r670b2303],
7	(	VBP	O	(	_	0	SENT_115	[p5l686t2265r956b2301],
8	OCTs/SLCZZA	NN	O	octs/slczza	nn	9	SENT_115	[p5l686t2265r956b2301],
9	)	NN	O	)	nsubj	13	SENT_115	[p5l686t2265r956b2301],
10	identiﬁed	VBN	O	identiﬁed	partmod	9	SENT_115	[p5l972t2264r1121b2293],
11	in	IN	O	in	_	0	SENT_115	[p5l1136t2265r1166b2293],
12	humans	NNS	O	human	prep_in	10	SENT_115	[p5l1181t2264r1303b2293],
13	include	VBP	O	include	ccomp	7	SENT_115	[p5l1318t2264r1433b2293],
14	OCT1	NN	O	oct1	nn	17	SENT_115	[p5l1449t2265r1551b2293],
15	(	CD	NUMBER	(	num	17	SENT_115	[p5l1571t2265r1744b2301],
16	SLC22/ll	NN	O	slc22/ll	nn	17	SENT_115	[p5l1571t2265r1744b2301],
17	)	NN	O	)	dobj	13	SENT_115	[p5l1571t2265r1744b2301],
18	and	CC	O	and	_	0	SENT_115	[p5l227t2311r282b2341],
19	OCT2	NN	O	oct2	nn	22	SENT_115	[p5l300t2312r403b2341],
20	(	CD	NUMBER	(	num	22	SENT_115	[p5l423t2312r605b2348],
21	SLC22/12	NN	O	slc22/12	nn	22	SENT_115	[p5l423t2312r605b2348],
22	)	NN	O	)	conj_and	17	SENT_115	[p5l423t2312r605b2348],
23	,	,	O	,	_	0	SENT_115	[p5l423t2312r605b2348],
24	which	WDT	O	which	nsubjpass	27	SENT_115	[p5l622t2311r717b2341],
25	are	VBP	O	be	auxpass	27	SENT_115	[p5l734t2322r780b2341],
26	predominantly	RB	O	predominantly	advmod	27	SENT_115	[p5l797t2311r1030b2350],
27	expressed	VBN	O	express	rcmod	22	SENT_115	[p5l1045t2311r1194b2350],
28	on	IN	O	on	_	0	SENT_115	[p5l1211t2322r1250b2341],
29	the	DT	O	the	det	31	SENT_115	[p5l1267t2311r1315b2341],
30	basolateral	JJ	O	basolateral	amod	31	SENT_115	[p5l1332t2311r1500b2341],
31	membranes	NNS	O	membrane	prep_on	27	SENT_115	[p5l1516t2311r1697b2341],
32	of	IN	O	of	_	0	SENT_115	[p5l1715t2311r1749b2341],
33	hepatocytes	NNS	O	hepatocyte	prep_of	31	SENT_115	[p5l226t2358r410b2397],
34	and	CC	O	and	_	0	SENT_115	[p5l427t2358r482b2387],
35	kidney	NN	O	kidney	dobj	13	SENT_115	[p5l498t2358r604b2397],
36	proximal	JJ	O	proximal	amod	37	SENT_115	[p5l618t2358r757b2397],
37	tubules	NNS	O	tubule	dep	35	SENT_115	[p5l773t2358r894b2394],
38	,	,	O	,	_	0	SENT_115	[p5l773t2358r894b2394],
39	respectively	RB	O	respectively	advmod	35	SENT_115	[p5l911t2358r1103b2397],
40	,	,	O	,	_	0	SENT_115	[p5l911t2358r1103b2397],
41	and	CC	O	and	_	0	SENT_115	[p5l1121t2358r1176b2387],
42	OCT3	NN	O	oct3	nn	45	SENT_115	[p5l1193t2359r1295b2388],
43	(	CD	NUMBER	(	num	45	SENT_115	[p5l1316t2359r1498b2395],
44	SLCZZA3	NN	O	slczza3	nn	45	SENT_115	[p5l1316t2359r1498b2395],
45	)	NN	O	)	dobj	13	SENT_115	[p5l1316t2359r1498b2395],
46	,	,	O	,	_	0	SENT_115	[p5l1316t2359r1498b2395],
47	which	WDT	O	which	nsubjpass	51	SENT_115	[p5l1514t2358r1608b2387],
48	is	VBZ	O	be	auxpass	51	SENT_115	[p5l1624t2360r1647b2387],
49	more	RBR	O	more	advmod	50	SENT_115	[p5l1663t2369r1744b2387],
50	widely	RB	O	widely	advmod	51	SENT_115	[p5l225t2405r329b2444],
51	expressed	VBN	O	express	rcmod	45	SENT_115	[p5l346t2405r494b2444],
52	in	IN	O	in	_	0	SENT_115	[p5l511t2406r541b2434],
53	tissues	NNS	O	tissue	prep_in	51	SENT_115	[p5l559t2406r658b2434],
54	throughout	IN	O	throughout	_	0	SENT_115	[p5l676t2405r856b2444],
55	the	DT	O	the	det	56	SENT_115	[p5l873t2405r921b2434],
56	body	NN	O	body	prep_throughout	53	SENT_115	[p5l939t2405r1024b2444],
57	.	.	O	.	_	0	SENT_115	[p5l939t2405r1024b2444],

1	OCTs	NNS	O	oct	nsubj	4	SENT_116	[p5l1043t2406r1143b2434],
2	are	VBP	O	be	cop	4	SENT_116	[p5l1161t2416r1208b2434],
3	uptake	NN	O	uptake	nn	4	SENT_116	[p5l1224t2405r1329b2444],
4	transporters	NNS	O	transporter	_	0	SENT_116	[p5l1346t2413r1535b2444],
5	that	WDT	O	that	nsubj	6	SENT_116	[p5l1553t2405r1615b2434],
6	control	VBP	O	control	rcmod	4	SENT_116	[p5l1632t2405r1744b2434],
7	cellular	JJ	O	cellular	amod	8	SENT_116	[p5l227t2452r342b2482],
8	entry	NN	O	entry	dobj	6	SENT_116	[p5l359t2460r442b2491],
9	of	IN	O	of	_	0	SENT_116	[p5l457t2452r491b2482],
10	small	JJ	O	small	prep_of	8	SENT_116	[p5l504t2452r593b2488],
11	,	,	O	,	_	0	SENT_116	[p5l504t2452r593b2488],
12	positively	RB	O	positively	advmod	13	SENT_116	[p5l611t2452r762b2491],
13	charged	VBN	O	charge	partmod	10	SENT_116	[p5l777t2452r901b2491],
14	compounds	NNS	O	compound	dobj	13	SENT_116	[p5l918t2452r1107b2491],
15	,	,	O	,	_	0	SENT_116	[p5l918t2452r1107b2491],
16	including	VBG	O	include	_	0	SENT_116	[p5l1125t2452r1274b2491],
17	endogenous	JJ	O	endogenous	amod	18	SENT_116	[p5l1290t2452r1477b2491],
18	substrates	NNS	O	substrate	prep_including	10	SENT_116	[p5l1495t2452r1657b2488],
19	,	,	O	,	_	0	SENT_116	[p5l1495t2452r1657b2488],
20	such	JJ	O	such	_	0	SENT_116	[p5l1675t2452r1745b2482],
21	as	IN	O	as	_	0	SENT_116	[p5l227t2510r255b2528],
22	monoamine	NN	O	monoamine	nn	23	SENT_116	[p5l271t2501r458b2528],
23	neurotransmitters	NNS	O	neurotransmitter	prep_such_as	10	SENT_116	[p5l473t2501r755b2528],
24	and	CC	O	and	_	0	SENT_116	[p5l771t2499r826b2528],
25	creatinine	NN	O	creatinine	conj_and	23	SENT_116	[p5l842t2501r1006b2535],
26	,	,	O	,	_	0	SENT_116	[p5l842t2501r1006b2535],
27	and	CC	O	and	_	0	SENT_116	[p5l1023t2499r1079b2528],
28	numerous	JJ	O	numerous	amod	30	SENT_116	[p5l1094t2510r1250b2528],
29	drug	NN	O	drug	nn	30	SENT_116	[p5l1267t2499r1340b2538],
30	substrates	NNS	O	substrate	prep_such_as	10	SENT_116	[p5l1354t2499r1516b2535],
31	,	,	O	,	_	0	SENT_116	[p5l1354t2499r1516b2535],
32	including	VBG	O	include	_	0	SENT_116	[p5l1532t2499r1681b2538],
33	the	DT	O	the	det	35	SENT_116	[p5l1696t2499r1744b2528],
34	platinum-containing	JJ	O	platinum-containing	amod	35	SENT_116	[p5l226t2547r551b2585],
35	antineoplastics	NNS	O	antineoplastic	prep_including	10	SENT_116	[p5l562t2547r801b2585],
36	,	,	O	,	_	0	SENT_116	[p5l562t2547r801b2585],
37	the	DT	O	the	det	39	SENT_116	[p5l814t2547r863b2576],
38	antidiabetic	JJ	O	antidiabetic	amod	39	SENT_116	[p5l875t2547r1058b2576],
39	metformin	NN	O	metformin	conj_and	35	SENT_116	[p5l1069t2547r1246b2582],
40	,	,	O	,	_	0	SENT_116	[p5l1069t2547r1246b2582],
41	and	CC	O	and	_	0	SENT_116	[p5l1259t2547r1314b2576],
42	the	DT	O	the	det	45	SENT_116	[p5l1327t2547r1375b2576],
43	histamine	NN	O	histamine	nn	45	SENT_116	[p5l1387t2547r1539b2576],
44	H2	NN	O	h2	nn	45	SENT_116	[p5l1551t2548r1599b2575],
45	receptor	NN	O	receptor	prep_including	10	SENT_116	[p5l1613t2555r1745b2585],

1	SNP	NN	O	snp	_	0	SENT_117	[p5l194t2816r270b2841],
2	:	:	O	:	_	0	SENT_117	[p5l194t2816r270b2841],
3	single-nucleotide	JJ	O	single-nucleotide	amod	4	SENT_117	[p5l193t2857r433b2891],
4	polymorphism	NN	O	polymorphism	dep	1	SENT_117	[p5l193t2903r397b2938],

1	*	NN	O	*	nn	2	SENT_118	[p5l1216t2648r1490b2678],
2	www.¢mnualreview5.arg	NN	O	www.¢mnualreview5.arg	_	0	SENT_118	[p5l1216t2648r1490b2678],
3	o	NN	O	o	nn	5	SENT_118	[p5l1505t2656r1514b2666],
4	Drug	NN	O	drug	nn	5	SENT_118	[p5l1531t2648r1594b2678],
5	Tmmponferx	NN	O	tmmponferx	dep	2	SENT_118	[p5l1602t2648r1746b2677],
6	251	CD	NUMBER	251	dep	2	SENT_118	[p5l1797t2655r1838b2677],

1	antagonist	NN	O	antagonist	nn	2	SENT_119	[p5l567t2691r730b2729],
2	cimetidine	NN	O	cimetidine	_	0	SENT_119	[p5l744t2690r909b2719],
3	(	CD	NUMBER	(	num	5	SENT_119	[p5l925t2691r1012b2727],
4	5-7	CD	NUMBER	5-7	num	5	SENT_119	[p5l925t2691r1012b2727],
5	)	NN	O	)	dep	2	SENT_119	[p5l925t2691r1012b2727],
6	.	.	O	.	_	0	SENT_119	[p5l925t2691r1012b2727],

1	OCT	NN	DATE	oct	nn	2	SENT_120	[p5l1029t2690r1116b2719],
2	expression	NN	O	expression	nsubj	5	SENT_120	[p5l1131t2691r1294b2729],
3	is	VBZ	O	be	cop	5	SENT_120	[p5l1309t2691r1331b2719],
4	highly	RB	O	highly	advmod	5	SENT_120	[p5l1346t2690r1447b2729],
5	variable	JJ	O	variable	_	0	SENT_120	[p5l1459t2690r1581b2719],
6	among	IN	O	among	_	0	SENT_120	[p5l1597t2701r1704b2729],
7	individuals	NNS	O	individual	prep_among	5	SENT_120	[p5l1718t2690r1896b2726],
8	,	,	O	,	_	0	SENT_120	[p5l1718t2690r1896b2726],
9	which	WDT	O	which	nsubj	13	SENT_120	[p5l1911t2690r2005b2719],
10	may	MD	O	may	aux	13	SENT_120	[p5l2020t2701r2086b2729],
11	be	VB	O	be	cop	13	SENT_120	[p5l567t2739r602b2769],
12	a	DT	O	a	det	13	SENT_120	[p5l617t2750r632b2769],
13	result	NN	O	result	rcmod	7	SENT_120	[p5l645t2739r734b2769],
14	of	IN	O	of	_	0	SENT_120	[p5l747t2739r781b2769],
15	genetic	JJ	O	genetic	amod	16	SENT_120	[p5l791t2741r903b2778],
16	variants	NNS	O	variant	prep_of	13	SENT_120	[p5l916t2741r1038b2769],
17	or	CC	O	or	_	0	SENT_120	[p5l1052t2750r1086b2769],
18	disease	NN	O	disease	nn	19	SENT_120	[p5l1099t2739r1206b2769],
19	processes	NNS	O	process	prep_of	13	SENT_120	[p5l1220t2750r1374b2778],
20	:	:	O	:	_	0	SENT_120	[p5l1220t2750r1374b2778],
21	A	DT	O	a	det	22	SENT_120	[p5l1388t2740r1415b2768],
22	study	NN	O	study	nsubj	34	SENT_120	[p5l1427t2739r1511b2778],
23	of	IN	O	of	_	0	SENT_120	[p5l1524t2739r1558b2769],
24	OCT1	NN	O	oct1	nn	27	SENT_120	[p5l1568t2740r1671b2769],
25	and	CC	O	and	_	0	SENT_120	[p5l1688t2739r1744b2769],
26	OCT3	NN	O	oct3	nn	27	SENT_120	[p5l1759t2740r1861b2769],
27	expression	NN	O	expression	prep_of	22	SENT_120	[p5l1879t2741r2042b2778],
28	in	IN	O	in	_	0	SENT_120	[p5l2054t2741r2085b2768],
29	150	CD	NUMBER	150	num	30	SENT_120	[p5l570t2791r623b2819],
30	livers	NNS	O	liver	prep_in	27	SENT_120	[p5l635t2789r717b2818],
31	from	IN	O	from	_	0	SENT_120	[p5l729t2790r806b2818],
32	Caucasian	JJ	LOCATION	caucasian	amod	33	SENT_120	[p5l818t2790r976b2818],
33	subjects	NNS	O	subject	prep_from	30	SENT_120	[p5l987t2789r1109b2828],
34	revealed	VBD	O	reveal	parataxis	5	SENT_120	[p5l1121t2789r1250b2818],
35	signiﬁcant	JJ	O	signiﬁcant	amod	36	SENT_120	[p5l1262t2790r1425b2828],
36	Variation	NN	O	variation	dobj	34	SENT_120	[p5l1434t2791r1573b2818],
37	that	WDT	O	that	nsubjpass	39	SENT_120	[p5l1585t2789r1646b2818],
38	was	VBD	O	be	auxpass	39	SENT_120	[p5l1656t2801r1712b2818],
39	associated	VBN	O	associate	rcmod	36	SENT_120	[p5l1724t2789r1880b2818],
40	with	IN	O	with	_	0	SENT_120	[p5l1891t2789r1961b2818],
41	genetic	JJ	O	genetic	amod	42	SENT_120	[p5l1973t2791r2085b2828],
42	polymorphisms	NNS	O	polymorphism	prep_with	39	SENT_120	[p5l567t2839r809b2878],
43	and	CC	O	and	_	0	SENT_120	[p5l821t2839r877b2868],
44	cholestasis	NN	O	cholestasis	nn	47	SENT_120	[p5l888t2839r1052b2868],
45	(	NN	O	(	nn	47	SENT_120	[p5l1064t2840r1113b2876],
46	8	CD	NUMBER	8	num	47	SENT_120	[p5l1064t2840r1113b2876],
47	)	NN	O	)	prep_with	39	SENT_120	[p5l1064t2840r1113b2876],
48	.	.	O	.	_	0	SENT_120	[p5l1064t2840r1113b2876],

1	Organic	NNP	O	Organic	nn	3	SENT_121	[p5l567t2920r704b2958],
2	cation	NN	O	cation	nn	3	SENT_121	[p5l713t2920r817b2949],
3	transporters	NNS	O	transporter	_	0	SENT_121	[p5l825t2927r1033b2958],
4	in	IN	O	in	_	0	SENT_121	[p5l1042t2921r1075b2948],
5	efﬁcacy	NN	O	efﬁcacy	prep_in	3	SENT_121	[p5l1084t2919r1218b2958],
6	.	.	O	.	_	0	SENT_121	[p5l1084t2919r1218b2958],

1	The	DT	O	the	det	2	SENT_122	[p5l1238t2919r1305b2949],
2	importance	NN	O	importance	nsubjpass	11	SENT_122	[p5l1313t2921r1491b2958],
3	of	IN	O	of	_	0	SENT_122	[p5l1500t2919r1534b2949],
4	cation	NN	O	cation	nn	5	SENT_122	[p5l1539t2921r1634b2949],
5	transport	NN	O	transport	prep_of	2	SENT_122	[p5l1642t2928r1786b2958],
6	in	IN	O	in	_	0	SENT_122	[p5l1793t2921r1823b2948],
7	drug	NN	O	drug	nn	8	SENT_122	[p5l1832t2919r1905b2958],
8	efﬁcacy	NN	O	efﬁcacy	prep_in	5	SENT_122	[p5l1913t2919r2028b2958],
9	has	VBZ	O	have	aux	11	SENT_122	[p5l2034t2919r2084b2949],
10	been	VBN	O	be	auxpass	11	SENT_122	[p5l567t2969r641b2998],
11	appreciated	VBN	O	appreciate	_	0	SENT_122	[p5l654t2969r834b3008],
12	as	IN	O	as	_	0	SENT_122	[p5l847t2980r875b2998],
13	a	DT	O	a	det	14	SENT_122	[p5l888t2980r903b2998],
14	result	NN	O	result	prep_as	11	SENT_122	[p5l915t2969r1004b2998],
15	of	IN	O	of	_	0	SENT_122	[p5l1016t2969r1050b2998],
16	studies	NNS	O	study	prep_of	14	SENT_122	[p5l1058t2969r1164b2998],
17	of	IN	O	of	_	0	SENT_122	[p5l1177t2969r1212b2998],
18	metformin	NN	O	metformin	prep_of	16	SENT_122	[p5l1220t2969r1396b3005],
19	,	,	O	,	_	0	SENT_122	[p5l1220t2969r1396b3005],
20	a	DT	O	a	det	22	SENT_122	[p5l1411t2980r1425b2998],
21	commonly	RB	O	commonly	advmod	22	SENT_122	[p5l1438t2969r1606b3008],
22	prescribed	VBN	O	prescribe	appos	18	SENT_122	[p5l1617t2969r1780b3008],
23	antidiabetic	JJ	O	antidiabetic	amod	22	SENT_122	[p5l1793t2969r1976b2998],
24	whose	WP$	O	whose	dep	29	SENT_122	[p5l1987t2969r2084b2998],
25	clinical	JJ	O	clinical	amod	26	SENT_122	[p5l567t3018r677b3047],
26	response	NN	O	response	nsubj	29	SENT_122	[p5l686t3029r822b3057],
27	is	VBZ	O	be	cop	29	SENT_122	[p5l831t3020r854b3047],
28	highly	RB	O	highly	advmod	29	SENT_122	[p5l863t3018r963b3057],
29	variable	JJ	O	variable	dep	22	SENT_122	[p5l969t3018r1100b3047],
30	.	.	O	.	_	0	SENT_122	[p5l969t3018r1100b3047],

1	Metformin	NNP	O	Metformin	nsubj	2	SENT_123	[p5l1110t3018r1284b3047],
2	lowers	VBZ	O	lower	_	0	SENT_123	[p5l1293t3018r1393b3047],
3	blood	NN	O	blood	nn	4	SENT_123	[p5l1403t3018r1492b3047],
4	glucose	NN	O	glucose	dobj	2	SENT_123	[p5l1502t3018r1617b3057],
5	primarily	RB	O	primarily	advmod	2	SENT_123	[p5l1626t3018r1772b3057],
6	by	IN	O	by	_	0	SENT_123	[p5l1780t3018r1818b3057],
7	reducing	VBG	O	reduce	prepc_by	2	SENT_123	[p5l1825t3018r1964b3057],
8	hepatic	JJ	O	hepatic	amod	10	SENT_123	[p5l1972t3018r2085b3057],
9	glucose	NN	O	glucose	nn	10	SENT_123	[p5l567t3068r683b3107],
10	production	NN	O	production	dobj	7	SENT_123	[p5l696t3068r870b3107],
11	and	CC	O	and	_	0	SENT_123	[p5l883t3068r938b3097],
12	enhancing	VBG	O	enhance	prepc_by	2	SENT_123	[p5l952t3068r1114b3107],
13	peripheral	JJ	O	peripheral	amod	15	SENT_123	[p5l1126t3068r1287b3107],
14	insulin	NN	O	insulin	nn	15	SENT_123	[p5l1299t3068r1405b3097],
15	sensitivity	NN	O	sensitivity	dobj	12	SENT_123	[p5l1418t3070r1575b3107],
16	and	CC	O	and	_	0	SENT_123	[p5l1587t3068r1642b3097],
17	is	VBZ	O	be	auxpass	18	SENT_123	[p5l1655t3070r1678b3097],
18	eliminated	VBN	O	eliminate	conj_and	2	SENT_123	[p5l1692t3068r1856b3097],
19	by	IN	O	by	_	0	SENT_123	[p5l1869t3068r1908b3107],
20	the	DT	O	the	det	21	SENT_123	[p5l1919t3068r1968b3097],
21	kidney	NN	O	kidney	agent	18	SENT_123	[p5l1981t3068r2086b3107],
22	unchanged	JJ	O	unchanged	acomp	2	SENT_123	[p5l566t3118r738b3157],
23	(	CD	NUMBER	(	number	24	SENT_123	[p5l751t3119r800b3155],
24	9	CD	NUMBER	9	num	25	SENT_123	[p5l751t3119r800b3155],
25	)	NN	O	)	dep	22	SENT_123	[p5l751t3119r800b3155],
26	.	.	O	.	_	0	SENT_123	[p5l751t3119r800b3155],

1	A	DT	O	a	det	3	SENT_124	[p5l813t3119r840b3147],
2	large	JJ	O	large	amod	3	SENT_124	[p5l851t3118r927b3157],
3	number	NN	O	number	nsubj	8	SENT_124	[p5l940t3118r1064b3147],
4	of	IN	O	of	_	0	SENT_124	[p5l1076t3118r1111b3147],
5	functional	JJ	O	functional	amod	6	SENT_124	[p5l1119t3118r1278b3147],
6	single-nucleotide	JJ	O	single-nucleotide	amod	7	SENT_124	[p5l1291t3118r1561b3157],
7	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_124	[p5l1574t3118r1816b3157],
8	(	VBP	O	(	_	0	SENT_124	[p5l1830t3119r1941b3155],
9	SNPS	NN	O	snp	nn	10	SENT_124	[p5l1830t3119r1941b3155],
10	)	NN	O	)	nsubjpass	19	SENT_124	[p5l1830t3119r1941b3155],
11	in	IN	O	in	_	0	SENT_124	[p5l1955t3119r1985b3147],
12	genes	NNS	O	gene	prep_in	10	SENT_124	[p5l1998t3129r2084b3157],
13	encoding	VBG	O	encode	partmod	12	SENT_124	[p5l567t3167r712b3206],
14	OCTs	NNS	MISC	oct	dobj	13	SENT_124	[p5l724t3168r823b3197],
15	have	VBP	O	have	aux	17	SENT_124	[p5l836t3167r906b3197],
16	been	VBN	O	be	auxpass	17	SENT_124	[p5l919t3167r993b3197],
17	identiﬁed	VBN	O	identiﬁed	ccomp	8	SENT_124	[p5l1005t3167r1154b3197],
18	and	CC	O	and	_	0	SENT_124	[p5l1167t3167r1222b3197],
19	characterized	VBN	O	characterize	ccomp	8	SENT_124	[p5l1235t3167r1443b3197],
20	in	FW	O	in	prep	17	SENT_124	[p5l1455t3169r1486b3196],
21	vitro	FW	O	vitro	nn	22	SENT_124	[p5l1496t3169r1571b3197],
22	(	FW	O	(	pobj	20	SENT_124	[p5l1584t3168r1710b3204],
23	10-16	CD	NUMBER	10-16	num	24	SENT_124	[p5l1584t3168r1710b3204],
24	)	NN	O	)	dep	22	SENT_124	[p5l1584t3168r1710b3204],
25	,	,	O	,	_	0	SENT_124	[p5l1584t3168r1710b3204],
26	and	CC	O	and	_	0	SENT_124	[p5l1724t3167r1779b3197],
27	subsequent	JJ	O	subsequent	amod	28	SENT_124	[p5l1792t3167r1967b3206],
28	studies	NNS	O	study	nsubj	30	SENT_124	[p5l1978t3167r2084b3197],
29	have	VBP	O	have	aux	30	SENT_124	[p5l566t3217r637b3246],
30	demonstrated	VBN	O	demonstrate	conj_and	8	SENT_124	[p5l652t3217r867b3246],
31	a	DT	O	a	det	32	SENT_124	[p5l881t3228r896b3246],
32	role	NN	O	role	dobj	30	SENT_124	[p5l910t3217r971b3246],
33	for	IN	O	for	_	0	SENT_124	[p5l985t3217r1031b3246],
34	SLC22/l1	NN	O	slc22/l1	nn	37	SENT_124	[p5l1044t3218r1192b3246],
35	and	CC	O	and	_	0	SENT_124	[p5l1210t3217r1265b3246],
36	SLC22A2	NN	O	slc22a2	conj_and	34	SENT_124	[p5l1280t3218r1430b3246],
37	polymorphisms	NNS	O	polymorphism	prep_for	32	SENT_124	[p5l1444t3217r1687b3256],
38	in	IN	O	in	_	0	SENT_124	[p5l1701t3219r1731b3246],
39	mediating	VBG	O	mediate	prepc_in	30	SENT_124	[p5l1745t3217r1903b3256],
40	metformin	JJ	O	metformin	amod	41	SENT_124	[p5l1916t3217r2085b3246],
41	pharmacokinetics	NNS	O	pharmacokinetic	dobj	39	SENT_124	[p5l566t3266r842b3305],
42	and	CC	O	and	_	0	SENT_124	[p5l853t3266r908b3296],
43	response	NN	O	response	nsubj	47	SENT_124	[p5l918t3277r1054b3305],
44	in	IN	O	in	_	0	SENT_124	[p5l1064t3268r1094b3295],
45	healthy	JJ	O	healthy	amod	46	SENT_124	[p5l1103t3266r1220b3305],
46	volunteers	NNS	O	volunteer	prep_in	43	SENT_124	[p5l1227t3266r1390b3296],
47	(	VBP	O	(	conj_and	30	SENT_124	[p5l1402t3267r1516b3303],
48	17-21	CD	DATE	17-21	dobj	47	SENT_124	[p5l1402t3267r1516b3303],
49	;	:	O	;	_	0	SENT_124	[p5l1402t3267r1516b3303],
50	Table	NNP	O	Table	dep	48	SENT_124	[p5l1526t3266r1626b3296],
51	1	CD	NUMBER	1	number	52	SENT_124	[p5l1640t3267r1676b3303],
52	)	CD	NUMBER	)	dep	50	SENT_124	[p5l1640t3267r1676b3303],
53	.	.	O	.	_	0	SENT_124	[p5l1640t3267r1676b3303],

1	The	DT	O	the	det	3	SENT_125	[p5l1686t3266r1753b3296],
2	relative	JJ	O	relative	amod	3	SENT_125	[p5l1763t3266r1877b3296],
3	contribution	NN	O	contribution	_	0	SENT_125	[p5l1888t3266r2085b3296],

1	Table	NNP	O	Table	_	0	SENT_126	[p5l199t3356r287b3382],
2	1	CD	NUMBER	1	num	4	SENT_126	[p5l301t3357r313b3381],
3	Transporter	NN	O	transporter	nn	4	SENT_126	[p5l349t3357r536b3390],
4	polymorphisms	NNS	O	polymorphism	dep	1	SENT_126	[p5l545t3356r778b3390],
5	involved	VBN	O	involve	partmod	1	SENT_126	[p5l789t3356r914b3382],
6	in	IN	O	in	_	0	SENT_126	[p5l924t3357r954b3381],
7	metformin	NN	O	metformin	nn	8	SENT_126	[p5l963t3356r1125b3382],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	5	SENT_126	[p5l1135t3356r1400b3390],
9	and	CC	O	and	_	0	SENT_126	[p5l1412t3356r1465b3382],
10	response	NN	O	response	conj_and	8	SENT_126	[p5l1475t3365r1608b3390],

1	Annu	NNP	PERSON	Annu	_	0	SENT_127	[p6l74t1076r97b1156],
2	.	.	O	.	_	0	SENT_127	[p6l74t1076r97b1156],

1	Rev.	NNP	O	Rev.	nn	2	SENT_128	[p6l74t1005r97b1065],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_128	[p6l74t846r97b995],
3	.	.	O	.	_	0	SENT_128	[p6l74t846r97b995],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_129	[p6l74t726r97b835],
2	.	.	O	.	_	0	SENT_129	[p6l74t726r97b835],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_130	[p6l74t480r98b714],
2	-273	CD	NUMBER	-273	_	0	SENT_130	[p6l74t480r98b714],
3	.	.	O	.	_	0	SENT_130	[p6l74t480r98b714],

1	Downloaded	VBN	O	download	_	0	SENT_131	[p6l74t300r97b470],
2	from	IN	O	from	_	0	SENT_131	[p6l74t226r97b291],
3	www	NN	O	www	prep_from	1	SENT_131	[p6l74t7r97b217],
4	.	.	O	.	_	0	SENT_131	[p6l74t7r97b217],

1	annua1rev	NN	O	annua1rev	_	0	SENT_132	[p6l74t7r97b217],
2	by	IN	O	by	_	0	SENT_132	[p6l107t988r138b1021],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_132	[p6l107t839r138b979],
4	of	IN	ORGANIZATION	of	_	0	SENT_132	[p6l107t801r131b829],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_132	[p6l107t654r131b794],
6	-	:	O	-	_	0	SENT_132	[p6l121t635r124b644],
7	Madison	NNP	O	Madison	dep	1	SENT_132	[p6l107t509r131b625],
8	on	IN	O	on	_	0	SENT_132	[p6l115t468r131b500],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_132	[p6l107t334r131b458],
10	.	.	O	.	_	0	SENT_132	[p6l107t334r131b458],

1	For	IN	O	for	_	0	SENT_133	[p6l108t277r131b324],
2	personal	JJ	O	personal	amod	3	SENT_133	[p6l107t157r138b269],
3	use	NN	O	use	pobj	1	SENT_133	[p6l115t104r131b148],
4	only	RB	O	only	advmod	3	SENT_133	[p6l107t30r138b94],
5	.	.	O	.	_	0	SENT_133	[p6l107t30r138b94],

1	Effect	NN	O	effect	_	0	SENT_134	[p6l1585t35r1677b60],
2	of	IN	O	of	prep	1	SENT_134	[p6l1686t35r1719b60],

1	Transporter/polymorphism	NNP	O	Transporter/polymorphism	nn	2	SENT_135	[p6l199t84r618b119],
2	Population	NNP	O	Population	nsubj	3	SENT_135	[p6l706t84r873b118],
3	studied	VBD	O	study	_	0	SENT_135	[p6l883t84r993b110],
4	Experimental	JJ	O	experimental	amod	6	SENT_135	[p6l1070t84r1274b118],
5	approach	NN	O	approach	nn	6	SENT_135	[p6l1284t84r1422b118],
6	polymorphism	NN	O	polymorphism	dobj	3	SENT_135	[p6l1540t84r1760b119],
7	Reference	NNP	O	Reference	nn	9	SENT_135	[p6l1877t84r2067b117],
8	(	CD	NUMBER	(	num	9	SENT_135	[p6l1877t84r2067b117],
9	s	NNS	O	s	nsubj	10	SENT_135	[p6l1877t84r2067b117],
10	)	VBP	O	)	rcmod	6	SENT_135	[p6l1877t84r2067b117],
11	OCT1	NN	O	oct1	nn	13	SENT_135	[p6l201t137r282b162],
12	Healthy	JJ	O	healthy	amod	13	SENT_135	[p6l692t136r806b170],
13	subjects	NNS	O	subject	dobj	10	SENT_135	[p6l814t136r923b170],
14	Candidate	NN	O	candidate	nn	15	SENT_135	[p6l1059t136r1201b162],
15	gene	NN	O	gene	dep	13	SENT_135	[p6l1212t146r1284b170],
16	;	:	O	;	_	0	SENT_135	[p6l1212t146r1284b170],
17	Increased	VBN	O	increase	amod	18	SENT_135	[p6l1485t136r1617b162],
18	Cmax	NN	O	cmax	dep	13	SENT_135	[p6l1628t137r1695b166],
19	and	CC	O	and	_	0	SENT_135	[p6l1707t136r1756b162],
20	20	CD	NUMBER	20	num	21	SENT_135	[p6l1956t137r1989b161],
21	R6lC	NN	O	r6lc	dep	13	SENT_135	[p6l200t182r281b207],
22	(	CD	NUMBER	(	num	23	SENT_135	[p6l292t182r445b214],
23	rs1220835	NN	O	rs1220835	dep	21	SENT_135	[p6l292t182r445b214],
24	7	CD	NUMBER	7	number	25	SENT_135	[p6l449t182r474b214],
25	)	CD	NUMBER	)	num	27	SENT_135	[p6l449t182r474b214],
26	(	NN	O	(	nn	27	SENT_135	[p6l709t182r734b214],
27	n	NN	O	n	npadvmod	28	SENT_135	[p6l709t182r734b214],
28	=	JJ	O	=	amod	23	SENT_135	[p6l751t194r774b203],
29	20	CD	NUMBER	20	number	30	SENT_135	[p6l791t182r833b214],
30	)	CD	NUMBER	)	num	32	SENT_135	[p6l791t182r833b214],
31	Full	JJ	O	full	amod	32	SENT_135	[p6l1075t181r1130b207],
32	pharrnacokinetics	NNS	O	pharrnacokinetic	dep	21	SENT_135	[p6l1140t182r1385b216],
33	AUC	NN	O	auc	nn	34	SENT_135	[p6l1500t182r1575b207],
34	G401S	NN	O	g401	dep	32	SENT_135	[p6l200t228r295b253],
35	(	CD	NUMBER	(	num	38	SENT_135	[p6l307t228r488b259],
36	rs3-4130495	NN	O	rs3-4130495	nn	38	SENT_135	[p6l307t228r488b259],
37	)	NN	O	)	nn	38	SENT_135	[p6l307t228r488b259],
38	proﬁle	NN	O	proﬁle	dep	32	SENT_135	[p6l1075t227r1166b261],
39	42	CD	NUMBER	42	num	47	SENT_135	[p6l199t274r230b299],
40	Odel	NNP	O	Odel	nn	47	SENT_135	[p6l235t273r293b299],
41	(	CD	NUMBER	(	num	47	SENT_135	[p6l303t274r485b305],
42	rs72552763	NN	O	rs72552763	nn	47	SENT_135	[p6l303t274r485b305],
43	)	CD	NUMBER	)	num	47	SENT_135	[p6l303t274r485b305],
44	G465R	NN	O	g465r	nn	47	SENT_135	[p6l200t319r302b344],
45	(	CD	NUMBER	(	num	47	SENT_135	[p6l312t319r493b351],
46	rs34059508	NN	O	rs34059508	nn	47	SENT_135	[p6l312t319r493b351],
47	)	NN	O	)	dep	3	SENT_135	[p6l312t319r493b351],

1	Healthy	JJ	O	healthy	amod	4	SENT_136	[p6l692t371r806b406],
2	subjects	NNS	O	subject	nn	4	SENT_136	[p6l814t371r923b405],
3	Candidate	NN	O	candidate	nn	4	SENT_136	[p6l1059t371r1201b397],
4	gene	NN	O	gene	_	0	SENT_136	[p6l1212t381r1284b406],
5	;	:	O	;	_	0	SENT_136	[p6l1212t381r1284b406],
6	Higher	JJR	O	higher	amod	8	SENT_136	[p6l1485t371r1586b406],
7	plasma	NN	O	plasma	nn	8	SENT_136	[p6l1595t371r1691b405],
8	glucose	NN	O	glucose	dep	4	SENT_136	[p6l1701t371r1804b406],
9	19	CD	NUMBER	19	num	10	SENT_136	[p6l1959t373r1989b397],
10	(	NN	O	(	dep	8	SENT_136	[p6l709t418r734b449],
11	n	NN	O	n	dep	18	SENT_136	[p6l709t418r734b449],
12	=	JJ	O	=	dep	11	SENT_136	[p6l751t430r774b439],
13	21	CD	NUMBER	21	dep	18	SENT_136	[p6l790t418r833b449],
14	)	CD	NUMBER	)	num	18	SENT_136	[p6l790t418r833b449],
15	Oral	JJ	O	oral	amod	18	SENT_136	[p6l1076t417r1138b443],
16	glucose	NN	O	glucose	nn	18	SENT_136	[p6l1149t417r1251b451],
17	tolerance	NN	O	tolerance	nn	18	SENT_136	[p6l1262t417r1390b443],
18	levels	NNS	O	level	dep	4	SENT_136	[p6l1501t417r1577b443],
19	test	NN	O	test	dep	18	SENT_136	[p6l1075t470r1125b488],

1	Polycystic	JJ	MISC	polycystic	amod	4	SENT_137	[p6l692t515r833b550],
2	ovary	NN	O	ovary	nn	4	SENT_137	[p6l843t525r919b550],
3	Candidate	NN	O	candidate	nn	4	SENT_137	[p6l1059t515r1201b541],
4	gene	NN	O	gene	_	0	SENT_137	[p6l1212t525r1284b550],
5	;	:	O	;	_	0	SENT_137	[p6l1212t525r1284b550],
6	Reduced	VBN	O	reduce	amod	7	SENT_137	[p6l1485t515r1606b541],
7	effect	NN	O	effect	dep	4	SENT_137	[p6l1616t515r1691b541],
8	on	IN	O	on	_	0	SENT_137	[p6l1701t525r1735b541],
9	total	JJ	O	total	prepc_on	7	SENT_137	[p6l1745t515r1808b541],
10	29	CD	NUMBER	29	num	12	SENT_137	[p6l1956t517r1989b541],
11	syndrome	NN	O	syndrome	nn	12	SENT_137	[p6l709t561r845b595],
12	patients	NNS	O	patient	iobj	9	SENT_137	[p6l855t562r964b595],
13	Prospective	JJ	MISC	prospective	amod	15	SENT_137	[p6l1075t562r1237b595],
14	population	NN	O	population	nn	15	SENT_137	[p6l1247t561r1398b595],
15	cholesterol	NN	O	cholesterol	dobj	9	SENT_137	[p6l1502t561r1662b592],
16	,	,	O	,	_	0	SENT_137	[p6l1502t561r1662b592],
17	(	NN	O	(	conj_and	4	SENT_137	[p6l709t607r734b639],
18	7	CD	NUMBER	7	num	17	SENT_137	[p6l709t607r734b639],
19	:	:	O	:	_	0	SENT_137	[p6l709t607r734b639],
20	=	JJ	O	=	amod	25	SENT_137	[p6l751t619r774b628],
21	150	CD	NUMBER	150	number	22	SENT_137	[p6l793t608r851b639],
22	)	CD	NUMBER	)	dep	20	SENT_137	[p6l793t608r851b639],
23	cohort	NN	O	cohort	nn	25	SENT_137	[p6l1075t606r1168b632],
24	study	NN	O	study	nn	25	SENT_137	[p6l1177t607r1252b641],
25	triglycerides	NNS	O	triglyceride	dep	17	SENT_137	[p6l1501t607r1681b641],
26	,	,	O	,	_	0	SENT_137	[p6l1501t607r1681b641],
27	and	CC	O	and	_	0	SENT_137	[p6l1693t607r1742b632],
28	insulin	NN	O	insulin	nn	29	SENT_137	[p6l1501t652r1595b678],
29	levels	NNS	O	level	conj_and	4	SENT_137	[p6l1605t652r1680b678],

1	OCT1	NN	O	oct1	nn	3	SENT_138	[p6l201t705r282b729],
2	(	CD	NUMBER	(	num	3	SENT_138	[p6l295t705r442b736],
3	rs62234-2	NN	O	rs62234-2	_	0	SENT_138	[p6l295t705r442b736],
4	)	CD	NUMBER	)	num	6	SENT_138	[p6l295t705r442b736],
5	Diabetic	NNP	MISC	Diabetic	nn	6	SENT_138	[p6l692t704r811b729],
6	patients	NNS	O	patient	dep	3	SENT_138	[p6l820t705r929b738],
7	Candidate	NN	O	candidate	nn	8	SENT_138	[p6l1059t704r1201b729],
8	gene	NN	O	gene	dep	3	SENT_138	[p6l1212t714r1284b738],
9	;	:	O	;	_	0	SENT_138	[p6l1212t714r1284b738],
10	Less	RBR	O	less	advmod	11	SENT_138	[p6l1485t705r1546b729],
11	reduction	NN	O	reduction	amod	8	SENT_138	[p6l1556t704r1690b729],
12	in	IN	O	in	_	0	SENT_138	[p6l1700t705r1727b729],
13	28	CD	NUMBER	28	prep_in	8	SENT_138	[p6l1956t705r1988b729],

1	(	NN	O	(	nn	2	SENT_139	[p6l709t750r734b782],
2	n	NN	O	n	_	0	SENT_139	[p6l709t750r734b782],
3	=	JJ	O	=	quantmod	5	SENT_139	[p6l751t762r774b771],
4	102	CD	NUMBER	102	number	5	SENT_139	[p6l793t750r851b781],
5	)	CD	NUMBER	)	dep	2	SENT_139	[p6l793t750r851b781],
6	Retrospective	JJ	O	retrospective	amod	11	SENT_139	[p6l1075t751r1265b783],
7	population	NN	O	population	nn	11	SENT_139	[p6l1275t749r1426b783],
8	HbAlc	NN	O	hbalc	nn	11	SENT_139	[p6l1501t749r1601b775],
9	measurement	NN	O	measurement	nn	11	SENT_139	[p6l1611t757r1799b775],
10	cohort	NN	O	cohort	nn	11	SENT_139	[p6l1076t795r1168b821],
11	study	NN	O	study	dep	5	SENT_139	[p6l1177t795r1252b829],

1	OC	NNP	O	OC	nn	2	SENT_140	[p6l201t847r247b872],
2	T2	NN	O	t2	nsubj	29	SENT_140	[p6l248t847r284b872],
3	Healthy	JJ	O	healthy	amod	6	SENT_140	[p6l692t846r806b881],
4	subjects	NNS	O	subject	nn	6	SENT_140	[p6l814t847r923b881],
5	Candidate	NN	O	candidate	nn	6	SENT_140	[p6l1059t847r1201b872],
6	gene	NN	O	gene	dep	2	SENT_140	[p6l1212t856r1284b881],
7	;	:	O	;	_	0	SENT_140	[p6l1212t856r1284b881],
8	Reduced	VBN	O	reduce	dep	2	SENT_140	[p6l1485t846r1606b872],
9	metformin	NN	O	metformin	dobj	8	SENT_140	[p6l1616t847r1765b872],
10	17	CD	NUMBER	17	num	9	SENT_140	[p6l1908t848r1945b878],
11	,	,	O	,	_	0	SENT_140	[p6l1908t848r1945b878],
12	18	CD	NUMBER	18	appos	9	SENT_140	[p6l1959t848r1997b878],
13	,	,	O	,	_	0	SENT_140	[p6l1959t848r1997b878],
14	21	CD	NUMBER	21	num	16	SENT_140	[p6l2008t848r2038b872],
15	c.	NN	O	c.	nn	16	SENT_140	[p6l200t893r354b918],
16	808G	NN	O	808g	conj_and	9	SENT_140	[p6l200t893r354b918],
17	>	JJR	O	>	amod	18	SENT_140	[p6l200t893r354b918],
18	T	NN	O	t	dep	16	SENT_140	[p6l200t893r354b918],
19	(	CD	NUMBER	(	num	21	SENT_140	[p6l363t893r510b924],
20	rs316019	NN	O	rs316019	nn	21	SENT_140	[p6l363t893r510b924],
21	)	NN	O	)	dep	16	SENT_140	[p6l363t893r510b924],
22	and	CC	O	and	_	0	SENT_140	[p6l521t892r571b918],
23	Full	JJ	O	full	amod	24	SENT_140	[p6l1075t892r1130b918],
24	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	9	SENT_140	[p6l1140t892r1385b926],
25	renal	JJ	O	renal	amod	26	SENT_140	[p6l1501t892r1571b918],
26	clearance	NN	O	clearance	dep	24	SENT_140	[p6l1581t892r1717b924],
27	;	:	O	;	_	0	SENT_140	[p6l1581t892r1717b924],
28	others	NNS	O	other	dep	2	SENT_140	[p6l217t938r303b964],
29	proﬁle	VBP	O	proﬁle	_	0	SENT_140	[p6l1075t938r1166b972],
30	Increased	VBN	O	increase	amod	31	SENT_140	[p6l1485t938r1617b964],
31	Cmax	NN	O	cmax	dobj	29	SENT_140	[p6l1628t939r1695b968],
32	and	CC	O	and	advmod	31	SENT_140	[p6l1707t938r1756b964],

1	AUC	NN	O	auc	_	0	SENT_141	[p6l1500t984r1575b1009],

1	OCT1	NN	O	oct1	dep	12	SENT_142	[p6l201t1036r291b1066],
2	,	,	O	,	_	0	SENT_142	[p6l201t1036r291b1066],
3	OCT2	NN	O	oct2	appos	1	SENT_142	[p6l305t1036r394b1066],
4	,	,	O	,	_	0	SENT_142	[p6l305t1036r394b1066],
5	OCT3	NN	O	oct3	appos	1	SENT_142	[p6l408t1036r498b1066],
6	,	,	O	,	_	0	SENT_142	[p6l408t1036r498b1066],
7	OCTN1	NN	O	octn1	appos	1	SENT_142	[p6l511t1036r627b1066],
8	,	,	O	,	_	0	SENT_142	[p6l511t1036r627b1066],
9	Healthy	JJ	O	healthy	amod	10	SENT_142	[p6l692t1035r806b1069],
10	subjects	NNS	O	subject	appos	1	SENT_142	[p6l814t1035r923b1069],
11	Candidate	NN	O	candidate	dep	12	SENT_142	[p6l1059t1035r1202b1061],
12	gene	NN	O	gene	dep	25	SENT_142	[p6l1212t1045r1284b1069],
13	;	:	O	;	_	0	SENT_142	[p6l1212t1045r1284b1069],
14	Renal	JJ	O	renal	amod	15	SENT_142	[p6l1485t1035r1565b1061],
15	secretion	NN	O	secretion	dep	12	SENT_142	[p6l1575t1036r1701b1061],
16	22	CD	NUMBER	22	dep	15	SENT_142	[p6l1956t1037r1987b1060],
17	and	CC	O	and	_	0	SENT_142	[p6l217t1080r266b1106],
18	ZVIATE1	NN	O	zviate1	dep	25	SENT_142	[p6l274t1081r386b1106],
19	(	CD	NUMBER	(	num	20	SENT_142	[p6l709t1081r734b1113],
20	n	NN	O	n	npadvmod	21	SENT_142	[p6l709t1081r734b1113],
21	=	JJ	O	=	amod	18	SENT_142	[p6l751t1093r774b1102],
22	103	CD	NUMBER	103	number	23	SENT_142	[p6l793t1082r851b1113],
23	)	CD	NUMBER	)	num	25	SENT_142	[p6l793t1082r851b1113],
24	Full	JJ	O	full	amod	25	SENT_142	[p6l1075t1080r1131b1106],
25	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_142	[p6l1140t1081r1385b1115],
26	increased	VBN	O	increase	partmod	25	SENT_142	[p6l1501t1080r1631b1106],
27	by	IN	O	by	_	0	SENT_142	[p6l1641t1081r1675b1115],
28	OCT	NN	DATE	oct	agent	26	SENT_142	[p6l1684t1081r1762b1106],

1	proﬁle	NN	O	proﬁle	nn	2	SENT_143	[p6l1075t1126r1166b1160],
2	variants	NNS	O	variant	_	0	SENT_143	[p6l1500t1128r1609b1152],

1	ZVIATEI	NNP	LOCATION	ZVIATEI	_	0	SENT_144	[p6l198t1178r319b1209],
2	,	,	O	,	_	0	SENT_144	[p6l198t1178r319b1209],
3	A/IATE2-K	CD	NUMBER	a/iate2-k	num	5	SENT_144	[p6l329t1179r484b1203],
4	Diabetic	NNP	MISC	Diabetic	nn	5	SENT_144	[p6l692t1178r811b1204],
5	patients	NNS	O	patient	appos	1	SENT_144	[p6l820t1179r929b1212],
6	Candidate	NN	O	candidate	nn	7	SENT_144	[p6l1059t1178r1201b1204],
7	gene	NN	O	gene	dep	1	SENT_144	[p6l1212t1188r1284b1212],
8	;	:	O	;	_	0	SENT_144	[p6l1212t1188r1284b1212],
9	No	DT	O	no	det	10	SENT_144	[p6l1484t1179r1530b1204],
10	effect	NN	O	effect	dep	7	SENT_144	[p6l1541t1178r1616b1204],
11	50	CD	NUMBER	50	dep	10	SENT_144	[p6l1957t1179r1989b1204],

1	(	NN	O	(	nn	2	SENT_145	[p6l709t1224r734b1256],
2	n	NN	O	n	nsubj	8	SENT_145	[p6l709t1224r734b1256],
3	=	JJ	O	=	amod	7	SENT_145	[p6l751t1236r774b1245],
4	48	CD	NUMBER	48	num	7	SENT_145	[p6l790t1224r833b1256],
5	)	CD	NUMBER	)	num	7	SENT_145	[p6l790t1224r833b1256],
6	Sparse	JJ	O	sparse	amod	7	SENT_145	[p6l1076t1224r1165b1257],
7	pharmacokinetics	NNS	O	pharmacokinetic	dep	2	SENT_145	[p6l1175t1223r1420b1257],
8	proﬁle	VBP	O	proﬁle	_	0	SENT_145	[p6l1075t1269r1166b1303],

1	ZWATE1	NN	O	zwate1	dep	6	SENT_146	[p6l198t1321r310b1346],
2	(	CD	NUMBER	(	dep	1	SENT_146	[p6l323t1322r488b1353],
3	rs2289669	NN	O	rs2289669	dep	6	SENT_146	[p6l323t1322r488b1353],
4	)	CD	NUMBER	)	num	3	SENT_146	[p6l323t1322r488b1353],
5	Diabetic	NNP	MISC	Diabetic	nn	6	SENT_146	[p6l692t1321r811b1346],
6	patients	NNS	O	patient	dep	10	SENT_146	[p6l820t1322r929b1355],
7	Candidate	NN	O	candidate	nn	8	SENT_146	[p6l1059t1321r1201b1346],
8	gene	NN	O	gene	dep	6	SENT_146	[p6l1212t1330r1284b1355],
9	;	:	O	;	_	0	SENT_146	[p6l1212t1330r1284b1355],
10	Increased	VBN	O	increase	_	0	SENT_146	[p6l1485t1321r1617b1346],
11	HbAlc	NN	O	hbalc	dobj	10	SENT_146	[p6l1627t1321r1727b1346],
12	51	CD	NUMBER	51	num	11	SENT_146	[p6l1958t1322r1986b1347],

1	(	NN	O	(	nn	2	SENT_147	[p6l709t1367r734b1398],
2	n	NN	O	n	nsubj	3	SENT_147	[p6l709t1367r734b1398],
3	=	JJ	O	=	_	0	SENT_147	[p6l751t1379r774b1388],
4	116	CD	NUMBER	116	number	5	SENT_147	[p6l793t1367r851b1398],
5	)	CD	NUMBER	)	dobj	3	SENT_147	[p6l793t1367r851b1398],
6	Population	NNP	O	Population	nn	10	SENT_147	[p6l1075t1366r1229b1400],
7	cohort	NN	O	cohort	nn	10	SENT_147	[p6l1239t1366r1331b1392],
8	study	NN	O	study	nn	10	SENT_147	[p6l1340t1366r1415b1401],
9	reduction	NN	O	reduction	nn	10	SENT_147	[p6l1501t1366r1636b1392],
10	Diabetic	NNP	MISC	Diabetic	dep	5	SENT_147	[p6l692t1419r811b1445],
11	patients	NNS	O	patient	nn	13	SENT_147	[p6l820t1420r929b1453],
12	Candidate	NN	O	candidate	nn	13	SENT_147	[p6l1059t1419r1201b1445],
13	gene	NN	O	gene	dep	5	SENT_147	[p6l1212t1429r1284b1453],
14	;	:	O	;	_	0	SENT_147	[p6l1212t1429r1284b1453],
15	Increased	VBN	O	increase	amod	16	SENT_147	[p6l1485t1419r1617b1445],
16	HbAlc	NN	O	hbalc	dep	5	SENT_147	[p6l1627t1419r1727b1445],
17	52	CD	NUMBER	52	num	19	SENT_147	[p6l1957t1420r1987b1445],
18	(	NN	O	(	nn	19	SENT_147	[p6l709t1465r734b1497],
19	n	NN	O	n	npadvmod	16	SENT_147	[p6l709t1465r734b1497],
20	=	JJ	O	=	rcmod	19	SENT_147	[p6l751t1477r774b1486],
21	98	CD	NUMBER	98	num	22	SENT_147	[p6l791t1465r833b1497],
22	)	CD	NUMBER	)	iobj	20	SENT_147	[p6l791t1465r833b1497],
23	Population	NNP	O	Population	nn	26	SENT_147	[p6l1075t1465r1229b1499],
24	cohort	NN	O	cohort	nn	26	SENT_147	[p6l1239t1465r1331b1490],
25	study	NN	O	study	nn	26	SENT_147	[p6l1340t1464r1415b1499],
26	reduction	NN	O	reduction	dobj	20	SENT_147	[p6l1501t1465r1636b1490],
27	in	IN	O	in	_	0	SENT_147	[p6l1645t1466r1672b1490],
28	patients	NNS	O	patient	prep_in	16	SENT_147	[p6l1682t1466r1790b1499],
29	with	IN	O	with	_	0	SENT_147	[p6l1500t1510r1562b1536],
30	OCT1	NN	O	oct1	nn	32	SENT_147	[p6l1573t1511r1664b1536],
31	rs622342	NN	O	rs622342	nn	32	SENT_147	[p6l1677t1512r1802b1536],
32	polymorphism	NN	O	polymorphism	prep_with	28	SENT_147	[p6l1501t1556r1705b1590],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_148	[p6l198t1647r375b1670],
2	:	:	O	:	_	0	SENT_148	[p6l198t1647r375b1670],
3	AUC	NN	O	auc	dep	1	SENT_148	[p6l384t1648r456b1674],
4	,	,	O	,	_	0	SENT_148	[p6l384t1648r456b1674],
5	area	NN	O	area	appos	3	SENT_148	[p6l466t1655r515b1670],
6	under	IN	O	under	_	0	SENT_148	[p6l523t1647r595b1670],
7	the	DT	O	the	det	8	SENT_148	[p6l603t1647r641b1670],
8	curve	NN	O	curve	prep_under	5	SENT_148	[p6l650t1655r722b1674],
9	;	:	O	;	_	0	SENT_148	[p6l650t1655r722b1674],
10	Cmax	NNP	O	Cmax	dep	1	SENT_148	[p6l732t1648r797b1674],
11	,	,	O	,	_	0	SENT_148	[p6l732t1648r797b1674],
12	maximum	NN	O	maximum	nn	13	SENT_148	[p6l806t1648r928b1670],
13	concentration	NN	O	concentration	appos	10	SENT_148	[p6l937t1648r1112b1674],
14	;	:	O	;	_	0	SENT_148	[p6l937t1648r1112b1674],
15	MATE	NNP	O	MATE	dep	1	SENT_148	[p6l1121t1647r1217b1674],
16	,	,	O	,	_	0	SENT_148	[p6l1121t1647r1217b1674],
17	multidrug	JJ	O	multidrug	amod	20	SENT_148	[p6l1227t1647r1350b1677],
18	and	CC	O	and	_	0	SENT_148	[p6l1358t1647r1401b1669],
19	toxin	NN	O	toxin	conj_and	17	SENT_148	[p6l1410t1648r1471b1670],
20	extrusion	NN	O	extrusion	appos	15	SENT_148	[p6l1480t1648r1599b1674],
21	;	:	O	;	_	0	SENT_148	[p6l1480t1648r1599b1674],
22	OCT	NN	DATE	oct	dep	1	SENT_148	[p6l1609t1648r1683b1674],
23	,	,	O	,	_	0	SENT_148	[p6l1609t1648r1683b1674],
24	organic	JJ	O	organic	amod	26	SENT_148	[p6l1693t1648r1783b1677],
25	cation	NN	O	cation	nn	26	SENT_148	[p6l1792t1648r1866b1670],
26	transporter	NN	O	transporter	appos	22	SENT_148	[p6l1875t1653r2018b1677],
27	.	.	O	.	_	0	SENT_148	[p6l1875t1653r2018b1677],

1	Annu	NNP	PERSON	Annu	_	0	SENT_149	[p6l181t3640r204b3720],
2	.	.	O	.	_	0	SENT_149	[p6l181t3640r204b3720],

1	Rev.	NNP	O	Rev.	nn	2	SENT_150	[p6l181t3570r204b3629],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_150	[p6l181t3411r204b3559],
3	.	.	O	.	_	0	SENT_150	[p6l181t3411r204b3559],

1	Toxico	NNP	PERSON	Toxico	nn	2	SENT_151	[p6l181t3307r204b3400],
2	l.	NNP	O	l.	_	0	SENT_151	[p6l181t3272r204b3287],
3	2012.52:249	CD	NUMBER	2012.52:249	number	4	SENT_151	[p6l181t3026r205b3260],
4	-273	CD	NUMBER	-273	num	2	SENT_151	[p6l181t3026r205b3260],
5	.	.	O	.	_	0	SENT_151	[p6l181t3026r205b3260],

1	Downloaded	VBN	O	download	_	0	SENT_152	[p6l181t2845r204b3016],
2	from	IN	O	from	_	0	SENT_152	[p6l181t2772r204b2836],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_152	[p6l181t2438r211b2763],
4	by	IN	O	by	_	0	SENT_152	[p6l214t3553r245b3585],
5	University	NNP	ORGANIZATION	University	dep	10	SENT_152	[p6l214t3404r245b3544],
6	of	IN	ORGANIZATION	of	_	0	SENT_152	[p6l214t3365r238b3394],
7	Wis	NNP	ORGANIZATION	Wis	nn	8	SENT_152	[p6l214t3306r238b3359],
8	consin	NN	O	consin	prep_of	5	SENT_152	[p6l214t3199r238b3286],
9	-	:	O	-	_	0	SENT_152	[p6l228t3182r231b3191],
10	Madison	NNP	O	Madison	prep_by	1	SENT_152	[p6l214t3055r238b3172],
11	on	IN	O	on	_	0	SENT_152	[p6l222t3014r238b3046],
12	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_152	[p6l214t2880r238b3004],
13	.	.	O	.	_	0	SENT_152	[p6l214t2880r238b3004],

1	For	IN	O	for	_	0	SENT_153	[p6l215t2823r238b2869],
2	personal	JJ	O	personal	amod	3	SENT_153	[p6l214t2701r245b2815],
3	use	NN	O	use	pobj	1	SENT_153	[p6l222t2648r238b2692],
4	only	RB	O	only	advmod	3	SENT_153	[p6l214t2573r245b2638],
5	.	.	O	.	_	0	SENT_153	[p6l214t2573r245b2638],

1	2	CD	NUMBER	2	num	3	SENT_154	[p6l473t1760r484b1774],
2	52	CD	NUMBER	52	num	3	SENT_154	[p6l487t1759r514b1781],
3	DeGo7ter	NN	O	dego7ter	_	0	SENT_154	[p6l567t1752r678b1774],
4	et	FW	O	et	nn	5	SENT_154	[p6l685t1757r705b1774],
5	til	FW	O	til	dep	3	SENT_154	[p6l711t1752r737b1774],
6	.	.	O	.	_	0	SENT_154	[p6l711t1752r737b1774],

1	of	IN	O	of	_	0	SENT_155	[p6l367t1856r401b1885],
2	each	DT	O	each	prep_of	16	SENT_155	[p6l405t1856r475b1885],
3	of	IN	O	of	_	0	SENT_155	[p6l483t1856r517b1885],
4	the	DT	O	the	det	5	SENT_155	[p6l520t1856r569b1885],
5	cation	NN	O	cation	prep_of	2	SENT_155	[p6l577t1857r672b1885],
6	transporters	NNS	O	transporter	nsubj	16	SENT_155	[p6l680t1864r869b1894],
7	to	TO	O	to	_	0	SENT_155	[p6l877t1864r907b1885],
8	the	DT	O	the	det	9	SENT_155	[p6l916t1856r964b1885],
9	distribution	NN	O	distribution	prep_to	6	SENT_155	[p6l973t1856r1157b1885],
10	of	IN	O	of	_	0	SENT_155	[p6l1164t1856r1198b1885],
11	shared	JJ	O	shared	amod	12	SENT_155	[p6l1202t1856r1303b1885],
12	substrates	NNS	O	substrate	prep_of	9	SENT_155	[p6l1311t1856r1464b1885],
13	such	JJ	O	such	_	0	SENT_155	[p6l1472t1856r1542b1885],
14	as	IN	O	as	_	0	SENT_155	[p6l1550t1867r1578b1885],
15	metformin	NN	O	metformin	prep_such_as	12	SENT_155	[p6l1586t1856r1755b1885],
16	remains	VBZ	O	remain	_	0	SENT_155	[p6l1762t1857r1884b1885],
17	to	TO	O	to	aux	19	SENT_155	[p6l367t1914r397b1935],
18	be	VB	O	be	auxpass	19	SENT_155	[p6l409t1905r445b1935],
19	determined	VBN	O	determine	xcomp	16	SENT_155	[p6l457t1905r644b1935],
20	.	.	O	.	_	0	SENT_155	[p6l457t1905r644b1935],

1	Genetic	JJ	O	genetic	amod	2	SENT_156	[p6l657t1906r781b1935],
2	variation	NN	O	variation	nsubj	5	SENT_156	[p6l791t1907r930b1935],
3	in	IN	O	in	_	0	SENT_156	[p6l941t1907r971b1934],
4	genes	NNS	O	gene	prep_in	2	SENT_156	[p6l983t1916r1069b1944],
5	encoding	VBG	O	encode	_	0	SENT_156	[p6l1081t1905r1225b1944],
6	OCT1	NN	O	oct1	dobj	5	SENT_156	[p6l1236t1906r1350b1941],
7	,	,	O	,	_	0	SENT_156	[p6l1236t1906r1350b1941],
8	OCT2	NN	O	oct2	dobj	5	SENT_156	[p6l1364t1906r1478b1941],
9	,	,	O	,	_	0	SENT_156	[p6l1364t1906r1478b1941],
10	OCT3	NN	O	oct3	dobj	5	SENT_156	[p6l1491t1906r1605b1941],
11	,	,	O	,	_	0	SENT_156	[p6l1491t1906r1605b1941],
12	and	CC	O	and	_	0	SENT_156	[p6l1618t1905r1673b1935],
13	MATE1	NN	O	mate1	dobj	5	SENT_156	[p6l1683t1906r1815b1934],
14	was	VBD	O	be	auxpass	15	SENT_156	[p6l1828t1916r1884b1935],
15	investigated	VBN	O	investigate	rcmod	6	SENT_156	[p6l366t1955r553b1994],
16	in	IN	O	in	_	0	SENT_156	[p6l562t1957r592b1984],
17	a	DT	O	a	det	19	SENT_156	[p6l602t1966r616b1984],
18	large	JJ	O	large	amod	19	SENT_156	[p6l625t1955r702b1994],
19	cohort	NN	O	cohort	prep_in	15	SENT_156	[p6l712t1955r815b1984],
20	of	IN	O	of	_	0	SENT_156	[p6l824t1955r858b1984],
21	103	CD	NUMBER	103	num	22	SENT_156	[p6l866t1957r916b1985],
22	subjects	NNS	O	subject	prep_of	19	SENT_156	[p6l929t1955r1059b1994],
23	,	,	O	,	_	0	SENT_156	[p6l929t1955r1059b1994],
24	and	CC	O	and	_	0	SENT_156	[p6l1070t1955r1125b1984],
25	in	IN	O	in	_	0	SENT_156	[p6l1134t1957r1164b1984],
26	this	DT	O	this	det	27	SENT_156	[p6l1173t1955r1229b1984],
27	analysis	NN	O	analysis	prep_in	34	SENT_156	[p6l1239t1955r1366b1994],
28	,	,	O	,	_	0	SENT_156	[p6l1239t1955r1366b1994],
29	only	RB	O	only	advmod	34	SENT_156	[p6l1376t1955r1445b1994],
30	reduced-function	JJ	O	reduced-function	amod	32	SENT_156	[p6l1453t1955r1725b1984],
31	SLCZZAI	NNP	O	SLCZZAI	nn	32	SENT_156	[p6l1734t1956r1882b1984],
32	polymorphisms	NNS	O	polymorphism	nsubjpass	34	SENT_156	[p6l366t2004r609b2043],
33	were	VBD	O	be	auxpass	34	SENT_156	[p6l617t2015r692b2033],
34	associated	VBN	O	associate	conj_and	5	SENT_156	[p6l702t2004r858b2033],
35	with	IN	O	with	_	0	SENT_156	[p6l866t2004r936b2033],
36	increased	VBN	O	increase	amod	38	SENT_156	[p6l944t2004r1090b2033],
37	renal	JJ	O	renal	amod	38	SENT_156	[p6l1099t2004r1178b2033],
38	clearance	NN	O	clearance	prep_with	34	SENT_156	[p6l1187t2004r1332b2033],
39	of	IN	O	of	_	0	SENT_156	[p6l1342t2004r1376b2033],
40	metformin	NN	O	metformin	prep_of	38	SENT_156	[p6l1381t2004r1557b2033],
41	.	.	O	.	_	0	SENT_156	[p6l1381t2004r1557b2033],

1	OCT1	NN	O	oct1	nsubj	3	SENT_157	[p6l1568t2005r1670b2033],
2	was	VBD	O	be	cop	3	SENT_157	[p6l1682t2015r1738b2033],
3	localized	JJ	O	localized	_	0	SENT_157	[p6l1747t2004r1884b2033],
4	to	TO	O	to	_	0	SENT_157	[p6l367t2062r397b2082],
5	the	DT	O	the	det	7	SENT_157	[p6l411t2053r459b2082],
6	apical	JJ	O	apical	amod	7	SENT_157	[p6l473t2053r561b2092],
7	membrane	NN	O	membrane	prep_to	3	SENT_157	[p6l574t2053r741b2082],
8	of	IN	O	of	_	0	SENT_157	[p6l755t2053r789b2082],
9	the	DT	O	the	det	10	SENT_157	[p6l797t2053r846b2082],
10	kidney	NN	O	kidney	prep_of	7	SENT_157	[p6l859t2053r965b2092],
11	in	IN	O	in	_	0	SENT_157	[p6l975t2055r1006b2082],
12	this	DT	O	this	det	13	SENT_157	[p6l1018t2053r1074b2082],
13	study	NN	O	study	prep_in	10	SENT_157	[p6l1087t2053r1178b2092],
14	,	,	O	,	_	0	SENT_157	[p6l1087t2053r1178b2092],
15	suggesting	VBG	O	suggest	xcomp	3	SENT_157	[p6l1192t2055r1359b2092],
16	that	IN	O	that	complm	27	SENT_157	[p6l1370t2053r1432b2082],
17	reduced	VBN	O	reduce	amod	19	SENT_157	[p6l1444t2053r1568b2082],
18	renal	JJ	O	renal	amod	19	SENT_157	[p6l1581t2053r1659b2082],
19	reuptake	NN	O	reuptake	nsubj	27	SENT_157	[p6l1672t2053r1807b2092],
20	may	MD	O	may	aux	23	SENT_157	[p6l1820t2064r1886b2092],
21	be	VB	O	be	cop	23	SENT_157	[p6l367t2103r402b2132],
22	the	DT	O	the	det	23	SENT_157	[p6l414t2103r462b2132],
23	mechanism	NN	O	mechanism	rcmod	19	SENT_157	[p6l474t2103r651b2132],
24	underlying	VBG	O	underlie	partmod	23	SENT_157	[p6l661t2103r833b2142],
25	their	PRP$	O	they	poss	26	SENT_157	[p6l843t2103r918b2132],
26	observations	NNS	O	observation	dobj	24	SENT_157	[p6l929t2103r1124b2132],
27	(	VBP	O	(	ccomp	15	SENT_157	[p6l1136t2104r1204b2140],
28	22	CD	NUMBER	22	num	29	SENT_157	[p6l1136t2104r1204b2140],
29	)	CD	NUMBER	)	dobj	27	SENT_157	[p6l1136t2104r1204b2140],
30	.	.	O	.	_	0	SENT_157	[p6l1136t2104r1204b2140],

1	In	IN	O	in	_	0	SENT_158	[p6l416t2154r450b2181],
2	addition	NN	O	addition	_	0	SENT_158	[p6l463t2152r592b2181],
3	to	TO	O	to	_	0	SENT_158	[p6l604t2160r635b2181],
4	genetic	JJ	O	genetic	amod	5	SENT_158	[p6l649t2154r761b2191],
5	polymorphisms	NNS	O	polymorphism	prep_in_addition_to	12	SENT_158	[p6l773t2152r1025b2191],
6	,	,	O	,	_	0	SENT_158	[p6l773t2152r1025b2191],
7	functional	JJ	O	functional	amod	8	SENT_158	[p6l1039t2152r1197b2181],
8	inhibition	NN	O	inhibition	nsubj	12	SENT_158	[p6l1210t2152r1365b2181],
9	of	IN	O	of	_	0	SENT_158	[p6l1378t2152r1412b2181],
10	OCTs	NNS	O	oct	prep_of	8	SENT_158	[p6l1422t2153r1521b2181],
11	may	MD	O	may	aux	12	SENT_158	[p6l1534t2163r1600b2191],
12	account	VB	O	account	_	0	SENT_158	[p6l1612t2160r1734b2181],
13	for	IN	O	for	_	0	SENT_158	[p6l1746t2152r1791b2181],
14	some	DT	O	some	prep_for	12	SENT_158	[p6l1804t2163r1884b2181],
15	of	IN	O	of	_	0	SENT_158	[p6l367t2201r401b2230],
16	the	DT	O	the	det	17	SENT_158	[p6l411t2201r460b2230],
17	variability	NN	O	variability	prep_of	14	SENT_158	[p6l473t2201r631b2240],
18	observed	VBN	O	observe	partmod	17	SENT_158	[p6l644t2201r782b2230],
19	in	IN	O	in	_	0	SENT_158	[p6l796t2203r827b2230],
20	metformin	NN	O	metformin	nn	21	SENT_158	[p6l840t2201r1009b2230],
21	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	18	SENT_158	[p6l1022t2201r1306b2240],
22	.	.	O	.	_	0	SENT_158	[p6l1022t2201r1306b2240],

1	In	FW	O	in	nn	3	SENT_159	[p6l1321t2202r1355b2230],
2	vitro	FW	O	vitro	nn	3	SENT_159	[p6l1367t2203r1441b2230],
3	studies	NNS	O	study	nsubj	7	SENT_159	[p6l1456t2201r1562b2230],
4	of	IN	O	of	_	0	SENT_159	[p6l1576t2201r1611b2230],
5	OCT1	NN	O	oct1	nn	6	SENT_159	[p6l1621t2202r1723b2230],
6	transport	NN	O	transport	prep_of	3	SENT_159	[p6l1741t2209r1886b2240],
7	demonstrated	VBD	O	demonstrate	_	0	SENT_159	[p6l367t2251r582b2280],
8	that	IN	O	that	complm	25	SENT_159	[p6l594t2251r656b2280],
9	inhibition	NN	O	inhibition	nsubj	25	SENT_159	[p6l666t2251r822b2280],
10	of	IN	O	of	_	0	SENT_159	[p6l834t2251r868b2280],
11	OCT1-mediated	JJ	O	oct1-mediated	amod	13	SENT_159	[p6l877t2251r1142b2280],
12	metformin	NN	O	metformin	nn	13	SENT_159	[p6l1154t2251r1323b2280],
13	uptake	NN	O	uptake	prep_of	9	SENT_159	[p6l1334t2251r1438b2290],
14	by	IN	O	by	_	0	SENT_159	[p6l1450t2251r1489b2290],
15	commonly	RB	O	commonly	advmod	16	SENT_159	[p6l1499t2251r1667b2290],
16	used	VBN	O	use	amod	17	SENT_159	[p6l1677t2251r1747b2280],
17	medications	NNS	O	medication	prep_by	13	SENT_159	[p6l1759t2251r1884b2280, p6l367t2302r442b2330],
18	such	JJ	O	such	_	0	SENT_159	[p6l458t2300r528b2330],
19	as	IN	O	as	_	0	SENT_159	[p6l543t2311r571b2330],
20	amitriptyline	NNP	O	amitriptyline	prep_such_as	17	SENT_159	[p6l586t2300r789b2339],
21	and	CC	O	and	_	0	SENT_159	[p6l804t2300r860b2330],
22	verapamil	NN	O	verapamil	prep_such_as	17	SENT_159	[p6l873t2300r1028b2339],
23	was	VBD	O	be	cop	25	SENT_159	[p6l1041t2311r1097b2330],
24	genotype	NN	O	genotype	npadvmod	25	SENT_159	[p6l1113t2308r1256b2339],
25	dependent	JJ	O	dependent	ccomp	7	SENT_159	[p6l1272t2300r1444b2339],
26	,	,	O	,	_	0	SENT_159	[p6l1272t2300r1444b2339],
27	suggesting	VBG	O	suggest	xcomp	25	SENT_159	[p6l1460t2302r1626b2339],
28	that	IN	O	that	complm	34	SENT_159	[p6l1640t2300r1702b2330],
29	individuals	NNS	O	individual	nsubj	34	SENT_159	[p6l1715t2300r1884b2330],
30	harboring	VBG	O	harbor	partmod	29	SENT_159	[p6l366t2350r523b2389],
31	certain	JJ	O	certain	amod	32	SENT_159	[p6l534t2352r641b2379],
32	polymorphisms	NNS	O	polymorphism	dobj	30	SENT_159	[p6l652t2350r894b2389],
33	may	MD	O	may	aux	34	SENT_159	[p6l906t2361r972b2389],
34	be	VB	O	be	ccomp	27	SENT_159	[p6l981t2350r1017b2379],
35	at	IN	O	at	_	0	SENT_159	[p6l1029t2358r1057b2379],
36	greater	JJR	O	greater	amod	37	SENT_159	[p6l1068t2358r1179b2389],
37	risk	NN	O	risk	prep_at	34	SENT_159	[p6l1189t2350r1247b2379],
38	for	IN	O	for	_	0	SENT_159	[p6l1257t2350r1302b2379],
39	OCT1-mediated	JJ	O	oct1-mediated	amod	41	SENT_159	[p6l1314t2350r1579b2379],
40	drug	NN	O	drug	nn	41	SENT_159	[p6l1591t2350r1753b2389],
41	—	NN	O	—	prep_for	37	SENT_159	[p6l1591t2350r1753b2389],
42	d1ug	NN	O	d1ug	nn	43	SENT_159	[p6l1591t2350r1753b2389],
43	interactions	NNS	O	interaction	nsubj	44	SENT_159	[p6l1762t2352r1884b2379, p6l367t2401r442b2429],
44	(	VBP	O	(	rcmod	41	SENT_159	[p6l456t2400r525b2436],
45	23	CD	NUMBER	23	num	46	SENT_159	[p6l456t2400r525b2436],
46	)	CD	NUMBER	)	dobj	44	SENT_159	[p6l456t2400r525b2436],
47	.	.	O	.	_	0	SENT_159	[p6l456t2400r525b2436],

1	Induction	NN	O	induction	nsubj	7	SENT_160	[p6l539t2399r693b2429],
2	of	IN	O	of	_	0	SENT_160	[p6l706t2399r741b2429],
3	OCTs	NNS	O	oct	prep_of	1	SENT_160	[p6l750t2400r850b2429],
4	may	MD	O	may	aux	7	SENT_160	[p6l863t2410r929b2438],
5	also	RB	O	also	advmod	7	SENT_160	[p6l941t2399r999b2429],
6	be	VB	O	be	cop	7	SENT_160	[p6l1013t2399r1048b2429],
7	important	JJ	O	important	_	0	SENT_160	[p6l1061t2401r1220b2438],
8	in	IN	O	in	_	0	SENT_160	[p6l1231t2401r1262b2428],
9	the	DT	O	the	det	10	SENT_160	[p6l1275t2399r1323b2429],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	7	SENT_160	[p6l1336t2399r1611b2438],
11	of	IN	O	of	_	0	SENT_160	[p6l1625t2399r1660b2429],
12	cationic	JJ	O	cationic	amod	13	SENT_160	[p6l1669t2401r1791b2429],
13	compounds	NNS	O	compound	prep_of	10	SENT_160	[p6l1804t2410r1884b2429, p6l367t2449r488b2488],
14	.	.	O	.	_	0	SENT_160	[p6l1804t2410r1884b2429, p6l367t2449r488b2488],

1	Recently	RB	DATE	recently	advmod	13	SENT_161	[p6l500t2449r646b2488],
2	,	,	O	,	_	0	SENT_161	[p6l500t2449r646b2488],
3	concomitant	JJ	O	concomitant	amod	4	SENT_161	[p6l658t2451r855b2479],
4	administration	NN	O	administration	nsubjpass	13	SENT_161	[p6l865t2449r1093b2479],
5	of	IN	O	of	_	0	SENT_161	[p6l1104t2450r1138b2479],
6	the	DT	O	the	det	11	SENT_161	[p6l1144t2449r1192b2479],
7	pregnane	NN	O	pregnane	nn	11	SENT_161	[p6l1203t2460r1348b2488],
8	X	NN	O	x	nn	11	SENT_161	[p6l1357t2451r1385b2478],
9	receptor	NN	O	receptor	nn	11	SENT_161	[p6l1394t2458r1526b2488],
10	agonist	NN	O	agonist	nn	11	SENT_161	[p6l1536t2451r1649b2488],
11	rifampicin	NN	O	rifampicin	prep_of	4	SENT_161	[p6l1658t2450r1819b2488],
12	was	VBD	O	be	auxpass	13	SENT_161	[p6l1828t2461r1884b2479],
13	demonstrated	VBN	O	demonstrate	_	0	SENT_161	[p6l367t2498r581b2528],
14	to	TO	O	to	aux	15	SENT_161	[p6l595t2507r625b2528],
15	increase	VB	O	increase	xcomp	13	SENT_161	[p6l638t2500r764b2528],
16	the	DT	O	the	det	18	SENT_161	[p6l778t2498r826b2528],
17	glucose-lowering	NN	O	glucose-lowering	nn	18	SENT_161	[p6l840t2498r1111b2537],
18	effect	NN	O	effect	dobj	15	SENT_161	[p6l1123t2499r1207b2528],
19	of	IN	O	of	_	0	SENT_161	[p6l1220t2499r1254b2528],
20	metformin	NN	O	metformin	prep_of	18	SENT_161	[p6l1263t2499r1431b2528],
21	in	IN	O	in	_	0	SENT_161	[p6l1443t2500r1474b2527],
22	healthy	JJ	O	healthy	amod	23	SENT_161	[p6l1486t2498r1603b2537],
23	subjects	NNS	O	subject	prep_in	15	SENT_161	[p6l1614t2498r1745b2537],
24	,	,	O	,	_	0	SENT_161	[p6l1614t2498r1745b2537],
25	possibly	RB	O	possibly	advmod	26	SENT_161	[p6l1759t2498r1886b2537],
26	owing	VBG	O	owe	partmod	15	SENT_161	[p6l367t2550r463b2587],
27	to	TO	O	to	_	0	SENT_161	[p6l473t2556r504b2577],
28	increased	VBN	O	increase	amod	30	SENT_161	[p6l515t2548r661b2578],
29	OCT1	NN	O	oct1	nn	30	SENT_161	[p6l673t2549r775b2578],
30	expression	NN	O	expression	prep_to	26	SENT_161	[p6l791t2550r954b2587],
31	and	CC	O	and	_	0	SENT_161	[p6l965t2548r1020b2578],
32	hepatic	JJ	O	hepatic	amod	33	SENT_161	[p6l1031t2548r1144b2587],
33	uptake	NN	O	uptake	conj_and	30	SENT_161	[p6l1155t2548r1259b2587],
34	of	IN	O	of	_	0	SENT_161	[p6l1271t2548r1305b2577],
35	metformin	NN	O	metformin	prep_of	33	SENT_161	[p6l1311t2548r1480b2577],
36	(	CD	NUMBER	(	num	35	SENT_161	[p6l1492t2549r1560b2585],
37	24	CD	NUMBER	24	num	38	SENT_161	[p6l1492t2549r1560b2585],
38	)	NN	O	)	dep	33	SENT_161	[p6l1492t2549r1560b2585],
39	.	.	O	.	_	0	SENT_161	[p6l1492t2549r1560b2585],

1	VVhether	NN	O	vvhether	nn	2	SENT_162	[p6l415t2598r560b2628],
2	changes	NNS	O	change	nsubj	22	SENT_162	[p6l575t2599r698b2637],
3	in	IN	O	in	_	0	SENT_162	[p6l714t2600r744b2627],
4	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	2	SENT_162	[p6l759t2598r1034b2637],
5	caused	VBN	O	cause	partmod	4	SENT_162	[p6l1051t2598r1153b2628],
6	by	IN	O	by	_	0	SENT_162	[p6l1169t2598r1207b2637],
7	altered	JJ	O	altered	amod	8	SENT_162	[p6l1222t2598r1328b2628],
8	OCT	NN	DATE	oct	agent	5	SENT_162	[p6l1345t2599r1432b2628],
9	expression	NN	O	expression	nsubj	12	SENT_162	[p6l1448t2600r1610b2637],
10	or	CC	O	or	_	0	SENT_162	[p6l1626t2609r1660b2628],
11	function	NN	O	function	nsubj	12	SENT_162	[p6l1675t2599r1806b2628],
12	lead	VBP	O	lead	rcmod	8	SENT_162	[p6l1821t2598r1884b2628],
13	directly	RB	O	directly	advmod	12	SENT_162	[p6l367t2648r486b2687],
14	to	TO	O	to	_	0	SENT_162	[p6l495t2657r525b2678],
15	a	DT	O	a	det	16	SENT_162	[p6l536t2660r550b2678],
16	change	NN	O	change	prep_to	12	SENT_162	[p6l561t2648r670b2687],
17	in	IN	O	in	_	0	SENT_162	[p6l679t2650r710b2677],
18	response	NN	O	response	prep_in	16	SENT_162	[p6l719t2659r855b2687],
19	is	VBZ	O	be	cop	22	SENT_162	[p6l865t2650r887b2678],
20	an	DT	O	a	det	22	SENT_162	[p6l898t2659r934b2678],
21	important	JJ	O	important	amod	22	SENT_162	[p6l943t2650r1101b2687],
22	question	NN	O	question	_	0	SENT_162	[p6l1110t2650r1251b2687],
23	.	.	O	.	_	0	SENT_162	[p6l1110t2650r1251b2687],

1	Octl	NN	O	octl	nsubj	6	SENT_163	[p6l1263t2646r1390b2678],
2	‘	CD	NUMBER	‘	num	1	SENT_163	[p6l1263t2646r1390b2678],
3	/	:	O	/	punct	5	SENT_163	[p6l1263t2646r1390b2678],
4	‘	CD	NUMBER	‘	num	5	SENT_163	[p6l1263t2646r1390b2678],
5	mice	NNS	O	mouse	dep	1	SENT_163	[p6l1402t2650r1476b2678],
6	exhibited	VBD	O	exhibit	_	0	SENT_163	[p6l1487t2648r1630b2678],
7	changes	NNS	O	change	dobj	6	SENT_163	[p6l1640t2648r1763b2687],
8	in	IN	O	in	_	0	SENT_163	[p6l1773t2650r1803b2677],
9	both	DT	O	both	preconj	11	SENT_163	[p6l1813t2648r1885b2678],
10	metformin	NN	O	metformin	nn	11	SENT_163	[p6l367t2699r535b2728],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	6	SENT_163	[p6l549t2699r824b2737],
12	and	CC	O	and	_	0	SENT_163	[p6l839t2699r894b2728],
13	metformin	NN	O	metformin	nn	14	SENT_163	[p6l909t2699r1077b2728],
14	response	NN	O	response	conj_and	11	SENT_163	[p6l1091t2710r1236b2737],
15	,	,	O	,	_	0	SENT_163	[p6l1091t2710r1236b2737],
16	as	IN	O	as	mark	22	SENT_163	[p6l1252t2710r1280b2728],
17	liver	NN	O	liver	nn	18	SENT_163	[p6l1295t2699r1364b2728],
18	accumulation	NN	O	accumulation	nsubjpass	22	SENT_163	[p6l1378t2699r1588b2728],
19	of	IN	O	of	_	0	SENT_163	[p6l1603t2699r1637b2728],
20	metformin	NN	O	metformin	prep_of	18	SENT_163	[p6l1647t2699r1815b2728],
21	was	VBD	O	be	auxpass	22	SENT_163	[p6l1828t2710r1884b2728],
22	reduced	VBN	O	reduce	dep	6	SENT_163	[p6l367t2749r491b2778],
23	30-fold	RB	O	30-fold	advmod	22	SENT_163	[p6l505t2749r617b2778],
24	compared	VBN	O	compare	_	0	SENT_163	[p6l629t2749r784b2788],
25	with	IN	O	with	prepc_compared_with	22	SENT_163	[p6l795t2749r864b2778],
26	wild	JJ	O	wild	amod	29	SENT_163	[p6l875t2749r1024b2788],
27	—	NN	O	—	nn	29	SENT_163	[p6l875t2749r1024b2788],
28	type	NN	O	type	nn	29	SENT_163	[p6l875t2749r1024b2788],
29	animals	NNS	O	animal	pobj	22	SENT_163	[p6l1036t2749r1154b2778],
30	(	CD	NUMBER	(	number	31	SENT_163	[p6l1167t2750r1193b2786],
31	2	CD	NUMBER	2	dep	29	SENT_163	[p6l1167t2750r1193b2786],
32	5	CD	NUMBER	5	num	33	SENT_163	[p6l1199t2750r1226b2786],
33	)	NN	O	)	dep	31	SENT_163	[p6l1199t2750r1226b2786],
34	and	CC	O	and	_	0	SENT_163	[p6l1239t2749r1295b2778],
35	as	IN	O	as	mark	40	SENT_163	[p6l1307t2760r1335b2778],
36	plasma	NN	O	plasma	nn	38	SENT_163	[p6l1347t2749r1455b2788],
37	glucose-lowering	NN	O	glucose-lowering	nn	38	SENT_163	[p6l1467t2749r1737b2788],
38	response	NN	O	response	nsubjpass	40	SENT_163	[p6l1748t2760r1884b2788],
39	was	VBD	O	be	auxpass	40	SENT_163	[p6l366t2810r422b2828],
40	eliminated	VBN	O	eliminate	conj_and	22	SENT_163	[p6l436t2799r600b2828],
41	(	NN	O	(	nn	43	SENT_163	[p6l614t2800r682b2836],
42	19	CD	NUMBER	19	num	43	SENT_163	[p6l614t2800r682b2836],
43	)	NN	O	)	dobj	40	SENT_163	[p6l614t2800r682b2836],
44	.	.	O	.	_	0	SENT_163	[p6l614t2800r682b2836],

1	Oct1	NN	O	oct1	nsubj	12	SENT_164	[p6l698t2797r806b2828],
2	"	''	O	"	punct	1	SENT_164	[p6l698t2797r806b2828],
3	/	:	O	/	punct	8	SENT_164	[p6l698t2797r806b2828],
4	‘	CD	NUMBER	‘	num	5	SENT_164	[p6l809t2807r825b2809],
5	mice	NNS	O	mouse	nsubjpass	8	SENT_164	[p6l841t2801r915b2828],
6	were	VBD	O	be	auxpass	8	SENT_164	[p6l927t2810r1002b2828],
7	also	RB	O	also	advmod	8	SENT_164	[p6l1015t2799r1074b2828],
8	protected	VBN	O	protect	dep	1	SENT_164	[p6l1087t2799r1237b2838],
9	from	IN	O	from	_	0	SENT_164	[p6l1250t2799r1326b2828],
10	metformin	NN	O	metformin	nn	11	SENT_164	[p6l1339t2799r1647b2828],
11	—	NN	O	—	prep_from	8	SENT_164	[p6l1339t2799r1647b2828],
12	induced	VBD	O	induce	_	0	SENT_164	[p6l1339t2799r1647b2828],
13	lactic	NN	O	lactic	nn	14	SENT_164	[p6l1660t2799r1742b2828],
14	acidosis	NN	O	acidosis	dobj	12	SENT_164	[p6l1755t2799r1883b2835],
15	,	,	O	,	_	0	SENT_164	[p6l1755t2799r1883b2835],
16	implicating	VBG	O	implicate	partmod	12	SENT_164	[p6l366t2849r545b2888],
17	the	DT	O	the	det	18	SENT_164	[p6l555t2849r604b2878],
18	liver	NN	O	liver	nn	36	SENT_164	[p6l616t2849r685b2878],
19	as	IN	O	as	_	0	SENT_164	[p6l696t2860r724b2878],
20	the	DT	O	the	det	22	SENT_164	[p6l736t2849r785b2878],
21	primary	JJ	O	primary	amod	22	SENT_164	[p6l796t2851r922b2888],
22	organ	NN	O	organ	prep_as	18	SENT_164	[p6l932t2860r1022b2888],
23	responsible	JJ	O	responsible	amod	36	SENT_164	[p6l1033t2849r1210b2888],
24	for	IN	O	for	_	0	SENT_164	[p6l1222t2849r1267b2878],
25	this	DT	O	this	det	29	SENT_164	[p6l1278t2849r1333b2878],
26	potentially	RB	O	potentially	advmod	27	SENT_164	[p6l1345t2849r1514b2888],
27	fatal	JJ	O	fatal	amod	29	SENT_164	[p6l1524t2849r1590b2878],
28	side	NN	O	side	nn	29	SENT_164	[p6l1602t2849r1662b2878],
29	effect	NN	O	effect	prep_for	23	SENT_164	[p6l1674t2849r1758b2878],
30	of	IN	O	of	_	0	SENT_164	[p6l1769t2849r1803b2878],
31	metformin	NN	O	metformin	nn	33	SENT_164	[p6l1810t2857r1884b2878, p6l367t2899r474b2928],
32	use	NN	O	use	nn	33	SENT_164	[p6l483t2910r533b2928],
33	(	NN	O	(	prep_of	29	SENT_164	[p6l544t2900r570b2935],
34	2	CD	NUMBER	2	number	35	SENT_164	[p6l544t2900r570b2935],
35	6	CD	NUMBER	6	amod	33	SENT_164	[p6l575t2900r612b2935],
36	)	NN	O	)	dobj	16	SENT_164	[p6l575t2900r612b2935],
37	.	.	O	.	_	0	SENT_164	[p6l575t2900r612b2935],

1	In	IN	O	in	_	0	SENT_165	[p6l623t2900r657b2928],
2	humans	NNS	O	human	prep_in	12	SENT_165	[p6l666t2899r796b2934],
3	,	,	O	,	_	0	SENT_165	[p6l666t2899r796b2934],
4	OCT1	NN	O	oct1	appos	2	SENT_165	[p6l808t2900r922b2934],
5	,	,	O	,	_	0	SENT_165	[p6l808t2900r922b2934],
6	but	CC	O	but	_	0	SENT_165	[p6l934t2899r986b2928],
7	not	RB	O	not	_	0	SENT_165	[p6l994t2907r1047b2928],
8	OCT2	NN	O	oct2	prep_in	12	SENT_165	[p6l1057t2900r1171b2934],
9	,	,	O	,	_	0	SENT_165	[p6l1057t2900r1171b2934],
10	expression	NN	O	expression	nsubjpass	12	SENT_165	[p6l1183t2901r1345b2937],
11	was	VBD	O	be	auxpass	12	SENT_165	[p6l1354t2910r1410b2928],
12	observed	VBN	O	observe	_	0	SENT_165	[p6l1421t2899r1559b2928],
13	in	IN	O	in	_	0	SENT_165	[p6l1569t2901r1599b2928],
14	subcutaneous	JJ	O	subcutaneous	amod	18	SENT_165	[p6l1609t2899r1818b2928],
15	and	CC	O	and	_	0	SENT_165	[p6l1829t2899r1884b2928],
16	visceral	JJ	O	visceral	conj_and	14	SENT_165	[p6l365t2949r482b2978],
17	adipose	NN	O	adipose	nn	18	SENT_165	[p6l494t2949r610b2987],
18	tissue	NN	O	tissue	prep_in	12	SENT_165	[p6l622t2951r717b2984],
19	,	,	O	,	_	0	SENT_165	[p6l622t2951r717b2984],
20	and	CC	O	and	_	0	SENT_165	[p6l730t2949r785b2978],
21	OCT1	NN	O	oct1	nn	22	SENT_165	[p6l798t2950r900b2978],
22	expression	NN	O	expression	nsubjpass	24	SENT_165	[p6l916t2951r1078b2987],
23	was	VBD	O	be	auxpass	24	SENT_165	[p6l1089t2960r1145b2978],
24	increased	VBN	O	increase	conj_and	12	SENT_165	[p6l1156t2949r1302b2978],
25	in	IN	O	in	_	0	SENT_165	[p6l1314t2951r1344b2978],
26	samples	NNS	O	sample	prep_in	24	SENT_165	[p6l1355t2949r1477b2987],
27	from	IN	O	from	_	0	SENT_165	[p6l1489t2949r1565b2978],
28	obese	JJ	O	obese	amod	29	SENT_165	[p6l1576t2949r1663b2978],
29	subjects	NNS	O	subject	prep_from	24	SENT_165	[p6l1675t2949r1805b2988],
30	,	,	O	,	_	0	SENT_165	[p6l1675t2949r1805b2988],
31	suggesting	VBG	O	suggest	xcomp	24	SENT_165	[p6l1818t2960r1884b2988, p6l367t3000r480b3038],
32	that	IN	O	that	complm	39	SENT_165	[p6l488t2999r550b3028],
33	metformin	NN	O	metformin	nn	34	SENT_165	[p6l557t2999r726b3028],
34	action	NN	O	action	nsubj	39	SENT_165	[p6l735t3000r830b3028],
35	in	IN	O	in	_	0	SENT_165	[p6l839t3000r869b3028],
36	these	DT	O	these	det	37	SENT_165	[p6l878t2999r958b3028],
37	tissues	NNS	O	tissue	prep_in	34	SENT_165	[p6l967t3000r1067b3028],
38	may	MD	O	may	aux	39	SENT_165	[p6l1076t3010r1142b3038],
39	account	VB	O	account	ccomp	31	SENT_165	[p6l1150t3007r1273b3028],
40	for	IN	O	for	mark	47	SENT_165	[p6l1281t2999r1326b3028],
41	better	JJR	O	better	amod	43	SENT_165	[p6l1335t2999r1428b3028],
42	metformin	NN	O	metformin	nn	43	SENT_165	[p6l1436t2999r1604b3028],
43	response	NN	O	response	nsubj	47	SENT_165	[p6l1613t3010r1749b3037],
44	in	IN	O	in	_	0	SENT_165	[p6l1758t3000r1789b3028],
45	obese	JJ	O	obese	amod	46	SENT_165	[p6l1798t2999r1884b3028],
46	individuals	NNS	O	individual	prep_in	43	SENT_165	[p6l366t3049r535b3078],
47	(	VBP	O	(	advcl	39	SENT_165	[p6l549t3050r617b3085],
48	27	CD	NUMBER	27	num	49	SENT_165	[p6l549t3050r617b3085],
49	)	CD	NUMBER	)	dobj	47	SENT_165	[p6l549t3050r617b3085],
50	.	.	O	.	_	0	SENT_165	[p6l549t3050r617b3085],

1	Analysis	NN	O	analysis	nsubj	16	SENT_166	[p6l630t3049r758b3087],
2	of	IN	O	of	_	0	SENT_166	[p6l771t3049r805b3078],
3	a	DT	O	a	det	5	SENT_166	[p6l814t3060r829b3078],
4	cohort	NN	O	cohort	nn	5	SENT_166	[p6l842t3049r945b3078],
5	study	NN	O	study	prep_of	1	SENT_166	[p6l957t3049r1041b3087],
6	revealed	VBD	O	reveal	_	0	SENT_166	[p6l1052t3049r1181b3078],
7	a	DT	O	a	det	9	SENT_166	[p6l1194t3060r1209b3078],
8	modest	JJ	O	modest	amod	9	SENT_166	[p6l1221t3049r1336b3078],
9	association	NN	O	association	dobj	6	SENT_166	[p6l1348t3050r1517b3078],
10	between	IN	O	between	_	0	SENT_166	[p6l1530t3049r1660b3078],
11	the	DT	O	the	det	14	SENT_166	[p6l1672t3049r1721b3078],
12	SLC22/11	NN	O	slc22/11	nn	14	SENT_166	[p6l1734t3050r1882b3078],
13	polymorphism	NN	O	polymorphism	nn	14	SENT_166	[p6l367t3098r596b3137],
14	rs622342	NN	O	rs622342	prep_between	9	SENT_166	[p6l608t3100r748b3128],
15	and	CC	O	and	_	0	SENT_166	[p6l764t3099r819b3128],
16	reduced	VBD	O	reduce	conj_and	6	SENT_166	[p6l832t3099r956b3128],
17	metformin	NN	O	metformin	nn	18	SENT_166	[p6l969t3099r1137b3128],
18	effect	NN	O	effect	dobj	16	SENT_166	[p6l1150t3099r1234b3128],
19	as	IN	O	as	mark	20	SENT_166	[p6l1246t3110r1274b3128],
20	measured	VBN	O	measure	advcl	16	SENT_166	[p6l1287t3099r1436b3128],
21	by	IN	O	by	_	0	SENT_166	[p6l1449t3099r1487b3137],
22	HbAlc	NN	O	hbalc	nn	23	SENT_166	[p6l1498t3099r1610b3128],
23	levels	NNS	O	level	prep_by	20	SENT_166	[p6l1622t3099r1707b3128],
24	in	IN	O	in	_	0	SENT_166	[p6l1720t3100r1750b3127],
25	diabetic	JJ	O	diabetic	amod	26	SENT_166	[p6l1763t3098r1885b3128],
26	patients	NNS	O	patient	prep_in	20	SENT_166	[p6l366t3150r489b3187],
27	(	IN	O	(	_	0	SENT_166	[p6l502t3150r528b3185],
28	2	CD	NUMBER	2	number	29	SENT_166	[p6l502t3150r528b3185],
29	8	CD	NUMBER	8	num	30	SENT_166	[p6l534t3150r570b3185],
30	)	NN	O	)	prep_(	20	SENT_166	[p6l534t3150r570b3185],
31	.	.	O	.	_	0	SENT_166	[p6l534t3150r570b3185],

1	In	IN	O	in	_	0	SENT_167	[p6l584t3150r618b3177],
2	a	DT	O	a	det	3	SENT_167	[p6l631t3160r645b3178],
3	study	NN	O	study	nsubj	7	SENT_167	[p6l658t3149r743b3187],
4	of	IN	O	of	_	0	SENT_167	[p6l754t3149r788b3178],
5	150	CD	NUMBER	150	num	6	SENT_167	[p6l800t3150r852b3178],
6	women	NNS	O	woman	prep_of	3	SENT_167	[p6l864t3159r980b3178],
7	receiving	VBG	O	receive	prepc_in	24	SENT_167	[p6l992t3150r1136b3188],
8	metformin	NN	O	metformin	dobj	7	SENT_167	[p6l1147t3149r1316b3178],
9	to	TO	O	to	aux	10	SENT_167	[p6l1328t3157r1358b3178],
10	treat	VB	O	treat	xcomp	7	SENT_167	[p6l1372t3157r1444b3178],
11	polycystic	JJ	O	polycystic	amod	13	SENT_167	[p6l1455t3148r1611b3188],
12	ovary	JJ	O	ovary	amod	13	SENT_167	[p6l1624t3159r1710b3187],
13	syndrome	NN	O	syndrome	dobj	10	SENT_167	[p6l1721t3149r1883b3187],
14	,	,	O	,	_	0	SENT_167	[p6l1721t3149r1883b3187],
15	the	DT	O	the	det	16	SENT_167	[p6l367t3198r415b3227],
16	presence	NN	O	presence	nsubjpass	24	SENT_167	[p6l430t3209r566b3236],
17	of	IN	O	of	_	0	SENT_167	[p6l581t3198r616b3227],
18	two	CD	NUMBER	two	num	22	SENT_167	[p6l626t3206r683b3227],
19	or	CC	O	or	_	0	SENT_167	[p6l698t3209r731b3227],
20	more	JJR	O	more	conj_or	18	SENT_167	[p6l745t3209r826b3227],
21	SLC22/11	NN	O	slc22/11	nn	22	SENT_167	[p6l841t3199r989b3227],
22	polymorphisms	NNS	O	polymorphism	prep_of	16	SENT_167	[p6l1006t3198r1249b3236],
23	was	VBD	O	be	auxpass	24	SENT_167	[p6l1263t3209r1319b3227],
24	associated	VBN	O	associate	_	0	SENT_167	[p6l1334t3198r1489b3227],
25	with	IN	O	with	_	0	SENT_167	[p6l1503t3198r1573b3227],
26	a	DT	O	a	det	28	SENT_167	[p6l1588t3209r1602b3227],
27	reduced	VBN	O	reduce	amod	28	SENT_167	[p6l1617t3198r1741b3227],
28	effect	NN	O	effect	prep_with	24	SENT_167	[p6l1756t3198r1841b3227],
29	of	IN	O	of	_	0	SENT_167	[p6l1855t3198r1889b3227],
30	metformin	NN	O	metformin	prep_of	28	SENT_167	[p6l366t3248r535b3277],
31	on	IN	O	on	_	0	SENT_167	[p6l550t3259r589b3277],
32	total	JJ	O	total	amod	33	SENT_167	[p6l604t3248r674b3277],
33	cholesterol	NN	O	cholesterol	prep_on	30	SENT_167	[p6l690t3247r870b3283],
34	,	,	O	,	_	0	SENT_167	[p6l690t3247r870b3283],
35	triglycerides	NNS	O	triglyceride	appos	33	SENT_167	[p6l886t3248r1088b3287],
36	,	,	O	,	_	0	SENT_167	[p6l886t3248r1088b3287],
37	and	CC	O	and	_	0	SENT_167	[p6l1105t3248r1160b3277],
38	insulin	NN	O	insulin	nn	39	SENT_167	[p6l1175t3248r1281b3277],
39	levels	NNS	O	level	nsubj	40	SENT_167	[p6l1295t3248r1380b3277],
40	(	VBP	O	(	conj_and	24	SENT_167	[p6l1396t3249r1464b3284],
41	29	CD	NUMBER	29	num	42	SENT_167	[p6l1396t3249r1464b3284],
42	)	CD	NUMBER	)	dobj	40	SENT_167	[p6l1396t3249r1464b3284],
43	.	.	O	.	_	0	SENT_167	[p6l1396t3249r1464b3284],

1	A	DT	O	a	det	2	SENT_168	[p6l1480t3249r1507b3277],
2	study	NN	O	study	_	0	SENT_168	[p6l1520t3248r1604b3287],
3	of	IN	O	of	_	0	SENT_168	[p6l1618t3248r1652b3277],
4	SLC22/11	NN	O	slc22/11	prep_of	2	SENT_168	[p6l1663t3249r1811b3277],
5	and	CC	O	and	advmod	4	SENT_168	[p6l1829t3248r1884b3277],

1	SLCZZAZ	JJ	O	slczzaz	amod	2	SENT_169	[p6l367t3318r517b3346],
2	polymorphisms	NNS	O	polymorphism	nsubj	12	SENT_169	[p6l528t3316r770b3355],
3	in	IN	O	in	_	0	SENT_169	[p6l781t3318r811b3345],
4	a	DT	O	a	det	6	SENT_169	[p6l822t3328r836b3346],
5	small	JJ	O	small	amod	6	SENT_169	[p6l847t3316r927b3346],
6	number	NN	O	number	prep_in	2	SENT_169	[p6l937t3317r1061b3346],
7	of	IN	O	of	_	0	SENT_169	[p6l1071t3317r1105b3346],
8	metformin	NN	O	metformin	nn	9	SENT_169	[p6l1111t3317r1280b3346],
9	responders	NNS	O	responder	prep_of	6	SENT_169	[p6l1290t3317r1460b3355],
10	and	CC	O	and	_	0	SENT_169	[p6l1472t3317r1527b3346],
11	nonresponders	NNS	O	nonresponder	conj_and	9	SENT_169	[p6l1537t3316r1769b3355],
12	identiﬁed	VBD	O	identiﬁed	_	0	SENT_169	[p6l1780t3316r1884b3346, p6l367t3366r424b3395],
13	SLC22/11	NN	O	slc22/11	nn	14	SENT_169	[p6l434t3367r582b3395],
14	variants	NNS	O	variant	dobj	12	SENT_169	[p6l594t3368r716b3395],
15	that	WDT	O	that	nsubj	18	SENT_169	[p6l727t3366r788b3395],
16	were	VBD	O	be	cop	18	SENT_169	[p6l796t3377r871b3395],
17	weak	JJ	O	weak	amod	18	SENT_169	[p6l881t3366r961b3395],
18	predictors	NNS	O	predictor	rcmod	14	SENT_169	[p6l969t3366r1127b3405],
19	of	IN	O	of	_	0	SENT_169	[p6l1138t3366r1173b3395],
20	response	NN	O	response	prep_of	18	SENT_169	[p6l1178t3377r1315b3405],
21	(	CD	NUMBER	(	num	20	SENT_169	[p6l1326t3367r1394b3403],
22	30	CD	NUMBER	30	num	23	SENT_169	[p6l1326t3367r1394b3403],
23	)	NN	O	)	dep	20	SENT_169	[p6l1326t3367r1394b3403],
24	,	,	O	,	_	0	SENT_169	[p6l1326t3367r1394b3403],
25	but	CC	O	but	_	0	SENT_169	[p6l1406t3366r1458b3395],
26	a	DT	O	a	det	28	SENT_169	[p6l1468t3377r1482b3395],
27	larger	JJR	O	larger	amod	28	SENT_169	[p6l1492t3366r1584b3405],
28	study	NN	O	study	nsubj	29	SENT_169	[p6l1594t3366r1679b3405],
29	failed	VBD	O	fail	conj_but	12	SENT_169	[p6l1687t3366r1772b3395],
30	to	TO	O	to	aux	31	SENT_169	[p6l1782t3374r1813b3395],
31	ﬁnd	VB	O	ﬁnd	xcomp	29	SENT_169	[p6l1824t3366r1884b3395],
32	an	DT	O	a	det	33	SENT_169	[p6l367t3427r403b3445],
33	association	NN	O	association	dobj	31	SENT_169	[p6l416t3418r586b3445],
34	between	IN	O	between	_	0	SENT_169	[p6l599t3416r729b3445],
35	SLC22/11	NN	O	slc22/11	nn	36	SENT_169	[p6l742t3417r890b3445],
36	variants	NNS	O	variant	prep_between	33	SENT_169	[p6l905t3418r1027b3445],
37	and	CC	O	and	_	0	SENT_169	[p6l1041t3416r1096b3445],
38	metformin	NN	O	metformin	nn	39	SENT_169	[p6l1110t3416r1278b3445],
39	response	NN	O	response	dobj	31	SENT_169	[p6l1291t3427r1427b3454],
40	(	CD	NUMBER	(	number	41	SENT_169	[p6l1441t3417r1509b3452],
41	31	CD	NUMBER	31	num	42	SENT_169	[p6l1441t3417r1509b3452],
42	)	NN	O	)	dep	39	SENT_169	[p6l1441t3417r1509b3452],
43	.	.	O	.	_	0	SENT_169	[p6l1441t3417r1509b3452],

1	Loss-of-function	JJ	O	loss-of-function	amod	2	SENT_170	[p6l1524t3416r1790b3445],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	7	SENT_170	[p6l1803t3416r1884b3455, p6l366t3466r541b3504],
3	in	IN	O	in	_	0	SENT_170	[p6l555t3467r586b3494],
4	SLC22/11	NN	O	slc22/11	prep_in	2	SENT_170	[p6l600t3467r748b3495],
5	were	VBD	O	be	auxpass	7	SENT_170	[p6l765t3477r839b3495],
6	also	RB	O	also	advmod	7	SENT_170	[p6l855t3466r914b3495],
7	associated	VBN	O	associate	_	0	SENT_170	[p6l929t3466r1085b3495],
8	with	IN	O	with	_	0	SENT_170	[p6l1099t3466r1169b3495],
9	higher	JJR	O	higher	amod	11	SENT_170	[p6l1183t3466r1285b3504],
10	plasma	NN	O	plasma	nn	11	SENT_170	[p6l1299t3466r1407b3504],
11	concentrations	NNS	O	concentration	prep_with	7	SENT_170	[p6l1422t3467r1653b3495],
12	and	CC	O	and	_	0	SENT_170	[p6l1668t3466r1724b3495],
13	increased	VBD	O	increase	conj_and	7	SENT_170	[p6l1738t3466r1884b3495],
14	clinical	JJ	O	clinical	amod	15	SENT_170	[p6l367t3516r477b3545],
15	efﬁcacy	NN	O	efﬁcacy	dobj	13	SENT_170	[p6l492t3516r608b3554],
16	of	IN	O	of	_	0	SENT_170	[p6l622t3516r656b3545],
17	the	DT	O	the	det	20	SENT_170	[p6l667t3516r715b3545],
18	antiemetic	JJ	O	antiemetic	amod	20	SENT_170	[p6l730t3517r894b3545],
19	drugs	NNS	O	drug	nn	20	SENT_170	[p6l909t3516r994b3554],
20	tropisetron	NN	O	tropisetron	prep_of	15	SENT_170	[p6l1009t3517r1184b3554],
21	and	CC	O	and	_	0	SENT_170	[p6l1199t3516r1254b3545],
22	ondansetron	NN	O	ondansetron	prep_of	15	SENT_170	[p6l1270t3516r1473b3551],
23	,	,	O	,	_	0	SENT_170	[p6l1270t3516r1473b3551],
24	presumably	RB	O	presumably	advmod	25	SENT_170	[p6l1489t3516r1671b3554],
25	owing	VBG	O	owe	partmod	15	SENT_170	[p6l1684t3517r1780b3554],
26	to	TO	O	to	_	0	SENT_170	[p6l1794t3524r1825b3545],
27	reduced	VBN	O	reduce	amod	29	SENT_170	[p6l1839t3526r1884b3545, p6l367t3565r459b3595],
28	hepatic	JJ	O	hepatic	amod	29	SENT_170	[p6l469t3566r582b3604],
29	uptake	NN	O	uptake	prep_to	25	SENT_170	[p6l592t3566r696b3604],
30	and	CC	O	and	_	0	SENT_170	[p6l706t3566r762b3595],
31	subsequent	JJ	O	subsequent	amod	32	SENT_170	[p6l772t3565r947b3604],
32	reduction	NN	O	reduction	prep_to	25	SENT_170	[p6l956t3566r1108b3595],
33	in	IN	O	in	_	0	SENT_170	[p6l1117t3567r1147b3594],
34	metabolic	JJ	O	metabolic	amod	35	SENT_170	[p6l1157t3565r1311b3595],
35	inactivation	NN	O	inactivation	prep_in	13	SENT_170	[p6l1320t3567r1504b3595],
36	of	IN	O	of	_	0	SENT_170	[p6l1515t3566r1549b3595],
37	the	DT	O	the	det	38	SENT_170	[p6l1555t3565r1603b3595],
38	drugs	NNS	O	drug	prep_of	35	SENT_170	[p6l1614t3565r1700b3604],
39	by	IN	O	by	_	0	SENT_170	[p6l1710t3565r1748b3604],
40	the	DT	O	the	det	44	SENT_170	[p6l1757t3566r1806b3595],
41	liver	NN	O	liver	nn	44	SENT_170	[p6l1816t3566r1885b3595],
42	(	NN	O	(	nn	44	SENT_170	[p6l367t3616r436b3652],
43	32	CD	NUMBER	32	num	44	SENT_170	[p6l367t3616r436b3652],
44	)	NN	O	)	prep_by	13	SENT_170	[p6l367t3616r436b3652],
45	.	.	O	.	_	0	SENT_170	[p6l367t3616r436b3652],

1	OCTs	NNS	O	oct	nsubjpass	5	SENT_171	[p6l417t3665r517b3694],
2	are	VBP	O	be	auxpass	5	SENT_171	[p6l531t3676r577b3694],
3	also	RB	O	also	advmod	5	SENT_171	[p6l591t3665r650b3694],
4	increasingly	RB	O	increasingly	advmod	5	SENT_171	[p6l663t3665r852b3703],
5	recognized	VBN	O	recognize	_	0	SENT_171	[p6l864t3665r1035b3703],
6	for	IN	O	for	_	0	SENT_171	[p6l1049t3665r1094b3694],
7	their	PRP$	O	they	poss	8	SENT_171	[p6l1107t3665r1182b3694],
8	importance	NN	O	importance	prep_for	5	SENT_171	[p6l1194t3666r1372b3703],
9	in	IN	O	in	_	0	SENT_171	[p6l1385t3666r1416b3693],
10	delivery	NN	O	delivery	prep_in	8	SENT_171	[p6l1429t3665r1554b3703],
11	of	IN	O	of	_	0	SENT_171	[p6l1566t3665r1600b3694],
12	antineoplastics	NNS	O	antineoplastic	prep_of	10	SENT_171	[p6l1610t3665r1840b3703],
13	to	TO	O	to	aux	14	SENT_171	[p6l1854t3673r1884b3694],
14	target	VB	O	target	xcomp	5	SENT_171	[p6l367t3723r459b3753],
15	tissues	NNS	O	tissue	dobj	14	SENT_171	[p6l472t3716r580b3743],
16	.	.	O	.	_	0	SENT_171	[p6l472t3716r580b3743],

1	OCT1	NN	O	oct1	nsubjpass	3	SENT_172	[p6l596t3715r698b3743],
2	was	VBD	O	be	auxpass	3	SENT_172	[p6l715t3726r770b3743],
3	identiﬁed	VBN	O	identiﬁed	_	0	SENT_172	[p6l784t3714r933b3743],
4	as	IN	O	as	mark	22	SENT_172	[p6l947t3726r976b3743],
5	a	DT	O	a	det	7	SENT_172	[p6l990t3726r1005b3743],
6	major	JJ	O	major	amod	7	SENT_172	[p6l1018t3716r1110b3753],
7	contributor	NN	O	contributor	nsubj	22	SENT_172	[p6l1123t3715r1304b3743],
8	to	TO	O	to	_	0	SENT_172	[p6l1317t3723r1348b3743],
9	the	DT	O	the	det	10	SENT_172	[p6l1362t3714r1411b3743],
10	uptake	NN	O	uptake	prep_to	7	SENT_172	[p6l1424t3714r1528b3753],
11	of	IN	O	of	_	0	SENT_172	[p6l1543t3715r1577b3743],
12	the	DT	O	the	det	16	SENT_172	[p6l1586t3714r1635b3743],
13	tyrosine	NN	O	tyrosine	nn	16	SENT_172	[p6l1649t3716r1775b3753],
14	kinase	NN	O	kinase	nn	16	SENT_172	[p6l1788t3715r1884b3743],
15	inhibitor	NN	O	inhibitor	nn	16	SENT_172	[p6l366t3764r506b3793],
16	imatinib	NN	O	imatinib	prep_of	10	SENT_172	[p6l517t3764r648b3793],
17	in	IN	O	in	_	0	SENT_172	[p6l661t3766r691b3793],
18	chronic	JJ	O	chronic	amod	21	SENT_172	[p6l704t3764r822b3793],
19	myeloid	JJ	O	myeloid	amod	21	SENT_172	[p6l834t3764r960b3803],
20	leukemia	NN	O	leukemia	nn	21	SENT_172	[p6l972t3764r1113b3793],
21	cells	NNS	O	cell	prep_in	16	SENT_172	[p6l1126t3764r1192b3793],
22	(	VBP	O	(	advcl	3	SENT_172	[p6l1206t3765r1274b3801],
23	33	CD	NUMBER	33	num	24	SENT_172	[p6l1206t3765r1274b3801],
24	)	CD	NUMBER	)	dobj	22	SENT_172	[p6l1206t3765r1274b3801],
25	.	.	O	.	_	0	SENT_172	[p6l1206t3765r1274b3801],

1	The	DT	O	the	det	2	SENT_173	[p6l1287t3764r1354b3793],
2	association	NN	O	association	_	0	SENT_173	[p6l1367t3766r1537b3793],
3	of	IN	O	of	_	0	SENT_173	[p6l1550t3764r1584b3793],
4	OCT1	NN	O	oct1	nn	6	SENT_173	[p6l1593t3765r1695b3793],
5	mRNA	NN	O	mrna	nn	6	SENT_173	[p6l1711t3765r1827b3793],
6	exAnnu	NN	O	exannu	prep_of	2	SENT_173	[p6l1838t3775r1884b3793, p7l72t2280r95b2360],
7	.	.	O	.	_	0	SENT_173	[p6l1838t3775r1884b3793, p7l72t2280r95b2360],

1	Rev.	NNP	O	Rev.	nn	2	SENT_174	[p7l72t2210r95b2269],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_174	[p7l72t2050r95b2199],
3	.	.	O	.	_	0	SENT_174	[p7l72t2050r95b2199],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_175	[p7l72t1930r95b2039],
2	.	.	O	.	_	0	SENT_175	[p7l72t1930r95b2039],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_176	[p7l72t1684r96b1918],
2	-273	CD	NUMBER	-273	_	0	SENT_176	[p7l72t1684r96b1918],
3	.	.	O	.	_	0	SENT_176	[p7l72t1684r96b1918],

1	Downloaded	VBN	O	download	_	0	SENT_177	[p7l72t1503r95b1674],
2	from	IN	O	from	_	0	SENT_177	[p7l72t1430r95b1494],
3	www.a11nualreviews.org	NN	O	www.a11nualreviews.org	prep_from	1	SENT_177	[p7l72t1097r102b1421],
4	by	IN	O	by	_	0	SENT_177	[p7l105t2193r136b2225],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_177	[p7l105t2043r136b2184],
6	of	IN	ORGANIZATION	of	_	0	SENT_177	[p7l105t2004r129b2033],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_177	[p7l105t1857r129b1998],
8	-	:	O	-	_	0	SENT_177	[p7l119t1840r122b1849],
9	Madison	NNP	O	Madison	prep_by	1	SENT_177	[p7l105t1712r129b1830],
10	on	IN	O	on	_	0	SENT_177	[p7l113t1672r129b1704],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_177	[p7l105t1538r129b1662],
12	.	.	O	.	_	0	SENT_177	[p7l105t1538r129b1662],

1	For	IN	O	for	_	0	SENT_178	[p7l106t1481r129b1527],
2	personal	JJ	O	personal	amod	3	SENT_178	[p7l105t1360r136b1472],
3	use	NN	O	use	pobj	1	SENT_178	[p7l113t1307r129b1351],
4	only	RB	O	only	advmod	3	SENT_178	[p7l105t1232r136b1297],
5	.	.	O	.	_	0	SENT_178	[p7l105t1232r136b1297],

1	views	NNS	O	view	_	0	SENT_179	[p7l181t3647r204b3723],
2	.	.	O	.	_	0	SENT_179	[p7l188t3580r211b3629],

1	org	NN	O	org	nn	2	SENT_180	[p7l188t3580r211b3629],
2	pression	NN	O	pression	nsubjpass	13	SENT_180	[p7l367t14r496b51],
3	and	CC	O	and	_	0	SENT_180	[p7l513t12r569b41],
4	polymorphisms	NNS	O	polymorphism	conj_and	2	SENT_180	[p7l585t12r828b51],
5	with	IN	O	with	_	0	SENT_180	[p7l844t12r914b41],
6	responses	NNS	O	response	prep_with	2	SENT_180	[p7l930t23r1080b51],
7	to	TO	O	to	_	0	SENT_180	[p7l1097t20r1128b41],
8	imatinib	NN	O	imatinib	prep_to	6	SENT_180	[p7l1145t12r1275b41],
9	has	VBZ	O	have	aux	13	SENT_180	[p7l1292t12r1342b41],
10	not	RB	O	not	neg	13	SENT_180	[p7l1358t20r1412b41],
11	been	VBN	O	be	auxpass	13	SENT_180	[p7l1428t12r1502b41],
12	consistently	RB	O	consistently	advmod	13	SENT_180	[p7l1519t12r1705b51],
13	replicated	VBN	O	replicate	_	0	SENT_180	[p7l1720t12r1883b51],
14	;	:	O	;	_	0	SENT_180	[p7l1720t12r1883b51],
15	however	RB	O	however	advmod	29	SENT_180	[p7l366t62r507b98],
16	,	,	O	,	_	0	SENT_180	[p7l366t62r507b98],
17	ex	FW	O	ex	nn	19	SENT_180	[p7l519t73r552b91],
18	vivo	FW	O	vivo	nn	19	SENT_180	[p7l559t63r624b91],
19	assays	NNS	O	assay	nsubj	29	SENT_180	[p7l635t73r725b101],
20	of	IN	O	of	_	0	SENT_180	[p7l736t62r771b91],
21	OCT1	NN	O	oct1	nn	22	SENT_180	[p7l777t63r879b91],
22	activity	NN	O	activity	prep_of	19	SENT_180	[p7l893t63r1007b101],
23	in	IN	O	in	_	0	SENT_180	[p7l1015t63r1045b91],
24	peripheral	JJ	O	peripheral	amod	25	SENT_180	[p7l1055t62r1216b101],
25	blood	NN	O	blood	prep_in	22	SENT_180	[p7l1226t62r1315b91],
26	mononuclear	JJ	O	mononuclear	amod	27	SENT_180	[p7l1325t62r1533b91],
27	cells	NNS	O	cell	dep	25	SENT_180	[p7l1542t62r1609b91],
28	may	MD	O	may	aux	29	SENT_180	[p7l1619t73r1685b101],
29	predict	VB	O	predict	parataxis	13	SENT_180	[p7l1693t62r1804b101],
30	imatinib	NN	O	imatinib	nn	31	SENT_180	[p7l1813t63r1884b91, p7l367t111r439b141],
31	response	NN	O	response	dobj	29	SENT_180	[p7l452t122r589b150],
32	(	CD	NUMBER	(	number	33	SENT_180	[p7l603t112r660b148],
33	34	CD	NUMBER	34	dep	31	SENT_180	[p7l603t112r660b148],
34	,	,	O	,	_	0	SENT_180	[p7l603t112r660b148],
35	35	CD	NUMBER	35	num	36	SENT_180	[p7l676t112r732b148],
36	)	NN	O	)	appos	31	SENT_180	[p7l676t112r732b148],
37	.	.	O	.	_	0	SENT_180	[p7l676t112r732b148],

1	Cytotoxicity	NN	O	cytotoxicity	nsubj	12	SENT_181	[p7l748t112r943b150],
2	induced	VBN	O	induce	partmod	1	SENT_181	[p7l954t111r1078b141],
3	by	IN	O	by	_	0	SENT_181	[p7l1092t111r1130b150],
4	the	DT	O	the	det	6	SENT_181	[p7l1142t111r1191b141],
5	platinum	NN	O	platinum	nn	6	SENT_181	[p7l1204t111r1447b150],
6	—	NN	O	—	agent	2	SENT_181	[p7l1204t111r1447b150],
7	based	VBN	O	base	partmod	6	SENT_181	[p7l1204t111r1447b150],
8	anticancer	JJ	O	anticancer	amod	10	SENT_181	[p7l1461t113r1622b141],
9	drug	NN	O	drug	nn	10	SENT_181	[p7l1636t111r1709b150],
10	oxaliplatin	NN	O	oxaliplatin	dobj	7	SENT_181	[p7l1722t111r1885b150],
11	was	VBD	O	be	cop	12	SENT_181	[p7l365t172r422b190],
12	dependent	JJ	O	dependent	_	0	SENT_181	[p7l430t161r595b199],
13	on	IN	O	on	_	0	SENT_181	[p7l603t172r642b190],
14	OCT1	NN	O	oct1	nn	17	SENT_181	[p7l650t162r752b190],
15	and	CC	O	and	_	0	SENT_181	[p7l764t161r820b190],
16	OCT2	NN	O	oct2	nn	17	SENT_181	[p7l828t162r931b190],
17	expression	NN	O	expression	prep_on	12	SENT_181	[p7l942t163r1105b199],
18	in	FW	O	in	prep	12	SENT_181	[p7l1112t163r1143b190],
19	vitro	FW	O	vitro	nn	20	SENT_181	[p7l1149t163r1223b190],
20	(	FW	O	(	pobj	18	SENT_181	[p7l1232t162r1300b197],
21	36	CD	NUMBER	36	num	22	SENT_181	[p7l1232t162r1300b197],
22	)	NN	O	)	dep	20	SENT_181	[p7l1232t162r1300b197],
23	.	.	O	.	_	0	SENT_181	[p7l1232t162r1300b197],

1	Studies	NNS	O	study	nsubj	10	SENT_182	[p7l1311t161r1423b190],
2	in	IN	O	in	_	0	SENT_182	[p7l1430t163r1461b190],
3	Octl	NNP	O	Octl	prep_in	1	SENT_182	[p7l1469t162r1543b190],
4	’	CD	NUMBER	’	num	3	SENT_182	[p7l1549t159r1596b181],
5	/	:	O	/	punct	7	SENT_182	[p7l1549t159r1596b181],
6	’	CD	NUMBER	’	num	7	SENT_182	[p7l1549t159r1596b181],
7	mice	NNS	O	mouse	dep	1	SENT_182	[p7l1607t163r1680b190],
8	did	VBD	O	do	aux	10	SENT_182	[p7l1689t161r1738b190],
9	not	RB	O	not	neg	10	SENT_182	[p7l1745t169r1798b190],
10	show	VB	O	show	_	0	SENT_182	[p7l1805t161r1886b190],
11	a	DT	O	a	det	12	SENT_182	[p7l367t221r382b239],
12	change	NN	O	change	dobj	10	SENT_182	[p7l395t210r504b249],
13	in	IN	O	in	_	0	SENT_182	[p7l517t211r547b239],
14	oxaliplatin	NN	O	oxaliplatin	nn	15	SENT_182	[p7l561t210r723b249],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	12	SENT_182	[p7l736t210r1020b249],
16	;	:	O	;	_	0	SENT_182	[p7l736t210r1020b249],
17	however	RB	O	however	advmod	28	SENT_182	[p7l1034t210r1174b246],
18	,	,	O	,	_	0	SENT_182	[p7l1034t210r1174b246],
19	this	DT	O	this	det	20	SENT_182	[p7l1189t210r1244b239],
20	result	NN	O	result	nsubj	28	SENT_182	[p7l1257t210r1346b239],
21	may	MD	O	may	aux	28	SENT_182	[p7l1357t221r1423b249],
22	be	VB	O	be	cop	28	SENT_182	[p7l1435t210r1470b239],
23	due	JJ	O	due	_	0	SENT_182	[p7l1484t210r1539b239],
24	to	TO	O	to	_	0	SENT_182	[p7l1552t218r1583b239],
25	species	NNS	O	species	nn	26	SENT_182	[p7l1596t210r1886b249],
26	—	NN	O	—	prep_due_to	28	SENT_182	[p7l1596t210r1886b249],
27	dependent	JJ	O	dependent	amod	28	SENT_182	[p7l1596t210r1886b249],
28	differences	NNS	O	difference	parataxis	10	SENT_182	[p7l367t259r535b289],
29	in	IN	O	in	_	0	SENT_182	[p7l550t261r581b288],
30	substrate	JJ	O	substrate	amod	34	SENT_182	[p7l596t259r736b289],
31	speciﬁcity	NN	O	speciﬁcity	nn	34	SENT_182	[p7l752t259r909b298],
32	(	NN	O	(	nn	34	SENT_182	[p7l924t260r992b296],
33	37	CD	NUMBER	37	num	34	SENT_182	[p7l924t260r992b296],
34	)	NN	O	)	prep_in	28	SENT_182	[p7l924t260r992b296],
35	.	.	O	.	_	0	SENT_182	[p7l924t260r992b296],

1	Thus	RB	O	thus	advmod	6	SENT_183	[p7l1008t259r1100b295],
2	,	,	O	,	_	0	SENT_183	[p7l1008t259r1100b295],
3	OCT	NN	DATE	oct	nn	4	SENT_183	[p7l1118t260r1205b289],
4	expression	NN	O	expression	nsubjpass	21	SENT_183	[p7l1221t261r1383b298],
5	may	MD	O	may	aux	6	SENT_183	[p7l1399t270r1465b298],
6	contribute	VB	O	contribute	_	0	SENT_183	[p7l1479t259r1642b289],
7	to	TO	O	to	_	0	SENT_183	[p7l1658t268r1689b289],
8	the	DT	O	the	det	9	SENT_183	[p7l1705t259r1753b289],
9	efﬁcacy	NN	O	efﬁcacy	prep_to	6	SENT_183	[p7l1770t259r1886b298],
10	of	IN	O	of	_	0	SENT_183	[p7l367t309r401b338],
11	anticancer	JJ	O	anticancer	amod	12	SENT_183	[p7l411t311r572b338],
12	agents	NNS	O	agent	prep_of	9	SENT_183	[p7l586t317r684b348],
13	such	JJ	O	such	_	0	SENT_183	[p7l698t309r768b338],
14	as	IN	O	as	_	0	SENT_183	[p7l782t320r810b338],
15	imatinib	NN	O	imatinib	prep_such_as	12	SENT_183	[p7l823t309r954b338],
16	and	CC	O	and	_	0	SENT_183	[p7l968t309r1024b338],
17	oxaliplatin	NN	O	oxaliplatin	prep_such_as	12	SENT_183	[p7l1038t309r1201b348],
18	and	CC	O	and	_	0	SENT_183	[p7l1215t309r1270b338],
19	has	VBZ	O	have	aux	21	SENT_183	[p7l1284t309r1333b338],
20	been	VBN	O	be	auxpass	21	SENT_183	[p7l1347t309r1421b338],
21	proposed	VBN	O	propose	conj_and	6	SENT_183	[p7l1435t309r1579b348],
22	as	IN	O	as	_	0	SENT_183	[p7l1593t320r1621b338],
23	a	DT	O	a	det	24	SENT_183	[p7l1636t320r1650b338],
24	biomarker	NN	O	biomarker	prep_as	21	SENT_183	[p7l1664t309r1826b338],
25	for	IN	O	for	_	0	SENT_183	[p7l1840t309r1885b338],
26	choosing	VBG	O	choose	prepc_for	21	SENT_183	[p7l367t359r508b398],
27	appropriate	JJ	O	appropriate	amod	29	SENT_183	[p7l519t360r699b398],
28	therapeutic	JJ	O	therapeutic	amod	29	SENT_183	[p7l711t359r888b398],
29	agents	NNS	O	agent	dobj	26	SENT_183	[p7l899t367r1006b398],
30	.	.	O	.	_	0	SENT_183	[p7l899t367r1006b398],

1	*	NN	O	*	nn	3	SENT_184	[p7l1356t473r1630b503],
2	www.mmualreview5.org	NN	O	www.mmualreview5.org	nn	3	SENT_184	[p7l1356t473r1630b503],
3	o	NN	O	o	_	0	SENT_184	[p7l1645t481r1654b491],
4	Dmg	NNP	O	Dmg	nn	5	SENT_184	[p7l1671t473r1734b503],
5	Tmnsponferx	NNP	O	Tmnsponferx	dep	3	SENT_184	[p7l1742t473r1886b502],
6	2	CD	NUMBER	2	number	7	SENT_184	[p7l1937t481r1948b495],
7	53	CD	NUMBER	53	dep	5	SENT_184	[p7l1950t480r1978b502],

1	Organic	NNP	O	Organic	nn	3	SENT_185	[p7l565t516r702b554],
2	cation	NN	O	cation	nn	3	SENT_185	[p7l711t516r815b544],
3	transporters	NNS	O	transporter	_	0	SENT_185	[p7l823t522r1032b553],
4	in	IN	O	in	_	0	SENT_185	[p7l1041t516r1074b544],
5	toxicity	NN	O	toxicity	prep_in	3	SENT_185	[p7l1082t516r1216b554],
6	.	.	O	.	_	0	SENT_185	[p7l1082t516r1216b554],

1	The	DT	O	the	det	3	SENT_186	[p7l1236t515r1303b544],
2	platinum	NN	O	platinum	nn	3	SENT_186	[p7l1311t515r1554b554],
3	—	NN	O	—	nsubj	11	SENT_186	[p7l1311t515r1554b554],
4	based	VBN	O	base	partmod	3	SENT_186	[p7l1311t515r1554b554],
5	antineoplastic	JJ	O	antineoplastic	amod	6	SENT_186	[p7l1563t515r1780b554],
6	cisplatin	NN	O	cisplatin	dobj	4	SENT_186	[p7l1789t515r1918b554],
7	is	VBZ	O	be	cop	11	SENT_186	[p7l1927t516r1949b544],
8	a	DT	O	a	det	11	SENT_186	[p7l1959t526r1973b544],
9	widely	RB	O	widely	advmod	10	SENT_186	[p7l1980t515r2084b554],
10	used	JJ	O	used	amod	11	SENT_186	[p7l564t564r634b594],
11	treatment	NN	O	treatment	_	0	SENT_186	[p7l643t572r797b594],
12	for	IN	O	for	_	0	SENT_186	[p7l804t564r850b594],
13	solid	JJ	O	solid	amod	14	SENT_186	[p7l857t564r930b594],
14	tumors	NNS	O	tumor	prep_for	11	SENT_186	[p7l938t572r1057b594],
15	.	.	O	.	_	0	SENT_186	[p7l938t572r1057b594],

1	However	RB	O	however	advmod	11	SENT_187	[p7l1066t566r1219b600],
2	,	,	O	,	_	0	SENT_187	[p7l1066t566r1219b600],
3	cisplatin-induced	JJ	O	cisplatin-induced	amod	4	SENT_187	[p7l1229t564r1498b603],
4	nephrotoxicity	NN	O	nephrotoxicity	nsubj	11	SENT_187	[p7l1505t564r1736b603],
5	and	CC	O	and	_	0	SENT_187	[p7l1743t564r1799b594],
6	ototoxicity	NN	O	ototoxicity	conj_and	4	SENT_187	[p7l1807t566r1976b603],
7	are	VBP	O	be	cop	11	SENT_187	[p7l1983t575r2029b594],
8	often	RB	O	often	advmod	11	SENT_187	[p7l2038t564r2082b594, p7l565t622r614b643],
9	dose-limiting	JJ	O	dose-limiting	amod	11	SENT_187	[p7l624t614r834b653],
10	side	JJ	O	side	amod	11	SENT_187	[p7l843t614r902b643],
11	effects	NNS	O	effect	_	0	SENT_187	[p7l913t614r1018b643],
12	.	.	O	.	_	0	SENT_187	[p7l913t614r1018b643],

1	The	DT	O	the	det	5	SENT_188	[p7l1028t614r1094b643],
2	reduced-function	JJ	O	reduced-function	amod	5	SENT_188	[p7l1104t614r1376b643],
3	SLC22A2	NN	O	slc22a2	nn	5	SENT_188	[p7l1386t615r1536b643],
4	SNP	NN	O	snp	nn	5	SENT_188	[p7l1547t615r1621b643],
5	rs316019	NN	O	rs316019	nsubjpass	7	SENT_188	[p7l1631t616r1774b644],
6	was	VBD	O	be	auxpass	7	SENT_188	[p7l1783t625r1839b643],
7	associated	VBN	O	associate	_	0	SENT_188	[p7l1849t614r2005b643],
8	with	IN	O	with	_	0	SENT_188	[p7l2013t614r2083b643],
9	reduced	VBN	O	reduce	amod	10	SENT_188	[p7l565t663r689b692],
10	nephrotoxicity	NN	O	nephrotoxicity	prep_with	7	SENT_188	[p7l702t663r934b702],
11	from	IN	O	from	_	0	SENT_188	[p7l946t663r1022b692],
12	cisplatin	NN	O	cisplatin	prep_from	10	SENT_188	[p7l1036t663r1165b702],
13	in	IN	O	in	_	0	SENT_188	[p7l1179t665r1209b692],
14	cancer	NN	O	cancer	nn	15	SENT_188	[p7l1223t674r1324b692],
15	patients	NNS	O	patient	prep_in	12	SENT_188	[p7l1337t665r1459b702],
16	(	CD	NUMBER	(	number	17	SENT_188	[p7l1474t664r1542b700],
17	38	CD	NUMBER	38	num	18	SENT_188	[p7l1474t664r1542b700],
18	)	NN	O	)	dep	15	SENT_188	[p7l1474t664r1542b700],
19	.	.	O	.	_	0	SENT_188	[p7l1474t664r1542b700],

1	This	DT	O	this	det	2	SENT_189	[p7l1556t663r1629b692],
2	observation	NN	O	observation	nsubjpass	4	SENT_189	[p7l1644t663r1825b692],
3	is	VBZ	O	be	auxpass	4	SENT_189	[p7l1839t665r1861b692],
4	supported	VBN	O	support	_	0	SENT_189	[p7l1876t663r2032b702],
5	by	IN	O	by	_	0	SENT_189	[p7l2046t663r2084b702],
6	studies	NNS	O	study	agent	4	SENT_189	[p7l565t712r671b741],
7	of	IN	O	of	_	0	SENT_189	[p7l680t712r714b741],
8	cisplatin	NN	O	cisplatin	nn	9	SENT_189	[p7l719t712r848b751],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	6	SENT_189	[p7l856t712r1131b751],
10	in	IN	O	in	_	0	SENT_189	[p7l1139t714r1170b741],
11	Octl	NNP	O	Octl	prep_in	6	SENT_189	[p7l1179t713r1252b741],
12	"	``	O	"	punct	6	SENT_189	[p7l1259t710r1306b732],
13	/	:	O	/	punct	14	SENT_189	[p7l1259t710r1306b732],
14	‘	NN	O	‘	dep	4	SENT_189	[p7l1259t710r1306b732],
15	and	CC	O	and	_	0	SENT_189	[p7l1317t712r1373b741],
16	Oct2	NN	O	oct2	dep	4	SENT_189	[p7l1382t713r1456b741],
17	‘	CD	NUMBER	‘	num	16	SENT_189	[p7l1462t710r1509b732],
18	/	:	O	/	punct	14	SENT_189	[p7l1462t710r1509b732],
19	‘	CD	NUMBER	‘	num	20	SENT_189	[p7l1462t710r1509b732],
20	mice	NNS	O	mouse	dobj	4	SENT_189	[p7l1520t714r1602b741],
21	.	.	O	.	_	0	SENT_189	[p7l1520t714r1602b741],

1	Octl	NN	O	octl	nsubjpass	7	SENT_190	[p7l1613t713r1687b741],
2	and	CC	O	and	_	0	SENT_190	[p7l1699t712r1754b741],
3	Oct2	NN	O	oct2	conj_and	1	SENT_190	[p7l1764t713r1838b741],
4	are	VBP	O	be	auxpass	7	SENT_190	[p7l1850t723r1896b741],
5	both	DT	O	both	advmod	7	SENT_190	[p7l1904t712r1976b741],
6	highly	RB	O	highly	advmod	7	SENT_190	[p7l1984t712r2084b751],
7	expressed	VBN	O	express	_	0	SENT_190	[p7l565t761r714b800],
8	in	IN	O	in	_	0	SENT_190	[p7l722t763r752b790],
9	mouse	NN	O	mouse	nn	10	SENT_190	[p7l760t772r861b790],
10	kidney	NN	O	kidney	prep_in	7	SENT_190	[p7l870t761r982b800],
11	,	,	O	,	_	0	SENT_190	[p7l870t761r982b800],
12	whereas	IN	O	whereas	mark	20	SENT_190	[p7l991t761r1116b790],
13	in	IN	O	in	_	0	SENT_190	[p7l1125t763r1155b790],
14	human	JJ	O	human	amod	15	SENT_190	[p7l1163t761r1271b790],
15	kidney	NN	O	kidney	prep_in	20	SENT_190	[p7l1279t761r1392b800],
16	,	,	O	,	_	0	SENT_190	[p7l1279t761r1392b800],
17	OCT2	NN	O	oct2	nn	18	SENT_190	[p7l1402t762r1505b790],
18	expression	NN	O	expression	nsubj	20	SENT_190	[p7l1517t763r1680b800],
19	is	VBZ	O	be	cop	20	SENT_190	[p7l1687t763r1710b790],
20	dominant	JJ	O	dominant	advcl	7	SENT_190	[p7l1719t761r1878b790],
21	.	.	O	.	_	0	SENT_190	[p7l1719t761r1878b790],

1	Octl	NN	O	octl	nsubjpass	33	SENT_191	[p7l1888t762r1962b790],
2	‘	CD	NUMBER	‘	num	1	SENT_191	[p7l1968t759r2015b782],
3	/	:	O	/	punct	4	SENT_191	[p7l1968t759r2015b782],
4	‘	CD	NUMBER	‘	dep	1	SENT_191	[p7l1968t759r2015b782],
5	and	CC	O	and	_	0	SENT_191	[p7l2027t761r2083b790],
6	Oct2	NN	O	oct2	dep	1	SENT_191	[p7l566t808r692b840],
7	‘	CD	NUMBER	‘	num	6	SENT_191	[p7l566t808r692b840],
8	/	:	O	/	punct	4	SENT_191	[p7l566t808r692b840],
9	‘	CD	NUMBER	‘	num	10	SENT_191	[p7l566t808r692b840],
10	mice	NNS	O	mouse	nsubj	11	SENT_191	[p7l708t812r782b840],
11	showed	VBD	O	show	rcmod	1	SENT_191	[p7l795t810r911b840],
12	no	DT	O	no	det	13	SENT_191	[p7l924t821r963b840],
13	difference	NN	O	difference	dobj	11	SENT_191	[p7l977t810r1130b840],
14	in	IN	O	in	_	0	SENT_191	[p7l1143t812r1173b839],
15	cisplatin	NN	O	cisplatin	nn	16	SENT_191	[p7l1186t810r1316b849],
16	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	11	SENT_191	[p7l1328t810r1612b849],
17	;	:	O	;	_	0	SENT_191	[p7l1328t810r1612b849],
18	however	RB	O	however	advmod	27	SENT_191	[p7l1625t810r1766b846],
19	,	,	O	,	_	0	SENT_191	[p7l1625t810r1766b846],
20	in	IN	O	in	_	0	SENT_191	[p7l1780t812r1810b839],
21	Oct1/2	NN	O	oct1/2	prep_in	27	SENT_191	[p7l1823t808r1965b840],
22	‘	CD	NUMBER	‘	num	21	SENT_191	[p7l1823t808r1965b840],
23	/	:	O	/	punct	25	SENT_191	[p7l1823t808r1965b840],
24	‘	CD	NUMBER	‘	num	25	SENT_191	[p7l1968t818r1983b820],
25	mice	NNS	O	mouse	dep	21	SENT_191	[p7l1999t812r2081b846],
26	,	,	O	,	_	0	SENT_191	[p7l1999t812r2081b846],
27	reduced	VBD	O	reduce	parataxis	11	SENT_191	[p7l565t860r689b889],
28	urinary	JJ	O	urinary	amod	29	SENT_191	[p7l701t862r817b899],
29	excretion	NN	O	excretion	dobj	27	SENT_191	[p7l828t862r972b889],
30	and	CC	O	and	_	0	SENT_191	[p7l984t860r1040b889],
31	nephrotoxicity	NN	O	nephrotoxicity	dobj	27	SENT_191	[p7l1052t860r1283b899],
32	was	VBD	O	be	auxpass	33	SENT_191	[p7l1292t871r1348b889],
33	observed	VBN	O	observe	_	0	SENT_191	[p7l1361t860r1500b889],
34	(	RB	O	(	advmod	33	SENT_191	[p7l1513t861r1538b897],
35	3	CD	NUMBER	3	number	36	SENT_191	[p7l1513t861r1538b897],
36	8	CD	NUMBER	8	num	37	SENT_191	[p7l1544t861r1581b897],
37	)	NN	O	)	dobj	33	SENT_191	[p7l1544t861r1581b897],
38	.	.	O	.	_	0	SENT_191	[p7l1544t861r1581b897],

1	Octl/2	NN	O	octl/2	nsubjpass	8	SENT_192	[p7l1596t861r1703b889],
2	”	CD	NUMBER	”	num	1	SENT_192	[p7l1709t858r1756b880],
3	/	:	O	/	punct	5	SENT_192	[p7l1709t858r1756b880],
4	”	CD	NUMBER	”	num	5	SENT_192	[p7l1709t858r1756b880],
5	mice	NNS	O	mouse	dep	1	SENT_192	[p7l1771t862r1845b889],
6	were	VBD	O	be	auxpass	8	SENT_192	[p7l1856t871r1931b889],
7	also	RB	O	also	advmod	8	SENT_192	[p7l1944t860r2002b889],
8	protected	VBN	O	protect	_	0	SENT_192	[p7l2015t871r2082b899, p7l565t910r659b939],
9	from	IN	O	from	_	0	SENT_192	[p7l670t910r746b939],
10	cisplatin-induced	JJ	O	cisplatin-induced	amod	12	SENT_192	[p7l756t910r1025b949],
11	ototoxicity	NN	O	ototoxicity	nn	12	SENT_192	[p7l1035t911r1204b949],
12	(	NN	O	(	prep_from	8	SENT_192	[p7l1213t911r1239b946],
13	3	CD	NUMBER	3	number	14	SENT_192	[p7l1213t911r1239b946],
14	9	CD	NUMBER	9	num	15	SENT_192	[p7l1244t911r1282b947],
15	)	NN	O	)	dep	8	SENT_192	[p7l1244t911r1282b947],
16	.	.	O	.	_	0	SENT_192	[p7l1244t911r1282b947],

1	Oct2	NN	O	oct2	nn	2	SENT_193	[p7l1294t911r1368b939],
2	mRNA	NN	O	mrna	nsubjpass	4	SENT_193	[p7l1381t911r1496b939],
3	was	VBD	O	be	auxpass	4	SENT_193	[p7l1503t921r1559b939],
4	observed	VBN	O	observe	_	0	SENT_193	[p7l1570t910r1708b939],
5	in	IN	O	in	_	0	SENT_193	[p7l1718t911r1748b939],
6	murine	JJ	O	murine	amod	9	SENT_193	[p7l1758t911r1870b939],
7	cochlear	JJ	O	cochlear	amod	9	SENT_193	[p7l1881t910r2013b939],
8	hair	NN	O	hair	nn	9	SENT_193	[p7l2022t910r2083b939],
9	cells	NNS	O	cell	prep_in	4	SENT_193	[p7l565t959r640b995],
10	,	,	O	,	_	0	SENT_193	[p7l565t959r640b995],
11	suggesting	VBG	O	suggest	xcomp	4	SENT_193	[p7l650t961r816b998],
12	that	IN	O	that	complm	17	SENT_193	[p7l823t959r885b989],
13	OCT	NN	DATE	oct	nn	14	SENT_193	[p7l893t960r981b989],
14	inhibition	NN	O	inhibition	nsubj	17	SENT_193	[p7l987t959r1143b989],
15	may	MD	O	may	aux	17	SENT_193	[p7l1151t970r1217b998],
16	be	VB	O	be	cop	17	SENT_193	[p7l1223t959r1259b989],
17	useful	JJ	O	useful	ccomp	11	SENT_193	[p7l1267t959r1360b989],
18	in	IN	O	in	_	0	SENT_193	[p7l1367t961r1398b988],
19	protecting	VBG	O	protect	prepc_in	17	SENT_193	[p7l1406t961r1569b998],
20	against	IN	O	against	_	0	SENT_193	[p7l1577t961r1686b998],
21	hearing	NN	O	hearing	nn	22	SENT_193	[p7l1693t959r1812b998],
22	loss	NN	O	loss	prep_against	19	SENT_193	[p7l1820t959r1884b989],
23	.	.	O	.	_	0	SENT_193	[p7l1820t959r1884b989],

1	In	IN	O	in	_	0	SENT_194	[p7l1894t961r1928b988],
2	this	DT	O	this	det	4	SENT_194	[p7l1936t959r1991b989],
3	study	NN	O	study	nn	4	SENT_194	[p7l2000t959r2084b998],
4	(	NN	O	(	prep_in	15	SENT_194	[p7l566t1010r591b1046],
5	3	CD	DATE	3	number	6	SENT_194	[p7l566t1010r591b1046],
6	9	CD	DATE	9	num	7	SENT_194	[p7l597t1010r634b1046],
7	)	NN	DATE	)	dep	4	SENT_194	[p7l597t1010r634b1046],
8	,	,	O	,	_	0	SENT_194	[p7l597t1010r634b1046],
9	mRNA	NN	O	mrna	nsubj	15	SENT_194	[p7l645t1010r760b1038],
10	from	IN	O	from	_	0	SENT_194	[p7l768t1009r844b1038],
11	pediatric	JJ	O	pediatric	amod	12	SENT_194	[p7l853t1009r990b1048],
12	tumors	NNS	O	tumor	prep_from	9	SENT_194	[p7l1000t1017r1110b1038],
13	did	VBD	O	do	aux	15	SENT_194	[p7l1120t1009r1169b1038],
14	not	RB	O	not	neg	15	SENT_194	[p7l1178t1017r1231b1038],
15	express	VB	O	express	_	0	SENT_194	[p7l1240t1020r1351b1048],
16	OCTs	NNS	MISC	oct	dobj	15	SENT_194	[p7l1362t1010r1470b1045],
17	,	,	O	,	_	0	SENT_194	[p7l1362t1010r1470b1045],
18	suggesting	VBG	O	suggest	partmod	15	SENT_194	[p7l1481t1011r1648b1048],
19	that	IN	O	that	complm	24	SENT_194	[p7l1656t1009r1718b1038],
20	OCT	NN	DATE	oct	nn	21	SENT_194	[p7l1727t1010r1814b1038],
21	inhibition	NN	O	inhibition	nsubj	24	SENT_194	[p7l1823t1009r1978b1038],
22	would	MD	O	would	aux	24	SENT_194	[p7l1986t1009r2083b1038],
23	not	RB	O	not	neg	24	SENT_194	[p7l564t1067r618b1088],
24	affect	VB	O	affect	ccomp	18	SENT_194	[p7l627t1058r711b1088],
25	tumor	NN	O	tumor	nn	27	SENT_194	[p7l720t1067r817b1088],
26	cisplatin	NN	O	cisplatin	nn	27	SENT_194	[p7l827t1058r957b1097],
27	uptake	NN	O	uptake	dobj	24	SENT_194	[p7l966t1058r1070b1097],
28	and	CC	O	and	_	0	SENT_194	[p7l1081t1058r1136b1088],
29	thus	RB	O	thus	advmod	34	SENT_194	[p7l1147t1058r1212b1088],
30	may	MD	O	may	aux	34	SENT_194	[p7l1222t1069r1288b1097],
31	be	VB	O	be	cop	34	SENT_194	[p7l1296t1058r1332b1088],
32	a	DT	O	a	det	34	SENT_194	[p7l1343t1069r1358b1088],
33	feasible	JJ	O	feasible	amod	34	SENT_194	[p7l1368t1058r1484b1088],
34	approach	NN	O	approach	conj_and	15	SENT_194	[p7l1494t1058r1646b1097],
35	.	.	O	.	_	0	SENT_194	[p7l1494t1058r1646b1097],

1	The	DT	O	the	det	2	SENT_195	[p7l1656t1058r1723b1088],
2	use	NN	O	use	nsubjpass	12	SENT_195	[p7l1733t1069r1783b1088],
3	of	IN	O	of	_	0	SENT_195	[p7l1793t1058r1828b1088],
4	OCT	NN	DATE	oct	nn	5	SENT_195	[p7l1834t1059r1921b1088],
5	inhibitors	NNS	O	inhibitor	prep_of	2	SENT_195	[p7l1930t1058r2082b1088],
6	to	TO	O	to	aux	7	SENT_195	[p7l565t1117r595b1138],
7	prevent	VB	O	prevent	infmod	2	SENT_195	[p7l606t1117r725b1147],
8	cisplatin	NN	O	cisplatin	nn	9	SENT_195	[p7l735t1108r865b1147],
9	toxicity	NN	O	toxicity	dobj	7	SENT_195	[p7l875t1110r992b1147],
10	has	VBZ	O	have	aux	12	SENT_195	[p7l1000t1108r1050b1138],
11	been	VBN	O	be	auxpass	12	SENT_195	[p7l1061t1108r1135b1138],
12	studied	VBN	O	study	_	0	SENT_195	[p7l1146t1108r1258b1138],
13	in	IN	O	in	_	0	SENT_195	[p7l1268t1110r1298b1137],
14	other	JJ	O	other	amod	16	SENT_195	[p7l1309t1108r1393b1138],
15	rodent	JJ	O	rodent	amod	16	SENT_195	[p7l1402t1109r1507b1138],
16	models	NNS	O	model	prep_in	12	SENT_195	[p7l1516t1108r1636b1138],
17	.	.	O	.	_	0	SENT_195	[p7l1516t1108r1636b1138],

1	Administration	NN	O	administration	nsubj	11	SENT_196	[p7l1646t1108r1885b1138],
2	of	IN	O	of	_	0	SENT_196	[p7l1896t1109r1930b1138],
3	the	DT	O	the	det	6	SENT_196	[p7l1936t1109r1985b1138],
4	OCT	NN	DATE	oct	nn	6	SENT_196	[p7l1996t1109r2084b1138],
5	substrate	NN	O	substrate	nn	6	SENT_196	[p7l565t1157r704b1187],
6	imatinib	NN	O	imatinib	prep_of	1	SENT_196	[p7l712t1157r842b1187],
7	in	IN	O	in	_	0	SENT_196	[p7l850t1159r881b1186],
8	combination	NN	O	combination	prep_in	6	SENT_196	[p7l888t1157r1086b1187],
9	with	IN	O	with	_	0	SENT_196	[p7l1093t1157r1162b1187],
10	cisplatin	NN	O	cisplatin	prep_with	8	SENT_196	[p7l1170t1157r1300b1196],
11	prevented	VBD	O	prevent	_	0	SENT_196	[p7l1307t1157r1463b1196],
12	nephrotoxicity	NN	O	nephrotoxicity	dobj	11	SENT_196	[p7l1470t1157r1701b1196],
13	caused	VBN	O	cause	partmod	12	SENT_196	[p7l1708t1157r1810b1187],
14	by	IN	O	by	_	0	SENT_196	[p7l1818t1157r1856b1196],
15	renal	JJ	O	renal	amod	16	SENT_196	[p7l1862t1157r1941b1187],
16	accumulation	NN	O	accumulation	agent	13	SENT_196	[p7l1949t1168r2082b1187, p7l565t1207r654b1236],
17	of	IN	O	of	_	0	SENT_196	[p7l666t1207r700b1236],
18	platinum	NN	O	platinum	prep_of	16	SENT_196	[p7l707t1207r848b1246],
19	in	IN	O	in	_	0	SENT_196	[p7l859t1209r889b1236],
20	rats	NNS	O	rat	prep_in	18	SENT_196	[p7l901t1215r956b1236],
21	(	RB	O	(	advmod	18	SENT_196	[p7l969t1208r1038b1244],
22	40	CD	NUMBER	40	num	23	SENT_196	[p7l969t1208r1038b1244],
23	)	NN	O	)	dep	18	SENT_196	[p7l969t1208r1038b1244],
24	,	,	O	,	_	0	SENT_196	[p7l969t1208r1038b1244],
25	and	CC	O	and	_	0	SENT_196	[p7l1051t1207r1106b1237],
26	concomitant	JJ	O	concomitant	amod	27	SENT_196	[p7l1119t1209r1316b1237],
27	administration	NN	O	administration	nsubj	30	SENT_196	[p7l1327t1207r1555b1236],
28	of	IN	O	of	_	0	SENT_196	[p7l1567t1207r1601b1236],
29	cimetidine	NN	O	cimetidine	prep_of	27	SENT_196	[p7l1609t1207r1774b1236],
30	inhibited	VBD	O	inhibit	conj_and	11	SENT_196	[p7l1785t1207r1926b1237],
31	cisplatininduced	JJ	O	cisplatininduced	amod	32	SENT_196	[p7l1939t1207r2082b1246, p7l564t1258r688b1287],
32	nephrotoxicity	NN	O	nephrotoxicity	dobj	30	SENT_196	[p7l696t1257r927b1296],
33	in	IN	O	in	_	0	SENT_196	[p7l934t1259r964b1286],
34	mice	NNS	O	mouse	prep_in	30	SENT_196	[p7l972t1259r1046b1287],
35	(	CD	NUMBER	(	number	36	SENT_196	[p7l1055t1259r1123b1294],
36	41	CD	NUMBER	41	num	37	SENT_196	[p7l1055t1259r1123b1294],
37	)	NN	O	)	dep	30	SENT_196	[p7l1055t1259r1123b1294],
38	.	.	O	.	_	0	SENT_196	[p7l1055t1259r1123b1294],

1	A	DT	O	a	det	2	SENT_197	[p7l1132t1259r1159b1286],
2	case	NN	O	case	nsubjpass	16	SENT_197	[p7l1166t1269r1228b1287],
3	of	IN	O	of	_	0	SENT_197	[p7l1237t1258r1271b1287],
4	severe	JJ	O	severe	amod	5	SENT_197	[p7l1275t1268r1371b1287],
5	arrhythmia	NN	O	arrhythmium	prep_of	2	SENT_197	[p7l1380t1257r1554b1296],
6	caused	VBN	O	cause	partmod	5	SENT_197	[p7l1562t1258r1665b1287],
7	by	IN	O	by	_	0	SENT_197	[p7l1673t1257r1711b1296],
8	reduced	VBN	O	reduce	amod	10	SENT_197	[p7l1718t1258r1843b1287],
9	renal	JJ	O	renal	amod	10	SENT_197	[p7l1851t1258r1929b1287],
10	clearance	NN	O	clearance	agent	6	SENT_197	[p7l1938t1258r2082b1287],
11	of	IN	O	of	_	0	SENT_197	[p7l565t1308r600b1337],
12	the	DT	O	the	det	14	SENT_197	[p7l607t1307r655b1337],
13	antiarrhythmic	JJ	O	antiarrhythmic	amod	14	SENT_197	[p7l668t1307r902b1346],
14	pilsicainide	NN	O	pilsicainide	prep_of	10	SENT_197	[p7l913t1307r1089b1346],
15	was	VBD	O	be	auxpass	16	SENT_197	[p7l1099t1319r1155b1337],
16	postulated	VBN	O	postulate	_	0	SENT_197	[p7l1167t1307r1329b1346],
17	to	TO	O	to	aux	19	SENT_197	[p7l1341t1316r1371b1337],
18	be	VB	O	be	auxpass	19	SENT_197	[p7l1383t1307r1419b1337],
19	caused	VBN	O	cause	xcomp	16	SENT_197	[p7l1431t1307r1533b1337],
20	by	IN	O	by	_	0	SENT_197	[p7l1545t1307r1583b1346],
21	inhibition	NN	O	inhibition	agent	19	SENT_197	[p7l1593t1307r1748b1337],
22	of	IN	O	of	_	0	SENT_197	[p7l1760t1308r1794b1337],
23	P-glycoprotein	NN	O	p-glycoprotein	prep_of	21	SENT_197	[p7l1801t1307r2038b1346],
24	or	CC	O	or	_	0	SENT_197	[p7l2050t1318r2083b1337],
25	OCT2	NN	O	oct2	prep_of	21	SENT_197	[p7l566t1358r668b1387],
26	by	IN	O	by	_	0	SENT_197	[p7l683t1358r721b1397],
27	the	DT	O	the	det	29	SENT_197	[p7l731t1358r779b1387],
28	antihistamine	NN	O	antihistamine	nn	29	SENT_197	[p7l791t1358r1003b1387],
29	cetirizine	NN	O	cetirizine	agent	19	SENT_197	[p7l1015t1359r1159b1387],
30	(	CD	NUMBER	(	number	31	SENT_197	[p7l1172t1359r1240b1394],
31	42	CD	NUMBER	42	num	32	SENT_197	[p7l1172t1359r1240b1394],
32	)	NN	O	)	dep	19	SENT_197	[p7l1172t1359r1240b1394],
33	.	.	O	.	_	0	SENT_197	[p7l1172t1359r1240b1394],

1	This	DT	O	this	nsubj	2	SENT_198	[p7l1252t1358r1325b1387],
2	suggests	VBZ	O	suggest	_	0	SENT_198	[p7l1337t1366r1465b1397],
3	that	IN	O	that	complm	9	SENT_198	[p7l1477t1358r1539b1387],
4	there	EX	O	there	expl	9	SENT_198	[p7l1549t1358r1630b1387],
5	may	MD	O	may	aux	9	SENT_198	[p7l1641t1369r1707b1397],
6	be	VB	O	be	cop	9	SENT_198	[p7l1717t1358r1752b1387],
7	additional	JJ	O	additional	amod	9	SENT_198	[p7l1764t1358r1920b1387],
8	drug	NN	O	drug	nn	9	SENT_198	[p7l1932t1358r2005b1397],
9	substrates	NNS	O	substrate	ccomp	2	SENT_198	[p7l2016t1358r2082b1387, p7l565t1416r664b1437],
10	of	IN	O	of	_	0	SENT_198	[p7l679t1408r713b1437],
11	OCTs	NNS	O	oct	prep_of	9	SENT_198	[p7l724t1409r833b1443],
12	,	,	O	,	_	0	SENT_198	[p7l724t1409r833b1443],
13	particularly	RB	O	particularly	advmod	14	SENT_198	[p7l848t1408r1029b1447],
14	OCTS	NN	O	oct	appos	11	SENT_198	[p7l1043t1409r1143b1437],
15	expressed	VBN	O	express	partmod	14	SENT_198	[p7l1158t1408r1307b1446],
16	in	IN	O	in	_	0	SENT_198	[p7l1321t1410r1351b1437],
17	an	DT	O	a	det	19	SENT_198	[p7l1366t1419r1402b1437],
18	organ-speciﬁc	JJ	O	organ-speciﬁc	amod	19	SENT_198	[p7l1416t1408r1637b1447],
19	fashion	NN	O	fashion	prep_in	15	SENT_198	[p7l1651t1408r1764b1437],
20	such	JJ	O	such	_	0	SENT_198	[p7l1778t1408r1848b1437],
21	as	IN	O	as	_	0	SENT_198	[p7l1863t1419r1891b1437],
22	OCT1	NN	O	oct1	prep_such_as	19	SENT_198	[p7l1907t1409r2009b1437],
23	and	CC	O	and	_	0	SENT_198	[p7l2027t1408r2082b1437],
24	OCT2	NN	O	oct2	prep_such_as	19	SENT_198	[p7l566t1458r680b1493],
25	,	,	O	,	_	0	SENT_198	[p7l566t1458r680b1493],
26	which	WDT	O	which	nsubjpass	28	SENT_198	[p7l690t1457r785b1486],
27	are	VBP	O	be	auxpass	28	SENT_198	[p7l796t1468r842b1486],
28	involved	VBN	O	involve	rcmod	22	SENT_198	[p7l853t1457r985b1486],
29	in	IN	O	in	_	0	SENT_198	[p7l995t1459r1026b1486],
30	OCT	NN	DATE	oct	prep_in	28	SENT_198	[p7l1037t1457r1283b1486],
31	—	CD	NUMBER	—	num	30	SENT_198	[p7l1037t1457r1283b1486],
32	mediated	VBN	O	mediate	partmod	30	SENT_198	[p7l1037t1457r1283b1486],
33	hepatic	JJ	O	hepatic	acomp	32	SENT_198	[p7l1293t1457r1406b1496],
34	or	CC	O	or	_	0	SENT_198	[p7l1417t1468r1450b1486],
35	renal	JJ	O	renal	amod	37	SENT_198	[p7l1460t1457r1538b1486],
36	drug	NN	O	drug	nn	37	SENT_198	[p7l1550t1457r1623b1496],
37	elimination	NN	O	elimination	conj_or	19	SENT_198	[p7l1633t1457r1811b1486],
38	and	CC	O	and	_	0	SENT_198	[p7l1822t1457r1878b1486],
39	interactions	NNS	O	interaction	conj_and	37	SENT_198	[p7l1888t1459r2081b1486],
40	.	.	O	.	_	0	SENT_198	[p7l1888t1459r2081b1486],

1	Multidrug	JJ	O	multidrug	_	0	SENT_199	[p7l564t1587r760b1631],
2	and	CC	O	and	_	0	SENT_199	[p7l772t1588r839b1620],
3	Toxin	NN	O	toxin	nn	5	SENT_199	[p7l850t1588r966b1620],
4	Extrusion	NN	O	extrusion	nn	5	SENT_199	[p7l977t1589r1162b1620],
5	Transporters	NNS	O	transporter	conj_and	1	SENT_199	[p7l1173t1588r1424b1630],

1	The	DT	O	the	det	2	SENT_200	[p7l564t1657r630b1686],
2	multidrug	JJ	O	multidrug	nsubj	7	SENT_200	[p7l645t1657r804b1696],
3	and	CC	O	and	_	0	SENT_200	[p7l818t1657r873b1686],
4	toxin	NN	O	toxin	nn	6	SENT_200	[p7l889t1659r968b1686],
5	extrusion	NN	O	extrusion	nn	6	SENT_200	[p7l983t1659r1127b1686],
6	transporters	NNS	O	transporter	conj_and	2	SENT_200	[p7l1142t1665r1331b1695],
7	(	VBP	O	(	_	0	SENT_200	[p7l1347t1658r1472b1693],
8	MATE	NN	O	mate	nn	10	SENT_200	[p7l1347t1658r1472b1693],
9	transporters/SLC47/1	NN	O	transporters/slc47/1	nn	10	SENT_200	[p7l1487t1658r1835b1695],
10	)	NN	O	)	nsubj	11	SENT_200	[p7l1487t1658r1835b1695],
11	are	VBP	O	be	ccomp	7	SENT_200	[p7l1851t1668r1897b1686],
12	among	IN	O	among	_	0	SENT_200	[p7l1913t1668r2020b1696],
13	the	DT	O	the	prep_among	11	SENT_200	[p7l2034t1657r2082b1686],
14	most	RBS	O	most	advmod	13	SENT_200	[p7l565t1714r642b1735],
15	recently	RB	DATE	recently	advmod	16	SENT_200	[p7l654t1706r781b1745],
16	identiﬁed	VBN	O	identiﬁed	partmod	13	SENT_200	[p7l793t1706r942b1735],
17	transporters	NNS	O	transporter	dobj	16	SENT_200	[p7l955t1714r1144b1745],
18	of	IN	O	of	_	0	SENT_200	[p7l1158t1706r1192b1735],
19	functional	JJ	O	functional	amod	20	SENT_200	[p7l1201t1706r1359b1735],
20	importance	NN	O	importance	prep_of	17	SENT_200	[p7l1372t1707r1550b1745],
21	in	IN	O	in	_	0	SENT_200	[p7l1563t1707r1594b1735],
22	cation	NN	O	cation	nn	23	SENT_200	[p7l1607t1707r1702b1735],
23	transport	NN	O	transport	prep_in	20	SENT_200	[p7l1715t1714r1867b1745],
24	,	,	O	,	_	0	SENT_200	[p7l1715t1714r1867b1745],
25	although	IN	O	although	mark	36	SENT_200	[p7l1882t1706r2021b1745],
26	the	DT	O	the	det	27	SENT_200	[p7l2034t1706r2083b1735],
27	existence	NN	O	existence	nsubjpass	36	SENT_200	[p7l565t1758r706b1786],
28	of	IN	O	of	_	0	SENT_200	[p7l714t1756r748b1786],
29	a	DT	O	a	det	33	SENT_200	[p7l751t1767r766b1785],
30	renal	JJ	O	renal	amod	33	SENT_200	[p7l773t1756r852b1786],
31	eﬂlux	NN	O	eﬂlux	nn	33	SENT_200	[p7l860t1756r944b1785],
32	transport	NN	O	transport	nn	33	SENT_200	[p7l951t1764r1095b1795],
33	system	NN	O	system	prep_of	27	SENT_200	[p7l1102t1764r1207b1795],
34	had	VBD	O	have	aux	36	SENT_200	[p7l1214t1756r1270b1785],
35	been	VBN	O	be	auxpass	36	SENT_200	[p7l1277t1756r1352b1786],
36	known	VBN	O	know	advcl	16	SENT_200	[p7l1359t1756r1464b1786],
37	for	IN	O	for	_	0	SENT_200	[p7l1472t1756r1517b1786],
38	some	DT	O	some	det	42	SENT_200	[p7l1524t1767r1604b1786],
39	time	NN	O	time	nn	42	SENT_200	[p7l1612t1758r1682b1785],
40	(	NN	O	(	nn	42	SENT_200	[p7l1690t1757r1758b1793],
41	43	CD	NUMBER	43	num	42	SENT_200	[p7l1690t1757r1758b1793],
42	)	NN	O	)	prep_for	36	SENT_200	[p7l1690t1757r1758b1793],
43	.	.	O	.	_	0	SENT_200	[p7l1690t1757r1758b1793],

1	MATE	NN	O	mate	nsubjpass	7	SENT_201	[p7l1766t1757r1897b1785],
2	]	CD	NUMBER	]	num	1	SENT_201	[p7l1766t1757r1897b1785],
3	(	CD	NUMBER	(	num	5	SENT_201	[p7l1909t1757r2082b1793],
4	SLC47/11	NN	O	slc47/11	nn	5	SENT_201	[p7l1909t1757r2082b1793],
5	)	NN	O	)	dep	1	SENT_201	[p7l1909t1757r2082b1793],
6	is	VBZ	O	be	auxpass	7	SENT_201	[p7l564t1808r587b1836],
7	expressed	VBN	O	express	conj_but	7	SENT_201	[p7l598t1806r746b1845],
8	throughout	IN	O	throughout	_	0	SENT_201	[p7l756t1806r936b1846],
9	the	DT	O	the	det	10	SENT_201	[p7l945t1806r993b1836],
10	body	NN	O	body	prep_throughout	7	SENT_201	[p7l1003t1806r1088b1845],
11	,	,	O	,	_	0	SENT_201	[p7l1003t1806r1088b1845],
12	but	CC	O	but	_	0	SENT_201	[p7l1099t1806r1151b1836],
13	predominantly	RB	O	predominantly	advmod	7	SENT_201	[p7l1159t1806r1392b1846],
14	in	IN	O	in	_	0	SENT_201	[p7l1400t1808r1430b1835],
15	the	DT	O	the	det	16	SENT_201	[p7l1440t1806r1488b1836],
16	liver	NN	O	liver	prep_in	7	SENT_201	[p7l1498t1806r1567b1836],
17	and	CC	O	and	_	0	SENT_201	[p7l1577t1806r1632b1836],
18	kidneys	NNS	O	kidney	prep_in	7	SENT_201	[p7l1641t1806r1767b1846],
19	,	,	O	,	_	0	SENT_201	[p7l1641t1806r1767b1846],
20	where	WRB	O	where	advmod	23	SENT_201	[p7l1777t1807r1873b1836],
21	it	PRP	O	it	nsubj	23	SENT_201	[p7l1882t1808r1905b1836],
22	is	VBZ	O	be	cop	23	SENT_201	[p7l1913t1808r1936b1836],
23	localized	JJ	O	localized	dep	7	SENT_201	[p7l1946t1806r2082b1836],
24	to	TO	O	to	_	0	SENT_201	[p7l565t1864r595b1885],
25	the	DT	O	the	det	27	SENT_201	[p7l608t1856r656b1885],
26	canalicular	JJ	O	canalicular	amod	27	SENT_201	[p7l669t1856r837b1885],
27	membrane	NN	O	membrane	prep_to	23	SENT_201	[p7l848t1856r1015b1885],
28	of	IN	O	of	_	0	SENT_201	[p7l1028t1856r1062b1885],
29	hepatocytes	NNS	O	hepatocyte	prep_of	27	SENT_201	[p7l1069t1856r1253b1894],
30	and	CC	O	and	_	0	SENT_201	[p7l1266t1856r1321b1885],
31	the	DT	O	the	det	33	SENT_201	[p7l1333t1856r1382b1885],
32	luminal	JJ	O	luminal	amod	33	SENT_201	[p7l1394t1856r1512b1885],
33	membrane	NN	O	membrane	prep_to	23	SENT_201	[p7l1524t1856r1691b1885],
34	of	IN	O	of	_	0	SENT_201	[p7l1704t1856r1738b1885],
35	proximal	JJ	O	proximal	amod	37	SENT_201	[p7l1745t1856r1884b1894],
36	tubule	JJ	O	tubule	amod	37	SENT_201	[p7l1896t1856r1994b1885],
37	cells	NNS	O	cell	prep_of	33	SENT_201	[p7l2006t1856r2081b1891],
38	,	,	O	,	_	0	SENT_201	[p7l2006t1856r2081b1891],
39	respectively	RB	O	respectively	dep	41	SENT_201	[p7l565t1906r750b1945],
40	(	CD	NUMBER	(	num	41	SENT_201	[p7l757t1907r813b1942],
41	44	CD	NUMBER	44	dep	23	SENT_201	[p7l757t1907r813b1942],
42	,	,	O	,	_	0	SENT_201	[p7l757t1907r813b1942],
43	45	CD	NUMBER	45	num	44	SENT_201	[p7l821t1907r879b1942],
44	)	NN	O	)	appos	41	SENT_201	[p7l821t1907r879b1942],
45	.	.	O	.	_	0	SENT_201	[p7l821t1907r879b1942],

1	In	IN	O	in	_	0	SENT_202	[p7l887t1907r921b1935],
2	contrast	NN	O	contrast	prep_in	22	SENT_202	[p7l928t1914r1062b1941],
3	,	,	O	,	_	0	SENT_202	[p7l928t1914r1062b1941],
4	MATE2	NN	O	mate2	nsubj	31	SENT_202	[p7l1069t1906r1201b1935],
5	-	:	O	-	_	0	SENT_202	[p7l1206t1907r1255b1941],
6	K	NNP	O	K	dep	4	SENT_202	[p7l1206t1907r1255b1941],
7	,	,	O	,	_	0	SENT_202	[p7l1206t1907r1255b1941],
8	the	DT	O	the	det	14	SENT_202	[p7l1264t1906r1312b1935],
9	protein	NN	O	protein	nn	14	SENT_202	[p7l1320t1907r1434b1944],
10	form	NN	O	form	nn	14	SENT_202	[p7l1441t1906r1517b1935],
11	ofMATE2	NN	O	ofmate2	nn	14	SENT_202	[p7l1525t1906r1693b1935],
12	(	CD	NUMBER	(	num	14	SENT_202	[p7l1703t1906r1876b1942],
13	SLC47/12	NN	O	slc47/12	nn	14	SENT_202	[p7l1703t1906r1876b1942],
14	)	NN	O	)	appos	6	SENT_202	[p7l1703t1906r1876b1942],
15	that	WDT	O	that	nsubjpass	19	SENT_202	[p7l1884t1906r1946b1935],
16	has	VBZ	O	have	aux	19	SENT_202	[p7l1951t1906r2001b1935],
17	been	VBN	O	be	auxpass	19	SENT_202	[p7l2009t1906r2083b1935],
18	functionally	RB	O	functionally	advmod	19	SENT_202	[p7l565t1955r753b1995],
19	characterized	VBN	O	characterize	rcmod	14	SENT_202	[p7l763t1955r980b1991],
20	,	,	O	,	_	0	SENT_202	[p7l763t1955r980b1991],
21	is	VBZ	O	be	auxpass	22	SENT_202	[p7l992t1957r1015b1985],
22	expressed	VBN	O	express	_	0	SENT_202	[p7l1027t1956r1176b1994],
23	speciﬁcally	RB	O	speciﬁcally	advmod	22	SENT_202	[p7l1187t1955r1359b1995],
24	in	IN	O	in	_	0	SENT_202	[p7l1368t1957r1399b1984],
25	the	DT	O	the	det	28	SENT_202	[p7l1410t1955r1458b1985],
26	kidney	NN	O	kidney	nn	28	SENT_202	[p7l1470t1955r1575b1995],
27	proximal	JJ	O	proximal	amod	28	SENT_202	[p7l1585t1956r1723b1994],
28	tubule	NN	O	tubule	prep_in	22	SENT_202	[p7l1735t1955r1833b1985],
29	and	CC	O	and	_	0	SENT_202	[p7l1845t1955r1900b1985],
30	is	VBZ	O	be	cop	31	SENT_202	[p7l1911t1957r1934b1985],
31	localized	JJ	O	localized	conj_and	22	SENT_202	[p7l1946t1955r2082b1985],
32	to	TO	O	to	_	0	SENT_202	[p7l565t2014r595b2035],
33	the	DT	O	the	det	35	SENT_202	[p7l607t2005r656b2035],
34	luminal	JJ	O	luminal	amod	35	SENT_202	[p7l668t2005r786b2035],
35	membranes	NNS	O	membrane	prep_to	31	SENT_202	[p7l797t2005r987b2035],
36	.	.	O	.	_	0	SENT_202	[p7l797t2005r987b2035],

1	Many	JJ	O	many	nsubj	10	SENT_203	[p7l998t2007r1091b2044],
2	of	IN	O	of	_	0	SENT_203	[p7l1102t2005r1136b2035],
3	the	DT	O	the	det	4	SENT_203	[p7l1143t2005r1192b2035],
4	substrates	NNS	O	substrate	prep_of	1	SENT_203	[p7l1204t2005r1357b2035],
5	and	CC	O	and	_	0	SENT_203	[p7l1369t2005r1424b2035],
6	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_203	[p7l1436t2005r1588b2035],
7	of	IN	O	of	_	0	SENT_203	[p7l1600t2005r1634b2035],
8	MATE	NN	O	mate	nn	9	SENT_203	[p7l1640t2006r1756b2034],
9	transporters	NNS	O	transporter	prep_of	4	SENT_203	[p7l1767t2014r1956b2044],
10	overlap	VBP	O	overlap	_	0	SENT_203	[p7l1968t2005r2082b2044],
11	with	IN	O	with	_	0	SENT_203	[p7l564t2055r633b2085],
12	those	DT	O	those	prep_with	10	SENT_203	[p7l644t2055r726b2085],
13	of	IN	O	of	_	0	SENT_203	[p7l737t2056r772b2085],
14	OCTs	NNS	MISC	oct	prep_of	12	SENT_203	[p7l779t2056r887b2091],
15	;	:	O	;	_	0	SENT_203	[p7l779t2056r887b2091],
16	therefore	RB	O	therefore	advmod	36	SENT_203	[p7l899t2056r1052b2091],
17	,	,	O	,	_	0	SENT_203	[p7l899t2056r1052b2091],
18	the	DT	O	the	det	19	SENT_203	[p7l1064t2055r1112b2085],
19	role	NN	O	role	nsubjpass	36	SENT_203	[p7l1123t2056r1183b2085],
20	of	IN	O	of	_	0	SENT_203	[p7l1195t2056r1229b2085],
21	MATE	NN	O	mate	nn	22	SENT_203	[p7l1233t2056r1349b2085],
22	transporters	NNS	O	transporter	prep_of	19	SENT_203	[p7l1360t2064r1548b2094],
23	in	IN	O	in	_	0	SENT_203	[p7l1559t2057r1589b2084],
24	mediating	VBG	O	mediate	prepc_in	22	SENT_203	[p7l1599t2055r1757b2094],
25	cation	NN	O	cation	nn	26	SENT_203	[p7l1767t2057r1862b2085],
26	transport	NN	O	transport	dobj	24	SENT_203	[p7l1873t2064r2017b2094],
27	and	CC	O	and	_	0	SENT_203	[p7l2027t2056r2082b2085],
28	drug-drug	NN	O	drug-drug	nn	29	SENT_203	[p7l565t2105r727b2144],
29	interactions	NNS	O	interaction	dobj	24	SENT_203	[p7l737t2107r921b2135],
30	in	IN	O	in	_	0	SENT_203	[p7l932t2107r963b2134],
31	the	DT	O	the	det	32	SENT_203	[p7l974t2105r1022b2135],
32	kidney	NN	O	kidney	prep_in	24	SENT_203	[p7l1033t2105r1139b2144],
33	may	MD	O	may	aux	36	SENT_203	[p7l1148t2117r1214b2144],
34	have	VB	O	have	aux	36	SENT_203	[p7l1224t2105r1294b2135],
35	been	VBN	O	be	auxpass	36	SENT_203	[p7l1306t2106r1380b2135],
36	underestimated	VBN	O	underestimate	parataxis	10	SENT_203	[p7l1390t2105r1633b2135],
37	in	IN	O	in	_	0	SENT_203	[p7l1644t2107r1675b2134],
38	the	DT	DATE	the	det	41	SENT_203	[p7l1686t2105r1734b2135],
39	past	JJ	DATE	past	amod	41	SENT_203	[p7l1745t2114r1808b2144],
40	(	CD	NUMBER	(	number	41	SENT_203	[p7l1819t2107r1856b2142],
41	5	CD	NUMBER	5	prep_in	36	SENT_203	[p7l1819t2107r1856b2142],
42	,	,	O	,	_	0	SENT_203	[p7l1819t2107r1856b2142],
43	7	CD	NUMBER	7	num	44	SENT_203	[p7l1870t2106r1907b2142],
44	)	NN	O	)	appos	41	SENT_203	[p7l1870t2106r1907b2142],
45	.	.	O	.	_	0	SENT_203	[p7l1870t2106r1907b2142],

1	Multidrug	JJ	O	multidrug	amod	5	SENT_204	[p7l564t2205r741b2244],
2	and	CC	O	and	_	0	SENT_204	[p7l752t2205r812b2234],
3	toxin	NN	O	toxin	amod	5	SENT_204	[p7l824t2207r910b2234],
4	extrusion	NN	O	extrusion	nn	5	SENT_204	[p7l922t2207r1080b2234],
5	transporters	NNS	O	transporter	_	0	SENT_204	[p7l1092t2213r1300b2244],
6	in	IN	O	in	_	0	SENT_204	[p7l1312t2207r1345b2234],
7	efﬁcacy	NN	O	efﬁcacy	prep_in	5	SENT_204	[p7l1357t2206r1492b2244],
8	.	.	O	.	_	0	SENT_204	[p7l1357t2206r1492b2244],

1	Several	JJ	O	several	amod	2	SENT_205	[p7l1514t2205r1626b2234],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	10	SENT_205	[p7l1637t2205r1880b2244],
3	in	IN	O	in	_	0	SENT_205	[p7l1891t2207r1922b2234],
4	genes	NNS	O	gene	prep_in	2	SENT_205	[p7l1933t2216r2020b2244],
5	encoding	VBG	O	encode	partmod	4	SENT_205	[p7l2032t2216r2082b2234, p7l565t2255r672b2294],
6	MATE	NN	O	mate	nn	7	SENT_205	[p7l680t2256r795b2284],
7	transporters	NNS	O	transporter	dobj	5	SENT_205	[p7l806t2264r995b2294],
8	have	VBP	O	have	aux	10	SENT_205	[p7l1005t2255r1076b2284],
9	been	VBN	O	be	auxpass	10	SENT_205	[p7l1087t2255r1161b2284],
10	identiﬁed	VBN	O	identiﬁed	_	0	SENT_205	[p7l1171t2255r1320b2284],
11	and	CC	O	and	_	0	SENT_205	[p7l1331t2255r1386b2284],
12	functionally	RB	O	functionally	advmod	13	SENT_205	[p7l1397t2255r1585b2294],
13	characterized	VBN	O	characterize	conj_and	10	SENT_205	[p7l1595t2255r1803b2284],
14	(	NN	O	(	nn	16	SENT_205	[p7l1814t2256r1940b2292],
15	46-49	CD	NUMBER	46-49	num	16	SENT_205	[p7l1814t2256r1940b2292],
16	)	NN	O	)	dobj	13	SENT_205	[p7l1814t2256r1940b2292],
17	.	.	O	.	_	0	SENT_205	[p7l1814t2256r1940b2292],

1	Many	JJ	O	many	nsubj	5	SENT_206	[p7l1951t2257r2043b2294],
2	of	IN	O	of	_	0	SENT_206	[p7l2053t2255r2087b2284],
3	these	DT	O	these	det	4	SENT_206	[p7l565t2305r645b2334],
4	Variants	NNS	O	variant	prep_of	1	SENT_206	[p7l655t2306r777b2334],
5	exhibit	VBP	O	exhibit	_	0	SENT_206	[p7l789t2304r896b2334],
6	changes	NNS	O	change	dobj	5	SENT_206	[p7l907t2305r1030b2343],
7	to	TO	O	to	_	0	SENT_206	[p7l1042t2313r1073b2334],
8	transport	NN	O	transport	nn	9	SENT_206	[p7l1085t2313r1229b2343],
9	activity	NN	O	activity	prep_to	5	SENT_206	[p7l1240t2306r1354b2343],
10	in	FW	O	in	nn	11	SENT_206	[p7l1363t2306r1394b2333],
11	vitro	FW	O	vitro	advmod	5	SENT_206	[p7l1404t2306r1487b2340],
12	;	:	O	;	_	0	SENT_206	[p7l1404t2306r1487b2340],
13	however	RB	O	however	advmod	22	SENT_206	[p7l1499t2305r1640b2340],
14	,	,	O	,	_	0	SENT_206	[p7l1499t2305r1640b2340],
15	the	DT	O	the	det	16	SENT_206	[p7l1653t2304r1701b2334],
16	inﬂuence	NN	O	inﬂuence	nsubj	22	SENT_206	[p7l1713t2305r1856b2334],
17	of	IN	O	of	_	0	SENT_206	[p7l1868t2305r1902b2333],
18	these	DT	O	these	det	19	SENT_206	[p7l1910t2304r1989b2334],
19	polymorphisms	NNS	O	polymorphism	prep_of	16	SENT_206	[p7l2001t2305r2082b2343, p7l564t2354r739b2393],
20	in	FW	O	in	prep	19	SENT_206	[p7l750t2356r781b2383],
21	vivo	FW	O	vivo	pobj	20	SENT_206	[p7l791t2356r856b2383],
22	remains	VBZ	O	remain	parataxis	5	SENT_206	[p7l868t2356r991b2383],
23	to	TO	O	to	aux	25	SENT_206	[p7l1003t2363r1033b2383],
24	be	VB	O	be	auxpass	25	SENT_206	[p7l1045t2355r1081b2383],
25	seen	VBN	O	see	xcomp	22	SENT_206	[p7l1094t2365r1169b2383],
26	.	.	O	.	_	0	SENT_206	[p7l1094t2365r1169b2383],

1	In	IN	O	in	_	0	SENT_207	[p7l1182t2356r1216b2383],
2	one	CD	NUMBER	one	num	3	SENT_207	[p7l1228t2365r1284b2383],
3	study	NN	O	study	prep_in	15	SENT_207	[p7l1296t2354r1381b2393],
4	of	IN	O	of	_	0	SENT_207	[p7l1391t2355r1426b2383],
5	diabetic	JJ	O	diabetic	amod	6	SENT_207	[p7l1434t2354r1556b2383],
6	patients	NNS	O	patient	prep_of	3	SENT_207	[p7l1567t2356r1698b2393],
7	,	,	O	,	_	0	SENT_207	[p7l1567t2356r1698b2393],
8	heterozygous	JJ	O	heterozygous	amod	9	SENT_207	[p7l1711t2354r1920b2393],
9	SLC47AI	NN	O	slc47aus	nsubj	15	SENT_207	[p7l1932t2355r2080b2383],
10	and	CC	O	and	_	0	SENT_207	[p7l565t2403r621b2432],
11	SLC47A2	NN	O	slc47a2	nn	12	SENT_207	[p7l635t2404r785b2432],
12	variants	NNS	O	variant	conj_and	9	SENT_207	[p7l798t2405r920b2432],
13	did	VBD	O	do	aux	15	SENT_207	[p7l935t2403r983b2432],
14	not	RB	O	not	neg	15	SENT_207	[p7l996t2412r1050b2432],
15	alter	VB	O	alter	_	0	SENT_207	[p7l1063t2403r1133b2432],
16	the	DT	O	the	det	17	SENT_207	[p7l1146t2403r1195b2432],
17	pharmacokinetics	NNS	O	pharmacokinetic	dobj	15	SENT_207	[p7l1209t2403r1484b2442],
18	of	IN	O	of	_	0	SENT_207	[p7l1499t2403r1533b2432],
19	metformin	NN	O	metformin	prep_of	17	SENT_207	[p7l1542t2403r1711b2432],
20	(	CD	NUMBER	(	number	21	SENT_207	[p7l1725t2404r1794b2439],
21	50	CD	NUMBER	50	num	22	SENT_207	[p7l1725t2404r1794b2439],
22	)	NN	O	)	dep	19	SENT_207	[p7l1725t2404r1794b2439],
23	,	,	O	,	_	0	SENT_207	[p7l1725t2404r1794b2439],
24	although	IN	O	although	mark	27	SENT_207	[p7l1809t2403r1948b2442],
25	another	DT	O	another	det	26	SENT_207	[p7l1962t2403r2083b2432],
26	study	NN	O	study	nsubj	27	SENT_207	[p7l565t2452r649b2491],
27	found	VBD	O	find	dep	19	SENT_207	[p7l657t2452r748b2481],
28	an	DT	O	a	det	29	SENT_207	[p7l757t2463r793b2481],
29	association	NN	O	association	dobj	27	SENT_207	[p7l802t2454r971b2481],
30	between	IN	O	between	_	0	SENT_207	[p7l980t2452r1110b2481],
31	the	DT	O	the	det	35	SENT_207	[p7l1119t2452r1168b2481],
32	SLC4	NN	O	slc4	nn	35	SENT_207	[p7l1177t2453r1263b2481],
33	7A1	CD	NUMBER	7a1	num	35	SENT_207	[p7l1268t2453r1325b2481],
34	SNP	NN	O	snp	nn	35	SENT_207	[p7l1337t2453r1411b2481],
35	rs2289669	NN	O	rs2289669	prep_between	29	SENT_207	[p7l1420t2454r1582b2482],
36	and	CC	O	and	_	0	SENT_207	[p7l1592t2452r1648b2481],
37	increased	VBD	O	increase	amod	39	SENT_207	[p7l1656t2452r1802b2481],
38	HbAlc	JJ	O	hbalc	amod	39	SENT_207	[p7l1811t2452r1923b2481],
39	reduction	NN	O	reduction	conj_and	35	SENT_207	[p7l1932t2452r2083b2481],
40	in	IN	O	in	_	0	SENT_207	[p7l565t2503r595b2531],
41	patients	NNS	O	patient	prep_in	39	SENT_207	[p7l607t2503r729b2541],
42	taking	VBG	O	take	partmod	41	SENT_207	[p7l742t2502r839b2541],
43	metformin	JJ	O	metformin	amod	44	SENT_207	[p7l850t2502r1019b2531],
44	(	NN	O	(	dobj	42	SENT_207	[p7l1032t2503r1100b2539],
45	51	CD	NUMBER	51	num	46	SENT_207	[p7l1032t2503r1100b2539],
46	)	NN	O	)	dep	44	SENT_207	[p7l1032t2503r1100b2539],
47	.	.	O	.	_	0	SENT_207	[p7l1032t2503r1100b2539],

1	A	DT	O	a	det	3	SENT_208	[p7l1113t2503r1139b2531],
2	third	JJ	ORDINAL	third	amod	3	SENT_208	[p7l1150t2502r1226b2531],
3	study	NN	O	study	nsubj	4	SENT_208	[p7l1239t2502r1323b2541],
4	found	VBD	O	find	_	0	SENT_208	[p7l1334t2502r1425b2531],
5	that	IN	O	that	complm	15	SENT_208	[p7l1438t2502r1499b2531],
6	the	DT	O	the	det	7	SENT_208	[p7l1511t2502r1559b2531],
7	effect	NN	O	effect	nsubj	15	SENT_208	[p7l1573t2502r1657b2531],
8	of	IN	O	of	_	0	SENT_208	[p7l1669t2502r1703b2531],
9	the	DT	O	the	det	11	SENT_208	[p7l1711t2502r1760b2531],
10	SLC47/11	NN	O	slc47/11	nn	11	SENT_208	[p7l1772t2503r1920b2531],
11	polymorphism	NN	O	polymorphism	prep_of	7	SENT_208	[p7l1935t2502r2082b2541, p7l565t2551r660b2590],
12	on	IN	O	on	_	0	SENT_208	[p7l670t2562r709b2581],
13	metformin	NN	O	metformin	nn	14	SENT_208	[p7l718t2551r1046b2581],
14	—	NN	O	—	prep_on	11	SENT_208	[p7l718t2551r1046b2581],
15	mediated	VBD	O	mediate	ccomp	4	SENT_208	[p7l718t2551r1046b2581],
16	HbAlc	NN	O	hbalc	nn	17	SENT_208	[p7l1056t2551r1168b2581],
17	levels	NNS	O	level	nsubj	19	SENT_208	[p7l1177t2551r1262b2581],
18	was	VBD	O	be	cop	19	SENT_208	[p7l1271t2562r1327b2581],
19	larger	JJR	O	larger	ccomp	15	SENT_208	[p7l1337t2551r1429b2590],
20	in	IN	O	in	_	0	SENT_208	[p7l1438t2553r1469b2580],
21	patients	NNS	O	patient	prep_in	19	SENT_208	[p7l1478t2553r1600b2590],
22	homozygous	JJ	O	homozygous	amod	21	SENT_208	[p7l1610t2551r1808b2590],
23	for	IN	O	for	_	0	SENT_208	[p7l1819t2551r1864b2581],
24	the	DT	O	the	det	27	SENT_208	[p7l1873t2551r1922b2581],
25	SLC22/11	NN	O	slc22/11	nn	27	SENT_208	[p7l1932t2552r2080b2580],
26	polymorphism	NN	O	polymorphism	nn	27	SENT_208	[p7l565t2601r794b2640],
27	rs622342	NN	O	rs622342	prep_for	22	SENT_208	[p7l806t2603r947b2631],
28	than	IN	O	than	advmod	38	SENT_208	[p7l962t2601r1031b2630],
29	in	IN	O	in	_	0	SENT_208	[p7l1043t2603r1073b2630],
30	individuals	NNS	O	individual	prep_in	28	SENT_208	[p7l1085t2601r1254b2630],
31	with	IN	O	with	_	0	SENT_208	[p7l1266t2601r1336b2630],
32	the	DT	O	the	det	35	SENT_208	[p7l1348t2601r1397b2630],
33	SLCZZAI	NNP	O	SLCZZAI	nn	35	SENT_208	[p7l1410t2602r1558b2630],
34	reference	NN	O	reference	nn	35	SENT_208	[p7l1573t2601r1719b2630],
35	allele	NN	O	allele	prep_with	30	SENT_208	[p7l1732t2601r1821b2637],
36	,	,	O	,	_	0	SENT_208	[p7l1732t2601r1821b2637],
37	thus	RB	O	thus	advmod	28	SENT_208	[p7l1835t2601r1900b2630],
38	illustrating	VBG	O	illustrate	partmod	27	SENT_208	[p7l1912t2601r2084b2640],
39	an	DT	O	a	det	40	SENT_208	[p7l565t2662r601b2680],
40	example	NN	O	example	dobj	38	SENT_208	[p7l612t2651r739b2690],
41	of	IN	O	of	_	0	SENT_208	[p7l751t2651r786b2680],
42	a	DT	O	a	det	45	SENT_208	[p7l793t2662r808b2680],
43	MATEI-OCT1	NN	O	matei-oct1	nn	45	SENT_208	[p7l817t2652r1071b2680],
44	genotype	NN	O	genotype	nn	45	SENT_208	[p7l1086t2659r1229b2690],
45	interaction	NN	O	interaction	prep_of	40	SENT_208	[p7l1240t2652r1412b2680],
46	(	CD	NUMBER	(	num	48	SENT_208	[p7l1423t2652r1492b2688],
47	52	CD	NUMBER	52	num	48	SENT_208	[p7l1423t2652r1492b2688],
48	)	NN	O	)	dep	45	SENT_208	[p7l1423t2652r1492b2688],
49	.	.	O	.	_	0	SENT_208	[p7l1423t2652r1492b2688],

1	Multidrug	JJ	O	multidrug	amod	5	SENT_209	[p7l564t2750r741b2789],
2	and	CC	O	and	_	0	SENT_209	[p7l750t2750r810b2779],
3	toxin	NN	O	toxin	amod	5	SENT_209	[p7l820t2752r906b2779],
4	extrusion	NN	O	extrusion	nn	5	SENT_209	[p7l916t2752r1075b2779],
5	transporters	NNS	O	transporter	_	0	SENT_209	[p7l1084t2758r1292b2789],
6	in	IN	O	in	_	0	SENT_209	[p7l1303t2752r1336b2779],
7	toxicity	NN	O	toxicity	prep_in	5	SENT_209	[p7l1345t2752r1479b2789],
8	.	.	O	.	_	0	SENT_209	[p7l1345t2752r1479b2789],

1	Pharmacokinetic	JJ	MISC	pharmacokinetic	amod	2	SENT_210	[p7l1500t2750r1765b2779],
2	studies	NNS	O	study	nsubj	10	SENT_210	[p7l1775t2750r1881b2779],
3	in	IN	O	in	_	0	SENT_210	[p7l1890t2752r1920b2779],
4	Mate1	NN	O	mate1	prep_in	2	SENT_210	[p7l1928t2748r2061b2779],
5	‘	CD	NUMBER	‘	num	4	SENT_210	[p7l1928t2748r2061b2779],
6	/	:	O	/	punct	8	SENT_210	[p7l1928t2748r2061b2779],
7	‘	CD	NUMBER	‘	num	8	SENT_210	[p7l2064t2758r2079b2760],
8	mice	NNS	O	mouse	dep	2	SENT_210	[p7l565t2799r638b2826],
9	have	VBP	O	have	aux	10	SENT_210	[p7l654t2797r725b2826],
10	provided	VBN	O	provide	_	0	SENT_210	[p7l741t2797r879b2836],
11	some	DT	O	some	det	12	SENT_210	[p7l896t2808r976b2826],
12	insight	NN	O	insight	dobj	10	SENT_210	[p7l992t2797r1100b2836],
13	into	IN	O	into	_	0	SENT_210	[p7l1114t2799r1176b2826],
14	the	DT	O	the	det	15	SENT_210	[p7l1193t2797r1241b2826],
15	potential	NN	O	potential	prep_into	10	SENT_210	[p7l1257t2797r1397b2836],
16	for	IN	O	for	_	0	SENT_210	[p7l1413t2797r1458b2826],
17	MATE	NNP	O	MATE	nn	19	SENT_210	[p7l1472t2798r1588b2826],
18	transporter	NN	O	transporter	nn	19	SENT_210	[p7l1603t2797r1943b2836],
19	—	NN	O	—	prep_for	15	SENT_210	[p7l1603t2797r1943b2836],
20	mediated	VBN	O	mediate	partmod	19	SENT_210	[p7l1603t2797r1943b2836],
21	changes	NNS	O	change	dobj	20	SENT_210	[p7l1959t2797r2082b2836],

1	DeGo7ter	NN	O	dego7ter	_	0	SENT_211	[p7l565t2911r676b2933],
2	et	FW	O	et	nn	3	SENT_211	[p7l683t2916r703b2933],
3	til	FW	O	til	dep	1	SENT_211	[p7l709t2911r735b2933],
4	.	.	O	.	_	0	SENT_211	[p7l709t2911r735b2933],

1	in	IN	O	in	_	0	SENT_212	[p7l366t3016r397b3044],
2	substrate	JJ	O	substrate	amod	3	SENT_212	[p7l411t3015r550b3044],
3	clearance	NN	O	clearance	pobj	1	SENT_212	[p7l566t3015r710b3044],
4	and	CC	O	and	_	0	SENT_212	[p7l725t3015r781b3044],
5	incidence	NN	O	incidence	conj_and	3	SENT_212	[p7l795t3015r944b3044],
6	of	IN	O	of	_	0	SENT_212	[p7l959t3015r994b3044],
7	toxicity	NN	O	toxicity	prep_of	3	SENT_212	[p7l1004t3016r1127b3054],
8	.	.	O	.	_	0	SENT_212	[p7l1004t3016r1127b3054],

1	Metformin	JJ	O	metformin	amod	2	SENT_213	[p7l1142t3015r1317b3044],
2	concentration	NN	O	concentration	nsubjpass	11	SENT_213	[p7l1332t3016r1549b3044],
3	in	IN	O	in	_	0	SENT_213	[p7l1563t3016r1593b3044],
4	kidney	NN	O	kidney	prep_in	2	SENT_213	[p7l1608t3015r1720b3054],
5	,	,	O	,	_	0	SENT_213	[p7l1608t3015r1720b3054],
6	liver	NN	O	liver	prep_in	2	SENT_213	[p7l1736t3015r1813b3051],
7	,	,	O	,	_	0	SENT_213	[p7l1736t3015r1813b3051],
8	and	CC	O	and	_	0	SENT_213	[p7l1829t3015r1884b3044],
9	plasma	NN	O	plasma	conj_and	4	SENT_213	[p7l366t3063r474b3102],
10	was	VBD	O	be	auxpass	11	SENT_213	[p7l485t3074r541b3093],
11	increased	VBN	O	increase	_	0	SENT_213	[p7l554t3063r700b3093],
12	in	IN	O	in	_	0	SENT_213	[p7l712t3065r743b3092],
13	Mate1	NN	O	mate1	prep_in	11	SENT_213	[p7l754t3061r886b3093],
14	‘	CD	NUMBER	‘	num	13	SENT_213	[p7l754t3061r886b3093],
15	/	:	O	/	punct	16	SENT_213	[p7l754t3061r886b3093],
16	‘	CD	NUMBER	‘	dep	11	SENT_213	[p7l889t3071r905b3073],
17	compared	VBN	O	compare	_	0	SENT_213	[p7l921t3063r1075b3102],
18	with	IN	O	with	prepc_compared_with	16	SENT_213	[p7l1087t3063r1157b3093],
19	wild	JJ	O	wild	amod	22	SENT_213	[p7l1168t3063r1317b3102],
20	—	NN	O	—	nn	22	SENT_213	[p7l1168t3063r1317b3102],
21	type	NN	O	type	nn	22	SENT_213	[p7l1168t3063r1317b3102],
22	mice	NNS	O	mouse	pobj	16	SENT_213	[p7l1330t3065r1404b3093],
23	following	VBG	O	follow	_	0	SENT_213	[p7l1417t3063r1566b3102],
24	intravenous	JJ	O	intravenous	amod	25	SENT_213	[p7l1577t3065r1759b3093],
25	administration	NN	O	administration	prep_following	11	SENT_213	[p7l1773t3063r1884b3093, p7l366t3113r505b3147],
26	,	,	O	,	_	0	SENT_213	[p7l1773t3063r1884b3093, p7l366t3113r505b3147],
27	whereas	IN	O	whereas	mark	31	SENT_213	[p7l519t3111r645b3140],
28	urinary	JJ	O	urinary	amod	29	SENT_213	[p7l658t3113r774b3150],
29	excretion	NN	O	excretion	nsubjpass	31	SENT_213	[p7l786t3113r930b3140],
30	was	VBD	O	be	auxpass	31	SENT_213	[p7l942t3122r998b3140],
31	reduced	VBN	O	reduce	dep	25	SENT_213	[p7l1012t3111r1137b3140],
32	(	CD	NUMBER	(	num	34	SENT_213	[p7l1151t3112r1219b3148],
33	53	CD	NUMBER	53	num	34	SENT_213	[p7l1151t3112r1219b3148],
34	)	NN	O	)	dobj	31	SENT_213	[p7l1151t3112r1219b3148],
35	.	.	O	.	_	0	SENT_213	[p7l1151t3112r1219b3148],

1	Reduced	VBN	O	reduce	dep	19	SENT_214	[p7l1235t3111r1370b3140],
2	urinary	JJ	O	urinary	amod	3	SENT_214	[p7l1384t3113r1499b3150],
3	excretion	NN	O	excretion	dobj	1	SENT_214	[p7l1512t3113r1656b3140],
4	and	CC	O	and	_	0	SENT_214	[p7l1670t3111r1725b3140],
5	increased	VBD	O	increase	conj_and	1	SENT_214	[p7l1738t3111r1884b3140],
6	renal	JJ	O	renal	amod	7	SENT_214	[p7l366t3159r445b3189],
7	concentration	NN	O	concentration	nsubjpass	13	SENT_214	[p7l458t3161r676b3189],
8	of	IN	O	of	_	0	SENT_214	[p7l689t3159r723b3189],
9	the	DT	O	the	det	11	SENT_214	[p7l732t3159r780b3189],
10	antibiotic	JJ	O	antibiotic	amod	11	SENT_214	[p7l794t3159r942b3189],
11	cephalexin	NN	O	cephalexin	prep_of	7	SENT_214	[p7l955t3159r1121b3198],
12	was	VBD	O	be	auxpass	13	SENT_214	[p7l1132t3170r1188b3189],
13	observed	VBN	O	observe	ccomp	5	SENT_214	[p7l1202t3159r1340b3189],
14	in	IN	O	in	_	0	SENT_214	[p7l1353t3161r1383b3188],
15	Mate1	NN	O	mate1	prep_in	13	SENT_214	[p7l1394t3157r1527b3189],
16	‘	CD	NUMBER	‘	num	15	SENT_214	[p7l1394t3157r1527b3189],
17	/	:	O	/	punct	19	SENT_214	[p7l1394t3157r1527b3189],
18	‘	CD	NUMBER	‘	num	19	SENT_214	[p7l1530t3167r1545b3169],
19	mice	NNS	O	mouse	_	0	SENT_214	[p7l1561t3161r1635b3189],
20	compared	VBN	O	compare	_	0	SENT_214	[p7l1649t3159r1803b3198],
21	with	IN	O	with	prepc_compared_with	19	SENT_214	[p7l1815t3159r1885b3189],
22	wild	JJ	O	wild	amod	25	SENT_214	[p7l366t3207r514b3246],
23	—	NN	O	—	nn	25	SENT_214	[p7l366t3207r514b3246],
24	type	NN	O	type	nn	25	SENT_214	[p7l366t3207r514b3246],
25	animals	NNS	O	animal	pobj	19	SENT_214	[p7l527t3207r644b3236],
26	(	CD	NUMBER	(	number	27	SENT_214	[p7l657t3208r726b3244],
27	54	CD	NUMBER	54	num	28	SENT_214	[p7l657t3208r726b3244],
28	)	NN	O	)	dep	25	SENT_214	[p7l657t3208r726b3244],
29	.	.	O	.	_	0	SENT_214	[p7l657t3208r726b3244],

1	Following	VBG	O	follow	_	0	SENT_215	[p7l739t3207r899b3246],
2	cisplatin	NN	O	cisplatin	nn	3	SENT_215	[p7l911t3207r1040b3246],
3	exposure	NN	O	exposure	prep_following	16	SENT_215	[p7l1053t3218r1199b3246],
4	,	,	O	,	_	0	SENT_215	[p7l1053t3218r1199b3246],
5	the	DT	O	the	det	7	SENT_215	[p7l1212t3207r1261b3236],
6	life	NN	O	life	nn	7	SENT_215	[p7l1273t3207r1321b3236],
7	span	NN	O	span	nsubj	16	SENT_215	[p7l1334t3218r1403b3246],
8	of	IN	O	of	_	0	SENT_215	[p7l1416t3207r1450b3236],
9	Mate1	NN	O	mate1	prep_of	7	SENT_215	[p7l1456t3205r1588b3236],
10	‘	CD	NUMBER	‘	num	9	SENT_215	[p7l1456t3205r1588b3236],
11	/	:	O	/	punct	13	SENT_215	[p7l1456t3205r1588b3236],
12	‘	CD	NUMBER	‘	num	13	SENT_215	[p7l1591t3215r1607b3217],
13	mice	NNS	O	mouse	dep	7	SENT_215	[p7l1622t3209r1696b3236],
14	was	VBD	O	be	cop	16	SENT_215	[p7l1707t3218r1763b3236],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_215	[p7l1775t3207r1884b3246, p7l367t3255r462b3294],
16	shorter	JJR	O	shorter	_	0	SENT_215	[p7l470t3255r590b3291],
17	,	,	O	,	_	0	SENT_215	[p7l470t3255r590b3291],
18	with	IN	O	with	_	0	SENT_215	[p7l600t3255r670b3284],
19	a	DT	O	a	det	21	SENT_215	[p7l680t3266r694b3284],
20	higher	JJR	O	higher	amod	21	SENT_215	[p7l704t3255r806b3294],
21	plasma	NN	O	plasma	prep_with	16	SENT_215	[p7l816t3255r923b3294],
22	and	CC	O	and	_	0	SENT_215	[p7l933t3255r988b3284],
23	renal	JJ	O	renal	amod	24	SENT_215	[p7l998t3255r1076b3284],
24	concentration	NN	O	concentration	conj_and	21	SENT_215	[p7l1087t3256r1304b3284],
25	in	IN	O	in	_	0	SENT_215	[p7l1314t3256r1344b3284],
26	the	DT	O	the	det	28	SENT_215	[p7l1353t3255r1402b3284],
27	knockout	JJ	O	knockout	amod	28	SENT_215	[p7l1412t3255r1559b3284],
28	mice	NNS	O	mouse	prep_in	24	SENT_215	[p7l1568t3256r1641b3284],
29	compared	VBN	O	compare	_	0	SENT_215	[p7l1652t3255r1806b3294],
30	with	IN	O	with	prepc_compared_with	28	SENT_215	[p7l1815t3255r1885b3284],
31	control	NN	O	control	nn	32	SENT_215	[p7l367t3303r480b3332],
32	animals	NNS	O	animal	pobj	28	SENT_215	[p7l492t3303r609b3332],
33	(	CD	NUMBER	(	number	34	SENT_215	[p7l621t3304r648b3339],
34	5	CD	NUMBER	5	dep	32	SENT_215	[p7l621t3304r648b3339],
35	5	CD	NUMBER	5	num	36	SENT_215	[p7l653t3304r689b3339],
36	)	NN	O	)	dep	34	SENT_215	[p7l653t3304r689b3339],
37	.	.	O	.	_	0	SENT_215	[p7l653t3304r689b3339],

1	A	DT	O	a	det	3	SENT_216	[p7l415t3351r442b3379],
2	transporter	NN	O	transporter	nn	3	SENT_216	[p7l449t3350r784b3389],
3	—	NN	O	—	nsubj	4	SENT_216	[p7l449t3350r784b3389],
4	mediated	VBD	O	mediate	dep	27	SENT_216	[p7l449t3350r784b3389],
5	interaction	NN	O	interaction	nsubjpass	14	SENT_216	[p7l793t3352r964b3379],
6	between	IN	O	between	_	0	SENT_216	[p7l973t3350r1103b3379],
7	a	DT	O	a	det	8	SENT_216	[p7l1112t3361r1126b3379],
8	drug	NN	O	drug	prep_between	5	SENT_216	[p7l1136t3350r1209b3389],
9	and	CC	O	and	_	0	SENT_216	[p7l1217t3350r1273b3379],
10	an	DT	O	a	det	12	SENT_216	[p7l1282t3361r1318b3379],
11	endogenous	JJ	O	endogenous	amod	12	SENT_216	[p7l1327t3350r1514b3389],
12	substrate	NN	O	substrate	prep_between	5	SENT_216	[p7l1524t3350r1663b3379],
13	was	VBD	O	be	auxpass	14	SENT_216	[p7l1671t3361r1727b3379],
14	identiﬁed	VBN	O	identiﬁed	ccomp	4	SENT_216	[p7l1735t3350r1884b3379],
15	in	IN	O	in	_	0	SENT_216	[p7l366t3399r397b3427],
16	a	DT	O	a	det	17	SENT_216	[p7l408t3409r423b3427],
17	study	NN	O	study	prep_in	14	SENT_216	[p7l434t3398r519b3437],
18	of	IN	O	of	_	0	SENT_216	[p7l529t3398r563b3427],
19	the	DT	O	the	det	23	SENT_216	[p7l570t3398r618b3427],
20	novel	JJ	O	novel	amod	23	SENT_216	[p7l630t3398r714b3427],
21	antibacterial	JJ	O	antibacterial	amod	23	SENT_216	[p7l726t3398r919b3427],
22	agent	NN	O	agent	nn	23	SENT_216	[p7l931t3406r1016b3437],
23	DX-619	NN	O	dx-619	prep_of	17	SENT_216	[p7l1027t3399r1155b3427],
24	in	IN	O	in	_	0	SENT_216	[p7l1167t3399r1197b3427],
25	healthy	JJ	O	healthy	amod	26	SENT_216	[p7l1208t3398r1325b3437],
26	volunteers	NNS	O	volunteer	prep_in	23	SENT_216	[p7l1333t3398r1496b3427],
27	(	VBP	O	(	_	0	SENT_216	[p7l1509t3399r1535b3435],
28	5	CD	NUMBER	5	dobj	27	SENT_216	[p7l1509t3399r1535b3435],
29	6	CD	NUMBER	6	num	30	SENT_216	[p7l1540t3399r1577b3435],
30	)	NN	O	)	nsubj	27	SENT_216	[p7l1540t3399r1577b3435],
31	.	.	O	.	_	0	SENT_216	[p7l1540t3399r1577b3435],

1	This	DT	O	this	det	2	SENT_217	[p7l1589t3398r1662b3427],
2	study	NN	O	study	nsubj	3	SENT_217	[p7l1674t3398r1758b3437],
3	showed	VBD	O	show	_	0	SENT_217	[p7l1768t3398r1884b3427],
4	that	IN	O	that	complm	14	SENT_217	[p7l367t3446r429b3476],
5	the	DT	O	the	det	9	SENT_217	[p7l443t3446r491b3476],
6	elevated	JJ	O	elevated	amod	9	SENT_217	[p7l507t3446r634b3476],
7	serum	NN	O	serum	nn	9	SENT_217	[p7l649t3457r745b3476],
8	creatinine	NN	O	creatinine	nn	9	SENT_217	[p7l760t3448r915b3476],
9	levels	NNS	O	level	nsubj	14	SENT_217	[p7l930t3446r1015b3476],
10	caused	VBN	O	cause	partmod	9	SENT_217	[p7l1031t3446r1133b3476],
11	by	IN	O	by	_	0	SENT_217	[p7l1148t3446r1187b3485],
12	this	DT	O	this	det	13	SENT_217	[p7l1200t3446r1256b3476],
13	compound	NN	O	compound	agent	10	SENT_217	[p7l1272t3446r1438b3485],
14	resulted	VBD	O	result	ccomp	3	SENT_217	[p7l1453t3446r1578b3476],
15	from	IN	O	from	_	0	SENT_217	[p7l1593t3446r1669b3476],
16	inhibition	NN	O	inhibition	prep_from	14	SENT_217	[p7l1684t3446r1839b3476],
17	of	IN	O	of	_	0	SENT_217	[p7l1855t3446r1889b3476],
18	OCT2	NN	O	oct2	prep_of	16	SENT_217	[p7l368t3495r481b3529],
19	,	,	O	,	_	0	SENT_217	[p7l368t3495r481b3529],
20	MATE1	NN	O	mate1	conj_and	18	SENT_217	[p7l489t3495r633b3529],
21	,	,	O	,	_	0	SENT_217	[p7l489t3495r633b3529],
22	and	CC	O	and	_	0	SENT_217	[p7l642t3494r698b3523],
23	MATE2	NN	O	mate2	conj_and	18	SENT_217	[p7l705t3495r837b3523],
24	-	:	O	-	_	0	SENT_217	[p7l842t3495r884b3523],
25	K	NN	O	k	dep	18	SENT_217	[p7l842t3495r884b3523],
26	and	CC	O	and	_	0	SENT_217	[p7l891t3494r946b3523],
27	from	IN	O	from	_	0	SENT_217	[p7l955t3494r1031b3523],
28	the	DT	O	the	det	32	SENT_217	[p7l1039t3494r1087b3523],
29	subsequent	JJ	O	subsequent	amod	32	SENT_217	[p7l1096t3494r1271b3532],
30	reduced	VBN	O	reduce	amod	32	SENT_217	[p7l1278t3494r1402b3523],
31	tubular	JJ	O	tubular	amod	32	SENT_217	[p7l1410t3494r1524b3523],
32	secretion	NN	O	secretion	conj_and	16	SENT_217	[p7l1531t3496r1673b3523],
33	of	IN	O	of	_	0	SENT_217	[p7l1681t3494r1715b3523],
34	creatinine	NN	O	creatinine	prep_of	32	SENT_217	[p7l1720t3496r1883b3523],
35	.	.	O	.	_	0	SENT_217	[p7l1720t3496r1883b3523],

1	To	TO	O	to	_	0	SENT_218	[p7l366t3542r414b3571],
2	date	NN	O	date	prep_to	7	SENT_218	[p7l425t3541r498b3577],
3	,	,	O	,	_	0	SENT_218	[p7l425t3541r498b3577],
4	MATE	NN	O	mate	nn	6	SENT_218	[p7l507t3542r623b3570],
5	transporter	NN	O	transporter	nn	6	SENT_218	[p7l633t3541r972b3580],
6	—	NN	O	—	nsubj	7	SENT_218	[p7l633t3541r972b3580],
7	mediated	VBD	O	mediate	dep	17	SENT_218	[p7l633t3541r972b3580],
8	potential	JJ	O	potential	amod	10	SENT_218	[p7l982t3541r1121b3580],
9	drug-drug	JJ	O	drug-drug	amod	10	SENT_218	[p7l1132t3541r1294b3580],
10	interactions	NNS	O	interaction	dobj	7	SENT_218	[p7l1302t3543r1487b3571],
11	that	WDT	O	that	nsubjpass	14	SENT_218	[p7l1497t3541r1559b3571],
12	have	VBP	O	have	aux	14	SENT_218	[p7l1567t3541r1638b3571],
13	been	VBN	O	be	auxpass	14	SENT_218	[p7l1648t3541r1722b3571],
14	studied	VBN	O	study	rcmod	10	SENT_218	[p7l1732t3541r1845b3571],
15	in	FW	O	in	nn	16	SENT_218	[p7l1854t3543r1885b3570],
16	vitro	FW	O	vitro	advmod	14	SENT_218	[p7l365t3593r440b3621],
17	include	VBP	O	include	_	0	SENT_218	[p7l449t3591r563b3621],
18	cimetidine	NN	O	cimetidine	nn	19	SENT_218	[p7l573t3592r738b3621],
19	inhibition	NN	O	inhibition	dobj	17	SENT_218	[p7l747t3592r903b3621],
20	of	IN	O	of	_	0	SENT_218	[p7l912t3592r946b3621],
21	fexofenadine	NN	O	fexofenadine	nn	22	SENT_218	[p7l952t3591r1150b3621],
22	transport	NN	O	transport	prep_of	19	SENT_218	[p7l1160t3600r1305b3630],
23	(	CD	NUMBER	(	num	26	SENT_218	[p7l1314t3592r1341b3628],
24	5	CD	NUMBER	5	number	25	SENT_218	[p7l1314t3592r1341b3628],
25	7	CD	NUMBER	7	amod	26	SENT_218	[p7l1346t3593r1373b3628],
26	)	NN	O	)	dep	22	SENT_218	[p7l1346t3593r1373b3628],
27	and	CC	O	and	_	0	SENT_218	[p7l1384t3591r1439b3621],
28	the	DT	O	the	det	29	SENT_218	[p7l1449t3592r1498b3621],
29	ability	NN	O	ability	conj_and	22	SENT_218	[p7l1508t3592r1606b3630],
30	of	IN	O	of	_	0	SENT_218	[p7l1614t3592r1648b3621],
31	tyrosine	NN	O	tyrosine	nn	33	SENT_218	[p7l1653t3593r1779b3630],
32	kinase	NN	O	kinase	nn	33	SENT_218	[p7l1788t3592r1884b3621],
33	inhibitors	NNS	O	inhibitor	prep_of	29	SENT_218	[p7l366t3655r518b3685],
34	to	TO	O	to	aux	35	SENT_218	[p7l530t3664r561b3685],
35	inhibit	VB	O	inhibit	xcomp	17	SENT_218	[p7l572t3655r677b3685],
36	MATE	NN	O	mate	nn	38	SENT_218	[p7l685t3656r801b3685],
37	transporter	NN	O	transporter	nn	38	SENT_218	[p7l813t3664r989b3694],
38	function	NN	O	function	dobj	35	SENT_218	[p7l999t3656r1131b3685],
39	(	CD	NUMBER	(	num	42	SENT_218	[p7l1142t3657r1169b3692],
40	5	CD	NUMBER	5	number	41	SENT_218	[p7l1142t3657r1169b3692],
41	8	CD	NUMBER	8	amod	42	SENT_218	[p7l1174t3656r1210b3692],
42	)	NN	O	)	nsubj	17	SENT_218	[p7l1174t3656r1210b3692],
43	.	.	O	.	_	0	SENT_218	[p7l1174t3656r1210b3692],

1	I	PRP	O	I	nsubj	2	SENT_219	[p8l182t1194r204b1205],
2	Xnnu	VBP	O	xnnu	_	0	SENT_219	[p8l181t1112r204b1181],
3	.	.	O	.	_	0	SENT_219	[p8l181t1112r204b1181],

1	Rev.	NNP	O	Rev.	nn	2	SENT_220	[p8l181t1042r204b1101],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_220	[p8l181t883r204b1031],
3	.	.	O	.	_	0	SENT_220	[p8l181t883r204b1031],

1	Toxico	NNP	O	Toxico	_	0	SENT_221	[p8l181t779r204b872],
2	1	CD	NUMBER	1	dep	1	SENT_221	[p8l181t749r204b764],
3	.	.	O	.	_	0	SENT_221	[p8l181t749r204b764],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_222	[p8l181t504r205b737],
2	-273	CD	NUMBER	-273	_	0	SENT_222	[p8l181t504r205b737],
3	.	.	O	.	_	0	SENT_222	[p8l181t504r205b737],

1	Downloaded	VBN	O	download	_	0	SENT_223	[p8l181t323r204b494],
2	from	IN	O	from	_	0	SENT_223	[p8l181t250r204b314],
3	www	NN	O	www	prep_from	1	SENT_223	[p8l189t170r204b241],
4	.	.	O	.	_	0	SENT_223	[p8l181t7r204b127],

1	annua1re	NN	O	annua1re	_	0	SENT_224	[p8l181t7r204b127],
2	by	IN	O	by	_	0	SENT_224	[p8l214t1025r245b1057],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_224	[p8l214t876r245b1016],
4	of	IN	ORGANIZATION	of	_	0	SENT_224	[p8l214t837r238b866],
5	Wis	NNP	ORGANIZATION	Wis	nn	6	SENT_224	[p8l214t778r238b831],
6	consin	NN	O	consin	prep_of	3	SENT_224	[p8l214t676r238b763],
7	-	:	O	-	_	0	SENT_224	[p8l228t660r231b669],
8	Madison	NNP	O	Madison	dep	1	SENT_224	[p8l214t533r238b650],
9	on	IN	O	on	_	0	SENT_224	[p8l222t492r238b524],
10	01/05/14	CD	DATE	01/05/14	prep_on	8	SENT_224	[p8l214t358r238b482],
11	.	.	O	.	_	0	SENT_224	[p8l214t358r238b482],

1	For	IN	O	for	_	0	SENT_225	[p8l215t301r238b347],
2	personal	JJ	O	personal	amod	3	SENT_225	[p8l214t180r245b293],
3	use	NN	O	use	pobj	1	SENT_225	[p8l222t88r238b130],
4	only	RB	O	only	advmod	3	SENT_225	[p8l214t13r245b78],
5	.	.	O	.	_	0	SENT_225	[p8l214t13r245b78],

1	Annu	NNP	PERSON	Annu	_	0	SENT_226	[p8l72t3544r95b3624],
2	.	.	O	.	_	0	SENT_226	[p8l72t3544r95b3624],

1	Rev.	NNP	O	Rev.	nn	2	SENT_227	[p8l72t3474r95b3533],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_227	[p8l72t3315r95b3463],
3	.	.	O	.	_	0	SENT_227	[p8l72t3315r95b3463],

1	Toxico	NNP	O	Toxico	_	0	SENT_228	[p8l72t3211r95b3304],
2	1	CD	NUMBER	1	dep	1	SENT_228	[p8l72t3176r95b3191],
3	.	.	O	.	_	0	SENT_228	[p8l72t3176r95b3191],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_229	[p8l72t2930r96b3164],
2	-273	CD	NUMBER	-273	_	0	SENT_229	[p8l72t2930r96b3164],
3	.	.	O	.	_	0	SENT_229	[p8l72t2930r96b3164],

1	Downloaded	VBN	O	download	_	0	SENT_230	[p8l72t2749r95b2920],
2	from	IN	O	from	_	0	SENT_230	[p8l72t2676r95b2740],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_230	[p8l72t2343r102b2667],
4	by	IN	O	by	_	0	SENT_230	[p8l105t3457r136b3489],
5	University	NNP	ORGANIZATION	University	dep	10	SENT_230	[p8l105t3308r136b3448],
6	of	IN	ORGANIZATION	of	_	0	SENT_230	[p8l105t3269r129b3298],
7	Wis	NNP	ORGANIZATION	Wis	nn	8	SENT_230	[p8l105t3210r129b3263],
8	consin	NN	O	consin	prep_of	5	SENT_230	[p8l105t3103r129b3190],
9	-	:	O	-	_	0	SENT_230	[p8l119t3086r122b3095],
10	Madison	NNP	O	Madison	prep_by	1	SENT_230	[p8l105t2959r129b3076],
11	on	IN	O	on	_	0	SENT_230	[p8l113t2918r129b2950],
12	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_230	[p8l105t2784r129b2908],
13	.	.	O	.	_	0	SENT_230	[p8l105t2784r129b2908],

1	For	IN	O	for	_	0	SENT_231	[p8l106t2727r129b2773],
2	personal	JJ	O	personal	amod	3	SENT_231	[p8l105t2606r136b2718],
3	use	NN	O	use	pobj	1	SENT_231	[p8l113t2553r129b2597],
4	only	RB	O	only	advmod	3	SENT_231	[p8l105t2478r136b2543],
5	.	.	O	.	_	0	SENT_231	[p8l105t2478r136b2543],

1	Organic	NNP	O	Organic	nn	3	SENT_232	[p8l367t69r519b111],
2	Anion	NNP	O	Anion	nn	3	SENT_232	[p8l530t69r646b100],
3	Transporters	NNPS	O	Transporters	_	0	SENT_232	[p8l657t69r908b110],

1	The	DT	O	the	det	4	SENT_233	[p8l366t178r432b207],
2	organic	JJ	O	organic	amod	4	SENT_233	[p8l442t179r559b216],
3	anion	NN	O	anion	nn	4	SENT_233	[p8l568t179r655b207],
4	transporters	NNS	O	transporter	nsubj	5	SENT_233	[p8l664t186r853b216],
5	(	VBP	O	(	_	0	SENT_233	[p8l863t178r1129b214],
6	OATs/SLCZZA	NN	O	oats/slczza	nn	8	SENT_233	[p8l863t178r1129b214],
7	)	CD	NUMBER	)	num	8	SENT_233	[p8l863t178r1129b214],
8	move	NN	O	move	dobj	5	SENT_233	[p8l1139t189r1223b207],
9	small	JJ	O	small	amod	11	SENT_233	[p8l1233t178r1313b207],
10	organic	JJ	O	organic	amod	11	SENT_233	[p8l1323t179r1440b216],
11	anions	NNS	O	anion	nsubj	16	SENT_233	[p8l1449t179r1549b207],
12	against	IN	O	against	_	0	SENT_233	[p8l1559t179r1668b216],
13	their	PRP$	O	they	poss	15	SENT_233	[p8l1676t178r1751b207],
14	concentration	NN	O	concentration	nn	15	SENT_233	[p8l1760t189r1884b207, p8l367t229r473b257],
15	gradient	NN	O	gradient	prep_against	11	SENT_233	[p8l484t228r614b267],
16	using	VBG	O	use	dep	8	SENT_233	[p8l624t229r708b267],
17	a	DT	O	a	det	21	SENT_233	[p8l719t239r733b257],
18	Na	NN	O	na	nn	21	SENT_233	[p8l744t228r811b257],
19	‘	NN	O	‘	nn	21	SENT_233	[p8l744t228r811b257],
20	'	''	O	'	_	0	SENT_233	[p8l744t228r811b257],
21	gradient	NN	O	gradient	nsubj	28	SENT_233	[p8l825t228r956b267],
22	maintained	VBN	O	maintain	partmod	21	SENT_233	[p8l965t228r1140b257],
23	by	IN	O	by	_	0	SENT_233	[p8l1151t228r1190b267],
24	Na	NN	O	na	agent	22	SENT_233	[p8l1198t228r1329b257],
25	+	CC	O	+	dep	22	SENT_233	[p8l1198t228r1329b257],
26	/	:	O	/	punct	27	SENT_233	[p8l1198t228r1329b257],
27	K	NN	O	k	dep	21	SENT_233	[p8l1198t228r1329b257],
28	+	CC	O	+	xcomp	16	SENT_233	[p8l1198t228r1329b257],
29	-	:	O	-	_	0	SENT_233	[p8l1334t228r1479b257],
30	ATPase	NN	O	atpase	dep	8	SENT_233	[p8l1334t228r1479b257],
31	.	.	O	.	_	0	SENT_233	[p8l1334t228r1479b257],

1	Of	IN	O	of	_	0	SENT_234	[p8l1493t228r1538b257],
2	particular	JJ	O	particular	amod	3	SENT_234	[p8l1544t228r1696b266],
3	importance	NN	O	importance	prep_of	7	SENT_234	[p8l1706t229r1884b266],
4	in	IN	O	in	_	0	SENT_234	[p8l366t279r397b306],
5	drug	NN	O	drug	nn	6	SENT_234	[p8l410t277r483b316],
6	disposition	NN	O	disposition	prep_in	3	SENT_234	[p8l496t277r666b316],
7	are	VBP	O	be	_	0	SENT_234	[p8l680t288r726b306],
8	OAT1	NN	O	oat1	nn	11	SENT_234	[p8l740t278r839b306],
9	(	CD	NUMBER	(	num	11	SENT_234	[p8l857t278r1039b314],
10	SLC22A6	NN	O	slc22a6	nn	11	SENT_234	[p8l857t278r1039b314],
11	)	NN	O	)	nsubj	7	SENT_234	[p8l857t278r1039b314],
12	,	,	O	,	_	0	SENT_234	[p8l857t278r1039b314],
13	which	WDT	O	which	nsubjpass	16	SENT_234	[p8l1052t277r1147b306],
14	is	VBZ	O	be	auxpass	16	SENT_234	[p8l1159t279r1182b306],
15	predominantly	RB	O	predominantly	advmod	16	SENT_234	[p8l1196t277r1428b316],
16	expressed	VBN	O	express	rcmod	11	SENT_234	[p8l1440t277r1589b316],
17	on	IN	O	on	_	0	SENT_234	[p8l1603t288r1642b306],
18	the	DT	O	the	det	20	SENT_234	[p8l1655t277r1704b306],
19	basolateral	JJ	O	basolateral	amod	20	SENT_234	[p8l1717t277r1884b306],
20	membrane	NN	O	membrane	prep_on	16	SENT_234	[p8l367t327r534b356],
21	of	IN	O	of	_	0	SENT_234	[p8l547t327r582b356],
22	proximal	JJ	O	proximal	amod	24	SENT_234	[p8l590t327r728b366],
23	renal	JJ	O	renal	amod	24	SENT_234	[p8l741t327r819b356],
24	tubules	NNS	O	tubule	prep_of	20	SENT_234	[p8l832t327r953b363],
25	,	,	O	,	_	0	SENT_234	[p8l832t327r953b363],
26	and	CC	O	and	_	0	SENT_234	[p8l968t327r1024b356],
27	OAT3	NN	O	oat3	nn	30	SENT_234	[p8l1037t328r1136b356],
28	(	CD	NUMBER	(	num	30	SENT_234	[p8l1153t328r1335b364],
29	SLC22/18	NN	O	slc22/18	nn	30	SENT_234	[p8l1153t328r1335b364],
30	)	NN	O	)	conj_and	11	SENT_234	[p8l1153t328r1335b364],
31	,	,	O	,	_	0	SENT_234	[p8l1153t328r1335b364],
32	which	WDT	O	which	nsubjpass	35	SENT_234	[p8l1348t327r1443b356],
33	is	VBZ	O	be	auxpass	35	SENT_234	[p8l1455t329r1478b356],
34	predominantly	RB	O	predominantly	advmod	35	SENT_234	[p8l1491t327r1724b366],
35	expressed	VBN	O	express	conj_and	35	SENT_234	[p8l1736t327r1884b366],
36	throughout	IN	O	throughout	_	0	SENT_234	[p8l367t377r547b416],
37	the	DT	O	the	det	38	SENT_234	[p8l557t377r606b406],
38	kidney	NN	O	kidney	prep_throughout	35	SENT_234	[p8l617t377r722b416],
39	and	CC	O	and	_	0	SENT_234	[p8l732t377r788b406],
40	in	IN	O	in	_	0	SENT_234	[p8l798t379r828b406],
41	the	DT	O	the	det	43	SENT_234	[p8l840t377r888b406],
42	choroid	NN	O	choroid	nn	43	SENT_234	[p8l900t377r1020b406],
43	plexus	NN	O	plexus	prep_in	35	SENT_234	[p8l1031t377r1137b415],
44	,	,	O	,	_	0	SENT_234	[p8l1031t377r1137b415],
45	although	IN	O	although	mark	51	SENT_234	[p8l1150t377r1288b416],
46	both	DT	O	both	preconj	47	SENT_234	[p8l1299t377r1371b406],
47	OATI	NN	O	oatus	nsubjpass	51	SENT_234	[p8l1383t378r1482b406],
48	and	CC	O	and	_	0	SENT_234	[p8l1497t377r1552b406],
49	OAT3	NN	O	oat3	nsubjpass	51	SENT_234	[p8l1564t378r1663b406],
50	are	VBP	O	be	auxpass	51	SENT_234	[p8l1678t388r1724b406],
51	expressed	VBN	O	express	advcl	35	SENT_234	[p8l1736t377r1884b415],
52	in	IN	O	in	_	0	SENT_234	[p8l366t429r397b456],
53	other	JJ	O	other	amod	54	SENT_234	[p8l408t427r492b456],
54	tissues	NNS	O	tissue	prep_in	51	SENT_234	[p8l503t429r603b456],
55	in	IN	O	in	_	0	SENT_234	[p8l614t429r645b456],
56	the	DT	O	the	det	57	SENT_234	[p8l656t427r705b456],
57	body	NN	O	body	prep_in	54	SENT_234	[p8l716t427r801b466],
58	.	.	O	.	_	0	SENT_234	[p8l716t427r801b466],

1	In	IN	O	in	_	0	SENT_235	[p8l814t428r848b456],
2	the	DT	O	the	det	3	SENT_235	[p8l859t427r908b456],
3	kidney	NN	O	kidney	prep_in	8	SENT_235	[p8l919t427r1031b466],
4	,	,	O	,	_	0	SENT_235	[p8l919t427r1031b466],
5	OAT1	NN	O	oat1	nsubj	8	SENT_235	[p8l1045t428r1144b456],
6	and	CC	O	and	_	0	SENT_235	[p8l1159t427r1215b456],
7	OAT3	NN	O	oat3	conj_and	5	SENT_235	[p8l1227t428r1326b456],
8	facilitate	VBP	O	facilitate	_	0	SENT_235	[p8l1341t427r1474b456],
9	the	DT	O	the	det	10	SENT_235	[p8l1486t427r1534b456],
10	uptake	NN	O	uptake	dobj	8	SENT_235	[p8l1546t427r1650b465],
11	of	IN	O	of	_	0	SENT_235	[p8l1662t427r1696b456],
12	compounds	NNS	O	compound	prep_of	10	SENT_235	[p8l1704t427r1884b465],
13	from	IN	O	from	_	0	SENT_235	[p8l367t477r443b506],
14	the	DT	O	the	det	15	SENT_235	[p8l454t477r503b506],
15	blood	NN	O	blood	prep_from	8	SENT_235	[p8l515t477r604b506],
16	and	CC	O	and	_	0	SENT_235	[p8l616t477r671b506],
17	share	NN	O	share	prep_from	8	SENT_235	[p8l683t477r764b506],
18	a	DT	O	a	det	19	SENT_235	[p8l777t488r791b506],
19	broad	JJ	O	broad	dep	15	SENT_235	[p8l803t477r892b506],
20	and	CC	O	and	_	0	SENT_235	[p8l905t477r960b506],
21	partially	RB	O	partially	advmod	22	SENT_235	[p8l971t477r1101b516],
22	overlapping	VBG	O	overlap	amod	24	SENT_235	[p8l1112t477r1297b516],
23	substrate	JJ	O	substrate	amod	24	SENT_235	[p8l1308t477r1447b506],
24	speciﬁcity	NN	O	speciﬁcity	prep_from	8	SENT_235	[p8l1459t477r1623b516],
25	.	.	O	.	_	0	SENT_235	[p8l1459t477r1623b516],

1	OAT	NN	O	oat	nn	2	SENT_236	[p8l1637t478r1720b506],
2	substrates	NNS	O	substrate	nsubj	3	SENT_236	[p8l1731t477r1884b506],
3	include	VBP	O	include	_	0	SENT_236	[p8l366t527r480b556],
4	steroid	NN	O	steroid	nn	5	SENT_236	[p8l491t527r598b556],
5	hormones	NNS	O	hormone	dobj	3	SENT_236	[p8l607t527r773b562],
6	,	,	O	,	_	0	SENT_236	[p8l607t527r773b562],
7	biogenic	JJ	O	biogenic	amod	8	SENT_236	[p8l784t527r918b565],
8	amines	NNS	O	amine	dobj	3	SENT_236	[p8l928t528r1045b562],
9	,	,	O	,	_	0	SENT_236	[p8l928t528r1045b562],
10	and	CC	O	and	_	0	SENT_236	[p8l1056t527r1112b556],
11	drugs	NNS	O	drug	dobj	3	SENT_236	[p8l1122t527r1208b565],
12	such	JJ	O	such	_	0	SENT_236	[p8l1218t527r1288b556],
13	as	IN	O	as	_	0	SENT_236	[p8l1298t538r1326b556],
14	the	DT	O	the	det	15	SENT_236	[p8l1337t527r1385b556],
15	angiotensin	NN	O	angiotensin	prep_such_as	11	SENT_236	[p8l1396t528r1577b565],
16	converting	VBG	O	convert	partmod	15	SENT_236	[p8l1587t528r1756b565],
17	enzyme	NN	O	enzyme	nn	18	SENT_236	[p8l1765t538r1884b565],
18	inhibitors	NNS	O	inhibitor	dobj	16	SENT_236	[p8l366t577r518b606],
19	captopril	NN	O	captopril	dep	18	SENT_236	[p8l531t577r670b615],
20	and	CC	O	and	_	0	SENT_236	[p8l683t576r738b606],
21	quinaprilat	NN	O	quinaprilat	dep	18	SENT_236	[p8l751t577r929b615],
22	,	,	O	,	_	0	SENT_236	[p8l751t577r929b615],
23	the	DT	O	the	det	28	SENT_236	[p8l943t577r991b606],
24	angiotensin	NN	O	angiotensin	nn	28	SENT_236	[p8l1004t578r1185b615],
25	II	CD	NUMBER	ii	num	28	SENT_236	[p8l1196t578r1223b605],
26	receptor	NN	O	receptor	nn	28	SENT_236	[p8l1234t585r1367b615],
27	blocker	NN	O	blocker	nn	28	SENT_236	[p8l1378t576r1495b606],
28	olmesartan	NN	O	olmesartan	appos	19	SENT_236	[p8l1506t577r1686b612],
29	,	,	O	,	_	0	SENT_236	[p8l1506t577r1686b612],
30	and	CC	O	and	_	0	SENT_236	[p8l1700t577r1756b606],
31	numerous	JJ	O	numerous	amod	32	SENT_236	[p8l1767t587r1884b606, p8l367t638r419b656],
32	antibiotics	NNS	O	antibiotic	conj_and	18	SENT_236	[p8l430t626r592b656],
33	and	CC	O	and	_	0	SENT_236	[p8l604t627r659b656],
34	antivirals	NNS	O	antiviral	conj_and	18	SENT_236	[p8l670t626r819b656],
35	.	.	O	.	_	0	SENT_236	[p8l670t626r819b656],

1	Many	JJ	O	many	amod	2	SENT_237	[p8l830t628r923b666],
2	drugs	NNS	O	drug	nsubj	7	SENT_237	[p8l933t627r1018b666],
3	in	IN	O	in	_	0	SENT_237	[p8l1029t628r1059b655],
4	clinical	JJ	O	clinical	amod	5	SENT_237	[p8l1070t626r1180b656],
5	use	NN	O	use	prep_in	2	SENT_237	[p8l1190t638r1240b656],
6	are	VBP	O	be	cop	7	SENT_237	[p8l1252t637r1298b656],
7	inhibitors	NNS	O	inhibitor	dep	23	SENT_237	[p8l1308t626r1461b656],
8	of	IN	O	of	_	0	SENT_237	[p8l1472t627r1506b656],
9	OAT	NN	O	oat	nn	10	SENT_237	[p8l1513t627r1597b656],
10	transport	NN	O	transport	prep_of	7	SENT_237	[p8l1607t635r1752b665],
11	in	FW	O	in	nn	12	SENT_237	[p8l1761t628r1791b655],
12	vitro	FW	O	vitro	advmod	7	SENT_237	[p8l1800t628r1883b662],
13	,	,	O	,	_	0	SENT_237	[p8l1800t628r1883b662],
14	including	VBG	O	include	_	0	SENT_237	[p8l367t675r515b714],
15	antibiotics	NNS	O	antibiotic	prep_including	7	SENT_237	[p8l526t675r696b710],
16	,	,	O	,	_	0	SENT_237	[p8l526t675r696b710],
17	antivirals	NNS	O	antiviral	prep_including	7	SENT_237	[p8l709t675r859b711],
18	,	,	O	,	_	0	SENT_237	[p8l709t675r859b711],
19	and	CC	O	and	_	0	SENT_237	[p8l871t675r927b704],
20	nonsteroidal	JJ	O	nonsteroidal	amod	22	SENT_237	[p8l938t675r1134b704],
21	anti-inﬂammatory	JJ	O	anti-inﬂammatory	amod	22	SENT_237	[p8l1145t675r1433b714],
22	drugs	NNS	O	drug	prep_including	7	SENT_237	[p8l1443t675r1528b714],
23	(	VBP	O	(	_	0	SENT_237	[p8l1541t676r1584b711],
24	N	NN	O	n	nn	25	SENT_237	[p8l1541t676r1584b711],
25	SAIDS	NN	O	said	dobj	23	SENT_237	[p8l1586t676r1698b711],
26	)	CD	NUMBER	)	num	27	SENT_237	[p8l1586t676r1698b711],
27	(	NN	O	(	nsubj	23	SENT_237	[p8l1711t676r1738b712],
28	5	CD	NUMBER	5	number	29	SENT_237	[p8l1711t676r1738b712],
29	9	CD	NUMBER	9	amod	27	SENT_237	[p8l1742t677r1768b711],
30	,	,	O	,	_	0	SENT_237	[p8l1742t677r1768b711],
31	60	CD	NUMBER	60	num	32	SENT_237	[p8l1781t676r1837b711],
32	)	NN	O	)	appos	27	SENT_237	[p8l1781t676r1837b711],
33	.	.	O	.	_	0	SENT_237	[p8l1781t676r1837b711],

1	Oat1	NN	O	oat1	nsubj	12	SENT_238	[p8l417t723r525b754],
2	’	CD	NUMBER	’	num	1	SENT_238	[p8l417t723r525b754],
3	/	:	O	/	punct	4	SENT_238	[p8l417t723r525b754],
4	’	CD	NUMBER	’	dep	1	SENT_238	[p8l528t733r544b734],
5	and	CC	O	and	_	0	SENT_238	[p8l564t725r619b754],
6	Oat3	NN	O	oat3	dep	1	SENT_238	[p8l637t723r763b754],
7	’	CD	NUMBER	’	num	6	SENT_238	[p8l637t723r763b754],
8	/	:	O	/	punct	4	SENT_238	[p8l637t723r763b754],
9	’	CD	NUMBER	’	num	10	SENT_238	[p8l637t723r763b754],
10	mice	NNS	O	mouse	dep	1	SENT_238	[p8l783t727r856b754],
11	have	VBP	O	have	aux	12	SENT_238	[p8l873t725r943b754],
12	provided	VBN	O	provide	_	0	SENT_238	[p8l959t725r1098b763],
13	some	DT	O	some	det	14	SENT_238	[p8l1115t736r1195b754],
14	insight	NN	O	insight	dobj	12	SENT_238	[p8l1211t725r1319b764],
15	into	IN	O	into	_	0	SENT_238	[p8l1334t727r1396b754],
16	the	DT	O	the	det	17	SENT_238	[p8l1413t725r1462b754],
17	role	NN	O	role	prep_into	12	SENT_238	[p8l1478t725r1539b754],
18	of	IN	O	of	_	0	SENT_238	[p8l1556t725r1590b754],
19	OATs	NNS	O	oats	prep_of	17	SENT_238	[p8l1603t726r1699b754],
20	in	FW	O	in	prep	19	SENT_238	[p8l1716t727r1746b754],
21	vivo	FW	O	vivo	pobj	20	SENT_238	[p8l1760t727r1833b754],
22	.	.	O	.	_	0	SENT_238	[p8l1760t727r1833b754],

1	In	IN	O	in	_	0	SENT_239	[p8l1851t726r1885b754],

1	Oat3	NN	O	oat3	nsubjpass	22	SENT_240	[p8l368t790r441b818],
2	‘	CD	NUMBER	‘	num	1	SENT_240	[p8l447t786r494b809],
3	/	:	O	/	punct	5	SENT_240	[p8l447t786r494b809],
4	‘	CD	NUMBER	‘	num	5	SENT_240	[p8l447t786r494b809],
5	mice	NNS	O	mouse	dep	1	SENT_240	[p8l510t790r593b824],
6	,	,	O	,	_	0	SENT_240	[p8l510t790r593b824],
7	clearance	NN	O	clearance	appos	5	SENT_240	[p8l608t788r752b818],
8	of	IN	O	of	_	0	SENT_240	[p8l766t789r800b818],
9	the	DT	O	the	det	12	SENT_240	[p8l809t788r858b818],
10	antibiotics	NNS	O	antibiotic	nn	12	SENT_240	[p8l872t789r1033b818],
11	penicillin	NN	O	penicillin	nn	12	SENT_240	[p8l1047t788r1193b827],
12	G	NN	O	g	prep_of	1	SENT_240	[p8l1207t790r1237b818],
13	(	CD	NUMBER	(	number	14	SENT_240	[p8l1250t789r1309b825],
14	61	CD	NUMBER	61	num	15	SENT_240	[p8l1250t789r1309b825],
15	)	NN	O	)	dep	12	SENT_240	[p8l1250t789r1309b825],
16	and	CC	O	and	_	0	SENT_240	[p8l1324t789r1379b818],
17	ciproﬂoxacin	NN	O	ciproﬂoxacin	conj_and	12	SENT_240	[p8l1393t788r1595b827],
18	(	CD	NUMBER	(	number	19	SENT_240	[p8l1609t789r1668b825],
19	62	CD	NUMBER	62	num	20	SENT_240	[p8l1609t789r1668b825],
20	)	NN	O	)	dep	17	SENT_240	[p8l1609t789r1668b825],
21	was	VBD	O	be	auxpass	22	SENT_240	[p8l1681t800r1737b818],
22	reduced	VBN	O	reduce	_	0	SENT_240	[p8l1750t789r1883b824],
23	,	,	O	,	_	0	SENT_240	[p8l1750t789r1883b824],
24	and	CC	O	and	_	0	SENT_240	[p8l367t838r423b867],
25	brain	NN	O	brain	nn	26	SENT_240	[p8l432t838r513b867],
26	concentration	NN	O	concentration	nsubj	40	SENT_240	[p8l523t840r740b867],
27	of	IN	O	of	_	0	SENT_240	[p8l750t838r784b867],
28	the	DT	O	the	det	30	SENT_240	[p8l789t838r838b867],
29	active	JJ	O	active	amod	30	SENT_240	[p8l848t840r937b867],
30	form	NN	O	form	prep_of	26	SENT_240	[p8l946t838r1022b867],
31	of	IN	O	of	_	0	SENT_240	[p8l1032t838r1066b867],
32	the	DT	O	the	det	35	SENT_240	[p8l1071t838r1120b867],
33	anti-inﬂuenza	JJ	O	anti-inﬂuenza	amod	35	SENT_240	[p8l1130t838r1347b867],
34	drug	NN	O	drug	nn	35	SENT_240	[p8l1357t838r1430b877],
35	oseltamivir	NN	O	oseltamivir	prep_of	30	SENT_240	[p8l1439t838r1620b874],
36	,	,	O	,	_	0	SENT_240	[p8l1439t838r1620b874],
37	R064-0802	NN	O	r064-0802	appos	35	SENT_240	[p8l1631t840r1818b874],
38	,	,	O	,	_	0	SENT_240	[p8l1631t840r1818b874],
39	was	VBD	O	be	cop	40	SENT_240	[p8l1828t849r1884b867],
40	higher	JJR	O	higher	conj_and	22	SENT_240	[p8l366t888r469b927],
41	than	IN	O	than	mark	46	SENT_240	[p8l479t888r548b917],
42	that	DT	O	that	nsubj	46	SENT_240	[p8l558t888r620b917],
43	of	IN	O	of	_	0	SENT_240	[p8l629t888r663b917],
44	wild-type	JJ	O	wild-type	amod	45	SENT_240	[p8l668t888r817b927],
45	controls	NNS	O	control	prep_of	42	SENT_240	[p8l828t888r954b917],
46	(	VBP	O	(	ccomp	40	SENT_240	[p8l966t889r1034b924],
47	63	CD	NUMBER	63	number	48	SENT_240	[p8l966t889r1034b924],
48	)	CD	NUMBER	)	dobj	46	SENT_240	[p8l966t889r1034b924],
49	.	.	O	.	_	0	SENT_240	[p8l966t889r1034b924],

1	The	DT	O	the	det	2	SENT_241	[p8l1045t888r1111b917],
2	loop	NN	O	loop	dep	7	SENT_241	[p8l1121t888r1190b926],
3	and	CC	O	and	_	0	SENT_241	[p8l1201t888r1257b917],
4	thiazide	JJ	O	thiazide	amod	5	SENT_241	[p8l1267t888r1390b917],
5	diuretics	NNS	O	diuretic	npadvmod	6	SENT_241	[p8l1401t888r1534b917],
6	likely	JJ	O	likely	conj_and	2	SENT_241	[p8l1545t888r1630b927],
7	rely	VBP	O	rely	_	0	SENT_241	[p8l1638t888r1699b927],
8	on	IN	O	on	_	0	SENT_241	[p8l1708t899r1747b917],
9	Oats	NNP	O	Oats	prep_on	7	SENT_241	[p8l1758t889r1829b917],
10	for	IN	O	for	_	0	SENT_241	[p8l1840t888r1885b917],
11	their	PRP$	O	they	poss	12	SENT_241	[p8l367t938r441b967],
12	secretion	NN	O	secretion	prep_for	9	SENT_241	[p8l453t939r595b967],
13	into	IN	O	into	_	0	SENT_241	[p8l607t939r669b967],
14	the	DT	O	the	det	15	SENT_241	[p8l682t938r731b967],
15	kidney	NN	O	kidney	prep_into	7	SENT_241	[p8l743t938r849b976],
16	proximal	JJ	O	proximal	amod	17	SENT_241	[p8l859t938r998b976],
17	tubules	NNS	O	tubule	tmod	15	SENT_241	[p8l1010t938r1131b973],
18	,	,	O	,	_	0	SENT_241	[p8l1010t938r1131b973],
19	as	IN	O	as	mark	20	SENT_241	[p8l1145t949r1173b967],
20	demonstrated	VBN	O	demonstrate	dep	17	SENT_241	[p8l1187t938r1401b967],
21	in	IN	O	in	_	0	SENT_241	[p8l1413t939r1444b966],
22	Oat1	NN	O	oat1	prep_in	20	SENT_241	[p8l1457t936r1565b967],
23	‘	CD	NUMBER	‘	nsubj	7	SENT_241	[p8l1457t936r1565b967],
24	/	:	O	/	punct	25	SENT_241	[p8l1457t936r1565b967],
25	‘	CD	NUMBER	‘	dep	23	SENT_241	[p8l1568t945r1584b947],
26	and	CC	O	and	_	0	SENT_241	[p8l1599t938r1655b967],
27	Oat3	NN	O	oat3	conj_and	25	SENT_241	[p8l1668t939r1742b967],
28	‘	CD	NUMBER	‘	num	27	SENT_241	[p8l1748t935r1795b958],
29	/	:	O	/	punct	25	SENT_241	[p8l1748t935r1795b958],
30	’	CD	NUMBER	’	num	31	SENT_241	[p8l1748t935r1795b958],
31	mice	NNS	O	mouse	dep	23	SENT_241	[p8l1810t939r1884b967],
32	given	VBN	O	give	partmod	31	SENT_241	[p8l367t989r451b1026],
33	furosemide	NN	O	furosemide	iobj	32	SENT_241	[p8l462t988r636b1017],
34	or	CC	O	or	_	0	SENT_241	[p8l648t998r681b1017],
35	bendroﬂumethiazide	NN	O	bendroﬂumethiazide	conj_or	33	SENT_241	[p8l692t988r1017b1017],
36	(	CD	NUMBER	(	number	37	SENT_241	[p8l1029t989r1098b1024],
37	64	CD	NUMBER	64	num	38	SENT_241	[p8l1029t989r1098b1024],
38	)	NN	O	)	dobj	32	SENT_241	[p8l1029t989r1098b1024],
39	.	.	O	.	_	0	SENT_241	[p8l1029t989r1098b1024],

1	Inhibition	NN	O	inhibition	nsubj	5	SENT_242	[p8l416t1037r575b1066],
2	of	IN	O	of	_	0	SENT_242	[p8l583t1038r617b1066],
3	OAT	NN	O	oat	nn	4	SENT_242	[p8l621t1037r864b1066],
4	—	NN	O	—	prep_of	1	SENT_242	[p8l621t1037r864b1066],
5	mediated	VBD	O	mediate	_	0	SENT_242	[p8l621t1037r864b1066],
6	kidney	NN	O	kidney	dobj	5	SENT_242	[p8l871t1037r977b1076],
7	proximal	JJ	O	proximal	amod	9	SENT_242	[p8l983t1037r1121b1076],
8	tubule	NN	O	tubule	nn	9	SENT_242	[p8l1129t1037r1227b1066],
9	secretion	NN	O	secretion	nsubjpass	16	SENT_242	[p8l1235t1039r1377b1066],
10	by	IN	O	by	_	0	SENT_242	[p8l1384t1037r1423b1076],
11	coadministered	JJ	O	coadministered	amod	13	SENT_242	[p8l1429t1037r1669b1066],
12	anionic	JJ	O	anionic	amod	13	SENT_242	[p8l1677t1039r1791b1066],
13	drugs	NNS	O	drug	prep_by	9	SENT_242	[p8l1799t1037r1884b1076],
14	has	VBZ	O	have	aux	16	SENT_242	[p8l366t1087r416b1116],
15	been	VBN	O	be	auxpass	16	SENT_242	[p8l429t1087r503b1116],
16	implicated	VBN	O	implicate	rcmod	6	SENT_242	[p8l515t1087r679b1126],
17	in	IN	O	in	_	0	SENT_242	[p8l692t1089r722b1116],
18	numerous	JJ	O	numerous	amod	22	SENT_242	[p8l734t1098r890b1116],
19	drug	NN	O	drug	nn	22	SENT_242	[p8l904t1087r1065b1126],
20	—	NN	O	—	nn	22	SENT_242	[p8l904t1087r1065b1126],
21	drug	NN	O	drug	nn	22	SENT_242	[p8l904t1087r1065b1126],
22	interactions	NNS	O	interaction	prep_in	16	SENT_242	[p8l1077t1089r1261b1116],
23	that	WDT	O	that	nsubj	25	SENT_242	[p8l1274t1087r1336b1116],
24	may	MD	O	may	aux	25	SENT_242	[p8l1347t1098r1413b1126],
25	have	VB	O	have	rcmod	22	SENT_242	[p8l1424t1087r1495b1116],
26	desirable	JJ	O	desirable	amod	29	SENT_242	[p8l1508t1087r1646b1116],
27	or	CC	O	or	_	0	SENT_242	[p8l1659t1098r1693b1116],
28	undesirable	JJ	O	undesirable	conj_or	26	SENT_242	[p8l1704t1087r1884b1116],
29	consequences	NNS	O	consequence	dobj	25	SENT_242	[p8l367t1148r588b1175],
30	.	.	O	.	_	0	SENT_242	[p8l367t1148r588b1175],

1	A	DT	O	a	det	3	SENT_243	[p8l601t1138r627b1166],
2	classic	JJ	O	classic	amod	3	SENT_243	[p8l639t1136r735b1166],
3	example	NN	O	example	nsubj	6	SENT_243	[p8l748t1137r875b1175],
4	is	VBZ	O	be	cop	6	SENT_243	[p8l888t1138r910b1166],
5	the	DT	O	the	det	6	SENT_243	[p8l924t1136r972b1166],
6	probenecid	NN	O	probenecid	_	0	SENT_243	[p8l985t1136r1161b1175],
7	and	CC	O	and	_	0	SENT_243	[p8l1174t1137r1229b1166],
8	[	NN	O	[	nn	11	SENT_243	[p8l1246t1137r1385b1173],
9	3-lactam	JJ	O	3-lactam	amod	11	SENT_243	[p8l1246t1137r1385b1173],
10	antibiotic	JJ	O	antibiotic	amod	11	SENT_243	[p8l1398t1137r1546b1166],
11	interaction	NN	O	interaction	conj_and	6	SENT_243	[p8l1558t1138r1738b1172],
12	,	,	O	,	_	0	SENT_243	[p8l1558t1138r1738b1172],
13	whereby	WRB	O	whereby	advmod	15	SENT_243	[p8l1751t1136r1886b1176],
14	probenecid	NN	O	probenecid	nsubj	15	SENT_243	[p8l367t1200r542b1239],
15	inhibits	VBZ	O	inhibit	rcmod	11	SENT_243	[p8l552t1200r669b1229],
16	penicillin	NN	O	penicillin	nn	17	SENT_243	[p8l679t1200r825b1239],
17	secretion	NN	O	secretion	dobj	15	SENT_243	[p8l835t1202r985b1236],
18	,	,	O	,	_	0	SENT_243	[p8l835t1202r985b1236],
19	likely	JJ	O	likely	amod	17	SENT_243	[p8l996t1200r1081b1239],
20	at	IN	O	at	_	0	SENT_243	[p8l1089t1208r1118b1229],
21	OAT3	NN	O	oat3	prep_at	19	SENT_243	[p8l1127t1201r1238b1236],
22	,	,	O	,	_	0	SENT_243	[p8l1127t1201r1238b1236],
23	resulting	VBG	O	result	partmod	17	SENT_243	[p8l1248t1200r1387b1239],
24	in	IN	O	in	_	0	SENT_243	[p8l1395t1202r1426b1229],
25	increased	VBN	O	increase	amod	27	SENT_243	[p8l1435t1200r1581b1229],
26	penicillin	NN	O	penicillin	nn	27	SENT_243	[p8l1591t1200r1737b1239],
27	exposure	NN	O	exposure	prep_in	23	SENT_243	[p8l1747t1211r1884b1239],
28	(	CD	NUMBER	(	number	29	SENT_243	[p8l367t1249r394b1284],
29	5	CD	NUMBER	5	dep	6	SENT_243	[p8l367t1249r394b1284],
30	9	CD	NUMBER	9	num	31	SENT_243	[p8l398t1249r436b1284],
31	)	NN	O	)	dep	29	SENT_243	[p8l398t1249r436b1284],
32	.	.	O	.	_	0	SENT_243	[p8l398t1249r436b1284],

1	Conversely	RB	O	conversely	advmod	9	SENT_244	[p8l448t1248r632b1287],
2	,	,	O	,	_	0	SENT_244	[p8l448t1248r632b1287],
3	NSAID	NN	O	nsaid	nn	4	SENT_244	[p8l642t1249r763b1277],
4	inhibition	NN	O	inhibition	nsubj	9	SENT_244	[p8l774t1248r929b1277],
5	of	IN	O	of	_	0	SENT_244	[p8l940t1248r974b1277],
6	OAT	NN	O	oat	nn	7	SENT_244	[p8l980t1249r1064b1277],
7	transport	NN	O	transport	prep_of	4	SENT_244	[p8l1073t1257r1218b1287],
8	may	MD	O	may	aux	9	SENT_244	[p8l1226t1259r1292b1287],
9	result	VB	O	result	_	0	SENT_244	[p8l1300t1248r1389b1277],
10	in	IN	O	in	_	0	SENT_244	[p8l1397t1250r1427b1277],
11	a	DT	O	a	det	14	SENT_244	[p8l1437t1259r1452b1277],
12	potentially	RB	O	potentially	advmod	13	SENT_244	[p8l1462t1248r1631b1287],
13	life-threatening	JJ	O	life-threatening	amod	14	SENT_244	[p8l1639t1248r1886b1287],
14	exposure	NN	O	exposure	prep_in	9	SENT_244	[p8l367t1306r505b1334],
15	to	TO	O	to	_	0	SENT_244	[p8l515t1303r545b1324],
16	methotrexate	NN	O	methotrexate	prep_to	14	SENT_244	[p8l555t1295r762b1324],
17	when	WRB	O	when	advmod	22	SENT_244	[p8l771t1295r856b1324],
18	these	DT	O	these	det	20	SENT_244	[p8l866t1295r945b1324],
19	two	CD	NUMBER	two	num	20	SENT_244	[p8l955t1303r1012b1324],
20	compounds	NNS	O	compound	nsubjpass	22	SENT_244	[p8l1023t1295r1203b1334],
21	are	VBP	O	be	auxpass	22	SENT_244	[p8l1213t1306r1260b1324],
22	administered	VBN	O	administer	advcl	9	SENT_244	[p8l1270t1295r1473b1324],
23	together	RB	O	together	prt	22	SENT_244	[p8l1483t1295r1616b1334],
24	(	CD	NUMBER	(	num	25	SENT_244	[p8l1626t1296r1682b1332],
25	65	CD	NUMBER	65	dobj	22	SENT_244	[p8l1626t1296r1682b1332],
26	,	,	O	,	_	0	SENT_244	[p8l1626t1296r1682b1332],
27	66	CD	NUMBER	66	num	28	SENT_244	[p8l1694t1296r1750b1332],
28	)	NN	O	)	appos	25	SENT_244	[p8l1694t1296r1750b1332],
29	.	.	O	.	_	0	SENT_244	[p8l1694t1296r1750b1332],

1	In	IN	O	in	_	0	SENT_245	[p8l1761t1296r1795b1324],
2	addition	NN	O	addition	prep_in	14	SENT_245	[p8l1805t1295r1884b1324, p8l367t1344r437b1379],
3	,	,	O	,	_	0	SENT_245	[p8l1805t1295r1884b1324, p8l367t1344r437b1379],
4	the	DT	O	the	det	6	SENT_245	[p8l450t1343r499b1372],
5	nephrotoxic	JJ	O	nephrotoxic	amod	6	SENT_245	[p8l510t1343r699b1382],
6	effects	NNS	O	effect	nsubjpass	14	SENT_245	[p8l710t1343r807b1372],
7	of	IN	O	of	_	0	SENT_245	[p8l819t1343r853b1372],
8	antivirals	NNS	O	antiviral	prep_of	6	SENT_245	[p8l861t1343r1002b1372],
9	such	JJ	O	such	_	0	SENT_245	[p8l1013t1343r1083b1372],
10	as	IN	O	as	_	0	SENT_245	[p8l1095t1354r1123b1372],
11	adefovir	NN	O	adefovir	prep_such_as	8	SENT_245	[p8l1135t1343r1262b1372],
12	may	MD	O	may	aux	14	SENT_245	[p8l1272t1354r1338b1382],
13	be	VB	O	be	auxpass	14	SENT_245	[p8l1348t1343r1384b1372],
14	attenuated	VBN	O	attenuate	_	0	SENT_245	[p8l1396t1343r1560b1372],
15	by	IN	O	by	_	0	SENT_245	[p8l1571t1343r1609b1382],
16	coadministration	NN	O	coadministration	agent	14	SENT_245	[p8l1619t1343r1885b1372],
17	with	IN	O	with	_	0	SENT_245	[p8l366t1391r435b1421],
18	NSAIDs	NNS	MISC	nsaid	prep_with	14	SENT_245	[p8l446t1392r590b1427],
19	,	,	O	,	_	0	SENT_245	[p8l446t1392r590b1427],
20	which	WDT	O	which	nsubj	21	SENT_245	[p8l601t1391r696b1420],
21	inhibit	VBP	O	inhibit	rcmod	18	SENT_245	[p8l707t1391r812b1421],
22	their	PRP$	O	they	poss	24	SENT_245	[p8l822t1391r896b1421],
23	OAT	NN	O	oat	nn	24	SENT_245	[p8l908t1391r1150b1421],
24	—	NN	O	—	nsubj	25	SENT_245	[p8l908t1391r1150b1421],
25	mediated	VBD	O	mediate	ccomp	21	SENT_245	[p8l908t1391r1150b1421],
26	uptake	NN	O	uptake	dobj	25	SENT_245	[p8l1161t1391r1265b1430],
27	in	FW	O	in	prep	25	SENT_245	[p8l1276t1393r1306b1420],
28	vitro	FW	O	vitro	nn	29	SENT_245	[p8l1316t1393r1390b1421],
29	(	FW	O	(	pobj	27	SENT_245	[p8l1402t1392r1471b1428],
30	67	CD	NUMBER	67	num	31	SENT_245	[p8l1402t1392r1471b1428],
31	)	NN	O	)	dep	29	SENT_245	[p8l1402t1392r1471b1428],
32	.	.	O	.	_	0	SENT_245	[p8l1402t1392r1471b1428],

1	To	TO	O	to	_	0	SENT_246	[p8l415t1440r464b1468],
2	date	NN	O	date	prep_to	13	SENT_246	[p8l478t1439r550b1475],
3	,	,	O	,	_	0	SENT_246	[p8l478t1439r550b1475],
4	genetic	JJ	O	genetic	amod	5	SENT_246	[p8l565t1441r677b1478],
5	variants	NNS	O	variant	nsubjpass	13	SENT_246	[p8l688t1441r810b1468],
6	in	IN	O	in	_	0	SENT_246	[p8l823t1441r854b1468],
7	genes	NNS	O	gene	prep_in	5	SENT_246	[p8l867t1450r953b1478],
8	encoding	VBG	O	encode	partmod	7	SENT_246	[p8l967t1439r1111b1478],
9	OATs	NNS	O	oats	dobj	8	SENT_246	[p8l1124t1440r1220b1468],
10	have	VBP	O	have	aux	13	SENT_246	[p8l1233t1439r1303b1468],
11	not	RB	O	not	neg	13	SENT_246	[p8l1316t1447r1369b1468],
12	been	VBN	O	be	auxpass	13	SENT_246	[p8l1381t1439r1455b1468],
13	associated	VBN	O	associate	_	0	SENT_246	[p8l1468t1439r1624b1468],
14	with	IN	O	with	_	0	SENT_246	[p8l1636t1439r1705b1468],
15	changes	NNS	O	change	prep_with	13	SENT_246	[p8l1719t1439r1841b1478],
16	in	IN	O	in	_	0	SENT_246	[p8l1854t1441r1885b1468],
17	drug	NN	O	drug	nn	19	SENT_246	[p8l367t1487r440b1526],
18	disposition	NN	O	disposition	nn	19	SENT_246	[p8l454t1487r624b1526],
19	(	NN	O	(	prep_in	15	SENT_246	[p8l638t1488r687b1524],
20	1	CD	NUMBER	1	num	21	SENT_246	[p8l638t1488r687b1524],
21	)	NN	O	)	tmod	13	SENT_246	[p8l638t1488r687b1524],
22	,	,	O	,	_	0	SENT_246	[p8l638t1488r687b1524],
23	although	IN	O	although	mark	43	SENT_246	[p8l703t1487r842b1526],
24	a	DT	O	a	det	25	SENT_246	[p8l856t1498r871b1516],
25	polymorphism	NN	O	polymorphism	nsubjpass	43	SENT_246	[p8l884t1487r1113b1526],
26	in	IN	O	in	_	0	SENT_246	[p8l1127t1488r1157b1516],
27	the	DT	O	the	det	29	SENT_246	[p8l1171t1487r1219b1516],
28	intergenic	JJ	O	intergenic	amod	29	SENT_246	[p8l1233t1488r1392b1526],
29	region	NN	O	region	prep_in	25	SENT_246	[p8l1405t1488r1507b1526],
30	between	IN	O	between	_	0	SENT_246	[p8l1520t1487r1650b1516],
31	SLC22A6	NN	O	slc22a6	prep_between	29	SENT_246	[p8l1664t1488r1817b1516],
32	and	CC	O	and	_	0	SENT_246	[p8l1829t1487r1884b1516],
33	SLCZZA8	NN	O	slczza8	prep_between	29	SENT_246	[p8l367t1536r518b1564],
34	(	CD	NUMBER	(	num	35	SENT_246	[p8l527t1536r564b1572],
35	rs	NNS	O	r	dep	31	SENT_246	[p8l527t1536r564b1572],
36	1	CD	NUMBER	1	number	37	SENT_246	[p8l570t1537r580b1564],
37	0792	CD	DATE	0792	dep	35	SENT_246	[p8l586t1536r659b1565],
38	3	CD	NUMBER	3	number	39	SENT_246	[p8l665t1537r677b1565],
39	67	CD	NUMBER	67	num	40	SENT_246	[p8l683t1536r731b1572],
40	)	NN	O	)	dep	35	SENT_246	[p8l683t1536r731b1572],
41	was	VBD	O	be	auxpass	43	SENT_246	[p8l739t1546r795b1565],
42	recently	RB	DATE	recently	advmod	43	SENT_246	[p8l803t1535r931b1574],
43	found	VBN	O	find	dep	21	SENT_246	[p8l938t1535r1029b1565],
44	to	TO	O	to	aux	47	SENT_246	[p8l1037t1543r1068b1565],
45	be	VB	O	be	auxpass	47	SENT_246	[p8l1077t1535r1112b1565],
46	modestly	RB	O	modestly	advmod	47	SENT_246	[p8l1121t1535r1264b1574],
47	associated	VBN	O	associate	xcomp	43	SENT_246	[p8l1272t1535r1427b1565],
48	with	IN	O	with	_	0	SENT_246	[p8l1435t1535r1504b1565],
49	blood	NN	O	blood	nn	51	SENT_246	[p8l1513t1535r1602b1565],
50	pressure	NN	O	pressure	nn	51	SENT_246	[p8l1610t1546r1740b1574],
51	response	NN	O	response	prep_with	47	SENT_246	[p8l1748t1546r1884b1574],
52	to	TO	O	to	_	0	SENT_246	[p8l367t1591r397b1612],
53	hydrochlorothiazide	NN	O	hydrochlorothiazide	prep_to	51	SENT_246	[p8l410t1583r729b1622],
54	(	CD	NUMBER	(	num	53	SENT_246	[p8l743t1584r811b1620],
55	68	CD	NUMBER	68	num	56	SENT_246	[p8l743t1584r811b1620],
56	)	NN	O	)	dep	21	SENT_246	[p8l743t1584r811b1620],
57	.	.	O	.	_	0	SENT_246	[p8l743t1584r811b1620],

1	The	DT	O	the	det	3	SENT_247	[p8l824t1583r891b1612],
2	large	JJ	O	large	amod	3	SENT_247	[p8l904t1583r980b1622],
3	number	NN	O	number	nsubj	11	SENT_247	[p8l993t1583r1116b1612],
4	of	IN	O	of	_	0	SENT_247	[p8l1129t1583r1163b1612],
5	substrates	NNS	O	substrate	prep_of	3	SENT_247	[p8l1172t1583r1325b1612],
6	and	CC	O	and	_	0	SENT_247	[p8l1338t1583r1394b1612],
7	inhibitors	NNS	O	inhibitor	prep_of	3	SENT_247	[p8l1406t1583r1558b1612],
8	of	IN	O	of	_	0	SENT_247	[p8l1572t1583r1606b1612],
9	the	DT	O	the	det	10	SENT_247	[p8l1615t1583r1663b1612],
10	OATs	NNS	O	oats	prep_of	5	SENT_247	[p8l1677t1584r1773b1612],
11	means	VBZ	O	mean	_	0	SENT_247	[p8l1786t1594r1884b1612],
12	that	IN	O	that	complm	14	SENT_247	[p8l367t1633r429b1662],
13	they	PRP	O	they	nsubj	14	SENT_247	[p8l439t1633r507b1672],
14	continue	VBP	O	continue	ccomp	11	SENT_247	[p8l517t1635r653b1662],
15	to	TO	O	to	aux	17	SENT_247	[p8l665t1642r696b1662],
16	be	VB	O	be	cop	17	SENT_247	[p8l707t1633r743b1662],
17	transporters	NNS	O	transporter	xcomp	14	SENT_247	[p8l754t1641r943b1672],
18	of	IN	O	of	_	0	SENT_247	[p8l955t1633r989b1662],
19	interest	NN	O	interest	prep_of	17	SENT_247	[p8l996t1635r1115b1662],
20	in	IN	O	in	_	0	SENT_247	[p8l1124t1635r1155b1662],
21	drug	NN	O	drug	nn	22	SENT_247	[p8l1166t1633r1239b1672],
22	disposition	NN	O	disposition	prep_in	19	SENT_247	[p8l1250t1633r1420b1672],
23	and	CC	O	and	_	0	SENT_247	[p8l1432t1633r1487b1662],
24	response	NN	O	response	conj_and	22	SENT_247	[p8l1498t1644r1643b1672],
25	.	.	O	.	_	0	SENT_247	[p8l1498t1644r1643b1672],

1	*	NN	O	*	nn	3	SENT_248	[p8l1356t1747r1630b1777],
2	www.mmualreview5.org	NN	O	www.mmualreview5.org	nn	3	SENT_248	[p8l1356t1747r1630b1777],
3	o	NN	O	o	_	0	SENT_248	[p8l1645t1755r1654b1765],
4	Dmg	NNP	O	Dmg	nn	5	SENT_248	[p8l1671t1747r1734b1777],
5	Tmnspomarx	NNP	O	Tmnspomarx	dep	3	SENT_248	[p8l1742t1747r1886b1776],
6	255	CD	NUMBER	255	dep	3	SENT_248	[p8l1937t1754r1979b1776],

1	Organic	NNP	O	Organic	nn	2	SENT_249	[p8l565t1785r717b1827],
2	Anion	NNP	O	Anion	nsubj	50	SENT_249	[p8l728t1785r844b1816],
3	Transporting	VBG	O	transport	partmod	2	SENT_249	[p8l855t1785r1111b1827],
4	Polypeptides	NNS	O	polypeptide	dobj	3	SENT_249	[p8l1122t1784r1365b1827],
5	The	DT	O	the	det	7	SENT_249	[p8l564t1834r630b1863],
6	organic	JJ	O	organic	amod	7	SENT_249	[p8l640t1836r757b1873],
7	anion	NN	O	anion	nsubj	13	SENT_249	[p8l766t1836r853b1863],
8	transporting	VBG	O	transport	partmod	7	SENT_249	[p8l863t1836r1058b1873],
9	polypeptides	NNS	O	polypeptide	dobj	8	SENT_249	[p8l1066t1834r1264b1873],
10	(	CD	NUMBER	(	num	11	SENT_249	[p8l1275t1835r1528b1871],
11	OATPs/SLCO	NN	O	oatps/slco	tmod	8	SENT_249	[p8l1275t1835r1528b1871],
12	)	CD	NUMBER	)	dep	11	SENT_249	[p8l1275t1835r1528b1871],
13	have	VBP	O	have	rcmod	4	SENT_249	[p8l1537t1834r1608b1863],
14	a	DT	O	a	det	17	SENT_249	[p8l1618t1845r1633b1863],
15	wide	JJ	O	wide	amod	17	SENT_249	[p8l1641t1834r1714b1863],
16	substrate	NN	O	substrate	nn	17	SENT_249	[p8l1724t1834r1863b1863],
17	speciﬁcity	NN	O	speciﬁcity	dobj	13	SENT_249	[p8l1873t1834r2030b1873],
18	for	IN	O	for	_	0	SENT_249	[p8l2038t1834r2083b1863],
19	amphipathic	JJ	O	amphipathic	amod	20	SENT_249	[p8l565t1882r759b1921],
20	molecules	NNS	O	molecule	prep_for	17	SENT_249	[p8l771t1882r935b1918],
21	,	,	O	,	_	0	SENT_249	[p8l771t1882r935b1918],
22	including	VBG	O	include	_	0	SENT_249	[p8l948t1882r1097b1921],
23	endogenous	JJ	O	endogenous	amod	24	SENT_249	[p8l1108t1882r1295b1921],
24	compounds	NNS	O	compound	prep_including	17	SENT_249	[p8l1308t1882r1488b1921],
25	such	JJ	O	such	_	0	SENT_249	[p8l1501t1882r1571b1911],
26	as	IN	O	as	_	0	SENT_249	[p8l1583t1893r1611b1911],
27	bile	NN	O	bile	nn	28	SENT_249	[p8l1623t1882r1680b1911],
28	acids	NNS	O	acid	prep_such_as	24	SENT_249	[p8l1692t1882r1776b1918],
29	,	,	O	,	_	0	SENT_249	[p8l1692t1882r1776b1918],
30	thyroid	NN	O	thyroid	nn	31	SENT_249	[p8l1789t1882r1904b1921],
31	hormones	NNS	O	hormone	appos	28	SENT_249	[p8l1916t1882r2081b1918],
32	,	,	O	,	_	0	SENT_249	[p8l1916t1882r2081b1918],
33	sulfated	JJ	O	sulfated	amod	36	SENT_249	[p8l565t1930r686b1959],
34	and	CC	O	and	_	0	SENT_249	[p8l700t1930r755b1959],
35	glucuronidated	JJ	O	glucuronidated	amod	36	SENT_249	[p8l769t1930r1006b1969],
36	hormones	NNS	O	hormone	conj_and	4	SENT_249	[p8l1019t1930r1184b1966],
37	,	,	O	,	_	0	SENT_249	[p8l1019t1930r1184b1966],
38	and	CC	O	and	_	0	SENT_249	[p8l1199t1930r1255b1959],
39	drug	NN	O	drug	nn	40	SENT_249	[p8l1269t1930r1342b1969],
40	substrates	NNS	O	substrate	conj_and	4	SENT_249	[p8l1354t1930r1507b1959],
41	including	VBG	O	include	_	0	SENT_249	[p8l1520t1930r1669b1969],
42	rifampicin	NN	O	rifampicin	prep_including	40	SENT_249	[p8l1681t1930r1851b1969],
43	,	,	O	,	_	0	SENT_249	[p8l1681t1930r1851b1969],
44	methotrexate	NN	O	methotrexate	prep_including	40	SENT_249	[p8l1865t1930r2081b1966],
45	,	,	O	,	_	0	SENT_249	[p8l1865t1930r2081b1966],
46	antidiabetics	NNS	O	antidiabetic	prep_including	40	SENT_249	[p8l565t1977r769b2012],
47	,	,	O	,	_	0	SENT_249	[p8l565t1977r769b2012],
48	and	CC	O	and	_	0	SENT_249	[p8l782t1977r838b2006],
49	statins	NNS	O	statin	prep_including	40	SENT_249	[p8l849t1979r947b2006],
50	(	VBP	O	(	_	0	SENT_249	[p8l960t1978r1085b2013],
51	69-71	CD	NUMBER	69-71	num	52	SENT_249	[p8l960t1978r1085b2013],
52	)	CD	NUMBER	)	dobj	50	SENT_249	[p8l960t1978r1085b2013],
53	.	.	O	.	_	0	SENT_249	[p8l960t1978r1085b2013],

1	Organic	NNP	O	Organic	nn	2	SENT_250	[p8l565t2058r702b2096],
2	anion	NN	O	anion	_	0	SENT_250	[p8l723t2059r816b2086],
3	transporting	VBG	O	transport	partmod	2	SENT_250	[p8l835t2059r1048b2096],
4	polypeptides	NNS	O	polypeptide	dobj	3	SENT_250	[p8l1066t2057r1282b2096],
5	in	IN	O	in	_	0	SENT_250	[p8l1302t2059r1335b2086],
6	efﬁcacy	NN	O	efﬁcacy	prep_in	4	SENT_250	[p8l1355t2057r1489b2096],
7	.	.	O	.	_	0	SENT_250	[p8l1355t2057r1489b2096],

1	Of	IN	O	of	_	0	SENT_251	[p8l1512t2057r1557b2086],
2	the	DT	O	the	det	4	SENT_251	[p8l1570t2057r1619b2086],
3	human	JJ	O	human	amod	4	SENT_251	[p8l1637t2057r1746b2086],
4	OATPs	NNS	O	oatp	prep_of	34	SENT_251	[p8l1765t2058r1893b2092],
5	,	,	O	,	_	0	SENT_251	[p8l1765t2058r1893b2092],
6	OATPlBl	NN	O	oatplbl	nsubj	34	SENT_251	[p8l1913t2058r2079b2086],
7	(	CD	NUMBER	(	num	8	SENT_251	[p8l566t2107r742b2143],
8	SLCOIB1	NN	O	slcoib1	nsubjpass	22	SENT_251	[p8l566t2107r742b2143],
9	;	:	O	;	_	0	SENT_251	[p8l566t2107r742b2143],
10	previously	RB	DATE	previously	advmod	11	SENT_251	[p8l756t2106r918b2145],
11	known	VBN	O	know	dep	8	SENT_251	[p8l930t2106r1036b2135],
12	as	IN	O	as	_	0	SENT_251	[p8l1050t2117r1078b2135],
13	OATP-C	NN	O	oatp-c	nn	15	SENT_251	[p8l1093t2107r1250b2142],
14	,	,	O	,	_	0	SENT_251	[p8l1093t2107r1250b2142],
15	OATP2	NN	O	oatp2	prep_as	11	SENT_251	[p8l1266t2107r1400b2142],
16	,	,	O	,	_	0	SENT_251	[p8l1266t2107r1400b2142],
17	and	CC	O	and	_	0	SENT_251	[p8l1416t2106r1471b2135],
18	LST-1	NN	O	lst-1	nn	19	SENT_251	[p8l1485t2107r1604b2143],
19	)	NN	O	)	prep_as	11	SENT_251	[p8l1485t2107r1604b2143],
20	has	VBZ	O	have	aux	22	SENT_251	[p8l1618t2106r1667b2135],
21	been	VBN	O	be	auxpass	22	SENT_251	[p8l1681t2106r1756b2135],
22	studied	VBN	O	study	rcmod	6	SENT_251	[p8l1769t2106r1882b2135],
23	most	RBS	O	most	advmod	22	SENT_251	[p8l1895t2114r1973b2135],
24	extensively	RB	O	extensively	advmod	22	SENT_251	[p8l1986t2114r2082b2135, p8l565t2156r659b2195],
25	,	,	O	,	_	0	SENT_251	[p8l1986t2114r2082b2135, p8l565t2156r659b2195],
26	owing	VBG	O	owe	xcomp	22	SENT_251	[p8l671t2157r768b2195],
27	to	TO	O	to	_	0	SENT_251	[p8l778t2164r808b2185],
28	the	DT	O	the	det	29	SENT_251	[p8l819t2156r868b2185],
29	prevalence	NN	O	prevalence	prep_to	26	SENT_251	[p8l879t2156r1046b2195],
30	of	IN	O	of	_	0	SENT_251	[p8l1057t2156r1091b2185],
31	clinically	RB	O	clinically	advmod	32	SENT_251	[p8l1098t2156r1239b2195],
32	relevant	JJ	O	relevant	amod	33	SENT_251	[p8l1248t2156r1374b2185],
33	polymorphisms	NNS	O	polymorphism	prep_of	29	SENT_251	[p8l1384t2156r1626b2195],
34	(	VBP	O	(	_	0	SENT_251	[p8l1638t2157r1706b2193],
35	72	CD	NUMBER	72	number	36	SENT_251	[p8l1638t2157r1706b2193],
36	)	CD	NUMBER	)	dobj	34	SENT_251	[p8l1638t2157r1706b2193],
37	.	.	O	.	_	0	SENT_251	[p8l1638t2157r1706b2193],

1	OATPlBl	NN	O	oatplbl	nsubjpass	14	SENT_252	[p8l1720t2157r1885b2185],
2	is	VBZ	O	be	auxpass	3	SENT_252	[p8l1900t2157r1922b2185],
3	expressed	VBN	O	express	_	0	SENT_252	[p8l1934t2156r2083b2195],
4	exclusively	RB	O	exclusively	advmod	3	SENT_252	[p8l565t2205r733b2244],
5	on	IN	O	on	_	0	SENT_252	[p8l746t2216r785b2235],
6	the	DT	O	the	det	8	SENT_252	[p8l799t2205r848b2235],
7	basolateral	JJ	O	basolateral	amod	8	SENT_252	[p8l862t2205r1030b2235],
8	membrane	NN	O	membrane	prep_on	3	SENT_252	[p8l1043t2205r1211b2235],
9	of	IN	O	of	_	0	SENT_252	[p8l1226t2205r1260b2235],
10	the	DT	O	the	det	11	SENT_252	[p8l1270t2205r1318b2235],
11	liver	NN	O	liver	prep_of	8	SENT_252	[p8l1333t2205r1402b2235],
12	and	CC	O	and	_	0	SENT_252	[p8l1416t2205r1471b2235],
13	is	VBZ	O	be	auxpass	14	SENT_252	[p8l1485t2207r1508b2235],
14	thought	VBN	O	think	conj_and	3	SENT_252	[p8l1523t2205r1648b2244],
15	to	TO	O	to	aux	19	SENT_252	[p8l1661t2213r1692b2235],
16	be	VB	O	be	cop	19	SENT_252	[p8l1706t2205r1742b2235],
17	the	DT	O	the	det	19	SENT_252	[p8l1756t2205r1805b2235],
18	driving	VBG	O	drive	amod	19	SENT_252	[p8l1820t2205r1932b2244],
19	force	NN	O	force	xcomp	14	SENT_252	[p8l1945t2205r2023b2235],
20	for	IN	O	for	_	0	SENT_252	[p8l2038t2205r2083b2235],
21	hepatic	JJ	O	hepatic	amod	22	SENT_252	[p8l564t2255r678b2294],
22	uptake	NN	O	uptake	prep_for	19	SENT_252	[p8l688t2255r792b2294],
23	of	IN	O	of	_	0	SENT_252	[p8l804t2255r838b2284],
24	statins	NNS	O	statin	prep_of	22	SENT_252	[p8l845t2257r944b2284],
25	and	CC	O	and	_	0	SENT_252	[p8l956t2255r1011b2284],
26	certain	JJ	O	certain	amod	28	SENT_252	[p8l1023t2257r1130b2284],
27	antidiabetic	JJ	O	antidiabetic	amod	28	SENT_252	[p8l1141t2255r1324b2284],
28	drugs	NNS	O	drug	prep_of	22	SENT_252	[p8l1335t2255r1421b2294],
29	that	WDT	O	that	nsubj	30	SENT_252	[p8l1433t2255r1494b2284],
30	target	VBP	O	target	rcmod	19	SENT_252	[p8l1505t2263r1597b2294],
31	the	DT	O	the	det	32	SENT_252	[p8l1607t2255r1656b2284],
32	liver	NN	O	liver	dobj	30	SENT_252	[p8l1667t2255r1736b2284],
33	as	IN	O	as	_	0	SENT_252	[p8l1747t2266r1775b2284],
34	their	PRP$	O	they	poss	35	SENT_252	[p8l1787t2255r1862b2284],
35	site	NN	O	site	prep_as	30	SENT_252	[p8l1872t2257r1924b2284],
36	of	IN	O	of	_	0	SENT_252	[p8l1936t2255r1971b2284],
37	action	NN	O	action	prep_of	35	SENT_252	[p8l1978t2257r2081b2284],
38	.	.	O	.	_	0	SENT_252	[p8l1978t2257r2081b2284],

1	SLCO1	NN	O	slco1	nn	2	SENT_253	[p8l565t2305r676b2334],
2	B1	NN	O	b1	nsubj	5	SENT_253	[p8l680t2306r718b2333],
3	is	VBZ	O	be	cop	5	SENT_253	[p8l734t2306r756b2334],
4	highly	RB	O	highly	advmod	5	SENT_253	[p8l769t2304r870b2343],
5	polymorphic	JJ	O	polymorphic	dep	24	SENT_253	[p8l881t2304r1082b2343],
6	(	NN	O	(	attr	5	SENT_253	[p8l1095t2305r1152b2341],
7	72	CD	NUMBER	72	num	6	SENT_253	[p8l1095t2305r1152b2341],
8	,	,	O	,	_	0	SENT_253	[p8l1095t2305r1152b2341],
9	73	CD	NUMBER	73	num	10	SENT_253	[p8l1168t2305r1224b2341],
10	)	NN	O	)	appos	6	SENT_253	[p8l1168t2305r1224b2341],
11	;	:	O	;	_	0	SENT_253	[p8l1168t2305r1224b2341],
12	the	DT	O	the	det	16	SENT_253	[p8l1238t2304r1287b2334],
13	most	RBS	O	most	advmod	15	SENT_253	[p8l1300t2313r1377b2334],
14	extensively	RB	O	extensively	advmod	15	SENT_253	[p8l1389t2304r1560b2343],
15	characterized	VBN	O	characterize	amod	16	SENT_253	[p8l1572t2304r1781b2334],
16	variant	NN	O	variant	dep	6	SENT_253	[p8l1792t2306r1902b2334],
17	is	VBZ	O	be	cop	24	SENT_253	[p8l1913t2306r1936b2334],
18	the	DT	O	the	det	24	SENT_253	[p8l1950t2304r1998b2334],
19	lossof	JJ	O	lossof	amod	24	SENT_253	[p8l2011t2304r2082b2334, p8l565t2355r743b2384],
20	—	NN	O	—	nn	24	SENT_253	[p8l2011t2304r2082b2334, p8l565t2355r743b2384],
21	function	NN	O	function	nn	24	SENT_253	[p8l2011t2304r2082b2334, p8l565t2355r743b2384],
22	polymorphism	NN	O	polymorphism	nn	24	SENT_253	[p8l753t2355r983b2393],
23	c.	NN	O	c.	nn	24	SENT_253	[p8l993t2355r1162b2384],
24	521T	NN	O	521t	_	0	SENT_253	[p8l993t2355r1162b2384],
25	>	JJR	O	>	amod	26	SENT_253	[p8l993t2355r1162b2384],
26	C	NN	O	c	dep	24	SENT_253	[p8l993t2355r1162b2384],
27	(	CD	NUMBER	(	num	28	SENT_253	[p8l1174t2355r1326b2391],
28	rs414905	NN	O	rs414905	dep	26	SENT_253	[p8l1174t2355r1326b2391],
29	6	CD	NUMBER	6	num	30	SENT_253	[p8l1330t2356r1368b2391],
30	)	NN	O	)	nsubj	24	SENT_253	[p8l1330t2356r1368b2391],
31	,	,	O	,	_	0	SENT_253	[p8l1330t2356r1368b2391],
32	which	WDT	O	which	nsubj	33	SENT_253	[p8l1379t2354r1473b2384],
33	has	VBZ	O	have	rcmod	30	SENT_253	[p8l1483t2354r1533b2384],
34	a	DT	O	a	det	35	SENT_253	[p8l1545t2366r1559b2384],
35	frequency	NN	O	frequency	dobj	33	SENT_253	[p8l1570t2355r1726b2393],
36	of	IN	O	of	_	0	SENT_253	[p8l1736t2355r1770b2384],
37	approximately	RB	O	approximately	quantmod	38	SENT_253	[p8l1777t2355r2001b2393],
38	15	CD	PERCENT	15	num	39	SENT_253	[p8l2014t2356r2079b2384],
39	%	NN	PERCENT	%	prep_of	35	SENT_253	[p8l2014t2356r2079b2384],
40	in	IN	O	in	_	0	SENT_253	[p8l564t2405r595b2432],
41	Asian	JJ	MISC	asian	amod	44	SENT_253	[p8l606t2404r693b2433],
42	and	CC	O	and	_	0	SENT_253	[p8l707t2403r762b2433],
43	Caucasian	JJ	MISC	caucasian	conj_and	41	SENT_253	[p8l776t2404r934b2433],
44	populations	NNS	O	population	prep_in	39	SENT_253	[p8l947t2403r1138b2442],
45	.	.	O	.	_	0	SENT_253	[p8l947t2403r1138b2442],

1	Aberrant	JJ	O	aberrant	amod	4	SENT_254	[p8l1152t2403r1294b2433],
2	cell	NN	O	cell	nn	4	SENT_254	[p8l1307t2403r1359b2433],
3	surface	NN	O	surface	nn	4	SENT_254	[p8l1373t2404r1482b2433],
4	trafficking	NN	O	trafficking	nsubj	9	SENT_254	[p8l1496t2403r1656b2442],
5	of	IN	O	of	_	0	SENT_254	[p8l1668t2404r1703b2433],
6	this	DT	O	this	det	7	SENT_254	[p8l1712t2403r1767b2433],
7	allele	NN	O	allele	prep_of	4	SENT_254	[p8l1781t2403r1861b2433],
8	may	MD	O	may	aux	9	SENT_254	[p8l1875t2414r1941b2442],
9	result	VB	O	result	_	0	SENT_254	[p8l1952t2403r2041b2433],
10	in	IN	O	in	_	0	SENT_254	[p8l2053t2405r2083b2432],
11	reduced	VBN	O	reduce	amod	13	SENT_254	[p8l565t2453r689b2482],
12	hepatic	JJ	O	hepatic	amod	13	SENT_254	[p8l700t2453r813b2492],
13	uptake	NN	O	uptake	prep_in	9	SENT_254	[p8l824t2453r928b2492],
14	of	IN	O	of	_	0	SENT_254	[p8l939t2453r974b2482],
15	OATPlBl	NN	O	oatplbl	nn	16	SENT_254	[p8l981t2454r1147b2483],
16	substrates	NNS	O	substrate	prep_of	13	SENT_254	[p8l1162t2453r1315b2483],
17	in	IN	O	in	_	0	SENT_254	[p8l1326t2455r1356b2482],
18	affected	JJ	O	affected	amod	19	SENT_254	[p8l1368t2453r1488b2482],
19	individuals	NNS	O	individual	prep_in	16	SENT_254	[p8l1498t2453r1676b2482],
20	.	.	O	.	_	0	SENT_254	[p8l1498t2453r1676b2482],

1	Given	VBN	O	give	_	0	SENT_255	[p8l615t2505r710b2533],
2	that	IN	O	that	complm	4	SENT_255	[p8l720t2504r782b2533],
3	statins	NNS	O	statin	nsubj	4	SENT_255	[p8l791t2505r889b2533],
4	target	VBP	O	target	ccomp	1	SENT_255	[p8l900t2512r992b2542],
5	the	DT	O	the	det	11	SENT_255	[p8l1001t2503r1049b2533],
6	3-hydroxy	JJ	O	3-hydroxy	amod	11	SENT_255	[p8l1061t2503r1672b2542],
7	—	NN	O	—	nn	11	SENT_255	[p8l1061t2503r1672b2542],
8	3	CD	NUMBER	3	num	11	SENT_255	[p8l1061t2503r1672b2542],
9	—	NN	O	—	nn	11	SENT_255	[p8l1061t2503r1672b2542],
10	methylglutaryl-coenzyme	NN	O	methylglutaryl-coenzyme	nn	11	SENT_255	[p8l1061t2503r1672b2542],
11	A	NN	O	a	nsubj	13	SENT_255	[p8l1681t2505r1708b2532],
12	(	CD	NUMBER	(	num	13	SENT_255	[p8l1717t2505r1925b2540],
13	HMG	NN	O	hmg	xcomp	4	SENT_255	[p8l1717t2505r1925b2540],
14	.	.	O	.	_	0	SENT_255	[p8l1717t2505r1925b2540],

1	—	NN	O	—	_	0	SENT_256	[p8l1717t2505r1925b2540],
2	.	.	O	.	_	0	SENT_256	[p8l1717t2505r1925b2540],

1	CoA	NN	O	coa	nn	4	SENT_257	[p8l1717t2505r1925b2540],
2	)	CD	NUMBER	)	num	4	SENT_257	[p8l1717t2505r1925b2540],
3	reductase	NN	O	reductase	nn	4	SENT_257	[p8l1935t2504r2082b2533],
4	enzyme	NN	O	enzyme	ccomp	12	SENT_257	[p8l565t2564r684b2592],
5	in	IN	O	in	_	0	SENT_257	[p8l698t2555r729b2582],
6	the	DT	O	the	det	7	SENT_257	[p8l743t2553r792b2583],
7	liver	NN	O	liver	prep_in	4	SENT_257	[p8l806t2553r883b2589],
8	,	,	O	,	_	0	SENT_257	[p8l806t2553r883b2589],
9	it	PRP	O	it	nsubjpass	12	SENT_257	[p8l898t2555r921b2583],
10	might	MD	O	might	aux	12	SENT_257	[p8l934t2553r1028b2592],
11	be	VB	O	be	auxpass	12	SENT_257	[p8l1041t2553r1077b2583],
12	expected	VBN	O	expect	_	0	SENT_257	[p8l1092t2553r1228b2592],
13	that	IN	O	that	complm	21	SENT_257	[p8l1243t2553r1304b2583],
14	reduced	VBN	O	reduce	amod	16	SENT_257	[p8l1317t2553r1442b2583],
15	hepatic	JJ	O	hepatic	amod	16	SENT_257	[p8l1456t2553r1569b2592],
16	uptake	NN	O	uptake	nsubjpass	21	SENT_257	[p8l1583t2553r1687b2592],
17	by	IN	O	by	_	0	SENT_257	[p8l1701t2553r1740b2592],
18	OATPlBl	NN	O	oatplbl	prep_by	16	SENT_257	[p8l1753t2554r1919b2583],
19	would	MD	O	would	aux	21	SENT_257	[p8l1936t2553r2032b2583],
20	be	VB	O	be	auxpass	21	SENT_257	[p8l2047t2553r2082b2583],
21	accompanied	VBN	O	accompany	ccomp	12	SENT_257	[p8l565t2604r769b2642],
22	by	IN	O	by	_	0	SENT_257	[p8l780t2604r819b2643],
23	reduced	VBN	O	reduce	amod	24	SENT_257	[p8l828t2604r952b2633],
24	efﬁcacy	NN	O	efﬁcacy	agent	21	SENT_257	[p8l964t2604r1086b2643],
25	,	,	O	,	_	0	SENT_257	[p8l964t2604r1086b2643],
26	as	IN	O	as	mark	31	SENT_257	[p8l1099t2615r1127b2633],
27	the	DT	O	the	det	28	SENT_257	[p8l1139t2604r1187b2633],
28	statin	NN	O	statin	nsubj	31	SENT_257	[p8l1199t2605r1284b2633],
29	does	VBZ	O	do	aux	31	SENT_257	[p8l1295t2604r1364b2633],
30	not	RB	O	not	neg	31	SENT_257	[p8l1374t2612r1428b2633],
31	reach	VB	O	reach	dep	24	SENT_257	[p8l1437t2604r1522b2633],
32	sufﬁcient	JJ	O	sufﬁcient	amod	33	SENT_257	[p8l1533t2604r1675b2633],
33	concentration	NN	O	concentration	dobj	31	SENT_257	[p8l1685t2605r1903b2633],
34	in	IN	O	in	_	0	SENT_257	[p8l1913t2605r1943b2633],
35	the	DT	O	the	det	36	SENT_257	[p8l1954t2604r2003b2633],
36	liver	NN	O	liver	prep_in	31	SENT_257	[p8l2014t2604r2083b2633],
37	to	TO	O	to	aux	38	SENT_257	[p8l565t2662r595b2683],
38	inhibit	VB	O	inhibit	infmod	36	SENT_257	[p8l610t2654r715b2683],
39	the	DT	O	the	det	40	SENT_257	[p8l728t2654r777b2683],
40	enzyme	NN	O	enzyme	dobj	38	SENT_257	[p8l792t2665r911b2693],
41	effectively	RB	O	effectively	advmod	38	SENT_257	[p8l926t2654r1090b2693],
42	.	.	O	.	_	0	SENT_257	[p8l926t2654r1090b2693],

1	This	DT	O	this	nsubjpass	3	SENT_258	[p8l1105t2654r1179b2683],
2	was	VBD	O	be	auxpass	3	SENT_258	[p8l1192t2665r1248b2683],
3	demonstrated	VBN	O	demonstrate	_	0	SENT_258	[p8l1264t2654r1478b2683],
4	in	IN	O	in	_	0	SENT_258	[p8l1492t2656r1522b2683],
5	studies	NNS	O	study	prep_in	3	SENT_258	[p8l1536t2654r1642b2683],
6	that	WDT	O	that	nsubj	7	SENT_258	[p8l1657t2654r1719b2683],
7	showed	VBD	O	show	rcmod	5	SENT_258	[p8l1732t2654r1849b2683],
8	the	DT	O	the	det	11	SENT_258	[p8l1863t2654r1912b2683],
9	SLCOIBI	NNP	O	SLCOIBI	nn	11	SENT_258	[p8l1927t2655r2080b2683],
10	c.	NN	O	c.	nn	11	SENT_258	[p8l565t2704r734b2732],
11	521T	NN	O	521t	dobj	7	SENT_258	[p8l565t2704r734b2732],
12	>	JJR	O	>	amod	14	SENT_258	[p8l565t2704r734b2732],
13	C	NN	O	c	nn	14	SENT_258	[p8l565t2704r734b2732],
14	polymorphism	NN	O	polymorphism	nsubj	26	SENT_258	[p8l747t2703r976b2742],
15	was	VBD	O	be	auxpass	16	SENT_258	[p8l987t2714r1043b2732],
16	associated	VBN	O	associate	rcmod	14	SENT_258	[p8l1056t2703r1212b2732],
17	with	IN	O	with	_	0	SENT_258	[p8l1223t2703r1293b2732],
18	the	DT	O	the	det	20	SENT_258	[p8l1305t2703r1354b2732],
19	lipid-lowering	JJ	O	lipid-lowering	amod	20	SENT_258	[p8l1366t2703r1591b2742],
20	effect	NN	O	effect	prep_with	16	SENT_258	[p8l1603t2703r1687b2732],
21	of	IN	O	of	_	0	SENT_258	[p8l1699t2703r1733b2732],
22	statins	NNS	O	statin	prep_of	20	SENT_258	[p8l1742t2705r1840b2732],
23	in	IN	O	in	_	0	SENT_258	[p8l1852t2705r1882b2732],
24	healthy	JJ	O	healthy	amod	25	SENT_258	[p8l1894t2703r2011b2742],
25	volunteers	NNS	O	volunteer	prep_in	22	SENT_258	[p8l2020t2703r2082b2732, p8l564t2762r679b2782],
26	(	VBP	O	(	rcmod	11	SENT_258	[p8l691t2754r808b2790],
27	74-76	CD	NUMBER	74-76	num	28	SENT_258	[p8l691t2754r808b2790],
28	)	CD	NUMBER	)	dobj	26	SENT_258	[p8l691t2754r808b2790],
29	and	CC	O	and	_	0	SENT_258	[p8l820t2753r875b2782],
30	in	IN	O	in	_	0	SENT_258	[p8l886t2755r916b2782],
31	a	DT	O	a	det	33	SENT_258	[p8l927t2764r942b2782],
32	small	JJ	O	small	amod	33	SENT_258	[p8l952t2753r1033b2782],
33	group	NN	O	group	prep_in	3	SENT_258	[p8l1044t2764r1136b2792],
34	of	IN	O	of	_	0	SENT_258	[p8l1148t2753r1182b2782],
35	patients	NNS	O	patient	prep_of	33	SENT_258	[p8l1188t2755r1310b2792],
36	(	CD	NUMBER	(	number	37	SENT_258	[p8l1322t2754r1391b2790],
37	77	CD	NUMBER	77	num	38	SENT_258	[p8l1322t2754r1391b2790],
38	)	NN	O	)	dep	35	SENT_258	[p8l1322t2754r1391b2790],
39	,	,	O	,	_	0	SENT_258	[p8l1322t2754r1391b2790],
40	but	CC	O	but	_	0	SENT_258	[p8l1403t2753r1455b2782],
41	the	DT	O	the	det	42	SENT_258	[p8l1464t2753r1513b2782],
42	association	NN	O	association	conj_but	35	SENT_258	[p8l1525t2755r1694b2782],
43	of	IN	O	of	_	0	SENT_258	[p8l1705t2753r1740b2782],
44	SLC01	NN	O	slc01	nn	46	SENT_258	[p8l1746t2754r1857b2782],
45	BI	NN	O	bus	nn	46	SENT_258	[p8l1861t2755r1900b2782],
46	c.	NN	O	c.	prep_of	42	SENT_258	[p8l1914t2754r1974b2782],
47	52	CD	NUMBER	52	num	48	SENT_258	[p8l1914t2754r1974b2782],
48	lC	NN	O	lc	npadvmod	49	SENT_258	[p8l1982t2754r2084b2782],
49	>	JJR	O	>	amod	50	SENT_258	[p8l1982t2754r2084b2782],
50	T	NN	O	t	nsubjpass	59	SENT_258	[p8l1982t2754r2084b2782],
51	with	IN	O	with	_	0	SENT_258	[p8l564t2803r633b2832],
52	reduced	VBN	O	reduce	amod	54	SENT_258	[p8l644t2803r769b2832],
53	statin	NN	O	statin	nn	54	SENT_258	[p8l780t2805r865b2832],
54	efﬁcacy	NN	O	efﬁcacy	prep_with	50	SENT_258	[p8l877t2803r993b2842],
55	has	VBZ	O	have	aux	59	SENT_258	[p8l1002t2803r1051b2832],
56	not	RB	O	not	neg	59	SENT_258	[p8l1063t2811r1116b2832],
57	been	VBN	O	be	auxpass	59	SENT_258	[p8l1126t2803r1200b2832],
58	convincingly	RB	O	convincingly	advmod	59	SENT_258	[p8l1212t2803r1413b2842],
59	demonstrated	VBN	O	demonstrate	rcmod	46	SENT_258	[p8l1423t2803r1637b2832],
60	in	IN	O	in	_	0	SENT_258	[p8l1648t2805r1678b2832],
61	large	JJ	O	large	amod	63	SENT_258	[p8l1689t2803r1766b2842],
62	patient	NN	O	patient	nn	63	SENT_258	[p8l1777t2805r1887b2841],
63	cohorts	NNS	O	cohort	prep_in	59	SENT_258	[p8l1897t2803r2022b2832],
64	.	.	O	.	_	0	SENT_258	[p8l1897t2803r2022b2832],

1	In	IN	O	in	_	0	SENT_259	[p8l614t2854r648b2882],
2	total	NN	O	total	prep_in	21	SENT_259	[p8l663t2853r742b2888],
3	,	,	O	,	_	0	SENT_259	[p8l663t2853r742b2888],
4	the	DT	O	the	det	5	SENT_259	[p8l759t2853r808b2882],
5	inﬂuence	NN	O	inﬂuence	appos	2	SENT_259	[p8l824t2853r967b2882],
6	of	IN	O	of	_	0	SENT_259	[p8l983t2853r1018b2882],
7	SLCOIBI	NNP	O	SLCOIBI	nn	8	SENT_259	[p8l1029t2854r1182b2882],
8	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_259	[p8l1201t2853r1443b2892],
9	on	IN	O	on	_	0	SENT_259	[p8l1460t2864r1499b2882],
10	the	DT	O	the	det	11	SENT_259	[p8l1515t2853r1563b2882],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	8	SENT_259	[p8l1579t2853r1854b2891],
12	of	IN	O	of	_	0	SENT_259	[p8l1871t2853r1905b2882],
13	more	JJR	O	more	mwe	14	SENT_259	[p8l1916t2864r1997b2882],
14	than	IN	O	than	quantmod	15	SENT_259	[p8l2014t2853r2083b2882],
15	20	CD	NUMBER	20	prep_of	11	SENT_259	[p8l565t2905r602b2932],
16	clinically	RB	O	clinically	advmod	17	SENT_259	[p8l616t2903r756b2941],
17	used	VBN	O	use	amod	5	SENT_259	[p8l766t2903r837b2932],
18	drugs	NNS	O	drug	nsubjpass	21	SENT_259	[p8l851t2903r936b2942],
19	has	VBZ	O	have	aux	21	SENT_259	[p8l949t2903r999b2932],
20	been	VBN	O	be	auxpass	21	SENT_259	[p8l1012t2903r1087b2932],
21	studied	VBN	O	study	_	0	SENT_259	[p8l1099t2903r1212b2932],
22	(	CD	NUMBER	(	number	23	SENT_259	[p8l1226t2904r1294b2939],
23	72	CD	NUMBER	72	num	24	SENT_259	[p8l1226t2904r1294b2939],
24	)	NN	O	)	dobj	21	SENT_259	[p8l1226t2904r1294b2939],
25	;	:	O	;	_	0	SENT_259	[p8l1226t2904r1294b2939],
26	these	DT	O	these	det	27	SENT_259	[p8l1309t2903r1388b2932],
27	drugs	NNS	O	drug	nsubj	28	SENT_259	[p8l1403t2903r1488b2942],
28	include	VBP	O	include	parataxis	21	SENT_259	[p8l1501t2903r1615b2932],
29	fexofenadine	NN	O	fexofenadine	nn	30	SENT_259	[p8l1629t2903r1827b2932],
30	(	NN	O	(	dobj	28	SENT_259	[p8l1841t2904r1910b2939],
31	78	CD	NUMBER	78	num	32	SENT_259	[p8l1841t2904r1910b2939],
32	)	NN	O	)	dep	30	SENT_259	[p8l1841t2904r1910b2939],
33	,	,	O	,	_	0	SENT_259	[p8l1841t2904r1910b2939],
34	irinotecan	NN	O	irinotecan	dobj	28	SENT_259	[p8l1924t2904r2083b2932],
35	(	CD	NUMBER	(	number	36	SENT_259	[p8l566t2954r622b2989],
36	79	CD	NUMBER	79	dep	34	SENT_259	[p8l566t2954r622b2989],
37	,	,	O	,	_	0	SENT_259	[p8l566t2954r622b2989],
38	80	CD	NUMBER	80	num	39	SENT_259	[p8l640t2954r696b2989],
39	)	CD	NUMBER	)	conj_and	30	SENT_259	[p8l640t2954r696b2989],
40	,	,	O	,	_	0	SENT_259	[p8l640t2954r696b2989],
41	lopinavir	JJ	O	lopinavir	amod	42	SENT_259	[p8l712t2953r852b2991],
42	(	NN	O	(	appos	39	SENT_259	[p8l867t2954r923b2989],
43	81	CD	NUMBER	81	num	42	SENT_259	[p8l867t2954r923b2989],
44	,	,	O	,	_	0	SENT_259	[p8l867t2954r923b2989],
45	82	CD	NUMBER	82	num	46	SENT_259	[p8l941t2954r997b2989],
46	)	NN	O	)	appos	39	SENT_259	[p8l941t2954r997b2989],
47	,	,	O	,	_	0	SENT_259	[p8l941t2954r997b2989],
48	methotrexate	NN	O	methotrexate	appos	39	SENT_259	[p8l1013t2953r1220b2982],
49	(	CD	NUMBER	(	number	50	SENT_259	[p8l1236t2954r1304b2989],
50	83	CD	NUMBER	83	num	51	SENT_259	[p8l1236t2954r1304b2989],
51	)	NN	O	)	dep	48	SENT_259	[p8l1236t2954r1304b2989],
52	,	,	O	,	_	0	SENT_259	[p8l1236t2954r1304b2989],
53	and	CC	O	and	_	0	SENT_259	[p8l1321t2953r1376b2982],
54	repaglinide	NN	O	repaglinide	dobj	28	SENT_259	[p8l1391t2953r1567b2991],
55	(	CD	NUMBER	(	num	54	SENT_259	[p8l1583t2954r1708b2989],
56	84-86	CD	NUMBER	84-86	num	57	SENT_259	[p8l1583t2954r1708b2989],
57	)	NN	O	)	dep	54	SENT_259	[p8l1583t2954r1708b2989],
58	.	.	O	.	_	0	SENT_259	[p8l1583t2954r1708b2989],

1	In	IN	O	in	_	0	SENT_260	[p8l1724t2954r1758b2981],
2	addition	NN	O	addition	prep_in	5	SENT_260	[p8l1773t2953r1910b2988],
3	,	,	O	,	_	0	SENT_260	[p8l1773t2953r1910b2988],
4	SLCOIBI	NNP	PERSON	SLCOIBI	nsubj	5	SENT_260	[p8l1926t2954r2080b2982],
5	c.	VBD	O	c.	dep	12	SENT_260	[p8l565t3004r625b3032],
6	52	CD	NUMBER	52	num	7	SENT_260	[p8l565t3004r625b3032],
7	lT	NN	O	lt	dobj	5	SENT_260	[p8l633t3003r734b3032],
8	>	JJR	O	>	dep	9	SENT_260	[p8l633t3003r734b3032],
9	C	NN	O	c	amod	7	SENT_260	[p8l633t3003r734b3032],
10	has	VBZ	O	have	aux	12	SENT_260	[p8l747t3003r797b3032],
11	been	VBN	O	be	auxpass	12	SENT_260	[p8l811t3003r885b3032],
12	associated	VBN	O	associate	_	0	SENT_260	[p8l898t3002r1054b3032],
13	with	IN	O	with	_	0	SENT_260	[p8l1066t3003r1136b3032],
14	toxic	JJ	O	toxic	amod	16	SENT_260	[p8l1150t3004r1224b3032],
15	side	JJ	O	side	amod	16	SENT_260	[p8l1237t3003r1297b3032],
16	effects	NNS	O	effect	prep_with	12	SENT_260	[p8l1311t3003r1408b3032],
17	caused	VBN	O	cause	partmod	16	SENT_260	[p8l1422t3003r1524b3032],
18	by	IN	O	by	_	0	SENT_260	[p8l1538t3003r1576b3041],
19	the	DT	O	the	det	21	SENT_260	[p8l1588t3003r1637b3032],
20	anticancer	JJ	O	anticancer	amod	21	SENT_260	[p8l1651t3004r1812b3032],
21	drugs	NNS	O	drug	agent	17	SENT_260	[p8l1825t3003r1910b3041],
22	irinotecan	JJ	O	irinotecan	amod	23	SENT_260	[p8l1924t3004r2083b3032],
23	(	NN	O	(	nsubjpass	12	SENT_260	[p8l566t3053r622b3089],
24	87	CD	NUMBER	87	num	23	SENT_260	[p8l566t3053r622b3089],
25	,	,	O	,	_	0	SENT_260	[p8l566t3053r622b3089],
26	88	CD	NUMBER	88	num	27	SENT_260	[p8l637t3053r684b3089],
27	)	NN	O	)	appos	23	SENT_260	[p8l637t3053r684b3089],
28	and	CC	O	and	_	0	SENT_260	[p8l697t3052r752b3082],
29	methotrexate	NN	O	methotrexate	appos	23	SENT_260	[p8l764t3053r972b3082],
30	(	CD	NUMBER	(	number	31	SENT_260	[p8l985t3053r1053b3089],
31	89	CD	NUMBER	89	num	32	SENT_260	[p8l985t3053r1053b3089],
32	)	NN	O	)	dep	29	SENT_260	[p8l985t3053r1053b3089],
33	.	.	O	.	_	0	SENT_260	[p8l985t3053r1053b3089],

1	Not	RB	O	not	neg	2	SENT_261	[p8l1066t3054r1131b3082],
2	all	DT	O	all	nsubj	8	SENT_261	[p8l1143t3052r1178b3082],
3	in	FW	O	in	nn	4	SENT_261	[p8l1190t3054r1220b3081],
4	vitro	FW	O	vitro	advmod	5	SENT_261	[p8l1230t3054r1305b3082],
5	substrates	NNS	O	substrate	rcmod	2	SENT_261	[p8l1317t3052r1470b3082],
6	of	IN	O	of	_	0	SENT_261	[p8l1483t3053r1517b3082],
7	OATPlBl	NN	O	oatplbl	prep_of	5	SENT_261	[p8l1526t3053r1691b3082],
8	appear	VBP	O	appear	_	0	SENT_261	[p8l1707t3063r1811b3091],
9	to	TO	O	to	aux	11	SENT_261	[p8l1823t3061r1853b3082],
10	be	VB	O	be	auxpass	11	SENT_261	[p8l1865t3053r1901b3082],
11	affected	VBN	O	affect	xcomp	8	SENT_261	[p8l1914t3052r2034b3082],
12	by	IN	O	by	_	0	SENT_261	[p8l2046t3052r2084b3092],
13	OATPlBl	NN	O	oatplbl	nn	14	SENT_261	[p8l566t3102r731b3131],
14	polymorphisms	NNS	O	polymorphism	agent	11	SENT_261	[p8l746t3102r989b3141],
15	in	FW	O	in	prep	14	SENT_261	[p8l1000t3103r1031b3131],
16	vivo	FW	O	vivo	pobj	15	SENT_261	[p8l1040t3103r1114b3137],
17	,	,	O	,	_	0	SENT_261	[p8l1040t3103r1114b3137],
18	suggesting	VBG	O	suggest	xcomp	11	SENT_261	[p8l1127t3103r1293b3141],
19	that	IN	O	that	complm	27	SENT_261	[p8l1304t3102r1365b3131],
20	for	IN	O	for	_	0	SENT_261	[p8l1376t3102r1421b3131],
21	certain	JJ	O	certain	amod	22	SENT_261	[p8l1433t3103r1540b3131],
22	substrates	NNS	O	substrate	prep_for	27	SENT_261	[p8l1551t3102r1713b3137],
23	,	,	O	,	_	0	SENT_261	[p8l1551t3102r1713b3137],
24	additional	JJ	O	additional	amod	25	SENT_261	[p8l1726t3102r1882b3131],
25	transporters	NNS	O	transporter	nsubj	27	SENT_261	[p8l1893t3110r2082b3141],
26	may	MD	O	may	aux	27	SENT_261	[p8l565t3163r631b3191],
27	compensate	VB	O	compensate	ccomp	18	SENT_261	[p8l637t3160r821b3190],
28	for	IN	O	for	_	0	SENT_261	[p8l829t3152r874b3181],
29	loss	NN	O	loss	prep_for	27	SENT_261	[p8l881t3152r937b3181],
30	of	IN	O	of	_	0	SENT_261	[p8l945t3152r980b3181],
31	OATPIB	NN	ORGANIZATION	oatpib	nn	33	SENT_261	[p8l984t3153r1132b3181],
32	1	CD	NUMBER	1	num	33	SENT_261	[p8l1139t3154r1149b3181],
33	function	NN	O	function	prep_of	29	SENT_261	[p8l1161t3152r1300b3181],
34	.	.	O	.	_	0	SENT_261	[p8l1161t3152r1300b3181],

1	For	IN	O	for	_	0	SENT_262	[p8l1309t3153r1366b3181],
2	example	NN	O	example	prep_for	6	SENT_262	[p8l1373t3152r1509b3190],
3	,	,	O	,	_	0	SENT_262	[p8l1373t3152r1509b3190],
4	bosentan	NN	O	bosentan	nsubjpass	6	SENT_262	[p8l1517t3152r1658b3181],
5	was	VBD	O	be	auxpass	6	SENT_262	[p8l1664t3163r1720b3181],
6	described	VBN	O	describe	_	0	SENT_262	[p8l1729t3152r1877b3181],
7	as	IN	O	as	_	0	SENT_262	[p8l1885t3163r1913b3181],
8	a	DT	O	a	det	9	SENT_262	[p8l1921t3163r1936b3181],
9	substrate	NN	O	substrate	prep_as	6	SENT_262	[p8l1943t3152r2082b3181],
10	of	IN	O	of	_	0	SENT_262	[p8l565t3221r599b3250],
11	OATPlBl	NN	O	oatplbl	prep_of	9	SENT_262	[p8l609t3221r775b3250],
12	and	CC	O	and	_	0	SENT_262	[p8l791t3220r846b3250],
13	OATPIB3	NN	O	oatpib3	conj_and	9	SENT_262	[p8l860t3221r1026b3250],
14	(	CD	NUMBER	(	number	15	SENT_262	[p8l1043t3221r1111b3257],
15	90	CD	NUMBER	90	num	16	SENT_262	[p8l1043t3221r1111b3257],
16	)	NN	O	)	dep	13	SENT_262	[p8l1043t3221r1111b3257],
17	;	:	O	;	_	0	SENT_262	[p8l1043t3221r1111b3257],
18	however	RB	O	however	advmod	23	SENT_262	[p8l1125t3220r1266b3256],
19	,	,	O	,	_	0	SENT_262	[p8l1125t3220r1266b3256],
20	it	PRP	O	it	nsubj	23	SENT_262	[p8l1279t3222r1302b3250],
21	does	VBZ	O	do	aux	23	SENT_262	[p8l1314t3220r1383b3250],
22	not	RB	O	not	neg	23	SENT_262	[p8l1396t3229r1449b3250],
23	appear	VB	O	appear	parataxis	6	SENT_262	[p8l1461t3231r1565b3259],
24	that	IN	O	that	dep	23	SENT_262	[p8l1577t3221r1639b3250],
25	polymorphisms	NNS	O	polymorphism	dep	34	SENT_262	[p8l1650t3220r1893b3260],
26	in	IN	O	in	_	0	SENT_262	[p8l1906t3222r1936b3249],
27	either	DT	O	either	prep_in	25	SENT_262	[p8l1949t3221r2040b3250],
28	of	IN	O	of	_	0	SENT_262	[p8l2053t3221r2087b3250],
29	these	DT	O	these	det	30	SENT_262	[p8l565t3270r645b3299],
30	transporters	NNS	O	transporter	prep_of	27	SENT_262	[p8l656t3278r845b3309],
31	signiﬁcantly	RB	O	signiﬁcantly	advmod	30	SENT_262	[p8l857t3270r1048b3309],
32	inﬂuence	NN	O	inﬂuence	dep	34	SENT_262	[p8l1057t3270r1200b3299],
33	bosentan	NN	O	bosentan	nn	34	SENT_262	[p8l1211t3270r1352b3299],
34	pharmacokinetics	NNS	O	pharmacokinetic	dep	39	SENT_262	[p8l1363t3270r1638b3309],
35	in	FW	O	in	prep	34	SENT_262	[p8l1649t3272r1679b3299],
36	vivo	FW	O	vivo	nn	37	SENT_262	[p8l1689t3272r1754b3299],
37	(	FW	O	(	pobj	35	SENT_262	[p8l1766t3271r1834b3307],
38	91	CD	NUMBER	91	num	39	SENT_262	[p8l1766t3271r1834b3307],
39	)	NN	O	)	dep	24	SENT_262	[p8l1766t3271r1834b3307],
40	.	.	O	.	_	0	SENT_262	[p8l1766t3271r1834b3307],

1	OATPIB3	CD	NUMBER	oatpib3	number	2	SENT_263	[p8l615t3321r781b3349],
2	(	CD	NUMBER	(	num	3	SENT_263	[p8l802t3321r979b3356],
3	SLCOIB3	NN	O	slcoib3	_	0	SENT_263	[p8l802t3321r979b3356],
4	;	:	O	;	_	0	SENT_263	[p8l802t3321r979b3356],
5	previously	RB	DATE	previously	advmod	6	SENT_263	[p8l996t3320r1159b3359],
6	known	VBN	O	know	partmod	3	SENT_263	[p8l1174t3320r1279b3349],
7	as	IN	O	as	mark	14	SENT_263	[p8l1296t3331r1325b3349],
8	OATP8	NN	O	oatp8	nn	11	SENT_263	[p8l1343t3321r1467b3349],
9	and	CC	O	and	_	0	SENT_263	[p8l1486t3320r1541b3349],
10	LST-2	NN	O	lst-2	nn	11	SENT_263	[p8l1558t3321r1677b3356],
11	)	NN	O	)	nsubjpass	14	SENT_263	[p8l1558t3321r1677b3356],
12	is	VBZ	O	be	auxpass	14	SENT_263	[p8l1695t3322r1717b3349],
13	also	RB	O	also	advmod	14	SENT_263	[p8l1735t3320r1794b3349],
14	expressed	VBN	O	express	advcl	6	SENT_263	[p8l1812t3320r1960b3358],
15	on	IN	O	on	_	0	SENT_263	[p8l1978t3331r2017b3349],
16	the	DT	O	the	det	18	SENT_263	[p8l2034t3320r2082b3349],
17	basolateral	JJ	O	basolateral	amod	18	SENT_263	[p8l565t3370r732b3399],
18	membrane	NN	O	membrane	prep_on	14	SENT_263	[p8l743t3370r910b3399],
19	of	IN	O	of	_	0	SENT_263	[p8l922t3370r956b3399],
20	human	JJ	O	human	amod	21	SENT_263	[p8l962t3370r1071b3399],
21	hepatocytes	NNS	O	hepatocyte	prep_of	3	SENT_263	[p8l1081t3370r1273b3408],
22	.	.	O	.	_	0	SENT_263	[p8l1081t3370r1273b3408],

1	In	IN	O	in	csubj	10	SENT_264	[p8l1285t3371r1319b3398],
2	addition	NN	O	addition	pobj	1	SENT_264	[p8l1330t3370r1459b3399],
3	to	TO	O	to	_	0	SENT_264	[p8l1470t3378r1500b3399],
4	transporting	VBG	O	transport	prepc_to	2	SENT_264	[p8l1512t3371r1707b3408],
5	many	JJ	O	many	dobj	4	SENT_264	[p8l1716t3381r1804b3408],
6	of	IN	O	of	_	0	SENT_264	[p8l1813t3370r1847b3399],
7	the	DT	O	the	det	9	SENT_264	[p8l1854t3370r1903b3399],
8	same	JJ	O	same	amod	9	SENT_264	[p8l1914t3381r1991b3399],
9	compounds	NNS	O	compound	prep_of	5	SENT_264	[p8l2002t3381r2082b3399, p8l565t3420r678b3458],
10	transported	VBN	O	transport	_	0	SENT_264	[p8l692t3420r872b3458],
11	by	IN	O	by	_	0	SENT_264	[p8l886t3420r924b3458],
12	OATP1Bl	NN	O	oatp1bl	prep_by	10	SENT_264	[p8l937t3420r1115b3455],
13	,	,	O	,	_	0	SENT_264	[p8l937t3420r1115b3455],
14	OATPIB3	NN	O	oatpib3	nn	16	SENT_264	[p8l1130t3420r1296b3449],
15	transports	NNS	O	transport	nn	16	SENT_264	[p8l1313t3428r1470b3458],
16	taxanes	NNS	O	taxane	prep_by	10	SENT_264	[p8l1484t3428r1596b3449],
17	and	CC	O	and	_	0	SENT_264	[p8l1610t3420r1666b3449],
18	numerous	JJ	O	numerous	amod	20	SENT_264	[p8l1679t3430r1835b3449],
19	small	JJ	O	small	amod	20	SENT_264	[p8l1849t3420r1930b3449],
20	peptides	NNS	O	peptide	conj_and	12	SENT_264	[p8l1943t3420r2081b3458],
21	.	.	O	.	_	0	SENT_264	[p8l1943t3420r2081b3458],

1	Polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_265	[p8l565t3470r811b3508],
2	in	IN	O	in	_	0	SENT_265	[p8l827t3471r857b3498],
3	SLC01B3	NN	O	slc01b3	prep_in	1	SENT_265	[p8l873t3471r1029b3499],
4	have	VBP	O	have	aux	6	SENT_265	[p8l1045t3469r1115b3499],
5	been	VBN	O	be	auxpass	6	SENT_265	[p8l1132t3470r1206b3499],
6	identiﬁed	VBN	O	identiﬁed	_	0	SENT_265	[p8l1221t3469r1370b3499],
7	and	CC	O	and	_	0	SENT_265	[p8l1387t3469r1442b3499],
8	assessed	VBN	O	assess	conj_and	6	SENT_265	[p8l1459t3470r1583b3499],
9	for	IN	O	for	_	0	SENT_265	[p8l1600t3470r1645b3499],
10	transport	NN	O	transport	nn	11	SENT_265	[p8l1661t3478r1805b3508],
11	activity	NN	O	activity	prep_for	6	SENT_265	[p8l1821t3471r1935b3508],
12	(	CD	NUMBER	(	number	13	SENT_265	[p8l1950t3470r2006b3506],
13	92	CD	NUMBER	92	dep	11	SENT_265	[p8l1950t3470r2006b3506],
14	,	,	O	,	_	0	SENT_265	[p8l1950t3470r2006b3506],
15	93	CD	NUMBER	93	num	16	SENT_265	[p8l2024t3471r2081b3506],
16	)	NN	O	)	appos	11	SENT_265	[p8l2024t3471r2081b3506],
17	,	,	O	,	_	0	SENT_265	[p8l2024t3471r2081b3506],
18	although	IN	O	although	mark	29	SENT_265	[p8l565t3519r704b3558],
19	evidence	NN	O	evidence	nsubj	29	SENT_265	[p8l723t3519r858b3548],
20	for	IN	O	for	_	0	SENT_265	[p8l877t3519r922b3548],
21	the	DT	O	the	det	23	SENT_265	[p8l940t3519r989b3548],
22	clinical	JJ	O	clinical	amod	23	SENT_265	[p8l1008t3519r1119b3548],
23	importance	NN	O	importance	prep_for	19	SENT_265	[p8l1137t3521r1315b3558],
24	of	IN	O	of	_	0	SENT_265	[p8l1335t3519r1369b3548],
25	these	DT	O	these	det	26	SENT_265	[p8l1383t3519r1463b3548],
26	polymorphisms	NNS	O	polymorphism	prep_of	23	SENT_265	[p8l1482t3519r1724b3558],
27	is	VBZ	O	be	cop	29	SENT_265	[p8l1743t3521r1766b3548],
28	less	RBR	O	less	advmod	29	SENT_265	[p8l1785t3519r1838b3548],
29	clear	JJ	O	clear	advcl	6	SENT_265	[p8l1858t3519r1932b3548],
30	than	IN	O	than	prep	29	SENT_265	[p8l1950t3519r2019b3548],
31	for	IN	O	for	pcomp	30	SENT_265	[p8l2038t3519r2083b3548],
32	SLC01	NN	O	slc01	nn	33	SENT_265	[p8l565t3570r676b3598],
33	B1	NN	O	b1	pobj	31	SENT_265	[p8l680t3570r729b3598],
34	.	.	O	.	_	0	SENT_265	[p8l680t3570r729b3598],

1	Genetic	JJ	O	genetic	amod	2	SENT_266	[p8l745t3570r869b3598],
2	variants	NNS	O	variant	nsubjpass	7	SENT_266	[p8l880t3570r1002b3598],
3	in	IN	O	in	_	0	SENT_266	[p8l1016t3570r1046b3598],
4	SLCOIB3	NN	O	slcoib3	prep_in	2	SENT_266	[p8l1059t3570r1215b3598],
5	were	VBD	O	be	auxpass	7	SENT_266	[p8l1228t3580r1303b3598],
6	not	RB	O	not	neg	7	SENT_266	[p8l1316t3577r1369b3598],
7	associated	VBN	O	associate	_	0	SENT_266	[p8l1382t3569r1537b3598],
8	with	IN	O	with	_	0	SENT_266	[p8l1550t3569r1620b3598],
9	paclitaxel	NN	O	paclitaxel	nn	12	SENT_266	[p8l1632t3569r1778b3607],
10	or	CC	O	or	_	0	SENT_266	[p8l1792t3580r1826b3598],
11	docetaxel	NN	O	docetaxel	nn	12	SENT_266	[p8l1839t3569r1984b3598],
12	pharmacokinetics	NNS	O	pharmacokinetic	prep_with	7	SENT_266	[p8l1997t3569r2082b3607, p8l565t3619r768b3648],
13	in	IN	O	in	_	0	SENT_266	[p8l778t3621r808b3648],
14	Caucasian	JJ	MISC	caucasian	amod	16	SENT_266	[p8l818t3620r976b3648],
15	cancer	NN	O	cancer	nn	16	SENT_266	[p8l986t3630r1087b3648],
16	patients	NNS	O	patient	prep_in	7	SENT_266	[p8l1097t3621r1227b3657],
17	,	,	O	,	_	0	SENT_266	[p8l1097t3621r1227b3657],
18	despite	IN	O	despite	_	0	SENT_266	[p8l1239t3619r1348b3657],
19	evidence	NN	O	evidence	prep_despite	7	SENT_266	[p8l1359t3619r1494b3648],
20	for	IN	O	for	_	0	SENT_266	[p8l1504t3619r1550b3648],
21	OATP1B3-mediated	JJ	O	oatp1b3-mediated	amod	22	SENT_266	[p8l1560t3619r1889b3648],
22	transport	NN	O	transport	prep_for	19	SENT_266	[p8l1899t3627r2044b3657],
23	of	IN	O	of	_	0	SENT_266	[p8l2053t3619r2087b3648],
24	these	DT	O	these	det	25	SENT_266	[p8l565t3668r645b3697],
25	drugs	NNS	O	drug	prep_of	22	SENT_266	[p8l655t3668r741b3707],
26	in	FW	O	in	prep	25	SENT_266	[p8l751t3670r781b3697],
27	vitro	FW	O	vitro	nn	28	SENT_266	[p8l789t3670r863b3697],
28	(	FW	O	(	pobj	26	SENT_266	[p8l874t3669r1000b3705],
29	94-96	CD	NUMBER	94-96	num	30	SENT_266	[p8l874t3669r1000b3705],
30	)	NN	O	)	dep	28	SENT_266	[p8l874t3669r1000b3705],
31	.	.	O	.	_	0	SENT_266	[p8l874t3669r1000b3705],

1	SLCO1	NN	O	slco1	nn	3	SENT_267	[p8l1011t3669r1122b3697],
2	B3	NN	O	b3	nn	3	SENT_267	[p8l1126t3670r1167b3697],
3	variants	NNS	O	variant	nsubj	4	SENT_267	[p8l1176t3670r1298b3697],
4	were	VBD	O	be	_	0	SENT_267	[p8l1307t3679r1390b3704],
5	,	,	O	,	_	0	SENT_267	[p8l1307t3679r1390b3704],
6	however	RB	O	however	advmod	4	SENT_267	[p8l1401t3668r1542b3703],
7	,	,	O	,	_	0	SENT_267	[p8l1401t3668r1542b3703],
8	associated	VBN	O	associate	dep	4	SENT_267	[p8l1553t3668r1709b3697],
9	with	IN	O	with	_	0	SENT_267	[p8l1718t3668r1787b3697],
10	docetaxel	NN	O	docetaxel	nn	11	SENT_267	[p8l1798t3668r2082b3697],
11	—	NN	O	—	prep_with	8	SENT_267	[p8l1798t3668r2082b3697],
12	induced	VBD	O	induce	rcmod	11	SENT_267	[p8l1798t3668r2082b3697],
13	leukopenia	NN	O	leukopenia	dobj	12	SENT_267	[p8l565t3717r735b3755],
14	in	IN	O	in	_	0	SENT_267	[p8l749t3719r779b3746],
15	Japanese	JJ	MISC	japanese	amod	17	SENT_267	[p8l789t3718r928b3755],
16	cancer	NN	O	cancer	nn	17	SENT_267	[p8l944t3728r1045b3746],
17	patients	NNS	O	patient	prep_in	12	SENT_267	[p8l1059t3719r1181b3755],
18	(	CD	NUMBER	(	number	19	SENT_267	[p8l1197t3718r1265b3753],
19	97	CD	NUMBER	97	num	20	SENT_267	[p8l1197t3718r1265b3753],
20	)	NN	O	)	dep	17	SENT_267	[p8l1197t3718r1265b3753],
21	,	,	O	,	_	0	SENT_267	[p8l1197t3718r1265b3753],
22	and	CC	O	and	_	0	SENT_267	[p8l1281t3717r1337b3746],
23	SLCOIA/IB	NN	O	slcoia/ib	prep_in	12	SENT_267	[p8l1352t3715r1596b3746],
24	’	CD	NUMBER	’	num	23	SENT_267	[p8l1352t3715r1596b3746],
25	/	:	O	/	punct	29	SENT_267	[p8l1352t3715r1596b3746],
26	’	CD	NUMBER	’	num	28	SENT_267	[p8l1352t3715r1596b3746],
27	knockout	JJ	O	knockout	amod	28	SENT_267	[p8l1613t3717r1761b3746],
28	mice	NNS	O	mouse	nsubj	29	SENT_267	[p8l1774t3719r1848b3746],
29	had	VBD	O	have	dep	11	SENT_267	[p8l1863t3717r1919b3746],
30	a	DT	O	a	det	42	SENT_267	[p8l1934t3728r1948b3746],
31	twofold	RB	O	twofold	amod	42	SENT_267	[p8l1963t3717r2083b3746],
32	increased	VBN	O	increase	dep	31	SENT_267	[p8l565t3766r711b3795],
33	exposure	NN	O	exposure	dobj	32	SENT_267	[p8l719t3777r856b3805],
34	to	TO	O	to	_	0	SENT_267	[p8l864t3774r894b3795],
35	paclitaxel	NN	O	paclitaxel	prep_to	33	SENT_267	[p8l902t3766r1048b3805],
36	compared	VBN	O	compare	_	0	SENT_267	[p8l1055t3766r1210b3805],
37	with	IN	O	with	prepc_compared_with	32	SENT_267	[p8l1216t3766r1286b3795],
38	wild-type	JJ	O	wild-type	amod	39	SENT_267	[p8l1292t3766r1440b3805],
39	animals	NNS	O	animal	pobj	32	SENT_267	[p8l1448t3766r1566b3795],
40	(	CD	NUMBER	(	number	41	SENT_267	[p8l1574t3767r1642b3802],
41	98	CD	NUMBER	98	num	42	SENT_267	[p8l1574t3767r1642b3802],
42	)	NN	O	)	dobj	29	SENT_267	[p8l1574t3767r1642b3802],
43	.	.	O	.	_	0	SENT_267	[p8l1574t3767r1642b3802],

1	Thus	RB	O	thus	dep	8	SENT_268	[p8l1650t3766r1742b3801],
2	,	,	O	,	_	0	SENT_268	[p8l1650t3766r1742b3801],
3	the	DT	O	the	det	4	SENT_268	[p8l1751t3766r1799b3795],
4	role	NN	O	role	dep	8	SENT_268	[p8l1807t3766r1867b3795],
5	of	IN	O	of	_	0	SENT_268	[p8l1875t3766r1910b3795],
6	OATP	NN	O	oatp	prep_of	4	SENT_268	[p8l1913t3767r2019b3795],
7	1	CD	NUMBER	1	dep	4	SENT_268	[p8l2025t3768r2035b3795],
8	B3	NN	O	b3	_	0	SENT_268	[p8l2041t3767r2079b3795],

1	Annu	NNP	PERSON	Annu	_	0	SENT_269	[p9l180t2354r203b2434],
2	.	.	O	.	_	0	SENT_269	[p9l180t2354r203b2434],

1	Rev.	NNP	O	Rev.	nn	2	SENT_270	[p9l180t2283r203b2343],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_270	[p9l180t2124r203b2273],
3	.	.	O	.	_	0	SENT_270	[p9l180t2124r203b2273],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_271	[p9l180t2004r203b2113],
2	.	.	O	.	_	0	SENT_271	[p9l180t2004r203b2113],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_272	[p9l180t1758r204b1992],
2	-273	CD	NUMBER	-273	_	0	SENT_272	[p9l180t1758r204b1992],
3	.	.	O	.	_	0	SENT_272	[p9l180t1758r204b1992],

1	Downloaded	VBN	O	download	_	0	SENT_273	[p9l180t1577r203b1748],
2	from	IN	O	from	_	0	SENT_273	[p9l180t1504r203b1568],
3	w	NN	O	w	nn	4	SENT_273	[p9l188t1474r203b1495],
4	ww	NN	O	ww	prep_from	1	SENT_273	[p9l188t1404r203b1451],
5	.	.	O	.	_	0	SENT_273	[p9l180t1298r203b1391],

1	annual	JJ	SET	annual	amod	2	SENT_274	[p9l180t1298r203b1391],
2	revi	NN	O	revus	_	0	SENT_274	[p9l180t1231r203b1285],
3	ews	NNS	O	ew	dep	2	SENT_274	[p9l187t1166r203b1216],
4	.	.	O	.	_	0	SENT_274	[p9l187t1103r210b1152],

1	org	NN	O	org	_	0	SENT_275	[p9l187t1103r210b1152],
2	by	IN	O	by	_	0	SENT_275	[p9l213t2266r244b2299],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_275	[p9l213t2117r244b2257],
4	of	IN	ORGANIZATION	of	_	0	SENT_275	[p9l213t2079r237b2107],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_275	[p9l213t1932r237b2072],
6	-	:	O	-	_	0	SENT_275	[p9l227t1913r230b1922],
7	Madison	NNP	O	Madison	dep	1	SENT_275	[p9l213t1787r237b1903],
8	on	IN	O	on	_	0	SENT_275	[p9l221t1746r237b1778],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_275	[p9l213t1612r237b1736],
10	.	.	O	.	_	0	SENT_275	[p9l213t1612r237b1736],

1	For	IN	O	for	_	0	SENT_276	[p9l214t1555r237b1601],
2	perso	JJ	O	perso	amod	6	SENT_276	[p9l221t1476r244b1546],
3	nal	JJ	O	nal	amod	6	SENT_276	[p9l213t1414r237b1454],
4	use	NN	O	use	nn	6	SENT_276	[p9l221t1351r237b1394],
5	onl	NN	O	onl	nn	6	SENT_276	[p9l213t1300r237b1341],
6	y.	NN	O	y.	pobj	1	SENT_276	[p9l221t1263r244b1285],

1	in	IN	O	in	mark	7	SENT_277	[p9l564t14r595b41],
2	taxane	NN	O	taxane	nn	3	SENT_277	[p9l608t20r707b42],
3	transport	NN	O	transport	nsubjpass	7	SENT_277	[p9l721t20r866b51],
4	is	VBZ	O	be	auxpass	7	SENT_277	[p9l878t14r901b42],
5	not	RB	O	not	neg	7	SENT_277	[p9l915t20r968b42],
6	fully	RB	O	fully	advmod	7	SENT_277	[p9l981t12r1052b51],
7	understood	VBN	O	understand	csubj	38	SENT_277	[p9l1063t12r1250b48],
8	,	,	O	,	_	0	SENT_277	[p9l1063t12r1250b48],
9	although	IN	O	although	mark	12	SENT_277	[p9l1265t12r1404b51],
10	it	PRP	O	it	nsubj	12	SENT_277	[p9l1417t14r1440b42],
11	is	VBZ	O	be	cop	12	SENT_277	[p9l1453t14r1475b42],
12	interesting	JJ	O	interesting	advcl	7	SENT_277	[p9l1489t14r1659b51],
13	that	IN	O	that	complm	17	SENT_277	[p9l1672t12r1733b42],
14	OATPIB3	NN	O	oatpib3	nsubj	17	SENT_277	[p9l1747t13r1913b42],
15	is	VBZ	O	be	cop	17	SENT_277	[p9l1930t14r1952b42],
16	overex	JJ	O	overex	amod	17	SENT_277	[p9l1967t23r2082b42],
17	—	NN	O	—	ccomp	12	SENT_277	[p9l1967t23r2082b42],
18	pressed	VBN	O	press	partmod	17	SENT_277	[p9l565t62r680b101],
19	in	IN	O	in	_	0	SENT_277	[p9l692t64r723b91],
20	colorectal	JJ	O	colorectal	amod	23	SENT_277	[p9l735t62r888b91],
21	and	CC	O	and	_	0	SENT_277	[p9l901t62r957b91],
22	breast	NN	O	breast	conj_and	20	SENT_277	[p9l969t62r1064b91],
23	cancers	NNS	O	cancer	prep_in	18	SENT_277	[p9l1076t73r1189b91],
24	and	CC	O	and	_	0	SENT_277	[p9l1203t62r1258b91],
25	that	IN	O	that	complm	31	SENT_277	[p9l1271t62r1333b91],
26	its	PRP$	O	its	poss	28	SENT_277	[p9l1344t64r1379b91],
27	transport	NN	O	transport	nn	28	SENT_277	[p9l1392t70r1537b101],
28	activity	NN	O	activity	nsubj	31	SENT_277	[p9l1549t64r1662b101],
29	may	MD	O	may	aux	31	SENT_277	[p9l1673t73r1739b101],
30	be	VB	O	be	cop	31	SENT_277	[p9l1750t62r1786b91],
31	important	JJ	O	important	conj_and	17	SENT_277	[p9l1798t64r1956b101],
32	in	IN	O	in	_	0	SENT_277	[p9l1967t64r1998b91],
33	drug	NN	O	drug	nn	34	SENT_277	[p9l2011t62r2084b101],
34	entry	NN	O	entry	prep_in	31	SENT_277	[p9l565t120r648b151],
35	to	TO	O	to	_	0	SENT_277	[p9l658t120r688b141],
36	tumor	NN	O	tumor	nn	37	SENT_277	[p9l700t120r797b141],
37	cells	NNS	O	cell	prep_to	31	SENT_277	[p9l808t112r874b141],
38	(	VBP	O	(	_	0	SENT_277	[p9l886t113r955b149],
39	99	CD	NUMBER	99	number	40	SENT_277	[p9l886t113r955b149],
40	)	CD	NUMBER	)	dobj	38	SENT_277	[p9l886t113r955b149],
41	.	.	O	.	_	0	SENT_277	[p9l886t113r955b149],

1	The	DT	O	the	det	3	SENT_278	[p9l613t161r680b191],
2	other	JJ	O	other	amod	3	SENT_278	[p9l693t161r777b191],
3	OATP	NN	O	oatp	nsubj	4	SENT_278	[p9l790t162r896b191],
4	expressed	VBN	O	express	dep	25	SENT_278	[p9l909t161r1058b200],
5	on	IN	O	on	_	0	SENT_278	[p9l1071t172r1110b191],
6	the	DT	O	the	det	8	SENT_278	[p9l1122t161r1171b191],
7	basolateral	JJ	O	basolateral	amod	8	SENT_278	[p9l1184t161r1351b191],
8	membrane	NN	O	membrane	prep_on	4	SENT_278	[p9l1363t161r1531b191],
9	of	IN	O	of	_	0	SENT_278	[p9l1544t161r1578b191],
10	human	JJ	O	human	amod	15	SENT_278	[p9l1586t161r1694b191],
11	hepatocytes	NNS	O	hepatocyte	nn	15	SENT_278	[p9l1706t161r1899b200],
12	,	,	O	,	_	0	SENT_278	[p9l1706t161r1899b200],
13	OATP2B1	NN	O	oatp2b1	dep	15	SENT_278	[p9l1913t162r2079b191],
14	(	CD	NUMBER	(	num	15	SENT_278	[p9l566t212r742b248],
15	SLCOZBI	NN	O	slcozbus	prep_of	8	SENT_278	[p9l566t212r742b248],
16	;	:	O	;	_	0	SENT_278	[p9l566t212r742b248],
17	previously	RB	DATE	previously	advmod	18	SENT_278	[p9l755t211r917b250],
18	known	VBN	O	know	amod	8	SENT_278	[p9l927t211r1032b240],
19	as	IN	O	as	_	0	SENT_278	[p9l1045t222r1073b240],
20	OATP-B	NN	O	oatp-b	nn	21	SENT_278	[p9l1086t212r1251b248],
21	)	NN	O	)	prep_as	4	SENT_278	[p9l1086t212r1251b248],
22	,	,	O	,	_	0	SENT_278	[p9l1086t212r1251b248],
23	is	VBZ	O	be	auxpass	25	SENT_278	[p9l1264t213r1287b240],
24	also	RB	O	also	advmod	25	SENT_278	[p9l1300t211r1358b240],
25	expressed	VBN	O	express	_	0	SENT_278	[p9l1371t211r1520b250],
26	on	IN	O	on	_	0	SENT_278	[p9l1532t222r1571b240],
27	the	DT	O	the	det	29	SENT_278	[p9l1583t211r1632b240],
28	apical	JJ	O	apical	amod	29	SENT_278	[p9l1645t211r1733b250],
29	membrane	NN	O	membrane	prep_on	25	SENT_278	[p9l1745t211r1912b240],
30	of	IN	O	of	_	0	SENT_278	[p9l1925t211r1959b240],
31	entero	NN	O	entero	prep_of	29	SENT_278	[p9l1968t219r2082b240],
32	—	CD	NUMBER	—	num	33	SENT_278	[p9l1968t219r2082b240],
33	cytes	NNS	O	cyte	nsubjpass	25	SENT_278	[p9l565t269r650b299],
34	,	,	O	,	_	0	SENT_278	[p9l565t269r650b299],
35	where	WRB	O	where	advmod	39	SENT_278	[p9l657t260r753b289],
36	it	PRP	O	it	nsubjpass	39	SENT_278	[p9l760t262r782b289],
37	may	MD	O	may	aux	39	SENT_278	[p9l788t271r854b299],
38	be	VB	O	be	auxpass	39	SENT_278	[p9l860t260r895b289],
39	involved	VBN	O	involve	rcmod	33	SENT_278	[p9l902t260r1035b289],
40	in	IN	O	in	_	0	SENT_278	[p9l1042t262r1072b289],
41	the	DT	O	the	det	43	SENT_278	[p9l1079t260r1128b289],
42	intestinal	JJ	O	intestinal	amod	43	SENT_278	[p9l1135t260r1279b289],
43	uptake	NN	O	uptake	prep_in	39	SENT_278	[p9l1285t260r1389b299],
44	of	IN	O	of	_	0	SENT_278	[p9l1397t260r1431b289],
45	its	PRP$	O	its	poss	46	SENT_278	[p9l1434t262r1469b289],
46	substrates	NNS	O	substrate	prep_of	43	SENT_278	[p9l1476t260r1638b289],
47	.	.	O	.	_	0	SENT_278	[p9l1476t260r1638b289],

1	Reduced	VBN	O	reduce	amod	3	SENT_279	[p9l1647t260r1783b289],
2	plasma	NN	O	plasma	nn	3	SENT_279	[p9l1790t260r1897b299],
3	levels	NNS	O	level	nsubjpass	11	SENT_279	[p9l1904t260r1989b289],
4	of	IN	O	of	_	0	SENT_279	[p9l1997t260r2031b289],
5	the	DT	O	the	det	9	SENT_279	[p9l2034t260r2082b289],
6	leukotriene	NN	O	leukotriene	nn	9	SENT_279	[p9l565t309r742b338],
7	receptor	NN	O	receptor	nn	9	SENT_279	[p9l753t317r885b348],
8	antagonist	NN	O	antagonist	nn	9	SENT_279	[p9l895t311r1058b348],
9	montelukast	NN	O	montelukast	prep_of	3	SENT_279	[p9l1067t309r1260b338],
10	were	VBD	O	be	auxpass	11	SENT_279	[p9l1269t320r1343b338],
11	associated	VBN	O	associate	_	0	SENT_279	[p9l1355t309r1510b338],
12	with	IN	O	with	_	0	SENT_279	[p9l1520t309r1590b338],
13	the	DT	O	the	det	15	SENT_279	[p9l1600t309r1649b338],
14	nonsynonymous	JJ	O	nonsynonymous	amod	15	SENT_279	[p9l1659t320r1915b348],
15	SLCOZBI	NN	O	slcozbus	prep_with	11	SENT_279	[p9l1927t310r2080b338],

1	2	CD	NUMBER	2	num	3	SENT_280	[p9l471t424r482b438],
2	56	CD	NUMBER	56	num	3	SENT_280	[p9l485t416r515b445],
3	DeGo7ter	NN	O	dego7ter	_	0	SENT_280	[p9l565t416r676b438],
4	et	FW	O	et	nn	5	SENT_280	[p9l683t421r703b438],
5	til	FW	O	til	dep	3	SENT_280	[p9l709t416r735b438],
6	.	.	O	.	_	0	SENT_280	[p9l709t416r735b438],

1	polymorphism	NN	O	polymorphism	nn	2	SENT_281	[p9l366t520r595b559],
2	c.	NN	O	c.	nsubj	28	SENT_281	[p9l604t522r664b549],
3	93	CD	NUMBER	93	num	4	SENT_281	[p9l604t522r664b549],
4	5G	NN	O	5g	nsubj	16	SENT_281	[p9l671t521r995b557],
5	>	JJR	O	>	dep	4	SENT_281	[p9l671t521r995b557],
6	A	DT	O	a	det	9	SENT_281	[p9l671t521r995b557],
7	(	JJ	O	(	amod	9	SENT_281	[p9l671t521r995b557],
8	rs12422149	NN	O	rs12422149	nn	9	SENT_281	[p9l671t521r995b557],
9	)	NN	O	)	dep	4	SENT_281	[p9l671t521r995b557],
10	;	:	O	;	_	0	SENT_281	[p9l671t521r995b557],
11	individuals	NNS	O	individual	dep	9	SENT_281	[p9l1006t520r1174b549],
12	with	IN	O	with	_	0	SENT_281	[p9l1183t520r1252b549],
13	this	DT	O	this	det	14	SENT_281	[p9l1262t520r1317b549],
14	polymorphism	NN	O	polymorphism	prep_with	11	SENT_281	[p9l1327t520r1556b559],
15	also	RB	O	also	advmod	16	SENT_281	[p9l1565t520r1624b549],
16	experienced	VBD	O	experience	rcmod	2	SENT_281	[p9l1634t520r1820b559],
17	less	JJR	O	less	amod	18	SENT_281	[p9l1830t520r1883b549],
18	improvement	NN	O	improvement	dobj	16	SENT_281	[p9l365t571r578b608],
19	in	IN	O	in	_	0	SENT_281	[p9l590t571r620b598],
20	their	PRP$	O	they	poss	21	SENT_281	[p9l634t569r709b599],
21	symptoms	NNS	O	symptom	prep_in	16	SENT_281	[p9l722t577r881b608],
22	compared	VBN	O	compare	_	0	SENT_281	[p9l896t569r1050b608],
23	with	IN	O	with	prepc_compared_with	16	SENT_281	[p9l1063t569r1133b599],
24	wild	JJ	O	wild	amod	27	SENT_281	[p9l1145t569r1294b608],
25	—	NN	O	—	nn	27	SENT_281	[p9l1145t569r1294b608],
26	type	NN	O	type	nn	27	SENT_281	[p9l1145t569r1294b608],
27	individuals	NNS	O	individual	pobj	16	SENT_281	[p9l1308t569r1477b599],
28	(	VBP	O	(	_	0	SENT_281	[p9l1492t570r1579b606],
29	101	CD	NUMBER	101	num	30	SENT_281	[p9l1492t570r1579b606],
30	)	CD	NUMBER	)	dobj	28	SENT_281	[p9l1492t570r1579b606],
31	.	.	O	.	_	0	SENT_281	[p9l1492t570r1579b606],

1	Reduced	VBN	O	reduce	_	0	SENT_282	[p9l1595t569r1731b599],
2	exposure	NN	O	exposure	dobj	1	SENT_282	[p9l1746t580r1883b608],
3	to	TO	O	to	_	0	SENT_282	[p9l366t627r396b648],
4	the	DT	O	the	det	7	SENT_282	[p9l411t619r459b648],
5	OATP2B1	NN	O	oatp2b1	nn	7	SENT_282	[p9l474t620r640b648],
6	substrate	NN	O	substrate	nn	7	SENT_282	[p9l658t619r797b648],
7	aliskiren	NN	O	aliskiren	prep_to	1	SENT_282	[p9l812t619r943b648],
8	following	VBG	O	follow	_	0	SENT_282	[p9l956t619r1106b658],
9	ingestion	NN	O	ingestion	prep_following	7	SENT_282	[p9l1118t621r1263b658],
10	of	IN	O	of	_	0	SENT_282	[p9l1277t619r1311b648],
11	apple	NN	O	apple	nn	13	SENT_282	[p9l1321t619r1412b658],
12	,	,	O	,	_	0	SENT_282	[p9l1321t619r1412b658],
13	orange	NN	O	orange	prep_of	9	SENT_282	[p9l1427t630r1543b658],
14	,	,	O	,	_	0	SENT_282	[p9l1427t630r1543b658],
15	or	CC	O	or	_	0	SENT_282	[p9l1558t630r1592b648],
16	grapefruit	NN	O	grapefruit	nn	17	SENT_282	[p9l1605t619r1762b658],
17	juice	NN	O	juice	conj_or	13	SENT_282	[p9l1773t621r1847b658],
18	is	VBZ	O	be	auxpass	19	SENT_282	[p9l1861t621r1883b648],
19	postulated	VBN	O	postulate	auxpass	1	SENT_282	[p9l365t668r527b707],
20	to	TO	O	to	aux	21	SENT_282	[p9l541t677r571b698],
21	result	VB	O	result	xcomp	19	SENT_282	[p9l585t668r673b698],
22	from	IN	O	from	_	0	SENT_282	[p9l686t668r762b698],
23	inhibition	NN	O	inhibition	prep_from	21	SENT_282	[p9l775t668r930b698],
24	of	IN	O	of	_	0	SENT_282	[p9l944t668r978b698],
25	intestinal	JJ	O	intestinal	amod	26	SENT_282	[p9l987t668r1131b698],
26	OATP2B1-mediated	JJ	O	oatp2b1-mediated	amod	28	SENT_282	[p9l1145t668r1474b698],
27	transport	NN	O	transport	nn	28	SENT_282	[p9l1488t677r1632b707],
28	(	NN	O	(	prep_of	23	SENT_282	[p9l1645t669r1721b705],
29	102	CD	NUMBER	102	nsubjpass	1	SENT_282	[p9l1645t669r1721b705],
30	,	,	O	,	_	0	SENT_282	[p9l1645t669r1721b705],
31	103	CD	NUMBER	103	num	32	SENT_282	[p9l1740t669r1813b705],
32	)	NN	O	)	appos	29	SENT_282	[p9l1740t669r1813b705],
33	.	.	O	.	_	0	SENT_282	[p9l1740t669r1813b705],

1	For	IN	O	for	_	0	SENT_283	[p9l1828t670r1884b698],
2	montelukast	NN	O	montelukast	prep_for	7	SENT_283	[p9l365t718r566b754],
3	,	,	O	,	_	0	SENT_283	[p9l365t718r566b754],
4	orange	JJ	O	orange	amod	6	SENT_283	[p9l581t729r688b757],
5	juice	NN	O	juice	nn	6	SENT_283	[p9l700t720r774b757],
6	consumption	NN	O	consumption	nsubj	7	SENT_283	[p9l788t720r993b757],
7	had	VBD	O	have	_	0	SENT_283	[p9l1005t718r1062b747],
8	an	DT	O	a	det	9	SENT_283	[p9l1076t729r1111b747],
9	effect	NN	O	effect	dobj	7	SENT_283	[p9l1125t718r1209b747],
10	on	IN	O	on	_	0	SENT_283	[p9l1222t729r1261b747],
11	plasma	NN	O	plasma	nn	12	SENT_283	[p9l1274t718r1382b757],
12	exposure	NN	O	exposure	prep_on	9	SENT_283	[p9l1396t729r1533b757],
13	for	IN	O	for	_	0	SENT_283	[p9l1547t718r1592b747],
14	wild	JJ	O	wild	amod	17	SENT_283	[p9l1604t718r1753b757],
15	—	NN	O	—	nn	17	SENT_283	[p9l1604t718r1753b757],
16	type	NN	O	type	nn	17	SENT_283	[p9l1604t718r1753b757],
17	carriers	NNS	O	carrier	prep_for	12	SENT_283	[p9l1767t720r1883b747],
18	but	CC	O	but	_	0	SENT_283	[p9l366t768r418b797],
19	not	RB	O	not	neg	9	SENT_283	[p9l426t776r480b797],
20	for	IN	O	for	_	0	SENT_283	[p9l489t768r534b797],
21	SLCOZBI	NNP	O	SLCOZBI	nn	22	SENT_283	[p9l544t769r697b797],
22	C93	NN	O	c93	prep_for	9	SENT_283	[p9l710t770r770b797],
23	5	CD	NUMBER	5	num	22	SENT_283	[p9l777t769r791b797],
24	G	NN	O	g	amod	22	SENT_283	[p9l795t769r880b797],
25	>	JJR	O	>	dep	24	SENT_283	[p9l795t769r880b797],
26	A	DT	O	a	det	27	SENT_283	[p9l795t769r880b797],
27	carriers	NNS	O	carrier	dep	9	SENT_283	[p9l889t769r1013b804],
28	;	:	O	;	_	0	SENT_283	[p9l889t769r1013b804],
29	the	DT	O	the	det	30	SENT_283	[p9l1025t768r1074b797],
30	latter	JJ	O	latter	nsubj	32	SENT_283	[p9l1084t768r1167b797],
31	had	VBD	O	have	aux	32	SENT_283	[p9l1176t768r1232b797],
32	reduced	VBN	O	reduce	parataxis	7	SENT_283	[p9l1242t768r1367b797],
33	montelukast	JJ	O	montelukast	amod	34	SENT_283	[p9l1376t768r1570b797],
34	exposure	NN	O	exposure	npadvmod	32	SENT_283	[p9l1580t779r1717b807],
35	regardless	RB	O	regardless	_	0	SENT_283	[p9l1727t768r1883b807],
36	of	IN	O	of	_	0	SENT_283	[p9l366t818r400b847],
37	treatment	NN	O	treatment	nn	38	SENT_283	[p9l407t826r562b847],
38	(	NN	O	(	prep_regardless_of	32	SENT_283	[p9l573t819r660b854],
39	104	CD	NUMBER	104	num	40	SENT_283	[p9l573t819r660b854],
40	)	NN	O	)	dep	38	SENT_283	[p9l573t819r660b854],
41	.	.	O	.	_	0	SENT_283	[p9l573t819r660b854],

1	Oatp1b2	NN	O	oatp1b2	nsubj	6	SENT_284	[p9l416t867r550b905],
2	was	VBD	O	be	cop	6	SENT_284	[p9l562t878r618b896],
3	the	DT	O	the	det	6	SENT_284	[p9l629t867r678b896],
4	ﬁrst	NN	O	ﬁrst	nn	6	SENT_284	[p9l688t867r750b896],
5	murine	JJ	O	murine	amod	6	SENT_284	[p9l759t869r872b896],
6	Oatp	NN	O	oatp	_	0	SENT_284	[p9l883t868r961b905],
7	to	TO	O	to	aux	9	SENT_284	[p9l971t875r1002b896],
8	be	VB	O	be	auxpass	9	SENT_284	[p9l1012t867r1048b896],
9	studied	VBN	O	study	infmod	6	SENT_284	[p9l1059t867r1171b896],
10	in	IN	O	in	_	0	SENT_284	[p9l1181t869r1212b896],
11	a	DT	O	a	det	14	SENT_284	[p9l1222t878r1237b896],
12	knockout	JJ	O	knockout	amod	14	SENT_284	[p9l1247t867r1394b896],
13	mouse	NN	O	mouse	nn	14	SENT_284	[p9l1403t878r1504b896],
14	model	NN	O	model	prep_in	9	SENT_284	[p9l1514t867r1612b896],
15	and	CC	O	and	_	0	SENT_284	[p9l1622t867r1678b896],
16	is	VBZ	O	be	auxpass	24	SENT_284	[p9l1688t869r1711b896],
17	the	DT	O	the	det	19	SENT_284	[p9l1721t867r1770b896],
18	closest	JJS	O	closest	amod	19	SENT_284	[p9l1781t867r1885b896],
19	ortholog	NN	O	ortholog	attr	24	SENT_284	[p9l366t916r503b955],
20	of	IN	O	of	_	0	SENT_284	[p9l519t916r553b945],
21	the	DT	O	the	det	23	SENT_284	[p9l565t916r614b945],
22	human	JJ	O	human	amod	23	SENT_284	[p9l631t916r739b945],
23	OATPs	NNS	O	oatp	prep_of	19	SENT_284	[p9l756t917r876b945],
24	expressed	VBN	O	express	infmod	6	SENT_284	[p9l894t916r1042b955],
25	in	IN	O	in	_	0	SENT_284	[p9l1058t918r1089b945],
26	the	DT	O	the	det	27	SENT_284	[p9l1105t916r1154b945],
27	liver	NN	O	liver	prep_in	24	SENT_284	[p9l1170t916r1247b952],
28	,	,	O	,	_	0	SENT_284	[p9l1170t916r1247b952],
29	OATP1B1	NN	O	oatp1b1	conj_and	27	SENT_284	[p9l1266t917r1432b945],
30	and	CC	O	and	_	0	SENT_284	[p9l1452t916r1508b945],
31	OATPIB3	NN	O	oatpib3	conj_and	27	SENT_284	[p9l1525t917r1703b945],
32	.	.	O	.	_	0	SENT_284	[p9l1525t917r1703b945],

1	SlcoIlz2	NN	O	slcoilz2	nsubj	30	SENT_285	[p9l1721t914r1880b945],
2	‘	CD	NUMBER	‘	num	1	SENT_285	[p9l1721t914r1880b945],
3	/	:	O	/	punct	6	SENT_285	[p9l1721t914r1880b945],
4	‘	CD	NUMBER	‘	num	5	SENT_285	[p9l1721t914r1880b945],
5	mice	NNS	O	mouse	nsubj	6	SENT_285	[p9l365t967r439b995],
6	had	VBD	O	have	dep	1	SENT_285	[p9l461t965r518b995],
7	lower	JJR	O	lower	amod	8	SENT_285	[p9l540t965r628b995],
8	liver	NN	O	liver	dobj	6	SENT_285	[p9l649t965r888b1004],
9	—	CD	NUMBER	—	number	11	SENT_285	[p9l649t965r888b1004],
10	to	TO	O	to	dep	11	SENT_285	[p9l649t965r888b1004],
11	—	CD	NUMBER	—	num	13	SENT_285	[p9l649t965r888b1004],
12	plasma	NN	O	plasma	nn	13	SENT_285	[p9l649t965r888b1004],
13	ratios	NNS	O	ratio	dep	8	SENT_285	[p9l910t967r996b995],
14	of	IN	O	of	_	0	SENT_285	[p9l1019t965r1053b995],
15	the	DT	O	the	det	19	SENT_285	[p9l1071t965r1120b995],
16	prototypical	JJ	O	prototypical	amod	19	SENT_285	[p9l1142t965r1333b1004],
17	OATPIB	NN	O	oatpib	nn	19	SENT_285	[p9l1356t966r1505b995],
18	substrates	NNS	O	substrate	nn	19	SENT_285	[p9l1528t965r1681b995],
19	pravastatin	NN	O	pravastatin	prep_of	13	SENT_285	[p9l1703t967r1882b1004],
20	,	,	O	,	_	0	SENT_285	[p9l1703t967r1882b1004],
21	lovastatin	NN	O	lovastatin	conj_and	8	SENT_285	[p9l366t1015r523b1051],
22	,	,	O	,	_	0	SENT_285	[p9l366t1015r523b1051],
23	and	CC	O	and	_	0	SENT_285	[p9l534t1015r590b1044],
24	rifampicin	NN	O	rifampicin	conj_and	8	SENT_285	[p9l599t1015r761b1054],
25	compared	VBN	O	compare	_	0	SENT_285	[p9l770t1015r925b1054],
26	with	IN	O	with	prepc_compared_with	24	SENT_285	[p9l933t1015r1003b1044],
27	wild	JJ	O	wild	amod	29	SENT_285	[p9l1011t1015r1160b1054],
28	—	NN	O	—	nn	29	SENT_285	[p9l1011t1015r1160b1054],
29	type	NN	O	type	pobj	24	SENT_285	[p9l1011t1015r1160b1054],
30	controls	VBZ	O	control	_	0	SENT_285	[p9l1170t1015r1296b1044],
31	(	NN	O	(	nsubj	37	SENT_285	[p9l1307t1016r1383b1052],
32	105	CD	NUMBER	105	num	31	SENT_285	[p9l1307t1016r1383b1052],
33	,	,	O	,	_	0	SENT_285	[p9l1307t1016r1383b1052],
34	106	CD	NUMBER	106	num	35	SENT_285	[p9l1397t1016r1470b1052],
35	)	NN	O	)	appos	31	SENT_285	[p9l1397t1016r1470b1052],
36	,	,	O	,	_	0	SENT_285	[p9l1397t1016r1470b1052],
37	indicating	VBG	O	indicate	dep	30	SENT_285	[p9l1481t1015r1638b1054],
38	the	DT	O	the	det	39	SENT_285	[p9l1647t1015r1695b1044],
39	importance	NN	O	importance	dobj	37	SENT_285	[p9l1705t1017r1883b1054],
40	of	IN	O	of	_	0	SENT_285	[p9l366t1064r400b1094],
41	Oatp1b2	NN	O	oatp1b2	prep_of	39	SENT_285	[p9l413t1064r547b1103],
42	in	IN	O	in	_	0	SENT_285	[p9l566t1066r596b1093],
43	mediating	VBG	O	mediate	prepc_in	37	SENT_285	[p9l612t1064r770b1103],
44	the	DT	O	the	det	46	SENT_285	[p9l786t1064r835b1094],
45	hepatic	JJ	O	hepatic	amod	46	SENT_285	[p9l851t1064r964b1103],
46	uptake	NN	O	uptake	dobj	43	SENT_285	[p9l980t1064r1084b1103],
47	of	IN	O	of	_	0	SENT_285	[p9l1101t1064r1135b1094],
48	these	DT	O	these	det	49	SENT_285	[p9l1148t1064r1227b1094],
49	compounds	NNS	O	compound	prep_of	46	SENT_285	[p9l1245t1064r1433b1103],
50	.	.	O	.	_	0	SENT_285	[p9l1245t1064r1433b1103],

1	Reduced	VBN	O	reduce	amod	3	SENT_286	[p9l1452t1064r1587b1094],
2	hepatic	JJ	O	hepatic	amod	3	SENT_286	[p9l1604t1064r1717b1103],
3	uptake	NN	O	uptake	nsubj	25	SENT_286	[p9l1733t1064r1836b1103],
4	of	IN	O	of	_	0	SENT_286	[p9l1854t1064r1888b1094],
5	the	DT	O	the	det	7	SENT_286	[p9l366t1114r414b1144],
6	toxins	NNS	O	toxin	nn	7	SENT_286	[p9l435t1116r527b1144],
7	phalloidin	NN	O	phalloidin	prep_of	3	SENT_286	[p9l547t1114r706b1153],
8	and	CC	O	and	_	0	SENT_286	[p9l726t1114r781b1144],
9	microcystin-LR	NN	O	microcystin-lr	prep_of	3	SENT_286	[p9l801t1116r1052b1153],
10	in	IN	O	in	_	0	SENT_286	[p9l1070t1116r1100b1143],
11	SlcoIl72	NN	O	slcoil72	prep_in	3	SENT_286	[p9l1120t1112r1281b1143],
12	"	''	O	"	punct	11	SENT_286	[p9l1120t1112r1281b1143],
13	/	:	O	/	punct	16	SENT_286	[p9l1120t1112r1281b1143],
14	‘	CD	NUMBER	‘	num	15	SENT_286	[p9l1120t1112r1281b1143],
15	mice	NNS	O	mouse	nsubj	16	SENT_286	[p9l1304t1116r1378b1144],
16	resulted	VBD	O	result	dep	3	SENT_286	[p9l1398t1114r1522b1144],
17	in	IN	O	in	_	0	SENT_286	[p9l1542t1116r1572b1143],
18	protection	NN	O	protection	prep_in	16	SENT_286	[p9l1592t1116r1755b1153],
19	against	IN	O	against	_	0	SENT_286	[p9l1775t1116r1885b1153],
20	hepatotoxicity	NN	O	hepatotoxicity	prep_against	3	SENT_286	[p9l365t1174r590b1213],
21	induced	VBN	O	induce	partmod	3	SENT_286	[p9l604t1174r728b1204],
22	by	IN	O	by	_	0	SENT_286	[p9l745t1174r783b1213],
23	these	DT	O	these	det	24	SENT_286	[p9l798t1174r878b1204],
24	compounds	NNS	O	compound	agent	21	SENT_286	[p9l895t1174r1075b1213],
25	(	VBP	O	(	_	0	SENT_286	[p9l1092t1175r1180b1211],
26	107	CD	NUMBER	107	number	27	SENT_286	[p9l1092t1175r1180b1211],
27	)	CD	NUMBER	)	dobj	25	SENT_286	[p9l1092t1175r1180b1211],
28	.	.	O	.	_	0	SENT_286	[p9l1092t1175r1180b1211],

1	There	EX	O	there	expl	2	SENT_287	[p9l1197t1174r1295b1204],
2	are	VBP	O	be	_	0	SENT_287	[p9l1312t1185r1358b1204],
3	additional	JJ	O	additional	amod	4	SENT_287	[p9l1376t1174r1531b1204],
4	Oatps	NNS	O	oatp	nsubj	2	SENT_287	[p9l1549t1175r1640b1213],
5	of	IN	O	of	_	0	SENT_287	[p9l1657t1175r1691b1204],
6	the	DT	O	the	det	8	SENT_287	[p9l1704t1174r1752b1204],
7	Oatpla	NNP	O	Oatpla	nn	8	SENT_287	[p9l1770t1175r1884b1213],
8	family	NN	O	family	prep_of	4	SENT_287	[p9l366t1238r464b1277],
9	that	WDT	O	that	nsubjpass	11	SENT_287	[p9l474t1238r536b1267],
10	are	VBP	O	be	auxpass	11	SENT_287	[p9l547t1249r593b1267],
11	expressed	VBN	O	express	rcmod	4	SENT_287	[p9l606t1238r754b1277],
12	in	IN	O	in	_	0	SENT_287	[p9l766t1240r796b1267],
13	mouse	NN	O	mouse	prep_in	11	SENT_287	[p9l807t1249r908b1267],
14	but	CC	O	but	_	0	SENT_287	[p9l920t1238r972b1267],
15	not	RB	O	not	_	0	SENT_287	[p9l983t1247r1036b1267],
16	human	JJ	O	human	amod	17	SENT_287	[p9l1046t1238r1155b1267],
17	liver	NN	O	liver	conj_negcc	13	SENT_287	[p9l1166t1238r1243b1274],
18	,	,	O	,	_	0	SENT_287	[p9l1166t1238r1243b1274],
19	and	CC	O	and	_	0	SENT_287	[p9l1256t1238r1312b1267],
20	compensation	NN	O	compensation	nsubj	33	SENT_287	[p9l1324t1240r1542b1277],
21	by	IN	O	by	_	0	SENT_287	[p9l1554t1238r1592b1277],
22	these	DT	O	these	det	23	SENT_287	[p9l1602t1238r1682b1267],
23	transporters	NNS	O	transporter	prep_by	20	SENT_287	[p9l1694t1246r1883b1277],
24	in	IN	O	in	_	0	SENT_287	[p9l365t1303r396b1330],
25	Slco1lz2	NN	O	slco1lz2	prep_in	23	SENT_287	[p9l407t1299r566b1330],
26	‘	CD	NUMBER	‘	num	25	SENT_287	[p9l407t1299r566b1330],
27	/	:	O	/	punct	29	SENT_287	[p9l407t1299r566b1330],
28	‘	CD	NUMBER	‘	num	29	SENT_287	[p9l407t1299r566b1330],
29	mice	NNS	O	mouse	dep	25	SENT_287	[p9l580t1303r654b1331],
30	may	MD	O	may	aux	33	SENT_287	[p9l665t1312r732b1340],
31	not	RB	O	not	neg	33	SENT_287	[p9l741t1310r794b1331],
32	fully	RB	O	fully	advmod	33	SENT_287	[p9l805t1301r875b1340],
33	reflect	VB	O	reflect	conj_and	2	SENT_287	[p9l885t1301r984b1331],
34	the	DT	O	the	det	35	SENT_287	[p9l995t1301r1043b1331],
35	effect	NN	O	effect	dobj	33	SENT_287	[p9l1055t1302r1140b1331],
36	of	IN	O	of	_	0	SENT_287	[p9l1150t1302r1185b1331],
37	OATPIB	NNP	O	OATPIB	nn	38	SENT_287	[p9l1192t1302r1341b1331],
38	loss	NN	O	loss	prep_of	35	SENT_287	[p9l1353t1301r1410b1331],
39	in	IN	O	in	_	0	SENT_287	[p9l1421t1303r1452b1330],
40	humans	NNS	O	human	prep_in	33	SENT_287	[p9l1462t1302r1592b1331],
41	.	.	O	.	_	0	SENT_287	[p9l1462t1302r1592b1331],

1	Slcolcz/I17	NN	O	slcolcz/i17	nsubj	20	SENT_288	[p9l1605t1299r1795b1330],
2	‘	CD	NUMBER	‘	num	1	SENT_288	[p9l1605t1299r1795b1330],
3	/	:	O	/	punct	5	SENT_288	[p9l1605t1299r1795b1330],
4	‘	CD	NUMBER	‘	num	5	SENT_288	[p9l1605t1299r1795b1330],
5	mice	NNS	O	mouse	dep	1	SENT_288	[p9l1809t1303r1883b1331],
6	with	IN	O	with	_	0	SENT_288	[p9l365t1351r434b1381],
7	deletion	NN	O	deletion	prep_with	5	SENT_288	[p9l451t1351r578b1381],
8	of	IN	O	of	_	0	SENT_288	[p9l595t1352r629b1381],
9	Oatp1b2	NN	O	oatp1b2	nn	15	SENT_288	[p9l642t1351r787b1390],
10	,	,	O	,	_	0	SENT_288	[p9l642t1351r787b1390],
11	Oatplal	NN	O	oatplal	dep	15	SENT_288	[p9l806t1352r947b1390],
12	,	,	O	,	_	0	SENT_288	[p9l806t1352r947b1390],
13	Oatp1a4	NN	O	oatp1a4	dep	15	SENT_288	[p9l966t1352r1108b1390],
14	,	,	O	,	_	0	SENT_288	[p9l966t1352r1108b1390],
15	Oatp1a5	NN	O	oatp1a5	prep_of	5	SENT_288	[p9l1126t1352r1268b1390],
16	,	,	O	,	_	0	SENT_288	[p9l1126t1352r1268b1390],
17	and	CC	O	and	_	0	SENT_288	[p9l1286t1351r1342b1381],
18	Oatpla6	NN	O	oatpla6	nn	19	SENT_288	[p9l1359t1352r1492b1390],
19	expression	NN	O	expression	conj_and	15	SENT_288	[p9l1510t1353r1672b1390],
20	demonstrate	VBP	O	demonstrate	_	0	SENT_288	[p9l1689t1351r1883b1381],
21	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_288	[p9l366t1412r557b1451],
22	reduced	VBN	O	reduce	amod	24	SENT_288	[p9l574t1412r699b1441],
23	hepatic	JJ	O	hepatic	amod	24	SENT_288	[p9l717t1412r831b1450],
24	concentrations	NNS	O	concentration	dobj	20	SENT_288	[p9l850t1413r1081b1441],
25	and	CC	O	and	_	0	SENT_288	[p9l1101t1412r1156b1441],
26	elevated	JJ	O	elevated	amod	28	SENT_288	[p9l1176t1412r1302b1441],
27	plasma	NN	O	plasma	nn	28	SENT_288	[p9l1321t1412r1429b1450],
28	levels	NNS	O	level	dobj	20	SENT_288	[p9l1448t1412r1532b1441],
29	of	IN	O	of	_	0	SENT_288	[p9l1552t1412r1586b1441],
30	methotrexate	NN	O	methotrexate	nn	33	SENT_288	[p9l1601t1412r1808b1441],
31	and	CC	O	and	_	0	SENT_288	[p9l1828t1412r1884b1441],
32	fexofenadine	NN	O	fexofenadine	conj_and	30	SENT_288	[p9l366t1482r564b1511],
33	(	NN	O	(	prep_of	28	SENT_288	[p9l576t1483r655b1518],
34	108	CD	NUMBER	108	num	35	SENT_288	[p9l576t1483r655b1518],
35	)	NN	O	)	dep	28	SENT_288	[p9l576t1483r655b1518],
36	and	CC	O	and	_	0	SENT_288	[p9l666t1482r722b1511],
37	provide	VB	O	provide	dep	28	SENT_288	[p9l732t1482r850b1520],
38	a	DT	O	a	det	39	SENT_288	[p9l861t1493r876b1511],
39	model	NN	O	model	dobj	37	SENT_288	[p9l886t1482r984b1511],
40	to	TO	O	to	aux	42	SENT_288	[p9l994t1490r1025b1511],
41	further	RB	O	further	advmod	42	SENT_288	[p9l1036t1482r1146b1511],
42	elucidate	VB	O	elucidate	xcomp	20	SENT_288	[p9l1157t1482r1295b1511],
43	the	DT	O	the	det	45	SENT_288	[p9l1306t1482r1355b1511],
44	combined	JJ	O	combined	amod	45	SENT_288	[p9l1366t1482r1520b1511],
45	role	NN	O	role	dobj	42	SENT_288	[p9l1531t1482r1591b1511],
46	of	IN	O	of	_	0	SENT_288	[p9l1603t1482r1637b1511],
47	the	DT	O	the	det	51	SENT_288	[p9l1643t1482r1692b1511],
48	Oatpla	NNP	LOCATION	Oatpla	nn	51	SENT_288	[p9l1703t1483r1817b1520],
49	and	CC	O	and	_	0	SENT_288	[p9l1828t1482r1883b1511],
50	Oatplb	NNP	LOCATION	Oatplb	conj_and	48	SENT_288	[p9l367t1531r483b1570],
51	families	NNS	O	family	prep_of	45	SENT_288	[p9l495t1531r615b1560],
52	in	IN	O	in	_	0	SENT_288	[p9l626t1533r656b1560],
53	drug	NN	O	drug	nn	54	SENT_288	[p9l668t1531r741b1570],
54	disposition	NN	O	disposition	prep_in	45	SENT_288	[p9l752t1531r930b1570],
55	.	.	O	.	_	0	SENT_288	[p9l752t1531r930b1570],

1	Organic	NNP	O	Organic	nn	2	SENT_289	[p9l366t1645r503b1682],
2	anion	NN	O	anion	_	0	SENT_289	[p9l513t1645r607b1673],
3	transporting	VBG	O	transport	partmod	2	SENT_289	[p9l616t1645r829b1682],
4	polypeptides	NNS	O	polypeptide	dobj	3	SENT_289	[p9l836t1644r1052b1682],
5	in	IN	O	in	_	0	SENT_289	[p9l1062t1645r1095b1672],
6	toxicity	NN	O	toxicity	prep_in	4	SENT_289	[p9l1104t1645r1237b1682],
7	.	.	O	.	_	0	SENT_289	[p9l1104t1645r1237b1682],

1	Numerous	JJ	O	numerous	amod	2	SENT_290	[p9l1258t1645r1426b1673],
2	studies	NNS	O	study	nsubj	10	SENT_290	[p9l1436t1644r1542b1673],
3	of	IN	O	of	_	0	SENT_290	[p9l1552t1644r1586b1673],
4	statin	NN	O	statin	nn	5	SENT_290	[p9l1591t1645r1676b1673],
5	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	2	SENT_290	[p9l1685t1644r1883b1682, p9l365t1695r455b1723],
6	in	IN	O	in	_	0	SENT_290	[p9l465t1695r495b1722],
7	healthy	JJ	O	healthy	amod	8	SENT_290	[p9l504t1694r621b1732],
8	individuals	NNS	O	individual	prep_in	5	SENT_290	[p9l629t1694r798b1723],
9	have	VBP	O	have	aux	10	SENT_290	[p9l807t1694r878b1723],
10	demonstrated	VBN	O	demonstrate	ccomp	26	SENT_290	[p9l889t1694r1103b1723],
11	that	IN	O	that	complm	21	SENT_290	[p9l1113t1694r1175b1723],
12	reduced	VBN	O	reduce	dep	21	SENT_290	[p9l1183t1694r1456b1723],
13	—	NN	O	—	nn	17	SENT_290	[p9l1183t1694r1456b1723],
14	function	NN	O	function	nn	17	SENT_290	[p9l1183t1694r1456b1723],
15	SLC	NNP	O	SLC	nn	17	SENT_290	[p9l1465t1695r1535b1722],
16	01	CD	NUMBER	01	num	17	SENT_290	[p9l1535t1695r1576b1723],
17	BI	NNP	O	BI	nsubj	18	SENT_290	[p9l1580t1695r1619b1722],
18	polymorphisms	NNS	O	polymorphism	xcomp	12	SENT_290	[p9l1631t1694r1882b1732],
19	,	,	O	,	_	0	SENT_290	[p9l1631t1694r1882b1732],
20	particularly	RB	O	particularly	advmod	21	SENT_290	[p9l366t1743r546b1782],
21	c.	VBP	O	c.	ccomp	10	SENT_290	[p9l560t1744r737b1779],
22	521T	NN	O	521t	dobj	21	SENT_290	[p9l560t1744r737b1779],
23	>	JJR	O	>	dep	24	SENT_290	[p9l560t1744r737b1779],
24	C	NN	O	c	amod	22	SENT_290	[p9l560t1744r737b1779],
25	,	,	O	,	_	0	SENT_290	[p9l560t1744r737b1779],
26	increase	VBP	O	increase	_	0	SENT_290	[p9l753t1745r879b1772],
27	the	DT	O	the	det	28	SENT_290	[p9l895t1743r943b1772],
28	area	NN	O	area	dobj	26	SENT_290	[p9l959t1754r1022b1772],
29	under	IN	O	under	_	0	SENT_290	[p9l1036t1743r1129b1772],
30	the	DT	O	the	det	31	SENT_290	[p9l1143t1744r1192b1772],
31	curve	NN	O	curve	prep_under	26	SENT_290	[p9l1208t1754r1291b1772],
32	of	IN	O	of	_	0	SENT_290	[p9l1307t1744r1341b1772],
33	plasma	NN	O	plasma	nn	34	SENT_290	[p9l1351t1743r1458b1782],
34	exposure	NN	O	exposure	prep_of	31	SENT_290	[p9l1474t1754r1612b1782],
35	to	TO	O	to	_	0	SENT_290	[p9l1627t1752r1657b1772],
36	nearly	RB	O	nearly	quantmod	37	SENT_290	[p9l1672t1743r1770b1782],
37	all	PDT	O	all	num	39	SENT_290	[p9l1784t1743r1820b1772],
38	the	DT	O	the	quantmod	37	SENT_290	[p9l1835t1743r1883b1772],
39	statins	NNS	O	statin	prep_to	26	SENT_290	[p9l366t1795r473b1829],
40	,	,	O	,	_	0	SENT_290	[p9l366t1795r473b1829],
41	including	VBG	O	include	_	0	SENT_290	[p9l488t1793r636b1832],
42	atorvastadn	NN	O	atorvastadn	nn	43	SENT_290	[p9l650t1795r832b1822],
43	(	NN	O	(	prep_including	26	SENT_290	[p9l847t1794r923b1829],
44	109	CD	NUMBER	109	nsubj	26	SENT_290	[p9l847t1794r923b1829],
45	,	,	O	,	_	0	SENT_290	[p9l847t1794r923b1829],
46	110	CD	NUMBER	110	num	47	SENT_290	[p9l942t1794r1015b1829],
47	)	NN	O	)	appos	44	SENT_290	[p9l942t1794r1015b1829],
48	,	,	O	,	_	0	SENT_290	[p9l942t1794r1015b1829],
49	pravastatin	NN	O	pravastatin	nsubj	26	SENT_290	[p9l1030t1795r1200b1832],
50	(	CD	NUMBER	(	num	49	SENT_290	[p9l1215t1794r1380b1830],
51	111-117	CD	NUMBER	111-117	num	52	SENT_290	[p9l1215t1794r1380b1830],
52	)	NN	O	)	dep	49	SENT_290	[p9l1215t1794r1380b1830],
53	,	,	O	,	_	0	SENT_290	[p9l1215t1794r1380b1830],
54	pitavastatin	NN	O	pitavastatin	nsubj	26	SENT_290	[p9l1395t1795r1573b1832],
55	(	CD	NUMBER	(	num	54	SENT_290	[p9l1588t1794r1753b1829],
56	118-120	CD	NUMBER	118-120	num	57	SENT_290	[p9l1588t1794r1753b1829],
57	)	NN	O	)	dep	54	SENT_290	[p9l1588t1794r1753b1829],
58	,	,	O	,	_	0	SENT_290	[p9l1588t1794r1753b1829],
59	rosuva	NN	O	rosuva	nn	61	SENT_290	[p9l1768t1804r1883b1822],
60	—	NN	O	—	nn	61	SENT_290	[p9l1768t1804r1883b1822],
61	statin	NN	O	statin	nsubj	26	SENT_290	[p9l366t1845r451b1872],
62	(	NN	O	(	dep	61	SENT_290	[p9l463t1844r539b1879],
63	109	CD	NUMBER	109	num	62	SENT_290	[p9l463t1844r539b1879],
64	,	,	O	,	_	0	SENT_290	[p9l463t1844r539b1879],
65	121	CD	NUMBER	121	nsubj	26	SENT_290	[p9l555t1845r616b1878],
66	,	,	O	,	_	0	SENT_290	[p9l555t1845r616b1878],
67	122	CD	NUMBER	122	num	68	SENT_290	[p9l633t1844r706b1879],
68	)	NN	O	)	nsubj	26	SENT_290	[p9l633t1844r706b1879],
69	,	,	O	,	_	0	SENT_290	[p9l633t1844r706b1879],
70	and	CC	O	and	_	0	SENT_290	[p9l719t1843r774b1872],
71	simvastatin	NN	O	simvastatin	nn	73	SENT_290	[p9l786t1845r960b1872],
72	acid	NN	O	acid	nn	73	SENT_290	[p9l972t1843r1033b1872],
73	(	NN	O	(	nsubj	26	SENT_290	[p9l1046t1844r1124b1879],
74	123	CD	NUMBER	123	dep	73	SENT_290	[p9l1046t1844r1124b1879],
75	)	NN	O	)	nn	77	SENT_290	[p9l1046t1844r1124b1879],
76	(	CD	NUMBER	(	num	77	SENT_290	[p9l1137t1843r1247b1879],
77	Table	NNP	O	Table	dep	73	SENT_290	[p9l1137t1843r1247b1879],
78	2	CD	NUMBER	2	number	79	SENT_290	[p9l1259t1844r1298b1879],
79	)	CD	NUMBER	)	dep	77	SENT_290	[p9l1259t1844r1298b1879],
80	.	.	O	.	_	0	SENT_290	[p9l1259t1844r1298b1879],

1	Increased	VBN	O	increase	amod	4	SENT_291	[p9l1311t1843r1460b1872],
2	systemic	JJ	O	systemic	amod	4	SENT_291	[p9l1472t1845r1604b1882],
3	statin	NN	O	statin	nn	4	SENT_291	[p9l1615t1845r1700b1872],
4	exposure	NN	O	exposure	nsubj	20	SENT_291	[p9l1712t1854r1849b1881],
5	is	VBZ	O	be	auxpass	6	SENT_291	[p9l1861t1845r1883b1872],
6	thought	VBN	O	think	rcmod	4	SENT_291	[p9l366t1893r491b1932],
7	to	TO	O	to	aux	10	SENT_291	[p9l499t1901r529b1922],
8	be	VB	O	be	cop	10	SENT_291	[p9l539t1893r574b1922],
9	one	CD	NUMBER	one	num	10	SENT_291	[p9l584t1904r640b1922],
10	component	NN	O	component	xcomp	6	SENT_291	[p9l649t1901r828b1931],
11	of	IN	O	of	_	0	SENT_291	[p9l836t1893r870b1922],
12	risk	NN	O	risk	prep_of	10	SENT_291	[p9l874t1893r932b1922],
13	for	IN	O	for	_	0	SENT_291	[p9l939t1893r985b1922],
14	muscle	NN	O	muscle	nn	15	SENT_291	[p9l992t1893r1100b1922],
15	toxicity	NN	O	toxicity	prep_for	12	SENT_291	[p9l1109t1895r1233b1932],
16	,	,	O	,	_	0	SENT_291	[p9l1109t1895r1233b1932],
17	a	DT	O	a	det	19	SENT_291	[p9l1244t1904r1258b1922],
18	side	JJ	O	side	amod	19	SENT_291	[p9l1267t1893r1327b1922],
19	effect	NN	O	effect	appos	15	SENT_291	[p9l1336t1893r1421b1922],
20	associated	VBN	O	associate	_	0	SENT_291	[p9l1429t1893r1584b1922],
21	with	IN	O	with	_	0	SENT_291	[p9l1592t1893r1662b1922],
22	statin	NN	O	statin	nn	23	SENT_291	[p9l1671t1895r1756b1922],
23	use	NN	O	use	prep_with	20	SENT_291	[p9l1763t1904r1814b1922],
24	that	WDT	O	that	nsubj	26	SENT_291	[p9l1823t1893r1885b1922],
25	can	MD	O	can	aux	26	SENT_291	[p9l366t1954r419b1972],
26	range	VB	O	range	rcmod	23	SENT_291	[p9l429t1954r516b1981],
27	from	IN	O	from	_	0	SENT_291	[p9l528t1943r605b1972],
28	mild	JJ	O	mild	amod	30	SENT_291	[p9l615t1943r686b1972],
29	to	TO	O	to	dep	30	SENT_291	[p9l698t1951r728b1972],
30	life-threatening	JJ	O	life-threatening	prep_from	26	SENT_291	[p9l740t1943r987b1981],
31	in	IN	O	in	_	0	SENT_291	[p9l997t1944r1027b1971],
32	its	PRP$	O	its	poss	33	SENT_291	[p9l1038t1944r1073b1972],
33	severity	NN	O	severity	prep_in	30	SENT_291	[p9l1085t1944r1213b1981],
34	.	.	O	.	_	0	SENT_291	[p9l1085t1944r1213b1981],

1	In	IN	O	in	_	0	SENT_292	[p9l1226t1944r1259b1971],
2	2008	CD	DATE	2008	prep_in	8	SENT_292	[p9l1271t1945r1355b1978],
3	,	,	O	,	_	0	SENT_292	[p9l1271t1945r1355b1978],
4	a	DT	O	a	det	7	SENT_292	[p9l1368t1954r1383b1972],
5	genome-wide	JJ	O	genome-wide	amod	7	SENT_292	[p9l1395t1943r1607b1981],
6	association	NN	O	association	nn	7	SENT_292	[p9l1619t1944r1789b1972],
7	study	NN	O	study	nsubj	8	SENT_292	[p9l1801t1943r1885b1981],
8	identiﬁed	VBD	O	identiﬁed	_	0	SENT_292	[p9l365t1992r514b2022],
9	a	DT	O	a	det	10	SENT_292	[p9l525t2004r540b2021],
10	variant	NN	O	variant	dobj	8	SENT_292	[p9l548t1994r658b2022],
11	in	IN	O	in	_	0	SENT_292	[p9l667t1994r697b2021],
12	complete	JJ	O	complete	amod	14	SENT_292	[p9l708t1993r851b2031],
13	linkage	NN	O	linkage	nn	14	SENT_292	[p9l861t1992r973b2031],
14	disequilibrium	NN	O	disequilibrium	prep_in	10	SENT_292	[p9l984t1992r1211b2031],
15	with	IN	O	with	_	0	SENT_292	[p9l1220t1993r1290b2021],
16	SLC	NN	O	slc	nn	20	SENT_292	[p9l1300t1994r1370b2021],
17	01	CD	NUMBER	01	num	20	SENT_292	[p9l1370t1994r1411b2022],
18	BI	NN	O	bus	nn	20	SENT_292	[p9l1415t1994r1454b2021],
19	c.	NN	O	c.	nn	20	SENT_292	[p9l1467t1993r1635b2022],
20	521T	NN	O	521t	prep_with	8	SENT_292	[p9l1467t1993r1635b2022],
21	>	JJR	O	>	amod	22	SENT_292	[p9l1467t1993r1635b2022],
22	C	NN	O	c	tmod	8	SENT_292	[p9l1467t1993r1635b2022],
23	to	TO	O	to	aux	28	SENT_292	[p9l1647t2001r1677b2022],
24	be	VB	O	be	cop	28	SENT_292	[p9l1687t1993r1723b2022],
25	the	DT	O	the	det	28	SENT_292	[p9l1734t1992r1782b2022],
26	single	JJ	O	single	amod	28	SENT_292	[p9l1793t1993r1883b2031],
27	best	JJS	O	best	dep	26	SENT_292	[p9l366t2042r429b2071],
28	predictor	NN	O	predictor	infmod	22	SENT_292	[p9l440t2042r586b2081],
29	of	IN	O	of	_	0	SENT_292	[p9l598t2042r632b2071],
30	myopathy	NN	O	myopathy	nn	31	SENT_292	[p9l640t2042r798b2081],
31	risk	NN	O	risk	prep_of	28	SENT_292	[p9l809t2042r866b2071],
32	in	IN	O	in	_	0	SENT_292	[p9l877t2044r907b2071],
33	individuals	NNS	O	individual	prep_in	31	SENT_292	[p9l919t2042r1088b2071],
34	on	IN	O	on	_	0	SENT_292	[p9l1102t2053r1141b2071],
35	high	JJ	O	high	amod	36	SENT_292	[p9l1153t2042r1223b2081],
36	doses	NNS	O	dose	prep_on	33	SENT_292	[p9l1236t2042r1319b2071],
37	of	IN	O	of	_	0	SENT_292	[p9l1332t2042r1367b2071],
38	simvastatin	NN	O	simvastatin	nn	39	SENT_292	[p9l1375t2044r1549b2071],
39	(	NN	O	(	prep_of	36	SENT_292	[p9l1562t2043r1650b2079],
40	124	CD	NUMBER	124	num	41	SENT_292	[p9l1562t2043r1650b2079],
41	)	NN	O	)	dep	22	SENT_292	[p9l1562t2043r1650b2079],
42	.	.	O	.	_	0	SENT_292	[p9l1562t2043r1650b2079],

1	Subsequently	RB	O	subsequently	advmod	13	SENT_293	[p9l1666t2042r1882b2081],
2	,	,	O	,	_	0	SENT_293	[p9l1666t2042r1882b2081],
3	the	DT	O	the	det	8	SENT_293	[p9l366t2092r414b2121],
4	SLC	NNP	O	SLC	nn	8	SENT_293	[p9l425t2093r494b2121],
5	01	CD	NUMBER	01	num	8	SENT_293	[p9l495t2093r536b2121],
6	B1	NN	O	b1	nn	8	SENT_293	[p9l540t2094r578b2121],
7	c.	NN	O	c.	nn	8	SENT_293	[p9l592t2093r760b2121],
8	521T	NN	O	521t	nsubjpass	13	SENT_293	[p9l592t2093r760b2121],
9	>	JJR	O	>	amod	11	SENT_293	[p9l592t2093r760b2121],
10	C	NN	O	c	nn	11	SENT_293	[p9l592t2093r760b2121],
11	variant	NN	O	variant	dep	8	SENT_293	[p9l769t2094r879b2121],
12	was	VBD	O	be	auxpass	13	SENT_293	[p9l887t2103r943b2121],
13	found	VBN	O	find	_	0	SENT_293	[p9l953t2092r1045b2121],
14	to	TO	O	to	aux	19	SENT_293	[p9l1055t2100r1085b2121],
15	be	VB	O	be	cop	19	SENT_293	[p9l1096t2092r1131b2121],
16	a	DT	O	a	det	19	SENT_293	[p9l1142t2103r1157b2121],
17	modest	JJ	O	modest	amod	19	SENT_293	[p9l1167t2092r1282b2121],
18	risk	NN	O	risk	nn	19	SENT_293	[p9l1290t2092r1348b2121],
19	predictor	NN	O	predictor	xcomp	13	SENT_293	[p9l1356t2092r1502b2130],
20	for	IN	O	for	mark	23	SENT_293	[p9l1511t2092r1557b2121],
21	cerivastatin	NN	O	cerivastatin	nn	22	SENT_293	[p9l1567t2092r1883b2121],
22	—	NN	O	—	nsubj	23	SENT_293	[p9l1567t2092r1883b2121],
23	induced	VBD	O	induce	advcl	19	SENT_293	[p9l1567t2092r1883b2121],
24	rhabdomyolysis	NN	O	rhabdomyolysis	nsubj	36	SENT_293	[p9l366t2142r611b2181],
25	in	IN	O	in	_	0	SENT_293	[p9l627t2144r658b2171],
26	a	DT	O	a	det	29	SENT_293	[p9l674t2153r688b2171],
27	candidate	NN	O	candidate	nn	29	SENT_293	[p9l705t2142r853b2171],
28	gene	NN	O	gene	nn	29	SENT_293	[p9l870t2153r942b2181],
29	study	NN	O	study	prep_in	24	SENT_293	[p9l959t2142r1043b2181],
30	of	IN	O	of	_	0	SENT_293	[p9l1058t2142r1092b2171],
31	185	CD	NUMBER	185	num	32	SENT_293	[p9l1107t2143r1158b2171],
32	cases	NNS	O	case	prep_of	29	SENT_293	[p9l1177t2153r1252b2171],
33	matched	VBN	O	match	partmod	32	SENT_293	[p9l1268t2142r1402b2171],
34	to	TO	O	to	_	0	SENT_293	[p9l1418t2150r1448b2171],
35	controls	NNS	O	control	prep_to	33	SENT_293	[p9l1465t2142r1592b2171],
36	(	VBP	O	(	ccomp	23	SENT_293	[p9l1609t2143r1696b2178],
37	125	CD	NUMBER	125	number	38	SENT_293	[p9l1609t2143r1696b2178],
38	)	CD	NUMBER	)	dobj	36	SENT_293	[p9l1609t2143r1696b2178],
39	.	.	O	.	_	0	SENT_293	[p9l1609t2143r1696b2178],

1	In	IN	O	in	_	0	SENT_294	[p9l1713t2143r1747b2171],
2	another	DT	O	another	det	3	SENT_294	[p9l1763t2142r1884b2171],
3	study	NN	O	study	prep_in	13	SENT_294	[p9l366t2192r457b2230],
4	,	,	O	,	_	0	SENT_294	[p9l366t2192r457b2230],
5	SLC	NNP	O	SLC	nsubjpass	13	SENT_294	[p9l468t2193r538b2221],
6	01	CD	NUMBER	01	num	5	SENT_294	[p9l539t2193r580b2221],
7	B1	NN	O	b1	nn	9	SENT_294	[p9l583t2193r622b2220],
8	c.	NN	O	c.	nn	9	SENT_294	[p9l635t2193r804b2221],
9	521T	NN	O	521t	dep	5	SENT_294	[p9l635t2193r804b2221],
10	>	JJR	O	>	amod	11	SENT_294	[p9l635t2193r804b2221],
11	C	NN	O	c	dep	5	SENT_294	[p9l635t2193r804b2221],
12	was	VBD	O	be	auxpass	13	SENT_294	[p9l813t2203r869b2221],
13	associated	VBN	O	associate	_	0	SENT_294	[p9l880t2192r1036b2221],
14	with	IN	O	with	_	0	SENT_294	[p9l1045t2192r1115b2221],
15	severe	JJ	O	severe	amod	16	SENT_294	[p9l1125t2203r1220b2221],
16	myopathy	NN	O	myopathy	prep_with	13	SENT_294	[p9l1230t2192r1388b2230],
17	induced	VBN	O	induce	partmod	16	SENT_294	[p9l1396t2192r1520b2221],
18	by	IN	O	by	_	0	SENT_294	[p9l1530t2192r1568b2230],
19	simvastatin	NN	O	simvastatin	agent	17	SENT_294	[p9l1577t2193r1759b2227],
20	,	,	O	,	_	0	SENT_294	[p9l1577t2193r1759b2227],
21	but	CC	O	but	_	0	SENT_294	[p9l1771t2192r1823b2221],
22	not	RB	O	not	_	0	SENT_294	[p9l1831t2200r1885b2221],
23	atorvastatin	NN	O	atorvastatin	nn	24	SENT_294	[p9l366t2243r549b2271],
24	(	NN	O	(	agent	17	SENT_294	[p9l558t2243r646b2278],
25	126	CD	NUMBER	126	num	26	SENT_294	[p9l558t2243r646b2278],
26	)	NN	O	)	dep	24	SENT_294	[p9l558t2243r646b2278],
27	.	.	O	.	_	0	SENT_294	[p9l558t2243r646b2278],

1	Analysis	NN	O	analysis	nsubj	25	SENT_295	[p9l655t2242r783b2280],
2	of	IN	O	of	_	0	SENT_295	[p9l793t2242r827b2271],
3	509	CD	NUMBER	509	num	4	SENT_295	[p9l834t2243r888b2271],
4	subjects	NNS	O	subject	prep_of	1	SENT_295	[p9l898t2242r1020b2280],
5	who	WP	O	who	nsubjpass	7	SENT_295	[p9l1028t2242r1095b2271],
6	were	VBD	O	be	auxpass	7	SENT_295	[p9l1103t2252r1178b2271],
7	randomized	VBN	O	randomize	rcmod	4	SENT_295	[p9l1187t2242r1373b2271],
8	to	TO	O	to	aux	9	SENT_295	[p9l1383t2250r1413b2271],
9	receive	VB	O	receive	xcomp	7	SENT_295	[p9l1422t2243r1532b2271],
10	low-dose	JJ	O	low-dose	amod	11	SENT_295	[p9l1541t2242r1682b2271],
11	atorvastatin	NN	O	atorvastatin	dobj	9	SENT_295	[p9l1692t2243r1882b2277],
12	,	,	O	,	_	0	SENT_295	[p9l1692t2243r1882b2277],
13	simvastatin	NN	O	simvastatin	dobj	9	SENT_295	[p9l366t2293r548b2327],
14	,	,	O	,	_	0	SENT_295	[p9l366t2293r548b2327],
15	or	CC	O	or	_	0	SENT_295	[p9l559t2302r593b2320],
16	pravastatin	NN	O	pravastatin	dobj	9	SENT_295	[p9l602t2293r772b2330],
17	followed	VBN	O	follow	partmod	16	SENT_295	[p9l781t2291r916b2320],
18	by	IN	O	by	_	0	SENT_295	[p9l926t2292r964b2330],
19	higher	JJR	O	higher	amod	20	SENT_295	[p9l971t2291r1074b2330],
20	doses	NNS	O	dose	agent	17	SENT_295	[p9l1084t2291r1166b2320],
21	of	IN	O	of	_	0	SENT_295	[p9l1177t2292r1211b2320],
22	the	DT	O	the	det	24	SENT_295	[p9l1216t2291r1265b2320],
23	same	JJ	O	same	amod	24	SENT_295	[p9l1275t2302r1352b2320],
24	drug	NN	O	drug	prep_of	20	SENT_295	[p9l1362t2291r1435b2330],
25	demonstrated	VBD	O	demonstrate	_	0	SENT_295	[p9l1444t2291r1658b2320],
26	an	DT	O	a	det	27	SENT_295	[p9l1668t2302r1704b2320],
27	association	NN	O	association	dobj	25	SENT_295	[p9l1714t2293r1884b2320],
28	between	IN	O	between	_	0	SENT_295	[p9l366t2341r496b2370],
29	the	DT	O	the	det	31	SENT_295	[p9l506t2341r555b2370],
30	same	JJ	O	same	amod	31	SENT_295	[p9l565t2352r642b2370],
31	polymorphism	NN	O	polymorphism	prep_between	27	SENT_295	[p9l653t2341r882b2380],
32	and	CC	O	and	_	0	SENT_295	[p9l892t2341r948b2370],
33	adverse	JJ	O	adverse	amod	34	SENT_295	[p9l959t2341r1073b2370],
34	events	NNS	O	event	dobj	25	SENT_295	[p9l1084t2350r1181b2370],
35	such	JJ	O	such	_	0	SENT_295	[p9l1192t2341r1261b2370],
36	as	IN	O	as	_	0	SENT_295	[p9l1272t2352r1300b2370],
37	discontinuation	NN	O	discontinuation	prep_such_as	34	SENT_295	[p9l1311t2341r1563b2377],
38	,	,	O	,	_	0	SENT_295	[p9l1311t2341r1563b2377],
39	myalgia	NN	O	myalgium	appos	37	SENT_295	[p9l1575t2341r1704b2380],
40	,	,	O	,	_	0	SENT_295	[p9l1575t2341r1704b2380],
41	or	CC	O	or	_	0	SENT_295	[p9l1716t2352r1750b2370],
42	creatine	NN	O	creatine	nn	44	SENT_295	[p9l1760t2343r1883b2370],
43	kinase	NN	O	kinase	nn	44	SENT_295	[p9l365t2391r461b2420],
44	elevation	NN	O	elevation	conj_or	27	SENT_295	[p9l476t2391r617b2420],
45	following	VBG	O	follow	_	0	SENT_295	[p9l630t2391r779b2430],
46	the	DT	O	the	det	51	SENT_295	[p9l792t2391r840b2420],
47	dose	NN	O	dose	nn	51	SENT_295	[p9l855t2391r924b2420],
48	escalation	NN	O	escalation	nn	51	SENT_295	[p9l938t2391r1091b2420],
49	(	NN	O	(	nn	51	SENT_295	[p9l1105t2392r1193b2428],
50	127	CD	NUMBER	127	num	51	SENT_295	[p9l1105t2392r1193b2428],
51	)	NN	O	)	prep_following	44	SENT_295	[p9l1105t2392r1193b2428],
52	.	.	O	.	_	0	SENT_295	[p9l1105t2392r1193b2428],

1	Most	RBS	O	most	advmod	2	SENT_296	[p9l1206t2392r1290b2420],
2	recently	RB	DATE	recently	advmod	27	SENT_296	[p9l1302t2391r1436b2430],
3	,	,	O	,	_	0	SENT_296	[p9l1302t2391r1436b2430],
4	the	DT	O	the	det	5	SENT_296	[p9l1451t2391r1500b2420],
5	incidence	NN	O	incidence	nsubjpass	27	SENT_296	[p9l1514t2391r1662b2420],
6	of	IN	O	of	_	0	SENT_296	[p9l1677t2391r1711b2420],
7	less	RBR	O	less	advmod	8	SENT_296	[p9l1720t2391r1774b2420],
8	severe	JJ	O	severe	amod	9	SENT_296	[p9l1788t2402r1883b2420],
9	forms	NNS	O	form	prep_of	5	SENT_296	[p9l366t2441r455b2470],
10	of	IN	O	of	_	0	SENT_296	[p9l470t2441r505b2470],
11	statin	NN	O	statin	nn	12	SENT_296	[p9l515t2442r600b2470],
12	intolerance	NN	O	intolerance	prep_of	9	SENT_296	[p9l614t2441r798b2477],
13	,	,	O	,	_	0	SENT_296	[p9l614t2441r798b2477],
14	as	IN	O	as	mark	15	SENT_296	[p9l814t2452r842b2470],
15	manifested	VBN	O	manifest	dep	5	SENT_296	[p9l857t2441r1027b2470],
16	by	IN	O	by	_	0	SENT_296	[p9l1042t2441r1080b2480],
17	adjusting	VBG	O	adjust	prepc_by	15	SENT_296	[p9l1093t2441r1236b2480],
18	the	DT	O	the	det	19	SENT_296	[p9l1249t2441r1298b2470],
19	dose	NN	O	dose	dobj	17	SENT_296	[p9l1313t2441r1382b2470],
20	or	CC	O	or	_	0	SENT_296	[p9l1397t2452r1430b2470],
21	switching	NN	O	switching	conj_or	19	SENT_296	[p9l1444t2441r1595b2480],
22	to	TO	O	to	_	0	SENT_296	[p9l1608t2449r1638b2470],
23	another	DT	O	another	det	24	SENT_296	[p9l1654t2441r1775b2470],
24	statin	NN	O	statin	prep_to	17	SENT_296	[p9l1789t2442r1882b2477],
25	,	,	O	,	_	0	SENT_296	[p9l1789t2442r1882b2477],
26	was	VBD	O	be	auxpass	27	SENT_296	[p9l365t2501r421b2520],
27	associated	VBN	O	associate	_	0	SENT_296	[p9l434t2490r590b2520],
28	with	IN	O	with	_	0	SENT_296	[p9l602t2490r671b2520],
29	the	DT	O	the	det	33	SENT_296	[p9l684t2490r733b2520],
30	SLCO1	NN	O	slco1	nn	33	SENT_296	[p9l746t2491r857b2520],
31	B1	NN	O	b1	nn	33	SENT_296	[p9l861t2492r899b2519],
32	c.	NN	O	c.	nn	33	SENT_296	[p9l916t2491r1084b2520],
33	521T	NN	O	521t	prep_with	27	SENT_296	[p9l916t2491r1084b2520],
34	>	JJR	O	>	amod	36	SENT_296	[p9l916t2491r1084b2520],
35	C	NN	O	c	nn	36	SENT_296	[p9l916t2491r1084b2520],
36	polymorphism	NN	O	polymorphism	dobj	27	SENT_296	[p9l1097t2490r1327b2529],
37	in	IN	O	in	_	0	SENT_296	[p9l1339t2492r1369b2519],
38	a	DT	O	a	det	39	SENT_296	[p9l1382t2501r1397b2520],
39	study	NN	O	study	prep_in	36	SENT_296	[p9l1410t2490r1494b2529],
40	of	IN	O	of	_	0	SENT_296	[p9l1506t2490r1540b2520],
41	more	JJR	O	more	mwe	42	SENT_296	[p9l1548t2501r1630b2520],
42	than	IN	O	than	quantmod	43	SENT_296	[p9l1643t2490r1712b2520],
43	4,000	CD	NUMBER	4,000	num	45	SENT_296	[p9l1725t2492r1810b2526],
44	diabetic	JJ	O	diabetic	amod	45	SENT_296	[p9l1824t2490r1883b2520, p9l366t2540r441b2569],
45	patients	NNS	O	patient	prep_of	39	SENT_296	[p9l455t2542r577b2579],
46	(	IN	O	(	_	0	SENT_296	[p9l592t2541r680b2577],
47	128	CD	NUMBER	128	num	48	SENT_296	[p9l592t2541r680b2577],
48	)	NN	O	)	prep_(	45	SENT_296	[p9l592t2541r680b2577],
49	.	.	O	.	_	0	SENT_296	[p9l592t2541r680b2577],

1	Finally	RB	O	finally	advmod	5	SENT_297	[p9l695t2540r811b2579],
2	,	,	O	,	_	0	SENT_297	[p9l695t2540r811b2579],
3	OATP2B1	NN	O	oatp2b1	nsubjpass	5	SENT_297	[p9l828t2541r993b2569],
4	was	VBD	O	be	auxpass	5	SENT_297	[p9l1010t2551r1066b2569],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_297	[p9l1080t2540r1229b2569],
6	as	IN	O	as	_	0	SENT_297	[p9l1243t2551r1271b2569],
7	a	DT	O	a	det	9	SENT_297	[p9l1286t2551r1301b2569],
8	statin	NN	O	statin	nn	9	SENT_297	[p9l1315t2542r1400b2569],
9	transporter	NN	O	transporter	prep_as	5	SENT_297	[p9l1414t2548r1590b2579],
10	present	JJ	DATE	present	amod	9	SENT_297	[p9l1603t2548r1719b2579],
11	in	IN	O	in	_	0	SENT_297	[p9l1732t2542r1762b2569],
12	muscle	NN	O	muscle	nn	13	SENT_297	[p9l1775t2540r1883b2569],
13	tissue	NN	O	tissue	prep_in	10	SENT_297	[p9l366t2591r460b2626],
14	,	,	O	,	_	0	SENT_297	[p9l366t2591r460b2626],
15	indicating	VBG	O	indicate	xcomp	5	SENT_297	[p9l474t2590r632b2629],
16	a	DT	O	a	det	18	SENT_297	[p9l644t2601r659b2619],
17	potential	JJ	O	potential	amod	18	SENT_297	[p9l671t2590r811b2629],
18	role	NN	O	role	dobj	15	SENT_297	[p9l823t2590r884b2619],
19	for	IN	O	for	_	0	SENT_297	[p9l897t2590r943b2619],
20	statin	NN	O	statin	nn	21	SENT_297	[p9l955t2591r1040b2619],
21	entry	NN	O	entry	prep_for	18	SENT_297	[p9l1053t2598r1136b2629],
22	into	IN	O	into	_	0	SENT_297	[p9l1147t2591r1209b2619],
23	muscle	NN	O	muscle	nn	24	SENT_297	[p9l1222t2590r1329b2619],
24	tissue	NN	O	tissue	prep_into	15	SENT_297	[p9l1343t2591r1429b2619],
25	as	IN	O	as	_	0	SENT_297	[p9l1442t2601r1470b2619],
26	part	NN	O	part	prep_as	15	SENT_297	[p9l1483t2598r1547b2629],
27	of	IN	O	of	_	0	SENT_297	[p9l1559t2590r1593b2619],
28	the	DT	O	the	det	29	SENT_297	[p9l1602t2590r1650b2619],
29	mechanism	NN	O	mechanism	prep_of	26	SENT_297	[p9l1663t2590r1841b2619],
30	of	IN	O	of	_	0	SENT_297	[p9l1854t2590r1888b2619],
31	statin	NN	O	statin	nn	32	SENT_297	[p9l366t2639r623b2669],
32	—	NN	O	—	prep_of	29	SENT_297	[p9l366t2639r623b2669],
33	associated	VBN	O	associate	partmod	32	SENT_297	[p9l366t2639r623b2669],
34	muscle	NN	O	muscle	nn	36	SENT_297	[p9l634t2639r742b2669],
35	toxicity	NN	O	toxicity	nn	36	SENT_297	[p9l753t2641r870b2678],
36	(	NN	O	(	dobj	33	SENT_297	[p9l880t2640r968b2676],
37	129	CD	NUMBER	129	num	38	SENT_297	[p9l880t2640r968b2676],
38	)	NN	O	)	dep	36	SENT_297	[p9l880t2640r968b2676],
39	.	.	O	.	_	0	SENT_297	[p9l880t2640r968b2676],

1	EFFLUX	NNP	MISC	EFFLUX	nn	2	SENT_298	[p9l365t2754r541b2785],
2	TRANSPORTERS	NNPS	O	TRANSPORTERS	_	0	SENT_298	[p9l552t2753r917b2785],
3	OF	IN	O	of	_	0	SENT_298	[p9l931t2753r993b2785],
4	THE	DT	O	the	det	5	SENT_298	[p9l1004t2753r1103b2785],
5	ATP-BINDING	NN	O	atp-binding	prep_of	2	SENT_298	[p9l1114t2753r1430b2785],
6	CASSETTE	NNP	O	CASSETTE	nn	7	SENT_298	[p9l366t2803r600b2835],
7	SUPERFAMILY	NNP	O	SUPERFAMILY	dep	2	SENT_298	[p9l614t2803r931b2835],

1	ATP	NN	O	atp	nn	4	SENT_299	[p9l365t2872r579b2911],
2	—	NN	O	—	nn	4	SENT_299	[p9l365t2872r579b2911],
3	binding	NN	O	binding	nn	4	SENT_299	[p9l365t2872r579b2911],
4	cassette	NN	O	cassette	nsubj	9	SENT_299	[p9l591t2880r709b2901],
5	(	CD	NUMBER	(	num	8	SENT_299	[p9l723t2873r821b2909],
6	ABC	NNP	ORGANIZATION	ABC	nn	8	SENT_299	[p9l723t2873r821b2909],
7	)	CD	NUMBER	)	num	8	SENT_299	[p9l723t2873r821b2909],
8	transporters	NNS	O	transporter	dep	4	SENT_299	[p9l834t2880r1023b2911],
9	use	VBP	O	use	_	0	SENT_299	[p9l1035t2883r1085b2901],
10	energy	NN	O	energy	nsubj	17	SENT_299	[p9l1099t2883r1206b2911],
11	from	IN	O	from	_	0	SENT_299	[p9l1217t2872r1293b2901],
12	the	DT	O	the	det	13	SENT_299	[p9l1305t2872r1354b2901],
13	hydrolysis	NN	O	hydrolysis	prep_from	10	SENT_299	[p9l1366t2872r1525b2911],
14	of	IN	O	of	_	0	SENT_299	[p9l1538t2872r1572b2901],
15	ATP	NN	O	atp	prep_of	13	SENT_299	[p9l1579t2873r1656b2901],
16	to	TO	O	to	aux	17	SENT_299	[p9l1669t2880r1700b2901],
17	move	VB	O	move	xcomp	9	SENT_299	[p9l1713t2883r1797b2901],
18	their	PRP$	O	they	poss	19	SENT_299	[p9l1810t2872r1884b2901],
19	substrates	NNS	O	substrate	dobj	17	SENT_299	[p9l366t2919r519b2948],
20	across	IN	O	across	_	0	SENT_299	[p9l528t2930r621b2948],
21	biological	JJ	O	biological	amod	22	SENT_299	[p9l630t2919r783b2958],
22	membranes	NNS	O	membrane	prep_across	17	SENT_299	[p9l791t2919r972b2948],
23	and	CC	O	and	_	0	SENT_299	[p9l981t2919r1036b2948],
24	against	IN	O	against	_	0	SENT_299	[p9l1045t2921r1155b2958],
25	their	PRP$	O	they	poss	27	SENT_299	[p9l1162t2919r1236b2948],
26	concentration	NN	O	concentration	nn	27	SENT_299	[p9l1245t2921r1462b2948],
27	gradients	NNS	O	gradient	prep_against	17	SENT_299	[p9l1471t2919r1623b2958],
28	,	,	O	,	_	0	SENT_299	[p9l1471t2919r1623b2958],
29	thereby	RB	O	thereby	advmod	30	SENT_299	[p9l1633t2919r1753b2958],
30	limiting	VBG	O	limit	xcomp	9	SENT_299	[p9l1759t2919r1885b2958],

1	*	NN	O	*	nn	3	SENT_300	[p9l1355t3026r1629b3056],
2	www.mmualreview5.org	NN	O	www.mmualreview5.org	nn	3	SENT_300	[p9l1355t3026r1629b3056],
3	o	NN	O	o	_	0	SENT_300	[p9l1644t3034r1653b3044],
4	Dmg	NNP	O	Dmg	nn	5	SENT_300	[p9l1670t3026r1733b3056],
5	Tmnsponferr	NNP	O	Tmnsponferr	dep	3	SENT_300	[p9l1741t3026r1885b3055],

1	Table	NNP	O	Table	_	0	SENT_301	[p9l194t3061r283b3087],
2	2	CD	NUMBER	2	num	4	SENT_301	[p9l294t3063r309b3086],
3	Transporter	NN	O	transporter	nn	4	SENT_301	[p9l345t3062r532b3095],
4	polymorphisms	NNS	O	polymorphism	dep	1	SENT_301	[p9l541t3061r774b3095],
5	involved	VBN	O	involve	partmod	1	SENT_301	[p9l784t3061r910b3087],
6	in	IN	O	in	_	0	SENT_301	[p9l920t3062r949b3086],
7	statin	NN	O	statin	nn	8	SENT_301	[p9l960t3062r1043b3087],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	5	SENT_301	[p9l1052t3061r1318b3095],
9	and	CC	O	and	_	0	SENT_301	[p9l1330t3061r1382b3087],
10	response	NN	O	response	conj_and	8	SENT_301	[p9l1393t3070r1526b3095],

1	Annu	NNP	PERSON	Annu	_	0	SENT_302	[p10l74t1733r97b1813],
2	.	.	O	.	_	0	SENT_302	[p10l74t1733r97b1813],

1	Rev.	NNP	O	Rev.	nn	2	SENT_303	[p10l74t1663r97b1722],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_303	[p10l74t1504r97b1652],
3	.	.	O	.	_	0	SENT_303	[p10l74t1504r97b1652],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_304	[p10l74t1383r97b1493],
2	.	.	O	.	_	0	SENT_304	[p10l74t1383r97b1493],

1	2012522249-273	CD	NUMBER	2012522249-273	_	0	SENT_305	[p10l74t1138r98b1372],
2	.	.	O	.	_	0	SENT_305	[p10l74t1138r98b1372],

1	Downloaded	VBN	O	download	_	0	SENT_306	[p10l74t957r97b1127],
2	from	IN	O	from	_	0	SENT_306	[p10l74t884r97b948],
3	www.a.nnua1reviews.org	NN	O	www.a.nnua1reviews.org	prep_from	1	SENT_306	[p10l74t551r104b875],
4	by	IN	O	by	_	0	SENT_306	[p10l107t1646r138b1678],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_306	[p10l107t1497r138b1637],
6	of	IN	ORGANIZATION	of	_	0	SENT_306	[p10l107t1458r131b1487],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_306	[p10l107t1311r131b1452],
8	-	:	O	-	_	0	SENT_306	[p10l121t1293r124b1302],
9	Madison	NNP	O	Madison	prep_by	1	SENT_306	[p10l107t1167r131b1283],
10	on	IN	O	on	_	0	SENT_306	[p10l115t1125r131b1157],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_306	[p10l107t992r131b1116],
12	.	.	O	.	_	0	SENT_306	[p10l107t992r131b1116],

1	For	IN	O	for	_	0	SENT_307	[p10l108t935r131b981],
2	personal	JJ	O	personal	amod	3	SENT_307	[p10l107t814r138b926],
3	use	NN	O	use	pobj	1	SENT_307	[p10l115t762r131b805],
4	only	RB	O	only	advmod	3	SENT_307	[p10l107t687r138b752],
5	.	.	O	.	_	0	SENT_307	[p10l107t687r138b752],

1	Transporterl	NNP	O	Transporterl	_	0	SENT_308	[p10l452t30r652b63],
2	Effect	NN	O	effect	dep	1	SENT_308	[p10l1595t29r1687b55],
3	of	IN	O	of	prep	2	SENT_308	[p10l1696t29r1729b55],

1	Statin	NN	O	statin	nn	3	SENT_309	[p10l196t80r284b105],
2	polymorphism	NN	O	polymorphism	nn	3	SENT_309	[p10l442t79r662b113],
3	Population	NNP	O	Population	nsubj	4	SENT_309	[p10l755t79r922b113],
4	studied	VBD	O	study	_	0	SENT_309	[p10l931t79r1042b105],
5	Experimental	JJ	O	experimental	amod	8	SENT_309	[p10l1109t79r1313b113],
6	approach	NN	O	approach	nn	8	SENT_309	[p10l1323t79r1461b113],
7	polymorphism	NN	O	polymorphism	nn	8	SENT_309	[p10l1550t79r1770b113],
8	Reference	NNP	O	Reference	dobj	4	SENT_309	[p10l1874t79r2064b111],
9	(	CD	NUMBER	(	num	10	SENT_309	[p10l1874t79r2064b111],
10	s	NNS	O	s	dep	8	SENT_309	[p10l1874t79r2064b111],
11	)	CD	NUMBER	)	num	15	SENT_309	[p10l1874t79r2064b111],
12	Atorvastatin	NNP	O	Atorvastatin	nn	15	SENT_309	[p10l194t131r365b156],
13	SLCOIB1	NNP	O	SLCOIB1	nn	15	SENT_309	[p10l411t131r548b156],
14	Healthy	JJ	O	healthy	amod	15	SENT_309	[p10l743t130r857b165],
15	subjects	NNS	O	subject	dep	8	SENT_309	[p10l866t130r974b165],
16	Candidate	NN	O	candidate	nn	17	SENT_309	[p10l1105t130r1247b156],
17	gene	NN	O	gene	dep	15	SENT_309	[p10l1258t140r1330b165],
18	;	:	O	;	_	0	SENT_309	[p10l1258t140r1330b165],
19	Increased	VBN	O	increase	amod	20	SENT_309	[p10l1515t130r1648b156],
20	AUC	NN	O	auc	dep	8	SENT_309	[p10l1657t131r1732b156],
21	and	CC	O	and	_	0	SENT_309	[p10l1742t130r1792b156],
22	109	CD	NUMBER	109	dep	8	SENT_309	[p10l1913t132r1968b162],
23	,	,	O	,	_	0	SENT_309	[p10l1913t132r1968b162],
24	110	CD	NUMBER	110	appos	22	SENT_309	[p10l1982t132r2029b156],

1	c.	NN	O	c.	dep	8	SENT_310	[p10l428t186r448b202],
2	5	CD	NUMBER	5	num	1	SENT_310	[p10l453t177r465b202],
3	2	CD	NUMBER	2	num	4	SENT_310	[p10l469t178r482b201],
4	1T	NN	O	1t	dep	1	SENT_310	[p10l489t177r578b202],
5	>	JJR	O	>	amod	6	SENT_310	[p10l489t177r578b202],
6	C	NN	O	c	dep	8	SENT_310	[p10l489t177r578b202],
7	Full	JJ	O	full	amod	8	SENT_310	[p10l1121t176r1176b202],
8	pharmacokinetics	NNS	O	pharmacokinetic	dep	11	SENT_310	[p10l1186t176r1431b210],
9	Cmax	NN	O	cmax	dep	8	SENT_310	[p10l1533t177r1600b207],
10	(	CD	NUMBER	(	num	9	SENT_310	[p10l428t223r564b254],
11	rs4l4905	NN	O	rs4l4905	dep	14	SENT_310	[p10l428t223r564b254],
12	6	CD	NUMBER	6	num	11	SENT_310	[p10l567t223r593b254],
13	)	NN	O	)	nn	14	SENT_310	[p10l567t223r593b254],
14	proﬁle	NN	O	proﬁle	_	0	SENT_310	[p10l1121t222r1212b256],

1	Patients	NNS	O	patient	nsubj	2	SENT_311	[p10l743t276r855b300],
2	(	VBP	O	(	_	0	SENT_311	[p10l866t275r891b307],
3	n	NN	O	n	nsubj	4	SENT_311	[p10l866t275r891b307],
4	=	JJ	O	=	ccomp	2	SENT_311	[p10l908t287r931b296],
5	5	CD	NUMBER	5	number	6	SENT_311	[p10l948t276r961b300],
6	09	CD	NUMBER	09	dobj	4	SENT_311	[p10l965t275r1007b307],
7	)	CD	NUMBER	)	num	9	SENT_311	[p10l965t275r1007b307],
8	Candidate	NN	O	candidate	nn	9	SENT_311	[p10l1105t275r1247b300],
9	gene	NN	O	gene	dep	6	SENT_311	[p10l1258t284r1330b309],
10	;	:	O	;	_	0	SENT_311	[p10l1258t284r1330b309],
11	Increased	VBN	O	increase	amod	12	SENT_311	[p10l1515t274r1648b300],
12	incidence	NN	O	incidence	dep	6	SENT_311	[p10l1658t275r1790b300],
13	127	CD	NUMBER	127	tmod	12	SENT_311	[p10l1948t275r1993b301],

1	Dose	NN	O	dose	nn	2	SENT_312	[p10l1122t321r1193b346],
2	escalation	NN	O	escalation	_	0	SENT_312	[p10l1203t320r1340b346],
3	of	IN	O	of	_	0	SENT_312	[p10l1533t320r1563b346],
4	muscle	NN	O	muscle	nn	5	SENT_312	[p10l1569t320r1665b346],
5	toxicity	NN	O	toxicity	prep_of	2	SENT_312	[p10l1675t322r1779b354],

1	Patients	NNS	O	patient	nsubj	2	SENT_313	[p10l743t374r855b399],
2	(	VBP	O	(	dep	15	SENT_313	[p10l866t374r907b405],
3	25	CD	NUMBER	25	num	4	SENT_313	[p10l866t374r907b405],
4	cases	NNS	O	case	dobj	2	SENT_313	[p10l919t383r994b404],
5	,	,	O	,	_	0	SENT_313	[p10l919t383r994b404],
6	Candidate	NN	O	candidate	nn	7	SENT_313	[p10l1105t373r1248b399],
7	gene	NN	O	gene	appos	4	SENT_313	[p10l1258t383r1330b407],
8	;	:	O	;	_	0	SENT_313	[p10l1258t383r1330b407],
9	No	DT	O	no	det	10	SENT_313	[p10l1515t374r1561b399],
10	association	NN	O	association	dep	4	SENT_313	[p10l1571t374r1723b399],
11	with	IN	O	with	_	0	SENT_313	[p10l1731t373r1793b399],
12	126	CD	NUMBER	126	num	14	SENT_313	[p10l1948t375r1994b398],
13	84	CD	NUMBER	84	num	14	SENT_313	[p10l761t420r794b444],
14	controls	NNS	O	control	prep_with	10	SENT_313	[p10l803t419r926b451],
15	)	VBD	O	)	_	0	SENT_313	[p10l803t419r926b451],
16	Case	NNP	O	Case	dobj	15	SENT_313	[p10l1122t418r1303b444],
17	—	CD	NUMBER	—	num	21	SENT_313	[p10l1122t418r1303b444],
18	control	JJ	O	control	amod	21	SENT_313	[p10l1122t418r1303b444],
19	study	NN	O	study	nn	21	SENT_313	[p10l1313t418r1388b453],
20	muscle	NN	O	muscle	nn	21	SENT_313	[p10l1532t418r1628b444],
21	toxicity	NN	O	toxicity	nsubj	15	SENT_313	[p10l1638t420r1742b453],

1	ABC	NNP	ORGANIZATION	ABC	dep	6	SENT_314	[p10l408t472r477b497],
2	G2	NN	O	g2	nn	3	SENT_314	[p10l478t472r517b497],
3	c.	NN	O	c.	dep	1	SENT_314	[p10l528t473r581b497],
4	42	CD	NUMBER	42	num	5	SENT_314	[p10l528t473r581b497],
5	lC	NN	O	lc	dep	6	SENT_314	[p10l589t472r676b497],
6	>	JJR	O	>	dep	13	SENT_314	[p10l589t472r676b497],
7	A	DT	O	a	det	11	SENT_314	[p10l589t472r676b497],
8	Healthy	JJ	O	healthy	amod	11	SENT_314	[p10l743t471r857b506],
9	subjects	NNS	O	subject	nn	11	SENT_314	[p10l866t471r974b505],
10	Candidate	NN	O	candidate	nn	11	SENT_314	[p10l1105t471r1248b497],
11	gene	NN	O	gene	dep	6	SENT_314	[p10l1258t481r1330b506],
12	;	:	O	;	_	0	SENT_314	[p10l1258t481r1330b506],
13	Increased	VBN	O	increase	_	0	SENT_314	[p10l1515t471r1648b497],
14	AUC	NN	O	auc	nn	17	SENT_314	[p10l1657t472r1732b497],
15	169	CD	NUMBER	169	num	17	SENT_314	[p10l1948t473r1994b497],
16	(	NN	O	(	nn	17	SENT_314	[p10l428t518r593b549],
17	rs2231142	NN	O	rs2231142	dobj	13	SENT_314	[p10l428t518r593b549],
18	)	CD	NUMBER	)	num	20	SENT_314	[p10l428t518r593b549],
19	(	NN	O	(	nn	20	SENT_314	[p10l761t518r786b549],
20	n	NN	O	n	nsubj	26	SENT_314	[p10l761t518r786b549],
21	=	JJ	O	=	amod	25	SENT_314	[p10l803t530r825b539],
22	32	CD	NUMBER	32	num	25	SENT_314	[p10l843t518r885b549],
23	)	CD	NUMBER	)	num	25	SENT_314	[p10l843t518r885b549],
24	Full	JJ	O	full	amod	25	SENT_314	[p10l1121t517r1177b543],
25	pharrnacokinetics	NNS	O	pharrnacokinetic	dep	20	SENT_314	[p10l1186t517r1431b551],
26	proﬁle	VBP	O	proﬁle	rcmod	17	SENT_314	[p10l1121t563r1212b597],

1	Rosuvastatin	NNP	O	Rosuvastatin	nn	2	SENT_315	[p10l196t616r372b641],
2	SLCOIB1	NNP	O	SLCOIB1	_	0	SENT_315	[p10l411t616r548b641],
3	Healthy	JJ	O	healthy	amod	6	SENT_315	[p10l743t615r857b650],
4	subjects	NNS	O	subject	nn	6	SENT_315	[p10l866t615r974b649],
5	Candidate	NN	O	candidate	nn	6	SENT_315	[p10l1105t615r1248b641],
6	gene	NN	O	gene	dep	2	SENT_315	[p10l1258t625r1330b650],
7	;	:	O	;	_	0	SENT_315	[p10l1258t625r1330b650],
8	Increased	VBN	O	increase	amod	9	SENT_315	[p10l1515t615r1648b641],
9	AUC	NN	O	auc	dep	2	SENT_315	[p10l1657t616r1732b641],
10	and	CC	O	and	_	0	SENT_315	[p10l1742t615r1792b641],
11	109	CD	NUMBER	109	conj_and	9	SENT_315	[p10l1879t617r1933b647],
12	,	,	O	,	_	0	SENT_315	[p10l1879t617r1933b647],
13	121	CD	NUMBER	121	appos	2	SENT_315	[p10l1948t617r2002b647],
14	,	,	O	,	_	0	SENT_315	[p10l1948t617r2002b647],
15	122	CD	NUMBER	122	appos	13	SENT_315	[p10l2017t617r2061b641],

1	c.	NN	O	c.	_	0	SENT_316	[p10l428t671r448b687],
2	5	CD	NUMBER	5	number	3	SENT_316	[p10l453t662r465b687],
3	2	CD	NUMBER	2	num	4	SENT_316	[p10l469t663r482b686],
4	1T	NN	O	1t	npadvmod	5	SENT_316	[p10l489t662r578b687],
5	>	JJR	O	>	amod	6	SENT_316	[p10l489t662r578b687],
6	C	NN	O	c	dep	1	SENT_316	[p10l489t662r578b687],
7	Full	JJ	O	full	amod	8	SENT_316	[p10l1121t661r1176b687],
8	pharmacokinetics	NNS	O	pharmacokinetic	dep	6	SENT_316	[p10l1186t661r1431b695],
9	Cmax	NN	O	cmax	nn	10	SENT_316	[p10l1533t662r1600b692],
10	proﬁle	NN	O	proﬁle	dep	1	SENT_316	[p10l1121t707r1212b741],

1	ABC	NNP	ORGANIZATION	ABC	nsubj	2	SENT_317	[p10l408t760r477b785],
2	G2	NN	O	g2	_	0	SENT_317	[p10l478t760r517b785],
3	c.	NN	O	c.	nsubj	11	SENT_317	[p10l528t761r581b785],
4	42	CD	NUMBER	42	num	5	SENT_317	[p10l528t761r581b785],
5	lC	NN	O	lc	npadvmod	6	SENT_317	[p10l589t760r676b785],
6	>	JJR	O	>	dep	11	SENT_317	[p10l589t760r676b785],
7	A	DT	O	a	det	11	SENT_317	[p10l589t760r676b785],
8	Healthy	JJ	O	healthy	amod	11	SENT_317	[p10l743t759r857b794],
9	subjects	NNS	O	subject	nn	11	SENT_317	[p10l866t759r974b793],
10	Candidate	NN	O	candidate	nn	11	SENT_317	[p10l1105t759r1248b785],
11	gene	NN	O	gene	xcomp	2	SENT_317	[p10l1258t769r1330b794],
12	;	:	O	;	_	0	SENT_317	[p10l1258t769r1330b794],
13	Increased	VBN	O	increase	amod	14	SENT_317	[p10l1515t759r1648b785],
14	AUC	NN	O	auc	dep	11	SENT_317	[p10l1657t760r1732b785],
15	and	CC	O	and	_	0	SENT_317	[p10l1742t759r1792b785],
16	169	CD	NUMBER	169	dep	11	SENT_317	[p10l1948t761r1994b785],

1	(	NN	O	(	nn	2	SENT_318	[p10l761t806r786b837],
2	n	NN	O	n	_	0	SENT_318	[p10l761t806r786b837],
3	=	JJ	O	=	amod	7	SENT_318	[p10l803t818r825b827],
4	32	CD	NUMBER	32	num	7	SENT_318	[p10l843t806r885b837],
5	)	CD	NUMBER	)	num	7	SENT_318	[p10l843t806r885b837],
6	Full	JJ	O	full	amod	7	SENT_318	[p10l1121t805r1176b831],
7	pharmacokinetics	NNS	O	pharmacokinetic	dep	2	SENT_318	[p10l1186t805r1431b839],
8	Cmax	NN	O	cmax	nn	9	SENT_318	[p10l1533t806r1600b836],
9	proﬁle	NN	O	proﬁle	dep	2	SENT_318	[p10l1121t851r1212b885],

1	Patients	NNS	O	patient	nsubj	2	SENT_319	[p10l743t905r855b929],
2	(	VBP	O	(	_	0	SENT_319	[p10l866t904r891b936],
3	n	NN	O	n	nsubj	4	SENT_319	[p10l866t904r891b936],
4	=	JJ	O	=	ccomp	2	SENT_319	[p10l908t916r931b925],
5	386	CD	NUMBER	386	number	6	SENT_319	[p10l948t904r1007b936],
6	)	CD	NUMBER	)	num	8	SENT_319	[p10l948t904r1007b936],
7	Candidate	NN	O	candidate	nn	8	SENT_319	[p10l1105t903r1248b929],
8	gene	NN	O	gene	dobj	4	SENT_319	[p10l1258t913r1323b938],
9	(	CD	NUMBER	(	number	10	SENT_319	[p10l1334t904r1373b936],
10	61	CD	NUMBER	61	dep	8	SENT_319	[p10l1334t904r1373b936],
11	Enhanced	VBN	O	enhance	partmod	10	SENT_319	[p10l1516t903r1655b929],
12	174	CD	NUMBER	174	dobj	11	SENT_319	[p10l1948t905r1995b930],

1	genes	NNS	O	gene	nsubj	2	SENT_320	[p10l1122t950r1208b983],
2	)	VBP	O	)	_	0	SENT_320	[p10l1122t950r1208b983],
3	LDL-C-lowering	JJ	O	ldl-c-lowering	amod	4	SENT_320	[p10l1532t949r1780b983],
4	response	NN	O	response	dobj	2	SENT_320	[p10l1532t1004r1653b1029],

1	Hypercholesterolemic	JJ	O	hypercholesterolemic	amod	3	SENT_321	[p10l743t1047r1055b1082],
2	Candidate	NN	O	candidate	nn	3	SENT_321	[p10l1105t1047r1248b1073],
3	gene	NN	O	gene	_	0	SENT_321	[p10l1258t1057r1323b1082],
4	Enhanced	VBN	MISC	enhance	partmod	3	SENT_321	[p10l1516t1047r1655b1073],
5	175	CD	NUMBER	175	num	6	SENT_321	[p10l1948t1049r1993b1074],
6	patients	NNS	O	patient	dep	12	SENT_321	[p10l760t1094r868b1127],
7	(	CD	NUMBER	(	num	8	SENT_321	[p10l879t1094r905b1125],
8	n	NN	O	n	dep	6	SENT_321	[p10l879t1094r905b1125],
9	=	JJ	O	=	dep	12	SENT_321	[p10l921t1106r944b1115],
10	305	CD	NUMBER	305	number	11	SENT_321	[p10l962t1094r1021b1125],
11	)	CD	NUMBER	)	num	12	SENT_321	[p10l962t1094r1021b1125],
12	LDL-C-lowering	NN	O	ldl-c-lowering	dep	3	SENT_321	[p10l1532t1093r1780b1127],
13	response	NN	O	response	dep	12	SENT_321	[p10l1532t1148r1653b1173],

1	Myocardial	JJ	O	myocardial	amod	8	SENT_322	[p10l742t1191r901b1226],
2	infarction	NN	O	infarction	nn	8	SENT_322	[p10l911t1192r1047b1217],
3	Candidate	NN	O	candidate	nn	8	SENT_322	[p10l1105t1192r1247b1217],
4	gene	NN	O	gene	nn	8	SENT_322	[p10l1258t1201r1322b1226],
5	(	NN	O	(	nn	8	SENT_322	[p10l1333t1192r1358b1224],
6	6	CD	NUMBER	6	num	8	SENT_322	[p10l1333t1192r1358b1224],
7	genes	NNS	O	gene	nn	8	SENT_322	[p10l1368t1192r1463b1226],
8	)	NN	O	)	_	0	SENT_322	[p10l1368t1192r1463b1226],
9	;	:	O	;	_	0	SENT_322	[p10l1368t1192r1463b1226],
10	Enhanced	VBN	O	enhance	dep	8	SENT_322	[p10l1516t1191r1655b1217],
11	176	CD	NUMBER	176	num	12	SENT_322	[p10l1948t1193r1994b1218],
12	patients	NNS	O	patient	nsubj	18	SENT_322	[p10l760t1238r868b1271],
13	(	CD	NUMBER	(	num	14	SENT_322	[p10l879t1238r905b1269],
14	n	NN	O	n	npadvmod	15	SENT_322	[p10l879t1238r905b1269],
15	=	JJ	O	=	amod	12	SENT_322	[p10l921t1250r944b1259],
16	601	CD	NUMBER	601	number	17	SENT_322	[p10l961t1238r1021b1269],
17	)	CD	NUMBER	)	num	18	SENT_322	[p10l961t1238r1021b1269],
18	Substudy	NN	O	substudy	xcomp	10	SENT_322	[p10l1106t1237r1234b1271],
19	of	IN	O	of	_	0	SENT_322	[p10l1243t1237r1273b1263],
20	RCT	NNP	O	RCT	nn	22	SENT_322	[p10l1280t1238r1353b1263],
21	LDL-C-lowering	NN	O	ldl-c-lowering	nn	22	SENT_322	[p10l1532t1237r1780b1271],
22	response	NN	O	response	prep_of	18	SENT_322	[p10l1532t1292r1653b1317],

1	Simvastatin	NNP	O	Simvastatin	nn	2	SENT_323	[p10l196t1335r356b1360],
2	SLCOIB1	NNP	O	SLCOIB1	nsubj	3	SENT_323	[p10l411t1335r548b1360],
3	Healthy	JJ	O	healthy	_	0	SENT_323	[p10l743t1334r857b1369],
4	subjects	NNS	O	subject	dobj	3	SENT_323	[p10l866t1334r974b1368],
5	Candidate	NN	O	candidate	nn	6	SENT_323	[p10l1105t1334r1248b1360],
6	gene	NN	O	gene	dep	4	SENT_323	[p10l1258t1344r1330b1369],
7	;	:	O	;	_	0	SENT_323	[p10l1258t1344r1330b1369],
8	Increased	VBN	O	increase	amod	9	SENT_323	[p10l1515t1334r1648b1360],
9	AUC	NN	O	auc	dep	4	SENT_323	[p10l1657t1335r1732b1360],
10	and	CC	O	and	_	0	SENT_323	[p10l1742t1334r1792b1360],
11	123	CD	NUMBER	123	conj_and	9	SENT_323	[p10l1948t1336r1992b1360],

1	c.	NN	O	c.	nn	2	SENT_324	[p10l428t1381r578b1406],
2	521T	NN	O	521t	dep	11	SENT_324	[p10l428t1381r578b1406],
3	>	JJR	O	>	amod	4	SENT_324	[p10l428t1381r578b1406],
4	C	NN	O	c	dep	2	SENT_324	[p10l428t1381r578b1406],
5	(	CD	NUMBER	(	num	6	SENT_324	[p10l761t1381r786b1412],
6	n	NN	O	n	dep	11	SENT_324	[p10l761t1381r786b1412],
7	=	JJ	O	=	amod	11	SENT_324	[p10l803t1393r825b1402],
8	32	CD	NUMBER	32	num	11	SENT_324	[p10l843t1381r885b1412],
9	)	CD	NUMBER	)	num	11	SENT_324	[p10l843t1381r885b1412],
10	Full	JJ	O	full	amod	11	SENT_324	[p10l1121t1380r1177b1406],
11	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_324	[p10l1186t1380r1431b1414],
12	Cmax	NN	O	cmax	nn	13	SENT_324	[p10l1533t1381r1600b1411],
13	proﬁle	NN	O	proﬁle	dep	11	SENT_324	[p10l1121t1426r1212b1460],

1	Patients	NNS	O	patient	nsubj	2	SENT_325	[p10l743t1480r855b1504],
2	(	VBP	O	(	_	0	SENT_325	[p10l866t1479r907b1510],
3	85	CD	NUMBER	85	num	4	SENT_325	[p10l866t1479r907b1510],
4	cases	NNS	O	case	nsubj	12	SENT_325	[p10l919t1488r994b1510],
5	,	,	O	,	_	0	SENT_325	[p10l919t1488r994b1510],
6	90	CD	NUMBER	90	num	10	SENT_325	[p10l1006t1480r1038b1504],
7	Genome	NNP	O	Genome	dep	9	SENT_325	[p10l1105t1478r1304b1504],
8	—	CD	NUMBER	—	num	7	SENT_325	[p10l1105t1478r1304b1504],
9	wide	JJ	O	wide	amod	10	SENT_325	[p10l1105t1478r1304b1504],
10	association	NN	O	association	appos	4	SENT_325	[p10l1314t1480r1465b1504],
11	Increased	VBN	O	increase	amod	12	SENT_325	[p10l1515t1478r1648b1504],
12	incidence	NN	O	incidence	xcomp	2	SENT_325	[p10l1658t1478r1790b1504],
13	124	CD	NUMBER	124	num	14	SENT_325	[p10l1948t1480r1995b1504],
14	controls	NNS	O	control	nsubj	25	SENT_325	[p10l760t1524r883b1556],
15	)	CD	NUMBER	)	num	16	SENT_325	[p10l760t1524r883b1556],
16	study	NN	O	study	dep	14	SENT_325	[p10l1121t1524r1202b1558],
17	;	:	O	;	_	0	SENT_325	[p10l1121t1524r1202b1558],
18	Substudy	NNP	O	Substudy	dep	14	SENT_325	[p10l1214t1524r1343b1558],
19	of	IN	O	of	_	0	SENT_325	[p10l1352t1524r1382b1550],
20	RCT	NNP	O	RCT	prep_of	18	SENT_325	[p10l1388t1525r1462b1550],
21	of	IN	O	of	_	0	SENT_325	[p10l1533t1524r1563b1550],
22	muscle	NN	O	muscle	nn	24	SENT_325	[p10l1569t1524r1665b1550],
23	toxicity	NN	O	toxicity	nn	24	SENT_325	[p10l1675t1525r1779b1558],
24	Patients	NNS	O	patient	prep_of	14	SENT_325	[p10l743t1578r855b1602],
25	(	VBP	O	(	rcmod	12	SENT_325	[p10l866t1578r907b1609],
26	25	CD	NUMBER	25	num	27	SENT_325	[p10l866t1578r907b1609],
27	cases	NNS	O	case	dobj	25	SENT_325	[p10l919t1587r994b1608],
28	,	,	O	,	_	0	SENT_325	[p10l919t1587r994b1608],
29	84	CD	NUMBER	84	num	31	SENT_325	[p10l1006t1578r1039b1603],
30	Candidate	NN	O	candidate	nn	31	SENT_325	[p10l1105t1577r1248b1602],
31	gene	NN	O	gene	appos	27	SENT_325	[p10l1258t1586r1330b1611],
32	;	:	O	;	_	0	SENT_325	[p10l1258t1586r1330b1611],
33	Increased	VBN	O	increase	amod	34	SENT_325	[p10l1515t1577r1648b1602],
34	incidence	NN	O	incidence	nsubj	46	SENT_325	[p10l1658t1577r1790b1602],
35	126	CD	NUMBER	126	num	36	SENT_325	[p10l1948t1578r1994b1602],
36	controls	NNS	O	control	nsubj	37	SENT_325	[p10l760t1622r883b1654],
37	)	VBD	O	)	rcmod	34	SENT_325	[p10l760t1622r883b1654],
38	Case	NNP	O	Case	nsubj	41	SENT_325	[p10l1122t1622r1302b1648],
39	—	CD	NUMBER	—	num	41	SENT_325	[p10l1122t1622r1302b1648],
40	control	JJ	O	control	amod	41	SENT_325	[p10l1122t1622r1302b1648],
41	study	NN	O	study	xcomp	37	SENT_325	[p10l1313t1622r1388b1657],
42	of	IN	O	of	_	0	SENT_325	[p10l1533t1622r1563b1648],
43	muscle	NN	O	muscle	nn	45	SENT_325	[p10l1569t1622r1665b1648],
44	toxicity	NN	O	toxicity	nn	45	SENT_325	[p10l1675t1624r1779b1657],
45	Patients	NNS	O	patient	prep_of	41	SENT_325	[p10l743t1676r855b1701],
46	(	VBP	O	(	parataxis	2	SENT_325	[p10l866t1676r891b1707],
47	n	NN	O	n	dobj	46	SENT_325	[p10l866t1676r891b1707],
48	=	JJ	O	=	amod	47	SENT_325	[p10l908t1688r931b1697],
49	509	CD	NUMBER	509	number	50	SENT_325	[p10l948t1676r1007b1707],
50	)	CD	NUMBER	)	num	52	SENT_325	[p10l948t1676r1007b1707],
51	Candidate	NN	O	candidate	nn	52	SENT_325	[p10l1105t1675r1248b1701],
52	gene	NN	O	gene	dep	47	SENT_325	[p10l1258t1685r1330b1709],
53	;	:	O	;	_	0	SENT_325	[p10l1258t1685r1330b1709],
54	Increased	VBN	O	increase	amod	55	SENT_325	[p10l1515t1675r1648b1701],
55	incidence	NN	O	incidence	dep	47	SENT_325	[p10l1658t1675r1790b1701],
56	127	CD	NUMBER	127	tmod	55	SENT_325	[p10l1948t1676r1993b1701],

1	Dose	NN	O	dose	nn	2	SENT_326	[p10l1121t1722r1193b1746],
2	escalation	NN	O	escalation	_	0	SENT_326	[p10l1203t1721r1340b1746],
3	of	IN	O	of	_	0	SENT_326	[p10l1533t1721r1563b1746],
4	muscle	NN	O	muscle	nn	5	SENT_326	[p10l1569t1721r1665b1746],
5	toxicity	NN	O	toxicity	prep_of	2	SENT_326	[p10l1675t1722r1779b1755],

1	Diabetic	NNP	O	Diabetic	nn	2	SENT_327	[p10l744t1773r862b1799],
2	patients	NNS	O	patient	_	0	SENT_327	[p10l872t1775r980b1807],
3	Candidate	NN	O	candidate	nn	4	SENT_327	[p10l1105t1773r1247b1799],
4	gene	NN	O	gene	nsubj	12	SENT_327	[p10l1258t1783r1330b1808],
5	;	:	O	;	_	0	SENT_327	[p10l1258t1783r1330b1808],
6	Increased	VBN	O	increase	amod	7	SENT_327	[p10l1515t1773r1648b1799],
7	incidence	NN	O	incidence	dep	4	SENT_327	[p10l1658t1773r1790b1799],
8	12	CD	NUMBER	12	number	9	SENT_327	[p10l1948t1775r1975b1799],
9	8	CD	NUMBER	8	amod	7	SENT_327	[p10l1980t1775r1994b1799],
10	(	NN	O	(	nn	11	SENT_327	[p10l744t1820r769b1851],
11	n	NN	O	n	dep	4	SENT_327	[p10l744t1820r769b1851],
12	=	JJ	O	=	rcmod	2	SENT_327	[p10l786t1832r809b1841],
13	4,196	CD	NUMBER	4,196	num	14	SENT_327	[p10l825t1820r911b1851],
14	)	CD	NUMBER	)	iobj	12	SENT_327	[p10l825t1820r911b1851],
15	Population	NNP	O	Population	nn	17	SENT_327	[p10l1121t1819r1275b1853],
16	cohort	NN	O	cohort	nn	17	SENT_327	[p10l1285t1819r1377b1845],
17	study	NN	O	study	dobj	12	SENT_327	[p10l1387t1819r1462b1853],
18	of	IN	O	of	_	0	SENT_327	[p10l1533t1819r1563b1845],
19	statin	NN	O	statin	nn	20	SENT_327	[p10l1569t1821r1645b1845],
20	intolerance	NN	O	intolerance	prep_of	2	SENT_327	[p10l1532t1865r1688b1891],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_328	[p10l194t1955r370b1978],
2	:	:	O	:	_	0	SENT_328	[p10l194t1955r370b1978],
3	AUC	NN	O	auc	dep	1	SENT_328	[p10l378t1956r450b1983],
4	,	,	O	,	_	0	SENT_328	[p10l378t1956r450b1983],
5	area	NN	O	area	appos	1	SENT_328	[p10l459t1964r508b1978],
6	under	IN	O	under	_	0	SENT_328	[p10l516t1955r588b1978],
7	the	DT	O	the	det	8	SENT_328	[p10l595t1955r633b1978],
8	curve	NN	O	curve	prep_under	5	SENT_328	[p10l641t1964r713b1983],
9	;	:	O	;	_	0	SENT_328	[p10l641t1964r713b1983],
10	Cm	NN	O	cm	nn	11	SENT_328	[p10l722t1956r786b1983],
11	”	NN	O	”	dep	1	SENT_328	[p10l722t1956r786b1983],
12	,	,	O	,	_	0	SENT_328	[p10l722t1956r786b1983],
13	maximum	NN	O	maximum	nn	14	SENT_328	[p10l795t1956r916b1978],
14	concentration	NN	O	concentration	appos	11	SENT_328	[p10l924t1956r1100b1983],
15	;	:	O	;	_	0	SENT_328	[p10l924t1956r1100b1983],
16	LDL-C	NN	O	ldl-c	dep	1	SENT_328	[p10l1109t1956r1211b1983],
17	,	,	O	,	_	0	SENT_328	[p10l1109t1956r1211b1983],
18	low-density	JJ	O	low-density	amod	20	SENT_328	[p10l1220t1955r1363b1985],
19	lipoprotein	NN	O	lipoprotein	nn	20	SENT_328	[p10l1369t1955r1506b1985],
20	cholesterol	NN	O	cholesterol	appos	16	SENT_328	[p10l1514t1955r1654b1983],
21	;	:	O	;	_	0	SENT_328	[p10l1514t1955r1654b1983],
22	RCT	NNP	O	RCT	dep	1	SENT_328	[p10l1663t1956r1733b1983],
23	,	,	O	,	_	0	SENT_328	[p10l1663t1956r1733b1983],
24	randomized	VBN	O	randomize	partmod	22	SENT_328	[p10l1741t1955r1886b1978],
25	controlled	JJ	O	controlled	amod	26	SENT_328	[p10l1894t1955r2019b1978],
26	trial	NN	O	trial	dobj	24	SENT_328	[p10l2027t1955r2082b1978],
27	.	.	O	.	_	0	SENT_328	[p10l2027t1955r2082b1978],

1	cellular	JJ	O	cellular	amod	2	SENT_329	[p10l567t2060r682b2089],
2	accumulation	NN	O	accumulation	_	0	SENT_329	[p10l689t2060r899b2089],
3	of	IN	O	of	_	0	SENT_329	[p10l907t2060r941b2089],
4	their	PRP$	O	they	poss	5	SENT_329	[p10l944t2060r1018b2089],
5	substrates	NNS	O	substrate	prep_of	2	SENT_329	[p10l1025t2060r1186b2089],
6	.	.	O	.	_	0	SENT_329	[p10l1025t2060r1186b2089],

1	Members	NNS	O	member	nsubjpass	7	SENT_330	[p10l1194t2060r1343b2089],
2	of	IN	O	of	_	0	SENT_330	[p10l1351t2060r1386b2089],
3	this	DT	O	this	det	5	SENT_330	[p10l1389t2060r1444b2089],
4	large	JJ	O	large	amod	5	SENT_330	[p10l1451t2060r1528b2099],
5	family	NN	O	family	prep_of	1	SENT_330	[p10l1536t2060r1634b2099],
6	are	VBP	O	be	auxpass	7	SENT_330	[p10l1640t2071r1686b2089],
7	identiﬁed	VBN	O	identiﬁed	_	0	SENT_330	[p10l1693t2060r1842b2089],
8	by	IN	O	by	_	0	SENT_330	[p10l1849t2060r1888b2099],
9	the	DT	O	the	det	10	SENT_330	[p10l1893t2060r1942b2089],
10	presence	NN	O	presence	agent	7	SENT_330	[p10l1949t2071r2085b2099],
11	of	IN	O	of	prep	10	SENT_330	[p10l567t2107r602b2136],
12	a	DT	O	a	det	13	SENT_330	[p10l609t2118r623b2136],
13	highly	RB	O	highly	pobj	11	SENT_330	[p10l634t2107r735b2146],
14	conserved	VBN	O	conserve	partmod	13	SENT_330	[p10l744t2107r900b2136],
15	ATP-binding	JJ	O	atp-binding	amod	19	SENT_330	[p10l910t2107r1125b2146],
16	motif	NN	O	motif	nn	19	SENT_330	[p10l1135t2107r1224b2136],
17	(	NN	O	(	nn	19	SENT_330	[p10l1231t2108r1280b2144],
18	3	CD	NUMBER	3	num	19	SENT_330	[p10l1231t2108r1280b2144],
19	)	NN	O	)	dobj	14	SENT_330	[p10l1231t2108r1280b2144],
20	.	.	O	.	_	0	SENT_330	[p10l1231t2108r1280b2144],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	2	SENT_331	[p10l566t2152r851b2195],
2	P-glycoprotein	NN	O	p-glycoprotein	nsubj	9	SENT_331	[p10l567t2202r804b2241],
3	(	CD	NUMBER	(	num	5	SENT_331	[p10l812t2203r1075b2239],
4	MDR1/ABCB1	NN	O	mdr1/abcb1	nn	5	SENT_331	[p10l812t2203r1075b2239],
5	)	NN	O	)	dep	2	SENT_331	[p10l812t2203r1075b2239],
6	is	VBZ	O	be	cop	9	SENT_331	[p10l1083t2204r1106b2231],
7	an	DT	O	a	det	9	SENT_331	[p10l1114t2213r1150b2231],
8	ABC	NNP	ORGANIZATION	ABC	nn	9	SENT_331	[p10l1156t2203r1233b2231],
9	transporter	NN	O	transporter	_	0	SENT_331	[p10l1241t2210r1417b2241],
10	with	IN	O	with	_	0	SENT_331	[p10l1423t2202r1493b2231],
11	an	DT	O	a	det	13	SENT_331	[p10l1501t2213r1537b2231],
12	important	JJ	O	important	amod	13	SENT_331	[p10l1544t2204r1702b2241],
13	role	NN	O	role	prep_with	9	SENT_331	[p10l1709t2202r1770b2231],
14	in	IN	O	in	_	0	SENT_331	[p10l1777t2204r1807b2231],
15	protecting	VBG	O	protect	prepc_in	13	SENT_331	[p10l1815t2204r1978b2241],
16	tissues	NNS	O	tissue	dobj	15	SENT_331	[p10l1985t2204r2085b2231],
17	from	IN	O	from	_	0	SENT_331	[p10l567t2250r643b2279],
18	xenobiotics	NNS	O	xenobiotic	prep_from	15	SENT_331	[p10l654t2250r840b2279],
19	.	.	O	.	_	0	SENT_331	[p10l654t2250r840b2279],

1	The	DT	O	the	det	2	SENT_332	[p10l853t2250r920b2279],
2	protein	NN	O	protein	nsubjpass	5	SENT_332	[p10l932t2251r1047b2289],
3	was	VBD	O	be	auxpass	5	SENT_332	[p10l1058t2261r1114b2279],
4	originally	RB	O	originally	advmod	5	SENT_332	[p10l1127t2250r1277b2289],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_332	[p10l1288t2250r1437b2279],
6	in	IN	O	in	_	0	SENT_332	[p10l1449t2251r1479b2279],
7	cells	NNS	O	cell	prep_in	5	SENT_332	[p10l1491t2250r1558b2279],
8	selected	VBN	O	select	partmod	7	SENT_332	[p10l1571t2250r1694b2279],
9	for	IN	O	for	_	0	SENT_332	[p10l1707t2250r1752b2279],
10	multidrug	JJ	O	multidrug	amod	11	SENT_332	[p10l1764t2250r1922b2289],
11	resistance	NN	O	resistance	prep_for	8	SENT_332	[p10l1933t2251r2085b2279],

1	DEGWTET	NNP	O	DEGWTET	_	0	SENT_333	[p10l567t2352r678b2374],
2	et	FW	O	et	nn	3	SENT_333	[p10l685t2357r705b2374],
3	al.	FW	O	al.	dep	1	SENT_333	[p10l711t2352r737b2374],
4	.	.	O	.	_	0	SENT_333	[p10l711t2352r737b2374],

1	ww	NN	O	ww	_	0	SENT_334	[p10l189t3354r204b3400],
2	.	.	O	.	_	0	SENT_334	[p10l188t3294r204b3339],

1	an1	NN	O	an1	_	0	SENT_335	[p10l188t3294r204b3339],
2	1ual	JJ	O	1ual	amod	4	SENT_335	[p10l181t3236r204b3283],
3	revi	NN	O	revus	nn	4	SENT_335	[p10l181t3171r204b3224],
4	ews	NNS	O	ew	dep	1	SENT_335	[p10l188t3108r204b3157],
5	.	.	O	.	_	0	SENT_335	[p10l188t3044r211b3091],

1	org	NN	O	org	_	0	SENT_336	[p10l188t3044r211b3091],
2	;	:	O	;	_	0	SENT_336	[p10l189t3030r209b3032],
3	nal	JJ	O	nal	amod	6	SENT_336	[p10l214t3364r238b3403],
4	use	NN	O	use	nn	6	SENT_336	[p10l222t3300r238b3342],
5	onl	NN	O	onl	nn	6	SENT_336	[p10l214t3238r238b3279],
6	y.	NN	O	y.	dep	1	SENT_336	[p10l222t3203r245b3224],

1	(	NN	O	(	nn	19	SENT_337	[p10l367t2457r446b2492],
2	130	CD	NUMBER	130	num	3	SENT_337	[p10l367t2457r446b2492],
3	)	NN	O	)	nn	19	SENT_337	[p10l367t2457r446b2492],
4	and	CC	O	and	_	0	SENT_337	[p10l456t2456r511b2484],
5	has	VBZ	O	have	aux	8	SENT_337	[p10l519t2456r568b2484],
6	subsequently	RB	O	subsequently	advmod	8	SENT_337	[p10l577t2456r781b2494],
7	been	VBN	O	be	auxpass	8	SENT_337	[p10l788t2456r862b2484],
8	studied	VBN	O	study	conj_and	3	SENT_337	[p10l870t2456r982b2484],
9	extensively	RB	O	extensively	advmod	8	SENT_337	[p10l991t2456r1162b2494],
10	in	IN	O	in	_	0	SENT_337	[p10l1169t2457r1199b2484],
11	the	DT	O	the	det	12	SENT_337	[p10l1207t2456r1256b2484],
12	context	NN	O	context	prep_in	8	SENT_337	[p10l1265t2464r1380b2484],
13	of	IN	O	of	_	0	SENT_337	[p10l1387t2456r1422b2484],
14	normal	JJ	O	normal	amod	15	SENT_337	[p10l1425t2456r1537b2484],
15	physiology	NN	O	physiology	prep_of	12	SENT_337	[p10l1545t2456r1717b2494],
16	and	CC	O	and	_	0	SENT_337	[p10l1724t2456r1779b2484],
17	tumor	NN	O	tumor	nn	18	SENT_337	[p10l1788t2464r1885b2484],
18	biology	NN	O	biology	prep_of	12	SENT_337	[p10l367t2505r485b2543],
19	(	NN	O	(	_	0	SENT_337	[p10l498t2506r586b2541],
20	131	CD	NUMBER	131	num	21	SENT_337	[p10l498t2506r586b2541],
21	)	NN	O	)	dep	19	SENT_337	[p10l498t2506r586b2541],
22	.	.	O	.	_	0	SENT_337	[p10l498t2506r586b2541],

1	Of	IN	O	of	_	0	SENT_338	[p10l602t2505r647b2534],
2	particular	JJ	O	particular	amod	3	SENT_338	[p10l656t2505r807b2543],
3	importance	NN	O	importance	prep_of	9	SENT_338	[p10l820t2507r999b2543],
4	in	IN	O	in	_	0	SENT_338	[p10l1012t2507r1043b2533],
5	drug	NN	O	drug	nn	6	SENT_338	[p10l1057t2505r1130b2543],
6	disposition	NN	O	disposition	prep_in	3	SENT_338	[p10l1143t2505r1314b2543],
7	is	VBZ	O	be	cop	9	SENT_338	[p10l1327t2507r1350b2534],
8	the	DT	O	the	det	9	SENT_338	[p10l1364t2505r1412b2534],
9	expression	NN	O	expression	_	0	SENT_338	[p10l1427t2507r1590b2543],
10	of	IN	O	of	_	0	SENT_338	[p10l1604t2505r1638b2534],
11	P-glycoprotein	NN	O	p-glycoprotein	prep_of	9	SENT_338	[p10l1647t2505r1884b2543],
12	in	IN	O	in	_	0	SENT_338	[p10l366t2556r397b2582],
13	the	DT	O	the	det	15	SENT_338	[p10l413t2554r462b2583],
14	apical	JJ	O	apical	amod	15	SENT_338	[p10l479t2554r568b2592],
15	membrane	NN	O	membrane	prep_in	11	SENT_338	[p10l584t2554r751b2583],
16	of	IN	O	of	_	0	SENT_338	[p10l768t2554r803b2583],
17	enterocytes	NNS	O	enterocyte	prep_of	15	SENT_338	[p10l815t2562r1002b2592],
18	,	,	O	,	_	0	SENT_338	[p10l815t2562r1002b2592],
19	hepatocytes	NNS	O	hepatocyte	conj_and	17	SENT_338	[p10l1020t2554r1212b2592],
20	,	,	O	,	_	0	SENT_338	[p10l1020t2554r1212b2592],
21	and	CC	O	and	_	0	SENT_338	[p10l1230t2554r1286b2583],
22	kidney	NN	O	kidney	nn	24	SENT_338	[p10l1302t2554r1408b2592],
23	proximal	JJ	O	proximal	amod	24	SENT_338	[p10l1423t2554r1561b2592],
24	tubules	NNS	O	tubule	conj_and	17	SENT_338	[p10l1578t2554r1698b2589],
25	,	,	O	,	_	0	SENT_338	[p10l1578t2554r1698b2589],
26	and	CC	O	and	_	0	SENT_338	[p10l1717t2554r1772b2583],
27	in	IN	O	in	_	0	SENT_338	[p10l1788t2556r1819b2582],
28	the	DT	O	the	det	30	SENT_338	[p10l1835t2554r1884b2583],
29	endothelial	JJ	O	endothelial	amod	30	SENT_338	[p10l367t2602r542b2631],
30	cells	NNS	O	cell	prep_in	11	SENT_338	[p10l553t2602r619b2631],
31	of	IN	O	of	_	0	SENT_338	[p10l631t2602r666b2631],
32	the	DT	O	the	det	35	SENT_338	[p10l672t2602r721b2631],
33	blood-brain	JJ	O	blood-brain	amod	35	SENT_338	[p10l732t2602r919b2631],
34	barrier	NN	O	barrier	nn	35	SENT_338	[p10l929t2602r1037b2631],
35	(	NN	O	(	prep_of	30	SENT_338	[p10l1048t2603r1135b2638],
36	131	CD	NUMBER	131	num	37	SENT_338	[p10l1048t2603r1135b2638],
37	)	NN	O	)	nsubj	9	SENT_338	[p10l1048t2603r1135b2638],
38	.	.	O	.	_	0	SENT_338	[p10l1048t2603r1135b2638],

1	As	IN	O	as	mark	4	SENT_339	[p10l415t2652r453b2680],
2	it	PRP	O	it	nsubj	4	SENT_339	[p10l467t2653r490b2680],
3	became	VBD	O	become	cop	4	SENT_339	[p10l503t2651r620b2680],
4	apparent	JJ	O	apparent	advcl	28	SENT_339	[p10l635t2659r772b2689],
5	that	IN	O	that	complm	11	SENT_339	[p10l785t2651r847b2680],
6	P-glycoprotein	NN	MISC	p-glycoprotein	nsubj	11	SENT_339	[p10l860t2651r1096b2689],
7	was	VBD	O	be	cop	11	SENT_339	[p10l1109t2662r1165b2680],
8	not	RB	O	not	neg	11	SENT_339	[p10l1179t2659r1232b2680],
9	the	DT	O	the	det	11	SENT_339	[p10l1245t2651r1294b2680],
10	only	JJ	O	only	amod	11	SENT_339	[p10l1308t2651r1377b2689],
11	molecule	NN	O	molecule	ccomp	4	SENT_339	[p10l1389t2651r1531b2680],
12	capable	JJ	O	capable	amod	11	SENT_339	[p10l1546t2651r1661b2689],
13	of	IN	O	of	_	0	SENT_339	[p10l1676t2651r1710b2680],
14	conferring	VBG	O	confer	prepc_of	12	SENT_339	[p10l1720t2651r1885b2689],
15	a	DT	O	a	det	17	SENT_339	[p10l367t2711r382b2728],
16	multidrug-resistant	JJ	O	multidrug-resistant	amod	17	SENT_339	[p10l396t2700r701b2738],
17	phenotype	NN	O	phenotype	dobj	14	SENT_339	[p10l715t2700r888b2738],
18	,	,	O	,	_	0	SENT_339	[p10l715t2700r888b2738],
19	two	CD	NUMBER	two	num	22	SENT_339	[p10l904t2708r961b2728],
20	other	JJ	O	other	amod	22	SENT_339	[p10l977t2700r1061b2728],
21	ABC	NNP	ORGANIZATION	ABC	nn	22	SENT_339	[p10l1073t2701r1150b2728],
22	transporters	NNS	O	transporter	nsubjpass	28	SENT_339	[p10l1165t2708r1354b2738],
23	involved	VBN	O	involve	partmod	22	SENT_339	[p10l1369t2700r1501b2728],
24	in	IN	O	in	_	0	SENT_339	[p10l1516t2701r1546b2728],
25	multidrug	JJ	O	multidrug	amod	26	SENT_339	[p10l1560t2700r1718b2738],
26	resistance	NN	O	resistance	prep_in	23	SENT_339	[p10l1732t2701r1884b2728],
27	were	VBD	O	be	auxpass	28	SENT_339	[p10l365t2759r440b2777],
28	cloned	VBN	O	clone	_	0	SENT_339	[p10l454t2748r565b2777],
29	:	:	O	:	_	0	SENT_339	[p10l454t2748r565b2777],
30	multidrug	JJ	O	multidrug	amod	32	SENT_339	[p10l579t2748r738b2787],
31	resistance	NN	O	resistance	nn	32	SENT_339	[p10l749t2748r1073b2777],
32	—	NN	O	—	dobj	28	SENT_339	[p10l749t2748r1073b2777],
33	associated	VBN	O	associate	partmod	32	SENT_339	[p10l749t2748r1073b2777],
34	protein	NN	O	protein	dobj	33	SENT_339	[p10l1086t2750r1200b2786],
35	1	CD	NUMBER	1	number	36	SENT_339	[p10l1217t2750r1227b2777],
36	(	CD	NUMBER	(	num	37	SENT_339	[p10l1245t2749r1502b2784],
37	MRP1/ABCCI	NN	O	mrp1/abcci	dep	34	SENT_339	[p10l1245t2749r1502b2784],
38	)	CD	NUMBER	)	num	39	SENT_339	[p10l1245t2749r1502b2784],
39	(	NN	O	(	dep	48	SENT_339	[p10l1516t2749r1595b2784],
40	132	CD	NUMBER	132	num	41	SENT_339	[p10l1516t2749r1595b2784],
41	)	NN	O	)	dep	39	SENT_339	[p10l1516t2749r1595b2784],
42	and	CC	O	and	_	0	SENT_339	[p10l1609t2748r1664b2777],
43	breast	NN	O	breast	nn	45	SENT_339	[p10l1677t2748r1772b2777],
44	cancer	NN	O	cancer	nn	45	SENT_339	[p10l1784t2759r1885b2777],
45	resistance	NN	O	resistance	dep	39	SENT_339	[p10l366t2799r518b2826],
46	protein	NN	O	protein	dep	48	SENT_339	[p10l530t2799r645b2835],
47	(	CD	NUMBER	(	num	46	SENT_339	[p10l657t2798r915b2833],
48	BCRP/ABCG2	NN	O	bcrp/abcg2	dep	34	SENT_339	[p10l657t2798r915b2833],
49	)	CD	NUMBER	)	number	50	SENT_339	[p10l657t2798r915b2833],
50	(	CD	NUMBER	(	dep	48	SENT_339	[p10l928t2798r1092b2833],
51	133-135	CD	NUMBER	133-135	num	52	SENT_339	[p10l928t2798r1092b2833],
52	)	NN	O	)	dep	50	SENT_339	[p10l928t2798r1092b2833],
53	.	.	O	.	_	0	SENT_339	[p10l928t2798r1092b2833],

1	Expression	NN	O	expression	nsubjpass	15	SENT_340	[p10l1105t2798r1277b2835],
2	of	IN	O	of	_	0	SENT_340	[p10l1289t2797r1323b2826],
3	these	DT	O	these	det	4	SENT_340	[p10l1331t2797r1410b2826],
4	transporters	NNS	O	transporter	prep_of	1	SENT_340	[p10l1422t2805r1620b2835],
5	,	,	O	,	_	0	SENT_340	[p10l1422t2805r1620b2835],
6	along	IN	O	along	_	0	SENT_340	[p10l1633t2797r1720b2835],
7	with	IN	O	with	_	0	SENT_340	[p10l1729t2797r1799b2826],
8	their	PRP$	O	they	poss	11	SENT_340	[p10l1810t2797r1885b2826],
9	functional	JJ	O	functional	amod	11	SENT_340	[p10l367t2846r525b2874],
10	genetic	JJ	O	genetic	amod	11	SENT_340	[p10l539t2847r651b2884],
11	polymorphisms	NNS	O	polymorphism	prep_along_with	15	SENT_340	[p10l665t2846r916b2884],
12	,	,	O	,	_	0	SENT_340	[p10l665t2846r916b2884],
13	has	VBZ	O	have	aux	15	SENT_340	[p10l930t2846r980b2874],
14	been	VBN	O	be	auxpass	15	SENT_340	[p10l994t2846r1068b2874],
15	implicated	VBN	O	implicate	_	0	SENT_340	[p10l1081t2846r1245b2884],
16	in	IN	O	in	_	0	SENT_340	[p10l1258t2847r1288b2874],
17	drug	NN	O	drug	nn	18	SENT_340	[p10l1302t2846r1375b2884],
18	response	NN	O	response	prep_in	15	SENT_340	[p10l1387t2857r1524b2884],
19	and	CC	O	and	_	0	SENT_340	[p10l1538t2846r1593b2874],
20	prognosis	NN	O	prognosis	conj_and	18	SENT_340	[p10l1607t2847r1758b2884],
21	for	IN	O	for	_	0	SENT_340	[p10l1772t2846r1817b2874],
22	numerous	JJ	O	numerous	amod	24	SENT_340	[p10l1829t2857r1883b2874, p10l366t2905r482b2923],
23	tumor	NN	O	tumor	nn	24	SENT_340	[p10l496t2902r593b2923],
24	types	NNS	O	type	prep_for	15	SENT_340	[p10l607t2902r686b2932],
25	and	CC	O	and	_	0	SENT_340	[p10l701t2894r757b2923],
26	chemotherapeutic	JJ	O	chemotherapeutic	amod	27	SENT_340	[p10l771t2894r1054b2932],
27	agents	NNS	O	agent	prep_for	15	SENT_340	[p10l1068t2902r1174b2932],
28	.	.	O	.	_	0	SENT_340	[p10l1068t2902r1174b2932],

1	Many	JJ	O	many	amod	3	SENT_341	[p10l1188t2896r1281b2932],
2	detailed	JJ	O	detailed	amod	3	SENT_341	[p10l1295t2894r1417b2923],
3	reviews	NNS	O	review	nsubjpass	12	SENT_341	[p10l1431t2896r1546b2923],
4	of	IN	O	of	_	0	SENT_341	[p10l1561t2894r1595b2923],
5	ABC	NNP	ORGANIZATION	ABC	nn	6	SENT_341	[p10l1603t2895r1680b2923],
6	transporters	NNS	O	transporter	prep_of	3	SENT_341	[p10l1695t2902r1884b2932],
7	and	CC	O	and	_	0	SENT_341	[p10l367t2943r422b2972],
8	anticancer	JJ	O	anticancer	amod	9	SENT_341	[p10l434t2945r595b2972],
9	therapy	NN	O	therapy	prep_of	3	SENT_341	[p10l606t2943r726b2981],
10	have	VBP	O	have	aux	12	SENT_341	[p10l735t2943r805b2972],
11	been	VBN	O	be	auxpass	12	SENT_341	[p10l817t2943r891b2972],
12	published	VBN	O	publish	_	0	SENT_341	[p10l902t2943r1053b2981],
13	(	NN	O	(	dobj	12	SENT_341	[p10l1065t2944r1141b2979],
14	136	CD	NUMBER	136	num	13	SENT_341	[p10l1065t2944r1141b2979],
15	,	,	O	,	_	0	SENT_341	[p10l1065t2944r1141b2979],
16	137	CD	NUMBER	137	num	17	SENT_341	[p10l1157t2944r1230b2979],
17	)	NN	O	)	appos	13	SENT_341	[p10l1157t2944r1230b2979],
18	.	.	O	.	_	0	SENT_341	[p10l1157t2944r1230b2979],

1	P-glycoprotein	NN	O	p-glycoprotein	nsubj	2	SENT_342	[p10l416t2992r653b3030],
2	has	VBZ	O	have	_	0	SENT_342	[p10l666t2992r716b3021],
3	broad	JJ	O	broad	amod	5	SENT_342	[p10l729t2992r819b3021],
4	substrate	NN	O	substrate	nn	5	SENT_342	[p10l833t2992r972b3021],
5	speciﬁcity	NN	O	speciﬁcity	dobj	2	SENT_342	[p10l986t2992r1143b3030],
6	for	IN	O	for	_	0	SENT_342	[p10l1155t2992r1200b3021],
7	structurally	RB	O	structurally	advmod	8	SENT_342	[p10l1213t2992r1393b3030],
8	divergent	JJ	O	divergent	amod	9	SENT_342	[p10l1405t2992r1554b3030],
9	compounds	NNS	O	compound	prep_for	5	SENT_342	[p10l1567t2992r1756b3030],
10	;	:	O	;	_	0	SENT_342	[p10l1567t2992r1756b3030],
11	in	IN	O	in	_	0	SENT_342	[p10l1770t2994r1800b3020],
12	general	JJ	O	general	prep_in	5	SENT_342	[p10l1814t3003r1883b3030, p10l367t3054r432b3089],
13	,	,	O	,	_	0	SENT_342	[p10l1814t3003r1883b3030, p10l367t3054r432b3089],

1	its	PRP$	O	its	poss	2	SENT_343	[p10l449t3055r484b3083],
2	substrates	NNS	O	substrate	nsubj	8	SENT_343	[p10l500t3054r653b3083],
3	are	VBP	O	be	cop	4	SENT_343	[p10l669t3065r715b3083],
4	hydrophobic	JJ	O	hydrophobic	_	0	SENT_343	[p10l731t3053r931b3092],
5	and	CC	O	and	_	0	SENT_343	[p10l947t3053r1002b3083],
6	may	MD	O	may	aux	8	SENT_343	[p10l1017t3064r1084b3092],
7	be	VB	O	be	cop	8	SENT_343	[p10l1097t3054r1133b3083],
8	cationic	JJ	O	cationic	conj_and	4	SENT_343	[p10l1149t3055r1279b3083],
9	.	.	O	.	_	0	SENT_343	[p10l1149t3055r1279b3083],

1	Substrates	NNS	O	substrate	nsubj	4	SENT_344	[p10l1298t3053r1456b3083],
2	of	IN	O	of	_	0	SENT_344	[p10l1473t3054r1507b3083],
3	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_344	[p10l1518t3054r1755b3092],
4	include	VBP	O	include	_	0	SENT_344	[p10l1769t3053r1884b3083],

1	HIV	NN	MISC	hiv	nn	3	SENT_345	[p10l366t3118r442b3145],
2	protease	NN	O	protease	nn	3	SENT_345	[p10l454t3124r584b3154],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_345	[p10l599t3116r760b3151],
4	,	,	O	,	_	0	SENT_345	[p10l599t3116r760b3151],
5	calcium	NN	O	calcium	dep	3	SENT_345	[p10l776t3116r896b3145],
6	channel	NN	O	channel	nn	7	SENT_345	[p10l911t3116r1032b3145],
7	blockers	NNS	O	blocker	dep	5	SENT_345	[p10l1047t3116r1185b3151],
8	,	,	O	,	_	0	SENT_345	[p10l1047t3116r1185b3151],
9	and	CC	O	and	_	0	SENT_345	[p10l1202t3116r1257b3145],
10	anticancer	JJ	O	anticancer	amod	11	SENT_345	[p10l1273t3118r1434b3145],
11	drugs	NNS	O	drug	conj_and	5	SENT_345	[p10l1449t3116r1534b3154],
12	of	IN	O	of	_	0	SENT_345	[p10l1549t3116r1584b3145],
13	the	DT	O	the	det	15	SENT_345	[p10l1594t3116r1643b3145],
14	vinca	NN	O	vinca	nn	15	SENT_345	[p10l1656t3118r1738b3145],
15	alkaloid	NN	O	alkaloid	prep_of	11	SENT_345	[p10l1753t3116r1883b3151],
16	,	,	O	,	_	0	SENT_345	[p10l1753t3116r1883b3151],

1	anthracycline	NN	O	anthracycline	_	0	SENT_346	[p10l367t3178r585b3216],
2	,	,	O	,	_	0	SENT_346	[p10l367t3178r585b3216],
3	and	CC	O	and	_	0	SENT_346	[p10l598t3178r653b3207],
4	taxane	NN	O	taxane	nn	5	SENT_346	[p10l665t3186r763b3207],
5	classes	NNS	O	class	conj_and	1	SENT_346	[p10l775t3178r883b3207],
6	.	.	O	.	_	0	SENT_346	[p10l775t3178r883b3207],

1	P-glycoprotein	NN	O	p-glycoprotein	nsubjpass	3	SENT_347	[p10l896t3178r1133b3216],
2	is	VBZ	O	be	auxpass	3	SENT_347	[p10l1143t3180r1166b3207],
3	inhibited	VBN	O	inhibit	_	0	SENT_347	[p10l1177t3178r1318b3207],
4	by	IN	O	by	_	0	SENT_347	[p10l1330t3178r1368b3216],
5	numerous	JJ	O	numerous	amod	6	SENT_347	[p10l1377t3189r1533b3207],
6	compounds	NNS	O	compound	agent	3	SENT_347	[p10l1545t3178r1725b3216],
7	including	VBG	O	include	_	0	SENT_347	[p10l1736t3178r1885b3216],
8	verapamil	NN	O	verapamil	prep_including	6	SENT_347	[p10l365t3240r528b3278],
9	,	,	O	,	_	0	SENT_347	[p10l365t3240r528b3278],
10	ritonavir	NN	O	ritonavir	conj_and	8	SENT_347	[p10l540t3241r685b3275],
11	,	,	O	,	_	0	SENT_347	[p10l540t3241r685b3275],
12	and	CC	O	and	_	0	SENT_347	[p10l698t3240r754b3269],
13	cyclosporine	NN	O	cyclosporine	nn	14	SENT_347	[p10l766t3239r962b3278],
14	(	NN	O	(	prep_including	6	SENT_347	[p10l975t3241r1063b3276],
15	131	CD	NUMBER	131	num	16	SENT_347	[p10l975t3241r1063b3276],
16	)	NN	O	)	dep	14	SENT_347	[p10l975t3241r1063b3276],
17	.	.	O	.	_	0	SENT_347	[p10l975t3241r1063b3276],

1	A	DT	O	a	det	3	SENT_348	[p10l1075t3241r1101b3268],
2	great	JJ	O	great	amod	3	SENT_348	[p10l1112t3248r1191b3278],
3	deal	NN	O	deal	nsubjpass	8	SENT_348	[p10l1202t3240r1265b3269],
4	of	IN	O	of	_	0	SENT_348	[p10l1277t3240r1311b3269],
5	effort	NN	O	effort	prep_of	3	SENT_348	[p10l1319t3240r1404b3269],
6	has	VBZ	O	have	aux	8	SENT_348	[p10l1414t3240r1464b3269],
7	been	VBN	O	be	auxpass	8	SENT_348	[p10l1476t3240r1550b3269],
8	expended	VBN	O	expend	_	0	SENT_348	[p10l1563t3240r1710b3278],
9	to	TO	O	to	aux	10	SENT_348	[p10l1722t3248r1752b3269],
10	identify	VB	O	identify	xcomp	8	SENT_348	[p10l1764t3239r1886b3278],
11	potent	JJ	O	potent	amod	15	SENT_348	[p10l366t3308r469b3338],
12	and	CC	O	and	_	0	SENT_348	[p10l478t3300r533b3329],
13	selective	JJ	O	selective	conj_and	11	SENT_348	[p10l542t3300r673b3329],
14	P-glycoprotein	NN	MISC	p-glycoprotein	nn	15	SENT_348	[p10l682t3300r919b3338],
15	inhibitors	NNS	O	inhibitor	dobj	10	SENT_348	[p10l927t3300r1079b3329],
16	that	WDT	O	that	nsubjpass	19	SENT_348	[p10l1089t3300r1150b3329],
17	may	MD	O	may	aux	19	SENT_348	[p10l1158t3311r1224b3338],
18	be	VB	O	be	auxpass	19	SENT_348	[p10l1231t3300r1267b3329],
19	used	VBN	O	use	rcmod	15	SENT_348	[p10l1275t3300r1346b3329],
20	to	TO	O	to	aux	21	SENT_348	[p10l1355t3309r1385b3329],
21	overcome	VB	O	overcome	xcomp	19	SENT_348	[p10l1395t3311r1547b3329],
22	multidrug	JJ	O	multidrug	amod	23	SENT_348	[p10l1556t3300r1714b3338],
23	resistance	NN	O	resistance	dobj	21	SENT_348	[p10l1722t3302r1883b3335],
24	,	,	O	,	_	0	SENT_348	[p10l1722t3302r1883b3335],

1	but	CC	O	but	cc	8	SENT_349	[p10l367t3362r419b3390],
2	these	DT	O	these	det	3	SENT_349	[p10l426t3362r506b3390],
3	efforts	NNS	O	effort	nsubj	8	SENT_349	[p10l515t3362r612b3390],
4	have	VBP	O	have	aux	8	SENT_349	[p10l620t3362r691b3390],
5	not	RB	O	not	neg	8	SENT_349	[p10l699t3370r752b3390],
6	been	VBN	O	be	cop	8	SENT_349	[p10l759t3362r833b3390],
7	as	RB	O	as	advmod	8	SENT_349	[p10l842t3373r870b3390],
8	successful	JJ	O	successful	_	0	SENT_349	[p10l879t3362r1031b3390],
9	as	IN	O	as	mark	10	SENT_349	[p10l1040t3373r1068b3390],
10	hoped	VBN	O	hope	ccomp	8	SENT_349	[p10l1076t3362r1173b3399],
11	(	NN	O	(	nsubj	14	SENT_349	[p10l1182t3363r1227b3397],
12	13	CD	NUMBER	13	number	13	SENT_349	[p10l1182t3363r1227b3397],
13	8	CD	NUMBER	8	num	14	SENT_349	[p10l1233t3363r1269b3397],
14	)	NN	O	)	xcomp	10	SENT_349	[p10l1233t3363r1269b3397],
15	.	.	O	.	_	0	SENT_349	[p10l1233t3363r1269b3397],

1	Mouse	NN	O	mouse	nn	2	SENT_350	[p10l1278t3363r1385b3390],
2	P-glycoprotein	NN	O	p-glycoprotein	nsubj	3	SENT_350	[p10l1393t3362r1630b3400],
3	was	VBD	O	be	_	0	SENT_350	[p10l1637t3373r1692b3390],
4	recently	RB	DATE	recently	advmod	3	SENT_350	[p10l1701t3362r1828b3400],
5	the	DT	O	the	dep	3	SENT_350	[p10l1835t3362r1884b3390],

1	ﬁrst	NN	O	ﬁrst	nsubj	2	SENT_351	[p11l367t26r429b55],
2	mammalian	JJ	O	mammalian	_	0	SENT_351	[p11l439t26r623b55],
3	ABC	NNP	ORGANIZATION	ABC	nn	4	SENT_351	[p11l633t27r710b55],
4	transporter	NN	O	transporter	nsubjpass	9	SENT_351	[p11l722t34r898b64],
5	to	TO	O	to	aux	7	SENT_351	[p11l909t34r940b55],
6	be	VB	O	be	auxpass	7	SENT_351	[p11l952t26r988b55],
7	crystallized	VBN	O	crystallize	xcomp	2	SENT_351	[p11l1001t26r1176b65],
8	and	CC	O	and	_	0	SENT_351	[p11l1188t26r1243b55],
9	characterized	VBN	O	characterize	xcomp	2	SENT_351	[p11l1256t26r1464b55],
10	at	IN	O	at	_	0	SENT_351	[p11l1476t34r1505b55],
11	a	DT	O	a	det	16	SENT_351	[p11l1516t37r1531b55],
12	high	JJ	O	high	amod	16	SENT_351	[p11l1542t26r1612b65],
13	resolution	NN	O	resolution	nn	16	SENT_351	[p11l1624t26r1783b55],
14	(	NN	O	(	nn	16	SENT_351	[p11l1795t27r1882b62],
15	139	CD	NUMBER	139	num	16	SENT_351	[p11l1795t27r1882b62],
16	)	NN	O	)	prep_at	7	SENT_351	[p11l1795t27r1882b62],
17	.	.	O	.	_	0	SENT_351	[p11l1795t27r1882b62],

1	The	DT	O	the	det	2	SENT_352	[p11l366t75r432b104],
2	identiﬁcation	NN	O	identiﬁcation	nsubj	10	SENT_352	[p11l444t75r652b104],
3	of	IN	O	of	_	0	SENT_352	[p11l664t75r698b104],
4	substrate	NN	O	substrate	nn	8	SENT_352	[p11l706t75r845b104],
5	and	CC	O	and	_	0	SENT_352	[p11l857t75r913b104],
6	inhibitor	NN	O	inhibitor	nn	8	SENT_352	[p11l924t75r1063b104],
7	binding	NN	O	binding	nn	8	SENT_352	[p11l1074t75r1196b114],
8	sites	NNS	O	site	prep_of	2	SENT_352	[p11l1206t77r1272b104],
9	will	MD	O	will	aux	10	SENT_352	[p11l1283t75r1340b104],
10	contribute	VB	O	contribute	_	0	SENT_352	[p11l1352t75r1515b104],
11	to	TO	O	to	_	0	SENT_352	[p11l1527t84r1557b104],
12	an	DT	O	a	det	13	SENT_352	[p11l1570t86r1605b104],
13	understanding	NN	O	understanding	prep_to	10	SENT_352	[p11l1616t75r1843b114],
14	of	IN	O	of	_	0	SENT_352	[p11l1854t75r1889b104],
15	the	DT	O	the	det	16	SENT_352	[p11l367t125r415b154],
16	mechanism	NN	O	mechanism	prep_of	13	SENT_352	[p11l424t125r602b154],
17	of	IN	O	of	_	0	SENT_352	[p11l611t125r645b154],
18	ABC	NNP	ORGANIZATION	ABC	nn	19	SENT_352	[p11l648t126r725b154],
19	transporters	NNS	O	transporter	prep_of	16	SENT_352	[p11l734t133r923b163],
20	in	IN	O	in	_	0	SENT_352	[p11l932t127r962b154],
21	general	JJ	O	general	prep_in	10	SENT_352	[p11l971t125r1085b164],
22	and	CC	O	and	_	0	SENT_352	[p11l1094t125r1150b154],
23	assist	VB	O	assist	conj_and	10	SENT_352	[p11l1159t127r1239b154],
24	the	DT	O	the	det	25	SENT_352	[p11l1247t125r1296b154],
25	effort	NN	O	effort	dobj	23	SENT_352	[p11l1305t125r1390b154],
26	to	TO	O	to	_	0	SENT_352	[p11l1398t133r1428b154],
27	design	NN	O	design	nn	28	SENT_352	[p11l1438t125r1538b164],
28	molecules	NNS	O	molecule	prep_to	23	SENT_352	[p11l1546t125r1702b154],
29	that	WDT	O	that	nsubj	30	SENT_352	[p11l1711t125r1773b154],
30	inhibit	VBP	O	inhibit	rcmod	28	SENT_352	[p11l1780t125r1885b154],
31	P-glycoprotein	NN	O	p-glycoprotein	dobj	30	SENT_352	[p11l367t175r603b213],
32	in	IN	O	in	mark	35	SENT_352	[p11l614t176r644b203],
33	order	NN	O	order	dep	35	SENT_352	[p11l656t175r741b204],
34	to	TO	O	to	aux	35	SENT_352	[p11l751t183r782b204],
35	overcome	VB	O	overcome	purpcl	30	SENT_352	[p11l794t186r946b204],
36	multidrug	JJ	O	multidrug	amod	37	SENT_352	[p11l957t175r1115b213],
37	resistance	NN	O	resistance	dobj	35	SENT_352	[p11l1125t176r1285b204],
38	.	.	O	.	_	0	SENT_352	[p11l1125t176r1285b204],

1	The	DT	O	the	det	2	SENT_353	[p11l415t225r482b253],
2	role	NN	O	role	nsubjpass	14	SENT_353	[p11l492t225r552b253],
3	of	IN	O	of	_	0	SENT_353	[p11l563t225r597b253],
4	P-glycoprotein	NN	O	p-glycoprotein	prep_of	2	SENT_353	[p11l603t225r840b263],
5	in	IN	O	in	_	0	SENT_353	[p11l849t226r879b253],
6	reducing	VBG	O	reduce	prepc_in	4	SENT_353	[p11l888t224r1027b263],
7	the	DT	O	the	det	8	SENT_353	[p11l1036t225r1085b253],
8	absorption	NN	O	absorption	dobj	6	SENT_353	[p11l1096t225r1263b263],
9	of	IN	O	of	_	0	SENT_353	[p11l1273t225r1307b253],
10	xenobiotics	NNS	O	xenobiotic	prep_of	8	SENT_353	[p11l1311t224r1489b253],
11	can	MD	O	can	aux	14	SENT_353	[p11l1500t235r1552b253],
12	be	VB	O	be	auxpass	14	SENT_353	[p11l1562t225r1597b253],
13	directly	RB	O	directly	advmod	14	SENT_353	[p11l1608t224r1727b263],
14	examined	VBN	O	examine	_	0	SENT_353	[p11l1736t224r1884b253],
15	by	IN	O	by	_	0	SENT_353	[p11l367t274r405b313],
16	comparing	VBG	O	compare	agent	14	SENT_353	[p11l421t276r589b313],
17	oral	JJ	O	oral	amod	19	SENT_353	[p11l606t274r665b303],
18	drug	NN	O	drug	nn	19	SENT_353	[p11l683t274r756b313],
19	exposure	NN	O	exposure	dobj	16	SENT_353	[p11l773t285r910b312],
20	in	IN	O	in	_	0	SENT_353	[p11l927t276r957b303],
21	Mdr1a	NN	O	mdr1a	prep_in	16	SENT_353	[p11l973t274r1094b303],
22	/	:	O	/	punct	23	SENT_353	[p11l973t274r1094b303],
23	1b	NN	O	1b	dep	21	SENT_353	[p11l1098t272r1163b303],
24	'	''	O	'	_	0	SENT_353	[p11l1098t272r1163b303],
25	/	:	O	/	punct	23	SENT_353	[p11l1098t272r1163b303],
26	‘	CD	NUMBER	‘	num	27	SENT_353	[p11l1166t282r1182b284],
27	mice	NNS	O	mouse	tmod	16	SENT_353	[p11l1202t276r1275b303],
28	with	IN	O	with	_	0	SENT_353	[p11l1292t274r1361b303],
29	wild	JJ	O	wild	amod	32	SENT_353	[p11l1377t274r1526b313],
30	—	NN	O	—	nn	32	SENT_353	[p11l1377t274r1526b313],
31	type	NN	O	type	nn	32	SENT_353	[p11l1377t274r1526b313],
32	controls	NNS	O	control	prep_with	27	SENT_353	[p11l1544t274r1678b303],
33	.	.	O	.	_	0	SENT_353	[p11l1544t274r1678b303],

1	This	DT	O	this	det	2	SENT_354	[p11l1696t274r1769b303],
2	model	NN	O	model	nsubj	3	SENT_354	[p11l1787t274r1884b303],
3	proved	VBD	O	prove	_	0	SENT_354	[p11l366t324r474b362],
4	to	TO	O	to	aux	7	SENT_354	[p11l491t332r522b353],
5	be	VB	O	be	cop	7	SENT_354	[p11l539t324r574b353],
6	particularly	RB	O	particularly	advmod	7	SENT_354	[p11l591t324r772b362],
7	helpful	JJ	O	helpful	xcomp	3	SENT_354	[p11l786t324r896b362],
8	in	IN	O	in	_	0	SENT_354	[p11l912t326r942b353],
9	outlining	VBG	O	outline	prepc_in	7	SENT_354	[p11l959t324r1103b363],
10	the	DT	O	the	det	14	SENT_354	[p11l1119t324r1167b353],
11	likely	JJ	O	likely	dep	14	SENT_354	[p11l1184t324r1269b363],
12	in	FW	O	in	dep	11	SENT_354	[p11l1284t326r1314b353],
13	vivo	FW	O	vivo	pobj	12	SENT_354	[p11l1329t326r1394b353],
14	impact	NN	O	impact	dobj	9	SENT_354	[p11l1410t326r1518b362],
15	of	IN	O	of	_	0	SENT_354	[p11l1533t324r1568b353],
16	this	DT	O	this	det	17	SENT_354	[p11l1580t324r1636b353],
17	transporter	NN	O	transporter	prep_of	14	SENT_354	[p11l1653t332r1829b362],
18	on	IN	O	on	_	0	SENT_354	[p11l1845t335r1884b353],
19	the	DT	O	the	det	22	SENT_354	[p11l367t374r415b403],
20	observed	VBN	O	observe	amod	22	SENT_354	[p11l430t374r568b403],
21	oral	JJ	O	oral	amod	22	SENT_354	[p11l583t374r643b403],
22	bioavailability	NN	O	bioavailability	prep_on	9	SENT_354	[p11l656t374r876b412],
23	of	IN	O	of	_	0	SENT_354	[p11l889t374r923b403],
24	substrate	NN	O	substrate	nn	25	SENT_354	[p11l933t374r1072b403],
25	drugs	NNS	O	drug	prep_of	22	SENT_354	[p11l1087t374r1172b412],
26	such	JJ	O	such	_	0	SENT_354	[p11l1187t374r1257b403],
27	as	IN	O	as	_	0	SENT_354	[p11l1271t385r1299b403],
28	HIV	NN	MISC	hiv	nn	30	SENT_354	[p11l1313t375r1388b403],
29	protease	NN	O	protease	nn	30	SENT_354	[p11l1399t382r1530b412],
30	inhibitors	NNS	O	inhibitor	prep_such_as	25	SENT_354	[p11l1543t374r1704b409],
31	,	,	O	,	_	0	SENT_354	[p11l1543t374r1704b409],
32	topotecan	NN	O	topotecan	appos	30	SENT_354	[p11l1720t382r1883b412],
33	,	,	O	,	_	0	SENT_354	[p11l1720t382r1883b412],
34	etoposide	NN	O	etoposide	appos	30	SENT_354	[p11l367t423r525b461],
35	,	,	O	,	_	0	SENT_354	[p11l367t423r525b461],
36	tacrolimus	NN	O	tacrolimus	appos	30	SENT_354	[p11l537t423r710b458],
37	,	,	O	,	_	0	SENT_354	[p11l537t423r710b458],
38	ivermectin	NN	O	ivermectin	appos	30	SENT_354	[p11l722t425r898b458],
39	,	,	O	,	_	0	SENT_354	[p11l722t425r898b458],
40	and	CC	O	and	_	0	SENT_354	[p11l911t423r966b452],
41	loperamide	NN	O	loperamide	appos	30	SENT_354	[p11l977t423r1153b461],
42	(	NN	O	(	nn	44	SENT_354	[p11l1165t424r1253b459],
43	140	CD	NUMBER	140	num	44	SENT_354	[p11l1165t424r1253b459],
44	)	NN	O	)	dep	32	SENT_354	[p11l1165t424r1253b459],
45	.	.	O	.	_	0	SENT_354	[p11l1165t424r1253b459],

1	In	IN	O	in	_	0	SENT_355	[p11l416t474r450b501],
2	addition	NN	O	addition	_	0	SENT_355	[p11l459t473r588b502],
3	to	TO	O	to	_	0	SENT_355	[p11l597t481r628b502],
4	limiting	VBG	O	limit	prepc_in_addition_to	27	SENT_355	[p11l637t473r762b511],
5	oral	JJ	O	oral	amod	6	SENT_355	[p11l770t473r830b502],
6	bioavailability	NN	O	bioavailability	dobj	4	SENT_355	[p11l839t473r1065b511],
7	,	,	O	,	_	0	SENT_355	[p11l839t473r1065b511],
8	the	DT	O	the	det	9	SENT_355	[p11l1076t473r1125b502],
9	expression	NN	O	expression	nsubj	27	SENT_355	[p11l1135t474r1297b511],
10	and	CC	O	and	_	0	SENT_355	[p11l1306t473r1362b502],
11	function	NN	O	function	nsubj	27	SENT_355	[p11l1371t473r1503b502],
12	of	IN	O	of	_	0	SENT_355	[p11l1512t473r1546b502],
13	this	DT	O	this	det	15	SENT_355	[p11l1551t473r1606b502],
14	efflux	NN	O	efflux	nn	15	SENT_355	[p11l1616t473r1700b502],
15	transporter	NN	O	transporter	prep_of	9	SENT_355	[p11l1709t481r1885b511],
16	in	IN	O	in	_	0	SENT_355	[p11l366t524r396b551],
17	the	DT	O	the	det	19	SENT_355	[p11l411t522r460b551],
18	endothelial	JJ	O	endothelial	amod	19	SENT_355	[p11l476t522r650b551],
19	cells	NNS	O	cell	prep_in	15	SENT_355	[p11l665t522r731b551],
20	that	WDT	O	that	nsubj	21	SENT_355	[p11l747t522r809b551],
21	constitute	VBP	O	constitute	rcmod	19	SENT_355	[p11l823t524r977b551],
22	the	DT	O	the	det	26	SENT_355	[p11l992t522r1041b551],
23	blood	NN	O	blood	nn	26	SENT_355	[p11l1056t522r1242b551],
24	—	NN	O	—	nn	26	SENT_355	[p11l1056t522r1242b551],
25	brain	NN	O	brain	nn	26	SENT_355	[p11l1056t522r1242b551],
26	barrier	NN	O	barrier	dobj	21	SENT_355	[p11l1257t522r1364b551],
27	appear	VBP	O	appear	_	0	SENT_355	[p11l1378t533r1482b560],
28	to	TO	O	to	aux	30	SENT_355	[p11l1496t530r1527b551],
29	be	VB	O	be	cop	30	SENT_355	[p11l1542t522r1578b551],
30	critical	JJ	O	critical	xcomp	27	SENT_355	[p11l1594t522r1699b551],
31	to	TO	O	to	_	0	SENT_355	[p11l1714t530r1745b551],
32	limiting	VBG	O	limit	prepc_to	30	SENT_355	[p11l1760t522r1885b561],
33	the	DT	O	the	det	40	SENT_355	[p11l367t572r415b601],
34	central	JJ	O	central	amod	40	SENT_355	[p11l431t572r537b601],
35	nervous	JJ	O	nervous	amod	40	SENT_355	[p11l551t583r674b601],
36	system	NN	O	system	nn	40	SENT_355	[p11l689t581r794b611],
37	(	CD	NUMBER	(	num	40	SENT_355	[p11l809t573r911b608],
38	CNS	NN	O	cn	nn	40	SENT_355	[p11l809t573r911b608],
39	)	NN	O	)	nn	40	SENT_355	[p11l809t573r911b608],
40	entry	NN	O	entry	dobj	32	SENT_355	[p11l927t581r1010b611],
41	of	IN	O	of	_	0	SENT_355	[p11l1023t573r1057b601],
42	many	JJ	O	many	amod	44	SENT_355	[p11l1068t583r1154b611],
43	substrate	JJ	O	substrate	amod	44	SENT_355	[p11l1167t572r1306b601],
44	drugs	NNS	O	drug	prep_of	40	SENT_355	[p11l1322t572r1416b611],
45	,	,	O	,	_	0	SENT_355	[p11l1322t572r1416b611],
46	including	VBG	O	include	_	0	SENT_355	[p11l1432t572r1580b611],
47	those	DT	O	those	prep_including	40	SENT_355	[p11l1594t572r1676b601],
48	predicted	VBN	O	predict	partmod	47	SENT_355	[p11l1691t572r1838b610],
49	to	TO	O	to	aux	50	SENT_355	[p11l1853t581r1884b601],
50	have	VB	O	have	xcomp	48	SENT_355	[p11l366t621r437b650],
51	brain	NN	O	brain	nn	52	SENT_355	[p11l451t621r532b650],
52	accumulation	NN	O	accumulation	dobj	50	SENT_355	[p11l547t621r757b650],
53	on	IN	O	on	_	0	SENT_355	[p11l771t632r810b650],
54	the	DT	O	the	det	55	SENT_355	[p11l824t621r873b650],
55	basis	NN	O	basis	prep_on	52	SENT_355	[p11l887t621r960b650],
56	of	IN	O	of	_	0	SENT_355	[p11l975t621r1009b650],
57	physicochemical	JJ	O	physicochemical	amod	58	SENT_355	[p11l1019t621r1277b660],
58	properties	NNS	O	property	prep_of	55	SENT_355	[p11l1291t623r1450b660],
59	such	JJ	O	such	_	0	SENT_355	[p11l1464t621r1534b650],
60	as	IN	O	as	_	0	SENT_355	[p11l1549t632r1577b650],
61	lipophilicity	NN	O	lipophilicity	nn	62	SENT_355	[p11l1591t621r1782b660],
62	(	NN	O	(	prep_such_as	58	SENT_355	[p11l1795t622r1883b658],
63	141	CD	NUMBER	141	num	64	SENT_355	[p11l1795t622r1883b658],
64	)	NN	O	)	dep	62	SENT_355	[p11l1795t622r1883b658],
65	.	.	O	.	_	0	SENT_355	[p11l1795t622r1883b658],

1	Endoxifen	NNP	MISC	Endoxifen	nsubj	15	SENT_356	[p11l367t671r537b706],
2	,	,	O	,	_	0	SENT_356	[p11l367t671r537b706],
3	the	DT	O	the	det	5	SENT_356	[p11l545t671r594b700],
4	active	JJ	O	active	amod	5	SENT_356	[p11l602t673r690b700],
5	metabolite	NN	O	metabolite	appos	1	SENT_356	[p11l697t671r864b700],
6	of	IN	O	of	_	0	SENT_356	[p11l871t671r906b700],
7	the	DT	O	the	det	11	SENT_356	[p11l908t671r957b700],
8	estrogen	NN	O	estrogen	nn	11	SENT_356	[p11l965t679r1099b710],
9	receptor	NN	O	receptor	nn	11	SENT_356	[p11l1106t679r1238b709],
10	antagonist	NN	O	antagonist	nn	11	SENT_356	[p11l1244t673r1407b710],
11	tamoxifen	NN	O	tamoxifen	prep_of	5	SENT_356	[p11l1413t671r1577b706],
12	,	,	O	,	_	0	SENT_356	[p11l1413t671r1577b706],
13	is	VBZ	O	be	cop	15	SENT_356	[p11l1585t673r1607b700],
14	a	DT	O	a	det	15	SENT_356	[p11l1615t682r1630b700],
15	newly	RB	O	newly	dep	37	SENT_356	[p11l1637t671r1730b710],
16	identiﬁed	VBN	O	identiﬁed	partmod	15	SENT_356	[p11l1735t671r1884b700],
17	P-glycoprotein	NN	MISC	p-glycoprotein	nn	18	SENT_356	[p11l366t721r603b759],
18	substrate	NN	O	substrate	dobj	16	SENT_356	[p11l611t721r759b756],
19	,	,	O	,	_	0	SENT_356	[p11l611t721r759b756],
20	with	IN	O	with	_	0	SENT_356	[p11l766t721r836b750],
21	signiﬁcantly	RB	O	signiﬁcantly	advmod	22	SENT_356	[p11l843t721r1034b759],
22	higher	JJR	O	higher	amod	24	SENT_356	[p11l1040t721r1142b759],
23	endoxifen	NN	O	endoxifen	nn	24	SENT_356	[p11l1150t721r1303b750],
24	concentrations	NNS	O	concentration	prep_with	16	SENT_356	[p11l1311t722r1541b750],
25	observed	VBN	O	observe	partmod	24	SENT_356	[p11l1550t721r1688b750],
26	in	IN	O	in	_	0	SENT_356	[p11l1695t722r1726b749],
27	the	DT	O	the	det	28	SENT_356	[p11l1733t721r1781b750],
28	brains	NNS	O	brain	prep_in	25	SENT_356	[p11l1789t721r1884b750],
29	of	IN	O	of	_	0	SENT_356	[p11l367t771r401b800],
30	Mdr1a	NN	O	mdr1a	prep_of	28	SENT_356	[p11l411t771r533b800],
31	/	:	O	/	punct	32	SENT_356	[p11l411t771r533b800],
32	1b	JJ	O	1b	dep	30	SENT_356	[p11l537t769r602b800],
33	"	``	O	"	punct	30	SENT_356	[p11l537t769r602b800],
34	/	:	O	/	punct	35	SENT_356	[p11l537t769r602b800],
35	‘	NN	O	‘	dep	36	SENT_356	[p11l605t778r620b780],
36	mice	NNS	O	mouse	dep	30	SENT_356	[p11l639t772r713b800],
37	(	VBP	O	(	_	0	SENT_356	[p11l730t772r806b807],
38	142	CD	NUMBER	142	nsubj	37	SENT_356	[p11l730t772r806b807],
39	,	,	O	,	_	0	SENT_356	[p11l730t772r806b807],
40	143	CD	NUMBER	143	num	41	SENT_356	[p11l826t772r899b807],
41	)	NN	O	)	appos	38	SENT_356	[p11l826t772r899b807],
42	.	.	O	.	_	0	SENT_356	[p11l826t772r899b807],

1	Expression	NN	O	expression	nsubjpass	13	SENT_357	[p11l917t772r1089b809],
2	of	IN	O	of	_	0	SENT_357	[p11l1104t771r1139b800],
3	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_357	[p11l1150t771r1387b809],
4	at	IN	O	at	_	0	SENT_357	[p11l1403t779r1431b800],
5	the	DT	O	the	det	9	SENT_357	[p11l1446t771r1494b800],
6	blood	NN	O	blood	nn	9	SENT_357	[p11l1510t771r1697b800],
7	—	NN	O	—	nn	9	SENT_357	[p11l1510t771r1697b800],
8	brain	NN	O	brain	nn	9	SENT_357	[p11l1510t771r1697b800],
9	barrier	NN	O	barrier	prep_at	3	SENT_357	[p11l1712t771r1819b800],
10	has	VBZ	O	have	aux	13	SENT_357	[p11l1834t771r1883b800],
11	also	RB	O	also	advmod	13	SENT_357	[p11l367t821r426b849],
12	been	VBN	O	be	auxpass	13	SENT_357	[p11l442t820r517b849],
13	implicated	VBN	O	implicate	_	0	SENT_357	[p11l532t820r697b859],
14	in	IN	O	in	_	0	SENT_357	[p11l713t822r743b849],
15	anticonvulsant	JJ	O	anticonvulsant	amod	17	SENT_357	[p11l760t821r988b849],
16	therapy	NN	O	therapy	nn	17	SENT_357	[p11l1004t820r1123b859],
17	failure	NN	O	failure	prep_in	13	SENT_357	[p11l1138t820r1246b856],
18	,	,	O	,	_	0	SENT_357	[p11l1138t820r1246b856],
19	although	IN	O	although	mark	25	SENT_357	[p11l1264t820r1403b859],
20	its	PRP$	O	its	poss	22	SENT_357	[p11l1419t822r1454b849],
21	clinical	JJ	O	clinical	amod	22	SENT_357	[p11l1471t820r1582b849],
22	relevance	NN	O	relevance	nsubj	25	SENT_357	[p11l1598t820r1744b849],
23	remains	VBZ	O	remain	cop	25	SENT_357	[p11l1761t822r1884b849],
24	controversial	JJ	O	controversial	amod	25	SENT_357	[p11l367t870r570b899],
25	(	NN	O	(	advcl	13	SENT_357	[p11l584t871r672b906],
26	144	CD	NUMBER	144	num	27	SENT_357	[p11l584t871r672b906],
27	)	NN	O	)	dep	25	SENT_357	[p11l584t871r672b906],
28	.	.	O	.	_	0	SENT_357	[p11l584t871r672b906],

1	Conversely	RB	O	conversely	advmod	19	SENT_358	[p11l688t870r871b909],
2	,	,	O	,	_	0	SENT_358	[p11l688t870r871b909],
3	limited	JJ	O	limited	amod	5	SENT_358	[p11l886t870r997b899],
4	CNS	NN	O	cn	nn	5	SENT_358	[p11l1011t871r1089b899],
5	entry	NN	O	entry	nsubj	19	SENT_358	[p11l1105t879r1187b909],
6	by	IN	O	by	_	0	SENT_358	[p11l1199t870r1237b909],
7	third-generation	JJ	O	third-generation	amod	8	SENT_358	[p11l1249t870r1510b909],
8	antihistamines	NNS	O	antihistamine	prep_by	5	SENT_358	[p11l1524t870r1749b899],
9	that	WDT	O	that	nsubj	12	SENT_358	[p11l1763t870r1825b899],
10	are	VBP	O	be	cop	12	SENT_358	[p11l1837t881r1884b899],
11	P-glycoprotein	NN	O	p-glycoprotein	nn	12	SENT_358	[p11l367t920r603b958],
12	substrates	NNS	O	substrate	rcmod	8	SENT_358	[p11l612t919r774b955],
13	,	,	O	,	_	0	SENT_358	[p11l612t919r774b955],
14	such	JJ	O	such	_	0	SENT_358	[p11l784t920r854b948],
15	as	IN	O	as	_	0	SENT_358	[p11l864t931r892b948],
16	fexofenadine	NN	O	fexofenadine	prep_such_as	12	SENT_358	[p11l901t920r1109b955],
17	,	,	O	,	_	0	SENT_358	[p11l901t920r1109b955],
18	has	VBZ	O	have	aux	19	SENT_358	[p11l1119t920r1168b948],
19	proven	VBN	O	prove	_	0	SENT_358	[p11l1178t930r1287b958],
20	to	TO	O	to	aux	24	SENT_358	[p11l1296t928r1326b948],
21	be	VB	O	be	cop	24	SENT_358	[p11l1336t920r1371b948],
22	a	DT	O	a	det	24	SENT_358	[p11l1381t931r1396b948],
23	desirable	JJ	O	desirable	amod	24	SENT_358	[p11l1406t919r1543b948],
24	property	NN	O	property	xcomp	19	SENT_358	[p11l1553t928r1690b958],
25	as	IN	O	as	mark	27	SENT_358	[p11l1698t931r1726b948],
26	it	PRP	O	it	nsubj	27	SENT_358	[p11l1735t921r1758b948],
27	reduces	VBZ	O	reduce	advcl	24	SENT_358	[p11l1766t919r1884b948],
28	the	DT	O	the	det	30	SENT_358	[p11l367t969r415b998],
29	side	JJ	O	side	amod	30	SENT_358	[p11l427t969r487b998],
30	effect	NN	O	effect	dobj	27	SENT_358	[p11l499t969r583b998],
31	of	IN	O	of	_	0	SENT_358	[p11l593t969r628b998],
32	sedation	NN	O	sedation	nn	33	SENT_358	[p11l635t969r765b998],
33	(	NN	O	(	prep_of	30	SENT_358	[p11l776t970r864b1005],
34	145	CD	NUMBER	145	num	35	SENT_358	[p11l776t970r864b1005],
35	)	NN	O	)	dep	33	SENT_358	[p11l776t970r864b1005],
36	.	.	O	.	_	0	SENT_358	[p11l776t970r864b1005],

1	For	IN	O	for	_	0	SENT_359	[p11l416t1019r473b1046],
2	some	DT	O	some	det	3	SENT_359	[p11l485t1028r566b1046],
3	drugs	NNS	O	drug	prep_for	15	SENT_359	[p11l579t1017r665b1056],
4	that	WDT	O	that	nsubj	6	SENT_359	[p11l678t1017r740b1046],
5	are	VBP	O	be	cop	6	SENT_359	[p11l752t1028r798b1046],
6	substrates	NNS	O	substrate	rcmod	3	SENT_359	[p11l811t1017r964b1046],
7	of	IN	O	of	_	0	SENT_359	[p11l977t1017r1012b1046],
8	BCRP	NN	O	bcrp	prep_of	6	SENT_359	[p11l1020t1018r1129b1053],
9	,	,	O	,	_	0	SENT_359	[p11l1020t1018r1129b1053],
10	P-glycoprotein	NN	O	p-glycoprotein	nsubj	15	SENT_359	[p11l1143t1017r1380b1056],
11	alone	RB	O	alone	advmod	15	SENT_359	[p11l1393t1017r1476b1046],
12	does	VBZ	O	do	aux	15	SENT_359	[p11l1490t1017r1558b1046],
13	not	RB	O	not	neg	15	SENT_359	[p11l1571t1025r1624b1046],
14	fully	RB	O	fully	advmod	15	SENT_359	[p11l1636t1017r1707b1056],
15	limit	VB	O	limit	_	0	SENT_359	[p11l1718t1017r1792b1046],
16	CNS	NN	O	cn	nn	18	SENT_359	[p11l1805t1018r1883b1046],
17	drug	NN	O	drug	nn	18	SENT_359	[p11l367t1066r440b1104],
18	entry	NN	O	entry	dobj	15	SENT_359	[p11l452t1074r541b1104],
19	,	,	O	,	_	0	SENT_359	[p11l452t1074r541b1104],
20	and	CC	O	and	_	0	SENT_359	[p11l555t1066r611b1095],
21	only	RB	O	only	advmod	26	SENT_359	[p11l623t1066r692b1104],
22	when	WRB	O	when	advmod	26	SENT_359	[p11l702t1066r787b1095],
23	both	DT	O	both	det	24	SENT_359	[p11l799t1066r871b1095],
24	transporters	NNS	O	transporter	nsubj	26	SENT_359	[p11l883t1074r1072b1104],
25	are	VBP	O	be	cop	26	SENT_359	[p11l1085t1077r1131b1095],
26	absent	JJ	O	absent	csubj	35	SENT_359	[p11l1144t1066r1244b1095],
27	is	VBZ	O	be	cop	29	SENT_359	[p11l1255t1068r1278b1095],
28	the	DT	O	the	det	29	SENT_359	[p11l1290t1066r1339b1095],
29	magnitude	NN	O	magnitude	ccomp	26	SENT_359	[p11l1351t1066r1518b1104],
30	of	IN	O	of	_	0	SENT_359	[p11l1531t1066r1565b1095],
31	CNS	NN	ORGANIZATION	cn	nn	33	SENT_359	[p11l1574t1067r1652b1095],
32	drug	NN	O	drug	nn	33	SENT_359	[p11l1666t1066r1739b1104],
33	accumulation	NN	O	accumulation	prep_of	29	SENT_359	[p11l1751t1077r1883b1095, p11l366t1114r456b1143],
34	signiﬁcantly	RB	O	signiﬁcantly	advmod	35	SENT_359	[p11l471t1114r662b1153],
35	enhanced	VBD	O	enhance	conj_and	15	SENT_359	[p11l676t1114r832b1143],
36	.	.	O	.	_	0	SENT_359	[p11l676t1114r832b1143],

1	This	DT	O	this	nsubjpass	4	SENT_360	[p11l847t1114r920b1143],
2	has	VBZ	O	have	aux	4	SENT_360	[p11l935t1114r985b1143],
3	been	VBN	O	be	auxpass	4	SENT_360	[p11l1000t1114r1075b1143],
4	shown	VBN	O	show	dep	14	SENT_360	[p11l1090t1114r1190b1143],
5	through	IN	O	through	_	0	SENT_360	[p11l1205t1114r1331b1153],
6	the	DT	O	the	det	7	SENT_360	[p11l1346t1114r1395b1143],
7	use	NN	O	use	prep_through	4	SENT_360	[p11l1409t1125r1459b1143],
8	of	IN	O	of	_	0	SENT_360	[p11l1475t1115r1509b1143],
9	the	DT	O	the	det	10	SENT_360	[p11l1520t1114r1569b1143],
10	Mdrla/lb/Bcrp	NN	O	mdrla/lb/bcrp	prep_of	7	SENT_360	[p11l1582t1112r1881b1153],
11	‘	CD	NUMBER	‘	num	10	SENT_360	[p11l1582t1112r1881b1153],
12	/	:	O	/	punct	14	SENT_360	[p11l1582t1112r1881b1153],
13	‘	CD	NUMBER	‘	num	14	SENT_360	[p11l1582t1112r1881b1153],
14	mice	NNS	O	mouse	_	0	SENT_360	[p11l366t1165r440b1192],
15	for	IN	O	for	_	0	SENT_360	[p11l455t1163r500b1192],
16	tyrosine	NN	O	tyrosine	nn	18	SENT_360	[p11l514t1165r639b1201],
17	kinase	NN	O	kinase	nn	18	SENT_360	[p11l654t1163r750b1192],
18	inhibitors	NNS	O	inhibitor	prep_for	14	SENT_360	[p11l764t1163r916b1192],
19	such	JJ	O	such	_	0	SENT_360	[p11l931t1163r1001b1192],
20	as	IN	O	as	_	0	SENT_360	[p11l1015t1174r1043b1192],
21	lapatinib	NN	O	lapatinib	nn	25	SENT_360	[p11l1058t1163r1202b1201],
22	,	,	O	,	_	0	SENT_360	[p11l1058t1163r1202b1201],
23	imatinib	NN	O	imatinib	dep	25	SENT_360	[p11l1218t1163r1357b1198],
24	,	,	O	,	_	0	SENT_360	[p11l1218t1163r1357b1198],
25	sunitinib	NN	O	sunitinib	prep_such_as	14	SENT_360	[p11l1373t1163r1518b1198],
26	,	,	O	,	_	0	SENT_360	[p11l1373t1163r1518b1198],
27	and	CC	O	and	_	0	SENT_360	[p11l1534t1163r1590b1192],
28	tandutinib	NN	O	tandutinib	conj_and	25	SENT_360	[p11l1604t1163r1775b1198],
29	,	,	O	,	_	0	SENT_360	[p11l1604t1163r1775b1198],
30	which	WDT	O	which	nsubj	32	SENT_360	[p11l1789t1163r1884b1192],
31	are	VBP	O	be	cop	32	SENT_360	[p11l367t1223r413b1241],
32	substrates	NNS	O	substrate	rcmod	25	SENT_360	[p11l429t1212r582b1241],
33	of	IN	O	of	_	0	SENT_360	[p11l597t1212r632b1241],
34	P-glycoprotein	NN	O	p-glycoprotein	prep_of	32	SENT_360	[p11l642t1212r879b1250],
35	and	CC	O	and	_	0	SENT_360	[p11l894t1212r950b1241],
36	BCRP	NN	O	bcrp	rcmod	25	SENT_360	[p11l965t1213r1065b1241],
37	(	CD	NUMBER	(	num	36	SENT_360	[p11l1082t1213r1246b1248],
38	146-149	CD	NUMBER	146-149	num	39	SENT_360	[p11l1082t1213r1246b1248],
39	)	NN	O	)	dep	36	SENT_360	[p11l1082t1213r1246b1248],
40	.	.	O	.	_	0	SENT_360	[p11l1082t1213r1246b1248],

1	Species	NNP	O	Species	nn	2	SENT_361	[p11l1264t1213r1377b1250],
2	differences	NNS	O	difference	nsubjpass	13	SENT_361	[p11l1393t1212r1560b1241],
3	in	IN	O	in	_	0	SENT_361	[p11l1575t1214r1606b1240],
4	the	DT	O	the	det	6	SENT_361	[p11l1621t1212r1669b1241],
5	brain	NN	O	brain	nn	6	SENT_361	[p11l1685t1212r1766b1241],
6	uptake	NN	O	uptake	prep_in	2	SENT_361	[p11l1780t1212r1884b1250],
7	of	IN	O	of	_	0	SENT_361	[p11l367t1261r401b1289],
8	radiolabeled	VBN	O	radiolabele	prepc_of	6	SENT_361	[p11l408t1261r601b1289],
9	P-glycoprotein	NN	MISC	p-glycoprotein	nn	10	SENT_361	[p11l612t1261r849b1299],
10	substrates	NNS	O	substrate	dobj	8	SENT_361	[p11l861t1261r1014b1289],
11	have	VBP	O	have	aux	13	SENT_361	[p11l1025t1261r1096b1289],
12	been	VBN	O	be	auxpass	13	SENT_361	[p11l1108t1261r1182b1289],
13	observed	VBN	O	observe	_	0	SENT_361	[p11l1194t1261r1333b1289],
14	by	IN	O	by	_	0	SENT_361	[p11l1344t1261r1383b1299],
15	positron	NN	O	positron	nn	17	SENT_361	[p11l1393t1262r1524b1299],
16	emission	NN	O	emission	nn	17	SENT_361	[p11l1536t1262r1671b1289],
17	tomography	NN	O	tomography	agent	13	SENT_361	[p11l1683t1261r1883b1299],
18	,	,	O	,	_	0	SENT_361	[p11l1683t1261r1883b1299],
19	and	CC	O	and	_	0	SENT_361	[p11l367t1309r422b1338],
20	although	IN	O	although	mark	29	SENT_361	[p11l441t1309r580b1347],
21	the	DT	O	the	det	22	SENT_361	[p11l598t1309r647b1338],
22	mechanisms	NNS	O	mechanism	nsubjpass	29	SENT_361	[p11l666t1309r856b1338],
23	for	IN	O	for	_	0	SENT_361	[p11l875t1309r921b1338],
24	these	DT	O	these	det	25	SENT_361	[p11l939t1309r1018b1338],
25	differences	NNS	O	difference	prep_for	22	SENT_361	[p11l1038t1309r1205b1338],
26	are	VBP	O	be	auxpass	29	SENT_361	[p11l1224t1320r1270b1338],
27	not	RB	O	not	neg	29	SENT_361	[p11l1288t1317r1342b1338],
28	well	RB	O	well	advmod	29	SENT_361	[p11l1358t1309r1422b1338],
29	understood	VBN	O	understand	advcl	35	SENT_361	[p11l1440t1309r1627b1344],
30	,	,	O	,	_	0	SENT_361	[p11l1440t1309r1627b1344],
31	they	PRP	O	they	nsubj	35	SENT_361	[p11l1647t1309r1715b1347],
32	may	MD	O	may	aux	35	SENT_361	[p11l1732t1320r1798b1347],
33	be	VB	O	be	cop	35	SENT_361	[p11l1814t1309r1850b1338],
34	a	DT	O	a	det	35	SENT_361	[p11l1869t1320r1884b1338],
35	consideration	NN	O	consideration	conj_and	13	SENT_361	[p11l367t1358r579b1387],
36	for	IN	O	for	_	0	SENT_361	[p11l590t1358r635b1387],
37	animal	NN	O	animal	nn	38	SENT_361	[p11l646t1358r750b1387],
38	studies	NNS	O	study	prep_for	35	SENT_361	[p11l762t1358r867b1387],
39	conducted	VBN	O	conduct	partmod	38	SENT_361	[p11l879t1358r1041b1387],
40	in	IN	O	in	_	0	SENT_361	[p11l1052t1360r1083b1386],
41	preclinical	JJ	O	preclinical	amod	46	SENT_361	[p11l1093t1358r1256b1396],
42	drug	NN	O	drug	nn	46	SENT_361	[p11l1268t1358r1341b1396],
43	development	NN	O	development	nn	46	SENT_361	[p11l1351t1358r1554b1396],
44	(	NN	O	(	nn	46	SENT_361	[p11l1565t1359r1653b1394],
45	150	CD	NUMBER	150	num	46	SENT_361	[p11l1565t1359r1653b1394],
46	)	NN	O	)	prep_in	39	SENT_361	[p11l1565t1359r1653b1394],
47	.	.	O	.	_	0	SENT_361	[p11l1565t1359r1653b1394],

1	ABCBI	NNP	ORGANIZATION	ABCBI	nsubj	4	SENT_362	[p11l413t1407r528b1435],
2	is	VBZ	O	be	cop	4	SENT_362	[p11l541t1408r563b1435],
3	highly	RB	O	highly	advmod	4	SENT_362	[p11l574t1406r674b1445],
4	polymorphic	JJ	O	polymorphic	_	0	SENT_362	[p11l683t1406r892b1445],
5	;	:	O	;	_	0	SENT_362	[p11l683t1406r892b1445],
6	however	RB	O	however	advmod	19	SENT_362	[p11l904t1406r1045b1442],
7	,	,	O	,	_	0	SENT_362	[p11l904t1406r1045b1442],
8	the	DT	O	the	nsubjpass	19	SENT_362	[p11l1057t1406r1105b1435],
9	in	FW	O	in	nn	10	SENT_362	[p11l1116t1408r1146b1435],
10	vivo	FW	O	vivo	advmod	11	SENT_362	[p11l1155t1408r1220b1435],
11	role	NN	O	role	dep	8	SENT_362	[p11l1231t1406r1291b1435],
12	of	IN	O	of	_	0	SENT_362	[p11l1303t1406r1337b1435],
13	these	DT	O	these	det	14	SENT_362	[p11l1343t1406r1423b1435],
14	polymorphisms	NNS	O	polymorphism	prep_of	8	SENT_362	[p11l1434t1406r1676b1445],
15	has	VBZ	O	have	aux	19	SENT_362	[p11l1687t1406r1736b1435],
16	not	RB	O	not	neg	19	SENT_362	[p11l1747t1415r1801b1435],
17	been	VBN	O	be	auxpass	19	SENT_362	[p11l1810t1406r1884b1435],
18	consistently	RB	O	consistently	advmod	19	SENT_362	[p11l367t1455r554b1493],
19	demonstrated	VBN	O	demonstrate	parataxis	4	SENT_362	[p11l564t1455r787b1484],
20	.	.	O	.	_	0	SENT_362	[p11l564t1455r787b1484],

1	To	TO	O	to	dep	4	SENT_363	[p11l799t1456r848b1484],
2	date	NN	O	date	pobj	1	SENT_363	[p11l860t1455r933b1490],
3	,	,	O	,	_	0	SENT_363	[p11l860t1455r933b1490],
4	hundreds	NNS	O	hundred	_	0	SENT_363	[p11l946t1455r1092b1484],
5	of	IN	O	of	_	0	SENT_363	[p11l1105t1455r1139b1484],
6	studies	NNS	O	study	prep_of	4	SENT_363	[p11l1147t1455r1252b1484],
7	in	IN	O	in	_	0	SENT_363	[p11l1264t1457r1295b1483],
8	genotype	NN	O	genotype	prep_in	6	SENT_363	[p11l1307t1455r1581b1493],
9	—	CD	NUMBER	—	num	11	SENT_363	[p11l1307t1455r1581b1493],
10	deﬁned	JJ	O	deﬁned	amod	11	SENT_363	[p11l1307t1455r1581b1493],
11	subjects	NNS	O	subject	nsubj	13	SENT_363	[p11l1594t1455r1715b1493],
12	have	VBP	O	have	aux	13	SENT_363	[p11l1727t1455r1798b1484],
13	been	VBN	O	be	rcmod	8	SENT_363	[p11l1810t1455r1884b1484],

1	Annu	NNP	PERSON	Annu	_	0	SENT_364	[p11l181t895r204b974],
2	.	.	O	.	_	0	SENT_364	[p11l181t895r204b974],

1	Rev.	NNP	O	Rev.	nn	2	SENT_365	[p11l181t825r204b884],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_365	[p11l181t666r204b814],
3	.	.	O	.	_	0	SENT_365	[p11l181t666r204b814],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_366	[p11l181t546r204b655],
2	.	.	O	.	_	0	SENT_366	[p11l181t546r204b655],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_367	[p11l181t302r205b535],
2	-273	CD	NUMBER	-273	_	0	SENT_367	[p11l181t302r205b535],
3	.	.	O	.	_	0	SENT_367	[p11l181t302r205b535],

1	Downloaded	VBN	O	download	_	0	SENT_368	[p11l181t121r204b291],
2	from	IN	O	from	_	0	SENT_368	[p11l181t48r204b112],
3	w	NN	O	w	prep_from	1	SENT_368	[p11l189t18r204b39],
4	by	IN	O	by	_	0	SENT_368	[p11l214t808r245b840],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_368	[p11l214t659r245b799],
6	of	IN	ORGANIZATION	of	_	0	SENT_368	[p11l214t620r238b649],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_368	[p11l214t474r238b614],
8	-	:	O	-	_	0	SENT_368	[p11l228t456r231b465],
9	Madison	NNP	O	Madison	prep_by	1	SENT_368	[p11l214t330r238b446],
10	on	IN	O	on	_	0	SENT_368	[p11l222t289r238b321],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_368	[p11l214t156r238b280],
12	.	.	O	.	_	0	SENT_368	[p11l214t156r238b280],

1	For	IN	O	for	_	0	SENT_369	[p11l215t99r238b145],
2	perso	JJ	O	perso	amod	3	SENT_369	[p11l222t20r245b90],
3	wwwxmnmzlre-uiew	NN	O	wwwxmnmzlre-uiew	pobj	1	SENT_369	[p11l1356t1561r1630b1590],
4	:	:	O	:	_	0	SENT_369	[p11l1356t1561r1630b1590],
5	.	.	O	.	_	0	SENT_369	[p11l1356t1561r1630b1590],

1	org	SYM	O	org	dep	3	SENT_370	[p11l1356t1561r1630b1590],
2	-	:	O	-	_	0	SENT_370	[p11l1644t1569r1654b1578],
3	Drug	NN	O	drug	dep	7	SENT_370	[p11l1670t1561r1734b1590],
4	Tmmporter	NNP	O	Tmmporter	dep	3	SENT_370	[p11l1742t1561r1885b1589],
5	:	:	O	:	_	0	SENT_370	[p11l1742t1561r1885b1589],
6	2	CD	NUMBER	2	num	7	SENT_370	[p11l1936t1568r1948b1582],
7	59	CD	NUMBER	59	_	0	SENT_370	[p11l1950t1568r1978b1589],

1	conducted	VBN	O	conduct	_	0	SENT_371	[p11l565t1602r727b1631],
2	with	IN	O	with	_	0	SENT_371	[p11l737t1602r807b1631],
3	numerous	JJ	O	numerous	amod	5	SENT_371	[p11l817t1613r973b1631],
4	P-glycoprotein	NN	MISC	p-glycoprotein	nn	5	SENT_371	[p11l985t1602r1221b1641],
5	substrates	NNS	O	substrate	prep_with	1	SENT_371	[p11l1232t1602r1394b1638],
6	,	,	O	,	_	0	SENT_371	[p11l1232t1602r1394b1638],
7	and	CC	O	and	_	0	SENT_371	[p11l1406t1602r1462b1631],
8	the	DT	O	the	det	9	SENT_371	[p11l1473t1602r1521b1631],
9	results	NNS	O	result	nsubj	12	SENT_371	[p11l1532t1602r1633b1631],
10	have	VBP	O	have	aux	12	SENT_371	[p11l1644t1602r1715b1631],
11	been	VBN	O	be	cop	12	SENT_371	[p11l1726t1602r1800b1631],
12	mixed	JJ	O	mixed	conj_and	1	SENT_371	[p11l1810t1602r1905b1631],
13	(	NN	O	(	tmod	12	SENT_371	[p11l1916t1603r1992b1639],
14	131	CD	NUMBER	131	num	13	SENT_371	[p11l1916t1603r1992b1639],
15	,	,	O	,	_	0	SENT_371	[p11l1916t1603r1992b1639],
16	151	CD	NUMBER	151	num	17	SENT_371	[p11l2008t1603r2081b1639],
17	)	NN	O	)	appos	13	SENT_371	[p11l2008t1603r2081b1639],
18	.	.	O	.	_	0	SENT_371	[p11l2008t1603r2081b1639],

1	The	DT	O	the	det	3	SENT_372	[p11l564t1651r630b1681],
2	ABCB1	NN	O	abcb1	nn	3	SENT_372	[p11l635t1652r750b1680],
3	c.	NN	O	c.	dep	9	SENT_372	[p11l762t1653r841b1681],
4	343	CD	NUMBER	343	num	5	SENT_372	[p11l762t1653r841b1681],
5	5T	NN	O	5t	dep	3	SENT_372	[p11l847t1652r950b1681],
6	>	JJR	O	>	amod	7	SENT_372	[p11l847t1652r950b1681],
7	C	NN	O	c	dep	9	SENT_372	[p11l847t1652r950b1681],
8	(	CD	NUMBER	(	num	9	SENT_372	[p11l959t1652r1072b1688],
9	rs1045	NN	O	rs1045	dep	16	SENT_372	[p11l959t1652r1072b1688],
10	642	CD	NUMBER	642	num	12	SENT_372	[p11l1077t1652r1144b1688],
11	)	NN	O	)	nn	12	SENT_372	[p11l1077t1652r1144b1688],
12	variant	NN	O	variant	dep	9	SENT_372	[p11l1151t1653r1261b1681],
13	in	IN	O	in	dep	16	SENT_372	[p11l1268t1653r1298b1680],
14	particular	JJ	O	particular	nsubj	16	SENT_372	[p11l1306t1651r1458b1690],
15	has	VBZ	O	have	aux	16	SENT_372	[p11l1465t1651r1515b1681],
16	received	VBN	O	receive	_	0	SENT_372	[p11l1523t1651r1653b1681],
17	a	DT	O	a	det	19	SENT_372	[p11l1662t1662r1676b1681],
18	great	JJ	O	great	amod	19	SENT_372	[p11l1685t1659r1764b1690],
19	deal	NN	O	deal	dobj	16	SENT_372	[p11l1772t1651r1835b1681],
20	of	IN	O	of	_	0	SENT_372	[p11l1843t1651r1878b1681],
21	attention	NN	O	attention	prep_of	19	SENT_372	[p11l1882t1653r2024b1681],
22	but	CC	O	but	_	0	SENT_372	[p11l2032t1651r2084b1681],
23	the	DT	O	the	det	24	SENT_372	[p11l565t1701r614b1730],
24	data	NNS	O	datum	nsubj	26	SENT_372	[p11l623t1701r687b1730],
25	are	VBP	O	be	aux	26	SENT_372	[p11l696t1712r742b1730],
26	conﬂicting	VBG	O	conﬂicting	conj_but	16	SENT_372	[p11l752t1701r927b1740],
27	.	.	O	.	_	0	SENT_372	[p11l752t1701r927b1740],

1	These	DT	O	these	det	3	SENT_373	[p11l936t1701r1034b1730],
2	inconsistent	JJ	O	inconsistent	amod	3	SENT_373	[p11l1043t1703r1232b1730],
3	ﬁndings	NNS	O	ﬁndings	nsubj	5	SENT_373	[p11l1240t1701r1365b1740],
4	may	MD	O	may	aux	5	SENT_373	[p11l1374t1712r1440b1740],
5	result	VB	O	result	_	0	SENT_373	[p11l1447t1701r1535b1730],
6	from	IN	O	from	_	0	SENT_373	[p11l1543t1701r1619b1730],
7	different	JJ	O	different	amod	9	SENT_373	[p11l1628t1701r1762b1730],
8	experimental	JJ	O	experimental	amod	9	SENT_373	[p11l1770t1701r1973b1740],
9	conditions	NNS	O	condition	prep_from	5	SENT_373	[p11l1982t1701r2082b1730, p11l565t1763r649b1797],
10	,	,	O	,	_	0	SENT_373	[p11l1982t1701r2082b1730, p11l565t1763r649b1797],

1	inadequate	JJ	O	inadequate	amod	3	SENT_374	[p11l659t1761r829b1800],
2	sample	NN	O	sample	nn	3	SENT_374	[p11l838t1761r945b1800],
3	sizes	NNS	O	size	nsubj	11	SENT_374	[p11l954t1763r1033b1797],
4	,	,	O	,	_	0	SENT_374	[p11l954t1763r1033b1797],
5	or	CC	O	or	_	0	SENT_374	[p11l1043t1772r1076b1790],
6	heterogeneity	NN	O	heterogeneity	nsubj	11	SENT_374	[p11l1084t1761r1302b1800],
7	of	IN	O	of	_	0	SENT_374	[p11l1310t1761r1344b1790],
8	the	DT	O	the	det	10	SENT_374	[p11l1348t1761r1397b1790],
9	sample	NN	O	sample	nn	10	SENT_374	[p11l1406t1761r1513b1800],
10	population	NN	O	population	prep_of	6	SENT_374	[p11l1522t1761r1692b1800],
11	studied	VBN	O	study	_	0	SENT_374	[p11l1700t1761r1821b1790],
12	.	.	O	.	_	0	SENT_374	[p11l1700t1761r1821b1790],

1	Many	JJ	O	many	amod	2	SENT_375	[p11l1829t1763r1922b1800],
2	substrates	NNS	O	substrate	nsubj	13	SENT_375	[p11l1929t1761r2082b1790],
3	that	WDT	O	that	nsubjpass	5	SENT_375	[p11l565t1822r627b1851],
4	are	VBP	O	be	auxpass	5	SENT_375	[p11l636t1833r682b1851],
5	used	VBN	O	use	rcmod	2	SENT_375	[p11l691t1822r761b1851],
6	as	IN	O	as	_	0	SENT_375	[p11l771t1833r800b1851],
7	probes	NNS	O	probe	prep_as	5	SENT_375	[p11l809t1822r914b1861],
8	for	IN	O	for	_	0	SENT_375	[p11l924t1822r969b1851],
9	transporter	NN	O	transporter	nn	10	SENT_375	[p11l978t1830r1154b1861],
10	function	NN	O	function	prep_for	7	SENT_375	[p11l1163t1822r1295b1851],
11	are	VBP	O	be	cop	13	SENT_375	[p11l1305t1833r1351b1851],
12	also	RB	O	also	advmod	13	SENT_375	[p11l1361t1822r1420b1851],
13	substrates	NNS	O	substrate	_	0	SENT_375	[p11l1430t1822r1583b1851],
14	for	IN	O	for	_	0	SENT_375	[p11l1593t1822r1638b1851],
15	drug-metabolizing	JJ	O	drug-metabolizing	amod	16	SENT_375	[p11l1648t1822r1941b1861],
16	enzymes	NNS	O	enzyme	prep_for	13	SENT_375	[p11l1950t1833r2082b1861],
17	or	CC	O	or	_	0	SENT_375	[p11l565t1895r599b1913],
18	other	JJ	O	other	amod	19	SENT_375	[p11l613t1884r697b1913],
19	transporters	NNS	O	transporter	prep_for	13	SENT_375	[p11l710t1892r908b1923],
20	.	.	O	.	_	0	SENT_375	[p11l710t1892r908b1923],

1	For	IN	O	for	_	0	SENT_376	[p11l924t1885r980b1913],
2	example	NN	O	example	prep_for	12	SENT_376	[p11l995t1884r1130b1923],
3	,	,	O	,	_	0	SENT_376	[p11l995t1884r1130b1923],
4	transport	NN	O	transport	nn	5	SENT_376	[p11l1146t1892r1291b1923],
5	studies	NNS	O	study	nsubjpass	12	SENT_376	[p11l1304t1884r1410b1913],
6	with	IN	O	with	_	0	SENT_376	[p11l1424t1884r1493b1913],
7	cyclosporine	NN	O	cyclosporine	prep_with	5	SENT_376	[p11l1508t1884r1705b1923],
8	and	CC	O	and	_	0	SENT_376	[p11l1720t1884r1775b1913],
9	tacrolimus	NN	O	tacrolimus	conj_and	7	SENT_376	[p11l1790t1884r1954b1913],
10	may	MD	O	may	aux	12	SENT_376	[p11l1968t1895r2034b1923],
11	be	VB	O	be	auxpass	12	SENT_376	[p11l2047t1884r2083b1913],
12	complicated	VBN	O	complicate	ccomp	34	SENT_376	[p11l565t1933r755b1972],
13	by	IN	O	by	_	0	SENT_376	[p11l766t1933r804b1972],
14	the	DT	O	the	det	15	SENT_376	[p11l814t1933r863b1962],
15	involvement	NN	O	involvement	agent	12	SENT_376	[p11l874t1933r1069b1962],
16	of	IN	O	of	_	0	SENT_376	[p11l1080t1933r1114b1962],
17	CYP3A	NN	O	cyp3a	nn	18	SENT_376	[p11l1122t1934r1243b1962],
18	metabolism	NN	O	metabolism	prep_of	15	SENT_376	[p11l1252t1933r1442b1969],
19	,	,	O	,	_	0	SENT_376	[p11l1252t1933r1442b1969],
20	and	CC	O	and	_	0	SENT_376	[p11l1455t1933r1519b1969],
21	,	,	O	,	_	0	SENT_376	[p11l1455t1933r1519b1969],
22	in	IN	O	in	agent	12	SENT_376	[p11l1532t1935r1562b1962],
23	addition	NN	O	addition	pobj	22	SENT_376	[p11l1573t1933r1702b1962],
24	to	TO	O	to	_	0	SENT_376	[p11l1714t1942r1744b1962],
25	being	VBG	O	be	auxpass	26	SENT_376	[p11l1756t1933r1843b1972],
26	transported	VBN	O	transport	prepc_to	12	SENT_376	[p11l1854t1933r2035b1972],
27	by	IN	O	by	_	0	SENT_376	[p11l2046t1933r2084b1972],
28	P-glycoprotein	NN	O	p-glycoprotein	agent	26	SENT_376	[p11l565t1982r810b2021],
29	,	,	O	,	_	0	SENT_376	[p11l565t1982r810b2021],
30	fexofenadine	NN	O	fexofenadine	nsubj	34	SENT_376	[p11l821t1982r1020b2011],
31	is	VBZ	O	be	cop	34	SENT_376	[p11l1030t1984r1053b2011],
32	also	RB	O	also	advmod	34	SENT_376	[p11l1064t1982r1122b2011],
33	a	DT	O	a	det	34	SENT_376	[p11l1133t1993r1148b2011],
34	substrate	NN	O	substrate	_	0	SENT_376	[p11l1158t1982r1297b2011],
35	of	IN	O	of	_	0	SENT_376	[p11l1308t1982r1342b2011],
36	OATPs	NNS	O	oatp	prep_of	34	SENT_376	[p11l1349t1983r1469b2011],
37	(	CD	NUMBER	(	number	38	SENT_376	[p11l1480t1983r1567b2019],
38	152	CD	NUMBER	152	num	39	SENT_376	[p11l1480t1983r1567b2019],
39	)	NN	O	)	dep	36	SENT_376	[p11l1480t1983r1567b2019],
40	.	.	O	.	_	0	SENT_376	[p11l1480t1983r1567b2019],

1	Thus	RB	O	thus	advmod	12	SENT_377	[p11l1578t1982r1670b2018],
2	,	,	O	,	_	0	SENT_377	[p11l1578t1982r1670b2018],
3	metabolism	NN	O	metabolism	nsubj	12	SENT_377	[p11l1681t1982r1863b2011],
4	and	CC	O	and	_	0	SENT_377	[p11l1873t1982r1929b2011],
5	transport	NN	O	transport	nsubj	12	SENT_377	[p11l1939t1990r2084b2021],
6	by	IN	O	by	_	0	SENT_377	[p11l565t2032r603b2071],
7	proteins	NNS	O	protein	prep_by	3	SENT_377	[p11l613t2033r741b2071],
8	other	JJ	O	other	dep	7	SENT_377	[p11l754t2032r837b2061],
9	than	IN	O	than	_	0	SENT_377	[p11l849t2032r918b2061],
10	P-glycoprotein	NN	O	p-glycoprotein	prep_than	7	SENT_377	[p11l930t2032r1166b2071],
11	may	MD	O	may	aux	12	SENT_377	[p11l1178t2043r1244b2071],
12	contribute	VB	O	contribute	_	0	SENT_377	[p11l1255t2032r1417b2061],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_377	[p11l1429t2032r1620b2071],
14	to	TO	O	to	_	0	SENT_377	[p11l1631t2040r1661b2061],
15	the	DT	O	the	det	17	SENT_377	[p11l1674t2032r1722b2061],
16	observed	VBN	O	observe	amod	17	SENT_377	[p11l1735t2032r1874b2061],
17	variability	NN	O	variability	prep_to	12	SENT_377	[p11l1884t2032r2043b2071],
18	in	IN	O	in	_	0	SENT_377	[p11l2053t2033r2083b2061],
19	drug	NN	O	drug	nn	20	SENT_377	[p11l565t2082r638b2121],
20	disposition	NN	O	disposition	prep_in	17	SENT_377	[p11l652t2082r830b2121],
21	.	.	O	.	_	0	SENT_377	[p11l652t2082r830b2121],

1	Future	JJ	DATE	future	amod	2	SENT_378	[p11l845t2084r950b2112],
2	studies	NNS	O	study	nsubj	17	SENT_378	[p11l965t2082r1070b2112],
3	from	IN	O	from	_	0	SENT_378	[p11l1084t2082r1161b2112],
4	current	JJ	DATE	current	amod	6	SENT_378	[p11l1174t2091r1290b2112],
5	resequencing	JJ	O	resequencing	amod	6	SENT_378	[p11l1302t2084r1510b2121],
6	efforts	NNS	O	effort	prep_from	2	SENT_378	[p11l1523t2082r1621b2112],
7	with	IN	O	with	_	0	SENT_378	[p11l1633t2082r1703b2112],
8	larger	JJR	O	larger	amod	10	SENT_378	[p11l1716t2082r1808b2121],
9	sample	NN	O	sample	nn	10	SENT_378	[p11l1822t2082r1929b2121],
10	sizes	NNS	O	size	prep_with	6	SENT_378	[p11l1943t2084r2013b2112],
11	and	CC	O	and	_	0	SENT_378	[p11l2027t2082r2083b2112],
12	more	JJR	O	more	dep	13	SENT_378	[p11l565t2143r646b2161],
13	detailed	JJ	O	detailed	amod	15	SENT_378	[p11l662t2132r784b2161],
14	genetic	JJ	O	genetic	amod	15	SENT_378	[p11l800t2134r912b2171],
15	information	NN	O	information	prep_with	6	SENT_378	[p11l926t2132r1114b2161],
16	may	MD	O	may	aux	17	SENT_378	[p11l1128t2143r1195b2171],
17	help	VB	O	help	_	0	SENT_378	[p11l1207t2132r1274b2171],
18	clarify	VB	O	clarify	xcomp	17	SENT_378	[p11l1290t2132r1388b2171],
19	the	DT	O	the	det	20	SENT_378	[p11l1401t2132r1450b2161],
20	inﬂuence	NN	O	inﬂuence	dobj	18	SENT_378	[p11l1465t2132r1608b2161],
21	of	IN	O	of	_	0	SENT_378	[p11l1623t2132r1657b2161],
22	genetic	JJ	O	genetic	amod	23	SENT_378	[p11l1669t2134r1781b2171],
23	polymorphisms	NNS	O	polymorphism	prep_of	20	SENT_378	[p11l1795t2132r2038b2171],
24	in	IN	O	in	_	0	SENT_378	[p11l2053t2134r2083b2161],
25	ABCB1	NN	O	abcb1	prep_in	18	SENT_378	[p11l561t2182r687b2210],
26	.	.	O	.	_	0	SENT_378	[p11l561t2182r687b2210],

1	Breast	NN	O	breast	nn	4	SENT_379	[p11l565t2313r686b2344],
2	Cancer	NN	O	cancer	nn	4	SENT_379	[p11l698t2313r835b2344],
3	Resistance	NN	O	resistance	nn	4	SENT_379	[p11l846t2313r1046b2344],
4	Protein	NN	O	protein	_	0	SENT_379	[p11l1059t2313r1202b2344],

1	Breast	NN	O	breast	nsubjpass	10	SENT_380	[p11l565t2383r663b2410],
2	cancer	NN	O	cancer	nn	8	SENT_380	[p11l677t2392r778b2410],
3	resistance	NN	O	resistance	nn	8	SENT_380	[p11l791t2383r943b2410],
4	protein	NN	O	protein	nn	8	SENT_380	[p11l957t2383r1071b2420],
5	(	CD	NUMBER	(	num	8	SENT_380	[p11l1086t2382r1287b2418],
6	BCRP/ABC	NN	O	bcrp/abc	nn	8	SENT_380	[p11l1086t2382r1287b2418],
7	G2	NN	O	g2	nn	8	SENT_380	[p11l1288t2382r1343b2418],
8	)	NN	O	)	dep	1	SENT_380	[p11l1288t2382r1343b2418],
9	is	VBZ	O	be	auxpass	10	SENT_380	[p11l1358t2383r1380b2410],
10	expressed	VBN	O	express	dep	37	SENT_380	[p11l1395t2381r1544b2420],
11	on	IN	O	on	_	0	SENT_380	[p11l1558t2392r1597b2410],
12	the	DT	O	the	det	14	SENT_380	[p11l1611t2381r1660b2410],
13	luminal	JJ	O	luminal	amod	14	SENT_380	[p11l1674t2381r1792b2410],
14	membrane	NN	O	membrane	prep_on	10	SENT_380	[p11l1806t2381r1973b2410],
15	of	IN	O	of	_	0	SENT_380	[p11l1988t2381r2022b2410],
16	enterocytes	NNS	O	enterocyte	prep_of	14	SENT_380	[p11l2032t2392r2082b2410, p11l565t2440r714b2470],
17	,	,	O	,	_	0	SENT_380	[p11l2032t2392r2082b2410, p11l565t2440r714b2470],
18	with	IN	O	with	_	0	SENT_380	[p11l730t2431r799b2461],
19	greatest	JJS	O	greatest	amod	20	SENT_380	[p11l815t2440r938b2470],
20	expression	NN	O	expression	prep_with	10	SENT_380	[p11l953t2433r1116b2470],
21	observed	VBN	O	observe	partmod	20	SENT_380	[p11l1131t2431r1270b2461],
22	in	IN	O	in	_	0	SENT_380	[p11l1285t2433r1315b2460],
23	the	DT	O	the	det	24	SENT_380	[p11l1330t2431r1379b2461],
24	duodenum	NN	O	duodenum	prep_in	21	SENT_380	[p11l1395t2431r1571b2467],
25	;	:	O	;	_	0	SENT_380	[p11l1395t2431r1571b2467],
26	it	PRP	O	it	nsubj	28	SENT_380	[p11l1587t2433r1610b2461],
27	is	VBZ	O	be	cop	28	SENT_380	[p11l1624t2433r1646b2461],
28	important	JJ	O	important	parataxis	10	SENT_380	[p11l1662t2433r1820b2470],
29	for	IN	O	for	_	0	SENT_380	[p11l1835t2432r1880b2461],
30	limiting	VBG	O	limit	prepc_for	28	SENT_380	[p11l1894t2431r2019b2470],
31	the	DT	O	the	det	33	SENT_380	[p11l2034t2431r2083b2461],
32	oral	JJ	O	oral	amod	33	SENT_380	[p11l565t2494r625b2523],
33	bioavailability	NN	O	bioavailability	dobj	30	SENT_380	[p11l635t2494r855b2533],
34	of	IN	O	of	_	0	SENT_380	[p11l864t2494r899b2523],
35	its	PRP$	O	its	poss	36	SENT_380	[p11l904t2495r939b2523],
36	substrates	NNS	O	substrate	prep_of	33	SENT_380	[p11l950t2494r1103b2523],
37	(	VBP	O	(	_	0	SENT_380	[p11l1114t2495r1140b2530],
38	1	CD	NUMBER	1	num	39	SENT_380	[p11l1114t2495r1140b2530],
39	5	CD	NUMBER	5	dobj	37	SENT_380	[p11l1147t2495r1161b2523],
40	3	CD	NUMBER	3	num	41	SENT_380	[p11l1166t2495r1202b2530],
41	)	NN	O	)	nsubj	37	SENT_380	[p11l1166t2495r1202b2530],
42	.	.	O	.	_	0	SENT_380	[p11l1166t2495r1202b2530],

1	BCRP	NN	O	bcrp	nsubjpass	4	SENT_381	[p11l1214t2495r1314b2523],
2	is	VBZ	O	be	auxpass	4	SENT_381	[p11l1325t2495r1347b2523],
3	also	RB	O	also	advmod	4	SENT_381	[p11l1359t2494r1417b2523],
4	expressed	VBN	O	express	_	0	SENT_381	[p11l1428t2494r1577b2532],
5	on	IN	O	on	_	0	SENT_381	[p11l1588t2505r1627b2523],
6	the	DT	O	the	det	8	SENT_381	[p11l1637t2494r1686b2523],
7	canalicular	JJ	O	canalicular	amod	8	SENT_381	[p11l1697t2494r1865b2523],
8	membrane	NN	O	membrane	prep_on	4	SENT_381	[p11l1875t2494r2042b2523],
9	of	IN	O	of	_	0	SENT_381	[p11l2053t2494r2087b2523],
10	hepatocytes	NNS	O	hepatocyte	prep_of	8	SENT_381	[p11l564t2566r757b2605],
11	,	,	O	,	_	0	SENT_381	[p11l564t2566r757b2605],
12	where	WRB	O	where	advmod	15	SENT_381	[p11l767t2566r863b2595],
13	it	PRP	O	it	nsubjpass	15	SENT_381	[p11l873t2568r896b2595],
14	is	VBZ	O	be	auxpass	15	SENT_381	[p11l905t2568r927b2595],
15	involved	VBN	O	involve	rcmod	10	SENT_381	[p11l938t2566r1070b2595],
16	in	IN	O	in	_	0	SENT_381	[p11l1080t2568r1110b2595],
17	facilitating	VBG	O	facilitate	prepc_in	15	SENT_381	[p11l1120t2566r1288b2605],
18	biliary	JJ	O	biliary	amod	19	SENT_381	[p11l1297t2566r1398b2605],
19	excretion	NN	O	excretion	dobj	17	SENT_381	[p11l1407t2568r1559b2601],
20	,	,	O	,	_	0	SENT_381	[p11l1407t2568r1559b2601],
21	and	CC	O	and	_	0	SENT_381	[p11l1571t2566r1627b2595],
22	found	VBN	O	find	conj_and	4	SENT_381	[p11l1637t2566r1728b2595],
23	in	IN	O	in	_	0	SENT_381	[p11l1738t2568r1768b2595],
24	sanctuary	NN	O	sanctuary	nn	25	SENT_381	[p11l1778t2574r1928b2605],
25	sites	NNS	O	site	prep_in	22	SENT_381	[p11l1937t2568r2002b2595],
26	such	JJ	O	such	_	0	SENT_381	[p11l2013t2566r2083b2595],
27	as	IN	O	as	_	0	SENT_381	[p11l565t2626r593b2644],
28	the	DT	O	the	det	32	SENT_381	[p11l609t2615r657b2644],
29	blood	NN	O	blood	nn	32	SENT_381	[p11l672t2615r858b2644],
30	—	NN	O	—	nn	32	SENT_381	[p11l672t2615r858b2644],
31	brain	NN	O	brain	nn	32	SENT_381	[p11l672t2615r858b2644],
32	barrier	NN	O	barrier	prep_such_as	25	SENT_381	[p11l873t2615r988b2651],
33	,	,	O	,	_	0	SENT_381	[p11l873t2615r988b2651],
34	placenta	NN	O	placenta	prep_such_as	25	SENT_381	[p11l1004t2615r1141b2654],
35	,	,	O	,	_	0	SENT_381	[p11l1004t2615r1141b2654],
36	and	CC	O	and	_	0	SENT_381	[p11l1158t2615r1213b2644],
37	testes	NNS	O	testis	conj_and	32	SENT_381	[p11l1228t2623r1322b2644],
38	.	.	O	.	_	0	SENT_381	[p11l1228t2623r1322b2644],

1	BCRP	NN	O	bcrp	nn	2	SENT_382	[p11l1338t2616r1438b2644],
2	substrates	NNS	O	substrate	nsubj	3	SENT_382	[p11l1454t2615r1607b2644],
3	include	VBP	O	include	_	0	SENT_382	[p11l1621t2615r1736b2644],
4	numerous	JJ	O	numerous	amod	6	SENT_382	[p11l1750t2626r1906b2644],
5	anticancer	JJ	O	anticancer	amod	6	SENT_382	[p11l1922t2617r2083b2644],
6	agents	NNS	O	agent	dobj	3	SENT_382	[p11l565t2674r672b2704],
7	,	,	O	,	_	0	SENT_382	[p11l565t2674r672b2704],
8	such	JJ	O	such	_	0	SENT_382	[p11l685t2665r755b2694],
9	as	IN	O	as	_	0	SENT_382	[p11l767t2676r795b2694],
10	the	DT	O	the	det	14	SENT_382	[p11l807t2665r856b2694],
11	topoisomerase	NN	O	topoisomerase	nn	14	SENT_382	[p11l868t2667r1093b2704],
12	II	CD	NUMBER	ii	num	14	SENT_382	[p11l1105t2667r1132b2694],
13	inhibitor	NN	O	inhibitor	nn	14	SENT_382	[p11l1143t2665r1282b2694],
14	etoposide	NN	O	etoposide	prep_such_as	6	SENT_382	[p11l1294t2665r1451b2704],
15	,	,	O	,	_	0	SENT_382	[p11l1294t2665r1451b2704],
16	the	DT	O	the	det	19	SENT_382	[p11l1464t2665r1513b2694],
17	camptothecin	NN	O	camptothecin	nn	19	SENT_382	[p11l1525t2665r1739b2704],
18	derivatives	NNS	O	derivative	nn	19	SENT_382	[p11l1751t2665r1916b2694],
19	topotecan	NN	O	topotecan	prep_such_as	6	SENT_382	[p11l1928t2673r2083b2704],
20	and	CC	O	and	_	0	SENT_382	[p11l565t2715r621b2744],
21	irinotecan	NN	O	irinotecan	prep_such_as	6	SENT_382	[p11l629t2717r796b2750],
22	,	,	O	,	_	0	SENT_382	[p11l629t2717r796b2750],
23	and	CC	O	and	_	0	SENT_382	[p11l806t2715r861b2744],
24	the	DT	O	the	det	26	SENT_382	[p11l870t2715r919b2744],
25	tyrosine	NN	O	tyrosine	nn	26	SENT_382	[p11l927t2717r1053b2754],
26	kinase	NN	O	kinase	dobj	3	SENT_382	[p11l1061t2715r1157b2744],
27	inhibitors	NNS	O	inhibitor	nn	28	SENT_382	[p11l1166t2715r1318b2744],
28	imatinib	NN	O	imatinib	dep	26	SENT_382	[p11l1326t2715r1457b2744],
29	and	CC	O	and	_	0	SENT_382	[p11l1466t2715r1521b2744],
30	geﬁtinib	NN	O	geﬁtinib	dep	26	SENT_382	[p11l1530t2715r1668b2754],
31	.	.	O	.	_	0	SENT_382	[p11l1530t2715r1668b2754],

1	Other	JJ	O	other	amod	2	SENT_383	[p11l1679t2715r1774b2744],
2	substrates	NNS	O	substrate	nsubj	5	SENT_383	[p11l1782t2715r1934b2744],
3	of	IN	O	of	_	0	SENT_383	[p11l1944t2715r1978b2744],
4	BCRP	NN	O	bcrp	prep_of	2	SENT_383	[p11l1982t2716r2082b2744],
5	include	VBP	O	include	_	0	SENT_383	[p11l565t2765r679b2794],
6	statins	NNS	O	statin	dobj	5	SENT_383	[p11l693t2767r800b2800],
7	,	,	O	,	_	0	SENT_383	[p11l693t2767r800b2800],
8	antibiotics	NNS	O	antibiotic	dobj	5	SENT_383	[p11l816t2765r986b2800],
9	,	,	O	,	_	0	SENT_383	[p11l816t2765r986b2800],
10	numerous	JJ	O	numerous	amod	12	SENT_383	[p11l1001t2776r1157b2794],
11	environmental	JJ	O	environmental	amod	12	SENT_383	[p11l1172t2765r1400b2794],
12	toxins	NNS	O	toxin	dobj	5	SENT_383	[p11l1414t2767r1515b2800],
13	,	,	O	,	_	0	SENT_383	[p11l1414t2767r1515b2800],
14	and	CC	O	and	_	0	SENT_383	[p11l1531t2765r1586b2794],
15	endogenous	JJ	O	endogenous	amod	16	SENT_383	[p11l1601t2765r1788b2804],
16	substrates	NNS	O	substrate	conj_and	6	SENT_383	[p11l1803t2765r1955b2794],
17	such	JJ	O	such	_	0	SENT_383	[p11l1970t2765r2040b2794],
18	as	IN	O	as	_	0	SENT_383	[p11l2054t2776r2082b2794],
19	conjugated	VBN	O	conjugate	prepc_such_as	16	SENT_383	[p11l565t2815r736b2854],
20	steroid	NN	O	steroid	nn	21	SENT_383	[p11l748t2815r854b2844],
21	hormones	NNS	O	hormone	dobj	19	SENT_383	[p11l865t2815r1031b2850],
22	,	,	O	,	_	0	SENT_383	[p11l865t2815r1031b2850],
23	folates	NNS	O	folate	conj_and	21	SENT_383	[p11l1044t2815r1153b2850],
24	,	,	O	,	_	0	SENT_383	[p11l1044t2815r1153b2850],
25	and	CC	O	and	_	0	SENT_383	[p11l1166t2815r1221b2844],
26	uric	JJ	O	uric	amod	28	SENT_383	[p11l1232t2816r1293b2844],
27	acid	NN	O	acid	nn	28	SENT_383	[p11l1304t2815r1366b2844],
28	(	NN	O	(	conj_and	21	SENT_383	[p11l1378t2816r1542b2851],
29	154-156	CD	NUMBER	154-156	num	30	SENT_383	[p11l1378t2816r1542b2851],
30	)	NN	O	)	dep	28	SENT_383	[p11l1378t2816r1542b2851],
31	.	.	O	.	_	0	SENT_383	[p11l1378t2816r1542b2851],

1	Bcrp	NN	O	bcrp	nsubj	9	SENT_384	[p11l615t2866r688b2903],
2	1	CD	NUMBER	1	num	6	SENT_384	[p11l694t2867r705b2893],
3	"	``	O	"	punct	6	SENT_384	[p11l711t2862r757b2885],
4	/	:	O	/	punct	6	SENT_384	[p11l711t2862r757b2885],
5	'	''	O	'	_	0	SENT_384	[p11l711t2862r757b2885],
6	mice	NNS	O	mouse	dep	1	SENT_384	[p11l768t2866r841b2894],
7	have	VBP	O	have	aux	9	SENT_384	[p11l849t2865r919b2894],
8	been	VBN	O	be	cop	9	SENT_384	[p11l927t2865r1001b2894],
9	useful	JJ	O	useful	_	0	SENT_384	[p11l1008t2865r1100b2894],
10	in	IN	O	in	_	0	SENT_384	[p11l1107t2866r1138b2893],
11	elucidating	VBG	O	elucidate	prepc_in	9	SENT_384	[p11l1145t2865r1319b2903],
12	the	DT	O	the	det	14	SENT_384	[p11l1325t2865r1374b2894],
13	relative	JJ	O	relative	amod	14	SENT_384	[p11l1381t2865r1496b2894],
14	contribution	NN	O	contribution	dobj	11	SENT_384	[p11l1504t2865r1701b2894],
15	of	IN	O	of	_	0	SENT_384	[p11l1708t2865r1742b2894],
16	Bcrpl	NNP	LOCATION	Bcrpl	prep_of	14	SENT_384	[p11l1746t2866r1835b2903],
17	to	TO	O	to	_	0	SENT_384	[p11l1846t2873r1877b2894],
18	drug	NN	O	drug	nn	19	SENT_384	[p11l1885t2865r1958b2903],
19	absorption	NN	O	absorption	prep_to	11	SENT_384	[p11l1965t2865r2082b2903, p11l565t2916r635b2950],
20	,	,	O	,	_	0	SENT_384	[p11l1965t2865r2082b2903, p11l565t2916r635b2950],
21	distribution	NN	O	distribution	appos	19	SENT_384	[p11l645t2914r837b2950],
22	,	,	O	,	_	0	SENT_384	[p11l645t2914r837b2950],
23	and	CC	O	and	_	0	SENT_384	[p11l846t2915r902b2944],
24	excretion	NN	O	excretion	prepc_in	9	SENT_384	[p11l910t2916r1054b2944],
25	in	IN	O	in	_	0	SENT_384	[p11l1061t2916r1092b2943],
26	tissues	NNS	O	tissue	prep_in	24	SENT_384	[p11l1099t2916r1199b2944],
27	where	WRB	O	where	advmod	36	SENT_384	[p11l1206t2915r1302b2944],
28	other	JJ	O	other	amod	30	SENT_384	[p11l1310t2915r1394b2944],
29	ABC	NNP	ORGANIZATION	ABC	nn	30	SENT_384	[p11l1400t2916r1477b2944],
30	transporters	NNS	O	transporter	nsubj	36	SENT_384	[p11l1485t2923r1674b2953],
31	with	IN	O	with	_	0	SENT_384	[p11l1681t2915r1751b2944],
32	overlapping	VBG	O	overlap	amod	33	SENT_384	[p11l1759t2915r1945b2953],
33	function	NN	O	function	prep_with	30	SENT_384	[p11l1952t2915r2083b2944],
34	may	MD	O	may	aux	36	SENT_384	[p11l565t2976r631b3003],
35	be	VB	O	be	cop	36	SENT_384	[p11l637t2964r673b2994],
36	present	JJ	DATE	present	advcl	11	SENT_384	[p11l681t2973r804b3003],
37	.	.	O	.	_	0	SENT_384	[p11l681t2973r804b3003],

1	The	DT	O	the	det	2	SENT_385	[p11l813t2965r880b2994],
2	ﬁrst	NN	O	ﬁrst	nsubj	15	SENT_385	[p11l889t2965r950b2994],
3	in	FW	O	in	nn	4	SENT_385	[p11l957t2966r987b2993],
4	vivo	FW	O	vivo	advmod	5	SENT_385	[p11l994t2966r1059b2994],
5	evidence	NN	O	evidence	rcmod	2	SENT_385	[p11l1068t2964r1203b2994],
6	for	IN	O	for	_	0	SENT_385	[p11l1212t2965r1257b2994],
7	another	DT	O	another	det	8	SENT_385	[p11l1265t2964r1386b2994],
8	transporter	NN	O	transporter	prep_for	5	SENT_385	[p11l1394t2973r1570b3003],
9	active	JJ	O	active	amod	8	SENT_385	[p11l1578t2966r1667b2994],
10	along	IN	O	along	_	0	SENT_385	[p11l1676t2964r1762b3004],
11	with	IN	O	with	prepc_along_with	9	SENT_385	[p11l1768t2965r1838b2994],
12	P-glycoprotein	NN	MISC	p-glycoprotein	pobj	9	SENT_385	[p11l1846t2964r2083b3004],
13	was	VBD	O	be	cop	15	SENT_385	[p11l564t3026r620b3044],
14	the	DT	O	the	det	15	SENT_385	[p11l631t3015r680b3044],
15	observation	NN	O	observation	_	0	SENT_385	[p11l692t3015r874b3044],
16	that	IN	O	that	complm	32	SENT_385	[p11l885t3015r946b3044],
17	the	DT	O	the	det	19	SENT_385	[p11l957t3015r1005b3044],
18	oral	JJ	O	oral	amod	19	SENT_385	[p11l1017t3015r1077b3044],
19	bioavailability	NN	O	bioavailability	nsubjpass	32	SENT_385	[p11l1088t3015r1308b3054],
20	of	IN	O	of	_	0	SENT_385	[p11l1318t3015r1353b3044],
21	topotecan	NN	O	topotecan	prep_of	19	SENT_385	[p11l1360t3023r1523b3053],
22	,	,	O	,	_	0	SENT_385	[p11l1360t3023r1523b3053],
23	a	DT	O	a	det	25	SENT_385	[p11l1536t3026r1550b3044],
24	shared	JJ	O	shared	amod	25	SENT_385	[p11l1562t3015r1663b3044],
25	P-glycoprotein	NN	MISC	p-glycoprotein	appos	21	SENT_385	[p11l1674t3015r1911b3054],
26	and	CC	O	and	_	0	SENT_385	[p11l1923t3015r1978b3044],
27	Bcrpl	NN	PERSON	bcrpl	nn	28	SENT_385	[p11l1990t3016r2079b3053],
28	substrate	NN	O	substrate	conj_and	25	SENT_385	[p11l565t3065r713b3100],
29	,	,	O	,	_	0	SENT_385	[p11l565t3065r713b3100],
30	was	VBD	O	be	auxpass	32	SENT_385	[p11l722t3076r778b3094],
31	signiﬁcantly	RB	O	signiﬁcantly	advmod	32	SENT_385	[p11l787t3065r978b3104],
32	increased	VBN	O	increase	ccomp	15	SENT_385	[p11l985t3065r1131b3094],
33	when	WRB	O	when	advmod	41	SENT_385	[p11l1139t3065r1224b3094],
34	the	DT	O	the	det	35	SENT_385	[p11l1233t3065r1281b3094],
35	Bcrpl	NNP	O	Bcrpl	nsubjpass	41	SENT_385	[p11l1291t3066r1380b3103],
36	and	CC	O	and	_	0	SENT_385	[p11l1393t3065r1448b3094],
37	P-glycoprotein	NN	MISC	p-glycoprotein	nn	39	SENT_385	[p11l1457t3065r1694b3104],
38	inhibitor	NN	O	inhibitor	nn	39	SENT_385	[p11l1702t3065r1842b3094],
39	GF120916	NN	O	gf120916	nsubjpass	41	SENT_385	[p11l1851t3066r2018b3094],
40	was	VBD	O	be	auxpass	41	SENT_385	[p11l2026t3076r2082b3094],
41	coadministered	VBN	O	coadminister	advcl	32	SENT_385	[p11l565t3115r805b3145],
42	with	IN	O	with	prep	41	SENT_385	[p11l813t3116r883b3145],
43	topotecan	NN	O	topotecan	nn	45	SENT_385	[p11l892t3124r1047b3154],
44	to	TO	O	to	dep	45	SENT_385	[p11l1057t3124r1087b3145],
45	Mdrlzt/1/7	NN	O	mdrlzt/1/7	dep	42	SENT_385	[p11l1095t3113r1298b3145],
46	‘	CD	NUMBER	‘	dep	45	SENT_385	[p11l1095t3113r1298b3145],
47	/	:	O	/	punct	45	SENT_385	[p11l1095t3113r1298b3145],
48	‘	CD	NUMBER	‘	num	49	SENT_385	[p11l1095t3113r1298b3145],
49	mice	NNS	O	mouse	dep	45	SENT_385	[p11l1310t3117r1384b3145],
50	(	CD	NUMBER	(	number	51	SENT_385	[p11l1395t3116r1482b3152],
51	157	CD	NUMBER	157	num	52	SENT_385	[p11l1395t3116r1482b3152],
52	)	NN	O	)	dep	49	SENT_385	[p11l1395t3116r1482b3152],
53	.	.	O	.	_	0	SENT_385	[p11l1395t3116r1482b3152],

1	Since	IN	O	since	dep	13	SENT_386	[p11l1495t3117r1577b3145],
2	these	DT	O	these	det	4	SENT_386	[p11l1587t3115r1667b3145],
3	early	JJ	O	early	amod	4	SENT_386	[p11l1678t3116r1754b3154],
4	results	NNS	O	result	pobj	1	SENT_386	[p11l1761t3116r1871b3151],
5	,	,	O	,	_	0	SENT_386	[p11l1761t3116r1871b3151],
6	many	JJ	O	many	amod	7	SENT_386	[p11l1881t3127r1968b3154],
7	studies	NNS	O	study	appos	4	SENT_386	[p11l1976t3115r2082b3145],
8	in	IN	O	in	_	0	SENT_386	[p11l564t3167r595b3194],
9	Bcrp1	NN	O	bcrp1	prep_in	7	SENT_386	[p11l606t3163r730b3204],
10	‘	CD	NUMBER	‘	num	9	SENT_386	[p11l606t3163r730b3204],
11	/	:	O	/	punct	13	SENT_386	[p11l606t3163r730b3204],
12	‘	CD	NUMBER	‘	num	13	SENT_386	[p11l733t3173r749b3175],
13	mice	NNS	O	mouse	_	0	SENT_386	[p11l763t3167r837b3194],
14	have	VBP	O	have	aux	16	SENT_386	[p11l849t3165r919b3194],
15	been	VBN	O	be	auxpass	16	SENT_386	[p11l931t3165r1005b3194],
16	conducted	VBN	O	conduct	rcmod	13	SENT_386	[p11l1017t3165r1179b3194],
17	to	TO	O	to	aux	19	SENT_386	[p11l1191t3174r1221b3194],
18	better	JJR	O	better	advmod	19	SENT_386	[p11l1233t3165r1327b3194],
19	elucidate	VB	O	elucidate	xcomp	16	SENT_386	[p11l1338t3165r1477b3194],
20	the	DT	O	the	det	21	SENT_386	[p11l1489t3165r1538b3194],
21	role	NN	O	role	dobj	19	SENT_386	[p11l1549t3165r1610b3194],
22	of	IN	O	of	_	0	SENT_386	[p11l1622t3165r1656b3194],
23	BCRP	NN	O	bcrp	prep_of	21	SENT_386	[p11l1664t3166r1764b3194],
24	in	IN	O	in	_	0	SENT_386	[p11l1776t3167r1806b3194],
25	drug	NN	O	drug	nn	26	SENT_386	[p11l1818t3165r1891b3204],
26	penetration	NN	O	penetration	prep_in	19	SENT_386	[p11l1901t3167r2083b3204],
27	of	IN	O	of	_	0	SENT_386	[p11l565t3215r599b3244],
28	the	DT	O	the	det	29	SENT_386	[p11l606t3215r655b3244],
29	CNS	NN	O	cn	prep_of	26	SENT_386	[p11l667t3216r745b3244],
30	and	CC	O	and	_	0	SENT_386	[p11l758t3215r814b3244],
31	in	IN	O	in	_	0	SENT_386	[p11l825t3217r855b3244],
32	oral	JJ	O	oral	amod	34	SENT_386	[p11l866t3215r926b3244],
33	bioavailability	NN	O	bioavailability	nn	34	SENT_386	[p11l937t3215r1157b3254],
34	(	NN	O	(	prep_in	19	SENT_386	[p11l1167t3216r1255b3252],
35	158	CD	NUMBER	158	num	36	SENT_386	[p11l1167t3216r1255b3252],
36	)	NN	O	)	dep	19	SENT_386	[p11l1167t3216r1255b3252],
37	.	.	O	.	_	0	SENT_386	[p11l1167t3216r1255b3252],

1	Comparison	NN	O	comparison	_	0	SENT_387	[p11l615t3266r809b3304],
2	of	IN	O	of	_	0	SENT_387	[p11l824t3265r858b3294],
3	single	JJ	O	single	amod	8	SENT_387	[p11l868t3265r958b3304],
4	ABC	NNP	ORGANIZATION	ABC	nn	8	SENT_387	[p11l972t3266r1048b3294],
5	transporter	NN	O	transporter	nn	8	SENT_387	[p11l1063t3273r1239b3304],
6	gene	NN	O	gene	nn	8	SENT_387	[p11l1254t3276r1326b3304],
7	knockout	NN	O	knockout	nn	8	SENT_387	[p11l1340t3265r1488b3294],
8	mice	NNS	O	mouse	prep_of	1	SENT_387	[p11l1501t3267r1574b3294],
9	with	IN	O	with	_	0	SENT_387	[p11l1588t3265r1658b3294],
10	multiple	JJ	O	multiple	amod	13	SENT_387	[p11l1672t3265r1802b3304],
11	ABC	NNP	ORGANIZATION	ABC	nn	13	SENT_387	[p11l1816t3266r1892b3294],
12	transporter	NN	O	transporter	nn	13	SENT_387	[p11l1907t3273r2083b3304],
13	rmacol	NN	O	rmacol	prep_with	1	SENT_387	[p11l72t3210r95b3311],
14	.	.	O	.	_	0	SENT_387	[p11l72t3210r95b3311],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_388	[p11l72t3089r95b3199],
2	.	.	O	.	_	0	SENT_388	[p11l72t3089r95b3199],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_389	[p11l72t2842r96b3077],
2	-273	CD	NUMBER	-273	_	0	SENT_389	[p11l72t2842r96b3077],
3	.	.	O	.	_	0	SENT_389	[p11l72t2842r96b3077],

1	Downloaded	VBN	O	download	_	0	SENT_390	[p11l72t2661r95b2832],
2	from	IN	O	from	_	0	SENT_390	[p11l72t2588r95b2652],
3	w	NN	O	w	nn	4	SENT_390	[p11l80t2558r95b2579],
4	ww	NN	O	ww	prep_from	1	SENT_390	[p11l80t2486r95b2533],
5	.	.	O	.	_	0	SENT_390	[p11l72t2219r102b2471],

1	annualreviews.org	NN	O	annualreviews.org	nn	2	SENT_391	[p11l72t2219r102b2471],
2	iiversity	NN	O	iiversity	_	0	SENT_391	[p11l105t3203r136b3311],
3	of	IN	O	of	_	0	SENT_391	[p11l105t3164r129b3193],
4	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	2	SENT_391	[p11l105t3016r129b3158],
5	-	:	O	-	_	0	SENT_391	[p11l119t2998r122b3007],
6	Madison	NNP	O	Madison	dep	2	SENT_391	[p11l105t2871r129b2988],
7	on	IN	O	on	_	0	SENT_391	[p11l113t2830r129b2862],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_391	[p11l105t2696r129b2820],
9	.	.	O	.	_	0	SENT_391	[p11l105t2696r129b2820],

1	For	IN	O	for	_	0	SENT_392	[p11l106t2639r129b2685],
2	perso	JJ	O	perso	amod	4	SENT_392	[p11l113t2560r136b2630],
3	nal	JJ	O	nal	amod	4	SENT_392	[p11l105t2496r129b2536],
4	use	NN	O	use	pobj	1	SENT_392	[p11l113t2431r129b2474],
5	only	RB	O	only	advmod	4	SENT_392	[p11l105t2356r136b2421],
6	.	.	O	.	_	0	SENT_392	[p11l105t2356r136b2421],

1	I	PRP	O	I	nsubj	2	SENT_393	[p12l72t253r95b265],
2	mnu	VBP	O	mnu	_	0	SENT_393	[p12l72t173r95b241],
3	.	.	O	.	_	0	SENT_393	[p12l72t173r95b241],

1	Rev.	NNP	O	Rev.	nn	2	SENT_394	[p12l73t102r95b162],
2	Pha	NNP	PERSON	Pha	_	0	SENT_394	[p12l72t44r95b92],
3	by	IN	O	by	_	0	SENT_394	[p12l105t85r136b118],
4	U1	NN	O	u1	nn	7	SENT_394	[p12l106t44r129b76],
5	1	CD	NUMBER	1	num	7	SENT_394	[p12l184t2885r204b2895],
6	Xnn	NN	O	xnn	nn	7	SENT_394	[p12l181t2828r204b2875],
7	u.	NN	O	u.	prep_by	2	SENT_394	[p12l189t2793r204b2816],
8	Rev.	NNP	O	Rev.	nn	9	SENT_394	[p12l181t2723r204b2782],
9	Pharmacol	NNP	PERSON	Pharmacol	dep	7	SENT_394	[p12l181t2564r204b2712],
10	.	.	O	.	_	0	SENT_394	[p12l181t2564r204b2712],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_395	[p12l181t2444r204b2553],
2	.	.	O	.	_	0	SENT_395	[p12l181t2444r204b2553],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_396	[p12l181t2197r205b2432],
2	-273	CD	NUMBER	-273	_	0	SENT_396	[p12l181t2197r205b2432],
3	.	.	O	.	_	0	SENT_396	[p12l181t2197r205b2432],

1	Downloaded	VBN	O	download	_	0	SENT_397	[p12l181t2016r204b2187],
2	from	IN	O	from	_	0	SENT_397	[p12l181t1943r204b2007],
3	w	NN	O	w	nn	4	SENT_397	[p12l189t1913r204b1934],
4	ww	NN	O	ww	prep_from	1	SENT_397	[p12l189t1844r204b1891],
5	.	.	O	.	_	0	SENT_397	[p12l181t1683r204b1830],

1	annua1revi	NN	O	annua1revus	nn	2	SENT_398	[p12l181t1683r204b1830],
2	ews	NNS	O	ew	_	0	SENT_398	[p12l188t1618r204b1668],
3	.	.	O	.	_	0	SENT_398	[p12l188t1560r211b1603],

1	org	NN	O	org	_	0	SENT_399	[p12l188t1560r211b1603],
2	;	:	O	;	_	0	SENT_399	[p12l188t1542r211b1549],
3	by	IN	O	by	_	0	SENT_399	[p12l214t2706r245b2738],
4	University	NNP	ORGANIZATION	University	prep_by	1	SENT_399	[p12l214t2557r245b2697],
5	of	IN	ORGANIZATION	of	_	0	SENT_399	[p12l214t2518r238b2547],
6	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	1	SENT_399	[p12l214t2371r238b2512],
7	-	:	O	-	_	0	SENT_399	[p12l228t2353r231b2362],
8	Madison	NNP	O	Madison	dep	1	SENT_399	[p12l214t2226r238b2343],
9	on	IN	O	on	_	0	SENT_399	[p12l222t2185r238b2217],
10	01/05/14	CD	DATE	01/05/14	prep_on	8	SENT_399	[p12l214t2051r238b2175],
11	.	.	O	.	_	0	SENT_399	[p12l214t2051r238b2175],

1	For	IN	O	for	_	0	SENT_400	[p12l215t1994r238b2040],
2	perso	JJ	O	perso	amod	4	SENT_400	[p12l222t1915r245b1986],
3	nal	JJ	O	nal	amod	4	SENT_400	[p12l214t1854r238b1894],
4	use	NN	O	use	pobj	1	SENT_400	[p12l222t1790r238b1833],
5	only	RB	O	only	advmod	4	SENT_400	[p12l214t1715r245b1780],
6	.	.	O	.	_	0	SENT_400	[p12l214t1715r245b1780],

1	gene	NN	O	gene	nn	3	SENT_401	[p12l565t59r638b87],
2	knockout	NN	O	knockout	nn	3	SENT_401	[p12l654t48r801b77],
3	mice	NNS	O	mouse	nsubj	6	SENT_401	[p12l816t50r890b77],
4	may	MD	O	may	aux	6	SENT_401	[p12l906t59r972b87],
5	be	VB	O	be	cop	6	SENT_401	[p12l987t48r1023b77],
6	useful	JJ	O	useful	_	0	SENT_401	[p12l1038t48r1131b77],
7	in	IN	O	in	_	0	SENT_401	[p12l1147t50r1177b77],
8	understanding	VBG	O	understand	prepc_in	6	SENT_401	[p12l1192t48r1420b87],
9	the	DT	O	the	det	11	SENT_401	[p12l1435t48r1484b77],
10	overlapping	VBG	O	overlap	amod	11	SENT_401	[p12l1500t48r1686b87],
11	functions	NNS	O	function	nsubj	17	SENT_401	[p12l1702t48r1846b77],
12	of	IN	O	of	_	0	SENT_401	[p12l1863t48r1898b77],
13	BCRP	NN	O	bcrp	prep_of	11	SENT_401	[p12l1910t49r2010b77],
14	and	CC	O	and	_	0	SENT_401	[p12l2027t48r2083b77],
15	P	NN	O	p	prep_of	11	SENT_401	[p12l565t98r802b137],
16	—	CD	NUMBER	—	num	17	SENT_401	[p12l565t98r802b137],
17	glycoprotein	NN	O	glycoprotein	xcomp	8	SENT_401	[p12l565t98r802b137],
18	with	IN	O	with	_	0	SENT_401	[p12l814t98r884b127],
19	members	NNS	O	member	prep_with	17	SENT_401	[p12l898t98r1042b127],
20	of	IN	O	of	_	0	SENT_401	[p12l1057t98r1091b127],
21	the	DT	O	the	det	22	SENT_401	[p12l1101t98r1150b127],
22	MRPS	NNP	O	MRPS	prep_of	19	SENT_401	[p12l1163t99r1271b133],
23	,	,	O	,	_	0	SENT_401	[p12l1163t99r1271b133],
24	as	IN	O	as	mark	25	SENT_401	[p12l1287t109r1315b127],
25	demonstrated	VBN	O	demonstrate	advcl	6	SENT_401	[p12l1331t98r1545b127],
26	by	IN	O	by	_	0	SENT_401	[p12l1560t98r1598b137],
27	studies	NNS	O	study	prep_by	25	SENT_401	[p12l1611t98r1717b127],
28	of	IN	O	of	_	0	SENT_401	[p12l1732t98r1766b127],
29	methotrexate	NN	O	methotrexate	nn	30	SENT_401	[p12l1776t98r1983b127],
30	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	27	SENT_401	[p12l1997t98r2082b136, p12l564t148r768b177],
31	in	IN	O	in	_	0	SENT_401	[p12l782t149r812b176],
32	double	JJ	O	double	amod	36	SENT_401	[p12l826t148r932b177],
33	and	CC	O	and	_	0	SENT_401	[p12l947t148r1002b177],
34	triple	JJ	O	triple	amod	36	SENT_401	[p12l1016t148r1099b186],
35	knockout	JJ	O	knockout	amod	36	SENT_401	[p12l1113t148r1261b177],
36	animals	NNS	O	animal	prep_in	30	SENT_401	[p12l1274t148r1400b177],
37	.	.	O	.	_	0	SENT_401	[p12l1274t148r1400b177],

1	For	IN	O	for	_	0	SENT_402	[p12l1415t149r1472b177],
2	example	NN	O	example	prep_for	14	SENT_402	[p12l1486t148r1621b186],
3	,	,	O	,	_	0	SENT_402	[p12l1486t148r1621b186],
4	plasma	NN	O	plasma	nn	5	SENT_402	[p12l1636t148r1744b186],
5	concentration	NN	O	concentration	nsubj	14	SENT_402	[p12l1758t149r1976b177],
6	of	IN	O	of	_	0	SENT_402	[p12l1990t148r2024b177],
7	the	DT	O	the	det	10	SENT_402	[p12l2034t148r2082b177],
8	toxic	JJ	O	toxic	amod	10	SENT_402	[p12l565t199r640b227],
9	metabolite	NN	O	metabolite	nn	10	SENT_402	[p12l656t197r822b227],
10	7-hydroxymethotrexate	NN	O	7-hydroxymethotrexate	prep_of	5	SENT_402	[p12l841t198r1209b236],
11	was	VBD	O	be	cop	14	SENT_402	[p12l1224t209r1280b227],
12	not	RB	O	not	neg	14	SENT_402	[p12l1297t206r1350b227],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_402	[p12l1366t197r1557b236],
14	different	JJ	O	different	_	0	SENT_402	[p12l1573t198r1706b227],
15	in	IN	O	in	_	0	SENT_402	[p12l1722t199r1752b226],
16	Bcrpl	NNP	O	Bcrpl	prep_in	14	SENT_402	[p12l1769t195r1911b236],
17	‘	CD	NUMBER	‘	num	16	SENT_402	[p12l1769t195r1911b236],
18	/	:	O	/	punct	20	SENT_402	[p12l1769t195r1911b236],
19	"	``	O	"	punct	20	SENT_402	[p12l1769t195r1911b236],
20	mice	NNS	O	mouse	dep	16	SENT_402	[p12l1931t199r2013b233],
21	,	,	O	,	_	0	SENT_402	[p12l1931t199r2013b233],
22	but	CC	O	but	_	0	SENT_402	[p12l2031t198r2084b227],
23	6.2-fold	RB	O	6.2-fold	advmod	24	SENT_402	[p12l565t259r688b289],
24	increased	VBN	O	increase	dep	37	SENT_402	[p12l702t259r848b289],
25	in	IN	O	in	_	0	SENT_402	[p12l862t261r892b288],
26	Mrp2	NN	O	mrp2	prep_in	24	SENT_402	[p12l905t257r1044b298],
27	‘	CD	NUMBER	‘	num	26	SENT_402	[p12l905t257r1044b298],
28	/	:	O	/	punct	30	SENT_402	[p12l905t257r1044b298],
29	‘	CD	NUMBER	‘	num	30	SENT_402	[p12l905t257r1044b298],
30	mice	NNS	O	mouse	dep	26	SENT_402	[p12l1061t261r1135b289],
31	and	CC	O	and	_	0	SENT_402	[p12l1150t259r1205b289],
32	12.4-fold	RB	O	12.4-fold	advmod	33	SENT_402	[p12l1223t259r1362b289],
33	increased	VBN	O	increase	dep	37	SENT_402	[p12l1376t259r1522b289],
34	in	IN	O	in	_	0	SENT_402	[p12l1536t261r1566b288],
35	Mrp2	NN	O	mrp2	prep_in	33	SENT_402	[p12l1579t257r1823b298],
36	;	:	O	;	_	0	SENT_402	[p12l1579t257r1823b298],
37	Bcrp1	NN	O	bcrp1	appos	20	SENT_402	[p12l1579t257r1823b298],
38	‘	CD	NUMBER	‘	dep	37	SENT_402	[p12l1579t257r1823b298],
39	/	:	O	/	punct	20	SENT_402	[p12l1579t257r1823b298],
40	‘	CD	NUMBER	‘	num	41	SENT_402	[p12l1579t257r1823b298],
41	mice	NNS	O	mouse	dep	16	SENT_402	[p12l1840t261r1913b289],
42	compared	VBN	O	compare	_	0	SENT_402	[p12l1928t259r2082b298],
43	with	IN	O	with	prepc_compared_with	41	SENT_402	[p12l564t309r633b338],
44	wild	JJ	O	wild	amod	47	SENT_402	[p12l646t309r795b348],
45	—	NN	O	—	nn	47	SENT_402	[p12l646t309r795b348],
46	type	NN	O	type	nn	47	SENT_402	[p12l646t309r795b348],
47	animals	NNS	O	animal	pobj	41	SENT_402	[p12l810t309r936b338],
48	.	.	O	.	_	0	SENT_402	[p12l810t309r936b338],

1	These	DT	O	these	det	2	SENT_403	[p12l950t309r1048b338],
2	results	NNS	O	result	nsubj	3	SENT_403	[p12l1062t309r1163b338],
3	indicate	VBP	O	indicate	_	0	SENT_403	[p12l1177t309r1300b338],
4	that	IN	O	that	complm	11	SENT_403	[p12l1315t309r1377b338],
5	both	CC	O	both	preconj	6	SENT_403	[p12l1390t309r1462b338],
6	Mrp2	NN	O	mrp2	nsubj	11	SENT_403	[p12l1474t311r1561b348],
7	and	CC	O	and	_	0	SENT_403	[p12l1579t309r1634b338],
8	Bcrpl	NN	O	bcrpl	nsubj	11	SENT_403	[p12l1649t311r1738b348],
9	are	VBP	O	be	cop	11	SENT_403	[p12l1756t320r1803b338],
10	important	JJ	O	important	amod	11	SENT_403	[p12l1817t311r1975b348],
11	determinants	NNS	O	determinant	ccomp	3	SENT_403	[p12l1989t309r2082b338, p12l565t360r689b387],
12	of	IN	O	of	_	0	SENT_403	[p12l706t358r740b387],
13	methotrexate	NN	O	methotrexate	nn	14	SENT_403	[p12l753t358r960b387],
14	distribution	NN	O	distribution	prep_of	11	SENT_403	[p12l977t358r1161b387],
15	but	CC	O	but	_	0	SENT_403	[p12l1177t358r1229b387],
16	that	IN	O	that	complm	20	SENT_403	[p12l1245t358r1307b387],
17	Mrp2	NN	O	mrp2	nsubj	20	SENT_403	[p12l1321t359r1408b396],
18	is	VBZ	O	be	cop	20	SENT_403	[p12l1427t360r1449b387],
19	better	RBR	O	better	advmod	20	SENT_403	[p12l1466t358r1560b387],
20	able	JJ	O	able	ccomp	3	SENT_403	[p12l1576t358r1638b387],
21	than	IN	O	than	_	0	SENT_403	[p12l1655t358r1724b387],
22	Bcrpl	NN	PERSON	bcrpl	prep_than	20	SENT_403	[p12l1741t359r1830b396],
23	to	TO	O	to	aux	24	SENT_403	[p12l1850t366r1881b387],
24	compensate	VB	O	compensate	xcomp	20	SENT_403	[p12l1898t366r2082b396],
25	for	IN	O	for	_	0	SENT_403	[p12l565t408r610b437],
26	the	DT	O	the	det	27	SENT_403	[p12l622t407r671b437],
27	loss	NN	O	loss	prep_for	24	SENT_403	[p12l683t407r739b437],
28	of	IN	O	of	_	0	SENT_403	[p12l752t408r786b437],
29	the	DT	O	the	det	34	SENT_403	[p12l794t407r843b437],
30	other	JJ	O	other	amod	34	SENT_403	[p12l856t407r940b437],
31	transporter	NN	O	transporter	nn	34	SENT_403	[p12l951t416r1127b446],
32	(	NN	O	(	nn	34	SENT_403	[p12l1140t408r1227b444],
33	159	CD	NUMBER	159	num	34	SENT_403	[p12l1140t408r1227b444],
34	)	NN	O	)	prep_of	27	SENT_403	[p12l1140t408r1227b444],
35	.	.	O	.	_	0	SENT_403	[p12l1140t408r1227b444],

1	Triple	JJ	O	triple	amod	3	SENT_404	[p12l1240t407r1341b446],
2	knockout	NN	O	knockout	nn	3	SENT_404	[p12l1353t407r1500b437],
3	Mrp2	NN	O	mrp2	_	0	SENT_404	[p12l1510t405r1853b446],
4	;	:	O	;	_	0	SENT_404	[p12l1510t405r1853b446],
5	Mrp3	NN	O	mrp3	dep	3	SENT_404	[p12l1510t405r1853b446],
6	;	:	O	;	_	0	SENT_404	[p12l1510t405r1853b446],
7	Bcrp1	NN	O	bcrp1	dep	5	SENT_404	[p12l1510t405r1853b446],
8	‘	CD	NUMBER	‘	num	7	SENT_404	[p12l1510t405r1853b446],
9	/	:	O	/	punct	3	SENT_404	[p12l1510t405r1853b446],
10	‘	CD	NUMBER	‘	num	11	SENT_404	[p12l1510t405r1853b446],
11	mice	NNS	O	mouse	nsubj	12	SENT_404	[p12l1868t409r1942b437],
12	retained	VBD	O	retain	dep	3	SENT_404	[p12l1954t407r2082b437],
13	67	CD	PERCENT	67	num	14	SENT_404	[p12l565t458r634b487],
14	%	NN	PERCENT	%	dobj	12	SENT_404	[p12l565t458r634b487],
15	of	IN	O	of	_	0	SENT_404	[p12l653t457r687b487],
16	an	DT	O	a	det	18	SENT_404	[p12l698t468r734b487],
17	intravenous	JJ	O	intravenous	amod	18	SENT_404	[p12l748t459r931b487],
18	dose	NN	O	dose	prep_of	14	SENT_404	[p12l947t457r1016b487],
19	of	IN	O	of	_	0	SENT_404	[p12l1032t457r1066b487],
20	methotrexate	NN	O	methotrexate	prep_of	18	SENT_404	[p12l1076t457r1284b487],
21	in	IN	O	in	_	0	SENT_404	[p12l1299t459r1329b486],
22	their	PRP$	O	they	poss	23	SENT_404	[p12l1344t457r1419b487],
23	livers	NNS	O	liver	prep_in	12	SENT_404	[p12l1433t457r1515b487],
24	1	CD	NUMBER	1	num	25	SENT_404	[p12l1534t459r1545b486],
25	h	NN	O	h	dep	23	SENT_404	[p12l1563t457r1583b486],
26	after	IN	O	after	_	0	SENT_404	[p12l1598t457r1669b487],
27	administration	NN	O	administration	prep_after	12	SENT_404	[p12l1684t457r1913b487],
28	compared	VBN	O	compare	_	0	SENT_404	[p12l1928t457r2082b496],
29	with	IN	O	with	prepc_compared_with	12	SENT_404	[p12l564t507r633b536],
30	wild	JJ	O	wild	amod	33	SENT_404	[p12l645t507r794b546],
31	—	NN	O	—	nn	33	SENT_404	[p12l645t507r794b546],
32	type	NN	O	type	nn	33	SENT_404	[p12l645t507r794b546],
33	mice	NNS	O	mouse	pobj	12	SENT_404	[p12l808t509r881b536],
34	that	WDT	O	that	nsubj	35	SENT_404	[p12l895t507r957b536],
35	had	VBD	O	have	rcmod	33	SENT_404	[p12l969t507r1025b536],
36	only	RB	O	only	quantmod	37	SENT_404	[p12l1039t507r1108b546],
37	7	CD	PERCENT	7	num	38	SENT_404	[p12l1120t508r1169b537],
38	%	NN	PERCENT	%	dobj	35	SENT_404	[p12l1120t508r1169b537],
39	of	IN	O	of	_	0	SENT_404	[p12l1186t507r1220b536],
40	the	DT	O	the	det	41	SENT_404	[p12l1229t507r1278b536],
41	dose	NN	O	dose	prep_of	38	SENT_404	[p12l1292t507r1361b536],
42	remaining	VBG	O	remain	partmod	41	SENT_404	[p12l1374t509r1543b546],
43	.	.	O	.	_	0	SENT_404	[p12l1374t509r1543b546],

1	These	DT	O	these	det	2	SENT_405	[p12l1556t507r1654b536],
2	results	NNS	O	result	nsubj	3	SENT_405	[p12l1667t507r1768b536],
3	highlight	VBP	O	highlight	_	0	SENT_405	[p12l1781t507r1926b546],
4	the	DT	O	the	det	7	SENT_405	[p12l1938t507r1987b536],
5	overlapping	VBG	O	overlap	amod	7	SENT_405	[p12l2001t518r2082b536, p12l565t557r682b596],
6	functional	JJ	O	functional	amod	7	SENT_405	[p12l699t557r857b586],
7	roles	NNS	O	role	dobj	3	SENT_405	[p12l875t557r950b586],
8	of	IN	O	of	_	0	SENT_405	[p12l968t557r1003b586],
9	Mrp2	NN	O	mrp2	prep_of	7	SENT_405	[p12l1015t558r1113b596],
10	,	,	O	,	_	0	SENT_405	[p12l1015t558r1113b596],
11	Mrp3	NN	O	mrp3	appos	9	SENT_405	[p12l1131t558r1229b596],
12	,	,	O	,	_	0	SENT_405	[p12l1131t558r1229b596],
13	and	CC	O	and	_	0	SENT_405	[p12l1249t557r1305b586],
14	Bcrpl	NNP	PERSON	Bcrpl	nsubj	21	SENT_405	[p12l1323t558r1412b596],
15	in	IN	O	in	_	0	SENT_405	[p12l1434t558r1464b586],
16	biliary	JJ	O	biliary	amod	17	SENT_405	[p12l1482t557r1582b596],
17	excretion	NN	O	excretion	prep_in	14	SENT_405	[p12l1599t558r1743b586],
18	of	IN	O	of	_	0	SENT_405	[p12l1762t557r1796b586],
19	toxic	JJ	O	toxic	amod	20	SENT_405	[p12l1810t558r1884b586],
20	metabolites	NNS	O	metabolite	prep_of	17	SENT_405	[p12l1902t557r2082b586],
21	(	VBP	O	(	conj_and	3	SENT_405	[p12l566t607r653b643],
22	160	CD	NUMBER	160	number	23	SENT_405	[p12l566t607r653b643],
23	)	CD	NUMBER	)	dobj	21	SENT_405	[p12l566t607r653b643],
24	.	.	O	.	_	0	SENT_405	[p12l566t607r653b643],

1	BCRP	NN	O	bcrp	nsubj	9	SENT_406	[p12l615t657r715b685],
2	is	VBZ	O	be	auxpass	3	SENT_406	[p12l728t658r750b685],
3	expressed	VBN	O	express	_	0	SENT_406	[p12l764t656r913b695],
4	in	IN	O	in	_	0	SENT_406	[p12l925t658r955b685],
5	lactating	JJ	O	lactating	amod	7	SENT_406	[p12l967t656r1102b695],
6	mammary	JJ	O	mammary	amod	7	SENT_406	[p12l1114t667r1273b695],
7	glands	NNS	O	gland	prep_in	3	SENT_406	[p12l1284t656r1383b695],
8	and	CC	O	and	_	0	SENT_406	[p12l1396t656r1452b685],
9	has	VBZ	O	have	conj_and	3	SENT_406	[p12l1464t656r1514b685],
10	a	DT	O	a	det	12	SENT_406	[p12l1527t667r1542b685],
11	demonstrated	VBN	O	demonstrate	amod	12	SENT_406	[p12l1555t656r1769b685],
12	role	NN	O	role	dobj	9	SENT_406	[p12l1781t656r1842b685],
13	in	IN	O	in	_	0	SENT_406	[p12l1855t658r1885b685],
14	active	JJ	O	active	amod	15	SENT_406	[p12l1898t658r1986b685],
15	eﬂlux	NN	O	eﬂlux	prep_in	12	SENT_406	[p12l1999t656r2084b685],
16	of	IN	O	of	_	0	SENT_406	[p12l565t705r600b735],
17	xenobiotics	NNS	O	xenobiotic	prep_of	15	SENT_406	[p12l604t705r782b735],
18	into	IN	O	into	_	0	SENT_406	[p12l792t707r855b735],
19	milk	NN	O	milk	prep_into	9	SENT_406	[p12l865t705r942b734],
20	.	.	O	.	_	0	SENT_406	[p12l865t705r942b734],

1	Levels	NNS	O	level	_	0	SENT_407	[p12l954t705r1054b735],
2	of	IN	O	of	_	0	SENT_407	[p12l1065t705r1099b735],
3	topotecan	NN	O	topotecan	prep_of	1	SENT_407	[p12l1105t714r1268b744],
4	,	,	O	,	_	0	SENT_407	[p12l1105t714r1268b744],
5	the	DT	O	the	det	8	SENT_407	[p12l1280t705r1329b735],
6	H2	NN	O	h2	nn	8	SENT_407	[p12l1339t707r1382b740],
7	blocker	NN	O	blocker	nn	8	SENT_407	[p12l1395t705r1512b735],
8	cimetidine	NN	O	cimetidine	conj_and	3	SENT_407	[p12l1522t705r1695b741],
9	,	,	O	,	_	0	SENT_407	[p12l1522t705r1695b741],
10	and	CC	O	and	_	0	SENT_407	[p12l1707t705r1763b735],
11	the	DT	O	the	det	13	SENT_407	[p12l1773t705r1822b735],
12	antibiotic	JJ	O	antibiotic	amod	13	SENT_407	[p12l1833t705r1981b735],
13	nitrofurantoin	NN	O	nitrofurantoin	conj_and	3	SENT_407	[p12l1991t707r2082b735, p12l565t755r719b791],
14	,	,	O	,	_	0	SENT_407	[p12l1991t707r2082b735, p12l565t755r719b791],
15	as	RB	O	as	_	0	SENT_407	[p12l736t766r764b784],
16	well	RB	O	well	_	0	SENT_407	[p12l778t755r842b784],
17	as	IN	O	as	_	0	SENT_407	[p12l857t766r885b784],
18	the	DT	O	the	det	20	SENT_407	[p12l901t755r950b784],
19	dietary	JJ	O	dietary	amod	20	SENT_407	[p12l965t755r1074b794],
20	carcinogen	NN	O	carcinogen	conj_and	1	SENT_407	[p12l1088t757r1259b794],
21	2-amino-1-methyl-6-phenylimidazo	JJ	O	2-amino-1-methyl-6-phenylimidazo	amod	20	SENT_407	[p12l1274t755r2082b794],
22	[	CD	NUMBER	[	tmod	21	SENT_407	[p12l1274t755r2082b794],
23	4,5-b	JJ	O	4,5-b	amod	25	SENT_407	[p12l1274t755r2082b794],
24	]	NN	O	]	nn	25	SENT_407	[p12l1274t755r2082b794],
25	pyridine	NN	O	pyridine	dep	1	SENT_407	[p12l1274t755r2082b794],

1	260	CD	NUMBER	260	num	2	SENT_408	[p12l471t862r513b884],
2	DeGorter	NNP	O	DeGorter	_	0	SENT_408	[p12l564t862r676b884],
3	et	FW	O	et	nn	4	SENT_408	[p12l683t867r703b884],
4	al.	FW	O	al.	dep	2	SENT_408	[p12l709t862r735b884],
5	.	.	O	.	_	0	SENT_408	[p12l709t862r735b884],

1	(	NN	O	(	nn	3	SENT_409	[p12l367t961r479b998],
2	PhIP	NN	O	phip	nn	3	SENT_409	[p12l367t961r479b998],
3	)	NN	O	)	_	0	SENT_409	[p12l367t961r479b998],
4	,	,	O	,	_	0	SENT_409	[p12l367t961r479b998],
5	were	VBD	O	be	cop	7	SENT_409	[p12l489t972r563b991],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_409	[p12l574t961r765b1000],
7	lower	JJR	O	lower	rcmod	3	SENT_409	[p12l772t961r860b991],
8	in	IN	O	in	_	0	SENT_409	[p12l869t963r899b990],
9	milk	NN	O	milk	prep_in	7	SENT_409	[p12l909t961r980b990],
10	from	IN	O	from	_	0	SENT_409	[p12l988t961r1064b991],
11	Bcrp1	NN	O	bcrp1	prep_from	7	SENT_409	[p12l1074t959r1197b1000],
12	‘	CD	NUMBER	‘	num	11	SENT_409	[p12l1074t959r1197b1000],
13	/	:	O	/	punct	3	SENT_409	[p12l1074t959r1197b1000],
14	‘	CD	NUMBER	‘	num	15	SENT_409	[p12l1200t969r1216b971],
15	mice	NNS	O	mouse	npadvmod	16	SENT_409	[p12l1229t963r1303b991],
16	than	IN	O	than	advmod	22	SENT_409	[p12l1313t961r1382b991],
17	from	IN	O	from	_	0	SENT_409	[p12l1392t961r1468b991],
18	wild	JJ	O	wild	amod	21	SENT_409	[p12l1476t961r1625b1000],
19	—	NN	O	—	nn	21	SENT_409	[p12l1476t961r1625b1000],
20	type	NN	O	type	nn	21	SENT_409	[p12l1476t961r1625b1000],
21	mice	NNS	O	mouse	prep_from	16	SENT_409	[p12l1635t963r1709b991],
22	(	VBP	O	(	dep	3	SENT_409	[p12l1719t962r1795b998],
23	161	CD	NUMBER	161	dobj	22	SENT_409	[p12l1719t962r1795b998],
24	,	,	O	,	_	0	SENT_409	[p12l1719t962r1795b998],
25	162	CD	NUMBER	162	num	26	SENT_409	[p12l1810t962r1883b998],
26	)	NN	O	)	appos	23	SENT_409	[p12l1810t962r1883b998],
27	.	.	O	.	_	0	SENT_409	[p12l1810t962r1883b998],

1	The	DT	O	the	det	2	SENT_410	[p12l366t1011r432b1040],
2	involvement	NN	O	involvement	nsubj	15	SENT_410	[p12l441t1011r636b1040],
3	of	IN	O	of	_	0	SENT_410	[p12l644t1011r678b1040],
4	BCRP	NN	O	bcrp	prep_of	2	SENT_410	[p12l683t1012r783b1040],
5	in	IN	O	in	_	0	SENT_410	[p12l792t1013r822b1040],
6	the	DT	O	the	det	7	SENT_410	[p12l830t1011r879b1040],
7	secretion	NN	O	secretion	prep_in	4	SENT_410	[p12l888t1013r1030b1040],
8	of	IN	O	of	_	0	SENT_410	[p12l1039t1011r1073b1040],
9	toxic	JJ	O	toxic	amod	10	SENT_410	[p12l1078t1013r1152b1040],
10	compounds	NNS	O	compound	prep_of	7	SENT_410	[p12l1161t1011r1342b1049],
11	into	IN	O	into	_	0	SENT_410	[p12l1350t1013r1412b1040],
12	breast	NN	O	breast	nn	13	SENT_410	[p12l1422t1011r1516b1040],
13	milk	NN	O	milk	prep_into	10	SENT_410	[p12l1523t1011r1594b1040],
14	is	VBZ	O	be	cop	15	SENT_410	[p12l1601t1013r1624b1040],
15	counterintuitive	JJ	O	counterintuitive	_	0	SENT_410	[p12l1633t1013r1884b1040],
16	for	IN	O	for	_	0	SENT_410	[p12l367t1060r412b1089],
17	a	DT	O	a	det	18	SENT_410	[p12l422t1071r437b1089],
18	transporter	NN	O	transporter	prep_for	15	SENT_410	[p12l447t1068r624b1099],
19	that	WDT	O	that	nsubj	21	SENT_410	[p12l633t1060r695b1089],
20	otherwise	RB	O	otherwise	advmod	21	SENT_410	[p12l705t1060r856b1089],
21	plays	VBZ	O	play	rcmod	18	SENT_410	[p12l866t1060r943b1099],
22	a	DT	O	a	det	24	SENT_410	[p12l954t1071r969b1089],
23	protective	JJ	O	protective	amod	24	SENT_410	[p12l979t1062r1136b1099],
24	role	NN	O	role	dobj	21	SENT_410	[p12l1146t1060r1216b1095],
25	,	,	O	,	_	0	SENT_410	[p12l1146t1060r1216b1095],
26	and	CC	O	and	_	0	SENT_410	[p12l1228t1060r1283b1089],
27	avoidance	NN	O	avoidance	nsubj	34	SENT_410	[p12l1294t1060r1448b1089],
28	of	IN	O	of	_	0	SENT_410	[p12l1459t1060r1493b1089],
29	BCRP	NN	O	bcrp	nn	30	SENT_410	[p12l1499t1061r1600b1089],
30	substrates	NNS	O	substrate	prep_of	27	SENT_410	[p12l1610t1060r1763b1089],
31	may	MD	O	may	aux	34	SENT_410	[p12l1774t1071r1840b1099],
32	be	VB	O	be	cop	34	SENT_410	[p12l1848t1060r1884b1089],
33	a	DT	O	a	det	34	SENT_410	[p12l367t1120r382b1139],
34	consideration	NN	O	consideration	conj_and	15	SENT_410	[p12l395t1109r607b1139],
35	for	IN	O	for	_	0	SENT_410	[p12l619t1109r665b1139],
36	nursing	NN	O	nursing	nn	37	SENT_410	[p12l676t1111r796b1148],
37	women	NNS	O	woman	prep_for	34	SENT_410	[p12l806t1120r929b1139],
38	.	.	O	.	_	0	SENT_410	[p12l806t1120r929b1139],

1	BCRP	NN	ORGANIZATION	bcrp	nsubjpass	3	SENT_411	[p12l944t1110r1044b1139],
2	was	VBD	O	be	auxpass	3	SENT_411	[p12l1056t1120r1112b1139],
3	demonstrated	VBN	O	demonstrate	_	0	SENT_411	[p12l1126t1109r1340b1139],
4	to	TO	O	to	aux	5	SENT_411	[p12l1353t1118r1383b1139],
5	concentrate	VB	O	concentrate	xcomp	3	SENT_411	[p12l1397t1117r1580b1139],
6	riboﬂavin	NN	O	riboﬂavin	nn	9	SENT_411	[p12l1592t1109r1743b1139],
7	(	NN	O	(	nn	9	SENT_411	[p12l1756t1110r1885b1146],
8	vitamin	NN	O	vitamin	nn	9	SENT_411	[p12l1756t1110r1885b1146],
9	B12	NN	O	b12	dobj	5	SENT_411	[p12l367t1160r439b1196],
10	)	CD	NUMBER	)	npadvmod	5	SENT_411	[p12l367t1160r439b1196],
11	into	IN	O	into	_	0	SENT_411	[p12l449t1161r511b1188],
12	breast	NN	O	breast	nn	13	SENT_411	[p12l520t1159r615b1188],
13	milk	NN	O	milk	prep_into	5	SENT_411	[p12l623t1159r700b1195],
14	,	,	O	,	_	0	SENT_411	[p12l623t1159r700b1195],
15	an	DT	O	a	det	16	SENT_411	[p12l711t1170r747b1188],
16	observation	NN	O	observation	appos	13	SENT_411	[p12l756t1159r938b1188],
17	that	WDT	O	that	nsubj	19	SENT_411	[p12l947t1159r1008b1188],
18	may	MD	O	may	aux	19	SENT_411	[p12l1016t1170r1082b1198],
19	provide	VB	O	provide	rcmod	16	SENT_411	[p12l1090t1159r1208b1198],
20	some	DT	O	some	det	21	SENT_411	[p12l1217t1170r1298b1188],
21	insight	NN	O	insight	dobj	19	SENT_411	[p12l1307t1159r1415b1198],
22	into	IN	O	into	_	0	SENT_411	[p12l1423t1161r1485b1188],
23	its	PRP$	O	its	poss	25	SENT_411	[p12l1494t1161r1529b1188],
24	physiological	JJ	O	physiological	amod	25	SENT_411	[p12l1538t1159r1744b1198],
25	function	NN	O	function	prep_into	19	SENT_411	[p12l1753t1159r1885b1188],
26	in	IN	O	in	_	0	SENT_411	[p12l366t1210r397b1237],
27	the	DT	O	the	det	32	SENT_411	[p12l408t1208r456b1237],
28	mammary	JJ	O	mammary	amod	32	SENT_411	[p12l467t1219r627b1247],
29	gland	NN	O	gland	nn	32	SENT_411	[p12l637t1208r722b1247],
30	(	NN	O	(	nn	32	SENT_411	[p12l734t1209r822b1245],
31	163	CD	NUMBER	163	num	32	SENT_411	[p12l734t1209r822b1245],
32	)	NN	O	)	prep_in	25	SENT_411	[p12l734t1209r822b1245],
33	.	.	O	.	_	0	SENT_411	[p12l734t1209r822b1245],

1	Reduced-function	JJ	O	reduced-function	amod	2	SENT_412	[p12l417t1257r700b1286],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_412	[p12l711t1257r953b1296],
3	in	IN	O	in	_	0	SENT_412	[p12l964t1259r995b1286],
4	ABC	NNP	ORGANIZATION	ABC	nn	5	SENT_412	[p12l1002t1258r1080b1286],
5	G2	NN	O	g2	prep_in	2	SENT_412	[p12l1081t1258r1122b1286],
6	have	VBP	O	have	aux	8	SENT_412	[p12l1136t1257r1206b1286],
7	been	VBN	O	be	auxpass	8	SENT_412	[p12l1218t1257r1292b1286],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_412	[p12l1302t1257r1460b1293],
9	,	,	O	,	_	0	SENT_412	[p12l1302t1257r1460b1293],
10	and	CC	O	and	_	0	SENT_412	[p12l1473t1257r1528b1286],
11	from	IN	O	from	_	0	SENT_412	[p12l1539t1257r1615b1286],
12	the	DT	O	the	det	14	SENT_412	[p12l1626t1257r1675b1286],
13	known	JJ	O	known	amod	14	SENT_412	[p12l1686t1257r1792b1286],
14	function	NN	O	function	prep_from	23	SENT_412	[p12l1802t1257r1884b1286, p12l367t1308r429b1336],
15	and	CC	O	and	_	0	SENT_412	[p12l447t1307r502b1336],
16	location	NN	O	location	conj_and	14	SENT_412	[p12l519t1307r645b1336],
17	of	IN	O	of	_	0	SENT_412	[p12l663t1307r697b1336],
18	BCRP	NN	O	bcrp	prep_of	14	SENT_412	[p12l711t1308r820b1343],
19	,	,	O	,	_	0	SENT_412	[p12l711t1308r820b1343],
20	they	PRP	O	they	nsubjpass	23	SENT_412	[p12l838t1307r907b1346],
21	would	MD	O	would	aux	23	SENT_412	[p12l922t1307r1018b1336],
22	be	VB	O	be	auxpass	23	SENT_412	[p12l1035t1307r1071b1336],
23	expected	VBN	O	expect	conj_and	8	SENT_412	[p12l1089t1307r1225b1346],
24	to	TO	O	to	aux	25	SENT_412	[p12l1242t1315r1273b1336],
25	increase	VB	O	increase	xcomp	23	SENT_412	[p12l1290t1308r1416b1336],
26	the	DT	O	the	det	27	SENT_412	[p12l1434t1307r1482b1336],
27	bioavailability	NN	O	bioavailability	dobj	25	SENT_412	[p12l1500t1307r1720b1346],
28	of	IN	O	of	_	0	SENT_412	[p12l1736t1307r1771b1336],
29	BCRP	NN	O	bcrp	nn	30	SENT_412	[p12l1784t1308r1884b1336],
30	substrates	NNS	O	substrate	prep_of	27	SENT_412	[p12l367t1356r520b1385],
31	owing	VBG	O	owe	partmod	30	SENT_412	[p12l534t1358r630b1395],
32	to	TO	O	to	_	0	SENT_412	[p12l643t1365r673b1385],
33	reduced	VBN	O	reduce	amod	34	SENT_412	[p12l687t1356r812b1385],
34	eﬂlux	NN	O	eﬂlux	prep_to	31	SENT_412	[p12l826t1356r910b1385],
35	from	IN	O	from	_	0	SENT_412	[p12l923t1356r999b1385],
36	enterocytes	NNS	O	enterocyte	prep_from	34	SENT_412	[p12l1013t1365r1191b1395],
37	and	CC	O	and	_	0	SENT_412	[p12l1206t1356r1261b1385],
38	reduced	VBN	O	reduce	amod	40	SENT_412	[p12l1275t1356r1399b1385],
39	biliary	JJ	O	biliary	amod	40	SENT_412	[p12l1413t1356r1514b1395],
40	excretion	NN	O	excretion	conj_and	36	SENT_412	[p12l1526t1358r1678b1385],
41	.	.	O	.	_	0	SENT_412	[p12l1526t1358r1678b1385],

1	Exposure	NN	O	exposure	nsubjpass	6	SENT_413	[p12l1693t1358r1840b1395],
2	to	TO	O	to	_	0	SENT_413	[p12l1854t1365r1884b1385],
3	sulfasalazine	NN	O	sulfasalazine	prep_to	1	SENT_413	[p12l367t1405r560b1434],
4	was	VBD	O	be	auxpass	6	SENT_413	[p12l571t1416r627b1434],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_413	[p12l640t1405r831b1444],
6	increased	VBN	O	increase	_	0	SENT_413	[p12l841t1405r987b1434],
7	in	IN	O	in	_	0	SENT_413	[p12l999t1407r1030b1434],
8	healthy	JJ	O	healthy	amod	9	SENT_413	[p12l1041t1405r1158b1444],
9	volunteers	NNS	O	volunteer	prep_in	6	SENT_413	[p12l1167t1405r1331b1434],
10	with	IN	O	with	_	0	SENT_413	[p12l1342t1405r1412b1434],
11	one	CD	NUMBER	one	num	16	SENT_413	[p12l1424t1416r1480b1434],
12	or	CC	O	or	_	0	SENT_413	[p12l1493t1416r1526b1434],
13	more	JJR	O	more	num	16	SENT_413	[p12l1538t1416r1619b1434],
14	ABC	NNP	ORGANIZATION	ABC	nn	16	SENT_413	[p12l1628t1406r1706b1434],
15	G2	NN	O	g2	nn	16	SENT_413	[p12l1707t1406r1751b1434],
16	variants	NNS	O	variant	prep_with	6	SENT_413	[p12l1762t1407r1884b1434],
17	following	VBG	O	follow	_	0	SENT_413	[p12l367t1455r516b1494],
18	oral	JJ	O	oral	amod	19	SENT_413	[p12l523t1455r583b1484],
19	administration	NN	O	administration	prep_following	16	SENT_413	[p12l591t1455r820b1484],
20	of	IN	O	of	_	0	SENT_413	[p12l828t1455r863b1484],
21	the	DT	O	the	det	23	SENT_413	[p12l867t1455r915b1484],
22	drug	NN	O	drug	nn	23	SENT_413	[p12l924t1455r997b1494],
23	(	NN	O	(	prep_of	19	SENT_413	[p12l1005t1456r1081b1492],
24	164	CD	NUMBER	164	tmod	19	SENT_413	[p12l1005t1456r1081b1492],
25	,	,	O	,	_	0	SENT_413	[p12l1005t1456r1081b1492],
26	165	CD	NUMBER	165	num	27	SENT_413	[p12l1094t1456r1167b1492],
27	)	NN	O	)	appos	24	SENT_413	[p12l1094t1456r1167b1492],
28	.	.	O	.	_	0	SENT_413	[p12l1094t1456r1167b1492],

1	These	DT	O	these	det	2	SENT_414	[p12l1176t1455r1273b1484],
2	ﬁndings	NNS	O	ﬁndings	nsubj	10	SENT_414	[p12l1282t1455r1407b1494],
3	were	VBD	O	be	cop	4	SENT_414	[p12l1414t1466r1489b1484],
4	consistent	JJ	O	consistent	_	0	SENT_414	[p12l1498t1456r1655b1484],
5	with	IN	O	with	_	0	SENT_414	[p12l1661t1455r1731b1484],
6	increased	VBN	O	increase	amod	8	SENT_414	[p12l1738t1455r1885b1484],
7	oral	JJ	O	oral	amod	8	SENT_414	[p12l367t1505r427b1534],
8	bioavailability	NN	O	bioavailability	prep_with	4	SENT_414	[p12l439t1505r660b1544],
9	and	CC	O	and	_	0	SENT_414	[p12l671t1505r727b1534],
10	reduced	VBD	O	reduce	conj_and	4	SENT_414	[p12l740t1505r864b1534],
11	excretion	NN	O	excretion	dobj	10	SENT_414	[p12l877t1507r1021b1534],
12	of	IN	O	of	_	0	SENT_414	[p12l1035t1505r1069b1534],
13	sulfasalazine	NN	O	sulfasalazine	prep_of	11	SENT_414	[p12l1077t1505r1270b1534],
14	in	IN	O	in	prep	10	SENT_414	[p12l1283t1507r1313b1534],
15	Bcrp1	NN	O	bcrp1	dep	14	SENT_414	[p12l1326t1503r1450b1543],
16	’	CD	NUMBER	’	dep	15	SENT_414	[p12l1326t1503r1450b1543],
17	/	:	O	/	punct	15	SENT_414	[p12l1326t1503r1450b1543],
18	’	CD	NUMBER	’	num	19	SENT_414	[p12l1453t1513r1469b1514],
19	mice	NNS	O	mouse	dep	15	SENT_414	[p12l1485t1507r1558b1534],
20	(	CD	NUMBER	(	number	21	SENT_414	[p12l1572t1506r1660b1541],
21	166	CD	NUMBER	166	num	22	SENT_414	[p12l1572t1506r1660b1541],
22	)	NN	O	)	dep	19	SENT_414	[p12l1572t1506r1660b1541],
23	.	.	O	.	_	0	SENT_414	[p12l1572t1506r1660b1541],

1	These	DT	O	these	det	2	SENT_415	[p12l1673t1505r1771b1534],
2	results	NNS	O	result	nsubj	3	SENT_415	[p12l1784t1505r1884b1534],
3	raised	VBD	O	raise	_	0	SENT_415	[p12l366t1566r458b1595],
4	the	DT	O	the	det	5	SENT_415	[p12l469t1566r518b1595],
5	possibility	NN	O	possibility	dobj	3	SENT_415	[p12l530t1566r690b1605],
6	of	IN	O	of	_	0	SENT_415	[p12l700t1566r734b1595],
7	using	VBG	O	use	prepc_of	5	SENT_415	[p12l741t1568r825b1605],
8	sulfasalazine	NN	O	sulfasalazine	dobj	7	SENT_415	[p12l836t1566r1029b1595],
9	as	IN	O	as	_	0	SENT_415	[p12l1041t1577r1069b1595],
10	an	DT	O	a	prep_as	7	SENT_415	[p12l1081t1577r1117b1595],
11	in	FW	O	in	nn	12	SENT_415	[p12l1128t1568r1158b1595],
12	vivo	FW	O	vivo	advmod	13	SENT_415	[p12l1168t1568r1233b1595],
13	probe	NN	O	probe	dep	10	SENT_415	[p12l1244t1566r1335b1605],
14	of	IN	O	of	_	0	SENT_415	[p12l1347t1566r1381b1595],
15	BCRP	NN	O	bcrp	nn	16	SENT_415	[p12l1389t1567r1489b1595],
16	activity	NN	O	activity	prep_of	13	SENT_415	[p12l1501t1568r1622b1605],
17	,	,	O	,	_	0	SENT_415	[p12l1501t1568r1622b1605],
18	an	DT	O	a	det	19	SENT_415	[p12l1635t1577r1670b1595],
19	especially	RB	O	especially	npadvmod	20	SENT_415	[p12l1682t1566r1833b1605],
20	attractive	JJ	O	attractive	amod	10	SENT_415	[p12l1843t1574r1884b1595, p12l367t1629r482b1657],

1	tool	NN	O	tool	nsubj	27	SENT_416	[p12l491t1628r552b1657],
2	given	VBN	O	give	prep	1	SENT_416	[p12l561t1629r644b1667],
3	that	IN	O	that	complm	12	SENT_416	[p12l653t1628r714b1657],
4	expression	NN	O	expression	nsubj	12	SENT_416	[p12l722t1629r885b1667],
5	of	IN	O	of	_	0	SENT_416	[p12l893t1628r927b1657],
6	both	CC	O	both	preconj	7	SENT_416	[p12l931t1628r1003b1657],
7	mRNA	NN	O	mrna	prep_of	4	SENT_416	[p12l1011t1629r1127b1657],
8	and	CC	O	and	_	0	SENT_416	[p12l1134t1628r1189b1657],
9	protein	NN	O	protein	conj_and	7	SENT_416	[p12l1197t1629r1311b1667],
10	is	VBZ	O	be	cop	12	SENT_416	[p12l1319t1629r1342b1657],
11	highly	RB	O	highly	advmod	12	SENT_416	[p12l1350t1628r1450b1667],
12	variable	JJ	O	variable	pcomp	2	SENT_416	[p12l1455t1628r1578b1657],
13	in	IN	O	in	_	0	SENT_416	[p12l1587t1629r1617b1657],
14	human	JJ	O	human	amod	16	SENT_416	[p12l1624t1628r1733b1657],
15	intestinal	JJ	O	intestinal	amod	16	SENT_416	[p12l1741t1628r1884b1657],
16	samples	NNS	O	sample	prep_in	12	SENT_416	[p12l367t1692r488b1730],
17	and	CC	O	and	_	0	SENT_416	[p12l501t1692r556b1721],
18	that	IN	O	that	complm	22	SENT_416	[p12l568t1692r630b1721],
19	this	DT	O	this	det	20	SENT_416	[p12l641t1692r696b1721],
20	variation	NN	O	variation	nsubj	22	SENT_416	[p12l707t1693r847b1721],
21	is	VBZ	O	be	cop	22	SENT_416	[p12l858t1693r881b1721],
22	independent	JJ	O	independent	conj_and	12	SENT_416	[p12l893t1691r1090b1730],
23	of	IN	O	of	_	0	SENT_416	[p12l1101t1692r1135b1721],
24	common	JJ	O	common	amod	26	SENT_416	[p12l1143t1702r1282b1721],
25	genetic	JJ	O	genetic	amod	26	SENT_416	[p12l1294t1693r1406b1731],
26	variants	NNS	O	variant	prep_of	1	SENT_416	[p12l1416t1693r1538b1721],
27	(	VBP	O	(	_	0	SENT_416	[p12l1552t1693r1628b1728],
28	164	CD	NUMBER	164	dobj	27	SENT_416	[p12l1552t1693r1628b1728],
29	,	,	O	,	_	0	SENT_416	[p12l1552t1693r1628b1728],
30	167	CD	NUMBER	167	num	31	SENT_416	[p12l1644t1693r1717b1728],
31	)	NN	O	)	appos	28	SENT_416	[p12l1644t1693r1717b1728],
32	.	.	O	.	_	0	SENT_416	[p12l1644t1693r1717b1728],

1	However	RB	O	however	advmod	13	SENT_417	[p12l1731t1693r1883b1727],
2	,	,	O	,	_	0	SENT_417	[p12l1731t1693r1883b1727],
3	a	DT	O	a	det	6	SENT_417	[p12l367t1753r382b1771],
4	recent	JJ	O	recent	amod	6	SENT_417	[p12l392t1750r491b1771],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_417	[p12l500t1742r762b1780],
6	study	NN	O	study	nsubj	13	SENT_417	[p12l773t1742r857b1780],
7	of	IN	O	of	_	0	SENT_417	[p12l866t1742r901b1771],
8	sulfasalazine	NN	O	sulfasalazine	prep_of	6	SENT_417	[p12l907t1742r1100b1771],
9	in	IN	O	in	_	0	SENT_417	[p12l1111t1743r1141b1770],
10	36	CD	NUMBER	36	num	12	SENT_417	[p12l1153t1744r1188b1771],
11	healthy	JJ	O	healthy	amod	12	SENT_417	[p12l1199t1742r1316b1780],
12	volunteers	NNS	O	volunteer	prep_in	8	SENT_417	[p12l1323t1742r1487b1771],
13	failed	VBD	O	fail	_	0	SENT_417	[p12l1498t1742r1582b1771],
14	to	TO	O	to	aux	15	SENT_417	[p12l1593t1750r1624b1771],
15	reproduce	VB	O	reproduce	xcomp	13	SENT_417	[p12l1635t1742r1793b1780],
16	these	DT	O	these	det	17	SENT_417	[p12l1804t1742r1884b1771],
17	results	NNS	O	result	dobj	15	SENT_417	[p12l367t1792r467b1821],
18	because	IN	O	because	mark	27	SENT_417	[p12l481t1792r601b1821],
19	the	DT	O	the	det	20	SENT_417	[p12l615t1792r664b1821],
20	presence	NN	O	presence	dep	27	SENT_417	[p12l678t1803r814b1830],
21	of	IN	O	of	_	0	SENT_417	[p12l828t1792r862b1821],
22	the	DT	O	the	det	26	SENT_417	[p12l872t1792r920b1821],
23	ABC	NNP	ORGANIZATION	ABC	nn	26	SENT_417	[p12l931t1793r1009b1821],
24	G2	NN	O	g2	nn	26	SENT_417	[p12l1010t1793r1054b1821],
25	c.	NN	O	c.	nn	26	SENT_417	[p12l1068t1793r1235b1821],
26	421C	NN	O	421c	prep_of	20	SENT_417	[p12l1068t1793r1235b1821],
27	>	JJR	O	>	advcl	15	SENT_417	[p12l1068t1793r1235b1821],
28	A	DT	O	a	det	32	SENT_417	[p12l1068t1793r1235b1821],
29	(	CD	NUMBER	(	num	32	SENT_417	[p12l1247t1793r1432b1828],
30	rs223l142	NN	O	rs223l142	nn	32	SENT_417	[p12l1247t1793r1432b1828],
31	)	CD	NUMBER	)	num	32	SENT_417	[p12l1247t1793r1432b1828],
32	polymorphism	NN	O	polymorphism	dobj	15	SENT_417	[p12l1446t1792r1676b1831],
33	or	CC	O	or	_	0	SENT_417	[p12l1690t1803r1723b1821],
34	coadministration	NN	O	coadministration	dobj	15	SENT_417	[p12l1736t1792r1884b1821, p12l366t1855r497b1882],

1	of	IN	O	of	_	0	SENT_418	[p12l509t1853r543b1882],
2	the	DT	O	the	det	3	SENT_418	[p12l551t1853r600b1882],
3	BCRP	NN	MISC	bcrp	prep_of	6	SENT_418	[p12l612t1854r712b1882],
4	inhibitor	NN	O	inhibitor	nn	5	SENT_418	[p12l724t1853r864b1882],
5	pantoprozole	NN	O	pantoprozole	nsubj	6	SENT_418	[p12l875t1853r1082b1892],
6	showed	VBD	O	show	_	0	SENT_418	[p12l1095t1853r1211b1882],
7	no	DT	O	no	det	8	SENT_418	[p12l1223t1864r1262b1882],
8	effect	NN	O	effect	nsubj	17	SENT_418	[p12l1275t1853r1359b1882],
9	on	IN	O	on	_	0	SENT_418	[p12l1371t1864r1410b1882],
10	sulfasalazine	NN	O	sulfasalazine	nn	12	SENT_418	[p12l1422t1853r1615b1882],
11	plasma	NN	O	plasma	nn	12	SENT_418	[p12l1627t1853r1734b1892],
12	exposure	NN	O	exposure	prep_on	8	SENT_418	[p12l1747t1864r1884b1892],
13	or	CC	O	or	_	0	SENT_418	[p12l367t1933r400b1951],
14	maximum	NN	O	maximum	nn	16	SENT_418	[p12l413t1924r569b1951],
15	plasma	NN	O	plasma	nn	16	SENT_418	[p12l583t1922r690b1961],
16	concentrations	NNS	O	concentration	prep_on	8	SENT_418	[p12l704t1924r935b1951],
17	(	VBP	O	(	ccomp	6	SENT_418	[p12l950t1923r1037b1959],
18	168	CD	NUMBER	168	number	19	SENT_418	[p12l950t1923r1037b1959],
19	)	CD	NUMBER	)	dobj	17	SENT_418	[p12l950t1923r1037b1959],
20	.	.	O	.	_	0	SENT_418	[p12l950t1923r1037b1959],

1	Thus	RB	O	thus	advmod	6	SENT_419	[p12l1052t1922r1143b1958],
2	,	,	O	,	_	0	SENT_419	[p12l1052t1922r1143b1958],
3	more	JJR	O	more	amod	4	SENT_419	[p12l1158t1933r1240b1951],
4	work	NN	O	work	nsubjpass	6	SENT_419	[p12l1253t1922r1334b1951],
5	is	VBZ	O	be	auxpass	6	SENT_419	[p12l1345t1924r1368b1951],
6	needed	VBN	O	need	_	0	SENT_419	[p12l1381t1922r1493b1951],
7	to	TO	O	to	aux	8	SENT_419	[p12l1507t1931r1538b1951],
8	validate	VB	O	validate	xcomp	6	SENT_419	[p12l1551t1922r1671b1951],
9	the	DT	O	the	det	10	SENT_419	[p12l1685t1922r1734b1951],
10	utility	NN	O	utility	dobj	8	SENT_419	[p12l1747t1922r1842b1961],
11	of	IN	O	of	_	0	SENT_419	[p12l1855t1922r1889b1951],
12	sulfasalazine	NN	O	sulfasalazine	prep_of	10	SENT_419	[p12l367t1972r560b2001],
13	as	IN	O	as	amod	10	SENT_419	[p12l572t1983r600b2001],
14	an	DT	O	a	dep	10	SENT_419	[p12l612t1982r648b2001],
15	in	FW	O	in	nn	16	SENT_419	[p12l658t1973r689b2000],
16	vivo	FW	O	vivo	advmod	17	SENT_419	[p12l698t1973r763b2001],
17	probe	NN	O	probe	dep	14	SENT_419	[p12l774t1972r864b2010],
18	of	IN	O	of	_	0	SENT_419	[p12l876t1972r910b2001],
19	BCRP	NN	O	bcrp	nn	20	SENT_419	[p12l918t1973r1018b2001],
20	activity	NN	O	activity	prep_of	17	SENT_419	[p12l1030t1973r1150b2010],
21	.	.	O	.	_	0	SENT_419	[p12l1030t1973r1150b2010],

1	The	DT	O	the	det	3	SENT_420	[p12l415t2022r482b2051],
2	total	JJ	O	total	amod	3	SENT_420	[p12l496t2022r566b2051],
3	exposure	NN	O	exposure	nsubj	22	SENT_420	[p12l580t2032r718b2060],
4	to	TO	O	to	_	0	SENT_420	[p12l732t2030r762b2051],
5	atorvastatin	NN	O	atorvastatin	prep_to	3	SENT_420	[p12l777t2023r959b2051],
6	and	CC	O	and	_	0	SENT_420	[p12l973t2021r1028b2051],
7	rosuvastatin	NN	O	rosuvastatin	prep_to	3	SENT_420	[p12l1042t2023r1230b2051],
8	is	VBZ	O	be	cop	22	SENT_420	[p12l1242t2023r1265b2051],
9	higher	JJR	O	higher	advmod	22	SENT_420	[p12l1279t2021r1381b2060],
10	in	IN	O	in	_	0	SENT_420	[p12l1394t2023r1424b2050],
11	individuals	NNS	O	individual	prep_in	9	SENT_420	[p12l1437t2021r1606b2051],
12	with	IN	O	with	_	0	SENT_420	[p12l1619t2021r1689b2051],
13	the	DT	O	the	det	17	SENT_420	[p12l1702t2021r1751b2051],
14	ABC	NNP	ORGANIZATION	ABC	nn	17	SENT_420	[p12l1761t2022r1839b2050],
15	G2	NN	O	g2	nn	17	SENT_420	[p12l1840t2023r1884b2050],
16	c.	NN	O	c.	nn	17	SENT_420	[p12l367t2072r536b2101],
17	421T	NN	O	421t	nn	21	SENT_420	[p12l367t2072r536b2101],
18	>	JJR	O	>	dep	19	SENT_420	[p12l367t2072r536b2101],
19	C	NN	O	c	amod	21	SENT_420	[p12l367t2072r536b2101],
20	polymorphism	NN	O	polymorphism	nn	21	SENT_420	[p12l547t2071r777b2110],
21	(	NN	O	(	prep_with	11	SENT_420	[p12l788t2072r864b2108],
22	169	CD	NUMBER	169	_	0	SENT_420	[p12l788t2072r864b2108],
23	,	,	O	,	_	0	SENT_420	[p12l788t2072r864b2108],
24	170	CD	NUMBER	170	num	25	SENT_420	[p12l880t2072r953b2108],
25	)	NN	O	)	appos	22	SENT_420	[p12l880t2072r953b2108],
26	,	,	O	,	_	0	SENT_420	[p12l880t2072r953b2108],
27	consistent	JJ	O	consistent	dep	25	SENT_420	[p12l966t2073r1124b2100],
28	with	IN	O	with	_	0	SENT_420	[p12l1133t2071r1203b2100],
29	reduced	VBN	O	reduce	amod	31	SENT_420	[p12l1213t2071r1338b2100],
30	biliary	JJ	O	biliary	amod	31	SENT_420	[p12l1349t2071r1450b2110],
31	excretion	NN	O	excretion	prep_with	27	SENT_420	[p12l1460t2073r1604b2100],
32	of	IN	O	of	_	0	SENT_420	[p12l1615t2072r1650b2100],
33	rosuvastatin	NN	O	rosuvastatin	prep_of	31	SENT_420	[p12l1656t2073r1844b2100],
34	in	IN	O	in	_	0	SENT_420	[p12l1854t2073r1885b2100],
35	Bcrp	NNP	LOCATION	Bcrp	prep_in	27	SENT_420	[p12l367t2123r440b2160],
36	1	CD	NUMBER	1	num	35	SENT_420	[p12l446t2123r456b2150],
37	"	``	O	"	punct	25	SENT_420	[p12l463t2119r509b2141],
38	/	:	O	/	punct	40	SENT_420	[p12l463t2119r509b2141],
39	‘	CD	NUMBER	‘	num	40	SENT_420	[p12l463t2119r509b2141],
40	mice	NNS	O	mouse	dep	22	SENT_420	[p12l521t2123r595b2150],
41	(	CD	NUMBER	(	number	42	SENT_420	[p12l606t2122r684b2158],
42	171	CD	NUMBER	171	dep	40	SENT_420	[p12l606t2122r684b2158],
43	)	NN	O	)	nn	45	SENT_420	[p12l606t2122r684b2158],
44	(	CD	NUMBER	(	num	45	SENT_420	[p12l695t2121r804b2158],
45	Table	NNP	O	Table	dep	42	SENT_420	[p12l695t2121r804b2158],
46	2	CD	NUMBER	2	num	47	SENT_420	[p12l815t2122r854b2158],
47	)	CD	NUMBER	)	dep	42	SENT_420	[p12l815t2122r854b2158],
48	.	.	O	.	_	0	SENT_420	[p12l815t2122r854b2158],

1	Conversely	RB	O	conversely	advmod	7	SENT_421	[p12l865t2121r1049b2160],
2	,	,	O	,	_	0	SENT_421	[p12l865t2121r1049b2160],
3	pitavastatin	NN	O	pitavastatin	nn	4	SENT_421	[p12l1060t2123r1238b2160],
4	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	7	SENT_421	[p12l1247t2121r1522b2160],
5	were	VBD	O	be	auxpass	7	SENT_421	[p12l1530t2132r1605b2150],
6	not	RB	O	not	neg	7	SENT_421	[p12l1614t2130r1668b2150],
7	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_421	[p12l1675t2121r1839b2150],
8	by	IN	O	by	_	0	SENT_421	[p12l1848t2121r1886b2160],
9	the	DT	O	the	det	11	SENT_421	[p12l367t2171r415b2200],
10	ABCG2	NN	O	abcg2	nn	11	SENT_421	[p12l420t2172r543b2200],
11	c.	NN	O	c.	agent	7	SENT_421	[p12l551t2173r611b2200],
12	42	CD	NUMBER	42	num	13	SENT_421	[p12l551t2173r611b2200],
13	1C	NN	O	1c	npadvmod	14	SENT_421	[p12l619t2172r718b2200],
14	>	JJR	O	>	amod	11	SENT_421	[p12l619t2172r718b2200],
15	A	DT	O	a	det	16	SENT_421	[p12l619t2172r718b2200],
16	polymorphism	NN	O	polymorphism	dep	22	SENT_421	[p12l723t2171r953b2210],
17	in	IN	O	in	_	0	SENT_421	[p12l960t2173r990b2200],
18	healthyvolunteers	NNS	O	healthyvolunteer	prep_in	16	SENT_421	[p12l997t2171r1282b2210],
19	(	CD	NUMBER	(	dep	22	SENT_421	[p12l1291t2172r1316b2207],
20	1	CD	NUMBER	1	number	21	SENT_421	[p12l1291t2172r1316b2207],
21	19	CD	NUMBER	19	num	22	SENT_421	[p12l1325t2172r1369b2207],
22	)	NN	O	)	dep	7	SENT_421	[p12l1325t2172r1369b2207],
23	despite	IN	O	despite	_	0	SENT_421	[p12l1378t2171r1487b2210],
24	the	DT	O	the	det	25	SENT_421	[p12l1495t2171r1544b2200],
25	involvement	NN	O	involvement	prep_despite	22	SENT_421	[p12l1552t2171r1747b2200],
26	of	IN	O	of	_	0	SENT_421	[p12l1754t2171r1788b2200],
27	Bcrpl	NNP	LOCATION	Bcrpl	prep_of	25	SENT_421	[p12l1792t2173r1881b2210],
28	in	IN	O	in	_	0	SENT_421	[p12l366t2223r397b2250],
29	biliary	JJ	O	biliary	amod	30	SENT_421	[p12l407t2221r507b2260],
30	excretion	NN	O	excretion	prep_in	7	SENT_421	[p12l517t2223r661b2250],
31	of	IN	O	of	_	0	SENT_421	[p12l672t2221r706b2250],
32	pitavastatin	NN	O	pitavastatin	prep_of	30	SENT_421	[p12l712t2223r891b2259],
33	in	IN	O	in	_	0	SENT_421	[p12l901t2223r931b2250],
34	mice	NNS	O	mouse	prep_in	7	SENT_421	[p12l941t2223r1015b2250],
35	(	CD	NUMBER	(	number	36	SENT_421	[p12l1026t2222r1114b2257],
36	172	CD	NUMBER	172	num	37	SENT_421	[p12l1026t2222r1114b2257],
37	)	NN	O	)	dep	7	SENT_421	[p12l1026t2222r1114b2257],
38	.	.	O	.	_	0	SENT_421	[p12l1026t2222r1114b2257],

1	Another	DT	O	another	det	2	SENT_422	[p12l1125t2221r1256b2250],
2	study	NN	O	study	nsubj	3	SENT_422	[p12l1266t2221r1351b2260],
3	linked	VBD	O	link	_	0	SENT_422	[p12l1359t2221r1455b2250],
4	the	DT	O	the	det	7	SENT_422	[p12l1466t2221r1515b2250],
5	ABC	NNP	ORGANIZATION	ABC	nn	7	SENT_422	[p12l1522t2222r1600b2250],
6	G2	NN	O	g2	nn	7	SENT_422	[p12l1601t2222r1645b2250],
7	polymorphism	NN	O	polymorphism	dobj	3	SENT_422	[p12l1655t2221r1885b2260],
8	to	TO	O	to	prep	3	SENT_422	[p12l367t2279r397b2300],
9	the	DT	O	the	det	10	SENT_422	[p12l411t2271r460b2300],
10	pharmacokinetics	NNS	O	pharmacokinetic	pobj	8	SENT_422	[p12l473t2271r748b2309],
11	of	IN	O	of	_	0	SENT_422	[p12l763t2271r797b2300],
12	ﬂuvastatin	NN	O	ﬂuvastatin	nn	15	SENT_422	[p12l806t2271r967b2300],
13	and	CC	O	and	_	0	SENT_422	[p12l980t2271r1036b2300],
14	simvastatin	NN	O	simvastatin	nn	15	SENT_422	[p12l1049t2273r1224b2300],
15	lactone	NN	O	lactone	prep_of	10	SENT_422	[p12l1237t2271r1358b2306],
16	,	,	O	,	_	0	SENT_422	[p12l1237t2271r1358b2306],
17	but	CC	O	but	_	0	SENT_422	[p12l1373t2271r1425b2300],
18	not	RB	O	not	prep	3	SENT_422	[p12l1437t2279r1490b2300],
19	to	TO	O	to	dep	8	SENT_422	[p12l1502t2279r1533b2300],
20	the	DT	O	the	det	21	SENT_422	[p12l1547t2271r1596b2300],
21	pharmacokinetics	NNS	O	pharmacokinetic	pobj	19	SENT_422	[p12l1609t2271r1884b2309],
22	of	IN	O	of	_	0	SENT_422	[p12l367t2321r401b2350],
23	pravastatin	NN	O	pravastatin	prep_of	21	SENT_422	[p12l410t2323r580b2360],
24	or	CC	O	or	_	0	SENT_422	[p12l594t2332r627b2350],
25	simvastatin	NN	O	simvastatin	nn	27	SENT_422	[p12l640t2323r814b2350],
26	acid	NN	O	acid	nn	27	SENT_422	[p12l828t2321r889b2350],
27	(	NN	O	(	conj_or	21	SENT_422	[p12l904t2322r991b2358],
28	173	CD	NUMBER	173	num	29	SENT_422	[p12l904t2322r991b2358],
29	)	NN	O	)	dep	27	SENT_422	[p12l904t2322r991b2358],
30	.	.	O	.	_	0	SENT_422	[p12l904t2322r991b2358],

1	BCRP	NN	O	bcrp	nsubj	2	SENT_423	[p12l1006t2322r1106b2350],
2	appears	VBZ	O	appear	ccomp	18	SENT_423	[p12l1121t2332r1237b2360],
3	to	TO	O	to	aux	6	SENT_423	[p12l1251t2329r1282b2350],
4	be	VB	O	be	cop	6	SENT_423	[p12l1295t2321r1331b2350],
5	particularly	RB	O	particularly	advmod	6	SENT_423	[p12l1344t2321r1525b2360],
6	important	JJ	O	important	xcomp	2	SENT_423	[p12l1536t2323r1695b2360],
7	for	IN	O	for	_	0	SENT_423	[p12l1707t2321r1752b2350],
8	the	DT	O	the	det	9	SENT_423	[p12l1765t2321r1814b2350],
9	distribution	NN	O	distribution	prep_for	6	SENT_423	[p12l1828t2321r1884b2350, p12l367t2371r506b2400],
10	of	IN	O	of	_	0	SENT_423	[p12l518t2371r552b2400],
11	rosuvastatin	NN	O	rosuvastatin	prep_of	9	SENT_423	[p12l558t2373r754b2407],
12	,	,	O	,	_	0	SENT_423	[p12l558t2373r754b2407],
13	as	IN	O	as	_	0	SENT_423	[p12l767t2382r795b2400],
14	multiple	JJ	O	multiple	amod	15	SENT_423	[p12l806t2371r936b2410],
15	studies	NNS	O	study	prep_as	18	SENT_423	[p12l948t2371r1054b2400],
16	have	VBP	O	have	aux	18	SENT_423	[p12l1064t2371r1135b2400],
17	now	RB	DATE	now	advmod	18	SENT_423	[p12l1146t2382r1213b2400],
18	associated	VBN	O	associate	_	0	SENT_423	[p12l1223t2371r1379b2400],
19	reduced-function	JJ	O	reduced-function	amod	22	SENT_423	[p12l1390t2371r1662b2400],
20	ABC	NNP	ORGANIZATION	ABC	nn	22	SENT_423	[p12l1669t2372r1747b2400],
21	G2	NN	O	g2	nn	22	SENT_423	[p12l1748t2372r1792b2400],
22	polymorphisms	NNS	O	polymorphism	dobj	18	SENT_423	[p12l1803t2371r1884b2410, p12l367t2421r540b2460],
23	with	IN	O	with	_	0	SENT_423	[p12l551t2421r621b2450],
24	increased	VBN	O	increase	amod	26	SENT_423	[p12l632t2421r778b2450],
25	lipid-lowering	JJ	O	lipid-lowering	amod	26	SENT_423	[p12l789t2421r1014b2460],
26	response	NN	O	response	prep_with	22	SENT_423	[p12l1024t2432r1160b2460],
27	to	TO	O	to	_	0	SENT_423	[p12l1172t2429r1203b2450],
28	rosuvastatin	NN	O	rosuvastatin	nn	29	SENT_423	[p12l1214t2423r1402b2450],
29	therapy	NN	O	therapy	prep_to	26	SENT_423	[p12l1413t2421r1533b2460],
30	in	IN	O	in	_	0	SENT_423	[p12l1543t2423r1573b2450],
31	patients	NNS	O	patient	prep_in	29	SENT_423	[p12l1584t2423r1706b2460],
32	(	CD	NUMBER	(	num	34	SENT_423	[p12l1719t2422r1883b2458],
33	174-176	CD	NUMBER	174-176	num	34	SENT_423	[p12l1719t2422r1883b2458],
34	)	NN	O	)	nsubj	18	SENT_423	[p12l1719t2422r1883b2458],
35	,	,	O	,	_	0	SENT_423	[p12l1719t2422r1883b2458],
36	presumably	RB	O	presumably	advmod	38	SENT_423	[p12l366t2471r549b2510],
37	a	DT	O	a	det	38	SENT_423	[p12l560t2482r575b2500],
38	result	NN	O	result	rcmod	34	SENT_423	[p12l587t2471r676b2500],
39	of	IN	O	of	_	0	SENT_423	[p12l688t2471r722b2500],
40	increased	VBN	O	increase	amod	41	SENT_423	[p12l730t2471r876b2500],
41	exposure	NN	O	exposure	prep_of	38	SENT_423	[p12l890t2482r1027b2510],
42	to	TO	O	to	_	0	SENT_423	[p12l1040t2479r1071b2500],
43	rosuvastatin	NN	O	rosuvastatin	prep_to	41	SENT_423	[p12l1084t2473r1279b2507],
44	,	,	O	,	_	0	SENT_423	[p12l1084t2473r1279b2507],
45	which	WDT	O	which	nsubj	46	SENT_423	[p12l1292t2471r1387b2500],
46	mimics	VBZ	O	mimic	rcmod	43	SENT_423	[p12l1399t2473r1511b2500],
47	the	DT	O	the	det	48	SENT_423	[p12l1524t2471r1573b2500],
48	effect	NN	O	effect	dobj	46	SENT_423	[p12l1586t2471r1671b2500],
49	of	IN	O	of	_	0	SENT_423	[p12l1683t2471r1717b2500],
50	increasing	VBG	O	increase	prepc_of	48	SENT_423	[p12l1725t2473r1886b2510],
51	the	DT	O	the	det	53	SENT_423	[p12l367t2520r415b2550],
52	statin	NN	O	statin	nn	53	SENT_423	[p12l427t2522r512b2550],
53	dose	NN	O	dose	dobj	50	SENT_423	[p12l524t2521r601b2550],
54	.	.	O	.	_	0	SENT_423	[p12l524t2521r601b2550],

1	The	DT	O	the	det	2	SENT_424	[p12l415t2571r482b2599],
2	role	NN	O	role	nsubjpass	14	SENT_424	[p12l494t2570r555b2599],
3	of	IN	O	of	_	0	SENT_424	[p12l568t2571r602b2599],
4	BCRP	NN	O	bcrp	prep_of	2	SENT_424	[p12l610t2572r711b2599],
5	in	IN	O	in	_	0	SENT_424	[p12l723t2572r753b2599],
6	cancer	NN	O	cancer	nn	8	SENT_424	[p12l766t2581r867b2599],
7	treatment	NN	O	treatment	nn	8	SENT_424	[p12l878t2579r1033b2599],
8	efﬁcacy	NN	O	efﬁcacy	prep_in	4	SENT_424	[p12l1045t2571r1160b2609],
9	and	CC	O	and	_	0	SENT_424	[p12l1172t2570r1227b2599],
10	prognosis	NN	O	prognosis	prep_in	4	SENT_424	[p12l1239t2572r1390b2609],
11	has	VBZ	O	have	aux	14	SENT_424	[p12l1402t2570r1452b2599],
12	been	VBN	O	be	auxpass	14	SENT_424	[p12l1465t2570r1539b2599],
13	widely	RB	O	widely	advmod	14	SENT_424	[p12l1550t2570r1654b2609],
14	studied	VBN	O	study	_	0	SENT_424	[p12l1665t2570r1777b2599],
15	owing	VBG	O	owe	xcomp	14	SENT_424	[p12l1790t2572r1886b2609],
16	to	TO	O	to	_	0	SENT_424	[p12l367t2629r397b2649],
17	the	DT	O	the	det	19	SENT_424	[p12l410t2620r459b2649],
18	vast	JJ	O	vast	amod	19	SENT_424	[p12l470t2629r531b2649],
19	number	NN	O	number	prep_to	15	SENT_424	[p12l542t2620r666b2649],
20	of	IN	O	of	_	0	SENT_424	[p12l678t2620r712b2649],
21	antineoplastic	JJ	O	antineoplastic	amod	22	SENT_424	[p12l721t2620r938b2659],
22	drugs	NNS	O	drug	prep_of	19	SENT_424	[p12l951t2620r1036b2659],
23	that	WDT	O	that	nsubj	25	SENT_424	[p12l1049t2620r1111b2649],
24	are	VBP	O	be	cop	25	SENT_424	[p12l1123t2631r1169b2649],
25	substrates	NNS	O	substrate	rcmod	19	SENT_424	[p12l1182t2620r1335b2649],
26	for	IN	O	for	_	0	SENT_424	[p12l1347t2620r1393b2649],
27	this	DT	O	this	det	29	SENT_424	[p12l1405t2620r1460b2649],
28	efﬂux	NN	O	efﬂux	nn	29	SENT_424	[p12l1474t2620r1558b2649],
29	transporter	NN	O	transporter	prep_for	25	SENT_424	[p12l1569t2628r1753b2659],
30	.	.	O	.	_	0	SENT_424	[p12l1569t2628r1753b2659],

1	Indeed	RB	O	indeed	advmod	8	SENT_425	[p12l1767t2620r1883b2656],
2	,	,	O	,	_	0	SENT_425	[p12l1767t2620r1883b2656],
3	ABC	NNP	ORGANIZATION	ABC	nn	5	SENT_425	[p12l363t2671r441b2699],
4	G2	NN	O	g2	nn	5	SENT_425	[p12l442t2671r486b2699],
5	polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_425	[p12l497t2670r740b2709],
6	have	VBP	O	have	aux	8	SENT_425	[p12l752t2670r822b2699],
7	been	VBN	O	be	auxpass	8	SENT_425	[p12l834t2670r908b2699],
8	associated	VBN	O	associate	_	0	SENT_425	[p12l920t2670r1075b2699],
9	with	IN	O	with	_	0	SENT_425	[p12l1085t2670r1155b2699],
10	increased	VBN	O	increase	amod	13	SENT_425	[p12l1166t2670r1312b2699],
11	exposure	NN	O	exposure	nn	13	SENT_425	[p12l1324t2681r1462b2708],
12	and/or	NN	O	and/or	nn	13	SENT_425	[p12l1474t2670r1578b2699],
13	risk	NN	O	risk	prep_with	8	SENT_425	[p12l1589t2670r1647b2699],
14	for	IN	O	for	_	0	SENT_425	[p12l1657t2670r1702b2699],
15	toxicity	NN	O	toxicity	prep_for	13	SENT_425	[p12l1713t2672r1830b2709],
16	for	IN	O	for	_	0	SENT_425	[p12l1840t2670r1885b2699],
17	numerous	JJ	O	numerous	amod	19	SENT_425	[p12l366t2731r523b2749],
18	anticancer	JJ	O	anticancer	amod	19	SENT_425	[p12l537t2721r699b2749],
19	drugs	NNS	O	drug	prep_for	15	SENT_425	[p12l713t2720r798b2758],
20	in	IN	O	in	_	0	SENT_425	[p12l812t2721r842b2748],
21	clinical	JJ	O	clinical	amod	22	SENT_425	[p12l856t2720r966b2749],
22	use	NN	O	use	prep_in	19	SENT_425	[p12l980t2731r1038b2749],
23	.	.	O	.	_	0	SENT_425	[p12l980t2731r1038b2749],

1	For	IN	O	for	_	0	SENT_426	[p12l1054t2721r1110b2749],
2	example	NN	O	example	prep_for	8	SENT_426	[p12l1124t2720r1260b2758],
3	,	,	O	,	_	0	SENT_426	[p12l1124t2720r1260b2758],
4	reduced-function	JJ	O	reduced-function	amod	6	SENT_426	[p12l1275t2720r1547b2749],
5	BCRP	NN	O	bcrp	nn	6	SENT_426	[p12l1561t2721r1661b2749],
6	variants	NNS	O	variant	nsubjpass	8	SENT_426	[p12l1674t2721r1796b2749],
7	were	VBD	O	be	auxpass	8	SENT_426	[p12l1809t2731r1884b2749],
8	associated	VBN	O	associate	_	0	SENT_426	[p12l367t2770r523b2799],
9	with	IN	O	with	_	0	SENT_426	[p12l535t2770r605b2799],
10	higher	JJR	O	higher	amod	11	SENT_426	[p12l618t2770r721b2808],
11	area	NN	O	area	prep_with	8	SENT_426	[p12l734t2780r797b2799],
12	under	IN	O	under	_	0	SENT_426	[p12l810t2770r902b2799],
13	the	DT	O	the	det	14	SENT_426	[p12l915t2770r964b2799],
14	curve	NN	O	curve	prep_under	11	SENT_426	[p12l978t2781r1062b2799],
15	and	CC	O	and	_	0	SENT_426	[p12l1076t2770r1131b2799],
16	maximum	NN	O	maximum	nn	18	SENT_426	[p12l1144t2771r1301b2799],
17	concentration	NN	O	concentration	nn	18	SENT_426	[p12l1314t2771r1532b2799],
18	values	NNS	O	value	conj_and	14	SENT_426	[p12l1544t2770r1639b2799],
19	of	IN	O	of	_	0	SENT_426	[p12l1653t2770r1687b2799],
20	the	DT	O	the	det	24	SENT_426	[p12l1697t2770r1745b2799],
21	tyrosine	NN	O	tyrosine	nn	24	SENT_426	[p12l1759t2771r1884b2808],
22	kinase	NN	O	kinase	nn	24	SENT_426	[p12l366t2831r462b2860],
23	inhibitor	NN	O	inhibitor	nn	24	SENT_426	[p12l479t2831r618b2860],
24	erlotinib	NN	O	erlotinib	prep_of	11	SENT_426	[p12l634t2831r777b2867],
25	;	:	O	;	_	0	SENT_426	[p12l634t2831r777b2867],
26	higher	JJR	O	higher	amod	29	SENT_426	[p12l794t2831r897b2870],
27	trough	NN	O	trough	nn	29	SENT_426	[p12l913t2831r1019b2870],
28	erlotinib	NN	O	erlotinib	nn	29	SENT_426	[p12l1036t2831r1169b2860],
29	levels	NNS	O	level	nsubjpass	31	SENT_426	[p12l1186t2831r1271b2860],
30	were	VBD	O	be	auxpass	31	SENT_426	[p12l1286t2842r1361b2860],
31	associated	VBN	O	associate	parataxis	8	SENT_426	[p12l1378t2831r1534b2860],
32	with	IN	O	with	_	0	SENT_426	[p12l1549t2831r1619b2860],
33	skin	NN	O	skin	nn	35	SENT_426	[p12l1635t2831r1698b2860],
34	rash	NN	O	rash	nn	35	SENT_426	[p12l1714t2831r1778b2860],
35	(	NN	O	(	prep_with	31	SENT_426	[p12l1795t2832r1883b2868],
36	177	CD	NUMBER	177	num	37	SENT_426	[p12l1795t2832r1883b2868],
37	)	NN	O	)	dep	35	SENT_426	[p12l1795t2832r1883b2868],
38	.	.	O	.	_	0	SENT_426	[p12l1795t2832r1883b2868],

1	Expression	NN	O	expression	nsubjpass	9	SENT_427	[p12l367t2893r538b2930],
2	of	IN	O	of	_	0	SENT_427	[p12l554t2891r588b2920],
3	BCRP	NN	O	bcrp	prep_of	1	SENT_427	[p12l599t2892r699b2920],
4	in	IN	O	in	_	0	SENT_427	[p12l714t2893r744b2920],
5	cancer	NN	O	cancer	nn	6	SENT_427	[p12l760t2902r861b2920],
6	cells	NNS	O	cell	prep_in	3	SENT_427	[p12l875t2891r942b2920],
7	is	VBZ	O	be	auxpass	9	SENT_427	[p12l957t2893r979b2920],
8	generally	RB	O	generally	advmod	9	SENT_427	[p12l995t2891r1140b2930],
9	associated	VBN	O	associate	_	0	SENT_427	[p12l1153t2891r1309b2920],
10	with	IN	O	with	_	0	SENT_427	[p12l1323t2891r1393b2920],
11	poor	JJ	O	poor	amod	12	SENT_427	[p12l1407t2902r1481b2930],
12	prognosis	NN	O	prognosis	prep_with	9	SENT_427	[p12l1496t2893r1656b2930],
13	;	:	O	;	_	0	SENT_427	[p12l1496t2893r1656b2930],
14	however	RB	O	however	advmod	21	SENT_427	[p12l1671t2891r1812b2927],
15	,	,	O	,	_	0	SENT_427	[p12l1671t2891r1812b2927],
16	this	DT	O	this	det	17	SENT_427	[p12l1829t2891r1884b2920],
17	association	NN	O	association	nsubjpass	21	SENT_427	[p12l367t2942r537b2969],
18	has	VBZ	O	have	aux	21	SENT_427	[p12l550t2940r600b2969],
19	not	RB	O	not	neg	21	SENT_427	[p12l614t2948r667b2969],
20	been	VBN	O	be	auxpass	21	SENT_427	[p12l680t2940r755b2969],
21	demonstrated	VBN	O	demonstrate	parataxis	9	SENT_427	[p12l769t2940r983b2969],
22	for	IN	O	for	_	0	SENT_427	[p12l998t2940r1043b2969],
23	all	DT	O	all	det	25	SENT_427	[p12l1057t2940r1092b2969],
24	tumor	NN	O	tumor	nn	25	SENT_427	[p12l1106t2948r1204b2969],
25	types	NNS	O	type	prep_for	21	SENT_427	[p12l1217t2948r1305b2979],
26	.	.	O	.	_	0	SENT_427	[p12l1217t2948r1305b2979],

1	In	IN	O	in	_	0	SENT_428	[p12l1321t2941r1354b2969],
2	particular	JJ	O	particular	prep_in	8	SENT_428	[p12l1368t2940r1527b2979],
3	,	,	O	,	_	0	SENT_428	[p12l1368t2940r1527b2979],
4	BCRP	NN	O	bcrp	nn	5	SENT_428	[p12l1543t2941r1643b2969],
5	expression	NN	O	expression	nsubjpass	8	SENT_428	[p12l1658t2942r1821b2979],
6	has	VBZ	O	have	aux	8	SENT_428	[p12l1834t2940r1884b2969],
7	been	VBN	O	be	auxpass	8	SENT_428	[p12l367t2990r441b3019],
8	linked	VBN	O	link	dep	20	SENT_428	[p12l451t2990r548b3019],
9	to	TO	O	to	_	0	SENT_428	[p12l559t2998r589b3019],
10	poor	JJ	O	poor	amod	11	SENT_428	[p12l600t3001r674b3029],
11	prognosis	NN	O	prognosis	prep_to	8	SENT_428	[p12l684t2991r836b3029],
12	in	IN	O	in	_	0	SENT_428	[p12l847t2991r877b3019],
13	acute	JJ	O	acute	amod	15	SENT_428	[p12l888t2998r969b3019],
14	myeloid	JJ	O	myeloid	amod	15	SENT_428	[p12l980t2990r1106b3029],
15	leukemia	NN	O	leukemia	prep_in	8	SENT_428	[p12l1117t2990r1257b3019],
16	in	IN	O	in	_	0	SENT_428	[p12l1268t2991r1298b3019],
17	adults	NNS	O	adult	prep_in	15	SENT_428	[p12l1309t2990r1400b3019],
18	and	CC	O	and	_	0	SENT_428	[p12l1412t2990r1467b3019],
19	children	NNS	O	child	prep_in	15	SENT_428	[p12l1479t2990r1608b3019],
20	(	VBP	O	(	_	0	SENT_428	[p12l1619t2991r1695b3027],
21	178	CD	NUMBER	178	dobj	20	SENT_428	[p12l1619t2991r1695b3027],
22	,	,	O	,	_	0	SENT_428	[p12l1619t2991r1695b3027],
23	179	CD	NUMBER	179	num	24	SENT_428	[p12l1711t2991r1775b3027],
24	)	NN	O	)	appos	21	SENT_428	[p12l1711t2991r1775b3027],
25	and	CC	O	and	_	0	SENT_428	[p12l1787t2990r1843b3019],
26	to	TO	O	to	appos	21	SENT_428	[p12l1854t2998r1884b3019],
27	poor	JJ	O	poor	amod	28	SENT_428	[p12l366t3050r441b3078],
28	prognosis	NN	O	prognosis	pobj	26	SENT_428	[p12l451t3041r603b3078],
29	in	IN	O	in	_	0	SENT_428	[p12l614t3041r645b3068],
30	esophageal	JJ	O	esophageal	amod	34	SENT_428	[p12l657t3039r827b3078],
31	squamous	JJ	O	squamous	amod	34	SENT_428	[p12l839t3050r992b3078],
32	cell	NN	O	cell	nn	34	SENT_428	[p12l1005t3039r1058b3068],
33	carcinoma	NN	O	carcinoma	nn	34	SENT_428	[p12l1070t3041r1231b3068],
34	(	NN	O	(	prep_in	28	SENT_428	[p12l1244t3040r1331b3076],
35	180	CD	NUMBER	180	num	36	SENT_428	[p12l1244t3040r1331b3076],
36	)	NN	O	)	nsubj	20	SENT_428	[p12l1244t3040r1331b3076],
37	.	.	O	.	_	0	SENT_428	[p12l1244t3040r1331b3076],

1	Whether	IN	O	whether	complm	11	SENT_429	[p12l1344t3039r1488b3068],
2	the	DT	O	the	det	3	SENT_429	[p12l1499t3039r1548b3068],
3	association	NN	O	association	nsubj	11	SENT_429	[p12l1560t3041r1730b3068],
4	of	IN	O	of	_	0	SENT_429	[p12l1742t3039r1776b3068],
5	BCRP	NN	O	bcrp	prep_of	3	SENT_429	[p12l1784t3040r1884b3068],
6	with	IN	O	with	_	0	SENT_429	[p12l366t3088r435b3117],
7	reduced	VBN	O	reduce	amod	8	SENT_429	[p12l452t3088r576b3117],
8	survival	NN	O	survival	prep_with	5	SENT_429	[p12l593t3088r712b3117],
9	is	VBZ	O	be	cop	11	SENT_429	[p12l728t3090r751b3117],
10	a	DT	O	a	det	11	SENT_429	[p12l769t3099r783b3117],
11	result	NN	O	result	csubjpass	29	SENT_429	[p12l800t3088r888b3117],
12	of	IN	O	of	_	0	SENT_429	[p12l904t3088r938b3117],
13	increased	VBN	O	increase	amod	15	SENT_429	[p12l951t3088r1097b3117],
14	BCRP-mediated	JJ	O	bcrp-mediated	amod	15	SENT_429	[p12l1114t3088r1374b3117],
15	efﬂux	NN	O	efﬂux	prep_of	11	SENT_429	[p12l1392t3088r1476b3117],
16	of	IN	O	of	_	0	SENT_429	[p12l1492t3088r1526b3117],
17	anticancer	JJ	O	anticancer	amod	18	SENT_429	[p12l1539t3090r1700b3117],
18	drugs	NNS	O	drug	prep_of	15	SENT_429	[p12l1717t3088r1802b3127],
19	or	CC	O	or	_	0	SENT_429	[p12l1820t3099r1853b3117],
20	a	DT	O	a	det	21	SENT_429	[p12l1870t3099r1884b3117],
21	marker	NN	O	marker	conj_or	15	SENT_429	[p12l367t3138r479b3167],
22	of	IN	O	of	_	0	SENT_429	[p12l492t3138r526b3167],
23	more	JJR	O	more	amod	25	SENT_429	[p12l536t3149r617b3167],
24	complex	JJ	O	complex	amod	25	SENT_429	[p12l632t3138r763b3177],
25	biology	NN	O	biology	prep_of	21	SENT_429	[p12l776t3138r894b3177],
26	is	VBZ	O	be	auxpass	29	SENT_429	[p12l906t3139r929b3167],
27	not	RB	O	not	neg	29	SENT_429	[p12l943t3146r996b3167],
28	fully	RB	O	fully	advmod	29	SENT_429	[p12l1009t3138r1080b3177],
29	understood	VBN	O	understand	_	0	SENT_429	[p12l1091t3138r1278b3167],
30	.	.	O	.	_	0	SENT_429	[p12l1091t3138r1278b3167],

1	BCRP	NN	O	bcrp	nsubjpass	3	SENT_430	[p12l1293t3139r1393b3167],
2	is	VBZ	O	be	auxpass	3	SENT_430	[p12l1407t3139r1430b3167],
3	expressed	VBN	O	express	_	0	SENT_430	[p12l1445t3138r1594b3177],
4	in	IN	O	in	_	0	SENT_430	[p12l1607t3139r1637b3167],
5	stem	NN	O	stem	nn	6	SENT_430	[p12l1651t3146r1724b3167],
6	cells	NNS	O	cell	prep_in	3	SENT_430	[p12l1738t3138r1813b3174],
7	,	,	O	,	_	0	SENT_430	[p12l1738t3138r1813b3174],
8	and	CC	O	and	_	0	SENT_430	[p12l1829t3138r1884b3167],
9	indeed	RB	O	indeed	advmod	17	SENT_430	[p12l366t3187r479b3223],
10	,	,	O	,	_	0	SENT_430	[p12l366t3187r479b3223],
11	some	DT	O	some	det	12	SENT_430	[p12l494t3198r574b3217],
12	discrepancy	NN	O	discrepancy	nsubjpass	17	SENT_430	[p12l587t3187r771b3226],
13	in	IN	O	in	_	0	SENT_430	[p12l782t3189r812b3216],
14	ﬁndings	NNS	O	ﬁndings	prep_in	12	SENT_430	[p12l825t3187r949b3226],
15	may	MD	O	may	aux	17	SENT_430	[p12l962t3198r1028b3226],
16	be	VB	O	be	auxpass	17	SENT_430	[p12l1039t3187r1075b3217],
17	related	VBN	O	relate	conj_and	3	SENT_430	[p12l1087t3187r1194b3217],
18	to	TO	O	to	_	0	SENT_430	[p12l1207t3195r1238b3217],
19	the	DT	O	the	det	21	SENT_430	[p12l1251t3187r1299b3217],
20	relative	JJ	O	relative	amod	21	SENT_430	[p12l1312t3187r1426b3217],
21	composition	NN	O	composition	prep_to	17	SENT_430	[p12l1440t3189r1634b3226],
22	of	IN	O	of	_	0	SENT_430	[p12l1646t3187r1681b3217],
23	the	DT	O	the	det	24	SENT_430	[p12l1689t3187r1738b3217],
24	subtypes	NNS	O	subtype	prep_of	21	SENT_430	[p12l1751t3187r1884b3226],
25	of	IN	O	of	_	0	SENT_430	[p12l367t3237r401b3266],
26	cells	NNS	O	cell	prep_of	24	SENT_430	[p12l412t3237r478b3266],
27	in	IN	O	in	_	0	SENT_430	[p12l492t3239r522b3266],
28	the	DT	O	the	det	30	SENT_430	[p12l536t3237r585b3266],
29	tissue	NN	O	tissue	nn	30	SENT_430	[p12l599t3239r685b3266],
30	samples	NNS	O	sample	prep_in	17	SENT_430	[p12l700t3237r821b3275],
31	obtained	VBN	O	obtain	partmod	30	SENT_430	[p12l836t3237r980b3266],
32	.	.	O	.	_	0	SENT_430	[p12l836t3237r980b3266],

1	For	IN	O	for	_	0	SENT_431	[p12l996t3238r1052b3266],
2	a	DT	O	a	det	5	SENT_431	[p12l1066t3248r1081b3266],
3	more	RBR	O	more	advmod	4	SENT_431	[p12l1095t3248r1176b3266],
4	comprehensive	JJ	O	comprehensive	amod	5	SENT_431	[p12l1191t3237r1426b3275],
5	review	NN	O	review	prep_for	22	SENT_431	[p12l1440t3239r1544b3266],
6	of	IN	O	of	_	0	SENT_431	[p12l1557t3237r1591b3266],
7	the	DT	O	the	det	8	SENT_431	[p12l1601t3237r1650b3266],
8	role	NN	O	role	prep_of	5	SENT_431	[p12l1664t3237r1725b3266],
9	of	IN	O	of	_	0	SENT_431	[p12l1740t3237r1774b3266],
10	BCRP	NN	O	bcrp	prep_of	8	SENT_431	[p12l1784t3238r1884b3266],
11	in	IN	O	in	_	0	SENT_431	[p12l366t3288r397b3316],
12	anticancer	JJ	O	anticancer	amod	14	SENT_431	[p12l408t3288r569b3316],
13	drug	NN	O	drug	nn	14	SENT_431	[p12l580t3287r653b3326],
14	efﬁcacy	NN	O	efﬁcacy	prep_in	10	SENT_431	[p12l663t3287r786b3326],
15	,	,	O	,	_	0	SENT_431	[p12l663t3287r786b3326],
16	toxicity	NN	O	toxicity	nsubj	22	SENT_431	[p12l798t3288r921b3326],
17	,	,	O	,	_	0	SENT_431	[p12l798t3288r921b3326],
18	and	CC	O	and	_	0	SENT_431	[p12l934t3287r989b3316],
19	overall	JJ	O	overall	amod	20	SENT_431	[p12l1001t3287r1105b3316],
20	prognosis	NN	O	prognosis	nsubj	22	SENT_431	[p12l1116t3288r1276b3326],
21	,	,	O	,	_	0	SENT_431	[p12l1116t3288r1276b3326],
22	refer	VBP	O	refer	_	0	SENT_431	[p12l1288t3287r1362b3316],
23	to	TO	O	to	_	0	SENT_431	[p12l1373t3295r1403b3316],
24	recent	JJ	O	recent	amod	26	SENT_431	[p12l1414t3295r1513b3316],
25	comprehensive	JJ	O	comprehensive	amod	26	SENT_431	[p12l1523t3287r1758b3326],
26	reviews	NNS	O	review	prep_to	22	SENT_431	[p12l1769t3288r1884b3316],
27	(	VBP	O	(	rcmod	26	SENT_431	[p12l367t3338r414b3374],
28	18	CD	NUMBER	18	number	29	SENT_431	[p12l367t3338r414b3374],
29	1	CD	NUMBER	1	dobj	27	SENT_431	[p12l421t3339r443b3373],
30	,	,	O	,	_	0	SENT_431	[p12l421t3339r443b3373],
31	1	CD	NUMBER	1	number	32	SENT_431	[p12l460t3339r470b3366],
32	82	CD	NUMBER	82	num	33	SENT_431	[p12l477t3338r532b3374],
33	)	NN	O	)	appos	29	SENT_431	[p12l477t3338r532b3374],
34	.	.	O	.	_	0	SENT_431	[p12l477t3338r532b3374],

1	*	NN	O	*	nn	3	SENT_432	[p12l1356t3449r1630b3479],
2	www.mmualreview5.org	NN	O	www.mmualreview5.org	nn	3	SENT_432	[p12l1356t3449r1630b3479],
3	o	NN	O	o	_	0	SENT_432	[p12l1645t3457r1654b3467],
4	Dmg	NNP	O	Dmg	nn	5	SENT_432	[p12l1671t3449r1734b3479],
5	Tmnsponferr	NNP	O	Tmnsponferr	dep	3	SENT_432	[p12l1742t3449r1886b3478],
6	261	CD	NUMBER	261	dep	3	SENT_432	[p12l1937t3449r1978b3471],

1	Multidrug	JJ	O	multidrug	amod	3	SENT_433	[p12l563t3488r760b3531],
2	Resistance-Associated	JJ	O	resistance-associated	amod	3	SENT_433	[p12l771t3488r1191b3520],
3	Proteins	NNS	O	protein	nsubj	20	SENT_433	[p12l1203t3489r1363b3520],
4	Of	IN	O	of	_	0	SENT_433	[p12l566t3540r610b3569],
5	the	DT	O	the	det	12	SENT_433	[p12l628t3540r677b3569],
6	multidrug	JJ	O	multidrug	amod	12	SENT_433	[p12l699t3540r857b3579],
7	resistance-associated	JJ	O	resistance-associated	amod	12	SENT_433	[p12l877t3540r1202b3569],
8	protein	NN	O	protein	nn	12	SENT_433	[p12l1224t3542r1338b3579],
9	(	CD	NUMBER	(	num	12	SENT_433	[p12l1361t3541r1467b3577],
10	MRP	NN	O	mrp	nn	12	SENT_433	[p12l1361t3541r1467b3577],
11	)	NN	O	)	nn	12	SENT_433	[p12l1361t3541r1467b3577],
12	family	NN	O	family	prep_of	3	SENT_433	[p12l1490t3540r1588b3579],
13	of	IN	O	of	_	0	SENT_433	[p12l1609t3540r1643b3569],
14	ABC	NNP	ORGANIZATION	ABC	nn	15	SENT_433	[p12l1659t3541r1736b3569],
15	transporters	NNS	O	transporter	prep_of	12	SENT_433	[p12l1758t3548r1956b3579],
16	,	,	O	,	_	0	SENT_433	[p12l1758t3548r1956b3579],
17	MRP1	NN	O	mrp1	nn	19	SENT_433	[p12l1977t3541r2079b3569],
18	(	CD	NUMBER	(	num	19	SENT_433	[p12l566t3590r651b3626],
19	ABC	NNP	ORGANIZATION	ABC	appos	15	SENT_433	[p12l566t3590r651b3626],
20	C	NN	O	c	_	0	SENT_433	[p12l652t3590r676b3618],
21	I	PRP	O	I	nsubj	22	SENT_433	[p12l677t3591r690b3618],
22	)	VBP	O	)	ccomp	20	SENT_433	[p12l694t3590r713b3626],
23	,	,	O	,	_	0	SENT_433	[p12l694t3590r713b3626],
24	MRP2	VBP	O	mrp2	dep	22	SENT_433	[p12l727t3590r830b3618],
25	(	CD	NUMBER	(	num	28	SENT_433	[p12l848t3590r933b3626],
26	ABC	NNP	ORGANIZATION	ABC	nn	28	SENT_433	[p12l848t3590r933b3626],
27	C2	NN	O	c2	nn	28	SENT_433	[p12l934t3590r995b3626],
28	)	NN	O	)	dobj	22	SENT_433	[p12l934t3590r995b3626],
29	,	,	O	,	_	0	SENT_433	[p12l934t3590r995b3626],
30	and	CC	O	and	_	0	SENT_433	[p12l1011t3589r1067b3618],
31	MRP4	NN	O	mrp4	conj_and	28	SENT_433	[p12l1080t3590r1186b3619],
32	(	CD	NUMBER	(	num	31	SENT_433	[p12l1200t3590r1339b3626],
33	ABCC4	NN	O	abcc4	nsubjpass	39	SENT_433	[p12l1200t3590r1339b3626],
34	)	CD	NUMBER	)	num	33	SENT_433	[p12l1200t3590r1339b3626],
35	have	VBP	O	have	aux	39	SENT_433	[p12l1353t3589r1424b3618],
36	been	VBN	O	be	auxpass	39	SENT_433	[p12l1439t3589r1513b3618],
37	most	RBS	O	most	advmod	38	SENT_433	[p12l1527t3597r1604b3618],
38	widely	RB	O	widely	advmod	39	SENT_433	[p12l1616t3589r1720b3628],
39	studied	VBN	O	study	rcmod	31	SENT_433	[p12l1733t3589r1846b3618],
40	in	IN	O	in	_	0	SENT_433	[p12l1860t3591r1890b3618],
41	the	DT	O	the	det	42	SENT_433	[p12l1905t3589r1953b3618],
42	context	NN	O	context	prep_in	39	SENT_433	[p12l1968t3597r2084b3618],
43	of	IN	O	of	_	0	SENT_433	[p12l565t3639r600b3668],
44	drug	NN	O	drug	nn	45	SENT_433	[p12l612t3639r685b3678],
45	response	NN	O	response	prep_of	42	SENT_433	[p12l700t3650r836b3678],
46	and	CC	O	and	_	0	SENT_433	[p12l852t3639r908b3668],
47	toxicity	NN	O	toxicity	prep_of	42	SENT_433	[p12l924t3641r1047b3678],
48	.	.	O	.	_	0	SENT_433	[p12l924t3641r1047b3678],

1	In	IN	O	in	_	0	SENT_434	[p12l1065t3641r1098b3668],
2	some	DT	O	some	det	3	SENT_434	[p12l1114t3650r1195b3668],
3	cancers	NNS	O	cancer	prep_in	9	SENT_434	[p12l1211t3650r1334b3675],
4	,	,	O	,	_	0	SENT_434	[p12l1211t3650r1334b3675],
5	their	PRP$	O	they	poss	6	SENT_434	[p12l1351t3639r1426b3668],
6	expression	NN	O	expression	nsubjpass	9	SENT_434	[p12l1442t3641r1605b3678],
7	may	MD	O	may	aux	9	SENT_434	[p12l1620t3650r1686b3678],
8	be	VB	O	be	auxpass	9	SENT_434	[p12l1701t3639r1736b3668],
9	associated	VBN	O	associate	_	0	SENT_434	[p12l1753t3639r1909b3668],
10	with	IN	O	with	_	0	SENT_434	[p12l1924t3639r1993b3668],
11	poor	JJ	O	poor	amod	13	SENT_434	[p12l2009t3650r2083b3678],
12	overall	JJ	O	overall	amod	13	SENT_434	[p12l565t3688r670b3717],
13	prognosis	NN	O	prognosis	prep_with	9	SENT_434	[p12l681t3690r832b3727],
14	or	CC	O	or	_	0	SENT_434	[p12l844t3699r877b3717],
15	response	NN	O	response	conj_or	13	SENT_434	[p12l888t3699r1024b3727],
16	to	TO	O	to	_	0	SENT_434	[p12l1035t3696r1066b3717],
17	therapy	NN	O	therapy	nn	18	SENT_434	[p12l1078t3688r1197b3727],
18	(	NN	O	(	prep_to	9	SENT_434	[p12l1208t3689r1295b3725],
19	137	CD	NUMBER	137	num	20	SENT_434	[p12l1208t3689r1295b3725],
20	)	NN	O	)	dep	18	SENT_434	[p12l1208t3689r1295b3725],
21	.	.	O	.	_	0	SENT_434	[p12l1208t3689r1295b3725],

1	Annu	NNP	PERSON	Annu	_	0	SENT_435	[p13l72t1512r95b1592],
2	.	.	O	.	_	0	SENT_435	[p13l72t1512r95b1592],

1	Rev.	NNP	O	Rev.	nn	2	SENT_436	[p13l72t1441r95b1501],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_436	[p13l72t1282r95b1430],
3	.	.	O	.	_	0	SENT_436	[p13l72t1282r95b1430],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_437	[p13l72t1161r95b1271],
2	.	.	O	.	_	0	SENT_437	[p13l72t1161r95b1271],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_438	[p13l72t915r96b1150],
2	-273	CD	NUMBER	-273	_	0	SENT_438	[p13l72t915r96b1150],
3	.	.	O	.	_	0	SENT_438	[p13l72t915r96b1150],

1	Downloaded	VBN	O	download	_	0	SENT_439	[p13l72t733r95b904],
2	from	IN	O	from	_	0	SENT_439	[p13l72t660r95b724],
3	www	NN	O	www	prep_from	1	SENT_439	[p13l72t380r95b651],
4	.	.	O	.	_	0	SENT_439	[p13l72t380r95b651],

1	annualreviews	NNS	O	annualreview	_	0	SENT_440	[p13l72t380r95b651],
2	.	.	O	.	_	0	SENT_440	[p13l79t314r102b364],

1	org	NN	O	org	_	0	SENT_441	[p13l79t314r102b364],
2	by	IN	O	by	_	0	SENT_441	[p13l105t1424r136b1457],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_441	[p13l105t1275r136b1415],
4	of	IN	ORGANIZATION	of	_	0	SENT_441	[p13l105t1236r129b1265],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_441	[p13l105t1089r129b1230],
6	-	:	O	-	_	0	SENT_441	[p13l119t1071r122b1080],
7	Madison	NNP	O	Madison	dep	1	SENT_441	[p13l105t944r129b1061],
8	on	IN	O	on	_	0	SENT_441	[p13l113t902r129b934],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_441	[p13l105t768r129b893],
10	.	.	O	.	_	0	SENT_441	[p13l105t768r129b893],

1	For	IN	O	for	_	0	SENT_442	[p13l106t711r129b757],
2	personal	JJ	O	personal	amod	3	SENT_442	[p13l105t591r136b703],
3	use	NN	O	use	pobj	1	SENT_442	[p13l113t538r129b582],
4	only	RB	O	only	advmod	3	SENT_442	[p13l105t463r136b528],
5	.	.	O	.	_	0	SENT_442	[p13l105t463r136b528],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_443	[p13l181t3635r204b3745],
2	.	.	O	.	_	0	SENT_443	[p13l181t3635r204b3745],

1	201	CD	NUMBER	201	_	0	SENT_444	[p13l181t3579r204b3624],
2	2.52:249	CD	NUMBER	2.52:249	number	3	SENT_444	[p13l181t3380r205b3563],
3	-273	CD	NUMBER	-273	num	1	SENT_444	[p13l181t3380r205b3563],
4	.	.	O	.	_	0	SENT_444	[p13l181t3380r205b3563],

1	Downloaded	VBN	O	download	_	0	SENT_445	[p13l181t3199r204b3369],
2	from	IN	O	from	prep	1	SENT_445	[p13l181t3125r204b3189],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	dep	8	SENT_445	[p13l181t2792r211b3116],
4	of	IN	O	of	_	0	SENT_445	[p13l214t3710r238b3739],
5	Wisconsi	NN	PERSON	wisconsus	prep_of	3	SENT_445	[p13l214t3580r238b3704],
6	n	NN	O	n	dep	8	SENT_445	[p13l222t3553r237b3569],
7	—	CD	NUMBER	—	num	6	SENT_445	[p13l228t3534r231b3543],
8	Madison	NNP	O	Madison	dep	12	SENT_445	[p13l214t3408r238b3524],
9	on	IN	O	on	_	0	SENT_445	[p13l222t3367r238b3399],
10	01/05	CD	NUMBER	01/05	prep_on	8	SENT_445	[p13l214t3273r238b3358],
11	/	:	O	/	punct	12	SENT_445	[p13l214t3273r238b3358],
12	14	CD	NUMBER	14	dep	2	SENT_445	[p13l214t3233r238b3269],
13	.	.	O	.	_	0	SENT_445	[p13l214t3233r238b3269],

1	For	IN	O	for	_	0	SENT_446	[p13l215t3176r238b3222],
2	personal	JJ	O	personal	amod	3	SENT_446	[p13l214t3055r245b3167],
3	use	NN	O	use	pobj	1	SENT_446	[p13l222t3002r238b3046],
4	only	RB	O	only	advmod	3	SENT_446	[p13l214t2927r245b2992],
5	.	.	O	.	_	0	SENT_446	[p13l214t2927r245b2992],

1	Multidrug	JJ	O	multidrug	amod	3	SENT_447	[p13l564t27r741b66],
2	resistance-associated	JJ	O	resistance-associated	amod	3	SENT_447	[p13l756t27r1113b56],
3	protein	NN	O	protein	_	0	SENT_447	[p13l1129t29r1255b65],
4	1	CD	NUMBER	1	dep	3	SENT_447	[p13l1274t29r1287b56],
5	in	IN	O	in	_	0	SENT_447	[p13l1307t29r1340b56],
6	efﬁcacy	NN	O	efﬁcacy	prep_in	4	SENT_447	[p13l1357t27r1484b66],
7	and	CC	O	and	_	0	SENT_447	[p13l1499t27r1559b56],
8	toxicity	NN	O	toxicity	prep_in	4	SENT_447	[p13l1576t29r1709b66],
9	.	.	O	.	_	0	SENT_447	[p13l1576t29r1709b66],

1	MRP1	NN	O	mrp1	nsubjpass	3	SENT_448	[p13l1729t29r1831b56],
2	is	VBZ	O	be	auxpass	3	SENT_448	[p13l1850t29r1872b56],
3	expressed	VBN	O	express	_	0	SENT_448	[p13l1889t27r2038b66],
4	in	IN	O	in	_	0	SENT_448	[p13l2053t29r2083b56],
5	tissues	NNS	O	tissue	prep_in	3	SENT_448	[p13l565t78r665b106],
6	throughout	IN	O	throughout	_	0	SENT_448	[p13l678t76r858b115],
7	the	DT	O	the	det	8	SENT_448	[p13l870t76r919b106],
8	body	NN	O	body	prep_throughout	3	SENT_448	[p13l933t76r1018b115],
9	,	,	O	,	_	0	SENT_448	[p13l933t76r1018b115],
10	including	VBG	O	include	_	0	SENT_448	[p13l1032t76r1181b115],
11	the	DT	O	the	det	21	SENT_448	[p13l1193t76r1242b106],
12	lung	NN	O	lung	amod	21	SENT_448	[p13l1255t76r1332b115],
13	,	,	O	,	_	0	SENT_448	[p13l1255t76r1332b115],
14	testis	NN	O	testis	conj_and	12	SENT_448	[p13l1347t78r1434b112],
15	,	,	O	,	_	0	SENT_448	[p13l1347t78r1434b112],
16	kidney	NN	O	kidney	conj_and	12	SENT_448	[p13l1448t76r1561b115],
17	,	,	O	,	_	0	SENT_448	[p13l1448t76r1561b115],
18	cardiac	JJ	O	cardiac	conj_and	12	SENT_448	[p13l1576t76r1685b106],
19	and	CC	O	and	_	0	SENT_448	[p13l1699t76r1754b106],
20	skeletal	JJ	O	skeletal	conj_and	12	SENT_448	[p13l1768t76r1883b106],
21	muscle	NN	O	muscle	prep_including	3	SENT_448	[p13l1896t76r2012b112],
22	,	,	O	,	_	0	SENT_448	[p13l1896t76r2012b112],
23	and	CC	O	and	_	0	SENT_448	[p13l2027t76r2082b106],
24	placenta	NN	O	placenta	conj_and	21	SENT_448	[p13l565t126r702b165],
25	.	.	O	.	_	0	SENT_448	[p13l565t126r702b165],

1	As	IN	O	as	mark	2	SENT_449	[p13l712t127r750b155],
2	described	VBN	O	describe	advcl	12	SENT_449	[p13l761t126r909b155],
3	above	IN	O	above	prep	2	SENT_449	[p13l919t126r1017b162],
4	,	,	O	,	_	0	SENT_449	[p13l919t126r1017b162],
5	overexpression	NN	O	overexpression	nsubjpass	12	SENT_449	[p13l1028t128r1260b165],
6	of	IN	O	of	_	0	SENT_449	[p13l1270t126r1304b155],
7	MRP1	NN	O	mrp1	prep_of	5	SENT_449	[p13l1308t127r1410b155],
8	in	IN	O	in	_	0	SENT_449	[p13l1423t128r1453b155],
9	cancer	NN	O	cancer	nn	10	SENT_449	[p13l1463t137r1564b155],
10	cells	NNS	O	cell	prep_in	7	SENT_449	[p13l1573t126r1640b155],
11	is	VBZ	O	be	auxpass	12	SENT_449	[p13l1649t128r1672b155],
12	associated	VBN	O	associate	_	0	SENT_449	[p13l1682t126r1838b155],
13	with	IN	O	with	_	0	SENT_449	[p13l1847t126r1916b155],
14	multidrug	JJ	O	multidrug	amod	18	SENT_449	[p13l1925t126r2084b165],
15	resistance	NN	O	resistance	nn	18	SENT_449	[p13l565t177r717b205],
16	(	NN	O	(	nn	18	SENT_449	[p13l729t177r816b213],
17	183	CD	NUMBER	183	num	18	SENT_449	[p13l729t177r816b213],
18	)	NN	O	)	prep_with	12	SENT_449	[p13l729t177r816b213],
19	.	.	O	.	_	0	SENT_449	[p13l729t177r816b213],

1	Like	IN	O	like	_	0	SENT_450	[p13l829t176r899b205],
2	P-glycoprotein	NN	O	p-glycoprotein	prep_like	6	SENT_450	[p13l911t176r1156b215],
3	,	,	O	,	_	0	SENT_450	[p13l911t176r1156b215],
4	MRP1	NN	O	mrp1	nsubj	6	SENT_450	[p13l1167t177r1269b205],
5	is	VBZ	O	be	cop	6	SENT_450	[p13l1283t177r1306b205],
6	capable	JJ	O	capable	_	0	SENT_450	[p13l1318t176r1433b215],
7	of	IN	O	of	_	0	SENT_450	[p13l1445t176r1479b205],
8	transporting	VBG	O	transport	prepc_of	6	SENT_450	[p13l1486t177r1682b215],
9	structurally	RB	O	structurally	advmod	10	SENT_450	[p13l1692t176r1872b215],
10	diverse	JJ	O	diverse	amod	11	SENT_450	[p13l1882t176r1990b205],
11	compounds	NNS	O	compound	dobj	8	SENT_450	[p13l2002t187r2082b205, p13l565t225r686b264],
12	.	.	O	.	_	0	SENT_450	[p13l2002t187r2082b205, p13l565t225r686b264],

1	Endogenous	JJ	O	endogenous	amod	2	SENT_451	[p13l704t225r899b264],
2	substrates	NNS	O	substrate	nsubj	5	SENT_451	[p13l916t225r1069b255],
3	of	IN	O	of	_	0	SENT_451	[p13l1085t225r1119b255],
4	MRPI	NNP	O	MRPI	prep_of	2	SENT_451	[p13l1129t227r1231b254],
5	include	VBP	O	include	_	0	SENT_451	[p13l1249t225r1364b255],
6	oxidized	VBN	O	oxidize	dep	5	SENT_451	[p13l1380t225r1509b255],
7	glutathione	NN	O	glutathione	dobj	6	SENT_451	[p13l1526t225r1713b264],
8	,	,	O	,	_	0	SENT_451	[p13l1526t225r1713b264],
9	cysteinyl	NN	O	cysteinyl	nn	10	SENT_451	[p13l1730t225r1866b264],
10	leukotrienes	NNS	O	leukotriene	dobj	6	SENT_451	[p13l1881t225r2081b261],
11	,	,	O	,	_	0	SENT_451	[p13l1881t225r2081b261],
12	glucuronide	NN	O	glucuronide	nn	15	SENT_451	[p13l565t275r753b314],
13	and	CC	O	and	_	0	SENT_451	[p13l764t275r820b304],
14	sulfate	NN	O	sulfate	nn	15	SENT_451	[p13l831t275r931b304],
15	conjugates	NNS	O	conjugate	conj_and	7	SENT_451	[p13l943t277r1116b314],
16	,	,	O	,	_	0	SENT_451	[p13l943t277r1116b314],
17	and	CC	O	and	_	0	SENT_451	[p13l1129t275r1184b304],
18	drug	NN	O	drug	nn	19	SENT_451	[p13l1196t275r1269b314],
19	substrates	NNS	O	substrate	conj_and	7	SENT_451	[p13l1279t275r1432b304],
20	including	VBG	O	include	_	0	SENT_451	[p13l1443t275r1592b314],
21	anthracyclines	NNS	O	anthracycline	prep_including	6	SENT_451	[p13l1602t275r1834b314],
22	,	,	O	,	_	0	SENT_451	[p13l1602t275r1834b314],
23	vinca	NN	O	vinca	nn	24	SENT_451	[p13l1845t277r1927b304],
24	alkaloids	NNS	O	alkaloid	conj_and	21	SENT_451	[p13l1938t275r2081b310],
25	,	,	O	,	_	0	SENT_451	[p13l1938t275r2081b310],
26	and	CC	O	and	_	0	SENT_451	[p13l565t325r621b354],
27	antivirals	NNS	O	antiviral	conj_and	21	SENT_451	[p13l634t325r784b354],
28	.	.	O	.	_	0	SENT_451	[p13l634t325r784b354],

1	Mice	NNS	O	mouse	nsubj	4	SENT_452	[p13l797t326r877b354],
2	lacking	VBG	O	lack	partmod	1	SENT_452	[p13l891t325r1003b364],
3	Mrpl	NNP	O	Mrpl	dobj	2	SENT_452	[p13l1014t326r1100b364],
4	demonstrate	VBP	O	demonstrate	_	0	SENT_452	[p13l1118t325r1312b354],
5	increased	VBN	O	increase	amod	6	SENT_452	[p13l1325t325r1471b354],
6	sensitivity	NN	O	sensitivity	dobj	4	SENT_452	[p13l1484t326r1642b364],
7	to	TO	O	to	_	0	SENT_452	[p13l1653t333r1684b354],
8	the	DT	O	the	det	13	SENT_452	[p13l1697t325r1746b354],
9	topoisomerase	NN	O	topoisomerase	nn	13	SENT_452	[p13l1760t326r1985b364],
10	II	CD	NUMBER	ii	num	13	SENT_452	[p13l1999t326r2025b354],
11	inhibitor	NN	O	inhibitor	nn	13	SENT_452	[p13l2038t326r2082b354, p13l564t388r673b417],
12	etoposide	NN	O	etoposide	nn	13	SENT_452	[p13l686t388r835b426],
13	(	NN	O	(	prep_to	4	SENT_452	[p13l849t389r925b424],
14	184	CD	NUMBER	184	dep	13	SENT_452	[p13l849t389r925b424],
15	,	,	O	,	_	0	SENT_452	[p13l849t389r925b424],
16	185	CD	NUMBER	185	num	17	SENT_452	[p13l942t389r1015b424],
17	)	NN	O	)	appos	13	SENT_452	[p13l942t389r1015b424],
18	.	.	O	.	_	0	SENT_452	[p13l942t389r1015b424],

1	Functional	JJ	O	functional	amod	3	SENT_453	[p13l1030t388r1199b417],
2	ABCC1	NN	O	abcc1	nn	3	SENT_453	[p13l1209t388r1326b417],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	6	SENT_453	[p13l1341t388r1584b427],
4	have	VBP	O	have	aux	6	SENT_453	[p13l1597t388r1667b417],
5	been	VBN	O	be	auxpass	6	SENT_453	[p13l1680t388r1755b417],
6	described	VBN	O	describe	_	0	SENT_453	[p13l1768t388r1916b417],
7	(	CD	NUMBER	(	number	8	SENT_453	[p13l1930t389r2017b424],
8	186	CD	NUMBER	186	num	9	SENT_453	[p13l1930t389r2017b424],
9	)	NN	O	)	dobj	6	SENT_453	[p13l1930t389r2017b424],
10	,	,	O	,	_	0	SENT_453	[p13l1930t389r2017b424],
11	but	CC	O	but	_	0	SENT_453	[p13l2032t388r2084b417],
12	to	TO	O	to	_	0	SENT_453	[p13l565t446r595b467],
13	date	NN	O	date	prep_to	22	SENT_453	[p13l608t437r680b473],
14	,	,	O	,	_	0	SENT_453	[p13l608t437r680b473],
15	ABC	NNP	ORGANIZATION	ABC	nn	16	SENT_453	[p13l689t438r767b466],
16	C	NNP	O	C	nsubjpass	22	SENT_453	[p13l768t439r792b466],
17	1	CD	NUMBER	1	num	18	SENT_453	[p13l793t439r806b466],
18	variants	NNS	O	variant	dep	16	SENT_453	[p13l819t439r941b467],
19	have	VBP	O	have	aux	22	SENT_453	[p13l952t437r1022b467],
20	not	RB	O	not	neg	22	SENT_453	[p13l1033t446r1087b467],
21	been	VBN	O	be	auxpass	22	SENT_453	[p13l1097t437r1171b467],
22	associated	VBN	O	associate	conj_but	6	SENT_453	[p13l1182t437r1338b467],
23	with	IN	O	with	_	0	SENT_453	[p13l1348t438r1418b467],
24	striking	JJ	O	striking	amod	25	SENT_453	[p13l1429t437r1549b476],
25	changes	NNS	O	change	prep_with	22	SENT_453	[p13l1559t438r1682b476],
26	in	IN	O	in	_	0	SENT_453	[p13l1693t439r1724b466],
27	drug	NN	O	drug	nn	28	SENT_453	[p13l1735t437r1808b476],
28	response	NN	O	response	prep_in	25	SENT_453	[p13l1818t448r1963b476],
29	.	.	O	.	_	0	SENT_453	[p13l1818t448r1963b476],

1	Multidrug	JJ	O	multidrug	amod	3	SENT_454	[p13l564t542r741b581],
2	resistance-associated	JJ	O	resistance-associated	amod	3	SENT_454	[p13l755t542r1112b572],
3	protein	NN	O	protein	_	0	SENT_454	[p13l1127t544r1253b581],
4	2	CD	NUMBER	2	dep	3	SENT_454	[p13l1268t544r1285b571],
5	in	IN	O	in	_	0	SENT_454	[p13l1303t544r1336b571],
6	efﬁcacy	NN	O	efﬁcacy	prep_in	4	SENT_454	[p13l1351t543r1478b581],
7	and	CC	O	and	_	0	SENT_454	[p13l1493t542r1553b572],
8	toxicity	NN	O	toxicity	prep_in	4	SENT_454	[p13l1569t544r1702b581],
9	.	.	O	.	_	0	SENT_454	[p13l1569t544r1702b581],

1	MRP2	NN	O	mrp2	nsubjpass	3	SENT_455	[p13l1722t544r1825b571],
2	is	VBZ	O	be	auxpass	3	SENT_455	[p13l1842t544r1864b572],
3	expressed	VBN	O	express	_	0	SENT_455	[p13l1880t543r2029b581],
4	on	IN	O	on	_	0	SENT_455	[p13l2044t554r2083b572],
5	the	DT	O	the	det	7	SENT_455	[p13l565t592r614b621],
6	canalicular	JJ	O	canalicular	amod	7	SENT_455	[p13l624t592r792b621],
7	membrane	NN	O	membrane	prep_on	3	SENT_455	[p13l801t592r969b621],
8	of	IN	O	of	_	0	SENT_455	[p13l979t593r1013b621],
9	the	DT	O	the	det	10	SENT_455	[p13l1019t592r1068b621],
10	hepatocyte	NN	O	hepatocyte	prep_of	7	SENT_455	[p13l1077t592r1248b631],
11	and	CC	O	and	_	0	SENT_455	[p13l1258t592r1314b621],
12	on	IN	O	on	_	0	SENT_455	[p13l1324t603r1363b621],
13	the	DT	O	the	det	15	SENT_455	[p13l1373t592r1421b621],
14	apical	JJ	O	apical	amod	15	SENT_455	[p13l1432t592r1521b631],
15	membrane	NN	O	membrane	prep_on	3	SENT_455	[p13l1530t592r1698b621],
16	of	IN	O	of	_	0	SENT_455	[p13l1708t593r1742b621],
17	renal	JJ	O	renal	amod	21	SENT_455	[p13l1748t592r1826b621],
18	proximal	JJ	O	proximal	amod	21	SENT_455	[p13l1836t592r1974b631],
19	tubule	JJ	O	tubule	amod	21	SENT_455	[p13l1984t592r2083b621],
20	endothelial	JJ	O	endothelial	amod	21	SENT_455	[p13l565t642r740b671],
21	cells	NNS	O	cell	prep_of	15	SENT_455	[p13l754t642r820b671],
22	(	VBP	O	(	rcmod	21	SENT_455	[p13l835t643r922b679],
23	187	CD	NUMBER	187	number	24	SENT_455	[p13l835t643r922b679],
24	)	CD	NUMBER	)	dobj	22	SENT_455	[p13l835t643r922b679],
25	.	.	O	.	_	0	SENT_455	[p13l835t643r922b679],

1	MRP2	NN	O	mrp2	nsubj	2	SENT_456	[p13l936t644r1038b671],
2	transports	VBZ	O	transport	_	0	SENT_456	[p13l1054t650r1212b681],
3	a	DT	O	a	det	5	SENT_456	[p13l1226t653r1240b671],
4	wide	JJ	O	wide	amod	5	SENT_456	[p13l1253t642r1326b671],
5	range	NN	O	range	dobj	2	SENT_456	[p13l1340t653r1427b681],
6	of	IN	O	of	_	0	SENT_456	[p13l1441t642r1475b671],
7	glutathione	NN	O	glutathione	prep_of	5	SENT_456	[p13l1485t642r1672b681],
8	,	,	O	,	_	0	SENT_456	[p13l1485t642r1672b681],
9	sulfate	NN	O	sulfate	conj_and	5	SENT_456	[p13l1687t642r1796b677],
10	,	,	O	,	_	0	SENT_456	[p13l1687t642r1796b677],
11	and	CC	O	and	_	0	SENT_456	[p13l1811t642r1867b671],
12	glucuronide	NN	O	glucuronide	conj_and	5	SENT_456	[p13l1881t642r2082b681],
13	—	CD	NUMBER	—	num	12	SENT_456	[p13l1881t642r2082b681],
14	conjugated	VBN	O	conjugate	partmod	12	SENT_456	[p13l565t692r736b730],
15	endo	NN	O	endo	dobj	14	SENT_456	[p13l748t692r837b721],
16	-	:	O	-	_	0	SENT_456	[p13l748t692r837b721],
17	and	CC	O	and	_	0	SENT_456	[p13l849t692r904b721],
18	xenobiotics	NNS	O	xenobiotic	conj_and	5	SENT_456	[p13l914t692r1100b721],
19	.	.	O	.	_	0	SENT_456	[p13l914t692r1100b721],

1	Genetic	JJ	O	genetic	amod	2	SENT_457	[p13l1113t693r1237b721],
2	mutations	NNS	O	mutation	_	0	SENT_457	[p13l1247t693r1404b721],
3	in	IN	O	in	_	0	SENT_457	[p13l1414t693r1445b720],
4	MRP2	NN	O	mrp2	nn	7	SENT_457	[p13l1453t693r1556b721],
5	cause	NN	O	cause	nn	7	SENT_457	[p13l1570t703r1652b721],
6	Dubin-Johnson	NN	O	dubin-johnson	nn	7	SENT_457	[p13l1663t692r1909b728],
7	syndrome	NN	O	syndrome	prep_in	2	SENT_457	[p13l1919t692r2081b730],
8	,	,	O	,	_	0	SENT_457	[p13l1919t692r2081b730],
9	a	DT	O	a	det	10	SENT_457	[p13l565t753r580b771],
10	disease	NN	O	disease	appos	7	SENT_457	[p13l597t742r704b771],
11	characterized	VBN	O	characterize	partmod	10	SENT_457	[p13l721t741r929b771],
12	by	IN	O	by	_	0	SENT_457	[p13l946t742r984b780],
13	hyperbilirubinemia	NN	O	hyperbilirubinemia	agent	11	SENT_457	[p13l998t741r1300b780],
14	resulting	VBG	O	result	partmod	13	SENT_457	[p13l1317t742r1455b780],
15	from	IN	O	from	_	0	SENT_457	[p13l1471t742r1547b771],
16	reduced	VBN	O	reduce	amod	17	SENT_457	[p13l1563t742r1688b771],
17	transport	NN	O	transport	prep_from	14	SENT_457	[p13l1704t750r1849b780],
18	of	IN	O	of	prep	2	SENT_457	[p13l1865t742r1899b771],
19	conjugated	VBN	O	conjugate	partmod	2	SENT_457	[p13l1912t742r2082b780],
20	bilirubin	NN	O	bilirubin	dobj	19	SENT_457	[p13l565t792r701b821],
21	into	IN	O	into	_	0	SENT_457	[p13l717t793r779b821],
22	bile	NN	O	bile	nn	23	SENT_457	[p13l796t791r853b821],
23	(	NN	O	(	prep_into	19	SENT_457	[p13l871t792r958b828],
24	188	CD	NUMBER	188	num	25	SENT_457	[p13l871t792r958b828],
25	)	NN	O	)	dep	23	SENT_457	[p13l871t792r958b828],
26	.	.	O	.	_	0	SENT_457	[p13l871t792r958b828],

1	Polymorphisms	NNS	O	polymorphism	nsubjpass	6	SENT_458	[p13l977t791r1223b830],
2	in	IN	O	in	_	0	SENT_458	[p13l1240t793r1270b820],
3	ABCC2	NN	O	abcc2	prep_in	1	SENT_458	[p13l1283t792r1403b820],
4	have	VBP	O	have	aux	6	SENT_458	[p13l1420t791r1490b821],
5	been	VBN	O	be	auxpass	6	SENT_458	[p13l1507t791r1582b821],
6	associated	VBN	O	associate	_	0	SENT_458	[p13l1599t791r1754b821],
7	with	IN	O	with	_	0	SENT_458	[p13l1770t791r1840b821],
8	higher	JJR	O	higher	amod	10	SENT_458	[p13l1856t791r1959b830],
9	plasma	NN	O	plasma	nn	10	SENT_458	[p13l1975t791r2083b830],
10	concentrations	NNS	O	concentration	prep_with	6	SENT_458	[p13l565t843r796b871],
11	of	IN	O	of	_	0	SENT_458	[p13l809t842r843b871],
12	some	DT	O	some	det	14	SENT_458	[p13l851t852r932b870],
13	MRPZ	JJ	O	mrpz	amod	14	SENT_458	[p13l942t843r1045b870],
14	substrates	NNS	O	substrate	prep_of	10	SENT_458	[p13l1060t841r1213b871],
15	(	VBP	O	(	rcmod	14	SENT_458	[p13l1226t842r1313b878],
16	189	CD	NUMBER	189	number	17	SENT_458	[p13l1226t842r1313b878],
17	)	CD	NUMBER	)	dobj	15	SENT_458	[p13l1226t842r1313b878],
18	.	.	O	.	_	0	SENT_458	[p13l1226t842r1313b878],

1	The	DT	O	the	det	3	SENT_459	[p13l1326t841r1392b870],
2	gastrointestinal	JJ	O	gastrointestinal	amod	3	SENT_459	[p13l1405t841r1645b880],
3	toxicity	NN	O	toxicity	nsubj	19	SENT_459	[p13l1658t843r1774b880],
4	associated	VBN	O	associate	partmod	3	SENT_459	[p13l1785t841r1941b871],
5	with	IN	O	with	_	0	SENT_459	[p13l1952t841r2022b870],
6	the	DT	O	the	det	7	SENT_459	[p13l2034t841r2082b870],
7	use	NN	O	use	prep_with	4	SENT_459	[p13l564t903r614b921],
8	of	IN	O	of	_	0	SENT_459	[p13l624t892r658b921],
9	some	DT	O	some	det	10	SENT_459	[p13l663t903r743b921],
10	drugs	NNS	O	drug	prep_of	7	SENT_459	[p13l754t892r848b931],
11	,	,	O	,	_	0	SENT_459	[p13l754t892r848b931],
12	such	JJ	O	such	_	0	SENT_459	[p13l858t892r928b921],
13	as	IN	O	as	_	0	SENT_459	[p13l937t903r965b921],
14	NSAIDS	NNPS	O	NSAIDS	prep_such_as	3	SENT_459	[p13l974t893r1110b921],
15	and	CC	O	and	_	0	SENT_459	[p13l1120t892r1175b921],
16	antibiotics	NNS	O	antibiotic	conj_and	14	SENT_459	[p13l1185t892r1355b927],
17	,	,	O	,	_	0	SENT_459	[p13l1185t892r1355b927],
18	may	MD	O	may	aux	19	SENT_459	[p13l1365t903r1432b931],
19	result	VB	O	result	_	0	SENT_459	[p13l1439t892r1527b921],
20	from	IN	O	from	_	0	SENT_459	[p13l1535t892r1611b921],
21	enterohepatic	JJ	O	enterohepatic	amod	22	SENT_459	[p13l1621t892r1835b930],
22	recirculation	NN	O	recirculation	prep_from	19	SENT_459	[p13l1844t892r2044b921],
23	of	IN	O	of	_	0	SENT_459	[p13l2053t892r2087b921],
24	these	DT	O	these	det	25	SENT_459	[p13l565t942r645b971],
25	compounds	NNS	O	compound	prep_of	22	SENT_459	[p13l655t942r835b980],
26	and	CC	O	and	_	0	SENT_459	[p13l846t942r901b971],
27	their	PRP$	O	they	poss	28	SENT_459	[p13l911t942r985b971],
28	metabolites	NNS	O	metabolite	prep_from	19	SENT_459	[p13l994t942r1174b971],
29	that	WDT	O	that	nsubjpass	31	SENT_459	[p13l1184t942r1246b971],
30	is	VBZ	O	be	auxpass	31	SENT_459	[p13l1254t944r1277b971],
31	driven	VBN	O	drive	rcmod	28	SENT_459	[p13l1288t942r1394b977],
32	,	,	O	,	_	0	SENT_459	[p13l1288t942r1394b977],
33	in	IN	O	in	_	0	SENT_459	[p13l1405t944r1435b971],
34	large	JJ	O	large	amod	35	SENT_459	[p13l1444t942r1521b981],
35	part	NN	O	part	prep_in	31	SENT_459	[p13l1530t950r1601b980],
36	,	,	O	,	_	0	SENT_459	[p13l1530t950r1601b980],
37	by	IN	O	by	_	0	SENT_459	[p13l1612t942r1650b981],
38	MRP2	NN	O	mrp2	agent	31	SENT_459	[p13l1657t943r1759b971],
39	in	IN	O	in	_	0	SENT_459	[p13l1771t944r1801b971],
40	the	DT	O	the	det	43	SENT_459	[p13l1811t942r1859b971],
41	bile	NN	O	bile	nn	43	SENT_459	[p13l1869t942r1926b971],
42	canaliculi	JJ	O	canaliculi	amod	43	SENT_459	[p13l1936t942r2082b971],
43	(	NN	O	(	prep_in	38	SENT_459	[p13l566t993r653b1028],
44	190	CD	NUMBER	190	num	45	SENT_459	[p13l566t993r653b1028],
45	)	NN	O	)	dep	43	SENT_459	[p13l566t993r653b1028],
46	.	.	O	.	_	0	SENT_459	[p13l566t993r653b1028],

1	Multidrug	JJ	O	multidrug	amod	3	SENT_460	[p13l564t1097r741b1136],
2	resistance-associated	JJ	O	resistance-associated	amod	3	SENT_460	[p13l753t1097r1110b1126],
3	protein	NN	O	protein	_	0	SENT_460	[p13l1122t1099r1247b1135],
4	4	CD	NUMBER	4	dep	3	SENT_460	[p13l1260t1099r1280b1126],
5	in	IN	O	in	_	0	SENT_460	[p13l1293t1099r1325b1126],
6	efficacy	NN	O	efficacy	prep_in	4	SENT_460	[p13l1339t1097r1466b1136],
7	and	CC	O	and	_	0	SENT_460	[p13l1478t1097r1538b1126],
8	toxicity	NN	O	toxicity	prep_in	4	SENT_460	[p13l1551t1099r1684b1136],
9	.	.	O	.	_	0	SENT_460	[p13l1551t1099r1684b1136],

1	MRP4	NN	O	mrp4	nsubj	3	SENT_461	[p13l1704t1099r1810b1126],
2	is	VBZ	O	be	cop	3	SENT_461	[p13l1822t1099r1844b1126],
3	located	JJ	O	located	_	0	SENT_461	[p13l1857t1097r1969b1126],
4	on	IN	O	on	_	0	SENT_461	[p13l1982t1108r2021b1126],
5	the	DT	O	the	det	7	SENT_461	[p13l2034t1097r2082b1126],
6	basolateral	JJ	O	basolateral	amod	7	SENT_461	[p13l565t1147r732b1176],
7	membrane	NN	O	membrane	prep_on	3	SENT_461	[p13l743t1147r910b1176],
8	of	IN	O	of	_	0	SENT_461	[p13l921t1147r955b1176],
9	hepatocytes	NNS	O	hepatocyte	prep_of	7	SENT_461	[p13l961t1147r1145b1186],
10	and	CC	O	and	_	0	SENT_461	[p13l1156t1147r1212b1176],
11	choroid	NN	O	choroid	nn	13	SENT_461	[p13l1222t1147r1343b1176],
12	plexus	NN	O	plexus	nn	13	SENT_461	[p13l1353t1147r1450b1185],
13	epithelium	NN	O	epithelium	prep_of	7	SENT_461	[p13l1461t1147r1630b1185],
14	and	CC	O	and	_	0	SENT_461	[p13l1640t1147r1696b1176],
15	on	IN	O	on	_	0	SENT_461	[p13l1707t1158r1746b1176],
16	the	DT	O	the	det	18	SENT_461	[p13l1756t1147r1805b1176],
17	apical	JJ	O	apical	amod	18	SENT_461	[p13l1816t1147r1905b1185],
18	membrane	NN	O	membrane	prep_on	3	SENT_461	[p13l1915t1147r2082b1176],
19	of	IN	O	of	_	0	SENT_461	[p13l565t1197r599b1226],
20	kidney	NN	O	kidney	nn	23	SENT_461	[p13l611t1197r717b1236],
21	proximal	JJ	O	proximal	amod	23	SENT_461	[p13l731t1197r869b1235],
22	tubule	NN	O	tubule	nn	23	SENT_461	[p13l885t1197r984b1226],
23	cells	NNS	O	cell	prep_of	18	SENT_461	[p13l1001t1197r1067b1226],
24	and	CC	O	and	_	0	SENT_461	[p13l1084t1197r1139b1226],
25	brain	NN	O	brain	conj_and	18	SENT_461	[p13l1155t1197r1236b1226],
26	capillary	JJ	O	capillary	amod	28	SENT_461	[p13l1253t1197r1386b1236],
27	endothelium	NN	O	endothelium	nn	28	SENT_461	[p13l1401t1197r1600b1226],
28	(	NN	O	(	dep	25	SENT_461	[p13l1616t1198r1704b1233],
29	191	CD	NUMBER	191	num	30	SENT_461	[p13l1616t1198r1704b1233],
30	)	NN	O	)	dep	3	SENT_461	[p13l1616t1198r1704b1233],
31	.	.	O	.	_	0	SENT_461	[p13l1616t1198r1704b1233],

1	Localization	NN	O	localization	nsubjpass	19	SENT_462	[p13l1722t1197r1917b1226],
2	of	IN	O	of	_	0	SENT_462	[p13l1933t1197r1967b1226],
3	MRP4	NN	O	mrp4	prep_of	1	SENT_462	[p13l1977t1198r2083b1226],
4	to	TO	O	to	_	0	SENT_462	[p13l565t1255r595b1276],
5	the	DT	O	the	det	9	SENT_462	[p13l610t1247r659b1276],
6	basolateral	JJ	O	basolateral	amod	9	SENT_462	[p13l673t1247r840b1276],
7	or	CC	O	or	_	0	SENT_462	[p13l855t1258r888b1276],
8	apical	JJ	O	apical	amod	9	SENT_462	[p13l902t1247r991b1285],
9	membrane	NN	O	membrane	prep_to	3	SENT_462	[p13l1005t1247r1180b1282],
10	,	,	O	,	_	0	SENT_462	[p13l1005t1247r1180b1282],
11	depending	VBG	O	depend	_	0	SENT_462	[p13l1197t1247r1362b1286],
12	on	IN	O	on	prepc_depending_on	19	SENT_462	[p13l1375t1258r1414b1276],
13	the	DT	O	the	pobj	19	SENT_462	[p13l1428t1247r1477b1276],
14	polarized	VBN	O	polarize	partmod	13	SENT_462	[p13l1491t1247r1636b1285],
15	cell	NN	O	cell	nn	16	SENT_462	[p13l1650t1247r1703b1276],
16	type	NN	O	type	dobj	14	SENT_462	[p13l1717t1255r1792b1286],
17	,	,	O	,	_	0	SENT_462	[p13l1717t1255r1792b1286],
18	is	VBZ	O	be	auxpass	19	SENT_462	[p13l1807t1248r1830b1276],
19	associated	VBN	O	associate	_	0	SENT_462	[p13l1844t1247r2000b1276],
20	with	IN	O	with	_	0	SENT_462	[p13l2013t1247r2083b1276],
21	the	DT	O	the	det	22	SENT_462	[p13l565t1297r613b1326],
22	expression	NN	O	expression	prep_with	19	SENT_462	[p13l630t1298r792b1335],
23	of	IN	O	of	_	0	SENT_462	[p13l808t1297r842b1326],
24	the	DT	O	the	det	30	SENT_462	[p13l853t1297r901b1326],
25	adaptor	NN	O	adaptor	nn	30	SENT_462	[p13l917t1297r1036b1335],
26	protein	NN	O	protein	nn	30	SENT_462	[p13l1050t1298r1165b1335],
27	NHERF1	NN	O	nherf1	nn	30	SENT_462	[p13l1179t1298r1334b1326],
28	(	NN	O	(	nn	30	SENT_462	[p13l1353t1298r1441b1333],
29	192	CD	NUMBER	192	num	30	SENT_462	[p13l1353t1298r1441b1333],
30	)	NN	O	)	prep_of	22	SENT_462	[p13l1353t1298r1441b1333],
31	.	.	O	.	_	0	SENT_462	[p13l1353t1298r1441b1333],

1	Substrates	NNS	O	substrate	nsubj	4	SENT_463	[p13l1459t1297r1617b1326],
2	of	IN	O	of	_	0	SENT_463	[p13l1633t1297r1668b1326],
3	MRP4	NN	O	mrp4	prep_of	1	SENT_463	[p13l1677t1298r1783b1326],
4	include	VBP	O	include	_	0	SENT_463	[p13l1797t1297r1911b1326],
5	numerous	JJ	O	numerous	amod	7	SENT_463	[p13l1926t1308r2082b1326],
6	endogenous	JJ	O	endogenous	amod	7	SENT_463	[p13l565t1347r753b1385],
7	compounds	NNS	O	compound	dobj	4	SENT_463	[p13l770t1346r950b1385],
8	involved	VBN	O	involve	dep	7	SENT_463	[p13l966t1346r1098b1376],
9	in	IN	O	in	_	0	SENT_463	[p13l1114t1348r1144b1375],
10	cellular	JJ	O	cellular	amod	11	SENT_463	[p13l1161t1347r1276b1376],
11	signaling	NN	O	signaling	prep_in	8	SENT_463	[p13l1291t1347r1440b1385],
12	,	,	O	,	_	0	SENT_463	[p13l1291t1347r1440b1385],
13	such	JJ	O	such	_	0	SENT_463	[p13l1457t1347r1527b1376],
14	as	IN	O	as	_	0	SENT_463	[p13l1544t1358r1572b1376],
15	cyclic	JJ	O	cyclic	amod	16	SENT_463	[p13l1589t1347r1675b1385],
16	nucleotides	NNS	O	nucleotide	prep_such_as	8	SENT_463	[p13l1691t1347r1877b1382],
17	,	,	O	,	_	0	SENT_463	[p13l1691t1347r1877b1382],
18	eicosanoids	NNS	O	eicosanoid	appos	16	SENT_463	[p13l1895t1347r2081b1382],
19	,	,	O	,	_	0	SENT_463	[p13l1895t1347r2081b1382],
20	urate	NN	O	urate	appos	18	SENT_463	[p13l564t1405r653b1432],
21	,	,	O	,	_	0	SENT_463	[p13l564t1405r653b1432],
22	and	CC	O	and	_	0	SENT_463	[p13l669t1396r724b1426],
23	conjugated	VBN	O	conjugate	conj_and	8	SENT_463	[p13l739t1397r910b1435],
24	steroids	NNS	O	steroid	dobj	23	SENT_463	[p13l924t1396r1053b1432],
25	,	,	O	,	_	0	SENT_463	[p13l924t1396r1053b1432],
26	as	RB	O	as	_	0	SENT_463	[p13l1069t1408r1097b1426],
27	well	RB	O	well	_	0	SENT_463	[p13l1111t1396r1175b1426],
28	as	IN	O	as	_	0	SENT_463	[p13l1190t1408r1217b1426],
29	folate	NN	O	folate	dobj	23	SENT_463	[p13l1232t1396r1328b1432],
30	,	,	O	,	_	0	SENT_463	[p13l1232t1396r1328b1432],
31	bile	NN	O	bile	nn	32	SENT_463	[p13l1343t1396r1399b1426],
32	acids	NNS	O	acid	dobj	23	SENT_463	[p13l1414t1396r1498b1432],
33	,	,	O	,	_	0	SENT_463	[p13l1414t1396r1498b1432],
34	and	CC	O	and	_	0	SENT_463	[p13l1514t1397r1570b1426],
35	glutathione	NN	O	glutathione	conj_and	24	SENT_463	[p13l1584t1396r1771b1435],
36	.	.	O	.	_	0	SENT_463	[p13l1584t1396r1771b1435],

1	Drug	NN	O	drug	nn	2	SENT_464	[p13l1787t1398r1872b1435],
2	substrates	NNS	O	substrate	nsubj	5	SENT_464	[p13l1885t1397r2038b1426],
3	of	IN	O	of	_	0	SENT_464	[p13l2053t1397r2087b1426],
4	MRP4	NN	O	mrp4	prep_of	2	SENT_464	[p13l563t1448r669b1476],
5	include	VBP	O	include	_	0	SENT_464	[p13l681t1446r795b1475],
6	cephalosporin	NN	O	cephalosporin	nn	7	SENT_464	[p13l809t1446r1028b1485],
7	antibiotics	NNS	O	antibiotic	dobj	5	SENT_464	[p13l1041t1446r1212b1482],
8	,	,	O	,	_	0	SENT_464	[p13l1041t1446r1212b1482],
9	nucleotide	NN	O	nucleotide	nn	10	SENT_464	[p13l1225t1446r1390b1475],
10	analog	NN	O	analog	dobj	5	SENT_464	[p13l1403t1446r1506b1485],
11	reverse	JJ	O	reverse	amod	13	SENT_464	[p13l1517t1457r1628b1475],
12	transcriptase	NN	O	transcriptase	nn	13	SENT_464	[p13l1641t1448r1839b1485],
13	inhibitors	NNS	O	inhibitor	dep	10	SENT_464	[p13l1852t1446r2013b1482],
14	,	,	O	,	_	0	SENT_464	[p13l1852t1446r2013b1482],
15	and	CC	O	and	_	0	SENT_464	[p13l2027t1446r2083b1475],
16	cytotoxic	JJ	O	cytotoxic	amod	17	SENT_464	[p13l565t1498r707b1535],
17	agents	NNS	O	agent	conj_and	7	SENT_464	[p13l718t1505r816b1535],
18	such	JJ	O	such	_	0	SENT_464	[p13l828t1496r898b1525],
19	as	IN	O	as	_	0	SENT_464	[p13l909t1507r937b1525],
20	methotrexate	NN	O	methotrexate	nn	25	SENT_464	[p13l948t1496r1156b1525],
21	and	CC	O	and	_	0	SENT_464	[p13l1168t1496r1223b1525],
22	6	CD	NUMBER	6	nn	25	SENT_464	[p13l1235t1498r1518b1535],
23	—	NN	O	—	nn	25	SENT_464	[p13l1235t1498r1518b1535],
24	mercaptopurine	NN	O	mercaptopurine	nn	25	SENT_464	[p13l1235t1498r1518b1535],
25	(	NN	O	(	prep_such_as	17	SENT_464	[p13l1530t1497r1618b1533],
26	191	CD	NUMBER	191	num	27	SENT_464	[p13l1530t1497r1618b1533],
27	)	NN	O	)	dep	17	SENT_464	[p13l1530t1497r1618b1533],
28	.	.	O	.	_	0	SENT_464	[p13l1530t1497r1618b1533],

1	A	DT	O	a	det	2	SENT_465	[p13l613t1547r640b1575],
2	SNP	NN	O	snp	nsubj	18	SENT_465	[p13l648t1547r721b1576],
3	in	IN	O	in	_	0	SENT_465	[p13l730t1548r760b1575],
4	ABC	NNP	ORGANIZATION	ABC	prep_in	2	SENT_465	[p13l765t1547r842b1575],
5	C4	NN	O	c4	nn	8	SENT_465	[p13l843t1547r885b1575],
6	(	CD	NUMBER	(	num	8	SENT_465	[p13l893t1547r1071b1583],
7	c.	NN	O	c.	nn	8	SENT_465	[p13l893t1547r1071b1583],
8	G2269A	NN	O	g2269a	dep	4	SENT_465	[p13l893t1547r1071b1583],
9	,	,	O	,	_	0	SENT_465	[p13l893t1547r1071b1583],
10	rs3	NN	O	rs3	nn	12	SENT_465	[p13l1080t1548r1124b1576],
11	765534	CD	NUMBER	765534	num	12	SENT_465	[p13l1130t1547r1254b1583],
12	)	NN	O	)	appos	4	SENT_465	[p13l1130t1547r1254b1583],
13	caused	VBD	O	cause	_	0	SENT_465	[p13l1264t1546r1366b1576],
14	disrupted	VBN	O	disrupt	dep	13	SENT_465	[p13l1375t1546r1522b1585],
15	membrane	NN	O	membrane	nn	16	SENT_465	[p13l1530t1546r1697b1576],
16	localization	NN	O	localization	dobj	14	SENT_465	[p13l1706t1546r1886b1576],
17	and	CC	O	and	_	0	SENT_465	[p13l1894t1546r1950b1575],
18	reduced	VBD	O	reduce	conj_and	13	SENT_465	[p13l1958t1546r2083b1575],
19	MRP4	NN	O	mrp4	nn	20	SENT_465	[p13l563t1597r669b1626],
20	activity	NN	O	activity	dobj	18	SENT_465	[p13l682t1598r802b1635],
21	,	,	O	,	_	0	SENT_465	[p13l682t1598r802b1635],
22	and	CC	O	and	_	0	SENT_465	[p13l817t1596r872b1625],
23	it	PRP	O	it	nsubjpass	25	SENT_465	[p13l885t1598r908b1625],
24	was	VBD	O	be	auxpass	25	SENT_465	[p13l918t1607r974b1625],
25	hypothesized	VBN	O	hypothesize	conj_and	13	SENT_465	[p13l987t1596r1194b1635],
26	to	TO	O	to	aux	27	SENT_465	[p13l1206t1604r1237b1625],
27	increase	VB	O	increase	xcomp	25	SENT_465	[p13l1250t1598r1376b1625],
28	sensitivity	NN	O	sensitivity	dobj	27	SENT_465	[p13l1389t1598r1546b1635],
29	to	TO	O	to	_	0	SENT_465	[p13l1557t1604r1588b1625],
30	thiopurine-induced	JJ	O	thiopurine-induced	amod	33	SENT_465	[p13l1601t1596r1906b1635],
31	myelosup	JJ	O	myelosup	amod	33	SENT_465	[p13l1919t1596r2082b1635],
32	—	NN	O	—	nn	33	SENT_465	[p13l1919t1596r2082b1635],
33	pression	NN	O	pression	prep_to	27	SENT_465	[p13l565t1647r694b1684],
34	as	IN	O	as	mark	44	SENT_465	[p13l705t1656r733b1674],
35	a	DT	O	a	det	36	SENT_465	[p13l744t1656r759b1674],
36	result	NN	O	result	nsubj	44	SENT_465	[p13l769t1645r857b1674],
37	of	IN	O	of	_	0	SENT_465	[p13l867t1645r901b1674],
38	thiopurine	JJ	O	thiopurine	amod	40	SENT_465	[p13l907t1645r1072b1684],
39	metabolite	NN	O	metabolite	nn	40	SENT_465	[p13l1082t1645r1249b1674],
40	accumulation	NN	O	accumulation	prep_of	36	SENT_465	[p13l1260t1645r1470b1674],
41	in	IN	O	in	_	0	SENT_465	[p13l1480t1647r1510b1674],
42	hematopoietic	JJ	O	hematopoietic	amod	43	SENT_465	[p13l1520t1645r1744b1684],
43	cells	NNS	O	cell	prep_in	40	SENT_465	[p13l1755t1645r1821b1674],
44	(	VBP	O	(	advcl	27	SENT_465	[p13l1832t1646r1920b1681],
45	193	CD	NUMBER	193	number	46	SENT_465	[p13l1832t1646r1920b1681],
46	)	CD	NUMBER	)	dobj	44	SENT_465	[p13l1832t1646r1920b1681],
47	.	.	O	.	_	0	SENT_465	[p13l1832t1646r1920b1681],

1	Polymorphisms	NNS	O	polymorphism	nsubjpass	6	SENT_466	[p13l1932t1645r2082b1684, p13l564t1694r673b1732],
2	in	IN	O	in	_	0	SENT_466	[p13l684t1696r714b1723],
3	ABC	NNP	ORGANIZATION	ABC	nn	4	SENT_466	[p13l721t1695r799b1723],
4	C4	NN	O	c4	prep_in	1	SENT_466	[p13l800t1695r841b1723],
5	were	VBD	O	be	auxpass	6	SENT_466	[p13l850t1705r925b1723],
6	reported	VBN	O	report	_	0	SENT_466	[p13l936t1694r1071b1732],
7	to	TO	O	to	aux	9	SENT_466	[p13l1082t1702r1112b1723],
8	be	VB	O	be	auxpass	9	SENT_466	[p13l1124t1694r1159b1723],
9	associated	VBN	O	associate	xcomp	6	SENT_466	[p13l1171t1694r1326b1723],
10	with	IN	O	with	_	0	SENT_466	[p13l1336t1694r1406b1723],
11	side	JJ	O	side	amod	12	SENT_466	[p13l1417t1694r1476b1723],
12	effects	NNS	O	effect	prep_with	9	SENT_466	[p13l1488t1694r1585b1723],
13	and	CC	O	and	_	0	SENT_466	[p13l1596t1694r1652b1723],
14	survival	NN	O	survival	conj_and	12	SENT_466	[p13l1663t1694r1781b1723],
15	in	IN	O	in	_	0	SENT_466	[p13l1792t1696r1822b1723],
16	childhood	NN	O	childhood	nn	20	SENT_466	[p13l1833t1694r1990b1723],
17	acute	JJ	O	acute	amod	18	SENT_466	[p13l2002t1702r2082b1723],
18	lymphoblastic	JJ	O	lymphoblastic	amod	20	SENT_466	[p13l565t1743r784b1782],
19	leukemia	NN	O	leukemia	nn	20	SENT_466	[p13l792t1743r932b1772],
20	patients	NNS	O	patient	prep_in	14	SENT_466	[p13l940t1744r1062b1782],
21	treated	VBN	O	treat	partmod	14	SENT_466	[p13l1070t1743r1179b1772],
22	with	IN	O	with	_	0	SENT_466	[p13l1186t1743r1256b1772],
23	methotrexate	NN	O	methotrexate	nn	24	SENT_466	[p13l1263t1743r1471b1772],
24	(	NN	O	(	prep_with	21	SENT_466	[p13l1479t1744r1567b1780],
25	194	CD	NUMBER	194	num	26	SENT_466	[p13l1479t1744r1567b1780],
26	)	NN	O	)	dep	24	SENT_466	[p13l1479t1744r1567b1780],
27	;	:	O	;	_	0	SENT_466	[p13l1479t1744r1567b1780],
28	however	RB	O	however	advmod	35	SENT_466	[p13l1576t1743r1717b1779],
29	,	,	O	,	_	0	SENT_466	[p13l1576t1743r1717b1779],
30	the	DT	O	the	det	32	SENT_466	[p13l1726t1743r1775b1772],
31	same	JJ	O	same	amod	32	SENT_466	[p13l1783t1754r1860b1772],
32	genotypes	NNS	O	genotype	nsubj	35	SENT_466	[p13l1869t1751r2025b1782],
33	did	VBD	O	do	aux	35	SENT_466	[p13l2034t1743r2083b1772],
34	not	RB	O	not	neg	35	SENT_466	[p13l564t1801r618b1822],
35	show	VB	O	show	parataxis	6	SENT_466	[p13l629t1792r709b1822],
36	any	DT	O	any	det	37	SENT_466	[p13l720t1803r775b1831],
37	inﬂuence	NN	O	inﬂuence	dobj	35	SENT_466	[p13l785t1792r928b1822],
38	on	IN	O	on	_	0	SENT_466	[p13l940t1803r980b1822],
39	the	DT	O	the	det	43	SENT_466	[p13l991t1792r1040b1822],
40	event	NN	O	event	nn	43	SENT_466	[p13l1052t1792r1210b1822],
41	—	CD	NUMBER	—	num	43	SENT_466	[p13l1052t1792r1210b1822],
42	free	JJ	O	free	amod	43	SENT_466	[p13l1052t1792r1210b1822],
43	survival	NN	O	survival	prep_on	35	SENT_466	[p13l1223t1792r1341b1822],
44	in	IN	O	in	_	0	SENT_466	[p13l1353t1794r1383b1821],
45	adult	JJ	O	adult	amod	49	SENT_466	[p13l1395t1792r1474b1822],
46	acute	JJ	O	acute	amod	49	SENT_466	[p13l1485t1800r1565b1822],
47	lymphoblastic	JJ	O	lymphoblastic	amod	49	SENT_466	[p13l1577t1792r1797b1831],
48	leukemia	NN	O	leukemia	nn	49	SENT_466	[p13l1808t1792r1949b1822],
49	patients	NNS	O	patient	prep_in	43	SENT_466	[p13l1960t1794r2082b1831],
50	receiving	VBG	O	receive	partmod	49	SENT_466	[p13l565t1844r708b1881],
51	methotrexate	NN	O	methotrexate	nn	52	SENT_466	[p13l718t1842r926b1871],
52	(	NN	O	(	dobj	50	SENT_466	[p13l938t1843r1025b1879],
53	195	CD	NUMBER	195	num	54	SENT_466	[p13l938t1843r1025b1879],
54	)	NN	O	)	dep	52	SENT_466	[p13l938t1843r1025b1879],
55	.	.	O	.	_	0	SENT_466	[p13l938t1843r1025b1879],

1	CONCLUSIONS	NNS	O	conclusion	nsubj	9	SENT_467	[p13l565t1956r900b1988],
2	AND	CC	O	and	_	0	SENT_467	[p13l912t1956r1013b1988],
3	FUTURE	JJ	DATE	future	amod	4	SENT_467	[p13l1026t1956r1215b1988],
4	PERSPECTIVES	NNS	O	perspective	nsubj	9	SENT_467	[p13l1227t1956r1562b1988],
5	The	DT	DATE	the	det	7	SENT_467	[p13l564t2011r630b2040],
6	past	JJ	DATE	past	amod	7	SENT_467	[p13l641t2020r704b2050],
7	decade	NN	DATE	decade	dep	1	SENT_467	[p13l714t2011r820b2040],
8	has	VBZ	O	have	aux	9	SENT_467	[p13l831t2011r880b2040],
9	seen	VBN	O	see	_	0	SENT_467	[p13l892t2022r959b2040],
10	remarkable	JJ	O	remarkable	amod	11	SENT_467	[p13l970t2011r1145b2040],
11	progress	NN	O	progress	dobj	9	SENT_467	[p13l1156t2022r1288b2050],
12	in	IN	O	in	_	0	SENT_467	[p13l1299t2013r1329b2040],
13	the	DT	O	the	det	14	SENT_467	[p13l1340t2011r1389b2040],
14	ﬁeld	NN	O	ﬁeld	prep_in	9	SENT_467	[p13l1400t2011r1468b2040],
15	of	IN	O	of	_	0	SENT_467	[p13l1479t2011r1513b2040],
16	drug	NN	O	drug	nn	17	SENT_467	[p13l1520t2011r1593b2050],
17	transporters	NNS	O	transporter	prep_of	14	SENT_467	[p13l1603t2019r1801b2050],
18	,	,	O	,	_	0	SENT_467	[p13l1603t2019r1801b2050],
19	not	RB	O	not	neg	20	SENT_467	[p13l1812t2020r1866b2040],
20	only	RB	O	only	preconj	9	SENT_467	[p13l1876t2011r1945b2050],
21	in	IN	O	in	_	0	SENT_467	[p13l1954t2013r1984b2040],
22	terms	NNS	O	term	prep_in	9	SENT_467	[p13l1995t2020r2082b2040],
23	of	IN	O	of	_	0	SENT_467	[p13l565t2060r599b2089],
24	functional	JJ	O	functional	amod	25	SENT_467	[p13l607t2060r766b2089],
25	characterization	NN	O	characterization	prep_of	22	SENT_467	[p13l778t2060r1030b2089],
26	and	CC	O	and	_	0	SENT_467	[p13l1042t2060r1098b2089],
27	substrate	NN	O	substrate	nn	28	SENT_467	[p13l1110t2060r1249b2089],
28	speciﬁcity	NN	O	speciﬁcity	conj_and	25	SENT_467	[p13l1262t2060r1419b2099],
29	but	CC	O	but	_	0	SENT_467	[p13l1430t2060r1482b2089],
30	also	RB	O	also	advmod	9	SENT_467	[p13l1493t2060r1552b2089],
31	in	IN	O	in	_	0	SENT_467	[p13l1564t2062r1594b2089],
32	elucidating	VBG	O	elucidate	conj_but	22	SENT_467	[p13l1607t2060r1780b2099],
33	the	DT	O	the	det	35	SENT_467	[p13l1792t2060r1840b2089],
34	important	JJ	O	important	amod	35	SENT_467	[p13l1852t2062r2011b2099],
35	role	NN	O	role	dobj	32	SENT_467	[p13l2022t2060r2082b2089],

1	DeGorter	NNP	PERSON	DeGorter	_	0	SENT_468	[p13l564t2167r676b2189],
2	et	FW	O	et	nn	3	SENT_468	[p13l683t2172r703b2189],
3	ﬂl	FW	O	ﬂl	dep	1	SENT_468	[p13l709t2167r735b2189],
4	.	.	O	.	_	0	SENT_468	[p13l709t2167r735b2189],

1	that	IN	O	that	dep	3	SENT_469	[p13l367t2264r428b2293],
2	transporters	NNS	O	transporter	nsubj	3	SENT_469	[p13l442t2272r631b2303],
3	play	VBP	O	play	_	0	SENT_469	[p13l645t2264r710b2303],
4	in	IN	O	in	_	0	SENT_469	[p13l723t2265r753b2293],
5	the	DT	O	the	det	6	SENT_469	[p13l767t2264r816b2293],
6	disposition	NN	O	disposition	prep_in	3	SENT_469	[p13l831t2264r1001b2303],
7	and	CC	O	and	_	0	SENT_469	[p13l1016t2264r1071b2293],
8	efﬁcacy	NN	O	efﬁcacy	prep_in	3	SENT_469	[p13l1086t2264r1202b2303],
9	of	IN	O	of	_	0	SENT_469	[p13l1215t2264r1249b2293],
10	drugs	NNS	O	drug	prep_of	6	SENT_469	[p13l1260t2264r1345b2303],
11	in	IN	O	in	_	0	SENT_469	[p13l1359t2265r1389b2293],
12	clinical	JJ	O	clinical	amod	13	SENT_469	[p13l1404t2264r1514b2293],
13	use	NN	O	use	prep_in	10	SENT_469	[p13l1528t2275r1586b2293],
14	.	.	O	.	_	0	SENT_469	[p13l1528t2275r1586b2293],

1	Drug	NN	O	drug	nn	2	SENT_470	[p13l1603t2265r1687b2303],
2	interactions	NNS	O	interaction	nsubj	11	SENT_470	[p13l1699t2265r1884b2293],
3	that	WDT	O	that	nsubj	4	SENT_470	[p13l367t2313r429b2343],
4	target	VBP	O	target	rcmod	2	SENT_470	[p13l439t2321r531b2352],
5	uptake	NN	O	uptake	nn	8	SENT_470	[p13l541t2313r645b2352],
6	or	CC	O	or	_	0	SENT_470	[p13l658t2324r691b2343],
7	efﬂux	NN	O	efﬂux	nn	8	SENT_470	[p13l703t2313r787b2343],
8	transporters	NNS	O	transporter	dobj	4	SENT_470	[p13l798t2321r987b2352],
9	can	MD	O	can	aux	11	SENT_470	[p13l999t2324r1051b2343],
10	often	RB	O	often	advmod	11	SENT_470	[p13l1063t2313r1144b2343],
11	result	VB	O	result	_	0	SENT_470	[p13l1155t2313r1243b2343],
12	in	IN	O	in	_	0	SENT_470	[p13l1254t2315r1284b2342],
13	unexpected	JJ	O	unexpected	amod	15	SENT_470	[p13l1295t2313r1472b2352],
14	systemic	JJ	O	systemic	amod	15	SENT_470	[p13l1484t2315r1616b2352],
15	exposure	NN	O	exposure	prep_in	11	SENT_470	[p13l1628t2324r1766b2352],
16	and	CC	O	and	_	0	SENT_470	[p13l1778t2313r1842b2349],
17	,	,	O	,	_	0	SENT_470	[p13l1778t2313r1842b2349],
18	in	IN	O	in	dep	15	SENT_470	[p13l1854t2315r1885b2342],
19	some	DT	O	some	det	20	SENT_470	[p13l367t2374r447b2392],
20	cases	NNS	O	case	pobj	18	SENT_470	[p13l457t2374r541b2399],
21	,	,	O	,	_	0	SENT_470	[p13l457t2374r541b2399],
22	organ	NN	O	organ	nn	24	SENT_470	[p13l552t2374r641b2402],
23	speciﬁc	NN	O	speciﬁc	nn	24	SENT_470	[p13l650t2363r765b2402],
24	toxicity	NN	O	toxicity	prep_in	11	SENT_470	[p13l773t2365r897b2402],
25	.	.	O	.	_	0	SENT_470	[p13l773t2365r897b2402],

1	Interestingly	RB	O	interestingly	advmod	17	SENT_471	[p13l907t2363r1115b2402],
2	,	,	O	,	_	0	SENT_471	[p13l907t2363r1115b2402],
3	the	DT	O	the	det	5	SENT_471	[p13l1125t2363r1174b2392],
4	same	JJ	O	same	amod	5	SENT_471	[p13l1183t2374r1260b2392],
5	processes	NNS	O	process	nsubjpass	17	SENT_471	[p13l1269t2374r1414b2402],
6	that	WDT	O	that	nsubj	8	SENT_471	[p13l1423t2363r1485b2392],
7	can	MD	O	can	aux	8	SENT_471	[p13l1493t2374r1545b2392],
8	result	VB	O	result	rcmod	5	SENT_471	[p13l1554t2363r1642b2392],
9	in	IN	O	in	_	0	SENT_471	[p13l1649t2365r1679b2392],
10	higher	JJR	O	higher	amod	13	SENT_471	[p13l1687t2363r1790b2402],
11	tissue	NN	O	tissue	nn	13	SENT_471	[p13l1798t2365r1884b2392],
12	drug	NN	O	drug	nn	13	SENT_471	[p13l367t2403r440b2442],
13	accumulation	NN	O	accumulation	prep_in	8	SENT_471	[p13l453t2403r663b2432],
14	can	MD	O	can	aux	17	SENT_471	[p13l677t2414r730b2432],
15	also	RB	O	also	advmod	17	SENT_471	[p13l744t2403r802b2432],
16	be	VB	O	be	auxpass	17	SENT_471	[p13l816t2403r852b2432],
17	utilized	VBN	O	utilize	_	0	SENT_471	[p13l865t2403r982b2432],
18	to	TO	O	to	aux	19	SENT_471	[p13l996t2412r1027b2432],
19	produce	VB	O	produce	xcomp	17	SENT_471	[p13l1041t2403r1168b2442],
20	a	DT	O	a	det	23	SENT_471	[p13l1182t2414r1197b2432],
21	desirable	JJ	O	desirable	amod	23	SENT_471	[p13l1211t2403r1349b2432],
22	therapeutic	JJ	O	therapeutic	amod	23	SENT_471	[p13l1363t2403r1541b2442],
23	effect	NN	O	effect	dobj	19	SENT_471	[p13l1555t2403r1646b2439],
24	,	,	O	,	_	0	SENT_471	[p13l1555t2403r1646b2439],
25	as	IN	O	as	mark	26	SENT_471	[p13l1662t2414r1690b2432],
26	exempliﬁed	VBN	O	exempliﬁed	advcl	17	SENT_471	[p13l1705t2403r1885b2442],
27	by	IN	O	by	_	0	SENT_471	[p13l367t2452r405b2491],
28	the	DT	O	the	det	30	SENT_471	[p13l416t2452r465b2481],
29	statin	NN	O	statin	nn	30	SENT_471	[p13l478t2454r563b2481],
30	class	NN	O	class	nsubj	34	SENT_471	[p13l576t2452r645b2481],
31	of	IN	O	of	_	0	SENT_471	[p13l659t2452r693b2481],
32	lipid	NN	O	lipid	nn	33	SENT_471	[p13l701t2452r926b2491],
33	—	NN	O	—	prep_of	30	SENT_471	[p13l701t2452r926b2491],
34	lowering	VBG	O	lower	prepc_by	26	SENT_471	[p13l701t2452r926b2491],
35	drugs	NNS	O	drug	dobj	34	SENT_471	[p13l938t2452r1023b2491],
36	that	WDT	O	that	nsubj	37	SENT_471	[p13l1037t2452r1098b2481],
37	utilize	VBP	O	utilize	rcmod	35	SENT_471	[p13l1110t2452r1206b2481],
38	liver	NN	O	liver	nn	42	SENT_471	[p13l1219t2452r1418b2491],
39	—	NN	O	—	nn	42	SENT_471	[p13l1219t2452r1418b2491],
40	speciﬁc	NN	O	speciﬁc	nn	42	SENT_471	[p13l1219t2452r1418b2491],
41	uptake	NN	O	uptake	nn	42	SENT_471	[p13l1430t2452r1534b2491],
42	transporters	NNS	O	transporter	dobj	37	SENT_471	[p13l1547t2460r1737b2491],
43	to	TO	O	to	aux	44	SENT_471	[p13l1750t2461r1780b2481],
44	target	VB	O	target	xcomp	37	SENT_471	[p13l1794t2460r1886b2491],
45	hepatic	JJ	O	hepatic	amod	47	SENT_471	[p13l366t2493r480b2532],
46	HMG-CoA	NN	O	hmg-coa	nn	47	SENT_471	[p13l493t2494r681b2522],
47	reductase	NN	O	reductase	dobj	44	SENT_471	[p13l693t2493r849b2522],
48	.	.	O	.	_	0	SENT_471	[p13l693t2493r849b2522],

1	The	DT	DATE	the	det	3	SENT_472	[p13l864t2493r930b2522],
2	next	JJ	DATE	next	amod	3	SENT_472	[p13l944t2501r1011b2522],
3	decade	NN	DATE	decade	nsubj	4	SENT_472	[p13l1025t2493r1130b2522],
4	holds	VBZ	O	hold	_	0	SENT_472	[p13l1145t2493r1228b2522],
5	even	RB	O	even	advmod	6	SENT_472	[p13l1243t2504r1314b2522],
6	greater	JJR	O	greater	amod	7	SENT_472	[p13l1329t2501r1439b2532],
7	promise	NN	O	promise	dobj	4	SENT_472	[p13l1453t2494r1579b2532],
8	of	IN	O	of	_	0	SENT_472	[p13l1593t2493r1628b2522],
9	new	JJ	O	new	amod	10	SENT_472	[p13l1637t2504r1702b2522],
10	discoveries	NNS	O	discovery	prep_of	7	SENT_472	[p13l1715t2493r1884b2522],
11	relating	VBG	O	relate	partmod	10	SENT_472	[p13l367t2542r488b2581],
12	to	TO	O	to	_	0	SENT_472	[p13l498t2551r528b2571],
13	drug	NN	O	drug	nn	14	SENT_472	[p13l540t2542r613b2581],
14	transporters	NNS	O	transporter	prep_to	11	SENT_472	[p13l622t2550r820b2581],
15	.	.	O	.	_	0	SENT_472	[p13l622t2550r820b2581],

1	Indeed	RB	O	indeed	advmod	20	SENT_473	[p13l831t2542r948b2577],
2	,	,	O	,	_	0	SENT_473	[p13l831t2542r948b2577],
3	as	IN	O	as	mark	5	SENT_473	[p13l960t2553r988b2571],
4	we	PRP	O	we	nsubj	5	SENT_473	[p13l998t2553r1041b2571],
5	approach	VBP	O	approach	advcl	20	SENT_473	[p13l1052t2542r1196b2581],
6	the	DT	O	the	det	9	SENT_473	[p13l1206t2542r1255b2571],
7	personal	JJ	O	personal	amod	9	SENT_473	[p13l1265t2542r1397b2581],
8	genomics	NNS	O	genomic	nn	9	SENT_473	[p13l1408t2544r1556b2581],
9	era	NN	O	era	dobj	5	SENT_473	[p13l1567t2553r1622b2578],
10	,	,	O	,	_	0	SENT_473	[p13l1567t2553r1622b2578],
11	the	DT	O	the	det	12	SENT_473	[p13l1634t2542r1682b2571],
12	ﬁeld	NN	O	ﬁeld	nsubj	20	SENT_473	[p13l1693t2542r1761b2571],
13	of	IN	O	of	_	0	SENT_473	[p13l1772t2542r1806b2571],
14	drug	NN	O	drug	nn	16	SENT_473	[p13l1813t2542r1886b2581],
15	transporter	NN	O	transporter	nn	16	SENT_473	[p13l367t2599r543b2630],
16	phamnacogenomics	NNS	O	phamnacogenomic	prep_of	12	SENT_473	[p13l553t2591r857b2630],
17	will	MD	O	will	aux	20	SENT_473	[p13l868t2591r925b2620],
18	no	DT	O	no	det	19	SENT_473	[p13l936t2602r975b2620],
19	doubt	NN	O	doubt	advmod	20	SENT_473	[p13l987t2591r1079b2620],
20	prove	VBP	O	prove	_	0	SENT_473	[p13l1089t2602r1177b2630],
21	to	TO	O	to	aux	23	SENT_473	[p13l1188t2599r1219b2620],
22	be	VB	O	be	cop	23	SENT_473	[p13l1230t2591r1266b2620],
23	integral	JJ	O	integral	xcomp	20	SENT_473	[p13l1277t2591r1398b2630],
24	to	TO	O	to	_	0	SENT_473	[p13l1409t2599r1440b2620],
25	the	DT	O	the	det	26	SENT_473	[p13l1451t2591r1500b2620],
26	delivery	NN	O	delivery	prep_to	23	SENT_473	[p13l1512t2591r1637b2630],
27	of	IN	O	of	_	0	SENT_473	[p13l1647t2591r1681b2620],
28	personalized	JJ	O	personalized	amod	29	SENT_473	[p13l1688t2591r1884b2630],
29	medicine	NN	O	medicine	prep_of	26	SENT_473	[p13l367t2632r517b2661],
30	.	.	O	.	_	0	SENT_473	[p13l367t2632r517b2661],

1	In	IN	O	in	_	0	SENT_474	[p13l531t2633r564b2661],
2	addition	NN	O	addition	prep_in	19	SENT_474	[p13l577t2632r714b2668],
3	,	,	O	,	_	0	SENT_474	[p13l577t2632r714b2668],
4	the	DT	O	the	det	6	SENT_474	[p13l728t2632r776b2661],
5	systematic	JJ	O	systematic	amod	6	SENT_474	[p13l789t2633r950b2671],
6	inclusion	NN	O	inclusion	nsubj	19	SENT_474	[p13l962t2632r1104b2661],
7	of	IN	O	of	_	0	SENT_474	[p13l1117t2632r1151b2661],
8	drug	NN	O	drug	nn	10	SENT_474	[p13l1159t2632r1232b2671],
9	transporter	NN	O	transporter	nn	10	SENT_474	[p13l1244t2640r1420b2671],
10	studies	NNS	O	study	prep_of	6	SENT_474	[p13l1431t2632r1537b2661],
11	in	IN	O	in	_	0	SENT_474	[p13l1550t2633r1580b2661],
12	the	DT	O	the	det	14	SENT_474	[p13l1592t2632r1641b2661],
13	drug	NN	O	drug	nn	14	SENT_474	[p13l1654t2632r1727b2671],
14	discovery	NN	O	discovery	prep_in	10	SENT_474	[p13l1738t2632r1886b2671],
15	and	CC	O	and	_	0	SENT_474	[p13l367t2672r422b2702],
16	development	NN	O	development	nn	17	SENT_474	[p13l434t2672r637b2711],
17	process	NN	O	process	conj_and	14	SENT_474	[p13l647t2683r762b2711],
18	will	MD	O	will	aux	19	SENT_474	[p13l772t2672r829b2701],
19	result	VB	O	result	_	0	SENT_474	[p13l840t2672r929b2702],
20	in	IN	O	in	_	0	SENT_474	[p13l938t2674r969b2701],
21	drugs	NNS	O	drug	prep_in	19	SENT_474	[p13l980t2672r1066b2711],
22	with	IN	O	with	_	0	SENT_474	[p13l1076t2672r1146b2702],
23	greater	JJR	O	greater	amod	24	SENT_474	[p13l1157t2681r1268b2711],
24	efﬁcacy	NN	O	efﬁcacy	prep_with	21	SENT_474	[p13l1279t2672r1395b2711],
25	and	CC	O	and	_	0	SENT_474	[p13l1405t2672r1460b2702],
26	reduced	VBD	O	reduce	conj_and	19	SENT_474	[p13l1471t2672r1596b2702],
27	side	JJ	O	side	amod	28	SENT_474	[p13l1608t2672r1667b2702],
28	effects	NNS	O	effect	dobj	26	SENT_474	[p13l1679t2672r1784b2702],
29	.	.	O	.	_	0	SENT_474	[p13l1679t2672r1784b2702],

1	Finally	RB	O	finally	advmod	16	SENT_475	[p13l417t2713r533b2752],
2	,	,	O	,	_	0	SENT_475	[p13l417t2713r533b2752],
3	the	DT	O	the	det	4	SENT_475	[p13l547t2713r596b2742],
4	efforts	NNS	O	effort	nsubj	16	SENT_475	[p13l611t2713r708b2742],
5	of	IN	O	of	_	0	SENT_475	[p13l722t2713r756b2742],
6	dedicated	VBN	O	dedicate	prepc_of	4	SENT_475	[p13l766t2713r915b2742],
7	drug	NN	O	drug	nn	9	SENT_475	[p13l929t2713r1002b2752],
8	transporter	NN	O	transporter	nn	9	SENT_475	[p13l1014t2721r1190b2752],
9	researchers	NNS	O	researcher	dobj	6	SENT_475	[p13l1203t2713r1379b2742],
10	over	IN	O	over	_	0	SENT_475	[p13l1393t2724r1461b2742],
11	the	DT	DATE	the	det	14	SENT_475	[p13l1474t2713r1522b2742],
12	past	JJ	DATE	past	amod	14	SENT_475	[p13l1536t2721r1598b2752],
13	half	JJ	DATE	half	amod	14	SENT_475	[p13l1610t2713r1673b2742],
14	century	NN	DATE	century	prep_over	9	SENT_475	[p13l1683t2721r1802b2752],
15	have	VBP	O	have	aux	16	SENT_475	[p13l1814t2713r1884b2742],
16	resulted	VBN	O	result	_	0	SENT_475	[p13l366t2753r491b2783],
17	in	IN	O	in	_	0	SENT_475	[p13l500t2755r530b2782],
18	a	DT	O	a	det	20	SENT_475	[p13l539t2764r554b2783],
19	paradigm	NN	O	paradigm	nn	20	SENT_475	[p13l563t2753r711b2792],
20	shift	NN	O	shift	prep_in	16	SENT_475	[p13l720t2753r788b2783],
21	in	IN	O	in	_	0	SENT_475	[p13l796t2755r826b2782],
22	our	PRP$	O	we	poss	23	SENT_475	[p13l836t2764r889b2783],
23	understanding	NN	O	understanding	prep_in	16	SENT_475	[p13l897t2753r1124b2792],
24	of	IN	O	of	_	0	SENT_475	[p13l1133t2753r1167b2783],
25	how	WRB	O	how	advmod	28	SENT_475	[p13l1171t2753r1238b2783],
26	drugs	NNS	O	drug	nsubjpass	28	SENT_475	[p13l1247t2753r1332b2792],
27	are	VBP	O	be	auxpass	28	SENT_475	[p13l1342t2764r1389b2783],
28	handled	VBN	O	handle	prepc_of	23	SENT_475	[p13l1398t2753r1522b2783],
29	by	IN	O	by	_	0	SENT_475	[p13l1531t2753r1570b2792],
30	the	DT	O	the	det	31	SENT_475	[p13l1577t2753r1626b2783],
31	body	NN	O	body	agent	28	SENT_475	[p13l1635t2753r1720b2792],
32	.	.	O	.	_	0	SENT_475	[p13l1635t2753r1720b2792],

1	What	WP	O	what	nsubjpass	4	SENT_476	[p13l1730t2753r1821b2783],
2	was	VBD	O	be	auxpass	4	SENT_476	[p13l1828t2764r1884b2783],
3	once	RB	DATE	once	advmod	4	SENT_476	[p13l367t2814r440b2833],
4	thought	VBN	O	think	dep	18	SENT_476	[p13l451t2803r577b2842],
5	to	TO	O	to	aux	7	SENT_476	[p13l587t2812r617b2833],
6	be	VB	O	be	cop	7	SENT_476	[p13l629t2804r665b2833],
7	predictable	JJ	O	predictable	xcomp	4	SENT_476	[p13l676t2803r859b2842],
8	,	,	O	,	_	0	SENT_476	[p13l676t2803r859b2842],
9	on	IN	O	on	_	0	SENT_476	[p13l872t2814r911b2833],
10	the	DT	O	the	det	11	SENT_476	[p13l922t2803r970b2833],
11	basis	NN	O	basis	prep_on	18	SENT_476	[p13l982t2804r1055b2833],
12	of	IN	O	of	_	0	SENT_476	[p13l1067t2804r1101b2833],
13	simple	JJ	O	simple	amod	15	SENT_476	[p13l1108t2804r1209b2842],
14	physicochernical	JJ	O	physicochernical	amod	15	SENT_476	[p13l1220t2804r1479b2842],
15	properties	NNS	O	property	prep_of	11	SENT_476	[p13l1489t2805r1657b2842],
16	,	,	O	,	_	0	SENT_476	[p13l1489t2805r1657b2842],
17	has	VBZ	O	have	aux	18	SENT_476	[p13l1669t2804r1719b2833],
18	given	VBN	O	give	_	0	SENT_476	[p13l1731t2805r1814b2842],
19	way	NN	O	way	dobj	18	SENT_476	[p13l1824t2815r1886b2842],
20	to	TO	O	to	_	0	SENT_476	[p13l367t2861r397b2882],
21	our	PRP$	O	we	poss	23	SENT_476	[p13l409t2863r462b2882],
22	current	JJ	DATE	current	amod	23	SENT_476	[p13l473t2861r589b2882],
23	recognition	NN	O	recognition	prep_to	18	SENT_476	[p13l598t2854r780b2891],
24	of	IN	O	of	_	0	SENT_476	[p13l791t2853r826b2882],
25	the	DT	O	the	det	27	SENT_476	[p13l833t2852r881b2882],
26	important	JJ	O	important	amod	27	SENT_476	[p13l892t2854r1051b2891],
27	role	NN	O	role	prep_of	23	SENT_476	[p13l1060t2852r1121b2882],
28	that	WDT	O	that	dobj	31	SENT_476	[p13l1133t2852r1194b2882],
29	drug	NN	O	drug	nn	30	SENT_476	[p13l1205t2852r1278b2891],
30	transporters	NNS	O	transporter	nsubj	31	SENT_476	[p13l1288t2861r1477b2891],
31	play	VBP	O	play	rcmod	27	SENT_476	[p13l1488t2852r1553b2891],
32	in	IN	O	in	_	0	SENT_476	[p13l1562t2854r1593b2881],
33	all	DT	O	all	det	34	SENT_476	[p13l1604t2852r1639b2882],
34	aspects	NNS	O	aspect	prep_in	31	SENT_476	[p13l1651t2861r1759b2891],
35	of	IN	O	of	_	0	SENT_476	[p13l1771t2853r1805b2882],
36	drug	NN	O	drug	nn	37	SENT_476	[p13l1813t2852r1886b2891],
37	absorption	NN	O	absorption	prep_of	34	SENT_476	[p13l367t2902r542b2941],
38	,	,	O	,	_	0	SENT_476	[p13l367t2902r542b2941],
39	tissue	NN	O	tissue	nn	40	SENT_476	[p13l558t2904r644b2932],
40	distribution	NN	O	distribution	conj_and	37	SENT_476	[p13l659t2902r850b2938],
41	,	,	O	,	_	0	SENT_476	[p13l659t2902r850b2938],
42	and	CC	O	and	_	0	SENT_476	[p13l866t2902r921b2931],
43	elimination	NN	O	elimination	prep_of	34	SENT_476	[p13l936t2902r1123b2932],
44	.	.	O	.	_	0	SENT_476	[p13l936t2902r1123b2932],

1	Indeed	RB	O	indeed	advmod	7	SENT_477	[p13l1138t2902r1255b2938],
2	,	,	O	,	_	0	SENT_477	[p13l1138t2902r1255b2938],
3	drug	NN	O	drug	nn	5	SENT_477	[p13l1271t2902r1344b2941],
4	transporter	NN	O	transporter	nn	5	SENT_477	[p13l1357t2911r1533b2941],
5	research	NN	O	research	nsubj	9	SENT_477	[p13l1546t2902r1676b2931],
6	has	VBZ	O	have	aux	7	SENT_477	[p13l1690t2902r1740b2931],
7	matured	VBN	O	mature	_	0	SENT_477	[p13l1754t2902r1884b2931],
8	and	CC	O	and	_	0	SENT_477	[p13l367t2953r422b2982],
9	proven	VBN	O	prove	conj_and	7	SENT_477	[p13l434t2963r543b2991],
10	to	TO	O	to	aux	13	SENT_477	[p13l554t2961r584b2982],
11	be	VB	O	be	cop	13	SENT_477	[p13l596t2953r631b2982],
12	remarkably	RB	O	remarkably	advmod	13	SENT_477	[p13l642t2952r821b2991],
13	signiﬁcant	JJ	O	signiﬁcant	xcomp	7	SENT_477	[p13l830t2953r992b2991],
14	to	TO	O	to	_	0	SENT_477	[p13l1003t2961r1033b2982],
15	human	JJ	O	human	amod	16	SENT_477	[p13l1044t2953r1153b2982],
16	health	NN	O	health	prep_to	13	SENT_477	[p13l1163t2952r1261b2982],
17	and	CC	O	and	_	0	SENT_477	[p13l1272t2952r1327b2982],
18	optimal	JJ	O	optimal	amod	19	SENT_477	[p13l1339t2953r1458b2991],
19	therapeutics	NNS	O	therapeutics	prep_to	13	SENT_477	[p13l1470t2952r1668b2991],
20	.	.	O	.	_	0	SENT_477	[p13l1470t2952r1668b2991],

1	SUMMARY	NN	O	summary	nn	2	SENT_478	[p13l417t3105r623b3132],
2	POINTS	NNS	O	point	_	0	SENT_478	[p13l634t3104r788b3132],

1	1	LS	NUMBER	1	_	0	SENT_479	[p13l418t3172r441b3199],
2	.	.	O	.	_	0	SENT_479	[p13l418t3172r441b3199],

1	Drug	NN	O	drug	nn	2	SENT_480	[p13l460t3172r545b3209],
2	transporters	NNS	O	transporter	nsubjpass	5	SENT_480	[p13l556t3179r745b3209],
3	are	VBP	O	be	auxpass	5	SENT_480	[p13l758t3181r804b3200],
4	ubiquitously	RB	O	ubiquitously	advmod	5	SENT_480	[p13l816t3170r1012b3209],
5	expressed	VBN	O	express	_	0	SENT_480	[p13l1024t3170r1181b3209],
6	,	,	O	,	_	0	SENT_480	[p13l1024t3170r1181b3209],
7	and	CC	O	and	_	0	SENT_480	[p13l1195t3170r1250b3200],
8	many	JJ	O	many	nsubj	10	SENT_480	[p13l1262t3181r1349b3209],
9	are	VBP	O	be	cop	10	SENT_480	[p13l1360t3181r1406b3200],
10	critical	JJ	O	critical	conj_and	5	SENT_480	[p13l1419t3170r1525b3200],
11	for	IN	O	for	_	0	SENT_480	[p13l1537t3171r1583b3200],
12	drug	NN	O	drug	nn	13	SENT_480	[p13l1595t3171r1668b3209],
13	entry	NN	O	entry	prep_for	10	SENT_480	[p13l1680t3179r1762b3209],
14	into	IN	O	into	prep	10	SENT_480	[p13l1772t3172r1834b3200],
15	and	CC	O	and	_	0	SENT_480	[p13l460t3221r516b3250],
16	elimination	NN	O	elimination	conj_and	5	SENT_480	[p13l528t3221r707b3250],
17	from	IN	O	from	_	0	SENT_480	[p13l718t3221r794b3250],
18	tissues	NNS	O	tissue	prep_from	16	SENT_480	[p13l805t3222r904b3250],
19	in	IN	O	in	_	0	SENT_480	[p13l915t3222r946b3249],
20	the	DT	O	the	det	21	SENT_480	[p13l957t3220r1005b3250],
21	body	NN	O	body	prep_in	18	SENT_480	[p13l1017t3220r1102b3259],
22	.	.	O	.	_	0	SENT_480	[p13l1017t3220r1102b3259],

1	2	LS	NUMBER	2	_	0	SENT_481	[p13l415t3289r441b3316],
2	.	.	O	.	_	0	SENT_481	[p13l415t3289r441b3316],

1	Genetic	JJ	O	genetic	amod	2	SENT_482	[p13l461t3288r585b3317],
2	polymorphisms	NNS	O	polymorphism	nsubj	19	SENT_482	[p13l594t3287r837b3326],
3	in	IN	O	in	_	0	SENT_482	[p13l847t3289r877b3316],
4	drug	NN	O	drug	nn	5	SENT_482	[p13l888t3287r961b3326],
5	transporters	NNS	O	transporter	prep_in	2	SENT_482	[p13l970t3296r1159b3326],
6	may	MD	O	may	aux	7	SENT_482	[p13l1169t3298r1235b3326],
7	result	VB	O	result	_	0	SENT_482	[p13l1243t3287r1332b3317],
8	in	IN	O	in	_	0	SENT_482	[p13l1340t3289r1370b3316],
9	changes	NNS	O	change	prep_in	7	SENT_482	[p13l1381t3287r1504b3326],
10	in	IN	O	in	_	0	SENT_482	[p13l1514t3289r1544b3316],
11	drug	NN	O	drug	nn	12	SENT_482	[p13l1554t3287r1627b3326],
12	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	9	SENT_482	[p13l1636t3287r1834b3326, p13l459t3339r549b3366],
13	leading	VBG	O	lead	partmod	12	SENT_482	[p13l561t3337r675b3376],
14	to	TO	O	to	_	0	SENT_482	[p13l686t3345r716b3366],
15	reduced	VBN	O	reduce	amod	17	SENT_482	[p13l728t3337r852b3366],
16	drug	NN	O	drug	nn	17	SENT_482	[p13l864t3337r937b3376],
17	efﬁcacy	NN	O	efﬁcacy	prep_to	13	SENT_482	[p13l948t3337r1064b3376],
18	and	CC	O	and	_	0	SENT_482	[p13l1074t3337r1129b3366],
19	increased	VBD	O	increase	conj_and	7	SENT_482	[p13l1140t3337r1286b3366],
20	risk	NN	O	risk	nsubj	24	SENT_482	[p13l1297t3337r1355b3366],
21	for	IN	O	for	_	0	SENT_482	[p13l1364t3337r1410b3366],
22	drug	NN	O	drug	nn	23	SENT_482	[p13l1421t3337r1633b3376],
23	—	NN	O	—	prep_for	20	SENT_482	[p13l1421t3337r1633b3376],
24	induced	VBD	O	induce	ccomp	19	SENT_482	[p13l1421t3337r1633b3376],
25	toxicity	NN	O	toxicity	dobj	24	SENT_482	[p13l1644t3339r1767b3376],
26	.	.	O	.	_	0	SENT_482	[p13l1644t3339r1767b3376],

1	3	LS	NUMBER	3	_	0	SENT_483	[p13l417t3405r441b3432],
2	.	.	O	.	_	0	SENT_483	[p13l417t3405r441b3432],

1	Drug	NN	O	drug	nn	2	SENT_484	[p13l461t3404r545b3442],
2	transporters	NNS	O	transporter	nsubjpass	4	SENT_484	[p13l553t3411r742b3442],
3	are	VBP	O	be	auxpass	4	SENT_484	[p13l752t3414r798b3432],
4	involved	VBN	O	involve	_	0	SENT_484	[p13l807t3403r940b3432],
5	in	IN	O	in	_	0	SENT_484	[p13l949t3404r979b3432],
6	numerous	JJ	O	numerous	amod	8	SENT_484	[p13l987t3414r1143b3432],
7	drug-drug	JJ	O	drug-drug	amod	8	SENT_484	[p13l1154t3403r1315b3442],
8	interactions	NNS	O	interaction	prep_in	4	SENT_484	[p13l1323t3404r1516b3439],
9	;	:	O	;	_	0	SENT_484	[p13l1323t3404r1516b3439],
10	often	RB	O	often	advmod	15	SENT_484	[p13l1527t3403r1616b3439],
11	,	,	O	,	_	0	SENT_484	[p13l1527t3403r1616b3439],
12	this	DT	O	this	nsubj	15	SENT_484	[p13l1626t3403r1682b3432],
13	is	VBZ	O	be	cop	15	SENT_484	[p13l1691t3404r1714b3432],
14	a	DT	O	a	det	15	SENT_484	[p13l1724t3414r1739b3432],
15	result	NN	O	result	parataxis	4	SENT_484	[p13l1748t3403r1836b3432],
16	of	IN	O	of	_	0	SENT_484	[p13l460t3453r495b3482],
17	one	CD	NUMBER	one	num	18	SENT_484	[p13l502t3464r558b3482],
18	drug	NN	O	drug	prep_of	15	SENT_484	[p13l570t3453r643b3492],
19	inhibiting	VBG	O	inhibit	partmod	18	SENT_484	[p13l653t3453r808b3492],
20	the	DT	O	the	det	21	SENT_484	[p13l819t3453r867b3482],
21	transport	NN	O	transport	dobj	19	SENT_484	[p13l879t3462r1024b3491],
22	of	IN	O	of	_	0	SENT_484	[p13l1034t3453r1068b3482],
23	another	DT	O	another	prep_of	21	SENT_484	[p13l1076t3453r1204b3482],
24	.	.	O	.	_	0	SENT_484	[p13l1076t3453r1204b3482],

1	4	LS	NUMBER	4	_	0	SENT_485	[p13l415t3521r441b3549],
2	.	.	O	.	_	0	SENT_485	[p13l415t3521r441b3549],

1	Knockout	JJ	O	knockout	amod	3	SENT_486	[p13l460t3519r617b3549],
2	mouse	NN	O	mouse	nn	3	SENT_486	[p13l626t3530r727b3549],
3	models	NNS	O	model	nsubj	5	SENT_486	[p13l738t3519r849b3549],
4	have	VBP	O	have	aux	5	SENT_486	[p13l860t3519r931b3549],
5	provided	VBN	O	provide	ccomp	23	SENT_486	[p13l942t3519r1081b3558],
6	valuable	JJ	O	valuable	amod	7	SENT_486	[p13l1090t3519r1219b3549],
7	insight	NN	O	insight	dobj	5	SENT_486	[p13l1230t3519r1338b3558],
8	into	IN	O	into	_	0	SENT_486	[p13l1347t3521r1409b3549],
9	the	DT	O	the	prep_into	5	SENT_486	[p13l1421t3519r1470b3549],
10	in	FW	O	in	nn	11	SENT_486	[p13l1480t3521r1511b3548],
11	vivo	FW	O	vivo	advmod	12	SENT_486	[p13l1520t3521r1585b3549],
12	contribution	NN	O	contribution	dep	9	SENT_486	[p13l1597t3519r1794b3549],
13	of	IN	O	of	_	0	SENT_486	[p13l1805t3520r1839b3549],
14	numerous	JJ	O	numerous	amod	15	SENT_486	[p13l459t3590r616b3609],
15	transporters	NNS	O	transporter	prep_of	12	SENT_486	[p13l629t3588r827b3618],
16	;	:	O	;	_	0	SENT_486	[p13l629t3588r827b3618],
17	however	RB	O	however	advmod	9	SENT_486	[p13l840t3579r981b3615],
18	,	,	O	,	_	0	SENT_486	[p13l840t3579r981b3615],
19	these	DT	O	these	det	20	SENT_486	[p13l995t3579r1075b3609],
20	studies	NNS	O	study	nsubjpass	23	SENT_486	[p13l1088t3579r1194b3609],
21	are	VBP	O	be	auxpass	23	SENT_486	[p13l1207t3590r1253b3609],
22	sometimes	RB	O	sometimes	advmod	23	SENT_486	[p13l1267t3581r1432b3609],
23	limited	VBN	O	limit	_	0	SENT_486	[p13l1445t3579r1555b3609],
24	by	IN	O	by	_	0	SENT_486	[p13l1568t3579r1606b3618],
25	species	NNS	O	species	nn	26	SENT_486	[p13l1617t3581r1725b3618],
26	differences	NNS	O	difference	agent	23	SENT_486	[p13l1738t3579r1834b3609, p13l461t3641r544b3659],
27	in	IN	O	in	_	0	SENT_486	[p13l555t3631r585b3659],
28	transporter	NN	O	transporter	nn	29	SENT_486	[p13l596t3638r773b3668],
29	expression	NN	O	expression	prep_in	26	SENT_486	[p13l784t3631r947b3668],
30	and	CC	O	and	_	0	SENT_486	[p13l958t3630r1013b3659],
31	substrate	NN	O	substrate	nn	32	SENT_486	[p13l1025t3630r1164b3659],
32	speciﬁcity	NN	O	speciﬁcity	prep_in	26	SENT_486	[p13l1175t3630r1339b3669],
33	.	.	O	.	_	0	SENT_486	[p13l1175t3630r1339b3669],

1	Annu	NNP	PERSON	Annu	_	0	SENT_487	[p14l73t2653r96b2733],
2	.	.	O	.	_	0	SENT_487	[p14l73t2653r96b2733],

1	Rev.	NNP	O	Rev.	nn	2	SENT_488	[p14l73t2582r96b2642],
2	Pharrnacol	NNP	PERSON	Pharrnacol	_	0	SENT_488	[p14l73t2423r96b2571],
3	.	.	O	.	_	0	SENT_488	[p14l73t2423r96b2571],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_489	[p14l73t2303r96b2412],
2	.	.	O	.	_	0	SENT_489	[p14l73t2303r96b2412],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_490	[p14l73t2057r97b2291],
2	-273	CD	NUMBER	-273	_	0	SENT_490	[p14l73t2057r97b2291],
3	.	.	O	.	_	0	SENT_490	[p14l73t2057r97b2291],

1	Downloaded	VBN	O	download	_	0	SENT_491	[p14l73t1876r96b2046],
2	from	IN	O	from	_	0	SENT_491	[p14l73t1802r96b1867],
3	wwwannualrevie	NN	O	wwwannualrevie	nn	4	SENT_491	[p14l73t1558r96b1793],
4	ws	NNS	O	w	prep_from	1	SENT_491	[p14l80t1504r96b1547],
5	.	.	O	.	_	0	SENT_491	[p14l80t1504r96b1547],

1	org	NN	O	org	_	0	SENT_492	[p14l80t1448r103b1491],
2	by	IN	O	by	_	0	SENT_492	[p14l106t2565r137b2598],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_492	[p14l106t2416r137b2556],
4	of	IN	ORGANIZATION	of	_	0	SENT_492	[p14l106t2377r130b2406],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_492	[p14l106t2231r130b2371],
6	-	:	O	-	_	0	SENT_492	[p14l120t2212r123b2221],
7	Madison	NNP	O	Madison	dep	1	SENT_492	[p14l106t2086r130b2202],
8	on	IN	O	on	_	0	SENT_492	[p14l114t2044r130b2076],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_492	[p14l106t1910r130b2035],
10	.	.	O	.	_	0	SENT_492	[p14l106t1910r130b2035],

1	For	IN	O	for	_	0	SENT_493	[p14l107t1853r130b1900],
2	personal	JJ	O	personal	amod	3	SENT_493	[p14l106t1733r137b1845],
3	use	NN	O	use	pobj	1	SENT_493	[p14l114t1680r130b1724],
4	only	RB	O	only	advmod	3	SENT_493	[p14l106t1605r137b1670],
5	.	.	O	.	_	0	SENT_493	[p14l106t1605r137b1670],

1	Annu	NNP	PERSON	Annu	_	0	SENT_494	[p14l181t245r204b325],
2	.	.	O	.	_	0	SENT_494	[p14l181t245r204b325],

1	Rev.	NNP	O	Rev.	nn	2	SENT_495	[p14l181t175r204b234],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_495	[p14l181t16r204b165],
3	.	.	O	.	_	0	SENT_495	[p14l181t16r204b165],

1	by	IN	O	by	_	0	SENT_496	[p14l214t158r245b190],
2	University	NNP	O	University	pobj	1	SENT_496	[p14l214t9r245b149],

1	FUTURE	JJ	DATE	future	amod	2	SENT_497	[p14l416t133r585b160],
2	ISSUES	NNS	O	issue	_	0	SENT_497	[p14l597t133r731b160],

1	1	LS	NUMBER	1	_	0	SENT_498	[p14l418t200r441b227],
2	.	.	O	.	_	0	SENT_498	[p14l418t200r441b227],

1	Standards	NNP	O	Standards	nsubjpass	12	SENT_499	[p14l461t198r614b227],
2	for	IN	O	for	_	0	SENT_499	[p14l627t198r673b227],
3	transporter	NN	O	transporter	nn	4	SENT_499	[p14l685t206r862b237],
4	studies	NNS	O	study	prep_for	1	SENT_499	[p14l874t198r980b227],
5	in	IN	O	in	_	0	SENT_499	[p14l993t200r1023b227],
6	drug	NN	O	drug	nn	7	SENT_499	[p14l1037t198r1110b237],
7	discovery	NN	O	discovery	prep_in	4	SENT_499	[p14l1123t198r1270b237],
8	and	CC	O	and	_	0	SENT_499	[p14l1282t198r1338b227],
9	development	NN	O	development	prep_in	4	SENT_499	[p14l1351t198r1554b237],
10	should	MD	O	should	aux	12	SENT_499	[p14l1567t198r1670b227],
11	be	VB	O	be	auxpass	12	SENT_499	[p14l1683t198r1719b227],
12	implemented	VBN	O	implement	_	0	SENT_499	[p14l1732t198r1834b237, p14l460t248r586b283],
13	,	,	O	,	_	0	SENT_499	[p14l1732t198r1834b237, p14l460t248r586b283],
14	as	IN	O	as	mark	15	SENT_499	[p14l599t259r627b277],
15	described	VBN	O	describe	advcl	12	SENT_499	[p14l639t248r787b277],
16	in	IN	O	in	_	0	SENT_499	[p14l798t249r828b276],
17	a	DT	O	a	det	20	SENT_499	[p14l840t259r854b277],
18	recent	JJ	O	recent	amod	20	SENT_499	[p14l865t256r964b277],
19	white	JJ	O	white	amod	20	SENT_499	[p14l973t248r1059b277],
20	paper	NN	O	paper	prep_in	15	SENT_499	[p14l1071t259r1159b286],
21	by	IN	O	by	_	0	SENT_499	[p14l1169t248r1207b286],
22	the	DT	O	the	det	25	SENT_499	[p14l1217t248r1266b277],
23	International	NNP	O	International	nn	25	SENT_499	[p14l1277t248r1483b277],
24	Transporter	NNP	O	Transporter	nn	25	SENT_499	[p14l1492t248r1686b286],
25	Consortium	NNP	O	Consortium	prep_by	15	SENT_499	[p14l461t299r658b327],
26	.	.	O	.	_	0	SENT_499	[p14l461t299r658b327],

1	2	LS	NUMBER	2	_	0	SENT_500	[p14l415t366r441b393],
2	.	.	O	.	_	0	SENT_500	[p14l415t366r441b393],

1	Better	RBR	O	better	amod	2	SENT_501	[p14l461t365r557b393],
2	individualization	NN	O	individualization	nsubjpass	8	SENT_501	[p14l571t364r834b393],
3	of	IN	O	of	_	0	SENT_501	[p14l849t364r884b393],
4	drug	NN	O	drug	nn	5	SENT_501	[p14l895t364r968b403],
5	therapy	NN	O	therapy	prep_of	2	SENT_501	[p14l982t364r1102b403],
6	must	MD	O	must	aux	8	SENT_501	[p14l1115t372r1192b393],
7	be	VB	O	be	auxpass	8	SENT_501	[p14l1206t364r1242b393],
8	provided	VBN	O	provide	_	0	SENT_501	[p14l1257t364r1395b403],
9	through	IN	O	through	_	0	SENT_501	[p14l1410t364r1537b403],
10	the	DT	O	the	det	11	SENT_501	[p14l1552t364r1600b393],
11	integration	NN	O	integration	prep_through	8	SENT_501	[p14l1615t366r1790b403],
12	of	IN	O	of	_	0	SENT_501	[p14l1805t364r1839b393],
13	transporter	NN	O	transporter	nn	14	SENT_501	[p14l460t411r759b450],
14	—	NN	O	—	prep_of	11	SENT_501	[p14l460t411r759b450],
15	related	JJ	O	related	amod	16	SENT_501	[p14l460t411r759b450],
16	genetic	JJ	O	genetic	npadvmod	8	SENT_501	[p14l770t413r883b450],
17	and	CC	O	and	_	0	SENT_501	[p14l894t411r950b440],
18	clinical	JJ	O	clinical	amod	19	SENT_501	[p14l961t411r1071b440],
19	variables	NNS	O	variable	conj_and	16	SENT_501	[p14l1081t411r1218b440],
20	into	IN	O	into	_	0	SENT_501	[p14l1229t413r1291b440],
21	drug	NN	O	drug	nn	22	SENT_501	[p14l1303t411r1376b450],
22	choice	NN	O	choice	prep_into	8	SENT_501	[p14l1387t411r1486b440],
23	and	CC	O	and	_	0	SENT_501	[p14l1498t411r1554b440],
24	dose	NN	O	dose	nn	25	SENT_501	[p14l1566t411r1634b440],
25	algorithms	NNS	O	algorithm	prep_into	8	SENT_501	[p14l1646t411r1822b450],
26	.	.	O	.	_	0	SENT_501	[p14l1646t411r1822b450],

1	3	LS	NUMBER	3	_	0	SENT_502	[p14l417t460r441b488],
2	.	.	O	.	_	0	SENT_502	[p14l417t460r441b488],

1	Continued	VBN	O	continue	amod	2	SENT_503	[p14l461t458r629b488],
2	efforts	NNS	O	effort	nsubjpass	27	SENT_503	[p14l641t458r738b488],
3	to	TO	O	to	aux	4	SENT_503	[p14l751t467r781b488],
4	improve	VB	O	improve	infmod	2	SENT_503	[p14l793t460r922b497],
5	the	DT	O	the	det	6	SENT_503	[p14l934t458r983b488],
6	extrapolation	NN	O	extrapolation	dobj	4	SENT_503	[p14l996t458r1202b497],
7	of	IN	O	of	_	0	SENT_503	[p14l1214t458r1248b488],
8	data	NNS	O	datum	prep_of	6	SENT_503	[p14l1256t458r1320b488],
9	from	IN	O	from	_	0	SENT_503	[p14l1332t458r1408b488],
10	in	FW	O	in	nn	11	SENT_503	[p14l1419t460r1449b487],
11	vitro	FW	O	vitro	dep	16	SENT_503	[p14l1459t460r1534b488],
12	and	CC	O	and	_	0	SENT_503	[p14l1546t458r1602b488],
13	in	FW	O	in	conj_and	11	SENT_503	[p14l1613t460r1644b487],
14	vivo	FW	O	vivo	pobj	13	SENT_503	[p14l1653t460r1718b488],
15	animal	NN	O	animal	nn	16	SENT_503	[p14l1731t458r1835b488],
16	experiments	NNS	O	experiment	prep_from	4	SENT_503	[p14l461t507r650b544],
17	to	TO	O	to	_	0	SENT_503	[p14l661t513r692b534],
18	the	DT	O	the	prep_to	4	SENT_503	[p14l704t505r752b534],
19	in	FW	O	in	nn	20	SENT_503	[p14l763t507r794b534],
20	vivo	FW	O	vivo	advmod	22	SENT_503	[p14l803t507r868b534],
21	human	JJ	O	human	amod	22	SENT_503	[p14l879t505r987b534],
22	setting	NN	O	setting	dep	18	SENT_503	[p14l999t507r1104b544],
23	and	CC	O	and	_	0	SENT_503	[p14l1115t505r1170b534],
24	clinical	JJ	O	clinical	amod	25	SENT_503	[p14l1182t505r1292b534],
25	relevance	NN	O	relevance	conj_and	18	SENT_503	[p14l1303t505r1450b534],
26	are	VBP	O	be	auxpass	27	SENT_503	[p14l1462t516r1508b534],
27	needed	VBN	O	need	_	0	SENT_503	[p14l1519t505r1639b534],
28	.	.	O	.	_	0	SENT_503	[p14l1519t505r1639b534],

1	DISCLOSURE	NN	O	disclosure	nn	2	SENT_504	[p14l367t619r658b651],
2	STATEMENT	NN	O	statement	_	0	SENT_504	[p14l671t619r960b651],

1	The	DT	O	the	det	2	SENT_505	[p14l366t688r432b717],
2	authors	NNS	O	author	nsubj	5	SENT_505	[p14l447t688r563b717],
3	are	VBP	O	be	cop	5	SENT_505	[p14l577t699r624b717],
4	not	RB	O	not	neg	5	SENT_505	[p14l637t697r691b717],
5	aware	JJ	O	aware	_	0	SENT_505	[p14l704t699r793b717],
6	of	IN	O	of	_	0	SENT_505	[p14l808t688r842b717],
7	any	DT	O	any	det	8	SENT_505	[p14l852t699r907b727],
8	afﬁliations	NNS	O	afﬁliations	prep_of	5	SENT_505	[p14l920t688r1089b724],
9	,	,	O	,	_	0	SENT_505	[p14l920t688r1089b724],
10	memberships	NNS	O	membership	prep_of	5	SENT_505	[p14l1104t688r1322b727],
11	,	,	O	,	_	0	SENT_505	[p14l1104t688r1322b727],
12	funding	NN	O	funding	prep_of	5	SENT_505	[p14l1337t688r1467b727],
13	,	,	O	,	_	0	SENT_505	[p14l1337t688r1467b727],
14	or	CC	O	or	_	0	SENT_505	[p14l1483t699r1516b717],
15	ﬁnancial	JJ	O	ﬁnancial	amod	16	SENT_505	[p14l1530t688r1661b717],
16	holdings	NNS	O	holding	prep_of	5	SENT_505	[p14l1675t688r1809b727],
17	that	WDT	O	that	nsubjpass	20	SENT_505	[p14l1824t688r1886b717],
18	might	MD	O	might	aux	20	SENT_505	[p14l366t735r460b774],
19	be	VB	O	be	auxpass	20	SENT_505	[p14l470t735r506b764],
20	perceived	VBN	O	perceive	rcmod	16	SENT_505	[p14l517t735r667b774],
21	as	IN	O	as	_	0	SENT_505	[p14l678t746r706b764],
22	affecting	VBG	O	affect	prepc_as	20	SENT_505	[p14l718t735r853b774],
23	the	DT	O	the	det	24	SENT_505	[p14l863t735r912b764],
24	objectivity	NN	O	objectivity	dobj	22	SENT_505	[p14l923t735r1088b774],
25	of	IN	O	of	_	0	SENT_505	[p14l1098t735r1132b764],
26	this	DT	O	this	det	27	SENT_505	[p14l1139t735r1194b764],
27	review	NN	O	review	prep_of	24	SENT_505	[p14l1206t737r1316b764],
28	.	.	O	.	_	0	SENT_505	[p14l1206t737r1316b764],

1	1vww	NN	O	1vww	_	0	SENT_506	[p14l1356t842r1630b872],
2	.	.	O	.	_	0	SENT_506	[p14l1356t842r1630b872],

1	mmualreview5	NN	O	mmualreview5	_	0	SENT_507	[p14l1356t842r1630b872],
2	.	.	O	.	_	0	SENT_507	[p14l1356t842r1630b872],

1	org	NN	O	org	nn	4	SENT_508	[p14l1356t842r1630b872],
2	o	NN	O	o	nn	4	SENT_508	[p14l1645t850r1654b860],
3	Drug	NN	O	drug	nn	4	SENT_508	[p14l1671t842r1734b872],
4	Tmmpomarx	NN	O	tmmpomarx	_	0	SENT_508	[p14l1742t842r1886b871],
5	263	CD	NUMBER	263	dep	4	SENT_508	[p14l1937t842r1978b871],

1	ACKNOVVLEDGMENTS	NNS	O	acknovvledgment	_	0	SENT_509	[p14l564t896r1069b928],

1	This	DT	O	this	det	2	SENT_510	[p14l565t965r638b994],
2	work	NN	O	work	nsubjpass	4	SENT_510	[p14l653t965r734b994],
3	was	VBD	O	be	auxpass	4	SENT_510	[p14l747t976r803b994],
4	supported	VBN	O	support	_	0	SENT_510	[p14l820t965r977b1004],
5	by	IN	O	by	_	0	SENT_510	[p14l992t965r1031b1004],
6	grants	NNS	O	grant	agent	4	SENT_510	[p14l1045t973r1141b1004],
7	from	IN	O	from	_	0	SENT_510	[p14l1157t965r1233b994],
8	the	DT	O	the	det	18	SENT_510	[p14l1249t965r1298b994],
9	Canadian	JJ	ORGANIZATION	canadian	amod	18	SENT_510	[p14l1315t965r1463b994],
10	Institutes	NNPS	ORGANIZATION	Institutes	dep	18	SENT_510	[p14l1478t966r1624b994],
11	of	IN	ORGANIZATION	of	_	0	SENT_510	[p14l1641t965r1675b994],
12	Health	NNP	ORGANIZATION	Health	nn	13	SENT_510	[p14l1686t965r1795b994],
13	Research	NNP	ORGANIZATION	Research	prep_of	10	SENT_510	[p14l1811t965r1953b994],
14	(	CD	NUMBER	(	num	15	SENT_510	[p14l1969t966r2083b1002, p14l567t1013r640b1041],
15	MOP8975	NN	O	mop8975	dep	13	SENT_510	[p14l1969t966r2083b1002, p14l567t1013r640b1041],
16	3	CD	NUMBER	3	dep	15	SENT_510	[p14l645t1013r672b1048],
17	)	NN	O	)	nn	18	SENT_510	[p14l645t1013r672b1048],
18	(	NN	O	(	prep_from	6	SENT_510	[p14l687t1013r729b1048],
19	to	TO	O	to	_	0	SENT_510	[p14l687t1013r729b1048],
20	R.B.K.	NNP	O	R.B.K.	prep_to	4	SENT_510	[p14l742t1013r868b1048],
21	)	CD	NUMBER	)	num	20	SENT_510	[p14l742t1013r868b1048],
22	.	.	O	.	_	0	SENT_510	[p14l742t1013r868b1048],

1	M.K.D.	NNP	O	M.K.D.	nsubj	4	SENT_511	[p14l881t1013r1004b1041],
2	is	VBZ	O	be	cop	4	SENT_511	[p14l1019t1014r1041b1041],
3	the	DT	O	the	det	4	SENT_511	[p14l1055t1012r1104b1041],
4	recipient	JJ	O	recipient	_	0	SENT_511	[p14l1117t1014r1257b1050],
5	of	IN	O	of	_	0	SENT_511	[p14l1269t1012r1303b1041],
6	a	DT	O	a	det	10	SENT_511	[p14l1312t1023r1327b1041],
7	Vanier	NNP	ORGANIZATION	Vanier	nn	10	SENT_511	[p14l1338t1013r1446b1041],
8	Canada	NNP	ORGANIZATION	Canada	nn	10	SENT_511	[p14l1460t1012r1576b1041],
9	Graduate	NNP	O	Graduate	nn	10	SENT_511	[p14l1590t1012r1736b1041],
10	Scholarship	NNP	O	Scholarship	prep_of	4	SENT_511	[p14l1751t1012r1933b1050],
11	from	IN	O	from	_	0	SENT_511	[p14l1946t1012r2022b1041],
12	the	DT	O	the	det	14	SENT_511	[p14l2035t1012r2084b1041],
13	Canadian	JJ	ORGANIZATION	canadian	amod	14	SENT_511	[p14l567t1059r715b1088],
14	Institutes	NNPS	ORGANIZATION	Institutes	prep_from	4	SENT_511	[p14l725t1061r871b1088],
15	of	IN	ORGANIZATION	of	_	0	SENT_511	[p14l883t1059r917b1088],
16	Health	NNP	ORGANIZATION	Health	nn	17	SENT_511	[p14l924t1059r1033b1088],
17	Research	NNP	ORGANIZATION	Research	prep_of	4	SENT_511	[p14l1044t1059r1194b1088],
18	.	.	O	.	_	0	SENT_511	[p14l1044t1059r1194b1088],

1	LITERATURE	NN	O	literature	nsubj	2	SENT_512	[p14l565t1163r832b1192],
2	CITED	VBD	O	cite	_	0	SENT_512	[p14l844t1163r975b1192],

1	Giacornini	NNP	PERSON	Giacornini	nn	2	SENT_513	[p14l643t1229r790b1254],
2	KM	NNP	PERSON	KM	_	0	SENT_513	[p14l800t1229r864b1259],
3	,	,	O	,	_	0	SENT_513	[p14l800t1229r864b1259],
4	Huang	NNP	PERSON	Huang	nn	5	SENT_513	[p14l875t1229r972b1262],
5	SM	NNP	O	SM	appos	2	SENT_513	[p14l983t1229r1038b1259],
6	,	,	O	,	_	0	SENT_513	[p14l983t1229r1038b1259],
7	Tweedie	NNP	PERSON	Tweedie	nn	8	SENT_513	[p14l1049t1228r1171b1254],
8	DJ	NNP	O	DJ	appos	2	SENT_513	[p14l1182t1229r1227b1260],
9	,	,	O	,	_	0	SENT_513	[p14l1182t1229r1227b1260],
10	Benet	NNP	PERSON	Benet	nn	11	SENT_513	[p14l1239t1229r1320b1254],
11	LZ	NNP	O	LZ	appos	2	SENT_513	[p14l1330t1228r1381b1259],
12	,	,	O	,	_	0	SENT_513	[p14l1330t1228r1381b1259],
13	Brouwer	NNP	ORGANIZATION	Brouwer	nn	14	SENT_513	[p14l1393t1229r1514b1254],
14	KL	NNP	ORGANIZATION	KL	appos	2	SENT_513	[p14l1523t1229r1578b1259],
15	,	,	O	,	_	0	SENT_513	[p14l1523t1229r1578b1259],
16	et	FW	O	et	nn	17	SENT_513	[p14l1590t1235r1615b1254],
17	al.	FW	O	al.	appos	2	SENT_513	[p14l1625t1228r1654b1254],
18	2010	CD	DATE	2010	dep	17	SENT_513	[p14l1666t1230r1741b1254],
19	.	.	O	.	_	0	SENT_513	[p14l1666t1230r1741b1254],

1	Membrane	NN	O	membrane	nn	2	SENT_514	[p14l1751t1228r1905b1254],
2	transporters	NNS	O	transporter	_	0	SENT_514	[p14l1916t1235r2084b1262],
3	in	IN	O	in	_	0	SENT_514	[p14l642t1273r669b1298],
4	drug	NN	O	drug	nn	5	SENT_514	[p14l680t1272r745b1306],
5	development	NN	O	development	prep_in	2	SENT_514	[p14l754t1272r941b1306],
6	.	.	O	.	_	0	SENT_514	[p14l754t1272r941b1306],

1	Nat	NN	PERSON	nat	_	0	SENT_515	[p14l951t1273r1009b1298],
2	.	.	O	.	_	0	SENT_515	[p14l951t1273r1009b1298],

1	Rev.	NNP	O	Rev.	nn	3	SENT_516	[p14l1020t1273r1075b1298],
2	Dmg	NNP	PERSON	Dmg	nn	3	SENT_516	[p14l1087t1273r1160b1307],
3	Dixcov	NNP	PERSON	Dixcov	_	0	SENT_516	[p14l1168t1273r1257b1298],
4	.	.	O	.	_	0	SENT_516	[p14l1168t1273r1257b1298],

1	9:215	CD	NUMBER	9:215	_	0	SENT_517	[p14l1270t1273r1396b1298],
2	—	CD	NUMBER	—	number	3	SENT_517	[p14l1270t1273r1396b1298],
3	36	CD	NUMBER	36	num	1	SENT_517	[p14l1270t1273r1396b1298],
4	.	.	O	.	_	0	SENT_517	[p14l619t1337r623b1341],

1	Ho	NNP	O	Ho	nn	2	SENT_518	[p14l643t1317r688b1342],
2	RH	NNP	O	RH	_	0	SENT_518	[p14l700t1317r758b1347],
3	,	,	O	,	_	0	SENT_518	[p14l700t1317r758b1347],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_518	[p14l770t1317r831b1341],
5	RB	NN	O	rb	appos	2	SENT_518	[p14l842t1317r893b1341],
6	.	.	O	.	_	0	SENT_518	[p14l842t1317r893b1341],

1	2005	CD	DATE	2005	_	0	SENT_519	[p14l905t1317r980b1342],
2	.	.	O	.	_	0	SENT_519	[p14l905t1317r980b1342],

1	Transporters	NNS	O	transporter	_	0	SENT_520	[p14l991t1317r1175b1350],
2	and	CC	O	and	_	0	SENT_520	[p14l1187t1316r1236b1342],
3	drug	NN	O	drug	nn	4	SENT_520	[p14l1248t1316r1313b1350],
4	therapy	NN	O	therapy	conj_and	1	SENT_520	[p14l1323t1316r1435b1350],
5	:	:	O	:	_	0	SENT_520	[p14l1323t1316r1435b1350],
6	implications	NNS	O	implication	dep	1	SENT_520	[p14l1448t1316r1618b1350],
7	for	IN	O	for	_	0	SENT_520	[p14l1629t1316r1670b1342],
8	drug	NN	O	drug	nn	9	SENT_520	[p14l1681t1316r1746b1350],
9	disposition	NN	O	disposition	prep_for	6	SENT_520	[p14l1757t1316r1908b1350],
10	and	CC	O	and	_	0	SENT_520	[p14l1919t1316r1968b1342],
11	disease	NN	O	disease	prep_for	6	SENT_520	[p14l1980t1316r2083b1342],
12	.	.	O	.	_	0	SENT_520	[p14l1980t1316r2083b1342],

1	Clin	NNP	O	Clin	_	0	SENT_521	[p14l644t1361r705b1386],
2	.	.	O	.	_	0	SENT_521	[p14l644t1361r705b1386],

1	Plmrmzzcal	JJ	O	plmrmzzcal	_	0	SENT_522	[p14l716t1361r860b1386],
2	.	.	O	.	_	0	SENT_522	[p14l716t1361r860b1386],

1	Tber	NNP	O	Tber	_	0	SENT_523	[p14l874t1361r942b1386],
2	.	.	O	.	_	0	SENT_523	[p14l874t1361r942b1386],

1	78:260	CD	NUMBER	78:260	_	0	SENT_524	[p14l956t1361r1098b1386],
2	—	CD	NUMBER	—	number	3	SENT_524	[p14l956t1361r1098b1386],
3	77	CD	NUMBER	77	num	1	SENT_524	[p14l956t1361r1098b1386],
4	.	.	O	.	_	0	SENT_524	[p14l619t1425r623b1429],

1	Schinkel	NNP	PERSON	Schinkel	nn	2	SENT_525	[p14l644t1404r762b1430],
2	AH	NNP	O	AH	_	0	SENT_525	[p14l770t1405r828b1435],
3	,	,	O	,	_	0	SENT_525	[p14l770t1405r828b1435],
4	Jonker	NNP	PERSON	Jonker	nn	5	SENT_525	[p14l834t1404r931b1436],
5	JW	NNP	O	JW	appos	2	SENT_525	[p14l936t1405r994b1436],
6	.	.	O	.	_	0	SENT_525	[p14l936t1405r994b1436],

1	2003	CD	DATE	2003	_	0	SENT_526	[p14l1005t1406r1079b1430],
2	.	.	O	.	_	0	SENT_526	[p14l1005t1406r1079b1430],

1	Mammalian	JJ	O	mammalian	amod	4	SENT_527	[p14l1088t1404r1257b1430],
2	drug	NN	O	drug	nn	4	SENT_527	[p14l1266t1404r1331b1438],
3	efflux	NN	O	efflux	nn	4	SENT_527	[p14l1340t1404r1415b1430],
4	transporters	NNS	O	transporter	dep	11	SENT_527	[p14l1423t1411r1591b1438],
5	of	IN	O	of	_	0	SENT_527	[p14l1601t1404r1631b1430],
6	the	DT	O	the	det	8	SENT_527	[p14l1636t1404r1680b1430],
7	ATP	NN	O	atp	nn	8	SENT_527	[p14l1687t1405r1756b1429],
8	binding	NN	O	binding	prep_of	4	SENT_527	[p14l1765t1404r1873b1438],
9	cassette	NN	O	cassette	dep	11	SENT_527	[p14l1882t1411r1987b1430],
10	(	CD	NUMBER	(	num	9	SENT_527	[p14l1997t1405r2084b1436],
11	ABC	NNP	ORGANIZATION	ABC	dep	16	SENT_527	[p14l1997t1405r2084b1436],
12	)	CD	NUMBER	)	num	13	SENT_527	[p14l1997t1405r2084b1436],
13	family	NN	O	family	dep	11	SENT_527	[p14l643t1449r736b1483],
14	:	:	O	:	_	0	SENT_527	[p14l643t1449r736b1483],
15	an	DT	O	a	det	16	SENT_527	[p14l748t1459r779b1475],
16	overview	NN	O	overview	_	0	SENT_527	[p14l789t1450r920b1475],
17	.	.	O	.	_	0	SENT_527	[p14l789t1450r920b1475],

1	Adv	NNP	O	Adv	_	0	SENT_528	[p14l928t1450r990b1475],
2	.	.	O	.	_	0	SENT_528	[p14l928t1450r990b1475],

1	Drug	NN	O	drug	_	0	SENT_529	[p14l1002t1450r1075b1484],
2	Deliv	NNP	O	Deliv	dep	1	SENT_529	[p14l1083t1450r1160b1475],
3	.	.	O	.	_	0	SENT_529	[p14l1083t1450r1160b1475],

1	Rev.	NNP	O	Rev.	nn	5	SENT_530	[p14l1171t1450r1226b1475],
2	5	CD	NUMBER	5	num	5	SENT_530	[p14l1240t1450r1253b1475],
3	523-29	CD	NUMBER	523-29	num	5	SENT_530	[p14l1257t1450r1348b1475],
4	Hediger	NNP	O	Hediger	nn	5	SENT_530	[p14l643t1504r759b1538],
5	MA	NNP	O	MA	_	0	SENT_530	[p14l763t1505r825b1535],
6	,	,	O	,	_	0	SENT_530	[p14l763t1505r825b1535],
7	Romero	NNP	PERSON	Romero	nn	8	SENT_530	[p14l833t1505r946b1530],
8	MF	NN	O	mf	appos	5	SENT_530	[p14l951t1505r1011b1535],
9	,	,	O	,	_	0	SENT_530	[p14l951t1505r1011b1535],
10	Pen	NN	O	pen	nn	11	SENT_530	[p14l1018t1505r1072b1530],
11	gJB	NN	O	gjb	appos	8	SENT_530	[p14l1074t1505r1136b1538],
12	,	,	O	,	_	0	SENT_530	[p14l1074t1505r1136b1538],
13	Rolfs	NNP	PERSON	Rolfs	nn	14	SENT_530	[p14l1143t1504r1215b1530],
14	A	NNP	O	A	appos	8	SENT_530	[p14l1220t1505r1250b1535],
15	,	,	O	,	_	0	SENT_530	[p14l1220t1505r1250b1535],
16	Takanaga	NNP	PERSON	Takanaga	nn	17	SENT_530	[p14l1256t1504r1393b1538],
17	H	NNP	O	H	appos	8	SENT_530	[p14l1399t1505r1434b1535],
18	,	,	O	,	_	0	SENT_530	[p14l1399t1505r1434b1535],
19	Bruford	NNP	PERSON	Bruford	nn	20	SENT_530	[p14l1442t1504r1552b1530],
20	EA	NN	O	ea	appos	8	SENT_530	[p14l1558t1505r1609b1529],
21	.	.	O	.	_	0	SENT_530	[p14l1558t1505r1609b1529],

1	2	CD	NUMBER	2	num	2	SENT_531	[p14l1617t1505r1630b1529],
2	004	CD	NUMBER	004	_	0	SENT_531	[p14l1634t1505r1692b1530],
3	.	.	O	.	_	0	SENT_531	[p14l1634t1505r1692b1530],

1	The	DT	O	the	det	2	SENT_532	[p14l1698t1504r1757b1530],
2	ABCs	NNS	O	ABC	_	0	SENT_532	[p14l1763t1505r1844b1530],
3	of	IN	O	of	_	0	SENT_532	[p14l1851t1504r1881b1530],
4	solute	JJ	O	solute	amod	5	SENT_532	[p14l1884t1504r1966b1530],
5	carriers	NNS	O	carrier	prep_of	2	SENT_532	[p14l1973t1505r2083b1530],
6	:	:	O	:	_	0	SENT_532	[p14l1973t1505r2083b1530],
7	physiological	JJ	O	physiological	amod	12	SENT_532	[p14l643t1559r833b1594],
8	,	,	O	,	_	0	SENT_532	[p14l643t1559r833b1594],
9	pathological	JJ	O	pathological	amod	12	SENT_532	[p14l841t1559r1012b1594],
10	and	CC	O	and	_	0	SENT_532	[p14l1020t1559r1070b1585],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_532	[p14l1077t1559r1235b1594],
12	implications	NNS	O	implication	dep	2	SENT_532	[p14l1242t1560r1412b1594],
13	of	IN	O	of	_	0	SENT_532	[p14l1421t1560r1451b1585],
14	human	JJ	O	human	amod	17	SENT_532	[p14l1454t1559r1551b1585],
15	membrane	NN	O	membrane	nn	17	SENT_532	[p14l1558t1559r1707b1585],
16	transport	NN	O	transport	nn	17	SENT_532	[p14l1714t1567r1843b1594],
17	proteins	NNS	O	protein	prep_of	12	SENT_532	[p14l1850t1561r1971b1594],
18	.	.	O	.	_	0	SENT_532	[p14l1850t1561r1971b1594],

1	Pflugers	NNP	O	Pflugers	nn	2	SENT_533	[p14l1979t1560r2086b1594],
2	Arch	NNP	O	Arch	_	0	SENT_533	[p14l640t1606r711b1631],
3	.	.	O	.	_	0	SENT_533	[p14l640t1606r711b1631],

1	447	CD	NUMBER	447	_	0	SENT_534	[p14l723t1606r772b1631],
2	:465	CD	NUMBER	:465	number	3	SENT_534	[p14l777t1606r832b1631],
3	-68	CD	NUMBER	-68	num	1	SENT_534	[p14l835t1607r884b1631],
4	.	.	O	.	_	0	SENT_534	[p14l619t1671r623b1675],

1	Nies	NNPS	PERSON	Nies	_	0	SENT_535	[p14l642t1651r707b1675],
2	AT	IN	O	at	prep	1	SENT_535	[p14l718t1650r773b1681],
3	,	,	O	,	_	0	SENT_535	[p14l718t1650r773b1681],
4	Koepsell	NNP	PERSON	Koepsell	nn	5	SENT_535	[p14l786t1650r907b1684],
5	H	NNP	PERSON	H	appos	1	SENT_535	[p14l918t1651r954b1681],
6	,	,	O	,	_	0	SENT_535	[p14l918t1651r954b1681],
7	Damme	NNP	PERSON	Damme	nn	8	SENT_535	[p14l967t1651r1078b1675],
8	K	NNP	PERSON	K	appos	1	SENT_535	[p14l1090t1651r1121b1681],
9	,	,	O	,	_	0	SENT_535	[p14l1090t1651r1121b1681],
10	Schwab	NNP	PERSON	Schwab	nn	11	SENT_535	[p14l1135t1650r1240b1675],
11	M.	NNP	O	M.	appos	1	SENT_535	[p14l1251t1651r1290b1675],
12	2011	CD	DATE	2011	dep	11	SENT_535	[p14l1303t1651r1378b1675],
13	.	.	O	.	_	0	SENT_535	[p14l1303t1651r1378b1675],

1	Organic	NNP	O	Organic	nn	3	SENT_536	[p14l1392t1651r1505b1684],
2	cation	NN	O	cation	nn	3	SENT_536	[p14l1517t1651r1602b1675],
3	transporters	NNS	O	transporter	nsubj	4	SENT_536	[p14l1613t1657r1781b1684],
4	(	VBP	O	(	ccomp	8	SENT_536	[p14l1794t1650r1901b1682],
5	OCTs	NNS	O	oct	dobj	4	SENT_536	[p14l1794t1650r1901b1682],
6	,	,	O	,	_	0	SENT_536	[p14l1794t1650r1901b1682],
7	MATES	NNS	O	mate	nsubj	8	SENT_536	[p14l1912t1650r2045b1682],
8	)	VBP	O	)	_	0	SENT_536	[p14l1912t1650r2045b1682],
9	,	,	O	,	_	0	SENT_536	[p14l1912t1650r2045b1682],
10	in	FW	O	in	nn	11	SENT_536	[p14l2058t1651r2084b1675],
11	vitro	FW	O	vitro	dep	15	SENT_536	[p14l641t1697r708b1721],
12	and	CC	O	and	_	0	SENT_536	[p14l718t1695r768b1721],
13	in	FW	O	in	conj_and	11	SENT_536	[p14l777t1697r804b1721],
14	vivo	FW	O	vivo	pobj	13	SENT_536	[p14l812t1697r870b1721],
15	evidence	NN	O	evidence	dobj	8	SENT_536	[p14l881t1695r1000b1721],
16	for	IN	O	for	_	0	SENT_536	[p14l1011t1695r1051b1721],
17	the	DT	O	the	det	18	SENT_536	[p14l1061t1695r1104b1721],
18	importance	NN	O	importance	prep_for	15	SENT_536	[p14l1114t1697r1272b1729],
19	in	IN	O	in	_	0	SENT_536	[p14l1282t1697r1309b1721],
20	drug	NN	O	drug	nn	21	SENT_536	[p14l1319t1695r1384b1730],
21	therapy	NN	O	therapy	prep_in	18	SENT_536	[p14l1393t1695r1506b1730],
22	.	.	O	.	_	0	SENT_536	[p14l1393t1695r1506b1730],

1	Hmzdla	NNP	PERSON	Hmzdla	_	0	SENT_537	[p14l1516t1696r1610b1721],
2	.	.	O	.	_	0	SENT_537	[p14l1516t1696r1610b1721],

1	Exp	NN	O	exp	_	0	SENT_538	[p14l1622t1696r1679b1729],
2	.	.	O	.	_	0	SENT_538	[p14l1622t1696r1679b1729],

1	Plmrmacol	NNP	O	Plmrmacol	_	0	SENT_539	[p14l1691t1696r1834b1721],
2	.	.	O	.	_	0	SENT_539	[p14l1691t1696r1834b1721],

1	2011:105	CD	NUMBER	2011:105	num	5	SENT_540	[p14l1848t1696r2025b1722],
2	—	CD	NUMBER	—	num	5	SENT_540	[p14l1848t1696r2025b1722],
3	67	CD	NUMBER	67	num	5	SENT_540	[p14l1848t1696r2025b1722],
4	Choi	NNP	O	Choi	nn	5	SENT_540	[p14l643t1740r712b1766],
5	MK	NNP	O	MK	nsubj	8	SENT_540	[p14l719t1741r784b1771],
6	,	,	O	,	_	0	SENT_540	[p14l719t1741r784b1771],
7	Song	NN	O	song	appos	5	SENT_540	[p14l795t1741r865b1774],
8	IS	VBZ	O	be	_	0	SENT_540	[p14l873t1741r909b1766],
9	.	.	O	.	_	0	SENT_540	[p14l873t1741r909b1766],

1	2008	CD	DATE	2008	_	0	SENT_541	[p14l920t1741r994b1765],
2	.	.	O	.	_	0	SENT_541	[p14l920t1741r994b1765],

1	Organic	NNP	O	Organic	_	0	SENT_542	[p14l1005t1741r1118b1774],
2	cation	NN	O	cation	nn	3	SENT_542	[p14l1127t1741r1211b1766],
3	transporters	NNS	O	transporter	dep	1	SENT_542	[p14l1219t1747r1388b1774],
4	and	CC	O	and	_	0	SENT_542	[p14l1397t1740r1446b1766],
5	their	PRP$	O	they	poss	6	SENT_542	[p14l1455t1740r1521b1766],
6	pharmacokinetic	JJ	O	pharmacokinetic	dep	1	SENT_542	[p14l1529t1740r1761b1774],
7	and	CC	O	and	_	0	SENT_542	[p14l1770t1740r1819b1766],
8	pharmacodynamic	JJ	O	pharmacodynamic	amod	9	SENT_542	[p14l1828t1740r2085b1774],
9	consequences	NNS	O	consequence	conj_and	3	SENT_542	[p14l643t1795r839b1820],
10	.	.	O	.	_	0	SENT_542	[p14l643t1795r839b1820],

1	Drug	NN	O	drug	_	0	SENT_543	[p14l850t1787r923b1820],
2	Metab	NNP	O	Metab	dep	1	SENT_543	[p14l929t1786r1020b1811],
3	.	.	O	.	_	0	SENT_543	[p14l929t1786r1020b1811],

1	Plmrrrmco/einet	NN	O	plmrrrmco/einet	_	0	SENT_544	[p14l1031t1786r1232b1811],
2	.	.	O	.	_	0	SENT_544	[p14l1031t1786r1232b1811],

1	2	CD	NUMBER	2	number	2	SENT_545	[p14l1245t1787r1258b1811],
2	3	CD	NUMBER	3	_	0	SENT_545	[p14l1263t1787r1275b1811],
3	:243	CD	NUMBER	:243	num	4	SENT_545	[p14l1281t1787r1370b1811],
4	—	NN	O	—	dep	2	SENT_545	[p14l1281t1787r1370b1811],
5	5	CD	NUMBER	5	number	6	SENT_545	[p14l1281t1787r1370b1811],
6	3	CD	NUMBER	3	amod	2	SENT_545	[p14l1375t1787r1386b1811],
7	.	.	O	.	_	0	SENT_545	[p14l619t1851r623b1855],

1	Koepsell	NNP	PERSON	Koepsell	nn	2	SENT_546	[p14l643t1829r764b1864],
2	H	NNP	O	H	_	0	SENT_546	[p14l773t1831r808b1861],
3	,	,	O	,	_	0	SENT_546	[p14l773t1831r808b1861],
4	Lips	NNP	ORGANIZATION	Lips	nn	8	SENT_546	[p14l819t1831r879b1864],
5	K	NNP	ORGANIZATION	K	nn	8	SENT_546	[p14l889t1831r920b1861],
6	,	,	O	,	_	0	SENT_546	[p14l889t1831r920b1861],
7	Volk	NNP	PERSON	Volk	appos	8	SENT_546	[p14l929t1829r999b1855],
8	C.	NNP	O	C.	appos	2	SENT_546	[p14l1008t1830r1038b1855],
9	2007	CD	DATE	2007	num	8	SENT_546	[p14l1049t1830r1124b1856],
10	.	.	O	.	_	0	SENT_546	[p14l1049t1830r1124b1856],

1	Polyspeciﬁc	NNP	MISC	Polyspeciﬁc	_	0	SENT_547	[p14l1134t1829r1301b1864],
2	organic	JJ	O	organic	amod	4	SENT_547	[p14l1310t1831r1414b1864],
3	cation	NN	O	cation	nn	4	SENT_547	[p14l1423t1831r1508b1855],
4	transporters	NNS	O	transporter	dep	1	SENT_547	[p14l1517t1837r1693b1864],
5	:	:	O	:	_	0	SENT_547	[p14l1517t1837r1693b1864],
6	structure	NN	O	structure	dep	1	SENT_547	[p14l1704t1837r1836b1861],
7	,	,	O	,	_	0	SENT_547	[p14l1704t1837r1836b1861],
8	function	NN	O	function	dep	1	SENT_547	[p14l1846t1830r1970b1861],
9	,	,	O	,	_	0	SENT_547	[p14l1846t1830r1970b1861],
10	physiological	JJ	O	physiological	amod	11	SENT_547	[p14l1981t1829r2084b1864, p14l643t1875r734b1910],
11	roles	NNS	O	role	dep	1	SENT_547	[p14l743t1875r817b1907],
12	,	,	O	,	_	0	SENT_547	[p14l743t1875r817b1907],
13	and	CC	O	and	_	0	SENT_547	[p14l829t1875r878b1901],
14	biopharmaceutical	JJ	O	biopharmaceutical	amod	15	SENT_547	[p14l888t1875r1145b1910],
15	implications	NNS	O	implication	dep	1	SENT_547	[p14l1155t1875r1333b1910],
16	.	.	O	.	_	0	SENT_547	[p14l1155t1875r1333b1910],

1	Pbmm	NN	O	pbmm	_	0	SENT_548	[p14l1343t1876r1440b1901],
2	.	.	O	.	_	0	SENT_548	[p14l1343t1876r1440b1901],

1	Rex	NN	PERSON	rex	_	0	SENT_549	[p14l1451t1877r1500b1901],
2	.	.	O	.	_	0	SENT_549	[p14l1451t1877r1500b1901],

1	24	CD	NUMBER	24	_	0	SENT_550	[p14l1513t1876r1671b1902],
2	:	:	O	:	_	0	SENT_550	[p14l1513t1876r1671b1902],
3	l227	CD	NUMBER	l227	num	5	SENT_550	[p14l1513t1876r1671b1902],
4	—	CD	NUMBER	—	num	5	SENT_550	[p14l1513t1876r1671b1902],
5	5l	NN	O	5l	dep	1	SENT_550	[p14l1513t1876r1671b1902],
6	.	.	O	.	_	0	SENT_550	[p14l619t1941r623b1945],

1	Nies	NNPS	PERSON	Nies	_	0	SENT_551	[p14l642t1921r707b1946],
2	AT	IN	O	at	prep	1	SENT_551	[p14l715t1920r771b1951],
3	,	,	O	,	_	0	SENT_551	[p14l715t1920r771b1951],
4	Koepsell	NNP	PERSON	Koepsell	nn	5	SENT_551	[p14l781t1920r902b1954],
5	H	NNP	PERSON	H	appos	1	SENT_551	[p14l911t1921r946b1951],
6	,	,	O	,	_	0	SENT_551	[p14l911t1921r946b1951],
7	Winter	NNP	DATE	Winter	nn	8	SENT_551	[p14l956t1921r1059b1946],
8	S	NNP	O	S	appos	1	SENT_551	[p14l1069t1921r1092b1951],
9	,	,	O	,	_	0	SENT_551	[p14l1069t1921r1092b1951],
10	Burk	NNP	PERSON	Burk	nn	11	SENT_551	[p14l1103t1920r1172b1946],
11	O	NNP	PERSON	O	appos	1	SENT_551	[p14l1180t1921r1213b1951],
12	,	,	O	,	_	0	SENT_551	[p14l1180t1921r1213b1951],
13	Klein	NNP	PERSON	Klein	nn	14	SENT_551	[p14l1224t1920r1300b1946],
14	K	NNP	PERSON	K	appos	1	SENT_551	[p14l1309t1921r1340b1951],
15	,	,	O	,	_	0	SENT_551	[p14l1309t1921r1340b1951],
16	et	FW	O	et	nn	17	SENT_551	[p14l1351t1927r1377b1946],
17	al.	FW	O	al.	appos	1	SENT_551	[p14l1386t1920r1415b1946],
18	2009	CD	DATE	2009	dep	17	SENT_551	[p14l1426t1921r1500b1946],
19	.	.	O	.	_	0	SENT_551	[p14l1426t1921r1500b1946],

1	Expression	NN	O	expression	nsubjpass	16	SENT_552	[p14l1511t1921r1664b1954],
2	of	IN	O	of	_	0	SENT_552	[p14l1673t1920r1704b1946],
3	organic	JJ	O	organic	amod	5	SENT_552	[p14l1709t1921r1813b1954],
4	cation	NN	O	cation	nn	5	SENT_552	[p14l1822t1921r1907b1946],
5	transporters	NNS	O	transporter	prep_of	1	SENT_552	[p14l1916t1927r2084b1954],
6	OCTl	NN	O	octl	nn	9	SENT_552	[p14l643t1966r734b1992],
7	(	CD	NUMBER	(	num	9	SENT_552	[p14l748t1967r907b1998],
8	SLC22Al	NN	O	slc22al	nn	9	SENT_552	[p14l748t1967r907b1998],
9	)	NN	O	)	dep	5	SENT_552	[p14l748t1967r907b1998],
10	and	CC	O	and	_	0	SENT_552	[p14l918t1966r967b1992],
11	OCT3	NN	O	oct3	nn	14	SENT_552	[p14l978t1966r1069b1992],
12	(	CD	NUMBER	(	num	14	SENT_552	[p14l1083t1967r1242b1998],
13	SLC22A3	NN	O	slc22a3	nn	14	SENT_552	[p14l1083t1967r1242b1998],
14	)	NN	O	)	conj_and	5	SENT_552	[p14l1083t1967r1242b1998],
15	is	VBZ	O	be	auxpass	16	SENT_552	[p14l1252t1967r1272b1992],
16	affected	VBN	O	affect	_	0	SENT_552	[p14l1283t1966r1390b1992],
17	by	IN	O	by	_	0	SENT_552	[p14l1400t1966r1434b2000],
18	genetic	JJ	O	genetic	amod	19	SENT_552	[p14l1443t1967r1543b2000],
19	factors	NNS	O	factor	agent	16	SENT_552	[p14l1553t1966r1646b1992],
20	and	CC	O	and	_	0	SENT_552	[p14l1656t1966r1706b1992],
21	cholestasis	NN	O	cholestasis	agent	16	SENT_552	[p14l1716t1966r1862b1992],
22	in	IN	O	in	_	0	SENT_552	[p14l1872t1967r1899b1991],
23	human	JJ	O	human	amod	24	SENT_552	[p14l1909t1966r2005b1992],
24	liver	NN	O	liver	prep_in	16	SENT_552	[p14l2015t1966r2083b1992],
25	.	.	O	.	_	0	SENT_552	[p14l2015t1966r2083b1992],

1	Hepzztology	NNP	O	Hepzztology	_	0	SENT_553	[p14l642t2012r784b2047],
2	50	CD	NUMBER	50	num	1	SENT_553	[p14l796t2013r956b2038],
3	:	:	O	:	_	0	SENT_553	[p14l796t2013r956b2038],
4	l227	CD	NUMBER	l227	num	5	SENT_553	[p14l796t2013r956b2038],
5	—	CD	NUMBER	—	dep	1	SENT_553	[p14l796t2013r956b2038],
6	40	CD	NUMBER	40	num	8	SENT_553	[p14l796t2013r956b2038],
7	Kirpichnikov	NN	O	kirpichnikov	nn	8	SENT_553	[p14l643t2056r828b2090],
8	D	NN	O	d	dep	1	SENT_553	[p14l837t2057r870b2088],
9	,	,	O	,	_	0	SENT_553	[p14l837t2057r870b2088],
10	McFarlane	NNP	PERSON	McFarlane	nn	11	SENT_553	[p14l880t2056r1033b2082],
11	SI	NNP	O	SI	appos	1	SENT_553	[p14l1044t2057r1080b2088],
12	,	,	O	,	_	0	SENT_553	[p14l1044t2057r1080b2088],
13	Sowers	NNP	O	Sowers	nn	14	SENT_553	[p14l1092t2057r1189b2082],
14	JR.	NNP	O	JR.	appos	1	SENT_553	[p14l1195t2057r1241b2088],
15	2002	CD	DATE	2002	dep	14	SENT_553	[p14l1253t2058r1327b2082],
16	.	.	O	.	_	0	SENT_553	[p14l1253t2058r1327b2082],

1	Metformin	NNP	O	Metformin	_	0	SENT_554	[p14l1337t2056r1499b2082],
2	:	:	O	:	_	0	SENT_554	[p14l1337t2056r1499b2082],
3	an	DT	O	a	nsubj	4	SENT_554	[p14l1511t2066r1543b2082],
4	update	VBP	O	update	dep	1	SENT_554	[p14l1552t2056r1653b2090],
5	.	.	O	.	_	0	SENT_554	[p14l1552t2056r1653b2090],

1	Ann	NNP	PERSON	Ann	_	0	SENT_555	[p14l1662t2057r1726b2082],
2	.	.	O	.	_	0	SENT_555	[p14l1662t2057r1726b2082],

1	Intern	NNP	O	Intern	_	0	SENT_556	[p14l1738t2057r1826b2082],
2	.	.	O	.	_	0	SENT_556	[p14l1738t2057r1826b2082],

1	Med	NNP	O	Med	_	0	SENT_557	[p14l1837t2057r1902b2082],
2	.	.	O	.	_	0	SENT_557	[p14l1837t2057r1902b2082],

1	137:25	CD	NUMBER	137:25	_	0	SENT_558	[p14l1918t2057r2056b2082],
2	—	CD	NUMBER	—	number	3	SENT_558	[p14l1918t2057r2056b2082],
3	33	CD	NUMBER	33	num	1	SENT_558	[p14l1918t2057r2056b2082],
4	.	.	O	.	_	0	SENT_558	[p14l619t2122r623b2126],

1	Kerb	NNP	MISC	Kerb	nn	2	SENT_559	[p14l643t2101r712b2127],
2	R	NNP	O	R	_	0	SENT_559	[p14l728t2102r757b2132],
3	,	,	O	,	_	0	SENT_559	[p14l728t2102r757b2132],
4	Brinkmann	NNP	ORGANIZATION	Brinkmann	nn	5	SENT_559	[p14l774t2101r930b2127],
5	U	NNP	ORGANIZATION	U	appos	2	SENT_559	[p14l945t2102r979b2132],
6	,	,	O	,	_	0	SENT_559	[p14l945t2102r979b2132],
7	Chatskaia	NNP	ORGANIZATION	Chatskaia	nn	8	SENT_559	[p14l995t2100r1131b2127],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_559	[p14l1145t2102r1181b2132],
9	,	,	O	,	_	0	SENT_559	[p14l1145t2102r1181b2132],
10	Gorbunov	NNP	PERSON	Gorbunov	nn	11	SENT_559	[p14l1197t2101r1342b2127],
11	D	NNP	O	D	appos	2	SENT_559	[p14l1356t2102r1390b2132],
12	,	,	O	,	_	0	SENT_559	[p14l1356t2102r1390b2132],
13	Gorboulev	NNP	O	Gorboulev	nn	14	SENT_559	[p14l1406t2101r1558b2127],
14	V	NNP	O	V	appos	2	SENT_559	[p14l1570t2102r1602b2132],
15	,	,	O	,	_	0	SENT_559	[p14l1570t2102r1602b2132],
16	et	FW	O	et	nn	17	SENT_559	[p14l1619t2108r1644b2127],
17	al.	FW	O	al.	appos	2	SENT_559	[p14l1658t2100r1688b2127],
18	2002	CD	DATE	2002	dep	17	SENT_559	[p14l1704t2102r1779b2126],
19	.	.	O	.	_	0	SENT_559	[p14l1704t2102r1779b2126],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_560	[p14l1795t2100r1984b2127],
2	of	IN	O	of	_	0	SENT_560	[p14l1998t2101r2029b2127],
3	genetic	JJ	O	genetic	amod	4	SENT_560	[p14l2040t2110r2084b2135, p14l642t2148r711b2172],
4	variations	NNS	O	variation	prep_of	1	SENT_560	[p14l722t2148r858b2172],
5	of	IN	O	of	_	0	SENT_560	[p14l872t2147r903b2172],
6	the	DT	O	the	det	11	SENT_560	[p14l912t2146r955b2172],
7	human	JJ	O	human	amod	11	SENT_560	[p14l969t2146r1065b2172],
8	organic	JJ	O	organic	amod	11	SENT_560	[p14l1079t2148r1183b2181],
9	cation	NN	O	cation	nn	11	SENT_560	[p14l1196t2148r1281b2172],
10	transporter	NN	O	transporter	nn	11	SENT_560	[p14l1294t2154r1451b2180],
11	hOCT1	NN	O	hoct1	prep_of	1	SENT_560	[p14l1463t2146r1573b2172],
12	and	CC	O	and	_	0	SENT_560	[p14l1590t2146r1640b2172],
13	their	PRP$	O	they	poss	15	SENT_560	[p14l1653t2146r1719b2172],
14	functional	JJ	O	functional	amod	15	SENT_560	[p14l1732t2146r1873b2172],
15	consequences	NNS	O	consequence	conj_and	11	SENT_560	[p14l1887t2156r2083b2181],
16	.	.	O	.	_	0	SENT_560	[p14l1887t2156r2083b2181],

1	Plmrmacageneticx	NNP	O	Plmrmacageneticx	_	0	SENT_561	[p14l642t2193r870b2227],
2	12	CD	NUMBER	12	num	1	SENT_561	[p14l882t2194r909b2217],
3	:5	CD	NUMBER	:5	number	4	SENT_561	[p14l915t2193r936b2218],
4	9	CD	NUMBER	9	dep	1	SENT_561	[p14l939t2194r954b2218],
5	1-95	CD	NUMBER	1-95	num	7	SENT_561	[p14l959t2193r1021b2218],
6	Sakata	NNP	ORGANIZATION	Sakata	nn	7	SENT_561	[p14l644t2236r732b2262],
7	T	NN	ORGANIZATION	t	dep	1	SENT_561	[p14l741t2237r774b2268],
8	,	,	O	,	_	0	SENT_561	[p14l741t2237r774b2268],
9	Anzai	NNP	PERSON	Anzai	nn	10	SENT_561	[p14l784t2237r863b2262],
10	N	NNP	O	N	appos	7	SENT_561	[p14l873t2238r909b2268],
11	,	,	O	,	_	0	SENT_561	[p14l873t2238r909b2268],
12	Shin	NNP	PERSON	Shin	nn	13	SENT_561	[p14l921t2236r983b2262],
13	HJ	NNP	PERSON	HJ	appos	7	SENT_561	[p14l993t2238r1041b2269],
14	,	,	O	,	_	0	SENT_561	[p14l993t2238r1041b2269],
15	Noshiro	NNP	LOCATION	Noshiro	nn	16	SENT_561	[p14l1051t2236r1168b2262],
16	R	NNP	O	R	appos	7	SENT_561	[p14l1179t2238r1208b2268],
17	,	,	O	,	_	0	SENT_561	[p14l1179t2238r1208b2268],
18	Hirata	NNP	PERSON	Hirata	nn	19	SENT_561	[p14l1219t2238r1310b2262],
19	T	NN	O	t	appos	7	SENT_561	[p14l1319t2237r1352b2268],
20	,	,	O	,	_	0	SENT_561	[p14l1319t2237r1352b2268],
21	et	FW	O	et	nn	22	SENT_561	[p14l1364t2244r1389b2262],
22	al.	FW	O	al.	appos	7	SENT_561	[p14l1399t2236r1428b2262],
23	2004	CD	DATE	2004	dep	22	SENT_561	[p14l1440t2238r1515b2262],
24	.	.	O	.	_	0	SENT_561	[p14l1440t2238r1515b2262],

1	Novel	JJ	O	novel	amod	4	SENT_562	[p14l1526t2236r1612b2262],
2	single	JJ	O	single	amod	4	SENT_562	[p14l1622t2236r1702b2271],
3	nucleotide	NN	O	nucleotide	nn	4	SENT_562	[p14l1712t2236r1858b2262],
4	polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_562	[p14l1868t2236r2084b2271],
5	of	IN	O	of	_	0	SENT_562	[p14l643t2282r674b2308],
6	organic	JJ	O	organic	amod	7	SENT_562	[p14l679t2283r783b2316],
7	cation	NN	O	cation	prep_of	4	SENT_562	[p14l792t2283r877b2308],
8	transporter	NN	O	transporter	_	0	SENT_562	[p14l886t2289r1043b2316],
9	1	CD	NUMBER	1	number	10	SENT_562	[p14l1055t2284r1064b2307],
10	(	CD	NUMBER	(	num	12	SENT_562	[p14l1077t2283r1236b2314],
11	SLC22A1	NN	O	slc22a1	nn	12	SENT_562	[p14l1077t2283r1236b2314],
12	)	NN	O	)	dobj	8	SENT_562	[p14l1077t2283r1236b2314],
13	alfecting	VBG	O	alfect	partmod	12	SENT_562	[p14l1246t2282r1366b2316],
14	transport	NN	O	transport	nn	15	SENT_562	[p14l1374t2289r1503b2316],
15	functions	NNS	O	function	dobj	13	SENT_562	[p14l1511t2282r1647b2308],
16	.	.	O	.	_	0	SENT_562	[p14l1511t2282r1647b2308],

1	Biacbem	NNP	O	Biacbem	_	0	SENT_563	[p14l1657t2283r1770b2308],
2	.	.	O	.	_	0	SENT_563	[p14l1657t2283r1770b2308],

1	Biop/Jys	NNS	O	biop/jys	_	0	SENT_564	[p14l1782t2283r1884b2316],
2	.	.	O	.	_	0	SENT_564	[p14l1782t2283r1884b2316],

1	Rex	NN	PERSON	rex	_	0	SENT_565	[p14l1895t2283r1944b2308],
2	.	.	O	.	_	0	SENT_565	[p14l1895t2283r1944b2308],

1	Commun	NNP	O	Commun	_	0	SENT_566	[p14l1957t2283r2082b2308],
2	.	.	O	.	_	0	SENT_566	[p14l1957t2283r2082b2308],

1	3	CD	NUMBER	3	num	4	SENT_567	[p14l644t2329r656b2353],
2	132789-93	CD	NUMBER	132789-93	num	4	SENT_567	[p14l663t2328r802b2354],
3	Chen	NNP	O	Chen	nn	4	SENT_567	[p14l643t2372r719b2398],
4	L	NNP	O	L	_	0	SENT_567	[p14l731t2373r760b2403],
5	,	,	O	,	_	0	SENT_567	[p14l731t2373r760b2403],
6	Takizawa	NNP	PERSON	Takizawa	nn	7	SENT_567	[p14l773t2372r906b2398],
7	M	NNP	PERSON	M	appos	4	SENT_567	[p14l917t2373r957b2403],
8	,	,	O	,	_	0	SENT_567	[p14l917t2373r957b2403],
9	Chen	NNP	PERSON	Chen	nn	10	SENT_567	[p14l971t2372r1047b2398],
10	E	NNP	PERSON	E	appos	4	SENT_567	[p14l1059t2373r1088b2403],
11	,	,	O	,	_	0	SENT_567	[p14l1059t2373r1088b2403],
12	Schlessinger	NNP	PERSON	Schlessinger	nn	13	SENT_567	[p14l1102t2372r1275b2406],
13	A	NNP	O	A	appos	4	SENT_567	[p14l1285t2373r1314b2403],
14	,	,	O	,	_	0	SENT_567	[p14l1285t2373r1314b2403],
15	Segenthelar	NNP	O	Segenthelar	nn	16	SENT_567	[p14l1329t2372r1494b2406],
16	J	NNP	O	J	appos	4	SENT_567	[p14l1502t2373r1524b2404],
17	,	,	O	,	_	0	SENT_567	[p14l1502t2373r1524b2404],
18	et	FW	O	et	nn	19	SENT_567	[p14l1538t2379r1564b2398],
19	al.	FW	O	al.	appos	4	SENT_567	[p14l1575t2372r1605b2398],
20	2010	CD	DATE	2010	dep	19	SENT_567	[p14l1619t2373r1693b2398],
21	.	.	O	.	_	0	SENT_567	[p14l1619t2373r1693b2398],

1	Genetic	JJ	O	genetic	amod	2	SENT_568	[p14l1708t2373r1818b2398],
2	polymorphisms	NNS	O	polymorphism	nsubj	16	SENT_568	[p14l1830t2372r2045b2406],
3	in	IN	O	in	_	0	SENT_568	[p14l2058t2373r2085b2397],
4	organic	JJ	O	organic	amod	6	SENT_568	[p14l643t2419r747b2452],
5	cation	NN	O	cation	nn	6	SENT_568	[p14l762t2419r846b2443],
6	transporter	NN	O	transporter	prep_in	2	SENT_568	[p14l861t2425r1018b2451],
7	1	CD	NUMBER	1	number	8	SENT_568	[p14l1035t2419r1045b2443],
8	(	CD	NUMBER	(	num	10	SENT_568	[p14l1064t2418r1178b2449],
9	OCT1	NN	O	oct1	nn	10	SENT_568	[p14l1064t2418r1178b2449],
10	)	NN	O	)	dep	6	SENT_568	[p14l1064t2418r1178b2449],
11	in	IN	O	in	_	0	SENT_568	[p14l1193t2419r1220b2443],
12	Chinese	JJ	MISC	chinese	amod	15	SENT_568	[p14l1235t2417r1347b2443],
13	and	CC	O	and	_	0	SENT_568	[p14l1363t2417r1412b2443],
14	Japanese	JJ	MISC	japanese	conj_and	12	SENT_568	[p14l1423t2418r1547b2451],
15	populations	NNS	O	population	prep_in	10	SENT_568	[p14l1561t2417r1724b2451],
16	exhibit	VBP	O	exhibit	_	0	SENT_568	[p14l1740t2417r1835b2443],
17	altered	JJ	O	altered	amod	18	SENT_568	[p14l1849t2417r1944b2443],
18	function	NN	O	function	dobj	16	SENT_568	[p14l1959t2417r2083b2443],
19	.	.	O	.	_	0	SENT_568	[p14l1959t2417r2083b2443],

1	j	NN	O	j	_	0	SENT_569	[p14l638t2463r663b2497],
2	"	''	O	"	punct	1	SENT_569	[p14l638t2463r663b2497],
3	.	.	O	.	_	0	SENT_569	[p14l638t2463r663b2497],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_570	[p14l675t2464r819b2489],
2	.	.	O	.	_	0	SENT_570	[p14l675t2464r819b2489],

1	Exp	NN	O	exp	_	0	SENT_571	[p14l831t2464r888b2497],
2	.	.	O	.	_	0	SENT_571	[p14l831t2464r888b2497],

1	Ther	NNP	O	Ther	_	0	SENT_572	[p14l902t2464r970b2489],
2	.	.	O	.	_	0	SENT_572	[p14l902t2464r970b2489],

1	335	CD	NUMBER	335	number	2	SENT_573	[p14l984t2464r1031b2489],
2	:42	CD	NUMBER	:42	num	3	SENT_573	[p14l1036t2464r1126b2489],
3	—	NN	O	—	_	0	SENT_573	[p14l1036t2464r1126b2489],
4	50	CD	NUMBER	50	num	6	SENT_573	[p14l1036t2464r1126b2489],
5	Leabman	NNP	ORGANIZATION	Leabman	nn	6	SENT_573	[p14l643t2507r773b2533],
6	MK	NNP	ORGANIZATION	MK	dep	3	SENT_573	[p14l783t2508r847b2539],
7	,	,	O	,	_	0	SENT_573	[p14l783t2508r847b2539],
8	Huang	NNP	ORGANIZATION	Huang	nn	9	SENT_573	[p14l859t2508r956b2542],
9	CC	NN	ORGANIZATION	cc	appos	6	SENT_573	[p14l967t2508r1023b2539],
10	,	,	O	,	_	0	SENT_573	[p14l967t2508r1023b2539],
11	Kawamoto	NNP	PERSON	Kawamoto	nn	12	SENT_573	[p14l1035t2508r1186b2533],
12	M	NNP	O	M	appos	6	SENT_573	[p14l1196t2508r1235b2539],
13	,	,	O	,	_	0	SENT_573	[p14l1196t2508r1235b2539],
14	Johns	NNP	PERSON	Johns	nn	15	SENT_573	[p14l1243t2507r1325b2539],
15	SJ	NNP	PERSON	SJ	appos	6	SENT_573	[p14l1338t2508r1373b2540],
16	,	,	O	,	_	0	SENT_573	[p14l1338t2508r1373b2540],
17	Stryke	NNP	PERSON	Stryke	nn	18	SENT_573	[p14l1386t2507r1474b2542],
18	D	NNP	PERSON	D	appos	6	SENT_573	[p14l1486t2508r1519b2539],
19	,	,	O	,	_	0	SENT_573	[p14l1486t2508r1519b2539],
20	et	FW	O	et	nn	21	SENT_573	[p14l1532t2515r1558b2533],
21	al.	FW	O	al.	appos	6	SENT_573	[p14l1568t2507r1597b2533],
22	2002	CD	DATE	2002	dep	21	SENT_573	[p14l1610t2509r1685b2533],
23	.	.	O	.	_	0	SENT_573	[p14l1610t2509r1685b2533],

1	Polymorphisms	NNS	O	polymorphism	nsubj	11	SENT_574	[p14l1697t2507r1915b2542],
2	in	IN	O	in	_	0	SENT_574	[p14l1926t2509r1953b2533],
3	a	DT	O	a	det	7	SENT_574	[p14l1965t2517r1977b2533],
4	human	JJ	O	human	amod	7	SENT_574	[p14l1988t2507r2084b2533],
5	kidney	NN	O	kidney	nn	7	SENT_574	[p14l642t2553r736b2587],
6	xenobiotic	JJ	O	xenobiotic	amod	7	SENT_574	[p14l744t2553r890b2579],
7	transporter	NN	O	transporter	prep_in	1	SENT_574	[p14l900t2560r1063b2587],
8	,	,	O	,	_	0	SENT_574	[p14l900t2560r1063b2587],
9	OCT2	NN	O	oct2	appos	1	SENT_574	[p14l1075t2554r1177b2584],
10	,	,	O	,	_	0	SENT_574	[p14l1075t2554r1177b2584],
11	exhibit	VBP	O	exhibit	_	0	SENT_574	[p14l1188t2553r1283b2579],
12	altered	JJ	O	altered	amod	13	SENT_574	[p14l1293t2553r1388b2579],
13	function	NN	O	function	dobj	11	SENT_574	[p14l1398t2553r1522b2579],
14	.	.	O	.	_	0	SENT_574	[p14l1398t2553r1522b2579],

1	Plmrmacogeneticx	NN	O	plmrmacogeneticx	nn	2	SENT_575	[p14l1532t2554r1760b2588],
2	l2	NN	O	l2	_	0	SENT_575	[p14l1772t2554r1928b2579],
3	:395	CD	NUMBER	:395	num	6	SENT_575	[p14l1772t2554r1928b2579],
4	-405	CD	NUMBER	-405	num	6	SENT_575	[p14l1772t2554r1928b2579],
5	Ogasawara	NNP	ORGANIZATION	Ogasawara	nn	6	SENT_575	[p14l643t2598r794b2632],
6	K	NNP	ORGANIZATION	K	dep	2	SENT_575	[p14l800t2599r832b2629],
7	,	,	O	,	_	0	SENT_575	[p14l800t2599r832b2629],
8	Terada	NNP	PERSON	Terada	nn	9	SENT_575	[p14l838t2597r939b2623],
9	T	NN	O	t	appos	6	SENT_575	[p14l945t2598r978b2629],
10	,	,	O	,	_	0	SENT_575	[p14l945t2598r978b2629],
11	Motohashi	NNP	PERSON	Motohashi	nn	12	SENT_575	[p14l984t2597r1136b2623],
12	H	NNP	O	H	appos	6	SENT_575	[p14l1142t2599r1178b2629],
13	,	,	O	,	_	0	SENT_575	[p14l1142t2599r1178b2629],
14	AsakaJ	NNP	O	AsakaJ	appos	6	SENT_575	[p14l1184t2597r1289b2630],
15	,	,	O	,	_	0	SENT_575	[p14l1184t2597r1289b2630],
16	Aoki	NNP	PERSON	Aoki	nn	17	SENT_575	[p14l1296t2597r1361b2623],
17	M	NNP	O	M	appos	6	SENT_575	[p14l1366t2599r1406b2629],
18	,	,	O	,	_	0	SENT_575	[p14l1366t2599r1406b2629],
19	et	FW	O	et	nn	20	SENT_575	[p14l1414t2605r1440b2623],
20	al.	FW	O	al.	appos	6	SENT_575	[p14l1445t2597r1475b2623],
21	2008	CD	DATE	2008	dep	20	SENT_575	[p14l1483t2599r1557b2623],
22	.	.	O	.	_	0	SENT_575	[p14l1483t2599r1557b2623],

1	Analysis	NN	O	analysis	nsubj	10	SENT_576	[p14l1564t2597r1678b2632],
2	of	IN	O	of	_	0	SENT_576	[p14l1685t2598r1716b2623],
3	regulatory	JJ	O	regulatory	amod	4	SENT_576	[p14l1718t2597r1864b2632],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_576	[p14l1868t2597r2084b2632],
5	in	IN	O	in	_	0	SENT_576	[p14l643t2645r669b2669],
6	organic	JJ	O	organic	amod	9	SENT_576	[p14l679t2645r783b2678],
7	ion	NN	O	ion	nn	9	SENT_576	[p14l793t2645r837b2669],
8	transporter	NN	O	transporter	nn	9	SENT_576	[p14l847t2651r1004b2677],
9	genes	NNS	O	gene	prep_in	4	SENT_576	[p14l1013t2653r1090b2678],
10	(	VBP	O	(	_	0	SENT_576	[p14l1101t2644r1243b2675],
11	SLC22A	NN	O	slc22a	nn	12	SENT_576	[p14l1101t2644r1243b2675],
12	)	NN	O	)	dobj	10	SENT_576	[p14l1101t2644r1243b2675],
13	in	IN	O	in	_	0	SENT_576	[p14l1253t2645r1280b2669],
14	the	DT	O	the	det	15	SENT_576	[p14l1289t2643r1333b2669],
15	kidney	NN	O	kidney	prep_in	12	SENT_576	[p14l1343t2643r1474b2678],
16	.	.	O	.	_	0	SENT_576	[p14l1343t2643r1474b2678],

1	Hum	NNP	O	Hum	_	0	SENT_577	[p14l1486t2644r1561b2669],
2	.	.	O	.	_	0	SENT_577	[p14l1486t2644r1561b2669],

1	Genet	NNP	PERSON	Genet	_	0	SENT_578	[p14l1575t2644r1656b2669],
2	.	.	O	.	_	0	SENT_578	[p14l1575t2644r1656b2669],

1	53:607	CD	NUMBER	53:607	num	2	SENT_579	[p14l1670t2644r1814b2669],
2	—	CD	NUMBER	—	_	0	SENT_579	[p14l1670t2644r1814b2669],
3	14	CD	NUMBER	14	num	5	SENT_579	[p14l1670t2644r1814b2669],
4	Sakata	NNP	ORGANIZATION	Sakata	nn	5	SENT_579	[p14l644t2688r732b2714],
5	T	NN	ORGANIZATION	t	dep	2	SENT_579	[p14l740t2688r773b2719],
6	,	,	O	,	_	0	SENT_579	[p14l740t2688r773b2719],
7	Anzai	NNP	ORGANIZATION	Anzai	nn	8	SENT_579	[p14l783t2689r862b2714],
8	N	NNP	ORGANIZATION	N	appos	5	SENT_579	[p14l870t2689r906b2719],
9	,	,	O	,	_	0	SENT_579	[p14l870t2689r906b2719],
10	Kimura	NNP	ORGANIZATION	Kimura	nn	11	SENT_579	[p14l916t2689r1023b2714],
11	T	NN	ORGANIZATION	t	appos	5	SENT_579	[p14l1031t2688r1064b2719],
12	,	,	O	,	_	0	SENT_579	[p14l1031t2688r1064b2719],
13	Miura	NNP	ORGANIZATION	Miura	nn	14	SENT_579	[p14l1073t2689r1160b2714],
14	D	NNP	ORGANIZATION	D	appos	5	SENT_579	[p14l1170t2689r1204b2719],
15	,	,	O	,	_	0	SENT_579	[p14l1170t2689r1204b2719],
16	Fukutomi	NNP	ORGANIZATION	Fukutomi	nn	17	SENT_579	[p14l1214t2688r1351b2714],
17	T	NN	ORGANIZATION	t	appos	5	SENT_579	[p14l1360t2688r1392b2719],
18	,	,	O	,	_	0	SENT_579	[p14l1360t2688r1392b2719],
19	et	FW	O	et	nn	20	SENT_579	[p14l1403t2695r1429b2714],
20	al.	FW	O	al.	appos	5	SENT_579	[p14l1438t2688r1467b2714],
21	2010	CD	DATE	2010	dep	20	SENT_579	[p14l1478t2689r1553b2714],
22	.	.	O	.	_	0	SENT_579	[p14l1478t2689r1553b2714],

1	Functional	JJ	O	functional	amod	2	SENT_580	[p14l1564t2688r1714b2714],
2	analysis	NN	O	analysis	_	0	SENT_580	[p14l1724t2688r1829b2722],
3	of	IN	O	of	_	0	SENT_580	[p14l1839t2688r1870b2714],
4	human	JJ	O	human	amod	8	SENT_580	[p14l1875t2688r1971b2714],
5	organic	JJ	O	organic	amod	8	SENT_580	[p14l1981t2689r2084b2722],
6	cation	NN	O	cation	nn	8	SENT_580	[p14l643t2735r728b2759],
7	transporter	NN	O	transporter	nn	8	SENT_580	[p14l738t2741r894b2768],
8	OCT3	NN	O	oct3	prep_of	2	SENT_580	[p14l904t2734r995b2760],
9	(	CD	NUMBER	(	num	10	SENT_580	[p14l1009t2734r1168b2766],
10	SLC22A3	NN	O	slc22a3	dep	2	SENT_580	[p14l1009t2734r1168b2766],
11	)	CD	NUMBER	)	num	12	SENT_580	[p14l1009t2734r1168b2766],
12	polymorphisms	NNS	O	polymorphism	dep	10	SENT_580	[p14l1178t2733r1433b2768],
13	.	.	O	.	_	0	SENT_580	[p14l1178t2733r1433b2768],

1	Plmrmacol	NNP	O	Plmrmacol	_	0	SENT_581	[p14l1445t2734r1589b2759],
2	.	.	O	.	_	0	SENT_581	[p14l1445t2734r1589b2759],

1	Sci	NNP	O	Sci	_	0	SENT_582	[p14l1601t2734r1644b2759],
2	.	.	O	.	_	0	SENT_582	[p14l1601t2734r1644b2759],

1	l13	NN	O	l13	_	0	SENT_583	[p14l1660t2735r1818b2760],
2	:263	CD	NUMBER	:263	number	3	SENT_583	[p14l1660t2735r1818b2760],
3	—	CD	NUMBER	—	dep	1	SENT_583	[p14l1660t2735r1818b2760],
4	66	CD	NUMBER	66	num	6	SENT_583	[p14l1660t2735r1818b2760],
5	Shu	NNP	O	Shu	nn	6	SENT_583	[p14l644t2777r696b2803],
6	Y	NN	O	y	dep	1	SENT_583	[p14l709t2778r739b2808],
7	,	,	O	,	_	0	SENT_583	[p14l709t2778r739b2808],
8	Leabman	NNP	ORGANIZATION	Leabman	nn	9	SENT_583	[p14l754t2777r884b2803],
9	MK	NNP	ORGANIZATION	MK	appos	6	SENT_583	[p14l897t2778r962b2808],
10	,	,	O	,	_	0	SENT_583	[p14l897t2778r962b2808],
11	Feng	NNP	O	Feng	nn	12	SENT_583	[p14l977t2778r1048b2811],
12	B	NNP	O	B	appos	6	SENT_583	[p14l1061t2778r1089b2808],
13	,	,	O	,	_	0	SENT_583	[p14l1061t2778r1089b2808],
14	Mangravite	NNP	ORGANIZATION	Mangravite	nn	15	SENT_583	[p14l1103t2778r1264b2811],
15	LM	NNP	ORGANIZATION	LM	appos	6	SENT_583	[p14l1278t2778r1339b2808],
16	,	,	O	,	_	0	SENT_583	[p14l1278t2778r1339b2808],
17	Huang	NNP	ORGANIZATION	Huang	nn	18	SENT_583	[p14l1354t2778r1451b2811],
18	CC	NN	ORGANIZATION	cc	appos	6	SENT_583	[p14l1465t2778r1521b2808],
19	,	,	O	,	_	0	SENT_583	[p14l1465t2778r1521b2808],
20	et	FW	O	et	nn	21	SENT_583	[p14l1537t2784r1562b2803],
21	al.	FW	O	al.	appos	6	SENT_583	[p14l1576t2777r1605b2803],
22	2003	CD	DATE	2003	dep	21	SENT_583	[p14l1621t2779r1696b2803],
23	.	.	O	.	_	0	SENT_583	[p14l1621t2779r1696b2803],

1	Evolutionary	JJ	O	evolutionary	amod	2	SENT_584	[p14l1711t2777r1894b2811],
2	conservation	NN	O	conservation	nsubj	3	SENT_584	[p14l1907t2778r2084b2803],
3	predicts	VBZ	O	predict	_	0	SENT_584	[p14l643t2821r752b2856],
4	function	NN	O	function	dobj	3	SENT_584	[p14l762t2821r879b2847],
5	of	IN	O	of	_	0	SENT_584	[p14l889t2821r919b2847],
6	variants	NNS	O	variant	prep_of	4	SENT_584	[p14l924t2823r1032b2847],
7	of	IN	O	of	_	0	SENT_584	[p14l1043t2821r1073b2847],
8	the	DT	O	the	det	12	SENT_584	[p14l1079t2821r1122b2847],
9	human	JJ	O	human	amod	12	SENT_584	[p14l1132t2821r1228b2847],
10	organic	JJ	O	organic	amod	12	SENT_584	[p14l1238t2823r1341b2856],
11	cation	NN	O	cation	nn	12	SENT_584	[p14l1351t2823r1436b2847],
12	transporter	NN	O	transporter	prep_of	6	SENT_584	[p14l1445t2829r1609b2856],
13	,	,	O	,	_	0	SENT_584	[p14l1445t2829r1609b2856],
14	OCT1	NN	O	oct1	appos	12	SENT_584	[p14l1620t2822r1721b2847],
15	.	.	O	.	_	0	SENT_584	[p14l1620t2822r1721b2847],

1	Proc	NNP	O	Proc	_	0	SENT_585	[p14l1731t2822r1793b2847],
2	.	.	O	.	_	0	SENT_585	[p14l1731t2822r1793b2847],

1	Natl.	NNP	O	Natl.	nn	2	SENT_586	[p14l1804t2822r1871b2847],
2	Aazd	NNP	O	Aazd	_	0	SENT_586	[p14l1880t2822r1951b2847],
3	.	.	O	.	_	0	SENT_586	[p14l1880t2822r1951b2847],

1	Sci	NNP	O	Sci	_	0	SENT_587	[p14l1964t2822r2006b2847],
2	.	.	O	.	_	0	SENT_587	[p14l1964t2822r2006b2847],

1	USA	NNP	LOCATION	USA	nn	5	SENT_588	[p14l2022t2822r2083b2847],
2	10025	CD	NUMBER	10025	num	5	SENT_588	[p14l646t2867r717b2892],
3	902-7	CD	NUMBER	902-7	num	5	SENT_588	[p14l721t2867r803b2892],
4	Wang	NNP	O	Wang	nn	5	SENT_588	[p14l642t2910r729b2944],
5	ZJ	NNP	O	ZJ	_	0	SENT_588	[p14l737t2909r779b2942],
6	,	,	O	,	_	0	SENT_588	[p14l737t2909r779b2942],
7	Yin	NNP	PERSON	Yin	nn	8	SENT_588	[p14l788t2910r838b2935],
8	OQ	NNP	O	OQ	appos	5	SENT_588	[p14l848t2910r910b2941],
9	,	,	O	,	_	0	SENT_588	[p14l848t2910r910b2941],
10	Tomlinson	NNP	PERSON	Tomlinson	nn	11	SENT_588	[p14l919t2909r1076b2935],
11	B	NNP	PERSON	B	appos	5	SENT_588	[p14l1086t2910r1113b2941],
12	,	,	O	,	_	0	SENT_588	[p14l1086t2910r1113b2941],
13	Chow	NNP	LOCATION	Chow	nn	14	SENT_588	[p14l1124t2909r1208b2935],
14	MS.	NNP	O	MS.	appos	5	SENT_588	[p14l1215t2910r1273b2935],
15	2008	CD	DATE	2008	dep	14	SENT_588	[p14l1284t2911r1359b2935],
16	.	.	O	.	_	0	SENT_588	[p14l1284t2911r1359b2935],

1	OCT2	NN	O	oct2	nn	2	SENT_589	[p14l1370t2910r1462b2935],
2	polymorphisms	NNS	O	polymorphism	nn	9	SENT_589	[p14l1473t2909r1689b2944],
3	and	CC	O	and	_	0	SENT_589	[p14l1699t2909r1748b2935],
4	in	IN	O	in	nn	9	SENT_589	[p14l1758t2911r1855b2935],
5	—	FW	O	—	nn	6	SENT_589	[p14l1758t2911r1855b2935],
6	vivo	FW	O	vivo	pobj	4	SENT_589	[p14l1758t2911r1855b2935],
7	renal	JJ	O	renal	amod	8	SENT_589	[p14l1864t2909r1934b2935],
8	functional	JJ	O	functional	amod	6	SENT_589	[p14l1944t2909r2084b2935],
9	consequence	NN	O	consequence	_	0	SENT_589	[p14l643t2964r827b2988],
10	:	:	O	:	_	0	SENT_589	[p14l643t2964r827b2988],
11	studies	NNS	O	study	dep	9	SENT_589	[p14l838t2954r933b2980],
12	with	IN	O	with	_	0	SENT_589	[p14l942t2954r1004b2980],
13	metformin	NN	O	metformin	prep_with	11	SENT_589	[p14l1013t2954r1163b2980],
14	and	CC	O	and	_	0	SENT_589	[p14l1173t2954r1223b2980],
15	cimetidine	NN	O	cimetidine	conj_and	13	SENT_589	[p14l1233t2954r1387b2980],
16	.	.	O	.	_	0	SENT_589	[p14l1233t2954r1387b2980],

1	Pbvwmzcogenet	NNP	O	Pbvwmzcogenet	_	0	SENT_590	[p14l1397t2955r1600b2989],
2	.	.	O	.	_	0	SENT_590	[p14l1397t2955r1600b2989],

1	Genomicx	NN	O	genomicx	nn	2	SENT_591	[p14l1614t2955r1736b2980],
2	l8	NN	O	l8	nsubj	6	SENT_591	[p14l1748t2955r1887b2980],
3	:637	CD	NUMBER	:637	num	5	SENT_591	[p14l1748t2955r1887b2980],
4	-45	CD	NUMBER	-45	num	5	SENT_591	[p14l1748t2955r1887b2980],
5	Song	NN	O	song	dep	2	SENT_591	[p14l644t2999r714b3033],
6	IS	VBZ	O	be	_	0	SENT_591	[p14l728t2999r765b3030],
7	,	,	O	,	_	0	SENT_591	[p14l728t2999r765b3030],
8	Shin	NNP	PERSON	Shin	nn	9	SENT_591	[p14l782t2998r845b3024],
9	HJ	NNP	PERSON	HJ	nsubj	18	SENT_591	[p14l859t2999r907b3031],
10	,	,	O	,	_	0	SENT_591	[p14l859t2999r907b3031],
11	Shim	NNP	PERSON	Shim	nn	12	SENT_591	[p14l924t2998r995b3024],
12	EJ	NNP	PERSON	EJ	appos	9	SENT_591	[p14l1010t2999r1051b3031],
13	,	,	O	,	_	0	SENT_591	[p14l1010t2999r1051b3031],
14	Jung	NNP	PERSON	Jung	appos	12	SENT_591	[p14l1063t2999r1133b3033],
15	IS	VBZ	O	be	cop	18	SENT_591	[p14l1146t2999r1183b3030],
16	,	,	O	,	_	0	SENT_591	[p14l1146t2999r1183b3030],
17	Kim	NNP	PERSON	Kim	nn	18	SENT_591	[p14l1199t2999r1260b3024],
18	WY	NN	O	wy	ccomp	6	SENT_591	[p14l1274t2999r1340b3030],
19	,	,	O	,	_	0	SENT_591	[p14l1274t2999r1340b3030],
20	et	FW	O	et	nn	21	SENT_591	[p14l1356t3006r1382b3024],
21	al.	FW	O	al.	appos	18	SENT_591	[p14l1396t2998r1425b3024],
22	2008	CD	DATE	2008	dep	21	SENT_591	[p14l1442t3000r1516b3024],
23	.	.	O	.	_	0	SENT_591	[p14l1442t3000r1516b3024],

1	Genetic	JJ	O	genetic	amod	2	SENT_592	[p14l1533t2999r1644b3024],
2	variants	NNS	O	variant	_	0	SENT_592	[p14l1657t3000r1765b3024],
3	of	IN	O	of	_	0	SENT_592	[p14l1781t2998r1811b3024],
4	the	DT	O	the	det	9	SENT_592	[p14l1823t2998r1866b3024],
5	organic	JJ	O	organic	amod	9	SENT_592	[p14l1881t3000r1985b3033],
6	cation	NN	O	cation	nn	9	SENT_592	[p14l2000t3000r2084b3024],
7	transporter	NN	O	transporter	nn	9	SENT_592	[p14l643t3050r799b3077],
8	2	CD	NUMBER	2	num	9	SENT_592	[p14l809t3044r822b3069],
9	inﬂuence	NN	O	inﬂuence	prep_of	2	SENT_592	[p14l835t3043r962b3069],
10	the	DT	O	the	det	11	SENT_592	[p14l972t3043r1015b3069],
11	disposition	NN	O	disposition	dep	2	SENT_592	[p14l1026t3043r1177b3077],
12	of	IN	O	of	_	0	SENT_592	[p14l1188t3043r1218b3069],
13	metformin	NN	O	metformin	prep_of	11	SENT_592	[p14l1224t3043r1381b3069],
14	.	.	O	.	_	0	SENT_592	[p14l1224t3043r1381b3069],

1	Clin	NNP	O	Clin	_	0	SENT_593	[p14l1394t3044r1454b3069],
2	.	.	O	.	_	0	SENT_593	[p14l1394t3044r1454b3069],

1	Plmrmmol	NNP	O	Plmrmmol	_	0	SENT_594	[p14l1466t3044r1610b3069],
2	.	.	O	.	_	0	SENT_594	[p14l1466t3044r1610b3069],

1	Tber	NNP	O	Tber	_	0	SENT_595	[p14l1624t3044r1691b3069],
2	.	.	O	.	_	0	SENT_595	[p14l1624t3044r1691b3069],

1	84:5	CD	NUMBER	84:5	_	0	SENT_596	[p14l1705t3044r1761b3069],
2	59-62	CD	NUMBER	59-62	num	4	SENT_596	[p14l1766t3044r1846b3069],
3	Shu	NNP	O	Shu	nn	4	SENT_596	[p14l644t3087r697b3113],
4	Y	NN	O	y	dep	1	SENT_596	[p14l709t3088r738b3119],
5	,	,	O	,	_	0	SENT_596	[p14l709t3088r738b3119],
6	Sheardown	NNP	ORGANIZATION	Sheardown	nn	7	SENT_596	[p14l754t3087r909b3113],
7	SA	NNP	ORGANIZATION	SA	appos	4	SENT_596	[p14l924t3088r969b3119],
8	,	,	O	,	_	0	SENT_596	[p14l924t3088r969b3119],
9	Brown	NNP	PERSON	Brown	nn	10	SENT_596	[p14l984t3088r1077b3113],
10	C	NNP	O	C	appos	4	SENT_596	[p14l1091t3088r1122b3119],
11	,	,	O	,	_	0	SENT_596	[p14l1091t3088r1122b3119],
12	Owen	NNP	PERSON	Owen	nn	13	SENT_596	[p14l1137t3088r1220b3113],
13	RP	NNP	PERSON	RP	appos	4	SENT_596	[p14l1234t3088r1284b3119],
14	,	,	O	,	_	0	SENT_596	[p14l1234t3088r1284b3119],
15	Zhang	NNP	PERSON	Zhang	nn	16	SENT_596	[p14l1299t3087r1390b3122],
16	S	NNP	PERSON	S	appos	4	SENT_596	[p14l1404t3088r1427b3119],
17	,	,	O	,	_	0	SENT_596	[p14l1404t3088r1427b3119],
18	et	FW	O	et	nn	19	SENT_596	[p14l1442t3095r1468b3113],
19	al.	FW	O	al.	appos	4	SENT_596	[p14l1481t3087r1510b3113],
20	2007	CD	DATE	2007	dep	19	SENT_596	[p14l1526t3088r1600b3114],
21	.	.	O	.	_	0	SENT_596	[p14l1526t3088r1600b3114],

1	Eifect	NN	O	eifect	_	0	SENT_597	[p14l1615t3087r1698b3113],
2	of	IN	O	of	_	0	SENT_597	[p14l1711t3087r1741b3113],
3	genetic	JJ	O	genetic	amod	4	SENT_597	[p14l1752t3089r1852b3122],
4	variation	NN	O	variation	prep_of	1	SENT_597	[p14l1864t3089r1987b3113],
5	in	IN	O	in	_	0	SENT_597	[p14l2000t3088r2027b3113],
6	the	DT	O	the	det	9	SENT_597	[p14l2041t3087r2084b3113],
7	organic	JJ	O	organic	amod	9	SENT_597	[p14l643t3133r747b3167],
8	cation	NN	O	cation	nn	9	SENT_597	[p14l757t3133r842b3158],
9	transporter	NN	O	transporter	prep_in	4	SENT_597	[p14l851t3139r1008b3166],
10	1	CD	NUMBER	1	number	11	SENT_597	[p14l1021t3133r1030b3157],
11	(	CD	NUMBER	(	num	13	SENT_597	[p14l1044t3132r1158b3164],
12	OCT1	NN	O	oct1	nn	13	SENT_597	[p14l1044t3132r1158b3164],
13	)	NN	O	)	dep	1	SENT_597	[p14l1044t3132r1158b3164],
14	on	IN	O	on	_	0	SENT_597	[p14l1169t3141r1204b3158],
15	metformin	NN	O	metformin	nn	16	SENT_597	[p14l1213t3132r1363b3158],
16	action	NN	O	action	prep_on	13	SENT_597	[p14l1373t3133r1465b3158],
17	.	.	O	.	_	0	SENT_597	[p14l1373t3133r1465b3158],

1	tJ	NN	O	tj	_	0	SENT_598	[p14l1472t3132r1497b3166],
2	+	CC	O	+	cc	3	SENT_598	[p14l1472t3132r1497b3166],
3	Clin	NN	O	clin	dep	1	SENT_598	[p14l1511t3133r1571b3158],
4	.	.	O	.	_	0	SENT_598	[p14l1511t3133r1571b3158],

1	Invextig	NNP	O	Invextig	_	0	SENT_599	[p14l1583t3133r1691b3167],
2	.	.	O	.	_	0	SENT_599	[p14l1583t3133r1691b3167],

1	1l7	NN	O	1l7	_	0	SENT_600	[p14l1706t3133r1879b3158],
2	:	:	O	:	_	0	SENT_600	[p14l1706t3133r1879b3158],
3	l422-31	NN	O	l422-31	dep	1	SENT_600	[p14l1706t3133r1879b3158],
4	Shu	FW	O	shu	dep	3	SENT_600	[p14l644t3176r696b3202],
5	Y	NN	O	y	dep	3	SENT_600	[p14l704t3177r733b3207],
6	,	,	O	,	_	0	SENT_600	[p14l704t3177r733b3207],
7	Brown	NNP	PERSON	Brown	nn	8	SENT_600	[p14l743t3177r836b3202],
8	C	NNP	O	C	appos	5	SENT_600	[p14l845t3177r876b3207],
9	,	,	O	,	_	0	SENT_600	[p14l845t3177r876b3207],
10	Castro	NNP	PERSON	Castro	nn	11	SENT_600	[p14l886t3177r978b3202],
11	RA	NN	O	ra	appos	5	SENT_600	[p14l987t3177r1038b3207],
12	,	,	O	,	_	0	SENT_600	[p14l987t3177r1038b3207],
13	Shi	NNP	PERSON	Shi	nn	14	SENT_600	[p14l1049t3176r1093b3202],
14	RJ	NN	PERSON	rj	appos	5	SENT_600	[p14l1102t3177r1144b3208],
15	,	,	O	,	_	0	SENT_600	[p14l1102t3177r1144b3208],
16	Lin	NNP	PERSON	Lin	nn	17	SENT_600	[p14l1153t3177r1203b3201],
17	ET	NNP	O	ET	appos	5	SENT_600	[p14l1211t3177r1266b3207],
18	,	,	O	,	_	0	SENT_600	[p14l1211t3177r1266b3207],
19	et	FW	O	et	nn	20	SENT_600	[p14l1276t3183r1302b3202],
20	al.	FW	O	al.	appos	5	SENT_600	[p14l1310t3176r1339b3202],
21	2008	CD	DATE	2008	dep	20	SENT_600	[p14l1349t3178r1424b3202],
22	.	.	O	.	_	0	SENT_600	[p14l1349t3178r1424b3202],

1	Effect	NN	O	effect	_	0	SENT_601	[p14l1434t3176r1517b3202],
2	of	IN	O	of	_	0	SENT_601	[p14l1525t3176r1555b3202],
3	genetic	JJ	O	genetic	amod	4	SENT_601	[p14l1560t3177r1660b3210],
4	variation	NN	O	variation	prep_of	1	SENT_601	[p14l1668t3177r1791b3202],
5	in	IN	O	in	_	0	SENT_601	[p14l1799t3177r1826b3201],
6	the	DT	O	the	det	9	SENT_601	[p14l1835t3176r1878b3202],
7	organic	JJ	O	organic	amod	9	SENT_601	[p14l1887t3177r1991b3210],
8	cation	NN	O	cation	nn	9	SENT_601	[p14l2000t3177r2085b3202],
9	transporter	NN	O	transporter	prep_in	4	SENT_601	[p14l643t3228r800b3254],
10	1	CD	NUMBER	1	dep	1	SENT_601	[p14l812t3222r832b3251],
11	,	,	O	,	_	0	SENT_601	[p14l812t3222r832b3251],
12	OCT1	NN	O	oct1	appos	10	SENT_601	[p14l844t3221r945b3251],
13	,	,	O	,	_	0	SENT_601	[p14l844t3221r945b3251],
14	on	IN	O	on	_	0	SENT_601	[p14l957t3230r992b3246],
15	metformin	NN	O	metformin	nn	16	SENT_601	[p14l1001t3220r1151b3246],
16	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	10	SENT_601	[p14l1160t3220r1413b3254],
17	.	.	O	.	_	0	SENT_601	[p14l1160t3220r1413b3254],

1	Clin	NNP	O	Clin	_	0	SENT_602	[p14l1426t3221r1486b3246],
2	.	.	O	.	_	0	SENT_602	[p14l1426t3221r1486b3246],

1	Pbmmmol	NNP	O	Pbmmmol	_	0	SENT_603	[p14l1498t3221r1641b3246],
2	.	.	O	.	_	0	SENT_603	[p14l1498t3221r1641b3246],

1	Tber	NNP	O	Tber	_	0	SENT_604	[p14l1656t3221r1723b3246],
2	.	.	O	.	_	0	SENT_604	[p14l1656t3221r1723b3246],

1	83:273	CD	NUMBER	83:273	_	0	SENT_605	[p14l1737t3221r1880b3246],
2	—	CD	NUMBER	—	num	3	SENT_605	[p14l1737t3221r1880b3246],
3	80	CD	NUMBER	80	dep	1	SENT_605	[p14l1737t3221r1880b3246],

1	9-273	NN	O	9-273	_	0	SENT_606	[p15l72t3669r96b3753],
2	.	.	O	.	_	0	SENT_606	[p15l72t3669r96b3753],

1	Downloaded	VBN	O	download	_	0	SENT_607	[p15l72t3488r95b3658],
2	from	IN	O	from	_	0	SENT_607	[p15l72t3415r95b3479],
3	www	NN	O	www	prep_from	1	SENT_607	[p15l72t3128r95b3406],
4	.	.	O	.	_	0	SENT_607	[p15l72t3128r95b3406],

1	annualreviews	NNS	O	annualreview	_	0	SENT_608	[p15l72t3128r95b3406],
2	.	.	O	.	_	0	SENT_608	[p15l72t3128r95b3406],

1	org	NN	O	org	nn	2	SENT_609	[p15l79t3072r102b3115],
2	ison	NN	O	ison	dep	3	SENT_609	[p15l105t3698r129b3753],
3	on	IN	O	on	dep	6	SENT_609	[p15l113t3656r129b3688],
4	01/05	CD	NUMBER	01/05	pobj	3	SENT_609	[p15l105t3562r129b3647],
5	/	:	O	/	punct	6	SENT_609	[p15l105t3562r129b3647],
6	14	CD	NUMBER	14	_	0	SENT_609	[p15l105t3523r129b3559],
7	.	.	O	.	_	0	SENT_609	[p15l105t3523r129b3559],

1	For	IN	O	for	_	0	SENT_610	[p15l106t3466r129b3512],
2	personal	JJ	O	personal	amod	3	SENT_610	[p15l105t3346r136b3457],
3	use	NN	O	use	pobj	1	SENT_610	[p15l113t3293r129b3337],
4	only	RB	O	only	advmod	3	SENT_610	[p15l105t3218r136b3283],
5	.	.	O	.	_	0	SENT_610	[p15l105t3218r136b3283],

1	Annu	NNP	PERSON	Annu	_	0	SENT_611	[p15l181t1824r204b1904],
2	.	.	O	.	_	0	SENT_611	[p15l181t1824r204b1904],

1	Rev.	NNP	O	Rev.	nn	2	SENT_612	[p15l181t1753r204b1813],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_612	[p15l181t1594r204b1742],
3	.	.	O	.	_	0	SENT_612	[p15l181t1594r204b1742],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_613	[p15l181t1474r204b1583],
2	.	.	O	.	_	0	SENT_613	[p15l181t1474r204b1583],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_614	[p15l181t1228r205b1462],
2	-273	CD	NUMBER	-273	_	0	SENT_614	[p15l181t1228r205b1462],
3	.	.	O	.	_	0	SENT_614	[p15l181t1228r205b1462],

1	Downloaded	VBN	O	download	_	0	SENT_615	[p15l181t1046r204b1217],
2	from	IN	O	from	_	0	SENT_615	[p15l181t973r204b1037],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_615	[p15l181t639r211b964],
4	by	IN	O	by	_	0	SENT_615	[p15l214t1736r245b1768],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_615	[p15l214t1587r245b1727],
6	of	IN	ORGANIZATION	of	_	0	SENT_615	[p15l214t1549r238b1577],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_615	[p15l214t1402r238b1542],
8	-	:	O	-	_	0	SENT_615	[p15l228t1383r231b1392],
9	Madison	NNP	O	Madison	prep_by	1	SENT_615	[p15l214t1257r238b1373],
10	on	IN	O	on	_	0	SENT_615	[p15l222t1215r238b1247],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_615	[p15l214t1081r238b1206],
12	.	.	O	.	_	0	SENT_615	[p15l214t1081r238b1206],

1	For	IN	O	for	_	0	SENT_616	[p15l215t1024r238b1070],
2	personal	JJ	O	personal	amod	3	SENT_616	[p15l214t904r245b1015],
3	use	NN	O	use	pobj	1	SENT_616	[p15l222t851r238b895],
4	only	RB	O	only	advmod	3	SENT_616	[p15l214t776r245b841],
5	.	.	O	.	_	0	SENT_616	[p15l214t776r245b841],

1	264	CD	NUMBER	264	num	2	SENT_617	[p15l472t42r514b71],
2	DEGWTET	NNP	O	DEGWTET	_	0	SENT_617	[p15l566t42r677b64],
3	et	FW	O	et	nn	4	SENT_617	[p15l684t47r704b64],
4	al.	FW	O	al.	dep	2	SENT_617	[p15l710t42r736b64],
5	.	.	O	.	_	0	SENT_617	[p15l710t42r736b64],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_618	[p15l444t81r520b107],
2	Y	NN	PERSON	y	_	0	SENT_618	[p15l529t82r559b112],
3	,	,	O	,	_	0	SENT_618	[p15l529t82r559b112],
4	Li	NNP	PERSON	Li	nn	5	SENT_618	[p15l570t82r601b106],
5	S	NNP	PERSON	S	appos	2	SENT_618	[p15l613t82r636b112],
6	,	,	O	,	_	0	SENT_618	[p15l613t82r636b112],
7	Brown	NNP	PERSON	Brown	nn	8	SENT_618	[p15l648t82r741b107],
8	C	NNP	O	C	appos	2	SENT_618	[p15l752t82r782b112],
9	,	,	O	,	_	0	SENT_618	[p15l752t82r782b112],
10	Cheatham	NNP	PERSON	Cheatham	nn	11	SENT_618	[p15l795t81r939b107],
11	S	NNP	O	S	appos	2	SENT_618	[p15l950t82r974b112],
12	,	,	O	,	_	0	SENT_618	[p15l950t82r974b112],
13	Castro	NNP	PERSON	Castro	nn	14	SENT_618	[p15l986t82r1078b107],
14	RA	NN	O	ra	appos	2	SENT_618	[p15l1089t82r1140b112],
15	,	,	O	,	_	0	SENT_618	[p15l1089t82r1140b112],
16	et	FW	O	et	nn	17	SENT_618	[p15l1153t88r1178b107],
17	al.	FW	O	al.	appos	2	SENT_618	[p15l1188t81r1218b107],
18	2009	CD	DATE	2009	dep	17	SENT_618	[p15l1230t83r1304b107],
19	.	.	O	.	_	0	SENT_618	[p15l1230t83r1304b107],

1	Effect	NN	O	effect	_	0	SENT_619	[p15l1316t81r1399b107],
2	of	IN	O	of	_	0	SENT_619	[p15l1409t81r1439b107],
3	genetic	JJ	O	genetic	amod	4	SENT_619	[p15l1447t82r1546b115],
4	variation	NN	O	variation	prep_of	1	SENT_619	[p15l1556t82r1679b107],
5	in	IN	O	in	_	0	SENT_619	[p15l1689t82r1716b106],
6	the	DT	O	the	det	9	SENT_619	[p15l1727t81r1770b107],
7	organic	JJ	O	organic	amod	9	SENT_619	[p15l1781t82r1885b115],
8	cation	NN	O	cation	nn	9	SENT_619	[p15l444t126r528b150],
9	transporter	NN	O	transporter	prep_in	1	SENT_619	[p15l538t131r695b158],
10	2	CD	NUMBER	2	dep	1	SENT_619	[p15l705t126r718b149],
11	on	IN	O	on	dep	1	SENT_619	[p15l730t134r765b150],
12	the	DT	O	the	det	14	SENT_619	[p15l775t124r818b150],
13	renal	JJ	O	renal	amod	14	SENT_619	[p15l828t124r898b150],
14	elimination	NN	O	elimination	pobj	11	SENT_619	[p15l908t124r1067b150],
15	of	IN	O	of	_	0	SENT_619	[p15l1077t124r1108b150],
16	metformin	NN	O	metformin	prep_of	14	SENT_619	[p15l1114t124r1270b150],
17	.	.	O	.	_	0	SENT_619	[p15l1114t124r1270b150],

1	P/Jawnaeogenet	NN	O	p/jawnaeogenet	_	0	SENT_620	[p15l1281t125r1484b159],
2	.	.	O	.	_	0	SENT_620	[p15l1281t125r1484b159],

1	Genomiex	NNP	O	Genomiex	nn	5	SENT_621	[p15l1498t125r1620b150],
2	19:497	CD	NUMBER	19:497	num	5	SENT_621	[p15l1631t125r1790b150],
3	-504	CD	NUMBER	-504	num	5	SENT_621	[p15l1631t125r1790b150],
4	Tzvetkov	NNP	O	Tzvetkov	nn	5	SENT_621	[p15l443t167r576b193],
5	MV	NNP	O	MV	_	0	SENT_621	[p15l588t168r652b198],
6	,	,	O	,	_	0	SENT_621	[p15l588t168r652b198],
7	Vormfelde	NNP	O	Vormfelde	nn	8	SENT_621	[p15l667t167r818b193],
8	SV	NNP	O	SV	appos	5	SENT_621	[p15l834t168r882b198],
9	,	,	O	,	_	0	SENT_621	[p15l834t168r882b198],
10	Balen	NNP	PERSON	Balen	nn	11	SENT_621	[p15l898t167r976b193],
11	D	NNP	PERSON	D	appos	5	SENT_621	[p15l991t168r1025b198],
12	,	,	O	,	_	0	SENT_621	[p15l991t168r1025b198],
13	Meineke	NNP	O	Meineke	appos	5	SENT_621	[p15l1040t167r1162b193],
14	I	PRP	O	I	dep	13	SENT_621	[p15l1177t168r1195b198],
15	,	,	O	,	_	0	SENT_621	[p15l1177t168r1195b198],
16	Schmidt	NNP	PERSON	Schmidt	nn	17	SENT_621	[p15l1213t167r1329b193],
17	T	NN	O	t	appos	5	SENT_621	[p15l1341t168r1374b198],
18	,	,	O	,	_	0	SENT_621	[p15l1341t168r1374b198],
19	et	FW	O	et	nn	20	SENT_621	[p15l1391t174r1417b193],
20	al.	FW	O	al.	appos	5	SENT_621	[p15l1431t167r1460b193],
21	2009	CD	DATE	2009	dep	20	SENT_621	[p15l1477t169r1552b193],
22	.	.	O	.	_	0	SENT_621	[p15l1477t169r1552b193],

1	The	DT	O	the	det	2	SENT_622	[p15l1567t167r1626b193],
2	effects	NNS	O	effect	_	0	SENT_622	[p15l1642t167r1727b193],
3	of	IN	O	of	_	0	SENT_622	[p15l1743t167r1774b193],
4	genetic	JJ	O	genetic	amod	5	SENT_622	[p15l1785t168r1885b201],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_622	[p15l443t210r659b245],
6	in	IN	O	in	_	0	SENT_622	[p15l669t212r696b236],
7	the	DT	O	the	det	10	SENT_622	[p15l706t210r749b236],
8	organic	JJ	O	organic	amod	10	SENT_622	[p15l760t212r864b245],
9	cation	NN	O	cation	nn	10	SENT_622	[p15l875t212r959b236],
10	transporters	NNS	O	transporter	prep_in	5	SENT_622	[p15l969t218r1137b245],
11	OCT1	NN	O	oct1	dep	2	SENT_622	[p15l1148t211r1250b242],
12	,	,	O	,	_	0	SENT_622	[p15l1148t211r1250b242],
13	OCT2	NN	O	oct2	conj_and	11	SENT_622	[p15l1262t211r1363b242],
14	,	,	O	,	_	0	SENT_622	[p15l1262t211r1363b242],
15	and	CC	O	and	_	0	SENT_622	[p15l1375t210r1424b236],
16	OCT3	NN	O	oct3	conj_and	11	SENT_622	[p15l1435t211r1526b237],
17	on	IN	O	on	_	0	SENT_622	[p15l1540t220r1575b236],
18	the	DT	O	the	det	20	SENT_622	[p15l1585t210r1628b236],
19	renal	JJ	O	renal	amod	20	SENT_622	[p15l1638t210r1708b236],
20	clearance	NN	O	clearance	prep_on	11	SENT_622	[p15l1719t210r1847b236],
21	of	IN	O	of	_	0	SENT_622	[p15l1858t210r1889b236],
22	metformin	NN	O	metformin	prep_of	20	SENT_622	[p15l443t254r600b280],
23	.	.	O	.	_	0	SENT_622	[p15l443t254r600b280],

1	Clin	NNP	O	Clin	_	0	SENT_623	[p15l613t255r673b280],
2	.	.	O	.	_	0	SENT_623	[p15l613t255r673b280],

1	P/Jar/natal	NN	O	p/jar/natal	_	0	SENT_624	[p15l685t255r829b280],
2	.	.	O	.	_	0	SENT_624	[p15l685t255r829b280],

1	T/yer	NN	O	t/yer	_	0	SENT_625	[p15l843t255r911b280],
2	.	.	O	.	_	0	SENT_625	[p15l843t255r911b280],

1	86:299	CD	NUMBER	86:299	num	4	SENT_626	[p15l924t255r1085b280],
2	-306	CD	NUMBER	-306	num	4	SENT_626	[p15l924t255r1085b280],
3	Ahlin	NNP	PERSON	Ahlin	nn	4	SENT_626	[p15l442t297r520b322],
4	G	NNP	PERSON	G	_	0	SENT_626	[p15l534t298r568b328],
5	,	,	O	,	_	0	SENT_626	[p15l534t298r568b328],
6	Chen	NNP	PERSON	Chen	nn	7	SENT_626	[p15l583t297r659b323],
7	L	NNP	PERSON	L	appos	4	SENT_626	[p15l673t298r702b328],
8	,	,	O	,	_	0	SENT_626	[p15l673t298r702b328],
9	Lazorova	NNP	ORGANIZATION	Lazorova	nn	10	SENT_626	[p15l717t298r847b323],
10	L	NNP	ORGANIZATION	L	appos	4	SENT_626	[p15l860t298r889b328],
11	,	,	O	,	_	0	SENT_626	[p15l860t298r889b328],
12	Chen	NNP	LOCATION	Chen	nn	13	SENT_626	[p15l905t297r981b323],
13	Y	NN	LOCATION	y	appos	4	SENT_626	[p15l994t298r1023b328],
14	,	,	O	,	_	0	SENT_626	[p15l994t298r1023b328],
15	Ianculescu	NNP	ORGANIZATION	Ianculescu	nn	16	SENT_626	[p15l1038t297r1185b323],
16	AG	NNP	ORGANIZATION	AG	appos	4	SENT_626	[p15l1197t298r1254b328],
17	,	,	O	,	_	0	SENT_626	[p15l1197t298r1254b328],
18	et	FW	O	et	nn	19	SENT_626	[p15l1270t304r1296b323],
19	al.	FW	O	al.	appos	4	SENT_626	[p15l1309t297r1338b323],
20	2010	CD	DATE	2010	dep	19	SENT_626	[p15l1354t298r1429b322],
21	.	.	O	.	_	0	SENT_626	[p15l1354t298r1429b322],

1	Genotype-dependent	JJ	O	genotype-dependent	amod	2	SENT_627	[p15l1445t297r1744b331],
2	effects	NNS	O	effect	_	0	SENT_627	[p15l1757t297r1843b323],
3	of	IN	O	of	_	0	SENT_627	[p15l1858t297r1889b323],
4	inhibitors	NNS	O	inhibitor	prep_of	2	SENT_627	[p15l443t340r578b366],
5	of	IN	O	of	_	0	SENT_627	[p15l589t340r619b366],
6	the	DT	O	the	det	9	SENT_627	[p15l625t340r668b366],
7	organic	JJ	O	organic	amod	9	SENT_627	[p15l678t341r782b375],
8	cation	NN	O	cation	nn	9	SENT_627	[p15l792t341r876b366],
9	transporter	NN	O	transporter	prep_of	4	SENT_627	[p15l886t347r1049b374],
10	,	,	O	,	_	0	SENT_627	[p15l886t347r1049b374],
11	OCT1	NN	O	oct1	appos	9	SENT_627	[p15l1061t341r1162b366],
12	:	:	O	:	_	0	SENT_627	[p15l1061t341r1162b366],
13	predictions	NNS	O	prediction	dep	2	SENT_627	[p15l1173t340r1328b374],
14	of	IN	O	of	_	0	SENT_627	[p15l1338t340r1369b366],
15	metformin	NN	O	metformin	nn	16	SENT_627	[p15l1374t340r1524b366],
16	interactions	NNS	O	interaction	prep_of	13	SENT_627	[p15l1533t341r1705b366],
17	.	.	O	.	_	0	SENT_627	[p15l1533t341r1705b366],

1	PlJarrnacogenamicx	NN	O	pljarrnacogenamicx	_	0	SENT_628	[p15l1715t341r1884b375, p15l443t384r558b417],
2	]	NN	O	]	dep	1	SENT_628	[p15l1715t341r1884b375, p15l443t384r558b417],
3	.	.	O	.	_	0	SENT_628	[p15l1715t341r1884b375, p15l443t384r558b417],

1	In	IN	O	in	dep	10	SENT_629	[p15l571t384r600b409],
2	press	NN	O	press	pobj	1	SENT_629	[p15l610t393r687b417],
3	,	,	O	,	_	0	SENT_629	[p15l610t393r687b417],
4	doi	FW	O	doi	appos	2	SENT_629	[p15l699t383r1033b417],
5	:10.1038	CD	NUMBER	:10.1038	dep	4	SENT_629	[p15l699t383r1033b417],
6	/	:	O	/	punct	10	SENT_629	[p15l699t383r1033b417],
7	tpj	NN	O	tpj	nn	10	SENT_629	[p15l699t383r1033b417],
8	.2010.54	CD	NUMBER	.2010.54	num	10	SENT_629	[p15l699t383r1033b417],
9	Cho	NNP	ORGANIZATION	Cho	nn	10	SENT_629	[p15l444t426r503b452],
10	SK	NNP	ORGANIZATION	SK	_	0	SENT_629	[p15l517t427r566b457],
11	,	,	O	,	_	0	SENT_629	[p15l517t427r566b457],
12	Yoon	NNP	PERSON	Yoon	nn	14	SENT_629	[p15l579t427r655b452],
13	]	CD	NUMBER	]	num	14	SENT_629	[p15l663t427r704b458],
14	S	NN	O	s	appos	10	SENT_629	[p15l663t427r704b458],
15	,	,	O	,	_	0	SENT_629	[p15l663t427r704b458],
16	Lee	NNP	PERSON	Lee	nn	17	SENT_629	[p15l717t427r769b452],
17	MG	NN	PERSON	mg	appos	10	SENT_629	[p15l781t427r848b457],
18	,	,	O	,	_	0	SENT_629	[p15l781t427r848b457],
19	Lee	NNP	PERSON	Lee	nn	20	SENT_629	[p15l861t427r913b452],
20	DH	NNP	O	DH	appos	10	SENT_629	[p15l926t427r989b457],
21	,	,	O	,	_	0	SENT_629	[p15l926t427r989b457],
22	Lim	NNP	LOCATION	Lim	nn	23	SENT_629	[p15l1002t427r1061b451],
23	LA	NNP	LOCATION	LA	appos	10	SENT_629	[p15l1073t427r1124b457],
24	,	,	O	,	_	0	SENT_629	[p15l1073t427r1124b457],
25	et	FW	O	et	nn	26	SENT_629	[p15l1138t433r1164b452],
26	al.	FW	O	al.	appos	10	SENT_629	[p15l1175t426r1205b452],
27	2011	CD	DATE	2011	dep	26	SENT_629	[p15l1219t428r1294b452],
28	.	.	O	.	_	0	SENT_629	[p15l1219t428r1294b452],

1	Rifampin	NNP	MISC	Rifampin	nsubj	9	SENT_630	[p15l1308t426r1437b460],
2	enhances	VBZ	O	enhance	_	0	SENT_630	[p15l1450t426r1576b452],
3	the	DT	O	the	det	5	SENT_630	[p15l1589t426r1632b452],
4	glucose-lowering	JJ	O	glucose-lowering	amod	5	SENT_630	[p15l1645t426r1885b460],
5	eﬂfect	NN	O	eﬂfect	dobj	2	SENT_630	[p15l444t469r519b495],
6	of	IN	O	of	_	0	SENT_630	[p15l531t469r561b495],
7	metformin	NN	O	metformin	prep_of	5	SENT_630	[p15l570t469r720b495],
8	and	CC	O	and	_	0	SENT_630	[p15l732t469r781b495],
9	increases	VBZ	O	increase	conj_and	2	SENT_630	[p15l794t471r918b495],
10	OCT1	NN	O	oct1	nn	12	SENT_630	[p15l931t470r1022b495],
11	mRNA	NN	O	mrna	nn	12	SENT_630	[p15l1038t470r1140b495],
12	levels	NNS	O	level	dobj	9	SENT_630	[p15l1151t469r1226b495],
13	in	IN	O	in	_	0	SENT_630	[p15l1239t471r1266b495],
14	healthy	JJ	O	healthy	amod	15	SENT_630	[p15l1278t469r1382b504],
15	participants	NNS	O	participant	prep_in	9	SENT_630	[p15l1393t471r1563b504],
16	.	.	O	.	_	0	SENT_630	[p15l1393t471r1563b504],

1	Clin	NNP	O	Clin	_	0	SENT_631	[p15l1578t470r1638b495],
2	.	.	O	.	_	0	SENT_631	[p15l1578t470r1638b495],

1	P/yawnacol	NN	O	p/yawnacol	_	0	SENT_632	[p15l1653t470r1797b495],
2	.	.	O	.	_	0	SENT_632	[p15l1653t470r1797b495],

1	Tber	NNP	O	Tber	_	0	SENT_633	[p15l1814t470r1882b495],
2	.	.	O	.	_	0	SENT_633	[p15l1814t470r1882b495],

1	89:41	CD	NUMBER	89:41	num	2	SENT_634	[p15l445t514r516b538],
2	6-2	CD	NUMBER	6-2	_	0	SENT_634	[p15l522t514r568b538],
3	1	CD	NUMBER	1	num	5	SENT_634	[p15l576t514r585b538],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_634	[p15l443t556r530b589],
5	DS	NN	PERSON	d	dep	2	SENT_634	[p15l540t556r592b586],
6	,	,	O	,	_	0	SENT_634	[p15l540t556r592b586],
7	]	NN	O	]	nn	8	SENT_634	[p15l600t555r697b587],
8	onker	NN	O	onker	appos	5	SENT_634	[p15l600t555r697b587],
9	]	CD	NUMBER	]	num	10	SENT_634	[p15l703t556r762b587],
10	W	NN	O	w	dep	2	SENT_634	[p15l703t556r762b587],
11	,	,	O	,	_	0	SENT_634	[p15l703t556r762b587],
12	Kato	NNP	PERSON	Kato	nn	13	SENT_634	[p15l774t556r841b581],
13	Y	NN	PERSON	y	appos	10	SENT_634	[p15l852t556r881b586],
14	,	,	O	,	_	0	SENT_634	[p15l852t556r881b586],
15	Kusuhara	NN	PERSON	kusuhara	nn	16	SENT_634	[p15l893t555r1026b581],
16	H	NN	PERSON	h	appos	10	SENT_634	[p15l1037t556r1072b586],
17	,	,	O	,	_	0	SENT_634	[p15l1037t556r1072b586],
18	Schinkel	NNP	PERSON	Schinkel	nn	19	SENT_634	[p15l1085t555r1203b581],
19	AH	NNP	O	AH	appos	10	SENT_634	[p15l1213t556r1271b586],
20	,	,	O	,	_	0	SENT_634	[p15l1213t556r1271b586],
21	Sugiyama	NNP	PERSON	Sugiyama	nn	22	SENT_634	[p15l1285t556r1418b589],
22	Y.	NNP	O	Y.	appos	10	SENT_634	[p15l1428t556r1457b580],
23	2002	CD	DATE	2002	dep	22	SENT_634	[p15l1470t556r1544b580],
24	.	.	O	.	_	0	SENT_634	[p15l1470t556r1544b580],

1	Involvement	NN	O	involvement	_	0	SENT_635	[p15l1556t555r1733b581],
2	of	IN	O	of	_	0	SENT_635	[p15l1743t555r1774b581],
3	organic	JJ	O	organic	amod	5	SENT_635	[p15l1781t556r1885b589],
4	cation	NN	O	cation	nn	5	SENT_635	[p15l444t599r529b624],
5	transporter	NN	O	transporter	prep_of	1	SENT_635	[p15l536t605r692b632],
6	1	CD	NUMBER	1	dep	1	SENT_635	[p15l702t600r712b623],
7	in	IN	O	in	_	0	SENT_635	[p15l722t599r749b623],
8	hepatic	JJ	O	hepatic	amod	11	SENT_635	[p15l756t598r857b632],
9	and	CC	O	and	_	0	SENT_635	[p15l864t598r914b624],
10	intestinal	JJ	O	intestinal	amod	11	SENT_635	[p15l921t598r1049b624],
11	distribution	NN	O	distribution	prep_in	6	SENT_635	[p15l1057t598r1220b624],
12	of	IN	O	of	_	0	SENT_635	[p15l1228t598r1258b624],
13	metformin	NN	O	metformin	nn	14	SENT_635	[p15l1261t598r1448b632],
14	]	NN	O	]	prep_of	11	SENT_635	[p15l1261t598r1448b632],
15	.	.	O	.	_	0	SENT_635	[p15l1261t598r1448b632],

1	Plzawnaeol	NN	O	plzawnaeol	_	0	SENT_636	[p15l1457t599r1601b624],
2	.	.	O	.	_	0	SENT_636	[p15l1457t599r1601b624],

1	Exp	NN	O	exp	_	0	SENT_637	[p15l1610t599r1668b632],
2	.	.	O	.	_	0	SENT_637	[p15l1610t599r1668b632],

1	Tber	NNP	O	Tber	_	0	SENT_638	[p15l1680t599r1747b624],
2	.	.	O	.	_	0	SENT_638	[p15l1680t599r1747b624],

1	302	CD	NUMBER	302	num	2	SENT_639	[p15l1759t600r1805b624],
2	:5	CD	NUMBER	:5	_	0	SENT_639	[p15l1811t599r1832b624],
3	1015	CD	DATE	1015	num	5	SENT_639	[p15l1838t600r1886b624, p15l447t644r475b669],
4	Wang	NNP	O	Wang	nn	5	SENT_639	[p15l443t688r530b722],
5	DS	NN	O	d	dep	2	SENT_639	[p15l540t688r592b719],
6	,	,	O	,	_	0	SENT_639	[p15l540t688r592b719],
7	Kusuhara	NN	PERSON	kusuhara	nn	8	SENT_639	[p15l604t687r737b713],
8	H	NN	PERSON	h	appos	5	SENT_639	[p15l748t688r783b719],
9	,	,	O	,	_	0	SENT_639	[p15l748t688r783b719],
10	Kato	NNP	PERSON	Kato	nn	11	SENT_639	[p15l795t688r862b713],
11	Y	NN	PERSON	y	appos	5	SENT_639	[p15l873t688r902b719],
12	,	,	O	,	_	0	SENT_639	[p15l873t688r902b719],
13	]	NN	O	]	nn	14	SENT_639	[p15l910t687r1007b720],
14	onker	NN	O	onker	appos	5	SENT_639	[p15l910t687r1007b720],
15	]	CD	NUMBER	]	num	16	SENT_639	[p15l1013t688r1072b720],
16	W	NN	O	w	dep	14	SENT_639	[p15l1013t688r1072b720],
17	,	,	O	,	_	0	SENT_639	[p15l1013t688r1072b720],
18	Schinkel	NNP	PERSON	Schinkel	nn	22	SENT_639	[p15l1085t687r1203b713],
19	AH	NNP	O	AH	nn	22	SENT_639	[p15l1213t688r1271b719],
20	,	,	O	,	_	0	SENT_639	[p15l1213t688r1271b719],
21	Sugiyama	NNP	PERSON	Sugiyama	appos	22	SENT_639	[p15l1285t688r1418b722],
22	Y.	NNP	O	Y.	appos	5	SENT_639	[p15l1428t688r1457b713],
23	2003	CD	DATE	2003	num	22	SENT_639	[p15l1470t689r1544b713],
24	.	.	O	.	_	0	SENT_639	[p15l1470t689r1544b713],

1	Involvement	NN	O	involvement	nsubj	11	SENT_640	[p15l1557t687r1733b713],
2	of	IN	O	of	_	0	SENT_640	[p15l1743t687r1774b713],
3	organic	JJ	O	organic	amod	5	SENT_640	[p15l1781t688r1885b722],
4	cation	NN	O	cation	nn	5	SENT_640	[p15l444t735r528b759],
5	transporter	NN	O	transporter	prep_of	1	SENT_640	[p15l538t741r695b767],
6	1	CD	NUMBER	1	dep	5	SENT_640	[p15l707t735r717b759],
7	in	IN	O	in	_	0	SENT_640	[p15l730t735r756b759],
8	the	DT	O	the	det	10	SENT_640	[p15l767t733r810b759],
9	lactic	NN	O	lactic	nn	10	SENT_640	[p15l820t733r893b759],
10	acidosis	NN	O	acidosis	prep_in	1	SENT_640	[p15l903t733r1009b759],
11	caused	VBN	O	cause	_	0	SENT_640	[p15l1019t733r1111b759],
12	by	IN	O	by	_	0	SENT_640	[p15l1120t733r1154b768],
13	metformin	NN	O	metformin	prep_by	11	SENT_640	[p15l1163t733r1319b759],
14	.	.	O	.	_	0	SENT_640	[p15l1163t733r1319b759],

1	Mal	NNP	PERSON	Mal	_	0	SENT_641	[p15l1329t734r1388b759],
2	.	.	O	.	_	0	SENT_641	[p15l1329t734r1388b759],

1	Plyarmaeol	NN	O	plyarmaeol	_	0	SENT_642	[p15l1400t734r1544b759],
2	.	.	O	.	_	0	SENT_642	[p15l1400t734r1544b759],

1	63:844	CD	NUMBER	63:844	num	2	SENT_643	[p15l1557t735r1700b759],
2	-48	CD	NUMBER	-48	_	0	SENT_643	[p15l1557t735r1700b759],
3	Moreno-Navarrete	NNP	O	Moreno-Navarrete	nn	5	SENT_643	[p15l442t778r711b803],
4	]	CD	NUMBER	]	num	5	SENT_643	[p15l721t778r775b809],
5	M	NN	O	m	dep	2	SENT_643	[p15l721t778r775b809],
6	,	,	O	,	_	0	SENT_643	[p15l721t778r775b809],
7	Ortega	NNP	PERSON	Ortega	appos	5	SENT_643	[p15l790t778r887b812],
8	F	NN	O	f	nn	9	SENT_643	[p15l901t778r940b809],
9	]	NN	O	]	dep	2	SENT_643	[p15l901t778r940b809],
10	,	,	O	,	_	0	SENT_643	[p15l901t778r940b809],
11	Rodriguez-Hermosa	NNP	PERSON	Rodriguez-Hermosa	appos	9	SENT_643	[p15l955t777r1242b812],
12	]	CD	NUMBER	]	num	11	SENT_643	[p15l1252t778r1287b809],
13	I	PRP	O	I	dep	2	SENT_643	[p15l1252t778r1287b809],
14	,	,	O	,	_	0	SENT_643	[p15l1252t778r1287b809],
15	Sabater	NNP	O	Sabater	nn	16	SENT_643	[p15l1302t777r1406b803],
16	M	NNP	O	M	appos	13	SENT_643	[p15l1417t778r1457b809],
17	,	,	O	,	_	0	SENT_643	[p15l1417t778r1457b809],
18	Pardo	NNP	PERSON	Pardo	nn	19	SENT_643	[p15l1472t777r1554b803],
19	G	NNP	PERSON	G	appos	2	SENT_643	[p15l1569t778r1602b809],
20	,	,	O	,	_	0	SENT_643	[p15l1569t778r1602b809],
21	et	FW	O	et	nn	22	SENT_643	[p15l1617t785r1643b803],
22	al.	FW	O	al.	appos	2	SENT_643	[p15l1656t777r1685b803],
23	2011	CD	DATE	2011	dep	22	SENT_643	[p15l1701t779r1775b803],
24	.	.	O	.	_	0	SENT_643	[p15l1701t779r1775b803],

1	OCT1	NN	O	oct1	nn	2	SENT_644	[p15l1791t778r1882b803],
2	expression	NN	O	expression	nsubj	6	SENT_644	[p15l444t824r589b857],
3	in	IN	O	in	_	0	SENT_644	[p15l603t824r630b848],
4	adipocytes	NNS	O	adipocyte	prep_in	2	SENT_644	[p15l646t823r791b857],
5	could	MD	O	could	aux	6	SENT_644	[p15l807t823r882b849],
6	contribute	VB	O	contribute	_	0	SENT_644	[p15l898t823r1042b849],
7	to	TO	O	to	_	0	SENT_644	[p15l1058t830r1085b849],
8	increased	VBN	O	increase	amod	10	SENT_644	[p15l1100t823r1230b849],
9	metformin	NN	O	metformin	nn	10	SENT_644	[p15l1245t823r1395b849],
10	action	NN	O	action	prep_to	6	SENT_644	[p15l1410t824r1495b849],
11	in	IN	O	in	_	0	SENT_644	[p15l1510t824r1537b848],
12	obese	JJ	O	obese	amod	13	SENT_644	[p15l1552t823r1629b849],
13	subjects	NNS	O	subject	prep_in	10	SENT_644	[p15l1644t823r1760b857],
14	.	.	O	.	_	0	SENT_644	[p15l1644t823r1760b857],

1	Dialzetex	NNP	O	Dialzetex	_	0	SENT_645	[p15l1776t824r1886b849],
2	60	CD	NUMBER	60	num	1	SENT_645	[p15l444t869r588b895],
3	:	:	O	:	_	0	SENT_645	[p15l444t869r588b895],
4	l68	CD	NUMBER	l68	num	8	SENT_645	[p15l444t869r588b895],
5	—	CD	NUMBER	—	num	8	SENT_645	[p15l444t869r588b895],
6	76	CD	NUMBER	76	num	8	SENT_645	[p15l444t869r588b895],
7	Becker	NNP	ORGANIZATION	Becker	nn	8	SENT_645	[p15l444t913r539b938],
8	ML	NNP	ORGANIZATION	ML	dep	1	SENT_645	[p15l553t914r615b944],
9	,	,	O	,	_	0	SENT_645	[p15l553t914r615b944],
10	Visser	NNP	PERSON	Visser	nn	11	SENT_645	[p15l630t914r718b938],
11	LE	NNP	PERSON	LE	appos	8	SENT_645	[p15l732t914r784b944],
12	,	,	O	,	_	0	SENT_645	[p15l732t914r784b944],
13	van	NNP	PERSON	van	nn	15	SENT_645	[p15l799t922r848b938],
14	Schaik	NNP	PERSON	Schaik	nn	15	SENT_645	[p15l864t912r956b938],
15	RH	NNP	O	RH	appos	8	SENT_645	[p15l970t914r1028b944],
16	,	,	O	,	_	0	SENT_645	[p15l970t914r1028b944],
17	Hofman	NNP	PERSON	Hofman	nn	18	SENT_645	[p15l1044t913r1162b938],
18	A	NNP	O	A	appos	8	SENT_645	[p15l1175t914r1205b944],
19	,	,	O	,	_	0	SENT_645	[p15l1175t914r1205b944],
20	Uitterlinden	NNP	ORGANIZATION	Uitterlinden	nn	21	SENT_645	[p15l1221t913r1396b938],
21	AG	NNP	ORGANIZATION	AG	appos	8	SENT_645	[p15l1410t914r1467b944],
22	,	,	O	,	_	0	SENT_645	[p15l1410t914r1467b944],
23	Stricker	NNP	PERSON	Stricker	nn	24	SENT_645	[p15l1485t913r1595b938],
24	BH	NNP	O	BH	appos	8	SENT_645	[p15l1610t914r1666b938],
25	.	.	O	.	_	0	SENT_645	[p15l1610t914r1666b938],

1	2009	CD	DATE	2009	_	0	SENT_646	[p15l1683t914r1757b939],
2	.	.	O	.	_	0	SENT_646	[p15l1683t914r1757b939],

1	Genetic	JJ	O	genetic	amod	2	SENT_647	[p15l1775t914r1885b938],
2	variation	NN	O	variation	nsubjpass	10	SENT_647	[p15l442t960r566b984],
3	in	IN	O	in	_	0	SENT_647	[p15l580t960r607b984],
4	the	DT	O	the	det	7	SENT_647	[p15l621t958r664b984],
5	organic	JJ	O	organic	amod	7	SENT_647	[p15l679t960r783b993],
6	cation	NN	O	cation	nn	7	SENT_647	[p15l798t960r882b984],
7	transporter	NN	O	transporter	prep_in	2	SENT_647	[p15l897t966r1053b993],
8	1	CD	NUMBER	1	dep	7	SENT_647	[p15l1070t960r1080b984],
9	is	VBZ	O	be	auxpass	10	SENT_647	[p15l1097t960r1117b984],
10	associated	VBN	O	associate	_	0	SENT_647	[p15l1133t958r1271b984],
11	with	IN	O	with	_	0	SENT_647	[p15l1284t958r1346b984],
12	metformin	NN	O	metformin	nn	13	SENT_647	[p15l1360t958r1510b984],
13	response	NN	O	response	prep_with	10	SENT_647	[p15l1524t968r1645b993],
14	in	IN	O	in	_	0	SENT_647	[p15l1659t960r1686b984],
15	patients	NNS	O	patient	prep_in	10	SENT_647	[p15l1700t960r1809b993],
16	with	IN	O	with	_	0	SENT_647	[p15l1823t958r1885b984],
17	diabetes	NN	O	diabetes	nn	18	SENT_647	[p15l444t1003r556b1029],
18	mellitus	NN	O	mellitus	prep_with	15	SENT_647	[p15l566t1004r684b1029],
19	.	.	O	.	_	0	SENT_647	[p15l566t1004r684b1029],

1	Plyarrnaeogenomics	NNS	O	plyarrnaeogenomic	_	0	SENT_648	[p15l694t1004r967b1038],
2	]	CD	NUMBER	]	num	1	SENT_648	[p15l694t1004r967b1038],
3	.	.	O	.	_	0	SENT_648	[p15l694t1004r967b1038],

1	9:242	CD	NUMBER	9:242	num	4	SENT_649	[p15l980t1004r1106b1030],
2	-47	CD	NUMBER	-47	num	4	SENT_649	[p15l980t1004r1106b1030],
3	Gambineri	NNP	MISC	Gambineri	nn	4	SENT_649	[p15l444t1048r595b1073],
4	A	NNP	MISC	A	_	0	SENT_649	[p15l609t1049r639b1079],
5	,	,	O	,	_	0	SENT_649	[p15l609t1049r639b1079],
6	Tomassoni	NNP	PERSON	Tomassoni	nn	7	SENT_649	[p15l654t1048r810b1073],
7	F	NN	O	f	appos	4	SENT_649	[p15l825t1049r852b1079],
8	,	,	O	,	_	0	SENT_649	[p15l825t1049r852b1079],
9	Gasparini	NNP	PERSON	Gasparini	nn	10	SENT_649	[p15l869t1048r1004b1082],
10	DI	NNP	O	DI	appos	4	SENT_649	[p15l1019t1049r1065b1079],
11	,	,	O	,	_	0	SENT_649	[p15l1019t1049r1065b1079],
12	Di	NNP	PERSON	Di	nn	14	SENT_649	[p15l1082t1049r1117b1073],
13	Rocco	NNP	PERSON	Rocco	nn	14	SENT_649	[p15l1133t1049r1219b1073],
14	A	NNP	PERSON	A	appos	4	SENT_649	[p15l1234t1048r1263b1079],
15	,	,	O	,	_	0	SENT_649	[p15l1234t1048r1263b1079],
16	Mantovani	NNP	PERSON	Mantovani	nn	17	SENT_649	[p15l1278t1049r1430b1073],
17	V	NNP	O	V	appos	4	SENT_649	[p15l1444t1049r1476b1079],
18	,	,	O	,	_	0	SENT_649	[p15l1444t1049r1476b1079],
19	et	FW	O	et	nn	20	SENT_649	[p15l1493t1055r1519b1073],
20	al.	FW	O	al.	appos	4	SENT_649	[p15l1533t1048r1563b1073],
21	2010	CD	DATE	2010	dep	20	SENT_649	[p15l1580t1049r1654b1073],
22	.	.	O	.	_	0	SENT_649	[p15l1580t1049r1654b1073],

1	Organic	NNP	O	Organic	nn	3	SENT_650	[p15l1672t1049r1785b1082],
2	cation	NN	O	cation	nn	3	SENT_650	[p15l1800t1049r1885b1073],
3	transporter	NN	O	transporter	nsubj	6	SENT_650	[p15l444t1100r600b1127],
4	1	CD	NUMBER	1	num	5	SENT_650	[p15l611t1095r621b1119],
5	polymorphisms	NNS	O	polymorphism	dep	3	SENT_650	[p15l632t1093r848b1128],
6	predict	VBP	O	predict	_	0	SENT_650	[p15l856t1093r955b1127],
7	the	DT	O	the	det	9	SENT_650	[p15l962t1093r1006b1119],
8	metabolic	JJ	O	metabolic	amod	9	SENT_650	[p15l1014t1093r1151b1119],
9	response	NN	O	response	dobj	6	SENT_650	[p15l1159t1103r1280b1127],
10	to	TO	O	to	_	0	SENT_650	[p15l1288t1101r1315b1119],
11	metformin	NN	O	metformin	prep_to	6	SENT_650	[p15l1324t1093r1473b1119],
12	in	IN	O	in	_	0	SENT_650	[p15l1481t1095r1508b1119],
13	women	NNS	O	woman	prep_in	11	SENT_650	[p15l1515t1103r1618b1119],
14	with	IN	O	with	_	0	SENT_650	[p15l1625t1093r1687b1119],
15	the	DT	O	the	det	18	SENT_650	[p15l1695t1093r1739b1119],
16	polycystic	JJ	O	polycystic	amod	18	SENT_650	[p15l1747t1093r1885b1128],
17	ovary	NN	O	ovary	nn	18	SENT_650	[p15l444t1149r521b1174],
18	syndrome	NN	O	syndrome	prep_with	13	SENT_650	[p15l529t1139r705b1174],
19	]	CD	NUMBER	]	dep	18	SENT_650	[p15l529t1139r705b1174],
20	.	.	O	.	_	0	SENT_650	[p15l529t1139r705b1174],

1	Clin	NNP	O	Clin	_	0	SENT_651	[p15l719t1140r780b1165],
2	.	.	O	.	_	0	SENT_651	[p15l719t1140r780b1165],

1	Endomnol	NNP	O	Endomnol	_	0	SENT_652	[p15l791t1140r935b1165],
2	.	.	O	.	_	0	SENT_652	[p15l791t1140r935b1165],

1	Metab	NNP	PERSON	Metab	_	0	SENT_653	[p15l946t1140r1036b1165],
2	.	.	O	.	_	0	SENT_653	[p15l946t1140r1036b1165],

1	95	CD	NUMBER	95	_	0	SENT_654	[p15l1049t1141r1080b1165],
2	:	:	O	:	_	0	SENT_654	[p15l1085t1141r1198b1166],
3	E204-8	CD	NUMBER	e204-8	num	5	SENT_654	[p15l1085t1141r1198b1166],
4	Shikata	NNP	ORGANIZATION	Shikata	nn	5	SENT_654	[p15l445t1183r546b1210],
5	E	NNP	ORGANIZATION	E	dep	1	SENT_654	[p15l553t1185r581b1215],
6	,	,	O	,	_	0	SENT_654	[p15l553t1185r581b1215],
7	Yamamoto	NNP	PERSON	Yamamoto	nn	8	SENT_654	[p15l589t1185r742b1210],
8	R	NNP	PERSON	R	appos	5	SENT_654	[p15l749t1185r779b1215],
9	,	,	O	,	_	0	SENT_654	[p15l749t1185r779b1215],
10	Takane	NNP	PERSON	Takane	nn	11	SENT_654	[p15l786t1183r891b1210],
11	H	NNP	PERSON	H	appos	5	SENT_654	[p15l898t1185r934b1215],
12	,	,	O	,	_	0	SENT_654	[p15l898t1185r934b1215],
13	Shigemasa	NNP	ORGANIZATION	Shigemasa	nn	14	SENT_654	[p15l943t1184r1089b1218],
14	C	NNP	ORGANIZATION	C	appos	5	SENT_654	[p15l1097t1184r1127b1215],
15	,	,	O	,	_	0	SENT_654	[p15l1097t1184r1127b1215],
16	Ikeda	NNP	PERSON	Ikeda	nn	17	SENT_654	[p15l1135t1183r1211b1210],
17	T	NN	O	t	appos	5	SENT_654	[p15l1217t1184r1250b1215],
18	,	,	O	,	_	0	SENT_654	[p15l1217t1184r1250b1215],
19	et	FW	O	et	nn	20	SENT_654	[p15l1259t1191r1284b1210],
20	al.	FW	O	al.	appos	5	SENT_654	[p15l1291t1183r1320b1210],
21	2	CD	NUMBER	2	number	22	SENT_654	[p15l1329t1185r1342b1209],
22	007	CD	NUMBER	007	dep	20	SENT_654	[p15l1347t1185r1404b1210],
23	.	.	O	.	_	0	SENT_654	[p15l1347t1185r1404b1210],

1	Human	JJ	O	human	amod	4	SENT_655	[p15l1412t1185r1519b1210],
2	organic	JJ	O	organic	amod	4	SENT_655	[p15l1526t1185r1630b1218],
3	cation	NN	O	cation	nn	4	SENT_655	[p15l1637t1185r1722b1210],
4	transporter	NN	O	transporter	_	0	SENT_655	[p15l1728t1191r1885b1218],
5	(	CD	NUMBER	(	num	6	SENT_655	[p15l444t1230r545b1262],
6	OCT1	NN	O	oct1	dep	4	SENT_655	[p15l444t1230r545b1262],
7	and	CC	O	and	_	0	SENT_655	[p15l556t1229r605b1255],
8	OCT2	NN	O	oct2	nn	11	SENT_655	[p15l613t1230r717b1262],
9	)	NN	O	)	nn	11	SENT_655	[p15l613t1230r717b1262],
10	gene	NN	O	gene	nn	11	SENT_655	[p15l725t1239r789b1264],
11	polymorphisms	NNS	O	polymorphism	dep	4	SENT_655	[p15l797t1229r1012b1264],
12	and	CC	O	and	_	0	SENT_655	[p15l1020t1229r1069b1255],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_655	[p15l1076t1229r1234b1264],
14	effects	NNS	O	effect	conj_and	6	SENT_655	[p15l1241t1230r1327b1255],
15	of	IN	O	of	_	0	SENT_655	[p15l1335t1230r1365b1255],
16	metformin	NN	O	metformin	nn	17	SENT_655	[p15l1368t1230r1554b1264],
17	]	NN	O	]	prep_of	14	SENT_655	[p15l1368t1230r1554b1264],
18	.	.	O	.	_	0	SENT_655	[p15l1368t1230r1554b1264],

1	Hum	NNP	O	Hum	_	0	SENT_656	[p15l1563t1231r1638b1255],
2	.	.	O	.	_	0	SENT_656	[p15l1563t1231r1638b1255],

1	Genet	NNP	PERSON	Genet	_	0	SENT_657	[p15l1650t1230r1730b1255],
2	.	.	O	.	_	0	SENT_657	[p15l1650t1230r1730b1255],

1	52:1	CD	NUMBER	52:1	num	4	SENT_658	[p15l1742t1231r1796b1256],
2	17-22	CD	NUMBER	17-22	num	4	SENT_658	[p15l1804t1231r1882b1256],
3	Zhou	NNP	O	Zhou	nn	4	SENT_658	[p15l443t1274r519b1300],
4	K	NNP	O	K	_	0	SENT_658	[p15l529t1275r561b1305],
5	,	,	O	,	_	0	SENT_658	[p15l529t1275r561b1305],
6	Donnelly	NNP	ORGANIZATION	Donnelly	nn	7	SENT_658	[p15l573t1274r705b1308],
7	LA	NNP	ORGANIZATION	LA	appos	4	SENT_658	[p15l714t1275r765b1305],
8	,	,	O	,	_	0	SENT_658	[p15l714t1275r765b1305],
9	Kimber	NNP	PERSON	Kimber	nn	10	SENT_658	[p15l777t1274r884b1300],
10	CH	NN	O	ch	appos	4	SENT_658	[p15l895t1275r955b1305],
11	,	,	O	,	_	0	SENT_658	[p15l895t1275r955b1305],
12	Donnan	NNP	PERSON	Donnan	nn	13	SENT_658	[p15l967t1275r1081b1300],
13	PT	NN	O	pt	appos	4	SENT_658	[p15l1091t1274r1144b1305],
14	,	,	O	,	_	0	SENT_658	[p15l1091t1274r1144b1305],
15	Doney	NNP	PERSON	Doney	nn	16	SENT_658	[p15l1156t1275r1251b1308],
16	AS	NNP	O	AS	appos	4	SENT_658	[p15l1259t1275r1307b1305],
17	,	,	O	,	_	0	SENT_658	[p15l1259t1275r1307b1305],
18	et	FW	O	et	nn	19	SENT_658	[p15l1319t1281r1345b1300],
19	al.	FW	O	al.	appos	4	SENT_658	[p15l1355t1274r1384b1300],
20	2009	CD	DATE	2009	dep	19	SENT_658	[p15l1397t1275r1471b1300],
21	.	.	O	.	_	0	SENT_658	[p15l1397t1275r1471b1300],

1	Reduced	VBN	O	reduce	_	0	SENT_659	[p15l1483t1274r1735b1300],
2	—	NN	O	—	nn	5	SENT_659	[p15l1483t1274r1735b1300],
3	function	NN	O	function	nn	5	SENT_659	[p15l1483t1274r1735b1300],
4	SLC22Al	NN	O	slc22al	nn	5	SENT_659	[p15l1747t1275r1882b1300],
5	polymorphisms	NNS	O	polymorphism	dobj	1	SENT_659	[p15l443t1319r659b1354],
6	encoding	VBG	O	encode	partmod	5	SENT_659	[p15l667t1319r795b1354],
7	organic	JJ	O	organic	amod	9	SENT_659	[p15l801t1321r905b1354],
8	cation	NN	O	cation	nn	9	SENT_659	[p15l912t1321r997b1345],
9	transporter	NN	O	transporter	dobj	6	SENT_659	[p15l1003t1327r1160b1354],
10	1	CD	NUMBER	1	dep	9	SENT_659	[p15l1169t1321r1179b1345],
11	and	CC	O	and	_	0	SENT_659	[p15l1190t1319r1239b1345],
12	glycemic	JJ	O	glycemic	amod	13	SENT_659	[p15l1246t1320r1369b1354],
13	response	NN	O	response	dobj	6	SENT_659	[p15l1375t1329r1496b1354],
14	to	TO	O	to	_	0	SENT_659	[p15l1503t1327r1531b1345],
15	metformin	NN	O	metformin	prep_to	13	SENT_659	[p15l1538t1320r1694b1345],
16	:	:	O	:	_	0	SENT_659	[p15l1538t1320r1694b1345],
17	a	DT	O	a	det	19	SENT_659	[p15l1703t1329r1716b1345],
18	GODARTS	NNP	O	GODARTS	nn	19	SENT_659	[p15l1724t1320r1884b1345],
19	study	NN	O	study	dep	9	SENT_659	[p15l444t1365r524b1400],
20	.	.	O	.	_	0	SENT_659	[p15l444t1365r524b1400],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_660	[p15l536t1366r645b1391],
2	5	CD	NUMBER	5	num	1	SENT_660	[p15l655t1366r668b1391],
3	8:1434	CD	NUMBER	8:1434	num	5	SENT_660	[p15l672t1367r815b1391],
4	-39	CD	NUMBER	-39	num	5	SENT_660	[p15l672t1367r815b1391],
5	TzvetkovMV	NN	O	tzvetkovmv	dep	1	SENT_660	[p15l443t1409r644b1440],
6	,	,	O	,	_	0	SENT_660	[p15l443t1409r644b1440],
7	Saadatmand	NNP	ORGANIZATION	Saadatmand	nn	8	SENT_660	[p15l652t1409r820b1435],
8	AR	NNS	ORGANIZATION	ar	appos	5	SENT_660	[p15l826t1410r878b1440],
9	,	,	O	,	_	0	SENT_660	[p15l826t1410r878b1440],
10	Bokelmann	NNP	PERSON	Bokelmann	nn	11	SENT_660	[p15l886t1409r1045b1435],
11	K	NNP	PERSON	K	appos	5	SENT_660	[p15l1051t1410r1082b1440],
12	,	,	O	,	_	0	SENT_660	[p15l1051t1410r1082b1440],
13	Meineke	NNP	O	Meineke	nn	14	SENT_660	[p15l1089t1409r1211b1435],
14	I	NNP	O	I	appos	5	SENT_660	[p15l1217t1410r1236b1440],
15	,	,	O	,	_	0	SENT_660	[p15l1217t1410r1236b1440],
16	Kaiser	NNP	PERSON	Kaiser	nn	17	SENT_660	[p15l1244t1410r1333b1435],
17	R	NNP	PERSON	R	appos	5	SENT_660	[p15l1339t1410r1368b1440],
18	,	,	O	,	_	0	SENT_660	[p15l1339t1410r1368b1440],
19	Brockmoller	NNP	O	Brockmoller	appos	5	SENT_660	[p15l1376t1409r1575b1441],
20	]	CD	NUMBER	]	num	19	SENT_660	[p15l1376t1409r1575b1441],
21	.	.	O	.	_	0	SENT_660	[p15l1376t1409r1575b1441],

1	2	CD	NUMBER	2	num	2	SENT_661	[p15l1583t1411r1596b1434],
2	010	CD	NUMBER	010	_	0	SENT_661	[p15l1601t1411r1658b1435],
3	.	.	O	.	_	0	SENT_661	[p15l1601t1411r1658b1435],

1	Effects	NNS	O	effect	_	0	SENT_662	[p15l1666t1409r1759b1435],
2	of	IN	O	of	_	0	SENT_662	[p15l1767t1409r1797b1435],
3	OCT	NN	DATE	oct	nn	5	SENT_662	[p15l1801t1410r1882b1435],
4	]	CD	NUMBER	]	num	5	SENT_662	[p15l1801t1410r1882b1435],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_662	[p15l443t1455r659b1489],
6	on	IN	O	on	_	0	SENT_662	[p15l673t1464r708b1481],
7	the	DT	O	the	det	9	SENT_662	[p15l722t1455r765b1481],
8	cellular	JJ	O	cellular	amod	9	SENT_662	[p15l780t1455r882b1481],
9	uptake	NN	O	uptake	prep_on	1	SENT_662	[p15l895t1455r995b1489],
10	,	,	O	,	_	0	SENT_662	[p15l895t1455r995b1489],
11	plasma	NN	O	plasma	nn	12	SENT_662	[p15l1009t1455r1105b1489],
12	concentrations	NNS	O	concentration	prep_on	1	SENT_662	[p15l1119t1456r1324b1481],
13	and	CC	O	and	_	0	SENT_662	[p15l1339t1455r1388b1481],
14	efﬁcacy	NN	O	efﬁcacy	conj_and	9	SENT_662	[p15l1403t1455r1505b1489],
15	of	IN	O	of	_	0	SENT_662	[p15l1518t1455r1549b1481],
16	the	DT	O	the	det	17	SENT_662	[p15l1559t1455r1602b1481],
17	5-HT	NN	O	5-ht	prep_of	14	SENT_662	[p15l1618t1455r1711b1486],
18	;	:	O	;	_	0	SENT_662	[p15l1618t1455r1711b1486],
19	antagonists	NNS	O	antagonist	dep	1	SENT_662	[p15l1729t1456r1884b1489],
20	tropisetron	NN	O	tropisetron	dep	19	SENT_662	[p15l444t1502r599b1534],
21	and	CC	O	and	_	0	SENT_662	[p15l609t1500r659b1526],
22	ondansetron	NN	O	ondansetron	dep	19	SENT_662	[p15l669t1500r850b1526],
23	.	.	O	.	_	0	SENT_662	[p15l669t1500r850b1526],

1	Plyarrnaeogenomies	NNS	O	plyarrnaeogenomy	_	0	SENT_663	[p15l860t1501r1133b1535],
2	]	CD	NUMBER	]	num	1	SENT_663	[p15l860t1501r1133b1535],
3	.	.	O	.	_	0	SENT_663	[p15l860t1501r1133b1535],

1	In	IN	O	in	dep	10	SENT_664	[p15l1146t1502r1175b1526],
2	press	NN	O	press	pobj	1	SENT_664	[p15l1185t1510r1262b1534],
3	,	,	O	,	_	0	SENT_664	[p15l1185t1510r1262b1534],
4	doi	FW	O	doi	appos	2	SENT_664	[p15l1274t1500r1606b1535],
5	:10.1038	CD	NUMBER	:10.1038	dep	4	SENT_664	[p15l1274t1500r1606b1535],
6	/	:	O	/	punct	10	SENT_664	[p15l1274t1500r1606b1535],
7	tpj	NN	O	tpj	nn	10	SENT_664	[p15l1274t1500r1606b1535],
8	.2010.75	CD	NUMBER	.2010.75	num	10	SENT_664	[p15l1274t1500r1606b1535],
9	Thomas	NNP	PERSON	Thomas	nn	10	SENT_664	[p15l442t1544r587b1576],
10	]	NNP	O	]	_	0	SENT_664	[p15l442t1544r587b1576],
11	,	,	O	,	_	0	SENT_664	[p15l442t1544r587b1576],
12	Wang	NNP	PERSON	Wang	nn	13	SENT_664	[p15l596t1545r684b1579],
13	L	NNP	PERSON	L	appos	10	SENT_664	[p15l692t1545r721b1576],
14	,	,	O	,	_	0	SENT_664	[p15l692t1545r721b1576],
15	Clark	NNP	PERSON	Clark	nn	16	SENT_664	[p15l732t1544r810b1570],
16	RE	NNP	PERSON	RE	appos	10	SENT_664	[p15l819t1546r871b1576],
17	,	,	O	,	_	0	SENT_664	[p15l819t1546r871b1576],
18	Pirmohamed	NNP	O	Pirmohamed	nn	19	SENT_664	[p15l881t1544r1063b1570],
19	M.	NNP	O	M.	appos	10	SENT_664	[p15l1071t1545r1110b1570],
20	2004	CD	DATE	2004	dep	19	SENT_664	[p15l1121t1546r1196b1570],
21	.	.	O	.	_	0	SENT_664	[p15l1121t1546r1196b1570],

1	Active	JJ	O	active	amod	2	SENT_665	[p15l1205t1545r1293b1570],
2	transport	NN	O	transport	_	0	SENT_665	[p15l1302t1552r1431b1578],
3	of	IN	O	of	_	0	SENT_665	[p15l1440t1544r1470b1570],
4	imatinib	NN	O	imatinib	prep_of	2	SENT_665	[p15l1476t1544r1592b1570],
5	into	IN	O	into	prep	4	SENT_665	[p15l1601t1546r1657b1570],
6	and	CC	O	and	_	0	SENT_665	[p15l1667t1544r1716b1570],
7	out	IN	O	out	conj_and	5	SENT_665	[p15l1726t1552r1772b1570],
8	of	IN	O	of	pcomp	5	SENT_665	[p15l1781t1544r1811b1570],
9	cells	NNS	O	cell	pobj	8	SENT_665	[p15l1817t1544r1883b1570],
10	:	:	O	:	_	0	SENT_665	[p15l1817t1544r1883b1570],
11	implications	NNS	O	implication	dep	2	SENT_665	[p15l443t1589r613b1624],
12	for	IN	O	for	_	0	SENT_665	[p15l624t1590r664b1615],
13	drug	NN	O	drug	nn	14	SENT_665	[p15l674t1589r739b1624],
14	resistance	NN	O	resistance	prep_for	11	SENT_665	[p15l748t1591r890b1615],
15	.	.	O	.	_	0	SENT_665	[p15l748t1591r890b1615],

1	Blood	NN	O	blood	nn	5	SENT_666	[p15l901t1590r972b1615],
2	104:3739	CD	NUMBER	104:3739	num	5	SENT_666	[p15l983t1590r1158b1616],
3	-45	CD	NUMBER	-45	num	5	SENT_666	[p15l983t1590r1158b1616],
4	White	NNP	O	White	nn	5	SENT_666	[p15l443t1633r532b1659],
5	DL	NNP	O	DL	_	0	SENT_666	[p15l543t1635r599b1665],
6	,	,	O	,	_	0	SENT_666	[p15l543t1635r599b1665],
7	Dang	NNP	PERSON	Dang	nn	8	SENT_666	[p15l610t1635r688b1668],
8	P	NN	O	p	appos	5	SENT_666	[p15l696t1635r723b1665],
9	,	,	O	,	_	0	SENT_666	[p15l696t1635r723b1665],
10	Engler	NNP	PERSON	Engler	appos	5	SENT_666	[p15l734t1633r857b1668],
11	]	CD	NUMBER	]	num	10	SENT_666	[p15l734t1633r857b1668],
12	,	,	O	,	_	0	SENT_666	[p15l734t1633r857b1668],
13	Frede	NNP	PERSON	Frede	nn	14	SENT_666	[p15l868t1633r948b1659],
14	A	NNP	PERSON	A	appos	5	SENT_666	[p15l957t1634r986b1665],
15	,	,	O	,	_	0	SENT_666	[p15l957t1634r986b1665],
16	Zrim	NNP	O	Zrim	nn	17	SENT_666	[p15l997t1633r1069b1659],
17	S	NNP	O	S	appos	5	SENT_666	[p15l1079t1634r1103b1665],
18	,	,	O	,	_	0	SENT_666	[p15l1079t1634r1103b1665],
19	et	FW	O	et	nn	20	SENT_666	[p15l1114t1641r1140b1659],
20	al.	FW	O	al.	appos	5	SENT_666	[p15l1149t1633r1179b1659],
21	2010	CD	DATE	2010	dep	20	SENT_666	[p15l1190t1635r1265b1659],
22	.	.	O	.	_	0	SENT_666	[p15l1190t1635r1265b1659],

1	Functional	JJ	O	functional	_	0	SENT_667	[p15l1276t1633r1426b1659],
2	activity	NN	O	activity	dobj	6	SENT_667	[p15l1436t1635r1538b1668],
3	of	IN	O	of	_	0	SENT_667	[p15l1546t1633r1577b1659],
4	the	DT	O	the	det	5	SENT_667	[p15l1583t1633r1626b1659],
5	OCT-1	NN	MISC	oct-1	prep_of	2	SENT_667	[p15l1637t1634r1740b1659],
6	protein	NN	O	protein	dep	1	SENT_667	[p15l1753t1635r1855b1667],
7	is	VBZ	O	be	cop	8	SENT_667	[p15l1864t1635r1884b1659],
8	predictive	JJ	O	predictive	ccomp	6	SENT_667	[p15l443t1679r581b1713],
9	of	IN	O	of	_	0	SENT_667	[p15l592t1679r622b1705],
10	long-term	JJ	O	long-term	amod	11	SENT_667	[p15l628t1679r770b1713],
11	outcome	NN	O	outcome	prep_of	8	SENT_667	[p15l780t1686r901b1705],
12	in	IN	O	in	_	0	SENT_667	[p15l911t1681r938b1705],
13	patients	NNS	O	patient	prep_in	11	SENT_667	[p15l947t1680r1056b1713],
14	with	IN	O	with	_	0	SENT_667	[p15l1066t1679r1128b1705],
15	chronic-phase	JJ	O	chronic-phase	amod	18	SENT_667	[p15l1138t1679r1334b1713],
16	chronic	JJ	O	chronic	amod	18	SENT_667	[p15l1345t1679r1450b1705],
17	myeloid	JJ	O	myeloid	amod	18	SENT_667	[p15l1460t1679r1572b1713],
18	leukemia	NN	O	leukemia	prep_with	13	SENT_667	[p15l1582t1679r1707b1705],
19	treated	VBN	O	treat	partmod	18	SENT_667	[p15l1717t1679r1814b1705],
20	with	IN	O	with	_	0	SENT_667	[p15l1823t1679r1885b1705],
21	imatinib	NN	O	imatinib	prep_with	19	SENT_667	[p15l443t1725r599b1759],
22	.	.	O	.	_	0	SENT_667	[p15l443t1725r599b1759],
23	]	SYM	O	]	dep	1	SENT_667	[p15l443t1725r599b1759],

1	.	.	O	.	_	0	SENT_668	[p15l443t1725r599b1759],

1	Clin	NNP	O	Clin	_	0	SENT_669	[p15l613t1726r673b1751],
2	.	.	O	.	_	0	SENT_669	[p15l613t1726r673b1751],

1	Oncol	NN	O	oncol	_	0	SENT_670	[p15l687t1726r764b1751],
2	.	.	O	.	_	0	SENT_670	[p15l687t1726r764b1751],

1	28:276	CD	NUMBER	28:276	num	2	SENT_671	[p15l777t1726r937b1751],
2	l	NN	O	l	_	0	SENT_671	[p15l777t1726r937b1751],
3	—	CD	NUMBER	—	number	4	SENT_671	[p15l777t1726r937b1751],
4	67	CD	NUMBER	67	num	7	SENT_671	[p15l777t1726r937b1751],
5	Engler	NNP	PERSON	Engler	nn	7	SENT_671	[p15l444t1769r587b1803],
6	]	CD	NUMBER	]	num	7	SENT_671	[p15l444t1769r587b1803],
7	R	NN	O	r	dep	2	SENT_671	[p15l444t1769r587b1803],
8	,	,	O	,	_	0	SENT_671	[p15l444t1769r587b1803],
9	Hughes	NNP	ORGANIZATION	Hughes	nn	10	SENT_671	[p15l594t1769r703b1803],
10	TP	NNP	ORGANIZATION	TP	appos	2	SENT_671	[p15l709t1769r763b1800],
11	,	,	O	,	_	0	SENT_671	[p15l709t1769r763b1800],
12	White	NNP	O	White	nn	13	SENT_671	[p15l770t1769r860b1795],
13	DL	NNP	O	DL	appos	10	SENT_671	[p15l867t1770r923b1795],
14	.	.	O	.	_	0	SENT_671	[p15l867t1770r923b1795],

1	2011	CD	DATE	2011	_	0	SENT_672	[p15l932t1770r1006b1795],
2	.	.	O	.	_	0	SENT_672	[p15l932t1770r1006b1795],

1	OCT-1	NN	O	oct-1	_	0	SENT_673	[p15l1015t1769r1119b1795],
2	as	IN	O	as	_	0	SENT_673	[p15l1129t1779r1154b1795],
3	a	DT	O	a	det	4	SENT_673	[p15l1161t1779r1174b1795],
4	determinant	NN	O	determinant	prep_as	1	SENT_673	[p15l1182t1769r1353b1795],
5	of	IN	O	of	_	0	SENT_673	[p15l1359t1769r1390b1795],
6	response	NN	O	response	prep_of	4	SENT_673	[p15l1392t1778r1513b1803],
7	to	TO	O	to	_	0	SENT_673	[p15l1521t1776r1548b1795],
8	antileukemic	JJ	O	antileukemic	amod	9	SENT_673	[p15l1555t1769r1733b1795],
9	treatment	NN	O	treatment	prep_to	1	SENT_673	[p15l1740t1776r1883b1795],
10	.	.	O	.	_	0	SENT_673	[p15l1740t1776r1883b1795],

1	Clin	NNP	O	Clin	_	0	SENT_674	[p15l445t1816r505b1841],
2	.	.	O	.	_	0	SENT_674	[p15l445t1816r505b1841],

1	Pbawnaeol	NNP	O	Pbawnaeol	_	0	SENT_675	[p15l517t1816r661b1841],
2	.	.	O	.	_	0	SENT_675	[p15l517t1816r661b1841],

1	Tber	NNP	O	Tber	_	0	SENT_676	[p15l675t1816r743b1841],
2	.	.	O	.	_	0	SENT_676	[p15l675t1816r743b1841],

1	89:608	CD	NUMBER	89:608	number	2	SENT_677	[p15l756t1816r897b1841],
2	—	CD	NUMBER	—	num	3	SENT_677	[p15l756t1816r897b1841],
3	ll	NN	O	ll	_	0	SENT_677	[p15l756t1816r897b1841],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_677	[p15l443t1859r535b1894],
5	S	NNP	PERSON	S	dep	3	SENT_677	[p15l549t1860r572b1891],
6	,	,	O	,	_	0	SENT_677	[p15l549t1860r572b1891],
7	Lovejoy	NNP	ORGANIZATION	Lovejoy	nn	8	SENT_677	[p15l587t1860r701b1894],
8	KS	NN	ORGANIZATION	k	appos	5	SENT_677	[p15l713t1860r763b1890],
9	,	,	O	,	_	0	SENT_677	[p15l713t1860r763b1890],
10	Shima	NNP	PERSON	Shima	nn	12	SENT_677	[p15l779t1859r866b1885],
11	]	CD	NUMBER	]	num	12	SENT_677	[p15l875t1860r921b1891],
12	E	NN	O	e	appos	5	SENT_677	[p15l875t1860r921b1891],
13	,	,	O	,	_	0	SENT_677	[p15l875t1860r921b1891],
14	Lagpacan	NNP	PERSON	Lagpacan	nn	15	SENT_677	[p15l936t1860r1070b1894],
15	LL	NNP	O	LL	appos	5	SENT_677	[p15l1083t1860r1135b1891],
16	,	,	O	,	_	0	SENT_677	[p15l1083t1860r1135b1891],
17	Shu	NNP	O	Shu	nn	18	SENT_677	[p15l1151t1859r1204b1885],
18	Y	NN	O	y	appos	5	SENT_677	[p15l1216t1860r1246b1891],
19	,	,	O	,	_	0	SENT_677	[p15l1216t1860r1246b1891],
20	et	FW	O	et	nn	21	SENT_677	[p15l1261t1866r1287b1885],
21	al.	FW	O	al.	appos	5	SENT_677	[p15l1300t1859r1329b1885],
22	2006	CD	DATE	2006	dep	21	SENT_677	[p15l1345t1860r1419b1885],
23	.	.	O	.	_	0	SENT_677	[p15l1345t1860r1419b1885],

1	Organic	NNP	O	Organic	nn	3	SENT_678	[p15l1435t1860r1548b1894],
2	cation	NN	O	cation	nn	3	SENT_678	[p15l1563t1860r1647b1885],
3	transporters	NNS	O	transporter	nsubj	5	SENT_678	[p15l1661t1866r1829b1893],
4	are	VBP	O	be	cop	5	SENT_678	[p15l1843t1869r1885b1885],
5	determinants	NNS	O	determinant	_	0	SENT_678	[p15l444t1904r626b1930],
6	of	IN	O	of	_	0	SENT_678	[p15l637t1904r667b1930],
7	oxaliplatin	NN	O	oxaliplatin	nn	8	SENT_678	[p15l674t1904r819b1938],
8	cytotoxicity	NN	O	cytotoxicity	prep_of	5	SENT_678	[p15l829t1905r998b1938],
9	.	.	O	.	_	0	SENT_678	[p15l829t1905r998b1938],

1	Cancer	NN	O	cancer	_	0	SENT_679	[p15l1011t1905r1101b1930],
2	Res	NNP	O	Res	dep	1	SENT_679	[p15l1108t1905r1157b1930],
3	.	.	O	.	_	0	SENT_679	[p15l1108t1905r1157b1930],

1	66:8847	CD	NUMBER	66:8847	number	2	SENT_680	[p15l1170t1905r1312b1930],
2	—	CD	NUMBER	—	num	4	SENT_680	[p15l1170t1905r1312b1930],
3	5	CD	NUMBER	5	number	4	SENT_680	[p15l1170t1905r1312b1930],
4	7	CD	NUMBER	7	_	0	SENT_680	[p15l1316t1905r1330b1930],
5	Li	NNP	O	Li	nn	6	SENT_680	[p15l444t1947r474b1972],
6	S	NN	O	s	dep	4	SENT_680	[p15l484t1947r508b1978],
7	,	,	O	,	_	0	SENT_680	[p15l484t1947r508b1978],
8	Chen	NNP	LOCATION	Chen	nn	9	SENT_680	[p15l519t1946r595b1973],
9	Y	NN	LOCATION	y	appos	6	SENT_680	[p15l603t1947r632b1978],
10	,	,	O	,	_	0	SENT_680	[p15l603t1947r632b1978],
11	Zhang	NNP	PERSON	Zhang	nn	12	SENT_680	[p15l642t1946r734b1981],
12	S	NNP	PERSON	S	appos	6	SENT_680	[p15l743t1947r767b1978],
13	,	,	O	,	_	0	SENT_680	[p15l743t1947r767b1978],
14	More	JJR	O	more	amod	15	SENT_680	[p15l776t1947r853b1972],
15	SS	NN	O	ss	appos	6	SENT_680	[p15l864t1947r906b1978],
16	,	,	O	,	_	0	SENT_680	[p15l864t1947r906b1978],
17	Huang	NNP	PERSON	Huang	nn	18	SENT_680	[p15l916t1947r1013b1981],
18	X	NNP	PERSON	X	appos	6	SENT_680	[p15l1020t1947r1052b1978],
19	,	,	O	,	_	0	SENT_680	[p15l1020t1947r1052b1978],
20	Giacomini	NNP	PERSON	Giacomini	nn	21	SENT_680	[p15l1063t1947r1209b1973],
21	KM	NNP	O	KM	appos	6	SENT_680	[p15l1219t1947r1282b1972],
22	.	.	O	.	_	0	SENT_680	[p15l1219t1947r1282b1972],

1	2011	CD	DATE	2011	_	0	SENT_681	[p15l1293t1948r1367b1972],
2	.	.	O	.	_	0	SENT_681	[p15l1293t1948r1367b1972],

1	Role	NN	O	role	_	0	SENT_682	[p15l1378t1946r1442b1972],
2	of	IN	O	of	_	0	SENT_682	[p15l1452t1946r1482b1972],
3	organic	JJ	O	organic	amod	5	SENT_682	[p15l1488t1948r1592b1981],
4	cation	NN	O	cation	nn	5	SENT_682	[p15l1601t1948r1686b1972],
5	transporter	NN	O	transporter	prep_of	1	SENT_682	[p15l1695t1954r1851b1981],
6	1	CD	NUMBER	1	dep	5	SENT_682	[p15l1863t1948r1883b1978],
7	,	,	O	,	_	0	SENT_682	[p15l1863t1948r1883b1978],
8	OCT1	NN	O	oct1	conj_and	5	SENT_682	[p15l444t1990r535b2015],
9	in	IN	O	in	_	0	SENT_682	[p15l546t1990r573b2014],
10	the	DT	O	the	det	11	SENT_682	[p15l582t1989r625b2015],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	8	SENT_682	[p15l633t1989r878b2023],
12	and	CC	O	and	_	0	SENT_682	[p15l887t1989r936b2015],
13	toxicity	NN	O	toxicity	conj_and	5	SENT_682	[p15l945t1990r1049b2023],
14	of	IN	O	of	_	0	SENT_682	[p15l1056t1989r1087b2015],
15	cis-diammine	JJ	O	cis-diammine	amod	20	SENT_682	[p15l1091t1989r1672b2023],
16	(	NN	O	(	nn	20	SENT_682	[p15l1091t1989r1672b2023],
17	pyridine	NN	O	pyridine	nn	20	SENT_682	[p15l1091t1989r1672b2023],
18	)	CD	NUMBER	)	num	20	SENT_682	[p15l1091t1989r1672b2023],
19	chloroplatinum	NN	O	chloroplatinum	nn	20	SENT_682	[p15l1091t1989r1672b2023],
20	(	NN	O	(	prep_of	13	SENT_682	[p15l1091t1989r1672b2023],
21	II	CD	NUMBER	ii	num	22	SENT_682	[p15l1091t1989r1672b2023],
22	)	NN	O	)	dep	20	SENT_682	[p15l1091t1989r1672b2023],
23	and	CC	O	and	_	0	SENT_682	[p15l1682t1989r1731b2015],
24	oxaliplatin	NN	O	oxaliplatin	prep_of	13	SENT_682	[p15l1740t1989r1885b2023],
25	in	IN	O	in	_	0	SENT_682	[p15l443t2034r470b2058],
26	mice	NNS	O	mouse	prep_in	24	SENT_682	[p15l480t2034r553b2058],
27	.	.	O	.	_	0	SENT_682	[p15l480t2034r553b2058],

1	P/yawn	NN	O	p/yawn	_	0	SENT_683	[p15l563t2033r660b2058],
2	.	.	O	.	_	0	SENT_683	[p15l563t2033r660b2058],

1	Res	NNP	O	Res	_	0	SENT_684	[p15l671t2033r720b2058],
2	.	.	O	.	_	0	SENT_684	[p15l671t2033r720b2058],

1	282610-25	CD	NUMBER	282610-25	num	3	SENT_685	[p15l733t2033r875b2058],
2	Filipski	NNP	ORGANIZATION	Filipski	nn	3	SENT_685	[p15l444t2075r546b2110],
3	KK	NNP	ORGANIZATION	KK	_	0	SENT_685	[p15l554t2076r611b2107],
4	,	,	O	,	_	0	SENT_685	[p15l554t2076r611b2107],
5	Mathijssen	NNP	PERSON	Mathijssen	nn	6	SENT_685	[p15l618t2075r771b2110],
6	RH	NNP	O	RH	appos	3	SENT_685	[p15l779t2076r837b2107],
7	,	,	O	,	_	0	SENT_685	[p15l779t2076r837b2107],
8	Mikkelsen	NNP	PERSON	Mikkelsen	nn	9	SENT_685	[p15l845t2075r990b2101],
9	TS	NN	O	t	appos	3	SENT_685	[p15l997t2076r1048b2107],
10	,	,	O	,	_	0	SENT_685	[p15l997t2076r1048b2107],
11	Schinkel	NNP	PERSON	Schinkel	nn	12	SENT_685	[p15l1058t2075r1177b2101],
12	AH	NNP	O	AH	appos	3	SENT_685	[p15l1183t2076r1242b2107],
13	,	,	O	,	_	0	SENT_685	[p15l1183t2076r1242b2107],
14	Sparreboom	NNP	O	Sparreboom	nn	15	SENT_685	[p15l1252t2075r1423b2110],
15	A.	NNP	O	A.	appos	3	SENT_685	[p15l1430t2076r1459b2101],
16	2009	CD	DATE	2009	dep	15	SENT_685	[p15l1469t2077r1543b2101],
17	.	.	O	.	_	0	SENT_685	[p15l1469t2077r1543b2101],

1	Contribution	NN	O	contribution	nsubj	13	SENT_686	[p15l1553t2075r1738b2101],
2	of	IN	O	of	_	0	SENT_686	[p15l1746t2075r1777b2101],
3	organic	JJ	O	organic	amod	5	SENT_686	[p15l1781t2077r1885b2110],
4	cation	NN	O	cation	nn	5	SENT_686	[p15l444t2120r529b2144],
5	transporter	NN	O	transporter	prep_of	1	SENT_686	[p15l538t2126r695b2153],
6	2	CD	NUMBER	2	number	7	SENT_686	[p15l705t2120r718b2144],
7	(	CD	NUMBER	(	num	9	SENT_686	[p15l731t2119r845b2151],
8	OCT2	NN	O	oct2	nn	9	SENT_686	[p15l731t2119r845b2151],
9	)	NN	O	)	dep	5	SENT_686	[p15l731t2119r845b2151],
10	to	TO	O	to	_	0	SENT_686	[p15l856t2126r883b2144],
11	cisplatin	NN	O	cisplatin	nn	12	SENT_686	[p15l893t2118r1133b2153],
12	—	NN	O	—	prep_to	9	SENT_686	[p15l893t2118r1133b2153],
13	induced	VBD	O	induce	_	0	SENT_686	[p15l893t2118r1133b2153],
14	nephrotoxicity	NN	O	nephrotoxicity	dobj	13	SENT_686	[p15l1142t2118r1353b2153],
15	.	.	O	.	_	0	SENT_686	[p15l1142t2118r1353b2153],

1	Clin	NNP	O	Clin	_	0	SENT_687	[p15l1366t2119r1426b2144],
2	.	.	O	.	_	0	SENT_687	[p15l1366t2119r1426b2144],

1	P/yawnacol	NN	O	p/yawnacol	_	0	SENT_688	[p15l1438t2119r1582b2144],
2	.	.	O	.	_	0	SENT_688	[p15l1438t2119r1582b2144],

1	T/yer	NN	O	t/yer	_	0	SENT_689	[p15l1596t2119r1664b2144],
2	.	.	O	.	_	0	SENT_689	[p15l1596t2119r1664b2144],

1	86:396	CD	NUMBER	86:396	num	3	SENT_690	[p15l1678t2120r1836b2145],
2	-402	CD	NUMBER	-402	num	3	SENT_690	[p15l1678t2120r1836b2145],
3	Ciarimboli	NNS	MISC	ciarimbolus	_	0	SENT_690	[p15l444t2161r595b2187],
4	G	NN	O	g	dep	3	SENT_690	[p15l606t2162r639b2193],
5	,	,	O	,	_	0	SENT_690	[p15l606t2162r639b2193],
6	Deuster	NN	O	deuster	nn	7	SENT_690	[p15l651t2162r762b2187],
7	D	NN	O	d	appos	4	SENT_690	[p15l772t2162r805b2193],
8	,	,	O	,	_	0	SENT_690	[p15l772t2162r805b2193],
9	Knief	NNP	PERSON	Knief	nn	10	SENT_690	[p15l816t2161r898b2187],
10	A	NNP	O	A	appos	4	SENT_690	[p15l903t2162r932b2193],
11	,	,	O	,	_	0	SENT_690	[p15l903t2162r932b2193],
12	Sperling	NNP	O	Sperling	nn	13	SENT_690	[p15l944t2161r1062b2196],
13	M	NNP	O	M	appos	4	SENT_690	[p15l1069t2162r1109b2193],
14	,	,	O	,	_	0	SENT_690	[p15l1069t2162r1109b2193],
15	Holtkamp	NNP	PERSON	Holtkamp	nn	16	SENT_690	[p15l1120t2161r1262b2196],
16	M	NNP	O	M	appos	4	SENT_690	[p15l1271t2162r1311b2193],
17	,	,	O	,	_	0	SENT_690	[p15l1271t2162r1311b2193],
18	et	FW	O	et	nn	19	SENT_690	[p15l1322t2169r1348b2187],
19	al.	FW	O	al.	appos	4	SENT_690	[p15l1357t2161r1387b2187],
20	2010	CD	DATE	2010	dep	19	SENT_690	[p15l1398t2163r1473b2187],
21	.	.	O	.	_	0	SENT_690	[p15l1398t2163r1473b2187],

1	Organic	NNP	O	Organic	nn	3	SENT_691	[p15l1485t2162r1598b2196],
2	cation	NN	O	cation	nn	3	SENT_691	[p15l1608t2162r1693b2187],
3	transporter	NN	O	transporter	nsubj	5	SENT_691	[p15l1703t2168r1859b2196],
4	2	CD	NUMBER	2	dep	3	SENT_691	[p15l1869t2163r1882b2187],
5	mediates	VBZ	O	mediate	_	0	SENT_691	[p15l443t2207r565b2233],
6	cisplatin	NN	O	cisplatin	nn	7	SENT_691	[p15l578t2207r817b2241],
7	—	NN	O	—	dobj	5	SENT_691	[p15l578t2207r817b2241],
8	induced	VBD	O	induce	partmod	7	SENT_691	[p15l578t2207r817b2241],
9	oto	SYM	O	oto	dep	12	SENT_691	[p15l829t2214r887b2233],
10	-	:	O	-	_	0	SENT_691	[p15l829t2214r887b2233],
11	and	CC	O	and	cc	12	SENT_691	[p15l899t2207r948b2233],
12	nephrotoxicity	NN	O	nephrotoxicity	dep	7	SENT_691	[p15l960t2207r1165b2241],
13	and	CC	O	and	cc	16	SENT_691	[p15l1176t2207r1225b2233],
14	is	VBZ	O	be	cop	16	SENT_691	[p15l1236t2208r1257b2233],
15	a	DT	O	a	det	16	SENT_691	[p15l1269t2217r1282b2233],
16	target	NN	O	target	dep	12	SENT_691	[p15l1294t2214r1376b2241],
17	for	IN	O	for	_	0	SENT_691	[p15l1387t2207r1427b2233],
18	protective	JJ	O	protective	amod	19	SENT_691	[p15l1438t2208r1577b2241],
19	interventions	NNS	O	intervention	prep_for	16	SENT_691	[p15l1589t2208r1780b2233],
20	.	.	O	.	_	0	SENT_691	[p15l1589t2208r1780b2233],

1	Am	NNP	O	Am	_	0	SENT_692	[p15l1790t2208r1847b2232],
2	.	.	O	.	_	0	SENT_692	[p15l1790t2208r1847b2232],

1	o	NN	O	o	_	0	SENT_693	[p15l1857t2207r1882b2241],
2	*	CD	NUMBER	*	num	3	SENT_693	[p15l1857t2207r1882b2241],
3	Patbol	NN	O	patbol	dep	1	SENT_693	[p15l443t2253r532b2278],
4	.	.	O	.	_	0	SENT_693	[p15l443t2253r532b2278],

1	176	CD	NUMBER	176	_	0	SENT_694	[p15l547t2253r602b2278],
2	:	:	O	:	_	0	SENT_694	[p15l547t2253r602b2278],
3	1	CD	NUMBER	1	num	4	SENT_694	[p15l608t2254r618b2277],
4	169-80	CD	NUMBER	169-80	dep	1	SENT_694	[p15l625t2254r723b2278],
5	Tanihara	NNP	O	Tanihara	nn	6	SENT_694	[p15l443t2295r571b2321],
6	Y	NN	O	y	dep	4	SENT_694	[p15l579t2296r608b2326],
7	,	,	O	,	_	0	SENT_694	[p15l579t2296r608b2326],
8	Masuda	NNP	PERSON	Masuda	nn	9	SENT_694	[p15l617t2295r727b2321],
9	S	NNP	O	S	appos	6	SENT_694	[p15l736t2296r760b2326],
10	,	,	O	,	_	0	SENT_694	[p15l736t2296r760b2326],
11	Katsura	NNP	ORGANIZATION	Katsura	nn	12	SENT_694	[p15l770t2296r877b2321],
12	T	NN	ORGANIZATION	t	appos	6	SENT_694	[p15l885t2295r918b2326],
13	,	,	O	,	_	0	SENT_694	[p15l885t2295r918b2326],
14	Inui	NNP	LOCATION	Inui	nn	15	SENT_694	[p15l928t2296r984b2321],
15	K.	NNP	O	K.	appos	6	SENT_694	[p15l993t2296r1024b2320],
16	2009	CD	DATE	2009	dep	15	SENT_694	[p15l1035t2297r1109b2321],
17	.	.	O	.	_	0	SENT_694	[p15l1035t2297r1109b2321],

1	Protective	JJ	O	protective	amod	2	SENT_695	[p15l1119t2296r1262b2321],
2	effect	NN	O	effect	nsubj	11	SENT_695	[p15l1272t2295r1347b2321],
3	of	IN	O	of	_	0	SENT_695	[p15l1355t2295r1385b2321],
4	concomitant	JJ	O	concomitant	amod	5	SENT_695	[p15l1391t2296r1566b2321],
5	administration	NN	O	administration	prep_of	2	SENT_695	[p15l1574t2295r1777b2321],
6	of	IN	O	of	_	0	SENT_695	[p15l1786t2295r1817b2321],
7	imatinib	NN	O	imatinib	prep_of	5	SENT_695	[p15l1821t2296r1884b2321, p15l444t2337r508b2363],
8	on	IN	O	on	_	0	SENT_695	[p15l519t2347r554b2363],
9	cisplatin	NN	O	cisplatin	nn	10	SENT_695	[p15l564t2337r803b2371],
10	—	NN	O	—	prep_on	7	SENT_695	[p15l564t2337r803b2371],
11	induced	VBD	O	induce	_	0	SENT_695	[p15l564t2337r803b2371],
12	nephrotoxicity	NN	O	nephrotoxicity	dobj	11	SENT_695	[p15l814t2337r1019b2371],
13	focusing	VBG	O	focus	partmod	12	SENT_695	[p15l1028t2337r1146b2371],
14	on	IN	O	on	_	0	SENT_695	[p15l1155t2347r1190b2363],
15	renal	JJ	O	renal	amod	19	SENT_695	[p15l1200t2337r1270b2363],
16	organic	JJ	O	organic	amod	19	SENT_695	[p15l1281t2338r1384b2371],
17	cation	NN	O	cation	nn	19	SENT_695	[p15l1395t2338r1480b2363],
18	transporter	NN	O	transporter	nn	19	SENT_695	[p15l1490t2344r1646b2371],
19	OCT2	NN	O	oct2	prep_on	13	SENT_695	[p15l1657t2338r1758b2363],
20	.	.	O	.	_	0	SENT_695	[p15l1657t2338r1758b2363],

1	Bioclyem	NNP	O	Bioclyem	_	0	SENT_696	[p15l1769t2338r1882b2363],
2	.	.	O	.	_	0	SENT_696	[p15l1769t2338r1882b2363],

1	Pbarmacol	NNP	O	Pbarmacol	_	0	SENT_697	[p15l443t2381r586b2406],
2	.	.	O	.	_	0	SENT_697	[p15l443t2381r586b2406],

1	78:1263	CD	NUMBER	78:1263	_	0	SENT_698	[p15l600t2381r758b2407],
2	—	CD	NUMBER	—	num	3	SENT_698	[p15l600t2381r758b2407],
3	71	CD	NUMBER	71	dep	1	SENT_698	[p15l600t2381r758b2407],

1	www.annnalreview5.org	NN	O	www.annnalreview5.org	nn	2	SENT_699	[p15l1356t2482r1630b2512],
2	o	NN	O	o	_	0	SENT_699	[p15l1645t2490r1654b2500],
3	Drag	VB	O	drag	dep	2	SENT_699	[p15l1671t2482r1734b2512],
4	Transporterx	NN	O	transporterx	dobj	3	SENT_699	[p15l1742t2482r1886b2511],
5	265	CD	NUMBER	265	num	4	SENT_699	[p15l1937t2482r1979b2511],

1	Franke	NNP	PERSON	Franke	nn	2	SENT_700	[p15l642t2520r739b2546],
2	RM	NN	O	rm	_	0	SENT_700	[p15l753t2521r815b2551],
3	,	,	O	,	_	0	SENT_700	[p15l753t2521r815b2551],
4	Kosloske	NNP	ORGANIZATION	Kosloske	nn	5	SENT_700	[p15l830t2520r955b2546],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_700	[p15l969t2521r1030b2551],
6	,	,	O	,	_	0	SENT_700	[p15l969t2521r1030b2551],
7	Lancaster	NNP	ORGANIZATION	Lancaster	nn	8	SENT_700	[p15l1046t2521r1182b2546],
8	CS	NNP	ORGANIZATION	CS	appos	2	SENT_700	[p15l1196t2521r1246b2551],
9	,	,	O	,	_	0	SENT_700	[p15l1196t2521r1246b2551],
10	Filipski	NNP	ORGANIZATION	Filipski	nn	11	SENT_700	[p15l1261t2520r1364b2554],
11	KK	NNP	ORGANIZATION	KK	appos	2	SENT_700	[p15l1378t2521r1435b2551],
12	,	,	O	,	_	0	SENT_700	[p15l1378t2521r1435b2551],
13	Hu	NNP	O	Hu	nn	14	SENT_700	[p15l1450t2521r1496b2546],
14	C	NNP	O	C	appos	2	SENT_700	[p15l1510t2521r1541b2551],
15	,	,	O	,	_	0	SENT_700	[p15l1510t2521r1541b2551],
16	et	FW	O	et	nn	17	SENT_700	[p15l1557t2527r1583b2546],
17	al.	FW	O	al.	appos	2	SENT_700	[p15l1596t2520r1626b2546],
18	2010	CD	DATE	2010	dep	17	SENT_700	[p15l1642t2522r1716b2546],
19	.	.	O	.	_	0	SENT_700	[p15l1642t2522r1716b2546],

1	Inﬂuence	NN	O	inﬂuence	nsubj	8	SENT_701	[p15l1732t2520r1862b2546],
2	of	IN	O	of	_	0	SENT_701	[p15l1877t2520r1908b2546],
3	Oct1/Oct2de	NN	O	oct1/oct2de	nn	4	SENT_701	[p15l1919t2521r2083b2546, p15l642t2562r783b2597],
4	ﬁciency	NN	O	ﬁciency	prep_of	1	SENT_701	[p15l1919t2521r2083b2546, p15l642t2562r783b2597],
5	on	IN	O	on	_	0	SENT_701	[p15l798t2572r832b2588],
6	cisplatin	NN	O	cisplatin	nn	7	SENT_701	[p15l849t2562r1088b2597],
7	—	NN	O	—	prep_on	4	SENT_701	[p15l849t2562r1088b2597],
8	induced	VBD	O	induce	_	0	SENT_701	[p15l849t2562r1088b2597],
9	changes	NNS	O	change	dobj	8	SENT_701	[p15l1104t2562r1214b2597],
10	in	IN	O	in	_	0	SENT_701	[p15l1230t2564r1256b2588],
11	urinary	JJ	O	urinary	amod	12	SENT_701	[p15l1272t2564r1375b2597],
12	N	NN	O	n	prep_in	8	SENT_701	[p15l1388t2562r1827b2597],
13	.	.	O	.	_	0	SENT_701	[p15l1388t2562r1827b2597],

1	—	NN	O	—	_	0	SENT_702	[p15l1388t2562r1827b2597],
2	.	.	O	.	_	0	SENT_702	[p15l1388t2562r1827b2597],

1	acetyl	NN	O	acetyl	_	0	SENT_703	[p15l1388t2562r1827b2597],
2	.	.	O	.	_	0	SENT_703	[p15l1388t2562r1827b2597],

1	—	NN	O	—	_	0	SENT_704	[p15l1388t2562r1827b2597],
2	.	.	O	.	_	0	SENT_704	[p15l1388t2562r1827b2597],

1	[	NN	O	[	_	0	SENT_705	[p15l1388t2562r1827b2597],
2	3	CD	NUMBER	3	dep	1	SENT_705	[p15l1388t2562r1827b2597],
3	.	.	O	.	_	0	SENT_705	[p15l1388t2562r1827b2597],

1	—	NN	O	—	_	0	SENT_706	[p15l1388t2562r1827b2597],
2	.	.	O	.	_	0	SENT_706	[p15l1388t2562r1827b2597],

1	D	NN	O	d	_	0	SENT_707	[p15l1388t2562r1827b2597],
2	.	.	O	.	_	0	SENT_707	[p15l1388t2562r1827b2597],

1	—	NN	O	—	_	0	SENT_708	[p15l1388t2562r1827b2597],
2	.	.	O	.	_	0	SENT_708	[p15l1388t2562r1827b2597],

1	glucosaminidase	NN	O	glucosaminidase	_	0	SENT_709	[p15l1388t2562r1827b2597],
2	.	.	O	.	_	0	SENT_709	[p15l1388t2562r1827b2597],

1	Clin	NNP	O	Clin	_	0	SENT_710	[p15l1846t2563r1906b2588],
2	.	.	O	.	_	0	SENT_710	[p15l1846t2563r1906b2588],

1	Cancer	NN	O	cancer	_	0	SENT_711	[p15l1928t2563r2018b2588],
2	Res	NNP	O	Res	dep	1	SENT_711	[p15l2032t2563r2081b2588],
3	.	.	O	.	_	0	SENT_711	[p15l2032t2563r2081b2588],

1	l6	NN	O	l6	nn	4	SENT_712	[p15l645t2606r820b2630],
2	:4	CD	NUMBER	:4	num	4	SENT_712	[p15l645t2606r820b2630],
3	l98	NN	O	l98	nn	4	SENT_712	[p15l645t2606r820b2630],
4	—	NN	O	—	_	0	SENT_712	[p15l645t2606r820b2630],
5	206	CD	NUMBER	206	num	7	SENT_712	[p15l645t2606r820b2630],
6	Tsuruoka	NNP	LOCATION	Tsuruoka	nn	7	SENT_712	[p15l641t2646r776b2672],
7	S	NN	LOCATION	s	dep	4	SENT_712	[p15l790t2647r813b2678],
8	,	,	O	,	_	0	SENT_712	[p15l790t2647r813b2678],
9	Ioka	NNP	LOCATION	Ioka	nn	10	SENT_712	[p15l827t2646r887b2672],
10	T	NN	LOCATION	t	appos	7	SENT_712	[p15l899t2647r932b2678],
11	,	,	O	,	_	0	SENT_712	[p15l899t2647r932b2678],
12	Wakaumi	NNP	ORGANIZATION	Wakaumi	nn	13	SENT_712	[p15l945t2646r1081b2672],
13	M	NNP	ORGANIZATION	M	appos	7	SENT_712	[p15l1093t2647r1132b2678],
14	,	,	O	,	_	0	SENT_712	[p15l1093t2647r1132b2678],
15	Sakamoto	NNP	PERSON	Sakamoto	nn	16	SENT_712	[p15l1147t2646r1283b2672],
16	K	NNP	PERSON	K	appos	7	SENT_712	[p15l1296t2647r1327b2678],
17	,	,	O	,	_	0	SENT_712	[p15l1296t2647r1327b2678],
18	Ookami	NNP	PERSON	Ookami	nn	19	SENT_712	[p15l1342t2646r1453b2672],
19	H	NNP	PERSON	H	appos	7	SENT_712	[p15l1466t2647r1501b2678],
20	,	,	O	,	_	0	SENT_712	[p15l1466t2647r1501b2678],
21	Fujimura	NNP	PERSON	Fujimura	nn	22	SENT_712	[p15l1515t2647r1643b2681],
22	A.	NNP	O	A.	appos	7	SENT_712	[p15l1654t2647r1683b2672],
23	2006	CD	DATE	2006	dep	22	SENT_712	[p15l1697t2648r1772b2672],
24	.	.	O	.	_	0	SENT_712	[p15l1697t2648r1772b2672],

1	Severe	JJ	O	severe	amod	2	SENT_713	[p15l1787t2647r1877b2672],
2	arrhythmia	NN	O	arrhythmium	_	0	SENT_713	[p15l1890t2646r2045b2681],
3	as	IN	O	as	_	0	SENT_713	[p15l2058t2656r2083b2672],
4	a	DT	O	a	det	5	SENT_713	[p15l642t2699r655b2715],
5	result	NN	O	result	prep_as	2	SENT_713	[p15l668t2689r747b2715],
6	of	IN	O	of	_	0	SENT_713	[p15l759t2689r790b2715],
7	the	DT	O	the	det	8	SENT_713	[p15l799t2689r842b2715],
8	interaction	NN	O	interaction	prep_of	5	SENT_713	[p15l855t2690r1007b2715],
9	of	IN	O	of	_	0	SENT_713	[p15l1020t2689r1051b2715],
10	cetirizine	NN	O	cetirizine	prep_of	8	SENT_713	[p15l1060t2690r1189b2715],
11	and	CC	O	and	_	0	SENT_713	[p15l1203t2689r1252b2715],
12	pilsicainide	NN	O	pilsicainide	conj_and	10	SENT_713	[p15l1265t2689r1421b2723],
13	in	IN	O	in	_	0	SENT_713	[p15l1434t2690r1461b2714],
14	a	DT	O	a	det	15	SENT_713	[p15l1474t2699r1487b2715],
15	patient	NN	O	patient	prep_in	2	SENT_713	[p15l1500t2690r1598b2723],
16	with	IN	O	with	_	0	SENT_713	[p15l1609t2689r1671b2715],
17	renal	JJ	O	renal	amod	18	SENT_713	[p15l1683t2689r1753b2715],
18	insufficiency	NN	O	insufficiency	prep_with	15	SENT_713	[p15l1765t2689r1946b2723],
19	:	:	O	:	_	0	SENT_713	[p15l1765t2689r1946b2723],
20	ﬁrst	VB	O	ﬁrst	dep	2	SENT_713	[p15l1960t2689r2015b2715],
21	case	NN	O	case	nn	22	SENT_713	[p15l2028t2699r2083b2715],
22	presentation	NN	O	presentation	dobj	20	SENT_713	[p15l642t2735r815b2768],
23	showing	VBG	O	show	xcomp	20	SENT_713	[p15l829t2734r945b2768],
24	competition	NN	O	competition	dobj	23	SENT_713	[p15l958t2735r1127b2768],
25	for	IN	O	for	_	0	SENT_713	[p15l1140t2734r1181b2760],
26	excretion	NN	O	excretion	prep_for	23	SENT_713	[p15l1194t2735r1322b2760],
27	via	IN	O	via	_	0	SENT_713	[p15l1334t2735r1374b2760],
28	renal	JJ	O	renal	amod	30	SENT_713	[p15l1387t2734r1457b2760],
29	multidrug	JJ	O	multidrug	amod	30	SENT_713	[p15l1470t2734r1611b2768],
30	resistance	NN	O	resistance	prep_via	26	SENT_713	[p15l1623t2735r1758b2760],
31	protein	NN	O	protein	tmod	23	SENT_713	[p15l1772t2735r1874b2768],
32	1	CD	NUMBER	1	num	31	SENT_713	[p15l1890t2736r1900b2759],
33	and	CC	O	and	_	0	SENT_713	[p15l1916t2734r1966b2760],
34	organic	JJ	O	organic	amod	36	SENT_713	[p15l1980t2735r2083b2768],
35	cation	NN	O	cation	nn	36	SENT_713	[p15l642t2776r727b2801],
36	transporter	NN	O	transporter	tmod	23	SENT_713	[p15l737t2782r893b2809],
37	2	CD	NUMBER	2	nsubj	20	SENT_713	[p15l903t2777r926b2801],
38	.	.	O	.	_	0	SENT_713	[p15l903t2777r926b2801],

1	Clin	NNP	O	Clin	_	0	SENT_714	[p15l939t2776r999b2801],
2	.	.	O	.	_	0	SENT_714	[p15l939t2776r999b2801],

1	Pbarmaeol	NNP	O	Pbarmaeol	_	0	SENT_715	[p15l1011t2776r1154b2801],
2	.	.	O	.	_	0	SENT_715	[p15l1011t2776r1154b2801],

1	Tber	NNP	O	Tber	_	0	SENT_716	[p15l1169t2776r1236b2801],
2	.	.	O	.	_	0	SENT_716	[p15l1169t2776r1236b2801],

1	79:389	CD	NUMBER	79:389	num	5	SENT_717	[p15l1250t2776r1393b2801],
2	—	CD	NUMBER	—	num	5	SENT_717	[p15l1250t2776r1393b2801],
3	96	CD	NUMBER	96	num	5	SENT_717	[p15l1250t2776r1393b2801],
4	Koepsell	NNP	PERSON	Koepsell	nn	5	SENT_717	[p15l642t2817r763b2851],
5	H.	NNP	O	H.	_	0	SENT_717	[p15l773t2818r808b2842],
6	1998	CD	DATE	1998	dep	5	SENT_717	[p15l823t2819r895b2843],
7	.	.	O	.	_	0	SENT_717	[p15l823t2819r895b2843],

1	Organic	NNP	O	Organic	nn	3	SENT_718	[p15l908t2818r1021b2851],
2	cation	NN	O	cation	nn	3	SENT_718	[p15l1032t2818r1117b2843],
3	transporters	NNS	O	transporter	_	0	SENT_718	[p15l1127t2824r1295b2851],
4	in	IN	O	in	_	0	SENT_718	[p15l1306t2818r1333b2842],
5	intestine	NN	O	intestine	prep_in	3	SENT_718	[p15l1343t2818r1470b2848],
6	,	,	O	,	_	0	SENT_718	[p15l1343t2818r1470b2848],
7	kidney	NN	O	kidney	appos	5	SENT_718	[p15l1482t2817r1582b2851],
8	,	,	O	,	_	0	SENT_718	[p15l1482t2817r1582b2851],
9	liver	NN	O	liver	appos	5	SENT_718	[p15l1593t2817r1662b2848],
10	,	,	O	,	_	0	SENT_718	[p15l1593t2817r1662b2848],
11	and	CC	O	and	_	0	SENT_718	[p15l1674t2817r1723b2843],
12	brain	NN	O	brain	appos	5	SENT_718	[p15l1734t2817r1813b2843],
13	.	.	O	.	_	0	SENT_718	[p15l1734t2817r1813b2843],

1	Annu	NNP	PERSON	Annu	_	0	SENT_719	[p15l1822t2818r1905b2843],
2	.	.	O	.	_	0	SENT_719	[p15l1822t2818r1905b2843],

1	Rev.	NNP	O	Rev.	nn	2	SENT_720	[p15l1917t2818r1972b2843],
2	Pbyxial	NNP	PERSON	Pbyxial	_	0	SENT_720	[p15l1985t2818r2081b2851],
3	.	.	O	.	_	0	SENT_720	[p15l1985t2818r2081b2851],

1	60:243	CD	NUMBER	60:243	_	0	SENT_721	[p15l642t2860r786b2885],
2	-66	CD	NUMBER	-66	num	4	SENT_721	[p15l642t2860r786b2885],
3	Otsuka	NNP	ORGANIZATION	Otsuka	nn	4	SENT_721	[p15l642t2901r741b2927],
4	M	NN	ORGANIZATION	m	dep	1	SENT_721	[p15l755t2902r794b2932],
5	,	,	O	,	_	0	SENT_721	[p15l755t2902r794b2932],
6	Matsumoto	NNP	ORGANIZATION	Matsumoto	nn	7	SENT_721	[p15l810t2902r972b2927],
7	T	NN	ORGANIZATION	t	appos	4	SENT_721	[p15l987t2902r1020b2932],
8	,	,	O	,	_	0	SENT_721	[p15l987t2902r1020b2932],
9	Morimoto	NNP	PERSON	Morimoto	nn	10	SENT_721	[p15l1035t2902r1181b2927],
10	R	NNP	PERSON	R	appos	7	SENT_721	[p15l1197t2902r1227b2932],
11	,	,	O	,	_	0	SENT_721	[p15l1197t2902r1227b2932],
12	Arioka	FW	LOCATION	arioka	dep	7	SENT_721	[p15l1242t2901r1336b2927],
13	S	NN	LOCATION	s	dep	1	SENT_721	[p15l1352t2902r1376b2932],
14	,	,	O	,	_	0	SENT_721	[p15l1352t2902r1376b2932],
15	Omote	NN	O	omote	nn	16	SENT_721	[p15l1393t2902r1491b2927],
16	H	NN	O	h	appos	13	SENT_721	[p15l1506t2902r1541b2932],
17	,	,	O	,	_	0	SENT_721	[p15l1506t2902r1541b2932],
18	Moriyama	NNP	PERSON	Moriyama	nn	19	SENT_721	[p15l1557t2902r1702b2935],
19	Y.	NNP	O	Y.	appos	1	SENT_721	[p15l1716t2902r1746b2926],
20	2005	CD	DATE	2005	dep	19	SENT_721	[p15l1763t2902r1837b2927],
21	.	.	O	.	_	0	SENT_721	[p15l1763t2902r1837b2927],

1	A	DT	O	a	det	4	SENT_722	[p15l1853t2902r1877b2926],
2	human	JJ	O	human	amod	4	SENT_722	[p15l1890t2901r1987b2927],
3	transporter	NN	O	transporter	nn	4	SENT_722	[p15l2002t2908r2083b2927, p15l642t2950r729b2977],
4	protein	NN	O	protein	_	0	SENT_722	[p15l743t2944r845b2977],
5	that	WDT	O	that	nsubj	6	SENT_722	[p15l860t2942r914b2968],
6	mediates	VBZ	O	mediate	rcmod	4	SENT_722	[p15l928t2942r1050b2968],
7	the	DT	O	the	det	10	SENT_722	[p15l1066t2942r1109b2968],
8	ﬁnal	JJ	O	ﬁnal	amod	10	SENT_722	[p15l1124t2942r1184b2968],
9	excretion	NN	O	excretion	nn	10	SENT_722	[p15l1200t2944r1328b2968],
10	step	NN	O	step	dobj	6	SENT_722	[p15l1342t2949r1397b2977],
11	for	IN	O	for	_	0	SENT_722	[p15l1413t2942r1453b2968],
12	toxic	JJ	O	toxic	amod	14	SENT_722	[p15l1467t2944r1534b2968],
13	organic	JJ	O	organic	amod	14	SENT_722	[p15l1549t2943r1652b2977],
14	cations	NNS	O	cation	prep_for	10	SENT_722	[p15l1667t2943r1771b2968],
15	.	.	O	.	_	0	SENT_722	[p15l1667t2943r1771b2968],

1	Proc	NNP	O	Proc	_	0	SENT_723	[p15l1787t2943r1849b2968],
2	.	.	O	.	_	0	SENT_723	[p15l1787t2943r1849b2968],

1	Natl.	NNP	O	Natl.	nn	2	SENT_724	[p15l1866t2943r1932b2968],
2	Acad	NNP	O	Acad	_	0	SENT_724	[p15l1948t2943r2019b2968],
3	.	.	O	.	_	0	SENT_724	[p15l1948t2943r2019b2968],

1	Sci	NNP	O	Sci	_	0	SENT_725	[p15l2038t2943r2081b2968],
2	.	.	O	.	_	0	SENT_725	[p15l2038t2943r2081b2968],

1	USA	NNP	LOCATION	USA	nn	2	SENT_726	[p15l645t2989r706b3014],
2	l02	NN	O	l02	_	0	SENT_726	[p15l721t2989r913b3015],
3	:	:	O	:	_	0	SENT_726	[p15l721t2989r913b3015],
4	l7923	NN	O	l7923	dep	2	SENT_726	[p15l721t2989r913b3015],
5	—	CD	NUMBER	—	num	4	SENT_726	[p15l721t2989r913b3015],
6	28	CD	NUMBER	28	num	8	SENT_726	[p15l721t2989r913b3015],
7	Masuda	NNP	ORGANIZATION	Masuda	nn	8	SENT_726	[p15l640t3030r750b3056],
8	S	NN	ORGANIZATION	s	dep	2	SENT_726	[p15l761t3031r785b3062],
9	,	,	O	,	_	0	SENT_726	[p15l761t3031r785b3062],
10	Terada	NNP	PERSON	Terada	nn	11	SENT_726	[p15l795t3030r897b3056],
11	T	NN	O	t	appos	2	SENT_726	[p15l906t3031r939b3062],
12	,	,	O	,	_	0	SENT_726	[p15l906t3031r939b3062],
13	Yonezawa	NNP	PERSON	Yonezawa	nn	14	SENT_726	[p15l950t3031r1091b3056],
14	A	NNP	O	A	appos	2	SENT_726	[p15l1100t3031r1129b3062],
15	,	,	O	,	_	0	SENT_726	[p15l1100t3031r1129b3062],
16	Tanihara	NNP	O	Tanihara	nn	17	SENT_726	[p15l1140t3030r1269b3056],
17	Y	NN	O	y	appos	2	SENT_726	[p15l1278t3031r1308b3062],
18	,	,	O	,	_	0	SENT_726	[p15l1278t3031r1308b3062],
19	Kishimoto	NNP	PERSON	Kishimoto	nn	20	SENT_726	[p15l1319t3030r1466b3056],
20	K	NNP	PERSON	K	appos	2	SENT_726	[p15l1477t3031r1508b3062],
21	,	,	O	,	_	0	SENT_726	[p15l1477t3031r1508b3062],
22	et	FW	O	et	nn	23	SENT_726	[p15l1521t3038r1546b3056],
23	al.	FW	O	al.	appos	2	SENT_726	[p15l1556t3030r1585b3056],
24	2006	CD	DATE	2006	dep	23	SENT_726	[p15l1597t3032r1672b3056],
25	.	.	O	.	_	0	SENT_726	[p15l1597t3032r1672b3056],

1	Identiﬁcation	NN	O	identiﬁcation	nn	4	SENT_727	[p15l1684t3030r1872b3056],
2	and	CC	O	and	_	0	SENT_727	[p15l1883t3030r1932b3056],
3	funcdonal	JJ	O	funcdonal	conj_and	1	SENT_727	[p15l1943t3030r2083b3056],
4	characterization	NN	O	characterization	_	0	SENT_727	[p15l642t3076r866b3101],
5	of	IN	O	of	_	0	SENT_727	[p15l873t3076r903b3101],
6	a	DT	O	a	det	12	SENT_727	[p15l907t3086r920b3101],
7	new	JJ	O	new	amod	12	SENT_727	[p15l926t3085r984b3101],
8	human	JJ	O	human	amod	12	SENT_727	[p15l989t3076r1086b3101],
9	kidney	NN	O	kidney	nn	12	SENT_727	[p15l1092t3076r1301b3110],
10	—	NN	O	—	nn	12	SENT_727	[p15l1092t3076r1301b3110],
11	speciﬁc	NN	O	speciﬁc	nn	12	SENT_727	[p15l1092t3076r1301b3110],
12	H	NN	O	h	prep_of	4	SENT_727	[p15l1307t3074r1370b3101],
13	+	CC	O	+	rcmod	12	SENT_727	[p15l1307t3074r1370b3101],
14	/	:	O	/	punct	4	SENT_727	[p15l1307t3074r1370b3101],
15	organic	JJ	O	organic	amod	17	SENT_727	[p15l1371t3077r1474b3110],
16	cation	NN	O	cation	nn	17	SENT_727	[p15l1481t3077r1566b3101],
17	antiporter	NN	O	antiporter	dep	4	SENT_727	[p15l1573t3077r1720b3110],
18	,	,	O	,	_	0	SENT_727	[p15l1573t3077r1720b3110],
19	kidney	NN	O	kidney	nn	21	SENT_727	[p15l1728t3076r1937b3110],
20	—	NN	O	—	nn	21	SENT_727	[p15l1728t3076r1937b3110],
21	speciﬁc	NN	O	speciﬁc	appos	17	SENT_727	[p15l1728t3076r1937b3110],
22	multidrug	JJ	O	multidrug	amod	21	SENT_727	[p15l1943t3076r2084b3110],
23	and	CC	O	and	_	0	SENT_727	[p15l642t3131r691b3158],
24	toxin	NN	O	toxin	dep	4	SENT_727	[p15l702t3133r772b3158],
25	extrusion	NN	O	extrusion	rcmod	24	SENT_727	[p15l782t3133r910b3158],
26	2	CD	NUMBER	2	rcmod	25	SENT_727	[p15l920t3132r975b3166],
27	.	.	O	.	_	0	SENT_727	[p15l920t3132r975b3166],
28	]	SYM	O	]	dep	25	SENT_727	[p15l920t3132r975b3166],

1	.	.	O	.	_	0	SENT_728	[p15l920t3132r975b3166],

1	Am	NNP	O	Am	_	0	SENT_729	[p15l984t3132r1041b3157],
2	.	.	O	.	_	0	SENT_729	[p15l984t3132r1041b3157],

1	Soc	NN	O	soc	_	0	SENT_730	[p15l1053t3132r1100b3157],
2	.	.	O	.	_	0	SENT_730	[p15l1053t3132r1100b3157],

1	Nep/yrol	NN	O	nep/yrol	_	0	SENT_731	[p15l1111t3132r1221b3166],
2	.	.	O	.	_	0	SENT_731	[p15l1111t3132r1221b3166],

1	17:2127	CD	NUMBER	17:2127	_	0	SENT_732	[p15l1237t3132r1394b3158],
2	-35	CD	NUMBER	-35	num	4	SENT_732	[p15l1237t3132r1394b3158],
3	Chen	NNP	O	Chen	nn	4	SENT_732	[p15l642t3175r718b3200],
4	Y	NN	O	y	dep	1	SENT_732	[p15l728t3176r757b3206],
5	,	,	O	,	_	0	SENT_732	[p15l728t3176r757b3206],
6	Teranishi	NNP	PERSON	Teranishi	nn	7	SENT_732	[p15l769t3175r905b3200],
7	K	NNP	PERSON	K	appos	4	SENT_732	[p15l916t3176r947b3206],
8	,	,	O	,	_	0	SENT_732	[p15l916t3176r947b3206],
9	Li	NNP	PERSON	Li	nn	10	SENT_732	[p15l959t3176r990b3200],
10	S	NNP	PERSON	S	appos	4	SENT_732	[p15l1002t3176r1026b3206],
11	,	,	O	,	_	0	SENT_732	[p15l1002t3176r1026b3206],
12	Yee	NNP	PERSON	Yee	nn	13	SENT_732	[p15l1037t3176r1089b3200],
13	SW	NNP	O	SW	appos	4	SENT_732	[p15l1102t3176r1161b3206],
14	,	,	O	,	_	0	SENT_732	[p15l1102t3176r1161b3206],
15	Hesselson	NNP	O	Hesselson	nn	16	SENT_732	[p15l1173t3175r1315b3200],
16	S	NNP	O	S	appos	4	SENT_732	[p15l1326t3176r1350b3206],
17	,	,	O	,	_	0	SENT_732	[p15l1326t3176r1350b3206],
18	et	FW	O	et	nn	19	SENT_732	[p15l1363t3182r1388b3200],
19	al.	FW	O	al.	appos	4	SENT_732	[p15l1399t3175r1428b3200],
20	2009	CD	DATE	2009	dep	19	SENT_732	[p15l1441t3176r1515b3201],
21	.	.	O	.	_	0	SENT_732	[p15l1441t3176r1515b3201],

1	Genetic	JJ	O	genetic	amod	2	SENT_733	[p15l1529t3176r1639b3200],
2	Variants	NNS	O	variant	nsubj	14	SENT_733	[p15l1648t3176r1757b3200],
3	in	IN	O	in	_	0	SENT_733	[p15l1768t3176r1795b3200],
4	multidrug	JJ	O	multidrug	amod	8	SENT_733	[p15l1805t3175r1946b3209],
5	and	CC	O	and	_	0	SENT_733	[p15l1957t3175r2006b3200],
6	toxic	JJ	O	toxic	conj_and	4	SENT_733	[p15l2017t3176r2083b3200],
7	compound	NN	O	compound	nn	8	SENT_733	[p15l642t3220r790b3254],
8	extrusion	NN	O	extrusion	prep_in	2	SENT_733	[p15l801t3222r966b3252],
9	—	NN	O	—	dep	8	SENT_733	[p15l801t3222r966b3252],
10	1	CD	NUMBER	1	num	9	SENT_733	[p15l801t3222r966b3252],
11	,	,	O	,	_	0	SENT_733	[p15l801t3222r966b3252],
12	hl\/IATE1	NN	O	hl\/iate1	appos	8	SENT_733	[p15l977t3220r1122b3252],
13	,	,	O	,	_	0	SENT_733	[p15l977t3220r1122b3252],
14	alter	VBP	O	alter	_	0	SENT_733	[p15l1134t3220r1196b3246],
15	transport	NN	O	transport	nn	16	SENT_733	[p15l1205t3228r1334b3254],
16	function	NN	O	function	dobj	14	SENT_733	[p15l1343t3220r1467b3246],
17	.	.	O	.	_	0	SENT_733	[p15l1343t3220r1467b3246],

1	Plzarmacogenomierj	NN	O	plzarmacogenomierj	_	0	SENT_734	[p15l1478t3221r1751b3255],
2	’	NN	O	’	dep	1	SENT_734	[p15l1478t3221r1751b3255],
3	.	.	O	.	_	0	SENT_734	[p15l1478t3221r1751b3255],

1	9:127	CD	NUMBER	9:127	num	2	SENT_735	[p15l1764t3221r1890b3247],
2	-36	CD	NUMBER	-36	dep	6	SENT_735	[p15l1764t3221r1890b3247],
3	Meyer	NNP	PERSON	Meyer	nn	5	SENT_735	[p15l641t3266r733b3299],
4	zu	NN	O	zu	nn	5	SENT_735	[p15l742t3274r773b3290],
5	Schwabedissen	NNP	O	Schwabedissen	dep	2	SENT_735	[p15l784t3264r990b3290],
6	HE	PRP	O	he	_	0	SENT_735	[p15l999t3265r1057b3296],
7	,	,	O	,	_	0	SENT_735	[p15l999t3265r1057b3296],
8	Verstuyft	NNP	O	Verstuyft	nn	9	SENT_735	[p15l1067t3264r1199b3299],
9	C	NNP	O	C	appos	6	SENT_735	[p15l1209t3265r1239b3296],
10	,	,	O	,	_	0	SENT_735	[p15l1209t3265r1239b3296],
11	Kroemer	NNP	PERSON	Kroemer	nn	12	SENT_735	[p15l1250t3265r1377b3290],
12	HK	NNP	O	HK	appos	6	SENT_735	[p15l1386t3265r1446b3296],
13	,	,	O	,	_	0	SENT_735	[p15l1386t3265r1446b3296],
14	Becquemont	NNP	O	Becquemont	nn	15	SENT_735	[p15l1457t3265r1634b3298],
15	L	NNP	O	L	appos	6	SENT_735	[p15l1643t3265r1672b3296],
16	,	,	O	,	_	0	SENT_735	[p15l1643t3265r1672b3296],
17	Kim	NNP	PERSON	Kim	nn	18	SENT_735	[p15l1683t3265r1744b3290],
18	RB	NN	O	rb	appos	6	SENT_735	[p15l1754t3265r1804b3290],
19	.	.	O	.	_	0	SENT_735	[p15l1754t3265r1804b3290],

1	2010	CD	DATE	2010	_	0	SENT_736	[p15l1815t3266r1890b3290],
2	.	.	O	.	_	0	SENT_736	[p15l1815t3266r1890b3290],

1	Human	JJ	O	human	amod	10	SENT_737	[p15l1901t3265r2007b3290],
2	multidrug	JJ	O	multidrug	amod	10	SENT_737	[p15l2017t3264r2083b3290, p15l642t3310r728b3344],
3	and	CC	O	and	_	0	SENT_737	[p15l739t3310r789b3336],
4	toxin	NN	O	toxin	nn	5	SENT_737	[p15l801t3311r871b3336],
5	extrusion	NN	O	extrusion	conj_and	2	SENT_737	[p15l884t3311r1012b3336],
6	1	CD	NUMBER	1	number	7	SENT_737	[p15l1027t3312r1037b3335],
7	(	CD	NUMBER	(	dep	5	SENT_737	[p15l1053t3311r1344b3342],
8	MATE1/SLC47A1	NN	O	mate1/slc47a1	dep	7	SENT_737	[p15l1053t3311r1344b3342],
9	)	CD	NUMBER	)	num	8	SENT_737	[p15l1053t3311r1344b3342],
10	transporter	NN	O	transporter	_	0	SENT_737	[p15l1357t3317r1520b3344],
11	:	:	O	:	_	0	SENT_737	[p15l1357t3317r1520b3344],
12	functional	JJ	O	functional	amod	13	SENT_737	[p15l1534t3310r1674b3336],
13	characterization	NN	O	characterization	dep	10	SENT_737	[p15l1687t3310r1918b3342],
14	,	,	O	,	_	0	SENT_737	[p15l1687t3310r1918b3342],
15	interaction	NN	O	interaction	dep	10	SENT_737	[p15l1931t3311r2083b3336],
16	with	IN	O	with	_	0	SENT_737	[p15l641t3356r703b3382],
17	OCT2	NN	O	oct2	nn	20	SENT_737	[p15l713t3357r805b3382],
18	(	CD	NUMBER	(	num	20	SENT_737	[p15l818t3357r985b3388],
19	SLC22A2	NN	O	slc22a2	nn	20	SENT_737	[p15l818t3357r985b3388],
20	)	NN	O	)	prep_with	15	SENT_737	[p15l818t3357r985b3388],
21	,	,	O	,	_	0	SENT_737	[p15l818t3357r985b3388],
22	and	CC	O	and	_	0	SENT_737	[p15l997t3356r1046b3382],
23	single	JJ	O	single	amod	25	SENT_737	[p15l1056t3356r1136b3390],
24	nucleotide	NN	O	nucleotide	nn	25	SENT_737	[p15l1146t3356r1292b3382],
25	polymorphisms	NNS	O	polymorphism	dep	10	SENT_737	[p15l1302t3356r1526b3390],
26	.	.	O	.	_	0	SENT_737	[p15l1302t3356r1526b3390],

1	Am	NNP	O	Am	_	0	SENT_738	[p15l1534t3356r1624b3390],
2	.	.	O	.	_	0	SENT_738	[p15l1534t3356r1624b3390],

1	Pbysiol	NNP	O	Pbysiol	_	0	SENT_739	[p15l1636t3357r1732b3390],
2	.	.	O	.	_	0	SENT_739	[p15l1636t3357r1732b3390],

1	Renal	JJ	O	renal	amod	2	SENT_740	[p15l1743t3357r1820b3382],
2	Pbysiol	NN	O	pbysiol	_	0	SENT_740	[p15l1827t3357r1923b3390],
3	.	.	O	.	_	0	SENT_740	[p15l1827t3357r1923b3390],

1	298	CD	NUMBER	298	_	0	SENT_741	[p15l1936t3357r2084b3382],
2	:	:	O	:	_	0	SENT_741	[p15l1936t3357r2084b3382],
3	F997	CD	NUMBER	f997	num	8	SENT_741	[p15l1936t3357r2084b3382],
4	—	CD	NUMBER	—	num	8	SENT_741	[p15l1936t3357r2084b3382],
5	1005	CD	DATE	1005	num	8	SENT_741	[p15l645t3403r708b3427],
6	Ha	NNP	O	Ha	nn	8	SENT_741	[p15l642t3446r684b3471],
7	Choi	NNP	O	Choi	nn	8	SENT_741	[p15l694t3445r790b3477],
8	]	NNP	O	]	dep	1	SENT_741	[p15l694t3445r790b3477],
9	,	,	O	,	_	0	SENT_741	[p15l694t3445r790b3477],
10	Wah	NNP	PERSON	Wah	nn	12	SENT_741	[p15l799t3445r869b3471],
11	Yee	NNP	PERSON	Yee	nn	12	SENT_741	[p15l876t3446r929b3471],
12	S	NN	O	s	appos	8	SENT_741	[p15l939t3446r963b3476],
13	,	,	O	,	_	0	SENT_741	[p15l939t3446r963b3476],
14	Kim	NNP	PERSON	Kim	nn	16	SENT_741	[p15l973t3446r1034b3470],
15	M	NNP	O	M	nn	16	SENT_741	[p15l1041t3446r1093b3477],
16	]	NN	O	]	appos	8	SENT_741	[p15l1041t3446r1093b3477],
17	,	,	O	,	_	0	SENT_741	[p15l1041t3446r1093b3477],
18	Nguyen	NNP	PERSON	Nguyen	nn	19	SENT_741	[p15l1103t3446r1216b3479],
19	L	NNP	PERSON	L	appos	8	SENT_741	[p15l1225t3446r1254b3476],
20	,	,	O	,	_	0	SENT_741	[p15l1225t3446r1254b3476],
21	Ho	NNP	PERSON	Ho	nn	23	SENT_741	[p15l1263t3446r1309b3471],
22	Lee	NNP	PERSON	Lee	nn	23	SENT_741	[p15l1318t3446r1398b3477],
23	]	NNP	O	]	appos	8	SENT_741	[p15l1318t3446r1398b3477],
24	,	,	O	,	_	0	SENT_741	[p15l1318t3446r1398b3477],
25	et	FW	O	et	nn	26	SENT_741	[p15l1408t3452r1434b3471],
26	al.	FW	O	al.	appos	8	SENT_741	[p15l1442t3445r1472b3471],
27	2009	CD	DATE	2009	dep	26	SENT_741	[p15l1483t3447r1557b3471],
28	.	.	O	.	_	0	SENT_741	[p15l1483t3447r1557b3471],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_742	[p15l1567t3445r1756b3471],
2	and	CC	O	and	_	0	SENT_742	[p15l1765t3445r1814b3471],
3	characterization	NN	O	characterization	conj_and	1	SENT_742	[p15l1824t3445r2047b3471],
4	of	IN	O	of	_	0	SENT_742	[p15l2057t3445r2087b3471],
5	novel	JJ	O	novel	amod	6	SENT_742	[p15l641t3491r717b3516],
6	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_742	[p15l725t3491r940b3525],
7	in	IN	O	in	_	0	SENT_742	[p15l948t3492r975b3516],
8	the	DT	O	the	det	10	SENT_742	[p15l983t3491r1026b3516],
9	basal	JJ	O	basal	amod	10	SENT_742	[p15l1034t3491r1102b3516],
10	promoter	NN	O	promoter	prep_in	1	SENT_742	[p15l1110t3498r1243b3525],
11	of	IN	O	of	_	0	SENT_742	[p15l1251t3491r1281b3516],
12	the	DT	O	the	det	14	SENT_742	[p15l1285t3491r1328b3516],
13	human	JJ	O	human	amod	14	SENT_742	[p15l1336t3491r1433b3516],
14	transporter	NN	O	transporter	prep_of	10	SENT_742	[p15l1441t3498r1604b3525],
15	,	,	O	,	_	0	SENT_742	[p15l1441t3498r1604b3525],
16	MATE1	NN	O	mate1	appos	14	SENT_742	[p15l1612t3491r1739b3516],
17	.	.	O	.	_	0	SENT_742	[p15l1612t3491r1739b3516],

1	Pbarmaeogenet	NNP	O	Pbarmaeogenet	_	0	SENT_743	[p15l1748t3492r1951b3525],
2	.	.	O	.	_	0	SENT_743	[p15l1748t3492r1951b3525],

1	Genomic	JJ	O	genomic	_	0	SENT_744	[p15l1963t3491r2085b3516],
2	:	:	O	:	_	0	SENT_744	[p15l1963t3491r2085b3516],
3	l9	NN	O	l9	nn	8	SENT_744	[p15l645t3537r786b3562],
4	:770	CD	NUMBER	:770	number	5	SENT_744	[p15l645t3537r786b3562],
5	—	CD	NUMBER	—	amod	8	SENT_744	[p15l645t3537r786b3562],
6	80	CD	NUMBER	80	dep	5	SENT_744	[p15l645t3537r786b3562],
7	Kajiwara	NNP	ORGANIZATION	Kajiwara	nn	8	SENT_744	[p15l642t3581r764b3614],
8	M	NN	ORGANIZATION	m	dep	1	SENT_744	[p15l774t3581r814b3611],
9	,	,	O	,	_	0	SENT_744	[p15l774t3581r814b3611],
10	Terada	NNP	ORGANIZATION	Terada	nn	11	SENT_744	[p15l825t3580r926b3606],
11	T	NN	ORGANIZATION	t	appos	8	SENT_744	[p15l936t3581r969b3611],
12	,	,	O	,	_	0	SENT_744	[p15l936t3581r969b3611],
13	Ogasawara	NNP	ORGANIZATION	Ogasawara	nn	14	SENT_744	[p15l982t3581r1133b3614],
14	K	NNP	ORGANIZATION	K	appos	11	SENT_744	[p15l1144t3581r1176b3611],
15	,	,	O	,	_	0	SENT_744	[p15l1144t3581r1176b3611],
16	Iwano	NNP	PERSON	Iwano	nn	17	SENT_744	[p15l1188t3581r1273b3606],
17	]	NNP	O	]	appos	11	SENT_744	[p15l1281t3581r1303b3612],
18	,	,	O	,	_	0	SENT_744	[p15l1281t3581r1303b3612],
19	Katsura	NNP	ORGANIZATION	Katsura	nn	20	SENT_744	[p15l1315t3581r1423b3606],
20	T	NN	ORGANIZATION	t	appos	11	SENT_744	[p15l1433t3581r1466b3611],
21	,	,	O	,	_	0	SENT_744	[p15l1433t3581r1466b3611],
22	et	FW	O	et	nn	23	SENT_744	[p15l1479t3587r1505b3606],
23	al.	FW	O	al.	appos	11	SENT_744	[p15l1515t3580r1545b3606],
24	2009	CD	DATE	2009	dep	23	SENT_744	[p15l1558t3582r1633b3606],
25	.	.	O	.	_	0	SENT_744	[p15l1558t3582r1633b3606],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_745	[p15l1645t3580r1833b3606],
2	of	IN	O	of	_	0	SENT_745	[p15l1845t3580r1875b3606],
3	multidrug	JJ	O	multidrug	amod	6	SENT_745	[p15l1882t3580r2023b3614],
4	and	CC	O	and	_	0	SENT_745	[p15l2034t3580r2083b3606],
5	toxin	NN	O	toxin	conj_and	3	SENT_745	[p15l642t3627r712b3652],
6	extrusion	NN	O	extrusion	prep_of	1	SENT_745	[p15l720t3627r848b3652],
7	(	CD	NUMBER	(	num	8	SENT_745	[p15l855t3626r981b3658],
8	MATE1	NN	O	mate1	dep	6	SENT_745	[p15l855t3626r981b3658],
9	and	CC	O	and	_	0	SENT_745	[p15l991t3626r1041b3652],
10	MATE2	NN	O	mate2	prep_of	1	SENT_745	[p15l1047t3626r1164b3651],
11	-	:	O	-	_	0	SENT_745	[p15l1169t3627r1215b3658],
12	K	NNP	O	K	nn	14	SENT_745	[p15l1169t3627r1215b3658],
13	)	CD	NUMBER	)	num	14	SENT_745	[p15l1169t3627r1215b3658],
14	variants	NNS	O	variant	dep	1	SENT_745	[p15l1221t3627r1330b3652],
15	with	IN	O	with	_	0	SENT_745	[p15l1336t3626r1399b3652],
16	complete	JJ	O	complete	amod	17	SENT_745	[p15l1406t3626r1533b3660],
17	loss	NN	O	loss	prep_with	14	SENT_745	[p15l1540t3626r1590b3652],
18	of	IN	O	of	_	0	SENT_745	[p15l1598t3626r1629b3652],
19	transport	NN	O	transport	nn	20	SENT_745	[p15l1632t3633r1761b3660],
20	activity	NN	O	activity	prep_of	17	SENT_745	[p15l1768t3626r1904b3660],
21	.	.	O	.	_	0	SENT_745	[p15l1768t3626r1904b3660],

1	Hum	NNP	O	Hum	_	0	SENT_746	[p15l1913t3627r1988b3651],
2	.	.	O	.	_	0	SENT_746	[p15l1913t3627r1988b3651],

1	Genet	NNP	PERSON	Genet	_	0	SENT_747	[p15l2000t3627r2081b3651],
2	.	.	O	.	_	0	SENT_747	[p15l2000t3627r2081b3651],

1	54:40	CD	NUMBER	54:40	num	4	SENT_748	[p15l643t3673r769b3698],
2	-46	CD	NUMBER	-46	num	4	SENT_748	[p15l643t3673r769b3698],
3	Toyama	NNP	ORGANIZATION	Toyama	nn	4	SENT_748	[p15l641t3716r757b3750],
4	K	NNP	ORGANIZATION	K	_	0	SENT_748	[p15l768t3717r799b3747],
5	,	,	O	,	_	0	SENT_748	[p15l768t3717r799b3747],
6	Yonezawa	NNP	PERSON	Yonezawa	nn	7	SENT_748	[p15l810t3717r951b3741],
7	A	NNP	O	A	appos	4	SENT_748	[p15l960t3716r990b3747],
8	,	,	O	,	_	0	SENT_748	[p15l960t3716r990b3747],
9	Tsuda	NNP	PERSON	Tsuda	nn	10	SENT_748	[p15l1001t3715r1089b3741],
10	M	NNP	O	M	appos	4	SENT_748	[p15l1098t3717r1138b3747],
11	,	,	O	,	_	0	SENT_748	[p15l1098t3717r1138b3747],
12	Masuda	NNP	PERSON	Masuda	nn	13	SENT_748	[p15l1148t3715r1258b3741],
13	S	NNP	PERSON	S	appos	4	SENT_748	[p15l1269t3716r1293b3747],
14	,	,	O	,	_	0	SENT_748	[p15l1269t3716r1293b3747],
15	Yano	NNP	PERSON	Yano	appos	4	SENT_748	[p15l1303t3717r1376b3741],
16	I	PRP	O	I	dep	15	SENT_748	[p15l1387t3717r1405b3747],
17	,	,	O	,	_	0	SENT_748	[p15l1387t3717r1405b3747],
18	et	FW	O	et	nn	19	SENT_748	[p15l1418t3723r1443b3741],
19	al.	FW	O	al.	appos	4	SENT_748	[p15l1453t3715r1483b3741],
20	2010	CD	DATE	2010	dep	19	SENT_748	[p15l1495t3717r1569b3741],
21	.	.	O	.	_	0	SENT_748	[p15l1495t3717r1569b3741],

1	Heterozygous	JJ	O	heterozygous	amod	2	SENT_749	[p15l1581t3717r1777b3750],
2	variants	NNS	O	variant	_	0	SENT_749	[p15l1787t3717r1895b3741],
3	of	IN	O	of	_	0	SENT_749	[p15l1907t3716r1937b3741],
4	multidrug	JJ	O	multidrug	prep_of	2	SENT_749	[p15l1943t3715r2084b3750],

1	Annu	NNP	PERSON	Annu	_	0	SENT_750	[p16l72t526r95b606],
2	.	.	O	.	_	0	SENT_750	[p16l72t526r95b606],

1	Rev.	NNP	O	Rev.	nn	2	SENT_751	[p16l73t448r95b508],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_751	[p16l72t289r95b437],
3	.	.	O	.	_	0	SENT_751	[p16l72t289r95b437],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_752	[p16l72t168r95b278],
2	.	.	O	.	_	0	SENT_752	[p16l72t168r95b278],

1	2012.52:24	CD	NUMBER	2012.52:24	_	0	SENT_753	[p16l72t7r95b157],
2	by	IN	O	by	_	0	SENT_753	[p16l105t431r136b463],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_753	[p16l105t282r136b422],
4	of	IN	ORGANIZATION	of	_	0	SENT_753	[p16l105t243r129b272],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_753	[p16l105t96r129b236],
6	-	:	O	-	_	0	SENT_753	[p16l119t77r122b86],
7	Mad	NNP	O	Mad	nn	8	SENT_753	[p16l105t7r129b67],
8	Annu	NNP	O	Annu	dep	1	SENT_753	[p16l180t3004r203b3084],
9	.	.	O	.	_	0	SENT_753	[p16l180t3004r203b3084],

1	Rev.	NNP	O	Rev.	nn	2	SENT_754	[p16l180t2934r203b2993],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_754	[p16l180t2775r203b2923],
3	.	.	O	.	_	0	SENT_754	[p16l180t2775r203b2923],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_755	[p16l180t2655r203b2764],
2	.	.	O	.	_	0	SENT_755	[p16l180t2655r203b2764],

1	2012	CD	DATE	2012	num	2	SENT_756	[p16l180t2580r203b2643],
2	‘	CD	NUMBER	‘	_	0	SENT_756	[p16l180t2436r204b2567],
3	,	,	O	,	_	0	SENT_756	[p16l180t2436r204b2567],
4	.52:249	CD	NUMBER	.52:249	number	5	SENT_756	[p16l180t2436r204b2567],
5	-2	CD	NUMBER	-2	appos	2	SENT_756	[p16l180t2436r204b2567],
6	73	CD	NUMBER	73	dep	5	SENT_756	[p16l180t2383r203b2422],
7	.	.	O	.	_	0	SENT_756	[p16l180t2383r203b2422],

1	Downloaded	VBN	O	download	_	0	SENT_757	[p16l180t2190r203b2360],
2	from	IN	O	from	_	0	SENT_757	[p16l180t2117r203b2181],
3	wwwannualreviews	NNS	O	wwwannualreview	prep_from	1	SENT_757	[p16l180t1829r203b2108],
4	.	.	O	.	_	0	SENT_757	[p16l180t1829r203b2108],

1	org	NN	O	org	_	0	SENT_758	[p16l187t1766r210b1809],
2	by	IN	O	by	_	0	SENT_758	[p16l213t2917r244b2949],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_758	[p16l213t2768r244b2908],
4	of	IN	ORGANIZATION	of	_	0	SENT_758	[p16l213t2729r237b2758],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_758	[p16l213t2582r237b2723],
6	-	:	O	-	_	0	SENT_758	[p16l227t2551r230b2560],
7	Madisoi	NN	ORGANIZATION	madisous	dep	1	SENT_758	[p16l213t2435r237b2541],
8	1	CD	NUMBER	1	num	11	SENT_758	[p16l221t2412r236b2423],
9	or	CC	O	or	_	0	SENT_758	[p16l221t2378r237b2403],
10	1	CD	NUMBER	1	num	11	SENT_758	[p16l221t2358r236b2366],
11	O1/O5	NN	O	o1/o5	dep	7	SENT_758	[p16l213t2264r237b2349],
12	/	:	O	/	punct	1	SENT_758	[p16l213t2264r237b2349],
13	14	CD	NUMBER	14	dep	1	SENT_758	[p16l213t2225r237b2261],
14	.	.	O	.	_	0	SENT_758	[p16l213t2225r237b2261],

1	For	IN	O	for	_	0	SENT_759	[p16l214t2168r237b2214],
2	personal	JJ	O	personal	amod	3	SENT_759	[p16l213t2047r244b2159],
3	use	NN	O	use	pobj	1	SENT_759	[p16l221t1995r237b2038],
4	only	RB	O	only	advmod	3	SENT_759	[p16l213t1920r244b1985],
5	.	.	O	.	_	0	SENT_759	[p16l213t1920r244b1985],

1	and	CC	O	and	cc	4	SENT_760	[p16l642t14r691b40],
2	toxin	NN	O	toxin	nn	3	SENT_760	[p16l702t16r772b40],
3	extrusions	NNS	O	extrusion	nsubj	4	SENT_760	[p16l783t16r923b40],
4	(	VBP	O	(	_	0	SENT_760	[p16l935t15r1060b47],
5	MATE1	NN	O	mate1	dobj	4	SENT_760	[p16l935t15r1060b47],
6	and	CC	O	and	_	0	SENT_760	[p16l1074t14r1123b40],
7	MATE2	NN	O	mate2	conj_and	5	SENT_760	[p16l1133t15r1250b40],
8	.	.	O	.	_	0	SENT_760	[p16l1255t15r1301b47],

1	—	NN	O	—	_	0	SENT_761	[p16l1255t15r1301b47],
2	.	.	O	.	_	0	SENT_761	[p16l1255t15r1301b47],

1	K	NNP	O	K	nsubj	3	SENT_762	[p16l1255t15r1301b47],
2	)	CD	NUMBER	)	num	1	SENT_762	[p16l1255t15r1301b47],
3	have	VBP	O	have	_	0	SENT_762	[p16l1311t14r1374b40],
4	little	JJ	O	little	amod	5	SENT_762	[p16l1385t14r1449b40],
5	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_762	[p16l1459t14r1586b40],
6	on	IN	O	on	_	0	SENT_762	[p16l1598t24r1633b40],
7	the	DT	O	the	det	8	SENT_762	[p16l1643t14r1686b40],
8	disposition	NN	O	disposition	prep_on	3	SENT_762	[p16l1698t14r1849b48],
9	of	IN	O	of	_	0	SENT_762	[p16l1860t15r1890b40],
10	metformin	NN	O	metformin	prep_of	8	SENT_762	[p16l1897t15r2046b40],
11	in	IN	O	in	_	0	SENT_762	[p16l2056t16r2083b40],
12	diabetic	JJ	O	diabetic	amod	13	SENT_762	[p16l642t60r751b86],
13	patients	NNS	O	patient	prep_in	10	SENT_762	[p16l760t62r876b94],
14	.	.	O	.	_	0	SENT_762	[p16l760t62r876b94],

1	Pbarmacogenet	NNP	O	Pbarmacogenet	_	0	SENT_763	[p16l887t61r1090b95],
2	.	.	O	.	_	0	SENT_763	[p16l887t61r1090b95],

1	Genomics	NNS	O	genomic	_	0	SENT_764	[p16l1104t61r1226b86],
2	20	CD	NUMBER	20	num	1	SENT_764	[p16l1234t62r1274b86],
3	:	:	O	:	_	0	SENT_764	[p16l1234t62r1274b86],
4	1	CD	NUMBER	1	num	8	SENT_764	[p16l1280t62r1290b86],
5	3	CD	NUMBER	3	num	8	SENT_764	[p16l1296t62r1307b86],
6	5-38	CD	NUMBER	5-38	num	8	SENT_764	[p16l1313t61r1378b86],
7	Becker	NNP	O	Becker	nn	8	SENT_764	[p16l642t104r738b130],
8	ML	NNP	O	ML	dep	1	SENT_764	[p16l751t105r813b135],
9	,	,	O	,	_	0	SENT_764	[p16l751t105r813b135],
10	Visser	NNP	PERSON	Visser	nn	11	SENT_764	[p16l828t105r916b130],
11	LE	NNP	PERSON	LE	appos	8	SENT_764	[p16l931t105r982b135],
12	,	,	O	,	_	0	SENT_764	[p16l931t105r982b135],
13	van	NNP	PERSON	van	nn	15	SENT_764	[p16l998t114r1046b130],
14	Schaik	NNP	PERSON	Schaik	nn	15	SENT_764	[p16l1063t104r1154b130],
15	RH	NNP	O	RH	appos	8	SENT_764	[p16l1168t105r1226b135],
16	,	,	O	,	_	0	SENT_764	[p16l1168t105r1226b135],
17	Hofman	NNP	PERSON	Hofman	nn	18	SENT_764	[p16l1243t104r1360b130],
18	A	NNP	O	A	appos	8	SENT_764	[p16l1374t105r1403b135],
19	,	,	O	,	_	0	SENT_764	[p16l1374t105r1403b135],
20	Uitterlinden	NNP	ORGANIZATION	Uitterlinden	nn	21	SENT_764	[p16l1420t104r1595b130],
21	AG	NNP	ORGANIZATION	AG	appos	8	SENT_764	[p16l1609t105r1666b135],
22	,	,	O	,	_	0	SENT_764	[p16l1609t105r1666b135],
23	Stricker	NNP	PERSON	Stricker	nn	24	SENT_764	[p16l1684t104r1793b130],
24	BH	NNP	O	BH	appos	8	SENT_764	[p16l1808t105r1864b130],
25	.	.	O	.	_	0	SENT_764	[p16l1808t105r1864b130],

1	2009	CD	DATE	2009	_	0	SENT_765	[p16l1881t106r1956b130],
2	.	.	O	.	_	0	SENT_765	[p16l1881t106r1956b130],

1	Genetic	JJ	O	genetic	amod	2	SENT_766	[p16l1974t105r2084b130],
2	variation	NN	O	variation	nsubj	12	SENT_766	[p16l641t151r764b176],
3	in	IN	O	in	_	0	SENT_766	[p16l777t151r804b175],
4	the	DT	O	the	det	8	SENT_766	[p16l818t150r861b176],
5	multidrug	JJ	O	multidrug	amod	8	SENT_766	[p16l875t150r1016b184],
6	and	CC	O	and	_	0	SENT_766	[p16l1029t150r1078b176],
7	toxin	NN	O	toxin	amod	8	SENT_766	[p16l1092t151r1162b176],
8	extrusion	NN	O	extrusion	prep_in	2	SENT_766	[p16l1176t151r1305b176],
9	1	CD	NUMBER	1	num	11	SENT_766	[p16l1321t151r1331b175],
10	transporter	NN	O	transporter	nn	11	SENT_766	[p16l1348t157r1504b184],
11	protein	NN	O	protein	dep	2	SENT_766	[p16l1517t151r1619b184],
12	inﬂuences	VBZ	O	inﬂuences	_	0	SENT_766	[p16l1632t150r1772b176],
13	the	DT	O	the	det	15	SENT_766	[p16l1786t150r1829b176],
14	glucose-lowering	JJ	O	glucose-lowering	amod	15	SENT_766	[p16l1844t150r2084b184],
15	effect	NN	O	effect	dobj	12	SENT_766	[p16l642t196r717b221],
16	of	IN	O	of	_	0	SENT_766	[p16l727t196r757b221],
17	metformin	NN	O	metformin	prep_of	15	SENT_766	[p16l763t196r913b221],
18	in	IN	O	in	_	0	SENT_766	[p16l922t197r949b221],
19	patients	NNS	O	patient	prep_in	17	SENT_766	[p16l959t197r1067b230],
20	with	IN	O	with	_	0	SENT_766	[p16l1076t195r1138b221],
21	diabetes	NN	O	diabetes	prep_with	19	SENT_766	[p16l1149t195r1268b221],
22	:	:	O	:	_	0	SENT_766	[p16l1149t195r1268b221],
23	a	DT	O	a	det	25	SENT_766	[p16l1280t205r1293b221],
24	preliminary	JJ	O	preliminary	amod	25	SENT_766	[p16l1302t195r1466b230],
25	study	NN	O	study	dep	15	SENT_766	[p16l1475t195r1556b230],
26	.	.	O	.	_	0	SENT_766	[p16l1475t195r1556b230],

1	Diabetes	NNP	O	Diabetes	nn	6	SENT_767	[p16l1567t196r1677b221],
2	5	CD	NUMBER	5	num	6	SENT_767	[p16l1687t197r1699b221],
3	8:745	CD	NUMBER	8:745	num	6	SENT_767	[p16l1703t196r1829b222],
4	-49	CD	NUMBER	-49	num	6	SENT_767	[p16l1703t196r1829b222],
5	Becker	NNP	PERSON	Becker	nn	6	SENT_767	[p16l642t239r738b265],
6	ML	NNP	O	ML	_	0	SENT_767	[p16l748t240r810b271],
7	,	,	O	,	_	0	SENT_767	[p16l748t240r810b271],
8	Visser	NNP	PERSON	Visser	nn	9	SENT_767	[p16l822t240r910b265],
9	LE	NNP	PERSON	LE	appos	6	SENT_767	[p16l921t240r973b271],
10	,	,	O	,	_	0	SENT_767	[p16l921t240r973b271],
11	van	NNP	PERSON	van	nn	13	SENT_767	[p16l985t249r1033b265],
12	Schaik	NNP	PERSON	Schaik	nn	13	SENT_767	[p16l1047t239r1138b265],
13	RH	NNP	O	RH	appos	9	SENT_767	[p16l1149t240r1207b271],
14	,	,	O	,	_	0	SENT_767	[p16l1149t240r1207b271],
15	Hofman	NNP	PERSON	Hofman	nn	16	SENT_767	[p16l1221t239r1338b265],
16	A	NNP	O	A	appos	9	SENT_767	[p16l1349t240r1378b271],
17	,	,	O	,	_	0	SENT_767	[p16l1349t240r1378b271],
18	Uitterlinden	NNP	ORGANIZATION	Uitterlinden	nn	19	SENT_767	[p16l1391t239r1566b265],
19	AG	NNP	ORGANIZATION	AG	appos	9	SENT_767	[p16l1577t240r1634b271],
20	,	,	O	,	_	0	SENT_767	[p16l1577t240r1634b271],
21	Stricker	NNP	PERSON	Stricker	nn	22	SENT_767	[p16l1649t239r1758b265],
22	BH	NNP	O	BH	appos	9	SENT_767	[p16l1770t240r1826b265],
23	.	.	O	.	_	0	SENT_767	[p16l1770t240r1826b265],

1	2010	CD	DATE	2010	_	0	SENT_768	[p16l1840t241r1915b265],
2	.	.	O	.	_	0	SENT_768	[p16l1840t241r1915b265],

1	Interaction	NN	O	interaction	_	0	SENT_769	[p16l1928t240r2083b265],
2	between	IN	O	between	_	0	SENT_769	[p16l642t285r758b311],
3	polymorphisms	NNS	O	polymorphism	prep_between	1	SENT_769	[p16l765t285r981b319],
4	in	IN	O	in	_	0	SENT_769	[p16l989t286r1016b311],
5	the	DT	O	the	det	9	SENT_769	[p16l1024t285r1067b311],
6	OCT1	NN	O	oct1	nn	9	SENT_769	[p16l1076t286r1166b311],
7	and	CC	O	and	_	0	SENT_769	[p16l1178t285r1227b311],
8	MATE1	NN	O	mate1	nn	9	SENT_769	[p16l1234t286r1351b311],
9	transporter	NN	O	transporter	prep_in	1	SENT_769	[p16l1362t292r1518b319],
10	and	CC	O	and	_	0	SENT_769	[p16l1526t285r1575b311],
11	metformin	NN	O	metformin	nn	12	SENT_769	[p16l1583t285r1733b311],
12	response	NN	O	response	conj_and	9	SENT_769	[p16l1741t295r1869b319],
13	.	.	O	.	_	0	SENT_769	[p16l1741t295r1869b319],

1	Pbarmacagenet	NNP	O	Pbarmacagenet	_	0	SENT_770	[p16l1878t286r2081b320],
2	.	.	O	.	_	0	SENT_770	[p16l1878t286r2081b320],

1	Genomics	NNS	O	genomic	_	0	SENT_771	[p16l643t332r765b356],
2	20:38	CD	TIME	20:38	num	1	SENT_771	[p16l774t332r901b357],
3	-44	CD	NUMBER	-44	num	5	SENT_771	[p16l774t332r901b357],
4	Tsuda	NNP	PERSON	Tsuda	nn	5	SENT_771	[p16l641t375r729b400],
5	M	NN	O	m	dep	1	SENT_771	[p16l737t376r776b406],
6	,	,	O	,	_	0	SENT_771	[p16l737t376r776b406],
7	Terada	NNP	ORGANIZATION	Terada	nn	8	SENT_771	[p16l786t375r887b400],
8	T	NN	ORGANIZATION	t	appos	5	SENT_771	[p16l895t375r928b406],
9	,	,	O	,	_	0	SENT_771	[p16l895t375r928b406],
10	Mizuno	NNP	ORGANIZATION	Mizuno	nn	11	SENT_771	[p16l937t376r1047b400],
11	T	NN	ORGANIZATION	t	appos	5	SENT_771	[p16l1055t375r1088b406],
12	,	,	O	,	_	0	SENT_771	[p16l1055t375r1088b406],
13	Katsura	NNP	ORGANIZATION	Katsura	nn	14	SENT_771	[p16l1098t376r1206b400],
14	T	NN	ORGANIZATION	t	appos	5	SENT_771	[p16l1214t375r1247b406],
15	,	,	O	,	_	0	SENT_771	[p16l1214t375r1247b406],
16	Shimakura	NN	PERSON	shimakura	nn	17	SENT_771	[p16l1258t375r1407b400],
17	J	NN	PERSON	j	appos	5	SENT_771	[p16l1412t376r1434b407],
18	,	,	O	,	_	0	SENT_771	[p16l1412t376r1434b407],
19	Inui	NNP	O	Inui	nn	20	SENT_771	[p16l1444t376r1501b400],
20	K.	NNP	O	K.	appos	5	SENT_771	[p16l1510t376r1541b400],
21	2009	CD	DATE	2009	dep	20	SENT_771	[p16l1552t376r1627b401],
22	.	.	O	.	_	0	SENT_771	[p16l1552t376r1627b401],

1	Targeted	VBN	O	target	_	0	SENT_772	[p16l1636t375r1766b409],
2	disruption	NN	O	disruption	dobj	1	SENT_772	[p16l1776t375r1919b409],
3	of	IN	O	of	_	0	SENT_772	[p16l1928t375r1959b400],
4	the	DT	O	the	det	13	SENT_772	[p16l1964t375r2008b400],
5	multidrug	JJ	O	multidrug	amod	8	SENT_772	[p16l2017t375r2083b400, p16l642t420r728b455],
6	and	CC	O	and	_	0	SENT_772	[p16l736t420r785b446],
7	toxin	NN	O	toxin	amod	8	SENT_772	[p16l795t422r865b446],
8	extrusion	NN	O	extrusion	nn	13	SENT_772	[p16l875t422r1003b446],
9	1	CD	NUMBER	1	number	10	SENT_772	[p16l1015t422r1024b446],
10	(	CD	NUMBER	(	num	8	SENT_772	[p16l1037t421r1142b453],
11	matel	NN	O	matel	nn	13	SENT_772	[p16l1037t421r1142b453],
12	)	NN	O	)	nn	13	SENT_772	[p16l1037t421r1142b453],
13	gene	NN	O	gene	prep_of	2	SENT_772	[p16l1152t430r1217b455],
14	in	IN	O	in	_	0	SENT_772	[p16l1226t422r1253b446],
15	mice	NNS	O	mouse	prep_in	13	SENT_772	[p16l1261t422r1327b446],
16	reduces	VBZ	O	reduce	dep	1	SENT_772	[p16l1336t420r1441b446],
17	renal	JJ	O	renal	amod	18	SENT_772	[p16l1451t420r1520b446],
18	secretion	NN	O	secretion	nsubj	1	SENT_772	[p16l1530t422r1656b446],
19	of	IN	O	of	_	0	SENT_772	[p16l1665t420r1696b446],
20	metformin	NN	O	metformin	prep_of	18	SENT_772	[p16l1701t420r1858b446],
21	.	.	O	.	_	0	SENT_772	[p16l1701t420r1858b446],

1	Mol	NNP	O	Mol	_	0	SENT_773	[p16l1866t421r1926b446],
2	.	.	O	.	_	0	SENT_773	[p16l1866t421r1926b446],

1	Plaarmacol	NN	O	plaarmacol	_	0	SENT_774	[p16l1937t421r2081b446],
2	.	.	O	.	_	0	SENT_774	[p16l1937t421r2081b446],

1	7	CD	NUMBER	7	num	2	SENT_775	[p16l643t467r656b493],
2	5	CD	NUMBER	5	_	0	SENT_775	[p16l661t467r673b492],
3	:	:	O	:	_	0	SENT_775	[p16l678t478r682b492],
4	12	CD	NUMBER	12	num	5	SENT_775	[p16l688t468r716b492],
5	80-86	CD	DATE	80-86	dep	2	SENT_775	[p16l721t468r803b492],
6	Watanabe	NNP	O	Watanabe	nn	7	SENT_775	[p16l641t518r784b544],
7	S	NN	O	s	dep	5	SENT_775	[p16l796t519r820b549],
8	,	,	O	,	_	0	SENT_775	[p16l796t519r820b549],
9	Tsuda	NNP	PERSON	Tsuda	nn	10	SENT_775	[p16l831t518r920b544],
10	M	NNP	O	M	appos	7	SENT_775	[p16l929t519r969b549],
11	,	,	O	,	_	0	SENT_775	[p16l929t519r969b549],
12	Terada	NNP	ORGANIZATION	Terada	nn	13	SENT_775	[p16l981t518r1082b544],
13	T	NN	ORGANIZATION	t	appos	7	SENT_775	[p16l1092t518r1125b549],
14	,	,	O	,	_	0	SENT_775	[p16l1092t518r1125b549],
15	Katsura	NNP	ORGANIZATION	Katsura	nn	16	SENT_775	[p16l1137t519r1245b544],
16	T	NN	ORGANIZATION	t	appos	7	SENT_775	[p16l1255t518r1288b549],
17	,	,	O	,	_	0	SENT_775	[p16l1255t518r1288b549],
18	Inui	NNP	LOCATION	Inui	nn	19	SENT_775	[p16l1301t519r1357b544],
19	K.	NNP	O	K.	appos	7	SENT_775	[p16l1369t519r1400b543],
20	2010	CD	DATE	2010	dep	19	SENT_775	[p16l1413t519r1487b543],
21	.	.	O	.	_	0	SENT_775	[p16l1413t519r1487b543],

1	Reduced	VBN	O	reduce	amod	3	SENT_776	[p16l1500t518r1621b544],
2	renal	JJ	O	renal	amod	3	SENT_776	[p16l1632t518r1702b544],
3	clearance	NN	O	clearance	_	0	SENT_776	[p16l1714t518r1842b544],
4	of	IN	O	of	_	0	SENT_776	[p16l1854t518r1885b544],
5	a	DT	O	a	det	8	SENT_776	[p16l1893t528r1906b544],
6	zwitterionic	JJ	O	zwitterionic	amod	8	SENT_776	[p16l1918t519r2083b544],
7	substrate	NN	O	substrate	nn	8	SENT_776	[p16l642t563r766b589],
8	cephalexin	NN	O	cephalexin	prep_of	3	SENT_776	[p16l776t563r923b597],
9	in	IN	O	in	_	0	SENT_776	[p16l932t565r959b589],
10	MATE1	NN	O	mate1	npadvmod	12	SENT_776	[p16l968t563r1223b589],
11	—	CD	NUMBER	—	num	10	SENT_776	[p16l968t563r1223b589],
12	deﬁcient	JJ	O	deﬁcient	amod	13	SENT_776	[p16l968t563r1223b589],
13	mice	NNS	O	mouse	prep_in	8	SENT_776	[p16l1231t564r1305b589],
14	.	.	O	.	_	0	SENT_776	[p16l1231t564r1305b589],

1	`	``	O	`	_	0	SENT_777	[p16l1311t564r1337b597],
2	-	:	O	-	_	0	SENT_777	[p16l1311t564r1337b597],
3	*	NN	O	*	nn	4	SENT_777	[p16l1311t564r1337b597],
4	P/aarmacol	NN	O	p/aarmacol	dep	1	SENT_777	[p16l1348t564r1492b589],
5	.	.	O	.	_	0	SENT_777	[p16l1348t564r1492b589],

1	Exp	NN	O	exp	_	0	SENT_778	[p16l1504t564r1561b597],
2	.	.	O	.	_	0	SENT_778	[p16l1504t564r1561b597],

1	T/yer	NN	O	t/yer	_	0	SENT_779	[p16l1575t564r1643b589],
2	.	.	O	.	_	0	SENT_779	[p16l1575t564r1643b589],

1	334:65	CD	NUMBER	334:65	num	2	SENT_780	[p16l1657t564r1747b589],
2	1-5	CD	NUMBER	1-5	_	0	SENT_780	[p16l1754t564r1798b589],
3	6	CD	NUMBER	6	num	5	SENT_780	[p16l1802t565r1817b589],
4	Nakamura	NNP	ORGANIZATION	Nakamura	nn	5	SENT_780	[p16l641t606r789b632],
5	T	NN	ORGANIZATION	t	dep	2	SENT_780	[p16l799t607r832b637],
6	,	,	O	,	_	0	SENT_780	[p16l799t607r832b637],
7	Yonezawa	NNP	PERSON	Yonezawa	nn	8	SENT_780	[p16l843t607r984b632],
8	A	NNP	O	A	appos	5	SENT_780	[p16l993t607r1023b637],
9	,	,	O	,	_	0	SENT_780	[p16l993t607r1023b637],
10	Hashimoto	NN	PERSON	hashimoto	nn	11	SENT_780	[p16l1035t606r1192b632],
11	S	NN	O	s	appos	5	SENT_780	[p16l1204t607r1227b637],
12	,	,	O	,	_	0	SENT_780	[p16l1204t607r1227b637],
13	Katsura	NNP	ORGANIZATION	Katsura	nn	14	SENT_780	[p16l1239t607r1347b632],
14	T	NN	ORGANIZATION	t	appos	5	SENT_780	[p16l1357t606r1390b637],
15	,	,	O	,	_	0	SENT_780	[p16l1357t606r1390b637],
16	Inui	NNP	LOCATION	Inui	nn	17	SENT_780	[p16l1402t607r1459b632],
17	K.	NNP	O	K.	appos	5	SENT_780	[p16l1469t607r1501b631],
18	2010	CD	DATE	2010	dep	17	SENT_780	[p16l1513t607r1588b631],
19	.	.	O	.	_	0	SENT_780	[p16l1513t607r1588b631],

1	Disruption	NN	O	disruption	nsubj	8	SENT_781	[p16l1600t607r1754b640],
2	of	IN	O	of	_	0	SENT_781	[p16l1765t606r1795b632],
3	multidrug	JJ	O	multidrug	prep_of	1	SENT_781	[p16l1802t606r1943b640],
4	and	CC	O	and	_	0	SENT_781	[p16l1953t606r2002b632],
5	toxin	NN	O	toxin	nn	7	SENT_781	[p16l2013t607r2084b632],
6	extrusion	NN	O	extrusion	nn	7	SENT_781	[p16l642t648r771b673],
7	MATE1	NN	O	mate1	prep_of	1	SENT_781	[p16l779t648r896b673],
8	potentiates	VBZ	O	potentiate	_	0	SENT_781	[p16l908t648r1061b681],
9	cisplatin-induced	JJ	O	cisplatin-induced	amod	10	SENT_781	[p16l1072t647r1311b681],
10	nephrotoxicity	NN	O	nephrotoxicity	dobj	8	SENT_781	[p16l1321t647r1532b681],
11	.	.	O	.	_	0	SENT_781	[p16l1321t647r1532b681],

1	Biochem	NNP	ORGANIZATION	Biochem	_	0	SENT_782	[p16l1543t648r1656b673],
2	.	.	O	.	_	0	SENT_782	[p16l1543t648r1656b673],

1	P/Jarmacol	NN	O	p/jarmacol	_	0	SENT_783	[p16l1667t648r1811b673],
2	.	.	O	.	_	0	SENT_783	[p16l1667t648r1811b673],

1	80:1762	CD	NUMBER	80:1762	num	2	SENT_784	[p16l1825t648r1985b673],
2	—	CD	NUMBER	—	_	0	SENT_784	[p16l1825t648r1985b673],
3	67	CD	NUMBER	67	num	5	SENT_784	[p16l1825t648r1985b673],
4	Imamura	NNP	O	Imamura	nn	5	SENT_784	[p16l641t690r768b715],
5	Y	NN	O	y	dep	2	SENT_784	[p16l790t690r820b720],
6	,	,	O	,	_	0	SENT_784	[p16l790t690r820b720],
7	Murayama	NN	PERSON	murayama	nn	8	SENT_784	[p16l843t690r994b723],
8	N	NN	PERSON	n	appos	5	SENT_784	[p16l1016t690r1052b720],
9	,	,	O	,	_	0	SENT_784	[p16l1016t690r1052b720],
10	Okudaira	NNP	PERSON	Okudaira	nn	11	SENT_784	[p16l1077t689r1207b715],
11	N	NNP	O	N	appos	5	SENT_784	[p16l1229t690r1265b720],
12	,	,	O	,	_	0	SENT_784	[p16l1229t690r1265b720],
13	Kurihara	NNP	PERSON	Kurihara	nn	14	SENT_784	[p16l1289t689r1414b715],
14	A	NNP	O	A	appos	5	SENT_784	[p16l1436t690r1466b720],
15	,	,	O	,	_	0	SENT_784	[p16l1436t690r1466b720],
16	Okazaki	NNP	PERSON	Okazaki	nn	17	SENT_784	[p16l1491t689r1603b715],
17	O	NNP	O	O	appos	5	SENT_784	[p16l1627t690r1660b720],
18	,	,	O	,	_	0	SENT_784	[p16l1627t690r1660b720],
19	et	FW	O	et	nn	20	SENT_784	[p16l1685t696r1711b715],
20	al.	FW	O	al.	appos	5	SENT_784	[p16l1733t689r1763b715],
21	2011	CD	DATE	2011	dep	20	SENT_784	[p16l1788t690r1862b714],
22	.	.	O	.	_	0	SENT_784	[p16l1788t690r1862b714],

1	Prediction	NN	O	prediction	_	0	SENT_785	[p16l1887t689r2033b715],
2	of	IN	O	of	_	0	SENT_785	[p16l2057t689r2087b715],
3	ﬂuoroquinolone-induced	JJ	O	ﬂuoroquinolone-induced	amod	4	SENT_785	[p16l642t731r992b765],
4	elevation	NN	O	elevation	prep_of	1	SENT_785	[p16l1004t731r1129b757],
5	in	IN	O	in	_	0	SENT_785	[p16l1139t732r1166b756],
6	serum	NN	O	serum	nn	8	SENT_785	[p16l1176t741r1261b757],
7	creatinine	NN	O	creatinine	nn	8	SENT_785	[p16l1272t732r1410b757],
8	levels	NNS	O	level	prep_in	4	SENT_785	[p16l1420t731r1503b757],
9	:	:	O	:	_	0	SENT_785	[p16l1420t731r1503b757],
10	a	DT	O	a	det	11	SENT_785	[p16l1516t741r1529b757],
11	case	NN	O	case	dep	1	SENT_785	[p16l1540t741r1595b757],
12	of	IN	O	of	_	0	SENT_785	[p16l1606t731r1637b757],
13	drug-endogenous	JJ	O	drug-endogenous	amod	15	SENT_785	[p16l1644t731r1889b765],
14	substance	NN	O	substance	nn	15	SENT_785	[p16l1900t731r2033b757],
15	interaction	NN	O	interaction	prep_of	11	SENT_785	[p16l2044t732r2083b756, p16l642t774r766b798],
16	involving	VBG	O	involve	_	0	SENT_785	[p16l775t772r906b807],
17	the	DT	O	the	det	18	SENT_785	[p16l915t772r958b798],
18	inhibition	NN	O	inhibition	prep_involving	15	SENT_785	[p16l968t772r1106b798],
19	of	IN	O	of	_	0	SENT_785	[p16l1116t772r1147b798],
20	renal	JJ	O	renal	amod	21	SENT_785	[p16l1153t772r1222b798],
21	secretion	NN	O	secretion	prep_of	18	SENT_785	[p16l1233t774r1366b798],
22	.	.	O	.	_	0	SENT_785	[p16l1233t774r1366b798],

1	Clin	NNP	O	Clin	_	0	SENT_786	[p16l1379t773r1439b798],
2	.	.	O	.	_	0	SENT_786	[p16l1379t773r1439b798],

1	Pbarmacol	NNP	O	Pbarmacol	_	0	SENT_787	[p16l1451t773r1594b798],
2	.	.	O	.	_	0	SENT_787	[p16l1451t773r1594b798],

1	Tlyer	NNP	O	Tlyer	_	0	SENT_788	[p16l1609t773r1676b798],
2	.	.	O	.	_	0	SENT_788	[p16l1609t773r1676b798],

1	89:81	CD	NUMBER	89:81	_	0	SENT_789	[p16l1690t774r1815b798],
2	-88	CD	NUMBER	-88	num	4	SENT_789	[p16l1690t774r1815b798],
3	Matsushima	NNP	PERSON	Matsushima	nn	4	SENT_789	[p16l640t815r811b841],
4	S	NN	O	s	dep	1	SENT_789	[p16l822t816r846b846],
5	,	,	O	,	_	0	SENT_789	[p16l822t816r846b846],
6	Maeda	NNP	PERSON	Maeda	nn	7	SENT_789	[p16l856t815r951b841],
7	K	NNP	PERSON	K	appos	4	SENT_789	[p16l960t816r992b846],
8	,	,	O	,	_	0	SENT_789	[p16l960t816r992b846],
9	Inoue	NNP	PERSON	Inoue	nn	10	SENT_789	[p16l1003t816r1084b841],
10	K	NNP	PERSON	K	appos	4	SENT_789	[p16l1094t816r1126b846],
11	,	,	O	,	_	0	SENT_789	[p16l1094t816r1126b846],
12	Ohta	NNP	LOCATION	Ohta	nn	13	SENT_789	[p16l1138t815r1208b841],
13	KY	NNP	LOCATION	KY	appos	4	SENT_789	[p16l1218t816r1272b846],
14	,	,	O	,	_	0	SENT_789	[p16l1218t816r1272b846],
15	Yuasa	NNP	ORGANIZATION	Yuasa	nn	16	SENT_789	[p16l1282t816r1364b841],
16	H	NNP	O	H	appos	4	SENT_789	[p16l1373t816r1409b846],
17	,	,	O	,	_	0	SENT_789	[p16l1373t816r1409b846],
18	et	FW	O	et	nn	19	SENT_789	[p16l1421t822r1446b841],
19	al.	FW	O	al.	appos	4	SENT_789	[p16l1456t815r1485b841],
20	2009	CD	DATE	2009	dep	19	SENT_789	[p16l1497t817r1572b841],
21	.	.	O	.	_	0	SENT_789	[p16l1497t817r1572b841],

1	The	DT	O	the	det	2	SENT_790	[p16l1583t815r1642b841],
2	inhibition	NN	O	inhibition	nsubjpass	11	SENT_790	[p16l1652t815r1790b841],
3	of	IN	O	of	_	0	SENT_790	[p16l1801t815r1831b841],
4	human	JJ	O	human	amod	5	SENT_790	[p16l1837t815r1934b841],
5	multidrug	JJ	O	multidrug	prep_of	2	SENT_790	[p16l1943t815r2084b849],
6	and	CC	O	and	_	0	SENT_790	[p16l642t856r691b882],
7	toxin	NN	O	toxin	nn	8	SENT_790	[p16l701t858r771b882],
8	extrusion	NN	O	extrusion	conj_and	2	SENT_790	[p16l781t858r909b882],
9	1	CD	NUMBER	1	dep	8	SENT_790	[p16l922t858r932b882],
10	is	VBZ	O	be	auxpass	11	SENT_790	[p16l944t858r964b882],
11	involved	VBN	O	involve	_	0	SENT_790	[p16l974t856r1091b882],
12	in	IN	O	in	_	0	SENT_790	[p16l1101t858r1128b881],
13	the	DT	O	the	det	15	SENT_790	[p16l1137t856r1180b882],
14	drug-drug	JJ	O	drug-drug	amod	15	SENT_790	[p16l1191t856r1335b890],
15	interaction	NN	O	interaction	prep_in	11	SENT_790	[p16l1343t857r1495b882],
16	caused	VBN	O	cause	partmod	15	SENT_790	[p16l1505t856r1596b882],
17	by	IN	O	by	_	0	SENT_790	[p16l1606t856r1640b890],
18	cimetidine	NN	O	cimetidine	agent	16	SENT_790	[p16l1648t856r1802b882],
19	.	.	O	.	_	0	SENT_790	[p16l1648t856r1802b882],

1	Drug	NN	O	drug	_	0	SENT_791	[p16l1813t857r1885b891],
2	Metab	NNP	O	Metab	dep	1	SENT_791	[p16l1891t857r1981b882],
3	.	.	O	.	_	0	SENT_791	[p16l1891t857r1981b882],

1	Dispos	NNP	O	Dispos	_	0	SENT_792	[p16l1993t857r2081b890],
2	.	.	O	.	_	0	SENT_792	[p16l1993t857r2081b890],

1	37	CD	NUMBER	37	number	2	SENT_793	[p16l643t899r673b925],
2	:5	CD	NUMBER	:5	num	4	SENT_793	[p16l678t899r699b925],
3	5	CD	NUMBER	5	number	4	SENT_793	[p16l704t900r716b925],
4	5	CD	NUMBER	5	_	0	SENT_793	[p16l721t900r733b925],
5	-5	CD	NUMBER	-5	number	6	SENT_793	[p16l736t900r767b925],
6	9	CD	NUMBER	9	num	8	SENT_793	[p16l771t900r786b925],
7	Minematsu	NN	ORGANIZATION	minematsu	nn	8	SENT_793	[p16l640t941r800b966],
8	T	NN	ORGANIZATION	t	dep	4	SENT_793	[p16l806t941r839b972],
9	,	,	O	,	_	0	SENT_793	[p16l806t941r839b972],
10	Giacomini	NNP	PERSON	Giacomini	nn	11	SENT_793	[p16l849t941r996b966],
11	KM	NNP	O	KM	appos	8	SENT_793	[p16l1004t941r1067b966],
12	.	.	O	.	_	0	SENT_793	[p16l1004t941r1067b966],

1	201	CD	NUMBER	201	num	2	SENT_794	[p16l1077t942r1124b966],
2	1	CD	NUMBER	1	_	0	SENT_794	[p16l1132t942r1151b966],
3	.	.	O	.	_	0	SENT_794	[p16l1132t942r1151b966],

1	Interactions	NNS	O	interaction	_	0	SENT_795	[p16l1161t941r1328b966],
2	of	IN	O	of	_	0	SENT_795	[p16l1337t940r1367b966],
3	tyrosine	NN	O	tyrosine	nn	5	SENT_795	[p16l1371t942r1483b975],
4	kinase	NN	O	kinase	nn	5	SENT_795	[p16l1491t940r1576b966],
5	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_795	[p16l1585t940r1720b966],
6	with	IN	O	with	_	0	SENT_795	[p16l1727t940r1789b966],
7	organic	JJ	O	organic	amod	9	SENT_795	[p16l1798t941r1901b975],
8	cation	NN	O	cation	nn	9	SENT_795	[p16l1910t942r1994b966],
9	transporters	NNS	O	transporter	prep_with	5	SENT_795	[p16l2002t948r2083b966, p16l642t990r748b1017],
10	,	,	O	,	_	0	SENT_795	[p16l2002t948r2083b966, p16l642t990r748b1017],
11	OCTs	NNS	O	oct	conj_and	5	SENT_795	[p16l760t983r856b1014],
12	,	,	O	,	_	0	SENT_795	[p16l760t983r856b1014],
13	and	CC	O	and	_	0	SENT_795	[p16l868t982r917b1008],
14	multidrug	JJ	O	multidrug	amod	19	SENT_795	[p16l927t982r1068b1017],
15	and	CC	O	and	_	0	SENT_795	[p16l1077t982r1126b1008],
16	toxic	JJ	O	toxic	conj_and	14	SENT_795	[p16l1137t984r1203b1008],
17	compound	NN	O	compound	nn	19	SENT_795	[p16l1213t982r1361b1017],
18	extrusion	NN	O	extrusion	nn	19	SENT_795	[p16l1372t984r1500b1008],
19	proteins	NNS	O	protein	conj_and	5	SENT_795	[p16l1509t984r1631b1017],
20	.	.	O	.	_	0	SENT_795	[p16l1509t984r1631b1017],

1	Mol	NNP	O	Mol	_	0	SENT_796	[p16l1640t983r1699b1008],
2	.	.	O	.	_	0	SENT_796	[p16l1640t983r1699b1008],

1	Cancer	NN	O	cancer	_	0	SENT_797	[p16l1714t983r1804b1008],
2	Tber	NN	O	tber	dep	1	SENT_797	[p16l1813t983r1881b1008],
3	.	.	O	.	_	0	SENT_797	[p16l1813t983r1881b1008],

1	10:531	CD	NUMBER	10:531	num	5	SENT_798	[p16l1897t984r2038b1009],
2	—	CD	NUMBER	—	num	5	SENT_798	[p16l1897t984r2038b1009],
3	39	CD	NUMBER	39	num	5	SENT_798	[p16l1897t984r2038b1009],
4	Burckhardt	NNP	PERSON	Burckhardt	nn	5	SENT_798	[p16l642t1024r800b1050],
5	G	NNP	PERSON	G	_	0	SENT_798	[p16l811t1025r844b1055],
6	,	,	O	,	_	0	SENT_798	[p16l811t1025r844b1055],
7	Burckhardt	NNP	PERSON	Burckhardt	nn	8	SENT_798	[p16l856t1024r1015b1050],
8	BC	NNP	O	BC	appos	5	SENT_798	[p16l1025t1025r1077b1050],
9	.	.	O	.	_	0	SENT_798	[p16l1025t1025r1077b1050],

1	2011	CD	DATE	2011	_	0	SENT_799	[p16l1090t1026r1164b1050],
2	.	.	O	.	_	0	SENT_799	[p16l1090t1026r1164b1050],

1	In	FW	O	in	nn	2	SENT_800	[p16l1177t1025r1207b1049],
2	vitro	FW	O	vitro	dep	6	SENT_800	[p16l1216t1025r1282b1050],
3	and	CC	O	and	_	0	SENT_800	[p16l1294t1024r1343b1050],
4	in	FW	O	in	conj_and	2	SENT_800	[p16l1354t1025r1381b1049],
5	vivo	FW	O	vivo	pobj	4	SENT_800	[p16l1390t1025r1448b1050],
6	evidence	NN	O	evidence	nsubj	14	SENT_800	[p16l1460t1024r1580b1050],
7	of	IN	O	of	_	0	SENT_800	[p16l1591t1024r1622b1050],
8	the	DT	O	the	det	9	SENT_800	[p16l1629t1024r1672b1050],
9	importance	NN	O	importance	prep_of	6	SENT_800	[p16l1683t1025r1842b1058],
10	of	IN	O	of	_	0	SENT_800	[p16l1853t1024r1884b1050],
11	organic	JJ	O	organic	amod	13	SENT_800	[p16l1891t1025r1995b1058],
12	anion	NN	O	anion	nn	13	SENT_800	[p16l2006t1025r2084b1050],
13	transporters	NNS	O	transporter	prep_of	9	SENT_800	[p16l642t1074r810b1101],
14	(	VBP	O	(	_	0	SENT_800	[p16l821t1067r927b1099],
15	OATS	NNS	O	oats	dobj	14	SENT_800	[p16l821t1067r927b1099],
16	)	CD	NUMBER	)	num	15	SENT_800	[p16l821t1067r927b1099],
17	in	IN	O	in	_	0	SENT_800	[p16l937t1068r964b1092],
18	drug	NN	O	drug	nn	19	SENT_800	[p16l975t1066r1039b1101],
19	therapy	NN	O	therapy	prep_in	15	SENT_800	[p16l1048t1066r1161b1101],
20	.	.	O	.	_	0	SENT_800	[p16l1048t1066r1161b1101],

1	Handb	NNP	PERSON	Handb	_	0	SENT_801	[p16l1171t1067r1265b1092],
2	.	.	O	.	_	0	SENT_801	[p16l1171t1067r1265b1092],

1	Exp	NN	O	exp	_	0	SENT_802	[p16l1277t1067r1334b1101],
2	.	.	O	.	_	0	SENT_802	[p16l1277t1067r1334b1101],

1	P/yarmatol	NN	O	p/yarmatol	_	0	SENT_803	[p16l1346t1067r1490b1092],
2	.	.	O	.	_	0	SENT_803	[p16l1346t1067r1490b1092],

1	20l1	NN	O	20l1	_	0	SENT_804	[p16l1503t1068r1682b1093],
2	:29	CD	NUMBER	:29	num	3	SENT_804	[p16l1503t1068r1682b1093],
3	—	NN	O	—	dep	1	SENT_804	[p16l1503t1068r1682b1093],
4	104	CD	NUMBER	104	dep	1	SENT_804	[p16l1503t1068r1682b1093],

1	266	CD	NUMBER	266	num	2	SENT_805	[p16l471t1170r515b1192],
2	DeGorter	NNP	O	DeGorter	_	0	SENT_805	[p16l565t1170r676b1192],
3	et	FW	O	et	nn	4	SENT_805	[p16l683t1175r703b1192],
4	al.	FW	O	al.	dep	2	SENT_805	[p16l709t1170r735b1192],
5	.	.	O	.	_	0	SENT_805	[p16l709t1170r735b1192],

1	Vanwert	NNP	ORGANIZATION	Vanwert	nn	2	SENT_806	[p16l441t1210r563b1235],
2	AL	NNP	ORGANIZATION	AL	_	0	SENT_806	[p16l571t1210r623b1240],
3	,	,	O	,	_	0	SENT_806	[p16l571t1210r623b1240],
4	Gionfriddo	NNP	PERSON	Gionfriddo	nn	5	SENT_806	[p16l635t1209r792b1235],
5	MR	NN	PERSON	mr	appos	2	SENT_806	[p16l801t1210r864b1240],
6	,	,	O	,	_	0	SENT_806	[p16l801t1210r864b1240],
7	Sweet	NNP	O	Sweet	nn	8	SENT_806	[p16l877t1210r959b1235],
8	DH	NNP	O	DH	appos	5	SENT_806	[p16l969t1210r1031b1235],
9	.	.	O	.	_	0	SENT_806	[p16l969t1210r1031b1235],

1	2010	CD	DATE	2010	_	0	SENT_807	[p16l1043t1211r1117b1235],
2	.	.	O	.	_	0	SENT_807	[p16l1043t1211r1117b1235],

1	Organic	NNP	O	Organic	nn	3	SENT_808	[p16l1130t1210r1243b1243],
2	anion	NN	O	anion	nn	3	SENT_808	[p16l1253t1210r1331b1235],
3	transporters	NNS	O	transporter	_	0	SENT_808	[p16l1341t1216r1516b1243],
4	:	:	O	:	_	0	SENT_808	[p16l1341t1216r1516b1243],
5	discovery	NN	O	discovery	dep	3	SENT_808	[p16l1528t1209r1666b1243],
6	,	,	O	,	_	0	SENT_808	[p16l1528t1209r1666b1243],
7	pharmacology	NN	O	pharmacology	dep	3	SENT_808	[p16l1677t1209r1882b1243],
8	,	,	O	,	_	0	SENT_808	[p16l1677t1209r1882b1243],
9	regulation	NN	O	regulation	dep	3	SENT_808	[p16l442t1252r585b1286],
10	and	CC	O	and	_	0	SENT_808	[p16l595t1252r645b1278],
11	roles	NNS	O	role	conj_and	5	SENT_808	[p16l655t1252r721b1278],
12	in	IN	O	in	_	0	SENT_808	[p16l731t1254r757b1278],
13	pathophysiology	NN	O	pathophysiology	prep_in	5	SENT_808	[p16l767t1252r1005b1286],
14	.	.	O	.	_	0	SENT_808	[p16l767t1252r1005b1286],

1	Biopharm	NNP	ORGANIZATION	Biopharm	_	0	SENT_809	[p16l1016t1253r1149b1286],
2	.	.	O	.	_	0	SENT_809	[p16l1016t1253r1149b1286],

1	Drag	VB	O	drag	_	0	SENT_810	[p16l1162t1253r1234b1287],
2	Dispos	NNP	O	Dispos	dobj	1	SENT_810	[p16l1242t1253r1330b1286],
3	.	.	O	.	_	0	SENT_810	[p16l1242t1253r1330b1286],

1	31:1	CD	NUMBER	31:1	num	5	SENT_811	[p16l1344t1253r1449b1278],
2	—	CD	NUMBER	—	num	5	SENT_811	[p16l1344t1253r1449b1278],
3	71	CD	NUMBER	71	num	5	SENT_811	[p16l1344t1253r1449b1278],
4	Vanwert	NNP	ORGANIZATION	Vanwert	nn	5	SENT_811	[p16l441t1296r563b1321],
5	AL	NNP	ORGANIZATION	AL	_	0	SENT_811	[p16l571t1296r623b1326],
6	,	,	O	,	_	0	SENT_811	[p16l571t1296r623b1326],
7	Bailey	NNP	PERSON	Bailey	nn	8	SENT_811	[p16l635t1295r721b1329],
8	RM	NN	O	rm	appos	5	SENT_811	[p16l730t1296r791b1326],
9	,	,	O	,	_	0	SENT_811	[p16l730t1296r791b1326],
10	Sweet	NNP	O	Sweet	nn	11	SENT_811	[p16l804t1296r886b1321],
11	DH	NNP	O	DH	appos	8	SENT_811	[p16l896t1296r958b1321],
12	.	.	O	.	_	0	SENT_811	[p16l896t1296r958b1321],

1	2007	CD	DATE	2007	_	0	SENT_812	[p16l970t1296r1044b1321],
2	.	.	O	.	_	0	SENT_812	[p16l970t1296r1044b1321],

1	Organic	NNP	O	Organic	nn	3	SENT_813	[p16l1057t1296r1170b1329],
2	anion	NN	O	anion	nn	3	SENT_813	[p16l1180t1296r1258b1321],
3	transporter	NN	O	transporter	nsubj	10	SENT_813	[p16l1268t1302r1424b1329],
4	3	CD	NUMBER	3	num	6	SENT_813	[p16l1436t1297r1447b1321],
5	(	NN	O	(	nn	6	SENT_813	[p16l1461t1296r1667b1327],
6	Oat3/Slc22a8	NN	O	oat3/slc22a8	dep	3	SENT_813	[p16l1461t1296r1667b1327],
7	)	CD	NUMBER	)	num	9	SENT_813	[p16l1461t1296r1667b1327],
8	knockout	NN	O	knockout	nn	9	SENT_813	[p16l1678t1295r1809b1321],
9	mice	NNS	O	mouse	dep	3	SENT_813	[p16l1818t1296r1883b1321],
10	exhibit	VBP	O	exhibit	_	0	SENT_813	[p16l443t1338r538b1364],
11	altered	JJ	O	altered	amod	12	SENT_813	[p16l547t1338r642b1364],
12	clearance	NN	O	clearance	dobj	10	SENT_813	[p16l653t1338r781b1364],
13	and	CC	O	and	_	0	SENT_813	[p16l792t1338r841b1364],
14	distribution	NN	O	distribution	conj_and	12	SENT_813	[p16l851t1338r1015b1364],
15	of	IN	O	of	_	0	SENT_813	[p16l1025t1338r1055b1364],
16	penicillin	NN	O	penicillin	nn	18	SENT_813	[p16l1061t1338r1191b1373],
17	G.	NNP	O	G.	nn	18	SENT_813	[p16l1201t1339r1234b1364],
18	Am	NNP	O	Am	prep_of	12	SENT_813	[p16l1243t1339r1299b1364],
19	.	.	O	.	_	0	SENT_813	[p16l1243t1339r1299b1364],

1	@Z	SYM	O	@z	dep	4	SENT_814	[p16l1307t1339r1332b1373],
2	-	:	O	-	_	0	SENT_814	[p16l1307t1339r1332b1373],
3	*	NN	O	*	nn	4	SENT_814	[p16l1307t1339r1332b1373],
4	Pbysiol	NN	O	pbysiol	_	0	SENT_814	[p16l1344t1339r1440b1373],
5	.	.	O	.	_	0	SENT_814	[p16l1344t1339r1440b1373],

1	Renal	JJ	O	renal	amod	2	SENT_815	[p16l1451t1339r1528b1364],
2	P/yysiol	NN	O	p/yysiol	_	0	SENT_815	[p16l1534t1339r1630b1373],
3	.	.	O	.	_	0	SENT_815	[p16l1534t1339r1630b1373],

1	293	CD	NUMBER	293	_	0	SENT_816	[p16l1643t1339r1839b1365],
2	:	:	O	:	_	0	SENT_816	[p16l1643t1339r1839b1365],
3	F1332-41	NN	O	f1332-41	dep	1	SENT_816	[p16l1643t1339r1839b1365],
4	Vanwert	NNP	ORGANIZATION	Vanwert	nn	5	SENT_816	[p16l441t1382r563b1407],
5	AL	NNP	ORGANIZATION	AL	dep	1	SENT_816	[p16l574t1382r626b1413],
6	,	,	O	,	_	0	SENT_816	[p16l574t1382r626b1413],
7	Srimaroeng	NNP	O	Srimaroeng	nn	8	SENT_816	[p16l642t1382r805b1416],
8	C	NNP	O	C	appos	1	SENT_816	[p16l819t1382r849b1413],
9	,	,	O	,	_	0	SENT_816	[p16l819t1382r849b1413],
10	Sweet	NNP	O	Sweet	nn	11	SENT_816	[p16l865t1382r947b1407],
11	DH	NNP	O	DH	appos	1	SENT_816	[p16l960t1382r1022b1407],
12	.	.	O	.	_	0	SENT_816	[p16l960t1382r1022b1407],

1	2008	CD	DATE	2008	_	0	SENT_817	[p16l1038t1383r1112b1407],
2	.	.	O	.	_	0	SENT_817	[p16l1038t1383r1112b1407],

1	Organic	NNP	O	Organic	nn	3	SENT_818	[p16l1128t1382r1241b1416],
2	anion	NN	O	anion	nn	3	SENT_818	[p16l1255t1382r1332b1407],
3	transporter	NN	O	transporter	tmod	8	SENT_818	[p16l1345t1389r1502b1416],
4	3	CD	NUMBER	3	num	5	SENT_818	[p16l1516t1383r1528b1407],
5	(	NN	O	(	dep	3	SENT_818	[p16l1545t1382r1751b1414],
6	Oat3/Slc22a8	NN	O	oat3/slc22a8	nsubj	8	SENT_818	[p16l1545t1382r1751b1414],
7	)	CD	NUMBER	)	num	6	SENT_818	[p16l1545t1382r1751b1414],
8	interacts	VBZ	O	interact	_	0	SENT_818	[p16l1765t1383r1883b1407],
9	with	IN	O	with	_	0	SENT_818	[p16l442t1425r504b1451],
10	carboxyﬂuoroquinolones	NNS	O	carboxyﬂuoroquinolones	prep_with	8	SENT_818	[p16l511t1425r866b1459],
11	,	,	O	,	_	0	SENT_818	[p16l511t1425r866b1459],
12	and	CC	O	and	_	0	SENT_818	[p16l875t1425r924b1451],
13	deletion	NN	O	deletion	nn	14	SENT_818	[p16l932t1425r1045b1451],
14	increases	NNS	O	increase	dep	16	SENT_818	[p16l1052t1426r1176b1451],
15	systemic	JJ	O	systemic	amod	16	SENT_818	[p16l1184t1426r1301b1459],
16	exposure	NN	O	exposure	conj_and	8	SENT_818	[p16l1309t1434r1431b1459],
17	to	TO	O	to	_	0	SENT_818	[p16l1439t1432r1466b1451],
18	ciproﬂoxacin	NN	O	ciproﬂoxacin	prep_to	16	SENT_818	[p16l1474t1425r1661b1459],
19	.	.	O	.	_	0	SENT_818	[p16l1474t1425r1661b1459],

1	Mol	NNP	O	Mol	_	0	SENT_819	[p16l1668t1426r1728b1451],
2	.	.	O	.	_	0	SENT_819	[p16l1668t1426r1728b1451],

1	Pbarmacol	NNP	O	Pbarmacol	_	0	SENT_820	[p16l1737t1426r1881b1450],
2	.	.	O	.	_	0	SENT_820	[p16l1737t1426r1881b1450],

1	74	CD	NUMBER	74	_	0	SENT_821	[p16l444t1469r483b1494],
2	:	:	O	:	_	0	SENT_821	[p16l444t1469r483b1494],
3	l	NN	O	l	dep	8	SENT_821	[p16l489t1470r498b1493],
4	2	CD	NUMBER	2	num	5	SENT_821	[p16l503t1470r516b1493],
5	2-3	CD	NUMBER	2-3	dep	3	SENT_821	[p16l520t1470r567b1494],
6	1	CD	NUMBER	1	num	7	SENT_821	[p16l574t1470r584b1493],
7	Ose	NN	O	ose	dep	8	SENT_821	[p16l443t1512r496b1537],
8	A	NN	O	a	dep	24	SENT_821	[p16l514t1512r543b1542],
9	,	,	O	,	_	0	SENT_821	[p16l514t1512r543b1542],
10	Ito	NNP	O	Ito	nn	11	SENT_821	[p16l563t1512r602b1537],
11	M	NNP	O	M	appos	8	SENT_821	[p16l620t1512r659b1542],
12	,	,	O	,	_	0	SENT_821	[p16l620t1512r659b1542],
13	Kusuhara	NNP	PERSON	Kusuhara	nn	14	SENT_821	[p16l679t1511r812b1537],
14	H	NNP	PERSON	H	appos	8	SENT_821	[p16l830t1512r865b1542],
15	,	,	O	,	_	0	SENT_821	[p16l830t1512r865b1542],
16	Yamatsugu	NNP	PERSON	Yamatsugu	nn	17	SENT_821	[p16l884t1512r1039b1545],
17	K	NNP	PERSON	K	appos	8	SENT_821	[p16l1057t1512r1089b1542],
18	,	,	O	,	_	0	SENT_821	[p16l1057t1512r1089b1542],
19	Kanai	NNP	PERSON	Kanai	nn	20	SENT_821	[p16l1108t1512r1190b1537],
20	M	NNP	O	M	appos	8	SENT_821	[p16l1207t1512r1246b1542],
21	,	,	O	,	_	0	SENT_821	[p16l1207t1512r1246b1542],
22	et	FW	O	et	nn	23	SENT_821	[p16l1266t1518r1292b1537],
23	al.	FW	O	al.	appos	8	SENT_821	[p16l1310t1511r1339b1537],
24	2009	CD	DATE	2009	dep	1	SENT_821	[p16l1359t1513r1434b1537],
25	.	.	O	.	_	0	SENT_821	[p16l1359t1513r1434b1537],

1	Limited	JJ	O	limited	amod	3	SENT_822	[p16l1454t1511r1566b1537],
2	brain	NN	O	brain	nn	3	SENT_822	[p16l1584t1511r1656b1537],
3	distribution	NN	O	distribution	dep	10	SENT_822	[p16l1675t1511r1838b1537],
4	of	IN	O	of	_	0	SENT_822	[p16l1857t1511r1887b1537],
5	[	CD	NUMBER	[	num	6	SENT_822	[p16l445t1553r1603b1587],
6	3R	NN	O	3r	prep_of	3	SENT_822	[p16l445t1553r1603b1587],
7	,4	CD	NUMBER	,4	num	8	SENT_822	[p16l445t1553r1603b1587],
8	R	NN	O	r	dep	10	SENT_822	[p16l445t1553r1603b1587],
9	,5	CD	NUMBER	,5	num	10	SENT_822	[p16l445t1553r1603b1587],
10	S	NN	O	s	dep	14	SENT_822	[p16l445t1553r1603b1587],
11	]	CD	NUMBER	]	num	12	SENT_822	[p16l445t1553r1603b1587],
12	-4	CD	NUMBER	-4	dep	10	SENT_822	[p16l445t1553r1603b1587],
13	-	:	O	-	_	0	SENT_822	[p16l445t1553r1603b1587],
14	acetamido-5-amino-3	NN	O	acetamido-5-amino-3	nsubj	44	SENT_822	[p16l445t1553r1603b1587],
15	-	:	O	-	_	0	SENT_822	[p16l445t1553r1603b1587],
16	(	CD	NUMBER	(	num	18	SENT_822	[p16l445t1553r1603b1587],
17	1-ethylpropoxy	JJ	O	1-ethylpropoxy	amod	18	SENT_822	[p16l445t1553r1603b1587],
18	)	NN	O	)	dep	14	SENT_822	[p16l445t1553r1603b1587],
19	-1	CD	NUMBER	-1	dep	18	SENT_822	[p16l445t1553r1603b1587],
20	-	:	O	-	_	0	SENT_822	[p16l445t1553r1603b1587],
21	cyclohexene-1-carboxylate	JJ	O	cyclohexene-1-carboxylate	amod	22	SENT_822	[p16l445t1553r1603b1587],
22	phosphate	NN	O	phosphate	dep	18	SENT_822	[p16l1616t1553r1758b1587],
23	(	CD	NUMBER	(	num	24	SENT_822	[p16l1772t1554r1821b1585],
24	Ro	NN	O	ro	dep	22	SENT_822	[p16l1772t1554r1821b1585],
25	640802	CD	NUMBER	640802	num	26	SENT_822	[p16l1835t1555r1885b1579, p16l443t1597r528b1629],
26	)	NN	O	)	dep	24	SENT_822	[p16l1835t1555r1885b1579, p16l443t1597r528b1629],
27	,	,	O	,	_	0	SENT_822	[p16l1835t1555r1885b1579, p16l443t1597r528b1629],
28	a	DT	O	a	det	31	SENT_822	[p16l543t1606r556b1622],
29	pharmacologically	RB	O	pharmacologically	advmod	30	SENT_822	[p16l570t1596r826b1631],
30	active	JJ	O	active	amod	31	SENT_822	[p16l839t1598r917b1622],
31	form	NN	O	form	appos	24	SENT_822	[p16l931t1596r999b1622],
32	of	IN	O	of	_	0	SENT_822	[p16l1013t1596r1043b1622],
33	oseltamivir	NN	O	oseltamivir	prep_of	31	SENT_822	[p16l1053t1596r1214b1628],
34	,	,	O	,	_	0	SENT_822	[p16l1053t1596r1214b1628],
35	by	IN	O	by	_	0	SENT_822	[p16l1229t1596r1263b1631],
36	active	JJ	O	active	amod	37	SENT_822	[p16l1275t1598r1354b1622],
37	efﬂux	NN	O	efﬂux	prep_by	14	SENT_822	[p16l1368t1596r1443b1622],
38	across	IN	O	across	_	0	SENT_822	[p16l1456t1606r1539b1622],
39	the	DT	O	the	det	43	SENT_822	[p16l1553t1596r1596b1622],
40	blood	NN	O	blood	nn	43	SENT_822	[p16l1610t1596r1776b1622],
41	—	NN	O	—	nn	43	SENT_822	[p16l1610t1596r1776b1622],
42	brain	NN	O	brain	nn	43	SENT_822	[p16l1610t1596r1776b1622],
43	barrier	NN	O	barrier	prep_across	37	SENT_822	[p16l1789t1596r1884b1622],
44	mediated	VBN	O	mediate	_	0	SENT_822	[p16l442t1640r570b1666],
45	by	IN	O	by	_	0	SENT_822	[p16l582t1640r616b1674],
46	organic	JJ	O	organic	amod	52	SENT_822	[p16l626t1641r730b1674],
47	anion	NN	O	anion	nn	52	SENT_822	[p16l741t1641r819b1666],
48	transporter	NN	O	transporter	nn	52	SENT_822	[p16l830t1647r986b1674],
49	3	CD	NUMBER	3	num	52	SENT_822	[p16l999t1641r1010b1666],
50	(	NN	O	(	nn	52	SENT_822	[p16l1025t1641r1231b1672],
51	Oat3/Slc22a8	NN	O	oat3/slc22a8	nn	52	SENT_822	[p16l1025t1641r1231b1672],
52	)	NN	O	)	prep_by	44	SENT_822	[p16l1025t1641r1231b1672],
53	and	CC	O	and	_	0	SENT_822	[p16l1243t1640r1293b1666],
54	multidrug	JJ	O	multidrug	amod	56	SENT_822	[p16l1304t1640r1445b1674],
55	resistance-associated	JJ	O	resistance-associated	amod	56	SENT_822	[p16l1455t1640r1743b1666],
56	protein	NN	O	protein	conj_and	52	SENT_822	[p16l1755t1641r1857b1674],
57	4	CD	NUMBER	4	number	58	SENT_822	[p16l1867t1641r1884b1666],
58	(	CD	NUMBER	(	num	60	SENT_822	[p16l443t1683r637b1716],
59	Mrp4/Al7ec4	NN	O	mrp4/al7ec4	nn	60	SENT_822	[p16l443t1683r637b1716],
60	)	NN	O	)	dobj	44	SENT_822	[p16l443t1683r637b1716],
61	.	.	O	.	_	0	SENT_822	[p16l443t1683r637b1716],

1	Drag	VB	O	drag	_	0	SENT_823	[p16l648t1683r720b1717],
2	Metalr	NNP	O	Metalr	dobj	1	SENT_823	[p16l727t1683r817b1708],
3	.	.	O	.	_	0	SENT_823	[p16l727t1683r817b1708],

1	Dispos	NNP	O	Dispos	_	0	SENT_824	[p16l829t1683r916b1716],
2	.	.	O	.	_	0	SENT_824	[p16l829t1683r916b1716],

1	3	CD	NUMBER	3	num	6	SENT_825	[p16l930t1684r942b1708],
2	7:3	CD	NUMBER	7:3	num	6	SENT_825	[p16l947t1683r985b1708],
3	15-2	CD	NUMBER	15-2	num	6	SENT_825	[p16l992t1683r1054b1708],
4	1	CD	NUMBER	1	num	6	SENT_825	[p16l1061t1684r1070b1707],
5	Vallon	NNP	ORGANIZATION	Vallon	nn	6	SENT_825	[p16l441t1725r536b1751],
6	V	NNP	ORGANIZATION	V	_	0	SENT_825	[p16l549t1726r581b1756],
7	,	,	O	,	_	0	SENT_825	[p16l549t1726r581b1756],
8	Rieg	NNP	PERSON	Rieg	nn	9	SENT_825	[p16l598t1726r662b1759],
9	T	NN	O	t	appos	6	SENT_825	[p16l676t1726r709b1756],
10	,	,	O	,	_	0	SENT_825	[p16l676t1726r709b1756],
11	Ahn	NNP	PERSON	Ahn	nn	12	SENT_825	[p16l724t1725r783b1750],
12	SY	NNP	PERSON	SY	appos	9	SENT_825	[p16l799t1726r844b1756],
13	,	,	O	,	_	0	SENT_825	[p16l799t1726r844b1756],
14	Wu	NNP	O	Wu	nn	15	SENT_825	[p16l860t1726r914b1751],
15	W	NNP	O	W	appos	9	SENT_825	[p16l928t1726r971b1756],
16	,	,	O	,	_	0	SENT_825	[p16l928t1726r971b1756],
17	Eraly	NNP	O	Eraly	nn	18	SENT_825	[p16l988t1725r1063b1759],
18	SA	NNP	O	SA	appos	9	SENT_825	[p16l1078t1726r1124b1756],
19	,	,	O	,	_	0	SENT_825	[p16l1078t1726r1124b1756],
20	Nigam	NNP	ORGANIZATION	Nigam	nn	21	SENT_825	[p16l1139t1726r1237b1759],
21	SK	NNP	ORGANIZATION	SK	appos	9	SENT_825	[p16l1253t1726r1301b1751],
22	.	.	O	.	_	0	SENT_825	[p16l1253t1726r1301b1751],

1	2008	CD	DATE	2008	_	0	SENT_826	[p16l1318t1727r1393b1751],
2	.	.	O	.	_	0	SENT_826	[p16l1318t1727r1393b1751],

1	Overlapping	NNP	O	Overlapping	_	0	SENT_827	[p16l1410t1725r1585b1759],
2	in	FW	O	in	nn	3	SENT_827	[p16l1599t1726r1626b1750],
3	vitro	FW	O	vitro	dep	7	SENT_827	[p16l1639t1726r1705b1751],
4	and	CC	O	and	_	0	SENT_827	[p16l1721t1725r1770b1751],
5	in	FW	O	in	conj_and	3	SENT_827	[p16l1785t1726r1812b1750],
6	vivo	FW	O	vivo	pobj	5	SENT_827	[p16l1826t1726r1883b1751],
7	specificities	NNS	O	specificity	dep	1	SENT_827	[p16l443t1770r601b1804],
8	of	IN	O	of	_	0	SENT_827	[p16l613t1770r643b1796],
9	the	DT	O	the	det	12	SENT_827	[p16l650t1770r694b1796],
10	organic	JJ	O	organic	amod	12	SENT_827	[p16l705t1771r809b1804],
11	anion	NN	O	anion	nn	12	SENT_827	[p16l819t1771r897b1796],
12	transporters	NNS	O	transporter	prep_of	7	SENT_827	[p16l908t1778r1075b1804],
13	OAT1	NN	O	oat1	dep	1	SENT_827	[p16l1087t1771r1175b1796],
14	and	CC	O	and	_	0	SENT_827	[p16l1189t1770r1238b1796],
15	OAT3	NN	O	oat3	conj_and	13	SENT_827	[p16l1250t1771r1338b1796],
16	for	IN	O	for	_	0	SENT_827	[p16l1352t1770r1392b1796],
17	loop	NN	O	loop	nn	20	SENT_827	[p16l1402t1770r1463b1804],
18	and	CC	O	and	_	0	SENT_827	[p16l1475t1770r1524b1796],
19	thiazide	JJ	O	thiazide	nn	20	SENT_827	[p16l1535t1770r1644b1796],
20	diuretics	NNS	O	diuretic	prep_for	13	SENT_827	[p16l1656t1770r1781b1796],
21	.	.	O	.	_	0	SENT_827	[p16l1656t1770r1781b1796],

1	Am	NNP	O	Am	_	0	SENT_828	[p16l1791t1771r1881b1804],
2	.	.	O	.	_	0	SENT_828	[p16l1791t1771r1881b1804],

1	Pbysiol	NNP	O	Pbysiol	_	0	SENT_829	[p16l442t1834r537b1867],
2	.	.	O	.	_	0	SENT_829	[p16l442t1834r537b1867],

1	Renal	JJ	O	renal	amod	2	SENT_830	[p16l549t1834r626b1859],
2	Physio	NN	O	physio	_	0	SENT_830	[p16l632t1834r728b1867],
3	]	NN	O	]	dep	2	SENT_830	[p16l632t1834r728b1867],
4	.	.	O	.	_	0	SENT_830	[p16l632t1834r728b1867],

1	294	CD	NUMBER	294	_	0	SENT_831	[p16l741t1834r920b1859],
2	:	:	O	:	_	0	SENT_831	[p16l741t1834r920b1859],
3	F867-73	NN	O	f867-73	nn	5	SENT_831	[p16l741t1834r920b1859],
4	Thyss	NN	O	thyss	nn	5	SENT_831	[p16l441t1877r526b1911],
5	A	NN	O	a	dep	1	SENT_831	[p16l535t1878r565b1909],
6	,	,	O	,	_	0	SENT_831	[p16l535t1878r565b1909],
7	Milano	NNP	O	Milano	nn	8	SENT_831	[p16l575t1877r676b1903],
8	G	NNP	O	G	appos	5	SENT_831	[p16l687t1878r721b1909],
9	,	,	O	,	_	0	SENT_831	[p16l687t1878r721b1909],
10	Kubar	NNP	O	Kubar	nn	11	SENT_831	[p16l732t1877r848b1909],
11	]	NNP	O	]	appos	5	SENT_831	[p16l732t1877r848b1909],
12	,	,	O	,	_	0	SENT_831	[p16l732t1877r848b1909],
13	Namer	NNP	PERSON	Namer	nn	14	SENT_831	[p16l859t1878r958b1903],
14	M	NNP	O	M	appos	5	SENT_831	[p16l967t1878r1006b1909],
15	,	,	O	,	_	0	SENT_831	[p16l967t1878r1006b1909],
16	Schneider	NNP	PERSON	Schneider	nn	17	SENT_831	[p16l1019t1877r1158b1903],
17	M.	NNP	O	M.	appos	5	SENT_831	[p16l1166t1878r1206b1903],
18	1986	CD	DATE	1986	dep	17	SENT_831	[p16l1221t1879r1292b1903],
19	.	.	O	.	_	0	SENT_831	[p16l1221t1879r1292b1903],

1	Clinical	JJ	O	clinical	amod	4	SENT_832	[p16l1305t1877r1413b1903],
2	and	CC	O	and	_	0	SENT_832	[p16l1423t1877r1473b1903],
3	pharmacokinetic	JJ	O	pharmacokinetic	conj_and	1	SENT_832	[p16l1483t1877r1716b1911],
4	evidence	NN	O	evidence	_	0	SENT_832	[p16l1726t1877r1846b1903],
5	of	IN	O	of	_	0	SENT_832	[p16l1857t1877r1887b1903],
6	a	DT	O	a	det	8	SENT_832	[p16l443t1933r456b1949],
7	life-threatening	JJ	O	life-threatening	amod	8	SENT_832	[p16l466t1923r685b1957],
8	interaction	NN	O	interaction	prep_of	4	SENT_832	[p16l694t1924r846b1949],
9	between	IN	O	between	_	0	SENT_832	[p16l856t1923r972b1949],
10	methotrexate	NN	O	methotrexate	prep_between	4	SENT_832	[p16l981t1923r1165b1949],
11	and	CC	O	and	_	0	SENT_832	[p16l1176t1923r1225b1949],
12	ketoprofen	NN	O	ketoprofen	prep_between	4	SENT_832	[p16l1235t1923r1395b1957],
13	.	.	O	.	_	0	SENT_832	[p16l1235t1923r1395b1957],

1	Lancet	NNP	O	Lancet	_	0	SENT_833	[p16l1405t1924r1493b1949],
2	1:25	CD	TIME	1:25	num	1	SENT_833	[p16l1504t1924r1558b1949],
3	6-5	CD	NUMBER	6-5	number	4	SENT_833	[p16l1562t1924r1609b1949],
4	8	CD	NUMBER	8	dep	1	SENT_833	[p16l1613t1924r1627b1948],
5	Takeda	NNP	ORGANIZATION	Takeda	dep	4	SENT_833	[p16l442t1967r546b1992],
6	M	NN	ORGANIZATION	m	dep	1	SENT_833	[p16l559t1968r599b1998],
7	,	,	O	,	_	0	SENT_833	[p16l559t1968r599b1998],
8	Khamdang	NNP	PERSON	Khamdang	nn	9	SENT_833	[p16l614t1967r768b2001],
9	S	NNP	PERSON	S	appos	6	SENT_833	[p16l783t1968r807b1998],
10	,	,	O	,	_	0	SENT_833	[p16l783t1968r807b1998],
11	Narikawa	NNP	LOCATION	Narikawa	nn	12	SENT_833	[p16l822t1967r956b1992],
12	S	NNP	LOCATION	S	appos	6	SENT_833	[p16l972t1968r995b1998],
13	,	,	O	,	_	0	SENT_833	[p16l972t1968r995b1998],
14	Kimura	NNP	PERSON	Kimura	nn	15	SENT_833	[p16l1011t1968r1117b1992],
15	H	NNP	PERSON	H	appos	6	SENT_833	[p16l1132t1968r1167b1998],
16	,	,	O	,	_	0	SENT_833	[p16l1132t1968r1167b1998],
17	Hosoyamada	NNP	O	Hosoyamada	nn	18	SENT_833	[p16l1182t1967r1364b2001],
18	M	NNP	O	M	appos	6	SENT_833	[p16l1377t1968r1416b1998],
19	,	,	O	,	_	0	SENT_833	[p16l1377t1968r1416b1998],
20	et	FW	O	et	nn	21	SENT_833	[p16l1433t1974r1458b1992],
21	al.	FW	O	al.	appos	6	SENT_833	[p16l1472t1967r1501b1992],
22	2002	CD	DATE	2002	dep	21	SENT_833	[p16l1517t1968r1592b1992],
23	.	.	O	.	_	0	SENT_833	[p16l1517t1968r1592b1992],

1	Characterization	NN	O	characterization	_	0	SENT_834	[p16l1609t1967r1842b1992],
2	of	IN	O	of	_	0	SENT_834	[p16l1857t1967r1888b1992],
3	methotrexate	NN	O	methotrexate	nn	4	SENT_834	[p16l442t2012r626b2038],
4	transport	NN	O	transport	prep_of	1	SENT_834	[p16l638t2020r767b2046],
5	and	CC	O	and	_	0	SENT_834	[p16l778t2012r827b2038],
6	its	PRP$	O	its	poss	8	SENT_834	[p16l838t2014r869b2038],
7	drug	NN	O	drug	nn	8	SENT_834	[p16l881t2012r946b2047],
8	interactions	NNS	O	interaction	prep_of	1	SENT_834	[p16l956t2014r1120b2038],
9	with	IN	O	with	_	0	SENT_834	[p16l1131t2012r1193b2038],
10	human	JJ	O	human	amod	13	SENT_834	[p16l1204t2012r1300b2038],
11	organic	JJ	O	organic	amod	13	SENT_834	[p16l1311t2014r1415b2047],
12	anion	NN	O	anion	nn	13	SENT_834	[p16l1427t2014r1504b2038],
13	transporters	NNS	O	transporter	prep_with	1	SENT_834	[p16l1515t2013r1724b2046],
14	.	.	O	.	_	0	SENT_834	[p16l1515t2013r1724b2046],

1	Plyarmaml	NNP	O	Plyarmaml	_	0	SENT_835	[p16l1737t2013r1881b2038],
2	.	.	O	.	_	0	SENT_835	[p16l1737t2013r1881b2038],

1	Exp	NN	O	exp	_	0	SENT_836	[p16l442t2059r499b2092],
2	.	.	O	.	_	0	SENT_836	[p16l442t2059r499b2092],

1	Ther	NNP	O	Ther	_	0	SENT_837	[p16l513t2059r581b2084],
2	.	.	O	.	_	0	SENT_837	[p16l513t2059r581b2084],

1	302:666	CD	NUMBER	302:666	num	5	SENT_838	[p16l595t2059r752b2084],
2	—	CD	NUMBER	—	num	5	SENT_838	[p16l595t2059r752b2084],
3	71	CD	NUMBER	71	num	5	SENT_838	[p16l595t2059r752b2084],
4	Mulato	NNP	O	Mulato	nn	5	SENT_838	[p16l441t2102r544b2128],
5	AS	NNP	O	AS	_	0	SENT_838	[p16l549t2103r597b2133],
6	,	,	O	,	_	0	SENT_838	[p16l549t2103r597b2133],
7	Ho	NNP	O	Ho	nn	8	SENT_838	[p16l605t2103r650b2128],
8	ES	NN	O	e	appos	5	SENT_838	[p16l657t2103r704b2133],
9	,	,	O	,	_	0	SENT_838	[p16l657t2103r704b2133],
10	Cihlar	NNP	PERSON	Cihlar	nn	11	SENT_838	[p16l712t2102r801b2128],
11	T.	NNP	O	T.	appos	5	SENT_838	[p16l806t2103r838b2128],
12	2	CD	NUMBER	2	num	13	SENT_838	[p16l847t2104r860b2127],
13	ooo	NN	O	ooo	dep	11	SENT_838	[p16l864t2104r921b2128],
14	.	.	O	.	_	0	SENT_838	[p16l864t2104r921b2128],

1	Nonsteroidal	JJ	O	nonsteroidal	amod	3	SENT_839	[p16l928t2102r1113b2128],
2	anti-inﬂammatory	JJ	O	anti-inﬂammatory	amod	3	SENT_839	[p16l1120t2102r1376b2136],
3	drugs	NNS	O	drug	_	0	SENT_839	[p16l1381t2102r1457b2136],
4	efﬁciently	RB	O	efﬁciently	dep	3	SENT_839	[p16l1465t2102r1601b2136],
5	reduce	VB	O	reduce	ccomp	4	SENT_839	[p16l1606t2102r1699b2128],
6	the	DT	O	the	det	7	SENT_839	[p16l1706t2102r1749b2128],
7	transport	NN	O	transport	dobj	5	SENT_839	[p16l1756t2109r1885b2136],
8	and	CC	O	and	_	0	SENT_839	[p16l443t2148r492b2173],
9	cytotoxicity	NN	O	cytotoxicity	dobj	5	SENT_839	[p16l501t2149r665b2182],
10	of	IN	O	of	_	0	SENT_839	[p16l672t2148r703b2173],
11	adefovir	NN	O	adefovir	prep_of	7	SENT_839	[p16l708t2148r821b2173],
12	mediated	VBN	O	mediate	partmod	11	SENT_839	[p16l828t2147r956b2173],
13	by	IN	O	by	prep	4	SENT_839	[p16l965t2148r999b2182],
14	the	DT	O	the	det	19	SENT_839	[p16l1006t2148r1050b2173],
15	human	JJ	O	human	amod	19	SENT_839	[p16l1058t2147r1155b2173],
16	renal	JJ	O	renal	amod	19	SENT_839	[p16l1163t2148r1233b2173],
17	organic	JJ	O	organic	amod	19	SENT_839	[p16l1242t2149r1345b2182],
18	anion	NN	O	anion	nn	19	SENT_839	[p16l1354t2149r1432b2173],
19	transporter	NN	O	transporter	dep	13	SENT_839	[p16l1440t2155r1597b2182],
20	1	CD	NUMBER	1	dep	19	SENT_839	[p16l1608t2148r1659b2182],
21	.	.	O	.	_	0	SENT_839	[p16l1608t2148r1659b2182],
22	]	SYM	O	]	dep	3	SENT_839	[p16l1608t2148r1659b2182],

1	.	.	O	.	_	0	SENT_840	[p16l1608t2148r1659b2182],

1	Plaarmacol	NN	O	plaarmacol	_	0	SENT_841	[p16l1669t2148r1813b2173],
2	.	.	O	.	_	0	SENT_841	[p16l1669t2148r1813b2173],

1	Exp	NN	O	exp	_	0	SENT_842	[p16l1824t2149r1881b2182],
2	.	.	O	.	_	0	SENT_842	[p16l1824t2149r1881b2182],

1	Tlaer	NNP	O	Tlaer	_	0	SENT_843	[p16l444t2194r512b2219],
2	.	.	O	.	_	0	SENT_843	[p16l444t2194r512b2219],

1	295:10	CD	NUMBER	295:10	num	4	SENT_844	[p16l525t2194r667b2219],
2	-15	CD	NUMBER	-15	num	4	SENT_844	[p16l525t2194r667b2219],
3	Han	NNP	O	Han	nn	4	SENT_844	[p16l442t2238r503b2263],
4	YF	NNP	O	YF	_	0	SENT_844	[p16l509t2238r558b2268],
5	,	,	O	,	_	0	SENT_844	[p16l509t2238r558b2268],
6	Fan	NNP	LOCATION	Fan	nn	7	SENT_844	[p16l566t2238r618b2263],
7	XH	NNP	LOCATION	XH	appos	4	SENT_844	[p16l624t2238r684b2269],
8	,	,	O	,	_	0	SENT_844	[p16l624t2238r684b2269],
9	Wang	NNP	PERSON	Wang	nn	11	SENT_844	[p16l691t2238r778b2272],
10	X	NNP	O	X	nn	11	SENT_844	[p16l783t2238r826b2269],
11	]	NN	O	]	appos	4	SENT_844	[p16l783t2238r826b2269],
12	,	,	O	,	_	0	SENT_844	[p16l783t2238r826b2269],
13	Sun	NNP	LOCATION	Sun	nn	14	SENT_844	[p16l835t2238r887b2263],
14	K	NNP	LOCATION	K	appos	4	SENT_844	[p16l894t2238r925b2269],
15	,	,	O	,	_	0	SENT_844	[p16l894t2238r925b2269],
16	Xue	NNP	O	Xue	nn	17	SENT_844	[p16l932t2238r988b2263],
17	H	NNP	O	H	appos	4	SENT_844	[p16l995t2238r1030b2269],
18	,	,	O	,	_	0	SENT_844	[p16l995t2238r1030b2269],
19	et	FW	O	et	nn	20	SENT_844	[p16l1038t2245r1064b2263],
20	al.	FW	O	al.	appos	4	SENT_844	[p16l1070t2237r1099b2263],
21	201	CD	NUMBER	201	number	22	SENT_844	[p16l1108t2239r1155b2263],
22	1	CD	NUMBER	1	dep	20	SENT_844	[p16l1162t2239r1182b2263],
23	.	.	O	.	_	0	SENT_844	[p16l1162t2239r1182b2263],

1	Association	NNP	O	Association	nsubj	8	SENT_845	[p16l1189t2238r1349b2263],
2	of	IN	O	of	_	0	SENT_845	[p16l1356t2237r1386b2263],
3	intergenic	JJ	O	intergenic	amod	4	SENT_845	[p16l1389t2239r1530b2272],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_845	[p16l1536t2237r1740b2272],
5	of	IN	O	of	_	0	SENT_845	[p16l1747t2237r1777b2263],
6	organic	JJ	O	organic	amod	7	SENT_845	[p16l1780t2239r1884b2272],
7	anion	NN	O	anion	prep_of	4	SENT_845	[p16l443t2284r520b2309],
8	transporter	NN	O	transporter	_	0	SENT_845	[p16l529t2290r686b2317],
9	1	CD	NUMBER	1	num	12	SENT_845	[p16l698t2285r707b2308],
10	and	CC	O	and	_	0	SENT_845	[p16l720t2283r769b2309],
11	3	CD	NUMBER	3	num	12	SENT_845	[p16l780t2285r792b2309],
12	genes	NNS	O	gene	dobj	8	SENT_845	[p16l804t2293r881b2317],
13	with	IN	O	with	_	0	SENT_845	[p16l890t2283r952b2309],
14	hypertension	NN	O	hypertension	nn	18	SENT_845	[p16l960t2283r1143b2317],
15	and	CC	O	and	_	0	SENT_845	[p16l1152t2283r1202b2309],
16	blood	NN	O	blood	nn	18	SENT_845	[p16l1211t2283r1290b2309],
17	pressure	NN	O	pressure	nn	18	SENT_845	[p16l1299t2293r1415b2317],
18	response	NN	O	response	prep_with	12	SENT_845	[p16l1424t2292r1545b2317],
19	to	TO	O	to	_	0	SENT_845	[p16l1555t2290r1582b2309],
20	hydrochlorothiazide	NN	O	hydrochlorothiazide	prep_to	8	SENT_845	[p16l1591t2283r1882b2317],
21	.	.	O	.	_	0	SENT_845	[p16l1591t2283r1882b2317],

1	Am	NNP	O	Am	_	0	SENT_846	[p16l440t2328r529b2362],
2	.	.	O	.	_	0	SENT_846	[p16l440t2328r529b2362],

1	Hypertens	NNS	O	hyperten	_	0	SENT_847	[p16l540t2329r676b2363],
2	.	.	O	.	_	0	SENT_847	[p16l540t2329r676b2363],

1	24:340	CD	NUMBER	24:340	num	5	SENT_848	[p16l689t2330r833b2354],
2	—	CD	NUMBER	—	num	5	SENT_848	[p16l689t2330r833b2354],
3	46	CD	NUMBER	46	num	5	SENT_848	[p16l689t2330r833b2354],
4	Niemi	NNP	PERSON	Niemi	nn	5	SENT_848	[p16l442t2386r531b2411],
5	M.	NNP	O	M.	_	0	SENT_848	[p16l540t2386r579b2410],
6	2007	CD	DATE	2007	dep	5	SENT_848	[p16l591t2386r665b2411],
7	.	.	O	.	_	0	SENT_848	[p16l591t2386r665b2411],

1	Role	NN	O	role	_	0	SENT_849	[p16l677t2385r741b2411],
2	of	IN	O	of	_	0	SENT_849	[p16l752t2385r782b2411],
3	OATP	NN	O	oatp	nn	4	SENT_849	[p16l789t2385r883b2411],
4	transporters	NNS	O	transporter	prep_of	1	SENT_849	[p16l893t2392r1061b2419],
5	in	IN	O	in	_	0	SENT_849	[p16l1071t2386r1098b2410],
6	the	DT	O	the	det	7	SENT_849	[p16l1108t2385r1151b2411],
7	disposition	NN	O	disposition	prep_in	1	SENT_849	[p16l1162t2384r1314b2419],
8	of	IN	O	of	_	0	SENT_849	[p16l1323t2385r1354b2411],
9	drugs	NNS	O	drug	prep_of	7	SENT_849	[p16l1361t2385r1444b2419],
10	.	.	O	.	_	0	SENT_849	[p16l1361t2385r1444b2419],

1	Plyarmacogenomics	NNS	O	plyarmacogenomic	_	0	SENT_850	[p16l1454t2385r1698b2420],
2	82787-802	CD	NUMBER	82787-802	num	4	SENT_850	[p16l1708t2385r1849b2411],
3	Tirona	NNP	O	Tirona	nn	4	SENT_850	[p16l442t2442r540b2467],
4	RG	NNP	O	RG	dep	1	SENT_850	[p16l550t2442r607b2472],
5	,	,	O	,	_	0	SENT_850	[p16l550t2442r607b2472],
6	Kim	NNP	PERSON	Kim	nn	7	SENT_850	[p16l618t2442r679b2466],
7	RB	NN	O	rb	appos	4	SENT_850	[p16l689t2442r740b2466],
8	.	.	O	.	_	0	SENT_850	[p16l689t2442r740b2466],

1	2007	CD	DATE	2007	_	0	SENT_851	[p16l751t2442r826b2467],
2	.	.	O	.	_	0	SENT_851	[p16l751t2442r826b2467],

1	Organic	NNP	O	Organic	_	0	SENT_852	[p16l838t2442r951b2475],
2	anion-transporting	JJ	O	anion-transporting	amod	3	SENT_852	[p16l961t2442r1226b2475],
3	polypeptides	NNS	O	polypeptide	dep	1	SENT_852	[p16l1235t2441r1419b2475],
4	.	.	O	.	_	0	SENT_852	[p16l1235t2441r1419b2475],

1	In	IN	O	in	_	0	SENT_853	[p16l1429t2442r1459b2466],
2	Drug	NN	O	drug	nn	3	SENT_853	[p16l1469t2442r1541b2476],
3	Transporters	NNS	O	transporter	prep_in	5	SENT_853	[p16l1551t2442r1721b2475],
4	,	,	O	,	_	0	SENT_853	[p16l1551t2442r1721b2475],
5	ed	VBN	O	ed	_	0	SENT_853	[p16l1733t2441r1771b2467],
6	.	.	O	.	_	0	SENT_853	[p16l1733t2441r1771b2467],

1	G	NN	O	g	_	0	SENT_854	[p16l1783t2442r1810b2467],
2	You	PRP	O	you	dep	1	SENT_854	[p16l1817t2442r1883b2472],
3	,	,	O	,	_	0	SENT_854	[p16l1817t2442r1883b2472],
4	ME	NNP	O	ME	nn	5	SENT_854	[p16l441t2488r496b2512],
5	Morris	NNP	PERSON	Morris	appos	2	SENT_854	[p16l504t2488r609b2518],
6	,	,	O	,	_	0	SENT_854	[p16l504t2488r609b2518],
7	pp	NN	O	pp	appos	2	SENT_854	[p16l620t2496r662b2521],
8	.	.	O	.	_	0	SENT_854	[p16l620t2496r662b2521],

1	75-104	CD	NUMBER	75-104	_	0	SENT_855	[p16l674t2487r782b2513],
2	.	.	O	.	_	0	SENT_855	[p16l674t2487r782b2513],

1	Hoboken	NNP	LOCATION	Hoboken	nn	3	SENT_856	[p16l793t2486r932b2518],
2	,	,	O	,	_	0	SENT_856	[p16l793t2486r932b2518],
3	NJ	NNP	O	NJ	_	0	SENT_856	[p16l942t2488r990b2519],
4	:	:	O	:	_	0	SENT_856	[p16l942t2488r990b2519],
5	Wiley	NNP	PERSON	Wiley	nn	10	SENT_856	[p16l1001t2487r1088b2521],
6	Kalliokoski	NNP	PERSON	Kalliokoski	nn	10	SENT_856	[p16l442t2531r599b2557],
7	A	NNP	O	A	nn	10	SENT_856	[p16l611t2532r640b2562],
8	,	,	O	,	_	0	SENT_856	[p16l611t2532r640b2562],
9	Niemi	NNP	PERSON	Niemi	appos	10	SENT_856	[p16l653t2532r743b2557],
10	M.	NNP	O	M.	dep	3	SENT_856	[p16l754t2532r793b2557],
11	2009	CD	DATE	2009	num	10	SENT_856	[p16l808t2532r882b2557],
12	.	.	O	.	_	0	SENT_856	[p16l808t2532r882b2557],

1	Impact	NN	O	impact	_	0	SENT_857	[p16l896t2532r994b2565],
2	of	IN	O	of	_	0	SENT_857	[p16l1006t2531r1036b2557],
3	OATP	NN	O	oatp	nn	4	SENT_857	[p16l1046t2531r1140b2557],
4	transporters	NNS	O	transporter	prep_of	1	SENT_857	[p16l1153t2538r1321b2565],
5	on	IN	O	on	_	0	SENT_857	[p16l1334t2540r1369b2557],
6	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_857	[p16l1381t2531r1633b2565],
7	.	.	O	.	_	0	SENT_857	[p16l1381t2531r1633b2565],

1	Br	NN	O	br	_	0	SENT_858	[p16l1647t2532r1686b2557],
2	.	.	O	.	_	0	SENT_858	[p16l1647t2532r1686b2557],

1	ou@-�*	JJ	O	ou@-�*	amod	2	SENT_859	[p16l1697t2531r1722b2565],
2	Pharmaeol	NN	O	pharmaeol	_	0	SENT_859	[p16l1737t2532r1881b2557],
3	.	.	O	.	_	0	SENT_859	[p16l1737t2532r1881b2557],

1	15	CD	NUMBER	15	number	2	SENT_860	[p16l446t2591r474b2616],
2	8:693	CD	NUMBER	8:693	_	0	SENT_860	[p16l478t2591r620b2616],
3	-705	CD	NUMBER	-705	num	5	SENT_860	[p16l478t2591r620b2616],
4	Niemi	NNP	O	Niemi	nn	5	SENT_860	[p16l442t2635r531b2660],
5	M	NN	O	m	dep	2	SENT_860	[p16l539t2635r579b2665],
6	,	,	O	,	_	0	SENT_860	[p16l539t2635r579b2665],
7	Pasanen	NNP	PERSON	Pasanen	nn	8	SENT_860	[p16l589t2635r703b2660],
8	MK	NNP	O	MK	appos	2	SENT_860	[p16l710t2635r775b2665],
9	,	,	O	,	_	0	SENT_860	[p16l710t2635r775b2665],
10	Neuvonen	NNP	PERSON	Neuvonen	nn	12	SENT_860	[p16l785t2635r932b2660],
11	P	NN	O	p	nn	12	SENT_860	[p16l940t2635r980b2666],
12	]	NN	O	]	appos	8	SENT_860	[p16l940t2635r980b2666],
13	.	.	O	.	_	0	SENT_860	[p16l940t2635r980b2666],

1	201	CD	NUMBER	201	num	2	SENT_861	[p16l990t2635r1037b2660],
2	1	CD	NUMBER	1	_	0	SENT_861	[p16l1045t2636r1065b2660],
3	.	.	O	.	_	0	SENT_861	[p16l1045t2636r1065b2660],

1	Organic	NNP	O	Organic	nn	2	SENT_862	[p16l1076t2635r1189b2668],
2	anion	NN	O	anion	_	0	SENT_862	[p16l1199t2635r1276b2660],
3	transporting	VBG	O	transport	partmod	2	SENT_862	[p16l1285t2635r1458b2668],
4	polypeptide	NN	O	polypeptide	nn	5	SENT_862	[p16l1466t2634r1630b2668],
5	1B1	NN	O	1b1	dobj	3	SENT_862	[p16l1643t2635r1701b2659],
6	:	:	O	:	_	0	SENT_862	[p16l1643t2635r1701b2659],
7	a	DT	O	a	det	10	SENT_862	[p16l1712t2644r1725b2660],
8	genetically	RB	O	genetically	advmod	9	SENT_862	[p16l1735t2634r1885b2668],
9	polymorphic	JJ	O	polymorphic	amod	10	SENT_862	[p16l442t2679r621b2714],
10	transporter	NN	O	transporter	dep	2	SENT_862	[p16l631t2687r787b2713],
11	of	IN	O	of	_	0	SENT_862	[p16l797t2679r827b2705],
12	major	JJ	O	major	amod	13	SENT_862	[p16l833t2681r915b2714],
13	importance	NN	O	importance	prep_of	10	SENT_862	[p16l924t2681r1082b2713],
14	for	IN	O	for	_	0	SENT_862	[p16l1093t2679r1133b2705],
15	hepatic	JJ	O	hepatic	amod	17	SENT_862	[p16l1142t2679r1243b2713],
16	drug	NN	O	drug	nn	17	SENT_862	[p16l1253t2679r1318b2714],
17	uptake	NN	O	uptake	prep_for	13	SENT_862	[p16l1326t2679r1426b2713],
18	.	.	O	.	_	0	SENT_862	[p16l1326t2679r1426b2713],

1	Pbarmacol	NNP	O	Pbarmacol	_	0	SENT_863	[p16l1437t2680r1580b2705],
2	.	.	O	.	_	0	SENT_863	[p16l1437t2680r1580b2705],

1	Rev.	NNP	O	Rev.	nn	5	SENT_864	[p16l1592t2680r1647b2705],
2	63:15	CD	NUMBER	63:15	num	5	SENT_864	[p16l1660t2680r1734b2705],
3	7-81	CD	NUMBER	7-81	num	5	SENT_864	[p16l1738t2680r1801b2706],
4	Tirona	NNP	O	Tirona	nn	5	SENT_864	[p16l442t2724r540b2749],
5	RG	NNP	O	RG	_	0	SENT_864	[p16l548t2724r605b2755],
6	,	,	O	,	_	0	SENT_864	[p16l548t2724r605b2755],
7	Leake	NNP	PERSON	Leake	nn	8	SENT_864	[p16l614t2723r697b2749],
8	BF	NNP	O	BF	appos	5	SENT_864	[p16l706t2725r753b2755],
9	,	,	O	,	_	0	SENT_864	[p16l706t2725r753b2755],
10	Merino	NNP	O	Merino	nn	11	SENT_864	[p16l761t2725r866b2749],
11	G	NNP	O	G	appos	5	SENT_864	[p16l875t2724r908b2755],
12	,	,	O	,	_	0	SENT_864	[p16l875t2724r908b2755],
13	Kim	NNP	PERSON	Kim	nn	14	SENT_864	[p16l917t2725r978b2749],
14	RB	NN	O	rb	appos	5	SENT_864	[p16l986t2725r1036b2749],
15	.	.	O	.	_	0	SENT_864	[p16l986t2725r1036b2749],

1	2001	CD	DATE	2001	_	0	SENT_865	[p16l1046t2725r1120b2749],
2	.	.	O	.	_	0	SENT_865	[p16l1046t2725r1120b2749],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_866	[p16l1129t2723r1348b2758],
2	in	IN	O	in	_	0	SENT_866	[p16l1356t2725r1383b2749],
3	OATP	NN	O	oatp	prep_in	1	SENT_866	[p16l1391t2724r1531b2749],
4	.	.	O	.	_	0	SENT_866	[p16l1391t2724r1531b2749],

1	—	NN	O	—	_	0	SENT_867	[p16l1391t2724r1531b2749],
2	.	.	O	.	_	0	SENT_867	[p16l1391t2724r1531b2749],

1	C	NN	O	c	_	0	SENT_868	[p16l1391t2724r1531b2749],
2	:	:	O	:	_	0	SENT_868	[p16l1391t2724r1531b2749],
3	identiﬁcation	NN	O	identiﬁcation	dep	1	SENT_868	[p16l1540t2723r1725b2749],
4	of	IN	O	of	_	0	SENT_868	[p16l1733t2723r1764b2749],
5	multiple	JJ	O	multiple	amod	7	SENT_868	[p16l1767t2723r1883b2758],
6	allelic	JJ	O	allelic	amod	7	SENT_868	[p16l443t2769r523b2795],
7	variants	NNS	O	variant	prep_of	3	SENT_868	[p16l529t2770r637b2795],
8	associated	VBN	O	associate	partmod	7	SENT_868	[p16l645t2769r783b2795],
9	with	IN	O	with	_	0	SENT_868	[p16l789t2769r851b2795],
10	altered	JJ	O	altered	amod	12	SENT_868	[p16l859t2769r953b2795],
11	transport	NN	O	transport	nn	12	SENT_868	[p16l961t2776r1089b2803],
12	activity	NN	O	activity	prep_with	8	SENT_868	[p16l1096t2770r1197b2803],
13	among	IN	O	among	_	0	SENT_868	[p16l1203t2778r1298b2803],
14	European	JJ	MISC	european	prep_among	12	SENT_868	[p16l1304t2770r1453b2803],
15	-	:	O	-	_	0	SENT_868	[p16l1304t2770r1453b2803],
16	and	CC	O	and	_	0	SENT_868	[p16l1461t2769r1510b2795],
17	African-Americans	NNPS	MISC	African-Americans	dep	1	SENT_868	[p16l1516t2769r1815b2803],
18	.	.	O	.	_	0	SENT_868	[p16l1516t2769r1815b2803],

1	_	NN	O	_	_	0	SENT_869	[p16l1516t2769r1815b2803],
2	7	CD	NUMBER	7	dep	1	SENT_869	[p16l1516t2769r1815b2803],
3	.	.	O	.	_	0	SENT_869	[p16l1516t2769r1815b2803],

1	Biol	NNP	O	Biol	_	0	SENT_870	[p16l1825t2770r1881b2794],
2	.	.	O	.	_	0	SENT_870	[p16l1825t2770r1881b2794],

1	Clyem	NNP	O	Clyem	_	0	SENT_871	[p16l444t2815r524b2840],
2	.	.	O	.	_	0	SENT_871	[p16l444t2815r524b2840],

1	276:3	CD	NUMBER	276:3	_	0	SENT_872	[p16l537t2815r610b2840],
2	5669-75	CD	NUMBER	5669-75	num	4	SENT_872	[p16l616t2815r731b2840],
3	Couvert	NN	O	couvert	nn	4	SENT_872	[p16l443t2859r558b2884],
4	P	NN	O	p	dep	1	SENT_872	[p16l564t2860r591b2890],
5	,	,	O	,	_	0	SENT_872	[p16l564t2860r591b2890],
6	Giral	NNP	PERSON	Giral	nn	7	SENT_872	[p16l600t2858r671b2884],
7	P	NN	PERSON	p	appos	4	SENT_872	[p16l678t2860r706b2890],
8	,	,	O	,	_	0	SENT_872	[p16l678t2860r706b2890],
9	Dejager	NNP	PERSON	Dejager	nn	10	SENT_872	[p16l714t2860r825b2893],
10	S	NNP	O	S	appos	4	SENT_872	[p16l832t2859r856b2890],
11	,	,	O	,	_	0	SENT_872	[p16l832t2859r856b2890],
12	Gu	NNP	PERSON	Gu	nn	13	SENT_872	[p16l865t2859r934b2891],
13	]	NNP	O	]	appos	4	SENT_872	[p16l865t2859r934b2891],
14	,	,	O	,	_	0	SENT_872	[p16l865t2859r934b2891],
15	Huby	NNP	PERSON	Huby	nn	16	SENT_872	[p16l942t2858r1022b2893],
16	T	NN	O	t	appos	4	SENT_872	[p16l1027t2859r1060b2890],
17	,	,	O	,	_	0	SENT_872	[p16l1027t2859r1060b2890],
18	et	FW	O	et	nn	19	SENT_872	[p16l1069t2866r1094b2884],
19	al.	FW	O	al.	appos	4	SENT_872	[p16l1101t2858r1130b2884],
20	2008	CD	DATE	2008	dep	19	SENT_872	[p16l1139t2860r1213b2884],
21	.	.	O	.	_	0	SENT_872	[p16l1139t2860r1213b2884],

1	Association	NNP	O	Association	_	0	SENT_873	[p16l1221t2859r1380b2884],
2	between	IN	O	between	_	0	SENT_873	[p16l1387t2858r1503b2884],
3	a	DT	O	a	det	5	SENT_873	[p16l1510t2868r1523b2884],
4	frequent	JJ	O	frequent	amod	5	SENT_873	[p16l1530t2859r1649b2892],
5	allele	NN	O	allele	prep_between	1	SENT_873	[p16l1656t2858r1727b2884],
6	of	IN	O	of	_	0	SENT_873	[p16l1734t2859r1765b2884],
7	the	DT	O	the	det	8	SENT_873	[p16l1768t2858r1811b2884],
8	gene	NN	O	gene	prep_of	5	SENT_873	[p16l1819t2868r1883b2893],
9	encoding	VBG	O	encode	dep	1	SENT_873	[p16l443t2904r571b2938],
10	OATP1B1	NN	O	oatp1b1	dobj	9	SENT_873	[p16l585t2905r732b2930],
11	and	CC	O	and	_	0	SENT_873	[p16l750t2904r799b2930],
12	enhanced	VBD	O	enhance	dep	1	SENT_873	[p16l814t2904r945b2930],
13	LDL-lowering	JJ	O	ldl-lowering	amod	14	SENT_873	[p16l959t2904r1168b2938],
14	response	NN	O	response	dobj	12	SENT_873	[p16l1181t2914r1302b2938],
15	to	TO	O	to	_	0	SENT_873	[p16l1317t2911r1344b2930],
16	ﬂuvastatin	NN	O	ﬂuvastatin	nn	17	SENT_873	[p16l1358t2904r1501b2930],
17	therapy	NN	O	therapy	prep_to	12	SENT_873	[p16l1515t2904r1627b2938],
18	.	.	O	.	_	0	SENT_873	[p16l1515t2904r1627b2938],

1	Plyarmacogenomics	NNS	O	plyarmacogenomic	_	0	SENT_874	[p16l1641t2905r1885b2939],
2	9	CD	NUMBER	9	num	1	SENT_874	[p16l443t2951r465b2976],
3	:	:	O	:	_	0	SENT_874	[p16l443t2951r465b2976],
4	12	CD	NUMBER	12	num	5	SENT_874	[p16l471t2951r499b2975],
5	17-2	CD	NUMBER	17-2	dep	1	SENT_874	[p16l506t2951r568b2976],
6	7	CD	NUMBER	7	num	8	SENT_874	[p16l572t2951r586b2976],
7	Niemi	NN	ORGANIZATION	niemus	nn	8	SENT_874	[p16l442t2995r531b3019],
8	M	NN	ORGANIZATION	m	dep	1	SENT_874	[p16l537t2995r577b3025],
9	,	,	O	,	_	0	SENT_874	[p16l537t2995r577b3025],
10	Neuvonen	NN	PERSON	neuvonen	nn	11	SENT_874	[p16l585t2995r732b3019],
11	P	NN	O	p	appos	1	SENT_874	[p16l739t2995r779b3026],
12	]	CD	NUMBER	]	dep	11	SENT_874	[p16l739t2995r779b3026],
13	,	,	O	,	_	0	SENT_874	[p16l739t2995r779b3026],
14	Hofmann	NNP	ORGANIZATION	Hofmann	nn	15	SENT_874	[p16l787t2994r923b3019],
15	U	NNP	ORGANIZATION	U	appos	1	SENT_874	[p16l929t2995r963b3025],
16	,	,	O	,	_	0	SENT_874	[p16l929t2995r963b3025],
17	Backman	NNP	PERSON	Backman	nn	19	SENT_874	[p16l972t2994r1151b3026],
18	]	CD	NUMBER	]	num	19	SENT_874	[p16l972t2994r1151b3026],
19	T	NN	O	t	appos	1	SENT_874	[p16l972t2994r1151b3026],
20	,	,	O	,	_	0	SENT_874	[p16l972t2994r1151b3026],
21	Schwab	NNP	ORGANIZATION	Schwab	nn	22	SENT_874	[p16l1160t2993r1265b3019],
22	M	NNP	ORGANIZATION	M	appos	1	SENT_874	[p16l1272t2995r1311b3025],
23	,	,	O	,	_	0	SENT_874	[p16l1272t2995r1311b3025],
24	et	FW	O	et	nn	25	SENT_874	[p16l1320t3001r1346b3019],
25	al.	FW	O	al.	appos	1	SENT_874	[p16l1353t2994r1382b3019],
26	2	CD	NUMBER	2	number	27	SENT_874	[p16l1391t2995r1404b3019],
27	005	CD	NUMBER	005	dep	25	SENT_874	[p16l1409t2995r1457b3020],
28	.	.	O	.	_	0	SENT_874	[p16l1461t3015r1466b3019],

1	Acute	JJ	O	acute	amod	2	SENT_875	[p16l1473t2994r1554b3019],
2	effects	NNS	O	effect	nsubjpass	9	SENT_875	[p16l1562t2994r1648b3019],
3	of	IN	O	of	_	0	SENT_875	[p16l1656t2994r1687b3019],
4	pravastatin	NN	O	pravastatin	prep_of	2	SENT_875	[p16l1690t2995r1842b3028],
5	on	IN	O	on	_	0	SENT_875	[p16l1849t3003r1884b3019],
6	cholesterol	NN	O	cholesterol	nn	7	SENT_875	[p16l443t3039r595b3065],
7	synthesis	NN	O	synthesis	prep_on	4	SENT_875	[p16l603t3039r727b3074],
8	are	VBP	O	be	auxpass	9	SENT_875	[p16l735t3049r776b3065],
9	associated	VBN	O	associate	_	0	SENT_875	[p16l784t3039r923b3065],
10	with	IN	O	with	_	0	SENT_875	[p16l929t3039r991b3065],
11	SLCO	NN	O	slco	nn	13	SENT_875	[p16l1000t3040r1091b3065],
12	1	CD	NUMBER	1	num	13	SENT_875	[p16l1096t3041r1105b3065],
13	B	NN	O	b	prep_with	9	SENT_875	[p16l1110t3040r1129b3065],
14	1	CD	NUMBER	1	num	15	SENT_875	[p16l1135t3041r1144b3065],
15	(	NN	O	(	dobj	9	SENT_875	[p16l1156t3039r1294b3074],
16	encoding	VBG	O	encode	partmod	15	SENT_875	[p16l1156t3039r1294b3074],
17	OATP	NN	O	oatp	nn	19	SENT_875	[p16l1302t3040r1396b3065],
18	1	CD	NUMBER	1	num	19	SENT_875	[p16l1401t3041r1410b3065],
19	B	NN	O	b	dobj	16	SENT_875	[p16l1415t3041r1434b3065],
20	1	CD	NUMBER	1	number	21	SENT_875	[p16l1440t3040r1462b3072],
21	)	CD	NUMBER	)	num	23	SENT_875	[p16l1440t3040r1462b3072],
22	haplotype	NN	O	haplotype	nn	23	SENT_875	[p16l1470t3039r1607b3074],
23	*	NN	O	*	dep	19	SENT_875	[p16l1615t3040r1626b3052],
24	17	CD	NUMBER	17	dep	23	SENT_875	[p16l1633t3040r1670b3065],
25	.	.	O	.	_	0	SENT_875	[p16l1633t3040r1670b3065],

1	Plyarmacogenet	NNP	O	Plyarmacogenet	_	0	SENT_876	[p16l1678t3040r1881b3074],
2	.	.	O	.	_	0	SENT_876	[p16l1678t3040r1881b3074],

1	Genomirs	NNP	O	Genomirs	_	0	SENT_877	[p16l444t3086r566b3111],
2	15:303	CD	NUMBER	15:303	num	1	SENT_877	[p16l577t3086r701b3111],
3	-9	CD	NUMBER	-9	num	5	SENT_877	[p16l577t3086r701b3111],
4	Gerloff	NNP	PERSON	Gerloff	nn	5	SENT_877	[p16l443t3128r547b3154],
5	T	NN	O	t	dep	1	SENT_877	[p16l554t3128r587b3159],
6	,	,	O	,	_	0	SENT_877	[p16l554t3128r587b3159],
7	Schaefer	NNP	ORGANIZATION	Schaefer	nn	8	SENT_877	[p16l600t3128r719b3154],
8	M	NNP	ORGANIZATION	M	appos	5	SENT_877	[p16l728t3129r767b3159],
9	,	,	O	,	_	0	SENT_877	[p16l728t3129r767b3159],
10	Mwinyi	NNP	PERSON	Mwinyi	nn	11	SENT_877	[p16l778t3129r887b3162],
11	J	NNP	PERSON	J	appos	5	SENT_877	[p16l894t3129r916b3160],
12	,	,	O	,	_	0	SENT_877	[p16l894t3129r916b3160],
13	Johne	NNP	O	Johne	nn	14	SENT_877	[p16l924t3128r1009b3160],
14	A	NNP	O	A	appos	5	SENT_877	[p16l1020t3129r1049b3159],
15	,	,	O	,	_	0	SENT_877	[p16l1020t3129r1049b3159],
16	Sudhop	NNP	O	Sudhop	nn	17	SENT_877	[p16l1062t3128r1168b3162],
17	T	NN	O	t	appos	5	SENT_877	[p16l1179t3128r1211b3159],
18	,	,	O	,	_	0	SENT_877	[p16l1179t3128r1211b3159],
19	et	FW	O	et	nn	20	SENT_877	[p16l1224t3135r1250b3154],
20	al.	FW	O	al.	appos	5	SENT_877	[p16l1260t3128r1290b3154],
21	2006	CD	DATE	2006	dep	20	SENT_877	[p16l1303t3129r1377b3153],
22	.	.	O	.	_	0	SENT_877	[p16l1303t3129r1377b3153],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_878	[p16l1389t3128r1520b3154],
2	of	IN	O	of	_	0	SENT_878	[p16l1532t3128r1562b3154],
3	the	DT	O	the	det	6	SENT_878	[p16l1569t3128r1613b3154],
4	SLCO1Bl	NN	O	slco1bl	nn	6	SENT_878	[p16l1625t3129r1785b3154],
5	*	CD	NUMBER	*	num	6	SENT_878	[p16l1625t3129r1785b3154],
6	lb	NN	O	lb	prep_of	1	SENT_878	[p16l1792t3128r1822b3154],
7	and	CC	O	and	_	0	SENT_878	[p16l1834t3128r1883b3154],
8	*	NN	O	*	prep_of	1	SENT_878	[p16l443t3171r472b3196],
9	5	CD	NUMBER	5	num	10	SENT_878	[p16l443t3171r472b3196],
10	haplotypes	NNS	O	haplotype	dep	8	SENT_878	[p16l485t3170r634b3204],
11	on	IN	O	on	_	0	SENT_878	[p16l647t3180r682b3196],
12	pravastatin	NN	O	pravastatin	poss	14	SENT_878	[p16l693t3171r865b3204],
13	’s	POS	O	’s	_	0	SENT_878	[p16l693t3171r865b3204],
14	cholesterol	NN	O	cholesterol	prep_on	1	SENT_878	[p16l878t3170r1030b3196],
15	lowering	VBG	O	lower	partmod	1	SENT_878	[p16l1042t3170r1165b3204],
16	capabilities	NNS	O	capability	dobj	15	SENT_878	[p16l1177t3170r1330b3204],
17	and	CC	O	and	_	0	SENT_878	[p16l1343t3170r1392b3196],
18	basal	JJ	O	basal	amod	21	SENT_878	[p16l1404t3170r1472b3196],
19	sterol	NN	O	sterol	nn	21	SENT_878	[p16l1484t3170r1561b3196],
20	serum	NN	O	serum	nn	21	SENT_878	[p16l1573t3180r1658b3196],
21	levels	NNS	O	level	dobj	15	SENT_878	[p16l1669t3170r1752b3196],
22	.	.	O	.	_	0	SENT_878	[p16l1669t3170r1752b3196],

1	NannynScI7mz	NN	O	nannynsci7mz	_	0	SENT_879	[p16l1764t3171r1883b3204, p16l443t3214r637b3248],
2	'	''	O	'	_	0	SENT_879	[p16l1764t3171r1883b3204, p16l443t3214r637b3248],
3	edel7erg	NN	O	edel7erg	poss	5	SENT_879	[p16l1764t3171r1883b3204, p16l443t3214r637b3248],
4	’s	POS	O	’s	_	0	SENT_879	[p16l1764t3171r1883b3204, p16l443t3214r637b3248],
5	Arcb	NN	O	arcb	dep	1	SENT_879	[p16l643t3214r713b3239],
6	.	.	O	.	_	0	SENT_879	[p16l643t3214r713b3239],

1	P	NN	O	p	nsubj	5	SENT_880	[p16l725t3214r869b3239],
2	/	:	O	/	punct	5	SENT_880	[p16l725t3214r869b3239],
3	;	:	O	;	_	0	SENT_880	[p16l725t3214r869b3239],
4	-	:	O	-	_	0	SENT_880	[p16l725t3214r869b3239],
5	armaeol	NN	O	armaeol	_	0	SENT_880	[p16l725t3214r869b3239],
6	.	.	O	.	_	0	SENT_880	[p16l725t3214r869b3239],

1	3	CD	NUMBER	3	num	2	SENT_881	[p16l883t3215r894b3239],
2	7	CD	NUMBER	7	_	0	SENT_881	[p16l900t3214r913b3239],
3	3	CD	NUMBER	3	number	4	SENT_881	[p16l918t3215r929b3239],
4	:45	CD	NUMBER	:45	dep	2	SENT_881	[p16l935t3214r973b3239],
5	-5	CD	NUMBER	-5	num	7	SENT_881	[p16l976t3214r1007b3239],
6	o	NN	O	o	nn	7	SENT_881	[p16l1011t3215r1026b3239],
7	Tachibana	NNP	PERSON	Tachibana	dep	4	SENT_881	[p16l442t3256r692b3282],
8	.	.	O	.	_	0	SENT_881	[p16l442t3256r692b3282],

1	—	NN	O	—	_	0	SENT_882	[p16l442t3256r692b3282],
2	.	.	O	.	_	0	SENT_882	[p16l442t3256r692b3282],

1	Iimori	NNP	PERSON	Iimori	nn	2	SENT_883	[p16l442t3256r692b3282],
2	R	NNP	PERSON	R	_	0	SENT_883	[p16l706t3257r735b3288],
3	,	,	O	,	_	0	SENT_883	[p16l706t3257r735b3288],
4	Tabara	NNP	PERSON	Tabara	nn	5	SENT_883	[p16l749t3256r850b3282],
5	Y	NN	PERSON	y	appos	2	SENT_883	[p16l862t3257r891b3288],
6	,	,	O	,	_	0	SENT_883	[p16l862t3257r891b3288],
7	Kusuhara	NN	PERSON	kusuhara	nn	8	SENT_883	[p16l906t3256r1039b3282],
8	H	NN	PERSON	h	appos	2	SENT_883	[p16l1053t3257r1088b3288],
9	,	,	O	,	_	0	SENT_883	[p16l1053t3257r1088b3288],
10	Kohara	NNP	PERSON	Kohara	nn	11	SENT_883	[p16l1102t3256r1205b3282],
11	K	NNP	PERSON	K	appos	2	SENT_883	[p16l1219t3257r1250b3288],
12	,	,	O	,	_	0	SENT_883	[p16l1219t3257r1250b3288],
13	Kawamoto	NNP	PERSON	Kawamoto	nn	14	SENT_883	[p16l1265t3257r1416b3282],
14	R	NNP	O	R	appos	2	SENT_883	[p16l1430t3257r1459b3288],
15	,	,	O	,	_	0	SENT_883	[p16l1430t3257r1459b3288],
16	et	FW	O	et	nn	17	SENT_883	[p16l1475t3264r1500b3282],
17	al.	FW	O	al.	appos	2	SENT_883	[p16l1513t3256r1543b3282],
18	2004	CD	DATE	2004	dep	17	SENT_883	[p16l1558t3258r1632b3282],
19	.	.	O	.	_	0	SENT_883	[p16l1558t3258r1632b3282],

1	Effect	NN	O	effect	_	0	SENT_884	[p16l1647t3256r1730b3282],
2	of	IN	O	of	_	0	SENT_884	[p16l1743t3256r1774b3282],
3	genetic	JJ	O	genetic	amod	4	SENT_884	[p16l1784t3258r1884b3291],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_884	[p16l442t3299r646b3334],
5	of	IN	O	of	_	0	SENT_884	[p16l655t3299r685b3325],
6	OATP	NN	O	oatp	prep_of	1	SENT_884	[p16l691t3300r823b3325],
7	.	.	O	.	_	0	SENT_884	[p16l691t3300r823b3325],

1	—	NN	O	—	_	0	SENT_885	[p16l691t3300r823b3325],
2	.	.	O	.	_	0	SENT_885	[p16l691t3300r823b3325],

1	C	NN	O	c	nn	4	SENT_886	[p16l691t3300r823b3325],
2	(	CD	NUMBER	(	num	4	SENT_886	[p16l833t3300r1001b3332],
3	SLCO1B1	NN	O	slco1b1	nn	4	SENT_886	[p16l833t3300r1001b3332],
4	)	NN	O	)	_	0	SENT_886	[p16l833t3300r1001b3332],
5	on	IN	O	on	_	0	SENT_886	[p16l1011t3309r1045b3325],
6	lipid	NN	O	lipid	nn	7	SENT_886	[p16l1053t3299r1253b3334],
7	—	NN	O	—	prep_on	4	SENT_886	[p16l1053t3299r1253b3334],
8	lowering	VBG	O	lower	partmod	4	SENT_886	[p16l1053t3299r1253b3334],
9	response	NN	O	response	dobj	8	SENT_886	[p16l1261t3309r1382b3334],
10	to	TO	O	to	_	0	SENT_886	[p16l1391t3307r1418b3325],
11	HMG	NN	O	hmg	prep_to	8	SENT_886	[p16l1426t3300r1594b3325],
12	.	.	O	.	_	0	SENT_886	[p16l1426t3300r1594b3325],

1	—	NN	O	—	_	0	SENT_887	[p16l1426t3300r1594b3325],
2	.	.	O	.	_	0	SENT_887	[p16l1426t3300r1594b3325],

1	CoA	NN	O	coa	_	0	SENT_888	[p16l1426t3300r1594b3325],
2	reductase	NN	O	reductase	nn	3	SENT_888	[p16l1600t3299r1731b3325],
3	inhibitors	NNS	O	inhibitor	dep	1	SENT_888	[p16l1739t3299r1882b3325],
4	.	.	O	.	_	0	SENT_888	[p16l1739t3299r1882b3325],

1	Drug	NN	O	drug	_	0	SENT_889	[p16l442t3344r515b3378],
2	Metab	NNP	O	Metab	dep	1	SENT_889	[p16l521t3344r611b3369],
3	.	.	O	.	_	0	SENT_889	[p16l521t3344r611b3369],

1	Plaarmacoleinet	NNP	O	Plaarmacoleinet	_	0	SENT_890	[p16l623t3344r823b3369],
2	.	.	O	.	_	0	SENT_890	[p16l623t3344r823b3369],

1	19	CD	NUMBER	19	_	0	SENT_891	[p16l839t3345r876b3369],
2	:	:	O	:	_	0	SENT_891	[p16l839t3345r876b3369],
3	3	CD	NUMBER	3	num	4	SENT_891	[p16l881t3345r892b3369],
4	75-80	CD	NUMBER	75-80	dep	1	SENT_891	[p16l898t3344r980b3370],
5	Niemi	NNP	O	Niemi	nn	6	SENT_891	[p16l442t3387r531b3412],
6	M	NN	O	m	dep	4	SENT_891	[p16l540t3387r579b3418],
7	,	,	O	,	_	0	SENT_891	[p16l540t3387r579b3418],
8	Kivisto	NNP	ORGANIZATION	Kivisto	nn	9	SENT_891	[p16l589t3387r688b3412],
9	KT	NNP	ORGANIZATION	KT	appos	6	SENT_891	[p16l698t3386r755b3418],
10	,	,	O	,	_	0	SENT_891	[p16l698t3386r755b3418],
11	Hofmann	NNP	PERSON	Hofmann	nn	12	SENT_891	[p16l765t3386r901b3412],
12	U	NNP	PERSON	U	appos	6	SENT_891	[p16l910t3387r944b3418],
13	,	,	O	,	_	0	SENT_891	[p16l910t3387r944b3418],
14	Schwab	NNP	ORGANIZATION	Schwab	nn	15	SENT_891	[p16l955t3386r1060b3412],
15	M	NNP	ORGANIZATION	M	appos	6	SENT_891	[p16l1069t3387r1108b3418],
16	,	,	O	,	_	0	SENT_891	[p16l1069t3387r1108b3418],
17	Eichelbaum	NNP	PERSON	Eichelbaum	nn	18	SENT_891	[p16l1119t3386r1285b3412],
18	M	NNP	O	M	appos	6	SENT_891	[p16l1293t3387r1333b3418],
19	,	,	O	,	_	0	SENT_891	[p16l1293t3387r1333b3418],
20	Fromm	NNP	PERSON	Fromm	nn	21	SENT_891	[p16l1343t3387r1448b3412],
21	MF	NN	O	mf	appos	6	SENT_891	[p16l1456t3387r1516b3412],
22	.	.	O	.	_	0	SENT_891	[p16l1456t3387r1516b3412],

1	2005	CD	DATE	2005	_	0	SENT_892	[p16l1527t3387r1601b3412],
2	.	.	O	.	_	0	SENT_892	[p16l1527t3387r1601b3412],

1	Fexofenadine	NN	O	fexofenadine	nn	2	SENT_893	[p16l1612t3386r1799b3412],
2	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	4	SENT_893	[p16l1808t3386r1883b3420, p16l442t3429r623b3455],
3	are	VBP	O	be	auxpass	4	SENT_893	[p16l635t3439r676b3455],
4	associated	VBN	O	associate	_	0	SENT_893	[p16l687t3429r826b3455],
5	with	IN	O	with	_	0	SENT_893	[p16l836t3429r898b3455],
6	a	DT	O	a	det	7	SENT_893	[p16l909t3439r923b3455],
7	polymorphism	NN	O	polymorphism	prep_with	4	SENT_893	[p16l933t3429r1137b3463],
8	of	IN	O	of	_	0	SENT_893	[p16l1149t3429r1179b3455],
9	the	DT	O	the	det	12	SENT_893	[p16l1186t3429r1230b3455],
10	SLCO1B1	NN	O	slco1b1	nn	12	SENT_893	[p16l1242t3430r1387b3455],
11	gene	NN	O	gene	nn	12	SENT_893	[p16l1401t3439r1466b3463],
12	(	NN	O	(	prep_of	7	SENT_893	[p16l1478t3429r1616b3463],
13	encoding	VBG	O	encode	xcomp	4	SENT_893	[p16l1478t3429r1616b3463],
14	OATP1B1	NN	O	oatp1b1	nn	15	SENT_893	[p16l1627t3430r1795b3461],
15	)	NN	O	)	dobj	13	SENT_893	[p16l1627t3430r1795b3461],
16	.	.	O	.	_	0	SENT_893	[p16l1627t3430r1795b3461],

1	Br	NN	O	br	_	0	SENT_894	[p16l1807t3430r1846b3455],
2	.	.	O	.	_	0	SENT_894	[p16l1807t3430r1846b3455],

1	*	SYM	O	*	dep	4	SENT_895	[p16l1856t3429r1881b3463],
2	-	:	O	-	_	0	SENT_895	[p16l1856t3429r1881b3463],
3	*	NN	O	*	nn	4	SENT_895	[p16l1856t3429r1881b3463],
4	Clin	NN	O	clin	_	0	SENT_895	[p16l444t3473r504b3498],
5	.	.	O	.	_	0	SENT_895	[p16l444t3473r504b3498],

1	Plaarmacol	NN	O	plaarmacol	_	0	SENT_896	[p16l516t3473r660b3498],
2	.	.	O	.	_	0	SENT_896	[p16l516t3473r660b3498],

1	59:602	NN	O	59:602	_	0	SENT_897	[p16l674t3473r800b3498],
2	-4	CD	NUMBER	-4	num	4	SENT_897	[p16l674t3473r800b3498],
3	Innocenti	NNP	O	Innocenti	nn	4	SENT_897	[p16l442t3516r577b3541],
4	F	NN	O	f	dep	1	SENT_897	[p16l585t3516r611b3546],
5	,	,	O	,	_	0	SENT_897	[p16l585t3516r611b3546],
6	Kroetz	NNP	PERSON	Kroetz	nn	7	SENT_897	[p16l620t3516r717b3541],
7	DL	NNP	O	DL	appos	4	SENT_897	[p16l724t3516r781b3546],
8	,	,	O	,	_	0	SENT_897	[p16l724t3516r781b3546],
9	Schuetz	NNP	PERSON	Schuetz	nn	10	SENT_897	[p16l791t3515r899b3541],
10	E	NNP	O	E	appos	4	SENT_897	[p16l907t3516r936b3546],
11	,	,	O	,	_	0	SENT_897	[p16l907t3516r936b3546],
12	Dolan	NNP	PERSON	Dolan	nn	13	SENT_897	[p16l945t3515r1031b3541],
13	ME	NNP	O	ME	appos	4	SENT_897	[p16l1038t3516r1100b3546],
14	,	,	O	,	_	0	SENT_897	[p16l1038t3516r1100b3546],
15	Ramirez	NNP	PERSON	Ramirez	nn	16	SENT_897	[p16l1109t3516r1252b3547],
16	]	NNP	O	]	appos	4	SENT_897	[p16l1109t3516r1252b3547],
17	,	,	O	,	_	0	SENT_897	[p16l1109t3516r1252b3547],
18	et	FW	O	et	nn	19	SENT_897	[p16l1261t3522r1287b3541],
19	al.	FW	O	al.	appos	4	SENT_897	[p16l1294t3515r1323b3541],
20	2009	CD	DATE	2009	dep	19	SENT_897	[p16l1333t3517r1408b3541],
21	.	.	O	.	_	0	SENT_897	[p16l1333t3517r1408b3541],

1	Comprehensive	NNP	O	Comprehensive	_	0	SENT_898	[p16l1417t3515r1637b3549],
2	pharmacogenetic	JJ	O	pharmacogenetic	amod	3	SENT_898	[p16l1644t3515r1884b3549],
3	analysis	NN	O	analysis	dep	1	SENT_898	[p16l443t3558r548b3593],
4	of	IN	O	of	_	0	SENT_898	[p16l558t3558r589b3584],
5	irinotecan	JJ	O	irinotecan	amod	6	SENT_898	[p16l595t3560r736b3584],
6	neutropenia	NN	O	neutropenia	prep_of	3	SENT_898	[p16l745t3560r913b3593],
7	and	CC	O	and	_	0	SENT_898	[p16l924t3558r973b3584],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	3	SENT_898	[p16l983t3558r1235b3593],
9	.	.	O	.	_	0	SENT_898	[p16l983t3558r1235b3593],

1	Po	NNP	O	Po	_	0	SENT_899	[p16l1242t3559r1267b3593],
2	!	.	O	!	_	0	SENT_899	[p16l1242t3559r1267b3593],

1	-	:	O	-	_	0	SENT_900	[p16l1242t3559r1267b3593],
2	*	NN	O	*	nn	3	SENT_900	[p16l1242t3559r1267b3593],
3	Clin	NN	O	clin	_	0	SENT_900	[p16l1281t3559r1341b3584],
4	.	.	O	.	_	0	SENT_900	[p16l1281t3559r1341b3584],

1	Oncol	NN	O	oncol	_	0	SENT_901	[p16l1355t3559r1432b3584],
2	.	.	O	.	_	0	SENT_901	[p16l1355t3559r1432b3584],

1	27:2604	CD	NUMBER	27:2604	num	2	SENT_902	[p16l1445t3559r1607b3585],
2	-14	CD	NUMBER	-14	_	0	SENT_902	[p16l1445t3559r1607b3585],

1	Annu	NNP	PERSON	Annu	_	0	SENT_903	[p17l72t1894r95b1974],
2	.	.	O	.	_	0	SENT_903	[p17l72t1894r95b1974],

1	Rev.	NNP	O	Rev.	nn	2	SENT_904	[p17l72t1824r95b1883],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_904	[p17l72t1665r95b1814],
3	.	.	O	.	_	0	SENT_904	[p17l72t1665r95b1814],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_905	[p17l72t1545r95b1654],
2	.	.	O	.	_	0	SENT_905	[p17l72t1545r95b1654],

1	2012522249-27	CD	NUMBER	2012522249-27	num	2	SENT_906	[p17l72t1324r96b1534],
2	3	CD	NUMBER	3	_	0	SENT_906	[p17l72t1226r95b1248],
3	.	.	O	.	_	0	SENT_906	[p17l72t1226r95b1248],

1	Downloaded	VBN	O	download	_	0	SENT_907	[p17l72t1045r95b1216],
2	from	IN	O	from	_	0	SENT_907	[p17l72t972r95b1036],
3	www	NN	O	www	prep_from	1	SENT_907	[p17l72t692r95b963],
4	.	.	O	.	_	0	SENT_907	[p17l72t692r95b963],

1	annua1reviews	NNS	O	annua1review	_	0	SENT_908	[p17l72t692r95b963],
2	.	.	O	.	_	0	SENT_908	[p17l79t624r102b674],

1	org	NN	O	org	_	0	SENT_909	[p17l79t624r102b674],
2	on	IN	O	on	_	0	SENT_909	[p17l113t1214r129b1246],
3	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_909	[p17l105t1080r129b1204],
4	.	.	O	.	_	0	SENT_909	[p17l105t1080r129b1204],

1	For	IN	O	for	_	0	SENT_910	[p17l106t1023r129b1069],
2	personal	JJ	O	personal	amod	3	SENT_910	[p17l105t902r136b1014],
3	use	NN	O	use	pobj	1	SENT_910	[p17l113t850r129b893],
4	only	RB	O	only	advmod	3	SENT_910	[p17l105t775r136b840],
5	.	.	O	.	_	0	SENT_910	[p17l105t775r136b840],

1	by	IN	O	by	_	0	SENT_911	[p17l105t1807r136b1840],
2	University	NNP	ORGANIZATION	University	prep_by	3	SENT_911	[p17l105t1658r136b1798],
3	of	IN	ORGANIZATION	of	_	0	SENT_911	[p17l105t1620r129b1648],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	pobj	3	SENT_911	[p17l105t1474r129b1613],
5	-	:	O	-	_	0	SENT_911	[p17l119t1455r122b1464],
6	Madison	NNP	O	Madison	dep	3	SENT_911	[p17l105t1328r129b1445],
7	9-2	CD	NUMBER	9-2	num	6	SENT_911	[p17l181t3778r205b3821],
8	73	CD	NUMBER	73	dep	6	SENT_911	[p17l181t3725r204b3763],
9	.	.	O	.	_	0	SENT_911	[p17l181t3725r204b3763],

1	Downloaded	VBN	O	download	_	0	SENT_912	[p17l181t3544r204b3714],
2	from	IN	O	from	_	0	SENT_912	[p17l181t3471r204b3535],
3	www	NN	O	www	prep_from	1	SENT_912	[p17l181t3186r204b3463],
4	.	.	O	.	_	0	SENT_912	[p17l181t3186r204b3463],

1	annua1reviews	NNS	O	annua1review	_	0	SENT_913	[p17l181t3186r204b3463],
2	.	.	O	.	_	0	SENT_913	[p17l181t3186r204b3463],

1	org	NN	O	org	nn	2	SENT_914	[p17l188t3129r211b3172],
2	1S0	NN	O	1s0	_	0	SENT_914	[p17l214t3777r238b3821],
3	]	NN	O	]	dep	2	SENT_914	[p17l214t3777r238b3821],
4	1	CD	NUMBER	1	num	3	SENT_914	[p17l222t3753r237b3764],
5	on	IN	O	on	_	0	SENT_914	[p17l222t3712r238b3744],
6	01/05	CD	NUMBER	01/05	prep_on	3	SENT_914	[p17l214t3618r238b3703],
7	/	:	O	/	punct	2	SENT_914	[p17l214t3618r238b3703],
8	14	CD	NUMBER	14	dep	2	SENT_914	[p17l214t3579r238b3615],
9	.	.	O	.	_	0	SENT_914	[p17l214t3579r238b3615],

1	For	IN	O	for	_	0	SENT_915	[p17l215t3522r238b3568],
2	personal	JJ	O	personal	amod	3	SENT_915	[p17l214t3402r245b3513],
3	use	NN	O	use	pobj	1	SENT_915	[p17l222t3349r238b3393],
4	only	RB	O	only	advmod	3	SENT_915	[p17l214t3275r245b3340],
5	.	.	O	.	_	0	SENT_915	[p17l214t3275r245b3340],

1	www.nnnunlreview5.org	NN	O	www.nnnunlreview5.org	nn	2	SENT_916	[p17l1355t41r1629b71],
2	o	NN	O	o	_	0	SENT_916	[p17l1644t49r1653b59],
3	Dmg	NNP	O	Dmg	nn	4	SENT_916	[p17l1670t41r1733b71],
4	Tmnspomarr	NNP	O	Tmnspomarr	dep	2	SENT_916	[p17l1741t41r1885b70],
5	267	CD	NUMBER	267	dep	2	SENT_916	[p17l1936t41r1979b70],

1	Xiang	NN	PERSON	xiang	nn	2	SENT_917	[p17l641t80r725b113],
2	X	NN	PERSON	x	_	0	SENT_917	[p17l737t80r768b110],
3	,	,	O	,	_	0	SENT_917	[p17l737t80r768b110],
4	Jada	NNP	O	Jada	nn	5	SENT_917	[p17l778t79r841b111],
5	SR	NN	O	sr	appos	2	SENT_917	[p17l856t80r902b110],
6	,	,	O	,	_	0	SENT_917	[p17l856t80r902b110],
7	Li	NNP	PERSON	Li	nn	8	SENT_917	[p17l917t80r948b104],
8	HH	NNP	PERSON	HH	appos	2	SENT_917	[p17l961t80r1025b110],
9	,	,	O	,	_	0	SENT_917	[p17l961t80r1025b110],
10	Fan	NN	O	fan	nn	11	SENT_917	[p17l1040t80r1093b105],
11	L	NN	O	l	appos	2	SENT_917	[p17l1106t80r1135b110],
12	,	,	O	,	_	0	SENT_917	[p17l1106t80r1135b110],
13	Tham	NNP	O	Tham	nn	14	SENT_917	[p17l1148t79r1235b105],
14	LS	NN	O	l	appos	2	SENT_917	[p17l1248t80r1296b110],
15	,	,	O	,	_	0	SENT_917	[p17l1248t80r1296b110],
16	et	FW	O	et	nn	17	SENT_917	[p17l1311t86r1337b105],
17	al.	FW	O	al.	appos	2	SENT_917	[p17l1350t79r1379b105],
18	2006	CD	DATE	2006	dep	17	SENT_917	[p17l1394t81r1469b105],
19	.	.	O	.	_	0	SENT_917	[p17l1394t81r1469b105],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nsubj	10	SENT_918	[p17l1484t79r1738b113],
2	of	IN	O	of	_	0	SENT_918	[p17l1752t79r1783b105],
3	SLCO1B1	NN	O	slco1b1	nn	4	SENT_918	[p17l1794t80r1938b105],
4	gene	NN	O	gene	prep_of	1	SENT_918	[p17l1955t89r2020b113],
5	and	CC	O	and	_	0	SENT_918	[p17l2034t79r2083b105],
6	the	DT	O	the	det	7	SENT_918	[p17l642t121r685b147],
7	impact	NN	O	impact	conj_and	1	SENT_918	[p17l695t122r790b155],
8	of	IN	O	of	_	0	SENT_918	[p17l800t121r830b147],
9	*	CD	NUMBER	*	prep_of	7	SENT_918	[p17l837t122r847b134],
10	lb	NN	O	lb	_	0	SENT_918	[p17l854t121r885b147],
11	and	CC	O	and	_	0	SENT_918	[p17l895t121r945b147],
12	*	NN	O	*	conj_and	10	SENT_918	[p17l955t122r1001b147],
13	15	CD	NUMBER	15	num	14	SENT_918	[p17l955t122r1001b147],
14	haplotypes	NNS	O	haplotype	dobj	10	SENT_918	[p17l1013t121r1162b155],
15	on	IN	O	on	_	0	SENT_918	[p17l1172t131r1207b147],
16	irinotecan	NN	O	irinotecan	nn	17	SENT_918	[p17l1217t123r1358b147],
17	disposition	NN	O	disposition	prep_on	14	SENT_918	[p17l1368t121r1520b155],
18	in	IN	O	in	_	0	SENT_918	[p17l1529t122r1556b147],
19	Asian	JJ	LOCATION	asian	amod	21	SENT_918	[p17l1565t122r1642b147],
20	cancer	NN	O	cancer	nn	21	SENT_918	[p17l1652t131r1742b147],
21	patients	NNS	O	patient	prep_in	10	SENT_918	[p17l1751t123r1867b155],
22	.	.	O	.	_	0	SENT_918	[p17l1751t123r1867b155],

1	Pbnwnncogenet	NNP	O	Pbnwnncogenet	_	0	SENT_919	[p17l1878t122r2081b156],
2	.	.	O	.	_	0	SENT_919	[p17l1878t122r2081b156],

1	Genonzicx	NN	O	genonzicx	_	0	SENT_920	[p17l643t165r765b190],
2	16:683	CD	NUMBER	16:683	num	1	SENT_920	[p17l777t165r915b190],
3	-91	CD	NUMBER	-91	num	5	SENT_920	[p17l777t165r915b190],
4	Kohlrausch	NN	O	kohlrausch	nn	5	SENT_920	[p17l642t206r802b232],
5	FB	NN	O	fb	nn	1	SENT_920	[p17l817t207r865b237],
6	,	,	O	,	_	0	SENT_920	[p17l817t207r865b237],
7	de	FW	O	de	dep	1	SENT_920	[p17l881t206r912b232],
8	Cassia	FW	ORGANIZATION	cassia	nn	10	SENT_920	[p17l927t207r1014b232],
9	Estrela	FW	ORGANIZATION	estrela	nn	10	SENT_920	[p17l1028t206r1125b232],
10	R	NN	ORGANIZATION	r	dep	1	SENT_920	[p17l1140t207r1169b237],
11	,	,	O	,	_	0	SENT_920	[p17l1140t207r1169b237],
12	Barroso	NNP	PERSON	Barroso	nn	16	SENT_920	[p17l1185t207r1293b232],
13	PF	NNP	O	PF	nn	16	SENT_920	[p17l1307t207r1355b237],
14	,	,	O	,	_	0	SENT_920	[p17l1307t207r1355b237],
15	Suarez-Kurtz	NNP	PERSON	Suarez-Kurtz	appos	16	SENT_920	[p17l1371t207r1558b232],
16	G.	NNP	O	G.	appos	10	SENT_920	[p17l1573t207r1606b232],
17	2010	CD	DATE	2010	num	16	SENT_920	[p17l1622t208r1697b232],
18	.	.	O	.	_	0	SENT_920	[p17l1622t208r1697b232],

1	The	DT	O	the	det	2	SENT_921	[p17l1711t206r1770b232],
2	impact	NN	O	impact	_	0	SENT_921	[p17l1785t208r1880b240],
3	of	IN	O	of	_	0	SENT_921	[p17l1894t206r1924b232],
4	SLCO1B1	NN	O	slco1b1	nn	5	SENT_921	[p17l1936t207r2080b232],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_921	[p17l642t249r857b283],
6	on	IN	O	on	_	0	SENT_921	[p17l867t259r902b275],
7	the	DT	O	the	det	9	SENT_921	[p17l910t249r954b275],
8	plasma	NN	O	plasma	nn	9	SENT_921	[p17l962t249r1058b283],
9	concentration	NN	O	concentration	prep_on	2	SENT_921	[p17l1067t250r1261b275],
10	of	IN	O	of	_	0	SENT_921	[p17l1269t249r1300b275],
11	lopinavir	NN	O	lopinavir	prep_of	9	SENT_921	[p17l1304t249r1429b283],
12	and	CC	O	and	_	0	SENT_921	[p17l1438t249r1487b275],
13	ritonavir	NN	O	ritonavir	conj_and	11	SENT_921	[p17l1495t250r1617b275],
14	in	IN	O	in	_	0	SENT_921	[p17l1625t250r1652b274],
15	HIV-infected	JJ	O	hiv-infected	amod	16	SENT_921	[p17l1660t249r1850b275],
16	men	NNS	O	man	prep_in	2	SENT_921	[p17l1859t258r1926b275],
17	.	.	O	.	_	0	SENT_921	[p17l1859t258r1926b275],

1	Br	NN	O	br	_	0	SENT_922	[p17l1936t250r1975b274],
2	.	.	O	.	_	0	SENT_922	[p17l1936t250r1975b274],

1	P	NN	O	p	_	0	SENT_923	[p17l1982t249r2007b283],
2	!	.	O	!	_	0	SENT_923	[p17l1982t249r2007b283],

1	;	:	O	;	_	0	SENT_924	[p17l1982t249r2007b283],
2	R	NN	O	r	_	0	SENT_924	[p17l1982t249r2007b283],
3	+	CC	O	+	_	0	SENT_924	[p17l1982t249r2007b283],
4	Clin	NN	O	clin	conj_+	2	SENT_924	[p17l2020t250r2081b274],
5	.	.	O	.	_	0	SENT_924	[p17l2020t250r2081b274],

1	P/Jnrrnzzeol	NN	O	p/jnrrnzzeol	_	0	SENT_925	[p17l641t292r785b317],
2	.	.	O	.	_	0	SENT_925	[p17l641t292r785b317],

1	69:95	CD	NUMBER	69:95	num	4	SENT_926	[p17l798t292r924b317],
2	-98	CD	NUMBER	-98	num	4	SENT_926	[p17l798t292r924b317],
3	Hartkoorn	NNP	O	Hartkoorn	nn	4	SENT_926	[p17l642t333r792b359],
4	RC	NNP	O	RC	_	0	SENT_926	[p17l801t334r855b365],
5	,	,	O	,	_	0	SENT_926	[p17l801t334r855b365],
6	Kwan	NNP	PERSON	Kwan	nn	7	SENT_926	[p17l865t334r945b359],
7	WS	NNP	O	WS	appos	4	SENT_926	[p17l953t334r1015b365],
8	,	,	O	,	_	0	SENT_926	[p17l953t334r1015b365],
9	Shallcross	NNP	PERSON	Shallcross	nn	10	SENT_926	[p17l1026t333r1163b359],
10	V	NNP	PERSON	V	appos	4	SENT_926	[p17l1171t334r1203b365],
11	,	,	O	,	_	0	SENT_926	[p17l1171t334r1203b365],
12	Chaikan	NNP	O	Chaikan	nn	13	SENT_926	[p17l1213t333r1329b359],
13	A	NNP	O	A	appos	4	SENT_926	[p17l1336t334r1366b365],
14	,	,	O	,	_	0	SENT_926	[p17l1336t334r1366b365],
15	Liptrott	NNP	ORGANIZATION	Liptrott	nn	16	SENT_926	[p17l1376t334r1489b367],
16	N	NNP	ORGANIZATION	N	appos	4	SENT_926	[p17l1496t334r1532b365],
17	,	,	O	,	_	0	SENT_926	[p17l1496t334r1532b365],
18	et	FW	O	et	nn	19	SENT_926	[p17l1542t340r1568b359],
19	al.	FW	O	al.	appos	4	SENT_926	[p17l1575t333r1605b359],
20	2	CD	NUMBER	2	number	21	SENT_926	[p17l1615t334r1628b359],
21	010	CD	NUMBER	010	dep	19	SENT_926	[p17l1633t334r1690b359],
22	.	.	O	.	_	0	SENT_926	[p17l1633t334r1690b359],

1	HIV	NN	MISC	hiv	nn	3	SENT_927	[p17l1700t334r1767b359],
2	protease	NN	O	protease	nn	3	SENT_927	[p17l1773t340r1889b367],
3	inhibitors	NNS	O	inhibitor	nsubj	5	SENT_927	[p17l1897t333r2033b359],
4	are	VBP	O	be	cop	5	SENT_927	[p17l2042t343r2083b359],
5	substrates	NNS	O	substrate	_	0	SENT_927	[p17l642t375r778b401],
6	for	IN	O	for	_	0	SENT_927	[p17l787t375r827b401],
7	OATP1A2	NN	O	oatp1a2	prep_for	5	SENT_927	[p17l835t376r994b406],
8	,	,	O	,	_	0	SENT_927	[p17l835t376r994b406],
9	OATP1B1	NN	O	oatp1b1	prep_for	5	SENT_927	[p17l1004t376r1152b401],
10	and	CC	O	and	_	0	SENT_927	[p17l1163t375r1213b401],
11	OATP1B3	NN	O	oatp1b3	prep_for	5	SENT_927	[p17l1222t376r1369b401],
12	and	CC	O	and	_	0	SENT_927	[p17l1381t375r1430b401],
13	lopinavir	NN	O	lopinavir	nn	15	SENT_927	[p17l1438t375r1563b409],
14	plasma	NN	O	plasma	nn	15	SENT_927	[p17l1570t375r1666b409],
15	concentrations	NNS	O	concentration	nsubjpass	17	SENT_927	[p17l1674t376r1879b401],
16	are	VBP	O	be	auxpass	17	SENT_927	[p17l1889t385r1930b401],
17	inﬂuenced	VBN	O	inﬂuenced	conj_and	5	SENT_927	[p17l1938t375r2083b401],
18	by	IN	O	by	_	0	SENT_927	[p17l642t417r676b451],
19	SLCO1B1	NN	O	slco1b1	nn	20	SENT_927	[p17l685t418r830b443],
20	polymorphisms	NNS	O	polymorphism	agent	17	SENT_927	[p17l843t417r1066b451],
21	.	.	O	.	_	0	SENT_927	[p17l843t417r1066b451],

1	Pbnrrnncogenet	NNP	O	Pbnrrnncogenet	_	0	SENT_928	[p17l1077t418r1279b452],
2	.	.	O	.	_	0	SENT_928	[p17l1077t418r1279b452],

1	Genomicx	NN	O	genomicx	_	0	SENT_929	[p17l1294t418r1415b443],
2	20:1	CD	NUMBER	20:1	dep	1	SENT_929	[p17l1424t419r1479b443],
3	12-2	RB	O	12-2	advmod	6	SENT_929	[p17l1487t419r1548b443],
4	o	NN	O	o	nn	6	SENT_929	[p17l1553t419r1568b443],
5	Trevino	NNP	ORGANIZATION	Trevino	nn	6	SENT_929	[p17l641t460r755b485],
6	LR	NNP	ORGANIZATION	LR	rcmod	2	SENT_929	[p17l767t460r820b490],
7	,	,	O	,	_	0	SENT_929	[p17l767t460r820b490],
8	Shimasaki	NNP	ORGANIZATION	Shimasaki	nn	9	SENT_929	[p17l834t459r973b485],
9	N	NNP	ORGANIZATION	N	appos	6	SENT_929	[p17l984t460r1020b490],
10	,	,	O	,	_	0	SENT_929	[p17l984t460r1020b490],
11	Yang	NNP	PERSON	Yang	nn	12	SENT_929	[p17l1032t460r1105b493],
12	W	NNP	PERSON	W	appos	6	SENT_929	[p17l1115t460r1159b490],
13	,	,	O	,	_	0	SENT_929	[p17l1115t460r1159b490],
14	Panetta	NNP	PERSON	Panetta	nn	15	SENT_929	[p17l1172t460r1277b485],
15	JC	NNP	O	JC	appos	6	SENT_929	[p17l1285t460r1333b491],
16	,	,	O	,	_	0	SENT_929	[p17l1285t460r1333b491],
17	Cheng	NNP	PERSON	Cheng	nn	18	SENT_929	[p17l1346t459r1440b493],
18	C	NNP	PERSON	C	appos	6	SENT_929	[p17l1452t460r1482b490],
19	,	,	O	,	_	0	SENT_929	[p17l1452t460r1482b490],
20	et	FW	O	et	nn	21	SENT_929	[p17l1496t466r1522b485],
21	al.	FW	O	al.	appos	6	SENT_929	[p17l1533t459r1563b485],
22	2009	CD	DATE	2009	dep	2	SENT_929	[p17l1576t461r1651b485],
23	.	.	O	.	_	0	SENT_929	[p17l1576t461r1651b485],

1	Germline	NN	O	germline	nn	3	SENT_930	[p17l1665t459r1798b485],
2	genetic	JJ	O	genetic	amod	3	SENT_930	[p17l1811t460r1911b493],
3	variation	NN	O	variation	_	0	SENT_930	[p17l1921t460r2045b485],
4	in	IN	O	in	_	0	SENT_930	[p17l2057t460r2084b484],
5	an	DT	O	a	det	9	SENT_930	[p17l642t514r674b530],
6	organic	JJ	O	organic	amod	9	SENT_930	[p17l687t506r791b539],
7	anion	NN	O	anion	nn	9	SENT_930	[p17l804t506r882b530],
8	transporter	NN	O	transporter	nn	9	SENT_930	[p17l894t512r1051b539],
9	polypeptide	NN	O	polypeptide	prep_in	3	SENT_930	[p17l1063t504r1227b539],
10	associated	VBN	O	associate	partmod	9	SENT_930	[p17l1241t504r1380b530],
11	with	IN	O	with	prt	10	SENT_930	[p17l1392t504r1454b530],
12	methotrexate	NN	O	methotrexate	nn	13	SENT_930	[p17l1466t504r1651b530],
13	pharmacokinetics	NNS	O	pharmacokinetic	dobj	10	SENT_930	[p17l1664t504r1909b539],
14	and	CC	O	and	_	0	SENT_930	[p17l1923t504r1972b530],
15	clinical	JJ	O	clinical	amod	18	SENT_930	[p17l1985t504r2083b530],
16	eﬁ	NN	O	eﬁ	nn	18	SENT_930	[p17l642t550r768b584],
17	‘	NN	O	‘	nn	18	SENT_930	[p17l642t550r768b584],
18	ects	NNS	O	ect	dobj	10	SENT_930	[p17l642t550r768b584],
19	.	.	O	.	_	0	SENT_930	[p17l642t550r768b584],
20	]	SYM	O	]	dep	13	SENT_930	[p17l642t550r768b584],

1	.	.	O	.	_	0	SENT_931	[p17l642t550r768b584],

1	Clin	NNP	O	Clin	_	0	SENT_932	[p17l782t551r842b576],
2	.	.	O	.	_	0	SENT_932	[p17l782t551r842b576],

1	Oneal	NNP	PERSON	Oneal	_	0	SENT_933	[p17l856t551r933b576],
2	.	.	O	.	_	0	SENT_933	[p17l856t551r933b576],

1	27:5	CD	NUMBER	27:5	_	0	SENT_934	[p17l946t551r1003b576],
2	972-78	CD	NUMBER	972-78	num	4	SENT_934	[p17l1007t551r1107b576],
3	Niemi	NNP	O	Niemi	nn	4	SENT_934	[p17l641t593r731b618],
4	M	NN	O	m	dep	1	SENT_934	[p17l738t593r778b623],
5	,	,	O	,	_	0	SENT_934	[p17l738t593r778b623],
6	Backman	NNP	PERSON	Backman	nn	7	SENT_934	[p17l787t592r914b618],
7	JT	NNP	O	JT	appos	4	SENT_934	[p17l919t593r967b624],
8	,	,	O	,	_	0	SENT_934	[p17l919t593r967b624],
9	Kajosaari	NNP	PERSON	Kajosaari	nn	10	SENT_934	[p17l977t593r1105b626],
10	LI	NNP	PERSON	LI	appos	4	SENT_934	[p17l1114t593r1155b623],
11	,	,	O	,	_	0	SENT_934	[p17l1114t593r1155b623],
12	LeathartJB	NNP	O	LeathartJB	appos	4	SENT_934	[p17l1165t592r1333b624],
13	,	,	O	,	_	0	SENT_934	[p17l1165t592r1333b624],
14	Neuvonen	NNP	O	Neuvonen	nn	15	SENT_934	[p17l1342t593r1489b618],
15	M	NNP	O	M	appos	4	SENT_934	[p17l1496t593r1536b624],
16	,	,	O	,	_	0	SENT_934	[p17l1496t593r1536b624],
17	et	FW	O	et	nn	18	SENT_934	[p17l1546t600r1572b618],
18	al.	FW	O	al.	appos	4	SENT_934	[p17l1579t592r1609b618],
19	2005	CD	DATE	2005	dep	18	SENT_934	[p17l1619t594r1684b618],
20	.	.	O	.	_	0	SENT_934	[p17l1689t613r1694b618],

1	Polymorphic	JJ	O	polymorphic	amod	3	SENT_935	[p17l1703t592r1885b627],
2	organic	JJ	O	organic	amod	3	SENT_935	[p17l1894t594r1998b627],
3	anion	NN	O	anion	nsubj	10	SENT_935	[p17l2006t594r2083b618],
4	transporting	VBG	O	transport	partmod	3	SENT_935	[p17l642t639r815b672],
5	polypeptide	NN	O	polypeptide	nn	6	SENT_935	[p17l825t638r989b672],
6	1B1	NN	O	1b1	dobj	4	SENT_935	[p17l1003t639r1052b663],
7	is	VBZ	O	be	cop	10	SENT_935	[p17l1065t639r1085b664],
8	a	DT	O	a	det	10	SENT_935	[p17l1097t648r1110b664],
9	major	JJ	O	major	amod	10	SENT_935	[p17l1120t639r1202b672],
10	determinant	NN	O	determinant	_	0	SENT_935	[p17l1212t638r1384b664],
11	of	IN	O	of	_	0	SENT_935	[p17l1394t638r1424b664],
12	repaglinide	NN	O	repaglinide	nn	13	SENT_935	[p17l1431t638r1587b672],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	10	SENT_935	[p17l1598t638r1850b672],
14	.	.	O	.	_	0	SENT_935	[p17l1598t638r1850b672],

1	Clin	NNP	O	Clin	_	0	SENT_936	[p17l1864t639r1924b664],
2	.	.	O	.	_	0	SENT_936	[p17l1864t639r1924b664],

1	Pbarmncol	NNP	O	Pbarmncol	_	0	SENT_937	[p17l1937t639r2081b664],
2	.	.	O	.	_	0	SENT_937	[p17l1937t639r2081b664],

1	Tber	NNP	O	Tber	_	0	SENT_938	[p17l643t699r711b724],
2	.	.	O	.	_	0	SENT_938	[p17l643t699r711b724],

1	77:468	CD	NUMBER	77:468	num	2	SENT_939	[p17l725t699r867b724],
2	—	NN	O	—	_	0	SENT_939	[p17l725t699r867b724],
3	78	CD	NUMBER	78	num	5	SENT_939	[p17l725t699r867b724],
4	Kalliokoski	NNP	O	Kalliokoski	nn	5	SENT_939	[p17l641t744r798b770],
5	A	NNP	O	A	dep	2	SENT_939	[p17l804t745r833b776],
6	,	,	O	,	_	0	SENT_939	[p17l804t745r833b776],
7	Neuvonen	NNP	O	Neuvonen	nn	8	SENT_939	[p17l840t746r987b770],
8	M	NNP	O	M	appos	5	SENT_939	[p17l992t746r1032b776],
9	,	,	O	,	_	0	SENT_939	[p17l992t746r1032b776],
10	Neuvonen	NNP	ORGANIZATION	Neuvonen	nn	11	SENT_939	[p17l1039t746r1186b770],
11	PJ	NNP	ORGANIZATION	PJ	appos	5	SENT_939	[p17l1192t746r1232b777],
12	,	,	O	,	_	0	SENT_939	[p17l1192t746r1232b777],
13	Niemi	NNP	PERSON	Niemi	nn	14	SENT_939	[p17l1239t746r1328b770],
14	M.	NNP	O	M.	appos	5	SENT_939	[p17l1334t746r1373b770],
15	2008	CD	DATE	2008	dep	14	SENT_939	[p17l1381t746r1455b770],
16	.	.	O	.	_	0	SENT_939	[p17l1381t746r1455b770],

1	Different	JJ	O	different	amod	2	SENT_940	[p17l1464t745r1592b770],
2	effects	NNS	O	effect	_	0	SENT_940	[p17l1598t745r1684b770],
3	of	IN	O	of	_	0	SENT_940	[p17l1691t744r1722b770],
4	SLCO	NN	O	slco	nn	6	SENT_940	[p17l1726t745r1817b770],
5	1	CD	NUMBER	1	num	6	SENT_940	[p17l1822t746r1831b770],
6	B	NN	O	b	prep_of	2	SENT_940	[p17l1836t746r1855b770],
7	1	CD	NUMBER	1	num	8	SENT_940	[p17l1861t746r1870b770],
8	polymorphism	NN	O	polymorphism	dep	2	SENT_940	[p17l1880t744r2084b779],
9	on	IN	O	on	_	0	SENT_940	[p17l642t800r677b816],
10	the	DT	O	the	det	11	SENT_940	[p17l692t790r735b816],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	8	SENT_940	[p17l751t790r995b824],
12	and	CC	O	and	_	0	SENT_940	[p17l1011t790r1060b816],
13	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	11	SENT_940	[p17l1076t790r1344b824],
14	of	IN	O	of	_	0	SENT_940	[p17l1360t790r1391b816],
15	repaglinide	NN	O	repaglinide	prep_of	11	SENT_940	[p17l1402t790r1558b824],
16	and	CC	O	and	_	0	SENT_940	[p17l1574t790r1623b816],
17	nateglinide	NN	O	nateglinide	prep_of	11	SENT_940	[p17l1638t790r1801b824],
18	.	.	O	.	_	0	SENT_940	[p17l1638t790r1801b824],

1	y	NN	O	y	_	0	SENT_941	[p17l1813t790r1838b824],
2	;	:	O	;	_	0	SENT_941	[p17l1813t790r1838b824],
3	R	NN	O	r	dep	1	SENT_941	[p17l1813t790r1838b824],
4	+	CC	O	+	_	0	SENT_941	[p17l1813t790r1838b824],
5	Clin	NN	O	clin	dep	1	SENT_941	[p17l1858t791r1919b816],
6	.	.	O	.	_	0	SENT_941	[p17l1858t791r1919b816],

1	Phnrmncol	NNP	O	Phnrmncol	_	0	SENT_942	[p17l1937t791r2081b816],
2	.	.	O	.	_	0	SENT_942	[p17l1937t791r2081b816],

1	48:3	CD	NUMBER	48:3	number	2	SENT_943	[p17l641t837r698b862],
2	1	CD	NUMBER	1	num	3	SENT_943	[p17l705t837r715b861],
3	1-2	CD	NUMBER	1-2	_	0	SENT_943	[p17l722t837r767b861],
4	1	CD	NUMBER	1	num	5	SENT_943	[p17l774t837r783b861],
5	HeJ	NN	O	hej	dep	3	SENT_943	[p17l642t883r711b914],
6	,	,	O	,	_	0	SENT_943	[p17l642t883r711b914],
7	Qiu	NNP	O	Qiu	nn	8	SENT_943	[p17l721t883r774b913],
8	Z	NNP	O	Z	appos	5	SENT_943	[p17l782t882r811b913],
9	,	,	O	,	_	0	SENT_943	[p17l782t882r811b913],
10	Li	NNP	PERSON	Li	nn	11	SENT_943	[p17l820t883r850b907],
11	N	NNP	PERSON	N	appos	5	SENT_943	[p17l858t883r893b913],
12	,	,	O	,	_	0	SENT_943	[p17l858t883r893b913],
13	Yu	NNP	O	Yu	nn	14	SENT_943	[p17l901t883r941b908],
14	Y	NN	O	y	appos	5	SENT_943	[p17l948t883r977b913],
15	,	,	O	,	_	0	SENT_943	[p17l948t883r977b913],
16	Lu	NNP	O	Lu	nn	17	SENT_943	[p17l986t883r1026b908],
17	Y	NN	O	y	appos	5	SENT_943	[p17l1032t883r1062b913],
18	,	,	O	,	_	0	SENT_943	[p17l1032t883r1062b913],
19	et	FW	O	et	nn	20	SENT_943	[p17l1071t889r1097b908],
20	al.	FW	O	al.	appos	5	SENT_943	[p17l1104t882r1134b908],
21	201	CD	NUMBER	201	number	22	SENT_943	[p17l1143t884r1190b908],
22	1	CD	NUMBER	1	dep	20	SENT_943	[p17l1198t884r1218b908],
23	.	.	O	.	_	0	SENT_943	[p17l1198t884r1218b908],

1	Effects	NNS	O	effect	_	0	SENT_944	[p17l1227t882r1321b908],
2	of	IN	O	of	_	0	SENT_944	[p17l1329t882r1360b908],
3	SLCO1B1	NN	O	slco1b1	nn	4	SENT_944	[p17l1365t883r1510b908],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_944	[p17l1520t882r1736b916],
5	on	IN	O	on	_	0	SENT_944	[p17l1745t892r1779b908],
6	the	DT	O	the	det	7	SENT_944	[p17l1787t882r1830b908],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_944	[p17l1838t882r2083b916],
8	and	CC	O	and	_	0	SENT_944	[p17l642t928r691b953],
9	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	1	SENT_944	[p17l701t928r970b962],
10	of	IN	O	of	_	0	SENT_944	[p17l980t928r1011b953],
11	repaglinide	NN	O	repaglinide	prep_of	7	SENT_944	[p17l1017t928r1173b962],
12	in	IN	O	in	_	0	SENT_944	[p17l1183t929r1210b953],
13	healthy	JJ	O	healthy	amod	15	SENT_944	[p17l1219t928r1323b962],
14	Chinese	JJ	MISC	chinese	amod	15	SENT_944	[p17l1332t928r1444b953],
15	volunteers	NNS	O	volunteer	prep_in	1	SENT_944	[p17l1453t928r1606b953],
16	.	.	O	.	_	0	SENT_944	[p17l1453t928r1606b953],

1	Eur	NNP	O	Eur	_	0	SENT_945	[p17l1616t929r1674b953],
2	.	.	O	.	_	0	SENT_945	[p17l1616t929r1674b953],

1	Clin	NNP	O	Clin	_	0	SENT_946	[p17l1721t929r1781b953],
2	.	.	O	.	_	0	SENT_946	[p17l1721t929r1781b953],

1	Pbnnrnntol	NN	O	pbnnrnntol	_	0	SENT_947	[p17l1793t929r1937b953],
2	.	.	O	.	_	0	SENT_947	[p17l1793t929r1937b953],

1	67:701	CD	NUMBER	67:701	num	2	SENT_948	[p17l1950t929r2076b954],
2	—	NN	O	—	_	0	SENT_948	[p17l1950t929r2076b954],
3	7	CD	NUMBER	7	num	5	SENT_948	[p17l1950t929r2076b954],
4	Sai	NN	O	saus	nn	5	SENT_948	[p17l643t975r683b1000],
5	K	NN	O	k	dep	2	SENT_948	[p17l692t975r724b1005],
6	,	,	O	,	_	0	SENT_948	[p17l692t975r724b1005],
7	Saito	NNP	O	Saito	nn	8	SENT_948	[p17l735t975r804b1000],
8	Y	NN	O	y	appos	5	SENT_948	[p17l813t975r842b1005],
9	,	,	O	,	_	0	SENT_948	[p17l813t975r842b1005],
10	Maekawa	NNP	PERSON	Maekawa	nn	11	SENT_948	[p17l851t974r983b1000],
11	K	NNP	O	K	appos	5	SENT_948	[p17l993t975r1024b1005],
12	,	,	O	,	_	0	SENT_948	[p17l993t975r1024b1005],
13	Kim	NNP	PERSON	Kim	nn	14	SENT_948	[p17l1035t975r1096b999],
14	SR	NN	O	sr	appos	5	SENT_948	[p17l1106t975r1153b1005],
15	,	,	O	,	_	0	SENT_948	[p17l1106t975r1153b1005],
16	Kaniwa	NN	PERSON	kaniwa	nn	17	SENT_948	[p17l1163t975r1268b1000],
17	N	NN	PERSON	n	appos	5	SENT_948	[p17l1277t975r1313b1005],
18	,	,	O	,	_	0	SENT_948	[p17l1277t975r1313b1005],
19	et	FW	O	et	nn	20	SENT_948	[p17l1324t981r1350b1000],
20	al.	FW	O	al.	appos	5	SENT_948	[p17l1358t974r1388b1000],
21	2010	CD	DATE	2010	dep	20	SENT_948	[p17l1399t976r1474b1000],
22	.	.	O	.	_	0	SENT_948	[p17l1399t976r1474b1000],

1	Additive	JJ	O	additive	amod	2	SENT_949	[p17l1483t974r1601b1000],
2	effects	NNS	O	effect	_	0	SENT_949	[p17l1611t974r1697b1000],
3	of	IN	O	of	_	0	SENT_949	[p17l1707t974r1738b1000],
4	drug	NN	O	drug	nn	7	SENT_949	[p17l1744t974r1809b1008],
5	transporter	NN	O	transporter	nn	7	SENT_949	[p17l1818t981r1974b1008],
6	genetic	JJ	O	genetic	amod	7	SENT_949	[p17l1984t975r2084b1008],
7	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_949	[p17l642t1020r857b1054],
8	on	IN	O	on	_	0	SENT_949	[p17l868t1029r903b1046],
9	irinotecan	NN	O	irinotecan	nn	10	SENT_949	[p17l912t1021r1054b1046],
10	pharmacokinetics/pharmacodynamics	NNS	O	pharmacokinetics/pharmacodynamics	prep_on	2	SENT_949	[p17l1063t1020r1590b1054],
11	in	IN	O	in	_	0	SENT_949	[p17l1600t1021r1627b1045],
12	Japanese	JJ	MISC	japanese	amod	14	SENT_949	[p17l1633t1021r1756b1054],
13	cancer	NN	O	cancer	nn	14	SENT_949	[p17l1767t1029r1857b1046],
14	patients	NNS	O	patient	prep_in	2	SENT_949	[p17l1866t1021r1982b1054],
15	.	.	O	.	_	0	SENT_949	[p17l1866t1021r1982b1054],

1	Cancer	NN	O	cancer	_	0	SENT_950	[p17l1995t1021r2085b1046],
2	C/aemot/yer	NN	O	c/aemot/yer	dep	1	SENT_950	[p17l643t1067r789b1092],
3	.	.	O	.	_	0	SENT_950	[p17l643t1067r789b1092],

1	Pbnrmncol	NNP	O	Pbnrmncol	_	0	SENT_951	[p17l801t1067r945b1092],
2	.	.	O	.	_	0	SENT_951	[p17l801t1067r945b1092],

1	66:95	CD	NUMBER	66:95	num	2	SENT_952	[p17l958t1067r1100b1092],
2	—	NN	O	—	_	0	SENT_952	[p17l958t1067r1100b1092],
3	105	CD	NUMBER	105	num	5	SENT_952	[p17l958t1067r1100b1092],
4	Han	NNP	O	Han	nn	5	SENT_952	[p17l642t1113r703b1138],
5	JY	NN	O	jy	dep	2	SENT_952	[p17l709t1113r754b1144],
6	,	,	O	,	_	0	SENT_952	[p17l709t1113r754b1144],
7	Lim	NNP	ORGANIZATION	Lim	nn	8	SENT_952	[p17l765t1113r824b1138],
8	HS	NN	ORGANIZATION	h	appos	5	SENT_952	[p17l834t1113r888b1144],
9	,	,	O	,	_	0	SENT_952	[p17l834t1113r888b1144],
10	Shin	NNP	PERSON	Shin	nn	11	SENT_952	[p17l900t1112r963b1138],
11	ES	NN	PERSON	e	appos	5	SENT_952	[p17l973t1113r1021b1144],
12	,	,	O	,	_	0	SENT_952	[p17l973t1113r1021b1144],
13	Yoo	NNP	O	Yoo	nn	14	SENT_952	[p17l1031t1113r1088b1138],
14	YK	NNP	O	YK	appos	5	SENT_952	[p17l1098t1113r1153b1144],
15	,	,	O	,	_	0	SENT_952	[p17l1098t1113r1153b1144],
16	Park	NNP	O	Park	nn	17	SENT_952	[p17l1164t1112r1230b1138],
17	YH	NNP	O	YH	appos	5	SENT_952	[p17l1238t1113r1296b1144],
18	,	,	O	,	_	0	SENT_952	[p17l1238t1113r1296b1144],
19	et	FW	O	et	nn	20	SENT_952	[p17l1308t1120r1334b1138],
20	al.	FW	O	al.	appos	5	SENT_952	[p17l1344t1112r1373b1138],
21	2008	CD	DATE	2008	dep	20	SENT_952	[p17l1385t1114r1460b1138],
22	.	.	O	.	_	0	SENT_952	[p17l1385t1114r1460b1138],

1	Inﬂuence	NN	O	inﬂuence	nsubj	9	SENT_953	[p17l1472t1112r1602b1138],
2	of	IN	O	of	_	0	SENT_953	[p17l1613t1112r1644b1138],
3	the	DT	O	the	det	7	SENT_953	[p17l1650t1112r1694b1138],
4	organic	JJ	O	organic	amod	7	SENT_953	[p17l1705t1114r1809b1147],
5	anion-transporting	JJ	O	anion-transporting	amod	7	SENT_953	[p17l1819t1114r2084b1147],
6	polypeptide	NN	O	polypeptide	nn	7	SENT_953	[p17l642t1158r806b1192],
7	1B1	NN	O	1b1	prep_of	1	SENT_953	[p17l820t1159r869b1183],
8	(	CD	NUMBER	(	num	9	SENT_953	[p17l884t1159r1055b1190],
9	OATP1B1	NN	O	oatp1b1	_	0	SENT_953	[p17l884t1159r1055b1190],
10	)	CD	NUMBER	)	num	11	SENT_953	[p17l884t1159r1055b1190],
11	polymorphisms	NNS	O	polymorphism	dobj	9	SENT_953	[p17l1067t1158r1283b1192],
12	on	IN	O	on	_	0	SENT_953	[p17l1295t1168r1330b1184],
13	irinotecan-pharmacokinetics	NNS	O	irinotecan-pharmacokinetic	prep_on	11	SENT_953	[p17l1341t1158r1741b1192],
14	and	CC	O	and	_	0	SENT_953	[p17l1753t1158r1802b1184],
15	clinical	JJ	O	clinical	amod	16	SENT_953	[p17l1814t1158r1912b1184],
16	outcome	NN	O	outcome	conj_and	11	SENT_953	[p17l1924t1165r2045b1184],
17	of	IN	O	of	_	0	SENT_953	[p17l2057t1158r2087b1184],
18	patients	NNS	O	patient	prep_of	16	SENT_953	[p17l642t1205r750b1238],
19	with	IN	O	with	_	0	SENT_953	[p17l759t1204r822b1229],
20	advanced	JJ	O	advanced	amod	22	SENT_953	[p17l832t1204r959b1229],
21	non	JJ	O	non	amod	22	SENT_953	[p17l968t1204r1109b1229],
22	—	NN	O	—	prep_with	9	SENT_953	[p17l968t1204r1109b1229],
23	small	JJ	O	small	amod	26	SENT_953	[p17l968t1204r1109b1229],
24	cell	NN	O	cell	nn	26	SENT_953	[p17l1119t1204r1166b1229],
25	lung	NN	O	lung	nn	26	SENT_953	[p17l1175t1204r1238b1238],
26	cancer	NN	O	cancer	dep	22	SENT_953	[p17l1247t1213r1344b1229],
27	.	.	O	.	_	0	SENT_953	[p17l1247t1213r1344b1229],

1	Lung	NN	O	lung	nn	2	SENT_954	[p17l1354t1205r1426b1238],
2	Cancer	NN	O	cancer	_	0	SENT_954	[p17l1436t1204r1526b1229],
3	59:69	CD	NUMBER	59:69	num	4	SENT_954	[p17l1535t1205r1659b1230],
4	-75	CD	NUMBER	-75	dep	2	SENT_954	[p17l1535t1205r1659b1230],

1	Lopez-Lopez	NNP	O	Lopez-Lopez	nn	2	SENT_955	[p17l642t1324r831b1357],
2	E	NNP	O	E	_	0	SENT_955	[p17l842t1324r871b1354],
3	,	,	O	,	_	0	SENT_955	[p17l842t1324r871b1354],
4	Martin	NNP	PERSON	Martin	appos	2	SENT_955	[p17l882t1324r1126b1349],
5	.	.	O	.	_	0	SENT_955	[p17l882t1324r1126b1349],

1	—	NN	O	—	_	0	SENT_956	[p17l882t1324r1126b1349],
2	.	.	O	.	_	0	SENT_956	[p17l882t1324r1126b1349],

1	Guerrero	NNP	O	Guerrero	nn	2	SENT_957	[p17l882t1324r1126b1349],
2	I	NNP	O	I	_	0	SENT_957	[p17l1137t1324r1156b1354],
3	,	,	O	,	_	0	SENT_957	[p17l1137t1324r1156b1354],
4	Ballesteros	NNP	PERSON	Ballesteros	nn	5	SENT_957	[p17l1169t1323r1318b1349],
5	J	NNP	PERSON	J	appos	2	SENT_957	[p17l1326t1324r1349b1355],
6	,	,	O	,	_	0	SENT_957	[p17l1326t1324r1349b1355],
7	Piﬁan	NNP	O	Piﬁan	nn	8	SENT_957	[p17l1361t1324r1442b1349],
8	MA	NNP	O	MA	appos	2	SENT_957	[p17l1451t1324r1513b1354],
9	,	,	O	,	_	0	SENT_957	[p17l1451t1324r1513b1354],
10	Garcia-Miguel	NNP	O	Garcia-Miguel	nn	11	SENT_957	[p17l1526t1323r1732b1357],
11	P	NN	O	p	appos	2	SENT_957	[p17l1743t1324r1770b1354],
12	,	,	O	,	_	0	SENT_957	[p17l1743t1324r1770b1354],
13	et	FW	O	et	nn	14	SENT_957	[p17l1783t1330r1809b1349],
14	al.	FW	O	al.	appos	2	SENT_957	[p17l1820t1323r1849b1349],
15	2011	CD	DATE	2011	dep	14	SENT_957	[p17l1862t1325r1937b1349],
16	.	.	O	.	_	0	SENT_957	[p17l1862t1325r1937b1349],

1	Polymorphisms	NNS	O	polymorphism	nsubj	6	SENT_958	[p17l1949t1323r2083b1357, p17l642t1369r738b1403],
2	of	IN	O	of	_	0	SENT_958	[p17l751t1369r781b1395],
3	the	DT	O	the	det	5	SENT_958	[p17l789t1369r833b1395],
4	SLCOIBI	NN	O	slcoibus	nn	5	SENT_958	[p17l846t1370r991b1395],
5	gene	NN	O	gene	prep_of	1	SENT_958	[p17l1006t1379r1071b1403],
6	predict	VBP	O	predict	_	0	SENT_958	[p17l1083t1369r1182b1403],
7	methotrexate	NN	O	methotrexate	nsubj	10	SENT_958	[p17l1192t1369r1486b1395],
8	—	RB	O	—	advmod	9	SENT_958	[p17l1192t1369r1486b1395],
9	related	JJ	O	related	amod	10	SENT_958	[p17l1192t1369r1486b1395],
10	toxicity	NN	O	toxicity	xcomp	6	SENT_958	[p17l1499t1370r1603b1403],
11	in	IN	O	in	_	0	SENT_958	[p17l1613t1370r1640b1394],
12	childhood	NN	O	childhood	nn	15	SENT_958	[p17l1652t1369r1792b1395],
13	acute	JJ	O	acute	amod	15	SENT_958	[p17l1804t1376r1876b1395],
14	lymphoblastic	JJ	O	lymphoblastic	amod	15	SENT_958	[p17l1888t1369r2084b1403],
15	leukemia	NN	O	leukemia	prep_in	10	SENT_958	[p17l641t1415r774b1440],
16	.	.	O	.	_	0	SENT_958	[p17l641t1415r774b1440],

1	Peelintr	NNP	O	Peelintr	_	0	SENT_959	[p17l784t1415r886b1440],
2	.	.	O	.	_	0	SENT_959	[p17l784t1415r886b1440],

1	Blood	NNP	O	Blood	nn	2	SENT_960	[p17l897t1415r969b1440],
2	Cancer	NNP	O	Cancer	_	0	SENT_960	[p17l979t1415r1069b1440],
3	5	CD	NUMBER	5	number	4	SENT_960	[p17l1078t1416r1091b1441],
4	7:612	CD	NUMBER	7:612	dep	2	SENT_960	[p17l1095t1416r1221b1441],
5	—	NN	O	—	dep	4	SENT_960	[p17l1095t1416r1221b1441],
6	19	CD	NUMBER	19	num	5	SENT_960	[p17l1095t1416r1221b1441],
7	Treiber	NNP	ORGANIZATION	Treiber	nn	8	SENT_960	[p17l641t1461r751b1487],
8	A	NNP	ORGANIZATION	A	dep	2	SENT_960	[p17l761t1462r790b1493],
9	,	,	O	,	_	0	SENT_960	[p17l761t1462r790b1493],
10	Schneiter	NNP	PERSON	Schneiter	nn	11	SENT_960	[p17l804t1461r937b1487],
11	R	NNP	PERSON	R	appos	8	SENT_960	[p17l948t1462r978b1493],
12	,	,	O	,	_	0	SENT_960	[p17l948t1462r978b1493],
13	Hausler	NNP	PERSON	Hausler	nn	14	SENT_960	[p17l991t1461r1101b1487],
14	S	NNP	O	S	appos	2	SENT_960	[p17l1114t1462r1137b1493],
15	,	,	O	,	_	0	SENT_960	[p17l1114t1462r1137b1493],
16	Stieger	NNP	PERSON	Stieger	nn	17	SENT_960	[p17l1151t1462r1249b1496],
17	B.	NNP	O	B.	appos	2	SENT_960	[p17l1261t1462r1288b1487],
18	2007	CD	DATE	2007	dep	17	SENT_960	[p17l1302t1462r1376b1488],
19	.	.	O	.	_	0	SENT_960	[p17l1302t1462r1376b1488],

1	Bosentan	NNP	O	Bosentan	nsubj	4	SENT_961	[p17l1390t1462r1518b1487],
2	is	VBZ	O	be	cop	4	SENT_961	[p17l1530t1463r1550b1487],
3	a	DT	O	a	det	4	SENT_961	[p17l1563t1471r1576b1487],
4	substrate	NN	O	substrate	_	0	SENT_961	[p17l1588t1461r1711b1487],
5	of	IN	O	of	_	0	SENT_961	[p17l1724t1461r1754b1487],
6	human	JJ	O	human	amod	7	SENT_961	[p17l1762t1461r1859b1487],
7	OATP1B1	NN	O	oatp1b1	prep_of	4	SENT_961	[p17l1871t1462r2018b1487],
8	and	CC	O	and	_	0	SENT_961	[p17l2034t1461r2083b1487],
9	OATP1B3	NN	O	oatp1b3	prep_of	4	SENT_961	[p17l642t1507r800b1533],
10	:	:	O	:	_	0	SENT_961	[p17l642t1507r800b1533],
11	inhibition	NN	O	inhibition	dep	4	SENT_961	[p17l811t1507r950b1533],
12	of	IN	O	of	_	0	SENT_961	[p17l960t1507r991b1533],
13	hepatic	JJ	O	hepatic	amod	14	SENT_961	[p17l996t1507r1097b1541],
14	uptake	NN	O	uptake	prep_of	11	SENT_961	[p17l1107t1507r1199b1541],
15	as	IN	O	as	_	0	SENT_961	[p17l1210t1517r1235b1533],
16	the	DT	O	the	det	18	SENT_961	[p17l1245t1507r1289b1533],
17	common	JJ	O	common	amod	18	SENT_961	[p17l1299t1516r1422b1533],
18	mechanism	NN	O	mechanism	prep_as	14	SENT_961	[p17l1432t1507r1590b1533],
19	of	IN	O	of	_	0	SENT_961	[p17l1600t1507r1631b1533],
20	its	PRP$	O	its	poss	21	SENT_961	[p17l1636t1508r1668b1533],
21	interactions	NNS	O	interaction	prep_of	18	SENT_961	[p17l1678t1508r1842b1533],
22	with	IN	O	with	_	0	SENT_961	[p17l1852t1507r1914b1533],
23	cyclosporin	NN	O	cyclosporin	nn	24	SENT_961	[p17l1924t1507r2084b1541],
24	A	NN	O	a	prep_with	21	SENT_961	[p17l640t1553r670b1583],
25	,	,	O	,	_	0	SENT_961	[p17l640t1553r670b1583],
26	rifampicin	NN	O	rifampicin	prep_with	21	SENT_961	[p17l681t1552r832b1586],
27	,	,	O	,	_	0	SENT_961	[p17l681t1552r832b1586],
28	and	CC	O	and	_	0	SENT_961	[p17l843t1552r893b1578],
29	sildenaﬁl	NN	O	sildenaﬁl	prep_with	21	SENT_961	[p17l903t1552r1034b1578],
30	.	.	O	.	_	0	SENT_961	[p17l903t1552r1034b1578],

1	Drug	NNP	O	Drug	nn	2	SENT_962	[p17l1045t1553r1118b1587],
2	Metnb	NNP	O	Metnb	_	0	SENT_962	[p17l1124t1553r1214b1578],
3	.	.	O	.	_	0	SENT_962	[p17l1124t1553r1214b1578],

1	Dispox	NNP	PERSON	Dispox	_	0	SENT_963	[p17l1226t1553r1314b1586],
2	.	.	O	.	_	0	SENT_963	[p17l1226t1553r1314b1586],

1	35	CD	NUMBER	35	number	2	SENT_964	[p17l1328t1553r1358b1578],
2	:1400	CD	NUMBER	:1400	num	3	SENT_964	[p17l1362t1553r1470b1578],
3	—	NN	O	—	_	0	SENT_964	[p17l1362t1553r1470b1578],
4	7	CD	NUMBER	7	num	6	SENT_964	[p17l1362t1553r1470b1578],
5	Taguchi	NNP	O	Taguchi	nn	6	SENT_964	[p17l641t1598r758b1633],
6	M	NN	O	m	dep	3	SENT_964	[p17l769t1599r809b1630],
7	,	,	O	,	_	0	SENT_964	[p17l769t1599r809b1630],
8	Ichida	NNP	PERSON	Ichida	nn	9	SENT_964	[p17l821t1598r908b1624],
9	F	NN	PERSON	f	appos	6	SENT_964	[p17l920t1599r946b1630],
10	,	,	O	,	_	0	SENT_964	[p17l920t1599r946b1630],
11	Hirono	NNP	PERSON	Hirono	nn	12	SENT_964	[p17l959t1599r1063b1624],
12	K	NNP	PERSON	K	appos	6	SENT_964	[p17l1075t1600r1106b1630],
13	,	,	O	,	_	0	SENT_964	[p17l1075t1600r1106b1630],
14	Miyawaki	NNP	ORGANIZATION	Miyawaki	nn	15	SENT_964	[p17l1118t1598r1254b1633],
15	T	NN	ORGANIZATION	t	appos	6	SENT_964	[p17l1265t1599r1298b1630],
16	,	,	O	,	_	0	SENT_964	[p17l1265t1599r1298b1630],
17	Yoshimura	NNP	PERSON	Yoshimura	nn	18	SENT_964	[p17l1310t1598r1463b1624],
18	N	NNP	O	N	appos	6	SENT_964	[p17l1474t1599r1510b1630],
19	,	,	O	,	_	0	SENT_964	[p17l1474t1599r1510b1630],
20	et	FW	O	et	nn	21	SENT_964	[p17l1523t1606r1549b1624],
21	al.	FW	O	al.	appos	6	SENT_964	[p17l1560t1598r1590b1624],
22	2011	CD	DATE	2011	dep	21	SENT_964	[p17l1604t1600r1678b1624],
23	.	.	O	.	_	0	SENT_964	[p17l1604t1600r1678b1624],

1	Pharmacokinetics	NNS	O	pharmacokinetic	nsubj	8	SENT_965	[p17l1691t1598r1939b1624],
2	of	IN	O	of	_	0	SENT_965	[p17l1951t1598r1982b1624],
3	bosen	NN	O	bosen	nn	5	SENT_965	[p17l1990t1598r2083b1624],
4	—	CD	NUMBER	—	num	5	SENT_965	[p17l1990t1598r2083b1624],
5	tan	NN	O	tan	prep_of	1	SENT_965	[p17l642t1651r685b1670],
6	in	IN	O	in	prep	5	SENT_965	[p17l696t1645r723b1669],
7	routinely	RB	O	routinely	pcomp	6	SENT_965	[p17l733t1644r861b1678],
8	treated	VBN	O	treat	_	0	SENT_965	[p17l871t1644r968b1670],
9	Japanese	JJ	MISC	japanese	amod	11	SENT_965	[p17l976t1645r1099b1678],
10	pediatric	JJ	O	pediatric	amod	11	SENT_965	[p17l1111t1644r1233b1678],
11	patients	NNS	O	patient	dobj	8	SENT_965	[p17l1243t1645r1352b1678],
12	with	IN	O	with	_	0	SENT_965	[p17l1363t1644r1425b1670],
13	pulmonary	JJ	O	pulmonary	amod	15	SENT_965	[p17l1436t1644r1588b1678],
14	arterial	JJ	O	arterial	amod	15	SENT_965	[p17l1599t1644r1697b1670],
15	hypertension	NN	O	hypertension	prep_with	8	SENT_965	[p17l1708t1644r1898b1678],
16	.	.	O	.	_	0	SENT_965	[p17l1708t1644r1898b1678],

1	Drug	NNP	O	Drug	nn	2	SENT_966	[p17l1910t1645r1983b1679],
2	Metnb	NNP	O	Metnb	_	0	SENT_966	[p17l1991t1645r2081b1670],
3	.	.	O	.	_	0	SENT_966	[p17l1991t1645r2081b1670],

1	P/Jnwnncokinet	NN	O	p/jnwnncokinet	_	0	SENT_967	[p17l641t1690r841b1715],
2	.	.	O	.	_	0	SENT_967	[p17l641t1690r841b1715],

1	26:280	CD	NUMBER	26:280	num	5	SENT_968	[p17l854t1691r997b1716],
2	—	CD	NUMBER	—	num	5	SENT_968	[p17l854t1691r997b1716],
3	87	CD	NUMBER	87	num	5	SENT_968	[p17l854t1691r997b1716],
4	Schwarz	NNP	ORGANIZATION	Schwarz	nn	5	SENT_968	[p17l643t1736r758b1762],
5	UI	NNP	ORGANIZATION	UI	_	0	SENT_968	[p17l766t1737r812b1767],
6	,	,	O	,	_	0	SENT_968	[p17l766t1737r812b1767],
7	Meyer	NNP	PERSON	Meyer	nn	9	SENT_968	[p17l820t1737r912b1770],
8	zu	NNP	O	zu	nn	9	SENT_968	[p17l921t1746r952b1762],
9	Schwabedissen	NNP	O	Schwabedissen	appos	5	SENT_968	[p17l961t1736r1167b1762],
10	HE	PRP	O	he	dep	9	SENT_968	[p17l1175t1737r1233b1767],
11	,	,	O	,	_	0	SENT_968	[p17l1175t1737r1233b1767],
12	Tirona	NNP	PERSON	Tirona	nn	13	SENT_968	[p17l1241t1737r1340b1762],
13	RG	NNP	O	RG	appos	5	SENT_968	[p17l1348t1737r1405b1767],
14	,	,	O	,	_	0	SENT_968	[p17l1348t1737r1405b1767],
15	Suzuki	NNP	PERSON	Suzuki	nn	16	SENT_968	[p17l1416t1736r1508b1762],
16	A	NNP	O	A	appos	5	SENT_968	[p17l1515t1737r1545b1767],
17	,	,	O	,	_	0	SENT_968	[p17l1515t1737r1545b1767],
18	Leake	NNP	PERSON	Leake	nn	19	SENT_968	[p17l1554t1736r1637b1762],
19	BF	NNP	O	BF	appos	5	SENT_968	[p17l1646t1737r1694b1767],
20	,	,	O	,	_	0	SENT_968	[p17l1646t1737r1694b1767],
21	et	FW	O	et	nn	22	SENT_968	[p17l1704t1743r1729b1762],
22	al.	FW	O	al.	appos	5	SENT_968	[p17l1737t1736r1766b1762],
23	201	CD	NUMBER	201	number	24	SENT_968	[p17l1776t1738r1823b1762],
24	1	CD	NUMBER	1	dep	22	SENT_968	[p17l1831t1738r1851b1762],
25	.	.	O	.	_	0	SENT_968	[p17l1831t1738r1851b1762],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_969	[p17l1860t1736r2049b1762],
2	of	IN	O	of	_	0	SENT_969	[p17l2057t1736r2087b1762],
3	novel	JJ	O	novel	amod	4	SENT_969	[p17l641t1782r717b1807],
4	functional	JJ	O	functional	amod	7	SENT_969	[p17l724t1782r865b1807],
5	organic	JJ	O	organic	amod	7	SENT_969	[p17l872t1783r976b1816],
6	anion-transporting	JJ	O	anion-transporting	amod	7	SENT_969	[p17l983t1783r1248b1816],
7	polypeptide	NN	O	polypeptide	prep_of	1	SENT_969	[p17l1255t1782r1419b1816],
8	1B3	NN	O	1b3	nn	9	SENT_969	[p17l1429t1783r1478b1808],
9	polymorphisms	NNS	O	polymorphism	dep	1	SENT_969	[p17l1488t1782r1703b1816],
10	and	CC	O	and	_	0	SENT_969	[p17l1711t1782r1760b1807],
11	assessment	NN	O	assessment	conj_and	9	SENT_969	[p17l1768t1789r1919b1807],
12	of	IN	O	of	_	0	SENT_969	[p17l1925t1782r1956b1807],
13	substrate	NN	O	substrate	nn	14	SENT_969	[p17l1959t1782r2083b1807],
14	speciﬁcity	NN	O	speciﬁcity	prep_of	9	SENT_969	[p17l642t1827r787b1862],
15	.	.	O	.	_	0	SENT_969	[p17l642t1827r787b1862],

1	Plmr/nncogenet	NN	O	plmr/nncogenet	_	0	SENT_970	[p17l798t1828r1001b1862],
2	.	.	O	.	_	0	SENT_970	[p17l798t1828r1001b1862],

1	Genomic	JJ	O	genomic	_	0	SENT_971	[p17l1015t1828r1137b1853],
2	:	:	O	:	_	0	SENT_971	[p17l1015t1828r1137b1853],
3	21:103	CD	NUMBER	21:103	num	6	SENT_971	[p17l1145t1829r1290b1853],
4	-14	CD	NUMBER	-14	num	6	SENT_971	[p17l1145t1829r1290b1853],
5	Letschert	NNP	O	Letschert	nn	6	SENT_971	[p17l642t1873r776b1899],
6	K	NNP	O	K	dep	1	SENT_971	[p17l781t1874r812b1904],
7	,	,	O	,	_	0	SENT_971	[p17l781t1874r812b1904],
8	Keppler	NNP	PERSON	Keppler	nn	9	SENT_971	[p17l819t1873r933b1907],
9	D	NNP	O	D	appos	1	SENT_971	[p17l939t1874r972b1904],
10	,	,	O	,	_	0	SENT_971	[p17l939t1874r972b1904],
11	KonigJ	NNP	O	KonigJ	appos	1	SENT_971	[p17l980t1874r1091b1907],
12	.	.	O	.	_	0	SENT_971	[p17l980t1874r1091b1907],

1	2004	CD	DATE	2004	_	0	SENT_972	[p17l1099t1875r1173b1899],
2	.	.	O	.	_	0	SENT_972	[p17l1099t1875r1173b1899],

1	Mutations	NNS	O	mutation	_	0	SENT_973	[p17l1180t1874r1324b1899],
2	in	IN	O	in	_	0	SENT_973	[p17l1330t1874r1357b1899],
3	the	DT	O	the	det	6	SENT_973	[p17l1364t1873r1407b1899],
4	SLCO	NNP	O	SLCO	nn	6	SENT_973	[p17l1414t1874r1505b1899],
5	1B3	NN	O	1b3	nn	6	SENT_973	[p17l1511t1874r1559b1899],
6	gene	NN	O	gene	prep_in	1	SENT_973	[p17l1569t1883r1633b1907],
7	affecting	VBG	O	affect	partmod	1	SENT_973	[p17l1640t1873r1760b1907],
8	the	DT	O	the	det	10	SENT_973	[p17l1765t1873r1808b1899],
9	substrate	NN	O	substrate	nn	10	SENT_973	[p17l1815t1873r1939b1899],
10	speciﬁcity	NN	O	speciﬁcity	dobj	7	SENT_973	[p17l1946t1873r2085b1907],
11	of	IN	O	of	_	0	SENT_973	[p17l642t1918r673b1944],
12	the	DT	O	the	det	15	SENT_973	[p17l679t1918r722b1944],
13	hepatocellular	JJ	O	hepatocellular	amod	15	SENT_973	[p17l732t1918r930b1952],
14	uptake	NN	O	uptake	nn	15	SENT_973	[p17l939t1918r1031b1952],
15	transporter	NN	O	transporter	prep_of	10	SENT_973	[p17l1042t1926r1198b1952],
16	OATPIB3	NN	O	oatpib3	nn	19	SENT_973	[p17l1208t1919r1356b1944],
17	(	CD	NUMBER	(	num	19	SENT_973	[p17l1370t1919r1510b1950],
18	OATP8	NN	O	oatp8	nn	19	SENT_973	[p17l1370t1919r1510b1950],
19	)	NN	O	)	dep	15	SENT_973	[p17l1370t1919r1510b1950],
20	.	.	O	.	_	0	SENT_973	[p17l1370t1919r1510b1950],

1	P/nzmnoogeneticr	NN	O	p/nzmnoogeneticr	nn	3	SENT_974	[p17l1520t1919r1748b1953],
2	14:441	CD	NUMBER	14:441	num	3	SENT_974	[p17l1760t1919r1882b1944],
3	—	NN	O	—	_	0	SENT_974	[p17l1760t1919r1882b1944],
4	5	CD	NUMBER	5	number	5	SENT_974	[p17l1760t1919r1882b1944],
5	2	CD	NUMBER	2	dep	3	SENT_974	[p17l1886t1920r1899b1944],
6	Baker	NNP	ORGANIZATION	Baker	dep	5	SENT_974	[p17l642t1965r722b1990],
7	SD	NN	ORGANIZATION	sd	dep	3	SENT_974	[p17l730t1966r781b1996],
8	,	,	O	,	_	0	SENT_974	[p17l730t1966r781b1996],
9	Verweij	NNP	PERSON	Verweij	nn	10	SENT_974	[p17l788t1966r896b1999],
10	J	NNP	PERSON	J	appos	7	SENT_974	[p17l901t1966r923b1997],
11	,	,	O	,	_	0	SENT_974	[p17l901t1966r923b1997],
12	Cusatis	NNP	O	Cusatis	nn	13	SENT_974	[p17l932t1966r1032b1990],
13	GA	NNP	O	GA	appos	7	SENT_974	[p17l1040t1966r1096b1996],
14	,	,	O	,	_	0	SENT_974	[p17l1040t1966r1096b1996],
15	van	NNP	PERSON	van	nn	17	SENT_974	[p17l1103t1974r1152b1990],
16	Schaik	NNP	PERSON	Schaik	nn	17	SENT_974	[p17l1159t1965r1251b1990],
17	RH	NNP	O	RH	appos	7	SENT_974	[p17l1257t1966r1315b1996],
18	,	,	O	,	_	0	SENT_974	[p17l1257t1966r1315b1996],
19	Marsh	NNP	PERSON	Marsh	nn	20	SENT_974	[p17l1322t1965r1413b1990],
20	S	NNP	O	S	appos	7	SENT_974	[p17l1420t1966r1444b1996],
21	,	,	O	,	_	0	SENT_974	[p17l1420t1966r1444b1996],
22	et	FW	O	et	nn	23	SENT_974	[p17l1453t1972r1478b1990],
23	al.	FW	O	al.	appos	7	SENT_974	[p17l1485t1965r1514b1990],
24	2	CD	NUMBER	2	number	25	SENT_974	[p17l1523t1966r1536b1990],
25	008	CD	NUMBER	008	dep	23	SENT_974	[p17l1541t1966r1598b1990],
26	.	.	O	.	_	0	SENT_974	[p17l1541t1966r1598b1990],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	3	SENT_975	[p17l1606t1965r1849b1999],
2	pathway	NN	O	pathway	nn	3	SENT_975	[p17l1855t1965r1972b1999],
3	analysis	NN	O	analysis	_	0	SENT_975	[p17l1978t1965r2083b1999],
4	of	IN	O	of	_	0	SENT_975	[p17l642t2008r673b2034],
5	docetaxel	NN	O	docetaxel	nn	6	SENT_975	[p17l679t2008r808b2034],
6	elimination	NN	O	elimination	prep_of	3	SENT_975	[p17l819t2008r985b2034],
7	.	.	O	.	_	0	SENT_975	[p17l819t2008r985b2034],

1	Clin	NNP	O	Clin	_	0	SENT_976	[p17l998t2009r1058b2034],
2	.	.	O	.	_	0	SENT_976	[p17l998t2009r1058b2034],

1	Pbnninncol	NN	O	pbnninncol	_	0	SENT_977	[p17l1070t2009r1214b2034],
2	.	.	O	.	_	0	SENT_977	[p17l1070t2009r1214b2034],

1	T/yer	NN	O	t/yer	_	0	SENT_978	[p17l1228t2009r1295b2034],
2	.	.	O	.	_	0	SENT_978	[p17l1228t2009r1295b2034],

1	85	CD	NUMBER	85	number	2	SENT_979	[p17l1309t2009r1339b2034],
2	:15	CD	NUMBER	:15	_	0	SENT_979	[p17l1344t2009r1382b2034],
3	5-63	CD	NUMBER	5-63	num	5	SENT_979	[p17l1387t2009r1450b2034],
4	Smith	NNP	ORGANIZATION	Smith	nn	5	SENT_979	[p17l643t2050r726b2076],
5	NF	NN	ORGANIZATION	nf	dep	2	SENT_979	[p17l738t2051r794b2082],
6	,	,	O	,	_	0	SENT_979	[p17l738t2051r794b2082],
7	Marsh	NNP	PERSON	Marsh	nn	8	SENT_979	[p17l807t2050r898b2076],
8	S	NNP	O	S	appos	2	SENT_979	[p17l912t2051r935b2082],
9	,	,	O	,	_	0	SENT_979	[p17l912t2051r935b2082],
10	Scott	NNP	PERSON	Scott	appos	8	SENT_979	[p17l951t2051r1142b2076],
11	.	.	O	.	_	0	SENT_979	[p17l951t2051r1142b2076],

1	—	NN	O	—	_	0	SENT_980	[p17l951t2051r1142b2076],
2	.	.	O	.	_	0	SENT_980	[p17l951t2051r1142b2076],

1	Horton	NNP	PERSON	Horton	nn	2	SENT_981	[p17l951t2051r1142b2076],
2	TJ	NNP	PERSON	TJ	_	0	SENT_981	[p17l1154t2051r1199b2083],
3	,	,	O	,	_	0	SENT_981	[p17l1154t2051r1199b2083],
4	Hamada	NNP	PERSON	Hamada	nn	5	SENT_981	[p17l1213t2050r1331b2076],
5	A	NNP	O	A	appos	2	SENT_981	[p17l1343t2051r1372b2082],
6	,	,	O	,	_	0	SENT_981	[p17l1343t2051r1372b2082],
7	Mielke	NNP	PERSON	Mielke	nn	8	SENT_981	[p17l1385t2050r1483b2076],
8	S	NNP	O	S	appos	2	SENT_981	[p17l1498t2051r1521b2082],
9	,	,	O	,	_	0	SENT_981	[p17l1498t2051r1521b2082],
10	et	FW	O	et	nn	11	SENT_981	[p17l1536t2058r1562b2076],
11	al.	FW	O	al.	appos	2	SENT_981	[p17l1574t2050r1604b2076],
12	2007	CD	DATE	2007	dep	11	SENT_981	[p17l1619t2051r1693b2077],
13	.	.	O	.	_	0	SENT_981	[p17l1619t2051r1693b2077],

1	Variants	NNS	O	variant	_	0	SENT_982	[p17l1707t2051r1824b2076],
2	in	IN	O	in	_	0	SENT_982	[p17l1838t2052r1865b2076],
3	the	DT	O	the	det	5	SENT_982	[p17l1878t2050r1921b2076],
4	SLCOIB3	NN	O	slcoib3	nn	5	SENT_982	[p17l1936t2051r2080b2077],
5	gene	NN	O	gene	prep_in	1	SENT_982	[p17l642t2102r714b2127],
6	:	:	O	:	_	0	SENT_982	[p17l642t2102r714b2127],
7	interethnic	JJ	O	interethnic	amod	8	SENT_982	[p17l727t2093r881b2119],
8	distribution	NN	O	distribution	dep	1	SENT_982	[p17l894t2093r1057b2119],
9	and	CC	O	and	_	0	SENT_982	[p17l1070t2093r1119b2119],
10	association	NN	O	association	conj_and	8	SENT_982	[p17l1132t2094r1283b2119],
11	with	IN	O	with	_	0	SENT_982	[p17l1294t2093r1356b2119],
12	paclitaxel	NN	O	paclitaxel	nn	13	SENT_982	[p17l1368t2093r1498b2127],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_with	8	SENT_982	[p17l1510t2093r1762b2127],
14	.	.	O	.	_	0	SENT_982	[p17l1510t2093r1762b2127],

1	Clin	NNP	O	Clin	_	0	SENT_983	[p17l1777t2094r1837b2118],
2	.	.	O	.	_	0	SENT_983	[p17l1777t2094r1837b2118],

1	P/Jnrmncol	NN	O	p/jnrmncol	_	0	SENT_984	[p17l1852t2094r1996b2119],
2	.	.	O	.	_	0	SENT_984	[p17l1852t2094r1996b2119],

1	T/yer	NN	O	t/yer	_	0	SENT_985	[p17l2013t2094r2081b2118],
2	.	.	O	.	_	0	SENT_985	[p17l2013t2094r2081b2118],

1	81:76	CD	NUMBER	81:76	_	0	SENT_986	[p17l643t2136r767b2161],
2	-82	CD	NUMBER	-82	num	4	SENT_986	[p17l643t2136r767b2161],
3	Smith	NNP	ORGANIZATION	Smith	nn	4	SENT_986	[p17l643t2177r726b2203],
4	NF	NN	ORGANIZATION	nf	dep	1	SENT_986	[p17l738t2178r794b2208],
5	,	,	O	,	_	0	SENT_986	[p17l738t2178r794b2208],
6	Acharya	NNP	ORGANIZATION	Acharya	nn	7	SENT_986	[p17l806t2177r920b2211],
7	MR	NN	ORGANIZATION	mr	appos	4	SENT_986	[p17l932t2178r995b2208],
8	,	,	O	,	_	0	SENT_986	[p17l932t2178r995b2208],
9	Desai	NNP	PERSON	Desai	nn	10	SENT_986	[p17l1009t2178r1087b2203],
10	N	NNP	O	N	appos	4	SENT_986	[p17l1099t2178r1135b2208],
11	,	,	O	,	_	0	SENT_986	[p17l1099t2178r1135b2208],
12	Figg	NNP	PERSON	Figg	nn	13	SENT_986	[p17l1149t2178r1213b2211],
13	WD	NNP	O	WD	appos	4	SENT_986	[p17l1224t2178r1295b2208],
14	,	,	O	,	_	0	SENT_986	[p17l1224t2178r1295b2208],
15	Sparreboom	NNP	O	Sparreboom	nn	16	SENT_986	[p17l1310t2177r1482b2211],
16	A.	NNP	O	A.	appos	4	SENT_986	[p17l1493t2178r1522b2202],
17	2005	CD	DATE	2005	dep	16	SENT_986	[p17l1537t2178r1612b2203],
18	.	.	O	.	_	0	SENT_986	[p17l1537t2178r1612b2203],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_987	[p17l1626t2177r1814b2203],
2	of	IN	O	of	_	0	SENT_987	[p17l1827t2177r1858b2203],
3	OATP	NN	O	oatp	nn	4	SENT_987	[p17l1868t2177r1962b2203],
4	1B3	NN	O	1b3	prep_of	1	SENT_987	[p17l1967t2178r2015b2203],
5	as	IN	O	as	_	0	SENT_987	[p17l2031t2187r2057b2203],
6	a	DT	O	a	det	9	SENT_987	[p17l2070t2187r2083b2203],
7	high-afﬁnity	JJ	O	high-afﬁnity	amod	9	SENT_987	[p17l641t2219r816b2253],
8	hepatocellular	JJ	O	hepatocellular	amod	9	SENT_987	[p17l824t2219r1022b2253],
9	transporter	NN	O	transporter	prep_as	1	SENT_987	[p17l1031t2226r1188b2253],
10	of	IN	O	of	_	0	SENT_987	[p17l1198t2219r1228b2245],
11	paclitaxel	NN	O	paclitaxel	prep_of	9	SENT_987	[p17l1234t2219r1371b2253],
12	.	.	O	.	_	0	SENT_987	[p17l1234t2219r1371b2253],

1	Cancer	NNP	O	Cancer	nn	2	SENT_988	[p17l1384t2220r1474b2245],
2	Biol	NNP	O	Biol	_	0	SENT_988	[p17l1482t2220r1538b2245],
3	.	.	O	.	_	0	SENT_988	[p17l1482t2220r1538b2245],

1	Then	RB	O	then	advmod	2	SENT_989	[p17l1552t2220r1620b2245],
2	4:815	CD	NUMBER	4:815	_	0	SENT_989	[p17l1632t2220r1739b2245],
3	—	NN	O	—	nn	7	SENT_989	[p17l1632t2220r1739b2245],
4	1	CD	NUMBER	1	num	7	SENT_989	[p17l1632t2220r1739b2245],
5	8	CD	NUMBER	8	num	7	SENT_989	[p17l1745t2221r1759b2245],
6	Kiyotani	NNP	ORGANIZATION	Kiyotani	nn	7	SENT_989	[p17l641t2263r762b2296],
7	K	NNP	ORGANIZATION	K	dep	2	SENT_989	[p17l769t2263r801b2293],
8	,	,	O	,	_	0	SENT_989	[p17l769t2263r801b2293],
9	Mushiroda	NNP	ORGANIZATION	Mushiroda	nn	10	SENT_989	[p17l807t2262r961b2288],
10	T	NN	ORGANIZATION	t	appos	7	SENT_989	[p17l967t2263r1000b2293],
11	,	,	O	,	_	0	SENT_989	[p17l967t2263r1000b2293],
12	Kubo	NNP	PERSON	Kubo	nn	13	SENT_989	[p17l1008t2262r1085b2288],
13	M	NNP	O	M	appos	7	SENT_989	[p17l1091t2263r1131b2293],
14	,	,	O	,	_	0	SENT_989	[p17l1091t2263r1131b2293],
15	Zembutsu	NNP	PERSON	Zembutsu	nn	16	SENT_989	[p17l1139t2262r1281b2288],
16	H	NNP	PERSON	H	appos	7	SENT_989	[p17l1287t2263r1323b2293],
17	,	,	O	,	_	0	SENT_989	[p17l1287t2263r1323b2293],
18	Sugiyama	NNP	PERSON	Sugiyama	nn	19	SENT_989	[p17l1332t2263r1466b2296],
19	Y	NN	PERSON	y	appos	7	SENT_989	[p17l1472t2263r1501b2293],
20	,	,	O	,	_	0	SENT_989	[p17l1472t2263r1501b2293],
21	Nakamura	NNP	PERSON	Nakamura	nn	22	SENT_989	[p17l1509t2262r1656b2288],
22	Y.	NNP	O	Y.	appos	7	SENT_989	[p17l1662t2263r1691b2287],
23	2	CD	NUMBER	2	number	24	SENT_989	[p17l1700t2264r1713b2287],
24	008	CD	NUMBER	008	dep	22	SENT_989	[p17l1718t2264r1775b2288],
25	.	.	O	.	_	0	SENT_989	[p17l1718t2264r1775b2288],

1	Association	NNP	O	Association	_	0	SENT_990	[p17l1782t2263r1942b2288],
2	of	IN	O	of	_	0	SENT_990	[p17l1949t2262r1980b2288],
3	genetic	JJ	O	genetic	amod	4	SENT_990	[p17l1983t2263r2083b2296],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_990	[p17l641t2304r857b2338],
5	in	IN	O	in	_	0	SENT_990	[p17l867t2305r894b2329],
6	SLCOIB3	NN	O	slcoib3	prep_in	1	SENT_990	[p17l905t2305r1049b2330],
7	and	CC	O	and	_	0	SENT_990	[p17l1063t2304r1112b2330],
8	ABCC2	NN	O	abcc2	prep_in	1	SENT_990	[p17l1121t2305r1230b2330],
9	with	IN	O	with	_	0	SENT_990	[p17l1241t2304r1303b2330],
10	docetaxel-induced	JJ	O	docetaxel-induced	amod	11	SENT_990	[p17l1313t2304r1567b2330],
11	leukopenia	NN	O	leukopenia	prep_with	1	SENT_990	[p17l1577t2304r1735b2338],
12	.	.	O	.	_	0	SENT_990	[p17l1577t2304r1735b2338],

1	Cancer	NN	O	cancer	_	0	SENT_991	[p17l1748t2305r1838b2330],
2	Sci	NNP	O	Sci	dep	1	SENT_991	[p17l1846t2305r1889b2330],
3	.	.	O	.	_	0	SENT_991	[p17l1846t2305r1889b2330],

1	99:967	CD	NUMBER	99:967	num	2	SENT_992	[p17l1902t2305r2044b2330],
2	—	CD	NUMBER	—	_	0	SENT_992	[p17l1902t2305r2044b2330],
3	72	CD	NUMBER	72	num	7	SENT_992	[p17l1902t2305r2044b2330],
4	van	NNP	PERSON	van	nn	7	SENT_992	[p17l641t2357r689b2373],
5	de	IN	PERSON	de	amod	7	SENT_992	[p17l702t2347r733b2373],
6	Steeg	NNP	PERSON	Steeg	nn	7	SENT_992	[p17l746t2348r822b2381],
7	E	NNP	PERSON	E	dep	2	SENT_992	[p17l833t2348r862b2378],
8	,	,	O	,	_	0	SENT_992	[p17l833t2348r862b2378],
9	van	NNP	O	van	nn	11	SENT_992	[p17l874t2357r923b2373],
10	Esch	NNP	ORGANIZATION	Esch	nn	11	SENT_992	[p17l934t2347r1002b2373],
11	A	NNP	ORGANIZATION	A	appos	7	SENT_992	[p17l1012t2348r1041b2378],
12	,	,	O	,	_	0	SENT_992	[p17l1012t2348r1041b2378],
13	Wagenaar	NNP	PERSON	Wagenaar	nn	14	SENT_992	[p17l1054t2348r1198b2381],
14	E	NNP	PERSON	E	appos	7	SENT_992	[p17l1210t2348r1239b2378],
15	,	,	O	,	_	0	SENT_992	[p17l1210t2348r1239b2378],
16	van	NNP	PERSON	van	nn	18	SENT_992	[p17l1251t2357r1299b2373],
17	der	FW	PERSON	der	nn	18	SENT_992	[p17l1312t2347r1356b2373],
18	Kruijssen	NNP	PERSON	Kruijssen	appos	7	SENT_992	[p17l1368t2348r1499b2381],
19	CM	NN	O	cm	nn	23	SENT_992	[p17l1511t2348r1574b2378],
20	,	,	O	,	_	0	SENT_992	[p17l1511t2348r1574b2378],
21	van	NN	PERSON	van	dep	23	SENT_992	[p17l1586t2357r1635b2373],
22	Tellingen	NN	PERSON	tellingen	nn	23	SENT_992	[p17l1645t2347r1784b2381],
23	O	NN	PERSON	o	dep	18	SENT_992	[p17l1796t2348r1829b2378],
24	,	,	O	,	_	0	SENT_992	[p17l1796t2348r1829b2378],
25	et	FW	O	et	nn	26	SENT_992	[p17l1843t2354r1869b2373],
26	al.	FW	O	al.	appos	7	SENT_992	[p17l1880t2347r1909b2373],
27	2010	CD	DATE	2010	dep	26	SENT_992	[p17l1923t2349r1998b2373],
28	.	.	O	.	_	0	SENT_992	[p17l1923t2349r1998b2373],

1	High	JJ	O	high	amod	2	SENT_993	[p17l2011t2347r2084b2381],
2	impact	NN	O	impact	_	0	SENT_993	[p17l641t2390r737b2423],
3	of	IN	O	of	_	0	SENT_993	[p17l747t2389r777b2415],
4	Oatp1a	NN	O	oatp1a	prep_of	2	SENT_993	[p17l785t2390r899b2423],
5	/	:	O	/	punct	2	SENT_993	[p17l785t2390r899b2423],
6	lb	NN	O	lb	nn	7	SENT_993	[p17l903t2389r933b2415],
7	transporters	NNS	O	transporter	dep	2	SENT_993	[p17l944t2396r1112b2423],
8	on	IN	O	on	prep	7	SENT_993	[p17l1124t2399r1158b2415],
9	in	IN	O	in	pcomp	8	SENT_993	[p17l1168t2390r1195b2414],
10	Vivo	NNP	O	Vivo	nn	11	SENT_993	[p17l1205t2390r1262b2415],
11	disposition	NN	O	disposition	pobj	9	SENT_993	[p17l1274t2389r1425b2423],
12	of	IN	O	of	_	0	SENT_993	[p17l1436t2389r1466b2415],
13	the	DT	O	the	det	17	SENT_993	[p17l1473t2389r1517b2415],
14	hydrophobic	JJ	O	hydrophobic	amod	17	SENT_993	[p17l1527t2389r1705b2423],
15	anticancer	JJ	O	anticancer	amod	17	SENT_993	[p17l1716t2390r1860b2415],
16	drug	NN	O	drug	nn	17	SENT_993	[p17l1870t2389r1935b2423],
17	paclitaxel	NN	O	paclitaxel	prep_of	7	SENT_993	[p17l1945t2389r2082b2423],
18	.	.	O	.	_	0	SENT_993	[p17l1945t2389r2082b2423],

1	Clin	NNP	O	Clin	_	0	SENT_994	[p17l643t2433r704b2458],
2	.	.	O	.	_	0	SENT_994	[p17l643t2433r704b2458],

1	Cancer	NN	O	cancer	nsubj	2	SENT_995	[p17l718t2433r808b2458],
2	Rex	NN	PERSON	rex	_	0	SENT_995	[p17l815t2433r864b2458],
3	.	.	O	.	_	0	SENT_995	[p17l815t2433r864b2458],

1	17:294	CD	NUMBER	17:294	num	2	SENT_996	[p17l879t2433r1035b2459],
2	—	NN	O	—	_	0	SENT_996	[p17l879t2433r1035b2459],
3	301	CD	NUMBER	301	dep	2	SENT_996	[p17l879t2433r1035b2459],

1	DeGorter	NNP	PERSON	DeGorter	_	0	SENT_997	[p17l565t2534r676b2556],
2	et	FW	O	et	nn	3	SENT_997	[p17l683t2539r703b2556],
3	al.	FW	O	al.	dep	1	SENT_997	[p17l709t2534r735b2556],
4	.	.	O	.	_	0	SENT_997	[p17l709t2534r735b2556],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_998	[p17l443t2574r495b2599],
2	W	NNP	PERSON	W	_	0	SENT_998	[p17l507t2574r550b2604],
3	,	,	O	,	_	0	SENT_998	[p17l507t2574r550b2604],
4	Belkhiri	NNP	O	Belkhiri	nn	5	SENT_998	[p17l563t2573r674b2599],
5	A	NNP	O	A	appos	2	SENT_998	[p17l685t2574r715b2604],
6	,	,	O	,	_	0	SENT_998	[p17l685t2574r715b2604],
7	Lockhart	NNP	ORGANIZATION	Lockhart	nn	8	SENT_998	[p17l728t2573r857b2599],
8	AC	NN	ORGANIZATION	ac	appos	2	SENT_998	[p17l866t2574r921b2604],
9	,	,	O	,	_	0	SENT_998	[p17l866t2574r921b2604],
10	Merchant	NN	O	merchant	nn	11	SENT_998	[p17l933t2573r1072b2599],
11	N	NN	O	n	appos	2	SENT_998	[p17l1082t2574r1118b2604],
12	,	,	O	,	_	0	SENT_998	[p17l1082t2574r1118b2604],
13	Glaeser	NN	PERSON	glaeser	nn	14	SENT_998	[p17l1132t2573r1238b2599],
14	H	NN	PERSON	h	appos	2	SENT_998	[p17l1249t2574r1284b2604],
15	,	,	O	,	_	0	SENT_998	[p17l1249t2574r1284b2604],
16	et	FW	O	et	nn	17	SENT_998	[p17l1298t2580r1323b2599],
17	al.	FW	O	al.	appos	2	SENT_998	[p17l1335t2573r1364b2599],
18	2008	CD	DATE	2008	dep	17	SENT_998	[p17l1378t2575r1452b2599],
19	.	.	O	.	_	0	SENT_998	[p17l1378t2575r1452b2599],

1	Overexpression	NN	O	overexpression	nsubj	4	SENT_999	[p17l1466t2574r1682b2607],
2	of	IN	O	of	_	0	SENT_999	[p17l1694t2573r1725b2599],
3	OATPIB3	NN	O	oatpib3	prep_of	1	SENT_999	[p17l1734t2574r1881b2599],
4	confers	VBZ	O	confer	_	0	SENT_999	[p17l444t2616r544b2642],
5	apoptotic	JJ	O	apoptotic	amod	6	SENT_999	[p17l555t2617r685b2650],
6	resistance	NN	O	resistance	dobj	4	SENT_999	[p17l695t2617r830b2642],
7	in	IN	O	in	_	0	SENT_999	[p17l840t2618r866b2642],
8	colon	NN	O	colon	nn	9	SENT_999	[p17l877t2616r953b2642],
9	cancer	NN	O	cancer	prep_in	6	SENT_999	[p17l963t2626r1060b2642],
10	.	.	O	.	_	0	SENT_999	[p17l963t2626r1060b2642],

1	Cancer	NN	O	cancer	_	0	SENT_1000	[p17l1073t2617r1163b2642],
2	Res	NNP	O	Res	dep	1	SENT_1000	[p17l1170t2617r1218b2642],
3	.	.	O	.	_	0	SENT_1000	[p17l1170t2617r1218b2642],

1	68:10315	CD	NUMBER	68:10315	number	2	SENT_1001	[p17l1231t2617r1407b2642],
2	—	CD	NUMBER	—	_	0	SENT_1001	[p17l1231t2617r1407b2642],
3	23	CD	NUMBER	23	number	4	SENT_1001	[p17l1231t2617r1407b2642],
4	Deleted	JJ	O	deleted	amod	2	SENT_1001	[p17l444t2659r554b2685],
5	in	IN	O	in	_	0	SENT_1001	[p17l564t2661r590b2685],
6	proof	NN	O	proof	nn	7	SENT_1001	[p17l600t2659r680b2693],
7	Mougey	NN	O	mougey	prep_in	2	SENT_1001	[p17l442t2703r560b2736],
8	EB	NNP	O	EB	dep	2	SENT_1001	[p17l571t2703r622b2733],
9	,	,	O	,	_	0	SENT_1001	[p17l571t2703r622b2733],
10	Feng	NNP	O	Feng	nn	11	SENT_1001	[p17l636t2703r707b2736],
11	H	NNP	O	H	appos	8	SENT_1001	[p17l719t2703r755b2733],
12	,	,	O	,	_	0	SENT_1001	[p17l719t2703r755b2733],
13	Castro	NNP	PERSON	Castro	nn	14	SENT_1001	[p17l770t2703r861b2727],
14	M	NNP	O	M	appos	8	SENT_1001	[p17l873t2703r913b2733],
15	,	,	O	,	_	0	SENT_1001	[p17l873t2703r913b2733],
16	Irvin	NNP	PERSON	Irvin	nn	17	SENT_1001	[p17l927t2703r994b2727],
17	CG	NNP	O	CG	appos	8	SENT_1001	[p17l1008t2703r1066b2733],
18	,	,	O	,	_	0	SENT_1001	[p17l1008t2703r1066b2733],
19	Lima	NNP	LOCATION	Lima	appos	8	SENT_1001	[p17l1081t2703r1197b2734],
20	2009	CD	DATE	2009	num	19	SENT_1001	[p17l1212t2704r1287b2728],
21	.	.	O	.	_	0	SENT_1001	[p17l1212t2704r1287b2728],

1	Absorption	NN	O	absorption	nsubj	5	SENT_1002	[p17l1300t2702r1458b2736],
2	of	IN	O	of	_	0	SENT_1002	[p17l1471t2702r1501b2727],
3	montelukast	NN	O	montelukast	prep_of	1	SENT_1002	[p17l1510t2702r1683b2728],
4	is	VBZ	O	be	cop	5	SENT_1002	[p17l1694t2703r1714b2727],
5	transporter	NN	O	transporter	_	0	SENT_1002	[p17l1728t2709r1885b2736],
6	mediated	VBN	O	mediate	partmod	5	SENT_1002	[p17l443t2745r578b2770],
7	:	:	O	:	_	0	SENT_1002	[p17l443t2745r578b2770],
8	A	DT	O	a	det	10	SENT_1002	[p17l590t2746r613b2770],
9	common	JJ	O	common	amod	10	SENT_1002	[p17l623t2754r745b2770],
10	variant	NN	O	variant	nsubjpass	14	SENT_1002	[p17l755t2746r852b2770],
11	of	IN	O	of	_	0	SENT_1002	[p17l863t2745r893b2770],
12	OATP2B1	NN	O	oatp2b1	prep_of	10	SENT_1002	[p17l901t2746r1048b2770],
13	is	VBZ	O	be	auxpass	14	SENT_1002	[p17l1062t2746r1082b2770],
14	associated	VBN	O	associate	parataxis	5	SENT_1002	[p17l1093t2745r1232b2770],
15	with	IN	O	with	_	0	SENT_1002	[p17l1242t2745r1304b2770],
16	reduced	VBN	O	reduce	amod	18	SENT_1002	[p17l1314t2745r1425b2770],
17	plasma	NN	O	plasma	nn	18	SENT_1002	[p17l1435t2745r1531b2778],
18	concentrations	NNS	O	concentration	prep_with	14	SENT_1002	[p17l1542t2746r1747b2770],
19	and	CC	O	and	_	0	SENT_1002	[p17l1759t2745r1808b2770],
20	poor	JJ	O	poor	amod	21	SENT_1002	[p17l1819t2754r1885b2778],
21	response	NN	O	response	conj_and	18	SENT_1002	[p17l443t2797r572b2821],
22	.	.	O	.	_	0	SENT_1002	[p17l443t2797r572b2821],

1	P/mwnneogenet	NN	O	p/mwnneogenet	_	0	SENT_1003	[p17l582t2788r785b2822],
2	.	.	O	.	_	0	SENT_1003	[p17l582t2788r785b2822],

1	Genomic	JJ	O	genomic	_	0	SENT_1004	[p17l799t2788r921b2813],
2	:	:	O	:	_	0	SENT_1004	[p17l799t2788r921b2813],
3	19:129	CD	NUMBER	19:129	number	4	SENT_1004	[p17l932t2789r1073b2813],
4	—	CD	NUMBER	—	dep	1	SENT_1004	[p17l932t2789r1073b2813],
5	38	CD	NUMBER	38	num	7	SENT_1004	[p17l932t2789r1073b2813],
6	Tapaninen	NN	ORGANIZATION	tapaninen	nn	7	SENT_1004	[p17l442t2831r596b2864],
7	T	NN	ORGANIZATION	t	dep	4	SENT_1004	[p17l603t2831r636b2861],
8	,	,	O	,	_	0	SENT_1004	[p17l603t2831r636b2861],
9	Neuvonen	NNP	ORGANIZATION	Neuvonen	nn	10	SENT_1004	[p17l646t2831r793b2856],
10	PJ	NNP	ORGANIZATION	PJ	appos	1	SENT_1004	[p17l801t2831r841b2862],
11	,	,	O	,	_	0	SENT_1004	[p17l801t2831r841b2862],
12	Niemi	NNP	PERSON	Niemi	nn	13	SENT_1004	[p17l850t2831r940b2856],
13	M.	NNP	O	M.	appos	1	SENT_1004	[p17l947t2831r987b2856],
14	2010	CD	DATE	2010	dep	13	SENT_1004	[p17l997t2832r1072b2856],
15	.	.	O	.	_	0	SENT_1004	[p17l997t2832r1072b2856],

1	Orange	NNP	O	Orange	nsubj	6	SENT_1005	[p17l1083t2831r1187b2864],
2	and	CC	O	and	_	0	SENT_1005	[p17l1196t2830r1246b2856],
3	apple	NN	O	apple	nn	4	SENT_1005	[p17l1255t2830r1328b2864],
4	juice	NN	O	juice	nsubj	6	SENT_1005	[p17l1336t2831r1401b2864],
5	greatly	RB	O	greatly	advmod	6	SENT_1005	[p17l1411t2830r1507b2864],
6	reduce	VB	O	reduce	_	0	SENT_1005	[p17l1515t2830r1607b2856],
7	the	DT	O	the	det	9	SENT_1005	[p17l1617t2830r1660b2856],
8	plasma	NN	O	plasma	nn	9	SENT_1005	[p17l1669t2830r1764b2864],
9	concentrations	NNS	O	concentration	dobj	6	SENT_1005	[p17l1773t2840r1884b2856, p17l444t2874r549b2899],
10	of	IN	O	of	_	0	SENT_1005	[p17l560t2873r590b2899],
11	the	DT	O	the	det	14	SENT_1005	[p17l597t2873r640b2899],
12	OATP2B1	NN	O	oatp2b1	nn	14	SENT_1005	[p17l651t2874r798b2899],
13	substrate	NN	O	substrate	nn	14	SENT_1005	[p17l811t2873r935b2899],
14	aliskiren	NN	O	aliskiren	prep_of	9	SENT_1005	[p17l945t2873r1069b2899],
15	.	.	O	.	_	0	SENT_1005	[p17l945t2873r1069b2899],

1	Br	NN	O	br	_	0	SENT_1006	[p17l1080t2874r1119b2899],
2	.	.	O	.	_	0	SENT_1006	[p17l1080t2874r1119b2899],

1	K	NNP	O	K	_	0	SENT_1007	[p17l1127t2874r1152b2907],
2	}	CD	NUMBER	}	num	1	SENT_1007	[p17l1127t2874r1152b2907],
3	:	:	O	:	_	0	SENT_1007	[p17l1127t2874r1152b2907],
4	R	NN	O	r	dep	1	SENT_1007	[p17l1127t2874r1152b2907],
5	+	CC	O	+	_	0	SENT_1007	[p17l1127t2874r1152b2907],
6	Clin	NN	O	clin	dep	1	SENT_1007	[p17l1166t2874r1226b2899],
7	.	.	O	.	_	0	SENT_1007	[p17l1166t2874r1226b2899],

1	Plmwnncol	NNP	O	Plmwnncol	_	0	SENT_1008	[p17l1238t2874r1382b2899],
2	.	.	O	.	_	0	SENT_1008	[p17l1238t2874r1382b2899],

1	71:718	CD	NUMBER	71:718	num	2	SENT_1009	[p17l1396t2874r1539b2899],
2	—	CD	NUMBER	—	_	0	SENT_1009	[p17l1396t2874r1539b2899],
3	26	CD	NUMBER	26	num	5	SENT_1009	[p17l1396t2874r1539b2899],
4	Tapaninen	NN	ORGANIZATION	tapaninen	nn	5	SENT_1009	[p17l442t2917r595b2950],
5	T	NN	ORGANIZATION	t	dep	2	SENT_1009	[p17l602t2917r635b2947],
6	,	,	O	,	_	0	SENT_1009	[p17l602t2917r635b2947],
7	Neuvonen	NNP	ORGANIZATION	Neuvonen	nn	11	SENT_1009	[p17l644t2917r791b2941],
8	PJ	NNP	ORGANIZATION	PJ	nn	11	SENT_1009	[p17l799t2917r838b2948],
9	,	,	O	,	_	0	SENT_1009	[p17l799t2917r838b2948],
10	Niemi	NNP	PERSON	Niemi	appos	11	SENT_1009	[p17l847t2917r937b2941],
11	M.	NNP	O	M.	appos	5	SENT_1009	[p17l944t2917r983b2941],
12	2010	CD	DATE	2010	num	11	SENT_1009	[p17l993t2918r1067b2941],
13	.	.	O	.	_	0	SENT_1009	[p17l993t2918r1067b2941],

1	Grapefruit	NN	O	grapefruit	nn	2	SENT_1010	[p17l1078t2916r1227b2950],
2	juice	NN	O	juice	nsubj	4	SENT_1010	[p17l1233t2917r1298b2950],
3	greatly	RB	O	greatly	advmod	4	SENT_1010	[p17l1307t2916r1403b2950],
4	reduces	VBZ	O	reduce	_	0	SENT_1010	[p17l1410t2916r1514b2941],
5	the	DT	O	the	det	7	SENT_1010	[p17l1523t2916r1566b2941],
6	plasma	NN	O	plasma	nn	7	SENT_1010	[p17l1575t2916r1670b2950],
7	concentrations	NNS	O	concentration	dobj	4	SENT_1010	[p17l1679t2917r1884b2941],
8	of	IN	O	of	_	0	SENT_1010	[p17l444t2958r474b2983],
9	the	DT	O	the	det	10	SENT_1010	[p17l480t2958r524b2983],
10	OATPZBI	NN	O	oatpzbus	prep_of	7	SENT_1010	[p17l535t2959r682b2983],
11	and	CC	O	and	_	0	SENT_1010	[p17l695t2958r745b2983],
12	CYP3A4	NN	O	cyp3a4	nn	14	SENT_1010	[p17l755t2959r879b2983],
13	substrate	NN	O	substrate	nn	14	SENT_1010	[p17l888t2958r1012b2983],
14	aliskiren	NN	O	aliskiren	prep_of	7	SENT_1010	[p17l1022t2958r1146b2983],
15	.	.	O	.	_	0	SENT_1010	[p17l1022t2958r1146b2983],

1	Clin	NNP	O	Clin	_	0	SENT_1011	[p17l1159t2959r1219b2983],
2	.	.	O	.	_	0	SENT_1011	[p17l1159t2959r1219b2983],

1	P/ynwnnrol	NN	O	p/ynwnnrol	_	0	SENT_1012	[p17l1231t2959r1375b2983],
2	.	.	O	.	_	0	SENT_1012	[p17l1231t2959r1375b2983],

1	T/yer	NN	O	t/yer	_	0	SENT_1013	[p17l1389t2959r1456b2983],
2	.	.	O	.	_	0	SENT_1013	[p17l1389t2959r1456b2983],

1	882339-42	CD	NUMBER	882339-42	num	3	SENT_1014	[p17l1470t2959r1611b2983],
2	Mougey	NN	O	mougey	nn	3	SENT_1014	[p17l442t3001r560b3034],
3	EB	NNP	O	EB	_	0	SENT_1014	[p17l571t3001r622b3031],
4	,	,	O	,	_	0	SENT_1014	[p17l571t3001r622b3031],
5	Lang	NNP	PERSON	Lang	nn	6	SENT_1014	[p17l636t3001r709b3034],
6	JE	NNP	O	JE	appos	3	SENT_1014	[p17l717t3001r762b3032],
7	,	,	O	,	_	0	SENT_1014	[p17l717t3001r762b3032],
8	Wen	NNP	O	Wen	nn	9	SENT_1014	[p17l776t3001r846b3026],
9	X	NNP	O	X	appos	3	SENT_1014	[p17l858t3001r889b3031],
10	,	,	O	,	_	0	SENT_1014	[p17l858t3001r889b3031],
11	Lima	NNP	LOCATION	Lima	nn	12	SENT_1014	[p17l903t3001r976b3026],
12	JJ	NN	O	jj	appos	3	SENT_1014	[p17l985t3001r1020b3032],
13	.	.	O	.	_	0	SENT_1014	[p17l985t3001r1020b3032],

1	2010	CD	DATE	2010	_	0	SENT_1015	[p17l1035t3001r1109b3025],
2	.	.	O	.	_	0	SENT_1015	[p17l1035t3001r1109b3025],

1	Effect	NN	O	effect	_	0	SENT_1016	[p17l1124t3000r1207b3026],
2	of	IN	O	of	_	0	SENT_1016	[p17l1219t3000r1250b3026],
3	citrus	NN	O	citrus	nn	4	SENT_1016	[p17l1259t3001r1335b3026],
4	juice	NN	O	juice	prep_of	1	SENT_1016	[p17l1348t3001r1413b3034],
5	and	CC	O	and	_	0	SENT_1016	[p17l1427t3000r1476b3026],
6	SLCOZB1	NN	O	slcozb1	nn	7	SENT_1016	[p17l1491t3001r1635b3026],
7	genotype	NN	O	genotype	prep_of	1	SENT_1016	[p17l1652t3007r1779b3034],
8	on	IN	O	on	_	0	SENT_1016	[p17l1793t3010r1828b3026],
9	the	DT	O	the	det	10	SENT_1016	[p17l1841t3000r1884b3026],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	4	SENT_1016	[p17l443t3043r688b3077],
11	of	IN	O	of	_	0	SENT_1016	[p17l698t3043r729b3069],
12	montelukast	NN	O	montelukast	prep_of	1	SENT_1016	[p17l735t3043r913b3069],
13	.	.	O	.	_	0	SENT_1016	[p17l735t3043r913b3069],

1	ѥ	NN	O	ѥ	_	0	SENT_1017	[p17l920t3043r945b3077],
2	:	:	O	:	_	0	SENT_1017	[p17l920t3043r945b3077],
3	R	NN	O	r	dep	1	SENT_1017	[p17l920t3043r945b3077],
4	+	CC	O	+	_	0	SENT_1017	[p17l920t3043r945b3077],
5	Clin	NN	O	clin	dep	1	SENT_1017	[p17l959t3044r1019b3069],
6	.	.	O	.	_	0	SENT_1017	[p17l959t3044r1019b3069],

1	P/Jnrmncol	NN	O	p/jnrmncol	_	0	SENT_1018	[p17l1031t3044r1175b3069],
2	.	.	O	.	_	0	SENT_1018	[p17l1031t3044r1175b3069],

1	51:751	CD	NUMBER	51:751	num	2	SENT_1019	[p17l1189t3044r1331b3069],
2	—	CD	NUMBER	—	_	0	SENT_1019	[p17l1189t3044r1331b3069],
3	60	CD	NUMBER	60	num	5	SENT_1019	[p17l1189t3044r1331b3069],
4	Zaher	NN	PERSON	zaher	nn	5	SENT_1019	[p17l443t3085r527b3111],
5	H	NN	PERSON	h	dep	2	SENT_1019	[p17l534t3086r569b3116],
6	,	,	O	,	_	0	SENT_1019	[p17l534t3086r569b3116],
7	Meyer	NNP	PERSON	Meyer	nn	9	SENT_1019	[p17l576t3086r668b3119],
8	zu	NNP	O	zu	nn	9	SENT_1019	[p17l676t3095r707b3111],
9	Schwabedissen	NNP	O	Schwabedissen	appos	5	SENT_1019	[p17l715t3085r921b3111],
10	HE	PRP	O	he	dep	2	SENT_1019	[p17l928t3086r986b3116],
11	,	,	O	,	_	0	SENT_1019	[p17l928t3086r986b3116],
12	Tirona	NNP	PERSON	Tirona	nn	13	SENT_1019	[p17l994t3086r1093b3111],
13	RG	NNP	O	RG	appos	10	SENT_1019	[p17l1100t3086r1157b3116],
14	,	,	O	,	_	0	SENT_1019	[p17l1100t3086r1157b3116],
15	Cox	NNP	ORGANIZATION	Cox	nn	16	SENT_1019	[p17l1166t3086r1223b3111],
16	ML	NNP	ORGANIZATION	ML	appos	10	SENT_1019	[p17l1228t3086r1290b3116],
17	,	,	O	,	_	0	SENT_1019	[p17l1228t3086r1290b3116],
18	Obert	NNP	ORGANIZATION	Obert	nn	19	SENT_1019	[p17l1300t3085r1384b3111],
19	LA	NNP	ORGANIZATION	LA	appos	10	SENT_1019	[p17l1390t3086r1441b3116],
20	,	,	O	,	_	0	SENT_1019	[p17l1390t3086r1441b3116],
21	et	FW	O	et	nn	22	SENT_1019	[p17l1450t3092r1476b3111],
22	al.	FW	O	al.	appos	10	SENT_1019	[p17l1482t3085r1512b3111],
23	2008	CD	DATE	2008	dep	22	SENT_1019	[p17l1521t3087r1596b3111],
24	.	.	O	.	_	0	SENT_1019	[p17l1521t3087r1596b3111],

1	Targeted	VBN	O	target	dep	13	SENT_1020	[p17l1604t3085r1733b3119],
2	disruption	NN	O	disruption	dobj	1	SENT_1020	[p17l1742t3085r1884b3119],
3	of	IN	O	of	_	0	SENT_1020	[p17l444t3130r474b3156],
4	murine	JJ	O	murine	amod	8	SENT_1020	[p17l480t3132r581b3156],
5	organic	JJ	O	organic	amod	8	SENT_1020	[p17l591t3132r695b3164],
6	anion-transporting	JJ	O	anion-transporting	amod	8	SENT_1020	[p17l705t3131r970b3164],
7	polypeptide	NN	O	polypeptide	nn	8	SENT_1020	[p17l979t3130r1143b3164],
8	1b2	NN	O	1b2	prep_of	2	SENT_1020	[p17l1157t3130r1202b3156],
9	(	CD	NUMBER	(	num	12	SENT_1020	[p17l1215t3130r1459b3164],
10	oatp1b2/Sleo1l72	NN	O	oatp1b2/sleo1l72	nn	12	SENT_1020	[p17l1215t3130r1459b3164],
11	)	NN	O	)	nn	12	SENT_1020	[p17l1215t3130r1459b3164],
12	signiﬁcantly	NN	O	signiﬁcantly	nsubj	13	SENT_1020	[p17l1470t3130r1639b3164],
13	alters	VBZ	O	alter	_	0	SENT_1020	[p17l1648t3130r1722b3156],
14	disposition	NN	O	disposition	dobj	13	SENT_1020	[p17l1733t3130r1884b3164],
15	of	IN	O	of	_	0	SENT_1020	[p17l444t3187r474b3212],
16	prototypical	JJ	O	prototypical	amod	19	SENT_1020	[p17l480t3187r649b3221],
17	drug	NN	O	drug	nn	19	SENT_1020	[p17l660t3187r725b3221],
18	substrates	NNS	O	substrate	nn	19	SENT_1020	[p17l734t3187r870b3212],
19	pravastatin	NN	O	pravastatin	prep_of	14	SENT_1020	[p17l880t3188r1031b3220],
20	and	CC	O	and	_	0	SENT_1020	[p17l1041t3187r1090b3212],
21	rifampin	NN	O	rifampin	prep_of	14	SENT_1020	[p17l1100t3187r1227b3220],
22	.	.	O	.	_	0	SENT_1020	[p17l1100t3187r1227b3220],

1	Mol	NNP	O	Mol	_	0	SENT_1021	[p17l1236t3188r1296b3212],
2	.	.	O	.	_	0	SENT_1021	[p17l1236t3188r1296b3212],

1	Plynwnncol	NN	O	plynwnncol	_	0	SENT_1022	[p17l1308t3188r1451b3212],
2	.	.	O	.	_	0	SENT_1022	[p17l1308t3188r1451b3212],

1	74:320	CD	NUMBER	74:320	num	4	SENT_1023	[p17l1465t3188r1608b3213],
2	-29	CD	NUMBER	-29	num	4	SENT_1023	[p17l1465t3188r1608b3213],
3	Chen	NNP	O	Chen	nn	4	SENT_1023	[p17l444t3229r520b3255],
4	C	NNP	O	C	_	0	SENT_1023	[p17l529t3230r559b3261],
5	,	,	O	,	_	0	SENT_1023	[p17l529t3230r559b3261],
6	StockJL	NNP	O	StockJL	appos	4	SENT_1023	[p17l570t3229r696b3261],
7	,	,	O	,	_	0	SENT_1023	[p17l570t3229r696b3261],
8	Liu	NNP	PERSON	Liu	nn	9	SENT_1023	[p17l706t3230r755b3255],
9	X	NNP	O	X	appos	4	SENT_1023	[p17l762t3230r793b3261],
10	,	,	O	,	_	0	SENT_1023	[p17l762t3230r793b3261],
11	ShiJ	NN	O	shij	appos	4	SENT_1023	[p17l803t3229r874b3261],
12	,	,	O	,	_	0	SENT_1023	[p17l803t3229r874b3261],
13	Van	NNP	PERSON	Van	nn	14	SENT_1023	[p17l882t3231r940b3255],
14	DeusenJW	NNP	PERSON	DeusenJW	appos	4	SENT_1023	[p17l949t3230r1117b3261],
15	,	,	O	,	_	0	SENT_1023	[p17l949t3230r1117b3261],
16	et	FW	O	et	nn	17	SENT_1023	[p17l1127t3237r1153b3255],
17	al.	FW	O	al.	appos	4	SENT_1023	[p17l1161t3229r1190b3255],
18	2008	CD	DATE	2008	dep	17	SENT_1023	[p17l1200t3231r1275b3255],
19	.	.	O	.	_	0	SENT_1023	[p17l1200t3231r1275b3255],

1	Utility	NN	O	utility	_	0	SENT_1024	[p17l1284t3229r1378b3264],
2	of	IN	O	of	_	0	SENT_1024	[p17l1386t3229r1416b3255],
3	a	DT	O	a	det	8	SENT_1024	[p17l1421t3239r1434b3255],
4	novel	JJ	O	novel	amod	8	SENT_1024	[p17l1442t3229r1517b3255],
5	Oatp1b2	NN	O	oatp1b2	nn	8	SENT_1024	[p17l1527t3229r1646b3263],
6	knockout	NN	O	knockout	nn	8	SENT_1024	[p17l1656t3229r1787b3255],
7	mouse	NN	O	mouse	nn	8	SENT_1024	[p17l1794t3239r1884b3255],
8	model	NN	O	model	prep_of	1	SENT_1024	[p17l443t3275r530b3301],
9	for	IN	O	for	_	0	SENT_1024	[p17l538t3275r579b3301],
10	evaluating	VBG	O	evaluate	prepc_for	8	SENT_1024	[p17l587t3275r729b3309],
11	the	DT	O	the	det	12	SENT_1024	[p17l736t3275r779b3301],
12	role	NN	O	role	dobj	10	SENT_1024	[p17l787t3275r841b3301],
13	of	IN	O	of	_	0	SENT_1024	[p17l850t3275r881b3301],
14	Oatp1b2	NN	O	oatp1b2	prep_of	12	SENT_1024	[p17l885t3275r1004b3309],
15	in	IN	O	in	_	0	SENT_1024	[p17l1014t3276r1042b3300],
16	the	DT	O	the	det	18	SENT_1024	[p17l1049t3275r1093b3301],
17	hepatic	JJ	O	hepatic	amod	18	SENT_1024	[p17l1101t3275r1201b3309],
18	uptake	NN	O	uptake	prep_in	10	SENT_1024	[p17l1209t3275r1301b3309],
19	of	IN	O	of	_	0	SENT_1024	[p17l1310t3275r1340b3301],
20	model	NN	O	model	nn	21	SENT_1024	[p17l1344t3275r1431b3301],
21	compounds	NNS	O	compound	prep_of	18	SENT_1024	[p17l1439t3275r1607b3309],
22	.	.	O	.	_	0	SENT_1024	[p17l1439t3275r1607b3309],

1	Drug	NNP	O	Drug	nn	2	SENT_1025	[p17l1616t3276r1689b3310],
2	Metnb	NNP	O	Metnb	_	0	SENT_1025	[p17l1694t3276r1784b3301],
3	.	.	O	.	_	0	SENT_1025	[p17l1694t3276r1784b3301],

1	Dispos	NNP	O	Dispos	_	0	SENT_1026	[p17l1794t3276r1882b3309],
2	.	.	O	.	_	0	SENT_1026	[p17l1794t3276r1882b3309],

1	36:1840	CD	NUMBER	36:1840	num	2	SENT_1027	[p17l445t3322r603b3346],
2	—	CD	NUMBER	—	_	0	SENT_1027	[p17l445t3322r603b3346],
3	45	CD	NUMBER	45	num	5	SENT_1027	[p17l445t3322r603b3346],
4	Lu	NN	PERSON	lu	nn	5	SENT_1027	[p17l443t3366r483b3390],
5	H	NN	PERSON	h	dep	2	SENT_1027	[p17l489t3366r524b3396],
6	,	,	O	,	_	0	SENT_1027	[p17l489t3366r524b3396],
7	Choudhuri	NNP	PERSON	Choudhuri	nn	8	SENT_1027	[p17l533t3364r686b3390],
8	S	NNP	PERSON	S	appos	5	SENT_1027	[p17l694t3365r717b3396],
9	,	,	O	,	_	0	SENT_1027	[p17l694t3365r717b3396],
10	Ogura	NNP	PERSON	Ogura	nn	11	SENT_1027	[p17l726t3365r814b3399],
11	K	NNP	PERSON	K	appos	5	SENT_1027	[p17l820t3366r852b3396],
12	,	,	O	,	_	0	SENT_1027	[p17l820t3366r852b3396],
13	Csanaky	NNP	ORGANIZATION	Csanaky	nn	14	SENT_1027	[p17l860t3364r978b3399],
14	IL	NN	ORGANIZATION	il	appos	5	SENT_1027	[p17l983t3366r1024b3396],
15	,	,	O	,	_	0	SENT_1027	[p17l983t3366r1024b3396],
16	Lei	NN	O	lei	nn	17	SENT_1027	[p17l1032t3366r1078b3390],
17	X	NN	O	x	appos	5	SENT_1027	[p17l1084t3366r1114b3396],
18	,	,	O	,	_	0	SENT_1027	[p17l1084t3366r1114b3396],
19	et	FW	O	et	nn	20	SENT_1027	[p17l1123t3372r1148b3390],
20	al.	FW	O	al.	appos	5	SENT_1027	[p17l1154t3364r1184b3390],
21	2008	CD	DATE	2008	dep	20	SENT_1027	[p17l1192t3366r1267b3390],
22	.	.	O	.	_	0	SENT_1027	[p17l1192t3366r1267b3390],

1	Characterization	NN	O	characterization	nsubj	5	SENT_1028	[p17l1275t3364r1509b3390],
2	of	IN	O	of	_	0	SENT_1028	[p17l1515t3364r1546b3390],
3	organic	JJ	O	organic	amod	4	SENT_1028	[p17l1549t3366r1653b3399],
4	anion	NN	O	anion	prep_of	1	SENT_1028	[p17l1659t3366r1737b3390],
5	transporting	VBG	O	transport	_	0	SENT_1028	[p17l1743t3372r1883b3398, p17l443t3411r488b3444],
6	polypeptide	NN	O	polypeptide	dobj	5	SENT_1028	[p17l494t3410r658b3444],
7	1b2	SYM	O	1b2	dep	5	SENT_1028	[p17l669t3410r714b3436],
8	-	:	O	-	_	0	SENT_1028	[p17l718t3410r784b3436],
9	null	JJ	O	null	dep	5	SENT_1028	[p17l718t3410r784b3436],
10	mice	NNS	O	mouse	dep	9	SENT_1028	[p17l791t3411r864b3436],
11	:	:	O	:	_	0	SENT_1028	[p17l791t3411r864b3436],
12	essential	JJ	O	essential	amod	13	SENT_1028	[p17l873t3410r990b3436],
13	role	NN	O	role	dep	9	SENT_1028	[p17l997t3410r1051b3436],
14	in	IN	O	in	_	0	SENT_1028	[p17l1058t3411r1085b3435],
15	hepatic	JJ	O	hepatic	amod	16	SENT_1028	[p17l1091t3410r1192b3444],
16	uptake	NN	O	uptake	prep_in	13	SENT_1028	[p17l1198t3410r1304b3444],
17	/	:	O	/	punct	9	SENT_1028	[p17l1198t3410r1304b3444],
18	toxicity	NN	O	toxicity	dep	9	SENT_1028	[p17l1305t3411r1409b3444],
19	of	IN	O	of	dep	18	SENT_1028	[p17l1415t3410r1445b3436],
20	phalloidin	NN	O	phalloidin	pobj	19	SENT_1028	[p17l1448t3410r1590b3444],
21	and	CC	O	and	_	0	SENT_1028	[p17l1597t3410r1646b3436],
22	microcystin-LR	NN	O	microcystin-lr	pobj	19	SENT_1028	[p17l1653t3411r1883b3444],
23	.	.	O	.	_	0	SENT_1028	[p17l1653t3411r1883b3444],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1029	[p17l445t3456r540b3481],
2	.	.	O	.	_	0	SENT_1029	[p17l445t3456r540b3481],

1	Sci	NNP	O	Sci	_	0	SENT_1030	[p17l553t3456r596b3481],
2	.	.	O	.	_	0	SENT_1030	[p17l553t3456r596b3481],

1	103	CD	NUMBER	103	num	3	SENT_1031	[p17l611t3457r656b3481],
2	:35	CD	NUMBER	:35	num	3	SENT_1031	[p17l662t3457r751b3481],
3	—	NN	O	—	_	0	SENT_1031	[p17l662t3457r751b3481],
4	45	CD	NUMBER	45	num	8	SENT_1031	[p17l662t3457r751b3481],
5	van	NNP	O	van	nn	8	SENT_1031	[p17l442t3509r491b3525],
6	de	IN	PERSON	de	amod	8	SENT_1031	[p17l501t3499r532b3525],
7	Steeg	NNP	PERSON	Steeg	nn	8	SENT_1031	[p17l544t3500r620b3533],
8	E	NNP	PERSON	E	dep	3	SENT_1031	[p17l629t3500r658b3530],
9	,	,	O	,	_	0	SENT_1031	[p17l629t3500r658b3530],
10	Wagenaar	NNP	PERSON	Wagenaar	nn	11	SENT_1031	[p17l668t3500r813b3533],
11	E	NNP	PERSON	E	appos	8	SENT_1031	[p17l822t3500r851b3530],
12	,	,	O	,	_	0	SENT_1031	[p17l822t3500r851b3530],
13	van	NNP	PERSON	van	nn	15	SENT_1031	[p17l861t3509r910b3525],
14	der	FW	PERSON	der	nn	15	SENT_1031	[p17l920t3499r965b3525],
15	Kruijssen	NNP	PERSON	Kruijssen	appos	8	SENT_1031	[p17l974t3500r1105b3533],
16	CM	NN	O	cm	dep	3	SENT_1031	[p17l1116t3500r1178b3530],
17	,	,	O	,	_	0	SENT_1031	[p17l1116t3500r1178b3530],
18	BurggraaffJE	NN	O	burggraaffje	appos	16	SENT_1031	[p17l1190t3499r1388b3533],
19	,	,	O	,	_	0	SENT_1031	[p17l1190t3499r1388b3533],
20	de	FW	O	de	nn	22	SENT_1031	[p17l1400t3499r1431b3525],
21	Waart	FW	O	waart	nn	22	SENT_1031	[p17l1440t3500r1531b3525],
22	DR	NN	O	dr	appos	3	SENT_1031	[p17l1540t3500r1597b3530],
23	,	,	O	,	_	0	SENT_1031	[p17l1540t3500r1597b3530],
24	et	FW	O	et	nn	25	SENT_1031	[p17l1608t3506r1634b3525],
25	al.	FW	O	al.	appos	3	SENT_1031	[p17l1643t3499r1673b3525],
26	2010	CD	DATE	2010	dep	25	SENT_1031	[p17l1684t3501r1759b3525],
27	.	.	O	.	_	0	SENT_1031	[p17l1684t3501r1759b3525],

1	Organic	NNP	O	Organic	nn	2	SENT_1032	[p17l1771t3500r1884b3533],
2	anion	NN	O	anion	nsubj	3	SENT_1032	[p17l444t3546r521b3570],
3	transporting	VBG	O	transport	dep	9	SENT_1032	[p17l529t3546r703b3579],
4	polypeptide	NN	O	polypeptide	nn	5	SENT_1032	[p17l710t3545r874b3579],
5	la/1b	NN	O	la/1b	dobj	3	SENT_1032	[p17l886t3545r1106b3570],
6	—	CD	NUMBER	—	num	8	SENT_1032	[p17l886t3545r1106b3570],
7	knockout	NN	O	knockout	nn	8	SENT_1032	[p17l886t3545r1106b3570],
8	mice	NNS	O	mouse	nsubj	9	SENT_1032	[p17l1113t3546r1179b3570],
9	provide	VBP	O	provide	_	0	SENT_1032	[p17l1187t3545r1292b3579],
10	insights	NNS	O	insight	dobj	9	SENT_1032	[p17l1300t3545r1407b3579],
11	into	IN	O	into	_	0	SENT_1032	[p17l1416t3546r1471b3570],
12	hepatic	JJ	O	hepatic	amod	13	SENT_1032	[p17l1480t3545r1580b3579],
13	handling	NN	O	handling	prep_into	9	SENT_1032	[p17l1588t3545r1712b3579],
14	of	IN	O	of	_	0	SENT_1032	[p17l1720t3545r1750b3570],
15	bilirubin	NN	O	bilirubin	prep_of	13	SENT_1032	[p17l1755t3545r1883b3576],
16	,	,	O	,	_	0	SENT_1032	[p17l1755t3545r1883b3576],
17	bile	NN	O	bile	nn	18	SENT_1032	[p17l443t3590r494b3616],
18	acids	NNS	O	acid	prep_of	13	SENT_1032	[p17l504t3590r579b3622],
19	,	,	O	,	_	0	SENT_1032	[p17l504t3590r579b3622],
20	and	CC	O	and	_	0	SENT_1032	[p17l590t3590r639b3616],
21	drugs	NNS	O	drug	prep_of	13	SENT_1032	[p17l650t3590r765b3625],
22	.	.	O	.	_	0	SENT_1032	[p17l650t3590r765b3625],

1	Clin	NNP	O	Clin	_	0	SENT_1033	[p17l779t3591r840b3616],
2	.	.	O	.	_	0	SENT_1033	[p17l779t3591r840b3616],

1	Investig	NNP	O	Investig	_	0	SENT_1034	[p17l851t3591r959b3625],
2	.	.	O	.	_	0	SENT_1034	[p17l851t3591r959b3625],

1	120:2942	CD	NUMBER	120:2942	num	2	SENT_1035	[p17l975t3592r1131b3616],
2	-5	CD	NUMBER	-5	_	0	SENT_1035	[p17l975t3592r1131b3616],
3	2	CD	NUMBER	2	num	5	SENT_1035	[p17l1135t3592r1148b3616],
4	Pasanen	NN	ORGANIZATION	pasanen	nn	5	SENT_1035	[p17l443t3636r557b3660],
5	MK	NN	ORGANIZATION	mk	dep	2	SENT_1035	[p17l563t3636r627b3666],
6	,	,	O	,	_	0	SENT_1035	[p17l563t3636r627b3666],
7	Fredrikson	NN	PERSON	fredrikson	nn	8	SENT_1035	[p17l635t3635r788b3660],
8	H	NN	O	h	appos	5	SENT_1035	[p17l794t3636r829b3666],
9	,	,	O	,	_	0	SENT_1035	[p17l794t3636r829b3666],
10	Neuvonen	NNP	ORGANIZATION	Neuvonen	nn	11	SENT_1035	[p17l837t3636r984b3660],
11	PJ	NNP	ORGANIZATION	PJ	appos	5	SENT_1035	[p17l990t3636r1030b3667],
12	,	,	O	,	_	0	SENT_1035	[p17l990t3636r1030b3667],
13	Niemi	NNP	PERSON	Niemi	nn	14	SENT_1035	[p17l1037t3636r1127b3660],
14	M.	NNP	O	M.	appos	5	SENT_1035	[p17l1132t3636r1171b3660],
15	2007	CD	DATE	2007	dep	14	SENT_1035	[p17l1180t3636r1254b3661],
16	.	.	O	.	_	0	SENT_1035	[p17l1180t3636r1254b3661],

1	Diﬂferent	JJ	O	diﬂferent	amod	2	SENT_1036	[p17l1263t3635r1392b3660],
2	effects	NNS	O	effect	_	0	SENT_1036	[p17l1398t3635r1484b3660],
3	of	IN	O	of	_	0	SENT_1036	[p17l1492t3635r1522b3660],
4	SLCO	NN	O	slco	nn	7	SENT_1036	[p17l1526t3636r1617b3660],
5	1	CD	NUMBER	1	num	7	SENT_1036	[p17l1622t3636r1632b3660],
6	B1	NN	O	b1	nn	7	SENT_1036	[p17l1637t3636r1671b3660],
7	polymorphism	NN	O	polymorphism	prep_of	2	SENT_1036	[p17l1681t3635r1884b3669],
8	on	IN	O	on	_	0	SENT_1036	[p17l444t3690r479b3706],
9	the	DT	O	the	det	10	SENT_1036	[p17l489t3680r532b3706],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	2	SENT_1036	[p17l542t3680r786b3714],
11	of	IN	O	of	_	0	SENT_1036	[p17l797t3680r827b3706],
12	atorvastatin	NN	O	atorvastatin	prep_of	10	SENT_1036	[p17l834t3682r996b3706],
13	and	CC	O	and	_	0	SENT_1036	[p17l1006t3680r1055b3706],
14	rosuvastatin	NN	O	rosuvastatin	conj_and	12	SENT_1036	[p17l1065t3682r1239b3706],
15	.	.	O	.	_	0	SENT_1036	[p17l1065t3682r1239b3706],

1	Clin	NNP	O	Clin	_	0	SENT_1037	[p17l1251t3681r1312b3706],
2	.	.	O	.	_	0	SENT_1037	[p17l1251t3681r1312b3706],

1	Pbnwnncol	NNP	O	Pbnwnncol	_	0	SENT_1038	[p17l1323t3681r1467b3706],
2	.	.	O	.	_	0	SENT_1038	[p17l1323t3681r1467b3706],

1	Then	RB	O	then	advmod	2	SENT_1039	[p17l1481t3681r1549b3706],
2	82:726	CD	NUMBER	82:726	_	0	SENT_1039	[p17l1563t3681r1703b3706],
3	-33	CD	NUMBER	-33	num	5	SENT_1039	[p17l1563t3681r1703b3706],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_1039	[p17l443t3725r495b3749],
5	YJ	NN	PERSON	yj	dep	2	SENT_1039	[p17l506t3725r548b3756],
6	,	,	O	,	_	0	SENT_1039	[p17l506t3725r548b3756],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_1039	[p17l560t3725r612b3749],
8	MG	NN	O	mg	appos	5	SENT_1039	[p17l622t3725r689b3755],
9	,	,	O	,	_	0	SENT_1039	[p17l622t3725r689b3755],
10	Lim	NNP	LOCATION	Lim	nn	11	SENT_1039	[p17l702t3725r761b3749],
11	LA	NNP	LOCATION	LA	appos	5	SENT_1039	[p17l772t3725r823b3755],
12	,	,	O	,	_	0	SENT_1039	[p17l772t3725r823b3755],
13	Jang	NNP	PERSON	Jang	nn	14	SENT_1039	[p17l831t3725r898b3758],
14	SB	NN	O	sb	appos	5	SENT_1039	[p17l909t3725r954b3755],
15	,	,	O	,	_	0	SENT_1039	[p17l909t3725r954b3755],
16	Chung	NNP	PERSON	Chung	nn	17	SENT_1039	[p17l968t3724r1064b3758],
17	JY	NN	O	jy	appos	5	SENT_1039	[p17l1070t3725r1114b3756],
18	.	.	O	.	_	0	SENT_1039	[p17l1070t3725r1114b3756],

1	2010	CD	DATE	2010	_	0	SENT_1040	[p17l1128t3726r1202b3749],
2	.	.	O	.	_	0	SENT_1040	[p17l1128t3726r1202b3749],

1	Effects	NNS	O	effect	_	0	SENT_1041	[p17l1215t3724r1309b3749],
2	of	IN	O	of	_	0	SENT_1041	[p17l1321t3724r1351b3749],
3	SLCO1Bl	NN	O	slco1bl	nn	6	SENT_1041	[p17l1360t3725r1504b3749],
4	and	CC	O	and	_	0	SENT_1041	[p17l1519t3724r1568b3749],
5	ABCBl	NN	O	abcbl	nn	6	SENT_1041	[p17l1579t3725r1683b3749],
6	genotypes	NNS	O	genotype	prep_of	1	SENT_1041	[p17l1698t3731r1837b3758],
7	on	IN	O	on	_	0	SENT_1041	[p17l1850t3734r1884b3749],
8	the	DT	O	the	det	9	SENT_1041	[p17l444t3782r487b3808],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_1041	[p17l497t3782r742b3816],
10	of	IN	O	of	_	0	SENT_1041	[p17l753t3782r783b3808],
11	atorvastatin	NN	O	atorvastatin	prep_of	9	SENT_1041	[p17l790t3783r952b3808],
12	and	CC	O	and	_	0	SENT_1041	[p17l962t3782r1012b3808],
13	2-hydroxyatorvastatin	NN	O	2-hydroxyatorvastatin	conj_and	11	SENT_1041	[p17l1023t3782r1328b3816],
14	in	IN	O	in	_	0	SENT_1041	[p17l1338t3783r1365b3808],
15	healthy	JJ	O	healthy	amod	17	SENT_1041	[p17l1375t3782r1479b3816],
16	Korean	JJ	MISC	korean	amod	17	SENT_1041	[p17l1488t3783r1591b3808],
17	subjects	NNS	O	subject	prep_in	1	SENT_1041	[p17l1601t3782r1717b3816],
18	.	.	O	.	_	0	SENT_1041	[p17l1601t3782r1717b3816],

1	Int	NN	O	int	_	0	SENT_1042	[p17l1728t3783r1807b3816],
2	.	.	O	.	_	0	SENT_1042	[p17l1728t3783r1807b3816],

1	Clin	NNP	O	Clin	_	0	SENT_1043	[p17l1821t3783r1882b3808],
2	.	.	O	.	_	0	SENT_1043	[p17l1821t3783r1882b3808],

1	A111	NN	O	a111	_	0	SENT_1044	[p18l72t3009r95b3058],
2	1u	NN	O	1u	dep	1	SENT_1044	[p18l79t2966r95b2997],
3	.	.	O	.	_	0	SENT_1044	[p18l79t2966r95b2997],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1045	[p18l72t2895r95b2955],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_1045	[p18l72t2736r95b2884],
3	.	.	O	.	_	0	SENT_1045	[p18l72t2736r95b2884],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1046	[p18l72t2615r95b2725],
2	.	.	O	.	_	0	SENT_1046	[p18l72t2615r95b2725],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_1047	[p18l72t2369r96b2604],
2	-273	CD	NUMBER	-273	_	0	SENT_1047	[p18l72t2369r96b2604],
3	.	.	O	.	_	0	SENT_1047	[p18l72t2369r96b2604],

1	Downloaded	VBN	O	download	_	0	SENT_1048	[p18l72t2188r95b2358],
2	from	IN	O	from	_	0	SENT_1048	[p18l72t2115r95b2179],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_1048	[p18l72t1784r102b2106],
4	by	IN	O	by	_	0	SENT_1048	[p18l105t2878r136b2910],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_1048	[p18l105t2729r136b2869],
6	of	IN	ORGANIZATION	of	_	0	SENT_1048	[p18l105t2690r129b2719],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_1048	[p18l105t2543r129b2683],
8	-	:	O	-	_	0	SENT_1048	[p18l119t2524r122b2533],
9	Madison	NNP	O	Madison	dep	7	SENT_1048	[p18l105t2398r129b2514],
10	on	IN	O	on	_	0	SENT_1048	[p18l113t2356r129b2388],
11	O1/05	NNP	O	O1/05	prep_on	9	SENT_1048	[p18l105t2262r129b2347],
12	/	:	O	/	punct	9	SENT_1048	[p18l105t2262r129b2347],
13	14	CD	NUMBER	14	tmod	5	SENT_1048	[p18l105t2223r129b2259],
14	.	.	O	.	_	0	SENT_1048	[p18l105t2223r129b2259],

1	For	IN	O	for	_	0	SENT_1049	[p18l106t2166r129b2212],
2	personal	JJ	O	personal	amod	3	SENT_1049	[p18l105t2046r136b2157],
3	use	NN	O	use	pobj	1	SENT_1049	[p18l113t1993r129b2037],
4	only	RB	O	only	advmod	3	SENT_1049	[p18l105t1918r136b1983],
5	.	.	O	.	_	0	SENT_1049	[p18l105t1918r136b1983],

1	Annu	NNP	PERSON	Annu	_	0	SENT_1050	[p18l181t521r204b600],
2	.	.	O	.	_	0	SENT_1050	[p18l181t521r204b600],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1051	[p18l181t451r204b510],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_1051	[p18l181t292r204b440],
3	.	.	O	.	_	0	SENT_1051	[p18l181t292r204b440],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1052	[p18l181t173r204b281],
2	.	.	O	.	_	0	SENT_1052	[p18l181t173r204b281],

1	201252224	CD	NUMBER	201252224	_	0	SENT_1053	[p18l181t13r204b162],
2	by	IN	O	by	_	0	SENT_1053	[p18l214t434r245b466],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_1053	[p18l214t285r245b424],
4	of	IN	ORGANIZATION	of	_	0	SENT_1053	[p18l214t247r238b275],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	1	SENT_1053	[p18l214t101r238b240],
6	-	:	O	-	_	0	SENT_1053	[p18l228t83r231b91],
7	Mad	NNP	O	Mad	dep	1	SENT_1053	[p18l214t13r238b73],

1	P/mrmacol	NN	O	p/mrmacol	_	0	SENT_1054	[p18l443t20r586b44],
2	.	.	O	.	_	0	SENT_1054	[p18l443t20r586b44],

1	Tber	NNP	O	Tber	_	0	SENT_1055	[p18l601t20r668b44],
2	.	.	O	.	_	0	SENT_1055	[p18l601t20r668b44],

1	48:36	CD	NUMBER	48:36	num	4	SENT_1056	[p18l680t20r806b44],
2	-45	CD	NUMBER	-45	num	4	SENT_1056	[p18l680t20r806b44],
3	Maeda	NNP	PERSON	Maeda	nn	4	SENT_1056	[p18l442t62r537b88],
4	K	NNP	PERSON	K	_	0	SENT_1056	[p18l550t63r581b94],
5	,	,	O	,	_	0	SENT_1056	[p18l550t63r581b94],
6	Ieiri	NNP	O	Ieiri	nn	10	SENT_1056	[p18l595t63r653b88],
7	I	PRP	O	I	dep	10	SENT_1056	[p18l666t63r685b94],
8	,	,	O	,	_	0	SENT_1056	[p18l666t63r685b94],
9	Yasuda	NNP	ORGANIZATION	Yasuda	dep	10	SENT_1056	[p18l698t62r797b88],
10	K	NNP	ORGANIZATION	K	appos	4	SENT_1056	[p18l810t63r841b93],
11	,	,	O	,	_	0	SENT_1056	[p18l810t63r841b93],
12	Fujino	NNP	PERSON	Fujino	nn	13	SENT_1056	[p18l856t63r946b96],
13	A	NNP	O	A	appos	4	SENT_1056	[p18l959t63r988b94],
14	,	,	O	,	_	0	SENT_1056	[p18l959t63r988b94],
15	Fujiwara	NNP	PERSON	Fujiwara	nn	16	SENT_1056	[p18l1002t63r1122b96],
16	H	NNP	O	H	appos	4	SENT_1056	[p18l1136t63r1171b94],
17	,	,	O	,	_	0	SENT_1056	[p18l1136t63r1171b94],
18	et	FW	O	et	nn	19	SENT_1056	[p18l1186t70r1211b88],
19	al.	FW	O	al.	appos	4	SENT_1056	[p18l1223t62r1253b88],
20	2006	CD	DATE	2006	dep	19	SENT_1056	[p18l1268t64r1342b88],
21	.	.	O	.	_	0	SENT_1056	[p18l1268t64r1342b88],

1	Effects	NNS	O	effect	_	0	SENT_1057	[p18l1357t62r1450b88],
2	of	IN	O	of	_	0	SENT_1057	[p18l1464t62r1495b88],
3	organic	JJ	O	organic	amod	4	SENT_1057	[p18l1504t64r1608b96],
4	anion	NN	O	anion	prep_of	1	SENT_1057	[p18l1621t64r1698b88],
5	transporting	VBG	O	transport	partmod	1	SENT_1057	[p18l1712t64r1885b96],
6	polypeptide	NN	O	polypeptide	nn	8	SENT_1057	[p18l443t108r607b142],
7	1B1	NN	O	1b1	nn	8	SENT_1057	[p18l617t109r665b133],
8	haplotype	NN	O	haplotype	dobj	5	SENT_1057	[p18l674t108r812b142],
9	on	IN	O	on	_	0	SENT_1057	[p18l819t117r853b133],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	8	SENT_1057	[p18l859t108r1104b142],
11	of	IN	O	of	_	0	SENT_1057	[p18l1111t108r1141b133],
12	pravastatin	NN	O	pravastatin	prep_of	10	SENT_1057	[p18l1144t109r1302b142],
13	,	,	O	,	_	0	SENT_1057	[p18l1144t109r1302b142],
14	valsartan	NN	O	valsartan	conj_and	12	SENT_1057	[p18l1308t108r1439b139],
15	,	,	O	,	_	0	SENT_1057	[p18l1308t108r1439b139],
16	and	CC	O	and	_	0	SENT_1057	[p18l1447t108r1496b133],
17	temocapril	NN	O	temocapril	prep_of	10	SENT_1057	[p18l1503t108r1659b142],
18	.	.	O	.	_	0	SENT_1057	[p18l1503t108r1659b142],

1	Clin	NNP	O	Clin	_	0	SENT_1058	[p18l1669t109r1729b133],
2	.	.	O	.	_	0	SENT_1058	[p18l1669t109r1729b133],

1	Plycirmacol	NN	O	plycirmacol	_	0	SENT_1059	[p18l1738t109r1881b133],
2	.	.	O	.	_	0	SENT_1059	[p18l1738t109r1881b133],

1	Tlier	NNP	O	Tlier	_	0	SENT_1060	[p18l445t154r513b179],
2	.	.	O	.	_	0	SENT_1060	[p18l445t154r513b179],

1	79:427	CD	NUMBER	79:427	num	2	SENT_1061	[p18l526t154r669b179],
2	—	CD	NUMBER	—	_	0	SENT_1061	[p18l526t154r669b179],
3	39	CD	NUMBER	39	num	5	SENT_1061	[p18l526t154r669b179],
4	Nishizato	NNP	O	Nishizato	nn	5	SENT_1061	[p18l443t197r578b222],
5	Y	NN	O	y	dep	2	SENT_1061	[p18l594t198r623b228],
6	,	,	O	,	_	0	SENT_1061	[p18l594t198r623b228],
7	Ieiri	NNP	O	Ieiri	nn	11	SENT_1061	[p18l640t198r698b222],
8	I	PRP	O	I	dep	11	SENT_1061	[p18l714t198r733b228],
9	,	,	O	,	_	0	SENT_1061	[p18l714t198r733b228],
10	Suzuki	NNP	PERSON	Suzuki	dep	11	SENT_1061	[p18l752t197r844b222],
11	H	NNP	O	H	appos	5	SENT_1061	[p18l860t198r895b228],
12	,	,	O	,	_	0	SENT_1061	[p18l860t198r895b228],
13	Kimura	NNP	PERSON	Kimura	nn	14	SENT_1061	[p18l912t198r1019b222],
14	M	NNP	PERSON	M	appos	5	SENT_1061	[p18l1034t198r1073b228],
15	,	,	O	,	_	0	SENT_1061	[p18l1034t198r1073b228],
16	Kawabata	NNP	PERSON	Kawabata	nn	17	SENT_1061	[p18l1091t197r1226b222],
17	K	NNP	PERSON	K	appos	5	SENT_1061	[p18l1242t198r1274b228],
18	,	,	O	,	_	0	SENT_1061	[p18l1242t198r1274b228],
19	et	FW	O	et	nn	20	SENT_1061	[p18l1292t204r1317b222],
20	al.	FW	O	al.	appos	5	SENT_1061	[p18l1333t197r1362b222],
21	2003	CD	DATE	2003	dep	20	SENT_1061	[p18l1380t198r1455b222],
22	.	.	O	.	_	0	SENT_1061	[p18l1380t198r1455b222],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_1062	[p18l1472t196r1691b231],
2	of	IN	O	of	_	0	SENT_1062	[p18l1708t197r1738b222],
3	OATP	NN	O	oatp	prep_of	1	SENT_1062	[p18l1752t197r1884b222],
4	.	.	O	.	_	0	SENT_1062	[p18l1752t197r1884b222],

1	—	NN	O	—	_	0	SENT_1063	[p18l1752t197r1884b222],
2	.	.	O	.	_	0	SENT_1063	[p18l1752t197r1884b222],

1	C	NN	O	c	nn	4	SENT_1064	[p18l1752t197r1884b222],
2	(	CD	NUMBER	(	num	4	SENT_1064	[p18l444t243r534b274],
3	SLC2	NN	O	slc2	nn	4	SENT_1064	[p18l444t243r534b274],
4	1A6	NN	O	1a6	_	0	SENT_1064	[p18l541t243r603b274],
5	)	NN	O	)	dep	4	SENT_1064	[p18l541t243r603b274],
6	and	CC	O	and	_	0	SENT_1064	[p18l615t242r665b268],
7	OAT3	NN	O	oat3	dep	4	SENT_1064	[p18l677t243r765b268],
8	(	CD	NUMBER	(	num	11	SENT_1064	[p18l781t243r939b274],
9	SLC22A8	NN	O	slc22a8	nn	11	SENT_1064	[p18l781t243r939b274],
10	)	NN	O	)	nn	11	SENT_1064	[p18l781t243r939b274],
11	genes	NNS	O	gene	dep	4	SENT_1064	[p18l952t252r1036b276],
12	:	:	O	:	_	0	SENT_1064	[p18l952t252r1036b276],
13	consequences	NNS	O	consequence	dep	4	SENT_1064	[p18l1050t252r1239b276],
14	for	IN	O	for	_	0	SENT_1064	[p18l1251t242r1291b268],
15	pravastatin	NN	O	pravastatin	nn	16	SENT_1064	[p18l1302t243r1454b276],
16	pharmacokinetics	NNS	O	pharmacokinetic	prep_for	13	SENT_1064	[p18l1465t242r1717b276],
17	.	.	O	.	_	0	SENT_1064	[p18l1465t242r1717b276],

1	Clin	NNP	O	Clin	_	0	SENT_1065	[p18l1732t243r1792b268],
2	.	.	O	.	_	0	SENT_1065	[p18l1732t243r1792b268],

1	Pharmizcol	NNP	O	Pharmizcol	_	0	SENT_1066	[p18l1807t243r1884b268, p18l443t288r521b313],
2	.	.	O	.	_	0	SENT_1066	[p18l1807t243r1884b268, p18l443t288r521b313],

1	T/yer	NN	O	t/yer	_	0	SENT_1067	[p18l535t288r603b313],
2	.	.	O	.	_	0	SENT_1067	[p18l535t288r603b313],

1	73:5	CD	NUMBER	73:5	_	0	SENT_1068	[p18l617t288r673b313],
2	54-65	CD	NUMBER	54-65	num	4	SENT_1068	[p18l677t288r758b313],
3	Niemi	NNP	O	Niemi	nn	4	SENT_1068	[p18l443t332r532b357],
4	M	NN	O	m	dep	1	SENT_1068	[p18l541t332r581b362],
5	,	,	O	,	_	0	SENT_1068	[p18l541t332r581b362],
6	Pasanen	NNP	PERSON	Pasanen	nn	7	SENT_1068	[p18l592t332r706b357],
7	MK	NNP	O	MK	appos	4	SENT_1068	[p18l715t332r780b362],
8	,	,	O	,	_	0	SENT_1068	[p18l715t332r780b362],
9	Neuvonen	NNP	PERSON	Neuvonen	nn	11	SENT_1068	[p18l791t332r938b357],
10	P	NN	O	p	nn	11	SENT_1068	[p18l948t332r987b363],
11	]	NN	O	]	appos	4	SENT_1068	[p18l948t332r987b363],
12	.	.	O	.	_	0	SENT_1068	[p18l948t332r987b363],

1	2006	CD	DATE	2006	_	0	SENT_1069	[p18l999t332r1074b356],
2	.	.	O	.	_	0	SENT_1069	[p18l999t332r1074b356],

1	SLCO1Bl	NN	O	slco1bl	nn	2	SENT_1070	[p18l1086t332r1231b357],
2	polymorphism	NN	O	polymorphism	nsubj	5	SENT_1070	[p18l1244t331r1448b365],
3	and	CC	O	and	_	0	SENT_1070	[p18l1458t331r1508b357],
4	sex	NN	O	sex	nsubj	5	SENT_1070	[p18l1518t341r1560b357],
5	affect	VBP	O	affect	_	0	SENT_1070	[p18l1570t331r1644b357],
6	the	DT	O	the	det	7	SENT_1070	[p18l1654t331r1697b357],
7	pharmacokinetics	NNS	O	pharmacokinetic	dobj	5	SENT_1070	[p18l1708t331r1884b365, p18l443t378r523b402],
8	of	IN	O	of	_	0	SENT_1070	[p18l533t377r564b402],
9	pravastatin	NN	O	pravastatin	prep_of	7	SENT_1070	[p18l570t378r721b410],
10	but	CC	O	but	_	0	SENT_1070	[p18l731t376r777b402],
11	not	RB	O	not	_	0	SENT_1070	[p18l786t384r833b402],
12	ﬂuvastatin	NN	O	ﬂuvastatin	conj_negcc	7	SENT_1070	[p18l842t376r992b402],
13	.	.	O	.	_	0	SENT_1070	[p18l842t376r992b402],

1	Clin	NNP	O	Clin	_	0	SENT_1071	[p18l1005t377r1065b402],
2	.	.	O	.	_	0	SENT_1071	[p18l1005t377r1065b402],

1	P/mrmacol	NN	O	p/mrmacol	_	0	SENT_1072	[p18l1077t377r1221b402],
2	.	.	O	.	_	0	SENT_1072	[p18l1077t377r1221b402],

1	T/yer	NN	O	t/yer	_	0	SENT_1073	[p18l1235t377r1302b402],
2	.	.	O	.	_	0	SENT_1073	[p18l1235t377r1302b402],

1	80:35	CD	NUMBER	80:35	_	0	SENT_1074	[p18l1316t378r1389b402],
2	6-66	CD	NUMBER	6-66	num	4	SENT_1074	[p18l1393t378r1459b402],
3	Niemi	NNP	O	Niemi	nn	4	SENT_1074	[p18l443t422r532b446],
4	M	NN	O	m	dep	1	SENT_1074	[p18l546t422r585b452],
5	,	,	O	,	_	0	SENT_1074	[p18l546t422r585b452],
6	Schaeffeler	NN	ORGANIZATION	schaeffeler	nn	7	SENT_1074	[p18l603t420r755b446],
7	E	NN	ORGANIZATION	e	appos	4	SENT_1074	[p18l769t422r798b452],
8	,	,	O	,	_	0	SENT_1074	[p18l769t422r798b452],
9	Lang	NNP	PERSON	Lang	nn	10	SENT_1074	[p18l814t422r887b455],
10	T	NN	O	t	appos	4	SENT_1074	[p18l900t421r933b452],
11	,	,	O	,	_	0	SENT_1074	[p18l900t421r933b452],
12	Fromm	NNP	ORGANIZATION	Fromm	nn	13	SENT_1074	[p18l949t422r1054b446],
13	MF	NN	ORGANIZATION	mf	appos	4	SENT_1074	[p18l1067t422r1127b452],
14	,	,	O	,	_	0	SENT_1074	[p18l1067t422r1127b452],
15	Neuvonen	NN	O	neuvonen	nn	16	SENT_1074	[p18l1143t422r1289b446],
16	M	NN	O	m	appos	4	SENT_1074	[p18l1303t422r1342b452],
17	,	,	O	,	_	0	SENT_1074	[p18l1303t422r1342b452],
18	et	FW	O	et	nn	19	SENT_1074	[p18l1359t428r1384b446],
19	al.	FW	O	al.	appos	4	SENT_1074	[p18l1399t420r1428b446],
20	2004	CD	DATE	2004	dep	19	SENT_1074	[p18l1445t422r1519b446],
21	.	.	O	.	_	0	SENT_1074	[p18l1445t422r1519b446],

1	High	JJ	O	high	amod	4	SENT_1075	[p18l1535t420r1608b455],
2	plasma	NN	O	plasma	nn	4	SENT_1075	[p18l1623t420r1718b454],
3	pravastatin	NN	O	pravastatin	nn	4	SENT_1075	[p18l1733t422r1884b454],
4	concentrations	NNS	O	concentration	nsubjpass	6	SENT_1075	[p18l444t467r649b492],
5	are	VBP	O	be	auxpass	6	SENT_1075	[p18l663t476r704b492],
6	associated	VBN	O	associate	_	0	SENT_1075	[p18l718t466r856b492],
7	with	IN	O	with	_	0	SENT_1075	[p18l868t466r930b492],
8	single	JJ	O	single	amod	10	SENT_1075	[p18l943t466r1023b500],
9	nucleotide	NN	O	nucleotide	nn	10	SENT_1075	[p18l1036t466r1182b492],
10	polymorphisms	NNS	O	polymorphism	prep_with	6	SENT_1075	[p18l1195t466r1411b500],
11	and	CC	O	and	_	0	SENT_1075	[p18l1425t466r1474b492],
12	haplotypes	NNS	O	haplotype	conj_and	10	SENT_1075	[p18l1487t466r1636b500],
13	of	IN	O	of	_	0	SENT_1075	[p18l1650t466r1680b492],
14	organic	JJ	O	organic	amod	15	SENT_1075	[p18l1690t467r1794b500],
15	anion	NN	O	anion	prep_of	10	SENT_1075	[p18l1807t467r1884b492],
16	transporting	VBG	O	transport	xcomp	6	SENT_1075	[p18l444t513r617b546],
17	polypeptide	NN	O	polypeptide	dobj	16	SENT_1075	[p18l626t511r828b546],
18	.	.	O	.	_	0	SENT_1075	[p18l626t511r828b546],

1	—	NN	O	—	_	0	SENT_1076	[p18l626t511r828b546],
2	.	.	O	.	_	0	SENT_1076	[p18l626t511r828b546],

1	C	NN	O	c	_	0	SENT_1077	[p18l626t511r828b546],
2	(	CD	NUMBER	(	num	3	SENT_1077	[p18l839t512r989b544],
3	OATP	NN	O	oatp	dep	1	SENT_1077	[p18l839t512r989b544],
4	.	.	O	.	_	0	SENT_1077	[p18l839t512r989b544],

1	—	NN	O	—	_	0	SENT_1078	[p18l839t512r989b544],
2	.	.	O	.	_	0	SENT_1078	[p18l839t512r989b544],

1	C	NN	O	c	_	0	SENT_1079	[p18l839t512r989b544],
2	,	,	O	,	_	0	SENT_1079	[p18l839t512r989b544],
3	SLCO1B1	NN	O	slco1b1	nn	4	SENT_1079	[p18l1002t512r1167b544],
4	)	NN	O	)	appos	1	SENT_1079	[p18l1002t512r1167b544],
5	.	.	O	.	_	0	SENT_1079	[p18l1002t512r1167b544],

1	P/mimiicogenetics	NNS	O	p/mimiicogenetics	_	0	SENT_1080	[p18l1177t512r1405b546],
2	14:42	CD	TIME	14:42	num	5	SENT_1080	[p18l1417t513r1487b537],
3	9-40	CD	NUMBER	9-40	num	5	SENT_1080	[p18l1492t513r1558b537],
4	Ho	NNP	O	Ho	nn	5	SENT_1080	[p18l443t557r488b581],
5	RH	NNP	O	RH	dep	1	SENT_1080	[p18l504t557r563b586],
6	,	,	O	,	_	0	SENT_1080	[p18l504t557r563b586],
7	Choi	NNP	PERSON	Choi	nn	8	SENT_1080	[p18l580t555r648b581],
8	L	NNP	PERSON	L	appos	5	SENT_1080	[p18l664t557r693b586],
9	,	,	O	,	_	0	SENT_1080	[p18l664t557r693b586],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_1080	[p18l709t557r761b581],
11	W	NNP	PERSON	W	appos	5	SENT_1080	[p18l776t557r819b586],
12	,	,	O	,	_	0	SENT_1080	[p18l776t557r819b586],
13	Mayo	NNP	O	Mayo	nn	14	SENT_1080	[p18l834t557r915b589],
14	G	NNP	O	G	appos	5	SENT_1080	[p18l931t556r964b586],
15	,	,	O	,	_	0	SENT_1080	[p18l931t556r964b586],
16	Schwarz	NNP	PERSON	Schwarz	nn	17	SENT_1080	[p18l982t555r1097b581],
17	UI	NNP	O	UI	appos	5	SENT_1080	[p18l1112t557r1158b586],
18	,	,	O	,	_	0	SENT_1080	[p18l1112t557r1158b586],
19	et	FW	O	et	nn	20	SENT_1080	[p18l1175t563r1201b581],
20	al.	FW	O	al.	appos	5	SENT_1080	[p18l1216t555r1245b581],
21	2007	CD	DATE	2007	dep	20	SENT_1080	[p18l1262t556r1337b581],
22	.	.	O	.	_	0	SENT_1080	[p18l1262t556r1337b581],

1	Effect	NN	O	effect	_	0	SENT_1081	[p18l1353t555r1436b581],
2	of	IN	O	of	_	0	SENT_1081	[p18l1451t555r1481b581],
3	drug	NN	O	drug	nn	5	SENT_1081	[p18l1493t555r1558b589],
4	transporter	NN	O	transporter	nn	5	SENT_1081	[p18l1573t563r1729b589],
5	genotypes	NNS	O	genotype	prep_of	1	SENT_1081	[p18l1745t563r1884b589],
6	on	IN	O	on	_	0	SENT_1081	[p18l444t620r479b636],
7	pravastatin	NN	O	pravastatin	nn	8	SENT_1081	[p18l492t611r644b644],
8	disposition	NN	O	disposition	prep_on	1	SENT_1081	[p18l659t610r810b644],
9	in	IN	O	in	_	0	SENT_1081	[p18l824t611r851b635],
10	European	JJ	LOCATION	european	prep_in	1	SENT_1081	[p18l865t611r1014b644],
11	-	:	O	-	_	0	SENT_1081	[p18l865t611r1014b644],
12	and	CC	O	and	_	0	SENT_1081	[p18l1029t610r1078b636],
13	African-American	JJ	MISC	african-american	amod	14	SENT_1081	[p18l1092t610r1343b636],
14	participants	NNS	O	participant	prep_in	1	SENT_1081	[p18l1356t612r1527b644],
15	.	.	O	.	_	0	SENT_1081	[p18l1356t612r1527b644],

1	Pbczrmzzcogenet	NNP	O	Pbczrmzzcogenet	_	0	SENT_1082	[p18l1542t611r1745b645],
2	.	.	O	.	_	0	SENT_1082	[p18l1542t611r1745b645],

1	Genomicr	NN	O	genomicr	_	0	SENT_1083	[p18l1764t611r1886b636],
2	17	CD	NUMBER	17	number	3	SENT_1083	[p18l447t656r475b681],
3	:647	CD	NUMBER	:647	dep	1	SENT_1083	[p18l480t656r569b681],
4	—	NN	O	—	dep	3	SENT_1083	[p18l480t656r569b681],
5	5	CD	NUMBER	5	number	6	SENT_1083	[p18l480t656r569b681],
6	6	CD	NUMBER	6	dep	1	SENT_1083	[p18l573t657r588b680],
7	Igel	NN	O	igel	nn	8	SENT_1083	[p18l443t697r496b731],
8	M	NN	O	m	dep	6	SENT_1083	[p18l505t698r544b728],
9	,	,	O	,	_	0	SENT_1083	[p18l505t698r544b728],
10	Arnold	NNP	ORGANIZATION	Arnold	nn	11	SENT_1083	[p18l555t697r653b723],
11	KA	NN	ORGANIZATION	ka	appos	1	SENT_1083	[p18l663t698r717b728],
12	,	,	O	,	_	0	SENT_1083	[p18l663t698r717b728],
13	Niemi	NNP	PERSON	Niemi	nn	14	SENT_1083	[p18l727t698r817b723],
14	M	NNP	O	M	appos	1	SENT_1083	[p18l826t698r865b728],
15	,	,	O	,	_	0	SENT_1083	[p18l826t698r865b728],
16	Hofmann	NNP	PERSON	Hofmann	nn	17	SENT_1083	[p18l876t697r1012b723],
17	U	NNP	PERSON	U	appos	1	SENT_1083	[p18l1022t698r1056b728],
18	,	,	O	,	_	0	SENT_1083	[p18l1022t698r1056b728],
19	Schwab	NNP	ORGANIZATION	Schwab	nn	20	SENT_1083	[p18l1068t697r1173b723],
20	M	NNP	ORGANIZATION	M	appos	1	SENT_1083	[p18l1182t698r1222b728],
21	,	,	O	,	_	0	SENT_1083	[p18l1182t698r1222b728],
22	et	FW	O	et	nn	23	SENT_1083	[p18l1234t704r1259b723],
23	al.	FW	O	al.	appos	1	SENT_1083	[p18l1269t697r1298b723],
24	2006	CD	DATE	2006	dep	23	SENT_1083	[p18l1310t699r1385b722],
25	.	.	O	.	_	0	SENT_1083	[p18l1310t699r1385b722],

1	Impact	NN	O	impact	_	0	SENT_1084	[p18l1396t698r1494b731],
2	of	IN	O	of	_	0	SENT_1084	[p18l1504t697r1534b723],
3	the	DT	O	the	det	5	SENT_1084	[p18l1541t697r1584b723],
4	SLCO1Bl	NN	O	slco1bl	nn	5	SENT_1084	[p18l1595t698r1740b723],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_1084	[p18l1753t697r1884b731, p18l443t740r528b774],
6	on	IN	O	on	_	0	SENT_1084	[p18l536t750r571b766],
7	the	DT	O	the	det	8	SENT_1084	[p18l580t740r623b766],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_1084	[p18l631t740r876b774],
9	and	CC	O	and	_	0	SENT_1084	[p18l885t740r934b766],
10	lipid-lowering	JJ	O	lipid-lowering	amod	11	SENT_1084	[p18l943t740r1143b774],
11	efficacy	NN	O	efficacy	conj_and	8	SENT_1084	[p18l1151t740r1254b774],
12	of	IN	O	of	_	0	SENT_1084	[p18l1261t740r1292b766],
13	multiple-dose	JJ	O	multiple-dose	amod	14	SENT_1084	[p18l1296t740r1489b774],
14	pravastatin	NN	O	pravastatin	prep_of	8	SENT_1084	[p18l1497t741r1655b774],
15	.	.	O	.	_	0	SENT_1084	[p18l1497t741r1655b774],

1	Clin	NNP	O	Clin	_	0	SENT_1085	[p18l1667t741r1727b766],
2	.	.	O	.	_	0	SENT_1085	[p18l1667t741r1727b766],

1	Plmmmcal	JJ	O	plmmmcal	_	0	SENT_1086	[p18l1738t741r1882b766],
2	.	.	O	.	_	0	SENT_1086	[p18l1738t741r1882b766],

1	Tlier	NNP	O	Tlier	_	0	SENT_1087	[p18l445t783r513b808],
2	.	.	O	.	_	0	SENT_1087	[p18l445t783r513b808],

1	79:419	CD	NUMBER	79:419	_	0	SENT_1088	[p18l526t783r669b808],
2	—	CD	NUMBER	—	number	3	SENT_1088	[p18l526t783r669b808],
3	26	CD	NUMBER	26	dep	1	SENT_1088	[p18l526t783r669b808],
4	Mwinyi	NNP	PERSON	Mwinyi	dep	3	SENT_1088	[p18l442t825r664b859],
5	]	CD	NUMBER	]	num	4	SENT_1088	[p18l442t825r664b859],
6	,	,	O	,	_	0	SENT_1088	[p18l442t825r664b859],
7	]	CD	NUMBER	]	num	4	SENT_1088	[p18l442t825r664b859],
8	ohne	NN	O	ohne	nn	9	SENT_1088	[p18l442t825r664b859],
9	A	NN	O	a	dep	1	SENT_1088	[p18l670t826r699b856],
10	,	,	O	,	_	0	SENT_1088	[p18l670t826r699b856],
11	Bauer	NNP	PERSON	Bauer	nn	12	SENT_1088	[p18l707t826r789b850],
12	S	NN	O	s	appos	9	SENT_1088	[p18l796t826r819b856],
13	,	,	O	,	_	0	SENT_1088	[p18l796t826r819b856],
14	Roots	NNS	O	root	appos	1	SENT_1088	[p18l828t826r908b850],
15	I	PRP	O	I	dep	14	SENT_1088	[p18l915t826r933b856],
16	,	,	O	,	_	0	SENT_1088	[p18l915t826r933b856],
17	Gerloff	NNP	PERSON	Gerloff	nn	18	SENT_1088	[p18l942t825r1046b850],
18	T.	NNP	O	T.	appos	1	SENT_1088	[p18l1048t826r1081b850],
19	2004	CD	DATE	2004	dep	18	SENT_1088	[p18l1089t827r1163b851],
20	.	.	O	.	_	0	SENT_1088	[p18l1089t827r1163b851],

1	Evidence	NN	O	evidence	_	0	SENT_1089	[p18l1172t825r1299b850],
2	for	IN	O	for	_	0	SENT_1089	[p18l1306t825r1346b850],
3	inverse	JJ	O	inverse	amod	4	SENT_1089	[p18l1352t826r1450b850],
4	effects	NNS	O	effect	prep_for	1	SENT_1089	[p18l1458t825r1543b851],
5	of	IN	O	of	_	0	SENT_1089	[p18l1551t825r1581b850],
6	OATP	NN	O	oatp	prep_of	1	SENT_1089	[p18l1585t826r1717b851],
7	.	.	O	.	_	0	SENT_1089	[p18l1585t826r1717b851],

1	—	NN	O	—	_	0	SENT_1090	[p18l1585t826r1717b851],
2	.	.	O	.	_	0	SENT_1090	[p18l1585t826r1717b851],

1	C	NN	O	c	nn	4	SENT_1091	[p18l1585t826r1717b851],
2	(	CD	NUMBER	(	num	4	SENT_1091	[p18l1725t826r1814b857],
3	SLC2	NN	O	slc2	nn	4	SENT_1091	[p18l1725t826r1814b857],
4	1A6	NN	O	1a6	_	0	SENT_1091	[p18l1821t826r1883b857],
5	)	CD	NUMBER	)	num	6	SENT_1091	[p18l1821t826r1883b857],
6	5	CD	NUMBER	5	dep	4	SENT_1091	[p18l445t869r457b893],
7	and	CC	O	and	_	0	SENT_1091	[p18l470t867r519b893],
8	lb	NN	O	lb	nn	9	SENT_1091	[p18l532t867r562b893],
9	haplotypes	NNS	O	haplotype	dep	4	SENT_1091	[p18l572t867r722b901],
10	on	IN	O	on	_	0	SENT_1091	[p18l732t877r767b893],
11	pravastatin	NN	O	pravastatin	nn	12	SENT_1091	[p18l776t869r928b901],
12	kinetics	NNS	O	kinetics	prep_on	4	SENT_1091	[p18l937t867r1050b893],
13	.	.	O	.	_	0	SENT_1091	[p18l937t867r1050b893],

1	Clin	NNP	O	Clin	_	0	SENT_1092	[p18l1063t868r1124b892],
2	.	.	O	.	_	0	SENT_1092	[p18l1063t868r1124b892],

1	Plmmmcol	NNP	O	Plmmmcol	_	0	SENT_1093	[p18l1135t868r1279b893],
2	.	.	O	.	_	0	SENT_1093	[p18l1135t868r1279b893],

1	Tber	NNP	O	Tber	_	0	SENT_1094	[p18l1293t868r1361b892],
2	.	.	O	.	_	0	SENT_1094	[p18l1293t868r1361b892],

1	75	CD	NUMBER	75	number	2	SENT_1095	[p18l1375t868r1405b893],
2	:415	CD	NUMBER	:415	_	0	SENT_1095	[p18l1410t868r1515b893],
3	—	NN	O	—	nn	5	SENT_1095	[p18l1410t868r1515b893],
4	21	CD	NUMBER	21	num	5	SENT_1095	[p18l1410t868r1515b893],
5	Chung	NNP	PERSON	Chung	dep	2	SENT_1095	[p18l444t909r540b943],
6	]	CD	NUMBER	]	num	7	SENT_1095	[p18l545t910r589b941],
7	Y	NN	O	y	dep	2	SENT_1095	[p18l545t910r589b941],
8	,	,	O	,	_	0	SENT_1095	[p18l545t910r589b941],
9	Cho	NNP	PERSON	Cho	nn	11	SENT_1095	[p18l600t909r660b935],
10	]	CD	NUMBER	]	num	11	SENT_1095	[p18l665t910r710b941],
11	Y	NN	O	y	appos	7	SENT_1095	[p18l665t910r710b941],
12	,	,	O	,	_	0	SENT_1095	[p18l665t910r710b941],
13	Yu	NNP	PERSON	Yu	nn	14	SENT_1095	[p18l719t910r759b935],
14	KS	NN	PERSON	k	appos	7	SENT_1095	[p18l768t910r818b940],
15	,	,	O	,	_	0	SENT_1095	[p18l768t910r818b940],
16	Kim	NNP	PERSON	Kim	appos	7	SENT_1095	[p18l828t910r890b934],
17	]	CD	NUMBER	]	num	16	SENT_1095	[p18l895t910r940b941],
18	R	NN	O	r	dep	16	SENT_1095	[p18l895t910r940b941],
19	,	,	O	,	_	0	SENT_1095	[p18l895t910r940b941],
20	Oh	UH	O	oh	dep	21	SENT_1095	[p18l952t909r996b935],
21	DS	NN	O	d	dobj	18	SENT_1095	[p18l1005t910r1057b940],
22	,	,	O	,	_	0	SENT_1095	[p18l1005t910r1057b940],
23	et	FW	O	et	nn	24	SENT_1095	[p18l1068t916r1094b935],
24	al.	FW	O	al.	appos	7	SENT_1095	[p18l1103t909r1132b935],
25	2005	CD	DATE	2005	dep	24	SENT_1095	[p18l1143t910r1218b935],
26	.	.	O	.	_	0	SENT_1095	[p18l1143t910r1218b935],

1	Effect	NN	O	effect	nsubj	5	SENT_1096	[p18l1228t909r1311b935],
2	of	IN	O	of	_	0	SENT_1096	[p18l1320t909r1350b935],
3	OATP1Bl	NN	O	oatp1bl	prep_of	1	SENT_1096	[p18l1357t910r1504b935],
4	(	CD	NUMBER	(	num	3	SENT_1096	[p18l1517t910r1686b941],
5	SLCOIBI	NNP	O	SLCOIBI	_	0	SENT_1096	[p18l1517t910r1686b941],
6	)	CD	NUMBER	)	num	8	SENT_1096	[p18l1517t910r1686b941],
7	variant	JJ	O	variant	amod	8	SENT_1096	[p18l1694t911r1792b935],
8	alleles	NNS	O	allele	dobj	5	SENT_1096	[p18l1800t909r1884b935],
9	on	IN	O	on	_	0	SENT_1096	[p18l444t962r479b978],
10	the	DT	O	the	det	11	SENT_1096	[p18l488t952r532b978],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	8	SENT_1096	[p18l542t952r786b986],
12	of	IN	O	of	_	0	SENT_1096	[p18l797t952r827b978],
13	pitavastatin	NN	O	pitavastatin	prep_of	11	SENT_1096	[p18l833t953r992b986],
14	in	IN	O	in	_	0	SENT_1096	[p18l1001t953r1028b977],
15	healthy	JJ	O	healthy	amod	16	SENT_1096	[p18l1037t952r1141b986],
16	volunteers	NNS	O	volunteer	prep_in	5	SENT_1096	[p18l1149t952r1301b978],
17	.	.	O	.	_	0	SENT_1096	[p18l1149t952r1301b978],

1	Clin	NNP	O	Clin	_	0	SENT_1097	[p18l1314t953r1375b978],
2	.	.	O	.	_	0	SENT_1097	[p18l1314t953r1375b978],

1	Plmrmczcol	NN	O	plmrmczcol	_	0	SENT_1098	[p18l1386t953r1530b978],
2	.	.	O	.	_	0	SENT_1098	[p18l1386t953r1530b978],

1	Tber	NNP	O	Tber	_	0	SENT_1099	[p18l1544t953r1612b978],
2	.	.	O	.	_	0	SENT_1099	[p18l1544t953r1612b978],

1	78:342	CD	NUMBER	78:342	num	4	SENT_1100	[p18l1625t953r1768b978],
2	—	CD	NUMBER	—	num	4	SENT_1100	[p18l1625t953r1768b978],
3	50	CD	NUMBER	50	num	4	SENT_1100	[p18l1625t953r1768b978],
4	Ieiri	NNS	O	ieirus	_	0	SENT_1100	[p18l443t996r501b1021],
5	I	PRP	O	I	dep	4	SENT_1100	[p18l514t996r532b1026],
6	,	,	O	,	_	0	SENT_1100	[p18l514t996r532b1026],
7	Suwannakul	NNP	O	Suwannakul	nn	8	SENT_1100	[p18l548t995r715b1021],
8	S	NNP	O	S	appos	5	SENT_1100	[p18l729t996r752b1026],
9	,	,	O	,	_	0	SENT_1100	[p18l729t996r752b1026],
10	Maeda	NNP	PERSON	Maeda	nn	11	SENT_1100	[p18l765t995r860b1021],
11	K	NNP	PERSON	K	appos	5	SENT_1100	[p18l872t996r904b1026],
12	,	,	O	,	_	0	SENT_1100	[p18l872t996r904b1026],
13	Uchimaru	NNP	O	Uchimaru	nn	14	SENT_1100	[p18l918t995r1060b1021],
14	H	NNP	O	H	appos	5	SENT_1100	[p18l1072t996r1108b1026],
15	,	,	O	,	_	0	SENT_1100	[p18l1072t996r1108b1026],
16	Hashimoto	NN	PERSON	hashimoto	nn	17	SENT_1100	[p18l1121t995r1278b1021],
17	K	NN	PERSON	k	appos	5	SENT_1100	[p18l1291t996r1323b1026],
18	,	,	O	,	_	0	SENT_1100	[p18l1291t996r1323b1026],
19	et	FW	O	et	nn	20	SENT_1100	[p18l1337t1002r1363b1021],
20	al.	FW	O	al.	appos	5	SENT_1100	[p18l1375t995r1404b1021],
21	2007	CD	DATE	2007	dep	20	SENT_1100	[p18l1419t996r1493b1021],
22	.	.	O	.	_	0	SENT_1100	[p18l1419t996r1493b1021],

1	SLCO1B1	NN	O	slco1b1	_	0	SENT_1101	[p18l1509t996r1653b1021],
2	(	CD	NUMBER	(	num	3	SENT_1101	[p18l1670t996r1838b1027],
3	OATP1B1	NN	O	oatp1b1	dep	1	SENT_1101	[p18l1670t996r1838b1027],
4	,	,	O	,	_	0	SENT_1101	[p18l1670t996r1838b1027],
5	an	DT	O	a	det	8	SENT_1101	[p18l1853t1005r1884b1021],
6	uptake	NN	O	uptake	nn	8	SENT_1101	[p18l443t1037r535b1071],
7	transporter	NN	O	transporter	nn	8	SENT_1101	[p18l547t1038r713b1071],
8	)	NN	O	)	conj_and	3	SENT_1101	[p18l547t1038r713b1071],
9	and	CC	O	and	_	0	SENT_1101	[p18l725t1037r775b1063],
10	ABCG2	NN	O	abcg2	conj_and	3	SENT_1101	[p18l785t1038r896b1063],
11	(	CD	NUMBER	(	num	12	SENT_1101	[p18l911t1038r1018b1069],
12	BCRP	NN	O	bcrp	dep	1	SENT_1101	[p18l911t1038r1018b1069],
13	,	,	O	,	_	0	SENT_1101	[p18l911t1038r1018b1069],
14	an	DT	O	a	det	16	SENT_1101	[p18l1031t1047r1062b1063],
15	eﬂflux	NN	O	eﬂflux	nn	16	SENT_1101	[p18l1074t1037r1149b1063],
16	transporter	NN	O	transporter	appos	12	SENT_1101	[p18l1160t1038r1325b1071],
17	)	CD	NUMBER	)	num	19	SENT_1101	[p18l1160t1038r1325b1071],
18	variant	JJ	O	variant	amod	19	SENT_1101	[p18l1336t1038r1434b1063],
19	alleles	NNS	O	allele	dep	1	SENT_1101	[p18l1445t1037r1528b1063],
20	and	CC	O	and	_	0	SENT_1101	[p18l1540t1037r1589b1063],
21	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	19	SENT_1101	[p18l1601t1037r1845b1071],
22	of	IN	O	of	_	0	SENT_1101	[p18l1857t1037r1888b1063],
23	pitavastatin	NN	O	pitavastatin	prep_of	19	SENT_1101	[p18l443t1082r602b1114],
24	in	IN	O	in	_	0	SENT_1101	[p18l611t1082r638b1105],
25	healthy	JJ	O	healthy	amod	26	SENT_1101	[p18l648t1080r751b1114],
26	volunteers	NNS	O	volunteer	prep_in	23	SENT_1101	[p18l759t1080r912b1106],
27	.	.	O	.	_	0	SENT_1101	[p18l759t1080r912b1106],

1	Clin	NNP	O	Clin	_	0	SENT_1102	[p18l924t1081r985b1105],
2	.	.	O	.	_	0	SENT_1102	[p18l924t1081r985b1105],

1	Pbczimacol	NN	O	pbczimacol	_	0	SENT_1103	[p18l996t1081r1140b1106],
2	.	.	O	.	_	0	SENT_1103	[p18l996t1081r1140b1106],

1	Tber	NNP	O	Tber	_	0	SENT_1104	[p18l1154t1081r1222b1105],
2	.	.	O	.	_	0	SENT_1104	[p18l1154t1081r1222b1105],

1	82:5	CD	NUMBER	82:5	num	2	SENT_1105	[p18l1236t1081r1292b1106],
2	41-47	CD	NUMBER	41-47	_	0	SENT_1105	[p18l1295t1081r1378b1106],

1	wwwxmnmzlre-uiew	NN	O	wwwxmnmzlre-uiew	_	0	SENT_1106	[p18l1356t1183r1630b1212],
2	:	:	O	:	_	0	SENT_1106	[p18l1356t1183r1630b1212],
3	.	.	O	.	_	0	SENT_1106	[p18l1356t1183r1630b1212],

1	arg	SYM	O	arg	dep	3	SENT_1107	[p18l1356t1183r1630b1212],
2	-	:	O	-	_	0	SENT_1107	[p18l1644t1191r1654b1200],
3	Drug	NN	O	drug	dep	6	SENT_1107	[p18l1670t1183r1734b1212],
4	Tmmporter	NNP	O	Tmmporter	dep	3	SENT_1107	[p18l1742t1183r1885b1211],
5	:	:	O	:	_	0	SENT_1107	[p18l1742t1183r1885b1211],
6	269	CD	NUMBER	269	_	0	SENT_1107	[p18l1936t1183r1978b1211],

1	.	.	O	.	_	0	SENT_1108	[p18l618t1250r622b1255],

1	Deng	NNP	PERSON	Deng	nn	3	SENT_1109	[p18l642t1230r781b1263],
2	]	NNP	O	]	nn	3	SENT_1109	[p18l642t1230r781b1263],
3	W	NNP	O	W	_	0	SENT_1109	[p18l642t1230r781b1263],
4	,	,	O	,	_	0	SENT_1109	[p18l642t1230r781b1263],
5	Song	NN	O	song	nsubj	6	SENT_1109	[p18l790t1230r860b1263],
6	IS	VBZ	O	be	dep	3	SENT_1109	[p18l865t1230r903b1260],
7	,	,	O	,	_	0	SENT_1109	[p18l865t1230r903b1260],
8	Shin	NNP	PERSON	Shin	nn	10	SENT_1109	[p18l912t1229r974b1255],
9	H	NNP	PERSON	H	nn	10	SENT_1109	[p18l980t1230r1028b1261],
10	]	NN	O	]	appos	3	SENT_1109	[p18l980t1230r1028b1261],
11	,	,	O	,	_	0	SENT_1109	[p18l980t1230r1028b1261],
12	Yeo	NNP	ORGANIZATION	Yeo	nn	13	SENT_1109	[p18l1035t1230r1089b1255],
13	CW	NNP	ORGANIZATION	CW	appos	3	SENT_1109	[p18l1097t1230r1164b1260],
14	,	,	O	,	_	0	SENT_1109	[p18l1097t1230r1164b1260],
15	Cho	NNP	PERSON	Cho	nn	16	SENT_1109	[p18l1172t1229r1232b1255],
16	DY	NNP	PERSON	DY	appos	3	SENT_1109	[p18l1239t1230r1294b1260],
17	,	,	O	,	_	0	SENT_1109	[p18l1239t1230r1294b1260],
18	et	FW	O	et	nn	19	SENT_1109	[p18l1303t1236r1328b1255],
19	al.	FW	O	al.	appos	3	SENT_1109	[p18l1334t1229r1364b1255],
20	2	CD	NUMBER	2	number	21	SENT_1109	[p18l1372t1231r1385b1254],
21	008	CD	NUMBER	008	dep	19	SENT_1109	[p18l1390t1231r1447b1255],
22	.	.	O	.	_	0	SENT_1109	[p18l1390t1231r1447b1255],

1	The	DT	O	the	det	2	SENT_1110	[p18l1454t1229r1513b1255],
2	effect	NN	O	effect	nsubj	18	SENT_1110	[p18l1520t1229r1595b1255],
3	of	IN	O	of	_	0	SENT_1110	[p18l1601t1229r1632b1255],
4	SLCO	NNP	O	SLCO	nn	5	SENT_1110	[p18l1636t1230r1727b1255],
5	1B	NN	O	1b	prep_of	2	SENT_1110	[p18l1732t1230r1765b1254],
6	1	CD	NUMBER	1	num	5	SENT_1110	[p18l1771t1231r1780b1254],
7	*	CD	NUMBER	*	number	8	SENT_1110	[p18l1785t1230r1796b1242],
8	15	CD	NUMBER	15	npadvmod	5	SENT_1110	[p18l1803t1230r1831b1255],
9	on	IN	O	on	_	0	SENT_1110	[p18l1840t1239r1875b1255],
10	the	DT	O	the	det	11	SENT_1110	[p18l1881t1229r1925b1255],
11	disposition	NN	O	disposition	prep_on	5	SENT_1110	[p18l1932t1229r2084b1263],
12	of	IN	O	of	_	0	SENT_1110	[p18l642t1274r673b1300],
13	pravastatin	NN	O	pravastatin	prep_of	11	SENT_1110	[p18l678t1276r829b1309],
14	and	CC	O	and	_	0	SENT_1110	[p18l839t1274r888b1300],
15	pitavastatin	NN	O	pitavastatin	prep_of	11	SENT_1110	[p18l898t1276r1057b1309],
16	is	VBZ	O	be	cop	18	SENT_1110	[p18l1065t1276r1085b1300],
17	substrate	JJ	O	substrate	amod	18	SENT_1110	[p18l1095t1274r1219b1300],
18	dependent	JJ	O	dependent	_	0	SENT_1110	[p18l1229t1274r1382b1309],
19	:	:	O	:	_	0	SENT_1110	[p18l1229t1274r1382b1309],
20	The	DT	O	the	det	21	SENT_1110	[p18l1392t1274r1451b1300],
21	contribution	NN	O	contribution	dep	18	SENT_1110	[p18l1461t1274r1636b1300],
22	of	IN	O	of	_	0	SENT_1110	[p18l1646t1274r1676b1300],
23	transporting	VBG	O	transport	prepc_of	21	SENT_1110	[p18l1682t1275r1855b1309],
24	activity	NN	O	activity	nn	25	SENT_1110	[p18l1864t1275r1965b1309],
25	changes	NNS	O	change	dobj	23	SENT_1110	[p18l1974t1274r2083b1309],
26	by	IN	O	by	_	0	SENT_1110	[p18l642t1317r676b1352],
27	SLCO1Bl	NN	O	slco1bl	prep_by	23	SENT_1110	[p18l685t1318r845b1343],
28	*	CD	NUMBER	*	number	29	SENT_1110	[p18l685t1318r845b1343],
29	15	CD	NUMBER	15	num	27	SENT_1110	[p18l852t1318r890b1343],
30	.	.	O	.	_	0	SENT_1110	[p18l852t1318r890b1343],

1	P/mwmicogenet	NN	O	p/mwmicogenet	_	0	SENT_1111	[p18l900t1318r1103b1352],
2	.	.	O	.	_	0	SENT_1111	[p18l900t1318r1103b1352],

1	Genomicx	NN	O	genomicx	nn	2	SENT_1112	[p18l1117t1318r1239b1343],
2	l8	NN	O	l8	_	0	SENT_1112	[p18l1251t1318r1389b1343],
3	:424	CD	NUMBER	:424	num	7	SENT_1112	[p18l1251t1318r1389b1343],
4	—	CD	NUMBER	—	num	7	SENT_1112	[p18l1251t1318r1389b1343],
5	33	CD	NUMBER	33	num	7	SENT_1112	[p18l1251t1318r1389b1343],
6	Lee	NNP	O	Lee	nn	7	SENT_1112	[p18l642t1361r694b1386],
7	E	NNP	O	E	dep	2	SENT_1112	[p18l705t1361r734b1391],
8	,	,	O	,	_	0	SENT_1112	[p18l705t1361r734b1391],
9	Ryan	NNP	PERSON	Ryan	nn	10	SENT_1112	[p18l746t1361r817b1394],
10	S	NNP	PERSON	S	appos	7	SENT_1112	[p18l829t1361r852b1391],
11	,	,	O	,	_	0	SENT_1112	[p18l829t1361r852b1391],
12	Birmingham	NNP	LOCATION	Birmingham	nn	13	SENT_1112	[p18l864t1360r1040b1394],
13	B	NNP	O	B	appos	7	SENT_1112	[p18l1051t1361r1078b1391],
14	,	,	O	,	_	0	SENT_1112	[p18l1051t1361r1078b1391],
15	Zalikowski	NNP	PERSON	Zalikowski	nn	16	SENT_1112	[p18l1090t1360r1241b1386],
16	]	NNP	O	]	appos	7	SENT_1112	[p18l1247t1361r1270b1392],
17	,	,	O	,	_	0	SENT_1112	[p18l1247t1361r1270b1392],
18	March	NNP	DATE	March	nn	19	SENT_1112	[p18l1280t1360r1374b1386],
19	R	NNP	O	R	appos	7	SENT_1112	[p18l1384t1361r1414b1391],
20	,	,	O	,	_	0	SENT_1112	[p18l1384t1361r1414b1391],
21	et	FW	O	et	nn	22	SENT_1112	[p18l1426t1367r1452b1386],
22	al.	FW	O	al.	appos	7	SENT_1112	[p18l1462t1360r1491b1386],
23	2005	CD	DATE	2005	dep	22	SENT_1112	[p18l1504t1361r1578b1386],
24	.	.	O	.	_	0	SENT_1112	[p18l1504t1361r1578b1386],

1	Rosuvastatin	NNP	O	Rosuvastatin	nn	2	SENT_1113	[p18l1591t1361r1768b1386],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_1113	[p18l1778t1360r2022b1394],
3	and	CC	O	and	_	0	SENT_1113	[p18l2034t1360r2083b1386],
4	pharmacogenetics	NNS	O	pharmacogenetic	conj_and	2	SENT_1113	[p18l642t1402r893b1437],
5	in	IN	O	in	_	0	SENT_1113	[p18l903t1403r930b1428],
6	white	JJ	O	white	amod	9	SENT_1113	[p18l939t1402r1016b1428],
7	and	CC	O	and	_	0	SENT_1113	[p18l1027t1402r1076b1428],
8	Asian	JJ	MISC	asian	amod	9	SENT_1113	[p18l1086t1403r1162b1428],
9	subjects	NNS	O	subject	prep_in	4	SENT_1113	[p18l1173t1402r1281b1437],
10	residing	VBG	O	reside	partmod	2	SENT_1113	[p18l1291t1402r1404b1437],
11	in	IN	O	in	_	0	SENT_1113	[p18l1413t1404r1440b1428],
12	the	DT	O	the	det	14	SENT_1113	[p18l1450t1402r1493b1428],
13	same	JJ	O	same	amod	14	SENT_1113	[p18l1504t1412r1572b1428],
14	environment	NN	O	environment	prep_in	10	SENT_1113	[p18l1583t1404r1769b1428],
15	.	.	O	.	_	0	SENT_1113	[p18l1583t1404r1769b1428],

1	Clin	NNP	O	Clin	_	0	SENT_1114	[p18l1782t1403r1842b1428],
2	.	.	O	.	_	0	SENT_1114	[p18l1782t1403r1842b1428],

1	Pbmmizcol	NNP	O	Pbmmizcol	_	0	SENT_1115	[p18l1855t1403r1998b1428],
2	.	.	O	.	_	0	SENT_1115	[p18l1855t1403r1998b1428],

1	T/yer	NN	O	t/yer	_	0	SENT_1116	[p18l2013t1403r2081b1428],
2	.	.	O	.	_	0	SENT_1116	[p18l2013t1403r2081b1428],

1	78:3	CD	NUMBER	78:3	number	2	SENT_1117	[p18l643t1446r698b1471],
2	3	CD	NUMBER	3	num	3	SENT_1117	[p18l704t1446r715b1471],
3	0-41	CD	NUMBER	0-41	_	0	SENT_1117	[p18l720t1446r783b1471],
4	Choi	NNP	O	Choi	nn	6	SENT_1117	[p18l642t1487r770b1519],
5	]	CD	NUMBER	]	num	6	SENT_1117	[p18l642t1487r770b1519],
6	H	NN	O	h	dep	3	SENT_1117	[p18l642t1487r770b1519],
7	,	,	O	,	_	0	SENT_1117	[p18l642t1487r770b1519],
8	Lee	NNP	PERSON	Lee	nn	9	SENT_1117	[p18l782t1488r834b1513],
9	MG	NN	O	mg	appos	6	SENT_1117	[p18l843t1488r911b1518],
10	,	,	O	,	_	0	SENT_1117	[p18l843t1488r911b1518],
11	Cho	NNP	PERSON	Cho	nn	13	SENT_1117	[p18l924t1487r983b1513],
12	]	CD	NUMBER	]	num	13	SENT_1117	[p18l990t1488r1035b1519],
13	Y	NN	O	y	appos	6	SENT_1117	[p18l990t1488r1035b1519],
14	,	,	O	,	_	0	SENT_1117	[p18l990t1488r1035b1519],
15	Lee	NNP	PERSON	Lee	nn	17	SENT_1117	[p18l1047t1488r1099b1513],
16	]	CD	NUMBER	]	num	17	SENT_1117	[p18l1106t1488r1151b1519],
17	E	NN	O	e	appos	6	SENT_1117	[p18l1106t1488r1151b1519],
18	,	,	O	,	_	0	SENT_1117	[p18l1106t1488r1151b1519],
19	Kim	NNP	PERSON	Kim	nn	20	SENT_1117	[p18l1163t1488r1224b1512],
20	KH	NNP	O	KH	appos	6	SENT_1117	[p18l1235t1488r1295b1518],
21	,	,	O	,	_	0	SENT_1117	[p18l1235t1488r1295b1518],
22	Park	NNP	O	Park	nn	23	SENT_1117	[p18l1307t1487r1373b1513],
23	K.	NNP	O	K.	appos	6	SENT_1117	[p18l1382t1488r1414b1512],
24	2008	CD	DATE	2008	dep	23	SENT_1117	[p18l1426t1489r1501b1513],
25	.	.	O	.	_	0	SENT_1117	[p18l1426t1489r1501b1513],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_1118	[p18l1513t1487r1643b1513],
2	of	IN	O	of	_	0	SENT_1118	[p18l1655t1487r1685b1513],
3	OATPlBl	NNP	O	OATPlBl	nn	4	SENT_1118	[p18l1693t1488r1841b1513],
4	genotype	NN	O	genotype	prep_of	1	SENT_1118	[p18l1855t1494r1982b1521],
5	on	IN	O	on	_	0	SENT_1118	[p18l1994t1497r2029b1513],
6	the	DT	O	the	det	7	SENT_1118	[p18l2040t1487r2083b1513],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_1118	[p18l641t1529r886b1563],
8	of	IN	O	of	_	0	SENT_1118	[p18l897t1529r927b1555],
9	rosuvastatin	NN	O	rosuvastatin	prep_of	7	SENT_1118	[p18l933t1530r1100b1555],
10	in	IN	O	in	_	0	SENT_1118	[p18l1110t1530r1136b1555],
11	Koreans	NNPS	LOCATION	Koreans	prep_in	1	SENT_1118	[p18l1146t1530r1269b1555],
12	.	.	O	.	_	0	SENT_1118	[p18l1146t1530r1269b1555],

1	Clin	NNP	O	Clin	_	0	SENT_1119	[p18l1282t1530r1342b1555],
2	.	.	O	.	_	0	SENT_1119	[p18l1282t1530r1342b1555],

1	Plmrmzzcol	NN	O	plmrmzzcol	_	0	SENT_1120	[p18l1354t1530r1498b1555],
2	.	.	O	.	_	0	SENT_1120	[p18l1354t1530r1498b1555],

1	T/Jer	NN	O	t/jer	_	0	SENT_1121	[p18l1512t1530r1580b1555],
2	.	.	O	.	_	0	SENT_1121	[p18l1512t1530r1580b1555],

1	83:25	CD	NUMBER	83:25	num	5	SENT_1122	[p18l1593t1530r1666b1555],
2	1-5	CD	NUMBER	1-5	num	5	SENT_1122	[p18l1673t1530r1718b1555],
3	7	CD	NUMBER	7	num	5	SENT_1122	[p18l1722t1530r1735b1555],
4	Pasanen	NNP	ORGANIZATION	Pasanen	nn	5	SENT_1122	[p18l642t1572r756b1597],
5	MK	NNP	ORGANIZATION	MK	_	0	SENT_1122	[p18l764t1572r829b1603],
6	,	,	O	,	_	0	SENT_1122	[p18l764t1572r829b1603],
7	Neuvonen	NNP	O	Neuvonen	nn	8	SENT_1122	[p18l839t1572r986b1597],
8	M	NNP	O	M	appos	5	SENT_1122	[p18l995t1572r1034b1603],
9	,	,	O	,	_	0	SENT_1122	[p18l995t1572r1034b1603],
10	Neuvonen	NNP	PERSON	Neuvonen	nn	12	SENT_1122	[p18l1045t1572r1192b1597],
11	P	NN	O	p	nn	12	SENT_1122	[p18l1201t1572r1241b1604],
12	]	NN	O	]	appos	5	SENT_1122	[p18l1201t1572r1241b1604],
13	,	,	O	,	_	0	SENT_1122	[p18l1201t1572r1241b1604],
14	Niemi	NNP	PERSON	Niemi	nn	15	SENT_1122	[p18l1251t1572r1341b1597],
15	M.	NNP	O	M.	appos	5	SENT_1122	[p18l1349t1572r1389b1597],
16	2006	CD	DATE	2006	dep	15	SENT_1122	[p18l1400t1573r1475b1597],
17	.	.	O	.	_	0	SENT_1122	[p18l1400t1573r1475b1597],

1	SLCOlB1	NN	O	slcolb1	nn	2	SENT_1123	[p18l1487t1572r1632b1597],
2	polymorphism	NN	O	polymorphism	nsubj	4	SENT_1123	[p18l1645t1571r1848b1606],
3	markedly	RB	O	markedly	advmod	4	SENT_1123	[p18l1858t1571r1989b1606],
4	affects	VBZ	O	affect	_	0	SENT_1123	[p18l1997t1571r2083b1597],
5	the	DT	O	the	det	6	SENT_1123	[p18l642t1614r685b1640],
6	pharmacokinetics	NNS	O	pharmacokinetic	dobj	4	SENT_1123	[p18l695t1614r940b1648],
7	of	IN	O	of	_	0	SENT_1123	[p18l950t1614r981b1640],
8	simvastatin	NN	O	simvastatin	nn	9	SENT_1123	[p18l987t1615r1142b1640],
9	acid	NN	O	acid	prep_of	6	SENT_1123	[p18l1152t1614r1214b1640],
10	.	.	O	.	_	0	SENT_1123	[p18l1152t1614r1214b1640],

1	Pbizrmizcogenet	NNP	O	Pbizrmizcogenet	_	0	SENT_1124	[p18l1225t1615r1428b1649],
2	.	.	O	.	_	0	SENT_1124	[p18l1225t1615r1428b1649],

1	Genomicx	NN	O	genomicx	_	0	SENT_1125	[p18l1442t1615r1563b1640],
2	16:873	CD	NUMBER	16:873	number	3	SENT_1125	[p18l1575t1615r1716b1640],
3	—	CD	NUMBER	—	dep	1	SENT_1125	[p18l1575t1615r1716b1640],
4	79	CD	NUMBER	79	num	5	SENT_1125	[p18l1575t1615r1716b1640],
5	Link	NN	O	link	dep	3	SENT_1125	[p18l642t1656r709b1682],
6	E	NN	O	e	dep	1	SENT_1125	[p18l719t1657r748b1688],
7	,	,	O	,	_	0	SENT_1125	[p18l719t1657r748b1688],
8	Parish	NNP	O	Parish	nn	9	SENT_1125	[p18l760t1656r848b1682],
9	S	NNP	O	S	appos	6	SENT_1125	[p18l860t1657r883b1688],
10	,	,	O	,	_	0	SENT_1125	[p18l860t1657r883b1688],
11	Armitage	NNP	PERSON	Armitage	nn	12	SENT_1125	[p18l894t1657r1024b1691],
12	]	NNP	O	]	appos	6	SENT_1125	[p18l1032t1657r1054b1689],
13	,	,	O	,	_	0	SENT_1125	[p18l1032t1657r1054b1689],
14	Bowman	NNP	PERSON	Bowman	nn	15	SENT_1125	[p18l1067t1657r1189b1682],
15	L	NNP	PERSON	L	appos	6	SENT_1125	[p18l1200t1657r1229b1688],
16	,	,	O	,	_	0	SENT_1125	[p18l1200t1657r1229b1688],
17	Heath	NNP	PERSON	Heath	nn	18	SENT_1125	[p18l1242t1656r1329b1682],
18	S	NNP	O	S	appos	6	SENT_1125	[p18l1341t1657r1365b1688],
19	,	,	O	,	_	0	SENT_1125	[p18l1341t1657r1365b1688],
20	et	FW	O	et	nn	21	SENT_1125	[p18l1378t1663r1403b1682],
21	al.	FW	O	al.	appos	6	SENT_1125	[p18l1414t1656r1443b1682],
22	2008	CD	DATE	2008	dep	21	SENT_1125	[p18l1457t1658r1531b1682],
23	.	.	O	.	_	0	SENT_1125	[p18l1457t1658r1531b1682],

1	SLCO1B1	NN	O	slco1b1	nn	2	SENT_1126	[p18l1545t1657r1689b1682],
2	variants	NNS	O	variant	nsubj	6	SENT_1126	[p18l1702t1657r1811b1682],
3	and	CC	O	and	_	0	SENT_1126	[p18l1823t1656r1872b1682],
4	statin	NN	O	statin	nn	5	SENT_1126	[p18l1884t1656r2083b1682],
5	—	NN	O	—	nsubj	6	SENT_1126	[p18l1884t1656r2083b1682],
6	induced	VBD	O	induce	_	0	SENT_1126	[p18l1884t1656r2083b1682],
7	myopathy	JJ	O	myopathy	amod	8	SENT_1126	[p18l642t1699r828b1734],
8	—	NN	O	—	iobj	6	SENT_1126	[p18l642t1699r828b1734],
9	a	DT	O	a	det	11	SENT_1126	[p18l642t1699r828b1734],
10	genomewide	JJ	O	genomewide	amod	11	SENT_1126	[p18l838t1699r1014b1734],
11	study	NN	O	study	dobj	6	SENT_1126	[p18l1025t1699r1105b1734],
12	.	.	O	.	_	0	SENT_1126	[p18l1025t1699r1105b1734],

1	N.	NNP	O	N.	nn	2	SENT_1127	[p18l1116t1700r1147b1725],
2	Engl	NNP	O	Engl	_	0	SENT_1127	[p18l1159t1700r1226b1734],
3	.	.	O	.	_	0	SENT_1127	[p18l1159t1700r1226b1734],

1	@T	NN	O	@t	_	0	SENT_1128	[p18l1234t1700r1260b1733],
2	]	NN	O	]	dep	1	SENT_1128	[p18l1234t1700r1260b1733],
3	+	CC	O	+	_	0	SENT_1128	[p18l1234t1700r1260b1733],
4	Med	NNP	O	Med	dep	1	SENT_1128	[p18l1271t1700r1336b1725],
5	.	.	O	.	_	0	SENT_1128	[p18l1271t1700r1336b1725],

1	35	CD	NUMBER	35	number	2	SENT_1129	[p18l1350t1700r1380b1725],
2	9:789	CD	NUMBER	9:789	num	4	SENT_1129	[p18l1383t1700r1510b1725],
3	—	CD	NUMBER	—	number	4	SENT_1129	[p18l1383t1700r1510b1725],
4	99	CD	NUMBER	99	_	0	SENT_1129	[p18l1383t1700r1510b1725],
5	Marciante	NNP	ORGANIZATION	Marciante	nn	6	SENT_1129	[p18l640t1743r783b1768],
6	KD	NN	ORGANIZATION	kd	dep	4	SENT_1129	[p18l795t1743r854b1773],
7	,	,	O	,	_	0	SENT_1129	[p18l795t1743r854b1773],
8	Durda	NNP	PERSON	Durda	nn	10	SENT_1129	[p18l867t1742r956b1768],
9	]	CD	NUMBER	]	num	10	SENT_1129	[p18l963t1743r1007b1774],
10	P	NN	O	p	appos	6	SENT_1129	[p18l963t1743r1007b1774],
11	,	,	O	,	_	0	SENT_1129	[p18l963t1743r1007b1774],
12	Heckbert	NNP	O	Heckbert	nn	13	SENT_1129	[p18l1019t1742r1151b1768],
13	SR	NN	O	sr	appos	6	SENT_1129	[p18l1163t1743r1210b1773],
14	,	,	O	,	_	0	SENT_1129	[p18l1163t1743r1210b1773],
15	Lumley	NNP	PERSON	Lumley	nn	16	SENT_1129	[p18l1222t1742r1331b1776],
16	T	NN	O	t	appos	6	SENT_1129	[p18l1340t1743r1373b1773],
17	,	,	O	,	_	0	SENT_1129	[p18l1340t1743r1373b1773],
18	Rice	NNP	ORGANIZATION	Rice	nn	19	SENT_1129	[p18l1385t1743r1446b1768],
19	K	NNP	ORGANIZATION	K	appos	6	SENT_1129	[p18l1457t1743r1489b1773],
20	,	,	O	,	_	0	SENT_1129	[p18l1457t1743r1489b1773],
21	et	FW	O	et	nn	22	SENT_1129	[p18l1502t1749r1527b1768],
22	al.	FW	O	al.	appos	6	SENT_1129	[p18l1538t1742r1567b1768],
23	2011	CD	DATE	2011	dep	22	SENT_1129	[p18l1580t1744r1655b1767],
24	.	.	O	.	_	0	SENT_1129	[p18l1580t1744r1655b1767],

1	Cerivastatin	NNP	O	Cerivastatin	_	0	SENT_1130	[p18l1668t1743r1843b1773],
2	,	,	O	,	_	0	SENT_1130	[p18l1668t1743r1843b1773],
3	genetic	JJ	O	genetic	amod	4	SENT_1130	[p18l1856t1743r1956b1776],
4	variants	NNS	O	variant	conj_and	1	SENT_1130	[p18l1966t1743r2082b1773],
5	,	,	O	,	_	0	SENT_1130	[p18l1966t1743r2082b1773],
6	and	CC	O	and	_	0	SENT_1130	[p18l642t1788r691b1813],
7	the	DT	O	the	det	8	SENT_1130	[p18l701t1787r745b1813],
8	risk	NN	O	risk	conj_and	1	SENT_1130	[p18l755t1787r806b1813],
9	of	IN	O	of	_	0	SENT_1130	[p18l815t1788r846b1813],
10	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	8	SENT_1130	[p18l851t1787r1078b1822],
11	.	.	O	.	_	0	SENT_1130	[p18l851t1787r1078b1822],

1	P/mimiicogenet	NN	O	p/mimiicogenet	_	0	SENT_1131	[p18l1088t1788r1291b1822],
2	.	.	O	.	_	0	SENT_1131	[p18l1088t1788r1291b1822],

1	Genomic	JJ	O	genomic	_	0	SENT_1132	[p18l1305t1788r1427b1813],
2	:	:	O	:	_	0	SENT_1132	[p18l1305t1788r1427b1813],
3	21:280	CD	NUMBER	21:280	num	7	SENT_1132	[p18l1436t1789r1579b1813],
4	—	CD	NUMBER	—	num	7	SENT_1132	[p18l1436t1789r1579b1813],
5	88	CD	NUMBER	88	num	7	SENT_1132	[p18l1436t1789r1579b1813],
6	Brunham	NNP	ORGANIZATION	Brunham	nn	7	SENT_1132	[p18l642t1830r772b1856],
7	LR	NNP	ORGANIZATION	LR	dep	1	SENT_1132	[p18l781t1831r834b1861],
8	,	,	O	,	_	0	SENT_1132	[p18l781t1831r834b1861],
9	Lansberg	NNP	PERSON	Lansberg	nn	11	SENT_1132	[p18l844t1830r975b1864],
10	P	NN	O	p	nn	11	SENT_1132	[p18l984t1831r1023b1862],
11	]	NN	O	]	appos	7	SENT_1132	[p18l984t1831r1023b1862],
12	,	,	O	,	_	0	SENT_1132	[p18l984t1831r1023b1862],
13	Zhang	NNP	PERSON	Zhang	nn	14	SENT_1132	[p18l1034t1830r1125b1864],
14	L	NNP	PERSON	L	appos	7	SENT_1132	[p18l1134t1831r1163b1861],
15	,	,	O	,	_	0	SENT_1132	[p18l1134t1831r1163b1861],
16	Miao	NNP	PERSON	Miao	nn	17	SENT_1132	[p18l1172t1831r1245b1856],
17	F	NN	O	f	appos	7	SENT_1132	[p18l1255t1831r1281b1861],
18	,	,	O	,	_	0	SENT_1132	[p18l1255t1831r1281b1861],
19	Carter	NNP	PERSON	Carter	nn	20	SENT_1132	[p18l1293t1831r1383b1856],
20	C	NNP	O	C	appos	7	SENT_1132	[p18l1393t1831r1424b1861],
21	,	,	O	,	_	0	SENT_1132	[p18l1393t1831r1424b1861],
22	et	FW	O	et	nn	23	SENT_1132	[p18l1435t1837r1460b1856],
23	al.	FW	O	al.	appos	7	SENT_1132	[p18l1469t1830r1498b1856],
24	2011	CD	DATE	2011	dep	23	SENT_1132	[p18l1509t1831r1584b1856],
25	.	.	O	.	_	0	SENT_1132	[p18l1509t1831r1584b1856],

1	Dilferential	JJ	O	dilferential	amod	2	SENT_1133	[p18l1595t1830r1756b1856],
2	effect	NN	O	effect	nsubj	12	SENT_1133	[p18l1766t1830r1841b1856],
3	of	IN	O	of	_	0	SENT_1133	[p18l1850t1830r1880b1856],
4	the	DT	O	the	det	7	SENT_1133	[p18l1886t1830r1929b1856],
5	rs414905	NN	O	rs414905	nn	7	SENT_1133	[p18l1939t1831r2064b1856],
6	6	CD	NUMBER	6	num	7	SENT_1133	[p18l2068t1831r2083b1856],
7	variant	NN	O	variant	prep_of	2	SENT_1133	[p18l641t1876r738b1901],
8	in	IN	O	in	_	0	SENT_1133	[p18l747t1876r774b1900],
9	SLCOlBl	NN	O	slcolbl	prep_in	7	SENT_1133	[p18l786t1876r931b1901],
10	on	IN	O	on	_	0	SENT_1133	[p18l945t1885r979b1901],
11	myopathy	NN	O	myopathy	prep_on	9	SENT_1133	[p18l990t1875r1129b1909],
12	associated	VBN	O	associate	_	0	SENT_1133	[p18l1139t1875r1278b1901],
13	with	IN	O	with	_	0	SENT_1133	[p18l1287t1875r1349b1901],
14	simvastatin	NN	O	simvastatin	prep_with	12	SENT_1133	[p18l1360t1876r1515b1901],
15	and	CC	O	and	_	0	SENT_1133	[p18l1526t1875r1575b1901],
16	atorvastatin	NN	O	atorvastatin	conj_and	14	SENT_1133	[p18l1586t1876r1755b1901],
17	.	.	O	.	_	0	SENT_1133	[p18l1586t1876r1755b1901],

1	P/Jammcogenomics	NNS	O	p/jammcogenomics	_	0	SENT_1134	[p18l1766t1875r2041b1910],
2	]	CD	NUMBER	]	num	1	SENT_1134	[p18l1766t1875r2041b1910],
3	.	.	O	.	_	0	SENT_1134	[p18l1766t1875r2041b1910],

1	In	IN	O	in	dep	10	SENT_1135	[p18l2054t1876r2084b1900],
2	press	NN	O	press	pobj	1	SENT_1135	[p18l642t1930r719b1955],
3	,	,	O	,	_	0	SENT_1135	[p18l642t1930r719b1955],
4	d0i	NN	O	d0us	appos	2	SENT_1135	[p18l730t1920r1062b1955],
5	:10.1038	CD	NUMBER	:10.1038	num	4	SENT_1135	[p18l730t1920r1062b1955],
6	/	:	O	/	punct	10	SENT_1135	[p18l730t1920r1062b1955],
7	tpj	NN	O	tpj	nn	10	SENT_1135	[p18l730t1920r1062b1955],
8	.2010.92	CD	NUMBER	.2010.92	num	10	SENT_1135	[p18l730t1920r1062b1955],
9	Voora	NN	ORGANIZATION	voora	nn	10	SENT_1135	[p18l640t1966r728b1991],
10	D	NN	ORGANIZATION	d	_	0	SENT_1135	[p18l744t1966r777b1996],
11	,	,	O	,	_	0	SENT_1135	[p18l744t1966r777b1996],
12	Shah	NNP	PERSON	Shah	nn	13	SENT_1135	[p18l794t1965r862b1991],
13	SH	NNP	O	SH	appos	10	SENT_1135	[p18l878t1966r931b1996],
14	,	,	O	,	_	0	SENT_1135	[p18l878t1966r931b1996],
15	Spasojevic	NNP	PERSON	Spasojevic	appos	10	SENT_1135	[p18l948t1966r1090b1999],
16	1	CD	NUMBER	1	num	15	SENT_1135	[p18l1105t1966r1123b1996],
17	,	,	O	,	_	0	SENT_1135	[p18l1105t1966r1123b1996],
18	Ali	NNP	PERSON	Ali	nn	19	SENT_1135	[p18l1138t1965r1179b1990],
19	S	NNP	O	S	appos	10	SENT_1135	[p18l1195t1966r1218b1996],
20	,	,	O	,	_	0	SENT_1135	[p18l1195t1966r1218b1996],
21	Reed	NNP	ORGANIZATION	Reed	nn	22	SENT_1135	[p18l1235t1965r1305b1991],
22	CR	NN	ORGANIZATION	cr	appos	10	SENT_1135	[p18l1321t1966r1375b1996],
23	,	,	O	,	_	0	SENT_1135	[p18l1321t1966r1375b1996],
24	et	FW	O	et	nn	25	SENT_1135	[p18l1391t1972r1417b1991],
25	al.	FW	O	al.	appos	10	SENT_1135	[p18l1431t1965r1461b1991],
26	2009	CD	DATE	2009	dep	25	SENT_1135	[p18l1477t1966r1552b1991],
27	.	.	O	.	_	0	SENT_1135	[p18l1477t1966r1552b1991],

1	The	DT	O	the	det	3	SENT_1136	[p18l1567t1965r1626b1991],
2	SLCO1B1	NN	O	slco1b1	nn	3	SENT_1136	[p18l1643t1966r1821b1991],
3	*	NN	O	*	nsubj	12	SENT_1136	[p18l1643t1966r1821b1991],
4	5	CD	NUMBER	5	num	6	SENT_1136	[p18l1643t1966r1821b1991],
5	genetic	JJ	O	genetic	amod	6	SENT_1136	[p18l1838t1966r1938b1999],
6	variant	NN	O	variant	nsubjpass	8	SENT_1136	[p18l1952t1966r2049b1991],
7	is	VBZ	O	be	auxpass	8	SENT_1136	[p18l2063t1966r2083b1991],
8	associated	VBN	O	associate	rcmod	3	SENT_1136	[p18l642t2011r780b2036],
9	with	IN	O	with	_	0	SENT_1136	[p18l790t2011r852b2036],
10	statin	NN	O	statin	nn	11	SENT_1136	[p18l861t2010r1061b2036],
11	—	NN	O	—	prep_with	8	SENT_1136	[p18l861t2010r1061b2036],
12	induced	VBD	O	induce	_	0	SENT_1136	[p18l861t2010r1061b2036],
13	side	JJ	O	side	amod	14	SENT_1136	[p18l1071t2010r1124b2036],
14	effects	NNS	O	effect	dobj	12	SENT_1136	[p18l1135t2011r1260b2045],
15	.	.	O	.	_	0	SENT_1136	[p18l1135t2011r1260b2045],

1	Am	NNP	O	Am	_	0	SENT_1137	[p18l1270t2011r1326b2036],
2	.	.	O	.	_	0	SENT_1137	[p18l1270t2011r1326b2036],

1	Coll	NNP	PERSON	Coll	_	0	SENT_1138	[p18l1340t2011r1396b2036],
2	.	.	O	.	_	0	SENT_1138	[p18l1340t2011r1396b2036],

1	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_1139	[p18l1410t2011r1510b2036],
2	.	.	O	.	_	0	SENT_1139	[p18l1410t2011r1510b2036],

1	5	CD	NUMBER	5	number	2	SENT_1140	[p18l1524t2012r1537b2036],
2	4:1609	CD	NUMBER	4:1609	num	3	SENT_1140	[p18l1540t2012r1684b2037],
3	—	NN	O	—	_	0	SENT_1140	[p18l1540t2012r1684b2037],
4	16	CD	NUMBER	16	num	6	SENT_1140	[p18l1540t2012r1684b2037],
5	Donnelly	NNP	ORGANIZATION	Donnelly	nn	6	SENT_1140	[p18l642t2055r774b2089],
6	LA	NNP	ORGANIZATION	LA	dep	3	SENT_1140	[p18l784t2056r835b2086],
7	,	,	O	,	_	0	SENT_1140	[p18l784t2056r835b2086],
8	Doney	NNP	PERSON	Doney	nn	9	SENT_1140	[p18l847t2056r942b2089],
9	AS	NNP	O	AS	appos	6	SENT_1140	[p18l950t2056r998b2086],
10	,	,	O	,	_	0	SENT_1140	[p18l950t2056r998b2086],
11	Tavendale	NNP	ORGANIZATION	Tavendale	nn	12	SENT_1140	[p18l1009t2055r1156b2081],
12	R	NNP	ORGANIZATION	R	appos	6	SENT_1140	[p18l1167t2056r1196b2086],
13	,	,	O	,	_	0	SENT_1140	[p18l1167t2056r1196b2086],
14	Lang	NNP	ORGANIZATION	Lang	nn	15	SENT_1140	[p18l1208t2056r1281b2089],
15	CC	NN	ORGANIZATION	cc	appos	6	SENT_1140	[p18l1292t2056r1348b2086],
16	,	,	O	,	_	0	SENT_1140	[p18l1292t2056r1348b2086],
17	Pearson	NNP	ORGANIZATION	Pearson	nn	18	SENT_1140	[p18l1359t2056r1471b2081],
18	ER	NN	ORGANIZATION	er	appos	6	SENT_1140	[p18l1482t2056r1534b2086],
19	,	,	O	,	_	0	SENT_1140	[p18l1482t2056r1534b2086],
20	et	FW	O	et	nn	21	SENT_1140	[p18l1546t2062r1572b2081],
21	al.	FW	O	al.	appos	6	SENT_1140	[p18l1582t2055r1612b2081],
22	2011	CD	DATE	2011	dep	21	SENT_1140	[p18l1624t2056r1699b2081],
23	.	.	O	.	_	0	SENT_1140	[p18l1624t2056r1699b2081],

1	Common	JJ	O	common	amod	3	SENT_1141	[p18l1712t2056r1845b2081],
2	nonsynonymous	JJ	O	nonsynonymous	amod	3	SENT_1141	[p18l1855t2064r2083b2089],
3	substitutions	NNS	O	substitution	nsubj	6	SENT_1141	[p18l642t2101r818b2126],
4	in	IN	O	in	_	0	SENT_1141	[p18l830t2102r857b2126],
5	SLCO1B1	NN	O	slco1b1	prep_in	3	SENT_1141	[p18l869t2102r1013b2126],
6	predispose	VBP	O	predispose	_	0	SENT_1141	[p18l1028t2101r1175b2135],
7	to	TO	O	to	_	0	SENT_1141	[p18l1187t2108r1214b2126],
8	statin	NN	O	statin	nn	9	SENT_1141	[p18l1225t2102r1301b2126],
9	intolerance	NN	O	intolerance	prep_to	6	SENT_1141	[p18l1312t2101r1468b2126],
10	in	IN	O	in	prep	9	SENT_1141	[p18l1479t2102r1506b2126],
11	routinely	RB	O	routinely	pcomp	10	SENT_1141	[p18l1517t2101r1645b2135],
12	treated	VBN	O	treat	partmod	9	SENT_1141	[p18l1655t2101r1752b2126],
13	individuals	NNS	O	individual	dobj	12	SENT_1141	[p18l1763t2101r1913b2126],
14	with	IN	O	with	_	0	SENT_1141	[p18l1924t2101r1986b2126],
15	type	NN	O	type	nn	17	SENT_1141	[p18l1997t2108r2056b2135],
16	2	CD	NUMBER	2	num	17	SENT_1141	[p18l2067t2102r2081b2126],
17	diabetes	NN	O	diabetes	prep_with	13	SENT_1141	[p18l642t2146r761b2172],
18	:	:	O	:	_	0	SENT_1141	[p18l642t2146r761b2172],
19	a	DT	O	a	det	20	SENT_1141	[p18l773t2156r786b2172],
20	go	NN	O	go	dep	13	SENT_1141	[p18l797t2146r959b2180],
21	.	.	O	.	_	0	SENT_1141	[p18l797t2146r959b2180],

1	—	NN	O	—	_	0	SENT_1142	[p18l797t2146r959b2180],
2	.	.	O	.	_	0	SENT_1142	[p18l797t2146r959b2180],

1	DARTS	NN	O	dart	_	0	SENT_1143	[p18l797t2146r959b2180],
2	study	NN	O	study	dep	1	SENT_1143	[p18l970t2146r1051b2180],
3	.	.	O	.	_	0	SENT_1143	[p18l970t2146r1051b2180],

1	Clin	NNP	O	Clin	_	0	SENT_1144	[p18l1064t2147r1124b2171],
2	.	.	O	.	_	0	SENT_1144	[p18l1064t2147r1124b2171],

1	P/mrmcicol	NN	O	p/mrmcicol	_	0	SENT_1145	[p18l1136t2147r1280b2171],
2	.	.	O	.	_	0	SENT_1145	[p18l1136t2147r1280b2171],

1	T/yer	NN	O	t/yer	_	0	SENT_1146	[p18l1294t2147r1362b2171],
2	.	.	O	.	_	0	SENT_1146	[p18l1294t2147r1362b2171],

1	89:210	CD	NUMBER	89:210	num	2	SENT_1147	[p18l1375t2147r1518b2172],
2	—	CD	NUMBER	—	_	0	SENT_1147	[p18l1375t2147r1518b2172],
3	16	CD	NUMBER	16	num	6	SENT_1147	[p18l1375t2147r1518b2172],
4	Knauer	NNP	PERSON	Knauer	nn	6	SENT_1147	[p18l642t2191r746b2216],
5	M	NN	O	m	nn	6	SENT_1147	[p18l755t2191r807b2222],
6	]	NN	O	]	dep	2	SENT_1147	[p18l755t2191r807b2222],
7	,	,	O	,	_	0	SENT_1147	[p18l755t2191r807b2222],
8	Urquhart	NNP	ORGANIZATION	Urquhart	nn	9	SENT_1147	[p18l819t2190r953b2224],
9	BL	NN	ORGANIZATION	bl	appos	6	SENT_1147	[p18l963t2191r1013b2221],
10	,	,	O	,	_	0	SENT_1147	[p18l963t2191r1013b2221],
11	Meyer	NNP	PERSON	Meyer	nn	13	SENT_1147	[p18l1025t2191r1117b2224],
12	zu	NNP	O	zu	nn	13	SENT_1147	[p18l1128t2200r1159b2216],
13	Schwabedissen	NNP	O	Schwabedissen	appos	6	SENT_1147	[p18l1172t2190r1378b2216],
14	HE	PRP	O	he	dep	2	SENT_1147	[p18l1389t2191r1447b2221],
15	,	,	O	,	_	0	SENT_1147	[p18l1389t2191r1447b2221],
16	Schwarz	NNP	PERSON	Schwarz	nn	17	SENT_1147	[p18l1461t2190r1576b2216],
17	UI	NNP	O	UI	appos	14	SENT_1147	[p18l1587t2191r1633b2221],
18	,	,	O	,	_	0	SENT_1147	[p18l1587t2191r1633b2221],
19	Lemke	NNP	PERSON	Lemke	nn	21	SENT_1147	[p18l1646t2190r1742b2216],
20	C	NNP	O	C	nn	21	SENT_1147	[p18l1755t2191r1798b2222],
21	]	NN	O	]	appos	2	SENT_1147	[p18l1755t2191r1798b2222],
22	,	,	O	,	_	0	SENT_1147	[p18l1755t2191r1798b2222],
23	et	FW	O	et	nn	24	SENT_1147	[p18l1811t2197r1836b2216],
24	al.	FW	O	al.	appos	2	SENT_1147	[p18l1847t2190r1877b2216],
25	2010	CD	DATE	2010	dep	24	SENT_1147	[p18l1890t2192r1964b2216],
26	.	.	O	.	_	0	SENT_1147	[p18l1890t2192r1964b2216],

1	Human	JJ	O	human	amod	5	SENT_1148	[p18l1977t2191r2084b2216],
2	skeletal	JJ	O	skeletal	amod	5	SENT_1148	[p18l642t2236r744b2261],
3	muscle	NN	O	muscle	nn	5	SENT_1148	[p18l753t2236r849b2261],
4	drug	NN	O	drug	nn	5	SENT_1148	[p18l858t2236r923b2270],
5	transporters	NNS	O	transporter	nsubj	6	SENT_1148	[p18l931t2243r1099b2270],
6	determine	VBP	O	determine	_	0	SENT_1148	[p18l1108t2236r1250b2261],
7	local	JJ	O	local	amod	8	SENT_1148	[p18l1258t2236r1323b2261],
8	exposure	NN	O	exposure	dobj	6	SENT_1148	[p18l1332t2245r1454b2270],
9	and	CC	O	and	_	0	SENT_1148	[p18l1464t2236r1513b2261],
10	toxicity	NN	O	toxicity	dobj	6	SENT_1148	[p18l1522t2237r1626b2270],
11	of	IN	O	of	_	0	SENT_1148	[p18l1633t2236r1664b2261],
12	statins	NNS	O	statin	prep_of	8	SENT_1148	[p18l1669t2237r1764b2261],
13	.	.	O	.	_	0	SENT_1148	[p18l1669t2237r1764b2261],

1	Circ	NNP	O	Circ	_	0	SENT_1149	[p18l1775t2236r1834b2261],
2	.	.	O	.	_	0	SENT_1149	[p18l1775t2236r1834b2261],

1	Rex	NN	PERSON	rex	_	0	SENT_1150	[p18l1844t2237r1893b2261],
2	.	.	O	.	_	0	SENT_1150	[p18l1844t2237r1893b2261],

1	106:297	CD	NUMBER	106:297	_	0	SENT_1151	[p18l1907t2236r2046b2262],
2	—	CD	NUMBER	—	number	3	SENT_1151	[p18l1907t2236r2046b2262],
3	3	CD	NUMBER	3	num	4	SENT_1151	[p18l1907t2236r2046b2262],
4	06	NN	NUMBER	06	dep	1	SENT_1151	[p18l2051t2237r2083b2261],
5	.	.	O	.	_	0	SENT_1151	[p18l618t2301r622b2305],
6	]	SYM	O	]	dep	1	SENT_1151	[p18l638t2280r740b2312],

1	uliano	NN	O	uliano	nn	2	SENT_1152	[p18l638t2280r740b2312],
2	RL	NN	O	rl	_	0	SENT_1152	[p18l753t2281r805b2311],
3	,	,	O	,	_	0	SENT_1152	[p18l753t2281r805b2311],
4	Ling	NNP	O	Ling	nn	5	SENT_1152	[p18l820t2281r887b2314],
5	V.	NNP	O	V.	appos	2	SENT_1152	[p18l898t2281r930b2306],
6	1976	CD	DATE	1976	dep	5	SENT_1152	[p18l947t2281r1019b2306],
7	.	.	O	.	_	0	SENT_1152	[p18l947t2281r1019b2306],

1	A	DT	O	a	det	3	SENT_1153	[p18l1032t2281r1056b2305],
2	surface	NN	O	surface	nn	3	SENT_1153	[p18l1068t2280r1164b2306],
3	glycoprotein	NN	O	glycoprotein	_	0	SENT_1153	[p18l1178t2280r1355b2314],
4	modulating	VBG	O	modulate	partmod	3	SENT_1153	[p18l1367t2280r1528b2314],
5	drug	NN	O	drug	nn	6	SENT_1153	[p18l1541t2280r1606b2314],
6	permeability	NN	O	permeability	dobj	4	SENT_1153	[p18l1618t2280r1795b2314],
7	in	IN	O	in	_	0	SENT_1153	[p18l1806t2281r1833b2305],
8	Chinese	JJ	MISC	chinese	amod	12	SENT_1153	[p18l1847t2280r1959b2306],
9	hamster	NN	O	hamster	nn	12	SENT_1153	[p18l1972t2280r2084b2306],
10	ovary	NN	O	ovary	nn	12	SENT_1153	[p18l642t2335r719b2360],
11	cell	NN	O	cell	nn	12	SENT_1153	[p18l728t2325r774b2351],
12	mutants	NNS	O	mutant	prep_in	6	SENT_1153	[p18l784t2333r904b2351],
13	.	.	O	.	_	0	SENT_1153	[p18l784t2333r904b2351],

1	Bioc/vim	NNP	O	Bioc/vim	_	0	SENT_1154	[p18l914t2326r1024b2351],
2	.	.	O	.	_	0	SENT_1154	[p18l914t2326r1024b2351],

1	Biop/yyx	NN	O	biop/yyx	_	0	SENT_1155	[p18l1036t2326r1138b2360],
2	.	.	O	.	_	0	SENT_1155	[p18l1036t2326r1138b2360],

1	Acta	NN	PERSON	acta	_	0	SENT_1156	[p18l1148t2326r1209b2351],
2	455	CD	NUMBER	455	num	1	SENT_1156	[p18l1218t2327r1276b2351],
3	:	:	O	:	_	0	SENT_1156	[p18l1218t2327r1276b2351],
4	1	CD	NUMBER	1	num	7	SENT_1156	[p18l1282t2327r1292b2351],
5	52-62	CD	NUMBER	52-62	num	7	SENT_1156	[p18l1298t2327r1378b2351],
6	Cascorbi	NNP	O	Cascorbi	nn	7	SENT_1156	[p18l642t2370r765b2396],
7	I.	NNP	O	I.	dep	1	SENT_1156	[p18l774t2371r793b2395],
8	2011	CD	DATE	2011	dep	7	SENT_1156	[p18l804t2371r878b2395],
9	.	.	O	.	_	0	SENT_1156	[p18l804t2371r878b2395],

1	P	NN	O	p	nn	3	SENT_1157	[p18l889t2370r1106b2404],
2	—	CD	NUMBER	—	num	3	SENT_1157	[p18l889t2370r1106b2404],
3	glycoprotein	NN	O	glycoprotein	_	0	SENT_1157	[p18l889t2370r1106b2404],
4	:	:	O	:	_	0	SENT_1157	[p18l889t2370r1106b2404],
5	tissue	NN	O	tissue	nn	6	SENT_1157	[p18l1117t2371r1194b2396],
6	distribution	NN	O	distribution	conj_and	3	SENT_1157	[p18l1204t2370r1374b2401],
7	,	,	O	,	_	0	SENT_1157	[p18l1204t2370r1374b2401],
8	substrates	NNS	O	substrate	conj_and	3	SENT_1157	[p18l1385t2370r1529b2401],
9	,	,	O	,	_	0	SENT_1157	[p18l1385t2370r1529b2401],
10	and	CC	O	and	_	0	SENT_1157	[p18l1539t2370r1588b2396],
11	functional	JJ	O	functional	amod	12	SENT_1157	[p18l1598t2370r1739b2396],
12	consequences	NNS	O	consequence	conj_and	3	SENT_1157	[p18l1749t2379r1937b2404],
13	of	IN	O	of	_	0	SENT_1157	[p18l1947t2370r1978b2396],
14	genetic	JJ	O	genetic	amod	15	SENT_1157	[p18l1984t2371r2083b2404],
15	variations	NNS	O	variation	prep_of	12	SENT_1157	[p18l640t2417r784b2441],
16	.	.	O	.	_	0	SENT_1157	[p18l640t2417r784b2441],

1	Hcmdb	NNP	O	Hcmdb	_	0	SENT_1158	[p18l794t2416r888b2441],
2	.	.	O	.	_	0	SENT_1158	[p18l794t2416r888b2441],

1	Exp	NN	O	exp	_	0	SENT_1159	[p18l900t2417r957b2450],
2	.	.	O	.	_	0	SENT_1159	[p18l900t2417r957b2450],

1	P/mrmczcol	NN	O	p/mrmczcol	_	0	SENT_1160	[p18l969t2416r1113b2441],
2	.	.	O	.	_	0	SENT_1160	[p18l969t2416r1113b2441],

1	2011:261	CD	NUMBER	2011:261	num	2	SENT_1161	[p18l1125t2417r1301b2442],
2	—	CD	NUMBER	—	_	0	SENT_1161	[p18l1125t2417r1301b2442],
3	83	CD	NUMBER	83	num	5	SENT_1161	[p18l1125t2417r1301b2442],
4	Cole	NNP	O	Cole	nn	5	SENT_1161	[p18l642t2460r708b2486],
5	SP	NN	O	sp	dep	2	SENT_1161	[p18l720t2461r765b2491],
6	,	,	O	,	_	0	SENT_1161	[p18l720t2461r765b2491],
7	Bhardwaj	NNP	PERSON	Bhardwaj	nn	8	SENT_1161	[p18l777t2460r906b2494],
8	G	NNP	PERSON	G	appos	5	SENT_1161	[p18l919t2461r952b2491],
9	,	,	O	,	_	0	SENT_1161	[p18l919t2461r952b2491],
10	Gerlach	NNP	PERSON	Gerlach	nn	12	SENT_1161	[p18l965t2460r1076b2486],
11	]	CD	NUMBER	]	num	12	SENT_1161	[p18l1083t2461r1134b2492],
12	H	NN	O	h	appos	5	SENT_1161	[p18l1083t2461r1134b2492],
13	,	,	O	,	_	0	SENT_1161	[p18l1083t2461r1134b2492],
14	Mackie	NNP	PERSON	Mackie	nn	16	SENT_1161	[p18l1145t2460r1248b2486],
15	]	CD	NUMBER	]	num	16	SENT_1161	[p18l1255t2461r1300b2492],
16	E	NN	O	e	appos	5	SENT_1161	[p18l1255t2461r1300b2492],
17	,	,	O	,	_	0	SENT_1161	[p18l1255t2461r1300b2492],
18	Grant	NNP	PERSON	Grant	nn	19	SENT_1161	[p18l1313t2461r1396b2486],
19	CE	NNP	O	CE	appos	5	SENT_1161	[p18l1407t2461r1460b2491],
20	,	,	O	,	_	0	SENT_1161	[p18l1407t2461r1460b2491],
21	et	FW	O	et	nn	22	SENT_1161	[p18l1473t2467r1499b2486],
22	al.	FW	O	al.	appos	5	SENT_1161	[p18l1509t2460r1538b2486],
23	1992	CD	DATE	1992	dep	22	SENT_1161	[p18l1554t2462r1625b2486],
24	.	.	O	.	_	0	SENT_1161	[p18l1554t2462r1625b2486],

1	Overexpression	NN	O	overexpression	_	0	SENT_1162	[p18l1638t2461r1854b2494],
2	of	IN	O	of	_	0	SENT_1162	[p18l1865t2460r1896b2486],
3	a	DT	O	a	det	5	SENT_1162	[p18l1903t2470r1916b2486],
4	transporter	NN	O	transporter	nn	5	SENT_1162	[p18l1927t2467r2084b2494],
5	gene	NN	O	gene	prep_of	1	SENT_1162	[p18l642t2515r707b2540],
6	in	IN	O	in	_	0	SENT_1162	[p18l716t2507r744b2531],
7	a	DT	O	a	det	15	SENT_1162	[p18l753t2516r767b2531],
8	multidrug	JJ	O	multidrug	amod	15	SENT_1162	[p18l776t2506r1047b2540],
9	—	NN	O	—	npadvmod	10	SENT_1162	[p18l776t2506r1047b2540],
10	resistant	JJ	O	resistant	amod	15	SENT_1162	[p18l776t2506r1047b2540],
11	human	JJ	O	human	amod	15	SENT_1162	[p18l1056t2506r1152b2531],
12	lung	NN	O	lung	nn	15	SENT_1162	[p18l1162t2506r1224b2540],
13	cancer	NN	O	cancer	nn	15	SENT_1162	[p18l1234t2515r1324b2531],
14	cell	NN	O	cell	nn	15	SENT_1162	[p18l1333t2506r1380b2531],
15	line	NN	O	line	prep_in	1	SENT_1162	[p18l1390t2506r1448b2531],
16	.	.	O	.	_	0	SENT_1162	[p18l1390t2506r1448b2531],

1	Science	NNP	O	Science	_	0	SENT_1163	[p18l1460t2507r1549b2531],
2	25	CD	NUMBER	25	number	3	SENT_1163	[p18l1559t2507r1590b2532],
3	8:165	CD	NUMBER	8:165	dep	1	SENT_1163	[p18l1595t2507r1668b2532],
4	0-54	CD	NUMBER	0-54	num	5	SENT_1163	[p18l1672t2507r1739b2532],
5	Allikmets	NNS	O	allikmet	dep	3	SENT_1163	[p18l641t2550r773b2576],
6	R	NN	O	r	dep	1	SENT_1163	[p18l784t2551r813b2581],
7	,	,	O	,	_	0	SENT_1163	[p18l784t2551r813b2581],
8	Schriml	NNP	ORGANIZATION	Schriml	nn	9	SENT_1163	[p18l826t2550r934b2576],
9	LM	NNP	ORGANIZATION	LM	appos	6	SENT_1163	[p18l945t2551r1006b2581],
10	,	,	O	,	_	0	SENT_1163	[p18l945t2551r1006b2581],
11	Hutchinson	NNP	PERSON	Hutchinson	nn	12	SENT_1163	[p18l1017t2550r1183b2576],
12	A	NNP	O	A	appos	1	SENT_1163	[p18l1192t2551r1222b2581],
13	,	,	O	,	_	0	SENT_1163	[p18l1192t2551r1222b2581],
14	Romano	NNP	PERSON	Romano	appos	1	SENT_1163	[p18l1234t2551r1440b2584],
15	.	.	O	.	_	0	SENT_1163	[p18l1234t2551r1440b2584],

1	—	NN	O	—	_	0	SENT_1164	[p18l1234t2551r1440b2584],
2	.	.	O	.	_	0	SENT_1164	[p18l1234t2551r1440b2584],

1	Spica	NNP	PERSON	Spica	nn	2	SENT_1165	[p18l1234t2551r1440b2584],
2	V	NNP	PERSON	V	_	0	SENT_1165	[p18l1449t2551r1481b2581],
3	,	,	O	,	_	0	SENT_1165	[p18l1449t2551r1481b2581],
4	Dean	NNP	PERSON	Dean	nn	5	SENT_1165	[p18l1493t2551r1568b2576],
5	M.	NNP	O	M.	appos	2	SENT_1165	[p18l1577t2551r1616b2575],
6	1998	CD	DATE	1998	dep	5	SENT_1165	[p18l1631t2551r1703b2576],
7	.	.	O	.	_	0	SENT_1165	[p18l1631t2551r1703b2576],

1	A	DT	O	a	det	12	SENT_1166	[p18l1713t2551r1737b2575],
2	human	JJ	O	human	amod	12	SENT_1166	[p18l1745t2550r1842b2576],
3	placenta-speciﬁc	JJ	O	placenta-speciﬁc	amod	12	SENT_1166	[p18l1852t2550r2083b2584],
4	ATP	NN	O	atp	nn	12	SENT_1166	[p18l641t2596r832b2630],
5	—	NN	O	—	nn	12	SENT_1166	[p18l641t2596r832b2630],
6	binding	NN	O	binding	nn	12	SENT_1166	[p18l641t2596r832b2630],
7	cassette	NN	O	cassette	nn	12	SENT_1166	[p18l838t2603r944b2621],
8	gene	NN	O	gene	nn	12	SENT_1166	[p18l952t2605r1016b2630],
9	(	CD	NUMBER	(	num	12	SENT_1166	[p18l1024t2596r1075b2628],
10	AB	NNP	O	AB	nn	12	SENT_1166	[p18l1024t2596r1075b2628],
11	CP	NNP	O	CP	nn	12	SENT_1166	[p18l1079t2596r1133b2628],
12	)	NN	O	)	_	0	SENT_1166	[p18l1079t2596r1133b2628],
13	on	IN	O	on	_	0	SENT_1166	[p18l1141t2605r1176b2621],
14	chromosome	NN	O	chromosome	nn	15	SENT_1166	[p18l1183t2596r1364b2621],
15	4q22	NN	O	4q22	prep_on	12	SENT_1166	[p18l1372t2597r1438b2630],
16	that	WDT	O	that	nsubjpass	18	SENT_1166	[p18l1448t2595r1503b2621],
17	is	VBZ	O	be	auxpass	18	SENT_1166	[p18l1509t2597r1529b2621],
18	involved	VBN	O	involve	rcmod	15	SENT_1166	[p18l1536t2595r1654b2621],
19	in	IN	O	in	_	0	SENT_1166	[p18l1661t2597r1688b2621],
20	multidrug	JJ	O	multidrug	amod	21	SENT_1166	[p18l1695t2595r1836b2630],
21	resistance	NN	O	resistance	prep_in	18	SENT_1166	[p18l1842t2597r1985b2621],
22	.	.	O	.	_	0	SENT_1166	[p18l1842t2597r1985b2621],

1	Ccmcer	NNP	O	Ccmcer	nn	2	SENT_1167	[p18l1995t2596r2085b2621],
2	Res	NNP	O	Res	_	0	SENT_1167	[p18l641t2642r690b2667],
3	‘	NN	O	‘	dep	2	SENT_1167	[p18l641t2642r690b2667],
4	.	.	O	.	_	0	SENT_1167	[p18l641t2642r690b2667],

1	585337-39	CD	NUMBER	585337-39	num	3	SENT_1168	[p18l704t2642r863b2667],
2	Nliyake	NNP	O	Nliyake	nn	3	SENT_1168	[p18l640t2685r744b2720],
3	K	NNP	O	K	_	0	SENT_1168	[p18l757t2687r788b2717],
4	,	,	O	,	_	0	SENT_1168	[p18l757t2687r788b2717],
5	Mickley	NNP	ORGANIZATION	Mickley	nn	6	SENT_1168	[p18l800t2685r915b2720],
6	L	NNP	ORGANIZATION	L	appos	3	SENT_1168	[p18l926t2687r955b2717],
7	,	,	O	,	_	0	SENT_1168	[p18l926t2687r955b2717],
8	Litman	NNP	PERSON	Litman	nn	9	SENT_1168	[p18l969t2687r1072b2711],
9	T	NN	O	t	appos	3	SENT_1168	[p18l1083t2686r1116b2717],
10	,	,	O	,	_	0	SENT_1168	[p18l1083t2686r1116b2717],
11	Zhan	NNP	PERSON	Zhan	nn	12	SENT_1168	[p18l1129t2685r1203b2711],
12	Z	NNP	PERSON	Z	appos	3	SENT_1168	[p18l1215t2685r1244b2717],
13	,	,	O	,	_	0	SENT_1168	[p18l1215t2685r1244b2717],
14	Robey	NNP	PERSON	Robey	nn	15	SENT_1168	[p18l1258t2685r1348b2720],
15	R	NNP	PERSON	R	appos	3	SENT_1168	[p18l1359t2687r1389b2717],
16	,	,	O	,	_	0	SENT_1168	[p18l1359t2687r1389b2717],
17	et	FW	O	et	nn	18	SENT_1168	[p18l1403t2693r1428b2711],
18	al.	FW	O	al.	appos	3	SENT_1168	[p18l1440t2685r1470b2711],
19	1999	CD	DATE	1999	dep	18	SENT_1168	[p18l1487t2687r1559b2711],
20	.	.	O	.	_	0	SENT_1168	[p18l1487t2687r1559b2711],

1	Molecular	JJ	O	molecular	amod	2	SENT_1169	[p18l1571t2685r1716b2711],
2	cloning	NN	O	cloning	_	0	SENT_1169	[p18l1728t2685r1832b2720],
3	of	IN	O	of	_	0	SENT_1169	[p18l1844t2686r1875b2711],
4	cDNAs	NNS	O	cdna	prep_of	2	SENT_1169	[p18l1884t2687r1988b2711],
5	which	WDT	O	which	nsubjpass	8	SENT_1169	[p18l1999t2685r2083b2711],
6	are	VBP	O	be	auxpass	8	SENT_1169	[p18l642t2741r683b2757],
7	highly	RB	O	highly	advmod	8	SENT_1169	[p18l693t2731r782b2766],
8	overexpressed	VBN	O	overexpress	rcmod	4	SENT_1169	[p18l791t2731r985b2765],
9	in	IN	O	in	_	0	SENT_1169	[p18l995t2733r1022b2757],
10	mitoxantrone-resistant	JJ	O	mitoxantrone-resistant	amod	11	SENT_1169	[p18l1032t2733r1351b2757],
11	cells	NNS	O	cell	prep_in	8	SENT_1169	[p18l1361t2731r1427b2757],
12	:	:	O	:	_	0	SENT_1169	[p18l1361t2731r1427b2757],
13	demonstration	NN	O	demonstration	dep	2	SENT_1169	[p18l1439t2731r1642b2757],
14	of	IN	O	of	_	0	SENT_1169	[p18l1653t2731r1683b2757],
15	homology	NN	O	homology	prep_of	13	SENT_1169	[p18l1689t2731r1832b2766],
16	to	TO	O	to	_	0	SENT_1169	[p18l1840t2738r1867b2757],
17	ABC	NNP	ORGANIZATION	ABC	nn	19	SENT_1169	[p18l1877t2732r1945b2757],
18	transport	NN	O	transport	nn	19	SENT_1169	[p18l1956t2738r2084b2765],
19	genes	NNS	O	gene	prep_to	15	SENT_1169	[p18l642t2787r726b2811],
20	.	.	O	.	_	0	SENT_1169	[p18l642t2787r726b2811],

1	Cancer	NN	O	cancer	_	0	SENT_1170	[p18l739t2778r830b2803],
2	Res	NNP	O	Res	dep	1	SENT_1170	[p18l836t2778r885b2803],
3	.	.	O	.	_	0	SENT_1170	[p18l836t2778r885b2803],

1	5928-13	CD	NUMBER	5928-13	num	3	SENT_1171	[p18l899t2778r1005b2803],
2	Doyle	NNP	ORGANIZATION	Doyle	nn	3	SENT_1171	[p18l642t2821r726b2856],
3	LA	NNP	ORGANIZATION	LA	_	0	SENT_1171	[p18l737t2822r788b2853],
4	,	,	O	,	_	0	SENT_1171	[p18l737t2822r788b2853],
5	Yang	NNP	PERSON	Yang	nn	6	SENT_1171	[p18l798t2822r871b2856],
6	W	NNP	PERSON	W	appos	3	SENT_1171	[p18l879t2822r923b2853],
7	,	,	O	,	_	0	SENT_1171	[p18l879t2822r923b2853],
8	Abruzzo	NNP	ORGANIZATION	Abruzzo	nn	9	SENT_1171	[p18l933t2821r1050b2847],
9	LV	NNP	ORGANIZATION	LV	appos	3	SENT_1171	[p18l1061t2822r1114b2853],
10	,	,	O	,	_	0	SENT_1171	[p18l1061t2822r1114b2853],
11	K.	NNP	O	K.	nn	13	SENT_1171	[p18l1125t2822r1277b2856],
12	rogmann	NN	O	rogmann	nn	13	SENT_1171	[p18l1125t2822r1277b2856],
13	T	NN	O	t	appos	3	SENT_1171	[p18l1286t2822r1319b2853],
14	,	,	O	,	_	0	SENT_1171	[p18l1286t2822r1319b2853],
15	Gao	NNP	LOCATION	Gao	nn	16	SENT_1171	[p18l1331t2822r1389b2847],
16	Y	NN	LOCATION	y	appos	3	SENT_1171	[p18l1398t2822r1427b2853],
17	,	,	O	,	_	0	SENT_1171	[p18l1398t2822r1427b2853],
18	et	FW	O	et	nn	19	SENT_1171	[p18l1439t2828r1465b2847],
19	al.	FW	O	al.	appos	3	SENT_1171	[p18l1474t2821r1504b2847],
20	1998	CD	DATE	1998	dep	19	SENT_1171	[p18l1518t2823r1590b2847],
21	.	.	O	.	_	0	SENT_1171	[p18l1518t2823r1590b2847],

1	A	DT	O	a	det	4	SENT_1172	[p18l1600t2822r1624b2847],
2	multidrug	JJ	O	multidrug	amod	4	SENT_1172	[p18l1632t2821r1773b2856],
3	resistance	NN	O	resistance	nn	4	SENT_1172	[p18l1782t2823r1917b2847],
4	transporter	NN	O	transporter	_	0	SENT_1172	[p18l1927t2829r2084b2855],
5	from	IN	O	from	_	0	SENT_1172	[p18l642t2867r710b2893],
6	human	JJ	O	human	amod	10	SENT_1172	[p18l719t2867r815b2893],
7	MCF-7	NN	MISC	mcf-7	nn	10	SENT_1172	[p18l824t2868r930b2893],
8	breast	NN	O	breast	nn	10	SENT_1172	[p18l941t2867r1025b2893],
9	cancer	NN	O	cancer	nn	10	SENT_1172	[p18l1035t2877r1124b2893],
10	cells	NNS	O	cell	prep_from	4	SENT_1172	[p18l1134t2867r1201b2893],
11	.	.	O	.	_	0	SENT_1172	[p18l1134t2867r1201b2893],

1	Proc	NNP	O	Proc	_	0	SENT_1173	[p18l1211t2868r1273b2893],
2	.	.	O	.	_	0	SENT_1173	[p18l1211t2868r1273b2893],

1	Natl.	NNP	O	Natl.	nn	2	SENT_1174	[p18l1285t2868r1351b2893],
2	Aciid	NNP	O	Aciid	_	0	SENT_1174	[p18l1360t2868r1432b2893],
3	.	.	O	.	_	0	SENT_1174	[p18l1360t2868r1432b2893],

1	Sci	NNP	O	Sci	_	0	SENT_1175	[p18l1445t2868r1487b2893],
2	.	.	O	.	_	0	SENT_1175	[p18l1445t2868r1487b2893],

1	USA	NNP	O	USA	_	0	SENT_1176	[p18l1503t2868r1564b2893],
2	95	CD	NUMBER	95	number	3	SENT_1176	[p18l1576t2868r1607b2893],
3	:15	CD	NUMBER	:15	dep	1	SENT_1176	[p18l1612t2868r1650b2893],
4	665-70	CD	NUMBER	665-70	dep	3	SENT_1176	[p18l1654t2868r1754b2893],
5	Sharom	FW	O	sharom	dep	1	SENT_1176	[p18l643t2911r751b2937],
6	F	NN	O	f	nn	7	SENT_1176	[p18l762t2912r800b2944],
7	]	NN	O	]	dep	5	SENT_1176	[p18l762t2912r800b2944],
8	.	.	O	.	_	0	SENT_1176	[p18l762t2912r800b2944],

1	2008	CD	DATE	2008	_	0	SENT_1177	[p18l814t2913r888b2937],
2	.	.	O	.	_	0	SENT_1177	[p18l814t2913r888b2937],

1	ABC	NNP	ORGANIZATION	ABC	nn	3	SENT_1178	[p18l900t2912r968b2937],
2	multidrug	JJ	O	multidrug	amod	3	SENT_1178	[p18l980t2911r1121b2946],
3	transporters	NNS	O	transporter	_	0	SENT_1178	[p18l1131t2919r1306b2945],
4	:	:	O	:	_	0	SENT_1178	[p18l1131t2919r1306b2945],
5	structure	NN	O	structure	dep	3	SENT_1178	[p18l1320t2919r1452b2943],
6	,	,	O	,	_	0	SENT_1178	[p18l1320t2919r1452b2943],
7	function	NN	O	function	dep	3	SENT_1178	[p18l1464t2911r1581b2937],
8	and	CC	O	and	_	0	SENT_1178	[p18l1593t2911r1642b2937],
9	role	NN	O	role	dep	3	SENT_1178	[p18l1654t2911r1708b2937],
10	in	IN	O	in	_	0	SENT_1178	[p18l1719t2912r1746b2937],
11	chemoresistance	NN	O	chemoresistance	prep_in	5	SENT_1178	[p18l1758t2911r1994b2937],
12	.	.	O	.	_	0	SENT_1178	[p18l1758t2911r1994b2937],

1	Pharmizcogenomics	NNS	O	pharmizcogenomic	_	0	SENT_1179	[p18l2006t2912r2083b2937, p18l641t2959r820b2992],
2	9:105	CD	NUMBER	9:105	dep	1	SENT_1179	[p18l829t2959r902b2983],
3	-27	CD	NUMBER	-27	num	4	SENT_1179	[p18l905t2958r954b2983],
4	Szakacs	NNS	O	szakac	dep	2	SENT_1179	[p18l643t3013r746b3039],
5	G	NN	O	g	dep	1	SENT_1179	[p18l761t3014r794b3045],
6	,	,	O	,	_	0	SENT_1179	[p18l761t3014r794b3045],
7	Paterson	NNP	PERSON	Paterson	appos	5	SENT_1179	[p18l809t3015r932b3039],
8	]	CD	NUMBER	]	num	7	SENT_1179	[p18l941t3015r989b3046],
9	K	NNP	O	K	dep	1	SENT_1179	[p18l941t3015r989b3046],
10	,	,	O	,	_	0	SENT_1179	[p18l941t3015r989b3046],
11	Ludwig	NNP	PERSON	Ludwig	nn	13	SENT_1179	[p18l1004t3013r1112b3048],
12	]	NNP	O	]	nn	13	SENT_1179	[p18l1121t3014r1165b3046],
13	A	NNP	O	A	appos	9	SENT_1179	[p18l1121t3014r1165b3046],
14	,	,	O	,	_	0	SENT_1179	[p18l1121t3014r1165b3046],
15	Booth	NNP	PERSON	Booth	appos	1	SENT_1179	[p18l1181t3013r1385b3039],
16	.	.	O	.	_	0	SENT_1179	[p18l1181t3013r1385b3039],

1	—	NN	O	—	_	0	SENT_1180	[p18l1181t3013r1385b3039],
2	.	.	O	.	_	0	SENT_1180	[p18l1181t3013r1385b3039],

1	Genthe	NNP	PERSON	Genthe	nn	2	SENT_1181	[p18l1181t3013r1385b3039],
2	C	NNP	O	C	_	0	SENT_1181	[p18l1400t3014r1430b3045],
3	,	,	O	,	_	0	SENT_1181	[p18l1400t3014r1430b3045],
4	Gottesman	NNP	PERSON	Gottesman	nn	5	SENT_1181	[p18l1446t3014r1600b3039],
5	MM	NN	O	mm	appos	2	SENT_1181	[p18l1613t3015r1684b3039],
6	.	.	O	.	_	0	SENT_1181	[p18l1613t3015r1684b3039],

1	2006	CD	DATE	2006	_	0	SENT_1182	[p18l1699t3015r1774b3039],
2	.	.	O	.	_	0	SENT_1182	[p18l1699t3015r1774b3039],

1	Targeting	NN	O	targeting	nn	3	SENT_1183	[p18l1788t3014r1931b3048],
2	multidrug	JJ	O	multidrug	amod	3	SENT_1183	[p18l1943t3013r2084b3048],
3	resistance	NN	O	resistance	_	0	SENT_1183	[p18l642t3058r777b3083],
4	in	IN	O	in	_	0	SENT_1183	[p18l787t3058r814b3082],
5	cancer	NN	O	cancer	prep_in	3	SENT_1183	[p18l824t3067r920b3083],
6	.	.	O	.	_	0	SENT_1183	[p18l824t3067r920b3083],

1	Nat	NN	PERSON	nat	_	0	SENT_1184	[p18l930t3058r988b3083],
2	.	.	O	.	_	0	SENT_1184	[p18l930t3058r988b3083],

1	Rev.	NNP	O	Rev.	nn	3	SENT_1185	[p18l999t3058r1054b3083],
2	Drug	NNP	PERSON	Drug	nn	3	SENT_1185	[p18l1066t3058r1139b3092],
3	Dixcov	NNP	PERSON	Dixcov	_	0	SENT_1185	[p18l1147t3058r1236b3083],
4	.	.	O	.	_	0	SENT_1185	[p18l1147t3058r1236b3083],

1	5	CD	NUMBER	5	num	5	SENT_1186	[p18l1250t3058r1263b3083],
2	:2	CD	NUMBER	:2	num	5	SENT_1186	[p18l1268t3059r1288b3083],
3	19-34	CD	DATE	19-34	num	5	SENT_1186	[p18l1295t3059r1377b3083],
4	McDevitt	NNP	PERSON	McDevitt	nn	5	SENT_1186	[p18l640t3100r778b3125],
5	CA	NNP	O	CA	_	0	SENT_1186	[p18l790t3100r843b3131],
6	,	,	O	,	_	0	SENT_1186	[p18l790t3100r843b3131],
7	Callaghan	NNP	PERSON	Callaghan	nn	8	SENT_1186	[p18l858t3099r998b3134],
8	R.	NNP	O	R.	appos	5	SENT_1186	[p18l1011t3100r1040b3125],
9	2007	CD	DATE	2007	dep	8	SENT_1186	[p18l1055t3100r1129b3126],
10	.	.	O	.	_	0	SENT_1186	[p18l1055t3100r1129b3126],

1	How	WRB	O	how	advmod	5	SENT_1187	[p18l1143t3100r1213b3125],
2	can	MD	O	can	aux	5	SENT_1187	[p18l1225t3109r1272b3125],
3	we	PRP	O	we	nsubj	5	SENT_1187	[p18l1283t3109r1321b3125],
4	best	JJS	O	best	advmod	5	SENT_1187	[p18l1335t3099r1391b3125],
5	use	VBP	O	use	_	0	SENT_1187	[p18l1402t3109r1446b3125],
6	structural	JJ	O	structural	amod	7	SENT_1187	[p18l1459t3099r1593b3125],
7	information	NN	O	information	dobj	5	SENT_1187	[p18l1605t3099r1772b3125],
8	on	IN	O	on	_	0	SENT_1187	[p18l1785t3109r1820b3125],
9	P	NN	O	p	nn	11	SENT_1187	[p18l1832t3099r2043b3134],
10	—	CD	NUMBER	—	num	11	SENT_1187	[p18l1832t3099r2043b3134],
11	glycoprotein	NN	O	glycoprotein	prep_on	7	SENT_1187	[p18l1832t3099r2043b3134],
12	to	TO	O	to	_	0	SENT_1187	[p18l2056t3106r2083b3125],
13	design	NN	O	design	nn	14	SENT_1187	[p18l642t3142r731b3176],
14	inhibitors	NNS	O	inhibitor	prep_to	11	SENT_1187	[p18l740t3142r888b3168],
15	?	.	O	?	_	0	SENT_1187	[p18l740t3142r888b3168],

1	Pbciwmicol	NN	O	pbciwmicol	_	0	SENT_1188	[p18l899t3143r1043b3167],
2	.	.	O	.	_	0	SENT_1188	[p18l899t3143r1043b3167],

1	Tber	NNP	O	Tber	_	0	SENT_1189	[p18l1057t3143r1125b3167],
2	.	.	O	.	_	0	SENT_1189	[p18l1057t3143r1125b3167],

1	ll3	NN	O	ll3	_	0	SENT_1190	[p18l1141t3143r1297b3168],
2	:429	CD	NUMBER	:429	number	3	SENT_1190	[p18l1141t3143r1297b3168],
3	—	CD	NUMBER	—	dep	1	SENT_1190	[p18l1141t3143r1297b3168],
4	4l	NN	O	4l	dep	3	SENT_1190	[p18l1141t3143r1297b3168],
5	Aller	NNP	PERSON	Aller	nn	6	SENT_1190	[p18l640t3184r710b3210],
6	SG	NNP	O	SG	dep	1	SENT_1190	[p18l724t3185r776b3215],
7	,	,	O	,	_	0	SENT_1190	[p18l724t3185r776b3215],
8	Yu	NNP	PERSON	Yu	nn	9	SENT_1190	[p18l789t3185r829b3210],
9	]	NNP	O	]	appos	6	SENT_1190	[p18l839t3185r862b3216],
10	,	,	O	,	_	0	SENT_1190	[p18l839t3185r862b3216],
11	Ward	NNP	ORGANIZATION	Ward	nn	12	SENT_1190	[p18l876t3184r957b3210],
12	A	NNP	ORGANIZATION	A	appos	6	SENT_1190	[p18l970t3185r999b3215],
13	,	,	O	,	_	0	SENT_1190	[p18l970t3185r999b3215],
14	Weng	NNP	PERSON	Weng	nn	15	SENT_1190	[p18l1013t3185r1101b3218],
15	Y	NN	PERSON	y	appos	6	SENT_1190	[p18l1113t3185r1143b3215],
16	,	,	O	,	_	0	SENT_1190	[p18l1113t3185r1143b3215],
17	Chittaboina	NNP	O	Chittaboina	nn	18	SENT_1190	[p18l1158t3184r1324b3210],
18	S	NNP	O	S	appos	6	SENT_1190	[p18l1339t3185r1363b3215],
19	,	,	O	,	_	0	SENT_1190	[p18l1339t3185r1363b3215],
20	et	FW	O	et	nn	21	SENT_1190	[p18l1378t3191r1404b3210],
21	al.	FW	O	al.	appos	6	SENT_1190	[p18l1417t3184r1447b3210],
22	2009	CD	DATE	2009	dep	21	SENT_1190	[p18l1462t3186r1537b3210],
23	.	.	O	.	_	0	SENT_1190	[p18l1462t3186r1537b3210],

1	Structure	NN	O	structure	nsubj	6	SENT_1191	[p18l1553t3185r1683b3210],
2	of	IN	O	of	_	0	SENT_1191	[p18l1697t3184r1728b3210],
3	P	NN	O	p	nn	5	SENT_1191	[p18l1738t3184r1948b3218],
4	—	CD	NUMBER	—	num	5	SENT_1191	[p18l1738t3184r1948b3218],
5	glycoprotein	NN	O	glycoprotein	prep_of	1	SENT_1191	[p18l1738t3184r1948b3218],
6	reveals	VBZ	O	reveal	_	0	SENT_1191	[p18l1962t3184r2056b3210],
7	a	DT	O	a	det	9	SENT_1191	[p18l2070t3194r2083b3210],
8	molecular	JJ	O	molecular	amod	9	SENT_1191	[p18l642t3226r781b3252],
9	basis	NN	O	basis	dobj	6	SENT_1191	[p18l790t3226r855b3252],
10	for	IN	O	for	_	0	SENT_1191	[p18l865t3226r906b3252],
11	poly	NN	O	poly	nn	12	SENT_1191	[p18l915t3226r1091b3261],
12	—	NN	O	—	prep_for	9	SENT_1191	[p18l915t3226r1091b3261],
13	speciﬁc	NN	O	speciﬁc	nn	15	SENT_1191	[p18l915t3226r1091b3261],
14	drug	NN	O	drug	nn	15	SENT_1191	[p18l1101t3226r1166b3261],
15	binding	NN	O	binding	dep	12	SENT_1191	[p18l1175t3226r1289b3261],
16	.	.	O	.	_	0	SENT_1191	[p18l1175t3226r1289b3261],

1	Science	NNP	O	Science	nn	6	SENT_1192	[p18l1301t3227r1390b3252],
2	323:1718	CD	NUMBER	323:1718	num	6	SENT_1192	[p18l1401t3227r1576b3253],
3	—	CD	NUMBER	—	num	6	SENT_1192	[p18l1401t3227r1576b3253],
4	22	CD	NUMBER	22	num	6	SENT_1192	[p18l1401t3227r1576b3253],
5	Chen	NNP	O	Chen	nn	6	SENT_1192	[p18l642t3269r718b3295],
6	C	NNP	O	C	_	0	SENT_1192	[p18l733t3270r764b3300],
7	,	,	O	,	_	0	SENT_1192	[p18l733t3270r764b3300],
8	Liu	NNP	LOCATION	Liu	nn	9	SENT_1192	[p18l779t3270r828b3295],
9	X	NNP	LOCATION	X	appos	6	SENT_1192	[p18l841t3270r872b3300],
10	,	,	O	,	_	0	SENT_1192	[p18l841t3270r872b3300],
11	Smith	NNP	PERSON	Smith	nn	13	SENT_1192	[p18l889t3269r971b3295],
12	B	NNP	O	B	nn	13	SENT_1192	[p18l985t3270r1025b3301],
13	]	NN	O	]	appos	9	SENT_1192	[p18l985t3270r1025b3301],
14	.	.	O	.	_	0	SENT_1192	[p18l985t3270r1025b3301],

1	2003	CD	DATE	2003	_	0	SENT_1193	[p18l1041t3270r1115b3295],
2	.	.	O	.	_	0	SENT_1193	[p18l1041t3270r1115b3295],

1	Utility	NN	O	utility	_	0	SENT_1194	[p18l1131t3269r1225b3303],
2	of	IN	O	of	_	0	SENT_1194	[p18l1238t3269r1268b3295],
3	Mdrl-gene	JJ	O	mdrl-gene	amod	5	SENT_1194	[p18l1277t3269r1437b3303],
4	deﬁcient	JJ	O	deﬁcient	amod	5	SENT_1194	[p18l1452t3269r1572b3295],
5	mice	NNS	O	mouse	prep_of	1	SENT_1194	[p18l1585t3270r1651b3295],
6	in	IN	O	in	_	0	SENT_1194	[p18l1665t3270r1692b3294],
7	assessing	VBG	O	assess	prepc_in	5	SENT_1194	[p18l1706t3270r1830b3303],
8	the	DT	O	the	det	9	SENT_1194	[p18l1843t3269r1887b3295],
9	impact	NN	O	impact	dobj	7	SENT_1194	[p18l1901t3270r1996b3303],
10	of	IN	O	of	_	0	SENT_1194	[p18l2010t3269r2040b3295],
11	Pglycoprotein	NN	LOCATION	pglycoprotein	prep_of	9	SENT_1194	[p18l2051t3270r2083b3294, p18l642t3314r819b3348],
12	on	IN	O	on	_	0	SENT_1194	[p18l832t3324r867b3340],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_1194	[p18l880t3314r1124b3348],
14	and	CC	O	and	_	0	SENT_1194	[p18l1138t3314r1188b3340],
15	pharmacodynarnics	NNS	O	pharmacodynarnic	conj_and	13	SENT_1194	[p18l1201t3314r1469b3348],
16	in	IN	O	in	_	0	SENT_1194	[p18l1483t3315r1510b3339],
17	drug	NN	O	drug	nn	18	SENT_1194	[p18l1523t3314r1588b3348],
18	discovery	NN	O	discovery	prep_in	1	SENT_1194	[p18l1601t3314r1732b3348],
19	and	CC	O	and	_	0	SENT_1194	[p18l1745t3314r1794b3340],
20	development	NN	O	development	conj_and	18	SENT_1194	[p18l1808t3314r1995b3348],
21	.	.	O	.	_	0	SENT_1194	[p18l1808t3314r1995b3348],

1	Curr	NN	O	curr	_	0	SENT_1195	[p18l2011t3315r2081b3340],
2	.	.	O	.	_	0	SENT_1195	[p18l2011t3315r2081b3340],

1	Drug	NN	O	drug	_	0	SENT_1196	[p18l642t3360r714b3394],
2	Metcilr	NNP	O	Metcilr	dep	1	SENT_1196	[p18l721t3360r811b3385],
3	.	.	O	.	_	0	SENT_1196	[p18l721t3360r811b3385],

1	4:272	CD	NUMBER	4:272	num	5	SENT_1197	[p18l823t3360r948b3385],
2	—	CD	NUMBER	—	num	5	SENT_1197	[p18l823t3360r948b3385],
3	91	CD	NUMBER	91	num	5	SENT_1197	[p18l823t3360r948b3385],
4	Loescher	NNP	PERSON	Loescher	nn	5	SENT_1197	[p18l642t3401r771b3427],
5	W	NNP	O	W	_	0	SENT_1197	[p18l781t3402r824b3433],
6	,	,	O	,	_	0	SENT_1197	[p18l781t3402r824b3433],
7	Potschka	NNP	LOCATION	Potschka	nn	8	SENT_1197	[p18l837t3401r962b3427],
8	H.	NNP	O	H.	appos	5	SENT_1197	[p18l974t3402r1009b3427],
9	2005	CD	DATE	2005	dep	8	SENT_1197	[p18l1022t3402r1096b3428],
10	.	.	O	.	_	0	SENT_1197	[p18l1022t3402r1096b3428],

1	Role	NN	O	role	_	0	SENT_1198	[p18l1110t3401r1173b3427],
2	of	IN	O	of	_	0	SENT_1198	[p18l1186t3401r1216b3427],
3	drug	NN	O	drug	nn	5	SENT_1198	[p18l1225t3401r1289b3436],
4	efﬂux	NN	O	efﬂux	nn	5	SENT_1198	[p18l1301t3401r1376b3427],
5	transporters	NNS	O	transporter	prep_of	1	SENT_1198	[p18l1386t3409r1554b3436],
6	in	IN	O	in	_	0	SENT_1198	[p18l1566t3403r1593b3427],
7	the	DT	O	the	det	8	SENT_1198	[p18l1604t3401r1647b3427],
8	brain	NN	O	brain	prep_in	1	SENT_1198	[p18l1659t3401r1731b3427],
9	for	IN	O	for	_	0	SENT_1198	[p18l1743t3401r1783b3427],
10	drug	NN	O	drug	nn	11	SENT_1198	[p18l1795t3401r1860b3436],
11	disposition	NN	O	disposition	prep_for	8	SENT_1198	[p18l1871t3401r2022b3436],
12	and	CC	O	and	_	0	SENT_1198	[p18l2034t3401r2083b3427],
13	treatment	NN	O	treatment	prep_for	8	SENT_1198	[p18l642t3451r779b3470],
14	of	IN	O	of	_	0	SENT_1198	[p18l788t3444r819b3470],
15	brain	NN	O	brain	nn	16	SENT_1198	[p18l825t3444r897b3470],
16	diseases	NNS	O	disease	prep_of	1	SENT_1198	[p18l907t3444r1022b3470],
17	.	.	O	.	_	0	SENT_1198	[p18l907t3444r1022b3470],

1	Prog	NN	O	prog	_	0	SENT_1199	[p18l1033t3445r1100b3479],
2	.	.	O	.	_	0	SENT_1199	[p18l1033t3445r1100b3479],

1	Neurolziol	NNP	O	Neurolziol	_	0	SENT_1200	[p18l1111t3445r1244b3470],
2	.	.	O	.	_	0	SENT_1200	[p18l1111t3445r1244b3470],

1	76:22	CD	NUMBER	76:22	num	4	SENT_1201	[p18l1257t3445r1383b3470],
2	-76	CD	NUMBER	-76	num	4	SENT_1201	[p18l1257t3445r1383b3470],
3	Teft	NNP	ORGANIZATION	Teft	nn	4	SENT_1201	[p18l641t3486r704b3512],
4	WA	NNP	ORGANIZATION	WA	_	0	SENT_1201	[p18l714t3487r779b3518],
5	,	,	O	,	_	0	SENT_1201	[p18l714t3487r779b3518],
6	Mansell	NNP	PERSON	Mansell	nn	7	SENT_1201	[p18l791t3486r902b3512],
7	SE	NN	O	se	appos	4	SENT_1201	[p18l915t3487r961b3518],
8	,	,	O	,	_	0	SENT_1201	[p18l915t3487r961b3518],
9	Kim	NNP	PERSON	Kim	nn	10	SENT_1201	[p18l973t3487r1035b3512],
10	RB	NN	O	rb	appos	7	SENT_1201	[p18l1046t3487r1097b3512],
11	.	.	O	.	_	0	SENT_1201	[p18l1046t3487r1097b3512],

1	2011	CD	DATE	2011	_	0	SENT_1202	[p18l1110t3488r1184b3512],
2	.	.	O	.	_	0	SENT_1202	[p18l1110t3488r1184b3512],

1	Endoxifen	NNP	O	Endoxifen	nsubj	11	SENT_1203	[p18l1198t3486r1349b3518],
2	,	,	O	,	_	0	SENT_1203	[p18l1198t3486r1349b3518],
3	the	DT	O	the	det	5	SENT_1203	[p18l1362t3486r1405b3512],
4	active	JJ	O	active	amod	5	SENT_1203	[p18l1417t3487r1496b3512],
5	metabolite	NN	O	metabolite	appos	1	SENT_1203	[p18l1507t3486r1655b3512],
6	of	IN	O	of	_	0	SENT_1203	[p18l1667t3486r1698b3512],
7	tamoxifen	NN	O	tamoxifen	prep_of	5	SENT_1203	[p18l1706t3486r1851b3518],
8	,	,	O	,	_	0	SENT_1203	[p18l1706t3486r1851b3518],
9	is	VBZ	O	be	cop	11	SENT_1203	[p18l1864t3487r1884b3512],
10	a	DT	O	a	det	11	SENT_1203	[p18l1896t3496r1909b3512],
11	substrate	NN	O	substrate	_	0	SENT_1203	[p18l1921t3486r2045b3512],
12	of	IN	O	of	_	0	SENT_1203	[p18l2057t3486r2087b3512],
13	the	DT	O	the	det	16	SENT_1203	[p18l642t3529r685b3555],
14	efflux	NN	O	efflux	nn	16	SENT_1203	[p18l696t3529r771b3555],
15	transporter	NN	O	transporter	nn	16	SENT_1203	[p18l780t3537r936b3563],
16	P	NN	O	p	prep_of	11	SENT_1203	[p18l946t3529r1156b3564],
17	—	CD	NUMBER	—	num	21	SENT_1203	[p18l946t3529r1156b3564],
18	glycoprotein	NN	O	glycoprotein	npadvmod	20	SENT_1203	[p18l946t3529r1156b3564],
19	(	CD	NUMBER	(	num	18	SENT_1203	[p18l1167t3529r1317b3564],
20	multidrug	JJ	O	multidrug	amod	21	SENT_1203	[p18l1167t3529r1317b3564],
21	resistance	NN	O	resistance	dep	16	SENT_1203	[p18l1326t3531r1461b3555],
22	1	CD	NUMBER	1	num	23	SENT_1203	[p18l1474t3530r1505b3561],
23	)	NN	O	)	dep	21	SENT_1203	[p18l1474t3530r1505b3561],
24	.	.	O	.	_	0	SENT_1203	[p18l1474t3530r1505b3561],

1	Drug	NNP	O	Drug	nn	2	SENT_1204	[p18l1516t3530r1588b3564],
2	Memli	NNP	O	Memli	_	0	SENT_1204	[p18l1595t3530r1685b3555],
3	.	.	O	.	_	0	SENT_1204	[p18l1595t3530r1685b3555],

1	Dirpax	NNP	O	Dirpax	_	0	SENT_1205	[p18l1697t3530r1785b3563],
2	.	.	O	.	_	0	SENT_1205	[p18l1697t3530r1785b3563],

1	39:558	CD	NUMBER	39:558	_	0	SENT_1206	[p18l1799t3530r1939b3555],
2	—	CD	NUMBER	—	num	3	SENT_1206	[p18l1799t3530r1939b3555],
3	62	CD	NUMBER	62	dep	1	SENT_1206	[p18l1799t3530r1939b3555],

1	views	NNS	O	view	_	0	SENT_1207	[p19l72t3144r95b3228],
2	.	.	O	.	_	0	SENT_1207	[p19l72t3144r95b3228],

1	org	NN	O	org	_	0	SENT_1208	[p19l79t3082r102b3125],
2	A	NN	O	a	nn	3	SENT_1208	[p19l181t1909r204b1932],
3	nnu	NN	O	nnu	dep	1	SENT_1208	[p19l188t1840r204b1895],
4	.	.	O	.	_	0	SENT_1208	[p19l188t1840r204b1895],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1209	[p19l181t1769r204b1829],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_1209	[p19l181t1610r204b1758],
3	.	.	O	.	_	0	SENT_1209	[p19l181t1610r204b1758],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1210	[p19l181t1490r204b1599],
2	.	.	O	.	_	0	SENT_1210	[p19l181t1490r204b1599],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_1211	[p19l181t1244r205b1478],
2	-273	CD	NUMBER	-273	_	0	SENT_1211	[p19l181t1244r205b1478],
3	.	.	O	.	_	0	SENT_1211	[p19l181t1244r205b1478],

1	Do	VB	O	do	aux	2	SENT_1212	[p19l181t1193r204b1233],
2	wnloaded	VBN	O	wnload	_	0	SENT_1212	[p19l181t1049r204b1178],
3	from	IN	O	from	_	0	SENT_1212	[p19l181t976r204b1040],
4	www	NN	O	www	prep_from	2	SENT_1212	[p19l188t847r204b967],
5	.	.	O	.	_	0	SENT_1212	[p19l188t847r204b967],

1	am	VBP	O	be	cop	2	SENT_1213	[p19l188t847r204b967],
2	1ua1reviews	NNS	O	1ua1review	_	0	SENT_1213	[p19l181t622r211b827],
3	.	.	O	.	_	0	SENT_1213	[p19l181t622r211b827],

1	org	NN	O	org	_	0	SENT_1214	[p19l181t622r211b827],
2	by	IN	O	by	_	0	SENT_1214	[p19l214t1752r245b1785],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_1214	[p19l214t1603r245b1743],
4	of	IN	ORGANIZATION	of	_	0	SENT_1214	[p19l214t1564r238b1593],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_1214	[p19l214t1418r238b1558],
6	-	:	O	-	_	0	SENT_1214	[p19l228t1399r231b1408],
7	Madison	NNP	O	Madison	dep	1	SENT_1214	[p19l214t1272r238b1389],
8	on	IN	O	on	_	0	SENT_1214	[p19l222t1231r238b1263],
9	O1	NN	O	o1	prep_on	7	SENT_1214	[p19l214t1192r238b1222],
10	/	:	O	/	punct	1	SENT_1214	[p19l214t1123r238b1175],
11	05	CD	NUMBER	05	dep	1	SENT_1214	[p19l214t1123r238b1175],
12	/	:	O	/	punct	11	SENT_1214	[p19l214t1123r238b1175],
13	14	CD	NUMBER	14	dep	11	SENT_1214	[p19l214t1084r238b1120],
14	.	.	O	.	_	0	SENT_1214	[p19l214t1084r238b1120],

1	For	IN	O	for	_	0	SENT_1215	[p19l215t1027r238b1073],
2	personal	JJ	O	personal	amod	3	SENT_1215	[p19l214t906r245b1018],
3	use	NN	O	use	pobj	1	SENT_1215	[p19l222t853r238b897],
4	only	RB	O	only	advmod	3	SENT_1215	[p19l214t758r245b823],
5	.	.	O	.	_	0	SENT_1215	[p19l214t758r245b823],

1	270	CD	NUMBER	270	num	2	SENT_1216	[p19l471t48r513b69],
2	DeGo7ter	NN	O	dego7ter	_	0	SENT_1216	[p19l564t41r676b62],
3	et	FW	O	et	nn	4	SENT_1216	[p19l683t46r703b62],
4	al.	FW	O	al.	dep	2	SENT_1216	[p19l709t41r735b62],
5	.	.	O	.	_	0	SENT_1216	[p19l709t41r735b62],

1	IusufD	NNP	O	IusufD	_	0	SENT_1217	[p19l443t79r553b110],
2	,	,	O	,	_	0	SENT_1217	[p19l443t79r553b110],
3	Teunissen	NNP	PERSON	Teunissen	nn	4	SENT_1217	[p19l560t80r706b105],
4	SF	NNP	O	SF	appos	1	SENT_1217	[p19l713t80r757b110],
5	,	,	O	,	_	0	SENT_1217	[p19l713t80r757b110],
6	Wagenaar	NNP	PERSON	Wagenaar	nn	7	SENT_1217	[p19l764t80r909b113],
7	E	NNP	O	E	appos	4	SENT_1217	[p19l915t80r944b110],
8	,	,	O	,	_	0	SENT_1217	[p19l915t80r944b110],
9	Rosing	NNP	PERSON	Rosing	nn	10	SENT_1217	[p19l952t80r1050b113],
10	H	NNP	PERSON	H	appos	4	SENT_1217	[p19l1055t80r1091b110],
11	,	,	O	,	_	0	SENT_1217	[p19l1055t80r1091b110],
12	BeijnenJH	NNP	O	BeijnenJH	appos	4	SENT_1217	[p19l1099t80r1258b113],
13	,	,	O	,	_	0	SENT_1217	[p19l1099t80r1258b113],
14	Schinkel	NNP	PERSON	Schinkel	nn	15	SENT_1217	[p19l1267t79r1386b105],
15	AH	NNP	O	AH	appos	4	SENT_1217	[p19l1391t80r1449b105],
16	.	.	O	.	_	0	SENT_1217	[p19l1391t80r1449b105],

1	201	CD	NUMBER	201	num	2	SENT_1218	[p19l1458t81r1505b105],
2	1	CD	NUMBER	1	_	0	SENT_1218	[p19l1512t81r1532b105],
3	.	.	O	.	_	0	SENT_1218	[p19l1512t81r1532b105],

1	P	NN	O	p	nsubj	8	SENT_1219	[p19l1540t79r1751b113],
2	—	CD	NUMBER	—	num	1	SENT_1219	[p19l1540t79r1751b113],
3	glycoprotein	NN	O	glycoprotein	nn	6	SENT_1219	[p19l1540t79r1751b113],
4	(	CD	NUMBER	(	num	6	SENT_1219	[p19l1758t80r1856b111],
5	ABCB	NN	O	abcb	nn	6	SENT_1219	[p19l1758t80r1856b111],
6	l	NN	O	l	dep	1	SENT_1219	[p19l1862t80r1884b111],
7	)	CD	NUMBER	)	dep	1	SENT_1219	[p19l1862t80r1884b111],
8	transports	VBZ	O	transport	_	0	SENT_1219	[p19l444t129r583b157],
9	the	DT	O	the	det	13	SENT_1219	[p19l597t122r640b148],
10	primary	JJ	O	primary	amod	13	SENT_1219	[p19l654t123r765b157],
11	active	JJ	O	active	amod	13	SENT_1219	[p19l777t123r856b148],
12	tamoxifen	NN	O	tamoxifen	nn	13	SENT_1219	[p19l869t122r1008b148],
13	metabolites	NNS	O	metabolite	nsubj	14	SENT_1219	[p19l1021t122r1181b148],
14	endoxifen	JJ	O	endoxifen	xcomp	8	SENT_1219	[p19l1195t122r1331b148],
15	and	CC	O	and	_	0	SENT_1219	[p19l1345t122r1394b148],
16	4	CD	NUMBER	4	num	18	SENT_1219	[p19l1407t122r1697b157],
17	—	NN	O	—	nn	18	SENT_1219	[p19l1407t122r1697b157],
18	hydroxytamoxifen	NN	O	hydroxytamoxifen	xcomp	8	SENT_1219	[p19l1407t122r1697b157],
19	,	,	O	,	_	0	SENT_1219	[p19l1407t122r1697b157],
20	and	CC	O	and	_	0	SENT_1219	[p19l1712t122r1761b148],
21	restricts	VBZ	O	restrict	conj_and	8	SENT_1219	[p19l1774t123r1884b148],
22	their	PRP$	O	they	poss	24	SENT_1219	[p19l444t166r510b192],
23	brain	NN	O	brain	nn	24	SENT_1219	[p19l519t166r591b192],
24	penetration	NN	O	penetration	dobj	21	SENT_1219	[p19l601t166r801b200],
25	.	.	O	.	_	0	SENT_1219	[p19l601t166r801b200],

1	Pbdrmncol	NNP	O	Pbdrmncol	_	0	SENT_1220	[p19l813t167r957b192],
2	.	.	O	.	_	0	SENT_1220	[p19l813t167r957b192],

1	Exp	NN	O	exp	_	0	SENT_1221	[p19l968t167r1026b200],
2	.	.	O	.	_	0	SENT_1221	[p19l968t167r1026b200],

1	Then	RB	O	then	advmod	3	SENT_1222	[p19l1040t167r1107b192],
2	337:710	CD	NUMBER	337:710	num	3	SENT_1222	[p19l1121t167r1261b192],
3	—	NN	O	—	_	0	SENT_1222	[p19l1121t167r1261b192],
4	1	CD	NUMBER	1	number	5	SENT_1222	[p19l1121t167r1261b192],
5	7	CD	NUMBER	7	amod	3	SENT_1222	[p19l1267t167r1280b192],
6	Potschka	NNP	O	Potschka	nn	7	SENT_1222	[p19l443t209r569b235],
7	H.	NNP	O	H.	dep	3	SENT_1222	[p19l583t210r618b235],
8	2010	CD	DATE	2010	dep	7	SENT_1222	[p19l634t211r709b235],
9	.	.	O	.	_	0	SENT_1222	[p19l634t211r709b235],

1	Modulating	VBG	O	modulate	_	0	SENT_1223	[p19l723t209r890b244],
2	P	NN	O	p	nn	5	SENT_1223	[p19l903t209r1114b244],
3	—	CD	NUMBER	—	num	5	SENT_1223	[p19l903t209r1114b244],
4	glycoprotein	NN	O	glycoprotein	nn	5	SENT_1223	[p19l903t209r1114b244],
5	regulation	NN	O	regulation	dobj	1	SENT_1223	[p19l1128t209r1278b244],
6	:	:	O	:	_	0	SENT_1223	[p19l1128t209r1278b244],
7	future	JJ	DATE	future	amod	8	SENT_1223	[p19l1294t209r1378b235],
8	perspectives	NNS	O	perspective	dep	5	SENT_1223	[p19l1392t211r1560b244],
9	for	IN	O	for	_	0	SENT_1223	[p19l1575t209r1616b235],
10	pharmacoresistant	JJ	O	pharmacoresistant	amod	11	SENT_1223	[p19l1629t209r1886b244],
11	epilepsies	NNS	O	epilepsy	prep_for	8	SENT_1223	[p19l444t253r588b287],
12	?	.	O	?	_	0	SENT_1223	[p19l444t253r588b287],

1	Epilepsid	NN	O	epilepsid	_	0	SENT_1224	[p19l599t254r714b287],
2	5	CD	NUMBER	5	number	3	SENT_1224	[p19l725t254r738b279],
3	1	CD	NUMBER	1	dep	1	SENT_1224	[p19l744t254r754b279],
4	:	:	O	:	_	0	SENT_1224	[p19l760t264r764b279],
5	1	CD	NUMBER	1	number	6	SENT_1224	[p19l770t255r780b279],
6	3	CD	NUMBER	3	dep	3	SENT_1224	[p19l786t254r797b279],
7	3	CD	NUMBER	3	dep	6	SENT_1224	[p19l803t254r814b279],
8	3-47	CD	NUMBER	3-47	num	10	SENT_1224	[p19l820t254r884b279],
9	Tahara	NN	O	tahara	nn	10	SENT_1224	[p19l443t296r544b322],
10	H	NN	O	h	dep	1	SENT_1224	[p19l555t297r591b328],
11	,	,	O	,	_	0	SENT_1224	[p19l555t297r591b328],
12	Kusuhara	NN	O	kusuhara	nn	13	SENT_1224	[p19l604t296r736b322],
13	H	NN	O	h	appos	10	SENT_1224	[p19l748t297r783b328],
14	,	,	O	,	_	0	SENT_1224	[p19l748t297r783b328],
15	Fuse	NN	O	fuse	nn	16	SENT_1224	[p19l797t297r861b322],
16	E	NN	O	e	appos	1	SENT_1224	[p19l873t297r902b328],
17	,	,	O	,	_	0	SENT_1224	[p19l873t297r902b328],
18	Sugiyama	NNP	PERSON	Sugiyama	nn	19	SENT_1224	[p19l916t297r1049b331],
19	Y.	NNP	O	Y.	appos	1	SENT_1224	[p19l1060t297r1089b322],
20	2005	CD	DATE	2005	dep	19	SENT_1224	[p19l1103t298r1168b323],
21	.	.	O	.	_	0	SENT_1224	[p19l1173t318r1177b322],

1	P	NN	O	p	nsubj	4	SENT_1225	[p19l1191t296r1401b331],
2	—	CD	NUMBER	—	num	3	SENT_1225	[p19l1191t296r1401b331],
3	glycoprotein	NN	O	glycoprotein	dep	1	SENT_1225	[p19l1191t296r1401b331],
4	plays	VBZ	O	play	_	0	SENT_1225	[p19l1413t296r1481b331],
5	a	DT	O	a	det	7	SENT_1225	[p19l1494t306r1507b322],
6	major	JJ	O	major	amod	7	SENT_1225	[p19l1519t298r1600b331],
7	role	NN	O	role	dobj	4	SENT_1225	[p19l1611t296r1665b322],
8	in	IN	O	in	_	0	SENT_1225	[p19l1677t298r1704b322],
9	the	DT	O	the	det	10	SENT_1225	[p19l1716t296r1759b322],
10	eﬂ	NN	O	eﬂ	poss	12	SENT_1225	[p19l1772t296r1847b322],
11	'	POS	O	'	_	0	SENT_1225	[p19l1772t296r1847b322],
12	1ux	NN	O	1ux	prep_in	7	SENT_1225	[p19l1772t296r1847b322],
13	of	IN	O	of	_	0	SENT_1225	[p19l1858t296r1888b322],
14	fexofenadine	NN	O	fexofenadine	prep_of	12	SENT_1225	[p19l444t340r620b366],
15	in	IN	O	in	_	0	SENT_1225	[p19l628t341r655b365],
16	the	DT	O	the	det	18	SENT_1225	[p19l663t340r707b366],
17	small	JJ	O	small	amod	18	SENT_1225	[p19l715t340r787b366],
18	intestine	NN	O	intestine	prep_in	14	SENT_1225	[p19l795t341r914b366],
19	and	CC	O	and	_	0	SENT_1225	[p19l923t340r972b366],
20	blood	NN	O	blood	nn	23	SENT_1225	[p19l980t340r1146b366],
21	—	NN	O	—	nn	23	SENT_1225	[p19l980t340r1146b366],
22	brain	NN	O	brain	nn	23	SENT_1225	[p19l980t340r1146b366],
23	barrier	NN	O	barrier	conj_and	18	SENT_1225	[p19l1154t340r1256b371],
24	,	,	O	,	_	0	SENT_1225	[p19l1154t340r1256b371],
25	but	CC	O	but	_	0	SENT_1225	[p19l1265t340r1312b366],
26	only	RB	O	only	_	0	SENT_1225	[p19l1319t340r1380b374],
27	a	DT	O	a	det	29	SENT_1225	[p19l1387t350r1401b366],
28	limited	JJ	O	limited	amod	29	SENT_1225	[p19l1409t340r1507b366],
29	role	NN	O	role	conj_only	12	SENT_1225	[p19l1515t340r1569b366],
30	in	IN	O	in	_	0	SENT_1225	[p19l1577t341r1604b365],
31	its	PRP$	O	its	poss	33	SENT_1225	[p19l1612t341r1643b366],
32	biliary	JJ	O	biliary	amod	33	SENT_1225	[p19l1651t340r1741b374],
33	excretion	NN	O	excretion	prep_in	29	SENT_1225	[p19l1748t341r1883b366],
34	.	.	O	.	_	0	SENT_1225	[p19l1748t341r1883b366],

1	Drug	NN	O	drug	_	0	SENT_1226	[p19l443t383r520b417],
2	.	.	O	.	_	0	SENT_1226	[p19l443t383r520b417],

1	Metal	NN	O	metal	_	0	SENT_1227	[p19l531t383r621b408],
2	)	NN	O	)	dep	1	SENT_1227	[p19l531t383r621b408],
3	.	.	O	.	_	0	SENT_1227	[p19l531t383r621b408],

1	Dlrpox	NNP	PERSON	Dlrpox	_	0	SENT_1228	[p19l633t383r720b416],
2	.	.	O	.	_	0	SENT_1228	[p19l633t383r720b416],

1	33:963	CD	NUMBER	33:963	num	2	SENT_1229	[p19l735t384r877b408],
2	—	CD	NUMBER	—	_	0	SENT_1229	[p19l735t384r877b408],
3	68	CD	NUMBER	68	num	5	SENT_1229	[p19l735t384r877b408],
4	Yang	NNP	PERSON	Yang	nn	5	SENT_1229	[p19l443t426r516b459],
5	JJ	NN	PERSON	jj	dep	2	SENT_1229	[p19l524t426r559b457],
6	,	,	O	,	_	0	SENT_1229	[p19l524t426r559b457],
7	Nﬁlton	NNP	O	Nﬁlton	nn	8	SENT_1229	[p19l571t425r669b451],
8	MN	NN	O	mn	appos	5	SENT_1229	[p19l681t426r749b456],
9	,	,	O	,	_	0	SENT_1229	[p19l681t426r749b456],
10	Yu	NNP	PERSON	Yu	nn	11	SENT_1229	[p19l762t426r802b451],
11	S	NNP	PERSON	S	appos	5	SENT_1229	[p19l816t426r840b456],
12	,	,	O	,	_	0	SENT_1229	[p19l816t426r840b456],
13	Liao	NNP	PERSON	Liao	nn	14	SENT_1229	[p19l854t426r917b451],
14	M	NNP	PERSON	M	appos	5	SENT_1229	[p19l929t426r968b456],
15	,	,	O	,	_	0	SENT_1229	[p19l929t426r968b456],
16	Liu	NNP	PERSON	Liu	nn	17	SENT_1229	[p19l982t426r1031b451],
17	N	NNP	PERSON	N	appos	5	SENT_1229	[p19l1043t426r1079b456],
18	,	,	O	,	_	0	SENT_1229	[p19l1043t426r1079b456],
19	et	FW	O	et	nn	20	SENT_1229	[p19l1094t432r1119b451],
20	al.	FW	O	al.	appos	5	SENT_1229	[p19l1132t425r1161b451],
21	2010	CD	DATE	2010	dep	20	SENT_1229	[p19l1176t427r1250b451],
22	.	.	O	.	_	0	SENT_1229	[p19l1176t427r1250b451],

1	P	NN	O	p	nn	3	SENT_1230	[p19l1265t425r1475b459],
2	—	CD	NUMBER	—	num	3	SENT_1230	[p19l1265t425r1475b459],
3	glycoprotein	NN	O	glycoprotein	nsubj	9	SENT_1230	[p19l1265t425r1475b459],
4	and	CC	O	and	_	0	SENT_1230	[p19l1488t425r1538b451],
5	breast	NN	O	breast	nn	8	SENT_1230	[p19l1551t425r1635b451],
6	cancer	NN	O	cancer	nn	8	SENT_1230	[p19l1647t435r1737b451],
7	resistance	NN	O	resistance	nn	8	SENT_1230	[p19l1749t426r1884b451],
8	protein	NN	O	protein	conj_and	3	SENT_1230	[p19l443t469r545b502],
9	affect	VBP	O	affect	_	0	SENT_1230	[p19l555t468r630b494],
10	disposition	NN	O	disposition	dobj	9	SENT_1230	[p19l639t468r791b502],
11	of	IN	O	of	_	0	SENT_1230	[p19l801t468r831b494],
12	tandutinib	NN	O	tandutinib	prep_of	10	SENT_1230	[p19l837t468r989b499],
13	,	,	O	,	_	0	SENT_1230	[p19l837t468r989b499],
14	a	DT	O	a	det	17	SENT_1230	[p19l1001t478r1014b494],
15	tyrosine	NN	O	tyrosine	nn	17	SENT_1230	[p19l1024t469r1135b502],
16	kinase	NN	O	kinase	nn	17	SENT_1230	[p19l1145t468r1230b494],
17	inhibitor	NN	O	inhibitor	appos	12	SENT_1230	[p19l1240t468r1371b494],
18	.	.	O	.	_	0	SENT_1230	[p19l1240t468r1371b494],

1	Drug	NNP	O	Drug	nn	2	SENT_1231	[p19l1382t469r1454b503],
2	Metal	NNP	O	Metal	_	0	SENT_1231	[p19l1461t469r1551b494],
3	)	NN	O	)	dep	2	SENT_1231	[p19l1461t469r1551b494],
4	.	.	O	.	_	0	SENT_1231	[p19l1461t469r1551b494],

1	Lett	NNP	PERSON	Lett	_	0	SENT_1232	[p19l1563t469r1622b494],
2	.	.	O	.	_	0	SENT_1232	[p19l1563t469r1622b494],

1	4:201	CD	NUMBER	4:201	num	4	SENT_1233	[p19l1634t470r1759b494],
2	-12	CD	NUMBER	-12	num	4	SENT_1233	[p19l1634t470r1759b494],
3	Polli	NNP	PERSON	Polli	nn	4	SENT_1233	[p19l443t511r509b537],
4	JW	NNP	O	JW	_	0	SENT_1233	[p19l520t512r579b543],
5	,	,	O	,	_	0	SENT_1233	[p19l520t512r579b543],
6	Olson	NNP	ORGANIZATION	Olson	nn	7	SENT_1233	[p19l596t511r679b537],
7	KL	NNP	ORGANIZATION	KL	appos	4	SENT_1233	[p19l694t512r748b542],
8	,	,	O	,	_	0	SENT_1233	[p19l694t512r748b542],
9	Chism	NNP	ORGANIZATION	Chism	nn	10	SENT_1233	[p19l765t511r857b537],
10	JP	NNP	ORGANIZATION	JP	appos	4	SENT_1233	[p19l867t512r911b543],
11	,	,	O	,	_	0	SENT_1233	[p19l867t512r911b543],
12	John-Williams	NNP	O	John-Williams	nn	13	SENT_1233	[p19l923t511r1133b543],
13	LS	NN	O	l	appos	4	SENT_1233	[p19l1149t512r1196b542],
14	,	,	O	,	_	0	SENT_1233	[p19l1149t512r1196b542],
15	Yeager	NNP	PERSON	Yeager	nn	16	SENT_1233	[p19l1212t512r1310b545],
16	RL	NNP	O	RL	appos	4	SENT_1233	[p19l1325t512r1376b542],
17	,	,	O	,	_	0	SENT_1233	[p19l1325t512r1376b542],
18	et	FW	O	et	nn	19	SENT_1233	[p19l1393t518r1419b537],
19	al.	FW	O	al.	appos	4	SENT_1233	[p19l1434t511r1463b537],
20	2009	CD	DATE	2009	dep	19	SENT_1233	[p19l1480t513r1555b537],
21	.	.	O	.	_	0	SENT_1233	[p19l1480t513r1555b537],

1	An	DT	O	a	det	4	SENT_1234	[p19l1570t512r1611b536],
2	unexpected	JJ	O	unexpected	amod	4	SENT_1234	[p19l1625t511r1783b545],
3	synergist	NN	O	synergist	nn	4	SENT_1234	[p19l1798t521r1884b545, p19l444t558r493b591],
4	role	NN	O	role	dep	13	SENT_1234	[p19l506t556r560b582],
5	of	IN	O	of	_	0	SENT_1234	[p19l575t556r606b582],
6	P	NN	O	p	nn	8	SENT_1234	[p19l616t556r827b591],
7	—	CD	NUMBER	—	num	8	SENT_1234	[p19l616t556r827b591],
8	glycoprotein	NN	O	glycoprotein	prep_of	4	SENT_1234	[p19l616t556r827b591],
9	and	CC	O	and	_	0	SENT_1234	[p19l842t556r891b582],
10	breast	NN	O	breast	nn	11	SENT_1234	[p19l906t556r989b582],
11	cancer	NN	O	cancer	prep_of	4	SENT_1234	[p19l1003t566r1093b582],
12	resistance	NN	O	resistance	dep	13	SENT_1234	[p19l1107t558r1242b582],
13	protein	NN	O	protein	dep	27	SENT_1234	[p19l1257t558r1359b591],
14	on	IN	O	on	_	0	SENT_1234	[p19l1373t566r1408b582],
15	the	DT	O	the	det	19	SENT_1234	[p19l1422t556r1466b582],
16	central	JJ	O	central	amod	19	SENT_1234	[p19l1481t556r1576b582],
17	nervous	JJ	O	nervous	amod	19	SENT_1234	[p19l1590t566r1699b582],
18	system	NN	O	system	nn	19	SENT_1234	[p19l1714t564r1807b591],
19	penetration	NN	O	penetration	prep_on	13	SENT_1234	[p19l1821t566r1884b591, p19l444t601r553b626],
20	of	IN	O	of	_	0	SENT_1234	[p19l567t600r598b626],
21	the	DT	O	the	det	25	SENT_1234	[p19l608t600r651b626],
22	tyrosine	NN	O	tyrosine	nn	25	SENT_1234	[p19l665t601r777b635],
23	kinase	NN	O	kinase	nn	25	SENT_1234	[p19l791t600r876b626],
24	inhibitor	NN	O	inhibitor	nn	25	SENT_1234	[p19l890t600r1014b626],
25	lapatinib	NN	O	lapatinib	prep_of	19	SENT_1234	[p19l1027t600r1148b634],
26	(	CD	NUMBER	(	num	27	SENT_1234	[p19l1163t600r1426b634],
27	N	NN	O	n	_	0	SENT_1234	[p19l1163t600r1426b634],
28	-	:	O	-	_	0	SENT_1234	[p19l1163t600r1426b634],
29	{	CD	NUMBER	{	num	30	SENT_1234	[p19l1163t600r1426b634],
30	3-chloro-4	NN	O	3-chloro-4	dep	27	SENT_1234	[p19l1163t600r1426b634],
31	-	:	O	-	_	0	SENT_1234	[p19l1163t600r1426b634],
32	[	CD	NUMBER	[	dep	45	SENT_1234	[p19l1163t600r1426b634],
33	(	CD	NUMBER	(	number	34	SENT_1234	[p19l1163t600r1426b634],
34	3	CD	NUMBER	3	dep	32	SENT_1234	[p19l1163t600r1426b634],
35	ﬂuorobenzyl	NN	O	ﬂuorobenzyl	nn	40	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
36	)	NN	O	)	nn	40	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
37	oxy	NN	O	oxy	nn	40	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
38	]	CD	NUMBER	]	num	40	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
39	phenyl	NN	O	phenyl	nn	40	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
40	}	NN	O	}	dep	34	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
41	6	CD	NUMBER	6	num	42	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
42	[	NN	O	[	dep	45	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
43	5	CD	NUMBER	5	num	45	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
44	(	CD	NUMBER	(	num	45	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
45	{	NN	O	{	dep	52	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
46	[	NN	O	[	dep	45	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
47	2	CD	NUMBER	2	num	46	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
48	-	:	O	-	_	0	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
49	(	CD	NUMBER	(	num	51	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
50	methylsulfonyl	NN	O	methylsulfonyl	nn	51	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
51	)	NN	O	)	dep	46	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
52	ethyl	NN	O	ethyl	dep	57	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
53	]	CD	NUMBER	]	num	52	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
54	amino	NN	O	amino	nn	57	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
55	}	NN	O	}	nn	57	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
56	methyl	NN	O	methyl	nn	57	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
57	)	NN	O	)	dep	30	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],
58	.	.	O	.	_	0	SENT_1234	[p19l1432t600r1884b635, p19l444t645r1437b680],

1	—	NN	O	—	_	0	SENT_1235	[p19l1432t600r1884b635, p19l444t645r1437b680],
2	.	.	O	.	_	0	SENT_1235	[p19l1432t600r1884b635, p19l444t645r1437b680],

1	2	LS	NUMBER	2	_	0	SENT_1236	[p19l1432t600r1884b635, p19l444t645r1437b680],
2	.	.	O	.	_	0	SENT_1236	[p19l1432t600r1884b635, p19l444t645r1437b680],

1	—	NN	O	—	_	0	SENT_1237	[p19l1432t600r1884b635, p19l444t645r1437b680],
2	.	.	O	.	_	0	SENT_1237	[p19l1432t600r1884b635, p19l444t645r1437b680],

1	furyl	NN	O	furyl	_	0	SENT_1238	[p19l1432t600r1884b635, p19l444t645r1437b680],
2	]	CD	NUMBER	]	number	3	SENT_1238	[p19l1432t600r1884b635, p19l444t645r1437b680],
3	-4	CD	NUMBER	-4	num	1	SENT_1238	[p19l1432t600r1884b635, p19l444t645r1437b680],
4	.	.	O	.	_	0	SENT_1238	[p19l1432t600r1884b635, p19l444t645r1437b680],

1	—	NN	O	—	_	0	SENT_1239	[p19l1432t600r1884b635, p19l444t645r1437b680],
2	.	.	O	.	_	0	SENT_1239	[p19l1432t600r1884b635, p19l444t645r1437b680],

1	quinazolinamine	NN	O	quinazolinamine	_	0	SENT_1240	[p19l1432t600r1884b635, p19l444t645r1437b680],
2	;	:	O	;	_	0	SENT_1240	[p19l1432t600r1884b635, p19l444t645r1437b680],
3	GW5	NN	O	gw5	nn	5	SENT_1240	[p19l1450t646r1527b671],
4	72016	CD	NUMBER	72016	num	5	SENT_1240	[p19l1531t646r1633b678],
5	)	NN	O	)	dep	1	SENT_1240	[p19l1531t646r1633b678],
6	.	.	O	.	_	0	SENT_1240	[p19l1531t646r1633b678],

1	Drug	NNP	O	Drug	nn	2	SENT_1241	[p19l1644t646r1717b680],
2	Metnb	NNP	O	Metnb	_	0	SENT_1241	[p19l1724t646r1815b671],
3	.	.	O	.	_	0	SENT_1241	[p19l1724t646r1815b671],

1	Dispox	NNP	PERSON	Dispox	_	0	SENT_1242	[p19l1828t646r1884b671, p19l440t698r486b725],
2	.	.	O	.	_	0	SENT_1242	[p19l1828t646r1884b671, p19l440t698r486b725],

1	37:43	CD	NUMBER	37:43	num	4	SENT_1243	[p19l500t692r571b717],
2	9-42	CD	NUMBER	9-42	num	4	SENT_1243	[p19l576t692r640b717],
3	Tang	NNP	ORGANIZATION	Tang	nn	4	SENT_1243	[p19l442t741r519b775],
4	SC	NNP	ORGANIZATION	SC	_	0	SENT_1243	[p19l527t741r576b772],
5	,	,	O	,	_	0	SENT_1243	[p19l527t741r576b772],
6	LagasJS	NNP	O	LagasJS	appos	4	SENT_1243	[p19l584t741r709b775],
7	,	,	O	,	_	0	SENT_1243	[p19l584t741r709b775],
8	Lankheet	NNP	ORGANIZATION	Lankheet	nn	9	SENT_1243	[p19l717t740r850b766],
9	NA	NNP	ORGANIZATION	NA	appos	4	SENT_1243	[p19l856t741r913b772],
10	,	,	O	,	_	0	SENT_1243	[p19l856t741r913b772],
11	Poller	NNP	PERSON	Poller	nn	12	SENT_1243	[p19l922t740r1007b766],
12	B	NNP	O	B	appos	4	SENT_1243	[p19l1014t741r1041b772],
13	,	,	O	,	_	0	SENT_1243	[p19l1014t741r1041b772],
14	Hillebrand	NNP	PERSON	Hillebrand	nn	15	SENT_1243	[p19l1050t740r1202b766],
15	MJ	NNP	O	MJ	appos	4	SENT_1243	[p19l1208t741r1260b773],
16	,	,	O	,	_	0	SENT_1243	[p19l1208t741r1260b773],
17	et	FW	O	et	nn	18	SENT_1243	[p19l1269t748r1295b766],
18	al.	FW	O	al.	appos	4	SENT_1243	[p19l1301t740r1331b766],
19	201	CD	NUMBER	201	number	20	SENT_1243	[p19l1340t742r1387b766],
20	1	CD	NUMBER	1	dep	18	SENT_1243	[p19l1395t742r1415b766],
21	.	.	O	.	_	0	SENT_1243	[p19l1395t742r1415b766],

1	Brain	NN	O	brain	nn	2	SENT_1244	[p19l1424t741r1499b766],
2	accumulation	NN	O	accumulation	nsubjpass	26	SENT_1244	[p19l1507t740r1693b766],
3	of	IN	O	of	_	0	SENT_1244	[p19l1701t740r1731b766],
4	sunitinib	NN	O	sunitinib	prep_of	2	SENT_1244	[p19l1735t740r1857b766],
5	is	VBZ	O	be	auxpass	6	SENT_1244	[p19l1864t742r1884b766],
6	restricted	VBN	O	restrict	_	0	SENT_1244	[p19l443t786r575b812],
7	by	IN	O	by	_	0	SENT_1244	[p19l582t786r616b821],
8	P	NN	O	p	nn	10	SENT_1244	[p19l621t786r831b821],
9	—	CD	NUMBER	—	num	10	SENT_1244	[p19l621t786r831b821],
10	glycoprotein	NN	O	glycoprotein	agent	6	SENT_1244	[p19l621t786r831b821],
11	(	CD	NUMBER	(	num	10	SENT_1244	[p19l838t787r936b818],
12	ABCB	NN	O	abcb	nn	14	SENT_1244	[p19l838t787r936b818],
13	1	CD	NUMBER	1	num	14	SENT_1244	[p19l942t787r964b818],
14	)	NN	O	)	tmod	6	SENT_1244	[p19l942t787r964b818],
15	and	CC	O	and	_	0	SENT_1244	[p19l972t786r1021b812],
16	breast	NN	O	breast	nn	22	SENT_1244	[p19l1028t786r1112b812],
17	cancer	NN	O	cancer	nn	22	SENT_1244	[p19l1118t796r1208b812],
18	resistance	NN	O	resistance	nn	22	SENT_1244	[p19l1214t788r1349b812],
19	protein	NN	O	protein	nn	22	SENT_1244	[p19l1356t788r1457b820],
20	(	CD	NUMBER	(	num	22	SENT_1244	[p19l1465t787r1597b818],
21	ABCG2	NN	O	abcg2	nn	22	SENT_1244	[p19l1465t787r1597b818],
22	)	NN	O	)	conj_and	14	SENT_1244	[p19l1465t787r1597b818],
23	and	CC	O	and	_	0	SENT_1244	[p19l1604t786r1654b812],
24	can	MD	O	can	aux	26	SENT_1244	[p19l1661t796r1707b812],
25	be	VB	O	be	auxpass	26	SENT_1244	[p19l1714t786r1745b812],
26	enhanced	VBN	O	enhance	conj_and	6	SENT_1244	[p19l1753t786r1884b812],
27	by	IN	O	by	_	0	SENT_1244	[p19l444t852r477b887],
28	oral	JJ	O	oral	amod	29	SENT_1244	[p19l486t852r539b878],
29	elacridar	NN	O	elacridar	agent	26	SENT_1244	[p19l550t852r670b878],
30	and	CC	O	and	_	0	SENT_1244	[p19l680t852r729b878],
31	sunitinib	NN	O	sunitinib	nn	32	SENT_1244	[p19l739t852r861b878],
32	coadministration	NN	O	coadministration	agent	26	SENT_1244	[p19l872t852r1115b878],
33	.	.	O	.	_	0	SENT_1244	[p19l872t852r1115b878],

1	Int	NN	O	int	_	0	SENT_1245	[p19l1125t852r1203b886],
2	.	.	O	.	_	0	SENT_1245	[p19l1125t852r1203b886],

1	Cancer	NN	O	cancer	npadvmod	13	SENT_1246	[p19l1217t853r1308b878],
2	In	IN	O	in	_	0	SENT_1246	[p19l1315t853r1345b878],
3	press	NN	O	press	prep_in	13	SENT_1246	[p19l1355t862r1432b886],
4	,	,	O	,	_	0	SENT_1246	[p19l1355t862r1432b886],
5	doi	FW	O	doi	appos	3	SENT_1246	[p19l1443t852r1746b887],
6	:10.1002	CD	NUMBER	:10.1002	dep	5	SENT_1246	[p19l1443t852r1746b887],
7	/	:	O	/	punct	8	SENT_1246	[p19l1443t852r1746b887],
8	ijc	NN	O	ijc	dep	6	SENT_1246	[p19l1443t852r1746b887],
9	.26000	CD	NUMBER	.26000	num	8	SENT_1246	[p19l1443t852r1746b887],
10	Oostendorp	NNP	ORGANIZATION	Oostendorp	nn	11	SENT_1246	[p19l444t901r611b935],
11	RL	NNP	ORGANIZATION	RL	nsubj	13	SENT_1246	[p19l630t902r682b933],
12	,	,	O	,	_	0	SENT_1246	[p19l630t902r682b933],
13	Buckle	VB	O	buckle	_	0	SENT_1246	[p19l701t901r795b927],
14	T	NN	O	t	dobj	13	SENT_1246	[p19l812t902r845b933],
15	,	,	O	,	_	0	SENT_1246	[p19l812t902r845b933],
16	Beijnen	NNP	PERSON	Beijnen	nn	17	SENT_1246	[p19l865t902r970b935],
17	JH	NNP	O	JH	appos	14	SENT_1246	[p19l984t902r1035b933],
18	,	,	O	,	_	0	SENT_1246	[p19l984t902r1035b933],
19	van	NNP	PERSON	van	nn	21	SENT_1246	[p19l1053t911r1102b927],
20	Tellingen	NNP	PERSON	Tellingen	nn	21	SENT_1246	[p19l1119t901r1257b936],
21	O	NNP	PERSON	O	appos	14	SENT_1246	[p19l1276t902r1309b933],
22	,	,	O	,	_	0	SENT_1246	[p19l1276t902r1309b933],
23	Schellens	NNP	O	Schellens	nn	24	SENT_1246	[p19l1330t901r1458b927],
24	JH	NNP	O	JH	appos	14	SENT_1246	[p19l1473t902r1524b933],
25	.	.	O	.	_	0	SENT_1246	[p19l1473t902r1524b933],

1	2009	CD	DATE	2009	_	0	SENT_1247	[p19l1544t903r1618b927],
2	.	.	O	.	_	0	SENT_1247	[p19l1544t903r1618b927],

1	The	DT	O	the	det	2	SENT_1248	[p19l1637t901r1696b927],
2	effect	NN	O	effect	_	0	SENT_1248	[p19l1715t901r1790b927],
3	of	IN	O	of	_	0	SENT_1248	[p19l1807t901r1838b927],
4	Pgp	NNP	O	Pgp	nn	6	SENT_1248	[p19l1852t902r1884b927, p19l444t957r477b981],
5	(	CD	NUMBER	(	num	6	SENT_1248	[p19l494t947r611b979],
6	Mdr1a	NN	O	mdr1a	prep_of	2	SENT_1248	[p19l494t947r611b979],
7	/	:	O	/	punct	2	SENT_1248	[p19l494t947r611b979],
8	lb	NN	O	lb	nn	14	SENT_1248	[p19l614t947r663b979],
9	)	NN	O	)	nn	14	SENT_1248	[p19l614t947r663b979],
10	,	,	O	,	_	0	SENT_1248	[p19l614t947r663b979],
11	BCRP	NN	O	bcrp	dep	14	SENT_1248	[p19l681t948r770b973],
12	(	NN	O	(	nn	14	SENT_1248	[p19l787t948r890b981],
13	Bcrpl	NN	O	bcrpl	nn	14	SENT_1248	[p19l787t948r890b981],
14	)	NN	O	)	dep	2	SENT_1248	[p19l787t948r890b981],
15	and	CC	O	and	_	0	SENT_1248	[p19l907t947r956b973],
16	P-gp/BCRP	NN	O	p-gp/bcrp	nn	17	SENT_1248	[p19l973t948r1143b981],
17	inhibitors	NNS	O	inhibitor	dep	2	SENT_1248	[p19l1160t947r1295b973],
18	on	IN	O	on	_	0	SENT_1248	[p19l1312t957r1347b973],
19	the	DT	O	the	prep_on	14	SENT_1248	[p19l1363t947r1407b973],
20	in	FW	O	in	nn	21	SENT_1248	[p19l1423t948r1450b972],
21	vivo	FW	O	vivo	advmod	22	SENT_1248	[p19l1465t948r1522b973],
22	absorption	NN	O	absorption	dep	19	SENT_1248	[p19l1539t947r1695b981],
23	,	,	O	,	_	0	SENT_1248	[p19l1539t947r1695b981],
24	distribution	NN	O	distribution	appos	19	SENT_1248	[p19l1713t947r1884b978],
25	,	,	O	,	_	0	SENT_1248	[p19l1713t947r1884b978],
26	metabolism	NN	O	metabolism	appos	19	SENT_1248	[p19l443t993r605b1018],
27	and	CC	O	and	_	0	SENT_1248	[p19l615t993r665b1018],
28	excretion	NN	O	excretion	appos	19	SENT_1248	[p19l675t994r803b1018],
29	of	IN	O	of	_	0	SENT_1248	[p19l813t993r844b1018],
30	imatinib	NN	O	imatinib	prep_of	24	SENT_1248	[p19l850t993r973b1018],
31	.	.	O	.	_	0	SENT_1248	[p19l850t993r973b1018],

1	Inzzertig	NNP	O	Inzzertig	_	0	SENT_1249	[p19l983t994r1091b1027],
2	.	.	O	.	_	0	SENT_1249	[p19l983t994r1091b1027],

1	New	NNP	O	New	nn	2	SENT_1250	[p19l1103t994r1162b1018],
2	Drugs	NNPS	O	Drugs	_	0	SENT_1250	[p19l1172t994r1255b1027],
3	27:31	CD	NUMBER	27:31	number	4	SENT_1250	[p19l1263t994r1390b1019],
4	-40	CD	NUMBER	-40	dep	2	SENT_1250	[p19l1263t994r1390b1019],
5	Syvanen	NNP	O	Syvanen	dep	4	SENT_1250	[p19l444t1042r559b1076],
6	S	NN	O	s	dep	2	SENT_1250	[p19l569t1042r592b1073],
7	,	,	O	,	_	0	SENT_1250	[p19l569t1042r592b1073],
8	Lindhe	NNP	PERSON	Lindhe	nn	9	SENT_1250	[p19l602t1041r702b1067],
9	O	NNP	PERSON	O	appos	6	SENT_1250	[p19l712t1042r745b1073],
10	,	,	O	,	_	0	SENT_1250	[p19l712t1042r745b1073],
11	Palner	NNP	O	Palner	nn	12	SENT_1250	[p19l755t1041r846b1067],
12	M	NNP	O	M	appos	6	SENT_1250	[p19l852t1043r892b1073],
13	,	,	O	,	_	0	SENT_1250	[p19l852t1043r892b1073],
14	Kornum	NNP	O	Kornum	nn	15	SENT_1250	[p19l901t1043r1020b1067],
15	BR	NNP	O	BR	appos	6	SENT_1250	[p19l1029t1043r1080b1073],
16	,	,	O	,	_	0	SENT_1250	[p19l1029t1043r1080b1073],
17	Rahman	NNP	PERSON	Rahman	nn	18	SENT_1250	[p19l1090t1041r1206b1067],
18	O	NNP	PERSON	O	appos	6	SENT_1250	[p19l1215t1042r1248b1073],
19	,	,	O	,	_	0	SENT_1250	[p19l1215t1042r1248b1073],
20	et	FW	O	et	nn	21	SENT_1250	[p19l1258t1049r1284b1067],
21	al.	FW	O	al.	appos	6	SENT_1250	[p19l1292t1042r1321b1067],
22	2009	CD	DATE	2009	dep	21	SENT_1250	[p19l1331t1043r1406b1067],
23	.	.	O	.	_	0	SENT_1250	[p19l1331t1043r1406b1067],

1	Species	NNP	O	Species	nn	2	SENT_1251	[p19l1417t1042r1517b1076],
2	differences	NNS	O	difference	_	0	SENT_1251	[p19l1527t1041r1675b1067],
3	in	IN	O	in	_	0	SENT_1251	[p19l1684t1043r1711b1067],
4	blood	NN	O	blood	nn	8	SENT_1251	[p19l1719t1041r1885b1067],
5	—	NN	O	—	nn	8	SENT_1251	[p19l1719t1041r1885b1067],
6	brain	NN	O	brain	nn	8	SENT_1251	[p19l1719t1041r1885b1067],
7	barrier	NN	O	barrier	nn	8	SENT_1251	[p19l444t1087r539b1113],
8	transport	NN	O	transport	prep_in	2	SENT_1251	[p19l548t1095r677b1121],
9	of	IN	O	of	_	0	SENT_1251	[p19l686t1087r717b1113],
10	three	CD	NUMBER	three	num	14	SENT_1251	[p19l723t1087r794b1113],
11	positron	JJ	O	positron	amod	14	SENT_1251	[p19l804t1089r921b1121],
12	emission	NN	O	emission	nn	14	SENT_1251	[p19l931t1089r1052b1113],
13	tomography	NN	O	tomography	nn	14	SENT_1251	[p19l1062t1087r1234b1122],
14	radioligands	NNS	O	radioligand	prep_of	8	SENT_1251	[p19l1242t1087r1412b1122],
15	with	IN	O	with	_	0	SENT_1251	[p19l1421t1087r1483b1113],
16	emphasis	NN	O	emphasis	prep_with	14	SENT_1251	[p19l1494t1087r1619b1121],
17	on	IN	O	on	_	0	SENT_1251	[p19l1630t1097r1665b1113],
18	P	NN	O	p	nn	21	SENT_1251	[p19l1674t1087r1885b1122],
19	—	CD	NUMBER	—	num	21	SENT_1251	[p19l1674t1087r1885b1122],
20	glycoprotein	NN	O	glycoprotein	nn	21	SENT_1251	[p19l1674t1087r1885b1122],
21	transport	NN	O	transport	prep_on	2	SENT_1251	[p19l444t1140r578b1167],
22	.	.	O	.	_	0	SENT_1251	[p19l444t1140r578b1167],

1	Drug	NNP	O	Drug	nn	2	SENT_1252	[p19l589t1134r662b1168],
2	Metdb	NNP	O	Metdb	_	0	SENT_1252	[p19l669t1134r759b1159],
3	.	.	O	.	_	0	SENT_1252	[p19l669t1134r759b1159],

1	Dixpos	NNP	O	Dixpos	nn	4	SENT_1253	[p19l771t1134r854b1167],
2	372635-43	CD	NUMBER	372635-43	num	4	SENT_1253	[p19l864t1134r1004b1159],
3	Chinn	NNP	ORGANIZATION	Chinn	nn	4	SENT_1253	[p19l444t1195r532b1221],
4	LW	NNP	ORGANIZATION	LW	_	0	SENT_1253	[p19l539t1196r604b1227],
5	,	,	O	,	_	0	SENT_1253	[p19l539t1196r604b1227],
6	Kroetz	NNP	PERSON	Kroetz	nn	7	SENT_1253	[p19l612t1196r708b1221],
7	DL	NNP	O	DL	appos	4	SENT_1253	[p19l715t1196r771b1221],
8	.	.	O	.	_	0	SENT_1253	[p19l715t1196r771b1221],

1	2007	CD	DATE	2007	_	0	SENT_1254	[p19l780t1196r854b1222],
2	.	.	O	.	_	0	SENT_1254	[p19l780t1196r854b1222],

1	ABCB1	NN	O	abcb1	nn	2	SENT_1255	[p19l861t1196r966b1221],
2	pharmacogeneﬁcs	NNS	O	pharmacogeneﬁcs	_	0	SENT_1255	[p19l975t1195r1234b1230],
3	:	:	O	:	_	0	SENT_1255	[p19l975t1195r1234b1230],
4	progress	NN	O	progress	dep	2	SENT_1255	[p19l1242t1205r1367b1230],
5	,	,	O	,	_	0	SENT_1255	[p19l1242t1205r1367b1230],
6	pitfalls	NNS	O	pitfall	dep	2	SENT_1255	[p19l1375t1195r1475b1230],
7	,	,	O	,	_	0	SENT_1255	[p19l1375t1195r1475b1230],
8	and	CC	O	and	_	0	SENT_1255	[p19l1484t1195r1533b1221],
9	promise	NN	O	promise	dep	2	SENT_1255	[p19l1540t1197r1659b1230],
10	.	.	O	.	_	0	SENT_1255	[p19l1540t1197r1659b1230],

1	Clin	NNP	O	Clin	_	0	SENT_1256	[p19l1669t1196r1729b1221],
2	.	.	O	.	_	0	SENT_1256	[p19l1669t1196r1729b1221],

1	Plmwnnml	NNP	O	Plmwnnml	_	0	SENT_1257	[p19l1738t1196r1882b1221],
2	.	.	O	.	_	0	SENT_1257	[p19l1738t1196r1882b1221],

1	Tlyer	NNP	O	Tlyer	_	0	SENT_1258	[p19l445t1242r513b1267],
2	.	.	O	.	_	0	SENT_1258	[p19l445t1242r513b1267],

1	81265-69	CD	NUMBER	81265-69	num	3	SENT_1259	[p19l526t1243r670b1267],
2	Glaeser	NNP	O	Glaeser	nn	3	SENT_1259	[p19l444t1290r550b1315],
3	H.	NNP	O	H.	_	0	SENT_1259	[p19l564t1291r599b1315],
4	2011	CD	DATE	2011	dep	3	SENT_1259	[p19l616t1291r691b1315],
5	.	.	O	.	_	0	SENT_1259	[p19l616t1291r691b1315],

1	Importance	NN	O	importance	_	0	SENT_1260	[p19l707t1291r869b1324],
2	of	IN	O	of	_	0	SENT_1260	[p19l884t1290r915b1315],
3	P	NN	O	p	nn	5	SENT_1260	[p19l926t1290r1136b1324],
4	—	CD	NUMBER	—	num	5	SENT_1260	[p19l926t1290r1136b1324],
5	glycoprotein	NN	O	glycoprotein	prep_of	1	SENT_1260	[p19l926t1290r1136b1324],
6	for	IN	O	for	_	0	SENT_1260	[p19l1151t1290r1192b1315],
7	drug	NN	O	drug	nn	10	SENT_1260	[p19l1207t1290r1350b1324],
8	—	CD	NUMBER	—	num	10	SENT_1260	[p19l1207t1290r1350b1324],
9	drug	NN	O	drug	nn	10	SENT_1260	[p19l1207t1290r1350b1324],
10	interactions	NNS	O	interaction	prep_for	1	SENT_1260	[p19l1364t1291r1536b1315],
11	.	.	O	.	_	0	SENT_1260	[p19l1364t1291r1536b1315],

1	Hdndb	NNP	O	Hdndb	_	0	SENT_1261	[p19l1551t1291r1645b1315],
2	.	.	O	.	_	0	SENT_1261	[p19l1551t1291r1645b1315],

1	Exp	NN	O	exp	_	0	SENT_1262	[p19l1663t1291r1720b1324],
2	.	.	O	.	_	0	SENT_1262	[p19l1663t1291r1720b1324],

1	Plmnrnntol	NN	O	plmnrnntol	_	0	SENT_1263	[p19l1738t1291r1882b1315],
2	.	.	O	.	_	0	SENT_1263	[p19l1738t1291r1882b1315],

1	201	CD	NUMBER	201	num	6	SENT_1264	[p19l444t1337r491b1361],
2	1	CD	NUMBER	1	num	6	SENT_1264	[p19l498t1337r508b1361],
3	:285	CD	NUMBER	:285	num	6	SENT_1264	[p19l514t1337r570b1362],
4	-97	CD	NUMBER	-97	num	6	SENT_1264	[p19l572t1337r621b1362],
5	Gutmann	NNP	PERSON	Gutmann	nn	6	SENT_1264	[p19l444t1386r578b1411],
6	H	NNP	PERSON	H	_	0	SENT_1264	[p19l593t1386r628b1416],
7	,	,	O	,	_	0	SENT_1264	[p19l593t1386r628b1416],
8	Hruz	NNP	O	Hruz	nn	9	SENT_1264	[p19l644t1386r718b1411],
9	P	NN	O	p	appos	6	SENT_1264	[p19l733t1386r760b1416],
10	,	,	O	,	_	0	SENT_1264	[p19l733t1386r760b1416],
11	Zimmermann	NNP	PERSON	Zimmermann	nn	12	SENT_1264	[p19l776t1385r970b1411],
12	C	NNP	O	C	appos	6	SENT_1264	[p19l986t1386r1017b1416],
13	,	,	O	,	_	0	SENT_1264	[p19l986t1386r1017b1416],
14	Beglinger	NNP	O	Beglinger	nn	15	SENT_1264	[p19l1033t1385r1169b1419],
15	C	NNP	O	C	appos	6	SENT_1264	[p19l1184t1386r1215b1416],
16	,	,	O	,	_	0	SENT_1264	[p19l1184t1386r1215b1416],
17	Drewe	NNP	PERSON	Drewe	nn	18	SENT_1264	[p19l1232t1386r1324b1411],
18	J.	NNP	O	J.	appos	6	SENT_1264	[p19l1336t1386r1358b1417],
19	2005	CD	DATE	2005	dep	18	SENT_1264	[p19l1375t1386r1450b1411],
20	.	.	O	.	_	0	SENT_1264	[p19l1375t1386r1450b1411],

1	Distribution	NN	O	distribution	_	0	SENT_1265	[p19l1466t1385r1640b1411],
2	of	IN	O	of	_	0	SENT_1265	[p19l1655t1385r1685b1411],
3	breast	NN	O	breast	nn	6	SENT_1265	[p19l1697t1385r1781b1411],
4	cancer	NN	O	cancer	nn	6	SENT_1265	[p19l1795t1395r1885b1411],
5	resistance	NN	O	resistance	nn	6	SENT_1265	[p19l443t1432r578b1457],
6	protein	NN	O	protein	prep_of	1	SENT_1265	[p19l591t1432r693b1465],
7	(	CD	NUMBER	(	num	8	SENT_1265	[p19l705t1432r941b1463],
8	BCRP/ABCG2	NN	O	bcrp/abcg2	dep	1	SENT_1265	[p19l705t1432r941b1463],
9	)	CD	NUMBER	)	num	11	SENT_1265	[p19l705t1432r941b1463],
10	mRNA	NN	O	mrna	nn	11	SENT_1265	[p19l953t1432r1056b1456],
11	expression	NN	O	expression	npadvmod	12	SENT_1265	[p19l1067t1432r1212b1465],
12	along	IN	O	along	advmod	16	SENT_1265	[p19l1224t1431r1301b1465],
13	the	DT	O	the	det	16	SENT_1265	[p19l1312t1431r1356b1457],
14	human	JJ	O	human	amod	16	SENT_1265	[p19l1368t1431r1464b1457],
15	GI	NN	O	gi	nn	16	SENT_1265	[p19l1477t1432r1515b1457],
16	tract	NN	O	tract	dep	8	SENT_1265	[p19l1527t1438r1597b1457],
17	.	.	O	.	_	0	SENT_1265	[p19l1527t1438r1597b1457],

1	Bincbem	NNP	O	Bincbem	_	0	SENT_1266	[p19l1611t1432r1724b1457],
2	.	.	O	.	_	0	SENT_1266	[p19l1611t1432r1724b1457],

1	Phzzrmtmzl	NNP	O	Phzzrmtmzl	_	0	SENT_1267	[p19l1738t1432r1882b1457],
2	.	.	O	.	_	0	SENT_1267	[p19l1738t1432r1882b1457],

1	70:695	CD	NUMBER	70:695	_	0	SENT_1268	[p19l445t1477r588b1503],
2	—	CD	NUMBER	—	number	3	SENT_1268	[p19l445t1477r588b1503],
3	99	CD	NUMBER	99	dep	1	SENT_1268	[p19l445t1477r588b1503],
4	Schwabedissen	NNP	O	Schwabedissen	nn	8	SENT_1268	[p19l444t1525r651b1551],
5	HE	PRP	O	he	dep	8	SENT_1268	[p19l658t1526r716b1557],
6	,	,	O	,	_	0	SENT_1268	[p19l658t1526r716b1557],
7	Kroemer	NNP	PERSON	Kroemer	dep	8	SENT_1268	[p19l725t1526r851b1551],
8	HK	NNP	O	HK	dep	3	SENT_1268	[p19l858t1526r918b1551],
9	.	.	O	.	_	0	SENT_1268	[p19l858t1526r918b1551],

1	2011	CD	DATE	2011	_	0	SENT_1269	[p19l928t1527r1002b1551],
2	.	.	O	.	_	0	SENT_1269	[p19l928t1527r1002b1551],

1	In	FW	O	in	nn	2	SENT_1270	[p19l1011t1526r1041b1551],
2	vitro	FW	O	vitro	dep	6	SENT_1270	[p19l1047t1527r1113b1551],
3	and	CC	O	and	_	0	SENT_1270	[p19l1121t1525r1171b1551],
4	in	FW	O	in	conj_and	2	SENT_1270	[p19l1178t1527r1205b1551],
5	vivo	FW	O	vivo	pobj	4	SENT_1270	[p19l1211t1527r1269b1551],
6	evidence	NN	O	evidence	nsubj	16	SENT_1270	[p19l1277t1525r1397b1551],
7	for	IN	O	for	_	0	SENT_1270	[p19l1405t1525r1445b1551],
8	the	DT	O	the	det	9	SENT_1270	[p19l1452t1525r1496b1551],
9	importance	NN	O	importance	prep_for	6	SENT_1270	[p19l1503t1527r1662b1560],
10	of	IN	O	of	_	0	SENT_1270	[p19l1670t1525r1700b1551],
11	breast	NN	O	breast	nn	15	SENT_1270	[p19l1704t1525r1788b1551],
12	cancer	NN	O	cancer	nn	15	SENT_1270	[p19l1795t1535r1885b1551],
13	resistance	NN	O	resistance	nn	15	SENT_1270	[p19l443t1572r578b1597],
14	protein	NN	O	protein	nn	15	SENT_1270	[p19l589t1572r690b1605],
15	transporters	NNS	O	transporter	prep_of	9	SENT_1270	[p19l700t1578r868b1605],
16	(	VBP	O	(	_	0	SENT_1270	[p19l879t1572r1316b1603],
17	BCRP/MXR/ABCP	NN	O	bcrp/mxr/abcp	dobj	16	SENT_1270	[p19l879t1572r1316b1603],
18	/	:	O	/	punct	20	SENT_1270	[p19l879t1572r1316b1603],
19	ABCG2	NN	O	abcg2	nn	20	SENT_1270	[p19l879t1572r1316b1603],
20	)	NN	O	)	dep	17	SENT_1270	[p19l879t1572r1316b1603],
21	.	.	O	.	_	0	SENT_1270	[p19l879t1572r1316b1603],

1	Hlzndb	NNP	O	Hlzndb	_	0	SENT_1271	[p19l1326t1572r1420b1596],
2	.	.	O	.	_	0	SENT_1271	[p19l1326t1572r1420b1596],

1	Exp	NN	O	exp	_	0	SENT_1272	[p19l1432t1572r1489b1605],
2	.	.	O	.	_	0	SENT_1272	[p19l1432t1572r1489b1605],

1	Plmrmncol	NNP	O	Plmrmncol	_	0	SENT_1273	[p19l1501t1572r1645b1596],
2	.	.	O	.	_	0	SENT_1273	[p19l1501t1572r1645b1596],

1	20112325-71	CD	NUMBER	20112325-71	num	3	SENT_1274	[p19l1658t1572r1833b1597],
2	Robey	NNP	PERSON	Robey	nn	3	SENT_1274	[p19l444t1620r534b1654],
3	RW	NNP	O	RW	_	0	SENT_1274	[p19l542t1621r608b1651],
4	,	,	O	,	_	0	SENT_1274	[p19l542t1621r608b1651],
5	To	TO	ORGANIZATION	to	_	0	SENT_1274	[p19l617t1620r660b1646],
6	KK	NNP	ORGANIZATION	KK	prep_to	3	SENT_1274	[p19l669t1621r726b1651],
7	,	,	O	,	_	0	SENT_1274	[p19l669t1621r726b1651],
8	Polgar	NNP	PERSON	Polgar	nn	9	SENT_1274	[p19l736t1620r829b1654],
9	O	NNP	O	O	appos	3	SENT_1274	[p19l838t1621r871b1651],
10	,	,	O	,	_	0	SENT_1274	[p19l838t1621r871b1651],
11	Dohse	NNP	O	Dohse	nn	12	SENT_1274	[p19l882t1620r972b1646],
12	M	NNP	O	M	appos	3	SENT_1274	[p19l980t1621r1019b1651],
13	,	,	O	,	_	0	SENT_1274	[p19l980t1621r1019b1651],
14	Fetsch	NNP	PERSON	Fetsch	nn	15	SENT_1274	[p19l1030t1620r1121b1646],
15	P	NN	O	p	appos	3	SENT_1274	[p19l1130t1621r1157b1651],
16	,	,	O	,	_	0	SENT_1274	[p19l1130t1621r1157b1651],
17	et	FW	O	et	nn	18	SENT_1274	[p19l1168t1627r1193b1646],
18	al.	FW	O	al.	appos	3	SENT_1274	[p19l1202t1620r1232b1645],
19	2009	CD	DATE	2009	dep	18	SENT_1274	[p19l1243t1621r1317b1646],
20	.	.	O	.	_	0	SENT_1274	[p19l1243t1621r1317b1646],

1	ABCG2	NNP	O	ABCG2	_	0	SENT_1275	[p19l1327t1621r1447b1646],
2	:	:	O	:	_	0	SENT_1275	[p19l1327t1621r1447b1646],
3	a	DT	O	a	det	4	SENT_1275	[p19l1459t1630r1472b1646],
4	perspective	NN	O	perspective	dep	1	SENT_1275	[p19l1481t1621r1644b1654],
5	.	.	O	.	_	0	SENT_1275	[p19l1481t1621r1644b1654],

1	Adv	NNP	O	Adv	_	0	SENT_1276	[p19l1652t1620r1713b1645],
2	.	.	O	.	_	0	SENT_1276	[p19l1652t1620r1713b1645],

1	Drug	NN	O	drug	_	0	SENT_1277	[p19l1725t1621r1798b1655],
2	Deliv	NNP	O	Deliv	dep	1	SENT_1277	[p19l1805t1621r1882b1645],
3	.	.	O	.	_	0	SENT_1277	[p19l1805t1621r1882b1645],

1	Rev.	NNP	O	Rev.	nn	5	SENT_1278	[p19l443t1667r497b1691],
2	61:3	CD	NUMBER	61:3	num	5	SENT_1278	[p19l511t1667r617b1691],
3	-13	CD	NUMBER	-13	num	5	SENT_1278	[p19l511t1667r617b1691],
4	Xia	NNP	O	Xia	nn	5	SENT_1278	[p19l442t1716r490b1740],
5	CQ	NNP	O	CQ	_	0	SENT_1278	[p19l503t1715r562b1746],
6	,	,	O	,	_	0	SENT_1278	[p19l503t1715r562b1746],
7	Yang	NNP	PERSON	Yang	nn	9	SENT_1278	[p19l574t1716r647b1749],
8	J	NNP	PERSON	J	nn	9	SENT_1278	[p19l654t1716r689b1747],
9	]	NN	O	]	appos	5	SENT_1278	[p19l654t1716r689b1747],
10	,	,	O	,	_	0	SENT_1278	[p19l654t1716r689b1747],
11	Gan	NNP	O	Gan	nn	12	SENT_1278	[p19l703t1715r762b1740],
12	LS	NN	O	l	appos	9	SENT_1278	[p19l774t1715r821b1740],
13	.	.	O	.	_	0	SENT_1278	[p19l774t1715r821b1740],

1	2005	CD	DATE	2005	_	0	SENT_1279	[p19l835t1716r900b1740],
2	.	.	O	.	_	0	SENT_1279	[p19l905t1736r909b1740],

1	Breast	NN	O	breast	nn	2	SENT_1280	[p19l923t1716r1010b1740],
2	cancer	NN	O	cancer	_	0	SENT_1280	[p19l1022t1724r1112b1740],
3	resistance	NN	O	resistance	nn	4	SENT_1280	[p19l1123t1716r1258b1740],
4	protein	NN	O	protein	dep	2	SENT_1280	[p19l1271t1716r1372b1749],
5	in	IN	O	in	_	0	SENT_1280	[p19l1384t1716r1411b1740],
6	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	4	SENT_1280	[p19l1423t1714r1667b1749],
7	and	CC	O	and	_	0	SENT_1280	[p19l1680t1714r1729b1740],
8	drug	NN	O	drug	prep_in	4	SENT_1280	[p19l1742t1714r1886b1749],
9	—	CD	NUMBER	—	num	11	SENT_1280	[p19l1742t1714r1886b1749],
10	drug	NN	O	drug	nn	11	SENT_1280	[p19l1742t1714r1886b1749],
11	interactions	NNS	O	interaction	dep	4	SENT_1280	[p19l443t1762r615b1786],
12	.	.	O	.	_	0	SENT_1280	[p19l443t1762r615b1786],

1	Expert	NN	O	expert	_	0	SENT_1281	[p19l625t1761r714b1794],
2	Opin	NN	PERSON	opin	dep	1	SENT_1281	[p19l724t1761r793b1794],
3	.	.	O	.	_	0	SENT_1281	[p19l724t1761r793b1794],

1	Drug	NN	O	drug	_	0	SENT_1282	[p19l805t1761r878b1795],
2	Metnlz	NNP	O	Metnlz	dep	1	SENT_1282	[p19l885t1761r974b1786],
3	.	.	O	.	_	0	SENT_1282	[p19l885t1761r974b1786],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1283	[p19l989t1761r1084b1786],
2	.	.	O	.	_	0	SENT_1283	[p19l989t1761r1084b1786],

1	1:5	CD	NUMBER	1:5	num	2	SENT_1284	[p19l1100t1761r1136b1786],
2	95-611	CD	NUMBER	95-611	_	0	SENT_1284	[p19l1140t1761r1238b1786],

1	157	CD	NUMBER	157	_	0	SENT_1285	[p19l370t1810r424b1835],
2	.	.	O	.	_	0	SENT_1285	[p19l370t1810r424b1835],

1	Jonker	NNP	PERSON	Jonker	nn	2	SENT_1286	[p19l439t1809r536b1841],
2	JW	NNP	O	JW	_	0	SENT_1286	[p19l546t1810r605b1841],
3	,	,	O	,	_	0	SENT_1286	[p19l546t1810r605b1841],
4	Smit	NNP	PERSON	Smit	nn	5	SENT_1286	[p19l622t1810r687b1835],
5	JW	NNP	O	JW	appos	2	SENT_1286	[p19l697t1810r756b1841],
6	,	,	O	,	_	0	SENT_1286	[p19l697t1810r756b1841],
7	Brinkhuis	NNP	PERSON	Brinkhuis	nn	8	SENT_1286	[p19l772t1809r907b1835],
8	RF	NNP	O	RF	appos	2	SENT_1286	[p19l923t1810r972b1841],
9	,	,	O	,	_	0	SENT_1286	[p19l923t1810r972b1841],
10	Maliepaard	NNP	O	Maliepaard	nn	11	SENT_1286	[p19l987t1809r1145b1843],
11	M	NNP	O	M	appos	2	SENT_1286	[p19l1159t1810r1198b1840],
12	,	,	O	,	_	0	SENT_1286	[p19l1159t1810r1198b1840],
13	Beijnen	NNP	O	Beijnen	nn	14	SENT_1286	[p19l1215t1810r1320b1843],
14	JH	NNP	O	JH	appos	2	SENT_1286	[p19l1331t1810r1382b1841],
15	,	,	O	,	_	0	SENT_1286	[p19l1331t1810r1382b1841],
16	et	FW	O	et	nn	17	SENT_1286	[p19l1399t1816r1425b1835],
17	al.	FW	O	al.	appos	2	SENT_1286	[p19l1439t1809r1468b1835],
18	2000	CD	DATE	2000	dep	17	SENT_1286	[p19l1485t1811r1560b1835],
19	.	.	O	.	_	0	SENT_1286	[p19l1485t1811r1560b1835],

1	Role	NN	O	role	_	0	SENT_1287	[p19l1576t1809r1640b1835],
2	of	IN	O	of	_	0	SENT_1287	[p19l1656t1809r1686b1835],
3	breast	NN	O	breast	nn	6	SENT_1287	[p19l1697t1809r1781b1835],
4	cancer	NN	O	cancer	nn	6	SENT_1287	[p19l1795t1819r1885b1835],
5	resistance	NN	O	resistance	nn	6	SENT_1287	[p19l443t1856r578b1880],
6	protein	NN	O	protein	prep_of	1	SENT_1287	[p19l588t1856r690b1888],
7	in	IN	O	in	_	0	SENT_1287	[p19l699t1856r726b1880],
8	the	DT	O	the	det	9	SENT_1287	[p19l735t1854r778b1880],
9	bioavailability	NN	O	bioavailability	prep_in	1	SENT_1287	[p19l788t1854r984b1889],
10	and	CC	O	and	_	0	SENT_1287	[p19l992t1854r1041b1880],
11	fetal	JJ	O	fetal	amod	12	SENT_1287	[p19l1051t1854r1110b1880],
12	penetration	NN	O	penetration	conj_and	9	SENT_1287	[p19l1120t1856r1281b1888],
13	of	IN	O	of	_	0	SENT_1287	[p19l1291t1855r1321b1880],
14	topotecanj	NN	O	topotecanj	nn	15	SENT_1287	[p19l1327t1855r1503b1888],
15	’	NN	O	’	prep_of	1	SENT_1287	[p19l1327t1855r1503b1888],
16	.	.	O	.	_	0	SENT_1287	[p19l1327t1855r1503b1888],

1	Natl.	NNP	O	Natl.	nn	3	SENT_1288	[p19l1514t1855r1580b1880],
2	Cancer	NNP	O	Cancer	nn	3	SENT_1288	[p19l1594t1855r1684b1880],
3	Inst	NNP	O	Inst	_	0	SENT_1288	[p19l1690t1856r1745b1880],
4	.	.	O	.	_	0	SENT_1288	[p19l1690t1856r1745b1880],

1	92:1651	CD	NUMBER	92:1651	num	5	SENT_1289	[p19l1758t1856r1886b1880],
2	—	CD	NUMBER	—	num	5	SENT_1289	[p19l1758t1856r1886b1880],
3	56	CD	NUMBER	56	num	5	SENT_1289	[p19l445t1914r476b1939],
4	Vlaming	NNP	ORGANIZATION	Vlaming	nn	5	SENT_1289	[p19l442t1956r564b1990],
5	ML	NNP	ORGANIZATION	ML	_	0	SENT_1289	[p19l569t1957r632b1987],
6	,	,	O	,	_	0	SENT_1289	[p19l569t1957r632b1987],
7	LagasJS	NNP	O	LagasJS	appos	5	SENT_1289	[p19l640t1957r765b1990],
8	,	,	O	,	_	0	SENT_1289	[p19l640t1957r765b1990],
9	Schinkel	NNP	PERSON	Schinkel	nn	10	SENT_1289	[p19l775t1956r893b1982],
10	AH	NNP	O	AH	appos	7	SENT_1289	[p19l899t1957r957b1981],
11	.	.	O	.	_	0	SENT_1289	[p19l899t1957r957b1981],

1	2009	CD	DATE	2009	_	0	SENT_1290	[p19l966t1958r1041b1982],
2	.	.	O	.	_	0	SENT_1290	[p19l966t1958r1041b1982],

1	Physiological	JJ	O	physiological	amod	4	SENT_1291	[p19l1049t1956r1235b1990],
2	and	CC	O	and	_	0	SENT_1291	[p19l1243t1956r1292b1982],
3	pharmacological	JJ	O	pharmacological	conj_and	1	SENT_1291	[p19l1300t1956r1530b1990],
4	roles	NNS	O	role	_	0	SENT_1291	[p19l1537t1956r1603b1982],
5	of	IN	O	of	_	0	SENT_1291	[p19l1611t1956r1642b1982],
6	ABCG2	NN	O	abcg2	nn	8	SENT_1291	[p19l1644t1957r1756b1982],
7	(	CD	NUMBER	(	num	8	SENT_1291	[p19l1766t1957r1883b1988],
8	BCRP	NN	O	bcrp	prep_of	4	SENT_1291	[p19l1766t1957r1883b1988],
9	)	CD	NUMBER	)	num	8	SENT_1291	[p19l1766t1957r1883b1988],
10	:	:	O	:	_	0	SENT_1291	[p19l1766t1957r1883b1988],
11	recent	JJ	O	recent	amod	12	SENT_1291	[p19l443t2005r531b2024],
12	ﬁndings	NNS	O	ﬁndings	dep	4	SENT_1291	[p19l540t1998r651b2032],
13	in	IN	O	in	_	0	SENT_1291	[p19l661t1999r688b2024],
14	Abcg2	NN	O	abcg2	nn	16	SENT_1291	[p19l696t1998r783b2032],
15	knockout	NN	O	knockout	nn	16	SENT_1291	[p19l795t1998r926b2024],
16	mice	NNS	O	mouse	prep_in	12	SENT_1291	[p19l935t1999r1008b2024],
17	.	.	O	.	_	0	SENT_1291	[p19l935t1999r1008b2024],

1	Adv	NNP	O	Adv	_	0	SENT_1292	[p19l1016t1999r1078b2024],
2	.	.	O	.	_	0	SENT_1292	[p19l1016t1999r1078b2024],

1	Drug	NN	O	drug	_	0	SENT_1293	[p19l1090t1999r1163b2033],
2	Deliv	NNP	O	Deliv	dep	1	SENT_1293	[p19l1171t1999r1248b2024],
3	.	.	O	.	_	0	SENT_1293	[p19l1171t1999r1248b2024],

1	Rev.	NNP	O	Rev.	nn	5	SENT_1294	[p19l1259t1999r1314b2024],
2	61:14	CD	NUMBER	61:14	num	5	SENT_1294	[p19l1327t1999r1452b2024],
3	-25	CD	NUMBER	-25	num	5	SENT_1294	[p19l1327t1999r1452b2024],
4	Vlaming	NNP	ORGANIZATION	Vlaming	nn	5	SENT_1294	[p19l442t2041r564b2075],
5	ML	NNP	ORGANIZATION	ML	_	0	SENT_1294	[p19l570t2042r632b2072],
6	,	,	O	,	_	0	SENT_1294	[p19l570t2042r632b2072],
7	Pala	NNP	LOCATION	Pala	nn	8	SENT_1294	[p19l641t2041r700b2067],
8	Z	NNP	LOCATION	Z	appos	5	SENT_1294	[p19l707t2041r737b2072],
9	,	,	O	,	_	0	SENT_1294	[p19l707t2041r737b2072],
10	van	NNP	PERSON	van	nn	12	SENT_1294	[p19l744t2051r793b2067],
11	Esch	NNP	PERSON	Esch	nn	12	SENT_1294	[p19l801t2041r868b2067],
12	A	NNP	O	A	appos	5	SENT_1294	[p19l875t2042r904b2072],
13	,	,	O	,	_	0	SENT_1294	[p19l875t2042r904b2072],
14	Wagenaar	NNP	PERSON	Wagenaar	nn	15	SENT_1294	[p19l912t2042r1057b2075],
15	E	NNP	O	E	appos	5	SENT_1294	[p19l1065t2042r1093b2072],
16	,	,	O	,	_	0	SENT_1294	[p19l1065t2042r1093b2072],
17	de	FW	O	de	nn	19	SENT_1294	[p19l1103t2041r1134b2067],
18	Waart	FW	O	waart	nn	19	SENT_1294	[p19l1142t2042r1232b2067],
19	DR	NN	O	dr	appos	5	SENT_1294	[p19l1239t2042r1296b2072],
20	,	,	O	,	_	0	SENT_1294	[p19l1239t2042r1296b2072],
21	et	FW	O	et	nn	22	SENT_1294	[p19l1306t2048r1331b2067],
22	al.	FW	O	al.	appos	5	SENT_1294	[p19l1339t2041r1368b2067],
23	2009	CD	DATE	2009	dep	22	SENT_1294	[p19l1378t2043r1452b2067],
24	.	.	O	.	_	0	SENT_1294	[p19l1378t2043r1452b2067],

1	Functionally	RB	O	functionally	advmod	2	SENT_1295	[p19l1462t2041r1639b2075],
2	overlapping	VBG	O	overlap	_	0	SENT_1295	[p19l1646t2041r1811b2075],
3	roles	NNS	O	role	dobj	2	SENT_1295	[p19l1818t2041r1884b2067],
4	of	IN	O	of	_	0	SENT_1295	[p19l444t2084r474b2110],
5	Abcg2	NN	O	abcg2	nn	8	SENT_1295	[p19l481t2084r568b2119],
6	(	CD	NUMBER	(	num	8	SENT_1295	[p19l583t2085r686b2119],
7	Bcrpl	NN	O	bcrpl	nn	8	SENT_1295	[p19l583t2085r686b2119],
8	)	NN	O	)	prep_of	3	SENT_1295	[p19l583t2085r686b2119],
9	and	CC	O	and	_	0	SENT_1295	[p19l699t2084r748b2110],
10	Abcc2	NN	O	abcc2	nn	13	SENT_1295	[p19l760t2084r844b2110],
11	(	CD	NUMBER	(	num	13	SENT_1295	[p19l859t2085r957b2119],
12	Mrp2	NN	O	mrp2	nn	13	SENT_1295	[p19l859t2085r957b2119],
13	)	NN	O	)	conj_and	3	SENT_1295	[p19l859t2085r957b2119],
14	in	IN	O	in	_	0	SENT_1295	[p19l970t2086r997b2110],
15	the	DT	O	the	det	16	SENT_1295	[p19l1009t2084r1052b2110],
16	elimination	NN	O	elimination	prep_in	13	SENT_1295	[p19l1065t2084r1224b2110],
17	of	IN	O	of	_	0	SENT_1295	[p19l1236t2084r1267b2110],
18	methotrexate	NN	O	methotrexate	prep_of	16	SENT_1295	[p19l1275t2084r1459b2110],
19	and	CC	O	and	_	0	SENT_1295	[p19l1472t2084r1521b2110],
20	its	PRP$	O	its	poss	26	SENT_1295	[p19l1533t2085r1564b2110],
21	main	JJ	O	main	amod	26	SENT_1295	[p19l1577t2085r1646b2110],
22	toxic	JJ	O	toxic	amod	26	SENT_1295	[p19l1658t2085r1725b2110],
23	metabolite	NN	O	metabolite	nn	26	SENT_1295	[p19l1736t2084r1884b2110],
24	7	CD	NUMBER	7	num	26	SENT_1295	[p19l445t2128r772b2162],
25	—	NN	O	—	nn	26	SENT_1295	[p19l445t2128r772b2162],
26	hydroXymethotrexate	NN	O	hydroxymethotrexate	prep_in	13	SENT_1295	[p19l445t2128r772b2162],
27	in	FW	O	in	prep	26	SENT_1295	[p19l781t2129r808b2153],
28	vivo	FW	O	vivo	pobj	27	SENT_1295	[p19l817t2129r882b2154],
29	.	.	O	.	_	0	SENT_1295	[p19l817t2129r882b2154],

1	Clin	NNP	O	Clin	_	0	SENT_1296	[p19l895t2129r955b2153],
2	.	.	O	.	_	0	SENT_1296	[p19l895t2129r955b2153],

1	Cancer	NN	O	cancer	_	0	SENT_1297	[p19l969t2129r1059b2153],
2	Res	NNP	O	Res	dep	1	SENT_1297	[p19l1066t2129r1115b2153],
3	.	.	O	.	_	0	SENT_1297	[p19l1066t2129r1115b2153],

1	15	CD	NUMBER	15	num	4	SENT_1298	[p19l1130t2129r1159b2154],
2	23084-93	CD	NUMBER	23084-93	num	4	SENT_1298	[p19l1163t2129r1286b2154],
3	Vlaming	NNP	O	Vlaming	nn	4	SENT_1298	[p19l442t2170r564b2205],
4	ML	NNP	O	ML	_	0	SENT_1298	[p19l573t2171r635b2202],
5	,	,	O	,	_	0	SENT_1298	[p19l573t2171r635b2202],
6	van	NNP	PERSON	van	nn	8	SENT_1298	[p19l646t2180r695b2196],
7	Esch	NNP	PERSON	Esch	nn	8	SENT_1298	[p19l705t2170r773b2196],
8	A	NNP	O	A	appos	4	SENT_1298	[p19l782t2171r811b2202],
9	,	,	O	,	_	0	SENT_1298	[p19l782t2171r811b2202],
10	Pala	NNP	O	Pala	nn	11	SENT_1298	[p19l823t2170r882b2196],
11	Z	NNP	O	Z	appos	4	SENT_1298	[p19l892t2170r922b2202],
12	,	,	O	,	_	0	SENT_1298	[p19l892t2170r922b2202],
13	Wagenaar	NNP	PERSON	Wagenaar	nn	14	SENT_1298	[p19l933t2171r1078b2205],
14	E	NNP	O	E	appos	4	SENT_1298	[p19l1088t2171r1117b2202],
15	,	,	O	,	_	0	SENT_1298	[p19l1088t2171r1117b2202],
16	van	NNP	O	van	nn	19	SENT_1298	[p19l1127t2180r1176b2196],
17	de	IN	O	de	amod	19	SENT_1298	[p19l1188t2170r1219b2196],
18	Wetering	NNP	O	Wetering	nn	19	SENT_1298	[p19l1229t2171r1365b2205],
19	K	NNP	O	K	appos	4	SENT_1298	[p19l1375t2171r1407b2202],
20	,	,	O	,	_	0	SENT_1298	[p19l1375t2171r1407b2202],
21	et	FW	O	et	nn	22	SENT_1298	[p19l1419t2178r1445b2196],
22	al.	FW	O	al.	appos	4	SENT_1298	[p19l1455t2170r1485b2196],
23	2009	CD	DATE	2009	dep	22	SENT_1298	[p19l1497t2172r1572b2196],
24	.	.	O	.	_	0	SENT_1298	[p19l1497t2172r1572b2196],

1	Abcc2	NN	O	abcc2	nn	4	SENT_1299	[p19l1583t2170r1667b2196],
2	(	CD	NUMBER	(	num	4	SENT_1299	[p19l1681t2171r1787b2205],
3	Mrp2	NN	O	mrp2	nn	4	SENT_1299	[p19l1681t2171r1787b2205],
4	)	NN	O	)	nsubj	19	SENT_1299	[p19l1681t2171r1787b2205],
5	,	,	O	,	_	0	SENT_1299	[p19l1681t2171r1787b2205],
6	Abcc3	NN	O	abcc3	nn	9	SENT_1299	[p19l1798t2170r1882b2197],
7	(	CD	NUMBER	(	num	9	SENT_1299	[p19l444t2215r551b2248],
8	Mrp3	NN	O	mrp3	nn	9	SENT_1299	[p19l444t2215r551b2248],
9	)	NN	O	)	conj_and	4	SENT_1299	[p19l444t2215r551b2248],
10	,	,	O	,	_	0	SENT_1299	[p19l444t2215r551b2248],
11	and	CC	O	and	_	0	SENT_1299	[p19l560t2214r610b2240],
12	Abcg2	NN	O	abcg2	nn	15	SENT_1299	[p19l617t2214r704b2248],
13	(	CD	NUMBER	(	num	15	SENT_1299	[p19l715t2215r818b2248],
14	Bcrpl	NN	O	bcrpl	nn	15	SENT_1299	[p19l715t2215r818b2248],
15	)	NN	O	)	nsubj	19	SENT_1299	[p19l715t2215r818b2248],
16	are	VBP	O	be	cop	19	SENT_1299	[p19l827t2223r868b2240],
17	the	DT	O	the	det	19	SENT_1299	[p19l877t2214r920b2240],
18	main	JJ	O	main	amod	19	SENT_1299	[p19l928t2215r998b2240],
19	determinants	NNS	O	determinant	_	0	SENT_1299	[p19l1006t2214r1188b2240],
20	for	IN	O	for	_	0	SENT_1299	[p19l1197t2214r1238b2240],
21	rapid	JJ	O	rapid	amod	22	SENT_1299	[p19l1245t2214r1316b2248],
22	elimination	NN	O	elimination	prep_for	19	SENT_1299	[p19l1326t2214r1484b2240],
23	of	IN	O	of	_	0	SENT_1299	[p19l1493t2214r1523b2240],
24	methotrexate	NN	O	methotrexate	prep_of	22	SENT_1299	[p19l1528t2214r1712b2240],
25	and	CC	O	and	_	0	SENT_1299	[p19l1721t2214r1770b2240],
26	its	PRP$	O	its	poss	29	SENT_1299	[p19l1778t2215r1810b2240],
27	toxic	JJ	O	toxic	amod	29	SENT_1299	[p19l1818t2215r1885b2240],
28	metabolite	NN	O	metabolite	nn	29	SENT_1299	[p19l443t2256r591b2282],
29	7-hydroxymethotrexate	NN	O	7-hydroxymethotrexate	prep_for	19	SENT_1299	[p19l603t2256r929b2290],
30	in	FW	O	in	prep	29	SENT_1299	[p19l939t2257r966b2281],
31	vivo	FW	O	vivo	pobj	30	SENT_1299	[p19l975t2257r1040b2282],
32	.	.	O	.	_	0	SENT_1299	[p19l975t2257r1040b2282],

1	Mol	NNP	O	Mol	_	0	SENT_1300	[p19l1049t2257r1109b2282],
2	.	.	O	.	_	0	SENT_1300	[p19l1049t2257r1109b2282],

1	Cancer	NN	O	cancer	_	0	SENT_1301	[p19l1123t2257r1213b2282],
2	Tber	NN	O	tber	dep	1	SENT_1301	[p19l1222t2257r1290b2282],
3	.	.	O	.	_	0	SENT_1301	[p19l1222t2257r1290b2282],

1	8:335	CD	NUMBER	8:335	_	0	SENT_1302	[p19l1304t2257r1377b2282],
2	0-5	CD	NUMBER	0-5	num	3	SENT_1302	[p19l1381t2257r1428b2282],
3	9	CD	NUMBER	9	dep	1	SENT_1302	[p19l1432t2258r1447b2282],

1	161	CD	NUMBER	161	_	0	SENT_1303	[p19l370t2300r424b2325],
2	.	.	O	.	_	0	SENT_1303	[p19l370t2300r424b2325],

1	Jonker	NNP	PERSON	Jonker	nn	2	SENT_1304	[p19l439t2299r536b2331],
2	JW	NNP	O	JW	_	0	SENT_1304	[p19l546t2300r605b2331],
3	,	,	O	,	_	0	SENT_1304	[p19l546t2300r605b2331],
4	Merino	NNP	PERSON	Merino	nn	5	SENT_1304	[p19l618t2300r724b2325],
5	G	NNP	PERSON	G	appos	2	SENT_1304	[p19l739t2300r773b2330],
6	,	,	O	,	_	0	SENT_1304	[p19l739t2300r773b2330],
7	Musters	NNP	PERSON	Musters	nn	8	SENT_1304	[p19l786t2300r900b2325],
8	S	NNP	PERSON	S	appos	2	SENT_1304	[p19l916t2300r939b2330],
9	,	,	O	,	_	0	SENT_1304	[p19l916t2300r939b2330],
10	van	NNP	PERSON	van	nn	12	SENT_1304	[p19l953t2309r1002b2325],
11	Herwaarden	NNP	PERSON	Herwaarden	nn	12	SENT_1304	[p19l1016t2299r1190b2325],
12	AE	NNP	O	AE	appos	2	SENT_1304	[p19l1202t2300r1255b2330],
13	,	,	O	,	_	0	SENT_1304	[p19l1202t2300r1255b2330],
14	Bolscher	NNP	O	Bolscher	nn	15	SENT_1304	[p19l1271t2299r1392b2325],
15	E	NNP	O	E	appos	2	SENT_1304	[p19l1406t2300r1434b2330],
16	,	,	O	,	_	0	SENT_1304	[p19l1406t2300r1434b2330],
17	et	FW	O	et	nn	18	SENT_1304	[p19l1450t2306r1476b2325],
18	al.	FW	O	al.	appos	2	SENT_1304	[p19l1489t2299r1519b2325],
19	2005	CD	DATE	2005	dep	18	SENT_1304	[p19l1535t2300r1610b2325],
20	.	.	O	.	_	0	SENT_1304	[p19l1535t2300r1610b2325],

1	The	DT	O	the	det	5	SENT_1305	[p19l1624t2299r1683b2325],
2	breast	NN	O	breast	nn	5	SENT_1305	[p19l1698t2299r1782b2325],
3	cancer	NN	O	cancer	nn	5	SENT_1305	[p19l1795t2309r1885b2325],
4	resistance	NN	O	resistance	nn	5	SENT_1305	[p19l443t2342r578b2367],
5	protein	NN	O	protein	nsubj	10	SENT_1305	[p19l587t2342r689b2375],
6	BCRP	NN	O	bcrp	nn	9	SENT_1305	[p19l698t2342r787b2367],
7	(	CD	NUMBER	(	num	9	SENT_1305	[p19l796t2342r928b2373],
8	ABCG2	NN	O	abcg2	nn	9	SENT_1305	[p19l796t2342r928b2373],
9	)	NN	O	)	dep	5	SENT_1305	[p19l796t2342r928b2373],
10	concentrates	VBZ	O	concentrate	_	0	SENT_1305	[p19l938t2348r1113b2367],
11	drugs	NNS	O	drug	nn	14	SENT_1305	[p19l1123t2341r1198b2375],
12	and	CC	O	and	_	0	SENT_1305	[p19l1208t2341r1257b2367],
13	carcinogenic	JJ	O	carcinogenic	conj_and	11	SENT_1305	[p19l1266t2342r1442b2375],
14	xenotoxins	NNS	O	xenotoxin	dobj	10	SENT_1305	[p19l1450t2342r1599b2367],
15	into	IN	O	into	_	0	SENT_1305	[p19l1608t2342r1663b2367],
16	milk	NN	O	milk	prep_into	10	SENT_1305	[p19l1672t2341r1741b2367],
17	.	.	O	.	_	0	SENT_1305	[p19l1672t2341r1741b2367],

1	Nat	NN	PERSON	nat	_	0	SENT_1306	[p19l1749t2342r1807b2367],
2	.	.	O	.	_	0	SENT_1306	[p19l1749t2342r1807b2367],

1	Med	NNP	O	Med	_	0	SENT_1307	[p19l1816t2342r1882b2367],
2	.	.	O	.	_	0	SENT_1307	[p19l1816t2342r1882b2367],

1	1	CD	NUMBER	1	num	2	SENT_1308	[p19l447t2386r456b2410],
2	1	CD	NUMBER	1	_	0	SENT_1308	[p19l464t2386r474b2410],
3	:	:	O	:	_	0	SENT_1308	[p19l480t2396r484b2410],
4	1	CD	NUMBER	1	number	5	SENT_1308	[p19l490t2386r499b2410],
5	2	CD	NUMBER	2	dep	2	SENT_1308	[p19l504t2386r517b2410],
6	7-2	CD	NUMBER	7-2	num	7	SENT_1308	[p19l522t2385r568b2411],
7	9	CD	NUMBER	9	dep	5	SENT_1308	[p19l573t2386r588b2411],

1	www.nnnudlreview5.org	NN	O	www.nnnudlreview5.org	nn	4	SENT_1309	[p19l1356t2486r1630b2516],
2	o	NN	O	o	nn	4	SENT_1309	[p19l1645t2494r1654b2504],
3	Drug	NN	O	drug	nn	4	SENT_1309	[p19l1671t2486r1734b2516],
4	Tmnsporterx	NN	O	tmnsporterx	_	0	SENT_1309	[p19l1742t2486r1886b2515],

1	162	CD	NUMBER	162	_	0	SENT_1310	[p19l568t2527r622b2551],
2	.	.	O	.	_	0	SENT_1310	[p19l568t2527r622b2551],

1	Merino	NN	O	merino	nn	2	SENT_1311	[p19l640t2526r746b2551],
2	G	NN	O	g	_	0	SENT_1311	[p19l757t2526r790b2556],
3	,	,	O	,	_	0	SENT_1311	[p19l757t2526r790b2556],
4	Jonker	NNP	PERSON	Jonker	nn	5	SENT_1311	[p19l797t2525r894b2557],
5	JW	NNP	O	JW	appos	2	SENT_1311	[p19l899t2526r958b2557],
6	,	,	O	,	_	0	SENT_1311	[p19l899t2526r958b2557],
7	Wagenaar	NNP	PERSON	Wagenaar	nn	8	SENT_1311	[p19l968t2526r1113b2559],
8	E	NNP	O	E	appos	2	SENT_1311	[p19l1122t2526r1151b2556],
9	,	,	O	,	_	0	SENT_1311	[p19l1122t2526r1151b2556],
10	Van	NNP	PERSON	Van	nn	12	SENT_1311	[p19l1161t2535r1210b2551],
11	Herwaarden	NNP	PERSON	Herwaarden	nn	12	SENT_1311	[p19l1219t2525r1393b2551],
12	AE	NNP	O	AE	appos	2	SENT_1311	[p19l1402t2526r1454b2556],
13	,	,	O	,	_	0	SENT_1311	[p19l1402t2526r1454b2556],
14	Schinkel	NNP	PERSON	Schinkel	nn	15	SENT_1311	[p19l1466t2525r1584b2551],
15	AH	NNP	O	AH	appos	2	SENT_1311	[p19l1593t2526r1651b2550],
16	.	.	O	.	_	0	SENT_1311	[p19l1593t2526r1651b2550],

1	2005	CD	DATE	2005	_	0	SENT_1312	[p19l1663t2526r1737b2551],
2	.	.	O	.	_	0	SENT_1312	[p19l1663t2526r1737b2551],

1	The	DT	O	the	det	8	SENT_1313	[p19l1748t2525r1807b2551],
2	breast	NN	O	breast	nn	8	SENT_1313	[p19l1817t2525r1901b2551],
3	cancer	NN	O	cancer	nn	8	SENT_1313	[p19l1910t2535r2000b2551],
4	resistance	NN	O	resistance	nn	8	SENT_1313	[p19l2009t2526r2083b2551, p19l642t2575r715b2594],
5	protein	NN	O	protein	nn	8	SENT_1313	[p19l725t2569r827b2603],
6	(	CD	NUMBER	(	num	8	SENT_1313	[p19l838t2569r1074b2601],
7	BCRP/ABCG2	NN	O	bcrp/abcg2	nn	8	SENT_1313	[p19l838t2569r1074b2601],
8	)	NN	O	)	_	0	SENT_1313	[p19l838t2569r1074b2601],
9	alfects	NNS	O	alfect	nn	10	SENT_1313	[p19l1085t2568r1171b2594],
10	pharmacokinetics	NNS	O	pharmacokinetic	dep	8	SENT_1313	[p19l1182t2568r1434b2603],
11	,	,	O	,	_	0	SENT_1313	[p19l1182t2568r1434b2603],
12	hepatobiliary	JJ	O	hepatobiliary	amod	13	SENT_1313	[p19l1445t2568r1630b2603],
13	excretion	NN	O	excretion	dep	8	SENT_1313	[p19l1640t2569r1775b2600],
14	,	,	O	,	_	0	SENT_1313	[p19l1640t2569r1775b2600],
15	and	CC	O	and	_	0	SENT_1313	[p19l1788t2568r1837b2594],
16	milk	NN	O	milk	nn	17	SENT_1313	[p19l1847t2568r1911b2594],
17	secretion	NN	O	secretion	dep	8	SENT_1313	[p19l1920t2569r2046b2594],
18	of	IN	O	of	_	0	SENT_1313	[p19l2057t2568r2087b2594],
19	the	DT	O	the	det	21	SENT_1313	[p19l642t2612r685b2638],
20	antibiotic	JJ	O	antibiotic	amod	21	SENT_1313	[p19l696t2612r828b2638],
21	nitrofurantoin	NN	O	nitrofurantoin	prep_of	8	SENT_1313	[p19l837t2612r1044b2638],
22	.	.	O	.	_	0	SENT_1313	[p19l837t2612r1044b2638],

1	Mol	NNP	O	Mol	_	0	SENT_1314	[p19l1053t2613r1113b2637],
2	.	.	O	.	_	0	SENT_1314	[p19l1053t2613r1113b2637],

1	Plmwnncol	NNP	O	Plmwnncol	_	0	SENT_1315	[p19l1124t2613r1268b2637],
2	.	.	O	.	_	0	SENT_1315	[p19l1124t2613r1268b2637],

1	672175	CD	NUMBER	672175	num	2	SENT_1316	[p19l1282t2613r1373b2638],
2	8-64	CD	NUMBER	8-64	_	0	SENT_1316	[p19l1377t2613r1443b2638],

1	163	CD	NUMBER	163	_	0	SENT_1317	[p19l568t2657r622b2681],
2	.	.	O	.	_	0	SENT_1317	[p19l568t2657r622b2681],

1	van	NNP	PERSON	van	nn	3	SENT_1318	[p19l641t2665r689b2681],
2	Herwaarden	NNP	PERSON	Herwaarden	nn	3	SENT_1318	[p19l703t2655r877b2681],
3	AE	NNP	O	AE	_	0	SENT_1318	[p19l890t2656r942b2686],
4	,	,	O	,	_	0	SENT_1318	[p19l890t2656r942b2686],
5	Wagenaar	NNP	PERSON	Wagenaar	nn	6	SENT_1318	[p19l957t2656r1102b2689],
6	E	NNP	O	E	appos	3	SENT_1318	[p19l1116t2656r1145b2686],
7	,	,	O	,	_	0	SENT_1318	[p19l1116t2656r1145b2686],
8	Merino	NNP	O	Merino	nn	9	SENT_1318	[p19l1159t2656r1264b2681],
9	G	NNP	O	G	appos	3	SENT_1318	[p19l1280t2656r1313b2686],
10	,	,	O	,	_	0	SENT_1318	[p19l1280t2656r1313b2686],
11	Jonker	NNP	PERSON	Jonker	nn	12	SENT_1318	[p19l1325t2655r1421b2687],
12	JW	NNP	O	JW	appos	3	SENT_1318	[p19l1431t2656r1490b2687],
13	,	,	O	,	_	0	SENT_1318	[p19l1431t2656r1490b2687],
14	Rosing	NNP	PERSON	Rosing	nn	15	SENT_1318	[p19l1506t2656r1604b2689],
15	H	NNP	PERSON	H	appos	3	SENT_1318	[p19l1617t2656r1652b2686],
16	,	,	O	,	_	0	SENT_1318	[p19l1617t2656r1652b2686],
17	et	FW	O	et	nn	18	SENT_1318	[p19l1669t2662r1694b2681],
18	al.	FW	O	al.	appos	3	SENT_1318	[p19l1708t2655r1737b2681],
19	2007	CD	DATE	2007	dep	18	SENT_1318	[p19l1753t2656r1828b2681],
20	.	.	O	.	_	0	SENT_1318	[p19l1753t2656r1828b2681],

1	Multidrug	JJ	O	multidrug	amod	3	SENT_1319	[p19l1842t2655r1989b2689],
2	transporter	NN	O	transporter	nn	3	SENT_1319	[p19l2002t2662r2083b2681, p19l641t2704r729b2731],
3	ABCG2/breast	NN	O	abcg2/breast	nsubj	7	SENT_1319	[p19l736t2697r947b2723],
4	cancer	NN	O	cancer	nn	6	SENT_1319	[p19l955t2707r1045b2723],
5	resistance	NN	O	resistance	nn	6	SENT_1319	[p19l1053t2698r1188b2723],
6	protein	NN	O	protein	dep	3	SENT_1319	[p19l1197t2698r1299b2731],
7	secretes	VBZ	O	secrete	_	0	SENT_1319	[p19l1307t2704r1415b2723],
8	riboﬂavin	NN	O	riboﬂavin	nn	11	SENT_1319	[p19l1423t2697r1557b2723],
9	(	NN	O	(	nn	11	SENT_1319	[p19l1566t2698r1681b2729],
10	vitamin	NN	O	vitamin	nn	11	SENT_1319	[p19l1566t2698r1681b2729],
11	B2	NN	O	b2	dobj	7	SENT_1319	[p19l1690t2698r1737b2729],
12	)	CD	NUMBER	)	npadvmod	7	SENT_1319	[p19l1690t2698r1737b2729],
13	into	IN	O	into	_	0	SENT_1319	[p19l1745t2698r1801b2723],
14	milk	NN	O	milk	prep_into	7	SENT_1319	[p19l1809t2697r1878b2722],
15	.	.	O	.	_	0	SENT_1319	[p19l1809t2697r1878b2722],

1	Mol	NNP	O	Mol	_	0	SENT_1320	[p19l1887t2698r1946b2723],
2	.	.	O	.	_	0	SENT_1320	[p19l1887t2698r1946b2723],

1	Cell	NN	O	cell	_	0	SENT_1321	[p19l1959t2698r2014b2723],
2	.	.	O	.	_	0	SENT_1321	[p19l1959t2698r2014b2723],

1	Biol	NNP	O	Biol	_	0	SENT_1322	[p19l2024t2698r2081b2723],
2	.	.	O	.	_	0	SENT_1322	[p19l2024t2698r2081b2723],

1	27:1247	CD	NUMBER	27:1247	_	0	SENT_1323	[p19l642t2741r801b2767],
2	—	CD	NUMBER	—	num	3	SENT_1323	[p19l642t2741r801b2767],
3	53	CD	NUMBER	53	dep	1	SENT_1323	[p19l642t2741r801b2767],

1	164	CD	NUMBER	164	_	0	SENT_1324	[p19l568t2785r622b2810],
2	.	.	O	.	_	0	SENT_1324	[p19l568t2785r622b2810],

1	Urquhart	NNP	ORGANIZATION	Urquhart	nn	2	SENT_1325	[p19l642t2784r775b2818],
2	BL	NN	ORGANIZATION	bl	_	0	SENT_1325	[p19l787t2785r837b2815],
3	,	,	O	,	_	0	SENT_1325	[p19l787t2785r837b2815],
4	Ware	NNP	ORGANIZATION	Ware	nn	5	SENT_1325	[p19l849t2785r928b2810],
5	JA	NNP	ORGANIZATION	JA	appos	2	SENT_1325	[p19l937t2785r981b2816],
6	,	,	O	,	_	0	SENT_1325	[p19l937t2785r981b2816],
7	Tirona	NNP	PERSON	Tirona	nn	8	SENT_1325	[p19l994t2785r1093b2810],
8	RG	NNP	O	RG	appos	2	SENT_1325	[p19l1105t2785r1162b2815],
9	,	,	O	,	_	0	SENT_1325	[p19l1105t2785r1162b2815],
10	Ho	NNP	O	Ho	nn	11	SENT_1325	[p19l1176t2785r1221b2810],
11	RH	NNP	O	RH	appos	2	SENT_1325	[p19l1234t2785r1292b2815],
12	,	,	O	,	_	0	SENT_1325	[p19l1234t2785r1292b2815],
13	Leake	NNP	PERSON	Leake	nn	14	SENT_1325	[p19l1306t2784r1389b2810],
14	BF	NNP	O	BF	appos	2	SENT_1325	[p19l1402t2785r1450b2815],
15	,	,	O	,	_	0	SENT_1325	[p19l1402t2785r1450b2815],
16	et	FW	O	et	nn	17	SENT_1325	[p19l1464t2791r1489b2810],
17	al.	FW	O	al.	appos	2	SENT_1325	[p19l1501t2784r1531b2810],
18	2008	CD	DATE	2008	dep	17	SENT_1325	[p19l1545t2785r1619b2809],
19	.	.	O	.	_	0	SENT_1325	[p19l1545t2785r1619b2809],

1	Breast	NN	O	breast	nn	7	SENT_1326	[p19l1633t2785r1721b2810],
2	cancer	NN	O	cancer	nn	7	SENT_1326	[p19l1732t2793r1822b2810],
3	resistance	NN	O	resistance	nn	7	SENT_1326	[p19l1834t2785r1969b2810],
4	protein	NN	O	protein	nn	7	SENT_1326	[p19l1982t2785r2084b2818],
5	(	CD	NUMBER	(	num	7	SENT_1326	[p19l642t2827r775b2858],
6	ABCG2	NN	O	abcg2	nn	7	SENT_1326	[p19l642t2827r775b2858],
7	)	NN	O	)	_	0	SENT_1326	[p19l642t2827r775b2858],
8	and	CC	O	and	_	0	SENT_1326	[p19l790t2826r839b2852],
9	drug	NN	O	drug	nn	10	SENT_1326	[p19l854t2826r919b2860],
10	disposition	NN	O	disposition	conj_and	7	SENT_1326	[p19l933t2826r1092b2860],
11	:	:	O	:	_	0	SENT_1326	[p19l933t2826r1092b2860],
12	intestinal	JJ	O	intestinal	amod	13	SENT_1326	[p19l1107t2826r1236b2852],
13	expression	NN	O	expression	dep	7	SENT_1326	[p19l1251t2827r1403b2860],
14	,	,	O	,	_	0	SENT_1326	[p19l1251t2827r1403b2860],
15	polymorphisms	NNS	O	polymorphism	conj_and	13	SENT_1326	[p19l1418t2826r1634b2860],
16	and	CC	O	and	_	0	SENT_1326	[p19l1649t2826r1698b2852],
17	sulfasalazine	NN	O	sulfasalazine	dep	7	SENT_1326	[p19l1713t2826r1885b2852],
18	as	IN	O	as	_	0	SENT_1326	[p19l1900t2836r1925b2852],
19	an	DT	O	a	conj_as	7	SENT_1326	[p19l1940t2836r1972b2852],
20	in	FW	O	in	nn	21	SENT_1326	[p19l1985t2827r2012b2851],
21	vivo	FW	O	vivo	advmod	22	SENT_1326	[p19l2025t2827r2083b2852],
22	probe	NN	O	probe	dep	19	SENT_1326	[p19l641t2869r729b2903],
23	.	.	O	.	_	0	SENT_1326	[p19l641t2869r729b2903],

1	Plmwndcogenet	NNP	O	Plmwndcogenet	_	0	SENT_1327	[p19l740t2870r943b2904],
2	.	.	O	.	_	0	SENT_1327	[p19l740t2870r943b2904],

1	Genomic	JJ	O	genomic	_	0	SENT_1328	[p19l957t2870r1079b2895],
2	:	:	O	:	_	0	SENT_1328	[p19l957t2870r1079b2895],
3	18:43	CD	TIME	18:43	number	4	SENT_1328	[p19l1090t2871r1160b2895],
4	9-48	CD	NUMBER	9-48	dep	1	SENT_1328	[p19l1165t2871r1231b2895],

1	165	CD	NUMBER	165	_	0	SENT_1329	[p19l568t2913r622b2939],
2	.	.	O	.	_	0	SENT_1329	[p19l568t2913r622b2939],

1	Yamasaki	NNP	PERSON	Yamasaki	nn	2	SENT_1330	[p19l641t2912r773b2938],
2	Y	NN	PERSON	y	_	0	SENT_1330	[p19l784t2913r813b2944],
3	,	,	O	,	_	0	SENT_1330	[p19l784t2913r813b2944],
4	Ieiri	NN	O	ieirus	nn	5	SENT_1330	[p19l826t2913r884b2938],
5	I	NN	O	i	appos	2	SENT_1330	[p19l897t2913r915b2944],
6	,	,	O	,	_	0	SENT_1330	[p19l897t2913r915b2944],
7	Kusuhara	NN	O	kusuhara	nn	8	SENT_1330	[p19l929t2912r1062b2938],
8	H	NN	O	h	appos	2	SENT_1330	[p19l1074t2913r1109b2944],
9	,	,	O	,	_	0	SENT_1330	[p19l1074t2913r1109b2944],
10	Sasaki	NNP	PERSON	Sasaki	nn	11	SENT_1330	[p19l1123t2912r1207b2938],
11	T	NN	O	t	appos	2	SENT_1330	[p19l1218t2913r1251b2944],
12	,	,	O	,	_	0	SENT_1330	[p19l1218t2913r1251b2944],
13	Kimura	NNP	PERSON	Kimura	nn	14	SENT_1330	[p19l1265t2913r1371b2938],
14	M	NNP	PERSON	M	appos	2	SENT_1330	[p19l1382t2913r1422b2944],
15	,	,	O	,	_	0	SENT_1330	[p19l1382t2913r1422b2944],
16	et	FW	O	et	nn	17	SENT_1330	[p19l1436t2920r1461b2938],
17	al.	FW	O	al.	appos	2	SENT_1330	[p19l1473t2912r1503b2938],
18	2008	CD	DATE	2008	dep	17	SENT_1330	[p19l1517t2914r1591b2938],
19	.	.	O	.	_	0	SENT_1330	[p19l1517t2914r1591b2938],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_1331	[p19l1605t2912r1847b2947],
2	characterization	NN	O	characterization	nsubj	6	SENT_1331	[p19l1860t2912r2084b2938],
3	of	IN	O	of	_	0	SENT_1331	[p19l642t2956r673b2982],
4	sulfasalazine	NN	O	sulfasalazine	nn	5	SENT_1331	[p19l678t2956r850b2982],
5	disposition	NN	O	disposition	prep_of	2	SENT_1331	[p19l861t2956r1012b2990],
6	based	VBN	O	base	_	0	SENT_1331	[p19l1021t2956r1098b2982],
7	on	IN	O	on	_	0	SENT_1331	[p19l1108t2966r1143b2982],
8	NAT2	NN	O	nat2	prep_on	6	SENT_1331	[p19l1152t2957r1243b2981],
9	and	CC	O	and	_	0	SENT_1331	[p19l1255t2956r1304b2982],
10	ABCG2	NN	O	abcg2	conj_and	8	SENT_1331	[p19l1313t2957r1424b2982],
11	(	CD	NUMBER	(	num	15	SENT_1331	[p19l1437t2957r1546b2988],
12	BCRP	NN	O	bcrp	nn	15	SENT_1331	[p19l1437t2957r1546b2988],
13	)	NN	O	)	nn	15	SENT_1331	[p19l1437t2957r1546b2988],
14	gene	NN	O	gene	nn	15	SENT_1331	[p19l1557t2966r1621b2990],
15	polymorphisms	NNS	O	polymorphism	dobj	6	SENT_1331	[p19l1631t2956r1847b2990],
16	in	IN	O	in	_	0	SENT_1331	[p19l1856t2957r1883b2981],
17	humans	NNS	O	human	prep_in	15	SENT_1331	[p19l1892t2956r2008b2982],
18	.	.	O	.	_	0	SENT_1331	[p19l1892t2956r2008b2982],

1	Clin	NNP	O	Clin	_	0	SENT_1332	[p19l2020t2957r2081b2982],
2	.	.	O	.	_	0	SENT_1332	[p19l2020t2957r2081b2982],

1	Plmrrnaeol	NN	O	plmrrnaeol	_	0	SENT_1333	[p19l641t3000r785b3025],
2	.	.	O	.	_	0	SENT_1333	[p19l641t3000r785b3025],

1	Then	RB	O	then	dep	3	SENT_1334	[p19l799t3000r867b3025],
2	84:95	CD	NUMBER	84:95	num	3	SENT_1334	[p19l880t3000r1021b3025],
3	-103	CD	NUMBER	-103	_	0	SENT_1334	[p19l880t3000r1021b3025],

1	166	CD	NUMBER	166	_	0	SENT_1335	[p19l568t3043r622b3067],
2	.	.	O	.	_	0	SENT_1335	[p19l568t3043r622b3067],

1	Zaher	NNP	PERSON	Zaher	nn	2	SENT_1336	[p19l642t3041r725b3067],
2	H	NNP	PERSON	H	_	0	SENT_1336	[p19l737t3042r772b3073],
3	,	,	O	,	_	0	SENT_1336	[p19l737t3042r772b3073],
4	Khan	NNP	ORGANIZATION	Khan	nn	5	SENT_1336	[p19l785t3041r860b3067],
5	AA	NNP	ORGANIZATION	AA	appos	2	SENT_1336	[p19l871t3042r923b3073],
6	,	,	O	,	_	0	SENT_1336	[p19l871t3042r923b3073],
7	Palandra	NNP	PERSON	Palandra	nn	8	SENT_1336	[p19l936t3041r1058b3067],
8	J	NNP	PERSON	J	appos	5	SENT_1336	[p19l1066t3042r1088b3074],
9	,	,	O	,	_	0	SENT_1336	[p19l1066t3042r1088b3074],
10	Brayman	NNP	PERSON	Brayman	nn	11	SENT_1336	[p19l1102t3042r1226b3076],
11	TG	NN	O	tg	appos	5	SENT_1336	[p19l1237t3042r1298b3073],
12	,	,	O	,	_	0	SENT_1336	[p19l1237t3042r1298b3073],
13	Yu	NN	O	yu	nn	14	SENT_1336	[p19l1310t3042r1350b3067],
14	L	NN	O	l	appos	5	SENT_1336	[p19l1361t3042r1390b3073],
15	,	,	O	,	_	0	SENT_1336	[p19l1361t3042r1390b3073],
16	Ware	NNP	O	Ware	nn	17	SENT_1336	[p19l1402t3042r1481b3067],
17	JA	NNP	O	JA	appos	5	SENT_1336	[p19l1489t3042r1533b3074],
18	.	.	O	.	_	0	SENT_1336	[p19l1489t3042r1533b3074],

1	2006	CD	DATE	2006	_	0	SENT_1337	[p19l1547t3043r1622b3067],
2	.	.	O	.	_	0	SENT_1337	[p19l1547t3043r1622b3067],

1	Breast	NN	O	breast	nn	3	SENT_1338	[p19l1635t3042r1722b3067],
2	cancer	NN	O	cancer	nn	3	SENT_1338	[p19l1734t3051r1824b3067],
3	resistance	NN	O	resistance	nsubj	11	SENT_1338	[p19l1835t3042r1970b3067],
4	protein	NN	O	protein	nn	7	SENT_1338	[p19l1982t3043r2084b3076],
5	(	CD	NUMBER	(	num	7	SENT_1338	[p19l642t3087r822b3121],
6	Bcrp/abcg2	NN	O	bcrp/abcg2	nn	7	SENT_1338	[p19l642t3087r822b3121],
7	)	NN	O	)	dep	3	SENT_1338	[p19l642t3087r822b3121],
8	is	VBZ	O	be	cop	11	SENT_1338	[p19l837t3088r857b3112],
9	a	DT	O	a	det	11	SENT_1338	[p19l872t3097r886b3112],
10	major	JJ	O	major	amod	11	SENT_1338	[p19l900t3088r981b3121],
11	determinant	NN	O	determinant	_	0	SENT_1338	[p19l996t3087r1167b3112],
12	of	IN	O	of	_	0	SENT_1338	[p19l1181t3087r1212b3112],
13	sulfasalazine	NN	O	sulfasalazine	nn	14	SENT_1338	[p19l1223t3087r1394b3112],
14	absorption	NN	O	absorption	prep_of	11	SENT_1338	[p19l1410t3087r1558b3121],
15	and	CC	O	and	_	0	SENT_1338	[p19l1573t3087r1622b3112],
16	elimination	NN	O	elimination	prep_of	11	SENT_1338	[p19l1637t3087r1797b3112],
17	in	IN	O	in	_	0	SENT_1338	[p19l1810t3088r1838b3112],
18	the	DT	O	the	det	19	SENT_1338	[p19l1852t3087r1895b3112],
19	mouse	NN	O	mouse	prep_in	11	SENT_1338	[p19l1910t3097r2007b3112],
20	.	.	O	.	_	0	SENT_1338	[p19l1910t3097r2007b3112],

1	Mol	NNP	O	Mol	_	0	SENT_1339	[p19l2021t3088r2081b3112],
2	.	.	O	.	_	0	SENT_1339	[p19l2021t3088r2081b3112],

1	Plmnm	NNP	O	Plmnm	_	0	SENT_1340	[p19l641t3149r737b3174],
2	.	.	O	.	_	0	SENT_1340	[p19l641t3149r737b3174],

1	3:55	CD	TIME	3:55	num	2	SENT_1341	[p19l752t3150r857b3175],
2	-61	CD	NUMBER	-61	_	0	SENT_1341	[p19l752t3150r857b3175],

1	167	CD	NUMBER	167	_	0	SENT_1342	[p19l568t3194r622b3219],
2	.	.	O	.	_	0	SENT_1342	[p19l568t3194r622b3219],

1	Zamber	NNP	O	Zamber	nn	2	SENT_1343	[p19l641t3193r752b3219],
2	CP	NNP	O	CP	_	0	SENT_1343	[p19l768t3194r819b3224],
3	,	,	O	,	_	0	SENT_1343	[p19l768t3194r819b3224],
4	Lamba	NNP	ORGANIZATION	Lamba	nn	5	SENT_1343	[p19l836t3193r933b3219],
5	JK	NNP	ORGANIZATION	JK	appos	2	SENT_1343	[p19l944t3194r991b3225],
6	,	,	O	,	_	0	SENT_1343	[p19l944t3194r991b3225],
7	Yasuda	NNP	ORGANIZATION	Yasuda	nn	8	SENT_1343	[p19l1007t3193r1106b3219],
8	K	NNP	ORGANIZATION	K	appos	2	SENT_1343	[p19l1122t3194r1153b3224],
9	,	,	O	,	_	0	SENT_1343	[p19l1122t3194r1153b3224],
10	Farnum	NNP	PERSON	Farnum	nn	11	SENT_1343	[p19l1170t3194r1281b3219],
11	J	NNP	PERSON	J	appos	2	SENT_1343	[p19l1292t3194r1314b3225],
12	,	,	O	,	_	0	SENT_1343	[p19l1292t3194r1314b3225],
13	Thuminel	NNP	O	Thuminel	nn	14	SENT_1343	[p19l1330t3193r1472b3219],
14	K	NNP	O	K	appos	2	SENT_1343	[p19l1487t3194r1518b3224],
15	,	,	O	,	_	0	SENT_1343	[p19l1487t3194r1518b3224],
16	et	FW	O	et	nn	17	SENT_1343	[p19l1535t3200r1561b3219],
17	al.	FW	O	al.	appos	2	SENT_1343	[p19l1576t3193r1605b3219],
18	2003	CD	DATE	2003	dep	17	SENT_1343	[p19l1622t3195r1697b3219],
19	.	.	O	.	_	0	SENT_1343	[p19l1622t3195r1697b3219],

1	Natural	JJ	O	natural	amod	3	SENT_1344	[p19l1713t3193r1822b3219],
2	allelic	JJ	O	allelic	amod	3	SENT_1344	[p19l1838t3193r1918b3219],
3	Variants	NNS	O	variant	_	0	SENT_1344	[p19l1932t3194r2041b3219],
4	of	IN	O	of	prep	3	SENT_1344	[p19l2057t3193r2087b3219],

1	Annu	NNP	PERSON	Annu	_	0	SENT_1345	[p20l72t1155r95b1236],
2	.	.	O	.	_	0	SENT_1345	[p20l72t1155r95b1236],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1346	[p20l72t1087r95b1147],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_1346	[p20l72t928r95b1076],
3	.	.	O	.	_	0	SENT_1346	[p20l72t928r95b1076],

1	TOX1C	NN	O	tox1c	_	0	SENT_1347	[p20l72t830r95b917],
2	(	CD	NUMBER	(	num	1	SENT_1347	[p20l72t830r95b917],
3	)	NN	O	)	dep	1	SENT_1347	[p20l72t760r95b782],
4	1	CD	NUMBER	1	num	3	SENT_1347	[p20l72t760r95b782],
5	.	.	O	.	_	0	SENT_1347	[p20l72t760r95b782],

1	2012	CD	DATE	2012	_	0	SENT_1348	[p20l72t684r109b748],
2	.52:249	CD	DATE	.52:249	number	3	SENT_1348	[p20l72t465r96b632],
3	-273	CD	DATE	-273	num	1	SENT_1348	[p20l72t465r96b632],
4	.	.	O	.	_	0	SENT_1348	[p20l72t465r96b632],

1	Downloaded	VBN	O	download	_	0	SENT_1349	[p20l72t283r95b454],
2	from	IN	O	from	_	0	SENT_1349	[p20l72t210r95b274],
3	wwwannualre	NN	O	wwwannualre	nn	4	SENT_1349	[p20l72t7r95b201],
4	sconsin	NN	O	sconsin	prep_from	1	SENT_1349	[p20l113t688r129b782],
5	by	IN	O	by	_	0	SENT_1349	[p20l105t1070r136b1103],
6	University	NNP	ORGANIZATION	University	dep	10	SENT_1349	[p20l105t921r136b1061],
7	of	IN	ORGANIZATION	of	_	0	SENT_1349	[p20l105t883r129b911],
8	Wis	NNP	ORGANIZATION	Wis	prep_of	6	SENT_1349	[p20l105t830r129b876],
9	-	:	O	-	_	0	SENT_1349	[p20l119t620r122b629],
10	Madison	NNP	O	Madison	prep_by	1	SENT_1349	[p20l105t494r129b610],
11	on	IN	O	on	_	0	SENT_1349	[p20l113t452r129b484],
12	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_1349	[p20l105t318r129b443],
13	.	.	O	.	_	0	SENT_1349	[p20l105t318r129b443],

1	For	IN	O	for	_	0	SENT_1350	[p20l106t261r129b307],
2	personal	JJ	O	personal	amod	3	SENT_1350	[p20l105t141r136b252],
3	use	NN	O	use	pobj	1	SENT_1350	[p20l113t88r129b132],
4	only	RB	O	only	advmod	3	SENT_1350	[p20l105t13r136b78],
5	.	.	O	.	_	0	SENT_1350	[p20l105t13r136b78],

1	An	DT	O	a	det	2	SENT_1351	[p20l181t3633r204b3673],
2	nu	NN	O	nu	_	0	SENT_1351	[p20l181t3523r204b3626],
3	.	.	O	.	_	0	SENT_1351	[p20l181t3523r204b3626],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1352	[p20l181t3523r204b3626],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_1352	[p20l181t3364r204b3512],
3	.	.	O	.	_	0	SENT_1352	[p20l181t3364r204b3512],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1353	[p20l181t3244r204b3353],
2	.	.	O	.	_	0	SENT_1353	[p20l181t3244r204b3353],

1	2012	CD	DATE	2012	_	0	SENT_1354	[p20l181t3167r204b3233],
2	.52:249	CD	DATE	.52:249	number	3	SENT_1354	[p20l181t2990r205b3156],
3	-273	CD	DATE	-273	num	1	SENT_1354	[p20l181t2990r205b3156],
4	.	.	O	.	_	0	SENT_1354	[p20l181t2990r205b3156],

1	Downloaded	VBN	O	download	_	0	SENT_1355	[p20l181t2809r204b2979],
2	from	IN	O	from	_	0	SENT_1355	[p20l181t2736r204b2800],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_1355	[p20l181t2403r211b2727],
4	by	IN	O	by	_	0	SENT_1355	[p20l214t3506r245b3538],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_1355	[p20l214t3357r245b3497],
6	of	IN	ORGANIZATION	of	_	0	SENT_1355	[p20l214t3318r238b3347],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_1355	[p20l214t3171r238b3312],
8	-	:	O	-	_	0	SENT_1355	[p20l228t3145r231b3154],
9	Madison	NNP	O	Madison	dep	7	SENT_1355	[p20l214t3019r238b3135],
10	on	IN	O	on	_	0	SENT_1355	[p20l222t2977r238b3009],
11	01/05	CD	NUMBER	01/05	prep_on	9	SENT_1355	[p20l214t2883r238b2968],
12	/	:	O	/	punct	9	SENT_1355	[p20l214t2883r238b2968],
13	14	CD	NUMBER	14	tmod	5	SENT_1355	[p20l214t2844r238b2880],
14	.	.	O	.	_	0	SENT_1355	[p20l214t2844r238b2880],

1	For	IN	O	for	_	0	SENT_1356	[p20l215t2787r238b2833],
2	personal	JJ	O	personal	amod	3	SENT_1356	[p20l214t2666r245b2778],
3	use	NN	O	use	pobj	1	SENT_1356	[p20l222t2614r238b2657],
4	only	RB	O	only	advmod	3	SENT_1356	[p20l214t2539r245b2604],
5	.	.	O	.	_	0	SENT_1356	[p20l214t2539r245b2604],

1	breast	NN	O	breast	nn	3	SENT_1357	[p20l642t17r726b43],
2	cancer	NN	O	cancer	nn	3	SENT_1357	[p20l735t26r825b43],
3	resistance	NN	O	resistance	_	0	SENT_1357	[p20l834t18r969b43],
4	protein	NN	O	protein	nn	7	SENT_1357	[p20l979t18r1081b51],
5	(	CD	NUMBER	(	num	7	SENT_1357	[p20l1091t18r1201b49],
6	BCRP	NN	O	bcrp	nn	7	SENT_1357	[p20l1091t18r1201b49],
7	)	NN	O	)	dep	3	SENT_1357	[p20l1091t18r1201b49],
8	and	CC	O	and	_	0	SENT_1357	[p20l1211t17r1260b43],
9	their	PRP$	O	they	poss	10	SENT_1357	[p20l1271t17r1337b43],
10	relationship	NN	O	relationship	dep	3	SENT_1357	[p20l1346t17r1511b51],
11	to	TO	O	to	_	0	SENT_1357	[p20l1522t24r1549b43],
12	BCRP	NN	O	bcrp	nn	13	SENT_1357	[p20l1559t18r1648b43],
13	expression	NN	O	expression	prep_to	3	SENT_1357	[p20l1659t18r1804b51],
14	in	IN	O	in	_	0	SENT_1357	[p20l1813t18r1840b42],
15	human	JJ	O	human	amod	16	SENT_1357	[p20l1849t17r1946b43],
16	intestine	NN	O	intestine	prep_in	13	SENT_1357	[p20l1955t18r2082b43],
17	.	.	O	.	_	0	SENT_1357	[p20l1955t18r2082b43],

1	P/mimneogenetier	NN	O	p/mimneogenetier	_	0	SENT_1358	[p20l641t63r869b97],
2	1	CD	NUMBER	1	number	3	SENT_1358	[p20l881t64r890b88],
3	3	CD	NUMBER	3	dep	1	SENT_1358	[p20l896t64r908b88],
4	:	:	O	:	_	0	SENT_1358	[p20l914t74r918b88],
5	19-2	CD	NUMBER	19-2	num	6	SENT_1358	[p20l924t64r985b88],
6	8	CD	NUMBER	8	dep	1	SENT_1358	[p20l990t64r1004b88],
7	.	.	O	.	_	0	SENT_1358	[p20l618t128r622b132],

1	Adkison	NNP	ORGANIZATION	Adkison	nn	2	SENT_1359	[p20l641t107r755b132],
2	KK	NNP	ORGANIZATION	KK	_	0	SENT_1359	[p20l769t108r825b138],
3	,	,	O	,	_	0	SENT_1359	[p20l769t108r825b138],
4	Vaidya	NNP	O	Vaidya	nn	5	SENT_1359	[p20l839t107r936b141],
5	SS	NNP	O	SS	appos	2	SENT_1359	[p20l951t108r993b138],
6	,	,	O	,	_	0	SENT_1359	[p20l951t108r993b138],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_1359	[p20l1008t108r1060b132],
8	DY	NNP	PERSON	DY	appos	2	SENT_1359	[p20l1075t108r1131b138],
9	,	,	O	,	_	0	SENT_1359	[p20l1075t108r1131b138],
10	Koo	NNP	PERSON	Koo	nn	11	SENT_1359	[p20l1145t108r1205b132],
11	SH	NNP	O	SH	appos	2	SENT_1359	[p20l1220t108r1273b138],
12	,	,	O	,	_	0	SENT_1359	[p20l1220t108r1273b138],
13	Li	NNP	PERSON	Li	nn	14	SENT_1359	[p20l1288t108r1318b132],
14	L	NNP	PERSON	L	appos	2	SENT_1359	[p20l1332t108r1361b138],
15	,	,	O	,	_	0	SENT_1359	[p20l1332t108r1361b138],
16	et	FW	O	et	nn	17	SENT_1359	[p20l1377t114r1402b132],
17	al.	FW	O	al.	appos	2	SENT_1359	[p20l1416t107r1445b132],
18	2010	CD	DATE	2010	dep	17	SENT_1359	[p20l1461t108r1536b132],
19	.	.	O	.	_	0	SENT_1359	[p20l1461t108r1536b132],

1	Oral	JJ	O	oral	amod	2	SENT_1360	[p20l1552t107r1614b132],
2	sulfasalazine	NN	O	sulfasalazine	_	0	SENT_1360	[p20l1628t107r1800b132],
3	as	IN	O	as	_	0	SENT_1360	[p20l1815t116r1840b132],
4	a	DT	O	a	det	8	SENT_1360	[p20l1854t116r1867b132],
5	clinical	JJ	O	clinical	amod	8	SENT_1360	[p20l1882t107r1980b132],
6	BCRP	NN	O	bcrp	nn	8	SENT_1360	[p20l1994t108r2083b132],
7	probe	NN	O	probe	nn	8	SENT_1360	[p20l642t152r722b187],
8	substrate	NN	O	substrate	prep_as	2	SENT_1360	[p20l729t152r860b178],
9	:	:	O	:	_	0	SENT_1360	[p20l729t152r860b178],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_1360	[p20l868t152r1101b187],
11	effects	NNS	O	effect	dep	2	SENT_1360	[p20l1107t153r1193b178],
12	of	IN	O	of	_	0	SENT_1360	[p20l1201t153r1231b178],
13	genetic	JJ	O	genetic	amod	18	SENT_1360	[p20l1234t154r1334b187],
14	variation	NN	O	variation	nn	18	SENT_1360	[p20l1339t154r1463b178],
15	(	NN	O	(	nn	18	SENT_1360	[p20l1470t153r1536b185],
16	C42	NN	O	c42	nn	18	SENT_1360	[p20l1470t153r1536b185],
17	1A	NN	O	1a	nn	18	SENT_1360	[p20l1543t153r1587b185],
18	)	NN	O	)	prep_of	11	SENT_1360	[p20l1543t153r1587b185],
19	and	CC	O	and	_	0	SENT_1360	[p20l1595t152r1644b178],
20	pantoprazole	NN	O	pantoprazole	nn	21	SENT_1360	[p20l1650t152r1832b187],
21	coadministration	NN	O	coadministration	conj_and	18	SENT_1360	[p20l1839t152r2082b178],
22	.	.	O	.	_	0	SENT_1360	[p20l1839t152r2082b178],

1	_	NN	O	_	_	0	SENT_1361	[p20l637t199r662b232],
2	7	CD	NUMBER	7	dep	1	SENT_1361	[p20l637t199r662b232],
3	.	.	O	.	_	0	SENT_1361	[p20l637t199r662b232],

1	PlJll7	NN	O	pljll7	_	0	SENT_1362	[p20l674t199r771b224],
2	"	''	O	"	punct	1	SENT_1362	[p20l674t199r771b224],
3	7ﬂ	NN	O	7ﬂ	dep	1	SENT_1362	[p20l674t199r771b224],
4	.	.	O	.	_	0	SENT_1362	[p20l674t199r771b224],

1	Sci	NNP	O	Sci	_	0	SENT_1363	[p20l783t199r826b224],
2	.	.	O	.	_	0	SENT_1363	[p20l783t199r826b224],

1	99	CD	NUMBER	99	_	0	SENT_1364	[p20l839t200r998b224],
2	:	:	O	:	_	0	SENT_1364	[p20l839t200r998b224],
3	l046-62	CD	NUMBER	l046-62	num	4	SENT_1364	[p20l839t200r998b224],
4	Keskitalo	NNP	O	Keskitalo	dep	1	SENT_1364	[p20l641t242r772b268],
5	]	CD	NUMBER	]	num	4	SENT_1364	[p20l776t243r822b274],
6	E	NN	O	e	dep	1	SENT_1364	[p20l776t243r822b274],
7	,	,	O	,	_	0	SENT_1364	[p20l776t243r822b274],
8	Zolk	NN	PERSON	zolk	nn	9	SENT_1364	[p20l831t242r898b268],
9	O	NN	PERSON	o	appos	1	SENT_1364	[p20l906t243r939b273],
10	,	,	O	,	_	0	SENT_1364	[p20l906t243r939b273],
11	Fromm	NNP	ORGANIZATION	Fromm	nn	12	SENT_1364	[p20l949t243r1054b268],
12	MF	NN	ORGANIZATION	mf	appos	1	SENT_1364	[p20l1061t243r1121b273],
13	,	,	O	,	_	0	SENT_1364	[p20l1061t243r1121b273],
14	Kurkinen	NN	PERSON	kurkinen	nn	16	SENT_1364	[p20l1130t242r1263b268],
15	K	NN	O	k	nn	16	SENT_1364	[p20l1271t243r1315b274],
16	]	NN	O	]	appos	1	SENT_1364	[p20l1271t243r1315b274],
17	,	,	O	,	_	0	SENT_1364	[p20l1271t243r1315b274],
18	Neuvonen	NN	PERSON	neuvonen	nn	20	SENT_1364	[p20l1324t243r1472b268],
19	P	NN	O	p	nn	20	SENT_1364	[p20l1479t243r1519b274],
20	]	NN	O	]	appos	1	SENT_1364	[p20l1479t243r1519b274],
21	,	,	O	,	_	0	SENT_1364	[p20l1479t243r1519b274],
22	Niemi	NNP	PERSON	Niemi	nn	23	SENT_1364	[p20l1528t243r1618b268],
23	M.	NNP	O	M.	appos	1	SENT_1364	[p20l1625t243r1664b267],
24	2009	CD	DATE	2009	dep	23	SENT_1364	[p20l1674t243r1749b268],
25	.	.	O	.	_	0	SENT_1364	[p20l1674t243r1749b268],

1	ABCG2	NN	O	abcg2	nn	2	SENT_1365	[p20l1758t243r1869b268],
2	polymorphism	NN	O	polymorphism	nsubj	4	SENT_1365	[p20l1880t242r2084b276],
3	markedly	RB	O	markedly	advmod	4	SENT_1365	[p20l641t288r772b322],
4	affects	VBZ	O	affect	_	0	SENT_1365	[p20l778t288r864b313],
5	the	DT	O	the	det	6	SENT_1365	[p20l871t287r915b313],
6	pharmacokinetics	NNS	O	pharmacokinetic	dobj	4	SENT_1365	[p20l922t287r1167b322],
7	of	IN	O	of	_	0	SENT_1365	[p20l1175t288r1205b313],
8	atorvastatin	NN	O	atorvastatin	prep_of	6	SENT_1365	[p20l1209t289r1371b313],
9	and	CC	O	and	_	0	SENT_1365	[p20l1378t288r1428b313],
10	rosuvastatin	NN	O	rosuvastatin	conj_and	8	SENT_1365	[p20l1435t289r1609b313],
11	.	.	O	.	_	0	SENT_1365	[p20l1435t289r1609b313],

1	Clin	NNP	O	Clin	_	0	SENT_1366	[p20l1619t288r1679b313],
2	.	.	O	.	_	0	SENT_1366	[p20l1619t288r1679b313],

1	P/mimdeol	NN	O	p/mimdeol	_	0	SENT_1367	[p20l1688t288r1832b313],
2	.	.	O	.	_	0	SENT_1367	[p20l1688t288r1832b313],

1	T/yer	NN	O	t/yer	_	0	SENT_1368	[p20l1844t288r1912b313],
2	.	.	O	.	_	0	SENT_1368	[p20l1844t288r1912b313],

1	86	CD	NUMBER	86	_	0	SENT_1369	[p20l1923t289r1962b313],
2	:	:	O	:	_	0	SENT_1369	[p20l1923t289r1962b313],
3	197-2	CD	NUMBER	197-2	num	6	SENT_1369	[p20l1968t288r2046b314],
4	03	CD	NUMBER	03	num	6	SENT_1369	[p20l2051t289r2080b313],
5	Zhang	NNP	PERSON	Zhang	nn	6	SENT_1369	[p20l642t331r733b366],
6	W	NNP	PERSON	W	dep	1	SENT_1369	[p20l738t333r782b363],
7	,	,	O	,	_	0	SENT_1369	[p20l738t333r782b363],
8	Yu	NNP	O	Yu	nn	9	SENT_1369	[p20l789t333r829b357],
9	BN	NNP	O	BN	appos	1	SENT_1369	[p20l836t333r892b363],
10	,	,	O	,	_	0	SENT_1369	[p20l836t333r892b363],
11	He	PRP	O	he	appos	1	SENT_1369	[p20l900t333r943b357],
12	Y	NN	O	y	dep	11	SENT_1369	[p20l950t333r991b364],
13	]	CD	NUMBER	]	num	12	SENT_1369	[p20l950t333r991b364],
14	,	,	O	,	_	0	SENT_1369	[p20l950t333r991b364],
15	Fan	NN	O	fan	nn	16	SENT_1369	[p20l999t333r1052b357],
16	L	NN	O	l	appos	1	SENT_1369	[p20l1059t333r1088b363],
17	,	,	O	,	_	0	SENT_1369	[p20l1059t333r1088b363],
18	Li	NNP	O	Li	nn	19	SENT_1369	[p20l1096t333r1127b357],
19	Q	NNP	O	Q	appos	1	SENT_1369	[p20l1135t332r1168b363],
20	,	,	O	,	_	0	SENT_1369	[p20l1135t332r1168b363],
21	et	FW	O	et	nn	22	SENT_1369	[p20l1177t339r1203b357],
22	al.	FW	O	al.	appos	1	SENT_1369	[p20l1209t331r1239b357],
23	2006	CD	DATE	2006	dep	22	SENT_1369	[p20l1248t333r1322b357],
24	.	.	O	.	_	0	SENT_1369	[p20l1248t333r1322b357],

1	Role	NN	O	role	_	0	SENT_1370	[p20l1331t331r1395b357],
2	of	IN	O	of	_	0	SENT_1370	[p20l1403t332r1433b357],
3	BCRP	NN	O	bcrp	nn	4	SENT_1370	[p20l1437t332r1526b357],
4	421C	NN	O	421c	prep_of	1	SENT_1370	[p20l1533t331r1868b366],
5	>	JJR	O	>	amod	6	SENT_1370	[p20l1533t331r1868b366],
6	Apolymorphism	NN	O	apolymorphism	dep	1	SENT_1370	[p20l1533t331r1868b366],
7	on	IN	O	on	_	0	SENT_1370	[p20l1875t341r1910b357],
8	rosuvastatin	NN	O	rosuvastatin	nn	9	SENT_1370	[p20l1916t333r2084b357],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	6	SENT_1370	[p20l642t378r886b412],
10	in	IN	O	in	_	0	SENT_1370	[p20l896t379r923b403],
11	healthy	JJ	O	healthy	amod	13	SENT_1370	[p20l932t378r1036b412],
12	Chinese	JJ	LOCATION	chinese	amod	13	SENT_1370	[p20l1045t378r1158b404],
13	males	NNS	O	male	prep_in	9	SENT_1370	[p20l1167t378r1253b404],
14	.	.	O	.	_	0	SENT_1370	[p20l1167t378r1253b404],

1	Clin	NNP	O	Clin	_	0	SENT_1371	[p20l1266t379r1326b404],
2	.	.	O	.	_	0	SENT_1371	[p20l1266t379r1326b404],

1	Cbim	NNP	O	Cbim	_	0	SENT_1372	[p20l1340t379r1417b404],
2	.	.	O	.	_	0	SENT_1372	[p20l1340t379r1417b404],

1	Arm	NN	O	arm	_	0	SENT_1373	[p20l1427t378r1488b404],
2	373 299-103	CD	NUMBER	373 299-103	num	4	SENT_1373	[p20l1551t379r1656b404],[p20l1499t379r1545b404],
3	Kitamura	NNP	PERSON	Kitamura	nn	4	SENT_1373	[p20l642t423r774b448],
4	S	NN	PERSON	s	dep	1	SENT_1373	[p20l784t423r808b454],
5	,	,	O	,	_	0	SENT_1373	[p20l784t423r808b454],
6	Maeda	NNP	PERSON	Maeda	nn	7	SENT_1373	[p20l817t422r912b448],
7	K	NNP	PERSON	K	appos	4	SENT_1373	[p20l921t423r952b454],
8	,	,	O	,	_	0	SENT_1373	[p20l921t423r952b454],
9	Wang	NNP	PERSON	Wang	nn	10	SENT_1373	[p20l962t423r1049b457],
10	Y	NN	PERSON	y	appos	4	SENT_1373	[p20l1056t423r1086b454],
11	,	,	O	,	_	0	SENT_1373	[p20l1056t423r1086b454],
12	Sugiyama	NNP	PERSON	Sugiyama	nn	13	SENT_1373	[p20l1097t423r1231b457],
13	Y.	NNP	O	Y.	appos	4	SENT_1373	[p20l1239t423r1268b448],
14	2008	CD	DATE	2008	dep	13	SENT_1373	[p20l1279t424r1353b448],
15	.	.	O	.	_	0	SENT_1373	[p20l1279t424r1353b448],

1	Involvement	NN	O	involvement	_	0	SENT_1374	[p20l1364t422r1540b448],
2	of	IN	O	of	_	0	SENT_1374	[p20l1549t422r1579b448],
3	multiple	JJ	O	multiple	amod	4	SENT_1374	[p20l1585t422r1701b456],
4	transporters	NNS	O	transporter	prep_of	1	SENT_1374	[p20l1710t430r1878b456],
5	in	IN	O	in	_	0	SENT_1374	[p20l1888t423r1914b448],
6	the	DT	O	the	det	8	SENT_1374	[p20l1924t422r1967b448],
7	hepato	NN	O	hepato	nn	8	SENT_1374	[p20l1976t422r2083b456],
8	—	NN	O	—	prep_in	4	SENT_1374	[p20l1976t422r2083b456],
9	biliary	JJ	O	biliary	amod	10	SENT_1374	[p20l642t468r731b503],
10	transport	NN	O	transport	dep	1	SENT_1374	[p20l740t475r868b502],
11	of	IN	O	of	_	0	SENT_1374	[p20l878t468r908b494],
12	rosuvastatin	NN	O	rosuvastatin	prep_of	10	SENT_1374	[p20l914t469r1088b494],
13	.	.	O	.	_	0	SENT_1374	[p20l914t469r1088b494],

1	Drug	NNP	O	Drug	nn	2	SENT_1375	[p20l1099t469r1172b503],
2	Metdb	NNP	O	Metdb	_	0	SENT_1375	[p20l1178t469r1268b494],
3	.	.	O	.	_	0	SENT_1375	[p20l1178t469r1268b494],

1	Dispor	NNP	O	Dispor	_	0	SENT_1376	[p20l1281t469r1368b502],
2	.	.	O	.	_	0	SENT_1376	[p20l1281t469r1368b502],

1	36:20	CD	NUMBER	36:20	num	4	SENT_1377	[p20l1382t470r1539b494],
2	l4-23	NN	O	l4-23	nn	4	SENT_1377	[p20l1382t470r1539b494],
3	Hirano	NN	PERSON	hirano	nn	4	SENT_1377	[p20l642t514r742b538],
4	M	NN	O	m	_	0	SENT_1377	[p20l751t514r791b544],
5	,	,	O	,	_	0	SENT_1377	[p20l751t514r791b544],
6	Maeda	NNP	PERSON	Maeda	nn	7	SENT_1377	[p20l800t512r895b538],
7	K	NNP	PERSON	K	appos	4	SENT_1377	[p20l905t514r936b544],
8	,	,	O	,	_	0	SENT_1377	[p20l905t514r936b544],
9	Matsushima	NNP	PERSON	Matsushima	nn	10	SENT_1377	[p20l946t512r1117b538],
10	S	NNP	O	S	appos	4	SENT_1377	[p20l1128t513r1151b544],
11	,	,	O	,	_	0	SENT_1377	[p20l1128t513r1151b544],
12	Nozaki	NNP	PERSON	Nozaki	nn	13	SENT_1377	[p20l1162t512r1263b538],
13	Y	NN	PERSON	y	appos	4	SENT_1377	[p20l1272t514r1301b544],
14	,	,	O	,	_	0	SENT_1377	[p20l1272t514r1301b544],
15	Kusuhara	NN	PERSON	kusuhara	nn	16	SENT_1377	[p20l1312t512r1445b538],
16	H	NN	PERSON	h	appos	4	SENT_1377	[p20l1455t514r1490b544],
17	,	,	O	,	_	0	SENT_1377	[p20l1455t514r1490b544],
18	Sugiyama	NNP	PERSON	Sugiyama	nn	19	SENT_1377	[p20l1502t513r1636b547],
19	Y.	NNP	O	Y.	appos	4	SENT_1377	[p20l1645t514r1674b538],
20	2005	CD	DATE	2005	dep	19	SENT_1377	[p20l1686t514r1760b538],
21	.	.	O	.	_	0	SENT_1377	[p20l1686t514r1760b538],

1	Involvement	NN	O	involvement	_	0	SENT_1378	[p20l1771t512r1948b538],
2	of	IN	O	of	_	0	SENT_1378	[p20l1957t513r1987b538],
3	BCRP	NN	O	bcrp	nn	6	SENT_1378	[p20l1994t513r2083b538],
4	(	CD	NUMBER	(	num	6	SENT_1378	[p20l642t559r775b590],
5	ABCG2	NN	O	abcg2	nn	6	SENT_1378	[p20l642t559r775b590],
6	)	NN	O	)	prep_of	1	SENT_1378	[p20l642t559r775b590],
7	in	IN	O	in	_	0	SENT_1378	[p20l785t560r812b584],
8	the	DT	O	the	det	10	SENT_1378	[p20l821t558r865b584],
9	biliary	JJ	O	biliary	amod	10	SENT_1378	[p20l875t558r964b592],
10	excretion	NN	O	excretion	prep_in	1	SENT_1378	[p20l973t560r1101b584],
11	of	IN	O	of	_	0	SENT_1378	[p20l1111t558r1142b584],
12	pitavastatin	NN	O	pitavastatin	prep_of	10	SENT_1378	[p20l1148t560r1314b592],
13	.	.	O	.	_	0	SENT_1378	[p20l1148t560r1314b592],

1	Mol	NNP	O	Mol	_	0	SENT_1379	[p20l1323t559r1383b584],
2	.	.	O	.	_	0	SENT_1379	[p20l1323t559r1383b584],

1	Plmwmzcol	NNP	O	Plmwmzcol	_	0	SENT_1380	[p20l1395t559r1538b584],
2	.	.	O	.	_	0	SENT_1380	[p20l1395t559r1538b584],

1	68:800	CD	NUMBER	68:800	num	2	SENT_1381	[p20l1551t559r1677b584],
2	—	NN	O	—	dep	6	SENT_1381	[p20l1551t559r1677b584],
3	7	CD	NUMBER	7	num	4	SENT_1381	[p20l1551t559r1677b584],
4	Keskitalo	NNP	O	Keskitalo	dep	2	SENT_1381	[p20l642t602r772b628],
5	]	CD	NUMBER	]	num	4	SENT_1381	[p20l779t603r824b634],
6	E	NN	O	e	_	0	SENT_1381	[p20l779t603r824b634],
7	,	,	O	,	_	0	SENT_1381	[p20l779t603r824b634],
8	Pasanen	NNP	PERSON	Pasanen	nn	9	SENT_1381	[p20l836t604r950b628],
9	MK	NNP	O	MK	appos	6	SENT_1381	[p20l960t603r1024b634],
10	,	,	O	,	_	0	SENT_1381	[p20l960t603r1024b634],
11	Neuvonen	NNP	PERSON	Neuvonen	nn	13	SENT_1381	[p20l1036t604r1183b628],
12	P	NN	O	p	nn	13	SENT_1381	[p20l1194t603r1233b634],
13	]	NN	O	]	appos	6	SENT_1381	[p20l1194t603r1233b634],
14	,	,	O	,	_	0	SENT_1381	[p20l1194t603r1233b634],
15	Niemi	NNP	PERSON	Niemi	nn	16	SENT_1381	[p20l1245t604r1334b628],
16	M.	NNP	O	M.	appos	6	SENT_1381	[p20l1344t604r1384b628],
17	2009	CD	DATE	2009	num	16	SENT_1381	[p20l1396t604r1471b628],
18	.	.	O	.	_	0	SENT_1381	[p20l1396t604r1471b628],

1	Different	JJ	O	different	amod	2	SENT_1382	[p20l1483t602r1612b628],
2	effects	NNS	O	effect	_	0	SENT_1382	[p20l1623t602r1709b628],
3	of	IN	O	of	_	0	SENT_1382	[p20l1721t602r1751b628],
4	the	DT	O	the	det	6	SENT_1382	[p20l1758t602r1801b628],
5	ABCG2	NN	O	abcg2	nn	6	SENT_1382	[p20l1812t603r1923b628],
6	c.	NN	O	c.	prep_of	2	SENT_1382	[p20l1937t603r2085b628],
7	421C	NN	O	421c	dep	2	SENT_1382	[p20l1937t603r2085b628],
8	>	JJR	O	>	dep	7	SENT_1382	[p20l1937t603r2085b628],
9	A	DT	O	a	dep	8	SENT_1382	[p20l1937t603r2085b628],

1	SNP	NN	O	snp	_	0	SENT_1383	[p20l643t698r708b723],
2	on	IN	O	on	_	0	SENT_1383	[p20l719t707r754b723],
3	the	DT	O	the	det	4	SENT_1383	[p20l764t697r807b723],
4	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_1383	[p20l817t697r1061b731],
5	of	IN	O	of	_	0	SENT_1383	[p20l1072t697r1103b723],
6	ﬂuvastatin	NN	O	ﬂuvastatin	prep_of	1	SENT_1383	[p20l1109t697r1259b728],
7	,	,	O	,	_	0	SENT_1383	[p20l1109t697r1259b728],
8	pravastatin	NN	O	pravastatin	prep_of	1	SENT_1383	[p20l1269t698r1421b731],
9	and	CC	O	and	_	0	SENT_1383	[p20l1431t697r1480b723],
10	simvastatin	NN	O	simvastatin	prep_of	1	SENT_1383	[p20l1491t698r1653b723],
11	.	.	O	.	_	0	SENT_1383	[p20l1491t698r1653b723],

1	Pljawmieogenomitx	NN	O	pljawmieogenomitx	_	0	SENT_1384	[p20l1663t698r1907b732],
2	10:1617	CD	NUMBER	10:1617	num	1	SENT_1384	[p20l1919t698r2078b723],
3	-24	CD	NUMBER	-24	num	5	SENT_1384	[p20l1919t698r2078b723],
4	Hu	NN	O	hu	nn	5	SENT_1384	[p20l642t742r687b767],
5	M	NN	O	m	dep	1	SENT_1384	[p20l695t742r734b772],
6	,	,	O	,	_	0	SENT_1384	[p20l695t742r734b772],
7	Lui	NNP	PERSON	Lui	nn	8	SENT_1384	[p20l745t742r793b767],
8	SS	NNP	O	SS	appos	5	SENT_1384	[p20l803t742r845b772],
9	,	,	O	,	_	0	SENT_1384	[p20l803t742r845b772],
10	Mak	NNP	PERSON	Mak	nn	12	SENT_1384	[p20l854t741r919b767],
11	V	NNP	PERSON	V	nn	12	SENT_1384	[p20l931t742r947b767],
12	W	NNP	PERSON	W	appos	5	SENT_1384	[p20l955t742r994b772],
13	,	,	O	,	_	0	SENT_1384	[p20l955t742r994b772],
14	Chu	NNP	O	Chu	nn	15	SENT_1384	[p20l1005t741r1064b767],
15	TT	NN	O	tt	appos	5	SENT_1384	[p20l1072t742r1131b772],
16	,	,	O	,	_	0	SENT_1384	[p20l1072t742r1131b772],
17	Lee	NNP	PERSON	Lee	nn	19	SENT_1384	[p20l1141t742r1193b767],
18	V	NNP	PERSON	V	nn	19	SENT_1384	[p20l1207t742r1222b767],
19	W	NNP	PERSON	W	appos	5	SENT_1384	[p20l1231t742r1270b772],
20	,	,	O	,	_	0	SENT_1384	[p20l1231t742r1270b772],
21	et	FW	O	et	nn	22	SENT_1384	[p20l1281t748r1306b767],
22	al.	FW	O	al.	appos	5	SENT_1384	[p20l1314t741r1344b767],
23	2010	CD	DATE	2010	dep	22	SENT_1384	[p20l1355t743r1429b767],
24	.	.	O	.	_	0	SENT_1384	[p20l1355t743r1429b767],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_1385	[p20l1440t741r1682b775],
2	analysis	NN	O	analysis	_	0	SENT_1385	[p20l1692t741r1797b775],
3	of	IN	O	of	_	0	SENT_1385	[p20l1806t741r1837b767],
4	lipid	NN	O	lipid	nn	5	SENT_1385	[p20l1842t741r1904b775],
5	responses	NNS	O	response	prep_of	2	SENT_1385	[p20l1913t751r2046b775],
6	to	TO	O	to	_	0	SENT_1385	[p20l2056t748r2083b767],
7	rosuvastatin	NN	O	rosuvastatin	prep_to	2	SENT_1385	[p20l641t836r809b860],
8	in	IN	O	in	_	0	SENT_1385	[p20l818t836r845b860],
9	Chinese	JJ	MISC	chinese	amod	10	SENT_1385	[p20l855t835r968b860],
10	patients	NNS	O	patient	prep_in	2	SENT_1385	[p20l978t836r1094b869],
11	.	.	O	.	_	0	SENT_1385	[p20l978t836r1094b869],

1	Plmnrndeogenet	NNP	O	Plmnrndeogenet	_	0	SENT_1386	[p20l1104t836r1307b870],
2	.	.	O	.	_	0	SENT_1386	[p20l1104t836r1307b870],

1	Genomiex	NNP	O	Genomiex	_	0	SENT_1387	[p20l1321t836r1443b860],
2	20:634	CD	NUMBER	20:634	num	1	SENT_1387	[p20l1452t836r1595b861],
3	-37	CD	NUMBER	-37	num	5	SENT_1387	[p20l1452t836r1595b861],
4	Tomlinson	NN	PERSON	tomlinson	nn	5	SENT_1387	[p20l641t879r798b905],
5	B	NN	PERSON	b	dep	1	SENT_1387	[p20l808t880r835b910],
6	,	,	O	,	_	0	SENT_1387	[p20l808t880r835b910],
7	Hu	NN	O	hu	nn	8	SENT_1387	[p20l846t880r892b905],
8	M	NN	O	m	appos	5	SENT_1387	[p20l900t880r940b910],
9	,	,	O	,	_	0	SENT_1387	[p20l900t880r940b910],
10	Lee	NNP	ORGANIZATION	Lee	nn	11	SENT_1387	[p20l951t880r1003b905],
11	VW	NNP	ORGANIZATION	VW	appos	5	SENT_1387	[p20l1012t880r1081b910],
12	,	,	O	,	_	0	SENT_1387	[p20l1012t880r1081b910],
13	Lui	NNP	PERSON	Lui	nn	14	SENT_1387	[p20l1092t880r1140b905],
14	SS	NNP	O	SS	appos	5	SENT_1387	[p20l1151t880r1193b910],
15	,	,	O	,	_	0	SENT_1387	[p20l1151t880r1193b910],
16	Chu	NNP	O	Chu	nn	17	SENT_1387	[p20l1205t879r1265b905],
17	TT	NN	O	tt	appos	5	SENT_1387	[p20l1274t879r1333b910],
18	,	,	O	,	_	0	SENT_1387	[p20l1274t879r1333b910],
19	et	FW	O	et	nn	20	SENT_1387	[p20l1345t886r1370b905],
20	al.	FW	O	al.	appos	5	SENT_1387	[p20l1380t879r1409b905],
21	2010	CD	DATE	2010	dep	20	SENT_1387	[p20l1421t880r1496b904],
22	.	.	O	.	_	0	SENT_1387	[p20l1421t880r1496b904],

1	ABCG2	NN	O	abcg2	nn	2	SENT_1388	[p20l1506t880r1617b905],
2	polymorphism	NN	O	polymorphism	nsubjpass	4	SENT_1388	[p20l1629t879r1833b913],
3	is	VBZ	O	be	auxpass	4	SENT_1388	[p20l1843t880r1863b905],
4	associated	VBN	O	associate	_	0	SENT_1388	[p20l1874t879r2012b905],
5	with	IN	O	with	_	0	SENT_1388	[p20l2022t879r2083b905],
6	the	DT	O	the	det	10	SENT_1388	[p20l642t924r685b950],
7	low-density	JJ	O	low-density	amod	10	SENT_1388	[p20l695t924r859b958],
8	lipoprotein	NN	O	lipoprotein	nn	10	SENT_1388	[p20l867t924r1023b958],
9	cholesterol	NN	O	cholesterol	nn	10	SENT_1388	[p20l1033t924r1186b950],
10	response	NN	O	response	prep_with	4	SENT_1388	[p20l1196t934r1317b958],
11	to	TO	O	to	_	0	SENT_1388	[p20l1327t931r1354b950],
12	rosuvastatin	NN	O	rosuvastatin	prep_to	4	SENT_1388	[p20l1364t925r1538b950],
13	.	.	O	.	_	0	SENT_1388	[p20l1364t925r1538b950],

1	Clin	NNP	O	Clin	_	0	SENT_1389	[p20l1551t925r1612b950],
2	.	.	O	.	_	0	SENT_1389	[p20l1551t925r1612b950],

1	Plmwnneol	NNP	O	Plmwnneol	_	0	SENT_1390	[p20l1623t925r1767b950],
2	.	.	O	.	_	0	SENT_1390	[p20l1623t925r1767b950],

1	Tber	NNP	O	Tber	_	0	SENT_1391	[p20l1781t925r1849b950],
2	.	.	O	.	_	0	SENT_1391	[p20l1781t925r1849b950],

1	87:5	CD	NUMBER	87:5	num	5	SENT_1392	[p20l1863t925r1919b950],
2	5	CD	NUMBER	5	num	5	SENT_1392	[p20l1923t925r1936b950],
3	8-62	CD	NUMBER	8-62	num	5	SENT_1392	[p20l1940t926r2004b950],
4	Bailey	NNP	PERSON	Bailey	nn	5	SENT_1392	[p20l642t968r728b1002],
5	KM	NNP	O	KM	_	0	SENT_1392	[p20l738t969r802b999],
6	,	,	O	,	_	0	SENT_1392	[p20l738t969r802b999],
7	Romaine	NNP	ORGANIZATION	Romaine	nn	8	SENT_1392	[p20l815t969r940b994],
8	SP	NN	ORGANIZATION	sp	appos	5	SENT_1392	[p20l954t969r998b999],
9	,	,	O	,	_	0	SENT_1392	[p20l954t969r998b999],
10	Jackson	NNP	PERSON	Jackson	nn	11	SENT_1392	[p20l1007t968r1117b1000],
11	BM	NN	O	bm	appos	5	SENT_1392	[p20l1129t969r1189b999],
12	,	,	O	,	_	0	SENT_1392	[p20l1129t969r1189b999],
13	Farrin	NNP	PERSON	Farrin	nn	15	SENT_1392	[p20l1202t969r1289b994],
14	A	NNP	O	A	nn	15	SENT_1392	[p20l1300t969r1342b1000],
15	]	NN	O	]	appos	5	SENT_1392	[p20l1300t969r1342b1000],
16	,	,	O	,	_	0	SENT_1392	[p20l1300t969r1342b1000],
17	Efthymiou	NN	O	efthymiou	nn	18	SENT_1392	[p20l1355t968r1505b1002],
18	M	NN	O	m	appos	5	SENT_1392	[p20l1516t969r1555b999],
19	,	,	O	,	_	0	SENT_1392	[p20l1516t969r1555b999],
20	et	FW	O	et	nn	21	SENT_1392	[p20l1569t975r1595b994],
21	al.	FW	O	al.	appos	5	SENT_1392	[p20l1606t968r1636b994],
22	2010	CD	DATE	2010	dep	21	SENT_1392	[p20l1649t970r1724b994],
23	.	.	O	.	_	0	SENT_1392	[p20l1649t970r1724b994],

1	Hepatic	JJ	O	hepatic	amod	2	SENT_1393	[p20l1737t969r1848b1002],
2	metabolism	NN	O	metabolism	nsubj	7	SENT_1393	[p20l1860t968r2022b994],
3	and	CC	O	and	_	0	SENT_1393	[p20l2034t968r2083b994],
4	transporter	NN	O	transporter	nn	6	SENT_1393	[p20l642t1021r799b1048],
5	gene	NN	O	gene	nn	6	SENT_1393	[p20l808t1024r873b1048],
6	variants	NNS	O	variant	conj_and	2	SENT_1393	[p20l881t1015r990b1039],
7	enhance	VBP	O	enhance	_	0	SENT_1393	[p20l1000t1014r1114b1039],
8	response	NN	O	response	dobj	7	SENT_1393	[p20l1124t1023r1245b1048],
9	to	TO	O	to	_	0	SENT_1393	[p20l1255t1021r1282b1039],
10	rosuvastatin	NN	O	rosuvastatin	prep_to	7	SENT_1393	[p20l1292t1015r1459b1039],
11	in	IN	O	in	_	0	SENT_1393	[p20l1468t1015r1495b1039],
12	patients	NNS	O	patient	prep_in	10	SENT_1393	[p20l1504t1015r1613b1048],
13	with	IN	O	with	_	0	SENT_1393	[p20l1622t1014r1684b1039],
14	acute	JJ	O	acute	amod	15	SENT_1393	[p20l1694t1021r1766b1039],
15	myocardial	JJ	O	myocardial	amod	16	SENT_1393	[p20l1775t1014r1929b1048],
16	infarction	NN	O	infarction	prep_with	12	SENT_1393	[p20l1938t1014r2082b1039],
17	:	:	O	:	_	0	SENT_1393	[p20l1938t1014r2082b1039],
18	the	DT	O	the	det	22	SENT_1393	[p20l642t1059r685b1086],
19	GEOSTAT	NNP	O	GEOSTAT	nn	22	SENT_1393	[p20l696t1060r892b1086],
20	—	CD	NUMBER	—	num	22	SENT_1393	[p20l696t1060r892b1086],
21	l	NN	O	l	nn	22	SENT_1393	[p20l696t1060r892b1086],
22	Study	NN	O	study	dep	16	SENT_1393	[p20l905t1059r992b1094],
23	.	.	O	.	_	0	SENT_1393	[p20l905t1059r992b1094],

1	Circ	NNP	O	Circ	_	0	SENT_1394	[p20l1004t1060r1063b1085],
2	.	.	O	.	_	0	SENT_1394	[p20l1004t1060r1063b1085],

1	Cdrdioi/dye	NN	O	cdrdioi/dye	_	0	SENT_1395	[p20l1077t1060r1220b1085],
2	.	.	O	.	_	0	SENT_1395	[p20l1077t1060r1220b1085],

1	Genet	NNP	PERSON	Genet	_	0	SENT_1396	[p20l1234t1060r1315b1085],
2	.	.	O	.	_	0	SENT_1396	[p20l1234t1060r1315b1085],

1	3:276	CD	NUMBER	3:276	num	2	SENT_1397	[p20l1329t1060r1453b1086],
2	—	CD	NUMBER	—	_	0	SENT_1397	[p20l1329t1060r1453b1086],
3	85	CD	NUMBER	85	num	5	SENT_1397	[p20l1329t1060r1453b1086],
4	Rudin	NNP	PERSON	Rudin	nn	5	SENT_1397	[p20l642t1104r728b1130],
5	CM	NN	O	cm	dep	2	SENT_1397	[p20l738t1105r801b1135],
6	,	,	O	,	_	0	SENT_1397	[p20l738t1105r801b1135],
7	Liu	NNP	PERSON	Liu	nn	8	SENT_1397	[p20l813t1105r862b1130],
8	W	NNP	PERSON	W	appos	5	SENT_1397	[p20l871t1105r914b1135],
9	,	,	O	,	_	0	SENT_1397	[p20l871t1105r914b1135],
10	Desai	NNP	PERSON	Desai	nn	11	SENT_1397	[p20l926t1105r1004b1130],
11	A	NNP	O	A	appos	5	SENT_1397	[p20l1013t1105r1043b1135],
12	,	,	O	,	_	0	SENT_1397	[p20l1013t1105r1043b1135],
13	Karrison	NNP	ORGANIZATION	Karrison	nn	14	SENT_1397	[p20l1054t1105r1177b1130],
14	T	NN	ORGANIZATION	t	appos	5	SENT_1397	[p20l1187t1105r1220b1135],
15	,	,	O	,	_	0	SENT_1397	[p20l1187t1105r1220b1135],
16	]	CD	NUMBER	]	num	18	SENT_1397	[p20l1227t1105r1303b1138],
17	iang	NN	O	iang	nn	18	SENT_1397	[p20l1227t1105r1303b1138],
18	X	NN	O	x	appos	5	SENT_1397	[p20l1311t1105r1343b1135],
19	,	,	O	,	_	0	SENT_1397	[p20l1311t1105r1343b1135],
20	et	FW	O	et	nn	21	SENT_1397	[p20l1355t1111r1381b1130],
21	al.	FW	O	al.	appos	5	SENT_1397	[p20l1390t1104r1420b1130],
22	2008	CD	DATE	2008	dep	21	SENT_1397	[p20l1432t1106r1507b1130],
23	.	.	O	.	_	0	SENT_1397	[p20l1432t1106r1507b1130],

1	Pharmacogenomic	JJ	PERSON	pharmacogenomic	amod	4	SENT_1398	[p20l1518t1104r1780b1138],
2	and	CC	O	and	_	0	SENT_1398	[p20l1791t1104r1840b1130],
3	pharmacokinetic	JJ	O	pharmacokinetic	conj_and	1	SENT_1398	[p20l1851t1104r2084b1138],
4	determinants	NNS	O	determinant	_	0	SENT_1398	[p20l642t1147r825b1173],
5	of	IN	O	of	_	0	SENT_1398	[p20l835t1147r866b1173],
6	erlotinib	NN	O	erlotinib	nn	7	SENT_1398	[p20l872t1147r991b1173],
7	toxicity	NN	O	toxicity	prep_of	4	SENT_1398	[p20l1002t1148r1143b1182],
8	.	.	O	.	_	0	SENT_1398	[p20l1002t1148r1143b1182],

1	Clin	NNP	O	Clin	_	0	SENT_1399	[p20l1157t1148r1218b1173],
2	.	.	O	.	_	0	SENT_1399	[p20l1157t1148r1218b1173],

1	Oneal	NNP	PERSON	Oneal	_	0	SENT_1400	[p20l1232t1148r1309b1173],
2	.	.	O	.	_	0	SENT_1400	[p20l1232t1148r1309b1173],

1	26:1119	CD	NUMBER	26:1119	_	0	SENT_1401	[p20l1322t1148r1482b1174],
2	-27	CD	NUMBER	-27	num	4	SENT_1401	[p20l1322t1148r1482b1174],
3	Benderra	NNP	O	Benderra	nn	4	SENT_1401	[p20l642t1192r770b1218],
4	Z	NN	O	z	dep	1	SENT_1401	[p20l781t1192r810b1223],
5	,	,	O	,	_	0	SENT_1401	[p20l781t1192r810b1223],
6	Faussat	NNP	ORGANIZATION	Faussat	nn	7	SENT_1401	[p20l822t1193r925b1218],
7	AM	NNP	ORGANIZATION	AM	appos	4	SENT_1401	[p20l934t1193r996b1223],
8	,	,	O	,	_	0	SENT_1401	[p20l934t1193r996b1223],
9	Sayada	NNP	PERSON	Sayada	nn	10	SENT_1401	[p20l1009t1192r1104b1226],
10	L	NNP	PERSON	L	appos	4	SENT_1401	[p20l1115t1193r1144b1223],
11	,	,	O	,	_	0	SENT_1401	[p20l1115t1193r1144b1223],
12	Perrot	NNP	PERSON	Perrot	nn	14	SENT_1401	[p20l1156t1193r1247b1218],
13	]	CD	NUMBER	]	num	14	SENT_1401	[p20l1253t1193r1298b1224],
14	Y	NN	O	y	appos	4	SENT_1401	[p20l1253t1193r1298b1224],
15	,	,	O	,	_	0	SENT_1401	[p20l1253t1193r1298b1224],
16	Chaoui	NN	PERSON	chaouus	nn	17	SENT_1401	[p20l1311t1192r1412b1218],
17	D	NN	PERSON	d	appos	4	SENT_1401	[p20l1424t1193r1457b1223],
18	,	,	O	,	_	0	SENT_1401	[p20l1424t1193r1457b1223],
19	et	FW	O	et	nn	20	SENT_1401	[p20l1470t1199r1496b1218],
20	al.	FW	O	al.	appos	4	SENT_1401	[p20l1507t1192r1536b1218],
21	2004	CD	DATE	2004	dep	20	SENT_1401	[p20l1549t1193r1624b1218],
22	.	.	O	.	_	0	SENT_1401	[p20l1549t1193r1624b1218],

1	Breast	NN	O	breast	nn	3	SENT_1402	[p20l1637t1193r1724b1218],
2	cancer	NN	O	cancer	nn	3	SENT_1402	[p20l1735t1201r1825b1218],
3	resistance	NN	O	resistance	_	0	SENT_1402	[p20l1835t1193r1970b1218],
4	protein	NN	O	protein	dep	3	SENT_1402	[p20l1982t1193r2084b1226],
5	and	CC	O	and	_	0	SENT_1402	[p20l642t1236r691b1262],
6	P-glycoprotein	NN	O	p-glycoprotein	dep	3	SENT_1402	[p20l701t1236r912b1270],
7	in	IN	O	in	_	0	SENT_1402	[p20l921t1237r948b1261],
8	149	CD	NUMBER	149	num	12	SENT_1402	[p20l961t1237r1008b1262],
9	adult	JJ	O	adult	amod	12	SENT_1402	[p20l1019t1236r1089b1262],
10	acute	JJ	O	acute	amod	12	SENT_1402	[p20l1098t1243r1170b1262],
11	myeloid	JJ	O	myeloid	amod	12	SENT_1402	[p20l1180t1236r1292b1270],
12	leukemias	NNS	O	leukemia	prep_in	4	SENT_1402	[p20l1302t1236r1446b1262],
13	.	.	O	.	_	0	SENT_1402	[p20l1302t1236r1446b1262],

1	Clin	NNP	O	Clin	_	0	SENT_1403	[p20l1459t1237r1519b1261],
2	.	.	O	.	_	0	SENT_1403	[p20l1459t1237r1519b1261],

1	Comer	NNP	O	Comer	nn	2	SENT_1404	[p20l1533t1237r1624b1261],
2	Res	NNP	O	Res	_	0	SENT_1404	[p20l1630t1237r1679b1261],
3	.	.	O	.	_	0	SENT_1404	[p20l1630t1237r1679b1261],

1	1027896-902	CD	NUMBER	1027896-902	num	3	SENT_1405	[p20l1695t1237r1869b1262],
2	Steinbach	NNP	PERSON	Steinbach	nn	3	SENT_1405	[p20l643t1279r779b1305],
3	D	NNP	O	D	_	0	SENT_1405	[p20l786t1280r819b1310],
4	,	,	O	,	_	0	SENT_1405	[p20l786t1280r819b1310],
5	Sell	VB	O	sell	dep	6	SENT_1405	[p20l828t1279r878b1305],
6	W	NN	O	w	appos	3	SENT_1405	[p20l883t1280r927b1310],
7	,	,	O	,	_	0	SENT_1405	[p20l883t1280r927b1310],
8	VoigtA	NN	O	voigta	appos	6	SENT_1405	[p20l933t1280r1048b1313],
9	,	,	O	,	_	0	SENT_1405	[p20l933t1280r1048b1313],
10	Hermaim	NNP	O	Hermaim	nn	11	SENT_1405	[p20l1055t1280r1215b1311],
11	]	NNP	O	]	appos	6	SENT_1405	[p20l1055t1280r1215b1311],
12	,	,	O	,	_	0	SENT_1405	[p20l1055t1280r1215b1311],
13	Zintl	NNP	O	Zintl	nn	14	SENT_1405	[p20l1223t1279r1292b1305],
14	F	NN	O	f	appos	11	SENT_1405	[p20l1299t1280r1325b1310],
15	,	,	O	,	_	0	SENT_1405	[p20l1299t1280r1325b1310],
16	SauerbreyA	NN	O	sauerbreya	appos	11	SENT_1405	[p20l1334t1279r1508b1313],
17	.	.	O	.	_	0	SENT_1405	[p20l1334t1279r1508b1313],

1	2002	CD	DATE	2002	_	0	SENT_1406	[p20l1516t1281r1590b1304],
2	.	.	O	.	_	0	SENT_1406	[p20l1516t1281r1590b1304],

1	BCRP	NN	O	bcrp	nn	3	SENT_1407	[p20l1598t1280r1687b1305],
2	gene	NN	O	gene	nn	3	SENT_1407	[p20l1695t1289r1759b1313],
3	expression	NN	O	expression	nsubjpass	5	SENT_1407	[p20l1766t1280r1911b1313],
4	is	VBZ	O	be	auxpass	5	SENT_1407	[p20l1917t1280r1937b1305],
5	associated	VBN	O	associate	_	0	SENT_1407	[p20l1944t1279r2083b1305],
6	with	IN	O	with	_	0	SENT_1407	[p20l641t1321r703b1347],
7	a	DT	O	a	det	9	SENT_1407	[p20l716t1331r729b1347],
8	poor	JJ	O	poor	amod	9	SENT_1407	[p20l742t1331r808b1356],
9	response	NN	O	response	prep_with	5	SENT_1407	[p20l820t1331r941b1356],
10	to	TO	O	to	_	0	SENT_1407	[p20l955t1329r982b1347],
11	remission	NN	O	remission	nn	13	SENT_1407	[p20l995t1323r1129b1347],
12	induction	NN	O	induction	nn	13	SENT_1407	[p20l1142t1321r1276b1347],
13	therapy	NN	O	therapy	prep_to	5	SENT_1407	[p20l1289t1321r1395b1356],
14	in	IN	O	in	_	0	SENT_1407	[p20l1406t1323r1433b1347],
15	childhood	NN	O	childhood	nn	18	SENT_1407	[p20l1446t1321r1586b1347],
16	acute	JJ	O	acute	amod	18	SENT_1407	[p20l1600t1328r1671b1347],
17	myeloid	JJ	O	myeloid	amod	18	SENT_1407	[p20l1685t1321r1797b1356],
18	leukemia	NN	O	leukemia	prep_in	13	SENT_1407	[p20l1809t1321r1942b1347],
19	.	.	O	.	_	0	SENT_1407	[p20l1809t1321r1942b1347],

1	Len/eemid	NN	O	len/eemid	_	0	SENT_1408	[p20l1955t1322r2083b1347],
2	1621443-47	CD	NUMBER	1621443-47	num	4	SENT_1408	[p20l645t1366r802b1391],
3	Tsunoda	NNP	PERSON	Tsunoda	nn	4	SENT_1408	[p20l641t1408r765b1434],
4	S	NN	O	s	dep	1	SENT_1408	[p20l778t1409r802b1440],
5	,	,	O	,	_	0	SENT_1408	[p20l778t1409r802b1440],
6	Okumura	NNP	PERSON	Okumura	nn	7	SENT_1408	[p20l815t1408r949b1434],
7	T	NN	O	t	appos	4	SENT_1408	[p20l959t1408r992b1440],
8	,	,	O	,	_	0	SENT_1408	[p20l959t1408r992b1440],
9	Ito	NN	PERSON	ito	nn	10	SENT_1408	[p20l1005t1409r1045b1434],
10	T	NN	O	t	appos	4	SENT_1408	[p20l1056t1408r1089b1440],
11	,	,	O	,	_	0	SENT_1408	[p20l1056t1408r1089b1440],
12	Kondo	NNP	PERSON	Kondo	nn	13	SENT_1408	[p20l1102t1408r1197b1434],
13	K	NNP	PERSON	K	appos	4	SENT_1408	[p20l1209t1409r1241b1440],
14	,	,	O	,	_	0	SENT_1408	[p20l1209t1409r1241b1440],
15	Ortiz	NNP	PERSON	Ortiz	nn	16	SENT_1408	[p20l1255t1409r1329b1434],
16	C	NNP	O	C	appos	4	SENT_1408	[p20l1341t1409r1371b1440],
17	,	,	O	,	_	0	SENT_1408	[p20l1341t1409r1371b1440],
18	et	FW	O	et	nn	19	SENT_1408	[p20l1385t1415r1410b1434],
19	al.	FW	O	al.	appos	4	SENT_1408	[p20l1422t1408r1451b1434],
20	2006	CD	DATE	2006	dep	19	SENT_1408	[p20l1465t1409r1539b1434],
21	.	.	O	.	_	0	SENT_1408	[p20l1465t1409r1539b1434],

1	ABCG2	NN	O	abcg2	nn	2	SENT_1409	[p20l1551t1409r1662b1434],
2	expression	NN	O	expression	nsubj	8	SENT_1409	[p20l1677t1409r1822b1442],
3	is	VBZ	O	be	cop	8	SENT_1409	[p20l1833t1409r1853b1434],
4	an	DT	O	a	det	8	SENT_1409	[p20l1866t1418r1897b1434],
5	independent	JJ	O	independent	amod	8	SENT_1409	[p20l1909t1408r2084b1442],
6	unfavorable	JJ	O	unfavorable	amod	8	SENT_1409	[p20l641t1451r805b1477],
7	prognostic	JJ	O	prognostic	amod	8	SENT_1409	[p20l815t1452r964b1485],
8	factor	NN	O	factor	_	0	SENT_1409	[p20l973t1451r1054b1477],
9	in	IN	O	in	_	0	SENT_1409	[p20l1063t1452r1090b1476],
10	esophageal	JJ	O	esophageal	amod	13	SENT_1409	[p20l1101t1451r1252b1485],
11	squamous	JJ	O	squamous	amod	13	SENT_1409	[p20l1262t1461r1399b1485],
12	cell	NN	O	cell	nn	13	SENT_1409	[p20l1409t1451r1456b1477],
13	carcinoma	NN	O	carcinoma	prep_in	8	SENT_1409	[p20l1466t1452r1617b1477],
14	.	.	O	.	_	0	SENT_1409	[p20l1466t1452r1617b1477],

1	Oncology	NNP	O	Oncology	nn	6	SENT_1410	[p20l1630t1452r1743b1486],
2	71:251	CD	NUMBER	71:251	num	6	SENT_1410	[p20l1754t1452r1896b1477],
3	—	CD	NUMBER	—	num	6	SENT_1410	[p20l1754t1452r1896b1477],
4	58	CD	NUMBER	58	num	6	SENT_1410	[p20l1754t1452r1896b1477],
5	Ross	NNP	PERSON	Ross	nn	6	SENT_1410	[p20l642t1495r706b1520],
6	DD	NNP	O	DD	_	0	SENT_1410	[p20l716t1495r777b1525],
7	,	,	O	,	_	0	SENT_1410	[p20l716t1495r777b1525],
8	Nakanishi	NNP	PERSON	Nakanishi	nn	9	SENT_1410	[p20l786t1494r928b1520],
9	T.	NNP	O	T.	appos	6	SENT_1410	[p20l937t1495r969b1519],
10	2010	CD	DATE	2010	dep	9	SENT_1410	[p20l980t1496r1055b1520],
11	.	.	O	.	_	0	SENT_1410	[p20l980t1496r1055b1520],

1	Impact	NN	O	impact	_	0	SENT_1411	[p20l1065t1495r1163b1528],
2	of	IN	O	of	_	0	SENT_1411	[p20l1172t1494r1202b1520],
3	breast	NN	O	breast	nn	6	SENT_1411	[p20l1207t1494r1291b1520],
4	cancer	NN	O	cancer	nn	6	SENT_1411	[p20l1300t1504r1390b1520],
5	resistance	NN	O	resistance	nn	6	SENT_1411	[p20l1398t1495r1533b1520],
6	protein	NN	O	protein	prep_of	1	SENT_1411	[p20l1542t1495r1644b1528],
7	on	IN	O	on	_	0	SENT_1411	[p20l1653t1504r1688b1520],
8	cancer	NN	O	cancer	nn	10	SENT_1411	[p20l1697t1504r1787b1520],
9	treatment	NN	O	treatment	nn	10	SENT_1411	[p20l1796t1501r1933b1520],
10	outcomes	NNS	O	outcome	prep_on	1	SENT_1411	[p20l1942t1501r2082b1520],
11	.	.	O	.	_	0	SENT_1411	[p20l1942t1501r2082b1520],

1	M8tfJ0d5	NN	O	m8tfj0d5	_	0	SENT_1412	[p20l640t1538r751b1563],
2	Mol	NNP	O	Mol	dep	1	SENT_1412	[p20l758t1538r817b1563],
3	.	.	O	.	_	0	SENT_1412	[p20l758t1538r817b1563],

1	Biol	NNP	O	Biol	_	0	SENT_1413	[p20l829t1538r885b1563],
2	.	.	O	.	_	0	SENT_1413	[p20l829t1538r885b1563],

1	596:2	CD	NUMBER	596:2	number	2	SENT_1414	[p20l899t1538r971b1563],
2	5	CD	NUMBER	5	_	0	SENT_1414	[p20l977t1538r989b1563],
3	1-90	CD	NUMBER	1-90	num	5	SENT_1414	[p20l996t1539r1059b1563],
4	Ishikawa	NNP	ORGANIZATION	Ishikawa	nn	5	SENT_1414	[p20l641t1580r762b1606],
5	T	NN	ORGANIZATION	t	dep	2	SENT_1414	[p20l773t1580r806b1611],
6	,	,	O	,	_	0	SENT_1414	[p20l773t1580r806b1611],
7	Nakagawa	NNP	PERSON	Nakagawa	nn	8	SENT_1414	[p20l818t1580r962b1614],
8	H.	NNP	O	H.	appos	2	SENT_1414	[p20l973t1581r1008b1605],
9	2009	CD	DATE	2009	dep	8	SENT_1414	[p20l1021t1581r1096b1606],
10	.	.	O	.	_	0	SENT_1414	[p20l1021t1581r1096b1606],

1	Human	JJ	O	human	amod	4	SENT_1415	[p20l1108t1581r1215b1606],
2	ABC	NNP	O	ABC	nn	4	SENT_1415	[p20l1225t1581r1294b1606],
3	transporter	NN	O	transporter	nn	4	SENT_1415	[p20l1305t1587r1462b1614],
4	ABCG2	NN	O	abcg2	_	0	SENT_1415	[p20l1472t1581r1583b1606],
5	in	IN	O	in	_	0	SENT_1415	[p20l1596t1581r1624b1605],
6	cancer	NN	O	cancer	nn	7	SENT_1415	[p20l1635t1590r1725b1606],
7	chemotherapy	NN	O	chemotherapy	prep_in	4	SENT_1415	[p20l1736t1580r1936b1614],
8	and	CC	O	and	_	0	SENT_1415	[p20l1947t1580r1996b1606],
9	pharmacogenomics	NNS	O	pharmacogenomic	prep_in	4	SENT_1415	[p20l2007t1580r2083b1614, p20l641t1623r887b1657],
10	]	CD	NUMBER	]	num	9	SENT_1415	[p20l2007t1580r2083b1614, p20l641t1623r887b1657],
11	.	.	O	.	_	0	SENT_1415	[p20l2007t1580r2083b1614, p20l641t1623r887b1657],

1	Exp	NN	O	exp	_	0	SENT_1416	[p20l899t1624r956b1657],
2	.	.	O	.	_	0	SENT_1416	[p20l899t1624r956b1657],

1	Tlyer	NNP	O	Tlyer	_	0	SENT_1417	[p20l970t1623r1038b1649],
2	.	.	O	.	_	0	SENT_1417	[p20l970t1623r1038b1649],

1	Oneol	NN	O	oneol	_	0	SENT_1418	[p20l1052t1623r1129b1649],
2	.	.	O	.	_	0	SENT_1418	[p20l1052t1623r1129b1649],

1	8:5	CD	NUMBER	8:5	num	4	SENT_1419	[p20l1143t1624r1235b1649],
2	-24	CD	NUMBER	-24	num	4	SENT_1419	[p20l1143t1624r1235b1649],
3	Deeley	NNP	PERSON	Deeley	nn	4	SENT_1419	[p20l642t1666r741b1700],
4	RG	NNP	O	RG	_	0	SENT_1419	[p20l750t1667r807b1697],
5	,	,	O	,	_	0	SENT_1419	[p20l750t1667r807b1697],
6	Westlake	NNP	LOCATION	Westlake	nn	7	SENT_1419	[p20l818t1666r948b1692],
7	C	NNP	O	C	appos	4	SENT_1419	[p20l959t1667r990b1697],
8	,	,	O	,	_	0	SENT_1419	[p20l959t1667r990b1697],
9	Cole	NNP	O	Cole	nn	10	SENT_1419	[p20l1002t1666r1067b1692],
10	SP	NN	O	sp	appos	7	SENT_1419	[p20l1079t1667r1123b1692],
11	.	.	O	.	_	0	SENT_1419	[p20l1079t1667r1123b1692],

1	2006	CD	DATE	2006	_	0	SENT_1420	[p20l1135t1668r1210b1692],
2	.	.	O	.	_	0	SENT_1420	[p20l1135t1668r1210b1692],

1	Transmembrane	NN	O	transmembrane	nn	2	SENT_1421	[p20l1220t1666r1454b1692],
2	transport	NN	O	transport	_	0	SENT_1421	[p20l1464t1673r1593b1700],
3	of	IN	O	of	_	0	SENT_1421	[p20l1603t1666r1633b1692],
4	endo	NN	O	endo	prep_of	2	SENT_1421	[p20l1640t1666r1720b1692],
5	-	:	O	-	_	0	SENT_1421	[p20l1640t1666r1720b1692],
6	and	CC	O	and	_	0	SENT_1421	[p20l1731t1666r1781b1692],
7	xenobiotics	NNS	O	xenobiotic	conj_and	4	SENT_1421	[p20l1790t1666r1948b1692],
8	by	IN	O	by	_	0	SENT_1421	[p20l1959t1666r1993b1700],
9	mammalian	JJ	O	mammalian	amod	16	SENT_1421	[p20l2001t1676r2083b1692, p20l641t1709r735b1735],
10	ATP	NN	O	atp	nn	16	SENT_1421	[p20l743t1709r934b1744],
11	—	NN	O	—	nn	16	SENT_1421	[p20l743t1709r934b1744],
12	binding	NN	O	binding	nn	16	SENT_1421	[p20l743t1709r934b1744],
13	cassette	NN	O	cassette	nn	16	SENT_1421	[p20l944t1717r1049b1735],
14	multidrug	JJ	O	multidrug	amod	16	SENT_1421	[p20l1059t1709r1199b1744],
15	resistance	NN	O	resistance	nn	16	SENT_1421	[p20l1208t1711r1343b1735],
16	proteins	NNS	O	protein	prep_by	2	SENT_1421	[p20l1353t1711r1474b1744],
17	.	.	O	.	_	0	SENT_1421	[p20l1353t1711r1474b1744],

1	Physiol	NNP	O	Physiol	_	0	SENT_1422	[p20l1485t1710r1581b1744],
2	.	.	O	.	_	0	SENT_1422	[p20l1485t1710r1581b1744],

1	Rev.	NNP	O	Rev.	_	0	SENT_1423	[p20l1592t1710r1647b1735],
2	86:849	CD	NUMBER	86:849	number	3	SENT_1423	[p20l1661t1711r1804b1736],
3	—	CD	NUMBER	—	dep	1	SENT_1423	[p20l1661t1711r1804b1736],
4	99	CD	NUMBER	99	dep	3	SENT_1423	[p20l1661t1711r1804b1736],

1	DeGo7ter	NN	O	dego7ter	_	0	SENT_1424	[p20l564t1813r676b1834],
2	et	FW	O	et	nn	3	SENT_1424	[p20l683t1818r703b1834],
3	nl	FW	O	nl	dep	1	SENT_1424	[p20l709t1813r735b1834],
4	.	.	O	.	_	0	SENT_1424	[p20l709t1813r735b1834],

1	Wijnholds	NNP	O	Wijnholds	nn	2	SENT_1425	[p20l443t1851r615b1885],
2	]	NNP	O	]	_	0	SENT_1425	[p20l443t1851r615b1885],
3	,	,	O	,	_	0	SENT_1425	[p20l443t1851r615b1885],
4	Evers	NNP	PERSON	Evers	nn	5	SENT_1425	[p20l623t1852r700b1877],
5	R	NNP	PERSON	R	appos	2	SENT_1425	[p20l707t1852r736b1882],
6	,	,	O	,	_	0	SENT_1425	[p20l707t1852r736b1882],
7	van	NNP	PERSON	van	nn	9	SENT_1425	[p20l742t1861r791b1877],
8	Leusden	NNP	PERSON	Leusden	nn	9	SENT_1425	[p20l797t1851r916b1877],
9	MR	NN	PERSON	mr	appos	2	SENT_1425	[p20l920t1852r983b1882],
10	,	,	O	,	_	0	SENT_1425	[p20l920t1852r983b1882],
11	Mol	NNP	ORGANIZATION	Mol	nn	12	SENT_1425	[p20l989t1851r1049b1877],
12	CA	NNP	O	CA	appos	2	SENT_1425	[p20l1055t1852r1108b1882],
13	,	,	O	,	_	0	SENT_1425	[p20l1055t1852r1108b1882],
14	Zaman	NNP	PERSON	Zaman	nn	16	SENT_1425	[p20l1115t1851r1213b1877],
15	G	NNP	O	G	nn	16	SENT_1425	[p20l1220t1852r1265b1883],
16	]	NNS	O	]	appos	2	SENT_1425	[p20l1220t1852r1265b1883],
17	,	,	O	,	_	0	SENT_1425	[p20l1220t1852r1265b1883],
18	et	FW	O	et	nn	19	SENT_1425	[p20l1273t1858r1299b1877],
19	al.	FW	O	al.	appos	2	SENT_1425	[p20l1304t1851r1334b1877],
20	1997	CD	DATE	1997	dep	19	SENT_1425	[p20l1345t1852r1416b1877],
21	.	.	O	.	_	0	SENT_1425	[p20l1345t1852r1416b1877],

1	Increased	VBN	O	increase	amod	2	SENT_1426	[p20l1424t1851r1557b1877],
2	sensitivity	NN	O	sensitivity	_	0	SENT_1426	[p20l1563t1852r1703b1885],
3	to	TO	O	to	_	0	SENT_1426	[p20l1708t1858r1735b1877],
4	anticancer	JJ	O	anticancer	amod	5	SENT_1426	[p20l1742t1852r1885b1877],
5	drugs	NNS	O	drug	prep_to	2	SENT_1426	[p20l444t1893r520b1928],
6	and	CC	O	and	_	0	SENT_1426	[p20l530t1893r579b1919],
7	decreased	VBD	O	decrease	conj_and	2	SENT_1426	[p20l588t1893r723b1919],
8	inﬂammatory	JJ	O	inﬂammatory	amod	9	SENT_1426	[p20l732t1893r921b1928],
9	response	NN	O	response	dobj	7	SENT_1426	[p20l929t1903r1050b1928],
10	in	IN	O	in	_	0	SENT_1426	[p20l1059t1895r1085b1919],
11	mice	NNS	O	mouse	prep_in	7	SENT_1426	[p20l1094t1894r1159b1919],
12	lacking	VBG	O	lack	partmod	11	SENT_1426	[p20l1169t1893r1269b1928],
13	the	DT	O	the	det	16	SENT_1426	[p20l1277t1893r1320b1919],
14	multidrug	JJ	O	multidrug	amod	16	SENT_1426	[p20l1329t1893r1469b1928],
15	resistance-associated	JJ	O	resistance-associated	amod	16	SENT_1426	[p20l1477t1893r1766b1919],
16	protein	NN	O	protein	dobj	12	SENT_1426	[p20l1775t1894r1883b1928],
17	.	.	O	.	_	0	SENT_1426	[p20l1775t1894r1883b1928],

1	Nat	NN	PERSON	nat	_	0	SENT_1427	[p20l442t1937r500b1962],
2	.	.	O	.	_	0	SENT_1427	[p20l442t1937r500b1962],

1	Med	NNP	O	Med	_	0	SENT_1428	[p20l510t1937r576b1962],
2	.	.	O	.	_	0	SENT_1428	[p20l510t1937r576b1962],

1	3:1275	CD	NUMBER	3:1275	num	4	SENT_1429	[p20l590t1937r733b1963],
2	-79	CD	NUMBER	-79	num	4	SENT_1429	[p20l590t1937r733b1963],
3	Lorico	NNP	O	Lorico	nn	4	SENT_1429	[p20l444t1980r537b2005],
4	A	NNP	O	A	_	0	SENT_1429	[p20l545t1980r575b2010],
5	,	,	O	,	_	0	SENT_1429	[p20l545t1980r575b2010],
6	Rappa	NNP	ORGANIZATION	Rappa	nn	7	SENT_1429	[p20l585t1980r672b2013],
7	G	NNP	ORGANIZATION	G	appos	4	SENT_1429	[p20l682t1980r715b2010],
8	,	,	O	,	_	0	SENT_1429	[p20l682t1980r715b2010],
9	Finch	NNP	O	Finch	nn	10	SENT_1429	[p20l725t1979r805b2005],
10	RA	NN	O	ra	appos	7	SENT_1429	[p20l814t1980r865b2010],
11	,	,	O	,	_	0	SENT_1429	[p20l814t1980r865b2010],
12	Yang	NNP	PERSON	Yang	nn	13	SENT_1429	[p20l875t1980r948b2013],
13	D	NNP	PERSON	D	appos	7	SENT_1429	[p20l956t1980r990b2010],
14	,	,	O	,	_	0	SENT_1429	[p20l956t1980r990b2010],
15	Flavell	NNP	PERSON	Flavell	nn	16	SENT_1429	[p20l1000t1979r1092b2005],
16	RA	NN	O	ra	appos	7	SENT_1429	[p20l1101t1980r1153b2010],
17	,	,	O	,	_	0	SENT_1429	[p20l1101t1980r1153b2010],
18	Sartorelli	NNP	PERSON	Sartorelli	nn	19	SENT_1429	[p20l1164t1979r1292b2005],
19	AC	NN	O	ac	appos	7	SENT_1429	[p20l1300t1980r1355b2005],
20	.	.	O	.	_	0	SENT_1429	[p20l1300t1980r1355b2005],

1	1997	CD	DATE	1997	_	0	SENT_1430	[p20l1368t1980r1440b2005],
2	.	.	O	.	_	0	SENT_1430	[p20l1368t1980r1440b2005],

1	Disruption	NN	O	disruption	nsubj	12	SENT_1431	[p20l1450t1980r1603b2013],
2	of	IN	O	of	_	0	SENT_1431	[p20l1613t1979r1643b2005],
3	the	DT	O	the	det	11	SENT_1431	[p20l1648t1979r1691b2005],
4	murine	JJ	O	murine	amod	11	SENT_1431	[p20l1700t1980r1801b2005],
5	MRP	NN	O	mrp	npadvmod	7	SENT_1431	[p20l1808t1980r1884b2005],
6	(	CD	NUMBER	(	num	5	SENT_1431	[p20l444t2021r595b2056],
7	multidrug	JJ	O	multidrug	amod	11	SENT_1431	[p20l444t2021r595b2056],
8	resistance	NN	O	resistance	nn	11	SENT_1431	[p20l607t2022r742b2047],
9	protein	NN	O	protein	nn	11	SENT_1431	[p20l756t2022r867b2056],
10	)	NN	O	)	nn	11	SENT_1431	[p20l756t2022r867b2056],
11	gene	NN	O	gene	prep_of	1	SENT_1431	[p20l882t2031r946b2056],
12	leads	VBZ	O	lead	_	0	SENT_1431	[p20l960t2021r1028b2047],
13	to	TO	O	to	_	0	SENT_1431	[p20l1042t2029r1069b2047],
14	increased	VBN	O	increase	amod	15	SENT_1431	[p20l1082t2021r1212b2047],
15	sensitivity	NN	O	sensitivity	prep_to	12	SENT_1431	[p20l1226t2022r1366b2056],
16	to	TO	O	to	_	0	SENT_1431	[p20l1378t2028r1405b2047],
17	etoposide	NN	O	etoposide	nn	20	SENT_1431	[p20l1419t2021r1552b2056],
18	(	CD	NUMBER	(	num	20	SENT_1431	[p20l1566t2022r1677b2054],
19	VP-16	NN	O	vp-16	nn	20	SENT_1431	[p20l1566t2022r1677b2054],
20	)	NN	O	)	prep_to	15	SENT_1431	[p20l1566t2022r1677b2054],
21	and	CC	O	and	_	0	SENT_1431	[p20l1692t2021r1741b2047],
22	increased	VBN	O	increase	amod	23	SENT_1431	[p20l1755t2021r1884b2047],
23	levels	NNS	O	level	prep_to	12	SENT_1431	[p20l443t2064r519b2090],
24	of	IN	O	of	_	0	SENT_1431	[p20l529t2064r560b2090],
25	glutathione	NN	O	glutathione	prep_of	23	SENT_1431	[p20l566t2064r732b2098],
26	.	.	O	.	_	0	SENT_1431	[p20l566t2064r732b2098],

1	Cll11L	NN	O	cll11l	_	0	SENT_1432	[p20l745t2065r835b2089],
2	‘	CD	NUMBER	‘	num	1	SENT_1432	[p20l745t2065r835b2089],
3	E1	NN	O	e1	nn	5	SENT_1432	[p20l745t2065r835b2089],
4	'	''	O	'	_	0	SENT_1432	[p20l745t2065r835b2089],
5	Rex	NN	O	rex	dep	1	SENT_1432	[p20l842t2065r891b2089],
6	.	.	O	.	_	0	SENT_1432	[p20l842t2065r891b2089],

1	5	CD	NUMBER	5	number	2	SENT_1433	[p20l905t2065r918b2090],
2	7:5	CD	NUMBER	7:5	num	3	SENT_1433	[p20l922t2065r961b2090],
3	238-42	CD	NUMBER	238-42	_	0	SENT_1433	[p20l964t2065r1063b2090],
4	Letourneau	NNP	PERSON	Letourneau	dep	3	SENT_1433	[p20l443t2107r607b2132],
5	I	PRP	O	I	nsubj	6	SENT_1433	[p20l617t2107r648b2138],
6	]	VBP	O	]	rcmod	4	SENT_1433	[p20l617t2107r648b2138],
7	,	,	O	,	_	0	SENT_1433	[p20l617t2107r648b2138],
8	Deeley	NNP	PERSON	Deeley	nn	9	SENT_1433	[p20l660t2106r759b2140],
9	RG	NNP	O	RG	appos	4	SENT_1433	[p20l769t2107r826b2137],
10	,	,	O	,	_	0	SENT_1433	[p20l769t2107r826b2137],
11	Cole	NNP	O	Cole	nn	12	SENT_1433	[p20l838t2106r904b2132],
12	SP	NN	O	sp	appos	9	SENT_1433	[p20l916t2107r960b2132],
13	.	.	O	.	_	0	SENT_1433	[p20l916t2107r960b2132],

1	2005	CD	DATE	2005	_	0	SENT_1434	[p20l973t2107r1047b2132],
2	.	.	O	.	_	0	SENT_1434	[p20l973t2107r1047b2132],

1	Functional	JJ	O	functional	amod	2	SENT_1435	[p20l1060t2106r1210b2132],
2	characterization	NN	O	characterization	_	0	SENT_1435	[p20l1221t2106r1445b2132],
3	of	IN	O	of	_	0	SENT_1435	[p20l1456t2106r1487b2132],
4	non-synonymous	JJ	O	non-synonymous	amod	7	SENT_1435	[p20l1493t2116r1734b2140],
5	single	JJ	O	single	amod	7	SENT_1435	[p20l1746t2106r1826b2140],
6	nucleotide	NN	O	nucleotide	nn	7	SENT_1435	[p20l1836t2116r1884b2132, p20l444t2148r553b2174],
7	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_1435	[p20l564t2148r779b2183],
8	in	IN	O	in	_	0	SENT_1435	[p20l790t2149r817b2174],
9	the	DT	O	the	det	10	SENT_1435	[p20l828t2148r871b2174],
10	gene	NN	O	gene	prep_in	7	SENT_1435	[p20l883t2158r947b2183],
11	encoding	VBG	O	encode	partmod	2	SENT_1435	[p20l959t2148r1087b2183],
12	human	JJ	O	human	amod	15	SENT_1435	[p20l1097t2148r1193b2174],
13	multidrug	JJ	O	multidrug	amod	15	SENT_1435	[p20l1203t2148r1344b2183],
14	resistance	NN	O	resistance	nn	15	SENT_1435	[p20l1354t2149r1489b2174],
15	protein	NN	O	protein	dobj	11	SENT_1435	[p20l1500t2149r1602b2183],
16	1	CD	NUMBER	1	number	17	SENT_1435	[p20l1616t2150r1625b2174],
17	(	CD	NUMBER	(	num	19	SENT_1435	[p20l1640t2149r1883b2181],
18	MRP1/ABCC1	NN	O	mrp1/abcc1	nn	19	SENT_1435	[p20l1640t2149r1883b2181],
19	)	NN	O	)	dep	15	SENT_1435	[p20l1640t2149r1883b2181],
20	.	.	O	.	_	0	SENT_1435	[p20l1640t2149r1883b2181],

1	Plmrmdcogenet	NNP	O	Plmrmdcogenet	_	0	SENT_1436	[p20l443t2192r646b2226],
2	.	.	O	.	_	0	SENT_1436	[p20l443t2192r646b2226],

1	Genomic	JJ	O	genomic	_	0	SENT_1437	[p20l660t2192r781b2217],
2	:	:	O	:	_	0	SENT_1437	[p20l660t2192r781b2217],
3	15	CD	NUMBER	15	number	4	SENT_1437	[p20l793t2192r821b2217],
4	:647	CD	NUMBER	:647	num	5	SENT_1437	[p20l826t2192r915b2218],
5	—	NN	O	—	dep	1	SENT_1437	[p20l826t2192r915b2218],
6	5	CD	NUMBER	5	number	7	SENT_1437	[p20l826t2192r915b2218],
7	7	CD	NUMBER	7	num	8	SENT_1437	[p20l920t2192r933b2217],
8	Nies	NNPS	ORGANIZATION	Nies	dep	5	SENT_1437	[p20l443t2235r508b2260],
9	AT	IN	O	at	amod	8	SENT_1437	[p20l514t2235r569b2266],
10	,	,	O	,	_	0	SENT_1437	[p20l514t2235r569b2266],
11	Keppler	NNP	PERSON	Keppler	nn	12	SENT_1437	[p20l578t2234r691b2268],
12	D.	NNP	O	D.	appos	1	SENT_1437	[p20l698t2235r731b2260],
13	2007	CD	DATE	2007	dep	12	SENT_1437	[p20l740t2235r815b2260],
14	.	.	O	.	_	0	SENT_1437	[p20l740t2235r815b2260],

1	The	DT	O	the	det	5	SENT_1438	[p20l822t2234r881b2260],
2	apical	JJ	O	apical	amod	5	SENT_1438	[p20l890t2234r968b2268],
3	conjugate	NN	O	conjugate	nn	5	SENT_1438	[p20l976t2235r1110b2269],
4	efflux	NN	O	efflux	nn	5	SENT_1438	[p20l1118t2234r1193b2260],
5	pump	NN	O	pump	_	0	SENT_1438	[p20l1199t2244r1279b2268],
6	ABCC2	NN	O	abcc2	nn	9	SENT_1438	[p20l1286t2235r1394b2260],
7	(	CD	NUMBER	(	num	9	SENT_1438	[p20l1404t2235r1524b2267],
8	MRP2	NN	O	mrp2	nn	9	SENT_1438	[p20l1404t2235r1524b2267],
9	)	NN	O	)	dep	5	SENT_1438	[p20l1404t2235r1524b2267],
10	.	.	O	.	_	0	SENT_1438	[p20l1404t2235r1524b2267],

1	Pﬂuger	NNP	O	Pﬂuger	_	0	SENT_1439	[p20l1532t2234r1713b2269],
2	:	:	O	:	_	0	SENT_1439	[p20l1532t2234r1713b2269],
3	Arel	NNP	O	Arel	dep	1	SENT_1439	[p20l1532t2234r1713b2269],
4	;	:	O	;	_	0	SENT_1439	[p20l1532t2234r1713b2269],
5	v.	CC	O	v.	dep	12	SENT_1439	[p20l1532t2234r1713b2269],
6	45	CD	NUMBER	45	number	7	SENT_1439	[p20l1723t2235r1754b2260],
7	3	CD	NUMBER	3	dep	5	SENT_1439	[p20l1759t2236r1770b2260],
8	:643	CD	NUMBER	:643	num	9	SENT_1439	[p20l1776t2235r1866b2260],
9	-5	CD	NUMBER	-5	dep	7	SENT_1439	[p20l1776t2235r1866b2260],
10	9	CD	NUMBER	9	num	12	SENT_1439	[p20l1869t2236r1884b2260],
11	Paulusma	NNP	ORGANIZATION	Paulusma	nn	12	SENT_1439	[p20l443t2276r577b2302],
12	CC	NN	ORGANIZATION	cc	dep	3	SENT_1439	[p20l592t2277r648b2308],
13	,	,	O	,	_	0	SENT_1439	[p20l592t2277r648b2308],
14	Kool	NNP	ORGANIZATION	Kool	nn	15	SENT_1439	[p20l664t2276r733b2302],
15	M	NNP	ORGANIZATION	M	appos	12	SENT_1439	[p20l745t2277r785b2308],
16	,	,	O	,	_	0	SENT_1439	[p20l745t2277r785b2308],
17	Bosma	NNP	PERSON	Bosma	nn	19	SENT_1439	[p20l801t2277r893b2302],
18	P	NN	O	p	nn	19	SENT_1439	[p20l907t2277r947b2309],
19	]	NN	O	]	appos	12	SENT_1439	[p20l907t2277r947b2309],
20	,	,	O	,	_	0	SENT_1439	[p20l907t2277r947b2309],
21	Scheffer	NNP	ORGANIZATION	Scheffer	nn	22	SENT_1439	[p20l963t2276r1076b2302],
22	GL	NNP	ORGANIZATION	GL	appos	12	SENT_1439	[p20l1091t2277r1146b2308],
23	,	,	O	,	_	0	SENT_1439	[p20l1091t2277r1146b2308],
24	ter	NN	O	ter	nn	26	SENT_1439	[p20l1162t2283r1200b2302],
25	Borg	NNP	PERSON	Borg	nn	26	SENT_1439	[p20l1215t2277r1283b2311],
26	F	NN	O	f	appos	12	SENT_1439	[p20l1297t2277r1323b2308],
27	,	,	O	,	_	0	SENT_1439	[p20l1297t2277r1323b2308],
28	et	FW	O	et	nn	29	SENT_1439	[p20l1339t2283r1365b2302],
29	al.	FW	O	al.	appos	12	SENT_1439	[p20l1378t2276r1408b2302],
30	1997	CD	DATE	1997	dep	3	SENT_1439	[p20l1427t2277r1499b2303],
31	.	.	O	.	_	0	SENT_1439	[p20l1427t2277r1499b2303],

1	A	DT	O	a	det	2	SENT_1440	[p20l1513t2277r1537b2302],
2	mutation	NN	O	mutation	nsubj	12	SENT_1440	[p20l1549t2277r1676b2302],
3	in	IN	O	in	_	0	SENT_1440	[p20l1690t2278r1717b2302],
4	the	DT	O	the	det	11	SENT_1440	[p20l1731t2276r1774b2302],
5	human	JJ	O	human	amod	11	SENT_1440	[p20l1788t2276r1885b2302],
6	canalicular	JJ	O	canalicular	amod	7	SENT_1440	[p20l444t2322r593b2348],
7	multispeciﬁc	JJ	O	multispeciﬁc	amod	11	SENT_1440	[p20l601t2322r778b2356],
8	organic	JJ	O	organic	amod	11	SENT_1440	[p20l786t2323r889b2357],
9	anion	NN	O	anion	nn	11	SENT_1440	[p20l897t2323r974b2348],
10	transporter	NN	O	transporter	nn	11	SENT_1440	[p20l982t2329r1139b2356],
11	gene	NN	O	gene	prep_in	2	SENT_1440	[p20l1146t2332r1211b2357],
12	causes	VBZ	O	cause	_	0	SENT_1440	[p20l1219t2332r1305b2348],
13	the	DT	O	the	det	14	SENT_1440	[p20l1313t2322r1356b2348],
14	Dubin	NNP	PERSON	Dubin	dobj	12	SENT_1440	[p20l1364t2322r1582b2354],
15	-	:	O	-	_	0	SENT_1440	[p20l1364t2322r1582b2354],
16	]	NN	O	]	nn	18	SENT_1440	[p20l1364t2322r1582b2354],
17	ohnson	NN	O	ohnson	nn	18	SENT_1440	[p20l1364t2322r1582b2354],
18	syndrome	NN	O	syndrome	dep	14	SENT_1440	[p20l1590t2322r1734b2357],
19	.	.	O	.	_	0	SENT_1440	[p20l1590t2322r1734b2357],

1	Hepotology	JJ	O	hepotology	amod	2	SENT_1441	[p20l1743t2323r1885b2357],
2	Z	NN	O	z	_	0	SENT_1441	[p20l444t2370r457b2394],
3	5	CD	NUMBER	5	number	4	SENT_1441	[p20l462t2369r475b2394],
4	:15	CD	NUMBER	:15	dep	2	SENT_1441	[p20l480t2369r518b2394],
5	3	CD	NUMBER	3	dep	4	SENT_1441	[p20l523t2370r534b2394],
6	9-42	CD	NUMBER	9-42	num	8	SENT_1441	[p20l539t2369r603b2394],
7	Gradhand	NN	O	gradhand	nn	8	SENT_1441	[p20l444t2414r585b2440],
8	U	NNP	O	U	dep	2	SENT_1441	[p20l592t2415r626b2445],
9	,	,	O	,	_	0	SENT_1441	[p20l592t2415r626b2445],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_1441	[p20l634t2415r695b2440],
11	RB	NN	O	rb	appos	8	SENT_1441	[p20l702t2415r753b2440],
12	.	.	O	.	_	0	SENT_1441	[p20l702t2415r753b2440],

1	2008	CD	DATE	2008	_	0	SENT_1442	[p20l762t2416r836b2440],
2	.	.	O	.	_	0	SENT_1442	[p20l762t2416r836b2440],

1	Pharmacogenomics	NNS	O	pharmacogenomic	nn	3	SENT_1443	[p20l845t2414r1118b2448],
2	ofMRP	NN	O	ofmrp	nn	3	SENT_1443	[p20l1126t2414r1234b2440],
3	transporters	NNS	O	transporter	nsubj	4	SENT_1443	[p20l1242t2421r1410b2448],
4	(	VBP	O	(	_	0	SENT_1443	[p20l1418t2415r1581b2446],
5	ABCC1	NN	O	abcc1	dobj	4	SENT_1443	[p20l1418t2415r1581b2446],
6	—	CD	NUMBER	—	number	7	SENT_1443	[p20l1418t2415r1581b2446],
7	5	CD	NUMBER	5	num	8	SENT_1443	[p20l1418t2415r1581b2446],
8	)	NN	O	)	dep	5	SENT_1443	[p20l1418t2415r1581b2446],
9	and	CC	O	and	_	0	SENT_1443	[p20l1589t2414r1639b2440],
10	BCRP	NN	O	bcrp	nn	13	SENT_1443	[p20l1646t2415r1735b2440],
11	(	CD	NUMBER	(	num	13	SENT_1443	[p20l1743t2415r1883b2446],
12	ABCG2	NN	O	abcg2	nn	13	SENT_1443	[p20l1743t2415r1883b2446],
13	)	NN	O	)	dobj	4	SENT_1443	[p20l1743t2415r1883b2446],
14	.	.	O	.	_	0	SENT_1443	[p20l1743t2415r1883b2446],

1	Drug	NN	O	drug	_	0	SENT_1444	[p20l443t2461r516b2494],
2	Metnlz	NNP	O	Metnlz	dep	1	SENT_1444	[p20l522t2460r612b2485],
3	.	.	O	.	_	0	SENT_1444	[p20l522t2460r612b2485],

1	Rev.	NNP	O	Rev.	_	0	SENT_1445	[p20l624t2460r679b2485],
2	40:3	CD	NUMBER	40:3	num	1	SENT_1445	[p20l691t2461r747b2485],
3	17-54	CD	NUMBER	17-54	num	5	SENT_1445	[p20l755t2460r837b2485],
4	Treinen-Moslen	NN	O	treinen-moslen	nn	5	SENT_1445	[p20l442t2505r676b2531],
5	M	NN	O	m	dep	1	SENT_1445	[p20l684t2506r724b2536],
6	,	,	O	,	_	0	SENT_1445	[p20l684t2506r724b2536],
7	Kanz	NNP	O	Kanz	nn	8	SENT_1445	[p20l734t2506r807b2531],
8	MF	NN	O	mf	appos	5	SENT_1445	[p20l814t2506r874b2531],
9	.	.	O	.	_	0	SENT_1445	[p20l814t2506r874b2531],

1	2006	CD	DATE	2006	_	0	SENT_1446	[p20l885t2506r960b2531],
2	.	.	O	.	_	0	SENT_1446	[p20l885t2506r960b2531],

1	Intestinal	JJ	O	intestinal	amod	3	SENT_1447	[p20l970t2505r1102b2531],
2	tract	NN	O	tract	nn	3	SENT_1447	[p20l1111t2512r1175b2531],
3	injury	NN	O	injury	_	0	SENT_1447	[p20l1184t2506r1267b2539],
4	by	IN	O	by	_	0	SENT_1447	[p20l1275t2505r1309b2539],
5	drugs	NNS	O	drug	prep_by	3	SENT_1447	[p20l1318t2505r1401b2539],
6	:	:	O	:	_	0	SENT_1447	[p20l1318t2505r1401b2539],
7	importance	NN	O	importance	dep	3	SENT_1447	[p20l1412t2506r1571b2539],
8	of	IN	O	of	_	0	SENT_1447	[p20l1581t2505r1611b2531],
9	metabolite	NN	O	metabolite	nn	10	SENT_1447	[p20l1617t2505r1765b2531],
10	delivery	NN	O	delivery	prep_of	7	SENT_1447	[p20l1775t2505r1886b2539],
11	by	IN	O	by	_	0	SENT_1447	[p20l443t2551r477b2585],
12	yellow	JJ	O	yellow	amod	14	SENT_1447	[p20l484t2550r577b2585],
13	bile	NN	O	bile	nn	14	SENT_1447	[p20l585t2550r636b2576],
14	road	NN	O	road	prep_by	10	SENT_1447	[p20l646t2550r715b2576],
15	.	.	O	.	_	0	SENT_1447	[p20l646t2550r715b2576],

1	Plmrmdcol	NNP	O	Plmrmdcol	_	0	SENT_1448	[p20l725t2552r869b2576],
2	.	.	O	.	_	0	SENT_1448	[p20l725t2552r869b2576],

1	Tlyer	NNP	O	Tlyer	_	0	SENT_1449	[p20l884t2552r951b2576],
2	.	.	O	.	_	0	SENT_1449	[p20l884t2552r951b2576],

1	112:649	CD	NUMBER	112:649	num	5	SENT_1450	[p20l967t2552r1124b2577],
2	—	CD	NUMBER	—	num	5	SENT_1450	[p20l967t2552r1124b2577],
3	67	CD	NUMBER	67	num	5	SENT_1450	[p20l967t2552r1124b2577],
4	Russel	NNP	ORGANIZATION	Russel	nn	5	SENT_1450	[p20l444t2596r532b2622],
5	FG	NNP	ORGANIZATION	FG	_	0	SENT_1450	[p20l547t2597r601b2628],
6	,	,	O	,	_	0	SENT_1450	[p20l547t2597r601b2628],
7	Koenderink	NNP	O	Koenderink	nn	11	SENT_1450	[p20l616t2596r784b2622],
8	JB	NNP	O	JB	nn	11	SENT_1450	[p20l792t2597r836b2628],
9	,	,	O	,	_	0	SENT_1450	[p20l792t2597r836b2628],
10	Masereeuw	NNP	O	Masereeuw	appos	11	SENT_1450	[p20l850t2597r1011b2622],
11	R.	NNP	O	R.	appos	5	SENT_1450	[p20l1024t2597r1053b2622],
12	2008	CD	DATE	2008	num	11	SENT_1450	[p20l1069t2598r1143b2622],
13	.	.	O	.	_	0	SENT_1450	[p20l1069t2598r1143b2622],

1	Multidrug	JJ	O	multidrug	amod	3	SENT_1451	[p20l1157t2596r1304b2631],
2	resistance	NN	O	resistance	nn	3	SENT_1451	[p20l1317t2598r1452b2622],
3	protein	NN	O	protein	_	0	SENT_1451	[p20l1466t2598r1568b2630],
4	4	CD	NUMBER	4	number	5	SENT_1451	[p20l1581t2598r1598b2622],
5	(	CD	NUMBER	(	dep	3	SENT_1451	[p20l1612t2597r1856b2628],
6	MRP4/ABCC4	NN	O	mrp4/abcc4	dep	5	SENT_1451	[p20l1612t2597r1856b2628],
7	)	CD	NUMBER	)	num	6	SENT_1451	[p20l1612t2597r1856b2628],
8	:	:	O	:	_	0	SENT_1451	[p20l1612t2597r1856b2628],
9	a	DT	O	a	det	12	SENT_1451	[p20l1872t2606r1885b2622],
10	versatile	JJ	O	versatile	amod	12	SENT_1451	[p20l442t2642r558b2668],
11	efflux	NN	O	efflux	nn	12	SENT_1451	[p20l568t2642r643b2668],
12	transporter	NN	O	transporter	dep	3	SENT_1451	[p20l652t2649r809b2676],
13	for	IN	O	for	_	0	SENT_1451	[p20l818t2642r859b2668],
14	drugs	NNS	O	drug	prep_for	12	SENT_1451	[p20l869t2642r944b2676],
15	and	CC	O	and	_	0	SENT_1451	[p20l955t2642r1004b2668],
16	signalling	NN	O	signalling	nn	17	SENT_1451	[p20l1014t2642r1149b2676],
17	molecules	NNS	O	molecule	prep_for	12	SENT_1451	[p20l1158t2642r1304b2668],
18	.	.	O	.	_	0	SENT_1451	[p20l1158t2642r1304b2668],

1	Trends	NNS	O	trend	_	0	SENT_1452	[p20l1317t2643r1406b2668],
2	Plmwnoeol	NNP	O	Plmwnoeol	dep	1	SENT_1452	[p20l1413t2643r1557b2668],
3	.	.	O	.	_	0	SENT_1452	[p20l1413t2643r1557b2668],

1	Sci	NNP	O	Sci	_	0	SENT_1453	[p20l1570t2643r1612b2668],
2	.	.	O	.	_	0	SENT_1453	[p20l1570t2643r1612b2668],

1	29:200	CD	NUMBER	29:200	num	2	SENT_1454	[p20l1625t2643r1751b2668],
2	—	NN	O	—	_	0	SENT_1454	[p20l1625t2643r1751b2668],
3	7	CD	NUMBER	7	num	5	SENT_1454	[p20l1625t2643r1751b2668],
4	Hoque	NNP	ORGANIZATION	Hoque	nn	5	SENT_1454	[p20l443t2689r540b2722],
5	MT	NNP	ORGANIZATION	MT	dep	2	SENT_1454	[p20l550t2688r616b2719],
6	,	,	O	,	_	0	SENT_1454	[p20l550t2688r616b2719],
7	Conseil	NNP	O	Conseil	nn	8	SENT_1454	[p20l629t2688r735b2713],
8	G	NNP	O	G	appos	5	SENT_1454	[p20l748t2689r781b2719],
9	,	,	O	,	_	0	SENT_1454	[p20l748t2689r781b2719],
10	Cole	NNP	O	Cole	nn	11	SENT_1454	[p20l794t2688r860b2713],
11	SP	NN	O	sp	appos	5	SENT_1454	[p20l873t2689r917b2713],
12	.	.	O	.	_	0	SENT_1454	[p20l873t2689r917b2713],

1	2009	CD	DATE	2009	_	0	SENT_1455	[p20l930t2689r1005b2713],
2	.	.	O	.	_	0	SENT_1455	[p20l930t2689r1005b2713],

1	Involvement	NN	O	involvement	_	0	SENT_1456	[p20l1018t2688r1195b2713],
2	of	IN	O	of	_	0	SENT_1456	[p20l1206t2688r1236b2713],
3	NHERF1	NN	O	nherf1	prep_of	1	SENT_1456	[p20l1243t2689r1381b2713],
4	in	IN	O	in	_	0	SENT_1456	[p20l1396t2689r1423b2713],
5	apical	JJ	O	apical	amod	7	SENT_1456	[p20l1435t2688r1514b2722],
6	membrane	NN	O	membrane	nn	7	SENT_1456	[p20l1525t2688r1674b2713],
7	localization	NN	O	localization	prep_in	1	SENT_1456	[p20l1686t2688r1846b2713],
8	of	IN	O	of	_	0	SENT_1456	[p20l1858t2688r1889b2713],
9	MRP4	NN	O	mrp4	prep_of	1	SENT_1456	[p20l442t2734r536b2759],
10	in	IN	O	in	prep	1	SENT_1456	[p20l545t2735r572b2759],
11	polarized	VBN	O	polarize	partmod	1	SENT_1456	[p20l582t2733r710b2767],
12	kidney	NN	O	kidney	nn	13	SENT_1456	[p20l720t2733r814b2767],
13	cells	NNS	O	cell	dobj	11	SENT_1456	[p20l823t2733r889b2759],
14	.	.	O	.	_	0	SENT_1456	[p20l823t2733r889b2759],

1	Biochem	NNP	ORGANIZATION	Biochem	_	0	SENT_1457	[p20l900t2734r1013b2759],
2	.	.	O	.	_	0	SENT_1457	[p20l900t2734r1013b2759],

1	Bioplyyx	NNP	PERSON	Bioplyyx	_	0	SENT_1458	[p20l1025t2734r1127b2767],
2	.	.	O	.	_	0	SENT_1458	[p20l1025t2734r1127b2767],

1	Res	NNP	O	Res	_	0	SENT_1459	[p20l1139t2734r1187b2759],
2	.	.	O	.	_	0	SENT_1459	[p20l1139t2734r1187b2759],

1	Commnn	NNP	O	Commnn	_	0	SENT_1460	[p20l1201t2734r1326b2759],
2	.	.	O	.	_	0	SENT_1460	[p20l1201t2734r1326b2759],

1	379260-64	CD	NUMBER	379260-64	num	3	SENT_1461	[p20l1340t2734r1484b2759],
2	Krishnamurthy	NNP	PERSON	Krishnamurthy	nn	3	SENT_1461	[p20l443t2779r659b2813],
3	P	NN	PERSON	p	_	0	SENT_1461	[p20l667t2780r694b2810],
4	,	,	O	,	_	0	SENT_1461	[p20l667t2780r694b2810],
5	Schwab	NNP	ORGANIZATION	Schwab	nn	6	SENT_1461	[p20l707t2779r811b2805],
6	M	NNP	ORGANIZATION	M	appos	3	SENT_1461	[p20l820t2780r860b2810],
7	,	,	O	,	_	0	SENT_1461	[p20l820t2780r860b2810],
8	Takenaka	NNP	PERSON	Takenaka	nn	9	SENT_1461	[p20l870t2779r1007b2805],
9	K	NNP	PERSON	K	appos	3	SENT_1461	[p20l1016t2780r1048b2810],
10	,	,	O	,	_	0	SENT_1461	[p20l1016t2780r1048b2810],
11	Nachagari	NNP	ORGANIZATION	Nachagari	nn	12	SENT_1461	[p20l1058t2779r1203b2813],
12	D	NNP	ORGANIZATION	D	appos	3	SENT_1461	[p20l1214t2780r1247b2810],
13	,	,	O	,	_	0	SENT_1461	[p20l1214t2780r1247b2810],
14	Morgan	NNP	PERSON	Morgan	nn	15	SENT_1461	[p20l1257t2780r1398b2813],
15	]	NNP	O	]	appos	3	SENT_1461	[p20l1257t2780r1398b2813],
16	,	,	O	,	_	0	SENT_1461	[p20l1257t2780r1398b2813],
17	et	FW	O	et	nn	18	SENT_1461	[p20l1410t2786r1436b2805],
18	al.	FW	O	al.	appos	3	SENT_1461	[p20l1445t2779r1474b2805],
19	2008	CD	DATE	2008	dep	18	SENT_1461	[p20l1486t2781r1561b2804],
20	.	.	O	.	_	0	SENT_1461	[p20l1486t2781r1561b2804],

1	Transporter-mediated	JJ	O	transporter-mediated	amod	2	SENT_1462	[p20l1571t2779r1885b2813],
2	protection	NN	O	protection	nsubj	6	SENT_1462	[p20l443t2826r589b2859],
3	against	IN	O	against	_	0	SENT_1462	[p20l599t2826r696b2859],
4	thiopurine	JJ	O	thiopurine	amod	5	SENT_1462	[p20l705t2824r976b2859],
5	—	NN	O	—	prep_against	2	SENT_1462	[p20l705t2824r976b2859],
6	induced	VBD	O	induce	_	0	SENT_1462	[p20l705t2824r976b2859],
7	hematopoietic	JJ	O	hematopoietic	amod	8	SENT_1462	[p20l986t2825r1185b2859],
8	toxicity	NN	O	toxicity	dobj	6	SENT_1462	[p20l1195t2826r1305b2859],
9	.	.	O	.	_	0	SENT_1462	[p20l1195t2826r1305b2859],

1	Cancer	NN	O	cancer	nsubj	2	SENT_1463	[p20l1318t2825r1408b2850],
2	Rex	NN	PERSON	rex	_	0	SENT_1463	[p20l1415t2826r1463b2850],
3	.	.	O	.	_	0	SENT_1463	[p20l1415t2826r1463b2850],

1	6824983-89	CD	NUMBER	6824983-89	num	3	SENT_1464	[p20l1477t2826r1637b2851],
2	Ansari	NNP	O	Ansari	nn	3	SENT_1464	[p20l442t2871r532b2896],
3	M	NN	O	m	_	0	SENT_1464	[p20l547t2871r586b2901],
4	,	,	O	,	_	0	SENT_1464	[p20l547t2871r586b2901],
5	Sauty	NNP	O	Sauty	nn	6	SENT_1464	[p20l605t2871r682b2905],
6	G	NNP	O	G	appos	3	SENT_1464	[p20l698t2871r731b2902],
7	,	,	O	,	_	0	SENT_1464	[p20l698t2871r731b2902],
8	Labuda	NNP	PERSON	Labuda	nn	9	SENT_1464	[p20l749t2870r853b2896],
9	M	NNP	O	M	appos	3	SENT_1464	[p20l868t2871r907b2901],
10	,	,	O	,	_	0	SENT_1464	[p20l868t2871r907b2901],
11	Gagne	NNP	PERSON	Gagne	nn	12	SENT_1464	[p20l926t2871r1017b2905],
12	V	NNP	O	V	appos	3	SENT_1464	[p20l1032t2871r1064b2902],
13	,	,	O	,	_	0	SENT_1464	[p20l1032t2871r1064b2902],
14	Laverdiere	NNP	PERSON	Laverdiere	nn	15	SENT_1464	[p20l1082t2870r1232b2896],
15	C	NNP	O	C	appos	3	SENT_1464	[p20l1250t2871r1280b2902],
16	,	,	O	,	_	0	SENT_1464	[p20l1250t2871r1280b2902],
17	et	FW	O	et	nn	18	SENT_1464	[p20l1298t2878r1324b2896],
18	al.	FW	O	al.	appos	3	SENT_1464	[p20l1340t2870r1369b2896],
19	2009	CD	DATE	2009	dep	18	SENT_1464	[p20l1387t2872r1462b2896],
20	.	.	O	.	_	0	SENT_1464	[p20l1387t2872r1462b2896],

1	Polymorphism	NN	O	polymorphism	nsubjpass	9	SENT_1465	[p20l1479t2870r1686b2905],
2	in	IN	O	in	_	0	SENT_1465	[p20l1702t2872r1729b2896],
3	multidrug	JJ	O	multidrug	amod	6	SENT_1465	[p20l1745t2870r1886b2905],
4	resistance-associated	JJ	O	resistance-associated	amod	6	SENT_1465	[p20l443t2916r732b2942],
5	protein	NN	O	protein	nn	6	SENT_1465	[p20l749t2917r851b2950],
6	gene	NN	O	gene	prep_in	1	SENT_1465	[p20l869t2926r934b2950],
7	4	CD	NUMBER	4	dep	6	SENT_1465	[p20l951t2918r968b2942],
8	is	VBZ	O	be	auxpass	9	SENT_1465	[p20l985t2917r1005b2942],
9	associated	VBN	O	associate	_	0	SENT_1465	[p20l1024t2916r1162b2942],
10	with	IN	O	with	_	0	SENT_1465	[p20l1179t2916r1241b2942],
11	outcome	NN	O	outcome	prep_with	9	SENT_1465	[p20l1259t2923r1379b2942],
12	in	IN	O	in	_	0	SENT_1465	[p20l1397t2917r1424b2941],
13	childhood	NN	O	childhood	nn	16	SENT_1465	[p20l1442t2916r1582b2942],
14	acute	JJ	O	acute	amod	16	SENT_1465	[p20l1600t2923r1672b2942],
15	lymphoblastic	JJ	O	lymphoblastic	amod	16	SENT_1465	[p20l1689t2916r1885b2950],
16	leukemia	NN	O	leukemia	prep_in	11	SENT_1465	[p20l443t2961r575b2987],
17	.	.	O	.	_	0	SENT_1465	[p20l443t2961r575b2987],

1	Blood	NN	O	blood	_	0	SENT_1466	[p20l586t2962r658b2987],
2	114:1383	CD	NUMBER	114:1383	num	1	SENT_1466	[p20l669t2963r844b2987],
3	-86	CD	NUMBER	-86	num	5	SENT_1466	[p20l669t2963r844b2987],
4	Briiggemann	NNP	O	Briiggemann	nn	5	SENT_1466	[p20l444t3008r624b3042],
5	M	NN	O	m	dep	1	SENT_1466	[p20l630t3008r669b3038],
6	,	,	O	,	_	0	SENT_1466	[p20l630t3008r669b3038],
7	Trautmann	NNP	PERSON	Trautmann	nn	8	SENT_1466	[p20l677t3008r839b3033],
8	H	NNP	O	H	appos	5	SENT_1466	[p20l846t3008r882b3039],
9	,	,	O	,	_	0	SENT_1466	[p20l846t3008r882b3039],
10	Hoelzer	NNP	PERSON	Hoelzer	nn	11	SENT_1466	[p20l890t3007r1004b3033],
11	D	NNP	O	D	appos	5	SENT_1466	[p20l1012t3008r1045b3039],
12	,	,	O	,	_	0	SENT_1466	[p20l1012t3008r1045b3039],
13	Kneba	NNP	ORGANIZATION	Kneba	nn	14	SENT_1466	[p20l1054t3007r1144b3033],
14	M	NNP	ORGANIZATION	M	appos	5	SENT_1466	[p20l1151t3008r1190b3039],
15	,	,	O	,	_	0	SENT_1466	[p20l1151t3008r1190b3039],
16	Gokbuget	NNP	ORGANIZATION	Gokbuget	nn	17	SENT_1466	[p20l1200t3007r1340b3042],
17	N	NNP	ORGANIZATION	N	appos	5	SENT_1466	[p20l1346t3008r1382b3039],
18	,	,	O	,	_	0	SENT_1466	[p20l1346t3008r1382b3039],
19	Raff	NNP	PERSON	Raff	nn	20	SENT_1466	[p20l1391t3007r1451b3033],
20	T.	NNP	O	T.	appos	5	SENT_1466	[p20l1459t3008r1492b3033],
21	2	CD	NUMBER	2	number	22	SENT_1466	[p20l1501t3009r1514b3033],
22	009	CD	NUMBER	009	dep	20	SENT_1466	[p20l1519t3009r1576b3033],
23	.	.	O	.	_	0	SENT_1466	[p20l1519t3009r1576b3033],

1	Multidrug	JJ	O	multidrug	amod	3	SENT_1467	[p20l1584t3007r1730b3042],
2	resistanceassociated	JJ	O	resistanceassociated	amod	3	SENT_1467	[p20l1736t3009r1884b3033, p20l444t3053r582b3079],
3	protein	NN	O	protein	_	0	SENT_1467	[p20l592t3054r694b3087],
4	4	CD	NUMBER	4	number	5	SENT_1467	[p20l703t3054r720b3079],
5	(	CD	NUMBER	(	num	9	SENT_1467	[p20l730t3054r842b3085],
6	MRP4	NN	O	mrp4	nn	9	SENT_1467	[p20l730t3054r842b3085],
7	)	NN	O	)	nn	9	SENT_1467	[p20l730t3054r842b3085],
8	gene	NN	O	gene	nn	9	SENT_1467	[p20l853t3063r918b3087],
9	polymorphisms	NNS	O	polymorphism	dep	3	SENT_1467	[p20l928t3053r1144b3087],
10	and	CC	O	and	_	0	SENT_1467	[p20l1154t3053r1204b3079],
11	treatment	NN	O	treatment	nn	12	SENT_1467	[p20l1214t3060r1351b3079],
12	response	NN	O	response	dep	3	SENT_1467	[p20l1360t3063r1481b3087],
13	in	IN	O	in	_	0	SENT_1467	[p20l1491t3054r1518b3078],
14	adult	JJ	O	adult	amod	17	SENT_1467	[p20l1528t3053r1598b3079],
15	acute	JJ	O	acute	amod	17	SENT_1467	[p20l1608t3060r1680b3079],
16	lymphoblastic	JJ	O	lymphoblastic	amod	17	SENT_1467	[p20l1690t3053r1885b3087],
17	leukemia	NN	O	leukemia	prep_in	12	SENT_1467	[p20l443t3098r575b3124],
18	.	.	O	.	_	0	SENT_1467	[p20l443t3098r575b3124],

1	Blood	NN	O	blood	_	0	SENT_1468	[p20l586t3099r658b3124],
2	114:5400	CD	NUMBER	114:5400	num	3	SENT_1468	[p20l669t3100r824b3124],
3	-1	CD	NUMBER	-1	dep	1	SENT_1468	[p20l669t3100r824b3124],

1	www.nnnndlreview5.org	NN	O	www.nnnndlreview5.org	nn	4	SENT_1469	[p20l1356t3748r1630b3778],
2	o	NN	O	o	nn	4	SENT_1469	[p20l1645t3756r1654b3766],
3	Dmg	NNP	O	Dmg	nn	4	SENT_1469	[p20l1671t3748r1734b3778],
4	Tmnsporterr	NNP	O	Tmnsporterr	_	0	SENT_1469	[p20l1742t3748r1886b3777],
5	xico	NN	O	xico	dep	4	SENT_1469	[p21l74t3591r97b3647],
6	1	CD	NUMBER	1	num	5	SENT_1469	[p21l74t3562r97b3577],
7	.	.	O	.	_	0	SENT_1469	[p21l74t3562r97b3577],

1	2012522249-273	CD	NUMBER	2012522249-273	_	0	SENT_1470	[p21l74t3316r98b3550],
2	.	.	O	.	_	0	SENT_1470	[p21l74t3316r98b3550],

1	Downloaded	VBN	O	download	_	0	SENT_1471	[p21l74t3135r97b3305],
2	from	IN	O	from	_	0	SENT_1471	[p21l74t3062r97b3126],
3	www.a.nnua1reviews.org	JJ	O	www.a.nnua1reviews.org	amod	5	SENT_1471	[p21l74t2728r104b3053],
4	Wis	NNP	O	Wis	nn	5	SENT_1471	[p21l107t3590r131b3643],
5	consin	NN	O	consin	prep_from	1	SENT_1471	[p21l107t3489r131b3576],
6	-	:	O	-	_	0	SENT_1471	[p21l121t3471r124b3480],
7	Madison	NNP	O	Madison	dep	5	SENT_1471	[p21l107t3344r131b3461],
8	on	IN	O	on	_	0	SENT_1471	[p21l115t3303r131b3335],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_1471	[p21l107t3170r131b3294],
10	.	.	O	.	_	0	SENT_1471	[p21l107t3170r131b3294],

1	For	IN	O	for	_	0	SENT_1472	[p21l108t3113r131b3159],
2	personal	JJ	O	personal	amod	3	SENT_1472	[p21l107t2992r138b3104],
3	use	NN	O	use	pobj	1	SENT_1472	[p21l115t2940r131b2983],
4	only	RB	O	only	advmod	3	SENT_1472	[p21l107t2865r138b2930],
5	.	.	O	.	_	0	SENT_1472	[p21l107t2865r138b2930],

1	Annu	NNP	PERSON	Annu	_	0	SENT_1473	[p21l63t1644r86b1724],
2	.	.	O	.	_	0	SENT_1473	[p21l63t1644r86b1724],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1474	[p21l63t1573r86b1633],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_1474	[p21l63t1414r86b1562],
3	.	.	O	.	_	0	SENT_1474	[p21l63t1414r86b1562],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1475	[p21l63t1294r86b1403],
2	.	.	O	.	_	0	SENT_1475	[p21l63t1294r86b1403],

1	20l2	NN	O	20l2	_	0	SENT_1476	[p21l63t1048r87b1283],
2	.52:249	CD	NUMBER	.52:249	number	3	SENT_1476	[p21l63t1048r87b1283],
3	-273	CD	NUMBER	-273	num	1	SENT_1476	[p21l63t1048r87b1283],
4	.	.	O	.	_	0	SENT_1476	[p21l63t1048r87b1283],

1	Downloaded	VBN	O	download	_	0	SENT_1477	[p21l63t867r86b1037],
2	from	IN	O	from	_	0	SENT_1477	[p21l63t794r86b858],
3	www.a.nnua1reviews.org	NN	O	www.a.nnua1reviews.org	prep_from	1	SENT_1477	[p21l63t460r93b785],
4	by	IN	O	by	_	0	SENT_1477	[p21l96t1556r127b1588],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_1477	[p21l97t1407r127b1547],
6	of	IN	ORGANIZATION	of	_	0	SENT_1477	[p21l96t1369r120b1397],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	8	SENT_1477	[p21l96t1222r120b1362],
8	Madison	NNP	ORGANIZATION	Madison	prep_of	5	SENT_1477	[p21l96t1077r120b1194],
9	on	IN	O	on	_	0	SENT_1477	[p21l104t1035r120b1067],
10	01/05/14	NN	DATE	01/05/14	prep_on	8	SENT_1477	[p21l96t909r120b1026],
11	For	IN	O	for	_	0	SENT_1477	[p21l97t845r120b891],
12	personal	JJ	O	personal	amod	13	SENT_1477	[p21l96t724r127b836],
13	use	NN	O	use	prep_for	1	SENT_1477	[p21l104t672r120b715],
14	only	RB	O	only	advmod	1	SENT_1477	[p21l96t604r127b662],

1	Contents	NNS	O	contents	_	0	SENT_1478	[p21l250t303r583b367],

1	Silver	NN	O	silver	nn	2	SENT_1479	[p21l248t447r346b479],
2	Spoons	NNS	O	spoon	_	0	SENT_1479	[p21l359t448r484b490],
3	and	CC	O	and	_	0	SENT_1479	[p21l497t447r559b479],
4	Other	JJ	O	other	amod	6	SENT_1479	[p21l573t447r678b479],
5	Personal	JJ	O	personal	amod	6	SENT_1479	[p21l689t447r840b479],
6	Reﬂections	NNS	O	reﬂections	conj_and	2	SENT_1479	[p21l852t447r1046b479],
7	Alfred	NNP	PERSON	Alfred	nn	9	SENT_1479	[p21l292t502r400b544],
8	G.	NNP	PERSON	G.	nn	9	SENT_1479	[p21l412t502r447b533],
9	Gilman	NNP	PERSON	Gilman	dep	2	SENT_1479	[p21l465t502r588b533],
10	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
11	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
12	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
13	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
14	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
15	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
16	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
17	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
18	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
19	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
20	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
21	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
22	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
23	.....	FW	O	.....	nn	24	SENT_1479	[p21l612t530r1706b535],
24	.....	FW	O	.....	dep	9	SENT_1479	[p21l612t530r1706b535],
25	.	.	O	.	_	0	SENT_1479	[p21l612t530r1706b535],

1	.	.	O	.	_	0	SENT_1480	[p21l1716t530r1735b535],

1	.	.	O	.	_	0	SENT_1481	[p21l1716t530r1735b535],

1	1	CD	NUMBER	1	_	0	SENT_1482	[p21l1752t503r1764b533],
2	Using	VBG	O	use	partmod	1	SENT_1482	[p21l246t582r352b623],
3	Genome	NNP	O	Genome	dobj	2	SENT_1482	[p21l364t580r629b612],
4	.	.	O	.	_	0	SENT_1482	[p21l364t580r629b612],

1	—	NN	O	—	_	0	SENT_1483	[p21l364t580r629b612],
2	.	.	O	.	_	0	SENT_1483	[p21l364t580r629b612],

1	Wide	NN	O	wide	nn	3	SENT_1484	[p21l364t580r629b612],
2	Association	NN	O	association	nn	3	SENT_1484	[p21l640t581r840b612],
3	Studies	NNS	O	study	nsubj	5	SENT_1484	[p21l854t580r978b612],
4	to	TO	O	to	aux	5	SENT_1484	[p21l991t589r1025b612],
5	Identify	VB	O	identify	_	0	SENT_1484	[p21l1037t580r1176b623],
6	Genes	NNS	O	gene	dobj	5	SENT_1484	[p21l1187t582r1296b612],
7	Important	JJ	O	important	amod	6	SENT_1484	[p21l1308t582r1488b623],
8	in	IN	O	in	_	0	SENT_1484	[p21l287t636r321b666],
9	Serious	NNP	MISC	Serious	nn	15	SENT_1484	[p21l335t636r461b666],
10	Adverse	JJ	MISC	adverse	amod	15	SENT_1484	[p21l472t634r611b666],
11	Drug	NN	MISC	drug	nn	15	SENT_1484	[p21l624t636r718b677],
12	Reactions	NNS	MISC	reaction	nn	15	SENT_1484	[p21l730t636r898b666],
13	Ann	NNP	PERSON	Ann	nn	15	SENT_1484	[p21l292t689r365b720],
14	K.	NNP	PERSON	K.	nn	15	SENT_1484	[p21l377t690r412b720],
15	Daly	NNP	PERSON	Daly	prep_in	6	SENT_1484	[p21l427t689r506b731],
16	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l597t717r602b722],[p21l539t717r544b722],
17	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l670t717r674b722],[p21l612t717r616b722],
18	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l742t717r747b722],[p21l684t717r689b722],
19	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l815t717r820b722],[p21l757t717r762b722],
20	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l888t717r892b722],[p21l830t717r834b722],
21	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l961t717r965b722],[p21l902t717r907b722],
22	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l1033t717r1038b722],[p21l975t717r980b722],
23	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l1106t717r1110b722],[p21l1048t717r1052b722],
24	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l1179t717r1183b722],[p21l1120t717r1125b722],
25	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l1251t717r1256b722],[p21l1193t717r1198b722],
26	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l1324t717r1328b722],[p21l1266t717r1270b722],
27	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l1396t717r1401b722],[p21l1338t717r1343b722],
28	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l1469t717r1474b722],[p21l1411t717r1416b722],
29	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l1542t717r1546b722],[p21l1484t717r1488b722],
30	. . . . .	FW	O	. . . . .	nn	31	SENT_1484	[p21l1615t717r1619b722],[p21l1556t717r1561b722],
31	. . . . .	FW	O	. . . . .	dep	15	SENT_1484	[p21l1687t717r1692b722],[p21l1629t717r1634b722],
32	.	.	O	.	_	0	SENT_1484	[p21l1702t690r1764b722],

1	.21	CD	NUMBER	.21	num	3	SENT_1485	[p21l1702t690r1764b722],
2	Xenobiotic	JJ	O	xenobiotic	amod	3	SENT_1485	[p21l245t767r439b799],
3	Metabolomics	NNS	O	metabolomic	_	0	SENT_1485	[p21l450t767r708b799],
4	:	:	O	:	_	0	SENT_1485	[p21l450t767r708b799],
5	Major	JJ	O	major	amod	6	SENT_1485	[p21l721t769r830b810],
6	Impact	NN	O	impact	dep	3	SENT_1485	[p21l841t769r964b810],
7	on	IN	O	on	_	0	SENT_1485	[p21l976t779r1019b799],
8	the	DT	O	the	det	9	SENT_1485	[p21l1031t767r1085b799],
9	Metabolome	NNP	O	Metabolome	prep_on	6	SENT_1485	[p21l1096t767r1320b799],

1	Caroline	NNP	PERSON	Caroline	nn	2	SENT_1486	[p21l298t822r434b853],
2	H.	NNP	PERSON	H.	_	0	SENT_1486	[p21l445t823r485b853],
3	]	CD	NUMBER	]	num	4	SENT_1486	[p21l495t822r635b863],
4	o/Jnson	NN	O	o/jnson	dep	2	SENT_1486	[p21l495t822r635b863],
5	,	,	O	,	_	0	SENT_1486	[p21l495t822r635b863],
6	Andrew	NNP	PERSON	Andrew	nn	8	SENT_1486	[p21l647t822r778b853],
7	D.	NNP	PERSON	D.	nn	8	SENT_1486	[p21l790t823r829b853],
8	Patterson	NNP	PERSON	Patterson	dep	2	SENT_1486	[p21l843t823r1003b860],
9	,	,	O	,	_	0	SENT_1486	[p21l843t823r1003b860],
10	feﬁrey	JJ	O	feﬁrey	amod	12	SENT_1486	[p21l1012t822r1126b864],
11	R.	NNP	PERSON	R.	nn	12	SENT_1486	[p21l1137t823r1170b853],
12	Idle	NNP	PERSON	Idle	dep	2	SENT_1486	[p21l1184t822r1252b860],
13	,	,	O	,	_	0	SENT_1486	[p21l1184t822r1252b860],
14	and	CC	O	and	_	0	SENT_1486	[p21l1266t822r1328b853],
15	Frank	NNP	PERSON	Frank	nn	17	SENT_1486	[p21l1337t822r1476b863],
16	Gonzalez	NNP	PERSON	Gonzalez	nn	17	SENT_1486	[p21l1494t822r1644b853],
17	....	NNP	O	....	conj_and	4	SENT_1486	[p21l1673t822r1766b855],
18	37	CD	NUMBER	37	dep	2	SENT_1486	[p21l1673t822r1766b855],

1	Chemical	NNP	O	Chemical	nn	2	SENT_1487	[p21l247t900r413b932],
2	Genetics	NNP	O	Genetics	_	0	SENT_1487	[p21l426t900r702b932],
3	.	.	O	.	_	0	SENT_1487	[p21l426t900r702b932],

1	—	NN	O	—	_	0	SENT_1488	[p21l426t900r702b932],
2	.	.	O	.	_	0	SENT_1488	[p21l426t900r702b932],

1	Based	VBN	O	base	_	0	SENT_1489	[p21l426t900r702b932],
2	Target	NN	O	target	nn	3	SENT_1489	[p21l713t901r836b943],
3	Identiﬁcation	NN	O	identiﬁcation	dep	1	SENT_1489	[p21l846t900r1082b932],
4	in	IN	O	in	_	0	SENT_1489	[p21l1094t902r1128b932],
5	Drug	NN	MISC	drug	nn	8	SENT_1489	[p21l1140t901r1234b943],
6	Discovery	NNP	MISC	Discovery	nn	8	SENT_1489	[p21l1245t901r1422b943],
7	Feng	NNP	MISC	Feng	nn	8	SENT_1489	[p21l295t955r377b997],
8	Cong	NNP	MISC	Cong	prep_in	3	SENT_1489	[p21l390t955r478b997],
9	,	,	O	,	_	0	SENT_1489	[p21l390t955r478b997],
10	Atwood	NNP	PERSON	Atwood	nn	12	SENT_1489	[p21l490t955r615b986],
11	K.	NNP	PERSON	K.	nn	12	SENT_1489	[p21l624t955r659b986],
12	C/Jenng	NNP	PERSON	C/Jenng	prep_in	3	SENT_1489	[p21l677t955r807b997],
13	,	,	O	,	_	0	SENT_1489	[p21l677t955r807b997],
14	and	CC	O	and	_	0	SENT_1489	[p21l821t955r883b986],
15	S/Ji/y	NNP	O	S/Ji/y	prep_in	3	SENT_1489	[p21l893t955r1055b986],
16	.	.	O	.	_	0	SENT_1489	[p21l893t955r1055b986],

1	—	NN	O	—	_	0	SENT_1490	[p21l893t955r1055b986],
2	.	.	O	.	_	0	SENT_1490	[p21l893t955r1055b986],

1	Min	NNP	DURATION	Min	nn	9	SENT_1491	[p21l893t955r1055b986],
2	A.	NNP	PERSON	A.	nn	9	SENT_1491	[p21l1065t955r1103b986],
3	Huang	NNP	PERSON	Huang	nn	9	SENT_1491	[p21l1117t955r1233b997],
4	.....	NNP	O	.....	nn	9	SENT_1491	[p21l1266t983r1692b988],
5	.....	NNP	O	.....	nn	9	SENT_1491	[p21l1266t983r1692b988],
6	.....	NNP	O	.....	nn	9	SENT_1491	[p21l1266t983r1692b988],
7	.....	NNP	O	.....	nn	9	SENT_1491	[p21l1266t983r1692b988],
8	.....	NNP	O	.....	nn	9	SENT_1491	[p21l1266t983r1692b988],
9	.....	NNP	O	.....	_	0	SENT_1491	[p21l1266t983r1692b988],
10	.	.	O	.	_	0	SENT_1491	[p21l1702t955r1744b988],

1	.5	NN	NUMBER	.5	nsubj	12	SENT_1492	[p21l1702t955r1744b988],
2	7	CD	NUMBER	7	num	1	SENT_1492	[p21l1749t955r1766b987],
3	Old	NNP	O	Old	nn	7	SENT_1492	[p21l247t1033r313b1065],
4	Versus	NNP	O	Versus	nn	7	SENT_1492	[p21l324t1034r443b1065],
5	New	NNP	O	New	nn	7	SENT_1492	[p21l455t1034r540b1065],
6	Oral	NNP	O	Oral	nn	7	SENT_1492	[p21l551t1033r630b1065],
7	Anticoagulants	NNPS	O	Anticoagulants	dep	1	SENT_1492	[p21l641t1033r911b1076],
8	:	:	O	:	_	0	SENT_1492	[p21l641t1033r911b1076],
9	Focus	NN	O	focus	dep	1	SENT_1492	[p21l925t1034r1027b1065],
10	on	IN	O	on	_	0	SENT_1492	[p21l1040t1045r1084b1065],
11	Pharmacology	NN	O	pharmacology	prep_on	9	SENT_1492	[p21l1096t1033r1349b1076],
12	jawed	VBD	O	jaw	_	0	SENT_1492	[p21l290t1087r399b1129],
13	Fareed	NNP	PERSON	Fareed	dobj	12	SENT_1492	[p21l407t1088r525b1126],
14	,	,	O	,	_	0	SENT_1492	[p21l407t1088r525b1126],
15	Indermo/van	NNP	O	Indermo/van	nn	16	SENT_1492	[p21l539t1088r736b1119],
16	T/yet/ii	NNP	O	T/yet/ii	dobj	12	SENT_1492	[p21l751t1088r864b1126],
17	,	,	O	,	_	0	SENT_1492	[p21l751t1088r864b1126],
18	and	CC	O	and	_	0	SENT_1492	[p21l879t1088r941b1119],
19	Debra	NNP	PERSON	Debra	nn	30	SENT_1492	[p21l950t1088r1050b1119],
20	Hoppenxteadt	NNP	PERSON	Hoppenxteadt	nn	30	SENT_1492	[p21l1061t1088r1278b1129],
21	. . . . .	NNP	O	. . . . .	nn	30	SENT_1492	[p21l1367t1116r1372b1120],[p21l1309t1116r1314b1120],
22	. . . . .	NNP	O	. . . . .	nn	30	SENT_1492	[p21l1440t1116r1445b1120],[p21l1382t1116r1386b1120],
23	. . . . .	NNP	O	. . . . .	nn	30	SENT_1492	[p21l1513t1116r1517b1120],[p21l1455t1116r1459b1120],
24	. . . . .	NNP	O	. . . . .	nn	30	SENT_1492	[p21l1585t1116r1590b1120],[p21l1527t1116r1532b1120],
25	. . . . .	NNP	O	. . . . .	nn	30	SENT_1492	[p21l1658t1116r1663b1120],[p21l1600t1116r1604b1120],
26	. . . .	NNP	O	. . . .	nn	30	SENT_1492	[p21l1716t1088r1767b1120],[p21l1673t1116r1677b1120],
27	79	CD	NUMBER	79	num	30	SENT_1492	[p21l1716t1088r1767b1120],
28	Adaptive	JJ	O	adaptive	amod	30	SENT_1492	[p21l245t1166r399b1209],
29	Trial	NN	O	trial	nn	30	SENT_1492	[p21l411t1166r500b1199],
30	Designs	NNS	O	design	conj_and	13	SENT_1492	[p21l513t1168r651b1209],

1	Tze	NNP	PERSON	Tze	nn	3	SENT_1493	[p21l298t1222r357b1253],
2	Leang	NNP	PERSON	Leang	nn	3	SENT_1493	[p21l368t1222r473b1264],
3	Lai	NNP	PERSON	Lai	_	0	SENT_1493	[p21l482t1222r545b1260],
4	,	,	O	,	_	0	SENT_1493	[p21l482t1222r545b1260],
5	P/yilip	NNP	O	P/yilip	nn	7	SENT_1493	[p21l559t1222r656b1263],
6	William	NNP	PERSON	William	nn	7	SENT_1493	[p21l673t1222r805b1253],
7	Lavori	NNP	PERSON	Lavori	appos	3	SENT_1493	[p21l816t1222r933b1260],
8	,	,	O	,	_	0	SENT_1493	[p21l816t1222r933b1260],
9	and	CC	O	and	_	0	SENT_1493	[p21l947t1222r1009b1253],
10	Mei	NNP	PERSON	Mei	appos	3	SENT_1493	[p21l1016t1222r1224b1264],
11	.	.	O	.	_	0	SENT_1493	[p21l1016t1222r1224b1264],

1	—	NN	O	—	_	0	SENT_1494	[p21l1016t1222r1224b1264],
2	.	.	O	.	_	0	SENT_1494	[p21l1016t1222r1224b1264],

1	C/Jinng	NN	O	c/jinng	nn	2	SENT_1495	[p21l1016t1222r1224b1264],
2	S/Ji/9	NN	O	s/ji/9	_	0	SENT_1495	[p21l1234t1222r1308b1253],
3	. . . . .	CD	NUMBER	. . . . .	number	4	SENT_1495	[p21l1397t1250r1401b1254],[p21l1338t1250r1343b1254],
4	. . . . .	CD	NUMBER	. . . . .	dep	2	SENT_1495	[p21l1469t1250r1474b1254],[p21l1411t1250r1416b1254],
5	. . . . .	CD	NUMBER	. . . . .	num	7	SENT_1495	[p21l1542t1250r1546b1254],[p21l1484t1250r1488b1254],
6	. . . . .	CD	NUMBER	. . . . .	num	7	SENT_1495	[p21l1615t1250r1619b1254],[p21l1556t1250r1561b1254],
7	. . . .	NN	O	. . . .	dep	4	SENT_1495	[p21l1673t1250r1692b1254],[p21l1629t1250r1634b1254],
8	.	.	O	.	_	0	SENT_1495	[p21l1673t1250r1692b1254],

1	101	CD	NUMBER	101	_	0	SENT_1496	[p21l1709t1223r1764b1253],

1	Chronic	JJ	O	chronic	amod	2	SENT_1497	[p21l247t1299r391b1331],
2	Pain	NN	O	pain	nn	3	SENT_1497	[p21l403t1301r481b1331],
3	States	NNPS	O	States	_	0	SENT_1497	[p21l495t1300r604b1331],
4	:	:	O	:	_	0	SENT_1497	[p21l495t1300r604b1331],
5	Pharmacological	JJ	O	pharmacological	amod	6	SENT_1497	[p21l618t1299r910b1342],
6	Strategies	NNS	O	strategy	dep	3	SENT_1497	[p21l924t1300r1092b1342],
7	to	TO	O	to	aux	8	SENT_1497	[p21l1105t1308r1139b1331],
8	Restore	VB	O	restore	infmod	6	SENT_1497	[p21l1152t1301r1285b1331],
9	Diminished	VBN	O	diminish	dep	8	SENT_1497	[p21l288t1353r493b1385],
10	Inhibitory	JJ	O	inhibitory	amod	16	SENT_1497	[p21l505t1353r685b1396],
11	Spinal	JJ	O	spinal	amod	16	SENT_1497	[p21l697t1353r804b1395],
12	Pain	NN	O	pain	nn	16	SENT_1497	[p21l816t1354r894b1385],
13	Control	NN	O	control	nn	16	SENT_1497	[p21l907t1353r1045b1385],
14	Hanns	NNP	PERSON	Hanns	nn	16	SENT_1497	[p21l295t1408r404b1438],
15	Ulric/9	NNP	O	Ulric/9	nn	16	SENT_1497	[p21l419t1408r518b1438],
16	Zeil/yofer	NNP	O	Zeil/yofer	dobj	9	SENT_1497	[p21l530t1407r683b1449],
17	,	,	O	,	_	0	SENT_1497	[p21l530t1407r683b1449],
18	Dietmar	NNP	PERSON	Dietmar	nn	19	SENT_1497	[p21l698t1408r840b1438],
19	Ben/ee	NNP	PERSON	Ben/ee	dobj	9	SENT_1497	[p21l849t1408r953b1446],
20	,	,	O	,	_	0	SENT_1497	[p21l849t1408r953b1446],
21	and	CC	O	and	_	0	SENT_1497	[p21l968t1408r1030b1438],
22	Gonzalo	NNP	PERSON	Gonzalo	nn	24	SENT_1497	[p21l1042t1408r1172b1438],
23	E.	NNP	PERSON	E.	nn	24	SENT_1497	[p21l1183t1408r1217b1438],
24	Y	NN	PERSON	y	dobj	9	SENT_1497	[p21l1234t1408r1263b1438],
25	evenes	VBZ	O	evene	dep	9	SENT_1497	[p21l1258t1419r1358b1438],
26	. . . . .	CD	NUMBER	. . . . .	number	27	SENT_1497	[p21l1440t1436r1445b1440],[p21l1382t1436r1387b1440],
27	. . . . .	CD	NUMBER	. . . . .	dobj	25	SENT_1497	[p21l1513t1436r1517b1440],[p21l1455t1436r1459b1440],
28	. . . . .	CD	NUMBER	. . . . .	num	29	SENT_1497	[p21l1585t1436r1590b1440],[p21l1527t1436r1532b1440],
29	. . . . .	NN	O	. . . . .	nsubj	9	SENT_1497	[p21l1658t1436r1663b1440],[p21l1600t1436r1604b1440],
30	.	.	O	.	_	0	SENT_1497	[p21l1673t1436r1692b1440],

1	.	.	O	.	_	0	SENT_1498	[p21l1673t1436r1692b1440],

1	111	CD	NUMBER	111	_	0	SENT_1499	[p21l1709t1408r1764b1438],

1	The	DT	O	the	det	2	SENT_1500	[p21l245t1485r319b1517],
2	Expression	NN	O	expression	_	0	SENT_1500	[p21l332t1487r523b1528],
3	and	CC	O	and	_	0	SENT_1500	[p21l535t1485r597b1517],
4	Function	NN	O	function	conj_and	2	SENT_1500	[p21l609t1487r768b1517],
5	of	IN	O	of	_	0	SENT_1500	[p21l780t1485r818b1517],
6	Organic	NNP	O	Organic	nn	7	SENT_1500	[p21l827t1487r968b1528],
7	Anion	NNP	O	Anion	prep_of	2	SENT_1500	[p21l979t1486r1087b1517],
8	Transporting	VBG	O	transport	partmod	2	SENT_1500	[p21l1098t1486r1335b1528],
9	Polypeptides	NNS	O	polypeptide	dobj	8	SENT_1500	[p21l288t1539r512b1582],
10	in	IN	O	in	_	0	SENT_1500	[p21l524t1541r558b1571],
11	Normal	JJ	O	normal	amod	12	SENT_1500	[p21l569t1539r708b1571],
12	Tissues	NNS	O	tissue	prep_in	8	SENT_1500	[p21l719t1540r849b1571],
13	and	CC	O	and	_	0	SENT_1500	[p21l863t1539r924b1571],
14	in	IN	O	in	_	0	SENT_1500	[p21l936t1541r970b1571],
15	Cancer	NNP	O	Cancer	nn	17	SENT_1500	[p21l983t1540r1108b1571],
16	Amanda	NNP	PERSON	Amanda	nn	17	SENT_1500	[p21l292t1594r435b1626],
17	Obaidat	NNP	PERSON	Obaidat	prep_in	8	SENT_1500	[p21l449t1594r584b1633],
18	,	,	O	,	_	0	SENT_1500	[p21l449t1594r584b1633],
19	Megan	NNP	PERSON	Megan	nn	20	SENT_1500	[p21l597t1595r711b1637],
20	Roth	NNP	PERSON	Roth	conj_and	12	SENT_1500	[p21l723t1594r807b1633],
21	,	,	O	,	_	0	SENT_1500	[p21l723t1594r807b1633],
22	and	CC	O	and	_	0	SENT_1500	[p21l821t1594r883b1626],
23	Bruno	NNP	PERSON	Bruno	nn	31	SENT_1500	[p21l892t1595r992b1626],
24	Hagen/me/7	NNP	O	Hagen/me/7	nn	31	SENT_1500	[p21l1004t1594r1184b1637],
25	. . . . .	NNP	O	. . . . .	nn	31	SENT_1500	[p21l1266t1623r1270b1627],[p21l1208t1623r1212b1627],
26	. . . . .	NNP	O	. . . . .	nn	31	SENT_1500	[p21l1338t1623r1343b1627],[p21l1280t1623r1285b1627],
27	. . . . .	NNP	O	. . . . .	nn	31	SENT_1500	[p21l1411t1623r1416b1627],[p21l1353t1623r1357b1627],
28	. . . . .	NNP	O	. . . . .	nn	31	SENT_1500	[p21l1484t1623r1488b1627],[p21l1426t1623r1430b1627],
29	. . . . .	NNP	O	. . . . .	nn	31	SENT_1500	[p21l1556t1623r1561b1627],[p21l1498t1623r1503b1627],
30	. . . . .	NNP	O	. . . . .	nn	31	SENT_1500	[p21l1629t1623r1634b1627],[p21l1571t1623r1575b1627],
31	. . .	NNP	O	. . .	conj_and	12	SENT_1500	[p21l1673t1623r1692b1627],[p21l1644t1623r1648b1627],
32	.	.	O	.	_	0	SENT_1500	[p21l1673t1623r1692b1627],

1	135	CD	NUMBER	135	_	0	SENT_1501	[p21l1709t1595r1765b1626],
2	The	DT	O	the	det	3	SENT_1501	[p21l245t1673r319b1705],
3	Best	NN	O	best	dep	1	SENT_1501	[p21l332t1674r407b1705],
4	of	IN	O	of	prep	3	SENT_1501	[p21l418t1673r456b1705],
5	Both	CC	O	both	dep	3	SENT_1501	[p21l464t1673r549b1705],
6	Worlds	NNS	O	world	conj	3	SENT_1501	[p21l560t1672r707b1705],
7	?	.	O	?	_	0	SENT_1501	[p21l560t1672r707b1705],

1	Bitopic	JJ	MISC	bitopic	amod	3	SENT_1502	[p21l723t1674r848b1715],
2	Orthosteric/Allosteric	JJ	MISC	orthosteric/allosteric	amod	3	SENT_1502	[p21l861t1672r1246b1705],
3	Ligands	NNS	MISC	ligand	_	0	SENT_1502	[p21l1258t1672r1396b1716],
4	of	IN	O	of	_	0	SENT_1502	[p21l1410t1673r1448b1705],
5	G	NN	O	g	nn	6	SENT_1502	[p21l289t1726r322b1758],
6	Protein	NN	O	protein	prep_of	3	SENT_1502	[p21l333t1725r636b1768],
7	.	.	O	.	_	0	SENT_1502	[p21l333t1725r636b1768],

1	—	NN	O	—	_	0	SENT_1503	[p21l333t1725r636b1768],
2	.	.	O	.	_	0	SENT_1503	[p21l333t1725r636b1768],

1	Coupled	VBN	O	couple	_	0	SENT_1504	[p21l333t1725r636b1768],
2	Receptors	NNS	O	receptor	dep	1	SENT_1504	[p21l649t1727r822b1768],
3	Celine	NNP	PERSON	Celine	nn	4	SENT_1504	[p21l298t1779r397b1810],
4	Valant	NNP	PERSON	Valant	dep	2	SENT_1504	[p21l413t1779r528b1817],
5	,	,	O	,	_	0	SENT_1504	[p21l413t1779r528b1817],
6	Robert	NNP	PERSON	Robert	nn	7	SENT_1504	[p21l583t1779r690b1810],
7	Lane	NNP	PERSON	Lane	appos	2	SENT_1504	[p21l699t1779r788b1817],
8	,	,	O	,	_	0	SENT_1504	[p21l699t1779r788b1817],
9	Patrick	NNP	PERSON	Patrick	nn	11	SENT_1504	[p21l802t1779r921b1810],
10	M.	NNP	PERSON	M.	nn	11	SENT_1504	[p21l930t1779r978b1809],
11	Sexton	NNP	PERSON	Sexton	appos	2	SENT_1504	[p21l993t1779r1109b1817],
12	,	,	O	,	_	0	SENT_1504	[p21l993t1779r1109b1817],
13	and	CC	O	and	_	0	SENT_1504	[p21l1123t1779r1185b1810],
14	Arthur	NNP	PERSON	Arthur	nn	16	SENT_1504	[p21l1191t1778r1313b1810],
15	C/iristopoulos	NNP	O	C/iristopoulos	nn	16	SENT_1504	[p21l1325t1779r1537b1820],
16	.....	NNP	O	.....	appos	2	SENT_1504	[p21l1556t1807r1663b1811],
17	...	:	O	...	_	0	SENT_1504	[p21l1556t1807r1663b1811],
18	.	.	O	.	_	0	SENT_1504	[p21l1673t1807r1677b1811],

1	.	.	O	.	_	0	SENT_1505	[p21l1687t1807r1692b1811],

1	153	CD	NUMBER	153	_	0	SENT_1506	[p21l1709t1779r1764b1810],

1	Molecular	JJ	O	molecular	amod	2	SENT_1507	[p21l245t1830r425b1862],
2	Mechanism	NN	O	mechanism	_	0	SENT_1507	[p21l435t1830r639b1862],
3	of	IN	O	of	_	0	SENT_1507	[p21l652t1830r690b1862],
4	|	NN	O	|	prep_of	2	SENT_1507	[p21l701t1830r1013b1870],
5	3	CD	NUMBER	3	num	4	SENT_1507	[p21l701t1830r1013b1870],
6	.	.	O	.	_	0	SENT_1507	[p21l701t1830r1013b1870],

1	—	NN	O	—	_	0	SENT_1508	[p21l701t1830r1013b1870],
2	.	.	O	.	_	0	SENT_1508	[p21l701t1830r1013b1870],

1	Arrestin-Biased	JJ	MISC	arrestin-biased	amod	2	SENT_1509	[p21l701t1830r1013b1870],
2	Agonism	NN	MISC	agonism	_	0	SENT_1509	[p21l1024t1831r1180b1873],
3	at	IN	O	at	_	0	SENT_1509	[p21l1192t1839r1224b1862],
4	Seven	CD	NUMBER	seven	prep_at	2	SENT_1509	[p21l289t1883r699b1915],
5	.	.	O	.	_	0	SENT_1509	[p21l289t1883r699b1915],

1	—	NN	O	—	_	0	SENT_1510	[p21l289t1883r699b1915],
2	.	.	O	.	_	0	SENT_1510	[p21l289t1883r699b1915],

1	Transmembrane	NN	O	transmembrane	nn	2	SENT_1511	[p21l289t1883r699b1915],
2	Receptors	NNS	O	receptor	_	0	SENT_1511	[p21l712t1884r885b1925],
3	Eric	NNP	PERSON	Eric	nn	4	SENT_1511	[p21l295t1937r364b1967],
4	Reiter	NNP	PERSON	Reiter	dep	2	SENT_1511	[p21l373t1937r479b1974],
5	,	,	O	,	_	0	SENT_1511	[p21l373t1937r479b1974],
6	Senng/eirlAl7n	NN	O	senng/eirlal7n	dep	2	SENT_1511	[p21l495t1936r742b1979],
7	,	,	O	,	_	0	SENT_1511	[p21l495t1936r742b1979],
8	Aran	NNP	PERSON	Aran	nn	10	SENT_1511	[p21l753t1936r844b1967],
9	K.	NNP	PERSON	K.	nn	10	SENT_1511	[p21l855t1937r890b1967],
10	S/an/ela	NNP	PERSON	S/an/ela	conj_and	4	SENT_1511	[p21l906t1936r1027b1974],
11	,	,	O	,	_	0	SENT_1511	[p21l906t1936r1027b1974],
12	and	CC	O	and	_	0	SENT_1511	[p21l1042t1937r1104b1967],
13	Robert	NNP	PERSON	Robert	nn	14	SENT_1511	[p21l1112t1936r1255b1978],
14	}	NNP	PERSON	}	conj_and	4	SENT_1511	[p21l1112t1936r1255b1978],
15	.	.	O	.	_	0	SENT_1511	[p21l1112t1936r1255b1978],

1	Leﬂeowitz	NNP	O	Leﬂeowitz	nn	4	SENT_1512	[p21l1270t1936r1430b1978],
2	. . . . .	NNP	O	. . . . .	nn	4	SENT_1512	[p21l1513t1964r1517b1969],[p21l1455t1964r1459b1969],
3	. . . . .	NNP	O	. . . . .	nn	4	SENT_1512	[p21l1585t1964r1590b1969],[p21l1527t1964r1532b1969],
4	. . . . .	NNP	O	. . . . .	_	0	SENT_1512	[p21l1658t1964r1663b1969],[p21l1600t1964r1604b1969],
5	.	.	O	.	_	0	SENT_1512	[p21l1673t1964r1692b1969],

1	.	.	O	.	_	0	SENT_1513	[p21l1673t1964r1692b1969],

1	179	CD	NUMBER	179	_	0	SENT_1514	[p21l1709t1936r1767b1968],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_1515	[p21l245t1987r462b2030],
2	Targeting	NN	O	targeting	_	0	SENT_1515	[p21l473t1988r651b2030],
3	of	IN	O	of	_	0	SENT_1515	[p21l663t1987r701b2019],
4	the	DT	O	the	det	6	SENT_1515	[p21l709t1987r763b2019],
5	Interleukin	NN	O	interleukin	nn	6	SENT_1515	[p21l775t1987r1007b2019],
6	—	NN	O	—	prep_of	2	SENT_1515	[p21l775t1987r1007b2019],
7	6	CD	NUMBER	6	num	8	SENT_1515	[p21l775t1987r1007b2019],
8	Receptor	NN	O	receptor	dep	2	SENT_1515	[p21l1020t1989r1180b2030],

1	Toy/aio	NNP	O	Toy/aio	nn	4	SENT_1516	[p21l298t2041r399b2072],
2	Tana/ea	NNP	O	Tana/ea	nn	4	SENT_1516	[p21l413t2041r544b2079],
3	,	,	O	,	_	0	SENT_1516	[p21l413t2041r544b2079],
4	Masai	NNP	PERSON	Masai	nsubj	18	SENT_1516	[p21l558t2041r694b2072],
5	"	``	O	"	punct	18	SENT_1516	[p21l558t2041r694b2072],
6	/	:	O	/	punct	7	SENT_1516	[p21l558t2041r694b2072],
7	ai	VBP	O	be	parataxis	18	SENT_1516	[p21l558t2041r694b2072],
8	Naraza/ei	NNP	O	Naraza/ei	attr	7	SENT_1516	[p21l704t2041r869b2079],
9	,	,	O	,	_	0	SENT_1516	[p21l704t2041r869b2079],
10	and	CC	O	and	_	0	SENT_1516	[p21l883t2041r945b2072],
11	Tadamitsu	NNP	PERSON	Tadamitsu	nn	12	SENT_1516	[p21l957t2041r1130b2072],
12	Ki	NN	PERSON	kus	conj_and	8	SENT_1516	[p21l1141t2041r1301b2072],
13	:	:	O	:	_	0	SENT_1516	[p21l1141t2041r1301b2072],
14	/	:	O	/	punct	7	SENT_1516	[p21l1141t2041r1301b2072],
15	yiinoto	FW	O	yiinoto	nn	18	SENT_1516	[p21l1141t2041r1301b2072],
16	.....	FW	O	.....	nn	18	SENT_1516	[p21l1324t2069r1663b2074],
17	.....	FW	O	.....	nn	18	SENT_1516	[p21l1324t2069r1663b2074],
18	.....	FW	O	.....	_	0	SENT_1516	[p21l1324t2069r1663b2074],
19	.....	FW	O	.....	nn	20	SENT_1516	[p21l1324t2069r1663b2074],
20	....	FW	O	....	amod	18	SENT_1516	[p21l1324t2069r1663b2074],
21	.	.	O	.	_	0	SENT_1516	[p21l1673t2069r1692b2074],

1	.	.	O	.	_	0	SENT_1517	[p21l1673t2069r1692b2074],

1	199	CD	NUMBER	199	_	0	SENT_1518	[p21l1709t2042r1767b2072],

1	The	DT	O	the	det	3	SENT_1519	[p21l563t2243r637b2275],
2	Chemical	NNP	O	Chemical	nn	3	SENT_1519	[p21l651t2243r817b2275],
3	Biology	NNP	O	Biology	dep	12	SENT_1519	[p21l829t2243r965b2286],
4	of	IN	O	of	_	0	SENT_1519	[p21l976t2243r1014b2275],
5	Naphthoquinones	NNPS	LOCATION	Naphthoquinones	prep_of	3	SENT_1519	[p21l1021t2243r1338b2286],
6	and	CC	O	and	_	0	SENT_1519	[p21l1352t2243r1413b2275],
7	Its	PRP$	O	its	poss	9	SENT_1519	[p21l606t2297r648b2328],
8	Environmental	JJ	O	environmental	amod	9	SENT_1519	[p21l661t2295r924b2328],
9	Implications	NNS	O	implication	prep_of	3	SENT_1519	[p21l936t2295r1153b2338],
10	Y	NN	O	y	dep	12	SENT_1519	[p21l616t2350r645b2380],
11	ox/yito	CD	NUMBER	ox/yito	num	10	SENT_1519	[p21l640t2349r728b2381],
12	Knmagai	NNP	O	Knmagai	dep	23	SENT_1519	[p21l739t2350r897b2392],
13	,	,	O	,	_	0	SENT_1519	[p21l739t2350r897b2392],
14	Yam/airo	NNP	O	Yam/airo	nn	15	SENT_1519	[p21l914t2349r1054b2381],
15	S/yin/eai	NNP	O	S/yin/eai	dep	23	SENT_1519	[p21l1067t2349r1201b2388],
16	,	,	O	,	_	0	SENT_1519	[p21l1067t2349r1201b2388],
17	Ta/eas/vi	NNP	PERSON	Ta/eas/vi	nn	18	SENT_1519	[p21l1218t2349r1347b2381],
18	Miara	NNP	PERSON	Miara	conj_and	12	SENT_1519	[p21l1356t2350r1472b2388],
19	,	,	O	,	_	0	SENT_1519	[p21l1356t2350r1472b2388],
20	and	CC	O	and	_	0	SENT_1519	[p21l1487t2349r1549b2381],
21	Arthur	NNP	PERSON	Arthur	nn	22	SENT_1519	[p21l1555t2349r1677b2381],
22	K.	NNP	PERSON	K.	conj_and	12	SENT_1519	[p21l1686t2350r1720b2381],
23	C/90	NN	PERSON	c/90	_	0	SENT_1519	[p21l1738t2349r1799b2381],

1	Drug	NN	MISC	drug	nn	2	SENT_1520	[p21l565t2403r659b2444],
2	Transporters	NNS	MISC	transporter	dep	9	SENT_1520	[p21l669t2402r898b2443],
3	in	IN	MISC	in	_	0	SENT_1520	[p21l911t2403r944b2433],
4	Drug	NN	MISC	drug	nn	5	SENT_1520	[p21l957t2403r1051b2444],
5	Efﬁcacy	NN	MISC	efﬁcacy	prep_in	2	SENT_1520	[p21l1062t2401r1201b2444],
6	and	CC	O	and	_	0	SENT_1520	[p21l1212t2401r1273b2433],
7	Toxicity	NN	O	toxicity	prep_in	2	SENT_1520	[p21l1285t2402r1434b2444],
8	M.K.	NNP	PERSON	M.K.	nn	9	SENT_1520	[p21l612t2445r698b2475],
9	DeGorter	NNP	PERSON	DeGorter	_	0	SENT_1520	[p21l713t2445r877b2483],
10	,	,	O	,	_	0	SENT_1520	[p21l713t2445r877b2483],
11	C.Q.	NNP	O	C.Q.	nn	12	SENT_1520	[p21l895t2445r968b2482],
12	Xia	NNP	O	Xia	conj_and	9	SENT_1520	[p21l980t2445r1049b2483],
13	,	,	O	,	_	0	SENT_1520	[p21l980t2445r1049b2483],
14	o	NN	O	o	nn	16	SENT_1520	[p21l1059t2444r1121b2486],
15	*	CD	NUMBER	*	num	16	SENT_1520	[p21l1059t2444r1121b2486],
16	Yang	NNP	PERSON	Yang	conj_and	9	SENT_1520	[p21l1139t2445r1229b2487],
17	,	,	O	,	_	0	SENT_1520	[p21l1139t2445r1229b2487],
18	and	CC	O	and	_	0	SENT_1520	[p21l1243t2445r1305b2476],
19	RB	NN	O	rb	conj_and	9	SENT_1520	[p21l1313t2445r1383b2475],
20	.	.	O	.	_	0	SENT_1520	[p21l1313t2445r1383b2475],

1	Kim	NNP	PERSON	Kim	nn	5	SENT_1521	[p21l1397t2445r1468b2476],
2	. . . . .	NNP	O	. . . . .	nn	5	SENT_1521	[p21l1555t2473r1559b2477],[p21l1497t2473r1501b2477],
3	. . . . .	NNP	O	. . . . .	nn	5	SENT_1521	[p21l1628t2473r1632b2477],[p21l1569t2473r1574b2477],
4	. . . . .	NNP	O	. . . . .	nn	5	SENT_1521	[p21l1700t2473r1705b2477],[p21l1642t2473r1647b2477],
5	. . . . .	NNP	O	. . . . .	_	0	SENT_1521	[p21l1773t2473r1777b2477],[p21l1715t2473r1719b2477],
6	.	.	O	.	_	0	SENT_1521	[p21l1787t2473r1806b2477],

1	.	.	O	.	_	0	SENT_1522	[p21l1787t2473r1806b2477],

1	Adherence	NN	O	adherence	_	0	SENT_1523	[p21l563t2496r751b2528],
2	to	TO	O	to	dep	1	SENT_1523	[p21l764t2505r798b2528],
3	Medications	NNPS	O	Medications	pobj	2	SENT_1523	[p21l809t2496r1034b2528],
4	:	:	O	:	_	0	SENT_1523	[p21l809t2496r1034b2528],
5	Insights	NNPS	O	Insights	dep	3	SENT_1523	[p21l1048t2496r1185b2539],
6	Arising	VBG	O	arise	partmod	5	SENT_1523	[p21l1197t2497r1325b2539],
7	from	IN	O	from	_	0	SENT_1523	[p21l1336t2496r1420b2528],
8	Studies	NNS	O	study	prep_from	6	SENT_1523	[p21l1434t2496r1558b2528],
9	on	IN	O	on	_	0	SENT_1523	[p21l606t2561r650b2581],
10	the	DT	O	the	det	12	SENT_1523	[p21l662t2549r716b2581],
11	Unreliable	JJ	O	unreliable	amod	12	SENT_1523	[p21l729t2549r915b2581],
12	Link	NNP	O	Link	prep_on	8	SENT_1523	[p21l927t2549r1012b2581],
13	Between	IN	O	between	_	0	SENT_1523	[p21l1022t2550r1171b2581],
14	Prescribed	NNP	O	Prescribed	prep_between	6	SENT_1523	[p21l1183t2549r1369b2581],
15	and	CC	O	and	_	0	SENT_1523	[p21l1382t2549r1443b2581],
16	Actual	NNP	O	Actual	nn	19	SENT_1523	[p21l1454t2549r1566b2581],
17	Drug	NNP	O	Drug	nn	19	SENT_1523	[p21l1579t2550r1673b2592],
18	Dosing	NNP	O	Dosing	nn	19	SENT_1523	[p21l606t2603r734b2644],
19	Histories	NNPS	O	Histories	prep_between	6	SENT_1523	[p21l745t2603r905b2633],

1	E	NN	O	e	_	0	SENT_1524	[p21l1818t54r1872b139],

1	Annual	JJ	SET	annual	amod	2	SENT_1525	[p21l1816t187r1925b213],
2	Review	NN	O	review	_	0	SENT_1525	[p21l1935t188r2045b213],
3	of	IN	O	of	_	0	SENT_1525	[p21l2055t187r2088b213],
4	Pharmacology	NNP	O	Pharmacology	prep_of	2	SENT_1525	[p21l1817t222r2034b257],
5	and	CC	O	and	_	0	SENT_1525	[p21l2044t222r2097b248],
6	Toxicology	NNP	O	Toxicology	conj_and	4	SENT_1525	[p21l1817t270r1989b304],
7	Volume	NN	O	volume	dep	2	SENT_1525	[p21l1816t340r1929b366],
8	52	CD	NUMBER	52	num	7	SENT_1525	[p21l1940t342r1980b372],
9	,	,	O	,	_	0	SENT_1525	[p21l1940t342r1980b372],
10	2012	CD	DATE	2012	appos	7	SENT_1525	[p21l1991t342r2056b366],

1	.....	NNP	O	.....	nn	2	SENT_1526	[p21l1831t2378r1981b2382],
2	.....	NNP	O	.....	_	0	SENT_1526	[p21l1831t2378r1981b2382],
3	.	.	O	.	_	0	SENT_1526	[p21l1831t2378r1981b2382],

1	.	.	O	.	_	0	SENT_1527	[p21l1991t2350r2082b2382],

1	.22	NN	NUMBER	.22	nn	2	SENT_1528	[p21l1991t2350r2082b2382],
2	l	NN	O	l	_	0	SENT_1528	[p21l1991t2350r2082b2382],

1	Terrence	NNP	PERSON	Terrence	nn	3	SENT_1529	[p21l616t2655r755b2685],
2	F.	NNP	PERSON	F.	nn	3	SENT_1529	[p21l766t2655r798b2685],
3	Blaxe/3/ee	NNP	PERSON	Blaxe/3/ee	_	0	SENT_1529	[p21l813t2654r956b2692],
4	,	,	O	,	_	0	SENT_1529	[p21l813t2654r956b2692],
5	Lars	NNP	PERSON	Lars	nn	6	SENT_1529	[p21l970t2655r1046b2685],
6	Osterlaerg	NNP	PERSON	Osterlaerg	conj_and	3	SENT_1529	[p21l1058t2654r1220b2697],
7	,	,	O	,	_	0	SENT_1529	[p21l1058t2654r1220b2697],
8	Bernard	NNP	PERSON	Bernard	nn	9	SENT_1529	[p21l1234t2655r1371b2685],
9	Vrijens	NNP	PERSON	Vrijens	conj_and	3	SENT_1529	[p21l1384t2655r1504b2696],
10	,	,	O	,	_	0	SENT_1529	[p21l1384t2655r1504b2696],
11	and	CC	O	and	_	0	SENT_1529	[p21l1518t2655r1580b2685],
12	]	NN	O	]	nn	14	SENT_1529	[p21l1584t2654r1666b2696],
13	o/an	NN	O	o/an	nn	14	SENT_1529	[p21l1584t2654r1666b2696],
14	Urqn/aart	NN	O	urqn/aart	conj_and	3	SENT_1529	[p21l1683t2655r1839b2696],
15	. . . . .	CD	NUMBER	. . . . .	number	16	SENT_1529	[p21l1918t2682r1923b2687],[p21l1860t2682r1865b2687],
16	. . . . .	CD	NUMBER	. . . . .	dep	14	SENT_1529	[p21l1991t2682r2010b2687],[p21l1933t2682r1937b2687],
17	.	.	O	.	_	0	SENT_1529	[p21l1991t2682r2010b2687],

1	275	CD	NUMBER	275	_	0	SENT_1530	[p21l2023t2654r2084b2686],

1	Therapeutic	JJ	O	therapeutic	_	0	SENT_1531	[p21l563t2706r780b2749],
2	Potential	JJ	O	potential	dep	1	SENT_1531	[p21l792t2706r950b2739],
3	for	IN	O	for	_	0	SENT_1531	[p21l963t2706r1013b2739],
4	HDAC	NN	O	hdac	nn	5	SENT_1531	[p21l1025t2707r1153b2739],
5	Inhibitors	NNS	O	inhibitor	prep_for	2	SENT_1531	[p21l1165t2706r1338b2739],
6	in	IN	O	in	_	0	SENT_1531	[p21l1351t2708r1384b2738],
7	the	DT	O	the	det	8	SENT_1531	[p21l1397t2706r1451b2739],
8	Heart	NNP	O	Heart	prep_in	5	SENT_1531	[p21l1463t2708r1567b2739],

1	Timothy	NNP	PERSON	Timothy	nn	5	SENT_1532	[p21l616t2762r752b2804],
2	A.	NNP	PERSON	A.	nn	5	SENT_1532	[p21l760t2762r798b2793],
3	McKin5ey	NNP	PERSON	McKin5ey	nn	5	SENT_1532	[p21l811t2762r970b2804],
4	. . . . .	NNP	O	. . . . .	nn	5	SENT_1532	[p21l1061t2790r1065b2795],[p21l1003t2790r1007b2795],
5	. . . . .	NNP	O	. . . . .	_	0	SENT_1532	[p21l1133t2790r1138b2795],[p21l1075t2790r1080b2795],
6	. . . . .	NNP	O	. . . . .	nn	14	SENT_1532	[p21l1206t2790r1211b2795],[p21l1148t2790r1152b2795],
7	. . . . .	NNP	O	. . . . .	nn	14	SENT_1532	[p21l1279t2790r1283b2795],[p21l1221t2790r1225b2795],
8	. . . . .	NNP	O	. . . . .	nn	14	SENT_1532	[p21l1351t2790r1356b2795],[p21l1293t2790r1298b2795],
9	. . . . .	NNP	O	. . . . .	nn	14	SENT_1532	[p21l1424t2790r1429b2795],[p21l1366t2790r1370b2795],
10	. . . . .	NNP	O	. . . . .	nn	14	SENT_1532	[p21l1497t2790r1501b2795],[p21l1439t2790r1443b2795],
11	. . . . .	NNP	O	. . . . .	nn	14	SENT_1532	[p21l1569t2790r1574b2795],[p21l1511t2790r1516b2795],
12	. . . . .	NNP	O	. . . . .	nn	14	SENT_1532	[p21l1642t2790r1647b2795],[p21l1584t2790r1588b2795],
13	. . . . .	NNP	O	. . . . .	nn	14	SENT_1532	[p21l1715t2790r1719b2795],[p21l1657t2790r1661b2795],
14	. . . . .	NNP	O	. . . . .	dep	5	SENT_1532	[p21l1787t2790r1792b2795],[p21l1729t2790r1734b2795],
15	.	.	O	.	_	0	SENT_1532	[p21l1802t2790r1806b2795],

1	Addiction	NN	O	addiction	nn	2	SENT_1533	[p21l563t2840r736b2872],
2	Circuitry	NN	O	circuitry	_	0	SENT_1533	[p21l749t2841r910b2883],
3	in	IN	O	in	_	0	SENT_1533	[p21l920t2842r954b2872],
4	the	DT	O	the	det	6	SENT_1533	[p21l966t2840r1020b2872],
5	Human	JJ	O	human	amod	6	SENT_1533	[p21l1032t2842r1166b2872],
6	Brain	NN	O	brain	prep_in	2	SENT_1533	[p21l1178t2842r1273b2872],

1	Nora	NNP	PERSON	Nora	nn	3	SENT_1534	[p21l613t2895r697b2926],
2	D.	NNP	PERSON	D.	nn	3	SENT_1534	[p21l709t2895r748b2926],
3	Vol/eow	NNP	PERSON	Vol/eow	_	0	SENT_1534	[p21l767t2895r889b2933],
4	,	,	O	,	_	0	SENT_1534	[p21l767t2895r889b2933],
5	Gene	NNP	PERSON	Gene	appos	3	SENT_1534	[p21l906t2895r1075b2936],
6	—	CD	NUMBER	—	num	5	SENT_1534	[p21l906t2895r1075b2936],
7	j	NN	O	j	nn	9	SENT_1534	[p21l906t2895r1075b2936],
8	"	''	O	"	punct	9	SENT_1534	[p21l906t2895r1075b2936],
9	ac/e	NN	O	ac/e	dep	5	SENT_1534	[p21l906t2895r1075b2936],
10	Wang	NNP	PERSON	Wang	dep	3	SENT_1534	[p21l1091t2895r1195b2937],
11	,	,	O	,	_	0	SENT_1534	[p21l1091t2895r1195b2937],
12	joanna	NNP	PERSON	joanna	nn	14	SENT_1534	[p21l1205t2894r1326b2936],
13	S.	NNP	PERSON	S.	nn	14	SENT_1534	[p21l1339t2895r1368b2926],
14	Fowler	NNP	PERSON	Fowler	dep	3	SENT_1534	[p21l1382t2895r1501b2933],
15	,	,	O	,	_	0	SENT_1534	[p21l1382t2895r1501b2933],
16	and	CC	O	and	_	0	SENT_1534	[p21l1515t2895r1577b2926],
17	Dardo	NNP	PERSON	Dardo	nn	20	SENT_1534	[p21l1587t2895r1689b2926],
18	Tomasi	NNP	PERSON	Tomasi	nn	20	SENT_1534	[p21l1704t2895r1821b2926],
19	.....	NNP	O	.....	nn	20	SENT_1534	[p21l1845t2923r1981b2928],
20	.....	NNP	O	.....	conj_and	10	SENT_1534	[p21l1845t2923r1981b2928],
21	.	.	O	.	_	0	SENT_1534	[p21l1991t2923r2010b2928],

1	.	.	O	.	_	0	SENT_1535	[p21l1991t2923r2010b2928],

1	321	CD	NUMBER	321	num	3	SENT_1536	[p21l2025t2896r2082b2926],
2	Emerging	VBG	O	emerge	amod	3	SENT_1536	[p21l565t2974r740b3016],
3	Themes	NNS	O	theme	_	0	SENT_1536	[p21l750t2973r893b3005],
4	and	CC	O	and	_	0	SENT_1536	[p21l906t2973r968b3005],
5	Therapeutic	JJ	O	therapeutic	amod	6	SENT_1536	[p21l979t2973r1196b3015],
6	Prospects	NNS	O	prospects	conj_and	3	SENT_1536	[p21l1208t2974r1375b3015],
7	for	IN	O	for	_	0	SENT_1536	[p21l606t3027r657b3059],
8	Anti	NNP	O	Anti	prep_for	6	SENT_1536	[p21l667t3027r912b3059],
9	.	.	O	.	_	0	SENT_1536	[p21l667t3027r912b3059],

1	—	NN	O	—	_	0	SENT_1537	[p21l667t3027r912b3059],
2	.	.	O	.	_	0	SENT_1537	[p21l667t3027r912b3059],

1	Infective	JJ	O	infective	amod	2	SENT_1538	[p21l667t3027r912b3059],
2	Peptides	NNS	O	peptide	_	0	SENT_1538	[p21l924t3027r1072b3069],
3	Nannette	NNP	PERSON	Nannette	nn	6	SENT_1538	[p21l613t3082r765b3113],
4	Y.	NNP	PERSON	Y.	nn	6	SENT_1538	[p21l778t3082r808b3113],
5	Y	NN	PERSON	y	nn	6	SENT_1538	[p21l825t3082r854b3112],
6	aunt	NN	O	aunt	dep	2	SENT_1538	[p21l849t3090r922b3113],
7	and	CC	O	and	_	0	SENT_1538	[p21l931t3082r993b3113],
8	Michael	NNP	PERSON	Michael	nn	9	SENT_1538	[p21l1000t3082r1134b3113],
9	R.	NNP	PERSON	R.	dep	2	SENT_1538	[p21l1142t3082r1175b3113],
10	Y	NN	PERSON	y	dep	2	SENT_1538	[p21l1193t3082r1221b3113],
11	eaman	NN	O	eaman	dep	10	SENT_1538	[p21l1217t3093r1322b3113],
12	.....	FW	O	.....	nn	11	SENT_1538	[p21l1351t3110r1777b3114],
13	.....	FW	O	.....	nn	11	SENT_1538	[p21l1351t3110r1777b3114],
14	.....	FW	O	.....	nn	11	SENT_1538	[p21l1351t3110r1777b3114],
15	.....	FW	O	.....	nn	11	SENT_1538	[p21l1351t3110r1777b3114],
16	.....	FW	O	.....	nn	11	SENT_1538	[p21l1351t3110r1777b3114],
17	.....	FW	O	.....	dep	11	SENT_1538	[p21l1351t3110r1777b3114],
18	.	.	O	.	_	0	SENT_1538	[p21l1787t3110r1792b3114],

1	.	.	O	.	_	0	SENT_1539	[p21l1802t3110r1806b3114],

1	Novel	JJ	O	novel	amod	3	SENT_1540	[p21l564t3160r671b3192],
2	Computational	JJ	O	computational	amod	3	SENT_1540	[p21l685t3160r948b3202],
3	Approaches	NNS	O	approach	_	0	SENT_1540	[p21l959t3160r1164b3202],
4	to	TO	O	to	_	0	SENT_1540	[p21l1176t3169r1211b3192],
5	Polypharmacology	NNP	PERSON	Polypharmacology	prep_to	3	SENT_1540	[p21l1223t3160r1553b3202],
6	as	IN	O	as	_	0	SENT_1540	[p21l607t3226r638b3246],
7	a	DT	O	a	det	8	SENT_1540	[p21l651t3226r667b3246],
8	Means	NNP	O	Means	prep_as	3	SENT_1540	[p21l678t3215r794b3246],
9	to	TO	O	to	_	0	SENT_1540	[p21l807t3223r841b3246],
10	Deﬁne	NNP	O	Deﬁne	nn	11	SENT_1540	[p21l854t3214r972b3246],
11	Responses	NNS	O	response	prep_to	3	SENT_1540	[p21l985t3215r1164b3256],
12	to	TO	O	to	_	0	SENT_1540	[p21l1176t3223r1210b3246],
13	Individual	NNP	O	Individual	nn	16	SENT_1540	[p21l1223t3214r1399b3246],
14	Drugs	NNPS	O	Drugs	nn	16	SENT_1540	[p21l1412t3215r1520b3256],
15	Lei	NNP	O	Lei	nn	16	SENT_1540	[p21l613t3269r666b3300],
16	Xie	NNP	O	Xie	prep_to	3	SENT_1540	[p21l674t3269r740b3307],
17	,	,	O	,	_	0	SENT_1540	[p21l674t3269r740b3307],
18	Li	NNP	PERSON	Li	nn	19	SENT_1540	[p21l754t3269r792b3300],
19	Xie	NNP	PERSON	Xie	conj_and	16	SENT_1540	[p21l800t3269r865b3307],
20	,	,	O	,	_	0	SENT_1540	[p21l800t3269r865b3307],
21	Sarah	NNP	PERSON	Sarah	nn	23	SENT_1540	[p21l880t3269r977b3300],
22	L.	NNP	PERSON	L.	nn	23	SENT_1540	[p21l989t3269r1021b3300],
23	Kinningx	NNP	PERSON	Kinningx	conj_and	16	SENT_1540	[p21l1036t3269r1190b3311],
24	,	,	O	,	_	0	SENT_1540	[p21l1036t3269r1190b3311],
25	and	CC	O	and	_	0	SENT_1540	[p21l1205t3269r1267b3300],
26	Philip	NNP	PERSON	Philip	nn	31	SENT_1540	[p21l1275t3269r1372b3310],
27	E.	NNP	PERSON	E.	nn	31	SENT_1540	[p21l1383t3269r1417b3300],
28	Boarne	NNP	PERSON	Boarne	nn	31	SENT_1540	[p21l1432t3269r1548b3300],
29	.....	NNP	O	.....	nn	31	SENT_1540	[p21l1569t3297r1777b3301],
30	.....	NNP	O	.....	nn	31	SENT_1540	[p21l1569t3297r1777b3301],
31	.....	NNP	O	.....	conj_and	16	SENT_1540	[p21l1569t3297r1777b3301],
32	.	.	O	.	_	0	SENT_1540	[p21l1787t3297r1806b3301],

1	.	.	O	.	_	0	SENT_1541	[p21l1787t3297r1806b3301],

1	AMPK	NNP	ORGANIZATION	AMPK	_	0	SENT_1542	[p21l563t3347r690b3378],
2	and	CC	O	and	_	0	SENT_1542	[p21l701t3346r763b3378],
3	mTOR	NNP	O	mTOR	conj_and	1	SENT_1542	[p21l775t3347r906b3378],
4	in	IN	O	in	_	0	SENT_1542	[p21l916t3348r950b3378],
5	Cellular	NNP	O	Cellular	nn	7	SENT_1542	[p21l963t3346r1103b3378],
6	Energy	NNP	O	Energy	nn	7	SENT_1542	[p21l1115t3347r1244b3389],
7	Homeostasis	NNP	O	Homeostasis	prep_in	1	SENT_1542	[p21l1254t3347r1477b3378],
8	and	CC	O	and	_	0	SENT_1542	[p21l1490t3346r1552b3378],
9	Drug	NNP	O	Drug	nn	12	SENT_1542	[p21l1564t3347r1658b3389],
10	Targets	NNP	O	Targets	nn	12	SENT_1542	[p21l1668t3347r1804b3389],
11	Ken	NNP	PERSON	Ken	nn	12	SENT_1542	[p21l613t3401r677b3432],
12	Ino/ei	NNP	PERSON	Ino/ei	prep_in	1	SENT_1542	[p21l688t3401r780b3439],
13	,	,	O	,	_	0	SENT_1542	[p21l688t3401r780b3439],
14	foungmo/e	NNP	O	foungmo/e	nn	15	SENT_1542	[p21l789t3401r961b3444],
15	Kim	NNP	PERSON	Kim	prep_in	1	SENT_1542	[p21l972t3401r1050b3439],
16	,	,	O	,	_	0	SENT_1542	[p21l972t3401r1050b3439],
17	and	CC	O	and	_	0	SENT_1542	[p21l1065t3401r1127b3432],
18	Kun	NNP	PERSON	Kun	conj_and	7	SENT_1542	[p21l1135t3401r1321b3444],
19	.	.	O	.	_	0	SENT_1542	[p21l1135t3401r1321b3444],

1	—	NN	O	—	_	0	SENT_1543	[p21l1135t3401r1321b3444],
2	.	.	O	.	_	0	SENT_1543	[p21l1135t3401r1321b3444],

1	Liang	NNP	PERSON	Liang	nn	7	SENT_1544	[p21l1135t3401r1321b3444],
2	Guan	NNP	PERSON	Guan	nn	7	SENT_1544	[p21l1333t3401r1423b3432],
3	. . . . .	NNP	O	. . . . .	nn	7	SENT_1544	[p21l1511t3429r1516b3434],[p21l1453t3429r1458b3434],
4	. . . . .	NNP	O	. . . . .	nn	7	SENT_1544	[p21l1584t3429r1588b3434],[p21l1526t3429r1530b3434],
5	. . . . .	NNP	O	. . . . .	nn	7	SENT_1544	[p21l1657t3429r1661b3434],[p21l1598t3429r1603b3434],
6	. . . . .	NNP	O	. . . . .	nn	7	SENT_1544	[p21l1729t3429r1734b3434],[p21l1671t3429r1676b3434],
7	. . . .	NNP	O	. . . .	_	0	SENT_1544	[p21l1787t3429r1806b3434],[p21l1744t3429r1748b3434],
8	.	.	O	.	_	0	SENT_1544	[p21l1787t3429r1806b3434],

1	Drug	NN	O	drug	nn	2	SENT_1545	[p21l565t3481r659b3522],
2	Hypersensitivity	NN	O	hypersensitivity	_	0	SENT_1545	[p21l670t3481r958b3522],
3	and	CC	O	and	_	0	SENT_1545	[p21l969t3479r1031b3512],
4	Human	JJ	O	human	amod	6	SENT_1545	[p21l1043t3481r1177b3512],
5	Leukocyte	NN	O	leukocyte	nn	6	SENT_1545	[p21l1189t3479r1371b3522],
6	Antigens	NNS	O	antigen	conj_and	2	SENT_1545	[p21l1383t3481r1537b3522],
7	of	IN	O	of	_	0	SENT_1545	[p21l1551t3479r1589b3512],
8	the	DT	O	the	det	11	SENT_1545	[p21l1596t3479r1650b3512],
9	Major	JJ	ORGANIZATION	major	amod	11	SENT_1545	[p21l1661t3481r1770b3522],
10	Histocompatibility	NN	ORGANIZATION	histocompatibility	nn	11	SENT_1545	[p21l606t3533r938b3577],
11	Complex	NN	ORGANIZATION	complex	prep_of	2	SENT_1545	[p21l949t3534r1108b3576],
12	Mandvi	NNP	ORGANIZATION	Mandvi	nn	13	SENT_1545	[p21l612t3601r745b3633],
13	B/yaradwaj	NNP	ORGANIZATION	B/yaradwaj	dep	2	SENT_1545	[p21l755t3601r940b3643],
14	,	,	O	,	_	0	SENT_1545	[p21l755t3601r940b3643],
15	Patricia	NNP	PERSON	Patricia	nn	16	SENT_1545	[p21l955t3602r1083b3633],
16	Illing	NNP	PERSON	Illing	appos	13	SENT_1545	[p21l1094t3601r1190b3644],
17	,	,	O	,	_	0	SENT_1545	[p21l1094t3601r1190b3644],
18	Alex	NNP	PERSON	Alex	nn	19	SENT_1545	[p21l1202t3601r1280b3633],
19	T/aeodossis	NNP	PERSON	T/aeodossis	appos	16	SENT_1545	[p21l1293t3601r1461b3640],
20	,	,	O	,	_	0	SENT_1545	[p21l1293t3601r1461b3640],
21	Ant/yony	NNP	O	Ant/yony	nn	23	SENT_1545	[p21l1472t3601r1613b3643],
22	W.	NNP	PERSON	W.	nn	23	SENT_1545	[p21l1629t3602r1673b3633],
23	Purcell	NNP	PERSON	Purcell	appos	19	SENT_1545	[p21l1687t3601r1808b3640],
24	,	,	O	,	_	0	SENT_1545	[p21l1687t3601r1808b3640],

1	Annu	NNP	PERSON	Annu	_	0	SENT_1546	[p22l74t282r97b362],
2	.	.	O	.	_	0	SENT_1546	[p22l74t282r97b362],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1547	[p22l74t213r97b273],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_1547	[p22l74t54r97b203],
3	.	.	O	.	_	0	SENT_1547	[p22l74t54r97b203],

1	To	TO	O	to	nsubj	2	SENT_1548	[p22l75t7r97b43],
2	by	IN	O	by	_	0	SENT_1548	[p22l107t196r138b228],
3	University	NNP	ORGANIZATION	University	pobj	2	SENT_1548	[p22l107t47r138b187],
4	of	IN	ORGANIZATION	of	_	0	SENT_1548	[p22l107t8r131b37],
5	An	DT	ORGANIZATION	a	det	6	SENT_1548	[p22l189t2710r212b2750],
6	nu	NN	O	nu	prep_of	3	SENT_1548	[p22l189t2599r212b2703],
7	.	.	O	.	_	0	SENT_1548	[p22l189t2599r212b2703],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1549	[p22l189t2599r212b2703],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_1549	[p22l189t2439r212b2587],
3	.	.	O	.	_	0	SENT_1549	[p22l189t2439r212b2587],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1550	[p22l189t2319r212b2428],
2	.	.	O	.	_	0	SENT_1550	[p22l189t2319r212b2428],

1	2012.52:249	CD	NUMBER	2012.52:249	num	2	SENT_1551	[p22l189t2072r213b2308],
2	-273	CD	NUMBER	-273	_	0	SENT_1551	[p22l189t2072r213b2308],
3	.	.	O	.	_	0	SENT_1551	[p22l189t2072r213b2308],

1	Do	VB	O	do	_	0	SENT_1552	[p22l189t2021r212b2061],
2	wnload	NN	O	wnload	dobj	1	SENT_1552	[p22l189t1877r212b1975],
3	ed	VBN	O	ed	partmod	2	SENT_1552	[p22l189t1833r212b1864],
4	from	IN	O	from	_	0	SENT_1552	[p22l189t1760r212b1824],
5	www.a11nualreviews.org	NN	O	www.a11nualreviews.org	prep_from	3	SENT_1552	[p22l189t1425r219b1751],
6	by	IN	O	by	prep	3	SENT_1552	[p22l222t2581r253b2614],
7	University	NNP	ORGANIZATION	University	dep	6	SENT_1552	[p22l222t2432r253b2572],
8	of	IN	ORGANIZATION	of	_	0	SENT_1552	[p22l222t2393r246b2422],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_1552	[p22l222t2246r246b2387],
10	-	:	O	-	_	0	SENT_1552	[p22l236t2228r239b2237],
11	Madison	NNP	PERSON	Madison	dep	7	SENT_1552	[p22l222t2100r246b2218],
12	on	IN	O	on	_	0	SENT_1552	[p22l230t2059r246b2091],
13	01	CD	NUMBER	01	prep_on	11	SENT_1552	[p22l222t2020r246b2050],
14	/	:	O	/	punct	7	SENT_1552	[p22l222t1920r246b1972],
15	05	CD	NUMBER	05	dep	7	SENT_1552	[p22l222t1920r246b1972],
16	/	:	O	/	punct	15	SENT_1552	[p22l222t1920r246b1972],
17	14	CD	NUMBER	14	dep	15	SENT_1552	[p22l222t1880r246b1916],
18	.	.	O	.	_	0	SENT_1552	[p22l222t1880r246b1916],

1	For	IN	O	for	_	0	SENT_1553	[p22l223t1811r246b1857],
2	personal	JJ	O	personal	amod	3	SENT_1553	[p22l222t1690r253b1802],
3	use	NN	O	use	pobj	1	SENT_1553	[p22l230t1637r246b1681],
4	only	RB	O	only	advmod	3	SENT_1553	[p22l222t1562r253b1627],
5	.	.	O	.	_	0	SENT_1553	[p22l222t1562r253b1627],

1	vi	LS	O	vi	dep	3	SENT_1554	[p22l492t765r514b786],
2	famie	NN	O	famie	nn	3	SENT_1554	[p22l642t14r745b56],
3	Rossjolan	NNP	PERSON	Rossjolan	_	0	SENT_1554	[p22l755t14r899b56],
4	,	,	O	,	_	0	SENT_1554	[p22l755t14r899b56],
5	and	CC	O	and	_	0	SENT_1554	[p22l913t14r975b45],
6	jamex	NN	O	jamex	conj_and	3	SENT_1554	[p22l979t14r1084b56],
7	McClus/eey	NN	O	mcclus/eey	dep	6	SENT_1554	[p22l1093t14r1271b56],
8	.....	FW	O	.....	nn	7	SENT_1554	[p22l1293t42r1981b47],
9	.....	FW	O	.....	nn	7	SENT_1554	[p22l1293t42r1981b47],
10	.....	FW	O	.....	nn	7	SENT_1554	[p22l1293t42r1981b47],
11	.....	FW	O	.....	nn	7	SENT_1554	[p22l1293t42r1981b47],
12	.....	FW	O	.....	nn	7	SENT_1554	[p22l1293t42r1981b47],
13	.....	FW	O	.....	nn	7	SENT_1554	[p22l1293t42r1981b47],
14	.....	FW	O	.....	nn	7	SENT_1554	[p22l1293t42r1981b47],
15	.....	FW	O	.....	nn	7	SENT_1554	[p22l1293t42r1981b47],
16	.....	FW	O	.....	dep	7	SENT_1554	[p22l1293t42r1981b47],
17	...	:	O	...	_	0	SENT_1554	[p22l1293t42r1981b47],
18	.	.	O	.	_	0	SENT_1554	[p22l1991t42r1995b47],

1	.	.	O	.	_	0	SENT_1555	[p22l2005t42r2010b47],

1	401	CD	NUMBER	401	_	0	SENT_1556	[p22l2023t15r2082b46],

1	Systematic	JJ	MISC	systematic	amod	2	SENT_1557	[p22l566t93r751b135],
2	Approaches	NNS	MISC	approach	_	0	SENT_1557	[p22l762t92r967b135],
3	to	TO	O	to	_	0	SENT_1557	[p22l980t101r1014b124],
4	Toxicology	NNP	O	Toxicology	prep_to	2	SENT_1557	[p22l1025t92r1227b135],
5	in	IN	O	in	_	0	SENT_1557	[p22l1237t94r1271b124],
6	the	DT	O	the	det	10	SENT_1557	[p22l1283t92r1337b124],
7	Zebraﬁsh	NNP	O	Zebraﬁsh	nn	10	SENT_1557	[p22l1350t92r1516b124],
8	Randall	NNP	PERSON	Randall	nn	10	SENT_1557	[p22l613t148r743b179],
9	T.	NNP	PERSON	T.	nn	10	SENT_1557	[p22l754t148r785b178],
10	Peterson	NNP	PERSON	Peterson	prep_in	2	SENT_1557	[p22l800t148r934b179],
11	and	CC	O	and	_	0	SENT_1557	[p22l946t148r1008b179],
12	Calum	NNP	PERSON	Calum	nn	23	SENT_1557	[p22l1020t148r1128b179],
13	A.	NNP	PERSON	A.	nn	23	SENT_1557	[p22l1136t147r1175b178],
14	MacRae	NNP	PERSON	MacRae	nn	23	SENT_1557	[p22l1188t148r1321b179],
15	. . . . .	NNP	O	. . . . .	nn	23	SENT_1557	[p22l1410t176r1414b180],[p22l1351t176r1356b180],
16	. . . . .	NNP	O	. . . . .	nn	23	SENT_1557	[p22l1482t176r1487b180],[p22l1424t176r1429b180],
17	. . . . .	NNP	O	. . . . .	nn	23	SENT_1557	[p22l1555t176r1559b180],[p22l1497t176r1501b180],
18	. . . . .	NNP	O	. . . . .	nn	23	SENT_1557	[p22l1628t176r1632b180],[p22l1569t176r1574b180],
19	. . . . .	NNP	O	. . . . .	nn	23	SENT_1557	[p22l1700t176r1705b180],[p22l1642t176r1647b180],
20	. . . . .	NNP	O	. . . . .	nn	23	SENT_1557	[p22l1773t176r1777b180],[p22l1715t176r1719b180],
21	. . . . .	NNP	O	. . . . .	nn	23	SENT_1557	[p22l1846t176r1850b180],[p22l1787t176r1792b180],
22	. . . . .	NNP	O	. . . . .	nn	23	SENT_1557	[p22l1918t176r1923b180],[p22l1860t176r1865b180],
23	. . . . .	NNP	O	. . . . .	conj_and	10	SENT_1557	[p22l1991t176r2010b180],[p22l1933t176r1937b180],
24	.	.	O	.	_	0	SENT_1557	[p22l1991t176r2010b180],

1	433	CD	NUMBER	433	nsubj	5	SENT_1558	[p22l2023t148r2082b179],
2	Perinatal	NNP	O	Perinatal	nn	4	SENT_1558	[p22l564t225r721b257],
3	Environmental	NNP	O	Environmental	nn	4	SENT_1558	[p22l734t225r997b257],
4	Exposures	NNS	O	exposure	dep	1	SENT_1558	[p22l1009t227r1187b268],
5	Affect	VB	O	affect	_	0	SENT_1558	[p22l1198t225r1302b257],
6	Mammary	NNP	O	Mammary	nn	7	SENT_1558	[p22l1312t227r1496b268],
7	Development	NNP	O	Development	dobj	5	SENT_1558	[p22l1507t225r1753b268],
8	,	,	O	,	_	0	SENT_1558	[p22l1507t225r1753b268],
9	Function	NN	O	function	dobj	5	SENT_1558	[p22l606t279r774b317],
10	,	,	O	,	_	0	SENT_1558	[p22l606t279r774b317],
11	and	CC	O	and	_	0	SENT_1558	[p22l788t278r850b310],
12	Cancer	NN	O	cancer	nn	13	SENT_1558	[p22l863t279r988b310],
13	Risk	NN	O	risk	conj_and	7	SENT_1558	[p22l1000t278r1077b310],
14	in	IN	O	in	_	0	SENT_1558	[p22l1087t280r1120b310],
15	Adulthood	NNP	O	Adulthood	nn	18	SENT_1558	[p22l1131t278r1318b310],
16	Suzanne	NNP	PERSON	Suzanne	nn	18	SENT_1558	[p22l614t333r755b363],
17	E.	NNP	PERSON	E.	nn	18	SENT_1558	[p22l765t333r799b363],
18	Fenton	NN	PERSON	fenton	prep_in	13	SENT_1558	[p22l813t333r933b370],
19	,	,	O	,	_	0	SENT_1558	[p22l813t333r933b370],
20	Casey	NNP	PERSON	Casey	nn	21	SENT_1558	[p22l950t332r1038b374],
21	Reed	NNP	PERSON	Reed	prep_in	13	SENT_1558	[p22l1049t332r1133b370],
22	,	,	O	,	_	0	SENT_1558	[p22l1049t332r1133b370],
23	and	CC	O	and	_	0	SENT_1558	[p22l1147t333r1209b363],
24	Ret/ya	NNP	O	Ret/ya	nn	32	SENT_1558	[p22l1217t332r1312b363],
25	R.	NNP	PERSON	R.	nn	32	SENT_1558	[p22l1323t333r1356b363],
26	Newbold	NNP	PERSON	Newbold	nn	32	SENT_1558	[p22l1370t333r1512b363],
27	. . . . .	NNP	O	. . . . .	nn	32	SENT_1558	[p22l1598t360r1603b365],[p22l1540t360r1545b365],
28	. . . . .	NNP	O	. . . . .	nn	32	SENT_1558	[p22l1671t360r1676b365],[p22l1613t360r1618b365],
29	. . . . .	NNP	O	. . . . .	nn	32	SENT_1558	[p22l1744t360r1748b365],[p22l1686t360r1690b365],
30	. . . . .	NNP	O	. . . . .	nn	32	SENT_1558	[p22l1816t360r1821b365],[p22l1758t360r1763b365],
31	. . . . .	NNP	O	. . . . .	nn	32	SENT_1558	[p22l1889t360r1894b365],[p22l1831t360r1836b365],
32	. . . . .	NNP	O	. . . . .	conj_and	18	SENT_1558	[p22l1962t360r1966b365],[p22l1904t360r1908b365],
33	.	.	O	.	_	0	SENT_1558	[p22l1976t360r1981b365],

1	.	.	O	.	_	0	SENT_1559	[p22l1991t360r2010b365],

1	.	.	O	.	_	0	SENT_1560	[p22l1991t360r2010b365],

1	45	CD	NUMBER	45	num	2	SENT_1561	[p22l2023t333r2062b364],
2	5	CD	NUMBER	5	_	0	SENT_1561	[p22l2068t333r2084b364],

1	Factors	NNS	O	factor	_	0	SENT_1562	[p22l564t386r692b416],
2	Controlling	VBG	O	control	partmod	1	SENT_1562	[p22l706t384r913b427],
3	Nanoparticle	NN	O	nanoparticle	nn	4	SENT_1562	[p22l923t384r1154b427],
4	Pharmacokinetics	NNS	O	pharmacokinetic	dobj	2	SENT_1562	[p22l1167t384r1485b416],
5	:	:	O	:	_	0	SENT_1562	[p22l1167t384r1485b416],
6	An	DT	O	a	det	8	SENT_1562	[p22l1498t385r1549b416],
7	Integrated	NNP	O	Integrated	nn	8	SENT_1562	[p22l1561t384r1742b427],
8	Analysis	NN	O	analysis	tmod	1	SENT_1562	[p22l605t436r747b479],
9	and	CC	O	and	_	0	SENT_1562	[p22l760t436r822b468],
10	Perspective	NNP	O	Perspective	nn	12	SENT_1562	[p22l834t438r1033b479],
11	S.M.	NNP	O	S.M.	nn	12	SENT_1562	[p22l614t489r693b520],
12	Mog/yimi	NNP	O	Mog/yimi	tmod	1	SENT_1562	[p22l707t489r866b532],
13	,	,	O	,	_	0	SENT_1562	[p22l707t489r866b532],
14	A.C.	NNP	PERSON	A.C.	nn	15	SENT_1562	[p22l877t489r954b520],
15	Hunter	NNP	PERSON	Hunter	conj_and	12	SENT_1562	[p22l968t490r1097b528],
16	,	,	O	,	_	0	SENT_1562	[p22l968t490r1097b528],
17	and	CC	O	and	_	0	SENT_1562	[p22l1111t489r1173b521],
18	TL	NN	O	tl	conj_and	12	SENT_1562	[p22l1185t489r1253b520],
19	.	.	O	.	_	0	SENT_1562	[p22l1185t489r1253b520],

1	Andresen	NNP	PERSON	Andresen	nn	9	SENT_1563	[p22l1265t489r1417b521],
2	. . . . .	NNP	O	. . . . .	nn	9	SENT_1563	[p22l1497t518r1501b522],[p22l1439t518r1443b522],
3	. . . . .	NNP	O	. . . . .	nn	9	SENT_1563	[p22l1569t518r1574b522],[p22l1511t518r1516b522],
4	. . . . .	NNP	O	. . . . .	nn	9	SENT_1563	[p22l1642t518r1647b522],[p22l1584t518r1588b522],
5	. . . . .	NNP	O	. . . . .	nn	9	SENT_1563	[p22l1715t518r1719b522],[p22l1657t518r1661b522],
6	. . . . .	NNP	O	. . . . .	nn	9	SENT_1563	[p22l1787t518r1792b522],[p22l1729t518r1734b522],
7	. . . . .	NNP	O	. . . . .	nn	9	SENT_1563	[p22l1860t518r1864b522],[p22l1802t518r1806b522],
8	. . . . .	NNP	O	. . . . .	nn	9	SENT_1563	[p22l1933t518r1937b522],[p22l1875t518r1879b522],
9	. . . .	NNP	O	. . . .	_	0	SENT_1563	[p22l1991t518r2010b522],[p22l1947t518r1952b522],
10	.	.	O	.	_	0	SENT_1563	[p22l1991t518r2010b522],

1	481	CD	NUMBER	481	num	2	SENT_1564	[p22l2023t490r2082b521],
2	Systems	NNPS	O	Systems	_	0	SENT_1564	[p22l566t542r704b584],
3	Pharmacology	NNP	O	Pharmacology	dep	2	SENT_1564	[p22l717t541r977b584],
4	:	:	O	:	_	0	SENT_1564	[p22l717t541r977b584],
5	Network	NNP	O	Network	nn	6	SENT_1564	[p22l990t541r1149b573],
6	Analysis	NN	O	analysis	dep	2	SENT_1564	[p22l1158t541r1300b584],
7	to	TO	O	to	aux	8	SENT_1564	[p22l1313t550r1347b573],
8	Identify	VB	O	identify	infmod	6	SENT_1564	[p22l1360t541r1499b584],
9	Multiscale	JJ	O	multiscale	amod	10	SENT_1564	[p22l1508t541r1690b573],
10	Mechanisms	NNS	O	mechanism	dobj	8	SENT_1564	[p22l604t593r823b625],
11	of	IN	O	of	_	0	SENT_1564	[p22l836t593r874b625],
12	Drug	NN	O	drug	nn	15	SENT_1564	[p22l882t594r976b636],
13	Action	NNP	O	Action	nn	15	SENT_1564	[p22l986t594r1103b625],
14	Slyan	NNP	O	Slyan	nn	15	SENT_1564	[p22l614t646r697b677],
15	Zbao	NNP	O	Zbao	prep_of	10	SENT_1564	[p22l709t646r791b677],
16	and	CC	O	and	_	0	SENT_1564	[p22l803t646r864b677],
17	Ravi	NNP	PERSON	Ravi	nn	18	SENT_1564	[p22l873t646r951b677],
18	Iyengar	NNP	PERSON	Iyengar	conj_and	10	SENT_1564	[p22l960t646r1087b689],
19	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
20	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
21	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
22	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
23	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
24	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
25	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
26	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
27	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
28	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
29	.....	FW	O	.....	nn	30	SENT_1564	[p22l1119t674r1981b679],
30	.....	FW	O	.....	dep	18	SENT_1564	[p22l1119t674r1981b679],
31	.	.	O	.	_	0	SENT_1564	[p22l1991t674r2010b679],

1	.	.	O	.	_	0	SENT_1565	[p22l1991t674r2010b679],

1	505	CD	NUMBER	505	_	0	SENT_1566	[p22l2025t646r2083b678],

1	Contentr	NNP	O	Contentr	_	0	SENT_1567	[p22l566t764r663b786],

1	Integrative	JJ	MISC	integrative	amod	2	SENT_1568	[p22l372t863r562b904],
2	Continuum	NN	MISC	continuum	_	0	SENT_1568	[p22l575t862r786b893],
3	:	:	O	:	_	0	SENT_1568	[p22l575t862r786b893],
4	Accelerating	VBG	O	accelerate	amod	6	SENT_1568	[p22l799t861r1019b904],
5	Therapeutic	JJ	O	therapeutic	amod	6	SENT_1568	[p22l1029t861r1246b904],
6	Advances	NNS	O	advance	dep	2	SENT_1568	[p22l1256t861r1419b893],
7	in	IN	O	in	_	0	SENT_1568	[p22l1432t863r1465b893],
8	Rare	JJ	O	rare	amod	13	SENT_1568	[p22l1478t863r1559b893],
9	Autoimmune	NN	O	autoimmune	nn	13	SENT_1568	[p22l412t915r643b946],
10	Diseases	NNS	O	disease	nn	13	SENT_1568	[p22l656t915r803b946],
11	Katja	NNP	PERSON	Katja	nn	13	SENT_1568	[p22l421t969r511b1010],
12	Van	NNP	PERSON	Van	nn	13	SENT_1568	[p22l526t969r590b999],
13	Herle	NNP	PERSON	Herle	prep_in	6	SENT_1568	[p22l601t968r700b1006],
14	,	,	O	,	_	0	SENT_1568	[p22l601t968r700b1006],
15	facinta	NNP	O	facinta	nn	17	SENT_1568	[p22l710t968r832b1010],
16	M.	NNP	PERSON	M.	nn	17	SENT_1568	[p22l842t969r889b999],
17	Be/yne	NNP	PERSON	Be/yne	appos	13	SENT_1568	[p22l904t968r1009b1006],
18	,	,	O	,	_	0	SENT_1568	[p22l904t968r1009b1006],
19	Andre	NNP	PERSON	Andre	nn	21	SENT_1568	[p22l1021t968r1125b999],
20	Van	NNP	PERSON	Van	nn	21	SENT_1568	[p22l1140t969r1204b999],
21	Herle	NNP	PERSON	Herle	appos	13	SENT_1568	[p22l1215t968r1314b1006],
22	,	,	O	,	_	0	SENT_1568	[p22l1215t968r1314b1006],
23	Terrence	NNP	PERSON	Terrence	nn	25	SENT_1568	[p22l1332t968r1471b999],
24	F.	NNP	PERSON	F.	nn	25	SENT_1568	[p22l1481t969r1513b999],
25	Blaxc/eke	NNP	PERSON	Blaxc/eke	appos	13	SENT_1568	[p22l1528t968r1672b1006],
26	,	,	O	,	_	0	SENT_1568	[p22l1528t968r1672b1006],
27	Terry	NNP	PERSON	Terry	nn	28	SENT_1568	[p22l457t1020r585b1062],
28	]	NNP	O	]	appos	13	SENT_1568	[p22l457t1020r585b1062],
29	.	.	O	.	_	0	SENT_1568	[p22l457t1020r585b1062],

1	Smith	NNP	PERSON	Smith	_	0	SENT_1569	[p22l601t1020r708b1058],
2	,	,	O	,	_	0	SENT_1569	[p22l601t1020r708b1058],
3	and	CC	O	and	dep	1	SENT_1569	[p22l723t1020r784b1051],
4	Michael	NNP	PERSON	Michael	nn	7	SENT_1569	[p22l792t1020r925b1051],
5	R.	NNP	PERSON	R.	nn	7	SENT_1569	[p22l934t1021r967b1051],
6	Yeaman	NNP	PERSON	Yeaman	nn	7	SENT_1569	[p22l984t1021r1113b1051],
7	. . . . .	NNP	O	. . . . .	dep	1	SENT_1569	[p22l1203t1048r1207b1053],[p22l1144t1048r1149b1053],
8	. . . . .	NNP	O	. . . . .	nn	15	SENT_1569	[p22l1275t1048r1280b1053],[p22l1217t1048r1222b1053],
9	. . . . .	NNP	O	. . . . .	nn	15	SENT_1569	[p22l1348t1048r1352b1053],[p22l1290t1048r1294b1053],
10	. . . . .	NNP	O	. . . . .	nn	15	SENT_1569	[p22l1420t1048r1425b1053],[p22l1362t1048r1367b1053],
11	. . . . .	NNP	O	. . . . .	nn	15	SENT_1569	[p22l1493t1048r1498b1053],[p22l1435t1048r1439b1053],
12	. . . . .	NNP	O	. . . . .	nn	15	SENT_1569	[p22l1566t1048r1570b1053],[p22l1508t1048r1512b1053],
13	. . . . .	NNP	O	. . . . .	nn	15	SENT_1569	[p22l1638t1048r1643b1053],[p22l1580t1048r1585b1053],
14	. . . . .	NNP	O	. . . . .	nn	15	SENT_1569	[p22l1711t1048r1716b1053],[p22l1653t1048r1657b1053],
15	. . . . .	NNP	O	. . . . .	dep	7	SENT_1569	[p22l1784t1048r1788b1053],[p22l1726t1048r1730b1053],
16	.	.	O	.	_	0	SENT_1569	[p22l1798t1048r1817b1053],

1	.	.	O	.	_	0	SENT_1570	[p22l1798t1048r1817b1053],

1	523	CD	NUMBER	523	_	0	SENT_1571	[p22l1832t1021r1889b1051],

1	Exploiting	VBG	O	exploit	csubj	14	SENT_1572	[p22l372t1098r556b1141],
2	the	DT	O	the	det	3	SENT_1572	[p22l568t1098r622b1130],
3	Cancer	NN	O	cancer	dobj	1	SENT_1572	[p22l635t1099r760b1130],
4	Genome	NNP	O	Genome	dep	3	SENT_1572	[p22l773t1099r932b1130],
5	:	:	O	:	_	0	SENT_1572	[p22l773t1099r932b1130],
6	Strategies	NNS	O	strategy	dep	3	SENT_1572	[p22l948t1099r1117b1141],
7	for	IN	O	for	_	0	SENT_1572	[p22l1130t1098r1180b1130],
8	the	DT	O	the	det	9	SENT_1572	[p22l1192t1098r1246b1130],
9	Discovery	NNP	O	Discovery	prep_for	6	SENT_1572	[p22l1259t1100r1435b1141],
10	and	CC	O	and	_	0	SENT_1572	[p22l1447t1098r1508b1130],
11	Clinical	JJ	O	clinical	amod	12	SENT_1572	[p22l415t1150r550b1182],
12	Development	NN	O	development	dobj	1	SENT_1572	[p22l562t1150r801b1192],
13	of	IN	O	of	prep	12	SENT_1572	[p22l812t1150r850b1182],
14	Targeted	VBN	O	target	_	0	SENT_1572	[p22l857t1150r1019b1193],
15	Molecular	JJ	O	molecular	amod	16	SENT_1572	[p22l1030t1150r1211b1182],
16	Therapeutics	NNS	O	therapeutics	nsubj	19	SENT_1572	[p22l1221t1150r1452b1192],
17	Timothy	NNP	PERSON	Timothy	nn	19	SENT_1572	[p22l424t1203r559b1245],
18	A.	NNP	PERSON	A.	nn	19	SENT_1572	[p22l568t1203r605b1234],
19	Yap	NNP	PERSON	Yap	xcomp	14	SENT_1572	[p22l623t1203r682b1245],
20	and	CC	O	and	_	0	SENT_1572	[p22l694t1203r756b1234],
21	Paul	NNP	PERSON	Paul	nn	33	SENT_1572	[p22l765t1203r843b1234],
22	Workman	NNP	PERSON	Workman	nn	33	SENT_1572	[p22l856t1203r1018b1234],
23	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1101t1231r1105b1236],[p22l1043t1231r1047b1236],
24	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1173t1231r1178b1236],[p22l1115t1231r1120b1236],
25	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1246t1231r1251b1236],[p22l1188t1231r1192b1236],
26	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1319t1231r1323b1236],[p22l1261t1231r1265b1236],
27	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1391t1231r1396b1236],[p22l1333t1231r1338b1236],
28	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1464t1231r1469b1236],[p22l1406t1231r1410b1236],
29	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1537t1231r1541b1236],[p22l1479t1231r1483b1236],
30	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1609t1231r1614b1236],[p22l1551t1231r1556b1236],
31	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1682t1231r1686b1236],[p22l1624t1231r1628b1236],
32	. . . . .	NNP	O	. . . . .	nn	33	SENT_1572	[p22l1755t1231r1759b1236],[p22l1697t1231r1701b1236],
33	. . .	NNP	O	. . .	xcomp	14	SENT_1572	[p22l1798t1231r1817b1236],[p22l1769t1231r1774b1236],
34	.	.	O	.	_	0	SENT_1572	[p22l1798t1231r1817b1236],

1	549	CD	NUMBER	549	_	0	SENT_1573	[p22l1832t1203r1893b1235],

1	Indexes	NNS	O	index	_	0	SENT_1574	[p22l372t1320r516b1352],

1	Contributing	VBG	O	contribute	_	0	SENT_1575	[p22l373t1424r605b1467],
2	Authors	NNS	O	author	dobj	1	SENT_1575	[p22l615t1424r764b1464],
3	,	,	O	,	_	0	SENT_1575	[p22l615t1424r764b1464],
4	Volumes	NNS	O	volume	appos	2	SENT_1575	[p22l776t1424r932b1457],
5	48-52	CD	NUMBER	48-52	num	4	SENT_1575	[p22l945t1425r1047b1457],
6	. . . . .	CD	NUMBER	. . . . .	number	7	SENT_1575	[p22l1130t1453r1134b1458],[p22l1072t1453r1076b1458],
7	. . . . .	CD	NUMBER	. . . . .	num	9	SENT_1575	[p22l1203t1453r1207b1458],[p22l1144t1453r1149b1458],
8	. . . . .	CD	NUMBER	. . . . .	number	9	SENT_1575	[p22l1275t1453r1280b1458],[p22l1217t1453r1222b1458],
9	. . . . .	CD	NUMBER	. . . . .	dep	4	SENT_1575	[p22l1348t1453r1352b1458],[p22l1290t1453r1294b1458],
10	. . . . .	CD	NUMBER	. . . . .	number	11	SENT_1575	[p22l1420t1453r1425b1458],[p22l1362t1453r1367b1458],
11	. . . . .	CD	NUMBER	. . . . .	num	13	SENT_1575	[p22l1493t1453r1498b1458],[p22l1435t1453r1439b1458],
12	. . . . .	CD	NUMBER	. . . . .	number	13	SENT_1575	[p22l1566t1453r1570b1458],[p22l1508t1453r1512b1458],
13	. . . . .	CD	NUMBER	. . . . .	dep	4	SENT_1575	[p22l1638t1453r1643b1458],[p22l1580t1453r1585b1458],
14	. . . . .	CD	NUMBER	. . . . .	num	15	SENT_1575	[p22l1711t1453r1716b1458],[p22l1653t1453r1657b1458],
15	. . . . .	NN	O	. . . . .	dep	13	SENT_1575	[p22l1784t1453r1788b1458],[p22l1726t1453r1730b1458],
16	.	.	O	.	_	0	SENT_1575	[p22l1798t1453r1803b1458],

1	.	.	O	.	_	0	SENT_1576	[p22l1813t1453r1817b1458],

1	5	CD	NUMBER	5	_	0	SENT_1577	[p22l1832t1425r1848b1457],
2	75	CD	NUMBER	75	num	4	SENT_1577	[p22l1853t1425r1891b1457],
3	Chapter	NN	O	chapter	nn	4	SENT_1577	[p22l373t1503r516b1546],
4	Titles	NNS	O	title	dep	1	SENT_1577	[p22l526t1503r639b1543],
5	,	,	O	,	_	0	SENT_1577	[p22l526t1503r639b1543],
6	Volumes	NNS	O	volume	appos	4	SENT_1577	[p22l651t1503r807b1536],
7	48-52	CD	NUMBER	48-52	dep	1	SENT_1577	[p22l819t1505r922b1536],
8	. . . . .	CD	NUMBER	. . . . .	number	9	SENT_1577	[p22l999t1533r1004b1537],[p22l941t1533r945b1537],
9	. . . . .	CD	NUMBER	. . . . .	num	11	SENT_1577	[p22l1072t1533r1076b1537],[p22l1014t1533r1018b1537],
10	. . . . .	CD	NUMBER	. . . . .	number	11	SENT_1577	[p22l1144t1533r1149b1537],[p22l1086t1533r1091b1537],
11	. . . . .	CD	NUMBER	. . . . .	dep	7	SENT_1577	[p22l1217t1533r1221b1537],[p22l1159t1533r1163b1537],
12	. . . . .	CD	NUMBER	. . . . .	number	13	SENT_1577	[p22l1290t1533r1294b1537],[p22l1232t1533r1236b1537],
13	. . . . .	CD	NUMBER	. . . . .	dep	1	SENT_1577	[p22l1362t1533r1367b1537],[p22l1304t1533r1309b1537],
14	. . . . .	CD	NUMBER	. . . . .	num	15	SENT_1577	[p22l1435t1533r1439b1537],[p22l1377t1533r1381b1537],
15	. . . . .	CD	NUMBER	. . . . .	dep	13	SENT_1577	[p22l1508t1533r1512b1537],[p22l1450t1533r1454b1537],
16	. . . . .	CD	NUMBER	. . . . .	number	17	SENT_1577	[p22l1580t1533r1585b1537],[p22l1522t1533r1527b1537],
17	. . . . .	CD	NUMBER	. . . . .	dep	1	SENT_1577	[p22l1653t1533r1657b1537],[p22l1595t1533r1599b1537],
18	. . . . .	CD	NUMBER	. . . . .	num	19	SENT_1577	[p22l1726t1533r1730b1537],[p22l1667t1533r1672b1537],
19	. . . . .	NN	O	. . . . .	dep	17	SENT_1577	[p22l1798t1533r1817b1537],[p22l1740t1533r1744b1537],
20	.	.	O	.	_	0	SENT_1577	[p22l1798t1533r1817b1537],

1	5	CD	NUMBER	5	num	2	SENT_1578	[p22l1832t1505r1848b1536],
2	78	CD	NUMBER	78	_	0	SENT_1578	[p22l1853t1505r1892b1536],

1	Errata	NNP	O	Errata	_	0	SENT_1579	[p22l372t1634r491b1665],

1	An	DT	O	a	det	3	SENT_1580	[p22l371t1739r422b1769],
2	online	JJ	O	online	amod	3	SENT_1580	[p22l434t1737r543b1770],
3	log	NN	O	log	nsubjpass	16	SENT_1580	[p22l555t1737r610b1781],
4	of	IN	O	of	_	0	SENT_1580	[p22l622t1738r660b1770],
5	corrections	NNS	O	correction	prep_of	3	SENT_1580	[p22l668t1739r862b1770],
6	to	TO	O	to	_	0	SENT_1580	[p22l875t1747r909b1770],
7	Annual	JJ	SET	annual	amod	8	SENT_1580	[p22l918t1738r1046b1770],
8	Review	NN	O	review	prep_to	5	SENT_1580	[p22l1054t1739r1170b1770],
9	of	IN	O	of	_	0	SENT_1580	[p22l1183t1738r1219b1780],
10	Pharmacology	NNP	O	Pharmacology	nn	13	SENT_1580	[p22l1221t1739r1446b1781],
11	and	CC	O	and	_	0	SENT_1580	[p22l1457t1739r1519b1770],
12	Toxicology	NNP	O	Toxicology	conj_and	10	SENT_1580	[p22l1530t1739r1695b1781],
13	articles	NNS	O	article	prep_of	8	SENT_1580	[p22l1707t1737r1829b1770],
14	may	MD	O	may	aux	16	SENT_1580	[p22l372t1803r445b1834],
15	be	VB	O	be	auxpass	16	SENT_1580	[p22l456t1791r495b1823],
16	found	VBN	O	find	_	0	SENT_1580	[p22l509t1791r610b1823],
17	at	IN	O	at	_	0	SENT_1580	[p22l623t1800r654b1823],
18	http://pharmtox.annualreviews.org/errata.sht1nl	NN	O	http://pharmtox.annualreviews.org/errata.sht1nl	prep_at	16	SENT_1580	[p22l665t1791r1502b1834],

1	Contents	NNS	O	contents	_	0	SENT_1581	[p22l1794t2825r1891b2847],

